ID   PK2L1_MOUSE             Reviewed;         760 AA.
AC   A2A259; Q14B55; Q14B73; Q80ZH4;
DT   19-FEB-2014, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   25-OCT-2017, entry version 81.
DE   RecName: Full=Polycystic kidney disease 2-like 1 protein;
DE   AltName: Full=Polycystin-2 homolog;
GN   Name=Pkd2l1; Synonyms=Trpp3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH PKD1L3, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=16891422; DOI=10.1073/pnas.0602702103;
RA   Ishimaru Y., Inada H., Kubota M., Zhuang H., Tominaga M.,
RA   Matsunami H.;
RT   "Transient receptor potential family members PKD1L3 and PKD2L1 form a
RT   candidate sour taste receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:12569-12574(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RA   Guo L., Zhou J.;
RT   "Cloning and gene targeting of murine Pkdl gene.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PKD1, AND MUTAGENESIS
RP   OF LYS-568 AND ASP-576.
RX   PubMed=15548533; DOI=10.1074/jbc.M411496200;
RA   Murakami M., Ohba T., Xu F., Shida S., Satoh E., Ono K., Miyoshi I.,
RA   Watanabe H., Ito H., Iijima T.;
RT   "Genomic organization and functional analysis of murine PKD2L1.";
RL   J. Biol. Chem. 280:5626-5635(2005).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16929298; DOI=10.1038/nature05084;
RA   Huang A.L., Chen X., Hoon M.A., Chandrashekar J., Guo W., Trankner D.,
RA   Ryba N.J., Zuker C.S.;
RT   "The cells and logic for mammalian sour taste detection.";
RL   Nature 442:934-938(2006).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=18156604; DOI=10.1093/chemse/bjm083;
RA   Kataoka S., Yang R., Ishimaru Y., Matsunami H., Sevigny J.,
RA   Kinnamon J.C., Finger T.E.;
RT   "The candidate sour taste receptor, PKD2L1, is expressed by type III
RT   taste cells in the mouse.";
RL   Chem. Senses 33:243-254(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=19833970; DOI=10.1126/science.1174601;
RA   Chandrashekar J., Yarmolinsky D., von Buchholtz L., Oka Y., Sly W.,
RA   Ryba N.J., Zuker C.S.;
RT   "The taste of carbonation.";
RL   Science 326:443-445(2009).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=20406802; DOI=10.1074/jbc.C110.132944;
RA   Kawaguchi H., Yamanaka A., Uchida K., Shibasaki K., Sokabe T.,
RA   Maruyama Y., Yanagawa Y., Murakami S., Tominaga M.;
RT   "Activation of polycystic kidney disease-2-like 1 (PKD2L1)-PKD1L3
RT   complex by acid in mouse taste cells.";
RL   J. Biol. Chem. 285:17277-17281(2010).
RN   [10]
RP   FUNCTION.
RX   PubMed=21098668; DOI=10.1073/pnas.1013664107;
RA   Chang R.B., Waters H., Liman E.R.;
RT   "A proton current drives action potentials in genetically identified
RT   sour taste cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:22320-22325(2010).
RN   [11]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-523; ASP-525 AND ASP-530.
RX   PubMed=21185261; DOI=10.1016/j.bbrc.2010.12.086;
RA   Fujimoto C., Ishimaru Y., Katano Y., Misaka T., Yamasoba T.,
RA   Asakura T., Abe K.;
RT   "The single pore residue Asp523 in PKD2L1 determines Ca2+ permeation
RT   of the PKD1L3/PKD2L1 complex.";
RL   Biochem. Biophys. Res. Commun. 404:946-951(2011).
RN   [12]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=21625513; DOI=10.1371/journal.pone.0020007;
RA   Horio N., Yoshida R., Yasumatsu K., Yanagawa Y., Ishimaru Y.,
RA   Matsunami H., Ninomiya Y.;
RT   "Sour taste responses in mice lacking PKD channels.";
RL   PLoS ONE 6:E20007-E20007(2011).
RN   [13]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24336288; DOI=10.1038/nature12833;
RA   Delling M., DeCaen P.G., Doerner J.F., Febvay S., Clapham D.E.;
RT   "Primary cilia are specialized calcium signalling organelles.";
RL   Nature 504:311-314(2013).
RN   [14]
RP   FUNCTION.
RX   PubMed=24336289; DOI=10.1038/nature12832;
RA   DeCaen P.G., Delling M., Vien T.N., Clapham D.E.;
RT   "Direct recording and molecular identification of the calcium channel
RT   of primary cilia.";
RL   Nature 504:315-318(2013).
CC   -!- FUNCTION: Pore-forming subunit of a ciliary calcium channel that
CC       controls calcium concentration within primary cilia without
CC       affecting cytoplasmic calcium concentration. Forms a heterodimer
CC       with PKD1L1 in primary cilia and forms a calcium-permeant ciliary
CC       channel that regulates sonic hedgehog/SHH signaling and GLI2
CC       transcription. May act as a sour taste receptor by forming a
CC       calcium channel with PKD1L3 in gustatory cells; however, its
CC       contribution to sour taste perception is unclear in vivo and may
CC       be indirect. May play a role in the perception of carbonation
CC       taste. {ECO:0000269|PubMed:15548533, ECO:0000269|PubMed:16891422,
CC       ECO:0000269|PubMed:16929298, ECO:0000269|PubMed:19833970,
CC       ECO:0000269|PubMed:21098668, ECO:0000269|PubMed:21625513,
CC       ECO:0000269|PubMed:24336288, ECO:0000269|PubMed:24336289}.
CC   -!- ENZYME REGULATION: The calcium channel is gated following an off-
CC       response property by acid: gated open after the removal of acid
CC       stimulus, but not during acid application.
CC       {ECO:0000269|PubMed:20406802}.
CC   -!- SUBUNIT: Homotrimer; trimerization is independent of calcium-
CC       binding. Calcium channels are probably composed of 3 subunit of
CC       PKD2L1 and 1 subunit of some PKD1 protein (PKD1, PKD1L1, PKD1L2 or
CC       PKDL3). Interacts with PKD1L1; to form ciliary calcium channel.
CC       Interacts with PKD1L3, to form putative sour taste receptor.
CC       Interacts with PKD1. Interacts with RACK1; inhibits the channel
CC       activity possibly by impairing localization to the cell membrane.
CC       {ECO:0000269|PubMed:15548533, ECO:0000269|PubMed:16891422}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-15594711, EBI-15594711;
CC       Q2EG98:Pkd1l3; NbExp=2; IntAct=EBI-15594711, EBI-15594779;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell
CC       membrane; Multi-pass membrane protein. Endoplasmic reticulum.
CC       Note=Interaction with PKD1 or PKD1L3 is required for localization
CC       to the cell membrane.
CC   -!- TISSUE SPECIFICITY: Expressed in all 4 taste areas in taste buds:
CC       circumvallate papillae, foliate papillae, fungiform papillae and
CC       palate. Expressed in cells distinct from those mediating sweet,
CC       umami and bitter taste (at protein level). Expressed in type III
CC       taste cells (at protein level). {ECO:0000269|PubMed:16891422,
CC       ECO:0000269|PubMed:16929298, ECO:0000269|PubMed:18156604,
CC       ECO:0000269|PubMed:21625513}.
CC   -!- DOMAIN: The EF-hand domain probably mediates calcium-binding. It
CC       is not required for channel activation (By similarity).
CC       {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Intestinal malrotation in 50% of animals,
CC       while other organs do not show major organ laterality defects
CC       Intestinal malformations are associated with SHH pathway defects
CC       during early development (PubMed:24336288). Partial reduction of
CC       chorda tympani nerve response to sour stimuli, without affecting
CC       sweet, salty, bitter, and umami perception (PubMed:21625513).
CC       {ECO:0000269|PubMed:21625513, ECO:0000269|PubMed:24336288}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- CAUTION: Pkd1l3 and Pkd2l1 have been defined as sour taste
CC       receptor in gustatory cells based on a number of indirect
CC       evidences: Pkd2l1 is expressed in a subset of taste receptor cells
CC       distinct from those responsible for sweet, bitter and unami taste
CC       and genetic elimination of cells expressing Pkd2l1 reduces
CC       gustatory nerve responses to sour taste stimuli (PubMed:16891422,
CC       PubMed:16929298). However, a number of experiments have recently
CC       shown that the sour taste receptor activity is probably indirect:
CC       mice lacking Pkd2l1 only show partial defects in sour taste
CC       perception (PubMed:21625513). Moreover, the PKD1L3-PKD2L1
CC       heteromer, when expressed in cells does not respond to acid
CC       stimuli used to evoke proton currents in taste cells
CC       (PubMed:21098668). {ECO:0000305|PubMed:16891422,
CC       ECO:0000305|PubMed:16929298, ECO:0000305|PubMed:21098668,
CC       ECO:0000305|PubMed:21625513}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB290927; BAF45380.1; -; mRNA.
DR   EMBL; AF271381; AAK58371.1; -; mRNA.
DR   EMBL; AC125101; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC116297; AAI16298.1; -; mRNA.
DR   EMBL; BC116323; AAI16324.2; -; mRNA.
DR   CCDS; CCDS29846.1; -.
DR   RefSeq; NP_852087.2; NM_181422.3.
DR   UniGene; Mm.308481; -.
DR   ProteinModelPortal; A2A259; -.
DR   SMR; A2A259; -.
DR   BioGrid; 236700; 1.
DR   DIP; DIP-61250N; -.
DR   IntAct; A2A259; 1.
DR   STRING; 10090.ENSMUSP00000045675; -.
DR   TCDB; 1.A.5.2.2; the polycystin cation channel (pcc) family.
DR   PhosphoSitePlus; A2A259; -.
DR   PaxDb; A2A259; -.
DR   PeptideAtlas; A2A259; -.
DR   PRIDE; A2A259; -.
DR   Ensembl; ENSMUST00000042026; ENSMUSP00000045675; ENSMUSG00000037578.
DR   GeneID; 329064; -.
DR   KEGG; mmu:329064; -.
DR   UCSC; uc008hpm.2; mouse.
DR   CTD; 9033; -.
DR   MGI; MGI:1352448; Pkd2l1.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   InParanoid; A2A259; -.
DR   KO; K04990; -.
DR   OMA; FSTFVKC; -.
DR   OrthoDB; EOG091G034F; -.
DR   PhylomeDB; A2A259; -.
DR   TreeFam; TF316484; -.
DR   PRO; PR:A2A259; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000037578; -.
DR   Genevisible; A2A259; MM.
DR   GO; GO:0034704; C:calcium channel complex; IMP:UniProtKB.
DR   GO; GO:0034703; C:cation channel complex; IDA:BHF-UCL.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0097730; C:non-motile cilium; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IPI:MGI.
DR   GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; ISO:MGI.
DR   GO; GO:0005227; F:calcium activated cation channel activity; ISO:MGI.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; ISO:MGI.
DR   GO; GO:0005261; F:cation channel activity; IPI:MGI.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; ISO:MGI.
DR   GO; GO:0005272; F:sodium channel activity; ISO:MGI.
DR   GO; GO:0006812; P:cation transport; IDA:BHF-UCL.
DR   GO; GO:0071468; P:cellular response to acidic pH; IDA:BHF-UCL.
DR   GO; GO:0001581; P:detection of chemical stimulus involved in sensory perception of sour taste; IDA:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0070207; P:protein homotrimerization; ISS:UniProtKB.
DR   GO; GO:0050915; P:sensory perception of sour taste; ISO:MGI.
DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Coiled coil; Complete proteome;
KW   Disulfide bond; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    760       Polycystic kidney disease 2-like 1
FT                                protein.
FT                                /FTId=PRO_0000425551.
FT   TOPO_DOM      1    103       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    313       Extracellular. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical. {ECO:0000255}.
FT   TOPO_DOM    335    347       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    348    368       Helical. {ECO:0000255}.
FT   TOPO_DOM    369    385       Extracellular. {ECO:0000255}.
FT   TRANSMEM    386    406       Helical. {ECO:0000255}.
FT   TOPO_DOM    407    476       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    477    497       Helical. {ECO:0000255}.
FT   TOPO_DOM    498    511       Extracellular. {ECO:0000255}.
FT   INTRAMEM    512    526       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    527    539       Extracellular. {ECO:0000255}.
FT   TRANSMEM    540    560       Helical. {ECO:0000255}.
FT   TOPO_DOM    561    760       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      630    665       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     643    654       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      701    760       Required for protein homotrimerization.
FT                                {ECO:0000250}.
FT   COILED      559    580       {ECO:0000255}.
FT   COILED      650    682       {ECO:0000255}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    210    223       {ECO:0000250|UniProtKB:Q13563}.
FT   MUTAGEN     523    523       D->E: Little or no effect on calcium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:21185261}.
FT   MUTAGEN     523    523       D->N: Impaired calcium channel activity.
FT                                {ECO:0000269|PubMed:21185261}.
FT   MUTAGEN     525    525       D->N: Little or no effect on calcium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:21185261}.
FT   MUTAGEN     530    530       D->N: Little or no effect on calcium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:21185261}.
FT   MUTAGEN     568    568       K->A: Induces localization to the cell
FT                                surface when expressed in absence of
FT                                PKD1. {ECO:0000269|PubMed:15548533}.
FT   MUTAGEN     576    576       D->A: Induces localization to the
FT                                endoplasmic reticulum when expressed in
FT                                absence of PKD1.
FT                                {ECO:0000269|PubMed:15548533}.
FT   CONFLICT    114    114       I -> V (in Ref. 2; AAK58371 and 4;
FT                                AAI16324/AAI16298). {ECO:0000305}.
FT   CONFLICT    202    203       QL -> HV (in Ref. 2; AAK58371).
FT                                {ECO:0000305}.
FT   CONFLICT    438    438       Y -> D (in Ref. 2; AAK58371).
FT                                {ECO:0000305}.
FT   CONFLICT    482    482       I -> V (in Ref. 2; AAK58371).
FT                                {ECO:0000305}.
FT   CONFLICT    756    756       L -> P (in Ref. 4; AAI16324/AAI16298).
FT                                {ECO:0000305}.
SQ   SEQUENCE   760 AA;  87234 MW;  4C76777051CFC2EF CRC64;
     MNSMESPKNQ ELQTLGNRAW DNPAYSDPPS PNRTLRICTV SSVALPETQP KKPEVRCQEK
     TQRTLVSSCC LHICRSIRGL WGTTLTENTA ENRELYVKTT LRELVVYIVF LVDICLLTYG
     MTSSSAYYYT KVMSELFLHT PSDSGVSFQT ISSMSDFWDF AQGPLLDSLY WTKWYNNQSL
     GRGSHSFIYY ENLLLGAPRL RQLRVRNDSC VVHEDFREDI LNCYDVYSPD KEDQLPFGPQ
     NGTAWTYHSQ NELGGSSHWG RLTSYSGGGY YLDLPGSRQA SAEALQGLQE GLWLDRGTRV
     VFIDFSVYNA NINLFCILRL VVEFPATGGT IPSWQIRTVK LIRYVNNWDF FIVGCEVVFC
     VFIFYYVVEE ILEIHLHRLR YLSSVWNILD LVVILLSIVA VGFHIFRTLE VNRLMGKLLQ
     QPDTYADFEF LAFWQTQYNN MNAVNLFFAW IKIFKYISFN KTMTQLSSTL ARCAKDILGF
     AIMFFIVFFA YAQLGYLLFG TQVENFSTFV KCIFTQFRII LGDFDYNAID NANRILGPVY
     FVTYVFFVFF VLLNMFLAII NDTYSEVKEE LAGQKDQLQL SDFLKQSYNK TLLRLRLRKE
     RVSDVQKVLK GGEPEIQFED FTSTLRELGH EEHEITAAFT RFDQDGDHIL DEEEQEQMRQ
     GLEEERVTLN AEIENLGRSV GHSPPGELGA EAARGQSWVS GEEFDMLTRR VLQLQCVLEG
     VVSQIDAVGS KLKMLERKGE LAPSPGMGEP AVWENLYNPS
//
ID   CTSR2_MOUSE             Reviewed;         588 AA.
AC   A2ARP9; A2RSK0; Q91ZP5;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   25-OCT-2017, entry version 79.
DE   RecName: Full=Cation channel sperm-associated protein 2;
DE            Short=CatSper2;
GN   Name=Catsper2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=129/SvEv;
RX   PubMed=11675491; DOI=10.1073/pnas.221454998;
RA   Quill T.A., Ren D., Clapham D.E., Garbers D.L.;
RT   "A voltage-gated ion channel expressed specifically in spermatozoa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12527-12531(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=14657366; DOI=10.1073/pnas.2136654100;
RA   Quill T.A., Sugden S.A., Rossi K.L., Doolittle L.K., Hammer R.E.,
RA   Garbers D.L.;
RT   "Hyperactivated sperm motility driven by CatSper2 is required for
RT   fertilization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:14869-14874(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=16036917; DOI=10.1074/jbc.M501430200;
RA   Carlson A.E., Quill T.A., Westenbroek R.E., Schuh S.M., Hille B.,
RA   Babcock D.F.;
RT   "Identical phenotypes of CatSper1 and CatSper2 null sperm.";
RL   J. Biol. Chem. 280:32238-32244(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=17174296; DOI=10.1016/j.ydbio.2006.11.007;
RA   Marquez B., Ignotz G., Suarez S.S.;
RT   "Contributions of extracellular and intracellular Ca2+ to regulation
RT   of sperm motility: release of intracellular stores can hyperactivate
RT   CatSper1 and CatSper2 null sperm.";
RL   Dev. Biol. 303:214-221(2007).
RN   [7]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [8]
RP   LACK OF ACTIVATION BY PROGESTERONE AND PGE1.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [9]
RP   IDENTIFICATION IN THE CATSPER COMPLEX.
RC   STRAIN=C57BL/6J;
RX   PubMed=21224844; DOI=10.1038/ncomms1153;
RA   Chung J.J., Navarro B., Krapivinsky G., Krapivinsky L., Clapham D.E.;
RT   "A novel gene required for male fertility and functional CATSPER
RT   channel formation in spermatozoa.";
RL   Nat. Commun. 2:153-153(2011).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in sperm cell hyperactivation. Controls calcium entry to mediate
CC       the hyperactivated motility, a step needed for sperm motility
CC       which is essential late in the preparation of sperm for
CC       fertilization. Activated by intracellular alkalinization.
CC       {ECO:0000269|PubMed:14657366, ECO:0000269|PubMed:16036917,
CC       ECO:0000269|PubMed:17174296}.
CC   -!- ENZYME REGULATION: In contrast to the human ortholog, not
CC       activated by progesterone. {ECO:0000269|PubMed:21412339}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Interacts with
CC       Ca(v)3.3/CACNA1I, leading to suppress T-type calcium channel
CC       activity (By similarity). Component of the CatSper complex.
CC       {ECO:0000250, ECO:0000269|PubMed:21224844, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000269|PubMed:11675491}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11675491}. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- TISSUE SPECIFICITY: Testis-specific.
CC       {ECO:0000269|PubMed:11675491}.
CC   -!- DEVELOPMENTAL STAGE: Present in testis of 8 day-old. Expressed in
CC       pachytene spermatocytes. {ECO:0000269|PubMed:17347248}.
CC   -!- DISRUPTION PHENOTYPE: Mice are normal but males are sterile. Male
CC       sterility is due to defects in sperm motility unability to
CC       fertilize intact eggs. In mice lacking Catsper1, the sperm lacks
CC       CatSper2, while in mice lacking CatSper1, the sperm lacks
CC       CatSper1, suggesting that stable expression of CatSper1 requires
CC       CatSper2 and vice versa. {ECO:0000269|PubMed:14657366}.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAM24230.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF411816; AAL26489.1; -; mRNA.
DR   EMBL; AL845466; CAM24230.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC132140; AAI32141.1; -; mRNA.
DR   UniGene; Mm.384318; -.
DR   ProteinModelPortal; A2ARP9; -.
DR   DIP; DIP-60801N; -.
DR   IntAct; A2ARP9; 2.
DR   MINT; MINT-4122221; -.
DR   STRING; 10090.ENSMUSP00000037222; -.
DR   GuidetoPHARMACOLOGY; 389; -.
DR   PhosphoSitePlus; A2ARP9; -.
DR   PaxDb; A2ARP9; -.
DR   PRIDE; A2ARP9; -.
DR   MGI; MGI:2387404; Catsper2.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG4111GC6; LUCA.
DR   HOGENOM; HOG000007710; -.
DR   HOVERGEN; HBG107782; -.
DR   InParanoid; A2ARP9; -.
DR   PhylomeDB; A2ARP9; -.
DR   TreeFam; TF343585; -.
DR   PRO; PR:A2ARP9; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_CATSPER2; -.
DR   GO; GO:0036128; C:CatSper complex; IDA:UniProtKB.
DR   GO; GO:0036126; C:sperm flagellum; IDA:MGI.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0009566; P:fertilization; IMP:MGI.
DR   GO; GO:0030317; P:flagellated sperm motility; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:0048240; P:sperm capacitation; IMP:MGI.
DR   InterPro; IPR028747; CatSper2.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF189; PTHR10037:SF189; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Developmental protein;
KW   Differentiation; Flagellum; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Spermatogenesis; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    588       Cation channel sperm-associated protein
FT                                2.
FT                                /FTId=PRO_0000295677.
FT   TOPO_DOM      1    106       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    128    149       Extracellular. {ECO:0000255}.
FT   TRANSMEM    150    170       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    171    176       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    198    203       Extracellular. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    225    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    262    280       Extracellular. {ECO:0000255}.
FT   INTRAMEM    281    301       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    302    318       Extracellular. {ECO:0000255}.
FT   TRANSMEM    319    339       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    340    588       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    396    430       Asp-rich.
FT   CONFLICT     49     49       S -> A (in Ref. 1; AAL26489 and 3;
FT                                AAI32141). {ECO:0000305}.
FT   CONFLICT    303    303       D -> N (in Ref. 1; AAL26489).
FT                                {ECO:0000305}.
FT   CONFLICT    335    335       V -> I (in Ref. 1; AAL26489).
FT                                {ECO:0000305}.
FT   CONFLICT    426    426       N -> G (in Ref. 1; AAL26489 and 3;
FT                                AAI32141). {ECO:0000305}.
FT   CONFLICT    482    482       K -> E (in Ref. 1; AAL26489 and 3;
FT                                AAI32141). {ECO:0000305}.
FT   CONFLICT    515    515       T -> I (in Ref. 1; AAL26489 and 3;
FT                                AAI32141). {ECO:0000305}.
SQ   SEQUENCE   588 AA;  68572 MW;  93396326105828DA CRC64;
     MAQEQGHFQL LRADAIRSKL IDTFSLIEHL QGLSQAVPRH TLREILDPSY QQKLMSGDQE
     QLVRFSIKPR RMGHITHSRR LLSRLRVRCS RMPPLSLWAG WVLDSSVFSK FIISLIFLNT
     FVLMVEIELM ESTNTALWPV KLALEVADWF ILLSFIVEIL LMWLASFSLF WKDAWNVFDF
     FVTLLSLLPE LVVLLGVPAH SVWLQLLRVC RVLRSLKLFA RFRQIKVILL ALVRALKSMT
     FLLMLLLIFF YIFAVTGVYF FREYSRSTIE GLEYNMFFSD LLNSLVTVFI LFTLDHWYAV
     LQDIWKVPES SRVFSSIYVI LWLLLGSIIF RNIIVAMMVT NFQNIRSELS EEMSHLEVQY
     KADMFKQQII QRRQHSESLR GTSLGKVSED IIETSDASDD DDDDDDDDDD DDDDDDDKSD
     ATESDNEESD SENSESENSE SEKIDPEKDY AKKSYPEKSH PEKSYPEKSH PEKSYPEKSH
     PKKSYDEQAE AEKVKEESKE KAYPVSHSIS SHGSTAADTA FLENLDWETL VHENLPGLMD
     MDQDDRIVWP RDSLFRYFEL LEKLQYNLEE RKKLQEFAVQ ALMSFEDK
//
ID   CAC1A_APIME             Reviewed;        1904 AA.
AC   C9D7C2;
DT   08-FEB-2011, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 1.
DT   20-DEC-2017, entry version 41.
DE   RecName: Full=Voltage-dependent calcium channel type A subunit alpha-1;
DE   AltName: Full=Cacophony protein;
GN   Name=CAC;
OS   Apis mellifera (Honeybee).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Hymenoptera; Apocrita; Aculeata;
OC   Apoidea; Apidae; Apis.
OX   NCBI_TaxID=7460;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yang Z., Qiao M., Jin Y.;
RT   "Coding region for CAC.";
RL   Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, neurotransmitter release, gene expression, cell
CC       motility, cell division and cell death.
CC       {ECO:0000250|UniProtKB:O00555, ECO:0000250|UniProtKB:P91645}.
CC   -!- SUBUNIT: Interacts with CATSPER1 and CATSPER2, leading to suppress
CC       T-type calcium channel activity. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:O00555};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:O00555}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1I subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ202019; ACV86997.1; -; mRNA.
DR   RefSeq; NP_001159376.1; NM_001165904.1.
DR   UniGene; Ame.1428; -.
DR   ProteinModelPortal; C9D7C2; -.
DR   STRING; 7460.GB18730-PA; -.
DR   PaxDb; C9D7C2; -.
DR   PRIDE; C9D7C2; -.
DR   GeneID; 408764; -.
DR   KEGG; ame:408764; -.
DR   CTD; 12285; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; C9D7C2; -.
DR   PhylomeDB; C9D7C2; -.
DR   Proteomes; UP000005203; Unplaced.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1904       Voltage-dependent calcium channel type A
FT                                subunit alpha-1. {ECO:0000250}.
FT                                /FTId=PRO_0000404525.
FT   TOPO_DOM     30    168       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    169    187       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    188    205       Extracellular. {ECO:0000255}.
FT   TRANSMEM    206    225       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    226    237       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    238    259       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    260    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    283       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    284    302       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    303    322       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    323    419       Extracellular. {ECO:0000255}.
FT   TRANSMEM    420    444       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    445    568       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    569    587       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    588    602       Extracellular. {ECO:0000255}.
FT   TRANSMEM    603    622       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    623    630       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    631    649       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    650    658       Extracellular. {ECO:0000255}.
FT   TRANSMEM    659    677       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    678    696       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    697    716       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    717    769       Extracellular. {ECO:0000255}.
FT   TRANSMEM    770    794       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    795    895       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    896    914       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    915    930       Extracellular. {ECO:0000255}.
FT   TRANSMEM    931    950       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    951    962       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    963    981       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    982    994       Extracellular. {ECO:0000255}.
FT   TRANSMEM    995   1013       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1014   1032       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1033   1052       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1053   1141       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1142   1166       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1167   1221       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1222   1250       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1251   1255       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1256   1275       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1276   1283       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1284   1302       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1303   1309       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1310   1328       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1329   1347       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1348   1367       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1368   1431       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1432   1456       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1457   1904       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      155    447       I.
FT   REPEAT      554    797       II.
FT   REPEAT      890   1177       III.
FT   REPEAT     1214   1470       IV.
FT   DOMAIN     1476   1511       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND    1489   1500       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION     1430   1471       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS    132    144       Poly-Gly.
FT   COMPBIAS    807    813       Poly-Glu.
FT   SITE        402    402       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        748    748       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1117   1117       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1405   1405       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1471   1471       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    367    367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    782    782       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    993    993       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1904 AA;  215891 MW;  CBE8C7AE704FF84B CRC64;
     MLGGVGGRHM STRRRGSSPL VRGGAGLTGY AGPGASGNSN DVAAIPPDMQ RYAGRRRRAV
     TTSDHKSCAL VQTRIKLGDI MLAAQEAAQR DPGYASQYRR RPRLAGLSFG DWTSFGGEVP
     GLVDMAPGRD QGGGAGGGGG GGKGTTSLFI LSEDNCIRKH TRFIIEWPPF EYAVLLTIIA
     NCVVLALEEH LPKQDKTILA QKLEATEIYF LGIFCVEASL KILALGFVLH RGSYLRNIWN
     IMDFFVVVTG FITAFSQGIE LDMDLRTLRA IRVLRPLKLV SGIPSLQVVL KSIIKAMAPL
     LQIGLLVLFA IVIFAIIGLE FYSGTLHKTC YSIRDINVIV KEGEQASPCN TDNKSEAPFG
     AHVCDANIST CMDHWEGPNF GITSFDNIGF AMLTVFQCIT MEGWTAILYW TNDALGSTYN
     WIYFIPLIVL GSFFMLNLVL GVLSGEFAKE REKVENRQSF LKLRRQQQLE HELYCYLNWI
     CKAEEVILAE ERTTEEEKKH ILEGRKRAEA KKKKLGKSKS TDTEEEEGDD DQDDGELSSS
     TKEKGPCKQF WLAEKRFRYW IRKSVKSQKF YWFVIVLVFF NTVCVAVEHY GQPQWLTDFL
     YFAEFVFLAL FMLEMFIKVY ALGPRTYFDS SFNRFDCVVI SGSIFEVIWS EVKSGSFGLS
     VLRALRLLRI FKVTKYWKSL RNLVISLLSS MRSIISLLFL LFLFILIFAL LGMQLFGGQF
     NFDSGTPPTN FNTFPIALLT VFQILTGEDW NEVMYQGIES QGGHKKGMIY SLYFIVLVLF
     GNYTLLNVFL AIAVDNLANA QELSAAENEE EEEDKQKQAQ EIEKEIQSLQ NPKDGGAPKV
     EICPPNGKGG KQSSEEEKKQ DEDDDTGPKP MLPYSSMFIL SPTNPVRRAA HWVVNLRYFD
     FFIMVVISLS SIALAAEDPV WEDSPRNEVL NYFDYAFTGV FTVEMILKII DLGIILHPGS
     YLREFWNIMD AVVVICAAVS FAFDMTGSSA GQNLSTIKSL RVLRVLRPLK TIKRVPKLKA
     VFDCVVNSLK NVINILIVYI LFQFIFAVIA VQLFNGKFFY CSDESKYTQQ DCQGQYFVFE
     DGALLPEPKK REWQSQFFHY DNVMAAMLTL FAVQTGEGWP QILQNSMAAT YEDKGPIQNF
     RIEMSIFYIV YFIVFPFFFV NIFVALIIIT FQEQGEAELQ DGEIDKNQKS CIDFTIQARP
     LERYMPKERN SVKYKIWRIV VSTPFEYFIM GLIVLNTVLL MMKFHRQSDA YKNTLKYMNM
     CFTGMFTVEC ILKIAAFGVR NFFKDAWNTF DFITVIGSIV DALVIEFGEN FINVGFLRLF
     RAARLIKLLR QGYTIRILLW TFVQSFKALP YVCLLIAMLF FIYAIIGMQV FGNIALDADT
     SITKHNNFQS FIQGLMLLFR CATGEAWPNI MLSCVKGRPC DAKAGKQEGG CGSNIAYAYF
     VSFIFFCSFL MLNLFVAVIM DNFDYLTRDS SILGAHHLDE FVRIWAEYDP NATGKIHYTE
     MYDMLKNMDP PLGFGNKCPN RLAYKKLIRM NMPVDVDLKV NFTTTLFALI RENLNIKVRR
     ASERNQANEE LRDTIRSIWP LQAKKMLDLL IPRNEEIGRG KMTVGKIYVC LLILESWRTT
     RFGQIESAGQ PIMELQDVVV SDSRAGSLES LTHTGKRLHP PVQPVRHPSR SPSLRHSPGR
     PGYDHHGHYY HEGPGFSDTV SNVVEIQRHT HHPHPSQYNH RHRMRGPWSA STSPARTPSP
     IHHIDRGRHY GTTSLEQRSR SPSPIGGRQP PHTHQHYHRH HPHQHSYPVL VTRRGRGRRL
     PPTPNKPSTL QLKPANINFP KLNASPTHGS HIHVPIPAGM QHPPPGQHLP PMQPSHCPLS
     FEQAVAMGRG GRLLPSPVPN GYKPQPQAKQ RTPRHSDSDE DDWC
//
ID   CAHM1_MOUSE             Reviewed;         348 AA.
AC   D3Z291;
DT   01-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   22-NOV-2017, entry version 55.
DE   RecName: Full=Calcium homeostasis modulator protein 1;
GN   Name=Calhm1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=22711817; DOI=10.1073/pnas.1204023109;
RA   Ma Z., Siebert A.P., Cheung K.H., Lee R.J., Johnson B., Cohen A.S.,
RA   Vingtdeux V., Marambaud P., Foskett J.K.;
RT   "Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit
RT   of an ion channel that mediates extracellular Ca2+ regulation of
RT   neuronal excitability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E1963-E1971(2012).
RN   [4]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=22723178; DOI=10.1007/s13238-012-2932-6;
RA   Wu J., Peng S., Wu R., Hao Y., Ji G., Yuan Z.;
RT   "Generation of Calhm1 knockout mouse and characterization of calhm1
RT   gene expression.";
RL   Protein Cell 3:470-480(2012).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=23467090; DOI=10.1038/nature11906;
RA   Taruno A., Vingtdeux V., Ohmoto M., Ma Z., Dvoryanchikov G., Li A.,
RA   Adrien L., Zhao H., Leung S., Abernethy M., Koppel J., Davies P.,
RA   Civan M.M., Chaudhari N., Matsumoto I., Hellekant G., Tordoff M.G.,
RA   Marambaud P., Foskett J.K.;
RT   "CALHM1 ion channel mediates purinergic neurotransmission of sweet,
RT   bitter and umami tastes.";
RL   Nature 495:223-226(2013).
CC   -!- FUNCTION: Pore-forming subunit of a voltage-gated ion channel
CC       required for sensory perception of sweet, bitter and umami tastes.
CC       Specifically present in type II taste bud cells, where it plays a
CC       central role in sweet, bitter and umami taste perception by
CC       inducing ATP release from the cell, ATP acting as a
CC       neurotransmitter to activate afferent neural gustatory pathways.
CC       Acts both as a voltage-gated and calcium-activated ion channel:
CC       mediates neuronal excitability in response to changes in
CC       extracellular Ca(2+) concentration. Has poor ion selectivity and
CC       forms a wide pore (around 14 Angstroms) that mediates permeation
CC       of Ca(2+), Na(+) and K(+), as well as permeation of monovalent
CC       anions. Acts as an activator of the ERK1 and ERK2 cascade.
CC       Triggers endoplasmic reticulum stress by reducing the calcium
CC       content of the endoplasmic reticulum. May indirectly control
CC       amyloid precursor protein (APP) proteolysis and aggregated
CC       amyloid-beta (Abeta) peptides levels in a Ca(2+) dependent manner.
CC       {ECO:0000269|PubMed:22711817, ECO:0000269|PubMed:23467090}.
CC   -!- ENZYME REGULATION: Inhibited by Gd(3+), Ruthenium Red, and Zn(2+)
CC       and partially inhibited by 2-aminoethoxydiphenyl borate.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000250|UniProtKB:Q8IU99}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q8IU99}; Multi-pass membrane protein
CC       {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8IU99}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in type II taste bud
CC       cells. Not expressed in brain. {ECO:0000269|PubMed:22711817,
CC       ECO:0000269|PubMed:22723178, ECO:0000269|PubMed:23467090}.
CC   -!- DISRUPTION PHENOTYPE: Impaired perceptions of sweet, bitter and
CC       umami compounds. Mice are viable and fertile, with no visible
CC       morphological abnormalities in their taste buds or any altered
CC       expression of taste-related marker genes. They do however display
CC       a loss of both preference for sweet and umami compounds and for
CC       avoidance of bitter compounds. Perceptions of sour and salty
CC       tastes are unaffected. Reduced voltage-gated currents in type II
CC       cells and taste-evoked ATP release from taste buds without
CC       affecting the excitability of taste cells by taste stimuli.
CC       Elderly males and females do not show defects in spatial learning
CC       and memory retrieving. {ECO:0000269|PubMed:22723178,
CC       ECO:0000269|PubMed:23467090}.
CC   -!- SIMILARITY: Belongs to the CALHM family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC124724; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466534; EDL42030.1; -; Genomic_DNA.
DR   CCDS; CCDS38015.1; -.
DR   RefSeq; NP_001074740.1; NM_001081271.1.
DR   UniGene; Mm.439624; -.
DR   STRING; 10090.ENSMUSP00000107444; -.
DR   iPTMnet; D3Z291; -.
DR   PhosphoSitePlus; D3Z291; -.
DR   PaxDb; D3Z291; -.
DR   PRIDE; D3Z291; -.
DR   Ensembl; ENSMUST00000111813; ENSMUSP00000107444; ENSMUSG00000079258.
DR   GeneID; 546729; -.
DR   KEGG; mmu:546729; -.
DR   UCSC; uc008hus.1; mouse.
DR   CTD; 255022; -.
DR   MGI; MGI:3643383; Calhm1.
DR   eggNOG; ENOG410IG7G; Eukaryota.
DR   eggNOG; ENOG410YNIM; LUCA.
DR   GeneTree; ENSGT00530000062796; -.
DR   HOGENOM; HOG000111295; -.
DR   InParanoid; D3Z291; -.
DR   KO; K19738; -.
DR   OMA; VMNNNVS; -.
DR   OrthoDB; EOG091G09L8; -.
DR   PhylomeDB; D3Z291; -.
DR   TreeFam; TF329085; -.
DR   PRO; PR:D3Z291; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000079258; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:CACAO.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IMP:UniProtKB.
DR   GO; GO:0015867; P:ATP transport; IMP:UniProtKB.
DR   GO; GO:0006812; P:cation transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0050913; P:sensory perception of bitter taste; IMP:UniProtKB.
DR   GO; GO:0050916; P:sensory perception of sweet taste; IMP:UniProtKB.
DR   GO; GO:0050909; P:sensory perception of taste; IMP:CACAO.
DR   GO; GO:0050917; P:sensory perception of umami taste; IMP:UniProtKB.
DR   InterPro; IPR029568; CALHM1.
DR   InterPro; IPR029569; FAM26.
DR   PANTHER; PTHR32261; PTHR32261; 1.
DR   PANTHER; PTHR32261:SF2; PTHR32261:SF2; 1.
DR   Pfam; PF14798; Ca_hom_mod; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    348       Calcium homeostasis modulator protein 1.
FT                                /FTId=PRO_0000422239.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical. {ECO:0000255}.
FT   TOPO_DOM     38     48       Extracellular. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TOPO_DOM     70    107       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    180       Extracellular. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    348       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   348 AA;  38827 MW;  338717B7C1F8C354 CRC64;
     MDKFRMIFQF LQSNQESFMN GICGIMALAS AQMYSAFDFN CPCLPGYNVV YSLGILLTPP
     LVLFLLGLVM NNNISMLAEE WKRPAGRRAK DPAVLRYMFC SMAQRALIAP VVWVAVTLLD
     GKCFLCAFCT AVPVATLGNG SLVPGLPAPE LARLLARVPC PEIYDGNWLL AREVAVRYLR
     CISQALGWSF VLLTTLLAFV VRSVRPCFTQ VAFLKSKYWS HYIDIERKLF DETCTEHAKA
     FAKVCIQQFF EAMNHDLELG HTHGVLATAT ATATATEAVQ SPSDRTEEER EKLRGITDQG
     TMNRLLTSWH KCKPPLRLGQ EAPLMSNGWA GGEPRPPRKE VATYFSKV
//
ID   PK1L1_ORYLA             Reviewed;        2742 AA.
AC   E7FKV8;
DT   19-FEB-2014, integrated into UniProtKB/Swiss-Prot.
DT   19-FEB-2014, sequence version 2.
DT   25-OCT-2017, entry version 29.
DE   RecName: Full=Polycystic kidney disease 1 like 1;
DE   AltName: Full=Protein abecobe;
GN   Name=pkd1l1; Synonyms=abc;
OS   Oryzias latipes (Japanese rice fish) (Japanese killifish).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Neoteleostei; Acanthomorphata;
OC   Ovalentaria; Atherinomorphae; Beloniformes; Adrianichthyidae;
OC   Oryziinae; Oryzias.
OX   NCBI_TaxID=8090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, DISRUPTION
RP   PHENOTYPE, TISSUE SPECIFICITY, AND INTERACTION WITH PDK2.
RX   PubMed=21307098; DOI=10.1242/dev.058271;
RA   Kamura K., Kobayashi D., Uehara Y., Koshida S., Iijima N., Kudo A.,
RA   Yokoyama T., Takeda H.;
RT   "Pkd1l1 complexes with Pkd2 on motile cilia and functions to establish
RT   the left-right axis.";
RL   Development 138:1121-1129(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Hd-rR;
RX   PubMed=17554307; DOI=10.1038/nature05846;
RA   Kasahara M., Naruse K., Sasaki S., Nakatani Y., Qu W., Ahsan B.,
RA   Yamada T., Nagayasu Y., Doi K., Kasai Y., Jindo T., Kobayashi D.,
RA   Shimada A., Toyoda A., Kuroki Y., Fujiyama A., Sasaki T., Shimizu A.,
RA   Asakawa S., Shimizu N., Hashimoto S., Yang J., Lee Y., Matsushima K.,
RA   Sugano S., Sakaizumi M., Narita T., Ohishi K., Haga S., Ohta F.,
RA   Nomoto H., Nogata K., Morishita T., Endo T., Shin-I T., Takeda H.,
RA   Morishita S., Kohara Y.;
RT   "The medaka draft genome and insights into vertebrate genome
RT   evolution.";
RL   Nature 447:714-719(2007).
CC   -!- FUNCTION: Component of a ciliary calcium channel that controls
CC       calcium concentration within cilia without affecting cytoplasmic
CC       calcium concentration. Forms a heterodimer with pkd2l1 in cilia
CC       and forms a calcium-permeant ciliary channel that regulates sonic
CC       hedgehog/SHH signaling and gli2 transcription. Does not constitute
CC       the pore-forming subunit (By similarity). Also involved in
CC       left/right axis specification downstream of nodal flow: forms a
CC       complex with pkd2 in cilia to facilitate flow detection in
CC       left/right patterning. {ECO:0000250, ECO:0000269|PubMed:21307098}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes with PKD2 proteins to form a
CC       calcium channel. Interacts with pkd2l1; to form ciliary calcium
CC       channel (By similarity). Interacts with pkd2. {ECO:0000250,
CC       ECO:0000269|PubMed:21307098}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000269|PubMed:21307098}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21307098}.
CC   -!- TISSUE SPECIFICITY: Expressed in Kupffer's vesicle, an organ
CC       equivalent to the node. {ECO:0000269|PubMed:21307098}.
CC   -!- DISRUPTION PHENOTYPE: Defects in left-right axis patterning, while
CC       nodal flow is normal. {ECO:0000269|PubMed:21307098}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB573426; BAJ65629.1; -; mRNA.
DR   EMBL; BAAF04039115; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BAAF04039116; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BAAF04039117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   UniGene; Ola.29081; -.
DR   Proteomes; UP000001038; Unplaced.
DR   GO; GO:0034704; C:calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; IDA:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IMP:UniProtKB.
DR   GO; GO:0003127; P:detection of nodal flow; IMP:UniProtKB.
DR   GO; GO:0070986; P:left/right axis specification; IMP:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 2.60.60.20; -; 1.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR022409; PKD/Chitinase_dom.
DR   InterPro; IPR002859; PKD/REJ-like.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR000601; PKD_dom.
DR   InterPro; IPR035986; PKD_dom_sf.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR014010; REJ_dom.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF00801; PKD; 2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   Pfam; PF02010; REJ; 1.
DR   SMART; SM00308; LH2; 1.
DR   SMART; SM00089; PKD; 2.
DR   SUPFAM; SSF49299; SSF49299; 2.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS50093; PKD; 2.
DR   PROSITE; PS50095; PLAT; 1.
DR   PROSITE; PS51111; REJ; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   2742       Polycystic kidney disease 1 like 1.
FT                                /FTId=PRO_0000425550.
FT   TOPO_DOM      1   1602       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1603   1623       Helical. {ECO:0000255}.
FT   TOPO_DOM   1624   1812       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1813   1833       Helical. {ECO:0000255}.
FT   TOPO_DOM   1834   1851       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1852   1872       Helical. {ECO:0000255}.
FT   TOPO_DOM   1873   2005       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2006   2026       Helical. {ECO:0000255}.
FT   TOPO_DOM   2027   2040       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2041   2061       Helical. {ECO:0000255}.
FT   TOPO_DOM   2062   2151       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2152   2172       Helical. {ECO:0000255}.
FT   TOPO_DOM   2173   2344       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2345   2365       Helical. {ECO:0000255}.
FT   TOPO_DOM   2366   2378       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2379   2401       Helical. {ECO:0000255}.
FT   TOPO_DOM   2402   2442       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2443   2463       Helical. {ECO:0000255}.
FT   TOPO_DOM   2464   2467       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2468   2488       Helical. {ECO:0000255}.
FT   TOPO_DOM   2489   2528       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2529   2549       Helical. {ECO:0000255}.
FT   TOPO_DOM   2550   2742       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      286    372       PKD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      370    454       PKD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      452   1338       REJ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00511}.
FT   DOMAIN     1538   1586       GPS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00098}.
FT   DOMAIN     1648   1769       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   CARBOHYD     35     35       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    149    149       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    383    383       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    486    486       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    545    545       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    693    693       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    709    709       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    735    735       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1080   1080       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1101   1101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1201   1201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1318   1318       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1437   1437       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1490   1490       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1568   1568       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2218   2218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    847    847       L -> R (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT    974    974       L -> F (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1064   1064       K -> T (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1245   1245       R -> G (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1263   1263       T -> K (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1328   1328       L -> S (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1360   1360       S -> P (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1467   1467       I -> L (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1513   1513       L -> F (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1616   1616       N -> Y (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1814   1814       C -> Y (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1833   1833       Q -> K (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   1924   1924       T -> Q (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2014   2014       F -> L (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2036   2036       H -> L (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2182   2182       F -> I (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2189   2189       A -> G (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2192   2192       D -> E (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2195   2195       M -> T (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2257   2257       R -> C (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2348   2348       Y -> C (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2425   2425       V -> I (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2567   2567       V -> I (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2647   2647       L -> S (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
FT   CONFLICT   2665   2665       D -> V (in Ref. 1; BAJ65629).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2742 AA;  308537 MW;  FD9D7BD479F71201 CRC64;
     MFCLWIFSLA FLHLHLCSVS SSSLEGSGFF VGWINASSLQ LFASIGGCDL SPCMDEGQEG
     MEALYRSEEP FQCSIRASAS PGRRQAGRTC VRKVPGNLAV HCHLLSENEG LEEEDLLRIT
     VMTPRGQSSL QVNVSHGGLL TACSDWIWNT SEKHKNNVPA SGLHLGISLE VPCCTSCTRF
     GSDSELVEEQ CSALHVSVSD VLVKDYICCL TPRDKDKTLN RTETPCLYSS NSLKDSLVRG
     RVYQMSFEEC FRWHLLVVLL MLEAQYNHSQ EVHEDPSSTV KLCDYAVRIH AEKQAYSTNT
     DIPLLAVVDI LDPVEFLWDF GDFTSARANS RTITKRYTNP GIYKLVVVAS WGQMSVRSHV
     LSLVVQRAVK LNRLVHEPSV LQNHTVTVSC RVNVGTNLTF LWNFGDGTVR TGLSTEQHVF
     TRTGEFRVMV IASNLVSSAS LSSYLFVVDR PCQPPPVKNL GPPNIQVRRN EVVFLGVTFE
     SELNCNVSRE LHYSWTVYDS AGLTFPLPLT NTHRQSLVLQ SYTLPYGIYK AIARVQIVGS
     VVYSNYSVRL QVVPNSVVVV IQGGTNIYVN TKSSNEVTLD GQASYDPDFP LNPLRYSWTC
     QPVSTISSSC FSQSIPTSYP VLKFPTSLLK SNFDQFKFTL TVHSGERSAS SEIFLTLTSH
     LAGKLFVHCP ECQGDQVSWD QSFSVRAECE DCNVSAEFIQ YSWSLFRVNA SSKPVAEIPF
     CYTVDLNAPS AVLENASTPT PAPEMSPSHH FNADWTRFTE DSLASSSPSR IYKSKNRNSE
     LTDSPVSSVT VGFSGSESFN GPPGVDRGSS QFSNFPGQRD MFSEFQSDPE SSAEWEFTFP
     YLESEDLRGQ RGDSRVPFPR PEEGDPGISA GRPKETDMES FPSDSDSFSH SSSNKGEGSN
     LVDPRPSVRL QKPGLLDLHR DSVDKSLFES YTYTGISSCF LSFRSFSLKP SSTYMLELTA
     KSQRRFYGQT QLFLKVKPVP KGVACQVQPV RGIELYTHFS IFCTSGREDL IYTYSFSVGG
     RMPRILYQGR DFLYYFSLPS GDPTDDYKVI IYTEIRSSMY GSAKKLCPVT VRVEPSFVRN
     ASSSYSHHEP DLMISDSGLR NVSVLVQLGN IAEIYNYISL LSTILNRLSL DSQANTHALK
     HLRNVLICIV CKLEYSAQAS PADGIFILNE LLRVTSQVTV QSARWVTAHV GALSVQFSES
     NRSILSALVS LLSSSLQVVT SSPETSDSAD SPQPLESHLV TGKSRNAFVD DADHCITDLS
     ETTYNKQSEP VPKRLMMRLV NDLLQTTSDL MLRNFDLQKT KELQVQSDLI TLCAGFLNKT
     STAINCGLIT FFLPASLIKM LLLHDGISAK RGFSQREQPS CVQRIGMELL HNPYEWGRYP
     IQLKGPVADL SLYSCKTRRK IPVHSFLQPI TVELRHPQKT SSMSEYTLLR SQINYHNFSI
     TQEHLQQAVQ VTVVFTAPPH MAFPVKILFR MFERPTPSMH HLHRLLNWRN NTILLTLPPS
     YLSAAGVGHL ALLDANFGKT PTRRHLAEQI SYSLTVESSL CLSWEDQQGS WTQNGCRAQT
     NDKTSAVNCS CHHLKPLKVL QQQIQSSHFR ADLDQFLSVS RDLTVVFVLL LCVSLNIPVL
     VWCKKTDATS EENNRAHFLP DNSATDQHFY AVTVHTGLCS AARMSARVYV VLHGEDGCSQ
     TKELHVPGCT LFRRNSQNTF ILSVADSLGS VQGVHIWHNN SGPSPEWYLK QVQVSELMPG
     HMEGRSWQFI SQCWLAVNKG DGQVERMLRV STHGLTFSKM LFLKLFEYMP DYHIWMSVYT
     CPSPHLFTRA QRLCVCLLLF LGYACVNIII THQRDDQLPF DLGVIDVTSV SIATGLVSVV
     AVLPVAMVIS FLFRVKSGRM TLENYDNVFS KRPSGKTKYQ DTDFLSVSTT NLENKDADDK
     EAVTPQRNKR RKDSVSFESI HELLFQEVLQ VSRRRSLFLK KSKGNDSELS PQSSEFCGAL
     KATKNEAQSV RVKRRYRLAS LLYHCVAWTL CLLFCLSCLI LSAVLGTRLN SGKILHWIHS
     LFVSLTFCFF VIHPATILVL AAVVSWRFKR SQDFHCFFNK MNSHLEDLKH QDPDQLRPSA
     FTRTRAPNAE KILEARQRAR YLRRVHPPTR AELRKTRTKR KKQAVIHKML RDLCLCGSMF
     FLMVCITYGS PVDEHYPLNA AFRRHFIRAH GDDFMSIKKY EDWWKWAQTS LLSSLYYNES
     ENPQMSFISI GAPLVQKTEV CGTFHSQVSM VTPPRPRYHT GSSSKQEVTV GLGYTRSEGA
     SKLRLLHLSG WLSEQTVALK VQFSLYSPAP NLFSSVTLLS EQSSTGLLQS SATVQSVRLY
     HSPSMLDYTV MVWQLLFLLL SLVNLYHQTS TAAQHGLMGY WKTTSISVEV SLVIVSLVYY
     VHYVYHPTMV MEVAEQLRRN HREHVDVSTL ANSEQFSRTL RGIILFLLAV KCVTVVRLNR
     ILAPSMPLLS LSSLLWPAIS GLLLLSIFSC MGRLLYIERT FHSIQTVLWH FWSLRKSRDL
     ISLWRDFYYF GLLYASSAML TTMVFAVMIR KAKRSPSTKN DPTIREVLGC ISQKFTGMKT
     QIPDCHTQKT YFLEECESLV DELLFKLNAL SNSLHHTLPP KLHTYTDKDS PDASSTTELC
     KERLQDLVRS LSVGQGEAAL TFPHDRSLLE LQEEEEVKHQ EGRCSVGCKE SRLPETLWTA
     DYRESMDEHW TEKKSSNGLG GATYSHVVVV EALVHHEQGT KN
//
ID   MCU6_ARATH              Reviewed;         292 AA.
AC   F4I111; O80539;
DT   26-NOV-2014, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 1.
DT   20-DEC-2017, entry version 42.
DE   RecName: Full=Calcium uniporter protein 6, mitochondrial;
DE   Flags: Precursor;
GN   OrderedLocusNames=At1g09575 {ECO:0000312|Araport:AT1G09575};
GN   ORFNames=F14J9.24 {ECO:0000312|EMBL:AAC33217.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [4]
RP   GENE FAMILY, AND REVIEW.
RX   PubMed=22200666; DOI=10.1093/jxb/err394;
RA   Stael S., Wurzinger B., Mair A., Mehlmer N., Vothknecht U.C.,
RA   Teige M.;
RT   "Plant organellar calcium signalling: an emerging field.";
RL   J. Exp. Bot. 63:1525-1542(2012).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria. Mitochondrial calcium
CC       homeostasis plays key roles in cellular physiology and regulates
CC       cell bioenergetics, cytoplasmic calcium signals and activation of
CC       cell death pathways. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC33217.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AY056149; Type=Frameshift; Positions=274; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC003970; AAC33217.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE28464.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM60638.1; -; Genomic_DNA.
DR   EMBL; AY056149; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; E86229; E86229.
DR   RefSeq; NP_001322910.1; NM_001331844.1.
DR   RefSeq; NP_563846.1; NM_100829.2.
DR   UniGene; At.26374; -.
DR   STRING; 3702.AT1G09575.1; -.
DR   PaxDb; F4I111; -.
DR   EnsemblPlants; AT1G09575.1; AT1G09575.1; AT1G09575.
DR   EnsemblPlants; AT1G09575.2; AT1G09575.2; AT1G09575.
DR   GeneID; 837484; -.
DR   Gramene; AT1G09575.1; AT1G09575.1; AT1G09575.
DR   Gramene; AT1G09575.2; AT1G09575.2; AT1G09575.
DR   KEGG; ath:AT1G09575; -.
DR   Araport; AT1G09575; -.
DR   TAIR; locus:505006112; AT1G09575.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   InParanoid; F4I111; -.
DR   KO; K20858; -.
DR   OMA; AMPMDET; -.
DR   OrthoDB; EOG09360K4O; -.
DR   Reactome; R-ATH-8949215; Mitochondrial calcium ion transport.
DR   PRO; PR:F4I111; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; F4I111; baseline and differential.
DR   Genevisible; F4I111; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; IDA:TAIR.
DR   GO; GO:0015292; F:uniporter activity; IBA:GO_Central.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     18       Mitochondrion. {ECO:0000255}.
FT   CHAIN        19    292       Calcium uniporter protein 6,
FT                                mitochondrial.
FT                                /FTId=PRO_0000431375.
FT   TRANSMEM    172    192       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical; Name=2. {ECO:0000255}.
FT   CONFLICT    286    286       A -> V (in Ref. 3; AY056149).
FT                                {ECO:0000305}.
SQ   SEQUENCE   292 AA;  33803 MW;  6BE7AD7FDACFDC94 CRC64;
     MWSMGLIRRT AMSNAIRASS QRTWLGHGGL RSCVTVKTPS EDEEEKKKEI TIAEAKKLMR
     LVNVEDMKKK LVGVADRDVV SYSTLLEASQ GMGIARSPDE AHVFARVLDD AGVVLIFRDK
     VYLHPDKVVD LIRRAMPLDQ NPEEDQIKEE FNKLRIMKEE IDVLAHRQVR KILWCGLATS
     MVQIGLFFRL TFWEFSWDVM EPITFFATAT GIIVGYAYFL MTSRDPTYQD FMKRLFLSRQ
     RKLLKSHKFD CERFKELERL FKMTSSCHAA ASIRNRVGLE LDLEDALQSR RD
//
ID   STIM1_CAEEL             Reviewed;         530 AA.
AC   G5EF60; H2L0R4; H2L0R5;
DT   03-APR-2013, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   22-NOV-2017, entry version 53.
DE   RecName: Full=Stromal interaction molecule 1 {ECO:0000303|PubMed:16966474};
DE   Flags: Precursor;
GN   Name=stim-1 {ECO:0000312|EMBL:CCD73857.1,
GN   ECO:0000312|WormBase:Y55B1BM.1a}; ORFNames=Y55B1BM.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:ABG89384.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   ASP-55 AND ASP-57.
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:ABG89384.1};
RX   PubMed=16966474; DOI=10.1085/jgp.200609611;
RA   Yan X., Xing J., Lorin-Nebel C., Estevez A.Y., Nehrke K., Lamitina T.,
RA   Strange K.;
RT   "Function of a STIM1 homologue in C. elegans: evidence that store-
RT   operated Ca2+ entry is not essential for oscillatory Ca2+ signaling
RT   and ER Ca2+ homeostasis.";
RL   J. Gen. Physiol. 128:443-459(2006).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CCD73857.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CCD73857.1};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH ORAI-1.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:17218360};
RX   PubMed=17218360; DOI=10.1113/jphysiol.2006.124883;
RA   Lorin-Nebel C., Xing J., Yan X., Strange K.;
RT   "CRAC channel activity in C. elegans is mediated by Orai1 and STIM1
RT   homologues and is essential for ovulation and fertility.";
RL   J. Physiol. (Lond.) 580:67-85(2007).
RN   [4] {ECO:0000305, ECO:0000312|PDB:3TER}
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 256-391, AND SUBUNIT.
RX   PubMed=22451904; DOI=10.1073/pnas.1118947109;
RA   Yang X., Jin H., Cai X., Li S., Shen Y.;
RT   "Structural and mechanistic insights into the activation of Stromal
RT   interaction molecule 1 (STIM1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:5657-5662(2012).
CC   -!- FUNCTION: Plays a role in mediating store-operated Ca(2+) entry
CC       (SOCE), a Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores. Acts as Ca(2+) sensor which upon Ca(2+) depletion,
CC       activates the Ca(2+) release-activated Ca(2+) (CRAC) channel
CC       subunit, orai-1. Essential for Ca (2+) and IP3-dependent
CC       contractile activity of gonad sheath cells and spermatheca.
CC       Essential for fertility. Does not play a role in posterior body
CC       wall muscle contraction (pBoc) rhythmicity, intestinal cell
CC       oscillatory Ca(2+) signaling or intestinal ER Ca(2+) hemeostasis.
CC       {ECO:0000269|PubMed:16966474, ECO:0000269|PubMed:17218360}.
CC   -!- SUBUNIT: Homodimer. Interacts with orai-1.
CC       {ECO:0000269|PubMed:17218360, ECO:0000269|PubMed:22451904}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-15975920, EBI-15975920;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:16966474,
CC       ECO:0000269|PubMed:17218360}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:16966474, ECO:0000269|PubMed:17218360}.
CC       Note=Localizes to intracellular puncta in the anterior intestine
CC       and reticular structure in the posterior intestine.
CC       {ECO:0000269|PubMed:16966474, ECO:0000269|PubMed:17218360}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a {ECO:0000269|PubMed:16966474};
CC         IsoId=G5EF60-1; Sequence=Displayed;
CC       Name=b {ECO:0000305};
CC         IsoId=G5EF60-2; Sequence=VSP_046320;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=c {ECO:0000305};
CC         IsoId=G5EF60-3; Sequence=VSP_046321, VSP_046322;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Coexpressed with orai-1 in spermatheca, gonad
CC       sheath cells and intestine. Also detected in neurons in the head
CC       and in the uterine epithelial cells. Heterogeneously expressed in
CC       the intestine with strong presence in the anterior and posterior
CC       intestine and weaker in the midsection.
CC       {ECO:0000269|PubMed:16966474, ECO:0000269|PubMed:17218360}.
CC   -!- DISRUPTION PHENOTYPE: Sterility due to dysfunction of somatic
CC       cells. Affects the store-operated Ca(2+) (SOC) activity.
CC       {ECO:0000269|PubMed:16966474}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ812088; ABG89384.1; -; mRNA.
DR   EMBL; FO081812; CCD73857.1; -; Genomic_DNA.
DR   EMBL; FO081812; CCD73858.1; -; Genomic_DNA.
DR   EMBL; FO081812; CCD73859.1; -; Genomic_DNA.
DR   RefSeq; NP_001022916.1; NM_001027745.3. [G5EF60-3]
DR   RefSeq; NP_741073.1; NM_171065.4. [G5EF60-2]
DR   RefSeq; NP_741074.1; NM_171858.4. [G5EF60-1]
DR   UniGene; Cel.8872; -.
DR   PDB; 3TER; X-ray; 2.55 A; A/B=256-391.
DR   PDBsum; 3TER; -.
DR   ProteinModelPortal; G5EF60; -.
DR   SMR; G5EF60; -.
DR   DIP; DIP-60032N; -.
DR   STRING; 6239.Y55B1BM.1a; -.
DR   EPD; G5EF60; -.
DR   PaxDb; G5EF60; -.
DR   PeptideAtlas; G5EF60; -.
DR   PRIDE; G5EF60; -.
DR   EnsemblMetazoa; Y55B1BM.1a; Y55B1BM.1a; WBGene00021910. [G5EF60-1]
DR   GeneID; 175201; -.
DR   KEGG; cel:CELE_Y55B1BM.1; -.
DR   CTD; 175201; -.
DR   WormBase; Y55B1BM.1a; CE29124; WBGene00021910; stim-1. [G5EF60-1]
DR   WormBase; Y55B1BM.1b; CE30055; WBGene00021910; stim-1. [G5EF60-2]
DR   WormBase; Y55B1BM.1c; CE34130; WBGene00021910; stim-1. [G5EF60-3]
DR   eggNOG; KOG4403; Eukaryota.
DR   eggNOG; ENOG410XRM6; LUCA.
DR   GeneTree; ENSGT00390000000214; -.
DR   InParanoid; G5EF60; -.
DR   KO; K16059; -.
DR   OMA; AVNNLQY; -.
DR   OrthoDB; EOG091G0CO0; -.
DR   PhylomeDB; G5EF60; -.
DR   Reactome; R-CEL-5578775; Ion homeostasis.
DR   Reactome; R-CEL-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:G5EF60; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00021910; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0030425; C:dendrite; IDA:WormBase.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043229; C:intracellular organelle; IDA:WormBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:WormBase.
DR   GO; GO:0005509; F:calcium ion binding; ISS:WormBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0032237; P:activation of store-operated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0030728; P:ovulation; IMP:WormBase.
DR   GO; GO:1901076; P:positive regulation of engulfment of apoptotic cell; IMP:WormBase.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IMP:WormBase.
DR   GO; GO:1901341; P:positive regulation of store-operated calcium channel activity; IMP:WormBase.
DR   GO; GO:0000003; P:reproduction; IMP:WormBase.
DR   GO; GO:0002115; P:store-operated calcium entry; IGI:WormBase.
DR   CDD; cd11722; SOAR; 1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR032393; SOAR.
DR   Pfam; PF07647; SAM_2; 1.
DR   Pfam; PF16533; SOAR; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Coiled coil; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    530       Stromal interaction molecule 1.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000422046.
FT   TRANSMEM    190    210       Helical. {ECO:0000255}.
FT   DOMAIN       42     77       EF-hand. {ECO:0000255}.
FT   DOMAIN      113    181       SAM. {ECO:0000255}.
FT   CA_BIND      55     66       {ECO:0000250}.
FT   COILED      208    329       {ECO:0000255}.
FT   VAR_SEQ     391    410       Missing (in isoform b). {ECO:0000305}.
FT                                /FTId=VSP_046320.
FT   VAR_SEQ     391    395       ETEHI -> GKFRQ (in isoform c).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_046321.
FT   VAR_SEQ     396    530       Missing (in isoform c). {ECO:0000305}.
FT                                /FTId=VSP_046322.
FT   MUTAGEN      55     55       D->A: Sterility along with defects in
FT                                ovulation, slow growth and stunted gonad
FT                                development; pBoc arrhythmia and fluid
FT                                accumulation in the pseudocoel; when
FT                                associated with A-57.
FT                                {ECO:0000269|PubMed:16966474}.
FT   MUTAGEN      57     57       D->A: Sterility along with defects in
FT                                ovulation, slow growth and stunted gonad
FT                                development; pBoc arrhythmia and fluid
FT                                accumulation in the pseudocoel; when
FT                                associated with A-55.
FT                                {ECO:0000269|PubMed:16966474}.
FT   HELIX       260    277       {ECO:0000244|PDB:3TER}.
FT   HELIX       290    328       {ECO:0000244|PDB:3TER}.
FT   HELIX       346    382       {ECO:0000244|PDB:3TER}.
SQ   SEQUENCE   530 AA;  60021 MW;  AEF628FA03BFDB3C CRC64;
     MGRVSWIIAL YLTINVVIVV NGDRVTRNVE VTAEEEKIRD KLGYEAIRDI HRDMDDDHSG
     SIDRNESTGF MKEDMQMRGS ERTRRENKFH GDDDAITVDD LWEAWFESIE RTWTNERLVE
     WLINDVNLPS IVEAVKAKKI DGKILPRFAS PNSDFLNKEL GIKSSVYRQK LRLNSLDVVL
     FGYKDNNNRT KDILLAFLAL LLTSLIFLYV RQKQKAQQKV NELSNKLTEL KCMETEFEDV
     QKMLNDERSK RSISDGVVNH TEMENLRVQL EEAERRLEAN SNGSQAPLAL QPLLRRTCEN
     EMAFLEKQRQ DCFKEMKEAI EMVDRLQKKQ GSVLSSLKLA TGAASTSDQV DSKIFALKSR
     MEKIHTLTRE TQERWLQIES LCGFPLLYLN ETEHINRSIA SSHFYNKSHE GSSSSGSISN
     AHSNPNAVNS NFVKKVSPPI PPSQQTANLR FVPTEQSDSI HSEDTSPIVE DVAISRSLTQ
     DLAEADMQSI VSGSTNGSGS VAALKKRKGI FPKLFRRNTS KSSSLGGTSN
//
ID   CAC1A_HUMAN             Reviewed;        2505 AA.
AC   O00555; J3KP41; P78510; P78511; Q16290; Q92690; Q99790; Q99791;
AC   Q99792; Q99793; Q9NS88; Q9UDC4;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   20-DEC-2017, entry version 187.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha-1A;
DE   AltName: Full=Brain calcium channel I;
DE            Short=BI;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide isoform 4;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.1;
GN   Name=CACNA1A; Synonyms=CACH4, CACN3, CACNL1A4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Neuron;
RX   PubMed=10049321; DOI=10.1016/S0006-3495(99)77300-5;
RA   Hans M., Urrutia A., Deal C., Brust P.F., Stauderman K., Ellis S.B.,
RA   Harpold M.M., Johnson E.C., Williams M.E.;
RT   "Structural elements in domain IV that influence biophysical and
RT   pharmacological properties of human alpha1A-containing high-voltage-
RT   activated calcium channels.";
RL   Biophys. J. 76:1384-1400(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 3), VARIANTS FHM1
RP   GLN-192; MET-666; ALA-714 AND LEU-1810, VARIANT THR-454, AND
RP   INVOLVEMENT IN EA2.
RC   TISSUE=Cerebellum;
RX   PubMed=8898206; DOI=10.1016/S0092-8674(00)81373-2;
RA   Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J.,
RA   Hoffman S.M.G., Lamerdin J.E., Mohrenweiser H.W., Bulman D.E.,
RA   Ferrari M., Haan J., Lindhout D., van Ommen G.-J.B., Hofker M.H.,
RA   Ferrari M.D., Frants R.R.;
RT   "Familial hemiplegic migraine and episodic ataxia type-2 are caused by
RT   mutations in the Ca2+ channel gene CACNL1A4.";
RL   Cell 87:543-552(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1313-2505 (ISOFORMS 1; 2; 3 AND 6), ALTERNATIVE SPLICING, AND
RP   INVOLVEMENT IN SCA6.
RC   TISSUE=Brain;
RX   PubMed=8988170; DOI=10.1038/ng0197-62;
RA   Zhuchenko O., Bailey J., Bonnen P.E., Ashizawa T., Stockton D.W.,
RA   Amos C., Dobyns W.B., Subramony S.H., Zoghbi H.Y., Lee C.C.;
RT   "Autosomal dominant cerebellar ataxia (SCA6) associated with small
RT   polyglutamine expansions in the alpha 1A-voltage-dependent calcium
RT   channel.";
RL   Nat. Genet. 15:62-69(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), VARIANT SER-1105, AND
RP   FUNCTION.
RC   TISSUE=Cerebellum;
RX   PubMed=10753886; DOI=10.1074/jbc.275.15.10893;
RA   Toru S., Murakoshi T., Ishikawa K., Saegusa H., Fujigasaki H.,
RA   Uchihara T., Nagayama S., Osanai M., Mizusawa H., Tanabe T.;
RT   "Spinocerebellar ataxia type 6 mutation alters P-type calcium channel
RT   function.";
RL   J. Biol. Chem. 275:10893-10898(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1693-1807.
RC   TISSUE=Lung carcinoma;
RX   PubMed=7823133;
RA   Barry E.L.R., Viglione M.P., Kim Y.I., Froehner S.C.;
RT   "Expression and antibody inhibition of P-type calcium channels in
RT   human small-cell lung carcinoma cells.";
RL   J. Neurosci. 15:274-283(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1702-1822, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=1335101; DOI=10.1016/S0025-6196(12)61144-6;
RA   Oguro-Okano M., Griesmann G.E., Wieben E.D., Slaymaker S.J.,
RA   Snutch T.P., Lennon V.A.;
RT   "Molecular diversity of neuronal-type calcium channels identified in
RT   small cell lung carcinoma.";
RL   Mayo Clin. Proc. 67:1150-1159(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2038-2258 (ISOFORMS 1/2/3/4).
RC   TISSUE=Frontal cortex;
RX   PubMed=8525433; DOI=10.1007/BF02255782;
RA   Margolis R.L., Breschel T.S., Li S.H., Kidwai A.S., Antonarakis S.E.,
RA   McInnis M.G., Ross C.A.;
RT   "Characterization of cDNA clones containing CCA trinucleotide repeats
RT   derived from human brain.";
RL   Somat. Cell Mol. Genet. 21:279-284(1995).
RN   [9]
RP   INTERACTION WITH CABP1.
RX   PubMed=11865310; DOI=10.1038/nn805;
RA   Lee A., Westenbroek R.E., Haeseleer F., Palczewski K., Scheuer T.,
RA   Catterall W.A.;
RT   "Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-
RT   binding protein 1.";
RL   Nat. Neurosci. 5:210-217(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 1955-1975.
RX   PubMed=18400181; DOI=10.1016/j.str.2008.01.011;
RA   Mori M.X., Vander Kooi C.W., Leahy D.J., Yue D.T.;
RT   "Crystal structure of the CaV2 IQ domain in complex with
RT   Ca2+/calmodulin: high-resolution mechanistic implications for channel
RT   regulation by Ca2+.";
RL   Structure 16:607-620(2008).
RN   [11]
RP   VARIANT SCA6 ARG-293.
RX   PubMed=9345107; DOI=10.1086/301613;
RA   Yue Q., Jen J.C., Nelson S.F., Baloh R.W.;
RT   "Progressive ataxia due to a missense mutation in a calcium-channel
RT   gene.";
RL   Am. J. Hum. Genet. 61:1078-1087(1997).
RN   [12]
RP   POLYMORPHISM, AND INVOLVEMENT IN SCA6 AND EA2.
RX   PubMed=9302278; DOI=10.1093/hmg/6.11.1973;
RA   Jodice C., Mantuano E., Veneziano L., Trettel F., Sabbadini G.,
RA   Calandriello L., Francia A., Spadaro M., Pierelli F., Salvi F.,
RA   Ophoff R.A., Frants R.R., Frontali M.;
RT   "Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6)
RT   due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.";
RL   Hum. Mol. Genet. 6:1973-1978(1997).
RN   [13]
RP   VARIANT EA2 HIS-1661.
RX   PubMed=10987655; DOI=10.1007/s004390051099;
RA   Friend K.L., Crimmins D., Phan T.G., Sue C.M., Colley A., Fung V.S.,
RA   Morris J.G., Sutherland G.R., Richards R.I.;
RT   "Detection of a novel missense mutation and second recurrent mutation
RT   in the CACNA1A gene in individuals with EA-2 and FHM.";
RL   Hum. Genet. 105:261-265(1999).
RN   [14]
RP   VARIANT VAL-993, AND VARIANT FHM1 LEU-1456.
RX   PubMed=10408532; DOI=10.1212/WNL.53.1.26;
RA   Carrera P., Piatti M., Stenirri S., Grimaldi L.M., Marchioni E.,
RA   Curcio M., Righetti P.G., Ferrari M., Gelfi C.;
RT   "Genetic heterogeneity in Italian families with familial hemiplegic
RT   migraine.";
RL   Neurology 53:26-33(1999).
RN   [15]
RP   VARIANT FHM1 LEU-218.
RX   PubMed=11409427; DOI=10.1002/ana.1031;
RA   Kors E.E., Terwindt G.M., Vermeulen F.L., Fitzsimons R.B.,
RA   Jardine P.E., Heywood P., Love S., van den Maagdenberg A.M., Haan J.,
RA   Frants R.R., Ferrari M.D.;
RT   "Delayed cerebral edema and fatal coma after minor head trauma: role
RT   of the CACNA1A calcium channel subunit gene and relationship with
RT   familial hemiplegic migraine.";
RL   Ann. Neurol. 49:753-760(2001).
RN   [16]
RP   VARIANT EA2 LYS-1756.
RX   PubMed=11176968; DOI=10.1001/archneur.58.2.292;
RA   Denier C., Ducros A., Durr A., Eymard B., Chassande B.,
RA   Tournier-Lasserve E.;
RT   "Missense CACNA1A mutation causing episodic ataxia type 2.";
RL   Arch. Neurol. 58:292-295(2001).
RN   [17]
RP   VARIANTS FHM1 LYS-195; GLN-583; MET-666; GLU-715; GLU-1335; CYS-1384;
RP   TRP-1667; ARG-1683 AND ILE-1695.
RX   PubMed=11439943; DOI=10.1056/NEJM200107053450103;
RA   Ducros A., Denier C., Joutel A., Cecillon M., Lescoat C., Vahedi K.,
RA   Darcel F., Vicaut E., Bousser M.G., Tournier-Lasserve E.;
RT   "The clinical spectrum of familial hemiplegic migraine associated with
RT   mutations in a neuronal calcium channel.";
RL   N. Engl. J. Med. 345:17-24(2001).
RN   [18]
RP   VARIANT EA2 CYS-1403, CHARACTERIZATION OF VARIANT EA2 CYS-1403, AND
RP   FUNCTION.
RX   PubMed=11723274; DOI=10.1212/WNL.57.10.1843;
RA   Jen J., Wan J., Graves M., Yu H., Mock A.F., Coulin C.J., Kim G.,
RA   Yue Q., Papazian D.M., Baloh R.W.;
RT   "Loss-of-function EA2 mutations are associated with impaired
RT   neuromuscular transmission.";
RL   Neurology 57:1843-1848(2001).
RN   [19]
RP   VARIANT EA2 TYR-253.
RX   PubMed=12420090; DOI=10.1007/s00415-002-0860-8;
RA   van den Maagdenberg A.M., Kors E.E., Brunt E.R., van Paesschen W.,
RA   Pascual J., Ravine D., Keeling S., Vanmolkot K.R., Vermeulen F.L.,
RA   Terwindt G.M., Haan J., Frants R.R., Ferrari M.D.;
RT   "Episodic ataxia type 2. Three novel truncating mutations and one
RT   novel missense mutation in the CACNA1A gene.";
RL   J. Neurol. 249:1515-1519(2002).
RN   [20]
RP   VARIANT EA2 LEU-1736, CHARACTERIZATION OF VARIANT EA2 LEU-1736, AND
RP   FUNCTION.
RX   PubMed=15293273; DOI=10.1002/ana.20169;
RA   Spacey S.D., Hildebrand M.E., Materek L.A., Bird T.D., Snutch T.P.;
RT   "Functional implications of a novel EA2 mutation in the P/Q-type
RT   calcium channel.";
RL   Ann. Neurol. 56:213-220(2004).
RN   [21]
RP   VARIANT FHM1 GLN-1346.
RX   PubMed=15032980; DOI=10.1111/j..2004.00187.x;
RA   Alonso I., Barros J., Tuna A., Seixas A., Coutinho P., Sequeiros J.,
RA   Silveira I.;
RT   "A novel R1347Q mutation in the predicted voltage sensor segment of
RT   the P/Q-type calcium-channel alpha-subunit in a family with
RT   progressive cerebellar ataxia and hemiplegic migraine.";
RL   Clin. Genet. 65:70-72(2004).
RN   [22]
RP   VARIANTS EA2 ARG-256; ARG-1482; SER-1490; ILE-1493 AND CYS-2135.
RX   PubMed=15173248; DOI=10.1136/jmg.2003.015396;
RA   Mantuano E., Veneziano L., Spadaro M., Giunti P., Guida S.,
RA   Leggio M.G., Verriello L., Wood N., Jodice C., Frontali M.;
RT   "Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit
RT   Ca(v)2.1 causing episodic ataxia 2.";
RL   J. Med. Genet. 41:E82-E82(2004).
RN   [23]
RP   VARIANTS EA2 TYR-287; ARG-293 AND MET-666.
RX   PubMed=14718690; DOI=10.1212/01.WNL.0000101675.61074.50;
RA   Jen J., Kim G.W., Baloh R.W.;
RT   "Clinical spectrum of episodic ataxia type 2.";
RL   Neurology 62:17-22(2004).
RN   [24]
RP   VARIANTS ASP-918; VAL-993 AND SER-1105.
RX   PubMed=16866717; DOI=10.1111/j.1526-4610.2006.00504.x;
RA   von Brevern M., Ta N., Shankar A., Wiste A., Siegel A., Radtke A.,
RA   Sander T., Escayg A.;
RT   "Migrainous vertigo: mutation analysis of the candidate genes CACNA1A,
RT   ATP1A2, SCN1A, and CACNB4.";
RL   Headache 46:1136-1141(2006).
RN   [25]
RP   VARIANT SCA6 GLN-1664.
RX   PubMed=16325861; DOI=10.1016/j.jns.2005.10.007;
RA   Tonelli A., D'Angelo M.G., Salati R., Villa L., Germinasi C.,
RA   Frattini T., Meola G., Turconi A.C., Bresolin N., Bassi M.T.;
RT   "Early onset, non fluctuating spinocerebellar ataxia and a novel
RT   missense mutation in CACNA1A gene.";
RL   J. Neurol. Sci. 241:13-17(2006).
RN   [26]
RP   VARIANT FHM1 GLN-1346.
RX   PubMed=18400034; DOI=10.1111/j.1399-0004.2008.00996.x;
RA   Stam A.H., Vanmolkot K.R., Kremer H.P., Gartner J., Brown J.,
RA   Leshinsky-Silver E., Gilad R., Kors E.E., Frankhuizen W.S.,
RA   Ginjaar H.B., Haan J., Frants R.R., Ferrari M.D.,
RA   van den Maagdenberg A.M., Terwindt G.M.;
RT   "CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic
RT   migraine.";
RL   Clin. Genet. 74:481-485(2008).
RN   [27]
RP   VARIANT EA2 CYS-248.
RX   PubMed=18602318; DOI=10.1016/j.ejpn.2008.02.011;
RA   Zafeiriou D.I., Lehmann-Horn F., Vargiami E., Teflioudi E.,
RA   Ververi A., Jurkat-Rott K.;
RT   "Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia
RT   and interictal chronic diarrhea due to a novel CACNA1A mutation.";
RL   Eur. J. Paediatr. Neurol. 13:191-193(2009).
RN   [28]
RP   VARIANT EA2 ASP-638, CHARACTERIZATION OF VARIANT EA2 ASP-638, AND
RP   FUNCTION.
RX   PubMed=19232643; DOI=10.1016/j.jns.2009.01.005;
RA   Cuenca-Leon E., Banchs I., Serra S.A., Latorre P.,
RA   Fernandez-Castillo N., Corominas R., Valverde M.A., Volpini V.,
RA   Fernandez-Fernandez J.M., Macaya A., Cormand B.;
RT   "Late-onset episodic ataxia type 2 associated with a novel loss-of-
RT   function mutation in the CACNA1A gene.";
RL   J. Neurol. Sci. 280:10-14(2009).
RN   [29]
RP   VARIANTS ASP-918 AND VAL-993.
RX   PubMed=19429006; DOI=10.1016/j.neulet.2009.01.081;
RA   D'Onofrio M., Ambrosini A., Di Mambro A., Arisi I., Santorelli F.M.,
RA   Grieco G.S., Nicoletti F., Nappi G., Pierelli F., Schoenen J.,
RA   Buzzi M.G.;
RT   "The interplay of two single nucleotide polymorphisms in the CACNA1A
RT   gene may contribute to migraine susceptibility.";
RL   Neurosci. Lett. 453:12-15(2009).
RN   [30]
RP   VARIANT SCA6 THR-405.
RX   PubMed=20682717; DOI=10.1136/jnnp.2008.163402;
RA   Romaniello R., Zucca C., Tonelli A., Bonato S., Baschirotto C.,
RA   Zanotta N., Epifanio R., Righini A., Bresolin N., Bassi M.T.,
RA   Borgatti R.;
RT   "A wide spectrum of clinical, neurophysiological and neuroradiological
RT   abnormalities in a family with a novel CACNA1A mutation.";
RL   J. Neurol. Neurosurg. Psych. 81:840-843(2010).
RN   [31]
RP   VARIANTS EA2 PHE-389; MET-501; THR-798; ARG-897; CYS-1679 AND
RP   ARG-1869.
RX   PubMed=20129625; DOI=10.1016/j.jns.2010.01.010;
RA   Mantuano E., Romano S., Veneziano L., Gellera C., Castellotti B.,
RA   Caimi S., Testa D., Estienne M., Zorzi G., Bugiani M., Rajabally Y.A.,
RA   Barcina M.J., Servidei S., Panico A., Frontali M., Mariotti C.;
RT   "Identification of novel and recurrent CACNA1A gene mutations in
RT   fifteen patients with episodic ataxia type 2.";
RL   J. Neurol. Sci. 291:30-36(2010).
RN   [32]
RP   VARIANT EA2 LYS-388.
RX   PubMed=21696515; DOI=10.1111/j.1442-200X.2011.03390.x;
RA   Nikaido K., Tachi N., Ohya K., Wada T., Tsutsumi H.;
RT   "New mutation of CACNA1A gene in episodic ataxia type 2.";
RL   Pediatr. Int. 53:415-416(2011).
RN   [33]
RP   VARIANT FHM1 PHE-1502 DEL, CHARACTERIZATION OF VARIANT FHM1 PHE-1502
RP   DEL, AND FUNCTION.
RX   PubMed=24836863; DOI=10.1016/j.jns.2014.04.027;
RA   Garcia Segarra N., Gautschi I., Mittaz-Crettol L., Kallay Zetchi C.,
RA   Al-Qusairi L., Van Bemmelen M.X., Maeder P., Bonafe L., Schild L.,
RA   Roulet-Perez E.;
RT   "Congenital ataxia and hemiplegic migraine with cerebral edema
RT   associated with a novel gain of function mutation in the calcium
RT   channel CACNA1A.";
RL   J. Neurol. Sci. 342:69-78(2014).
RN   [34]
RP   VARIANT FHM1 PHE-1502 DEL, CHARACTERIZATION OF VARIANT FHM1 PHE-1502
RP   DEL, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=26716990; DOI=10.1371/journal.pone.0146035;
RA   Bahamonde M.I., Serra S.A., Drechsel O., Rahman R., Marce-Grau A.,
RA   Prieto M., Ossowski S., Macaya A., Fernandez-Fernandez J.M.;
RT   "A single amino acid deletion (deltaf1502) in the s6 segment of cav2.1
RT   domain iii associated with congenital ataxia increases channel
RT   activity and promotes ca2+ influx.";
RL   PLoS ONE 10:E0146035-E0146035(2015).
RN   [35]
RP   INVOLVEMENT IN EIEE42, AND VARIANTS EIEE42 GLN-101; THR-713 AND
RP   SER-1508.
RX   PubMed=27476654; DOI=10.1016/j.ajhg.2016.06.003;
RG   Epi4K Consortium;
RT   "De novo mutations in SLC1A2 and CACNA1A are important causes of
RT   epileptic encephalopathies.";
RL   Am. J. Hum. Genet. 99:287-298(2016).
RN   [36]
RP   VARIANT EIEE42 ARG-1436.
RX   PubMed=27250579; DOI=10.1002/ajmg.a.37678;
RA   Reinson K., Oiglane-Shlik E., Talvik I., Vaher U., Ounapuu A.,
RA   Ennok M., Teek R., Pajusalu S., Murumets U., Tomberg T., Puusepp S.,
RA   Piirsoo A., Reimand T., Ounap K.;
RT   "Biallelic CACNA1A mutations cause early onset epileptic
RT   encephalopathy with progressive cerebral, cerebellar, and optic nerve
RT   atrophy.";
RL   Am. J. Med. Genet. A 170:2173-2176(2016).
RN   [37]
RP   VARIANT FHM1 GLN-583.
RX   PubMed=28900389; DOI=10.3389/fncel.2017.00263;
RA   Khaiboullina S.F., Mendelevich E.G., Shigapova L.H.,
RA   Shagimardanova E., Gazizova G., Nikitin A., Martynova E.,
RA   Davidyuk Y.N., Bogdanov E.I., Gusev O., van den Maagdenberg A.M.J.M.,
RA   Giniatullin R.A., Rizvanov A.A.;
RT   "Cerebellar Atrophy and Changes in Cytokines Associated with the
RT   CACNA1A R583Q Mutation in a Russian Familial Hemiplegic Migraine Type
RT   1 Family.";
RL   Front. Cell. Neurosci. 11:263-263(2017).
RN   [38]
RP   VARIANTS GLN-1664 AND PRO-1673, AND CHARACTERIZATION OF VARIANTS
RP   GLN-1664 AND PRO-1673.
RX   PubMed=3; DOI=10.1371/journal.pgen.1006905;
RG   Members of the UDN;
RA   Luo X., Rosenfeld J.A., Yamamoto S., Harel T., Zuo Z., Hall M.,
RA   Wierenga K.J., Pastore M.T., Bartholomew D., Delgado M.R.,
RA   Rotenberg J., Lewis R.A., Emrick L., Bacino C.A., Eldomery M.K.,
RA   Coban Akdemir Z., Xia F., Yang Y., Lalani S.R., Lotze T., Lupski J.R.,
RA   Lee B., Bellen H.J., Wangler M.F.;
RT   "Clinically severe CACNA1A alleles affect synaptic function and
RT   neurodegeneration differentially.";
RL   PLoS Genet. 13:E1006905-E1006905(2017).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000269|PubMed:10049321, ECO:0000269|PubMed:10753886,
CC       ECO:0000269|PubMed:11723274, ECO:0000269|PubMed:15293273,
CC       ECO:0000269|PubMed:19232643, ECO:0000269|PubMed:24836863,
CC       ECO:0000269|PubMed:26716990}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interact (via C-terminal CDB motif) with CABP1 in the pre- and
CC       postsynaptic membranes. {ECO:0000269|PubMed:11865310}.
CC   -!- INTERACTION:
CC       Q8IZP0:ABI1; NbExp=2; IntAct=EBI-766279, EBI-375446;
CC       O94910:ADGRL1; NbExp=2; IntAct=EBI-766279, EBI-3389315;
CC       Q86SJ2:AMIGO2; NbExp=2; IntAct=EBI-766279, EBI-3866830;
CC       Q7Z5H3:ARHGAP22; NbExp=2; IntAct=EBI-766279, EBI-3866859;
CC       P67870:CSNK2B; NbExp=2; IntAct=EBI-766279, EBI-348169;
CC       O75953:DNAJB5; NbExp=2; IntAct=EBI-766279, EBI-5655937;
CC       P28799:GRN; NbExp=2; IntAct=EBI-766279, EBI-747754;
CC       P15822:HIVEP1; NbExp=2; IntAct=EBI-766279, EBI-722264;
CC       Q8N2S1:LTBP4; NbExp=2; IntAct=EBI-766279, EBI-947718;
CC       O00339:MATN2; NbExp=2; IntAct=EBI-766279, EBI-949020;
CC       O75095:MEGF6; NbExp=2; IntAct=EBI-766279, EBI-947597;
CC       Q7Z7M0:MEGF8; NbExp=2; IntAct=EBI-766279, EBI-947617;
CC       Q9UHX1:PUF60; NbExp=2; IntAct=EBI-766279, EBI-1053259;
CC       Q8IXT5:RBM12B; NbExp=2; IntAct=EBI-766279, EBI-3044077;
CC       O95153:TSPOAP1; NbExp=2; IntAct=EBI-766279, EBI-5915931;
CC       Q9BVA1:TUBB2B; NbExp=2; IntAct=EBI-766279, EBI-355665;
CC       P22695:UQCRC2; NbExp=2; IntAct=EBI-766279, EBI-1051424;
CC       P49750:YLPM1; NbExp=2; IntAct=EBI-766279, EBI-712871;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10049321,
CC       ECO:0000269|PubMed:26716990}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=1A-1, BI-1-GGCAG;
CC         IsoId=O00555-1; Sequence=Displayed;
CC       Name=2; Synonyms=1A-2,BI-1;
CC         IsoId=O00555-2; Sequence=VSP_000875;
CC       Name=3; Synonyms=BI-1(V1);
CC         IsoId=O00555-3; Sequence=VSP_000871, VSP_000875;
CC       Name=4; Synonyms=BI-1(V1)-GGCAG;
CC         IsoId=O00555-4; Sequence=VSP_000871;
CC       Name=5; Synonyms=BI-1(V2);
CC         IsoId=O00555-5; Sequence=VSP_000872, VSP_000875;
CC       Name=6; Synonyms=BI-1(V2)-GGCAG;
CC         IsoId=O00555-6; Sequence=VSP_000872;
CC       Name=8;
CC         IsoId=O00555-8; Sequence=VSP_046165, VSP_046166;
CC   -!- TISSUE SPECIFICITY: Brain specific; mainly found in cerebellum,
CC       cerebral cortex, thalamus and hypothalamus. Expressed in the small
CC       cell lung carcinoma cell line SCC-9. No expression in heart,
CC       kidney, liver or muscle. Purkinje cells contain predominantly P-
CC       type VSCC, the Q-type being a prominent calcium current in
CC       cerebellar granule cells. {ECO:0000269|PubMed:1335101}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- POLYMORPHISM: The poly-Gln region of CACNA1A is polymorphic: 6 to
CC       17 repeats in the normal population, expanded to about 21 to 30
CC       repeats in SCA6. Repeat expansion has been reported also in a EA2
CC       family. {ECO:0000269|PubMed:9302278}.
CC   -!- DISEASE: Spinocerebellar ataxia 6 (SCA6) [MIM:183086]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA),
CC       mainly caused by expansion of a CAG repeat in the coding region of
CC       CACNA1A. There seems to be a correlation between the repeat number
CC       and earlier onset of the disorder. {ECO:0000269|PubMed:16325861,
CC       ECO:0000269|PubMed:20682717, ECO:0000269|PubMed:8988170,
CC       ECO:0000269|PubMed:9302278, ECO:0000269|PubMed:9345107}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]: A
CC       subtype of migraine with aura associated with ictal hemiparesis
CC       and, in some families, cerebellar ataxia and atrophy. Migraine is
CC       a disabling symptom complex of periodic headaches, usually
CC       temporal and unilateral. Headaches are often accompanied by
CC       irritability, nausea, vomiting and photophobia, preceded by
CC       constriction of the cranial arteries. Migraine with aura is
CC       characterized by recurrent attacks of reversible neurological
CC       symptoms (aura) that precede or accompany the headache. Aura may
CC       include a combination of sensory disturbances, such as blurred
CC       vision, hallucinations, vertigo, numbness and difficulty in
CC       concentrating and speaking. {ECO:0000269|PubMed:10408532,
CC       ECO:0000269|PubMed:11409427, ECO:0000269|PubMed:11439943,
CC       ECO:0000269|PubMed:15032980, ECO:0000269|PubMed:18400034,
CC       ECO:0000269|PubMed:24836863, ECO:0000269|PubMed:26716990,
CC       ECO:0000269|PubMed:28900389, ECO:0000269|PubMed:8898206}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Episodic ataxia 2 (EA2) [MIM:108500]: An autosomal
CC       dominant disorder characterized by acetozolamide-responsive
CC       attacks of ataxia, migraine-like symptoms, interictal nystagmus,
CC       and cerebellar atrophy. {ECO:0000269|PubMed:10987655,
CC       ECO:0000269|PubMed:11176968, ECO:0000269|PubMed:11723274,
CC       ECO:0000269|PubMed:12420090, ECO:0000269|PubMed:14718690,
CC       ECO:0000269|PubMed:15173248, ECO:0000269|PubMed:15293273,
CC       ECO:0000269|PubMed:18602318, ECO:0000269|PubMed:19232643,
CC       ECO:0000269|PubMed:20129625, ECO:0000269|PubMed:21696515,
CC       ECO:0000269|PubMed:8898206, ECO:0000269|PubMed:9302278}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 42 (EIEE42)
CC       [MIM:617106]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE42
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:27250579,
CC       ECO:0000269|PubMed:27476654}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB49678.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Calcium channel, voltage-dependent, P/Q type,
CC       alpha 1A subunit (CACNA1A); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://chromium.lovd.nl/LOVD2/home.php?select_db=CACNA1A";
CC   -!- WEB RESOURCE: Name=Familial hemiplegic migraine (FHM) variation
CC       database, calcium channel, voltage-dependent, P/Q type, alpha 1A
CC       subunit (CACNA1A); Note=Leiden Open Variation Database (LOVD);
CC       URL="http://grenada.lumc.nl/LOVD2/FHM/home.php?select_db=CACNA1A";
CC   -!- WEB RESOURCE: Name=Undiagnosed Disease Network; Note=CACNA1A;
CC       URL="https://undiagnosed.hms.harvard.edu/updates/genes-of-interest/cacna1a-gene/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF004883; AAB61612.1; -; mRNA.
DR   EMBL; AF004884; AAB61613.1; -; mRNA.
DR   EMBL; X99897; CAA68172.1; -; mRNA.
DR   EMBL; Z80114; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z80115; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U79663; AAB49674.1; -; mRNA.
DR   EMBL; U79664; AAB49675.1; -; mRNA.
DR   EMBL; U79665; AAB49676.1; -; mRNA.
DR   EMBL; U79666; AAB64179.1; -; mRNA.
DR   EMBL; U79667; AAB49677.1; -; mRNA.
DR   EMBL; U79668; AAB49678.1; ALT_SEQ; mRNA.
DR   EMBL; AB035727; BAA94766.2; -; mRNA.
DR   EMBL; AC005305; AAC26839.1; -; Genomic_DNA.
DR   EMBL; AC005513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S76537; AAB33068.1; -; mRNA.
DR   EMBL; U06702; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS45998.1; -. [O00555-8]
DR   CCDS; CCDS45999.1; -. [O00555-3]
DR   RefSeq; NP_000059.3; NM_000068.3.
DR   RefSeq; NP_001120693.1; NM_001127221.1. [O00555-3]
DR   RefSeq; NP_001120694.1; NM_001127222.1. [O00555-8]
DR   RefSeq; NP_001167551.1; NM_001174080.1.
DR   RefSeq; NP_075461.2; NM_023035.2.
DR   UniGene; Hs.501632; -.
DR   PDB; 3BXK; X-ray; 2.55 A; B/D=1955-1975.
DR   PDBsum; 3BXK; -.
DR   ProteinModelPortal; O00555; -.
DR   SMR; O00555; -.
DR   BioGrid; 107227; 100.
DR   CORUM; O00555; -.
DR   IntAct; O00555; 92.
DR   STRING; 9606.ENSP00000353362; -.
DR   BindingDB; O00555; -.
DR   ChEMBL; CHEMBL4266; -.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB00230; Pregabalin.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   TCDB; 1.A.1.11.27; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O00555; -.
DR   PhosphoSitePlus; O00555; -.
DR   BioMuta; CACNA1A; -.
DR   MaxQB; O00555; -.
DR   PaxDb; O00555; -.
DR   PeptideAtlas; O00555; -.
DR   PRIDE; O00555; -.
DR   DNASU; 773; -.
DR   Ensembl; ENST00000360228; ENSP00000353362; ENSG00000141837. [O00555-8]
DR   Ensembl; ENST00000635895; ENSP00000490323; ENSG00000141837. [O00555-2]
DR   Ensembl; ENST00000637276; ENSP00000489777; ENSG00000141837. [O00555-5]
DR   Ensembl; ENST00000638009; ENSP00000489913; ENSG00000141837. [O00555-3]
DR   GeneID; 773; -.
DR   KEGG; hsa:773; -.
DR   UCSC; uc002mwy.5; human. [O00555-1]
DR   CTD; 773; -.
DR   DisGeNET; 773; -.
DR   EuPathDB; HostDB:ENSG00000141837.18; -.
DR   GeneCards; CACNA1A; -.
DR   GeneReviews; CACNA1A; -.
DR   HGNC; HGNC:1388; CACNA1A.
DR   HPA; HPA064258; -.
DR   MalaCards; CACNA1A; -.
DR   MIM; 108500; phenotype.
DR   MIM; 141500; phenotype.
DR   MIM; 183086; phenotype.
DR   MIM; 601011; gene.
DR   MIM; 617106; phenotype.
DR   neXtProt; NX_O00555; -.
DR   OpenTargets; ENSG00000141837; -.
DR   Orphanet; 2131; Alternating hemiplegia of childhood.
DR   Orphanet; 71518; Benign paroxysmal torticollis of infancy.
DR   Orphanet; 569; Familial or sporadic hemiplegic migraine.
DR   Orphanet; 97; Familial paroxysmal ataxia.
DR   Orphanet; 98758; Spinocerebellar ataxia type 6.
DR   PharmGKB; PA26007; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000231530; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; O00555; -.
DR   KO; K04344; -.
DR   PhylomeDB; O00555; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   ChiTaRS; CACNA1A; human.
DR   EvolutionaryTrace; O00555; -.
DR   GeneWiki; Cav2.1; -.
DR   GenomeRNAi; 773; -.
DR   PRO; PR:O00555; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141837; -.
DR   ExpressionAtlas; O00555; baseline and differential.
DR   Genevisible; O00555; HS.
DR   GO; GO:0042995; C:cell projection; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019905; F:syntaxin binding; IDA:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0008219; P:cell death; IDA:UniProtKB.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IDA:ARUK-UCL.
DR   GO; GO:0051899; P:membrane depolarization; TAS:Reactome.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:1904645; P:response to amyloid-beta; IDA:ARUK-UCL.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Disease mutation;
KW   Disulfide bond; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Neurodegeneration; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Spinocerebellar ataxia;
KW   Transmembrane; Transmembrane helix; Transport;
KW   Triplet repeat expansion; Voltage-gated channel.
FT   CHAIN         1   2505       Voltage-dependent P/Q-type calcium
FT                                channel subunit alpha-1A.
FT                                /FTId=PRO_0000053916.
FT   TOPO_DOM      1     98       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     99    117       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    118    135       Extracellular. {ECO:0000255}.
FT   TRANSMEM    136    155       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    156    167       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    168    185       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    186    190       Extracellular. {ECO:0000255}.
FT   TRANSMEM    191    209       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    210    228       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    229    248       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    249    335       Extracellular. {ECO:0000255}.
FT   TRANSMEM    336    360       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    361    487       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    488    506       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    507    521       Extracellular. {ECO:0000255}.
FT   TRANSMEM    522    541       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    542    549       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    550    568       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    569    578       Extracellular. {ECO:0000255}.
FT   TRANSMEM    579    597       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    598    616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    617    636       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    637    689       Extracellular. {ECO:0000255}.
FT   TRANSMEM    690    714       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    715   1242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1243   1261       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1262   1277       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1278   1297       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1298   1309       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1310   1328       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1329   1339       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1340   1358       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1359   1377       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1378   1397       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1398   1484       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1485   1509       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1510   1564       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1565   1593       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1594   1598       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1599   1618       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1619   1626       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1627   1645       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1646   1652       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1653   1671       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1672   1690       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1691   1710       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1711   1782       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1783   1807       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1808   2505       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       85    363       I.
FT   REPEAT      473    717       II.
FT   REPEAT     1231   1514       III.
FT   REPEAT     1551   1814       IV.
FT   CA_BIND    1840   1851       {ECO:0000250}.
FT   REGION      383    400       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS     13     18       Poly-Gly.
FT   COMPBIAS    727    732       Poly-Glu.
FT   COMPBIAS   1002   1007       Poly-Arg.
FT   COMPBIAS   1204   1207       Poly-Glu.
FT   COMPBIAS   2211   2220       Poly-His.
FT   COMPBIAS   2221   2224       Poly-Pro.
FT   COMPBIAS   2314   2324       Poly-Gln.
FT   SITE        318    318       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        668    668       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1460   1460       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1649   1649       Binds to omega-Aga-IVA. {ECO:0000250}.
FT   SITE       1756   1756       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES     409    409       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     448    448       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     451    451       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     753    753       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     790    790       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1085   1085       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1094   1094       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1822   1822       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1984   1984       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2047   2047       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2065   2065       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2077   2077       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2079   2079       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2120   2120       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2140   2140       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     419    419       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:10753886}.
FT                                /FTId=VSP_046165.
FT   VAR_SEQ    1844   1875       WGRMPYLDMYQMLRHMSPPLGLGKKCPARVAY -> CGRIH
FT                                YKDMYSLLRVISPPLGLGKKCPHRVAC (in isoform 3
FT                                and isoform 4).
FT                                {ECO:0000303|PubMed:8898206,
FT                                ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000871.
FT   VAR_SEQ    2103   2114       Missing (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000872.
FT   VAR_SEQ    2262   2505       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:10049321,
FT                                ECO:0000303|PubMed:8898206,
FT                                ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000875.
FT   VAR_SEQ    2314   2314       Q -> QQQ (in isoform 8).
FT                                {ECO:0000303|PubMed:10753886}.
FT                                /FTId=VSP_046166.
FT   VARIANT      21     21       A -> V (in dbSNP:rs15999).
FT                                /FTId=VAR_014456.
FT   VARIANT     101    101       E -> Q (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077071.
FT   VARIANT     192    192       R -> Q (in FHM1; dbSNP:rs121908211).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001491.
FT   VARIANT     195    195       R -> K (in FHM1; dbSNP:rs121908222).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043820.
FT   VARIANT     218    218       S -> L (in FHM1; dbSNP:rs121908225).
FT                                {ECO:0000269|PubMed:11409427}.
FT                                /FTId=VAR_043821.
FT   VARIANT     248    248       Y -> C (in EA2; dbSNP:rs121908238).
FT                                {ECO:0000269|PubMed:18602318}.
FT                                /FTId=VAR_063683.
FT   VARIANT     253    253       H -> Y (in EA2; dbSNP:rs121908228).
FT                                {ECO:0000269|PubMed:12420090}.
FT                                /FTId=VAR_043822.
FT   VARIANT     256    256       C -> R (in EA2; dbSNP:rs121908231).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043823.
FT   VARIANT     287    287       C -> Y (in EA2; dbSNP:rs121908236).
FT                                {ECO:0000269|PubMed:14718690}.
FT                                /FTId=VAR_043824.
FT   VARIANT     293    293       G -> R (in EA2 and SCA6;
FT                                dbSNP:rs121908215).
FT                                {ECO:0000269|PubMed:14718690,
FT                                ECO:0000269|PubMed:9345107}.
FT                                /FTId=VAR_043825.
FT   VARIANT     388    388       E -> K (in EA2).
FT                                {ECO:0000269|PubMed:21696515}.
FT                                /FTId=VAR_067342.
FT   VARIANT     389    389       L -> F (in EA2; dbSNP:rs121908239).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063684.
FT   VARIANT     405    405       A -> T (in SCA6; dbSNP:rs121908245).
FT                                {ECO:0000269|PubMed:20682717}.
FT                                /FTId=VAR_063685.
FT   VARIANT     454    454       A -> T (in dbSNP:rs41276886).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_063686.
FT   VARIANT     501    501       T -> M (in EA2; dbSNP:rs121908240).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063687.
FT   VARIANT     583    583       R -> Q (in FHM1; dbSNP:rs121908217).
FT                                {ECO:0000269|PubMed:11439943,
FT                                ECO:0000269|PubMed:28900389}.
FT                                /FTId=VAR_043826.
FT   VARIANT     638    638       G -> D (in EA2; reduces P/Q current
FT                                densities; dbSNP:rs121908246).
FT                                {ECO:0000269|PubMed:19232643}.
FT                                /FTId=VAR_063688.
FT   VARIANT     666    666       T -> M (in FHM1 and EA2;
FT                                dbSNP:rs121908212).
FT                                {ECO:0000269|PubMed:11439943,
FT                                ECO:0000269|PubMed:14718690,
FT                                ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001492.
FT   VARIANT     713    713       A -> T (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077072.
FT   VARIANT     714    714       V -> A (in FHM1; dbSNP:rs121908213).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001493.
FT   VARIANT     715    715       D -> E (in FHM1; dbSNP:rs121908218).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043827.
FT   VARIANT     732    732       E -> A (in dbSNP:rs16019).
FT                                /FTId=VAR_059221.
FT   VARIANT     798    798       M -> T (in EA2; dbSNP:rs121908241).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063689.
FT   VARIANT     897    897       P -> R (in EA2; dbSNP:rs121908242).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063690.
FT   VARIANT     914    914       P -> S (in dbSNP:rs16020).
FT                                /FTId=VAR_014458.
FT   VARIANT     918    918       E -> D (in dbSNP:rs16022).
FT                                {ECO:0000269|PubMed:16866717,
FT                                ECO:0000269|PubMed:19429006}.
FT                                /FTId=VAR_014459.
FT   VARIANT     993    993       E -> V (in dbSNP:rs16023).
FT                                {ECO:0000269|PubMed:10408532,
FT                                ECO:0000269|PubMed:16866717,
FT                                ECO:0000269|PubMed:19429006}.
FT                                /FTId=VAR_043828.
FT   VARIANT    1015   1015       E -> K (in dbSNP:rs16024).
FT                                /FTId=VAR_014461.
FT   VARIANT    1105   1105       G -> S (in dbSNP:rs16027).
FT                                {ECO:0000269|PubMed:10753886,
FT                                ECO:0000269|PubMed:16866717}.
FT                                /FTId=VAR_014462.
FT   VARIANT    1173   1173       P -> L (in dbSNP:rs16028).
FT                                /FTId=VAR_059222.
FT   VARIANT    1335   1335       K -> E (in FHM1; dbSNP:rs121908223).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043829.
FT   VARIANT    1346   1346       R -> Q (in FHM1; with progressive
FT                                cerebellar ataxia; dbSNP:rs121908230).
FT                                {ECO:0000269|PubMed:15032980,
FT                                ECO:0000269|PubMed:18400034}.
FT                                /FTId=VAR_043830.
FT   VARIANT    1384   1384       Y -> C (in FHM1; dbSNP:rs121908219).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043831.
FT   VARIANT    1403   1403       F -> C (in EA2; loss of function;
FT                                dbSNP:rs121908227).
FT                                {ECO:0000269|PubMed:11723274}.
FT                                /FTId=VAR_043832.
FT   VARIANT    1436   1436       W -> R (in EIEE42).
FT                                {ECO:0000269|PubMed:27250579}.
FT                                /FTId=VAR_077073.
FT   VARIANT    1456   1456       V -> L (in FHM1; dbSNP:rs121908237).
FT                                {ECO:0000269|PubMed:10408532}.
FT                                /FTId=VAR_043833.
FT   VARIANT    1482   1482       G -> R (in EA2; dbSNP:rs121908232).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043834.
FT   VARIANT    1490   1490       F -> S (in EA2; dbSNP:rs121908233).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043835.
FT   VARIANT    1493   1493       V -> I (in EA2; dbSNP:rs121908234).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043836.
FT   VARIANT    1502   1502       Missing (in FHM1; increased high voltage-
FT                                gated calcium channel activity).
FT                                {ECO:0000269|PubMed:24836863,
FT                                ECO:0000269|PubMed:26716990}.
FT                                /FTId=VAR_077074.
FT   VARIANT    1508   1508       A -> S (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077075.
FT   VARIANT    1661   1661       R -> H (in EA2; dbSNP:rs121908216).
FT                                {ECO:0000269|PubMed:10987655}.
FT                                /FTId=VAR_043837.
FT   VARIANT    1664   1664       R -> Q (in SCA6; also found in patients
FT                                with global developmental delay and
FT                                congenital ataxia; loss of function
FT                                observed in the Drosophila homolog;
FT                                dbSNP:rs121908247).
FT                                {ECO:0000250|UniProtKB:P91645,
FT                                ECO:0000269|PubMed:16325861,
FT                                ECO:0000269|PubMed:3}.
FT                                /FTId=VAR_063691.
FT   VARIANT    1667   1667       R -> W (in FHM1; dbSNP:rs121908220).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043838.
FT   VARIANT    1673   1673       R -> P (also found in patients with
FT                                global developmental delay and congenital
FT                                ataxia; gain of function observed in the
FT                                Drosophila homolog).
FT                                {ECO:0000250|UniProtKB:P91645,
FT                                ECO:0000269|PubMed:3}.
FT                                /FTId=VAR_079826.
FT   VARIANT    1679   1679       R -> C (in EA2; dbSNP:rs121908243).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063692.
FT   VARIANT    1683   1683       W -> R (in FHM1; dbSNP:rs121908221).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043839.
FT   VARIANT    1695   1695       V -> I (in FHM1; dbSNP:rs121908224).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_063706.
FT   VARIANT    1736   1736       H -> L (in EA2; changed high voltage-
FT                                gated calcium channel activity;
FT                                dbSNP:rs121908229).
FT                                {ECO:0000269|PubMed:15293273}.
FT                                /FTId=VAR_043840.
FT   VARIANT    1756   1756       E -> K (in EA2; dbSNP:rs121908226).
FT                                {ECO:0000269|PubMed:11176968}.
FT                                /FTId=VAR_043841.
FT   VARIANT    1810   1810       I -> L (in FHM1; dbSNP:rs121908214).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001494.
FT   VARIANT    1869   1869       C -> R (in EA2; dbSNP:rs121908244).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063693.
FT   VARIANT    2135   2135       R -> C (in EA2; dbSNP:rs121908235).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043842.
FT   VARIANT    2394   2394       P -> S (in dbSNP:rs16056).
FT                                /FTId=VAR_014463.
FT   CONFLICT    725    725       K -> KVEA (in Ref. 1; AAB61613/AAB61612).
FT                                {ECO:0000305}.
FT   CONFLICT    896    896       G -> D (in Ref. 2; CAA68172 and 4;
FT                                BAA94766). {ECO:0000305}.
FT   CONFLICT    953    953       D -> N (in Ref. 4; BAA94766).
FT                                {ECO:0000305}.
FT   CONFLICT    964    964       R -> S (in Ref. 4; BAA94766).
FT                                {ECO:0000305}.
FT   CONFLICT   1207   1207       E -> EE (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1313   1315       WNI -> ILP (in Ref. 3; AAB49674/AAB49675/
FT                                AAB49676/AAB49677/AAB49678).
FT                                {ECO:0000305}.
FT   CONFLICT   1459   1459       G -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1604   1604       V -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1617   1617       V -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1651   1651       G -> GNP (in Ref. 1; AAB61613/AAB61612).
FT                                {ECO:0000305}.
FT   CONFLICT   1693   1693       P -> A (in Ref. 6; AAB33068).
FT                                {ECO:0000305}.
FT   CONFLICT   2038   2038       E -> G (in Ref. 8; U06702).
FT                                {ECO:0000305}.
FT   CONFLICT   2314   2314       Q -> QQ (in Ref. 3; AAB49676).
FT                                {ECO:0000305}.
FT   HELIX      1956   1970       {ECO:0000244|PDB:3BXK}.
SQ   SEQUENCE   2505 AA;  282365 MW;  2F2F378ACE02FD56 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS AKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAAIMT
     VFQILTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANA
     QELTKDEQEE EEAANQKLAL QKAKEVAEVS PLSAANMSIA VKEQQKNQKP AKSVWEQRTS
     EMRKQNLLAS REALYNEMDP DERWKAAYTR HLRPDMKTHL DRPLVVDPQE NRNNNTNKSR
     AAEPTVDQRL GQQRAEDFLR KQARYHDRAR DPSGSAGLDA RRPWAGSQEA ELSREGPYGR
     ESDHHAREGS LEQPGFWEGE AERGKAGDPH RRHVHRQGGS RESRSGSPRT GADGEHRRHR
     AHRRPGEEGP EDKAERRARH REGSRPARGG EGEGEGPDGG ERRRRHRHGA PATYEGDARR
     EDKERRHRRR KENQGSGVPV SGPNLSTTRP IQQDLGRQDP PLAEDIDNMK NNKLATAESA
     APHGSLGHAG LPQSPAKMGN STDPGPMLAI PAMATNPQNA ASRRTPNNPG NPSNPGPPKT
     PENSLIVTNP SGTQTNSAKT ARKPDHTTVD IPPACPPPLN HTVVQVNKNA NPDPLPKKEE
     EKKEEEEDDR GEDGPKPMPP YSSMFILSTT NPLRRLCHYI LNLRYFEMCI LMVIAMSSIA
     LAAEDPVQPN APRNNVLRYF DYVFTGVFTF EMVIKMIDLG LVLHQGAYFR DLWNILDFIV
     VSGALVAFAF TGNSKGKDIN TIKSLRVLRV LRPLKTIKRL PKLKAVFDCV VNSLKNVFNI
     LIVYMLFMFI FAVVAVQLFK GKFFHCTDES KEFEKDCRGK YLLYEKNEVK ARDREWKKYE
     FHYDNVLWAL LTLFTVSTGE GWPQVLKHSV DATFENQGPS PGYRMEMSIF YVVYFVVFPF
     FFVNIFVALI IITFQEQGDK MMEEYSLEKN ERACIDFAIS AKPLTRHMPQ NKQSFQYRMW
     QFVVSPPFEY TIMAMIALNT IVLMMKFYGA SVAYENALRV FNIVFTSLFS LECVLKVMAF
     GILNYFRDAW NIFDFVTVLG SITDILVTEF GNNFINLSFL RLFRAARLIK LLRQGYTIRI
     LLWTFVQSFK ALPYVCLLIA MLFFIYAIIG MQVFGNIGID VEDEDSDEDE FQITEHNNFR
     TFFQALMLLF RSATGEAWHN IMLSCLSGKP CDKNSGILTR ECGNEFAYFY FVSFIFLCSF
     LMLNLFVAVI MDNFEYLTRD SSILGPHHLD EYVRVWAEYD PAAWGRMPYL DMYQMLRHMS
     PPLGLGKKCP ARVAYKRLLR MDLPVADDNT VHFNSTLMAL IRTALDIKIA KGGADKQQMD
     AELRKEMMAI WPNLSQKTLD LLVTPHKSTD LTVGKIYAAM MIMEYYRQSK AKKLQAMREE
     QDRTPLMFQR MEPPSPTQEG GPGQNALPST QLDPGGALMA HESGLKESPS WVTQRAQEMF
     QKTGTWSPEQ GPPTDMPNSQ PNSQSVEMRE MGRDGYSDSE HYLPMEGQGR AASMPRLPAE
     NQRRRGRPRG NNLSTISDTS PMKRSASVLG PKARRLDDYS LERVPPEENQ RHHQRRRDRS
     HRASERSLGR YTDVDTGLGT DLSMTTQSGD LPSKERDQER GRPKDRKHRQ HHHHHHHHHH
     PPPPDKDRYA QERPDHGRAR ARDQRWSRSP SEGREHMAHR QGSSSVSGSP APSTSGTSTP
     RRGRRQLPQT PSTPRPHVSY SPVIRKAGGS GPPQQQQQQQ QQQQAVARPG RAATSGPRRY
     PGPTAEPLAG DRPPTGGHSS GRSPRMERRV PGPARSESPR ACRHGGARWP ASGPHVSEGP
     PGPRHHGYYR GSDYDEADGP GSGGGEEAMA GAYDAPPPVR HASSGATGRS PRTPRASGPA
     CASPSRHGRR LPNGYYPAHG LARPRGPGSR KGLHEPYSES DDDWC
//
ID   CCH1_SCHPO              Reviewed;        1854 AA.
AC   O14234;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   25-OCT-2017, entry version 114.
DE   RecName: Full=Calcium-channel protein cch1;
GN   Name=cch1; ORFNames=SPAC6F6.01;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=16823372; DOI=10.1038/nbt1222;
RA   Matsuyama A., Arai R., Yashiroda Y., Shirai A., Kamata A., Sekido S.,
RA   Kobayashi Y., Hashimoto A., Hamamoto M., Hiraoka Y., Horinouchi S.,
RA   Yoshida M.;
RT   "ORFeome cloning and global analysis of protein localization in the
RT   fission yeast Schizosaccharomyces pombe.";
RL   Nat. Biotechnol. 24:841-847(2006).
CC   -!- FUNCTION: Voltage-gated, high-affinity calcium channel involved in
CC       calcium influx in response to some environmental stresses as well
CC       as exposure to mating pheromones. Functions together with yam8 to
CC       ensure that adequate levels of Ca(2+) are supplied to pmr1 to
CC       sustain secretion and growth. Required for growth in low-calcium
CC       environments (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with yam8 to form a Ca(2+) influx channel.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAB11726.1; -; Genomic_DNA.
DR   PIR; T39035; T39035.
DR   RefSeq; NP_593894.1; NM_001019324.2.
DR   ProteinModelPortal; O14234; -.
DR   BioGrid; 279259; 34.
DR   MINT; MINT-4671635; -.
DR   STRING; 4896.SPAC6F6.01.1; -.
DR   TCDB; 1.A.1.11.23; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O14234; -.
DR   MaxQB; O14234; -.
DR   PRIDE; O14234; -.
DR   EnsemblFungi; SPAC6F6.01.1; SPAC6F6.01.1:pep; SPAC6F6.01.
DR   GeneID; 2542812; -.
DR   KEGG; spo:SPAC6F6.01; -.
DR   EuPathDB; FungiDB:SPAC6F6.01; -.
DR   PomBase; SPAC6F6.01; cch1.
DR   InParanoid; O14234; -.
DR   KO; K21864; -.
DR   OMA; MLGDSAM; -.
DR   OrthoDB; EOG092C00XX; -.
DR   PhylomeDB; O14234; -.
DR   PRO; PR:O14234; -.
DR   Proteomes; UP000002485; Chromosome I.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:PomBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:PomBase.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; IMP:PomBase.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IMP:PomBase.
DR   GO; GO:0035585; P:calcium-mediated signaling using extracellular calcium source; IMP:PomBase.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
PE   3: Inferred from homology;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1   1854       Calcium-channel protein cch1.
FT                                /FTId=PRO_0000311769.
FT   TRANSMEM    184    204       Helical. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical. {ECO:0000255}.
FT   TRANSMEM    274    294       Helical. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical. {ECO:0000255}.
FT   TRANSMEM    427    447       Helical. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical. {ECO:0000255}.
FT   TRANSMEM    514    534       Helical. {ECO:0000255}.
FT   TRANSMEM    549    569       Helical. {ECO:0000255}.
FT   TRANSMEM    581    601       Helical. {ECO:0000255}.
FT   TRANSMEM    606    626       Helical. {ECO:0000255}.
FT   TRANSMEM    642    662       Helical. {ECO:0000255}.
FT   TRANSMEM    723    743       Helical. {ECO:0000255}.
FT   TRANSMEM    946    966       Helical. {ECO:0000255}.
FT   TRANSMEM    980   1000       Helical. {ECO:0000255}.
FT   TRANSMEM   1021   1041       Helical. {ECO:0000255}.
FT   TRANSMEM   1075   1095       Helical. {ECO:0000255}.
FT   TRANSMEM   1148   1168       Helical. {ECO:0000255}.
FT   TRANSMEM   1193   1213       Helical. {ECO:0000255}.
FT   TRANSMEM   1274   1294       Helical. {ECO:0000255}.
FT   TRANSMEM   1302   1322       Helical. {ECO:0000255}.
FT   TRANSMEM   1331   1351       Helical. {ECO:0000255}.
FT   TRANSMEM   1358   1378       Helical. {ECO:0000255}.
FT   TRANSMEM   1393   1413       Helical. {ECO:0000255}.
FT   TRANSMEM   1486   1506       Helical. {ECO:0000255}.
SQ   SEQUENCE   1854 AA;  213165 MW;  79C972D54E228DFA CRC64;
     MSSSSNSDPS SSPDNTDFIP LKDNPKDTSS YINKKNPFVN DSFDSHDDSY LDNVNPFEYN
     VADDEDTISM TSDGVEFHNL GITETVDEQD KILSELQLAY PTVSRYSETL DKGLLNGDKT
     TKGDYTSLRR FRKPFLFDKL SPYFTHFFSE IYAAVLRVVG PPRANETPGR NLPFSPILRQ
     IYNHPLYNIF IFVVIVLHAV LLMIRSDDPH DKSQTIDYLI IVIGILYTLE MLLKIYLFGF
     LYDGSSSFYD FINSYTKKTP RTMSYLRHSW NRVDFVAIVA LWISVIGKKQ QGIFRLFSMI
     ACLRLTRLLN ITRKTETILK SLKESSTPLV QVVSFNAFFG VMIAILGVQF FKASLNRQCV
     WLGDYGDQYL PTGQFCGGHW ENGIKRAYLD KNGFPSNVNP RGFICAEKSV CRVVENPYSN
     TVSFDNFFNS LELIFVIMSS NGFTDIMYDI MDAEYFVSCL LFIISAYFLT LWLMSLVIAV
     VTSSFIDLQH SGKNQKEQKS VDKHLIRNKL CEKYLFYSNF IWISFIVAQF VTLCTQTYDQ
     TSSTANRYLI FYACVDFLLA AEVILRFFAY LPDYRLFFRR YTNLVDIVLA VLNLVTLLPS
     IRKNPVAFGW LSIFAIARIY RCILLIPYTR KIAKLLFSNF KQLLNLMLFL VIVLFIASLC
     AVRLFQDLPN DGDSDDDAIS FATTYESFLY MYQILTSENW TDVMFAIQAR LAHLHLSWIP
     GAFFTLWFLF SNNVVLSMFI AVIQVNFAPS ESDLKMEQLK MYLARLLRNY NPFQASLTLN
     ALIKRNGSRK GKTVDESHYE WLYEDNIIKG FLRVTNIPPK EPLKPSLDTS PELSKYSLAK
     LSNNFKRFVM RDDPFSQAYF KRVIGIRWEK DMNLKTAAKD MQAAKAFVRI KQTEFLKNHP
     KYNDVFWVIK PSNRIRRFCQ RLVMPGVNER YGGVEPYQWV YRVIQVFIYA CILTAVIIEC
     IATPIYERDH LLNDKQHAWF VWTEVAFATI FTIEAAIKII ADGFCITPNA YLRSTWNCID
     FFVLVTLWIN LYAVLTSHAL LSRAFRAFKA LRVLRLINLT QTSQRMFHDA LISGFFKIFS
     AAVVSATLLI PFALWAKNVF GGLLYSCNDD NVLSASQCVL EYASTPNNWE VWAPRVWSNP
     PDYDFDRFPH ALLALFEIAS IEGWVDIMRS VMDITGFNNQ PQTNASSGNA MFFVLFNLVS
     MIYILTLFIA IIISNYAERT GSAFFTAEQR AWLELRRKIK SMRPSKRPAI RPLGLRGLCY
     DFAVQKHGIW RRTFTGLYIV HLLFLLTIFY PCPIAYTYVR NSIFLILSIC YTINICVKVY
     GLSFYYFFHS FWNMFDVVVT LGSLTCNIAI LAKFENRSLT LLQTTLLVLV TVHLIPKFDN
     FDQLSKTVVA SLPSIFSLIA TWIVLYITFA IAFNQIFGLT KLGLNGGPNK NFRSIRNALV
     LLFTMTFGEG WNDVMHDYTI SYPNCVNGDD FYNSDCGNKP WAYGLFIAWN IISMYIFVNM
     FITVVFDNFS YIHTKSSSFT NLQRNDFRQF KDSWAPFDPM VTGYIPKRNA VKFVLSLRGV
     YDFRIYRDEH TLRSIISKVQ SKTGQQSVPM LENPLMGSEI NLEALDQIID TIDVNVVKER
     RNVLNSLCTE IMTLPGNVIS FSNILMLVVL HKIVDHREAF PISDYIRRAY VLSELEKSIR
     MEKLLGLVET SIIRKTFLQH MEEKKKALEN PFILLSEVSE ILPETPIQEV LRQHNADPEQ
     LLMSTRTPSV SDRSFSIVES TVPTIASGEG DDNHSVEDHL KVPTDNEPRR SPSLKEVLLR
     GSHSLHSNND RTSFDIEAGF GTAESDFQFG GATEDINRIA DRIDDYLDRD SFKG
//
ID   TRPV1_RAT               Reviewed;         838 AA.
AC   O35433; Q920B3; Q920B4; Q9JLM0; Q9JM56; Q9JM57;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 156.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 1;
DE            Short=TrpV1;
DE   AltName: Full=Capsaicin receptor;
DE   AltName: Full=Osm-9-like TRP channel 1;
DE            Short=OTRPC1;
DE   AltName: Full=Vanilloid receptor 1;
DE   AltName: Full=Vanilloid receptor type 1-like;
GN   Name=Trpv1; Synonyms=Vr1, Vr1l;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Spinal ganglion;
RX   PubMed=9349813; DOI=10.1038/39807;
RA   Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D.,
RA   Julius D.;
RT   "The capsaicin receptor: a heat-activated ion channel in the pain
RT   pathway.";
RL   Nature 389:816-824(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND
RP   FUNCTION (ISOFORM 3).
RC   STRAIN=Sprague-Dawley;
RC   TISSUE=Spinal ganglion, and Trigeminal ganglion;
RX   PubMed=10644739; DOI=10.1074/jbc.275.4.2756;
RA   Schumacher M.A., Moff I., Sudanagunta S.P., Levine J.D.;
RT   "Molecular cloning of an N-terminal splice variant of the capsaicin
RT   receptor. Loss of N-terminal domain suggests functional divergence
RT   among capsaicin receptor subtypes.";
RL   J. Biol. Chem. 275:2756-2762(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11578842; DOI=10.1016/S0304-3940(01)02185-1;
RA   Tsutsumi S., Tomioka A., Sudo M., Nakamura A., Shirakura K.,
RA   Takagishi K., Kohama K.;
RT   "Propofol activates vanilloid receptor channels expressed in human
RT   embryonic kidney 293 cells.";
RL   Neurosci. Lett. 312:45-49(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-468, AND ALTERNATIVE SPLICING.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11549313; DOI=10.1006/geno.2001.6582;
RA   Xue Q., Yu Y., Trilk S.L., Jong B.E., Schumacher M.A.;
RT   "The genomic organization of the gene encoding the vanilloid receptor:
RT   evidence for multiple splice variants.";
RL   Genomics 76:14-20(2001).
RN   [5]
RP   CHARACTERIZATION OF CHANNEL PORE, AND MUTAGENESIS OF GLU-636; LYS-639;
RP   MET-644; ASP-646; GLU-648 AND GLU-651.
RX   PubMed=10931826; DOI=10.1074/jbc.M002391200;
RA   Garcia-Martinez C., Morenilla-Palao C., Planells-Cases R.,
RA   Merino J.M., Ferrer-Montiel A.V.;
RT   "Identification of an aspartic residue in the P-loop of the vanilloid
RT   receptor that modulates pore properties.";
RL   J. Biol. Chem. 275:32552-32558(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=11140687; DOI=10.1038/35050121;
RA   Premkumar L.S., Ahern G.P.;
RT   "Induction of vanilloid receptor channel activity by protein kinase
RT   C.";
RL   Nature 408:985-990(2000).
RN   [7]
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION AT ASN-604.
RX   PubMed=11683872; DOI=10.1046/j.1432-1033.2001.02500.x;
RA   Jahnel R., Dreger M., Gillen C., Bender O., Kurreck J., Hucho F.;
RT   "Biochemical characterization of the vanilloid receptor 1 expressed in
RT   a dorsal root ganglia derived cell line.";
RL   Eur. J. Biochem. 268:5489-5496(2001).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH PRKCG AND NTRK1.
RX   PubMed=11418861; DOI=10.1038/35082088;
RA   Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E.,
RA   Basbaum A.I., Chao M.V., Julius D.;
RT   "Bradykinin and nerve growth factor release the capsaicin receptor
RT   from PtdIns(4,5)P2-mediated inhibition.";
RL   Nature 411:957-962(2001).
RN   [9]
RP   PHOSPHORYLATION AT SER-502 AND SER-800, AND MUTAGENESIS OF SER-502 AND
RP   SER-800.
RX   PubMed=11884385; DOI=10.1074/jbc.C200104200;
RA   Numazaki M., Tominaga T., Toyooka H., Tominaga M.;
RT   "Direct phosphorylation of capsaicin receptor VR1 by protein kinase
RT   Cepsilon and identification of two target serine residues.";
RL   J. Biol. Chem. 277:13375-13378(2002).
RN   [10]
RP   FUNCTION.
RX   PubMed=12095983; DOI=10.1074/jbc.M201551200;
RA   Olah Z., Karai L., Iadarola M.J.;
RT   "Protein kinase C(alpha) is required for vanilloid receptor 1
RT   activation. Evidence for multiple signaling pathways.";
RL   J. Biol. Chem. 277:35752-35759(2002).
RN   [11]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-116; THR-144; THR-370; SER-502;
RP   SER-774 AND SER-820.
RX   PubMed=12194871; DOI=10.1016/S0896-6273(02)00802-4;
RA   Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV;
RT   "cAMP-dependent protein kinase regulates desensitization of the
RT   capsaicin receptor (VR1) by direct phosphorylation.";
RL   Neuron 35:721-731(2002).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH CALMODULIN.
RX   PubMed=12808128; DOI=10.1073/pnas.1337252100;
RA   Numazaki M., Tominaga T., Takeuchi K., Murayama N., Toyooka H.,
RA   Tominaga M.;
RT   "Structural determinant of TRPV1 desensitization interacts with
RT   calmodulin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8002-8006(2003).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF SER-502; THR-704 AND SER-800.
RX   PubMed=14523239; DOI=10.1073/pnas.2032100100;
RA   Bhave G., Hu H.J., Glauner K.S., Zhu W., Wang H., Brasier D.J.,
RA   Oxford G.S., Gereau R.W. IV;
RT   "Protein kinase C phosphorylation sensitizes but does not activate the
RT   capsaicin receptor transient receptor potential vanilloid 1 (TRPV1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12480-12485(2003).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF ARG-785; LYS-788; ARG-797 AND SER-800.
RX   PubMed=12764195; DOI=10.1126/science.1083646;
RA   Prescott E.D., Julius D.;
RT   "A modular PIP2 binding site as a determinant of capsaicin receptor
RT   sensitivity.";
RL   Science 300:1284-1288(2003).
RN   [15]
RP   INTERACTION WITH CSK.
RX   PubMed=15084474; DOI=10.1152/ajpcell.00113.2004;
RA   Jin X., Morsy N., Winston J., Pasricha P.J., Garrett K.,
RA   Akbarali H.I.;
RT   "Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase.";
RL   Am. J. Physiol. 287:C558-C563(2004).
RN   [16]
RP   MUTAGENESIS OF ARG-114; ARG-115 AND GLU-761.
RX   PubMed=12228246; DOI=10.1074/jbc.M207103200;
RA   Jung J., Lee S.Y., Hwang S.W., Cho H., Shin J., Kang Y.S., Kim S.,
RA   Oh U.;
RT   "Agonist recognition sites in the cytosolic tails of vanilloid
RT   receptor 1.";
RL   J. Biol. Chem. 277:44448-44454(2002).
RN   [17]
RP   FUNCTION, PHOSPHORYLATION AT SER-502 AND THR-704, AND MUTAGENESIS OF
RP   SER-502 AND THR-704.
RX   PubMed=14630912; DOI=10.1074/jbc.M311448200;
RA   Jung J., Shin J.S., Lee S.-Y., Hwang S.W., Koo J., Cho H., Oh U.;
RT   "Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent
RT   kinase II regulates its vanilloid binding.";
RL   J. Biol. Chem. 279:7048-7054(2004).
RN   [18]
RP   MUTAGENESIS OF TYR-511; MET-547 AND THR-550.
RX   PubMed=14996838; DOI=10.1074/jbc.M312577200;
RA   Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S.,
RA   Zhang T.J., Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W.,
RA   Porreca F., Blumberg P.M., Lile J., Sun Y., Wild K., Louis J.C.,
RA   Treanor J.J.;
RT   "Molecular determinants of vanilloid sensitivity in TRPV1.";
RL   J. Biol. Chem. 279:20283-20295(2004).
RN   [19]
RP   FUNCTION.
RX   PubMed=15173182; DOI=10.1074/jbc.M402966200;
RA   Hellwig N., Plant T.D., Janson W., Schafer M., Schultz G.,
RA   Schaefer M.;
RT   "TRPV1 acts as proton channel to induce acidification in nociceptive
RT   neurons.";
RL   J. Biol. Chem. 279:34553-34561(2004).
RN   [20]
RP   INTERACTION WITH PRKCM, PHOSPHORYLATION AT SER-116, AND MUTAGENESIS OF
RP   SER-116.
RX   PubMed=15471852; DOI=10.1074/jbc.M410331200;
RA   Wang Y., Kedei N., Wang M., Wang Q.J., Huppler A.R., Toth A., Tran R.,
RA   Blumberg P.M.;
RT   "Interaction between protein kinase Cmu and the vanilloid receptor
RT   type 1.";
RL   J. Biol. Chem. 279:53674-53682(2004).
RN   [21]
RP   SUBUNIT.
RX   PubMed=15190102; DOI=10.1523/JNEUROSCI.0202-04.2004;
RA   Garcia-Sanz N., Fernandez-Carvajal A., Morenilla-Palao C.,
RA   Planells-Cases R., Fajardo-Sanchez E., Fernandez-Ballester G.,
RA   Ferrer-Montiel A.;
RT   "Identification of a tetramerization domain in the C-terminus of the
RT   vanilloid receptor.";
RL   J. Neurosci. 24:5307-5314(2004).
RN   [22]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15857679; DOI=10.1016/j.molbrainres.2004.12.003;
RA   Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I.,
RA   Csiba L., Blumberg P.M.;
RT   "Expression and distribution of vanilloid receptor 1 (TRPV1) in the
RT   adult rat brain.";
RL   Brain Res. Mol. Brain Res. 135:162-168(2005).
RN   [23]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=20510930; DOI=10.1016/j.cell.2010.03.052;
RA   Bohlen C.J., Priel A., Zhou S., King D., Siemens J., Julius D.;
RT   "A bivalent tarantula toxin activates the capsaicin receptor, TRPV1,
RT   by targeting the outer pore domain.";
RL   Cell 141:834-845(2010).
RN   [24]
RP   FUNCTION.
RX   PubMed=21076423; DOI=10.1038/nn.2684;
RA   Chavez A.E., Chiu C.Q., Castillo P.E.;
RT   "TRPV1 activation by endogenous anandamide triggers postsynaptic long-
RT   term depression in dentate gyrus.";
RL   Nat. Neurosci. 13:1511-1518(2010).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 101-364 IN COMPLEX WITH ATP,
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, ATP-BINDING,
RP   CALMODULIN-BINDING, MUTAGENESIS OF LYS-155; LYS-160; TYR-199 AND
RP   GLN-202, AND ANKYRIN REPEATS.
RX   PubMed=17582331; DOI=10.1016/j.neuron.2007.05.027;
RA   Lishko P.V., Procko E., Jin X., Phelps C.B., Gaudet R.;
RT   "The ankyrin repeats of TRPV1 bind multiple ligands and modulate
RT   channel sensitivity.";
RL   Neuron 54:905-918(2007).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 767-801 IN COMPLEX WITH
RP   CALM, FUNCTION, MUTAGENESIS OF LYS-155; ARG-785; TRP-787 AND LYS-788,
RP   CALMODULIN-BINDING, INTERACTION WITH CALM, AND ENZYME REGULATION.
RX   PubMed=23109716; DOI=10.1085/jgp.201210810;
RA   Lau S.Y., Procko E., Gaudet R.;
RT   "Distinct properties of Ca2+-calmodulin binding to N- and C-terminal
RT   regulatory regions of the TRPV1 channel.";
RL   J. Gen. Physiol. 140:541-555(2012).
RN   [27]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.27 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, ANK REPEATS, AND SUBUNIT.
RX   PubMed=24305160; DOI=10.1038/nature12822;
RA   Liao M., Cao E., Julius D., Cheng Y.;
RT   "Structure of the TRPV1 ion channel determined by electron cryo-
RT   microscopy.";
RL   Nature 504:107-112(2013).
RN   [28]
RP   STRUCTURE BY ELECTROM MICROSCOPY (3.8 ANGSTROMS) IN COMPLEXES WITH
RP   CAPSAICIN AND TARANTULA DOUBLE-KNOT TOXIN, AND SUBUNIT.
RX   PubMed=24305161; DOI=10.1038/nature12823;
RA   Cao E., Liao M., Cheng Y., Julius D.;
RT   "TRPV1 structures in distinct conformations reveal activation
RT   mechanisms.";
RL   Nature 504:113-118(2013).
RN   [29]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.95 ANGSTROMS) OF 110-764 OF
RP   APOPROTEIN AND IN COMPLEX WITH AGONIST, SUBUNIT, TOPOLOGY, AND
RP   LIPID-BINDING.
RX   PubMed=27281200; DOI=10.1038/nature17964;
RA   Gao Y., Cao E., Julius D., Cheng Y.;
RT   "TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid
RT   action.";
RL   Nature 534:347-351(2016).
CC   -!- FUNCTION: Ligand-activated non-selective calcium permeant cation
CC       channel involved in detection of noxious chemical and thermal
CC       stimuli. Seems to mediate proton influx and may be involved in
CC       intracellular acidosis in nociceptive neurons. Involved in
CC       mediation of inflammatory pain and hyperalgesia. Sensitized by a
CC       phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases, which involves PKC isozymes and PCL. Activation
CC       by vanilloids, like capsaicin, and temperatures higher than 42
CC       degrees Celsius, exhibits a time- and Ca(2+)-dependent outward
CC       rectification, followed by a long-lasting refractory state. Mild
CC       extracellular acidic pH (6.5) potentiates channel activation by
CC       noxious heat and vanilloids, whereas acidic conditions (pH <6)
CC       directly activate the channel. Can be activated by endogenous
CC       compounds, including 12-hydroperoxytetraenoic acid and bradykinin.
CC       Acts as ionotropic endocannabinoid receptor with central
CC       neuromodulatory effects. Triggers a form of long-term depression
CC       (TRPV1-LTD) mediated by the endocannabinoid anandamine in the
CC       hippocampus and nucleus accumbens by affecting AMPA receptors
CC       endocytosis. {ECO:0000269|PubMed:11140687,
CC       ECO:0000269|PubMed:11418861, ECO:0000269|PubMed:11578842,
CC       ECO:0000269|PubMed:12095983, ECO:0000269|PubMed:12194871,
CC       ECO:0000269|PubMed:12764195, ECO:0000269|PubMed:12808128,
CC       ECO:0000269|PubMed:14523239, ECO:0000269|PubMed:14630912,
CC       ECO:0000269|PubMed:15173182, ECO:0000269|PubMed:17582331,
CC       ECO:0000269|PubMed:20510930, ECO:0000269|PubMed:21076423,
CC       ECO:0000269|PubMed:23109716, ECO:0000269|PubMed:24305160,
CC       ECO:0000269|PubMed:9349813}.
CC   -!- FUNCTION: Isoform 3: Does not display channel activity in response
CC       to noxious chemical compounds, such as capsaicin and the vanilloid
CC       resiniferatoxin. Channel activity is not elicited by mildly acidic
CC       extracellular pH, and only slight channel activity is observed in
CC       response to noxiuos heat stimuli. {ECO:0000269|PubMed:10644739}.
CC   -!- ENZYME REGULATION: Channel activity is activated via the
CC       interaction with PIRT and phosphatidylinositol 4,5-bisphosphate
CC       (PIP2). Both PIRT and PIP2 are required to activate channel
CC       activity (By similarity). The channel is sensitized by ATP
CC       binding. Repeated stimulation with capsaicin gives rise to
CC       progressively smaller responses, due to desensitization. This
CC       desensitization is triggered by the influx of calcium ions and is
CC       inhibited by elevated ATP levels. Ca(2+) and CALM displace ATP
CC       from its binding site and trigger a conformation change that leads
CC       to a closed, desensitized channel. Intracellular PIP2 inhibits
CC       desensitization. The double-knot toxin (DkTx) from the Chinese
CC       earth tiger tarantula activates the channel and traps it in an
CC       open conformation. {ECO:0000250, ECO:0000269|PubMed:17582331,
CC       ECO:0000269|PubMed:20510930, ECO:0000269|PubMed:23109716}.
CC   -!- SUBUNIT: Interacts with PIRT (By similarity). Homotetramer
CC       (PubMed:15190102, PubMed:24305160, PubMed:24305161,
CC       PubMed:27281200). May also form a heteromeric channel with TRPV3
CC       (By similarity). Interacts with CALM, PRKCM and CSK
CC       (PubMed:12808128, PubMed:15084474, PubMed:15471852,
CC       PubMed:17582331). Interacts with PRKCG and NTRK1, probably by
CC       forming a trimeric complex (PubMed:11418861). Interacts with
CC       TMEM100 (By similarity). {ECO:0000250|UniProtKB:Q704Y3,
CC       ECO:0000250|UniProtKB:Q8NER1, ECO:0000269|PubMed:11418861,
CC       ECO:0000269|PubMed:12808128, ECO:0000269|PubMed:15084474,
CC       ECO:0000269|PubMed:15190102, ECO:0000269|PubMed:15471852,
CC       ECO:0000269|PubMed:23109716, ECO:0000269|PubMed:24305160,
CC       ECO:0000269|PubMed:24305161, ECO:0000269|PubMed:27281200}.
CC   -!- INTERACTION:
CC       Self; NbExp=11; IntAct=EBI-2794004, EBI-2794004;
CC       P0CH43:- (xeno); NbExp=2; IntAct=EBI-2794004, EBI-2793994;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:15857679}; Multi-pass membrane
CC       protein {ECO:0000305}. Cell projection, dendritic spine membrane
CC       {ECO:0000269|PubMed:15857679}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell membrane {ECO:0000269|PubMed:11578842,
CC       ECO:0000269|PubMed:15857679, ECO:0000269|PubMed:9349813}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:24305160,
CC       ECO:0000269|PubMed:24305161, ECO:0000269|PubMed:27281200}.
CC       Note=Mostly, but not exclusively expressed in postsynaptic
CC       dendritic spines. {ECO:0000269|PubMed:15857679}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=VR1L1;
CC         IsoId=O35433-1; Sequence=Displayed;
CC       Name=2; Synonyms=VR1L2;
CC         IsoId=O35433-2; Sequence=VSP_013432;
CC       Name=3; Synonyms=VR.5'sv;
CC         IsoId=O35433-3; Sequence=VSP_013431, VSP_013432;
CC         Note=Inactive.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in trigeminal and
CC       dorsal root sensory ganglia. Expressed also in hippocampus,
CC       cortex, cerebellum, olfactory bulb, mesencephalon and hindbrain.
CC       High expression in the cell bodies and dendrites of neurons in the
CC       hippocampus and in the cortex. In the brain detected also in
CC       astrocytes and pericytes (at protein level) (PubMed:15857679).
CC       Isoform 1 and isoform 3 are expressed in brain and peripheral
CC       blood mononuclear cells. {ECO:0000269|PubMed:10644739,
CC       ECO:0000269|PubMed:15857679, ECO:0000269|PubMed:9349813}.
CC   -!- DOMAIN: The association domain (AD) is necessary for self-
CC       association.
CC   -!- PTM: Phosphorylation by PKA reverses capsaicin-induced
CC       dephosphorylation at multiple sites, probably including Ser-116 as
CC       a major phosphorylation site. Phosphorylation by CAMKII seems to
CC       regulate binding to vanilloids. Phosphorylated and modulated by
CC       PRKCE, PRKCM and probably PRKCZ. Dephosphorylation by calcineurin
CC       seems to lead to receptor desensitization and phosphorylation by
CC       CAMKII recovers activity. {ECO:0000269|PubMed:11884385,
CC       ECO:0000269|PubMed:12194871, ECO:0000269|PubMed:14630912,
CC       ECO:0000269|PubMed:15471852}.
CC   -!- MISCELLANEOUS: Responses evoked by capsaicin, but not by low pH
CC       and heat, can be antagonized by capsazepine.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF029310; AAC53398.1; -; mRNA.
DR   EMBL; AF158248; AAF28389.1; -; mRNA.
DR   EMBL; AB041029; BAA94306.1; -; mRNA.
DR   EMBL; AB040873; BAA94307.1; -; mRNA.
DR   EMBL; AF327067; AAK83151.1; -; Genomic_DNA.
DR   EMBL; AF327067; AAK83152.1; -; Genomic_DNA.
DR   PIR; T09054; T09054.
DR   RefSeq; NP_114188.1; NM_031982.1. [O35433-1]
DR   UniGene; Rn.3073; -.
DR   PDB; 2NYJ; X-ray; 3.20 A; A=101-364.
DR   PDB; 2PNN; X-ray; 2.70 A; A=101-364.
DR   PDB; 3J5P; EM; 3.28 A; A/B/C/D=111-719.
DR   PDB; 3J5Q; EM; 3.80 A; B/D/E/G=111-719.
DR   PDB; 3J5R; EM; 4.20 A; A/B/C/D=111-719.
DR   PDB; 3J9J; EM; -; A/B/C/D=111-719.
DR   PDB; 3SUI; X-ray; 1.95 A; B=767-801.
DR   PDB; 5IRX; EM; 2.95 A; A/B/C/D=110-764.
DR   PDB; 5IRZ; EM; 3.28 A; B/C/D/E=110-764.
DR   PDB; 5IS0; EM; 3.43 A; B/C/D/E=110-764.
DR   PDBsum; 2NYJ; -.
DR   PDBsum; 2PNN; -.
DR   PDBsum; 3J5P; -.
DR   PDBsum; 3J5Q; -.
DR   PDBsum; 3J5R; -.
DR   PDBsum; 3J9J; -.
DR   PDBsum; 3SUI; -.
DR   PDBsum; 5IRX; -.
DR   PDBsum; 5IRZ; -.
DR   PDBsum; 5IS0; -.
DR   ProteinModelPortal; O35433; -.
DR   SMR; O35433; -.
DR   BioGrid; 249845; 2.
DR   DIP; DIP-56949N; -.
DR   IntAct; O35433; 1.
DR   MINT; MINT-5117510; -.
DR   STRING; 10116.ENSRNOP00000026493; -.
DR   BindingDB; O35433; -.
DR   ChEMBL; CHEMBL5102; -.
DR   GuidetoPHARMACOLOGY; 507; -.
DR   TCDB; 1.A.4.2.1; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; O35433; -.
DR   PhosphoSitePlus; O35433; -.
DR   PaxDb; O35433; -.
DR   PRIDE; O35433; -.
DR   Ensembl; ENSRNOT00000026493; ENSRNOP00000026493; ENSRNOG00000019486. [O35433-1]
DR   GeneID; 83810; -.
DR   KEGG; rno:83810; -.
DR   CTD; 7442; -.
DR   RGD; 628841; Trpv1.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   GeneTree; ENSGT00550000074425; -.
DR   HOGENOM; HOG000234630; -.
DR   HOVERGEN; HBG054085; -.
DR   InParanoid; O35433; -.
DR   KO; K05222; -.
DR   OMA; VEEVNWN; -.
DR   OrthoDB; EOG091G01LY; -.
DR   PhylomeDB; O35433; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-RNO-3295583; TRP channels.
DR   EvolutionaryTrace; O35433; -.
DR   PRO; PR:O35433; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000019486; -.
DR   Genevisible; O35433; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0015278; F:calcium-release channel activity; IMP:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:RGD.
DR   GO; GO:0008324; F:cation transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0017081; F:chloride channel regulator activity; IDA:RGD.
DR   GO; GO:0005231; F:excitatory extracellular ligand-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005216; F:ion channel activity; ISO:RGD.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.
DR   GO; GO:0097603; F:temperature-gated ion channel activity; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0071468; P:cellular response to acidic pH; IDA:UniProtKB.
DR   GO; GO:0071312; P:cellular response to alkaloid; IMP:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:UniProtKB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEP:RGD.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0050968; P:detection of chemical stimulus involved in sensory perception of pain; ISO:RGD.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISO:RGD.
DR   GO; GO:0050960; P:detection of temperature stimulus involved in thermoception; ISO:RGD.
DR   GO; GO:0002024; P:diet induced thermogenesis; ISO:RGD.
DR   GO; GO:0001660; P:fever generation; ISO:RGD.
DR   GO; GO:0014047; P:glutamate secretion; IDA:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEP:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0001774; P:microglial cell activation; IMP:RGD.
DR   GO; GO:0090212; P:negative regulation of establishment of blood-brain barrier; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISO:RGD.
DR   GO; GO:0002790; P:peptide secretion; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0060454; P:positive regulation of gastric acid secretion; IMP:RGD.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:1901594; P:response to capsazepine; IMP:UniProtKB.
DR   GO; GO:0009408; P:response to heat; IDA:MGI.
DR   GO; GO:0010243; P:response to organonitrogen compound; ISO:RGD.
DR   GO; GO:0048265; P:response to pain; ISO:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0009268; P:response to pH; IDA:MGI.
DR   GO; GO:0050954; P:sensory perception of mechanical stimulus; ISO:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0060083; P:smooth muscle contraction involved in micturition; ISO:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; ISO:RGD.
DR   GO; GO:0050955; P:thermoception; ISO:RGD.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; ISO:RGD.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR024863; TRPV1.
DR   InterPro; IPR008347; TRPV1-4_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF17; PTHR10582:SF17; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; ATP-binding; Calcium;
KW   Calcium channel; Calcium transport; Calmodulin-binding; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Lipid-binding; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Repeat; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    838       Transient receptor potential cation
FT                                channel subfamily V member 1.
FT                                /FTId=PRO_0000215341.
FT   TOPO_DOM      1    432       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TRANSMEM    433    453       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    454    471       Extracellular.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TRANSMEM    472    497       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    498    510       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TRANSMEM    511    531       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    532    535       Extracellular.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TRANSMEM    536    556       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    557    571       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TRANSMEM    572    599       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    600    626       Extracellular.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   INTRAMEM    627    649       Pore-forming.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200,
FT                                ECO:0000305|PubMed:10931826}.
FT   TRANSMEM    658    686       Helical. {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   TOPO_DOM    687    838       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24305160,
FT                                ECO:0000269|PubMed:27281200}.
FT   REPEAT      110    152       ANK 1.
FT   REPEAT      153    199       ANK 2.
FT   REPEAT      200    246       ANK 3.
FT   REPEAT      247    282       ANK 4.
FT   REPEAT      283    331       ANK 5.
FT   REPEAT      332    358       ANK 6.
FT   NP_BIND     199    202       ATP. {ECO:0000244|PDB:2NYJ,
FT                                ECO:0000244|PDB:2PNN}.
FT   NP_BIND     210    211       ATP. {ECO:0000244|PDB:2PNN}.
FT   REGION      114    115       Important for channel activation by
FT                                agonists and heat.
FT                                {ECO:0000269|PubMed:12228246}.
FT   REGION      684    712       AD.
FT   REGION      767    801       Interaction with calmodulin.
FT                                {ECO:0000269|PubMed:23109716}.
FT   REGION      777    792       Required for PIP2-mediated channel
FT                                inhibition.
FT   MOTIF       643    646       Selectivity filter.
FT                                {ECO:0000305|PubMed:10931826}.
FT   METAL       646    646       Calcium; shared with neighboring
FT                                subunits. {ECO:0000250|UniProtKB:Q9R186}.
FT   BINDING     115    115       ATP. {ECO:0000244|PDB:2PNN}.
FT   BINDING     155    155       ATP. {ECO:0000244|PDB:2PNN}.
FT   BINDING     160    160       ATP. {ECO:0000244|PDB:2NYJ,
FT                                ECO:0000244|PDB:2PNN}.
FT   BINDING     164    164       ATP. {ECO:0000244|PDB:2NYJ,
FT                                ECO:0000244|PDB:2PNN}.
FT   BINDING     512    512       Agonist. {ECO:0000269|PubMed:27281200}.
FT   BINDING     550    550       Agonist. {ECO:0000269|PubMed:27281200}.
FT   SITE        557    557       Important for agonist binding.
FT                                {ECO:0000269|PubMed:27281200}.
FT   MOD_RES     116    116       Phosphoserine; by PKA and PKD.
FT                                {ECO:0000269|PubMed:12194871,
FT                                ECO:0000269|PubMed:15471852}.
FT   MOD_RES     144    144       Phosphothreonine; by PKA; in vitro.
FT                                {ECO:0000269|PubMed:12194871}.
FT   MOD_RES     370    370       Phosphothreonine; by PKA; in vitro.
FT                                {ECO:0000269|PubMed:12194871}.
FT   MOD_RES     502    502       Phosphoserine; by PKC/PRKCE.
FT                                {ECO:0000269|PubMed:11884385,
FT                                ECO:0000269|PubMed:12194871,
FT                                ECO:0000269|PubMed:14630912}.
FT   MOD_RES     704    704       Phosphothreonine.
FT                                {ECO:0000269|PubMed:14630912}.
FT   MOD_RES     774    774       Phosphoserine; by PKA; in vitro.
FT                                {ECO:0000269|PubMed:12194871}.
FT   MOD_RES     800    800       Phosphoserine; by PKC/PRKCE and
FT                                PKC/PRKCZ. {ECO:0000269|PubMed:11884385}.
FT   MOD_RES     820    820       Phosphoserine; by PKA; in vitro.
FT                                {ECO:0000269|PubMed:12194871}.
FT   CARBOHYD    604    604       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11683872}.
FT   VAR_SEQ       1    307       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10644739}.
FT                                /FTId=VSP_013431.
FT   VAR_SEQ     348    407       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10644739,
FT                                ECO:0000303|PubMed:11578842}.
FT                                /FTId=VSP_013432.
FT   MUTAGEN     114    114       R->E: Abolishes capsaicin-evoked current
FT                                and binding to resiniferatoxin.
FT                                {ECO:0000269|PubMed:12228246}.
FT   MUTAGEN     114    114       Missing: Abolishes sensitivity to acid.
FT                                {ECO:0000269|PubMed:12228246}.
FT   MUTAGEN     115    115       R->D: Abolishes capsaicin-evoked current
FT                                and binding to resiniferatoxin.
FT                                {ECO:0000269|PubMed:12228246}.
FT   MUTAGEN     116    116       S->A: Abolishes phosphorylation by PKCM
FT                                and enhances channel response to
FT                                capsaicin by PKCM.
FT                                {ECO:0000269|PubMed:15471852}.
FT   MUTAGEN     155    155       K->A: Abolishes ATP binding. Abolishes
FT                                CALM binding. Impairs normal
FT                                desensitization by repeated exposure to
FT                                capsaicin. {ECO:0000269|PubMed:17582331,
FT                                ECO:0000269|PubMed:23109716}.
FT   MUTAGEN     160    160       K->A: Abolishes ATP binding. Abolishes
FT                                CALM binding.
FT                                {ECO:0000269|PubMed:17582331}.
FT   MUTAGEN     199    199       Y->A: Strongly reduces affinity for ATP;
FT                                when associated with A-202.
FT                                {ECO:0000269|PubMed:17582331}.
FT   MUTAGEN     202    202       Q->A: Strongly reduces affinity for ATP;
FT                                when associated with A-199.
FT                                {ECO:0000269|PubMed:17582331}.
FT   MUTAGEN     502    502       S->A: Largely reduces PMA enhancement of
FT                                capsaicin-evoked currents, but no effect
FT                                on direct activation by PMA. Loss of
FT                                activation by capsaicin and loss of
FT                                vanilloid binding; when associated with
FT                                I-704. {ECO:0000269|PubMed:11884385,
FT                                ECO:0000269|PubMed:14523239,
FT                                ECO:0000269|PubMed:14630912}.
FT   MUTAGEN     511    511       Y->A: Loss of sensitivity to capsaicin.
FT                                {ECO:0000269|PubMed:14996838}.
FT   MUTAGEN     547    547       M->L: Reduces binding to resiniferatoxin.
FT                                {ECO:0000269|PubMed:14996838}.
FT   MUTAGEN     550    550       T->I: Reduces sensitivity to capsaicin
FT                                10-fold; no effect on sensitivity to
FT                                resiniferatoxin. Reduces binding to
FT                                resiniferatoxin.
FT                                {ECO:0000269|PubMed:14996838}.
FT   MUTAGEN     636    636       E->K: Abolishes channel activity.
FT                                Restored channel activity; when
FT                                associated with E-639.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     636    636       E->Q: Slight modification of pore
FT                                attributes.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     639    639       K->E: Restored channel activity; when
FT                                associated with K-636.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     644    644       M->Y: Slightly modifies channel
FT                                permeability.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     646    646       D->N: Strongly reduces the affinity for
FT                                pore blocker ruthenium red and lowered
FT                                channel permeability for Mg(2+).
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     648    648       E->Q: Minor modification of pore
FT                                attributes.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     651    651       E->Q: Minor modification of pore
FT                                attributes.
FT                                {ECO:0000269|PubMed:10931826}.
FT   MUTAGEN     704    704       T->A: No effect on PMA-induced
FT                                enhancement of capsaicin-evoked currents
FT                                but reduces direct activation by PMA.
FT                                {ECO:0000269|PubMed:14523239,
FT                                ECO:0000269|PubMed:14630912}.
FT   MUTAGEN     704    704       T->I: Loss of activation by capsaicin and
FT                                loss of vanilloid binding; when
FT                                associated with A-502.
FT                                {ECO:0000269|PubMed:14523239,
FT                                ECO:0000269|PubMed:14630912}.
FT   MUTAGEN     761    761       E->K,Q: Abolishes capsaiin-evoked current
FT                                and binding to resiniferatoxin.
FT                                {ECO:0000269|PubMed:12228246}.
FT   MUTAGEN     761    761       Missing: Abolishes sensitivity to acid.
FT                                {ECO:0000269|PubMed:12228246}.
FT   MUTAGEN     785    785       R->Q: Strongly reduces CALM-binding and
FT                                abolishes PLC-mediated channel activity;
FT                                when associated with Q-788.
FT                                {ECO:0000269|PubMed:12764195,
FT                                ECO:0000269|PubMed:23109716}.
FT   MUTAGEN     787    787       W->R: Reduces CALM-binding. Reduces
FT                                desensitization by repeated exposure to
FT                                capsaicin. {ECO:0000269|PubMed:23109716}.
FT   MUTAGEN     788    788       K->Q: Strongly reduces CALM-binding and
FT                                abolishes PLC-mediated channel activity;
FT                                when associated with Q-785 or Q-797.
FT                                {ECO:0000269|PubMed:12764195,
FT                                ECO:0000269|PubMed:23109716}.
FT   MUTAGEN     797    797       R->Q: Abolishes PLC-mediated channel
FT                                activity; when associated with Q-788.
FT                                {ECO:0000269|PubMed:12764195}.
FT   MUTAGEN     800    800       S->A: Largely reduces direct activation
FT                                of by PMA and PMA-induced currents; no
FT                                effect on receptor kinase-induced
FT                                currents. {ECO:0000269|PubMed:11884385,
FT                                ECO:0000269|PubMed:12764195,
FT                                ECO:0000269|PubMed:14523239}.
FT   CONFLICT     18     18       E -> D (in Ref. 3; BAA94307).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       V -> A (in Ref. 4; AAK83151).
FT                                {ECO:0000305}.
FT   CONFLICT     48     48       R -> G (in Ref. 3; BAA94306).
FT                                {ECO:0000305}.
FT   CONFLICT     51     51       G -> W (in Ref. 3; BAA94306).
FT                                {ECO:0000305}.
FT   CONFLICT     96     96       P -> Q (in Ref. 3; BAA94307).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       V -> I (in Ref. 4; AAK83151).
FT                                {ECO:0000305}.
FT   CONFLICT    735    735       K -> Q (in Ref. 3; BAA94306).
FT                                {ECO:0000305}.
FT   HELIX       114    122       {ECO:0000244|PDB:2PNN}.
FT   TURN        128    131       {ECO:0000244|PDB:2PNN}.
FT   HELIX       132    138       {ECO:0000244|PDB:2PNN}.
FT   HELIX       146    148       {ECO:0000244|PDB:2PNN}.
FT   TURN        151    153       {ECO:0000244|PDB:2PNN}.
FT   HELIX       157    163       {ECO:0000244|PDB:2PNN}.
FT   HELIX       171    182       {ECO:0000244|PDB:2PNN}.
FT   HELIX       186    190       {ECO:0000244|PDB:2PNN}.
FT   TURN        197    201       {ECO:0000244|PDB:2PNN}.
FT   HELIX       204    210       {ECO:0000244|PDB:2PNN}.
FT   HELIX       214    222       {ECO:0000244|PDB:2PNN}.
FT   HELIX       234    236       {ECO:0000244|PDB:2PNN}.
FT   STRAND      240    242       {ECO:0000244|PDB:2PNN}.
FT   HELIX       251    257       {ECO:0000244|PDB:2PNN}.
FT   HELIX       261    269       {ECO:0000244|PDB:2PNN}.
FT   TURN        282    284       {ECO:0000244|PDB:3J5P}.
FT   HELIX       287    294       {ECO:0000244|PDB:2PNN}.
FT   HELIX       299    319       {ECO:0000244|PDB:2PNN}.
FT   HELIX       325    327       {ECO:0000244|PDB:2PNN}.
FT   HELIX       336    342       {ECO:0000244|PDB:2PNN}.
FT   HELIX       346    356       {ECO:0000244|PDB:2PNN}.
FT   TURN        360    362       {ECO:0000244|PDB:5IRX}.
FT   TURN        363    365       {ECO:0000244|PDB:5IRZ}.
FT   STRAND      369    374       {ECO:0000244|PDB:5IRX}.
FT   STRAND      377    381       {ECO:0000244|PDB:5IRX}.
FT   STRAND      385    388       {ECO:0000244|PDB:5IRX}.
FT   TURN        390    392       {ECO:0000244|PDB:3J9J}.
FT   HELIX       395    400       {ECO:0000244|PDB:5IRX}.
FT   TURN        407    411       {ECO:0000244|PDB:3J5P}.
FT   HELIX       412    415       {ECO:0000244|PDB:5IRX}.
FT   HELIX       419    428       {ECO:0000244|PDB:5IRX}.
FT   HELIX       430    453       {ECO:0000244|PDB:5IRX}.
FT   STRAND      458    461       {ECO:0000244|PDB:3J5P}.
FT   HELIX       469    498       {ECO:0000244|PDB:5IRX}.
FT   HELIX       501    504       {ECO:0000244|PDB:3J9J}.
FT   TURN        506    508       {ECO:0000244|PDB:5IRX}.
FT   HELIX       511    531       {ECO:0000244|PDB:5IRX}.
FT   HELIX       537    550       {ECO:0000244|PDB:5IRX}.
FT   HELIX       551    554       {ECO:0000244|PDB:5IRX}.
FT   TURN        555    558       {ECO:0000244|PDB:5IRX}.
FT   TURN        560    563       {ECO:0000244|PDB:5IRX}.
FT   HELIX       564    574       {ECO:0000244|PDB:5IRX}.
FT   HELIX       576    580       {ECO:0000244|PDB:5IRX}.
FT   TURN        581    583       {ECO:0000244|PDB:5IRX}.
FT   HELIX       584    598       {ECO:0000244|PDB:5IRX}.
FT   STRAND      601    603       {ECO:0000244|PDB:3J5P}.
FT   STRAND      627    629       {ECO:0000244|PDB:5IRX}.
FT   HELIX       630    641       {ECO:0000244|PDB:5IRX}.
FT   STRAND      647    649       {ECO:0000244|PDB:5IS0}.
FT   HELIX       656    670       {ECO:0000244|PDB:5IRX}.
FT   TURN        671    673       {ECO:0000244|PDB:5IRX}.
FT   HELIX       674    691       {ECO:0000244|PDB:5IRX}.
FT   HELIX       693    712       {ECO:0000244|PDB:5IRX}.
FT   HELIX       716    719       {ECO:0000244|PDB:5IRX}.
FT   STRAND      732    734       {ECO:0000244|PDB:5IS0}.
FT   STRAND      743    746       {ECO:0000244|PDB:5IRX}.
FT   HELIX       788    792       {ECO:0000244|PDB:3SUI}.
FT   HELIX       793    795       {ECO:0000244|PDB:3SUI}.
SQ   SEQUENCE   838 AA;  94948 MW;  DAFC80B12BDF71BF CRC64;
     MEQRASLDSE ESESPPQENS CLDPPDRDPN CKPPPVKPHI FTTRSRTRLF GKGDSEEASP
     LDCPYEEGGL ASCPIITVSS VLTIQRPGDG PASVRPSSQD SVSAGEKPPR LYDRRSIFDA
     VAQSNCQELE SLLPFLQRSK KRLTDSEFKD PETGKTCLLK AMLNLHNGQN DTIALLLDVA
     RKTDSLKQFV NASYTDSYYK GQTALHIAIE RRNMTLVTLL VENGADVQAA ANGDFFKKTK
     GRPGFYFGEL PLSLAACTNQ LAIVKFLLQN SWQPADISAR DSVGNTVLHA LVEVADNTVD
     NTKFVTSMYN EILILGAKLH PTLKLEEITN RKGLTPLALA ASSGKIGVLA YILQREIHEP
     ECRHLSRKFT EWAYGPVHSS LYDLSCIDTC EKNSVLEVIA YSSSETPNRH DMLLVEPLNR
     LLQDKWDRFV KRIFYFNFFV YCLYMIIFTA AAYYRPVEGL PPYKLKNTVG DYFRVTGEIL
     SVSGGVYFFF RGIQYFLQRR PSLKSLFVDS YSEILFFVQS LFMLVSVVLY FSQRKEYVAS
     MVFSLAMGWT NMLYYTRGFQ QMGIYAVMIE KMILRDLCRF MFVYLVFLFG FSTAVVTLIE
     DGKNNSLPME STPHKCRGSA CKPGNSYNSL YSTCLELFKF TIGMGDLEFT ENYDFKAVFI
     ILLLAYVILT YILLLNMLIA LMGETVNKIA QESKNIWKLQ RAITILDTEK SFLKCMRKAF
     RSGKLLQVGF TPDGKDDYRW CFRVDEVNWT TWNTNVGIIN EDPGNCEGVK RTLSFSLRSG
     RVSGRNWKNF ALVPLLRDAS TRDRHATQQE EVQLKHYTGS LKPEDAEVFK DSMVPGEK
//
ID   CAC1C_CAVPO             Reviewed;         169 AA.
AC   O35505;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   25-OCT-2017, entry version 92.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
DE   Flags: Fragment;
GN   Name=CACNA1C; Synonyms=CACH2, CACN2, CACNL1A1, CCHL1A1;
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
OC   Hystricomorpha; Caviidae; Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Uterus;
RA   Collins P.L., Lundgren D.W., Kulp T.M., Shah P., Chang S.M.,
RA   Chang A.S.;
RT   "Gestational expression of voltage-dependent calcium channel subunits
RT   in guinea pig uterus.";
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1C
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing the alpha-1C subunit play an important
CC       role in excitation-contraction coupling in the heart. The various
CC       isoforms display marked differences in the sensitivity to DHP
CC       compounds. Binding of calmodulin or CABP1 at the same regulatory
CC       sites results in an opposit effects on the channel function.
CC       {ECO:0000250|UniProtKB:Q13936}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts (via C-terminal CDB motif) with CABP5; in a calcium-
CC       dependent manner. Interacts with CABP1 and CACNA2D4 (By
CC       similarity). Interacts with CIB1; the interaction increases upon
CC       cardiomyocytes hypertrophy. {ECO:0000250|UniProtKB:P22002,
CC       ECO:0000250|UniProtKB:Q01815, ECO:0000250|UniProtKB:Q13936}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P15381};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P15381}. Cell
CC       membrane {ECO:0000250|UniProtKB:P15381}. Note=The interaction
CC       between RRAD and CACNB2 regulates its trafficking to the cell
CC       membrane. {ECO:0000250|UniProtKB:P15381}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- PTM: Phosphorylation by PKA activates the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1C subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF005938; AAB62890.1; -; mRNA.
DR   ProteinModelPortal; O35505; -.
DR   SMR; O35505; -.
DR   STRING; 10141.ENSCPOP00000009195; -.
DR   BindingDB; O35505; -.
DR   ChEMBL; CHEMBL2366456; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   InParanoid; O35505; -.
DR   Proteomes; UP000005447; Unassembled WGS sequence.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; ISS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; ISS:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005452; LVDCC_a1dsu.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF139; PTHR10037:SF139; 2.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00167; CACHANNEL.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN        <1   >169       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1C.
FT                                /FTId=PRO_0000053927.
FT   TRANSMEM     <1     11       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     12     38       Extracellular. {ECO:0000255}.
FT   TRANSMEM     39     57       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     58     76       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     77     96       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     97    165       Extracellular. {ECO:0000255}.
FT   TRANSMEM    166   >169       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   REGION       <1     11       Dihydropyridine binding. {ECO:0000250}.
FT   REGION      144   >169       Dihydropyridine binding. {ECO:0000250}.
FT   REGION      158   >169       Phenylalkylamine binding. {ECO:0000250}.
FT   SITE        130    130       Calcium ion selectivity and permeability.
FT                                {ECO:0000250|UniProtKB:P15381}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   NON_TER       1      1
FT   NON_TER     169    169
SQ   SEQUENCE   169 AA;  19514 MW;  138E88E510D30CB8 CRC64;
     FQEQGEQEYK NCELDKNQRQ CVEYALKARP LRRYIPISIT FFRLFRVMRL VKLLSRGEGI
     RTLLWTFIKS FQALPYVALL IVMLFFIYAV IGMQVFGKIA LNDTTEINRN NNFQTFPQAV
     LLLFRCATGE AWQDIMLACM PGKKRAPESE PSNSTEGETP CGSSFAVFY
//
ID   CAC1G_HUMAN             Reviewed;        2377 AA.
AC   O43497; D6RA64; E7EPR0; O43498; O94770; Q19QY8; Q19QY9; Q19QZ0;
AC   Q19QZ1; Q19QZ2; Q19QZ3; Q19QZ4; Q19QZ5; Q19QZ6; Q19QZ7; Q19QZ8;
AC   Q19QZ9; Q19R00; Q19R01; Q19R02; Q19R03; Q19R04; Q19R05; Q19R06;
AC   Q19R07; Q19R08; Q19R09; Q19R10; Q19R11; Q19R12; Q19R13; Q19R15;
AC   Q19R16; Q19R17; Q19R18; Q2TAC4; Q9NYU4; Q9NYU5; Q9NYU6; Q9NYU7;
AC   Q9NYU8; Q9NYU9; Q9NYV0; Q9NYV1; Q9UHN9; Q9UHP0; Q9ULU6; Q9UNG7;
AC   Q9Y5T2; Q9Y5T3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 3.
DT   20-DEC-2017, entry version 160.
DE   RecName: Full=Voltage-dependent T-type calcium channel subunit alpha-1G;
DE   AltName: Full=Cav3.1c;
DE   AltName: Full=NBR13;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav3.1;
GN   Name=CACNA1G; Synonyms=KIAA1123;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND GENE STRUCTURE.
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=10493502;
RA   Toyota M., Ho C., Ohe-Toyota M., Baylin S.B., Issa J.-P.J.;
RT   "Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant
RT   methylation of its 5' CpG island in human tumors.";
RL   Cancer Res. 59:4535-4541(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING (ISOFORMS 4 AND
RP   5).
RC   TISSUE=Brain;
RX   PubMed=10548410; DOI=10.1016/S0304-3940(99)00716-8;
RA   Mittman S., Guo J., Agnew W.S.;
RT   "Structure and alternative splicing of the gene encoding alpha1G, a
RT   human brain T calcium channel alpha1 subunit.";
RL   Neurosci. Lett. 274:143-146(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10648811; DOI=10.1016/S0014-5793(99)01756-1;
RA   Cribbs L.L., Gomora J.C., Daud A.N., Lee J.-H., Perez-Reyes E.;
RT   "Molecular cloning and functional expression of ca(v)3.1c, a T-type
RT   calcium channel from human brain.";
RL   FEBS Lett. 466:54-58(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING (ISOFORMS 1-2 AND
RP   6-13), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10692398; DOI=10.1074/jbc.275.9.6090;
RA   Monteil A., Chemin J., Bourinet E., Mennessier G., Lory P.,
RA   Nargeot J.;
RT   "Molecular and functional properties of the human alpha1G subunit that
RT   forms T-type calcium channels.";
RL   J. Biol. Chem. 275:6090-6100(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4; 6; 7; 8; 9; 11; 12; 13;
RP   14; 15; 16; 17; 18; 19; 20; 21; 22; 23; 24; 25; 26; 27; 28; 29; 30;
RP   31; 33; 34 AND 35), AND DEVELOPMENTAL STAGE.
RC   TISSUE=Brain, and Fetal brain;
RX   PubMed=16671074; DOI=10.1002/prot.20877;
RA   Emerick M.C., Stein R., Kunze R., McNulty M.M., Regan M.R.,
RA   Hanck D.A., Agnew W.S.;
RT   "Profiling the array of Ca(v)3.1 variants from the human T-type
RT   calcium channel gene CACNA1G: alternative structures, developmental
RT   expression, and biophysical variations.";
RL   Proteins 64:320-342(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 550-2377 (ISOFORM 13).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [9]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1126-1444; 1778-1927 AND 2021-2312.
RC   TISSUE=Brain;
RX   PubMed=9495342; DOI=10.1038/36110;
RA   Perez-Reyes E., Cribbs L.L., Daud A., Lacerda A.E., Barclay J.,
RA   Williamson M.P., Fox M., Rees M., Lee J.-H.;
RT   "Molecular characterization of a neuronal low-voltage-activated T-type
RT   calcium channel.";
RL   Nature 391:896-900(1998).
RN   [11]
RP   INVOLVEMENT IN SCA42, VARIANT SCA42 HIS-1715, CHARACTERIZATION OF
RP   VARIANT SCA42 HIS-1715, AND FUNCTION.
RX   PubMed=26456284; DOI=10.1016/j.ajhg.2015.09.007;
RA   Coutelier M., Blesneac I., Monteil A., Monin M.L., Ando K.,
RA   Mundwiller E., Brusco A., Le Ber I., Anheim M., Castrioto A.,
RA   Duyckaerts C., Brice A., Durr A., Lory P., Stevanin G.;
RT   "A recurrent mutation in CACNA1G alters Cav3.1 T-type calcium-channel
RT   conduction and causes autosomal-dominant cerebellar ataxia.";
RL   Am. J. Hum. Genet. 97:726-737(2015).
RN   [12]
RP   INVOLVEMENT IN SCA42, VARIANT SCA42 HIS-1715, CHARACTERIZATION OF
RP   VARIANT SCA42 HIS-1715, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=26715324; DOI=10.1186/s13041-015-0180-4;
RA   Morino H., Matsuda Y., Muguruma K., Miyamoto R., Ohsawa R., Ohtake T.,
RA   Otobe R., Watanabe M., Maruyama H., Hashimoto K., Kawakami H.;
RT   "A mutation in the low voltage-gated calcium channel CACNA1G alters
RT   the physiological properties of the channel, causing spinocerebellar
RT   ataxia.";
RL   Mol. Brain 8:89-89(2015).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1G
CC       gives rise to T-type calcium currents. T-type calcium channels
CC       belong to the "low-voltage activated (LVA)" group and are strongly
CC       blocked by mibefradil. A particularity of this type of channel is
CC       an opening at quite negative potentials and a voltage-dependent
CC       inactivation. T-type channels serve pacemaking functions in both
CC       central neurons and cardiac nodal cells and support calcium
CC       signaling in secretory cells and vascular smooth muscle. They may
CC       also be involved in the modulation of firing patterns of neurons
CC       which is important for information processing as well as in cell
CC       growth processes. {ECO:0000269|PubMed:10648811,
CC       ECO:0000269|PubMed:10692398, ECO:0000269|PubMed:26456284,
CC       ECO:0000269|PubMed:26715324}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26715324};
CC       Multi-pass membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000269|PubMed:26715324}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=35;
CC       Name=5;
CC         IsoId=O43497-1; Sequence=Displayed;
CC       Name=1; Synonyms=Variant 89;
CC         IsoId=O43497-2; Sequence=VSP_000940, VSP_000943, VSP_000946;
CC       Name=2; Synonyms=Variant 25;
CC         IsoId=O43497-3; Sequence=VSP_000940, VSP_000944, VSP_000946;
CC       Name=3;
CC         IsoId=O43497-4; Sequence=VSP_000940;
CC       Name=4; Synonyms=Variant 88;
CC         IsoId=O43497-5; Sequence=VSP_000940, VSP_000943, VSP_000946,
CC                                  VSP_000948;
CC       Name=6; Synonyms=Variant 217;
CC         IsoId=O43497-6; Sequence=VSP_000943, VSP_000946;
CC       Name=7; Synonyms=Variant 221;
CC         IsoId=O43497-7; Sequence=VSP_000943, VSP_000947;
CC       Name=8; Synonyms=Variant 93;
CC         IsoId=O43497-8; Sequence=VSP_000940, VSP_000943, VSP_000947;
CC       Name=9; Synonyms=Variant 57;
CC         IsoId=O43497-9; Sequence=VSP_000940, VSP_000946;
CC       Name=10;
CC         IsoId=O43497-10; Sequence=VSP_000940, VSP_000945;
CC       Name=11; Synonyms=Variant 185;
CC         IsoId=O43497-11; Sequence=VSP_000946;
CC       Name=12; Synonyms=Variant 189;
CC         IsoId=O43497-12; Sequence=VSP_000947;
CC       Name=13; Synonyms=Variant 153;
CC         IsoId=O43497-13; Sequence=VSP_000944, VSP_000946;
CC       Name=14; Synonyms=Variant 137;
CC         IsoId=O43497-15; Sequence=VSP_000944, VSP_047550, VSP_000946;
CC       Name=15; Synonyms=Variant 157;
CC         IsoId=O43497-16; Sequence=VSP_000944, VSP_000947;
CC       Name=16; Synonyms=Variant 169;
CC         IsoId=O43497-17; Sequence=VSP_047550, VSP_000946;
CC       Name=17; Synonyms=Variant 184;
CC         IsoId=O43497-18; Sequence=VSP_000946, VSP_000948;
CC       Name=18; Synonyms=Variant 216;
CC         IsoId=O43497-19; Sequence=VSP_000943, VSP_000946, VSP_000948;
CC       Name=19; Synonyms=Variant 223;
CC         IsoId=O43497-20; Sequence=VSP_000943;
CC       Name=20; Synonyms=Variant 249;
CC         IsoId=O43497-21; Sequence=VSP_047548, VSP_000946;
CC       Name=21; Synonyms=Variant 313;
CC         IsoId=O43497-22; Sequence=VSP_000940, VSP_047545, VSP_000946;
CC       Name=22; Synonyms=Variant 409;
CC         IsoId=O43497-23; Sequence=VSP_047545, VSP_000944, VSP_000946;
CC       Name=23; Synonyms=Variant 441;
CC         IsoId=O43497-24; Sequence=VSP_047545, VSP_000946;
CC       Name=24; Synonyms=Variant 477;
CC         IsoId=O43497-25; Sequence=VSP_047545, VSP_000943, VSP_000947;
CC       Name=25; Synonyms=Variant 473;
CC         IsoId=O43497-26; Sequence=VSP_047545, VSP_000943, VSP_000946;
CC       Name=26; Synonyms=Variant 17;
CC         IsoId=O43497-27; Sequence=VSP_000940, VSP_000944, VSP_047551,
CC                                   VSP_047553;
CC       Name=27; Synonyms=Variant 33;
CC         IsoId=O43497-28; Sequence=VSP_000940, VSP_047549, VSP_047552;
CC       Name=28; Synonyms=Variant 49;
CC         IsoId=O43497-29; Sequence=VSP_000940, VSP_047551, VSP_047553;
CC       Name=29; Synonyms=Variant 145;
CC         IsoId=O43497-30; Sequence=VSP_000944, VSP_047551, VSP_047553;
CC       Name=30; Synonyms=Variant 177;
CC         IsoId=O43497-31; Sequence=VSP_047551, VSP_047553;
CC       Name=31; Synonyms=Variant 209;
CC         IsoId=O43497-32; Sequence=VSP_000943, VSP_047551, VSP_047553;
CC       Name=32;
CC         IsoId=O43497-33; Sequence=VSP_000940, VSP_000943;
CC         Note=Gene prediction based on EST data.;
CC       Name=33; Synonyms=Variant 441-d81;
CC         IsoId=O43497-34; Sequence=VSP_047546, VSP_000946;
CC       Name=34; Synonyms=Variant 473-d75;
CC         IsoId=O43497-35; Sequence=VSP_047547, VSP_000943, VSP_000946;
CC       Name=35; Synonyms=Variant 473-d81;
CC         IsoId=O43497-36; Sequence=VSP_047546, VSP_000943, VSP_000946;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, in particular in
CC       the amygdala, subthalamic nuclei, cerebellum and thalamus.
CC       Moderate expression in heart; low expression in placenta, kidney
CC       and lung. Also expressed in colon and bone marrow and in tumoral
CC       cells to a lesser extent. Highly expressed in fetal brain, but
CC       also in peripheral fetal tissues as heart, kidney and lung,
CC       suggesting a developmentally regulated expression.
CC   -!- DEVELOPMENTAL STAGE: Isoform 4, isoform 7, isoform 18, isoform 19,
CC       isoform 24, isoform 25 and isoform 31 are adult-specific. Isoform
CC       8, isoform 14, isoform 15, isoform 16, isoform 17, isoform 20,
CC       isoform 21, isoform 22, isoform 23, isoform 26, isoform 27,
CC       isoform 28, isoform 29 and isoform 30 are fetal-specific. Isoform
CC       1, isoform 2, isoform 6, isoform 9, isoform 11, isoform 12 and
CC       isoform 13 are expressed in both fetus and adult.
CC       {ECO:0000269|PubMed:16671074}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: The linker region between repeat III and IV probably plays
CC       a role in the inactivation of the channel. The C-terminal part may
CC       be implicated in the anchoring of the protein to the membrane by
CC       interfering with or restricting its lateral diffusion.
CC   -!- PTM: In response to raising of intracellular calcium, the T-type
CC       channels are activated by CaM-kinase II.
CC   -!- DISEASE: Spinocerebellar ataxia 42 (SCA42) [MIM:616795]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive
CC       incoordination of gait and often poor coordination of hands,
CC       speech and eye movements, due to degeneration of the cerebellum
CC       with variable involvement of the brainstem and spinal cord. SCA42
CC       is a slowly progressive, autosomal dominant form with variable
CC       severity. {ECO:0000269|PubMed:26456284,
CC       ECO:0000269|PubMed:26715324}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1G subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF124351; AAD34352.1; -; mRNA.
DR   EMBL; AF134985; AAF19346.1; -; mRNA.
DR   EMBL; AF134986; AAF19347.1; -; mRNA.
DR   EMBL; AF190860; AAF35287.1; -; mRNA.
DR   EMBL; AF126965; AAD29400.1; -; mRNA.
DR   EMBL; AF126966; AAD29401.1; -; mRNA.
DR   EMBL; AF227744; AAF37689.1; -; mRNA.
DR   EMBL; AF227745; AAF37690.1; -; mRNA.
DR   EMBL; AF227746; AAF37691.1; -; mRNA.
DR   EMBL; AF227747; AAF37692.1; -; mRNA.
DR   EMBL; AF227748; AAF37693.1; -; mRNA.
DR   EMBL; AF227749; AAF37694.1; -; mRNA.
DR   EMBL; AF227750; AAF37695.1; -; mRNA.
DR   EMBL; AF227751; AAF37696.1; -; mRNA.
DR   EMBL; DQ494449; ABF69900.1; -; mRNA.
DR   EMBL; DQ494450; ABF69901.1; -; mRNA.
DR   EMBL; DQ494451; ABF69902.1; -; mRNA.
DR   EMBL; DQ494452; ABF69903.1; -; mRNA.
DR   EMBL; DQ494453; ABF69904.1; -; mRNA.
DR   EMBL; DQ494454; ABF69905.1; -; mRNA.
DR   EMBL; DQ494455; ABF69906.1; -; mRNA.
DR   EMBL; DQ494456; ABF69907.1; -; mRNA.
DR   EMBL; DQ494457; ABF69908.1; -; mRNA.
DR   EMBL; DQ494458; ABF69909.1; -; mRNA.
DR   EMBL; DQ494459; ABF69910.1; -; mRNA.
DR   EMBL; DQ494460; ABF69911.1; -; mRNA.
DR   EMBL; DQ494461; ABF69912.1; -; mRNA.
DR   EMBL; DQ494462; ABF69913.1; -; mRNA.
DR   EMBL; DQ494463; ABF69914.1; -; mRNA.
DR   EMBL; DQ494464; ABF69915.1; -; mRNA.
DR   EMBL; DQ494465; ABF69916.1; -; mRNA.
DR   EMBL; DQ494466; ABF69917.1; -; mRNA.
DR   EMBL; DQ494467; ABF69918.1; -; mRNA.
DR   EMBL; DQ494468; ABF69919.1; -; mRNA.
DR   EMBL; DQ494469; ABF69920.1; -; mRNA.
DR   EMBL; DQ494470; ABF69921.1; -; mRNA.
DR   EMBL; DQ494471; ABF69922.1; -; mRNA.
DR   EMBL; DQ494472; ABF69923.1; -; mRNA.
DR   EMBL; DQ494473; ABF69924.1; -; mRNA.
DR   EMBL; DQ494474; ABF69925.1; -; mRNA.
DR   EMBL; DQ494475; ABF69926.1; -; mRNA.
DR   EMBL; DQ494476; ABF69927.1; -; mRNA.
DR   EMBL; DQ494477; ABF69928.1; -; mRNA.
DR   EMBL; DQ494478; ABF69929.1; -; mRNA.
DR   EMBL; DQ494479; ABF69930.1; -; mRNA.
DR   EMBL; AC004590; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC110995; AAI10996.1; -; mRNA.
DR   EMBL; AB032949; BAA86437.2; -; mRNA.
DR   EMBL; AF029228; AAD12731.1; -; mRNA.
DR   EMBL; AF029229; AAD12732.1; -; mRNA.
DR   CCDS; CCDS45730.1; -. [O43497-1]
DR   CCDS; CCDS45731.1; -. [O43497-12]
DR   CCDS; CCDS45732.1; -. [O43497-11]
DR   CCDS; CCDS45733.1; -. [O43497-13]
DR   CCDS; CCDS45734.1; -. [O43497-33]
DR   CCDS; CCDS45735.1; -. [O43497-2]
DR   CCDS; CCDS45736.1; -. [O43497-5]
DR   CCDS; CCDS45737.1; -. [O43497-10]
DR   CCDS; CCDS54142.1; -. [O43497-7]
DR   CCDS; CCDS54143.1; -. [O43497-6]
DR   CCDS; CCDS54144.1; -. [O43497-9]
DR   CCDS; CCDS54145.1; -. [O43497-3]
DR   CCDS; CCDS54146.1; -. [O43497-8]
DR   CCDS; CCDS58565.1; -. [O43497-17]
DR   CCDS; CCDS58566.1; -. [O43497-18]
DR   CCDS; CCDS58567.1; -. [O43497-15]
DR   CCDS; CCDS58568.1; -. [O43497-16]
DR   CCDS; CCDS58569.1; -. [O43497-21]
DR   CCDS; CCDS58570.1; -. [O43497-20]
DR   CCDS; CCDS58571.1; -. [O43497-19]
DR   CCDS; CCDS58572.1; -. [O43497-24]
DR   CCDS; CCDS58573.1; -. [O43497-23]
DR   CCDS; CCDS58574.1; -. [O43497-25]
DR   CCDS; CCDS58575.1; -. [O43497-26]
DR   CCDS; CCDS58576.1; -. [O43497-22]
DR   RefSeq; NP_001243253.1; NM_001256324.1. [O43497-16]
DR   RefSeq; NP_001243254.1; NM_001256325.1. [O43497-21]
DR   RefSeq; NP_001243255.1; NM_001256326.1. [O43497-25]
DR   RefSeq; NP_001243256.1; NM_001256327.1. [O43497-17]
DR   RefSeq; NP_001243257.1; NM_001256328.1. [O43497-15]
DR   RefSeq; NP_001243258.1; NM_001256329.1. [O43497-24]
DR   RefSeq; NP_001243259.1; NM_001256330.1. [O43497-26]
DR   RefSeq; NP_001243260.1; NM_001256331.1. [O43497-23]
DR   RefSeq; NP_001243261.1; NM_001256332.1. [O43497-22]
DR   RefSeq; NP_001243262.1; NM_001256333.1. [O43497-18]
DR   RefSeq; NP_001243263.1; NM_001256334.1. [O43497-19]
DR   RefSeq; NP_001243288.1; NM_001256359.1. [O43497-34]
DR   RefSeq; NP_001243289.1; NM_001256360.1. [O43497-35]
DR   RefSeq; NP_001243290.1; NM_001256361.1. [O43497-36]
DR   RefSeq; NP_061496.2; NM_018896.4. [O43497-1]
DR   RefSeq; NP_938190.1; NM_198376.2. [O43497-5]
DR   RefSeq; NP_938191.2; NM_198377.2. [O43497-20]
DR   RefSeq; NP_938192.1; NM_198378.2. [O43497-6]
DR   RefSeq; NP_938193.1; NM_198379.2. [O43497-8]
DR   RefSeq; NP_938194.1; NM_198380.2. [O43497-7]
DR   RefSeq; NP_938196.1; NM_198382.2. [O43497-9]
DR   RefSeq; NP_938197.1; NM_198383.2. [O43497-10]
DR   RefSeq; NP_938198.1; NM_198384.2. [O43497-11]
DR   RefSeq; NP_938199.1; NM_198385.2. [O43497-12]
DR   RefSeq; NP_938200.1; NM_198386.2. [O43497-13]
DR   RefSeq; NP_938201.1; NM_198387.2. [O43497-2]
DR   RefSeq; NP_938202.1; NM_198388.2. [O43497-3]
DR   RefSeq; NP_938406.1; NM_198396.2. [O43497-33]
DR   UniGene; Hs.591169; -.
DR   ProteinModelPortal; O43497; -.
DR   BioGrid; 114427; 2.
DR   IntAct; O43497; 2.
DR   MINT; MINT-2796172; -.
DR   STRING; 9606.ENSP00000352011; -.
DR   BindingDB; O43497; -.
DR   ChEMBL; CHEMBL4641; -.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB00593; Ethosuximide.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB05246; Methsuximide.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00347; Trimethadione.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 535; -.
DR   iPTMnet; O43497; -.
DR   PhosphoSitePlus; O43497; -.
DR   BioMuta; CACNA1G; -.
DR   PaxDb; O43497; -.
DR   PeptideAtlas; O43497; -.
DR   PRIDE; O43497; -.
DR   Ensembl; ENST00000352832; ENSP00000339302; ENSG00000006283. [O43497-2]
DR   Ensembl; ENST00000354983; ENSP00000347078; ENSG00000006283. [O43497-33]
DR   Ensembl; ENST00000358244; ENSP00000350979; ENSG00000006283. [O43497-5]
DR   Ensembl; ENST00000359106; ENSP00000352011; ENSG00000006283. [O43497-1]
DR   Ensembl; ENST00000360761; ENSP00000353990; ENSG00000006283. [O43497-9]
DR   Ensembl; ENST00000429973; ENSP00000414388; ENSG00000006283. [O43497-13]
DR   Ensembl; ENST00000442258; ENSP00000409759; ENSG00000006283. [O43497-3]
DR   Ensembl; ENST00000502264; ENSP00000425522; ENSG00000006283. [O43497-10]
DR   Ensembl; ENST00000503436; ENSP00000427231; ENSG00000006283. [O43497-29]
DR   Ensembl; ENST00000503485; ENSP00000427238; ENSG00000006283. [O43497-24]
DR   Ensembl; ENST00000503607; ENSP00000426558; ENSG00000006283. [O43497-27]
DR   Ensembl; ENST00000504076; ENSP00000425153; ENSG00000006283. [O43497-32]
DR   Ensembl; ENST00000505165; ENSP00000422268; ENSG00000006283. [O43497-18]
DR   Ensembl; ENST00000506406; ENSP00000426313; ENSG00000006283. [O43497-31]
DR   Ensembl; ENST00000507336; ENSP00000420918; ENSG00000006283. [O43497-20]
DR   Ensembl; ENST00000507510; ENSP00000423112; ENSG00000006283. [O43497-12]
DR   Ensembl; ENST00000507609; ENSP00000423045; ENSG00000006283. [O43497-17]
DR   Ensembl; ENST00000507896; ENSP00000421518; ENSG00000006283. [O43497-19]
DR   Ensembl; ENST00000510115; ENSP00000427173; ENSG00000006283. [O43497-8]
DR   Ensembl; ENST00000510366; ENSP00000426814; ENSG00000006283. [O43497-23]
DR   Ensembl; ENST00000511765; ENSP00000427247; ENSG00000006283. [O43497-30]
DR   Ensembl; ENST00000511768; ENSP00000424664; ENSG00000006283. [O43497-28]
DR   Ensembl; ENST00000512389; ENSP00000426261; ENSG00000006283. [O43497-6]
DR   Ensembl; ENST00000513689; ENSP00000426172; ENSG00000006283. [O43497-25]
DR   Ensembl; ENST00000513964; ENSP00000425451; ENSG00000006283. [O43497-26]
DR   Ensembl; ENST00000514079; ENSP00000423317; ENSG00000006283. [O43497-21]
DR   Ensembl; ENST00000514181; ENSP00000425698; ENSG00000006283. [O43497-15]
DR   Ensembl; ENST00000514717; ENSP00000422407; ENSG00000006283. [O43497-22]
DR   Ensembl; ENST00000515165; ENSP00000426098; ENSG00000006283. [O43497-11]
DR   Ensembl; ENST00000515411; ENSP00000423155; ENSG00000006283. [O43497-16]
DR   Ensembl; ENST00000515765; ENSP00000426232; ENSG00000006283. [O43497-7]
DR   GeneID; 8913; -.
DR   KEGG; hsa:8913; -.
DR   UCSC; uc002irj.3; human. [O43497-1]
DR   CTD; 8913; -.
DR   DisGeNET; 8913; -.
DR   EuPathDB; HostDB:ENSG00000006283.17; -.
DR   GeneCards; CACNA1G; -.
DR   HGNC; HGNC:1394; CACNA1G.
DR   HPA; HPA004714; -.
DR   MalaCards; CACNA1G; -.
DR   MIM; 604065; gene.
DR   MIM; 616795; phenotype.
DR   neXtProt; NX_O43497; -.
DR   OpenTargets; ENSG00000006283; -.
DR   PharmGKB; PA381; -.
DR   eggNOG; KOG2302; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128242; -.
DR   HOGENOM; HOG000007742; -.
DR   HOVERGEN; HBG050764; -.
DR   InParanoid; O43497; -.
DR   KO; K04854; -.
DR   OMA; FWRLICD; -.
DR   OrthoDB; EOG091G02L1; -.
DR   PhylomeDB; O43497; -.
DR   TreeFam; TF313555; -.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   ChiTaRS; CACNA1G; human.
DR   GeneWiki; CACNA1G; -.
DR   GenomeRNAi; 8913; -.
DR   PRO; PR:O43497; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000006283; -.
DR   ExpressionAtlas; O43497; baseline and differential.
DR   Genevisible; O43497; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; ISS:BHF-UCL.
DR   GO; GO:0008332; F:low voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0086056; F:voltage-gated calcium channel activity involved in AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086059; F:voltage-gated calcium channel activity involved SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0086016; P:AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086027; P:AV node cell to bundle of His cell signaling; ISS:BHF-UCL.
DR   GO; GO:0070509; P:calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISS:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0086045; P:membrane depolarization during AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IBA:GO_Central.
DR   GO; GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IEA:Ensembl.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISS:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0010045; P:response to nickel cation; IEA:Ensembl.
DR   GO; GO:0086015; P:SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086018; P:SA node cell to atrial cardiac muscle cell signaling; ISS:BHF-UCL.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005445; VDCC_T_a1.
DR   InterPro; IPR030154; VDCC_T_a1G.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF137; PTHR10037:SF137; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01629; TVDCCALPHA1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Cytoplasm; Disease mutation;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Neurodegeneration;
KW   Phosphoprotein; Reference proteome; Repeat; Spinocerebellar ataxia;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2377       Voltage-dependent T-type calcium channel
FT                                subunit alpha-1G.
FT                                /FTId=PRO_0000053952.
FT   TOPO_DOM      1     80       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     81    101       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    102    119       Extracellular. {ECO:0000255}.
FT   TRANSMEM    120    141       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    142    150       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    151    170       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    171    175       Extracellular. {ECO:0000255}.
FT   TRANSMEM    176    193       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    194    213       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    235    370       Extracellular. {ECO:0000255}.
FT   TRANSMEM    371    395       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    396    743       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    744    764       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    765    777       Extracellular. {ECO:0000255}.
FT   TRANSMEM    778    799       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    800    805       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    806    824       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    825    832       Extracellular. {ECO:0000255}.
FT   TRANSMEM    833    856       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    857    867       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    868    888       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    889    939       Extracellular. {ECO:0000255}.
FT   TRANSMEM    940    964       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    965   1272       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1273   1295       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1296   1313       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1314   1334       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1335   1344       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1345   1364       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1365   1378       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1379   1400       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1401   1410       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1411   1434       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1435   1511       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1512   1537       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1538   1610       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1611   1631       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1632   1645       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1646   1667       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1668   1674       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1675   1693       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1694   1707       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1708   1731       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1732   1745       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1746   1766       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1767   1826       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1827   1854       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1855   2377       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       68    398       I.
FT   REPEAT      729    967       II.
FT   REPEAT     1263   1540       III.
FT   REPEAT     1596   1854       IV.
FT   COMPBIAS    290    295       Poly-Gly.
FT   COMPBIAS    496    506       Poly-His.
FT   SITE        354    354       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        924    924       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1465   1465       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1770   1770       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54898}.
FT   MOD_RES     715    715       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54898}.
FT   MOD_RES    1139   1139       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54898}.
FT   MOD_RES    1145   1145       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54898}.
FT   MOD_RES    1146   1146       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54898}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    306    306       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1448   1448       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1451   1451       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1698   1698       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     971    993       Missing (in isoform 1, isoform 2, isoform
FT                                3, isoform 4, isoform 8, isoform 9,
FT                                isoform 10, isoform 21, isoform 26,
FT                                isoform 27, isoform 28 and isoform 32).
FT                                {ECO:0000303|PubMed:10493502,
FT                                ECO:0000303|PubMed:10648811,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000940.
FT   VAR_SEQ    1505   1538       Missing (in isoform 21, isoform 22,
FT                                isoform 23, isoform 24 and isoform 25).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047545.
FT   VAR_SEQ    1505   1531       Missing (in isoform 33 and isoform 35).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047546.
FT   VAR_SEQ    1505   1529       Missing (in isoform 34).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047547.
FT   VAR_SEQ    1569   1587       NLMLDDVIASGSSASAASE -> K (in isoform 2,
FT                                isoform 13, isoform 14, isoform 15,
FT                                isoform 22, isoform 26 and isoform 29).
FT                                {ECO:0000303|PubMed:10574461,
FT                                ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000944.
FT   VAR_SEQ    1569   1586       NLMLDDVIASGSSASAAS -> SKEKQMA (in isoform
FT                                1, isoform 4, isoform 6, isoform 7,
FT                                isoform 8, isoform 18, isoform 19,
FT                                isoform 24, isoform 25, isoform 31,
FT                                isoform 32, isoform 34 and isoform 35).
FT                                {ECO:0000303|PubMed:10648811,
FT                                ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000943.
FT   VAR_SEQ    1569   1569       N -> SKEKQMAD (in isoform 20).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047548.
FT   VAR_SEQ    1736   1769       VMQALPQVGNLGLLFMLLFFIFAALGVELFGDLE -> LWA
FT                                WSSLETWSVTRHTPVRAWAVMPPFGTLAWPS (in
FT                                isoform 27).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047549.
FT   VAR_SEQ    1737   1743       Missing (in isoform 14 and isoform 16).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047550.
FT   VAR_SEQ    1743   1776       VGNLGLLFMLLFFIFAALGVELFGDLECDETHPC -> LWA
FT                                WSSLETWSVTRHTPVRAWAVMPPFGTLAWPS (in
FT                                isoform 26, isoform 28, isoform 29,
FT                                isoform 30 and isoform 31).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047551.
FT   VAR_SEQ    1770   2377       Missing (in isoform 27).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047552.
FT   VAR_SEQ    1777   2377       Missing (in isoform 26, isoform 28,
FT                                isoform 29, isoform 30 and isoform 31).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_047553.
FT   VAR_SEQ    1928   2020       Missing (in isoform 1, isoform 2, isoform
FT                                4, isoform 6, isoform 9, isoform 11,
FT                                isoform 13, isoform 14, isoform 16,
FT                                isoform 17, isoform 18, isoform 20,
FT                                isoform 21, isoform 22, isoform 23,
FT                                isoform 25, isoform 33, isoform 34 and
FT                                isoform 35).
FT                                {ECO:0000303|PubMed:10574461,
FT                                ECO:0000303|PubMed:10648811,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000946.
FT   VAR_SEQ    1928   1975       Missing (in isoform 10). {ECO:0000305}.
FT                                /FTId=VSP_000945.
FT   VAR_SEQ    1976   2020       Missing (in isoform 7, isoform 8, isoform
FT                                12, isoform 15 and isoform 24).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000947.
FT   VAR_SEQ    2156   2234       Missing (in isoform 4, isoform 17 and
FT                                isoform 18).
FT                                {ECO:0000303|PubMed:16671074}.
FT                                /FTId=VSP_000948.
FT   VARIANT    1715   1715       R -> H (in SCA42; changed voltage-gated
FT                                calcium channel activity; membrane
FT                                potential dependency is shifted toward
FT                                more positive potentials;
FT                                dbSNP:rs755221106).
FT                                {ECO:0000269|PubMed:26456284,
FT                                ECO:0000269|PubMed:26715324}.
FT                                /FTId=VAR_076292.
FT   CONFLICT   1345   1345       S -> I (in Ref. 10; AAD12731).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2377 AA;  262472 MW;  1C9F7C557D9D32DF CRC64;
     MDEEEDGAGA EESGQPRSFM RLNDLSGAGG RPGPGSAEKD PGSADSEAEG LPYPALAPVV
     FFYLSQDSRP RSWCLRTVCN PWFERISMLV ILLNCVTLGM FRPCEDIACD SQRCRILQAF
     DDFIFAFFAV EMVVKMVALG IFGKKCYLGD TWNRLDFFIV IAGMLEYSLD LQNVSFSAVR
     TVRVLRPLRA INRVPSMRIL VTLLLDTLPM LGNVLLLCFF VFFIFGIVGV QLWAGLLRNR
     CFLPENFSLP LSVDLERYYQ TENEDESPFI CSQPRENGMR SCRSVPTLRG DGGGGPPCGL
     DYEAYNSSSN TTCVNWNQYY TNCSAGEHNP FKGAINFDNI GYAWIAIFQV ITLEGWVDIM
     YFVMDAHSFY NFIYFILLII VGSFFMINLC LVVIATQFSE TKQRESQLMR EQRVRFLSNA
     STLASFSEPG SCYEELLKYL VYILRKAARR LAQVSRAAGV RVGLLSSPAP LGGQETQPSS
     SCSRSHRRLS VHHLVHHHHH HHHHYHLGNG TLRAPRASPE IQDRDANGSR RLMLPPPSTP
     ALSGAPPGGA ESVHSFYHAD CHLEPVRCQA PPPRSPSEAS GRTVGSGKVY PTVHTSPPPE
     TLKEKALVEV AASSGPPTLT SLNIPPGPYS SMHKLLETQS TGACQSSCKI SSPCLKADSG
     ACGPDSCPYC ARAGAGEVEL ADREMPDSDS EAVYEFTQDA QHSDLRDPHS RRQRSLGPDA
     EPSSVLAFWR LICDTFRKIV DSKYFGRGIM IAILVNTLSM GIEYHEQPEE LTNALEISNI
     VFTSLFALEM LLKLLVYGPF GYIKNPYNIF DGVIVVISVW EIVGQQGGGL SVLRTFRLMR
     VLKLVRFLPA LQRQLVVLMK TMDNVATFCM LLMLFIFIFS ILGMHLFGCK FASERDGDTL
     PDRKNFDSLL WAIVTVFQIL TQEDWNKVLY NGMASTSSWA ALYFIALMTF GNYVLFNLLV
     AILVEGFQAE EISKREDASG QLSCIQLPVD SQGGDANKSE SEPDFFSPSL DGDGDRKKCL
     ALVSLGEHPE LRKSLLPPLI IHTAATPMSL PKSTSTGLGE ALGPASRRTS SSGSAEPGAA
     HEMKSPPSAR SSPHSPWSAA SSWTSRRSSR NSLGRAPSLK RRSPSGERRS LLSGEGQESQ
     DEEESSEEER ASPAGSDHRH RGSLEREAKS SFDLPDTLQV PGLHRTASGR GSASEHQDCN
     GKSASGRLAR ALRPDDPPLD GDDADDEGNL SKGERVRAWI RARLPACCLE RDSWSAYIFP
     PQSRFRLLCH RIITHKMFDH VVLVIIFLNC ITIAMERPKI DPHSAERIFL TLSNYIFTAV
     FLAEMTVKVV ALGWCFGEQA YLRSSWNVLD GLLVLISVID ILVSMVSDSG TKILGMLRVL
     RLLRTLRPLR VISRAQGLKL VVETLMSSLK PIGNIVVICC AFFIIFGILG VQLFKGKFFV
     CQGEDTRNIT NKSDCAEASY RWVRHKYNFD NLGQALMSLF VLASKDGWVD IMYDGLDAVG
     VDQQPIMNHN PWMLLYFISF LLIVAFFVLN MFVGVVVENF HKCRQHQEEE EARRREEKRL
     RRLEKKRRNL MLDDVIASGS SASAASEAQC KPYYSDYSRF RLLVHHLCTS HYLDLFITGV
     IGLNVVTMAM EHYQQPQILD EALKICNYIF TVIFVLESVF KLVAFGFRRF FQDRWNQLDL
     AIVLLSIMGI TLEEIEVNAS LPINPTIIRI MRVLRIARVL KLLKMAVGMR ALLDTVMQAL
     PQVGNLGLLF MLLFFIFAAL GVELFGDLEC DETHPCEGLG RHATFRNFGM AFLTLFRVST
     GDNWNGIMKD TLRDCDQEST CYNTVISPIY FVSFVLTAQF VLVNVVIAVL MKHLEESNKE
     AKEEAELEAE LELEMKTLSP QPHSPLGSPF LWPGVEGPDS PDSPKPGALH PAAHARSASH
     FSLEHPTDRQ LFDTISLLIQ GSLEWELKLM DELAGPGGQP SAFPSAPSLG GSDPQIPLAE
     MEALSLTSEI VSEPSCSLAL TDDSLPDDMH TLLLSALESN MQPHPTELPG PDLLTVRKSG
     VSRTHSLPND SYMCRHGSTA EGPLGHRGWG LPKAQSGSVL SVHSQPADTS YILQLPKDAP
     HLLQPHSAPT WGTIPKLPPP GRSPLAQRPL RRQAAIRTDS LDVQGLGSRE DLLAEVSGPS
     PPLARAYSFW GQSSTQAQQH SRSHSKISKH MTPPAPCPGP EPNWGKGPPE TRSSLELDTE
     LSWISGDLLP PGGQEEPPSP RDLKKCYSVE AQSCQRRPTS WLDEQRRHSI AVSCLDSGSQ
     PHLGTDPSNL GGQPLGGPGS RPKKKLSPPS ITIDPPESQG PRTPPSPGIC LRRRAPSSDS
     KDPLASGPPD SMAASPSPKK DVLSLSGLSS DPADLDP
//
ID   CAC1B_MOUSE             Reviewed;        2327 AA.
AC   O55017; Q60609;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 171.
DE   RecName: Full=Voltage-dependent N-type calcium channel subunit alpha-1B;
DE   AltName: Full=Brain calcium channel III;
DE            Short=BIII;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide isoform 5;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.2;
GN   Name=Cacna1b; Synonyms=Cach5, Cacnl1a5, Cchn1a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RA   Hong T., Birnbaumer L.;
RT   "Nucleotide sequence polymorphism of mouse alpha1 B.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS NB1 AND NB2).
RC   TISSUE=Neuroblastoma;
RX   PubMed=8307146; DOI=10.1016/0014-5793(94)80105-3;
RA   Coppola T., Waldmann R., Borsotto M., Heurteaux C., Romey G.,
RA   Mattei M.-G., Lazdunski M.;
RT   "Molecular cloning of a murine N-type calcium channel alpha 1 subunit.
RT   Evidence for isoforms, brain distribution, and chromosomal
RT   localization.";
RL   FEBS Lett. 338:1-5(1994).
RN   [3]
RP   INTERACTION WITH RIMS1.
RC   TISSUE=Brain;
RX   PubMed=11438518; DOI=10.1074/jbc.M100929200;
RA   Coppola T., Magnin-Luethi S., Perret-Menoud V., Gattesco S.,
RA   Schiavo G., Regazzi R.;
RT   "Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-
RT   25, and synaptotagmin.";
RL   J. Biol. Chem. 276:32756-32762(2001).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.T500041-MCP200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,
RA   Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=17114649; DOI=10.1074/mcp.M600046-MCP200;
RA   Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA   Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,
RA   Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
RT   "Qualitative and quantitative analyses of protein phosphorylation in
RT   naive and stimulated mouse synaptosomal preparations.";
RL   Mol. Cell. Proteomics 6:283-293(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411; SER-745; SER-748;
RP   SER-783; SER-1058; SER-2056; SER-2212; SER-2221 AND SER-2244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [8]
RP   INTERACTION WITH FMR1.
RX   PubMed=24709664; DOI=10.1038/ncomms4628;
RA   Ferron L., Nieto-Rostro M., Cassidy J.S., Dolphin A.C.;
RT   "Fragile X mental retardation protein controls synaptic vesicle
RT   exocytosis by modulating N-type calcium channel density.";
RL   Nat. Commun. 5:3628-3628(2014).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1B
CC       gives rise to N-type calcium currents. N-type calcium channels
CC       belong to the 'high-voltage activated' (HVA) group and are blocked
CC       by omega-conotoxin-GVIA (omega-CTx-GVIA) and by omega-agatoxin-
CC       IIIA (omega-Aga-IIIA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing alpha-1B subunit may play a role in
CC       directed migration of immature neurons.
CC   -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity. Interacts with RIMS1 (PubMed:11438518).
CC       Interacts with FMR1 (via C-terminus); this interaction induces a
CC       deacrease in the number of presynaptic functional CACNA1B channels
CC       at the cell surface (PubMed:24709664).
CC       {ECO:0000269|PubMed:11438518, ECO:0000269|PubMed:24709664}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=NB1;
CC         IsoId=O55017-1; Sequence=Displayed;
CC       Name=NB2;
CC         IsoId=O55017-2; Sequence=VSP_000883;
CC   -!- TISSUE SPECIFICITY: Widespread expression throughout the brain.
CC       Highest levels in pyramidal cell layers C1, C2 and C3 of the
CC       hippocampus, in the dentate gyrus, in the cortex layers 2 et 4, in
CC       the subiculum and the habenula.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1B subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB60437.1; Type=Frameshift; Positions=1924, 1934, 2121, 2127; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF042317; AAB97840.1; -; mRNA.
DR   EMBL; U04999; AAB60437.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS38065.1; -. [O55017-1]
DR   PIR; S41080; S41080.
DR   RefSeq; NP_001035993.1; NM_001042528.2. [O55017-1]
DR   UniGene; Mm.4424; -.
DR   ProteinModelPortal; O55017; -.
DR   BioGrid; 198431; 5.
DR   IntAct; O55017; 2.
DR   STRING; 10090.ENSMUSP00000037416; -.
DR   ChEMBL; CHEMBL3637936; -.
DR   TCDB; 1.A.1.11.9; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O55017; -.
DR   PhosphoSitePlus; O55017; -.
DR   MaxQB; O55017; -.
DR   PaxDb; O55017; -.
DR   PRIDE; O55017; -.
DR   Ensembl; ENSMUST00000041342; ENSMUSP00000037416; ENSMUSG00000004113. [O55017-1]
DR   GeneID; 12287; -.
DR   KEGG; mmu:12287; -.
DR   UCSC; uc008ipe.2; mouse. [O55017-1]
DR   CTD; 774; -.
DR   MGI; MGI:88296; Cacna1b.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000231530; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; O55017; -.
DR   KO; K04849; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-MMU-112308; Presynaptic depolarization and calcium channel opening.
DR   PRO; PR:O55017; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000004113; -.
DR   ExpressionAtlas; O55017; baseline and differential.
DR   Genevisible; O55017; MM.
DR   GO; GO:0030425; C:dendrite; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0007626; P:locomotory behavior; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007269; P:neurotransmitter secretion; IMP:MGI.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:MGI.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:MGI.
DR   GO; GO:0008016; P:regulation of heart contraction; IMP:MGI.
DR   GO; GO:0048265; P:response to pain; IMP:MGI.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005447; VDCC_N_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF161; PTHR10037:SF161; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01631; NVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   2327       Voltage-dependent N-type calcium channel
FT                                subunit alpha-1B.
FT                                /FTId=PRO_0000053922.
FT   TOPO_DOM      1     95       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     96    114       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    115    133       Extracellular. {ECO:0000255}.
FT   TRANSMEM    134    151       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    152    164       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    165    179       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    180    186       Extracellular. {ECO:0000255}.
FT   TRANSMEM    187    205       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    206    225       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    226    245       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    246    331       Extracellular. {ECO:0000255}.
FT   TRANSMEM    332    356       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    357    482       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    483    502       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    503    516       Extracellular. {ECO:0000255}.
FT   TRANSMEM    517    536       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    537    544       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    545    563       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    564    574       Extracellular. {ECO:0000255}.
FT   TRANSMEM    575    592       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    593    611       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    612    631       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    632    684       Extracellular. {ECO:0000255}.
FT   TRANSMEM    685    709       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    710   1134       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1135   1158       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1159   1175       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1176   1195       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1196   1203       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1204   1226       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1227   1241       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1242   1256       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1257   1277       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1278   1297       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1298   1383       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1384   1408       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1409   1465       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1466   1484       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1485   1498       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1499   1518       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1519   1527       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1528   1546       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1547   1554       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1555   1573       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1574   1592       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1593   1612       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1613   1674       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1675   1694       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1695   2327       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       82    359       I.
FT   REPEAT      468    712       II.
FT   REPEAT     1126   1412       III.
FT   REPEAT     1449   1702       IV.
FT   DOMAIN     1715   1750       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   NP_BIND     451    458       ATP. {ECO:0000255}.
FT   CA_BIND    1728   1739       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      379    396       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS   2040   2044       Poly-His.
FT   COMPBIAS   2106   2110       Poly-Ser.
FT   SITE        314    314       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        663    663       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1358   1358       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1646   1646       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES      22     22       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     411    411       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     745    745       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     748    748       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     783    783       Phosphoserine.
FT                                {ECO:0000244|PubMed:16452087,
FT                                ECO:0000244|PubMed:21183079}.
FT   MOD_RES    1058   1058       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    1710   1710       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    2056   2056       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    2212   2212       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    2221   2221       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    2244   2244       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1554   1554       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1666   1666       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     756    756       A -> AFVKQTRGTVSRSSSVSSVNSP (in isoform
FT                                NB2). {ECO:0000303|PubMed:8307146}.
FT                                /FTId=VSP_000883.
FT   VARIANT     414    414       D -> DA.
FT   CONFLICT    238    238       A -> G (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT    645    645       N -> I (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT    757    759       RQQ -> QE (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT    880    880       A -> P (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1128   1128       L -> F (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1173   1173       K -> E (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1185   1185       F -> C (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1227   1230       Missing (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1388   1388       F -> L (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1549   1549       A -> AET (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1615   1615       I -> S (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1636   1636       L -> I (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1657   1657       G -> D (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1802   1837       Missing (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1942   1942       A -> G (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1949   1949       G -> D (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1963   1963       A -> L (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1979   1979       E -> D (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   1994   1994       P -> L (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2021   2021       H -> D (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2075   2075       A -> AA (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2141   2141       T -> A (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2168   2168       S -> I (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2309   2309       S -> N (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2313   2313       R -> G (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
FT   CONFLICT   2316   2316       H -> A (in Ref. 2; AAB60437).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2327 AA;  261481 MW;  AD42CDD38482895A CRC64;
     MVRFGDELGG RYGGTGGGER ARGGGAGGAG GPGQGGLPPG QRVLYKQSIA QRARTMALYN
     PIPVKQNCFT VNRSLFVFSE DNVVRKYAKR ITEWPPFEYM ILATIIANCI VLALEQHLPD
     GDKTPMSERL DDTEPYFIGI FCFEAGIKII ALGFVFHKGS YLRNGWNVMD FVVVLTGILA
     TAGTDFDLRT LRAVRVLRPL KLVSGIPSLQ VVLKSIMKAM VPLLQIGLLL FFAILMFAII
     GLEFYMGKFH KACFPNSTDT EPVGDFPCGK DPPARQCDGD TECREYWPGP NFGITNFDNI
     LFAILTVFQC ITMEGWTDIL YNTNDAAGNT WNWLYFIPLI IIGSFFMLNL VLGVLSGEFA
     KERERVENRR AFLKLRRQQQ IERELNGYLE WIFKAEEVML AEEDKNAEEK SPLDVLKRAA
     TKKSRNDLIH AEEGEDRFVD LCAVGSPFAR ASLKSGKTES SSYFRRKEKM FRFFIRRMVK
     AQSFYWVVLC VVALNTLCVA MVHYNQPQRL TTALYFAEFV FLGLFLTEMS LKMYGLGPRS
     YFRSSFNCFD FGVIVGSIFE VVWAAIKPGT SFGISVLRAL RLLRIFKVTK YWNSLRNLVV
     SLLNSMKSII SLLFLLFLFI VVFALLGMQL FGGQFNFQDE TPTTNFDTFP AAILTVFQIL
     TGEDWNAVMY HGIESQGGVS KGMFSSFYFI VLTLFGNYTL LNVFLAIAVD NLANAQELTK
     DEEEMEEAAN QKLALQKAKE VAEVSPMSAA NISIAARQQN SAKARSVWEQ RASQLRLQNL
     RASCEALYSE MDPEERLRYA STRHVRPDMK THMDRPLVVE PGRDGLRGPV GSKSKPEGTE
     ATESADLPRR HHRHRDRDKT SATAPAGGEQ DRTESTETGA REERARPRRS HSKETPGADT
     QVRCERSRRH HRRGSPEEAT EREPRRHRAH RHAQDSSKEG TAPVLVPKGE RRARHRGPRT
     GPREAENNEE PTRRHRARHK VPPTLQPPER EAAEKESNAV EGDKETRNHQ PKEPHCDLEA
     IAVTGVGPLH MLPSTCLQKV DEQPEDADNQ RNVTRMGSQP SDPSTTVHVP VTLTGPPGET
     PVVPSGNMNL EGQAEGKKEA EADDVLRRGP RPIVPYSSMF CLSPTNLLRR FCHYIVTMRY
     FEMVILVVIA LSSIALAAED PVRTDSFRNN ALKYMDYIFT GVFTFEMVIK MIDLGLLLHP
     GAYFRDLWNI LDFIVVSGAL VAFAFSSFMG GSKGKDINTI KSLRVLRVLR PLKTIKRLPK
     LKAVFDCVVN SLKNVLNILI VYMLFMFIFA VIAVQLFKGK FFYCTDESKE LERDCRGQYL
     DYEKEEVEAQ PRQWKKYDFH YDNVLWALLT LFTVSTGEGW PMVLKHSVDA TYEEQGPSPG
     FRMELSIFYV VYFVVFPFFF VNIFVALIII TFQEQGDKVM SECSLEKNER ACIDFAISAK
     PLTRYMPQNK QSFQYKTWTF VVSPPFEYFI MAMIALNTVV LMMKFYDAPY EYELMLKCLN
     IVFTSMFSME CILKIIAFGV LNYFRDAWNV FDFVTVLGSI TDILVTEIAN NFINLSFLRL
     FRAARLIKLL RQGYTIRILL WTFVQSFKAL PYVCLLIAML FFIYAIIGMQ VFGNIALDDD
     TSINRHNNFR TFLQALMLLF RSATGEAWHE IMLSCLGNRA CDPHANASEC GSDFAYFYFV
     SFIFLCSFLM LNLFVAVIMD NFEYLTRDSS ILGPHHLDEF IRVWAEYDPA ACGRISYNDM
     FEMLKHMSPP LGLGKKCPAR VAYKRLVRMN MPISNEDMTV HFTSTLMALI RTALEIKLAP
     AGTKQHQCDA ELRKEISSVW ANLPQKTLDL LVPPHKPDEM TVGKVYAALM IFDFYKQNKT
     TRDQTHQAPG GLSQMGPVSL FHPLKATLEQ TQPAVLRGAR VFLRQKSATS LSNGGAIQTQ
     ESGIKESLSW GTQRTQDALY EARAPLERGH SAEIPVGQSG TLAVDVQMQN MTLRGPDGEP
     QPGLESQGRA ASMPRLAAET QPAPNASPMK RSISTLAPRP HGTQLCSTVL DRPPPSQASH
     HHHHRCHRRR DKKQRSLEKG PSLSVDPEGA PSTAAGPGLP HGEGSTACRR DRKQERGRSQ
     ERRQPSSSSS EKQRFYSCDR FGSREPPQLM PSLSSHPTSP TAALEPAPHP QGSGSVNGSP
     LMSTSGASTP GRGGRRQLPQ TPLTPRPSIT YKTANSSPVH FAEGQSGLPA FSPGRLSRGL
     SEHNALLQKE PLSQPLAPGS RIGSDPYLGQ RLDSEASAHT LPEDTLTFEE AVATNSGRSS
     RTSYVSSLTS QSHPLRRVPN GYHCTLGLST GVRARHSYHH PDQDHWC
//
ID   CAC1S_LITCT             Reviewed;        1688 AA.
AC   O57483;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 87.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1S;
DE   AltName: Full=FGalpha1S;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.1;
OS   Lithobates catesbeiana (American bullfrog) (Rana catesbeiana).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Neobatrachia; Ranoidea; Ranidae; Rana;
OC   Aquarana.
OX   NCBI_TaxID=8400;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=9738021; DOI=10.1074/jbc.273.39.25503;
RA   Zhou J., Cribbs L., Yi J., Shirokov R., Perez-Reyes E., Rios E.;
RT   "Molecular cloning and functional expression of a skeletal muscle
RT   dihydropyridine receptor from Rana catesbeiana.";
RL   J. Biol. Chem. 273:25503-25509(1998).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, gene expression, cell motility, cell division and
CC       cell death. The isoform alpha-1S gives rise to L-type calcium
CC       currents. Long-lasting (L-type) calcium channels belong to the
CC       'high-voltage activated' (HVA) group. They are blocked by
CC       dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and B
CC       omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive
CC       to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA
CC       (omega-Aga-IVA). Calcium channels containing the alpha-1S subunit
CC       play an important role in excitation-contraction coupling in
CC       skeletal muscle (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity. An additional gamma subunit is present only in
CC       skeletal muscle L-type channel (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Skeletal muscle specific.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: Phosphorylation by PKA stimulates the calcium channel
CC       function. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF037625; AAC36126.1; -; mRNA.
DR   ProteinModelPortal; O57483; -.
DR   HOVERGEN; HBG050763; -.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005450; VDCC_L_a1ssu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF190; PTHR10037:SF190; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01634; LVDCCALPHA1S.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1688       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1S.
FT                                /FTId=PRO_0000053949.
FT   TOPO_DOM      1     51       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     52     70       Helical; Name=S1 of repeat I.
FT   TOPO_DOM     71     88       Extracellular. {ECO:0000255}.
FT   TRANSMEM     89    108       Helical; Name=S2 of repeat I.
FT   TOPO_DOM    109    120       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    121    139       Helical; Name=S3 of repeat I.
FT   TOPO_DOM    140    158       Extracellular. {ECO:0000255}.
FT   TRANSMEM    159    177       Helical; Name=S4 of repeat I.
FT   TOPO_DOM    178    196       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    197    216       Helical; Name=S5 of repeat I.
FT   TOPO_DOM    217    307       Extracellular. {ECO:0000255}.
FT   TRANSMEM    308    332       Helical; Name=S6 of repeat I.
FT   TOPO_DOM    333    431       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    432    450       Helical; Name=S1 of repeat II.
FT   TOPO_DOM    451    465       Extracellular. {ECO:0000255}.
FT   TRANSMEM    466    485       Helical; Name=S2 of repeat II.
FT   TOPO_DOM    486    493       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    494    512       Helical; Name=S3 of repeat II.
FT   TOPO_DOM    513    522       Extracellular. {ECO:0000255}.
FT   TRANSMEM    523    541       Helical; Name=S4 of repeat II.
FT   TOPO_DOM    542    560       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    561    580       Helical; Name=S5 of repeat II.
FT   TOPO_DOM    581    635       Extracellular. {ECO:0000255}.
FT   TRANSMEM    636    660       Helical; Name=S6 of repeat II.
FT   TOPO_DOM    661    797       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    798    816       Helical; Name=S1 of repeat III.
FT   TOPO_DOM    817    832       Extracellular. {ECO:0000255}.
FT   TRANSMEM    833    852       Helical; Name=S2 of repeat III.
FT   TOPO_DOM    853    864       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    865    883       Helical; Name=S3 of repeat III.
FT   TOPO_DOM    884    890       Extracellular. {ECO:0000255}.
FT   TRANSMEM    891    909       Helical; Name=S4 of repeat III.
FT   TOPO_DOM    910    928       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    929    948       Helical; Name=S5 of repeat III.
FT   TOPO_DOM    949   1038       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1039   1063       Helical; Name=S6 of repeat III.
FT   TOPO_DOM   1064   1116       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1117   1135       Helical; Name=S1 of repeat IV.
FT   TOPO_DOM   1136   1150       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1151   1170       Helical; Name=S2 of repeat IV.
FT   TOPO_DOM   1171   1178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1179   1197       Helical; Name=S3 of repeat IV.
FT   TOPO_DOM   1198   1218       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1219   1237       Helical; Name=S4 of repeat IV.
FT   TOPO_DOM   1238   1256       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1257   1276       Helical; Name=S5 of repeat IV.
FT   TOPO_DOM   1277   1343       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1344   1368       Helical; Name=S6 of repeat IV.
FT   TOPO_DOM   1369   1688       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       38    335       I.
FT   REPEAT      417    663       II.
FT   REPEAT      784   1066       III.
FT   REPEAT     1103   1371       IV.
FT   CA_BIND    1397   1408       {ECO:0000250}.
FT   REGION      355    372       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   REGION      986   1075       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1324   1390       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1336   1379       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS     22     28       Poly-Pro.
FT   COMPBIAS    438    441       Poly-Ile.
FT   COMPBIAS    561    567       Poly-Leu.
FT   COMPBIAS    744    749       Poly-Glu.
FT   COMPBIAS   1552   1559       Poly-Glu.
FT   SITE        290    290       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        612    612       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1012   1012       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1310   1310       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1379   1379       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    255    255       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1688 AA;  192423 MW;  5BEA06B38823017A CRC64;
     MDAMGSAAEE GTQKKKRRPL VPPPPRPPRA LFCLGLQNPF RKFCINIVEW KPFEMIILLT
     IFANCVALAI FLPMPEDDTN STNSVLEKVE YIFLFIFTIE SFLKIVAYGF ILHTDAYLRN
     GWNILDFTIV SVGVFSVLLE QISKLQGLPA PGKSSGFNVK ALRAFRVLRP LRLVSGVPSL
     QVVLNSIIKA MIPLLHIALL VLFMIIIYAI VGLELFSGKM HKTCYFKDTD ITATVDNEKP
     APCSSTGQGR QCSINGSECR GWWPGPNNGI THFDNFGFAM LTVYQCITME GWTEVLYWVN
     DAIGNEWPWI YFVSLILLGS FFVLNLVLGV LSGEFTKERE KAKSRGAFQM LREQQAMDED
     LRGYLDWITH AEVMDPDMEP RDGFSQLEEG GSETDSLYEI EGINKFIAFF RQWRLWHRLL
     RRKSRDLVKS RFFYWLVIII ILLNTVIIAT EHHHQPDSLT KAQDIANEVL LALFTMEMIV
     KIYALGFQSY FMSLFNRFDS FVVCTGLLEV MLVASDIMSP LGISVLRCIR LLRIFKITRY
     WTSLNNLVAS LLNSVRSIAS LLLLLFLFMI IFALLGMQMF GGKFDFEDLE VRRSTFDTFP
     QALITVFQIL TGEDWTAVMY NGIMAYGGPT YSGMSVCIYF IILFVCGNYI LLNVFLAIAV
     DNLAEAENLT SAQKAKAEER KRKKLARANP DKTEEEKLLL AKKEQKAKGE GIPTTARLKI
     DEFESNVNEI KDPYPSADFP GDDEEEEPEI PISPRPRPLA ELQLKEKAVP MPEASSFFIF
     SPTNKIRVLC HRIINATTFT NFILLFILLS SISLAAEDPI QPESFRNKVL SKLDIVFTVI
     FTTEIVLKMT AYGAFLHKGS FCRNSFNILD LSVVGVSLIS MGIESSAISV VKILRVLRVL
     RPLRAINRAK GLKHVVQCLF VAIKTIGNIV LVTTLLQFMF SCIGVQLFKG KFYSCTDTTK
     ITADECRGYF FVAKDGNPAH MEAVPRVWSH SDFHFDNVLS GMMSLFTIST FEGWPQLLYR
     AIDSHAEDMG PIYNYRIEIA VFFIVYIILI AFFMMNIFVG FVIVTFQEQG EQEYKDCELD
     KNQRQCVQYA LKARPLRRYI PKNPHQYKIW YVVTSSYFEY LMFFLITLNT ISLGMQHYGQ
     TAEFSYMSDI LNVAFTGIFT VEMFLKLAAF KAKGYFGDPW NVFDFLIVIG SVIDVILSEI
     DTPGIPATPG AEESSRISIT FFRLFRVLRL VKLLSRGEGV RTLLWTFIKS FQALPYVALL
     IVMLFFIYAV IGMQVFGKIA LVDGTHINRN SNFQTFPQAV LLLFRCATGE AWQEILLACS
     YGKLCDPMSD FQPGEEYTCG TSFAYFYFIS FYMLCAFLII NLFVAVIMDN FDYLTRDWSI
     LGPHHLDEFK RIWAEYDPEA KGRIKHLDVV TLLRRIQPPL GFGKFCPHRV ACKRLVSMNM
     PLNSDGTVTF NATLFSLVRT ALKIKTEGNF EQSNEELRMI IKKIWKRTSM KLLDQVIPPI
     GDDEVTVGKF YAIFLIQEHF RKFKKRQEEY YGYRPKKNAN NVEIQAGLRT IEEEEGEGEL
     QRAISGDLTP EEELERAMVE AAIEEGIYRR TGGLFGQEDS FHTGPVSPLH TITSQRPLRF
     SEAGSEDLDS PVFLPEPVFF PPPRRNRNTN NSTISRGLDQ RLTTPDFERV QQSEEQWDTN
     SSISQATN
//
ID   CAC1F_HUMAN             Reviewed;        1977 AA.
AC   O60840; A6NI29; F5CIQ9; O43901; O95226; Q9UHB1;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 2.
DT   25-OCT-2017, entry version 179.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1F {ECO:0000305};
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.4;
GN   Name=CACNA1F {ECO:0000312|HGNC:HGNC:1393}; Synonyms=CACNAF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND VARIANTS
RP   CSNB2A ASP-369; GLN-519; TRP-1060 AND HIS-1375.
RC   TISSUE=Retina;
RX   PubMed=9662399; DOI=10.1038/940;
RA   Strom T.M., Nyakatura G., Apfelstedt-Sylla E., Hellebrand H.,
RA   Lorenz B., Weber B.H.F., Wutz K., Gutwillinger N., Ruether K.,
RA   Drescher B., Sauer C., Zrenner E., Meitinger T., Rosenthal A.,
RA   Meindl A.;
RT   "An L-type calcium-channel gene mutated in incomplete X-linked
RT   congenital stationary night blindness.";
RL   Nat. Genet. 19:260-263(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND INVOLVEMENT IN CSNB2A.
RX   PubMed=9662400; DOI=10.1038/947;
RA   Bech-Hansen N.T., Naylor M.J., Maybaum T.A., Pearce W.G., Koop B.,
RA   Fishman G.A., Mets M., Musarella M.A., Boycott K.M.;
RT   "Loss-of-function mutations in a calcium-channel alpha1-subunit gene
RT   in Xp11.23 cause incomplete X-linked congenital stationary night
RT   blindness.";
RL   Nat. Genet. 19:264-267(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10873387; DOI=10.1006/geno.2000.6204;
RA   Naylor M.J., Rancourt D.E., Bech-Hansen N.T.;
RT   "Isolation and characterization of a calcium channel gene, cacna1f,
RT   the murine orthologue of the gene for incomplete X-linked congenital
RT   stationary night blindness.";
RL   Genomics 66:324-327(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=19029287; DOI=10.1124/mol.108.049981;
RA   Sinnegger-Brauns M.J., Huber I.G., Koschak A., Wild C., Obermair G.J.,
RA   Einzinger U., Hoda J.C., Sartori S.B., Striessnig J.;
RT   "Expression and 1,4-dihydropyridine-binding properties of brain L-type
RT   calcium channel isoforms.";
RL   Mol. Pharmacol. 75:407-414(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1211-1977.
RX   PubMed=9344658; DOI=10.1006/geno.1997.4941;
RA   Fisher S.E., Ciccodicola A., Tanaka K., Curci A., Desicato S.,
RA   D'Urso M., Craig I.W.;
RT   "Sequence-based exon prediction around the synaptophysin locus reveals
RT   a gene-rich area containing novel genes in human proximal Xp.";
RL   Genomics 45:340-347(1997).
RN   [7]
RP   ALTERNATIVE SPLICING (ISOFORM 4; ISOFORM 5 AND ISOFORM 6), TISSUE
RP   SPECIFICITY, INTERACTION WITH CABP4, AND FUNCTION.
RX   PubMed=27226626; DOI=10.1074/jbc.M116.731737;
RA   Haeseleer F., Williams B., Lee A.;
RT   "Characterization of C-terminal Splice Variants of Cav1.4 Ca2+
RT   Channels in Human Retina.";
RL   J. Biol. Chem. 291:15663-15673(2016).
RN   [8]
RP   VARIANTS CSNB2A ASP-369; ASP-674 AND ASP-928.
RX   PubMed=11281458; DOI=10.1007/s004390100461;
RA   Boycott K.M., Maybaum T.A., Naylor M.J., Weleber R.G., Robitaille J.,
RA   Miyake Y., Bergen A.A.B., Pierpont M.E., Pearce W.G.,
RA   Bech-Hansen N.T.;
RT   "A summary of 20 CACNA1F mutations identified in 36 families with
RT   incomplete X-linked congenital stationary night blindness, and
RT   characterization of splice variants.";
RL   Hum. Genet. 108:91-97(2001).
RN   [9]
RP   VARIANTS CSNB2A ARG-74; PRO-229; ARG-261; ASP-369; CYS-753; PRO-860;
RP   ARG-1018; TRP-1060; PRO-1079; ARG-1499; ARG-1500 AND PRO-1508.
RX   PubMed=12111638; DOI=10.1038/sj.ejhg.5200828;
RA   Wutz K., Sauer C., Zrenner E., Lorenz B., Alitalo T., Broghammer M.,
RA   Hergersberg M., de la Chapelle A., Weber B.H.F., Wissinger B.,
RA   Meindl A., Pusch C.M.;
RT   "Thirty distinct CACNA1F mutations in 33 families with incomplete type
RT   of XLCSNB and Cacna1f expression profiling in mouse retina.";
RL   Eur. J. Hum. Genet. 10:449-456(2002).
RN   [10]
RP   VARIANTS CSNB2A ARG-150 AND ILE-635.
RX   PubMed=12187427; DOI=10.1076/opge.23.2.71.2214;
RA   Weleber R.G.;
RT   "Infantile and childhood retinal blindness: a molecular perspective
RT   (The Franceschetti Lecture).";
RL   Ophthalmic Genet. 23:71-97(2002).
RN   [11]
RP   VARIANT CSNB2A THR-756, AND CHARACTERIZATION OF VARIANT CSNB2A
RP   THR-756.
RX   PubMed=15897456; DOI=10.1073/pnas.0501907102;
RA   Hemara-Wahanui A., Berjukow S., Hope C.I., Dearden P.K., Wu S.-B.,
RA   Wilson-Wheeler J., Sharp D.M., Lundon-Treweek P., Clover G.M.,
RA   Hoda J.-C., Striessnig J., Marksteiner R., Hering S., Maw M.A.;
RT   "A CACNA1F mutation identified in an X-linked retinal disorder shifts
RT   the voltage dependence of Cav1.4 channel activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7553-7558(2005).
RN   [12]
RP   VARIANT THR-746.
RX   PubMed=16960802; DOI=10.1086/508067;
RA   Zeitz C., Kloeckener-Gruissem B., Forster U., Kohl S., Magyar I.,
RA   Wissinger B., Matyas G., Borruat F.-X., Schorderet D.F., Zrenner E.,
RA   Munier F.L., Berger W.;
RT   "Mutations in CABP4, the gene encoding the Ca2+-binding protein 4,
RT   cause autosomal recessive night blindness.";
RL   Am. J. Hum. Genet. 79:657-667(2006).
RN   [13]
RP   INVOLVEMENT IN CORDX3.
RX   PubMed=16505158; DOI=10.1136/jmg.2006.040741;
RA   Jalkanen R., Maentyjaervi M., Tobias R., Isosomppi J., Sankila E.-M.,
RA   Alitalo T., Bech-Hansen N.T.;
RT   "X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the
RT   CACNA1F gene.";
RL   J. Med. Genet. 43:699-704(2006).
RN   [14]
RP   INVOLVEMENT IN AIED.
RX   PubMed=17525176; DOI=10.1167/iovs.06-1103;
RA   Jalkanen R., Bech-Hansen N.T., Tobias R., Sankila E.-M.,
RA   Maentyjaervi M., Forsius H., de la Chapelle A., Alitalo T.;
RT   "A novel CACNA1F gene mutation causes Aland Island eye disease.";
RL   Invest. Ophthalmol. Vis. Sci. 48:2498-2502(2007).
RN   [15]
RP   VARIANT CSNB2A ARG-603, AND VARIANT AIED ARG-603.
RX   PubMed=22194652;
RA   Vincent A., Wright T., Day M.A., Westall C.A., Heon E.;
RT   "A novel p.Gly603Arg mutation in CACNA1F causes Aland island eye
RT   disease and incomplete congenital stationary night blindness
RT   phenotypes in a family.";
RL   Mol. Vis. 17:3262-3270(2011).
CC   -!- FUNCTION: Isoform 1: Voltage-sensitive calcium channels (VSCC)
CC       mediate the entry of calcium ions into excitable cells and are
CC       also involved in a variety of calcium-dependent processes,
CC       including muscle contraction, hormone or neurotransmitter release,
CC       gene expression, cell motility, cell division and cell death. The
CC       isoform alpha-1F gives rise to L-type calcium currents. Long-
CC       lasting (L-type) calcium channels belong to the 'high-voltage
CC       activated' (HVA) group. They are blocked by dihydropyridines
CC       (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-
CC       IIIA (omega-Aga-IIIA). They are however insensitive to omega-
CC       conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-
CC       IVA). Activates at more negative voltages and does not undergo
CC       calcium-dependent inactivation (CDI), due to incoming calcium
CC       ions, during depolarization. {ECO:0000269|PubMed:27226626}.
CC   -!- FUNCTION: Isoform 4: Voltage-dependent L-type calcium channel
CC       activates at more hyperpolarized voltages and exibits a robust
CC       calcium-dependent inactivation (CDI), due to incoming calcium
CC       ions, during depolarizations. {ECO:0000269|PubMed:27226626}.
CC   -!- FUNCTION: Isoform 6: Voltage-dependent L-type calcium channel
CC       activates at more hyperpolarized voltages and exibits a robust
CC       calcium-dependent inactivation (CDI), due to incoming calcium
CC       ions, during depolarizations. {ECO:0000269|PubMed:27226626}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts (via IQ domain) with CABP4; in a calcium independent
CC       manner (By similarity). Isoform 4: interacts with CABP4; suppreses
CC       robust calcium-dependent inactivation of channel whithout enhances
CC       the hyperpolarized voltage-dependent activation (PubMed:27226626).
CC       {ECO:0000250, ECO:0000269|PubMed:27226626}.
CC   -!- INTERACTION:
CC       P57796-1:CABP4; NbExp=2; IntAct=EBI-14063160, EBI-14063133;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Cav1.4FL {ECO:0000303|PubMed:27226626};
CC         IsoId=O60840-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60840-2; Sequence=VSP_036785;
CC       Name=3;
CC         IsoId=O60840-4; Sequence=VSP_045172;
CC       Name=4; Synonyms=Cav1.4Deltaex p45,47
CC       {ECO:0000303|PubMed:27226626};
CC         IsoId=O60840-5; Sequence=VSP_058923, VSP_058924;
CC       Name=5; Synonyms=Cav1.4Deltaex p45 {ECO:0000303|PubMed:27226626};
CC         IsoId=O60840-6; Sequence=VSP_058923;
CC       Name=6; Synonyms=Cav1.4Deltaex 47 {ECO:0000303|PubMed:27226626};
CC         IsoId=O60840-7; Sequence=VSP_058924;
CC   -!- TISSUE SPECIFICITY: Expression in skeletal muscle and retina
CC       (PubMed:10873387). Isoform 4 is expressed in retina
CC       (PubMed:27226626). {ECO:0000269|PubMed:10873387,
CC       ECO:0000269|PubMed:27226626}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DISEASE: Night blindness, congenital stationary, 2A (CSNB2A)
CC       [MIM:300071]: A non-progressive retinal disorder characterized by
CC       impaired night vision, often associated with nystagmus and myopia.
CC       {ECO:0000269|PubMed:11281458, ECO:0000269|PubMed:12111638,
CC       ECO:0000269|PubMed:12187427, ECO:0000269|PubMed:15897456,
CC       ECO:0000269|PubMed:22194652, ECO:0000269|PubMed:9662399,
CC       ECO:0000269|PubMed:9662400}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cone-rod dystrophy, X-linked 3 (CORDX3) [MIM:300476]: An
CC       inherited retinal dystrophy characterized by retinal pigment
CC       deposits visible on fundus examination, predominantly in the
CC       macular region, and initial loss of cone photoreceptors followed
CC       by rod degeneration. This leads to decreased visual acuity and
CC       sensitivity in the central visual field, followed by loss of
CC       peripheral vision. Severe loss of vision occurs earlier than in
CC       retinitis pigmentosa, due to cone photoreceptors degenerating at a
CC       higher rate than rod photoreceptors.
CC       {ECO:0000269|PubMed:16505158}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Aaland island eye disease (AIED) [MIM:300600]: A retinal
CC       disease characterized by a combination of fundus hypopigmentation,
CC       decreased visual acuity due to foveal hypoplasia, nystagmus,
CC       astigmatism, protan color vision defect, myopia, and defective
CC       dark adaptation. Except for progression of axial myopia, the
CC       disease can be considered to be a stationary condition.
CC       Electroretinography reveals abnormalities in both photopic and
CC       scotopic functions. {ECO:0000269|PubMed:17525176,
CC       ECO:0000269|PubMed:22194652}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1F subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB92359.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mutations of the CCNA1F gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/cacnamut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ006216; CAA06916.1; -; Genomic_DNA.
DR   EMBL; AF067227; AAD03587.1; -; mRNA.
DR   EMBL; AJ224874; CAA12175.1; -; mRNA.
DR   EMBL; AF201304; AAF15290.1; -; mRNA.
DR   EMBL; JF701915; AED89557.1; -; mRNA.
DR   EMBL; AF196779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF235097; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U93305; AAB92359.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS35253.1; -. [O60840-1]
DR   CCDS; CCDS59166.1; -. [O60840-4]
DR   CCDS; CCDS59167.1; -. [O60840-2]
DR   RefSeq; NP_001243718.1; NM_001256789.2. [O60840-2]
DR   RefSeq; NP_001243719.1; NM_001256790.2. [O60840-4]
DR   RefSeq; NP_005174.2; NM_005183.3. [O60840-1]
DR   UniGene; Hs.632799; -.
DR   ProteinModelPortal; O60840; -.
DR   SMR; O60840; -.
DR   BioGrid; 107232; 1.
DR   IntAct; O60840; 3.
DR   STRING; 9606.ENSP00000365441; -.
DR   BindingDB; O60840; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00393; Nimodipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 531; -.
DR   TCDB; 1.A.1.11.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O60840; -.
DR   PhosphoSitePlus; O60840; -.
DR   BioMuta; CACNA1F; -.
DR   PaxDb; O60840; -.
DR   PeptideAtlas; O60840; -.
DR   PRIDE; O60840; -.
DR   Ensembl; ENST00000323022; ENSP00000321618; ENSG00000102001. [O60840-2]
DR   Ensembl; ENST00000376251; ENSP00000365427; ENSG00000102001. [O60840-4]
DR   Ensembl; ENST00000376265; ENSP00000365441; ENSG00000102001. [O60840-1]
DR   GeneID; 778; -.
DR   KEGG; hsa:778; -.
DR   UCSC; uc004dnb.3; human. [O60840-1]
DR   CTD; 778; -.
DR   DisGeNET; 778; -.
DR   EuPathDB; HostDB:ENSG00000102001.12; -.
DR   GeneCards; CACNA1F; -.
DR   GeneReviews; CACNA1F; -.
DR   HGNC; HGNC:1393; CACNA1F.
DR   MalaCards; CACNA1F; -.
DR   MIM; 300071; phenotype.
DR   MIM; 300110; gene.
DR   MIM; 300476; phenotype.
DR   MIM; 300600; phenotype.
DR   neXtProt; NX_O60840; -.
DR   OpenTargets; ENSG00000102001; -.
DR   Orphanet; 178333; Aland Islands eye disease.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 215; Congenital stationary night blindness.
DR   PharmGKB; PA26010; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000231529; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; O60840; -.
DR   KO; K04853; -.
DR   OMA; LNQTECR; -.
DR   OrthoDB; EOG091G0TKO; -.
DR   PhylomeDB; O60840; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA1F; human.
DR   GeneWiki; Cav1.4; -.
DR   GenomeRNAi; 778; -.
DR   PRO; PR:O60840; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102001; -.
DR   CleanEx; HS_CACNA1F; -.
DR   ExpressionAtlas; O60840; baseline and differential.
DR   Genevisible; O60840; HS.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0050856; P:regulation of T cell receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0043029; P:T cell homeostasis; IEA:InterPro.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR030157; VDCC_L_a1F.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF184; PTHR10037:SF184; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Cone-rod dystrophy;
KW   Congenital stationary night blindness; Disease mutation;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Sensory transduction; Transmembrane; Transmembrane helix;
KW   Transport; Vision; Voltage-gated channel.
FT   CHAIN         1   1977       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1F.
FT                                /FTId=PRO_0000053950.
FT   TOPO_DOM      1     92       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     93    111       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    112    129       Extracellular. {ECO:0000255}.
FT   TRANSMEM    130    149       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    150    161       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    162    180       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    181    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    220       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    221    239       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    240    259       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    260    347       Extracellular. {ECO:0000255}.
FT   TRANSMEM    348    372       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    373    529       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    530    549       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    550    564       Extracellular. {ECO:0000255}.
FT   TRANSMEM    565    583       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    584    591       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    592    610       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    611    620       Extracellular. {ECO:0000255}.
FT   TRANSMEM    621    639       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    640    658       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    659    679       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    680    733       Extracellular. {ECO:0000255}.
FT   TRANSMEM    734    758       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    759    871       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    872    890       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    891    906       Extracellular. {ECO:0000255}.
FT   TRANSMEM    907    926       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    927    938       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    939    957       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    958    963       Extracellular. {ECO:0000255}.
FT   TRANSMEM    964    983       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    984   1002       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1003   1022       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1023   1112       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1113   1133       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1134   1190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1191   1209       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1210   1224       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1225   1244       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1245   1251       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1252   1273       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1274   1290       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1291   1310       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1311   1329       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1330   1349       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1350   1416       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1417   1441       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1442   1977       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       79    375       I.
FT   REPEAT      515    761       II.
FT   REPEAT      858   1140       III.
FT   REPEAT     1177   1444       IV.
FT   CA_BIND    1470   1481       {ECO:0000250}.
FT   REGION      395    412       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   REGION     1060   1150       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1397   1463       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1409   1452       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS    659    665       Poly-Leu.
FT   COMPBIAS    794    799       Poly-Glu.
FT   COMPBIAS    809    825       Poly-Glu.
FT   COMPBIAS   1121   1124       Poly-Ile.
FT   COMPBIAS   1640   1645       Poly-Glu.
FT   SITE        330    330       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        711    711       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1086   1086       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1383   1383       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1452   1452       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       9     86       DTTPEPSPANGAGPGPEWGLCPGPPAVEGESSGASGLGTPK
FT                                RRNQHSKHKTVAVASAQRSPRALFCLTLANPLRRSCI ->
FT                                GERILPSLQTLGA (in isoform 3).
FT                                {ECO:0000303|PubMed:9662400}.
FT                                /FTId=VSP_045172.
FT   VAR_SEQ     427    437       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:19029287,
FT                                ECO:0000303|PubMed:9662399}.
FT                                /FTId=VSP_036785.
FT   VAR_SEQ    1756   1775       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:27226626}.
FT                                /FTId=VSP_058923.
FT   VAR_SEQ    1836   1901       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:27226626}.
FT                                /FTId=VSP_058924.
FT   VARIANT      14     14       P -> L (in dbSNP:rs6520408).
FT                                /FTId=VAR_030807.
FT   VARIANT      74     74       C -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030808.
FT   VARIANT     150    150       G -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12187427}.
FT                                /FTId=VAR_030809.
FT   VARIANT     229    229       S -> P (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030810.
FT   VARIANT     261    261       G -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030811.
FT   VARIANT     369    369       G -> D (in CSNB2A; dbSNP:rs122456133).
FT                                {ECO:0000269|PubMed:11281458,
FT                                ECO:0000269|PubMed:12111638,
FT                                ECO:0000269|PubMed:9662399}.
FT                                /FTId=VAR_001504.
FT   VARIANT     519    519       R -> Q (in CSNB2A; dbSNP:rs34162630).
FT                                {ECO:0000269|PubMed:9662399}.
FT                                /FTId=VAR_001505.
FT   VARIANT     603    603       G -> R (in AIED and CSNB2A;
FT                                dbSNP:rs201654095).
FT                                {ECO:0000269|PubMed:22194652}.
FT                                /FTId=VAR_071433.
FT   VARIANT     635    635       V -> I (in CSNB2A; dbSNP:rs141010716).
FT                                {ECO:0000269|PubMed:12187427}.
FT                                /FTId=VAR_030812.
FT   VARIANT     674    674       G -> D (in CSNB2A).
FT                                {ECO:0000269|PubMed:11281458}.
FT                                /FTId=VAR_030813.
FT   VARIANT     746    746       N -> T (in dbSNP:rs141159097).
FT                                {ECO:0000269|PubMed:16960802}.
FT                                /FTId=VAR_029376.
FT   VARIANT     753    753       F -> C (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030814.
FT   VARIANT     756    756       I -> T (in CSNB2A; increases the number
FT                                of mutant channels open at physiologic
FT                                membrane potential and allows for
FT                                persistent Ca(2+) entry due to reduced
FT                                channel inactivation resulting in a gain-
FT                                of-function defect; dbSNP:rs122456136).
FT                                {ECO:0000269|PubMed:15897456}.
FT                                /FTId=VAR_030815.
FT   VARIANT     860    860       L -> P (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030816.
FT   VARIANT     928    928       A -> D (in CSNB2A).
FT                                {ECO:0000269|PubMed:11281458}.
FT                                /FTId=VAR_030817.
FT   VARIANT    1018   1018       G -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030818.
FT   VARIANT    1060   1060       R -> W (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638,
FT                                ECO:0000269|PubMed:9662399}.
FT                                /FTId=VAR_001506.
FT   VARIANT    1079   1079       L -> P (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030819.
FT   VARIANT    1259   1259       A -> T (in dbSNP:rs34308720).
FT                                /FTId=VAR_055662.
FT   VARIANT    1270   1270       A -> T (in dbSNP:rs34308720).
FT                                /FTId=VAR_031822.
FT   VARIANT    1375   1375       L -> H (in CSNB2A).
FT                                {ECO:0000269|PubMed:9662399}.
FT                                /FTId=VAR_001507.
FT   VARIANT    1499   1499       C -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030820.
FT   VARIANT    1500   1500       P -> R (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030821.
FT   VARIANT    1508   1508       L -> P (in CSNB2A).
FT                                {ECO:0000269|PubMed:12111638}.
FT                                /FTId=VAR_030822.
FT   VARIANT    1930   1930       R -> H (in dbSNP:rs33910054).
FT                                /FTId=VAR_054818.
FT   CONFLICT   1236   1236       E -> V (in Ref. 6; AAB92359).
FT                                {ECO:0000305}.
FT   CONFLICT   1860   1860       A -> G (in Ref. 6; AAB92359).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1977 AA;  220678 MW;  354336550C6D8E73 CRC64;
     MSESEGGKDT TPEPSPANGA GPGPEWGLCP GPPAVEGESS GASGLGTPKR RNQHSKHKTV
     AVASAQRSPR ALFCLTLANP LRRSCISIVE WKPFDILILL TIFANCVALG VYIPFPEDDS
     NTANHNLEQV EYVFLVIFTV ETVLKIVAYG LVLHPSAYIR NGWNLLDFII VVVGLFSVLL
     EQGPGRPGDA PHTGGKPGGF DVKALRAFRV LRPLRLVSGV PSLHIVLNSI MKALVPLLHI
     ALLVLFVIII YAIIGLELFL GRMHKTCYFL GSDMEAEEDP SPCASSGSGR ACTLNQTECR
     GRWPGPNGGI TNFDNFFFAM LTVFQCVTME GWTDVLYWMQ DAMGYELPWV YFVSLVIFGS
     FFVLNLVLGV LSGEFSKERE KAKARGDFQK QREKQQMEED LRGYLDWITQ AEELDMEDPS
     ADDNLGSMAE EGRAGHRPQL AELTNRRRGR LRWFSHSTRS THSTSSHASL PASDTGSMTE
     TQGDEDEEEG ALASCTRCLN KIMKTRVCRR LRRANRVLRA RCRRAVKSNA CYWAVLLLVF
     LNTLTIASEH HGQPVWLTQI QEYANKVLLC LFTVEMLLKL YGLGPSAYVS SFFNRFDCFV
     VCGGILETTL VEVGAMQPLG ISVLRCVRLL RIFKVTRHWA SLSNLVASLL NSMKSIASLL
     LLLFLFIIIF SLLGMQLFGG KFNFDQTHTK RSTFDTFPQA LLTVFQILTG EDWNVVMYDG
     IMAYGGPFFP GMLVCIYFII LFICGNYILL NVFLAIAVDN LASGDAGTAK DKGGEKSNEK
     DLPQENEGLV PGVEKEEEEG ARREGADMEE EEEEEEEEEE EEEEEGAGGV ELLQEVVPKE
     KVVPIPEGSA FFCLSQTNPL RKGCHTLIHH HVFTNLILVF IILSSVSLAA EDPIRAHSFR
     NHILGYFDYA FTSIFTVEIL LKMTVFGAFL HRGSFCRSWF NMLDLLVVSV SLISFGIHSS
     AISVVKILRV LRVLRPLRAI NRAKGLKHVV QCVFVAIRTI GNIMIVTTLL QFMFACIGVQ
     LFKGKFYTCT DEAKHTPQEC KGSFLVYPDG DVSRPLVRER LWVNSDFNFD NVLSAMMALF
     TVSTFEGWPA LLYKAIDAYA EDHGPIYNYR VEISVFFIVY IIIIAFFMMN IFVGFVIITF
     RAQGEQEYQN CELDKNQRQC VEYALKAQPL RRYIPKNPHQ YRVWATVNSA AFEYLMFLLI
     LLNTVALAMQ HYEQTAPFNY AMDILNMVFT GLFTIEMVLK IIAFKPKHYF TDAWNTFDAL
     IVVGSIVDIA VTEVNNGGHL GESSEDSSRI SITFFRLFRV MRLVKLLSKG EGIRTLLWTF
     IKSFQALPYV ALLIAMIFFI YAVIGMQMFG KVALQDGTQI NRNNNFQTFP QAVLLLFRCA
     TGEAWQEIML ASLPGNRCDP ESDFGPGEEF TCGSNFAIAY FISFFMLCAF LIINLFVAVI
     MDNFDYLTRD WSILGPHHLD EFKRIWSEYD PGAKGRIKHL DVVALLRRIQ PPLGFGKLCP
     HRVACKRLVA MNMPLNSDGT VTFNATLFAL VRTSLKIKTE GNLEQANQEL RIVIKKIWKR
     MKQKLLDEVI PPPDEEEVTV GKFYATFLIQ DYFRKFRRRK EKGLLGNDAA PSTSSALQAG
     LRSLQDLGPE MRQALTCDTE EEEEEGQEGV EEEDEKDLET NKATMVSQPS ARRGSGISVS
     LPVGDRLPDS LSFGPSDDDR GTPTSSQPSV PQAGSNTHRR GSGALIFTIP EEGNSQPKGT
     KGQNKQDEDE EVPDRLSYLD EQAGTPPCSV LLPPHRAQRY MDGHLVPRRR LLPPTPAGRK
     PSFTIQCLQR QGSCEDLPIP GTYHRGRNSG PNRAQGSWAT PPQRGRLLYA PLLLVEEGAA
     GEGYLGRSSG PLRTFTCLHV PGTHSDPSHG KRGSADSLVE AVLISEGLGL FARDPRFVAL
     AKQEIADACR LTLDEMDNAA SDLLAQGTSS LYSDEESILS RFDEEDLGDE MACVHAL
//
ID   CAC1C_CHICK             Reviewed;         177 AA.
AC   O73707;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   25-OCT-2017, entry version 101.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=CHCACHA1C;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
DE   Flags: Fragment;
GN   Name=CACNA1C;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=White leghorn; TISSUE=Basilar papilla;
RX   PubMed=9405708; DOI=10.1073/pnas.94.26.14883;
RA   Kollmar R., Montgomery L.G., Fak J., Henry L.J., Hudspeth A.J.;
RT   "Predominance of the alpha1D subunit in L-type voltage-gated Ca2+
RT   channels of hair cells in the chicken's cochlea.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14883-14888(1997).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1C
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing the alpha-1C subunit play an important
CC       role in excitation-contraction coupling in the heart. The various
CC       isoforms display marked differences in the sensitivity to DHP
CC       compounds. Binding of calmodulin or CABP1 at the same regulatory
CC       sites results in an opposit effects on the channel function.
CC       {ECO:0000250|UniProtKB:Q13936}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       {ECO:0000250|UniProtKB:P22002, ECO:0000250|UniProtKB:Q01815,
CC       ECO:0000250|UniProtKB:Q13936}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P15381};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P15381}. Cell
CC       membrane {ECO:0000250|UniProtKB:P15381}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- PTM: Phosphorylation by PKA activates the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1C subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF027610; AAC08311.1; -; mRNA.
DR   UniGene; Gga.525; -.
DR   ProteinModelPortal; O73707; -.
DR   STRING; 9031.ENSGALP00000021218; -.
DR   PaxDb; O73707; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   HOGENOM; HOG000231529; -.
DR   InParanoid; O73707; -.
DR   PhylomeDB; O73707; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; ISS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; ISS:UniProtKB.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005452; LVDCC_a1dsu.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF139; PTHR10037:SF139; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00167; CACHANNEL.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN        <1   >177       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1C.
FT                                /FTId=PRO_0000053932.
FT   TRANSMEM     <1     13       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     14     26       Extracellular. {ECO:0000255}.
FT   TRANSMEM     27     45       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     46     64       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     65     84       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM     85    153       Extracellular. {ECO:0000255}.
FT   TRANSMEM    154   >177       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   REPEAT       <1   >177       IV.
FT   REGION      132   >177       Dihydropyridine binding. {ECO:0000250}.
FT   REGION      146   >177       Phenylalkylamine binding. {ECO:0000250}.
FT   SITE        118    118       Calcium ion selectivity and permeability.
FT                                {ECO:0000250|UniProtKB:P15381}.
FT   CARBOHYD     90     90       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   NON_TER       1      1
FT   NON_TER     177    177
SQ   SEQUENCE   177 AA;  19957 MW;  84CB4656D78AAF23 CRC64;
     ALIVVGSIVD IAITEVNNAE ENSRISITFF RLFRVMRLVK LLSRGEGIRT LLWTFIKSFQ
     ALPYVALLIV MLFFIYAVIG MQVFGKIALN DTTEINRNNN FQTFPQAVLL LFRCATGEAW
     QEIMLACLPD KKCDPDSEPA NSTEADHSCG SSFAVFYFIS FYMLCAFLII DLFVAVI
//
ID   CCG2_MOUSE              Reviewed;         323 AA.
AC   O88602;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-NOV-2017, entry version 140.
DE   RecName: Full=Voltage-dependent calcium channel gamma-2 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-2 subunit;
DE   AltName: Full=Stargazin;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-2;
DE            Short=TARP gamma-2;
GN   Name=Cacng2; Synonyms=Stg;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DISEASE.
RC   STRAIN=ICR; TISSUE=Brain;
RX   PubMed=9697694; DOI=10.1038/1228;
RA   Letts V.A., Felix R., Biddlecome G.H., Arikkath J., Mahaffey C.L.,
RA   Valenzuela A., Bartlett F.S. II, Mori Y., Campbell K.P., Frankel W.N.;
RT   "The mouse stargazer gene encodes a neuronal Ca2+-channel gamma
RT   subunit.";
RL   Nat. Genet. 19:340-347(1998).
RN   [2]
RP   PHOSPHORYLATION AT THR-321, INTERACTION WITH DLG1 AND DLG4, AND
RP   MUTAGENESIS OF THR-321 AND VAL-323.
RX   PubMed=11805122; DOI=10.1074/jbc.M200528200;
RA   Choi J., Ko J., Park E., Lee J.-R., Yoon J., Lim S., Kim E.;
RT   "Phosphorylation of stargazin by protein kinase A regulates its
RT   interaction with PSD-95.";
RL   J. Biol. Chem. 277:12359-12363(2002).
RN   [3]
RP   INTERACTION WITH GOPC.
RX   PubMed=15136571; DOI=10.1074/jbc.M402214200;
RA   Ives J.H., Fung S., Tiwari P., Payne H.L., Thompson C.L.;
RT   "Microtubule-associated protein light chain 2 is a stargazin-AMPA
RT   receptor complex-interacting protein in vivo.";
RL   J. Biol. Chem. 279:31002-31009(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-271, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Regulates the trafficking and gating properties of AMPA-
CC       selective glutamate receptors (AMPARs). Promotes their targeting
CC       to the cell membrane and synapses and modulates their gating
CC       properties by slowing their rates of activation, deactivation and
CC       desensitization. Does not show subunit-specific AMPA receptor
CC       regulation and regulates all AMPAR subunits. Thought to stabilize
CC       the calcium channel in an inactivated (closed) state (By
CC       similarity). {ECO:0000250|UniProtKB:Q71RJ2,
CC       ECO:0000250|UniProtKB:Q9Y698}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Interacts with the PDZ
CC       domains of DLG4/PSD-95 and DLG1/SAP97. May interact with GOPC.
CC       Acts as an auxiliary subunit for AMPA-selective glutamate
CC       receptors (AMPARs). Found in a complex with GRIA1, GRIA2, GRIA3,
CC       GRIA4, CNIH2, CNIH3, CACNG3, CACNG4, CACNG5, CACNG7 and CACNG8.
CC       Interacts with GRIA1 and GRIA2 (By similarity). Interacts with
CC       MPP2. {ECO:0000250|UniProtKB:Q71RJ2,
CC       ECO:0000250|UniProtKB:Q9Y698}.
CC   -!- INTERACTION:
CC       P23818:Gria1; NbExp=2; IntAct=EBI-770326, EBI-445486;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       junction, synapse, synaptosome {ECO:0000250|UniProtKB:Q71RJ2}.
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- PTM: Phosphorylation of Thr-321 by PKA impairs interaction with
CC       DLG1 and DLG4. {ECO:0000269|PubMed:11805122}.
CC   -!- DISEASE: Note=Defects in Cacng2 cause the stargazer (stg)
CC       phenotype. Stg mice have spike-wave seizures characteristic of
CC       absence epilepsy, with accompanying defects in the cerebellum and
CC       inner ear. {ECO:0000269|PubMed:9697694}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077739; AAC40201.1; -; mRNA.
DR   CCDS; CCDS27608.1; -.
DR   RefSeq; NP_031609.1; NM_007583.2.
DR   UniGene; Mm.277338; -.
DR   UniGene; Mm.400802; -.
DR   PDB; 3JXT; X-ray; 1.50 A; C/D=318-323.
DR   PDB; 4X3H; X-ray; 2.40 A; B=225-233.
DR   PDB; 5KBS; EM; 8.70 A; A/B/C/D=2-208.
DR   PDB; 5KBT; EM; 6.40 A; A/B/C/D=2-208.
DR   PDB; 5KBU; EM; 7.80 A; A/B/C/D=2-208.
DR   PDB; 5WEO; EM; 4.20 A; A/B/C/D=2-208.
DR   PDBsum; 3JXT; -.
DR   PDBsum; 4X3H; -.
DR   PDBsum; 5KBS; -.
DR   PDBsum; 5KBT; -.
DR   PDBsum; 5KBU; -.
DR   PDBsum; 5WEO; -.
DR   ProteinModelPortal; O88602; -.
DR   SMR; O88602; -.
DR   BioGrid; 198444; 4.
DR   DIP; DIP-32457N; -.
DR   ELM; O88602; -.
DR   IntAct; O88602; 3.
DR   STRING; 10090.ENSMUSP00000019290; -.
DR   iPTMnet; O88602; -.
DR   PhosphoSitePlus; O88602; -.
DR   PaxDb; O88602; -.
DR   PeptideAtlas; O88602; -.
DR   PRIDE; O88602; -.
DR   Ensembl; ENSMUST00000019290; ENSMUSP00000019290; ENSMUSG00000019146.
DR   GeneID; 12300; -.
DR   KEGG; mmu:12300; -.
DR   UCSC; uc007wop.2; mouse.
DR   CTD; 10369; -.
DR   MGI; MGI:1316660; Cacng2.
DR   eggNOG; ENOG410IFNQ; Eukaryota.
DR   eggNOG; ENOG4110ISU; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233440; -.
DR   HOVERGEN; HBG003682; -.
DR   InParanoid; O88602; -.
DR   KO; K04867; -.
DR   OMA; NARATDY; -.
DR   OrthoDB; EOG091G0D2Z; -.
DR   PhylomeDB; O88602; -.
DR   TreeFam; TF327980; -.
DR   Reactome; R-MMU-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-MMU-399719; Trafficking of AMPA receptors.
DR   Reactome; R-MMU-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-MMU-5576893; Phase 2 - plateau phase.
DR   Reactome; R-MMU-5682910; LGI-ADAM interactions.
DR   PRO; PR:O88602; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   Bgee; ENSMUSG00000019146; -.
DR   ExpressionAtlas; O88602; baseline and differential.
DR   Genevisible; O88602; MM.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:MGI.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISS:SynGO.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0051899; P:membrane depolarization; IMP:MGI.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:MGI.
DR   GO; GO:0050877; P:nervous system process; IMP:MGI.
DR   GO; GO:0007528; P:neuromuscular junction development; IMP:MGI.
DR   GO; GO:0099590; P:neurotransmitter receptor internalization; IMP:SynGO.
DR   GO; GO:0098943; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; IMP:SynGO.
DR   GO; GO:0098970; P:postsynaptic neurotransmitter receptor diffusion trapping; IMP:SynGO.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:SynGO.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0098962; P:regulation of postsynaptic neurotransmitter receptor activity; IC:SynGO.
DR   GO; GO:0019226; P:transmission of nerve impulse; IGI:MGI.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR005422; VDCC_g2su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   PANTHER; PTHR12107:SF1; PTHR12107:SF1; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01602; VDCCGAMMA2.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium channel; Calcium transport;
KW   Cell junction; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Synapse;
KW   Synaptosome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    323       Voltage-dependent calcium channel gamma-2
FT                                subunit.
FT                                /FTId=PRO_0000164674.
FT   TRANSMEM     10     30       Helical. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TRANSMEM    134    154       Helical. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical. {ECO:0000255}.
FT   MOD_RES     253    253       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q71RJ2}.
FT   MOD_RES     271    271       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18034455}.
FT   MOD_RES     321    321       Phosphothreonine; by PKA.
FT                                {ECO:0000269|PubMed:11805122}.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     321    321       T->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:11805122}.
FT   MUTAGEN     321    321       T->D,E: No interaction with DLG1 and
FT                                DLG4. {ECO:0000269|PubMed:11805122}.
FT   MUTAGEN     323    323       V->A: No interaction with DLG1 and DLG4.
FT                                {ECO:0000269|PubMed:11805122}.
FT   STRAND      226    229       {ECO:0000244|PDB:4X3H}.
FT   STRAND      321    323       {ECO:0000244|PDB:3JXT}.
SQ   SEQUENCE   323 AA;  35895 MW;  AA9D475606A0FBA4 CRC64;
     MGLFDRGVQM LLTTVGAFAA FSLMTIAVGT DYWLYSRGVC KTKSVSENET SKKNEEVMTH
     SGLWRTCCLE GNFKGLCKQI DHFPEDADYE ADTAEYFLRA VRASSIFPIL SVILLFMGGL
     CIAASEFYKT RHNIILSAGI FFVSAGLSNI IGIIVYISAN AGDPSKSDSK KNSYSYGWSF
     YFGALSFIIA EMVGVLAVHM FIDRHKQLRA TARATDYLQA SAITRIPSYR YRYQRRSRSS
     SRSTEPSHSR DASPVGVKGF NTLPSTEISM YTLSRDPLKA ATTPTATYNS DRDNSFLQVH
     NCIQKDSKDS LHANTANRRT TPV
//
ID   TRPM2_HUMAN             Reviewed;        1503 AA.
AC   O94759; D3DSL6; Q5KTC2; Q6J3P5; Q96KN6; Q96Q93;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   22-NOV-2017, entry version 168.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 2;
DE   AltName: Full=Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};
DE   AltName: Full=Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};
DE            Short=LTrpC-2;
DE            Short=LTrpC2 {ECO:0000303|PubMed:11960981};
DE   AltName: Full=Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};
DE            Short=TrpC7 {ECO:0000303|PubMed:9806837};
DE   AltName: Full=Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};
GN   Name=TRPM2;
GN   Synonyms=EREG1 {ECO:0000303|Ref.9}, KNP3,
GN   LTRPC2 {ECO:0000303|PubMed:11960981},
GN   TRPC7 {ECO:0000303|PubMed:9806837};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-1189.
RC   TISSUE=Brain;
RX   PubMed=9806837; DOI=10.1006/geno.1998.5551;
RA   Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ito F.,
RA   Shimizu N.;
RT   "Molecular cloning of a novel putative Ca2+ channel protein (TRPC7)
RT   highly expressed in brain.";
RL   Genomics 54:124-131(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT ARG-1189, FUNCTION
RP   (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION, AND REGULATION BY OXIDATIVE
RP   STRESS.
RC   TISSUE=Promyelocytic leukemia;
RX   PubMed=11960981; DOI=10.1074/jbc.M112096200;
RA   Wehage E., Eisfeld J., Heiner I., Juengling E., Zitt C., Lueckhoff A.;
RT   "Activation of the cation channel long transient receptor potential
RT   channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a
RT   mode of activation independent of ADP-ribose.";
RL   J. Biol. Chem. 277:23150-23156(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT ARG-1189, FUNCTION
RP   (ISOFORMS 1 AND 3), INTERACTION BETWEEN ISOFORMS 1 AND 3, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Bone marrow;
RX   PubMed=12594222; DOI=10.1074/jbc.M300298200;
RA   Zhang W., Chu X., Tong Q., Cheung J.Y., Conrad K., Masker K.,
RA   Miller B.A.;
RT   "A novel TRPM2 isoform inhibits calcium influx and susceptibility to
RT   cell death.";
RL   J. Biol. Chem. 278:16222-16229(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-1189.
RC   TISSUE=Brain;
RX   PubMed=15708008; DOI=10.1016/j.bbrc.2005.01.086;
RA   Uemura T., Kudoh J., Noda S., Kanba S., Shimizu N.;
RT   "Characterization of human and mouse TRPM2 genes: identification of a
RT   novel N-terminal truncated protein specifically expressed in human
RT   striatum.";
RL   Biochem. Biophys. Res. Commun. 328:1232-1243(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-1189.
RA   Hayes P.D.;
RT   "Cloning of the human TRPM2.";
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-52; ILE-166;
RP   MET-385; GLU-543; GLU-780; TRP-1199; GLY-1201; SER-1249; MET-1347;
RP   LYS-1359; MET-1368 AND SER-1438.
RG   NIEHS SNPs program;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1190-1503.
RA   Hiroi H., Muramatsu M., Inoue S.;
RT   "Molecular cloning of a novel estrogen responsive gene, estrogen
RT   responsive element associated gene 1 (EREG1), which contains MutT like
RT   domain.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, REGULATION BY ADP-RIBOSE, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DOMAIN.
RX   PubMed=11385575; DOI=10.1038/35079100;
RA   Perraud A.-L., Fleig A., Dunn C.A., Bagley L.A., Launay P.,
RA   Schmitz C., Stokes A.J., Zhu Q., Bessman M.J., Penner R., Kinet J.-P.,
RA   Scharenberg A.M.;
RT   "ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by
RT   Nudix motif homology.";
RL   Nature 411:595-599(2001).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, REGULATION BY PYRIMIDINE NUCLEOTIDES,
RP   ENZYME REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=11509734; DOI=10.1126/science.1062473;
RA   Sano Y., Inamura K., Miyake A., Mochizuki S., Yokoi H., Matsushime H.,
RA   Furuichi K.;
RT   "Immunocyte Ca2+ influx system mediated by LTRPC2.";
RL   Science 293:1327-1330(2001).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND MUTAGENESIS OF
RP   MET-1397.
RX   PubMed=11804595; DOI=10.1016/S1097-2765(01)00438-5;
RA   Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T.,
RA   Yamada H., Shimizu S., Mori E., Kudoh J., Shimizu N., Kurose H.,
RA   Okada Y., Imoto K., Mori Y.;
RT   "LTRPC2 Ca2+-permeable channel activated by changes in redox status
RT   confers susceptibility to cell death.";
RL   Mol. Cell 9:163-173(2002).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF ARG-1404;
RP   1405-ILE--GLN-1408; 1408-GLN-GLU-1409 AND GLN-1408.
RX   PubMed=15561722; DOI=10.1074/jbc.M411446200;
RA   Perraud A.L., Takanishi C.L., Shen B., Kang S., Smith M.K.,
RA   Schmitz C., Knowles H.M., Ferraris D., Li W., Zhang J., Stoddard B.L.,
RA   Scharenberg A.M.;
RT   "Accumulation of free ADP-ribose from mitochondria mediates oxidative
RT   stress-induced gating of TRPM2 cation channels.";
RL   J. Biol. Chem. 280:6138-6148(2005).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=16601673; DOI=10.1038/sj.emboj.7601083;
RA   Togashi K., Hara Y., Tominaga T., Higashi T., Konishi Y., Mori Y.,
RA   Tominaga M.;
RT   "TRPM2 activation by cyclic ADP-ribose at body temperature is involved
RT   in insulin secretion.";
RL   EMBO J. 25:1804-1815(2006).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19171771; DOI=10.1085/jgp.200810109;
RA   Csanady L., Toerocsik B.;
RT   "Four Ca2+ ions activate TRPM2 channels by binding in deep crevices
RT   near the pore but intracellularly of the gate.";
RL   J. Gen. Physiol. 133:189-203(2009).
RN   [16]
RP   FUNCTION.
RX   PubMed=19454650; DOI=10.1126/scisignal.2000278;
RA   Lange I., Yamamoto S., Partida-Sanchez S., Mori Y., Fleig A.,
RA   Penner R.;
RT   "TRPM2 functions as a lysosomal Ca2+-release channel in beta cells.";
RL   Sci. Signal. 2:RA23-RA23(2009).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20650899; DOI=10.1074/jbc.M109.066464;
RA   Toth B., Csanady L.;
RT   "Identification of direct and indirect effectors of the transient
RT   receptor potential melastatin 2 (TRPM2) cation channel.";
RL   J. Biol. Chem. 285:30091-30102(2010).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND MUTAGENESIS OF
RP   LYS-952; HIS-958; ARG-961; ARG-962; ARG-968; HIS-973; HIS-995;
RP   ASP-1002; LYS-1005 AND LYS-1007.
RX   PubMed=20660597; DOI=10.1074/jbc.M110.139774;
RA   Yang W., Zou J., Xia R., Vaal M.L., Seymour V.A., Luo J., Beech D.J.,
RA   Jiang L.H.;
RT   "State-dependent inhibition of TRPM2 channel by acidic pH.";
RL   J. Biol. Chem. 285:30411-30418(2010).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF MET-215.
RX   PubMed=22493272; DOI=10.1073/pnas.1114193109;
RA   Kashio M., Sokabe T., Shintaku K., Uematsu T., Fukuta N.,
RA   Kobayashi N., Mori Y., Tominaga M.;
RT   "Redox signal-mediated sensitization of transient receptor potential
RT   melastatin 2 (TRPM2) to temperature affects macrophage functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:6745-6750(2012).
RN   [20]
RP   FUNCTION.
RX   PubMed=25562606; DOI=10.1042/BJ20140747;
RA   Manna P.T., Munsey T.S., Abuarab N., Li F., Asipu A., Howell G.,
RA   Sedo A., Yang W., Naylor J., Beech D.J., Jiang L.H.,
RA   Sivaprasadarao A.;
RT   "TRPM2-mediated intracellular Zn2+ release triggers pancreatic beta-
RT   cell death.";
RL   Biochem. J. 466:537-546(2015).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25918360; DOI=10.1085/jgp.201511377;
RA   Toth B., Iordanov I., Csanady L.;
RT   "Ruling out pyridine dinucleotides as true TRPM2 channel activators
RT   reveals novel direct agonist ADP-ribose-2'-phosphate.";
RL   J. Gen. Physiol. 145:419-430(2015).
RN   [22]
RP   LACK OF CATALYTIC ACTIVITY, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27383051; DOI=10.7554/eLife.17600;
RA   Iordanov I., Mihalyi C., Toth B., Csanady L.;
RT   "The proposed channel-enzyme transient receptor potential melastatin 2
RT   does not possess ADP ribose hydrolase activity.";
RL   Elife 5:0-0(2016).
RN   [23]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27068538; DOI=10.1242/jcs.179796;
RA   Li F., Abuarab N., Sivaprasadarao A.;
RT   "Reciprocal regulation of actin cytoskeleton remodelling and cell
RT   migration by Ca2+ and Zn2+: role of TRPM2 channels.";
RL   J. Cell Sci. 129:2016-2029(2016).
CC   -!- FUNCTION: Isoform 1: Nonselective, voltage-independent cation
CC       channel that mediates Na(+) and Ca(2+) influx, leading to
CC       increased cytoplasmic Ca(2+) levels (PubMed:11960981,
CC       PubMed:12594222, PubMed:11385575, PubMed:11509734,
CC       PubMed:11804595, PubMed:15561722, PubMed:16601673,
CC       PubMed:19171771, PubMed:20660597, PubMed:27383051,
CC       PubMed:27068538). Extracellular calcium passes through the channel
CC       and increases channel activity by binding to the cytoplasmic
CC       domain and stabilizing the channel in an open conformation
CC       (PubMed:19171771). Also contributes to Ca(2+) release from
CC       intracellular stores in response to ADP-ribose (PubMed:19454650).
CC       Plays a role in numerous processes that involve signaling via
CC       intracellular Ca(2+) levels (Probable). Besides, mediates the
CC       release of lysosomal Zn(2+) stores in response to reactive oxygen
CC       species, leading to increased cytosolic Zn(2+) levels
CC       (PubMed:25562606, PubMed:27068538). Activated by moderate heat (35
CC       to 40 degrees Celsius) (PubMed:16601673). Activated by
CC       intracellular ADP-ribose, beta-NAD (NAD(+)) and similar compounds,
CC       and by oxidative stress caused by reactive oxygen or nitrogen
CC       species (PubMed:11960981, PubMed:11385575, PubMed:11509734,
CC       PubMed:11804595, PubMed:15561722, PubMed:16601673,
CC       PubMed:19171771, PubMed:27383051, PubMed:27068538). The precise
CC       physiological activators are under debate; the true, physiological
CC       activators may be ADP-ribose and ADP-ribose-2'-phosphate
CC       (PubMed:20650899, PubMed:25918360). Activation by ADP-ribose and
CC       beta-NAD is strongly increased by moderate heat (35 to 40 degrees
CC       Celsius) (PubMed:16601673). Likewise, reactive oxygen species
CC       lower the threshold for activation by moderate heat (37 degrees
CC       Celsius) (PubMed:22493272). Plays a role in mediating behavorial
CC       and physiological responses to moderate heat and thereby
CC       contributes to body temperature homeostasis. Plays a role in
CC       insulin secretion, a process that requires increased cytoplasmic
CC       Ca(2+) levels (By similarity). Required for normal IFNG and
CC       cytokine secretion and normal innate immune immunity in response
CC       to bacterial infection. Required for normal phagocytosis and
CC       cytokine release by macrophages exposed to zymosan (in vitro).
CC       Plays a role in dendritic cell differentiation and maturation, and
CC       in dendritic cell chemotaxis via its role in regulating
CC       cytoplasmic Ca(2+) levels (By similarity). Plays a role in the
CC       regulation of the reorganization of the actin cytoskeleton and
CC       filopodia formation in response to reactive oxygen species via its
CC       role in increasing cytoplasmic Ca(2+) and Zn(2+) levels
CC       (PubMed:27068538). Confers susceptibility to cell death following
CC       oxidative stress (PubMed:12594222, PubMed:25562606).
CC       {ECO:0000250|UniProtKB:Q91YD4, ECO:0000269|PubMed:11385575,
CC       ECO:0000269|PubMed:11509734, ECO:0000269|PubMed:11804595,
CC       ECO:0000269|PubMed:11960981, ECO:0000269|PubMed:12594222,
CC       ECO:0000269|PubMed:15561722, ECO:0000269|PubMed:16601673,
CC       ECO:0000269|PubMed:19171771, ECO:0000269|PubMed:19454650,
CC       ECO:0000269|PubMed:20650899, ECO:0000269|PubMed:20660597,
CC       ECO:0000269|PubMed:22493272, ECO:0000269|PubMed:25562606,
CC       ECO:0000269|PubMed:25918360, ECO:0000269|PubMed:27068538,
CC       ECO:0000269|PubMed:27383051, ECO:0000305}.
CC   -!- FUNCTION: Isoform 2: Lacks cation channel activity. Does not
CC       mediate cation transport in response to oxidative stress or ADP-
CC       ribose. {ECO:0000269|PubMed:11960981}.
CC   -!- FUNCTION: Isoform 3: Lacks cation channel activity and negatively
CC       regulates the channel activity of isoform 1. Negatively regulates
CC       susceptibility to cell death in reposponse to oxidative stress.
CC       {ECO:0000269|PubMed:12594222}.
CC   -!- ENZYME REGULATION: Inactivated by exposure to extracellular pH
CC       between 4.0 and 6.5; irreversibly inactivated when open channels
CC       are exposed to extracellular pH between 4.0 and 6.5, while pre-
CC       exposure of closed channels to extracellular pH 5.5 gives rise to
CC       currents that rapidly inactivate, but protects against
CC       irreversible inactivation (PubMed:20660597). Inactivated by
CC       intracellular ATP (PubMed:11509734). Activated by arachidonic acid
CC       (PubMed:11804595). {ECO:0000269|PubMed:11509734,
CC       ECO:0000269|PubMed:11804595, ECO:0000269|PubMed:20660597}.
CC   -!- SUBUNIT: Isoform 1 can interact with isoform 3. This interaction
CC       decreases calcium influx through isoform 1 and suppresses
CC       susceptibility to oxidative stress-induced cell death.
CC       {ECO:0000269|PubMed:12594222}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11385575,
CC       ECO:0000269|PubMed:11509734, ECO:0000269|PubMed:11804595,
CC       ECO:0000269|PubMed:12594222, ECO:0000269|PubMed:15561722,
CC       ECO:0000269|PubMed:16601673, ECO:0000269|PubMed:19171771,
CC       ECO:0000269|PubMed:20650899, ECO:0000269|PubMed:20660597,
CC       ECO:0000269|PubMed:22493272, ECO:0000269|PubMed:25918360,
CC       ECO:0000269|PubMed:27068538, ECO:0000269|PubMed:27383051}; Multi-
CC       pass membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000250|UniProtKB:E9PTA2}. Cell projection
CC       {ECO:0000250|UniProtKB:E9PTA2}. Cytoplasmic vesicle
CC       {ECO:0000250|UniProtKB:E9PTA2}. Lysosome
CC       {ECO:0000269|PubMed:27068538}. Note=Detected at the cell membrane
CC       and in intracellular vesicles in cortical neurons. Detected on
CC       neuronal cell bodies and neurites (By similarity). Detected on the
CC       cell membrane in polymorphonuclear neutrophils. Detected on
CC       cytoplasmic vesicles and lysosomes in immature bone marrow
CC       dendritic cells (By similarity). {ECO:0000250|UniProtKB:E9PTA2,
CC       ECO:0000250|UniProtKB:Q91YD4}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane
CC       {ECO:0000269|PubMed:11960981, ECO:0000269|PubMed:12594222}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane
CC       {ECO:0000269|PubMed:11960981}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane
CC       {ECO:0000269|PubMed:12594222}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=TRPM2-L;
CC         IsoId=O94759-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O94759-2; Sequence=VSP_006574, VSP_006575;
CC       Name=3; Synonyms=TRPM2-S;
CC         IsoId=O94759-3; Sequence=VSP_013018;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and peripheral blood
CC       cells, such as neutrophils. Also detected in bone marrow, spleen,
CC       heart, liver and lung. Isoform 2 is found in neutrophil
CC       granulocytes. {ECO:0000269|PubMed:11385575,
CC       ECO:0000269|PubMed:11509734}.
CC   -!- DOMAIN: The cytosolic nudix box binds ADP-ribose and is required
CC       for channel activation by ADP-ribose (PubMed:15561722,
CC       PubMed:16601673). {ECO:0000269|PubMed:15561722,
CC       ECO:0000269|PubMed:16601673}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       LTrpC subfamily. TRPM2 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: The isolated nudix hydrolase domain was shown to have low
CC       catalytic activity with ADP-ribose upon heterologous expression
CC       (PubMed:11385575). However, a more recent publication demonstrates
CC       that the nudix hydrolase domain lacks enzyme activity and suggests
CC       that spontaneous degradation of the substrate underlies the
CC       previously reported low activity (PubMed:27383051).
CC       {ECO:0000269|PubMed:11385575, ECO:0000269|PubMed:27383051}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB64300.1; Type=Frameshift; Positions=1227, 1237; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/trpm2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001535; BAA34700.1; -; mRNA.
DR   EMBL; AJ417076; CAD01139.1; -; mRNA.
DR   EMBL; AY603182; AAT12288.1; -; mRNA.
DR   EMBL; AB166745; BAD83705.1; -; mRNA.
DR   EMBL; AJ878416; CAI47593.1; -; mRNA.
DR   EMBL; DQ012935; AAY22174.1; -; Genomic_DNA.
DR   EMBL; AP001754; BAA95563.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09426.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09427.1; -; Genomic_DNA.
DR   EMBL; AB017549; BAB64300.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS13710.1; -. [O94759-1]
DR   RefSeq; NP_001307279.1; NM_001320350.1.
DR   RefSeq; NP_001307280.1; NM_001320351.1.
DR   RefSeq; NP_003298.1; NM_003307.3.
DR   RefSeq; XP_005261228.1; XM_005261171.3. [O94759-1]
DR   UniGene; Hs.369759; -.
DR   ProteinModelPortal; O94759; -.
DR   SMR; O94759; -.
DR   IntAct; O94759; 1.
DR   STRING; 9606.ENSP00000300482; -.
DR   BindingDB; O94759; -.
DR   ChEMBL; CHEMBL1250402; -.
DR   GuidetoPHARMACOLOGY; 494; -.
DR   TCDB; 1.A.4.5.5; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; O94759; -.
DR   PhosphoSitePlus; O94759; -.
DR   BioMuta; TRPM2; -.
DR   EPD; O94759; -.
DR   PaxDb; O94759; -.
DR   PeptideAtlas; O94759; -.
DR   PRIDE; O94759; -.
DR   Ensembl; ENST00000300481; ENSP00000300481; ENSG00000142185. [O94759-2]
DR   Ensembl; ENST00000300482; ENSP00000300482; ENSG00000142185. [O94759-1]
DR   Ensembl; ENST00000397928; ENSP00000381023; ENSG00000142185. [O94759-1]
DR   GeneID; 7226; -.
DR   KEGG; hsa:7226; -.
DR   UCSC; uc002zet.1; human. [O94759-1]
DR   CTD; 7226; -.
DR   DisGeNET; 7226; -.
DR   EuPathDB; HostDB:ENSG00000142185.16; -.
DR   GeneCards; TRPM2; -.
DR   HGNC; HGNC:12339; TRPM2.
DR   HPA; HPA030976; -.
DR   HPA; HPA035260; -.
DR   MIM; 603749; gene.
DR   neXtProt; NX_O94759; -.
DR   OpenTargets; ENSG00000142185; -.
DR   PharmGKB; PA37012; -.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; KOG4195; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOGENOM; HOG000236350; -.
DR   HOVERGEN; HBG055825; -.
DR   InParanoid; O94759; -.
DR   KO; K04977; -.
DR   PhylomeDB; O94759; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   GeneWiki; TRPM2; -.
DR   GenomeRNAi; 7226; -.
DR   PRO; PR:O94759; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000142185; -.
DR   CleanEx; HS_TRPC7; -.
DR   CleanEx; HS_TRPM2; -.
DR   ExpressionAtlas; O94759; baseline and differential.
DR   Genevisible; O94759; HS.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IMP:UniProtKB.
DR   GO; GO:0015278; F:calcium-release channel activity; IMP:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IMP:UniProtKB.
DR   GO; GO:0099604; F:ligand-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IMP:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006816; P:calcium ion transport; TAS:ProtInc.
DR   GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0071415; P:cellular response to purine-containing compound; ISS:UniProtKB.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0002407; P:dendritic cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0097028; P:dendritic cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0051489; P:regulation of filopodium assembly; IMP:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0014074; P:response to purine-containing compound; IMP:UniProtKB.
DR   GO; GO:0001659; P:temperature homeostasis; ISS:UniProtKB.
DR   GO; GO:0071577; P:zinc II ion transmembrane transport; IMP:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR029594; TRPM2.
DR   PANTHER; PTHR13800:SF2; PTHR13800:SF2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Ion channel; Ion transport; Lysosome; Membrane;
KW   Polymorphism; Reference proteome; Sodium; Sodium channel;
KW   Sodium transport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1503       Transient receptor potential cation
FT                                channel subfamily M member 2.
FT                                /FTId=PRO_0000215326.
FT   TOPO_DOM      1    752       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    753    773       Helical. {ECO:0000255}.
FT   TOPO_DOM    774    795       Extracellular. {ECO:0000255}.
FT   TRANSMEM    796    816       Helical. {ECO:0000255}.
FT   TOPO_DOM    817    872       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    873    893       Helical. {ECO:0000255}.
FT   TOPO_DOM    894    896       Extracellular. {ECO:0000255}.
FT   TRANSMEM    897    917       Helical. {ECO:0000255}.
FT   TOPO_DOM    918    936       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    937    957       Helical. {ECO:0000255}.
FT   TOPO_DOM    958   1025       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1026   1046       Helical. {ECO:0000255}.
FT   TOPO_DOM   1047   1503       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN     1354   1498       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   MOTIF      1390   1411       Nudix box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   VAR_SEQ     538    557       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11960981}.
FT                                /FTId=VSP_006574.
FT   VAR_SEQ     847   1503       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12594222}.
FT                                /FTId=VSP_013018.
FT   VAR_SEQ    1291   1325       DTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPL -> E
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:11960981}.
FT                                /FTId=VSP_006575.
FT   VARIANT      52     52       N -> K (in dbSNP:rs45625933).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025216.
FT   VARIANT     166    166       V -> I (in dbSNP:rs45544142).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025217.
FT   VARIANT     385    385       V -> M (in dbSNP:rs45485992).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025218.
FT   VARIANT     543    543       D -> E (in dbSNP:rs1556314).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_020032.
FT   VARIANT     780    780       D -> E (in dbSNP:rs9974927).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025219.
FT   VARIANT    1189   1189       Q -> R (in dbSNP:rs9978351).
FT                                {ECO:0000269|PubMed:11960981,
FT                                ECO:0000269|PubMed:12594222,
FT                                ECO:0000269|PubMed:15708008,
FT                                ECO:0000269|PubMed:9806837,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025220.
FT   VARIANT    1199   1199       R -> W (in dbSNP:rs45611537).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025221.
FT   VARIANT    1201   1201       S -> G (in dbSNP:rs45519835).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025222.
FT   VARIANT    1249   1249       N -> S (in dbSNP:rs45513700).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025223.
FT   VARIANT    1347   1347       T -> M (in dbSNP:rs45589233).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025224.
FT   VARIANT    1359   1359       E -> K (in dbSNP:rs45570639).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025225.
FT   VARIANT    1368   1368       I -> M (in dbSNP:rs45613636).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025226.
FT   VARIANT    1438   1438       A -> S (in dbSNP:rs45578242).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025227.
FT   MUTAGEN     215    215       M->A: Abolishes lowering of temperature
FT                                threshold for activation in response to
FT                                reactive oxygen species.
FT                                {ECO:0000269|PubMed:22493272}.
FT   MUTAGEN     952    952       K->A: Strongly reduces channel activity
FT                                at ph 7.3. Increased residual channel
FT                                activity after exposure to pH 5.5.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     958    958       H->A: No effect on channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     961    961       R->A: Mildly decreases channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     962    962       R->A: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     968    968       R->A: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     973    973       H->A: No effect on channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN     995    995       H->A: Moderately decreases channel
FT                                activity. {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN    1002   1002       D->A: Strongly increased residual channel
FT                                activity after exposure to pH 5.5.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN    1005   1005       K->A: Decreases channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN    1007   1007       K->A: Nearly abolishes channel activity.
FT                                {ECO:0000269|PubMed:20660597}.
FT   MUTAGEN    1397   1397       M->I: Only slight effect on activity.
FT                                {ECO:0000269|PubMed:11804595}.
FT   MUTAGEN    1404   1404       R->Q: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:15561722}.
FT   MUTAGEN    1405   1408       ILRQ->EFRE: Decreased channel activity in
FT                                response to ADP-ribose.
FT                                {ECO:0000269|PubMed:15561722}.
FT   MUTAGEN    1408   1409       QE->KK: Expected to abolish the initially
FT                                proposed hydrolase activity. Does not
FT                                abolish channel activity in response to
FT                                ADP-ribose.
FT                                {ECO:0000269|PubMed:15561722}.
FT   MUTAGEN    1408   1408       Q->E: Decreased channel activity.
FT                                {ECO:0000269|PubMed:15561722}.
FT   CONFLICT   1088   1088       S -> N (in Ref. 2; CAD01139).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1503 AA;  171198 MW;  02338437501ABFAB CRC64;
     MEPSALRKAG SEQEEGFEGL PRRVTDLGMV SNLRRSNSSL FKSWRLQCPF GNNDKQESLS
     SWIPENIKKK ECVYFVESSK LSDAGKVVCQ CGYTHEQHLE EATKPHTFQG TQWDPKKHVQ
     EMPTDAFGDI VFTGLSQKVK KYVRVSQDTP SSVIYHLMTQ HWGLDVPNLL ISVTGGAKNF
     NMKPRLKSIF RRGLVKVAQT TGAWIITGGS HTGVMKQVGE AVRDFSLSSS YKEGELITIG
     VATWGTVHRR EGLIHPTGSF PAEYILDEDG QGNLTCLDSN HSHFILVDDG THGQYGVEIP
     LRTRLEKFIS EQTKERGGVA IKIPIVCVVL EGGPGTLHTI DNATTNGTPC VVVEGSGRVA
     DVIAQVANLP VSDITISLIQ QKLSVFFQEM FETFTESRIV EWTKKIQDIV RRRQLLTVFR
     EGKDGQQDVD VAILQALLKA SRSQDHFGHE NWDHQLKLAV AWNRVDIARS EIFMDEWQWK
     PSDLHPTMTA ALISNKPEFV KLFLENGVQL KEFVTWDTLL YLYENLDPSC LFHSKLQKVL
     VEDPERPACA PAAPRLQMHH VAQVLRELLG DFTQPLYPRP RHNDRLRLLL PVPHVKLNVQ
     GVSLRSLYKR SSGHVTFTMD PIRDLLIWAI VQNRRELAGI IWAQSQDCIA AALACSKILK
     ELSKEEEDTD SSEEMLALAE EYEHRAIGVF TECYRKDEER AQKLLTRVSE AWGKTTCLQL
     ALEAKDMKFV SHGGIQAFLT KVWWGQLSVD NGLWRVTLCM LAFPLLLTGL ISFREKRLQD
     VGTPAARARA FFTAPVVVFH LNILSYFAFL CLFAYVLMVD FQPVPSWCEC AIYLWLFSLV
     CEEMRQLFYD PDECGLMKKA ALYFSDFWNK LDVGAILLFV AGLTCRLIPA TLYPGRVILS
     LDFILFCLRL MHIFTISKTL GPKIIIVKRM MKDVFFFLFL LAVWVVSFGV AKQAILIHNE
     RRVDWLFRGA VYHSYLTIFG QIPGYIDGVN FNPEHCSPNG TDPYKPKCPE SDATQQRPAF
     PEWLTVLLLC LYLLFTNILL LNLLIAMFNY TFQQVQEHTD QIWKFQRHDL IEEYHGRPAA
     PPPFILLSHL QLFIKRVVLK TPAKRHKQLK NKLEKNEEAA LLSWEIYLKE NYLQNRQFQQ
     KQRPEQKIED ISNKVDAMVD LLDLDPLKRS GSMEQRLASL EEQVAQTAQA LHWIVRTLRA
     SGFSSEADVP TLASQKAAEE PDAEPGGRKK TEEPGDSYHV NARHLLYPNC PVTRFPVPNE
     KVPWETEFLI YDPPFYTAER KDAAAMDPMG DTLEPLSTIQ YNVVDGLRDR RSFHGPYTVQ
     AGLPLNPMGR TGLRGRGSLS CFGPNHTLYP MVTRWRRNED GAICRKSIKK MLEVLVVKLP
     LSEHWALPGG SREPGEMLPR KLKRILRQEH WPSFENLLKC GMEVYKGYMD DPRNTDNAWI
     ETVAVSVHFQ DQNDVELNRL NSNLHACDSG ASIRWQVVDR RIPLYANHKT LLQKAAAEFG
     AHY
//
ID   CAC1H_HUMAN             Reviewed;        2353 AA.
AC   O95180; B5ME00; F8WFD1; O95802; Q8WWI6; Q96QI6; Q96RZ9; Q9NYY4;
AC   Q9NYY5;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 4.
DT   20-DEC-2017, entry version 170.
DE   RecName: Full=Voltage-dependent T-type calcium channel subunit alpha-1H;
DE   AltName: Full=Low-voltage-activated calcium channel alpha1 3.2 subunit;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav3.2;
GN   Name=CACNA1H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ALA-664, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=9670923; DOI=10.1161/01.RES.83.1.103;
RA   Cribbs L.L., Lee J.-H., Yang J., Satin J., Zhang Y., Daud A.N.,
RA   Barclay J., Wiliamson M.P., Fox M., Rees M., Perez-Reyes E.;
RT   "Cloning and characterization of alpha1H from human heart, a member of
RT   the T-type Ca2+ channel gene family.";
RL   Circ. Res. 83:103-109(1998).
RN   [2]
RP   SEQUENCE REVISION.
RA   Cribbs L.L., Lee J.-H., Yang J., Daud A.N., Perez-Reyes E.;
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT HIS-2077, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Thyroid carcinoma;
RX   PubMed=9930755; DOI=10.1046/j.1471-4159.1999.0720791.x;
RA   Williams M.E., Washburn M.S., Hans M., Urrutia A., Brust P.F.,
RA   Prodanovich P., Harpold M.M., Stauderman K.A.;
RT   "Structure and functional characterization of a novel human low-
RT   voltage activated calcium channel.";
RL   J. Neurochem. 72:791-799(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT ALA-664, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11751928; DOI=10.1074/jbc.M105345200;
RA   Jagannathan S., Punt E.L., Gu Y., Arnoult C., Sakkas D., Barratt C.L.,
RA   Publicover S.J.;
RT   "Identification and localization of T-type voltage-operated calcium
RT   channel subunits in human male germ cells. Expression of multiple
RT   isoforms.";
RL   J. Biol. Chem. 277:8449-8456(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS VAL-313
RP   AND HIS-2060.
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-313.
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 424-661 AND 838-2373 (ISOFORM 1),
RP   AND VARIANTS LEU-640 AND HIS-2077.
RA   Mittman S., Agnew W.S.;
RT   "Organization and alternative splicing of CACNA1H.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   ZINC-BINDING SITES.
RX   PubMed=19940152; DOI=10.1074/jbc.M109.067660;
RA   Kang H.W., Vitko I., Lee S.S., Perez-Reyes E., Lee J.H.;
RT   "Structural determinants of the high affinity extracellular zinc
RT   binding site on Cav3.2 T-type calcium channels.";
RL   J. Biol. Chem. 285:3271-3281(2010).
RN   [9]
RP   VARIANTS ECA6 LEU-161; LYS-282; SER-456; SER-499; LEU-648; GLN-744;
RP   VAL-748; ASP-773; SER-784; MET-831; SER-848 AND ASN-1463, AND VARIANTS
RP   VAL-313; LEU-640; ALA-664; SER-684; CYS-788; HIS-2060; HIS-2077 AND
RP   SER-2173.
RX   PubMed=12891677; DOI=10.1002/ana.10607;
RA   Chen Y., Lu J., Pan H., Zhang Y., Wu H., Xu K., Liu X., Jiang Y.,
RA   Bao X., Yao Z., Ding K., Lo W.H., Qiang B., Chan P., Shen Y., Wu X.;
RT   "Association between genetic variation of CACNA1H and childhood
RT   absence epilepsy.";
RL   Ann. Neurol. 54:239-243(2003).
RN   [10]
RP   VARIANTS EIG6 LEU-618 AND ASP-755.
RX   PubMed=15048902; DOI=10.1002/ana.20028;
RA   Heron S.E., Phillips H.A., Mulley J.C., Mazarib A., Neufeld M.Y.,
RA   Berkovic S.F., Scheffer I.E.;
RT   "Genetic variation of CACNA1H in idiopathic generalized epilepsy.";
RL   Ann. Neurol. 55:595-596(2004).
RN   [11]
RP   VARIANT HALD4 VAL-1549, CHARACTERIZATION OF VARIANT HALD4 VAL-1549,
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=25907736; DOI=10.7554/eLife.06315;
RA   Scholl U.I., Stoelting G., Nelson-Williams C., Vichot A.A., Choi M.,
RA   Loring E., Prasad M.L., Goh G., Carling T., Juhlin C.C., Quack I.,
RA   Rump L.C., Thiel A., Lande M., Frazier B.G., Rasoulpour M.,
RA   Bowlin D.L., Sethna C.B., Trachtman H., Fahlke C., Lifton R.P.;
RT   "Recurrent gain of function mutation in calcium channel CACNA1H causes
RT   early-onset hypertension with primary aldosteronism.";
RL   Elife 4:E06315-E06315(2015).
RN   [12]
RP   VARIANT CYS-1970.
RX   PubMed=26637798; DOI=10.1016/j.neuron.2015.11.009;
RA   D'Gama A.M., Pochareddy S., Li M., Jamuar S.S., Reiff R.E., Lam A.T.,
RA   Sestan N., Walsh C.A.;
RT   "Targeted DNA Sequencing from Autism Spectrum Disorder Brains
RT   Implicates Multiple Genetic Mechanisms.";
RL   Neuron 88:910-917(2015).
RN   [13]
RP   VARIANTS HALD4 LEU-196; ILE-1549 AND LEU-2083, VARIANT GLU-1951,
RP   CHARACTERIZATION OF VARIANTS HALD4 LEU-196; ILE-1549 AND LEU-2083,
RP   CHARACTERIZATION OF VARIANT GLU-1951, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=27729216; DOI=10.1016/j.ebiom.2016.10.002;
RA   Daniil G., Fernandes-Rosa F.L., Chemin J., Blesneac I., Beltrand J.,
RA   Polak M., Jeunemaitre X., Boulkroun S., Amar L., Strom T.M., Lory P.,
RA   Zennaro M.C.;
RT   "CACNA1H mutations are associated with different forms of primary
RT   aldosteronism.";
RL   EBioMedicine 13:225-236(2016).
RN   [14]
RP   VARIANT TYR-516.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1H
CC       gives rise to T-type calcium currents. T-type calcium channels
CC       belong to the "low-voltage activated (LVA)" group and are strongly
CC       blocked by nickel and mibefradil. A particularity of this type of
CC       channels is an opening at quite negative potentials, and a
CC       voltage-dependent inactivation. T-type channels serve pacemaking
CC       functions in both central neurons and cardiac nodal cells and
CC       support calcium signaling in secretory cells and vascular smooth
CC       muscle. They may also be involved in the modulation of firing
CC       patterns of neurons which is important for information processing
CC       as well as in cell growth processes. In the adrenal zona
CC       glomerulosa, participates in the signaling pathway leading to
CC       aldosterone production in response to either AGT/angiotensin II,
CC       or hyperkalemia (PubMed:25907736, PubMed:27729216).
CC       {ECO:0000269|PubMed:25907736, ECO:0000269|PubMed:27729216}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=A1H-a;
CC         IsoId=O95180-1; Sequence=Displayed;
CC       Name=2; Synonyms=A1H-b;
CC         IsoId=O95180-2; Sequence=VSP_000949;
CC         Note=Ref.4 (CAD12646) sequence is in conflict in position:
CC         1587:K->E. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: In nonneuronal tissues, the highest expression
CC       levels are found in the kidney, liver, and heart. In the brain,
CC       most abundant in the amygdala, caudate nucleus, and putamen
CC       (PubMed:9670923, PubMed:9930755). In the heart, expressed in blood
CC       vessels. Isoform 1 and isoform 2 are expressed in testis,
CC       primarily in the germ cells, but not in other portions of the
CC       reproductive tract, such as ductus deferens. Isoform 2 is not
CC       detected in brain (PubMed:11751928). Expressed in the adrenal
CC       glomerulosa (at protein level) (PubMed:25907736, PubMed:27729216).
CC       {ECO:0000269|PubMed:11751928, ECO:0000269|PubMed:25907736,
CC       ECO:0000269|PubMed:27729216, ECO:0000269|PubMed:9670923,
CC       ECO:0000269|PubMed:9930755}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: In response to raising of intracellular calcium, the T-type
CC       channels are activated by CaM-kinase II.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A
CC       disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain.
CC       {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Absence
CC       seizures may either remit or persist into adulthood.
CC       {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Hyperaldosteronism, familial, 4 (HALD4) [MIM:617027]: A
CC       form of familial hyperaldosteronism, a disorder characterized by
CC       hypertension, elevated aldosterone levels despite low plasma renin
CC       activity, and abnormal adrenal steroid production. There is
CC       significant phenotypic heterogeneity, and some individuals never
CC       develop hypertension. {ECO:0000269|PubMed:25907736,
CC       ECO:0000269|PubMed:27729216}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1H subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK61268.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAC42094.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF051946; AAC67239.3; -; mRNA.
DR   EMBL; AF073931; AAD17668.1; -; mRNA.
DR   EMBL; AJ420779; CAD12646.1; -; mRNA.
DR   EMBL; AE006466; AAK61268.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL031703; CAC42094.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC120498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF223562; AAF60162.1; -; Genomic_DNA.
DR   EMBL; AF223563; AAF60163.1; -; Genomic_DNA.
DR   CCDS; CCDS45375.1; -. [O95180-1]
DR   CCDS; CCDS45376.1; -. [O95180-2]
DR   RefSeq; NP_001005407.1; NM_001005407.1. [O95180-2]
DR   RefSeq; NP_066921.2; NM_021098.2. [O95180-1]
DR   UniGene; Hs.459642; -.
DR   ProteinModelPortal; O95180; -.
DR   BioGrid; 114426; 5.
DR   IntAct; O95180; 2.
DR   STRING; 9606.ENSP00000334198; -.
DR   BindingDB; O95180; -.
DR   ChEMBL; CHEMBL1859; -.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB00270; Isradipine.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 536; -.
DR   TCDB; 1.A.1.11.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O95180; -.
DR   PhosphoSitePlus; O95180; -.
DR   BioMuta; CACNA1H; -.
DR   PaxDb; O95180; -.
DR   PeptideAtlas; O95180; -.
DR   PRIDE; O95180; -.
DR   Ensembl; ENST00000348261; ENSP00000334198; ENSG00000196557. [O95180-1]
DR   Ensembl; ENST00000358590; ENSP00000351401; ENSG00000196557. [O95180-2]
DR   Ensembl; ENST00000565831; ENSP00000455840; ENSG00000196557. [O95180-2]
DR   GeneID; 8912; -.
DR   KEGG; hsa:8912; -.
DR   UCSC; uc002cks.4; human. [O95180-1]
DR   CTD; 8912; -.
DR   DisGeNET; 8912; -.
DR   EuPathDB; HostDB:ENSG00000196557.10; -.
DR   GeneCards; CACNA1H; -.
DR   H-InvDB; HIX0038538; -.
DR   HGNC; HGNC:1395; CACNA1H.
DR   HPA; HPA039125; -.
DR   MalaCards; CACNA1H; -.
DR   MIM; 607904; gene.
DR   MIM; 611942; phenotype.
DR   MIM; 617027; phenotype.
DR   neXtProt; NX_O95180; -.
DR   OpenTargets; ENSG00000196557; -.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   PharmGKB; PA380; -.
DR   eggNOG; ENOG410IP4J; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00830000128242; -.
DR   HOVERGEN; HBG050764; -.
DR   InParanoid; O95180; -.
DR   KO; K04855; -.
DR   OMA; QSSWNLL; -.
DR   OrthoDB; EOG091G02L1; -.
DR   PhylomeDB; O95180; -.
DR   TreeFam; TF313555; -.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   ChiTaRS; CACNA1H; human.
DR   GeneWiki; CACNA1H; -.
DR   GenomeRNAi; 8912; -.
DR   PRO; PR:O95180; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000196557; -.
DR   CleanEx; HS_CACNA1H; -.
DR   ExpressionAtlas; O95180; baseline and differential.
DR   Genevisible; O95180; HS.
DR   GO; GO:0016021; C:integral component of membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; TAS:ProtInc.
DR   GO; GO:0008332; F:low voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0032342; P:aldosterone biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0070509; P:calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0035865; P:cellular response to potassium ion; IEP:UniProtKB.
DR   GO; GO:0034651; P:cortisol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; NAS:ProtInc.
DR   GO; GO:0007520; P:myoblast fusion; TAS:ProtInc.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; IMP:UniProtKB.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IBA:GO_Central.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005445; VDCC_T_a1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR01629; TVDCCALPHA1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disease mutation; Epilepsy; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel; Zinc.
FT   CHAIN         1   2353       Voltage-dependent T-type calcium channel
FT                                subunit alpha-1H.
FT                                /FTId=PRO_0000053954.
FT   TOPO_DOM      1    100       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    101    119       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    120    141       Extracellular. {ECO:0000255}.
FT   TRANSMEM    142    160       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    161    169       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    170    184       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    185    193       Extracellular. {ECO:0000255}.
FT   TRANSMEM    194    212       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    213    232       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    254    394       Extracellular. {ECO:0000255}.
FT   TRANSMEM    395    419       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    420    793       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    794    814       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    815    827       Extracellular. {ECO:0000255}.
FT   TRANSMEM    828    849       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    850    855       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    856    874       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    875    882       Extracellular. {ECO:0000255}.
FT   TRANSMEM    883    906       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    907    917       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    918    938       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    939    990       Extracellular. {ECO:0000255}.
FT   TRANSMEM    991   1015       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1016   1290       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1291   1313       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1314   1331       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1332   1352       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1353   1362       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1363   1382       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1383   1396       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1397   1418       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1419   1428       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1429   1452       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1453   1529       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1530   1555       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1556   1616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1617   1637       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1638   1651       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1652   1673       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1674   1680       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1681   1699       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1700   1713       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1714   1737       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1738   1751       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1752   1772       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1773   1835       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1836   1863       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1864   2353       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       87    422       I.
FT   REPEAT      779   1018       II.
FT   REPEAT     1281   1558       III.
FT   REPEAT     1602   1863       IV.
FT   COMPBIAS    520    530       Poly-His.
FT   COMPBIAS   1107   1110       Poly-Ser.
FT   COMPBIAS   1583   1586       Poly-Arg.
FT   METAL       140    140       Zinc.
FT   METAL       189    189       Zinc.
FT   METAL       191    191       Zinc.
FT   SITE        378    378       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        974    974       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1504   1504       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1808   1808       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   CARBOHYD    192    192       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1466   1466       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ    1587   1593       STFPSPE -> K (in isoform 2).
FT                                {ECO:0000303|PubMed:11751928}.
FT                                /FTId=VSP_000949.
FT   VARIANT     161    161       F -> L (in ECA6; dbSNP:rs119454947).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045935.
FT   VARIANT     196    196       S -> L (in HALD4; changed calcium channel
FT                                activity; increased aldosterone
FT                                production in response to potassium ion
FT                                stimulation; increased expression of
FT                                genes involved in aldosterone
FT                                biosynthesis, with the strongest effect
FT                                observed on CYP11B2 expression in
FT                                response to potassium ion stimulation;
FT                                dbSNP:rs780596901).
FT                                {ECO:0000269|PubMed:27729216}.
FT                                /FTId=VAR_077064.
FT   VARIANT     282    282       E -> K (in ECA6; dbSNP:rs119454948).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045936.
FT   VARIANT     313    313       M -> V (in dbSNP:rs36117280).
FT                                {ECO:0000269|PubMed:11157797,
FT                                ECO:0000269|PubMed:12891677,
FT                                ECO:0000269|PubMed:15616553}.
FT                                /FTId=VAR_045937.
FT   VARIANT     456    456       C -> S (in ECA6).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045938.
FT   VARIANT     499    499       G -> S (in ECA6; dbSNP:rs560915333).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045939.
FT   VARIANT     516    516       H -> Y (found in a patient with drug-
FT                                resistant focal epilepsy; unknown
FT                                pathological significance;
FT                                dbSNP:rs1057519554).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078237.
FT   VARIANT     618    618       P -> L (in EIG6; dbSNP:rs60734921).
FT                                {ECO:0000269|PubMed:15048902}.
FT                                /FTId=VAR_066986.
FT   VARIANT     640    640       P -> L (in dbSNP:rs61734410).
FT                                {ECO:0000269|PubMed:12891677,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_045940.
FT   VARIANT     648    648       P -> L (in ECA6).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045941.
FT   VARIANT     664    664       V -> A (in dbSNP:rs4984636).
FT                                {ECO:0000269|PubMed:11751928,
FT                                ECO:0000269|PubMed:12891677,
FT                                ECO:0000269|PubMed:9670923}.
FT                                /FTId=VAR_045942.
FT   VARIANT     684    684       P -> S (in dbSNP:rs762185083).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045943.
FT   VARIANT     744    744       R -> Q (in ECA6; dbSNP:rs373764821).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045944.
FT   VARIANT     748    748       A -> V (in ECA6; dbSNP:rs770371468).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045945.
FT   VARIANT     755    755       G -> D (in EIG6; dbSNP:rs142306293).
FT                                {ECO:0000269|PubMed:15048902}.
FT                                /FTId=VAR_066987.
FT   VARIANT     773    773       G -> D (in ECA6; dbSNP:rs267606697).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045946.
FT   VARIANT     784    784       G -> S (in ECA6; dbSNP:rs779526640).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045947.
FT   VARIANT     788    788       R -> C (in dbSNP:rs3751664).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045948.
FT   VARIANT     812    812       V -> M (in dbSNP:rs28365119).
FT                                /FTId=VAR_045949.
FT   VARIANT     831    831       V -> M (in ECA6; dbSNP:rs119454949).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045950.
FT   VARIANT     848    848       G -> S (in ECA6; dbSNP:rs374272094).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045951.
FT   VARIANT    1463   1463       D -> N (in ECA6; dbSNP:rs542245543).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045952.
FT   VARIANT    1549   1549       M -> I (in HALD4; changed calcium channel
FT                                activity; increased aldosterone
FT                                production in response to potassium ion
FT                                stimulation; increased expression of
FT                                genes involved in aldosterone
FT                                biosynthesis, with the strongest effect
FT                                observed on CYP11B2 expression in
FT                                response to potassium ion stimulation).
FT                                {ECO:0000269|PubMed:27729216}.
FT                                /FTId=VAR_077065.
FT   VARIANT    1549   1549       M -> V (in HALD4; changed calcium channel
FT                                activity; dbSNP:rs786205050).
FT                                {ECO:0000269|PubMed:25907736}.
FT                                /FTId=VAR_077066.
FT   VARIANT    1871   1871       R -> Q (in dbSNP:rs58124832).
FT                                /FTId=VAR_061104.
FT   VARIANT    1951   1951       V -> E (probable disease-associated
FT                                mutation responsible for primary
FT                                aldosteronism found in a patient with
FT                                aldosterone-producing adenoma; changed
FT                                Ca(2+) channel activity;
FT                                dbSNP:rs746967306).
FT                                {ECO:0000269|PubMed:27729216}.
FT                                /FTId=VAR_077067.
FT   VARIANT    1970   1970       S -> C (found in a patient with autism;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:26637798}.
FT                                /FTId=VAR_078702.
FT   VARIANT    1974   1974       E -> G (in dbSNP:rs3751886).
FT                                /FTId=VAR_033698.
FT   VARIANT    2060   2060       R -> H (in dbSNP:rs1054644).
FT                                {ECO:0000269|PubMed:11157797,
FT                                ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045953.
FT   VARIANT    2077   2077       R -> H (in dbSNP:rs1054645).
FT                                {ECO:0000269|PubMed:12891677,
FT                                ECO:0000269|PubMed:9930755,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_045954.
FT   VARIANT    2083   2083       P -> L (in HALD4; changed calcium channel
FT                                activity; dbSNP:rs759924732).
FT                                {ECO:0000269|PubMed:27729216}.
FT                                /FTId=VAR_077068.
FT   VARIANT    2173   2173       P -> S (in dbSNP:rs200675829).
FT                                {ECO:0000269|PubMed:12891677}.
FT                                /FTId=VAR_045955.
FT   CONFLICT      7      7       A -> S (in Ref. 5; AC120498).
FT                                {ECO:0000305}.
FT   CONFLICT     31     31       E -> K (in Ref. 5; AC120498).
FT                                {ECO:0000305}.
FT   CONFLICT     55     55       A -> S (in Ref. 5; AC120498).
FT                                {ECO:0000305}.
FT   CONFLICT     94     94       L -> V (in Ref. 5; AC120498).
FT                                {ECO:0000305}.
FT   CONFLICT    215    215       S -> T (in Ref. 6; CAC42094).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2353 AA;  259163 MW;  E13E270635173D98 CRC64;
     MTEGARAADE VRVPLGAPPP GPAALVGASP ESPGAPGREA ERGSELGVSP SESPAAERGA
     ELGADEEQRV PYPALAATVF FCLGQTTRPR SWCLRLVCNP WFEHVSMLVI MLNCVTLGMF
     RPCEDVECGS ERCNILEAFD AFIFAFFAVE MVIKMVALGL FGQKCYLGDT WNRLDFFIVV
     AGMMEYSLDG HNVSLSAIRT VRVLRPLRAI NRVPSMRILV TLLLDTLPML GNVLLLCFFV
     FFIFGIVGVQ LWAGLLRNRC FLDSAFVRNN NLTFLRPYYQ TEEGEENPFI CSSRRDNGMQ
     KCSHIPGRRE LRMPCTLGWE AYTQPQAEGV GAARNACINW NQYYNVCRSG DSNPHNGAIN
     FDNIGYAWIA IFQVITLEGW VDIMYYVMDA HSFYNFIYFI LLIIVGSFFM INLCLVVIAT
     QFSETKQRES QLMREQRARH LSNDSTLASF SEPGSCYEEL LKYVGHIFRK VKRRSLRLYA
     RWQSRWRKKV DPSAVQGQGP GHRQRRAGRH TASVHHLVYH HHHHHHHHYH FSHGSPRRPG
     PEPGACDTRL VRAGAPPSPP SPGRGPPDAE SVHSIYHADC HIEGPQERAR VAHAAATAAA
     SLRLATGLGT MNYPTILPSG VGSGKGSTSP GPKGKWAGGP PGTGGHGPLS LNSPDPYEKI
     PHVVGEHGLG QAPGHLSGLS VPCPLPSPPA GTLTCELKSC PYCTRALEDP EGELSGSESG
     DSDGRGVYEF TQDVRHGDRW DPTRPPRATD TPGPGPGSPQ RRAQQRAAPG EPGWMGRLWV
     TFSGKLRRIV DSKYFSRGIM MAILVNTLSM GVEYHEQPEE LTNALEISNI VFTSMFALEM
     LLKLLACGPL GYIRNPYNIF DGIIVVISVW EIVGQADGGL SVLRTFRLLR VLKLVRFLPA
     LRRQLVVLVK TMDNVATFCT LLMLFIFIFS ILGMHLFGCK FSLKTDTGDT VPDRKNFDSL
     LWAIVTVFQI LTQEDWNVVL YNGMASTSSW AALYFVALMT FGNYVLFNLL VAILVEGFQA
     EGDANRSDTD EDKTSVHFEE DFHKLRELQT TELKMCSLAV TPNGHLEGRG SLSPPLIMCT
     AATPMPTPKS SPFLDAAPSL PDSRRGSSSS GDPPLGDQKP PASLRSSPCA PWGPSGAWSS
     RRSSWSSLGR APSLKRRGQC GERESLLSGE GKGSTDDEAE DGRAAPGPRA TPLRRAESLD
     PRPLRPAALP PTKCRDRDGQ VVALPSDFFL RIDSHREDAA ELDDDSEDSC CLRLHKVLEP
     YKPQWCRSRE AWALYLFSPQ NRFRVSCQKV ITHKMFDHVV LVFIFLNCVT IALERPDIDP
     GSTERVFLSV SNYIFTAIFV AEMMVKVVAL GLLSGEHAYL QSSWNLLDGL LVLVSLVDIV
     VAMASAGGAK ILGVLRVLRL LRTLRPLRVI SRAPGLKLVV ETLISSLRPI GNIVLICCAF
     FIIFGILGVQ LFKGKFYYCE GPDTRNISTK AQCRAAHYRW VRRKYNFDNL GQALMSLFVL
     SSKDGWVNIM YDGLDAVGVD QQPVQNHNPW MLLYFISFLL IVSFFVLNMF VGVVVENFHK
     CRQHQEAEEA RRREEKRLRR LERRRRSTFP SPEAQRRPYY ADYSPTRRSI HSLCTSHYLD
     LFITFIICVN VITMSMEHYN QPKSLDEALK YCNYVFTIVF VFEAALKLVA FGFRRFFKDR
     WNQLDLAIVL LSLMGITLEE IEMSAALPIN PTIIRIMRVL RIARVLKLLK MATGMRALLD
     TVVQALPQVG NLGLLFMLLF FIYAALGVEL FGRLECSEDN PCEGLSRHAT FSNFGMAFLT
     LFRVSTGDNW NGIMKDTLRE CSREDKHCLS YLPALSPVYF VTFVLVAQFV LVNVVVAVLM
     KHLEESNKEA REDAELDAEI ELEMAQGPGS ARRVDADRPP LPQESPGARD APNLVARKVS
     VSRMLSLPND SYMFRPVVPA SAPHPRPLQE VEMETYGAGT PLGSVASVHS PPAESCASLQ
     IPLAVSSPAR SGEPLHALSP RGTARSPSLS RLLCRQEAVH TDSLEGKIDS PRDTLDPAEP
     GEKTPVRPVT QGGSLQSPPR SPRPASVRTR KHTFGQRCVS SRPAAPGGEE AEASDPADEE
     VSHITSSACP WQPTAEPHGP EASPVAGGER DLRRLYSVDA QGFLDKPGRA DEQWRPSAEL
     GSGEPGEAKA WGPEAEPALG ARRKKKMSPP CISVEPPAED EGSARPSAAE GGSTTLRRRT
     PSCEATPHRD SLEPTEGSGA GGDPAAKGER WGQASCRAEH LTVPSFAFEP LDLGVPSGDP
     FLDGSHSVTP ESRASSSGAI VPLEPPESEP PMPVGDPPEK RRGLYLTVPQ CPLEKPGSPS
     ATPAPGGGAD DPV
//
ID   CAC1S_RABIT             Reviewed;        1873 AA.
AC   P07293;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   20-DEC-2017, entry version 150.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1S;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;
DE   AltName: Full=Dihydropyridine receptor alpha-1S subunit {ECO:0000303|PubMed:15201141, ECO:0000303|PubMed:1660150, ECO:0000303|PubMed:25667046};
DE            Short=DHPR {ECO:0000303|PubMed:10388749, ECO:0000303|PubMed:25667046};
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.1;
GN   Name=CACNA1S; Synonyms=CACH1, CACNL1A3;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, TISSUE
RP   SPECIFICITY, DIHYDROPYRIDINE BINDING, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=3037387; DOI=10.1038/328313a0;
RA   Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H.,
RA   Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S.;
RT   "Primary structure of the receptor for calcium channel blockers from
RT   skeletal muscle.";
RL   Nature 328:313-318(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=2458626; DOI=10.1126/science.2458626;
RA   Ellis S.B., Williams M.E., Ways N.R., Brenner R., Sharp A.H.,
RA   Leung A.T., Campbell K.P., McKenna E., Koch W.J., Hui A., Schwartz A.,
RA   Harpold M.M.;
RT   "Sequence and expression of mRNAs encoding the alpha 1 and alpha 2
RT   subunits of a DHP-sensitive calcium channel.";
RL   Science 241:1661-1664(1988).
RN   [3]
RP   BETA-SUBUNIT BINDING DOMAIN, AND INTERACTION WITH CACNB1.
RX   PubMed=7509046; DOI=10.1038/368067a0;
RA   Pragnell M., de Waard M., Mori Y., Tanabe T., Snutch T.P.,
RA   Campbell K.P.;
RT   "Calcium channel beta-subunit binds to a conserved motif in the I-II
RT   cytoplasmic linker of the alpha 1-subunit.";
RL   Nature 368:67-70(1994).
RN   [4]
RP   PHENYLALKYLAMINE-BINDING REGION.
RX   PubMed=2174553; DOI=10.1073/pnas.87.23.9108;
RA   Striessnig J., Glossmann H., Catterall W.A.;
RT   "Identification of a phenylalkylamine binding region within the alpha
RT   1 subunit of skeletal muscle Ca2+ channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:9108-9112(1990).
RN   [5]
RP   DIHYDROPYRIDINE-BINDING REGION.
RX   PubMed=1656465; DOI=10.1073/pnas.88.20.9203;
RA   Nakayama H., Taki M., Striessnig J., Glossmann H., Catterall W.A.,
RA   Kanaoka Y.;
RT   "Identification of 1,4-dihydropyridine binding regions within the
RT   alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity
RT   labeling with diazipine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9203-9207(1991).
RN   [6]
RP   DIHYDROPYRIDINE-BINDING REGION.
RX   PubMed=1660150; DOI=10.1073/pnas.88.23.10769;
RA   Striessnig J., Murphy B.J., Catterall W.A.;
RT   "Dihydropyridine receptor of L-type Ca2+ channels: identification of
RT   binding domains for [3H](+)-PN200-110 and [3H]azidopine within the
RT   alpha 1 subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10769-10773(1991).
RN   [7]
RP   PHOSPHORYLATION AT SER-687 AND SER-1617.
RX   PubMed=2844809;
RA   Roehrkasten A., Meyer H.E., Nastainczyk W., Sieber M., Hofmann F.;
RT   "CAMP-dependent protein kinase rapidly phosphorylates serine-687 of
RT   the skeletal muscle receptor for calcium channel blockers.";
RL   J. Biol. Chem. 263:15325-15329(1988).
RN   [8]
RP   PHOSPHORYLATION BY PKA.
RX   PubMed=2549550; DOI=10.1073/pnas.86.17.6816;
RA   Nunoki K., Florio V., Catterall W.A.;
RT   "Activation of purified calcium channels by stoichiometric protein
RT   phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:6816-6820(1989).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9465115;
RA   Grabner M., Dirksen R.T., Beam K.G.;
RT   "Tagging with green fluorescent protein reveals a distinct subcellular
RT   distribution of L-type and non-L-type Ca2+ channels expressed in
RT   dysgenic myotubes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:1903-1908(1998).
RN   [10]
RP   INTERACTION WITH RYR1, AND DOMAIN.
RX   PubMed=10388749; DOI=10.1016/S0006-3495(99)76881-5;
RA   Dulhunty A.F., Laver D.R., Gallant E.M., Casarotto M.G., Pace S.M.,
RA   Curtis S.;
RT   "Activation and inhibition of skeletal RyR channels by a part of the
RT   skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.";
RL   Biophys. J. 77:189-203(1999).
RN   [11]
RP   FUNCTION, MUTAGENESIS OF ARG-1086, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=15201141; DOI=10.1152/ajpcell.00173.2004;
RA   Weiss R.G., O'Connell K.M., Flucher B.E., Allen P.D., Grabner M.,
RA   Dirksen R.T.;
RT   "Functional analysis of the R1086H malignant hyperthermia mutation in
RT   the DHPR reveals an unexpected influence of the III-IV loop on
RT   skeletal muscle EC coupling.";
RL   Am. J. Physiol. 287:C1094-C1102(2004).
RN   [12]
RP   STRUCTURE BY NMR OF 671-690, AND DOMAIN.
RX   PubMed=10766780; DOI=10.1074/jbc.275.16.11631;
RA   Casarotto M.G., Gibson F., Pace S.M., Curtis S.M., Mulcair M.,
RA   Dulhunty A.F.;
RT   "A structural requirement for activation of skeletal ryanodine
RT   receptors by peptides of the dihydropyridine receptor II-III loop.";
RL   J. Biol. Chem. 275:11631-11637(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 34-415 IN COMPLEX WITH
RP   CACNB2, AND SUBUNIT.
RX   PubMed=15134636; DOI=10.1016/S0896-6273(04)00250-8;
RA   Opatowsky Y., Chen C.-C., Campbell K.P., Hirsch J.A.;
RT   "Structural analysis of the voltage-dependent calcium channel beta
RT   subunit functional core and its complex with the alpha1 interaction
RT   domain.";
RL   Neuron 42:387-399(2004).
RN   [14]
RP   STRUCTURE BY ELECTRON MICROSCOPY (15 ANGSTROMS), SUBUNIT, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND TOPOLOGY.
RC   TISSUE=Skeletal muscle {ECO:0000303|PubMed:25667046};
RX   PubMed=25667046; DOI=10.1038/srep08370;
RA   Hu H., Wang Z., Wei R., Fan G., Wang Q., Zhang K., Yin C.C.;
RT   "The molecular architecture of dihydropyrindine receptor/L-type Ca2+
RT   channel complex.";
RL   Sci. Rep. 5:8370-8370(2015).
RN   [15] {ECO:0000244|PDB:3JBR}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS) IN COMPLEX WITH
RP   CACNG1; CACNB2 AND CACNA2D1, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY,
RP   TISSUE SPECIFICITY, IDENTIFICATION BY MASS SPECTROMETRY, AND DOMAIN.
RC   TISSUE=Skeletal muscle {ECO:0000303|PubMed:26680202};
RX   PubMed=26680202; DOI=10.1126/science.aad2395;
RA   Wu J., Yan Z., Li Z., Yan C., Lu S., Dong M., Yan N.;
RT   "Structure of the voltage-gated calcium channel Cav1.1 complex.";
RL   Science 350:2395-2395(2015).
RN   [16] {ECO:0000244|PDB:5GJV, ECO:0000244|PDB:5GJW}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) IN COMPLEX WITH
RP   CALCIUM; CACNB1; CACNG1 AND CACNA2D1, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, TISSUE SPECIFICITY, IDENTIFICATION BY MASS SPECTROMETRY,
RP   DOMAIN, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-257.
RC   TISSUE=Skeletal muscle {ECO:0000303|PubMed:27580036};
RX   PubMed=27580036; DOI=10.1038/nature19321;
RA   Wu J., Yan Z., Li Z., Qian X., Lu S., Dong M., Zhou Q., Yan N.;
RT   "Structure of the voltage-gated calcium channel Cav1.1 at 3.6A
RT   resolution.";
RL   Nature 537:191-196(2016).
CC   -!- FUNCTION: Pore-forming, alpha-1S subunit of the voltage-gated
CC       calcium channel that gives rise to L-type calcium currents in
CC       skeletal muscle (PubMed:9465115, PubMed:15201141). Calcium
CC       channels containing the alpha-1S subunit play an important role in
CC       excitation-contraction coupling in skeletal muscle via their
CC       interaction with RYR1, which triggers Ca(2+) release from the
CC       sarcplasmic reticulum and ultimately results in muscle contraction
CC       (PubMed:9465115 PubMed:15201141). Long-lasting (L-type) calcium
CC       channels belong to the 'high-voltage activated' (HVA) group.
CC       {ECO:0000269|PubMed:15201141, ECO:0000269|PubMed:9465115,
CC       ECO:0000305}.
CC   -!- ENZYME REGULATION: Channel activity is blocked by dihydropyridines
CC       (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-
CC       IIIA (omega-Aga-IIIA). It is however insensitive to omega-
CC       conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-
CC       IVA). {ECO:0000305|PubMed:1656465, ECO:0000305|PubMed:1660150,
CC       ECO:0000305|PubMed:2174553, ECO:0000305|PubMed:3037387}.
CC   -!- SUBUNIT: Component of a calcium channel complex consisting of a
CC       pore-forming alpha subunit (CACNA1S) and the ancillary subunits
CC       CACNB1 or CACNB2, CACNG1 and CACNA2D1 (PubMed:3037387,
CC       PubMed:15134636, PubMed:25667046, PubMed:26680202,
CC       PubMed:27580036). The channel complex contains alpha, beta, gamma
CC       and delta subunits in a 1:1:1:1 ratio, i.e. it contains either
CC       CACNB1 or CACNB2 (PubMed:15134636, PubMed:25667046,
CC       PubMed:26680202, PubMed:27580036). CACNA1S channel activity is
CC       modulated by the auxiliary subunits (CACNB1 or CACNB2, CACNG1 and
CC       CACNA2D1). Interacts with DYSF and JSRP1 (By similarity).
CC       Interacts with RYR1 (PubMed:10388749). Interacts with CALM (By
CC       similarity). {ECO:0000250|UniProtKB:Q02789,
CC       ECO:0000250|UniProtKB:Q13698, ECO:0000269|PubMed:10388749,
CC       ECO:0000269|PubMed:15134636, ECO:0000269|PubMed:25667046,
CC       ECO:0000269|PubMed:26680202, ECO:0000269|PubMed:27580036,
CC       ECO:0000269|PubMed:3037387}.
CC   -!- INTERACTION:
CC       P13806:CACNA2D1; NbExp=3; IntAct=EBI-8613624, EBI-9683767;
CC       P19517:CACNB1; NbExp=4; IntAct=EBI-8613624, EBI-978604;
CC       P19518:CACNG1; NbExp=3; IntAct=EBI-8613624, EBI-9683808;
CC       Q96RG2:PASK (xeno); NbExp=2; IntAct=EBI-8613624, EBI-1042651;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:15201141, ECO:0000269|PubMed:25667046,
CC       ECO:0000269|PubMed:26680202, ECO:0000269|PubMed:27580036,
CC       ECO:0000269|PubMed:9465115, ECO:0000305|PubMed:3037387}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:25667046,
CC       ECO:0000269|PubMed:26680202, ECO:0000269|PubMed:27580036,
CC       ECO:0000305|PubMed:3037387}. Note=Detected on T-tubules
CC       (extensions of the sarcolemma). {ECO:0000269|PubMed:25667046}.
CC   -!- TISSUE SPECIFICITY: Detected in skeletal muscle T-tubules (at
CC       protein level). {ECO:0000269|PubMed:25667046,
CC       ECO:0000269|PubMed:26680202, ECO:0000269|PubMed:27580036,
CC       ECO:0000269|PubMed:3037387}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC       {ECO:0000269|PubMed:26680202, ECO:0000269|PubMed:27580036}.
CC   -!- DOMAIN: The loop between repeats II and III interacts with the
CC       ryanodine receptor, and is therefore important for calcium release
CC       from the endoplasmic reticulum necessary for muscle contraction.
CC       {ECO:0000305|PubMed:10388749, ECO:0000305|PubMed:10766780,
CC       ECO:0000305|PubMed:15201141}.
CC   -!- PTM: The alpha-1S subunit is found in two isoforms in the skeletal
CC       muscle: a minor form of 212 kDa containing the complete amino acid
CC       sequence, and a major form of 190 kDa derived from the full-length
CC       form by post-translational proteolysis close to Phe-1690.
CC       {ECO:0000305|PubMed:3037387}.
CC   -!- PTM: Both the minor and major forms are phosphorylated in vitro by
CC       PKA. Phosphorylation by PKA activates the calcium channel.
CC       {ECO:0000269|PubMed:2549550, ECO:0000269|PubMed:2844809}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1S subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X05921; CAA29355.1; -; mRNA.
DR   EMBL; M23919; AAA31159.1; -; mRNA.
DR   PIR; A30063; A30063.
DR   RefSeq; NP_001095190.1; NM_001101720.1.
DR   UniGene; Ocu.1826; -.
DR   PDB; 1DU1; NMR; -; A=671-690.
DR   PDB; 1JZP; NMR; -; A=671-690.
DR   PDB; 1T3L; X-ray; 2.20 A; B=357-374.
DR   PDB; 3JBR; EM; 4.20 A; A=1-1873.
DR   PDB; 5GJV; EM; 3.60 A; A=1-1873.
DR   PDB; 5GJW; EM; 3.90 A; A=1-1873.
DR   PDBsum; 1DU1; -.
DR   PDBsum; 1JZP; -.
DR   PDBsum; 1T3L; -.
DR   PDBsum; 3JBR; -.
DR   PDBsum; 5GJV; -.
DR   PDBsum; 5GJW; -.
DR   DisProt; DP00228; -.
DR   ProteinModelPortal; P07293; -.
DR   SMR; P07293; -.
DR   DIP; DIP-61879N; -.
DR   IntAct; P07293; 4.
DR   MINT; MINT-8146707; -.
DR   ChEMBL; CHEMBL4169; -.
DR   TCDB; 1.A.1.11.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P07293; -.
DR   SwissPalm; P07293; -.
DR   PRIDE; P07293; -.
DR   GeneID; 100009585; -.
DR   KEGG; ocu:100009585; -.
DR   CTD; 779; -.
DR   HOGENOM; HOG000231529; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; P07293; -.
DR   KO; K04857; -.
DR   EvolutionaryTrace; P07293; -.
DR   PRO; PR:P07293; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0044325; F:ion channel binding; IPI:CAFA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:UniProtKB.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IMP:CAFA.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005450; VDCC_L_a1ssu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF190; PTHR10037:SF190; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01634; LVDCCALPHA1S.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1   1873       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1S.
FT                                /FTId=PRO_0000053945.
FT   TOPO_DOM      1     51       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM     52     70       Helical; Name=S1 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM     71     85       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM     86    106       Helical; Name=S2 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    107    115       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    116    136       Helical; Name=S3 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    137    160       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    161    179       Helical; Name=S4 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    180    196       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    197    218       Helical; Name=S5 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    219    279       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   INTRAMEM    280    301       Pore-forming.
FT                                {ECO:0000269|PubMed:26680202,
FT                                ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    302    309       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    310    330       Helical; Name=S6 of repeat I.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    331    432       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    433    451       Helical; Name=S1 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    452    462       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    463    483       Helical; Name=S2 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    484    494       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    495    514       Helical; Name=S3 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    515    523       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    524    542       Helical; Name=S4 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    543    561       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    562    581       Helical; Name=S5 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    582    601       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   INTRAMEM    602    623       Pore-forming.
FT                                {ECO:0000269|PubMed:26680202,
FT                                ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    624    633       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    634    653       Helical; Name=S6 of repeat II.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    654    799       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    800    818       Helical; Name=S1 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    819    830       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    831    850       Helical; Name=S2 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    851    866       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    867    885       Helical; Name=S3 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    886    892       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    893    911       Helical; Name=S4 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    912    930       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM    931    950       Helical; Name=S5 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM    951   1000       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   INTRAMEM   1001   1021       Pore-forming.
FT                                {ECO:0000269|PubMed:26680202,
FT                                ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1022   1038       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1039   1060       Helical; Name=S6 of repeat III.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1061   1118       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1119   1140       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1141   1148       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1149   1170       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1171   1180       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1181   1200       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1201   1231       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1232   1250       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1251   1268       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1269   1289       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1290   1311       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   INTRAMEM   1312   1330       Pore-forming.
FT                                {ECO:0000269|PubMed:26680202,
FT                                ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1331   1356       Extracellular.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TRANSMEM   1357   1381       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000269|PubMed:27580036}.
FT   TOPO_DOM   1382   1873       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27580036}.
FT   REPEAT       38    337       I. {ECO:0000305}.
FT   REPEAT      418    664       II. {ECO:0000305}.
FT   REPEAT      786   1068       III. {ECO:0000305}.
FT   REPEAT     1105   1384       IV. {ECO:0000305}.
FT   CA_BIND    1410   1421       {ECO:0000250}.
FT   REGION      357    374       Binding to the beta subunit.
FT                                {ECO:0000269|PubMed:27580036}.
FT   REGION      988   1077       Dihydropyridine binding.
FT                                {ECO:0000269|PubMed:1656465,
FT                                ECO:0000269|PubMed:1660150}.
FT   REGION     1337   1403       Dihydropyridine binding.
FT                                {ECO:0000269|PubMed:1656465}.
FT   REGION     1349   1391       Phenylalkylamine binding.
FT                                {ECO:0000269|PubMed:2174553}.
FT   REGION     1522   1542       Interaction with calmodulin.
FT                                {ECO:0000250|UniProtKB:Q13698}.
FT   MOTIF       290    293       Selectivity filter of repeat I.
FT                                {ECO:0000305|PubMed:26680202,
FT                                ECO:0000305|PubMed:27580036}.
FT   MOTIF       612    615       Selectivity filter of repeat II.
FT                                {ECO:0000305|PubMed:26680202,
FT                                ECO:0000305|PubMed:27580036}.
FT   MOTIF      1012   1015       Selectivity filter of repeat III.
FT                                {ECO:0000305|PubMed:26680202,
FT                                ECO:0000305|PubMed:27580036}.
FT   MOTIF      1321   1324       Selectivity filter of repeat IV.
FT                                {ECO:0000305|PubMed:26680202,
FT                                ECO:0000305|PubMed:27580036}.
FT   COMPBIAS    562    568       Poly-Leu.
FT   METAL       292    292       Calcium. {ECO:0000244|PDB:5GJW,
FT                                ECO:0000269|PubMed:27580036}.
FT   METAL       614    614       Calcium. {ECO:0000244|PDB:5GJV,
FT                                ECO:0000269|PubMed:27580036}.
FT   METAL      1014   1014       Calcium. {ECO:0000244|PDB:5GJV,
FT                                ECO:0000269|PubMed:27580036}.
FT   SITE       1690   1691       Cleavage. {ECO:0000305}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02789}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02789}.
FT   MOD_RES     687    687       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:2844809}.
FT   MOD_RES    1392   1392       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1575   1575       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02485}.
FT   MOD_RES    1579   1579       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q02485}.
FT   MOD_RES    1617   1617       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:2844809}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5GJV}.
FT   DISULFID    226    254       {ECO:0000244|PDB:5GJV,
FT                                ECO:0000244|PDB:5GJW,
FT                                ECO:0000269|PubMed:27580036}.
FT   DISULFID    245    261       {ECO:0000244|PDB:5GJV,
FT                                ECO:0000244|PDB:5GJW,
FT                                ECO:0000269|PubMed:27580036}.
FT   DISULFID    957    968       {ECO:0000244|PDB:5GJV,
FT                                ECO:0000244|PDB:5GJW,
FT                                ECO:0000269|PubMed:27580036}.
FT   DISULFID   1338   1352       {ECO:0000244|PDB:5GJV,
FT                                ECO:0000244|PDB:5GJW,
FT                                ECO:0000269|PubMed:27580036}.
FT   VARIANT     165    165       R -> K.
FT   VARIANT     258    258       G -> D.
FT   VARIANT    1870   1870       P -> L.
FT   MUTAGEN    1086   1086       R->H: Shifts the threshold potential to
FT                                more negative values and lowers the
FT                                concentration threshold for channel
FT                                activation by caffeine.
FT                                {ECO:0000269|PubMed:15201141}.
FT   CONFLICT    694    694       T -> R (in Ref. 2; AAA31159).
FT                                {ECO:0000305}.
FT   CONFLICT   1808   1808       T -> M (in Ref. 2; AAA31159).
FT                                {ECO:0000305}.
FT   CONFLICT   1815   1815       A -> V (in Ref. 2; AAA31159).
FT                                {ECO:0000305}.
FT   CONFLICT   1835   1835       A -> E (in Ref. 2; AAA31159).
FT                                {ECO:0000305}.
FT   HELIX       359    372       {ECO:0000244|PDB:1T3L}.
FT   HELIX       672    677       {ECO:0000244|PDB:1DU1}.
FT   TURN        678    681       {ECO:0000244|PDB:1DU1}.
SQ   SEQUENCE   1873 AA;  212029 MW;  047B10D1946B0796 CRC64;
     MEPSSPQDEG LRKKQPKKPL PEVLPRPPRA LFCLTLQNPL RKACISIVEW KPFETIILLT
     IFANCVALAV YLPMPEDDNN SLNLGLEKLE YFFLTVFSIE AAMKIIAYGF LFHQDAYLRS
     GWNVLDFIIV FLGVFTAILE QVNVIQSNTA PMSSKGAGLD VKALRAFRVL RPLRLVSGVP
     SLQVVLNSIF KAMLPLFHIA LLVLFMVIIY AIIGLELFKG KMHKTCYYIG TDIVATVENE
     KPSPCARTGS GRPCTINGSE CRGGWPGPNH GITHFDNFGF SMLTVYQCIT MEGWTDVLYW
     VNDAIGNEWP WIYFVTLILL GSFFILNLVL GVLSGEFTKE REKAKSRGTF QKLREKQQLE
     EDLRGYMSWI TQGEVMDVED LREGKLSLEE GGSDTESLYE IEGLNKIIQF IRHWRQWNRV
     FRWKCHDLVK SRVFYWLVIL IVALNTLSIA SEHHNQPLWL THLQDIANRV LLSLFTIEML
     LKMYGLGLRQ YFMSIFNRFD CFVVCSGILE LLLVESGAMT PLGISVLRCI RLLRLFKITK
     YWTSLSNLVA SLLNSIRSIA SLLLLLFLFI IIFALLGMQL FGGRYDFEDT EVRRSNFDNF
     PQALISVFQV LTGEDWNSVM YNGIMAYGGP SYPGVLVCIY FIILFVCGNY ILLNVFLAIA
     VDNLAEAESL TSAQKAKAEE RKRRKMSRGL PDKTEEEKSV MAKKLEQKPK GEGIPTTAKL
     KVDEFESNVN EVKDPYPSAD FPGDDEEDEP EIPVSPRPRP LAELQLKEKA VPIPEASSFF
     IFSPTNKVRV LCHRIVNATW FTNFILLFIL LSSAALAAED PIRAESVRNQ ILGYFDIAFT
     SVFTVEIVLK MTTYGAFLHK GSFCRNYFNI LDLLVVAVSL ISMGLESSTI SVVKILRVLR
     VLRPLRAINR AKGLKHVVQC VFVAIRTIGN IVLVTTLLQF MFACIGVQLF KGKFFSCNDL
     SKMTEEECRG YYYVYKDGDP TQMELRPRQW IHNDFHFDNV LSAMMSLFTV STFEGWPQLL
     YRAIDSNEED MGPVYNNRVE MAIFFIIYII LIAFFMMNIF VGFVIVTFQE QGETEYKNCE
     LDKNQRQCVQ YALKARPLRC YIPKNPYQYQ VWYVVTSSYF EYLMFALIML NTICLGMQHY
     HQSEEMNHIS DILNVAFTII FTLEMILKLL AFKARGYFGD PWNVFDFLIV IGSIIDVILS
     EIDTFLASSG GLYCLGGGCG NVDPDESARI SSAFFRLFRV MRLIKLLSRA EGVRTLLWTF
     IKSFQALPYV ALLIVMLFFI YAVIGMQMFG KIALVDGTQI NRNNNFQTFP QAVLLLFRCA
     TGEAWQEILL ACSYGKLCDP ESDYAPGEEY TCGTNFAYYY FISFYMLCAF LIINLFVAVI
     MDNFDYLTRD WSILGPHHLD EFKAIWAEYD PEAKGRIKHL DVVTLLRRIQ PPLGFGKFCP
     HRVACKRLVG MNMPLNSDGT VTFNATLFAL VRTALKIKTE GNFEQANEEL RAIIKKIWKR
     TSMKLLDQVI PPIGDDEVTV GKFYATFLIQ EHFRKFMKRQ EEYYGYRPKK DTVQIQAGLR
     TIEEEAAPEI RRTISGDLTA EEELERAMVE AAMEERIFRR TGGLFGQVDT FLERTNSLPP
     VMANQRPLQF AEIEMEELES PVFLEDFPQD ARTNPLARAN TNNANANVAY GNSNHSNNQM
     FSSVHCEREF PGEAETPAAG RGALSHSHRA LGPHSKPCAG KLNGQLVQPG MPINQAPPAP
     CQQPSTDPPE RGQRRTSLTG SLQDEAPQRR SSEGSTPRRP APATALLIQE ALVRGGLDTL
     AADAGFVTAT SQALADACQM EPEEVEVAAT ELLKARESVQ GMASVPGSLS RRSSLGSLDQ
     VQGSQETLIP PRP
//
ID   TRP_DROME               Reviewed;        1275 AA.
AC   P19334; Q7YU76; Q9VAE1;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 3.
DT   22-NOV-2017, entry version 171.
DE   RecName: Full=Transient receptor potential protein;
GN   Name=trp; ORFNames=CG7875;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Oregon-R;
RX   PubMed=2516726; DOI=10.1016/0896-6273(89)90069-X;
RA   Montell C., Rubin G.M.;
RT   "Molecular characterization of the Drosophila trp locus: a putative
RT   integral membrane protein required for phototransduction.";
RL   Neuron 2:1313-1323(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=2482778; DOI=10.1016/0896-6273(89)90117-7;
RA   Wong F., Schaefer E.L., Roop B.C., Lamendola J.N., Johnson-Seaton D.,
RA   Shao D.;
RT   "Proper function of the Drosophila trp gene product during pupal
RT   development is important for normal visual transduction in the
RT   adult.";
RL   Neuron 3:81-94(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E.,
RA   George R.A., Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G.,
RA   Miranda A., Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S.,
RA   Patel S., Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M.,
RA   Celniker S.E.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1126-1275.
RX   PubMed=3118483; DOI=10.1007/BF01534486;
RA   Wong F., Yuh Z.T., Schaefer E.L., Roop B.C., Ally A.H.;
RT   "Overlapping transcription units in the transient receptor potential
RT   locus of Drosophila melanogaster.";
RL   Somat. Cell Mol. Genet. 13:661-669(1987).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7751943;
RA   Pollock J.A., Assaf A., Peretz A., Nichols C.D., Mojet M.H.,
RA   Hardie R.C., Minke B.;
RT   "TRP, a protein essential for inositide-mediated Ca2+ influx is
RT   localized adjacent to the calcium stores in Drosophila
RT   photoreceptors.";
RL   J. Neurosci. 15:3747-3760(1995).
RN   [8]
RP   HOMOMULTIMERIZATION, AND INTERACTION WITH TRPL.
RX   PubMed=9215637; DOI=10.1016/S0092-8674(00)80302-5;
RA   Xu X.-Z.S., Li H.-S., Guggino W.B., Montell C.;
RT   "Coassembly of TRP and TRPL produces a distinct store-operated
RT   conductance.";
RL   Cell 89:1155-1164(1997).
RN   [9]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH INAD;
RP   NORPA; RHODOPSIN AND CALMODULIN.
RX   PubMed=9010208; DOI=10.1016/S0896-6273(01)80049-0;
RA   Chevesich J., Kreuz A.J., Montell C.;
RT   "Requirement for the PDZ domain protein, INAD, for localization of the
RT   TRP store-operated channel to a signaling complex.";
RL   Neuron 18:95-105(1997).
RN   [10]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10366618;
RA   Stortkuhl K.F., Hovemann B.T., Carlson J.R.;
RT   "Olfactory adaptation depends on the Trp Ca2+ channel in Drosophila.";
RL   J. Neurosci. 19:4839-4846(1999).
RN   [11]
RP   FUNCTION.
RX   PubMed=9930700; DOI=10.1038/16703;
RA   Chyb S., Raghu P., Hardie R.C.;
RT   "Polyunsaturated fatty acids activate the Drosophila light-sensitive
RT   channels TRP and TRPL.";
RL   Nature 397:255-259(1999).
RN   [12]
RP   PHOSPHORYLATION.
RX   PubMed=10766855; DOI=10.1074/jbc.275.16.12194;
RA   Liu M., Parker L.L., Wadzinski B.E., Shieh B.-H.;
RT   "Reversible phosphorylation of the signal transduction complex in
RT   Drosophila photoreceptors.";
RL   J. Biol. Chem. 275:12194-12199(2000).
RN   [13]
RP   INTERACTION WITH INAD, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF VAL-1266.
RX   PubMed=10995445; DOI=10.1083/jcb.150.6.1411;
RA   Li H.-S., Montell C.;
RT   "TRP and the PDZ protein, INAD, form the core complex required for
RT   retention of the signalplex in Drosophila photoreceptor cells.";
RL   J. Cell Biol. 150:1411-1422(2000).
RN   [14]
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF PRO-500; HIS-531; PHE-550 AND
RP   SER-867.
RX   PubMed=10632594;
RA   Yoon J., Ben-Ami H.C., Hong Y.S., Park S., Strong L.L.R., Bowman J.D.,
RA   Geng C., Baek K., Minke B., Pak W.L.;
RT   "Novel mechanism of massive photoreceptor degeneration caused by
RT   mutations in the trp gene of Drosophila.";
RL   J. Neurosci. 20:649-659(2000).
RN   [15]
RP   FUNCTION.
RX   PubMed=10908615;
RA   Agam K., von Campenhausen M., Levy S., Ben-Ami H.C., Cook B.,
RA   Kirschfeld K., Minke B.;
RT   "Metabolic stress reversibly activates the Drosophila light-sensitive
RT   channels TRP and TRPL in vivo.";
RL   J. Neurosci. 20:5748-5755(2000).
RN   [16]
RP   INTERACTION WITH TRPGAMMA.
RX   PubMed=10896160; DOI=10.1016/S0896-6273(00)81201-5;
RA   Xu X.-Z.S., Chien F., Butler A., Salkoff L., Montell C.;
RT   "TRPgamma, a Drosophila TRP-related subunit, forms a regulated cation
RT   channel with TRPL.";
RL   Neuron 26:647-657(2000).
RN   [17]
RP   MUTAGENESIS OF PRO-500; HIS-531; PHE-550 AND SER-867.
RX   PubMed=12107168; DOI=10.1074/jbc.M204075200;
RA   Hong Y.S., Park S., Geng C., Baek K., Bowman J.D., Yoon J., Pak W.L.;
RT   "Single amino acid change in the fifth transmembrane segment of the
RT   TRP Ca2+ channel causes massive degeneration of photoreceptors.";
RL   J. Biol. Chem. 277:33884-33889(2002).
RN   [18]
RP   REVIEW.
RX   PubMed=11707492;
RA   Hardie R.C.;
RT   "Phototransduction in Drosophila melanogaster.";
RL   J. Exp. Biol. 204:3403-3409(2001).
CC   -!- FUNCTION: A light-sensitive calcium channel that is required for
CC       inositide-mediated Ca(2+) entry in the retina during phospholipase
CC       C (PLC)-mediated phototransduction. Ca(2+) influx may then feed
CC       back and inhibit PLC, thereby facilitating phosphatidylinositol
CC       4,5 bisphosphate (PIP2) recycling. Trp and trpl act together in
CC       the light response, though it is unclear whether as
CC       heteromultimers or as distinct units, and are activated by fatty
CC       acids and metabolic stress. Also required for olfactory adaptation
CC       and may be involved in olfactory system development.
CC       {ECO:0000269|PubMed:10366618, ECO:0000269|PubMed:10908615,
CC       ECO:0000269|PubMed:2482778, ECO:0000269|PubMed:2516726,
CC       ECO:0000269|PubMed:9930700}.
CC   -!- SUBUNIT: The C-terminus interacts with a PDZ domain of inaD to
CC       form the core of the inaD signaling complex. Other members of the
CC       complex include norpA (PLC), inaC (PKC), and possibly trpl, ninaC,
CC       FKBP59, calmodulin and rhodopsin. Forms homomultimers and
CC       heteromultimers with trpl. Interaction with trpl is mediated in
CC       part by the N-terminal region and the transmembrane domains. Also
CC       interacts, though to a lower extent, with Trpgamma.
CC       {ECO:0000269|PubMed:10896160, ECO:0000269|PubMed:10995445,
CC       ECO:0000269|PubMed:9010208, ECO:0000269|PubMed:9215637}.
CC   -!- INTERACTION:
CC       Q24008:inaD; NbExp=10; IntAct=EBI-165136, EBI-195326;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:10995445,
CC       ECO:0000305|PubMed:2516726, ECO:0000305|PubMed:7751943,
CC       ECO:0000305|PubMed:9010208}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:10995445, ECO:0000305|PubMed:2516726,
CC       ECO:0000305|PubMed:7751943, ECO:0000305|PubMed:9010208}.
CC       Note=Localized on plasma membrane loops found at the base of the
CC       rhabdomere, in close proximity to the calcium stores.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the rhabdomeres of
CC       photoreceptor cells. Expressed in the third antennal segment and
CC       in the olfactory segment at approximately 70 hours after puparium
CC       formation during antennal development.
CC       {ECO:0000269|PubMed:10366618, ECO:0000269|PubMed:10632594,
CC       ECO:0000269|PubMed:10995445, ECO:0000269|PubMed:2516726}.
CC   -!- PTM: Phosphorylated by inaC. {ECO:0000269|PubMed:10766855}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ22416.1; Type=Frameshift; Positions=721; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34394; AAA28976.1; -; Genomic_DNA.
DR   EMBL; M21306; AAA56928.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAF56970.1; -; Genomic_DNA.
DR   EMBL; BT009947; AAQ22416.1; ALT_FRAME; mRNA.
DR   EMBL; M18634; AAA28977.1; -; Genomic_DNA.
DR   PIR; JN0015; JN0015.
DR   PIR; JU0092; JU0092.
DR   RefSeq; NP_476768.1; NM_057420.4.
DR   UniGene; Dm.21694; -.
DR   PDB; 5F67; X-ray; 1.76 A; C/D=1259-1275.
DR   PDBsum; 5F67; -.
DR   ProteinModelPortal; P19334; -.
DR   SMR; P19334; -.
DR   BioGrid; 68399; 25.
DR   IntAct; P19334; 4.
DR   STRING; 7227.FBpp0084879; -.
DR   TCDB; 1.A.4.1.1; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   PaxDb; P19334; -.
DR   PRIDE; P19334; -.
DR   EnsemblMetazoa; FBtr0085513; FBpp0084879; FBgn0003861.
DR   GeneID; 43542; -.
DR   KEGG; dme:Dmel_CG7875; -.
DR   CTD; 43542; -.
DR   FlyBase; FBgn0003861; trp.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   InParanoid; P19334; -.
DR   KO; K04967; -.
DR   OMA; GRMISGW; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; P19334; -.
DR   Reactome; R-DME-3295583; TRP channels.
DR   Reactome; R-DME-5578775; Ion homeostasis.
DR   Reactome; R-DME-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P19334; -.
DR   ChiTaRS; trp; fly.
DR   GenomeRNAi; 43542; -.
DR   PRO; PR:P19334; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0003861; -.
DR   ExpressionAtlas; P19334; differential.
DR   Genevisible; P19334; DM.
DR   GO; GO:0034703; C:cation channel complex; IPI:FlyBase.
DR   GO; GO:0016027; C:inaD signaling complex; IPI:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016028; C:rhabdomere; IDA:UniProtKB.
DR   GO; GO:0035997; C:rhabdomere microvillus membrane; IDA:FlyBase.
DR   GO; GO:0005262; F:calcium channel activity; IDA:FlyBase.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:FlyBase.
DR   GO; GO:0010461; F:light-activated ion channel activity; IDA:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:FlyBase.
DR   GO; GO:0006816; P:calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0071454; P:cellular response to anoxia; IGI:FlyBase.
DR   GO; GO:0050962; P:detection of light stimulus involved in sensory perception; IMP:FlyBase.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:FlyBase.
DR   GO; GO:0008377; P:light-induced release of internally sequestered calcium ion; IDA:FlyBase.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:FlyBase.
DR   GO; GO:0008355; P:olfactory learning; IMP:UniProtKB.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IMP:FlyBase.
DR   GO; GO:0007602; P:phototransduction; IMP:FlyBase.
DR   GO; GO:0007603; P:phototransduction, visible light; IMP:FlyBase.
DR   GO; GO:0008104; P:protein localization; IMP:UniProtKB.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0009416; P:response to light stimulus; IMP:UniProtKB.
DR   GO; GO:0001895; P:retina homeostasis; IMP:FlyBase.
DR   GO; GO:0046154; P:rhodopsin metabolic process; IMP:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:FlyBase.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Olfaction; Reference proteome; Repeat;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1   1275       Transient receptor potential protein.
FT                                /FTId=PRO_0000215357.
FT   TOPO_DOM      1    366       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    367    387       Helical. {ECO:0000255}.
FT   TOPO_DOM    388    418       Extracellular. {ECO:0000255}.
FT   TRANSMEM    419    439       Helical. {ECO:0000255}.
FT   TOPO_DOM    440    450       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical. {ECO:0000255}.
FT   TOPO_DOM    472    541       Extracellular. {ECO:0000255}.
FT   TRANSMEM    542    562       Helical. {ECO:0000255}.
FT   TOPO_DOM    563    609       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    610    630       Helical. {ECO:0000255}.
FT   TOPO_DOM    631    637       Extracellular. {ECO:0000255}.
FT   TRANSMEM    638    658       Helical. {ECO:0000255}.
FT   TOPO_DOM    659   1275       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       69     98       ANK 1.
FT   REPEAT      143    172       ANK 2.
FT   COMPBIAS   1161   1236       Asp-rich.
FT   MUTAGEN     500    500       P->T: In P365; photoreceptors respond
FT                                normally to light.
FT                                {ECO:0000269|PubMed:10632594,
FT                                ECO:0000269|PubMed:12107168}.
FT   MUTAGEN     531    531       H->N: In P365; photoreceptors respond
FT                                normally to light.
FT                                {ECO:0000269|PubMed:10632594,
FT                                ECO:0000269|PubMed:12107168}.
FT   MUTAGEN     550    550       F->I: In P365; defective in the response
FT                                to light due to rapid degeneration of
FT                                photoreceptors.
FT                                {ECO:0000269|PubMed:10632594,
FT                                ECO:0000269|PubMed:12107168}.
FT   MUTAGEN     867    867       S->F: In P365; photoreceptors respond
FT                                normally to light.
FT                                {ECO:0000269|PubMed:10632594,
FT                                ECO:0000269|PubMed:12107168}.
FT   MUTAGEN    1266   1266       V->D: Does not disrupt inaD binding.
FT                                {ECO:0000269|PubMed:10995445}.
FT   CONFLICT    188    188       M -> T (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    222    222       A -> V (in Ref. 1; AAA28976).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       S -> T (in Ref. 5; AAQ22416).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       A -> T (in Ref. 5; AAQ22416).
FT                                {ECO:0000305}.
FT   CONFLICT    285    288       GQRQ -> ASSE (in Ref. 2; AAA56928).
FT                                {ECO:0000305}.
FT   CONFLICT    326    329       RRKQ -> PQE (in Ref. 2; AAA56928).
FT                                {ECO:0000305}.
FT   CONFLICT    365    374       KPFVKFITHS -> NPLSSSSRTP (in Ref. 2;
FT                                AAA56928). {ECO:0000305}.
FT   CONFLICT    785    785       N -> S (in Ref. 1; AAA28976).
FT                                {ECO:0000305}.
FT   CONFLICT   1008   1008       A -> P (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT   1197   1197       K -> R (in Ref. 5). {ECO:0000305}.
FT   STRAND     1262   1264       {ECO:0000244|PDB:5F67}.
FT   TURN       1265   1267       {ECO:0000244|PDB:5F67}.
SQ   SEQUENCE   1275 AA;  142594 MW;  4376C1B853868B4C CRC64;
     MGSNTESDAE KALGSRLDYD LMMAEEYILS DVEKNFILSC ERGDLPGVKK ILEEYQGTDK
     FNINCTDPMN RSALISAIEN ENFDLMVILL EHNIEVGDAL LHAISEEYVE AVEELLQWEE
     TNHKEGQPYS WEAVDRSKST FTVDITPLIL AAHRNNYEIL KILLDRGATL PMPHDVKCGC
     DECVTSQMTD SLRHSQSRIN AYRALSASSL IALSSRDPVL TAFQLSWELK RLQAMESEFR
     AEYTEMRQMV QDFGTSLLDH ARTSMELEVM LNFNHEPSHD IWCLGQRQTL ERLKLAIRYK
     QKTFVAHPNV QQLLAAIWYD GLPGFRRKQA SQQLMDVVKL GCSFPIYSLK YILAPDSEGA
     KFMRKPFVKF ITHSCSYMFF LMLLGAASLR VVQITFELLA FPWMLTMLED WRKHERGSLP
     GPIELAIITY IMALIFEELK SLYSDGLFEY IMDLWNIVDY ISNMFYVTWI LCRATAWVIV
     HRDLWFRGID PYFPREHWHP FDPMLLSEGA FAAGMVFSYL KLVHIFSINP HLGPLQVSLG
     RMIIDIIKFF FIYTLVLFAF GCGLNQLLWY YAELEKNKCY HLHPDVADFD DQEKACTIWR
     RFSNLFETSQ SLFWASFGLV DLVSFDLAGI KSFTRFWALL MFGSYSVINI IVLLNMLIAM
     MSNSYQIISE RADTEWKFAR SQLWMSYFED GGTIPPPFNL CPNMKMLRKT LGRKRPSRTK
     SFMRKSMERA QTLHDKVMKL LVRRYITAEQ RRRDDYGITE DDIIEVRQDI SSLRFELLEI
     FTNNNWDVPD IEKKSQGVAR TTKGKVMERR ILKDFQIGFV ENLKQEMSES ESGRDIFSSL
     AKVIGRKKTQ KGDKDWNAIA RKNTFASDPI GSKRSSMQRH SQRSLRRKII EQANEGLQMN
     QTQLIEFNPN LGDVTRATRV AYVKFMRKKM AADEVSLADD EGAPNGEGEK KPLDASGSKK
     SITSGGTGGG ASMLAAAALR ASVKNVDEKS GADGKPGTMG KPTDDKKAGD DKDKQQPPKD
     SKPSAGGPKP GDQKPTPGAG APKPQAAGTI SKPGESQKKD APAPPTKPGD TKPAAPKPGE
     SAKPEAAAKK EESSKTEASK PAATNGAAKS AAPSAPSDAK PDSKLKPGAA GAPEATKATN
     GASKPDEKKS GPEEPKKAAG DSKPGDDAKD KDKKPGDDKD KKPGDDKDKK PADNNDKKPA
     DDKDKKPGDD KDKKPGDDKD KKPSDDKDKK PADDKDKKPA AAPLKPAIKV GQSSAAAGGE
     RGKSTVTGRM ISGWL
//
ID   RYR1_HUMAN              Reviewed;        5038 AA.
AC   P21817; Q16314; Q16368; Q9NPK1; Q9P1U4;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 3.
DT   20-DEC-2017, entry version 207.
DE   RecName: Full=Ryanodine receptor 1;
DE            Short=RYR-1;
DE            Short=RyR1;
DE   AltName: Full=Skeletal muscle calcium release channel;
DE   AltName: Full=Skeletal muscle ryanodine receptor;
DE   AltName: Full=Skeletal muscle-type ryanodine receptor;
DE   AltName: Full=Type 1 ryanodine receptor;
GN   Name=RYR1; Synonyms=RYDR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Skeletal muscle;
RX   PubMed=2298749;
RA   Zorzato F., Fujii J., Otsu K., Phillips M.S., Green N.M., Lai F.A.,
RA   Meissner G., Maclennan D.H.;
RT   "Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+
RT   release channel (ryanodine receptor) of skeletal muscle sarcoplasmic
RT   reticulum.";
RL   J. Biol. Chem. 265:2244-2256(1990).
RN   [2]
RP   SEQUENCE REVISION TO 2324; 2840 AND 3380, INVOLVEMENT IN MHS1, VARIANT
RP   MHS1 ARG-248, AND VARIANTS CYS-471; LEU-1787; CYS-2060 AND VAL-2550.
RC   TISSUE=Muscle;
RX   PubMed=1354642; DOI=10.1016/0888-7543(92)90042-Q;
RA   Gillard E.F., Otsu K., Fujii J., Duff C.L., de Leon S., Khanna V.K.,
RA   Britt B.A., Worton R.G., McLennan D.H.;
RT   "Polymorphisms and deduced amino acid substitutions in the coding
RT   sequence of the ryanodine receptor (RYR1) gene in individuals with
RT   malignant hyperthermia.";
RL   Genomics 13:1247-1254(1992).
RN   [3]
RP   SEQUENCE REVISION TO 1365-1368, VARIANT CCD HIS-2435, AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Muscle;
RX   PubMed=8220422; DOI=10.1038/ng0993-46;
RA   Zhang Y., Chen H.S., Khanna V.K., de Leon S., Phillips M.S.,
RA   Schappert K.T., Britt B.A., Brownell A.K.W., McLennan D.H.;
RT   "A mutation in the human ryanodine receptor gene associated with
RT   central core disease.";
RL   Nat. Genet. 5:46-50(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   ALA-1832 AND VAL-2550.
RX   PubMed=8661021; DOI=10.1006/geno.1996.0238;
RA   Phillips M.S., Fujii J., Khanna V.K., de Leon S., Yokobata K.,
RA   de Jong P.J., McLennan D.H.;
RT   "The structural organization of the human skeletal muscle ryanodine
RT   receptor (RYR1) gene.";
RL   Genomics 34:24-41(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 598-722.
RC   TISSUE=Skeletal muscle;
RX   PubMed=1639409; DOI=10.1016/0888-7543(92)90163-M;
RA   Otsu K., Phillips M.S., Khanna V.K., de Leon S., McLennan D.H.;
RT   "Refinement of diagnostic assays for a probable causal mutation for
RT   porcine and human malignant hyperthermia.";
RL   Genomics 13:835-837(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 603-641, AND VARIANT MHS1
RP   CYS-614.
RX   PubMed=1774074; DOI=10.1016/0888-7543(91)90084-R;
RA   Gillard E.F., Otsu K., Fujii J., Khanna V.K., de Leon S.,
RA   Derdemezi J., Britt B.A., Duff C.L., Worton R.G., MacLennan D.H.;
RT   "A substitution of cysteine for arginine 614 in the ryanodine receptor
RT   is potentially causative of human malignant hyperthermia.";
RL   Genomics 11:751-755(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 603-627, AND VARIANT MHS1
RP   CYS-614.
RX   PubMed=7751854; DOI=10.1007/BF00936884;
RA   Moroni I., Gonano E.F., Comi G.P., Tegazzin V., Prelle A., Bordoni A.,
RA   Bresolin N., Scarlato G.;
RT   "Ryanodine receptor gene point mutation and malignant hyperthermia
RT   susceptibility.";
RL   J. Neurol. 242:127-133(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4696-4974, AND SUBCELLULAR LOCATION.
RC   TISSUE=Myometrium;
RX   PubMed=7556644; DOI=10.1016/0014-5793(95)00924-X;
RA   Lynn S., Morgan J.M., Lamb H.K., Meissner G., Gillespie J.I.;
RT   "Isolation and partial cloning of ryanodine-sensitive Ca2+ release
RT   channel protein isoforms from human myometrial smooth muscle.";
RL   FEBS Lett. 372:6-12(1995).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=9607712; DOI=10.1016/S0306-4522(97)00612-X;
RA   Martin C., Chapman K.E., Seckl J.R., Ashley R.H.;
RT   "Partial cloning and differential expression of ryanodine
RT   receptor/calcium-release channel genes in human tissues including the
RT   hippocampus and cerebellum.";
RL   Neuroscience 85:205-216(1998).
RN   [11]
RP   INTERACTION WITH CALM AND S100A1, AND ENZYME REGULATION.
RX   PubMed=18650434; DOI=10.1074/jbc.M804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [12]
RP   FUNCTION, PHOSPHORYLATION AT SER-2843, S-NITROSYLATION, AND
RP   IDENTIFICATION IN A COMPLEX WITH PDE4D; PKA; FKBP1A AND PROTEIN
RP   PHOSPHATASE 1.
RX   PubMed=18268335; DOI=10.1073/pnas.0711074105;
RA   Bellinger A.M., Reiken S., Dura M., Murphy P.W., Deng S.X.,
RA   Landry D.W., Nieman D., Lehnart S.E., Samaru M., LaCampagne A.,
RA   Marks A.R.;
RT   "Remodeling of ryanodine receptor complex causes 'leaky' channels: a
RT   molecular mechanism for decreased exercise capacity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2198-2202(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-4864 AND SER-4867, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   REVIEW.
RX   PubMed=20961976; DOI=10.1101/cshperspect.a003996;
RA   Lanner J.T., Georgiou D.K., Joshi A.D., Hamilton S.L.;
RT   "Ryanodine receptors: structure, expression, molecular details, and
RT   function in calcium release.";
RL   Cold Spring Harb. Perspect. Biol. 2:E3996-E3996(2010).
RN   [15]
RP   INVOLVEMENT IN SAMARITAN MYOPATHY, AND VARIANT CYS-1088.
RX   PubMed=22752422; DOI=10.1007/s00401-012-1007-3;
RA   Bohm J., Leshinsky-Silver E., Vassilopoulos S., Le Gras S.,
RA   Lerman-Sagie T., Ginzberg M., Jost B., Lev D., Laporte J.;
RT   "Samaritan myopathy, an ultimately benign congenital myopathy, is
RT   caused by a RYR1 mutation.";
RL   Acta Neuropathol. 124:575-581(2012).
RN   [16]
RP   VARIANTS CCD CYS-163 AND MET-403, AND VARIANTS MHS1 CYS-163 AND
RP   MET-403.
RX   PubMed=8220423; DOI=10.1038/ng0993-51;
RA   Quane K.A., Healy J.M.S., Keating K.E., Manning B.M., Couch F.J.,
RA   Palmucci L.M., Doriguzzi C., Fagerlund T.H., Berg K., Ording H.,
RA   Bendixen D., Mortier W., Linz U., Muller C.R., McCarthy T.V.;
RT   "Mutations in the ryanodine receptor gene in central core disease and
RT   malignant hyperthermia.";
RL   Nat. Genet. 5:51-55(1993).
RN   [17]
RP   VARIANT CCD SER-522.
RX   PubMed=7829078; DOI=10.1006/geno.1994.1483;
RA   Quane K.A., Keating K.E., Healy J.M.S., Manning B.M.,
RA   Krivosic-Horber R., Krivosic I., Monnier N., Lunardi J.,
RA   McCarthy T.V.;
RT   "Mutation screening of the RYR1 gene in malignant hyperthermia:
RT   detection of a novel Tyr to Ser mutation in a pedigree with associated
RT   central cores.";
RL   Genomics 23:236-239(1994).
RN   [18]
RP   VARIANT MHS1 ARG-341.
RX   PubMed=8012359; DOI=10.1093/hmg/3.3.471;
RA   Quane K.A., Keating K.E., Manning B.M., Healy J.M.S., Monsieurs K.,
RA   Heffron J.J.A., Lehane M., Heytens L., Krivosic-Horber R., Adnet P.,
RA   Ellis F.R., Monnier N., Lunardi J., McCarthy T.V.;
RT   "Detection of a novel common mutation in the ryanodine receptor gene
RT   in malignant hyperthermia: implications for diagnosis and
RT   heterogeneity studies.";
RL   Hum. Mol. Genet. 3:471-476(1994).
RN   [19]
RP   VARIANT MHS1 ARG-2434.
RX   PubMed=7849712; DOI=10.1093/hmg/3.10.1855;
RA   Keating K.E., Quane K.A., Manning B.M., Lehane M., Hartung E.,
RA   Censier K., Urwyler A., Klausnitzer M., Muller C.R., Heffron J.J.A.,
RA   McCarthy T.V.;
RT   "Detection of a novel RYR1 mutation in four malignant hyperthermia
RT   pedigrees.";
RL   Hum. Mol. Genet. 3:1855-1858(1994).
RN   [20]
RP   VARIANT MHS1 ARG-2434.
RX   PubMed=7881417; DOI=10.1093/hmg/3.12.2181;
RA   Phillips M.S., Khanna V.K., de Leon S., Frodis W., Britt B.A.,
RA   McLennan D.H.;
RT   "The substitution of Arg for Gly2433 in the human skeletal muscle
RT   ryanodine receptor is associated with malignant hyperthermia.";
RL   Hum. Mol. Genet. 3:2181-2186(1994).
RN   [21]
RP   VARIANT MHS1 ARG-35.
RX   PubMed=9066328; DOI=10.1097/00000542-199703000-00014;
RA   Lynch P.J., Krivosic-Horber R., Reyford H., Monnier N., Quane K.A.,
RA   Adnet P., Haudecoeur G., Krivosic I., McCarthy T.V., Lunardi J.;
RT   "Identification of heterozygous and homozygous individuals with the
RT   novel RYR1 mutation Cys35Arg in a large kindred.";
RL   Anesthesiology 86:620-626(1997).
RN   [22]
RP   VARIANT MHS1 LEU-614.
RX   PubMed=9389851; DOI=10.1093/bja/79.3.332;
RA   Quane K.A., Ording H., Keating K.E., Manning B.M., Heine R.,
RA   Bendixen D., Berg K., Krivosic-Horber R., Lehmann-Horn F.,
RA   Fagerlund T.H., McCarthy T.V.;
RT   "Detection of a novel mutation at amino acid position 614 in the
RT   ryanodine receptor in malignant hyperthermia.";
RL   Br. J. Anaesth. 79:332-337(1997).
RN   [23]
RP   VARIANT MHS1 TRP-552.
RX   PubMed=9138151; DOI=10.1136/jmg.34.4.291;
RA   Keating K.E., Giblin L., Lynch P.J., Quane K.A., Lehane M.,
RA   Heffron J.J.A., McCarthy T.V.;
RT   "Detection of a novel mutation in the ryanodine receptor gene in an
RT   Irish malignant hyperthermia pedigree: correlation of the IVCT
RT   response with the affected and unaffected haplotypes.";
RL   J. Med. Genet. 34:291-296(1997).
RN   [24]
RP   VARIANTS MHS1 CYS-2163; MET-2168 AND MET-2206, AND VARIANT CCD/MHS1
RP   HIS-2163.
RX   PubMed=9497245; DOI=10.1086/301748;
RA   Manning B.M., Quane K.A., Ording H., Urwyler A., Tegazzin V.,
RA   Lehane M., O'Halloran J., Hartung E., Giblin L.M., Lynch P.J.,
RA   Vaughan P., Censier K., Bendixen D., Comi G.P., Heytens L.,
RA   Monsieurs K., Fagerlund T.H., Wolz W., Heffron J.J.A., Mueller C.R.,
RA   McCarthy T.V.;
RT   "Identification of novel mutations in the ryanodine-receptor gene
RT   (RYR1) in malignant hyperthermia: genotype-phenotype correlation.";
RL   Am. J. Hum. Genet. 62:599-609(1998).
RN   [25]
RP   VARIANTS MHS1 CYS-2458 AND HIS-2458.
RX   PubMed=9450902;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.3.CO;2-H;
RA   Manning B.M., Quane K.A., Lynch P.J., Urwyler A., Tegazzin V.,
RA   Krivosic-Horber R., Censier K., Comi G.P., Adnet P., Wolz W.,
RA   Lunardi J., Muller C.R., McCarthy T.V.;
RT   "Novel mutations at a CpG dinucleotide in the ryanodine receptor in
RT   malignant hyperthermia.";
RL   Hum. Mutat. 11:45-50(1998).
RN   [26]
RP   VARIANTS MHS1.
RX   PubMed=10484775; DOI=10.1093/hmg/8.11.2055;
RA   Brandt A., Schleithoff L., Jurkat-Rott K., Klingler W., Baur C.,
RA   Lehmann-Horn F.;
RT   "Screening of the ryanodine receptor gene in 105 malignant
RT   hyperthermia families: novel mutations and concordance with the in
RT   vitro contracture test.";
RL   Hum. Mol. Genet. 8:2055-2062(1999).
RN   [27]
RP   VARIANTS MHS1 LEU-2435 AND HIS-2454.
RX   PubMed=10051009;
RA   Barone V., Massa O., Intravaia E., Bracco A., Di Martino A.,
RA   Tegazzin V., Cozzolino S., Sorrentino V.;
RT   "Mutation screening of the RYR1 gene and identification of two novel
RT   mutations in Italian malignant hyperthermia families.";
RL   J. Med. Genet. 36:115-118(1999).
RN   [28]
RP   VARIANT CCD THR-4898, AND CHARACTERIZATION OF VARIANT CCD THR-4898.
RX   PubMed=10097181; DOI=10.1073/pnas.96.7.4164;
RA   Lynch P.J., Tong J., Lehane M., Mallet A., Giblin L., Heffron J.J.A.,
RA   Vaughan P., Zafra G., MacLennan D.H., McCarthy T.V.;
RT   "A mutation in the transmembrane/luminal domain of the ryanodine
RT   receptor is associated with abnormal Ca(2+) release channel function
RT   and severe central core disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4164-4169(1999).
RN   [29]
RP   VARIANTS MHS1 TRP-2452 AND HIS-2454.
RX   PubMed=10823104; DOI=10.1093/oxfordjournals.bja.a013478;
RA   Chamley D., Pollock N.A., Stowell K.M., Brown R.L.;
RT   "Malignant hyperthermia in infancy and identification of novel RYR1
RT   mutation.";
RL   Br. J. Anaesth. 84:500-504(2000).
RN   [30]
RP   VARIANT MHS1 ILE-4826.
RX   PubMed=10888602; DOI=10.1093/hmg/9.10.1515;
RA   Brown R.L., Pollock A.N., Couchman K.G., Hodges M., Hutchinson D.O.,
RA   Waaka R., Lynch P., McCarthy T.V., Stowell K.M.;
RT   "A novel ryanodine receptor mutation and genotype-phenotype
RT   correlation in a large malignant hyperthermia New Zealand Maori
RT   pedigree.";
RL   Hum. Mol. Genet. 9:1515-1524(2000).
RN   [31]
RP   VARIANT MHS1 CYS-2454.
RX   PubMed=10612851;
RX   DOI=10.1002/(SICI)1098-1004(200001)15:1<122::AID-HUMU40>3.0.CO;2-A;
RA   Gencik M., Gencik A., Mortier W., Epplen J.T.;
RT   "Novel mutation in the RYR1 gene (R2454C) in a patient with malignant
RT   hyperthermia.";
RL   Hum. Mutat. 15:122-122(2000).
RN   [32]
RP   VARIANT CCD ALA-4637.
RX   PubMed=11113224; DOI=10.1212/WNL.55.11.1689;
RA   Scacheri P.C., Hoffman E.P., Fratkin J.D., Semino-Mora C., Senchak A.,
RA   Davis M.R., Laing N.G., Vedanarayanan V., Subramony S.H.;
RT   "A novel ryanodine receptor gene mutation causing both cores and rods
RT   in congenital myopathy.";
RL   Neurology 55:1689-1696(2000).
RN   [33]
RP   VARIANT MHS1 GLU-2347 DEL.
RX   PubMed=11389482; DOI=10.1086/321270;
RA   Sambuughin N., McWilliams S., de Bantel A., Sivakumar K., Nelson T.E.;
RT   "Single-amino-acid deletion in the RYR1 gene, associated with
RT   malignant hyperthermia susceptibility and unusual contraction
RT   phenotype.";
RL   Am. J. Hum. Genet. 69:204-208(2001).
RN   [34]
RP   VARIANTS MHS1 CYS-163; ARG-248; CYS-614; MET-2168; MET-2206; ILE-2214;
RP   THR-2367; ASN-2431; ARG-2434 AND HIS-2454.
RX   PubMed=11575529; DOI=10.1097/00000542-200109000-00009;
RA   Sambuughin N., Sei Y., Gallagher K.L., Wyre H.W., Madsen D.,
RA   Nelson T.E., Fletcher J.E., Rosenberg H., Muldoon S.M.;
RT   "North American malignant hyperthermia population: screening of the
RT   ryanodine receptor gene and identification of novel mutations.";
RL   Anesthesiology 95:594-599(2001).
RN   [35]
RP   VARIANTS CCD MET-2168; 4214-ARG--4216-PHE DEL; 4647-LEU-SER-4648 DEL;
RP   PRO-4793; CYS-4796; CYS-4825; PHE-4860 DEL; HIS-4861; TRP-4893;
RP   THR-4898; GLU-4899 AND GLY-4914.
RX   PubMed=11709545; DOI=10.1093/hmg/10.22.2581;
RA   Monnier N., Romero N.B., Lerale J., Landrieu P., Nivoche Y.,
RA   Fardeau M., Lunardi J.;
RT   "Familial and sporadic forms of central core disease are associated
RT   with mutations in the C-terminal domain of the skeletal muscle
RT   ryanodine receptor.";
RL   Hum. Mol. Genet. 10:2581-2592(2001).
RN   [36]
RP   VARIANTS CCD HIS-4861; ARG-4891; THR-4898; ARG-4899 AND VAL-4906,
RP   CHARACTERIZATION OF VARIANTS CCD MET-2168; HIS-4861; TRP-4893;
RP   THR-4898 AND ARG-4899, AND FUNCTION.
RX   PubMed=11741831; DOI=10.1093/hmg/10.25.2879;
RA   Tilgen N., Zorzato F., Halliger-Keller B., Muntoni F., Sewry C.,
RA   Palmucci L.M., Schneider C., Hauser E., Lehmann-Horn F., Mueller C.R.,
RA   Treves S.;
RT   "Identification of four novel mutations in the C-terminal membrane
RT   spanning domain of the ryanodine receptor 1: association with central
RT   core disease and alteration of calcium homeostasis.";
RL   Hum. Mol. Genet. 10:2879-2887(2001).
RN   [37]
RP   VARIANT MHS1 GLU-2129.
RX   PubMed=11241852; DOI=10.1002/humu.15;
RA   Rueffert H., Kraus H., Olthoff D., Deutrich C., Froster U.G.;
RT   "Identification of a novel mutation in the ryanodine receptor gene
RT   (RYR1) in patients with malignant hyperthermia.";
RL   Hum. Mutat. 17:238-238(2001).
RN   [38]
RP   VARIANT MHS1 THR-2350, AND CHARACTERIZATION OF VARIANT MHS1 THR-2350.
RX   PubMed=11525881; DOI=10.1016/S0960-8966(01)00202-4;
RA   Sambuughin N., Nelson T.E., Jankovic J., Xin C., Meissner G.,
RA   Mullakandov M., Ji J., Rosenberg H., Sivakumar K., Goldfarb L.G.;
RT   "Identification and functional characterization of a novel ryanodine
RT   receptor mutation causing malignant hyperthermia in North American and
RT   South American families.";
RL   Neuromuscul. Disord. 11:530-537(2001).
RN   [39]
RP   VARIANTS MHS1 CYS-163; ASN-166; ARG-341; HIS-401; CYS-614; GLU-2129;
RP   MET-2168; MET-2206; THR-2428; ARG-2434; HIS-2435; TRP-2452 AND
RP   HIS-2454.
RX   PubMed=12059893; DOI=10.1034/j.1399-6576.2002.460610.x;
RA   Rueffert H., Olthoff D., Deutrich C., Meinecke C.D., Froster U.G.;
RT   "Mutation screening in the ryanodine receptor 1 gene (RYR1) in
RT   patients susceptible to malignant hyperthermia who show definite IVCT
RT   results: identification of three novel mutations.";
RL   Acta Anaesthesiol. Scand. 46:692-698(2002).
RN   [40]
RP   VARIANTS MHS1 CYS-163; ARG-341; CYS-614; CYS-2454; MET-3916 AND
RP   LEU-4973.
RX   PubMed=12411788; DOI=10.1097/00000542-200211000-00007;
RA   Monnier N., Krivosic-Horber R., Payen J.-F., Kozak-Ribbens G.,
RA   Nivoche Y., Adnet P., Reyford H., Lunardi J.;
RT   "Presence of two different genetic traits in malignant hyperthermia
RT   families: implication for genetic analysis, diagnosis, and incidence
RT   of malignant hyperthermia susceptibility.";
RL   Anesthesiology 97:1067-1074(2002).
RN   [41]
RP   VARIANT CCD SER-3527.
RX   PubMed=12112081; DOI=10.1002/ana.10231;
RA   Ferreiro A., Monnier N., Romero N.B., Leroy J.-P., Boennemann C.,
RA   Haenggeli C.-A., Straub V., Voss W.D., Nivoche Y., Jungbluth H.,
RA   Lemainque A., Voit T., Lunardi J., Fardeau M., Guicheney P.;
RT   "A recessive form of central core disease, transiently presenting as
RT   multi-minicore disease, is associated with a homozygous mutation in
RT   the ryanodine receptor type 1 gene.";
RL   Ann. Neurol. 51:750-759(2002).
RN   [42]
RP   VARIANT MHS1 CYS-401.
RX   PubMed=12066726; DOI=10.1093/bja/88.4.508;
RA   Davis M., Brown R., Dickson A., Horton H., James D., Laing N.,
RA   Marston R., Norgate M., Perlman D., Pollock N., Stowell K.;
RT   "Malignant hyperthermia associated with exercise-induced
RT   rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation
RT   in New Zealand and Australian pedigrees.";
RL   Br. J. Anaesth. 88:508-515(2002).
RN   [43]
RP   VARIANTS MHS1 CYS-163; CYS-401; HIS-2163; MET-2206; ILE-2280;
RP   ARG-2434; LEU-2435; CYS-2458; SER-4136; LEU-4234; TRP-4737; VAL-4942
RP   AND LEU-4973.
RX   PubMed=12208234; DOI=10.1016/S0143-4160(02)00138-0;
RA   Galli L., Orrico A., Cozzolino S., Pietrini V., Tegazzin V.,
RA   Sorrentino V.;
RT   "Mutations in the RYR1 gene in Italian patients at risk for malignant
RT   hyperthermia: evidence for a cluster of novel mutations in the C-
RT   terminal region.";
RL   Cell Calcium 32:143-151(2002).
RN   [44]
RP   VARIANT MHS1 CYS-2355.
RX   PubMed=12123492; DOI=10.1034/j.1399-0004.2002.620111.x;
RA   McWilliams S., Nelson T., Sudo R.T., Zapata-Sudo G., Batti M.,
RA   Sambuughin N.;
RT   "Novel skeletal muscle ryanodine receptor mutation in a large
RT   Brazilian family with malignant hyperthermia.";
RL   Clin. Genet. 62:80-83(2002).
RN   [45]
RP   VARIANT MHS1 VAL-4838, AND VARIANTS ALA-1832; GLU-3756 AND SER-4668.
RX   PubMed=11928716; DOI=10.1254/jjp.88.159;
RA   Oyamada H., Oguchi K., Saitoh N., Yamazawa T., Hirose K., Kawana Y.,
RA   Wakatsuki K., Oguchi K., Tagami M., Hanaoka K., Endo M., Iino M.;
RT   "Novel mutations in C-terminal channel region of the ryanodine
RT   receptor in malignant hyperthermia patients.";
RL   Jpn. J. Pharmacol. 88:159-166(2002).
RN   [46]
RP   VARIANT CCD ILE-4849.
RX   PubMed=12136074; DOI=10.1212/WNL.59.2.284;
RA   Jungbluth H., Muller C.R., Halliger-Keller B., Brockington M.,
RA   Brown S.C., Feng L., Chattopadhyay A., Mercuri E., Manzur A.Y.,
RA   Ferreiro A., Laing N.G., Davis M.R., Roper H.P., Dubowitz V.,
RA   Bydder G., Sewry C.A., Muntoni F.;
RT   "Autosomal recessive inheritance of RYR1 mutations in a congenital
RT   myopathy with cores.";
RL   Neurology 59:284-287(2002).
RN   [47]
RP   VARIANT MHS1 TRP-328, AND CHARACTERIZATION OF VARIANT MHS1 TRP-328.
RX   PubMed=12883402; DOI=10.1097/00000542-200308000-00011;
RA   Loke J.C.P., Kraev N., Sharma P., Du G., Patel L., Kraev A.,
RA   MacLennan D.H.;
RT   "Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in
RT   a malignant hyperthermia family by sequencing of a leukocyte
RT   transcript.";
RL   Anesthesiology 99:297-302(2003).
RN   [48]
RP   VARIANTS CCD HIS-4861; CYS-4864; TRP-4893 AND THR-4940.
RX   PubMed=14670767; DOI=10.1136/adc.88.12.1051;
RA   Quinlivan R.M., Muller C.R., Davis M., Laing N.G., Evans G.A.,
RA   Dwyer J., Dove J., Roberts A.P., Sewry C.A.;
RT   "Central core disease: clinical, pathological, and genetic features.";
RL   Arch. Dis. Child. 88:1051-1055(2003).
RN   [49]
RP   VARIANTS CCD GLU-215; CYS-614; PRO-4650; GLN-4724 AND GLU-4899.
RX   PubMed=12937085; DOI=10.1093/brain/awg244;
RA   Romero N.B., Monnier N., Viollet L., Cortey A., Chevallay M.,
RA   Leroy J.P., Lunardi J., Fardeau M.;
RT   "Dominant and recessive central core disease associated with RYR1
RT   mutations and fetal akinesia.";
RL   Brain 126:2341-2349(2003).
RN   [50]
RP   VARIANTS MHS1 CYS-44; CYS-533; LEU-2117; PRO-2163; MET-2168; LEU-2435
RP   AND HIS-2454, AND VARIANT LYS-2101.
RX   PubMed=12709367; DOI=10.1373/49.5.761;
RA   Tammaro A., Bracco A., Cozzolino S., Esposito M., Di Martino A.,
RA   Savoia G., Zeuli L., Piluso G., Aurino S., Nigro V.;
RT   "Scanning for mutations of the ryanodine receptor (RYR1) gene by
RT   denaturing HPLC: detection of three novel malignant hyperthermia
RT   alleles.";
RL   Clin. Chem. 49:761-768(2003).
RN   [51]
RP   VARIANT CCD 4863-ARG--ASP-4869 DELINS TYR.
RX   PubMed=12566385; DOI=10.1093/hmg/ddg032;
RA   Zorzato F., Yamaguchi N., Xu L., Meissner G., Mueller C.R.,
RA   Pouliquin P., Muntoni F., Sewry C., Girard T., Treves S.;
RT   "Clinical and functional effects of a deletion in a COOH-terminal
RT   lumenal loop of the skeletal muscle ryanodine receptor.";
RL   Hum. Mol. Genet. 12:379-388(2003).
RN   [52]
RP   INVOLVEMENT IN MMDO.
RX   PubMed=12719381; DOI=10.1093/hmg/ddg121;
RA   Monnier N., Ferreiro A., Marty I., Labarre-Vila A., Mezin P.,
RA   Lunardi J.;
RT   "A homozygous splicing mutation causing a depletion of skeletal muscle
RT   RYR1 is associated with multi-minicore disease congenital myopathy
RT   with ophthalmoplegia.";
RL   Hum. Mol. Genet. 12:1171-1178(2003).
RN   [53]
RP   VARIANT CORE/ROD DISEASE ILE-4637, AND VARIANTS CCD ASP-4638;
RP   PRO-4651; CYS-4861; HIS-4861; GLN-4893; THR-4898; GLY-4914; THR-4914;
RP   4927-VAL-ILE-4928 DEL AND THR-4940.
RX   PubMed=12565913; DOI=10.1016/S0960-8966(02)00218-3;
RA   Davis M.R., Haan E., Jungbluth H., Sewry C., North K., Muntoni F.,
RA   Kuntzer T., Lamont P., Bankier A., Tomlinson P., Sanchez A., Walsh P.,
RA   Nagarajan L., Oley C., Colley A., Gedeon A., Quinlivan R., Dixon J.,
RA   James D., Mueller C.R., Laing N.G.;
RT   "Principal mutation hotspot for central core disease and related
RT   myopathies in the C-terminal transmembrane region of the RYR1 gene.";
RL   Neuromuscul. Disord. 13:151-157(2003).
RN   [54]
RP   VARIANTS MHS1 CYS-163; ARG-248; CYS-614; CYS-2163; MET-2168; MET-2206;
RP   ILE-2214; THR-2350; THR-2367; ASN-2431; ARG-2434; VAL-2437; HIS-2454
RP   AND PRO-4824.
RX   PubMed=15448513; DOI=10.1097/00000542-200410000-00005;
RA   Sei Y., Sambuughin N.N., Davis E.J., Sachs D., Cuenca P.B.,
RA   Brandom B.W., Tautz T., Rosenberg H., Nelson T.E., Muldoon S.M.;
RT   "Malignant hyperthermia in North America: genetic screening of the
RT   three hot spots in the type I ryanodine receptor gene.";
RL   Anesthesiology 101:824-830(2004).
RN   [55]
RP   VARIANTS MHS1 TRP-2676 AND SER-2787.
RX   PubMed=14732627; DOI=10.1001/archneur.61.1.106;
RA   Guis S., Figarella-Branger D., Monnier N., Bendahan D.,
RA   Kozak-Ribbens G., Mattei J.-P., Lunardi J., Cozzone P.J.,
RA   Pellissier J.-F.;
RT   "Multiminicore disease in a family susceptible to malignant
RT   hyperthermia: histology, in vitro contracture tests, and genetic
RT   characterization.";
RL   Arch. Neurol. 61:106-113(2004).
RN   [56]
RP   VARIANTS CCD GLY-160; ASP-4638; PHE-4814; HIS-4861 AND MET-4938, AND
RP   VARIANTS MHS1 CYS-614; MET-2346; GLY-2348; TRP-2452; HIS-2458;
RP   PRO-4824 AND GLU-4939.
RX   PubMed=14985404; DOI=10.1136/jmg.2003.014274;
RA   Shepherd S., Ellis F., Halsall J., Hopkins P., Robinson R.;
RT   "RYR1 mutations in UK central core disease patients: more than just
RT   the C-terminal transmembrane region of the RYR1 gene.";
RL   J. Med. Genet. 41:E33-E33(2004).
RN   [57]
RP   VARIANT MHS1 SER-2342.
RX   PubMed=15221887; DOI=10.1002/mus.20068;
RA   Marchant C.L., Ellis F.R., Halsall P.J., Hopkins P.M., Robinson R.L.;
RT   "Mutation analysis of two patients with hypokalemic periodic paralysis
RT   and suspected malignant hyperthermia.";
RL   Muscle Nerve 30:114-117(2004).
RN   [58]
RP   VARIANTS MHS1 ARG-35; CYS-163; LEU-163; ARG-165; ASN-166; CYS-177;
RP   CYS-178; VAL-227; ARG-248; TRP-328; ARG-341; SER-401; HIS-401;
RP   MET-403; SER-522; TRP-552; CYS-614; LEU-614; CYS-2163; HIS-2163;
RP   MET-2168; MET-2206; ARG-2206; ASP-2344; MET-2346; THR-2350; THR-2428;
RP   ARG-2434; HIS-2435; CYS-2454; HIS-2454; CYS-2458; TRP-2676; SER-2787;
RP   MET-3916; SER-4684; GLN-4737; TRP-4737; ILE-4826; VAL-4838; ILE-4849;
RP   ARG-4876; GLU-4939 AND LEU-4973, CHARACTERIZATION OF VARIANTS MHS1
RP   LEU-163; MET-2206; THR-2428; CYS-2454 AND HIS-2454, FUNCTION, AND
RP   ENZYME REGULATION.
RX   PubMed=16163667; DOI=10.1002/humu.20231;
RA   Monnier N., Kozak-Ribbens G., Krivosic-Horber R., Nivoche Y., Qi D.,
RA   Kraev N., Loke J., Sharma P., Tegazzin V., Figarella-Branger D.,
RA   Romero N., Mezin P., Bendahan D., Payen J.-F., Depret T.,
RA   Maclennan D.H., Lunardi J.;
RT   "Correlations between genotype and pharmacological, histological,
RT   functional, and clinical phenotypes in malignant hyperthermia
RT   susceptibility.";
RL   Hum. Mutat. 26:413-425(2005).
RN   [59]
RP   VARIANTS MMDO TRP-109 AND LYS-2423, AND VARIANTS VAL-485 AND CYS-2060.
RX   PubMed=16380615; DOI=10.1212/01.wnl.0000188870.37076.f2;
RA   Jungbluth H., Zhou H., Hartley L., Halliger-Keller B., Messina S.,
RA   Longman C., Brockington M., Robb S.A., Straub V., Voit T., Swash M.,
RA   Ferreiro A., Bydder G., Sewry C.A., Mueller C., Muntoni F.;
RT   "Minicore myopathy with ophthalmoplegia caused by mutations in the
RT   ryanodine receptor type 1 gene.";
RL   Neurology 65:1930-1935(2005).
RN   [60]
RP   VARIANT CCD VAL-4846.
RX   PubMed=17204054; DOI=10.1111/j.1399-0004.2006.00725.x;
RA   Gambelli S., Malandrini A., Berti G., Gaudiano C., Zicari E.,
RA   Brunori P., Perticoni G., Orrico A., Galli L., Sorrentino V.,
RA   Lunardi J., Federico A., Dotti M.T.;
RT   "Inheritance of a novel RYR1 mutation in a family with myotonic
RT   dystrophy type 1.";
RL   Clin. Genet. 71:93-94(2007).
RN   [61]
RP   VARIANTS CCD GLN-4558; VAL-4846; ILE-4849; HIS-4861; CYS-4861;
RP   VAL-4897 AND THR-4914.
RX   PubMed=17226826; DOI=10.1002/mus.20715;
RA   Kossugue P.M., Paim J.F., Navarro M.M., Silva H.C., Pavanello R.C.M.,
RA   Gurgel-Giannetti J., Zatz M., Vainzof M.;
RT   "Central core disease due to recessive mutations in RYR1 gene: is it
RT   more common than described?";
RL   Muscle Nerve 35:670-674(2007).
RN   [62]
RP   VARIANT CCD MET-4882.
RX   PubMed=18312400; DOI=10.1111/j.1468-1331.2008.02094.x;
RA   von der Hagen M., Kress W., Hahn G., Brocke K.S., Mitzscherling P.,
RA   Huebner A., Muller-Reible C., Stoltenburg-Didinger G., Kaindl A.M.;
RT   "Novel RYR1 missense mutation causes core rod myopathy.";
RL   Eur. J. Neurol. 15:E31-E32(2008).
RN   [63]
RP   VARIANTS CCD VAL-13; SER-1704; PRO-2421; LYS-2423; HIS-3539; GLN-3772;
RP   GLN-4558; MET-4842 AND ILE-4849.
RX   PubMed=18253926; DOI=10.1002/humu.20696;
RA   Monnier N., Marty I., Faure J., Castiglioni C., Desnuelle C.,
RA   Sacconi S., Estournet B., Ferreiro A., Romero N., Laquerriere A.,
RA   Lazaro L., Martin J.-J., Morava E., Rossi A., Van der Kooi A.,
RA   de Visser M., Verschuuren C., Lunardi J.;
RT   "Null mutations causing depletion of the type 1 ryanodine receptor
RT   (RYR1) are commonly associated with recessive structural congenital
RT   myopathies with cores.";
RL   Hum. Mutat. 29:670-678(2008).
RN   [64]
RP   VARIANTS MHS1 ARG-13; LYS-226; LEU-367; HIS-530; TYR-544; CYS-1043;
RP   GLY-1352; HIS-2336; LYS-2404; TRP-2676; GLY-2730; SER-2787; LYS-2880;
RP   PRO-3217; LYS-3290; TRP-3772; ARG-3806; LEU-4501; VAL-4838; ARG-4876
RP   AND THR-4938, AND VARIANTS GLY-1342; LEU-1787; ALA-1832; CYS-2060;
RP   VAL-2321; VAL-2550; GLN-3583 AND GLU-3756.
RX   PubMed=19191329; DOI=10.1002/humu.20878;
RA   Levano S., Vukcevic M., Singer M., Matter A., Treves S., Urwyler A.,
RA   Girard T.;
RT   "Increasing the number of diagnostic mutations in malignant
RT   hyperthermia.";
RL   Hum. Mutat. 30:590-598(2009).
RN   [65]
RP   VARIANT MHS1 CYS-2508, AND CHARACTERIZATION OF VARIANT MHS1 CYS-2508.
RX   PubMed=19685112; DOI=10.1007/s00540-009-0746-3;
RA   Migita T., Mukaida K., Hamada H., Yasuda T., Haraki T., Nishino I.,
RA   Murakami N., Kawamoto M.;
RT   "Functional analysis of ryanodine receptor type 1 p.R2508C mutation in
RT   exon 47.";
RL   J. Anesth. 23:341-346(2009).
RN   [66]
RP   VARIANTS MHS1 ASN-382; LYS-1058 AND ARG-1393, VARIANT CCD GLY-2508,
RP   AND VARIANT HIS-1679.
RX   PubMed=20142353; DOI=10.1213/ANE.0b013e3181cbd815;
RA   Vukcevic M., Broman M., Islander G., Bodelsson M., Ranklev-Twetman E.,
RA   Muller C.R., Treves S.;
RT   "Functional properties of RYR1 mutations identified in Swedish
RT   patients with malignant hyperthermia and central core disease.";
RL   Anesth. Analg. 111:185-190(2010).
RN   [67]
RP   VARIANTS MMDO THR-402; LEU-2035; LYS-3326 AND GLY-3402.
RX   PubMed=20583297; DOI=10.1002/humu.21278;
RA   Clarke N.F., Waddell L.B., Cooper S.T., Perry M., Smith R.L.L.,
RA   Kornberg A.J., Muntoni F., Lillis S., Straub V., Bushby K.,
RA   Guglieri M., King M.D., Farrell M.A., Marty I., Lunardi J.,
RA   Monnier N., North K.N.;
RT   "Recessive mutations in RYR1 are a common cause of congenital fiber
RT   type disproportion.";
RL   Hum. Mutat. 31:E1544-E1550(2010).
RN   [68]
RP   VARIANTS MHS1 ASN-1056; HIS-1127; ARG-1467; VAL-1571; GLN-2013;
RP   GLY-2400; GLY-2593; GLN-3410; TYR-3501 AND CYS-3933, AND VARIANTS
RP   LYS-899; CYS-2060; CYS-2248; TYR-2976 AND GLN-3360.
RX   PubMed=20681998; DOI=10.1111/j.1399-0004.2010.01493.x;
RA   Tammaro A., Di Martino A., Bracco A., Cozzolino S., Savoia G.,
RA   Andria B., Cannavo A., Spagnuolo M., Piluso G., Aurino S., Nigro V.;
RT   "Novel missense mutations and unexpected multiple changes of RYR1 gene
RT   in 75 malignant hyperthermia families.";
RL   Clin. Genet. 79:438-447(2011).
RN   [69]
RP   VARIANTS CCD GLY-160; GLN-2204; HIS-3366; CYS-3933 AND ASP-4743, AND
RP   VARIANTS LEU-1787; CYS-2060 AND ALA-4493.
RX   PubMed=21674524; DOI=10.1002/mus.22009;
RA   Duarte S.T., Oliveira J., Santos R., Pereira P., Barroso C.,
RA   Conceicao I., Evangelista T.;
RT   "Dominant and recessive RYR1 mutations in adults with core lesions and
RT   mild muscle symptoms.";
RL   Muscle Nerve 44:102-108(2011).
RN   [70]
RP   VARIANTS MHS1 HIS-1056; MET-2627 AND LEU-4234.
RX   PubMed=24013571; DOI=10.1097/ALN.0b013e3182a8a998;
RA   Kim J.H., Jarvik G.P., Browning B.L., Rajagopalan R., Gordon A.S.,
RA   Rieder M.J., Robertson P.D., Nickerson D.A., Fisher N.A.,
RA   Hopkins P.M.;
RT   "Exome sequencing reveals novel rare variants in the ryanodine
RT   receptor and calcium channel genes in malignant hyperthermia
RT   families.";
RL   Anesthesiology 119:1054-1065(2013).
RN   [71]
RP   VARIANTS MHS1 ALA-40; CYS-163; ARG-248; ARG-341; PRO-487; ALA-518;
RP   CYS-614; HIS-1043; HIS-2163; MET-2206; HIS-2248; HIS-2351; MET-2354;
RP   LEU-2358; GLN-2383; ARG-2434; HIS-2454; ARG-3711; VAL-4178; ARG-4230;
RP   GLU-4837; HIS-4861 AND GLY-4906, VARIANTS CCD TRP-975; MET-2168 AND
RP   GLY-3238, AND VARIANTS MET-974; LEU-1109; ARG-1393; LEU-1787; CYS-2060
RP   AND VAL-2321.
RX   PubMed=23558838; DOI=10.1213/ANE.0b013e31828a71ff;
RA   Brandom B.W., Bina S., Wong C.A., Wallace T., Visoiu M.,
RA   Isackson P.J., Vladutiu G.D., Sambuughin N., Muldoon S.M.;
RT   "Ryanodine receptor type 1 gene variants in the malignant
RT   hyperthermia-susceptible population of the United States.";
RL   Anesth. Analg. 116:1078-1086(2013).
RN   [72]
RP   VARIANTS CCD HIS-4861; ALA-4897 AND THR-4898.
RX   PubMed=24561095; DOI=10.1016/j.neulet.2014.02.015;
RA   Gu M., Zhang S., Hu J., Yuan Y., Wang Z., Da Y., Wu S.;
RT   "Novel RYR1 missense mutations in six Chinese patients with central
RT   core disease.";
RL   Neurosci. Lett. 566:32-35(2014).
RN   [73]
RP   CHARACTERIZATION OF VARIANT MHS1 CYS-2508, CHARACTERIZATION OF VARIANT
RP   CCD GLY-2508, AND MUTAGENESIS OF ARG-2508.
RX   PubMed=26381711; DOI=10.1213/ANE.0000000000000886;
RA   Miyoshi H., Yasuda T., Otsuki S., Kondo T., Haraki T., Mukaida K.,
RA   Nakamura R., Hamada H., Kawamoto M.;
RT   "Several ryanodine receptor type 1 gene mutations of p.Arg2508 are
RT   potential sources of malignant hyperthermia.";
RL   Anesth. Analg. 121:994-1000(2015).
RN   [74]
RP   CHARACTERIZATION OF VARIANTS MHS1 ARG-35; CYS-163; LEU-163; ARG-248;
RP   ARG-341; CYS-401; HIS-401; SER-522; CYS-614 AND LEU-614, AND
RP   MUTAGENESIS OF TYR-522.
RX   PubMed=26115329; DOI=10.1371/journal.pone.0130606;
RA   Murayama T., Kurebayashi N., Yamazawa T., Oyamada H., Suzuki J.,
RA   Kanemaru K., Oguchi K., Iino M., Sakurai T.;
RT   "Divergent activity profiles of type 1 ryanodine receptor channels
RT   carrying malignant hyperthermia and central core disease mutations in
RT   the amino-terminal Region.";
RL   PLoS ONE 10:E0130606-E0130606(2015).
RN   [75]
RP   CHARACTERIZATION OF VARIANTS MHS1 CYS-2163; HIS-2163; MET-2168;
RP   MET-2206; THR-2350; ARG-2434; HIS-2435; CYS-2454; HIS-2454; CYS-2458;
RP   HIS-2458 AND HIS-2508, CHARACTERIZATION OF VARIANT CCD CYS-2508, AND
RP   CHARACTERIZATION OF VARIANT ALA-2375 AND HIS-2508.
RX   PubMed=27586648; DOI=10.1002/humu.23072;
RA   Murayama T., Kurebayashi N., Ogawa H., Yamazawa T., Oyamada H.,
RA   Suzuki J., Kanemaru K., Oguchi K., Iino M., Sakurai T.;
RT   "Genotype-phenotype correlations of malignant hyperthermia and central
RT   core disease mutations in the central region of the RYR1 channel.";
RL   Hum. Mutat. 37:1231-1241(2016).
RN   [76]
RP   VARIANT MHS1 TRP-4737, AND CHARACTERIZATION OF VARIANT MHS1 TRP-4737.
RX   PubMed=26631338; DOI=10.1016/j.nmd.2015.11.001;
RA   Johannsen S., Treves S., Mueller C.R., Moegele S., Schneiderbanger D.,
RA   Roewer N., Schuster F.;
RT   "Functional characterization of the RYR1 mutation p.Arg4737Trp
RT   associated with susceptibility to malignant hyperthermia.";
RL   Neuromuscul. Disord. 26:21-25(2016).
RN   [77]
RP   VARIANT ARG-705.
RX   PubMed=27616680; DOI=10.1002/pd.4925;
RA   Casey J., Flood K., Ennis S., Doyle E., Farrell M., Lynch S.A.;
RT   "Intra-familial variability associated with recessive RYR1 mutation
RT   diagnosed prenatally by exome sequencing.";
RL   Prenat. Diagn. 36:1020-1026(2016).
RN   [78]
RP   VARIANTS CCD PRO-2963 AND ASP-4806.
RX   PubMed=27234031; DOI=10.1111/cge.12810;
RA   Fattahi Z., Kalhor Z., Fadaee M., Vazehan R., Parsimehr E.,
RA   Abolhassani A., Beheshtian M., Zamani G., Nafissi S., Nilipour Y.,
RA   Akbari M.R., Kahrizi K., Kariminejad A., Najmabadi H.;
RT   "Improved diagnostic yield of neuromuscular disorders applying
RT   clinical exome sequencing in patients arising from a consanguineous
RT   population.";
RL   Clin. Genet. 91:386-402(2017).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm and thereby plays a
CC       key role in triggering muscle contraction following depolarization
CC       of T-tubules (PubMed:11741831, PubMed:16163667). Repeated very
CC       high-level exercise increases the open probability of the channel
CC       and leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335).
CC       Can also mediate the release of Ca(2+) from intracellular stores
CC       in neurons, and may thereby promote prolonged Ca(2+) signaling in
CC       the brain. Required for normal embryonic development of muscle
CC       fibers and skeletal muscle. Required for normal heart
CC       morphogenesis, skin development and ossification during
CC       embryogenesis (By similarity). {ECO:0000250|UniProtKB:E9PZQ0,
CC       ECO:0000269|PubMed:18268335, ECO:0000305|PubMed:11741831,
CC       ECO:0000305|PubMed:16163667}.
CC   -!- ENZYME REGULATION: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity (By similarity). Channel activity is regulated by
CC       calmodulin (CALM) (PubMed:18650434). The calcium release is
CC       activated by increased cytoplasmic calcium levels, by nitric oxyde
CC       (NO), caffeine and ATP (PubMed:18268335, PubMed:16163667). Channel
CC       activity is inhibited by magnesium ions, possibly by competition
CC       for calcium binding sites (By similarity).
CC       {ECO:0000250|UniProtKB:P11716, ECO:0000269|PubMed:16163667,
CC       ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434}.
CC   -!- SUBUNIT: Homotetramer. Can also form heterotetramers with RYR2 (By
CC       similarity). Identified in a complex composed of RYR1, PDE4D, PKA,
CC       FKBP1A and protein phosphatase 1 (PP1) (PubMed:18268335). Repeated
CC       very high-level exercise decreases interaction with PDE4D and
CC       protein phosphatase 1 (PP1) (PubMed:18268335). Interacts with
CC       CALM; CALM with bound calcium inhibits the RYR1 channel activity
CC       (PubMed:18650434). Interacts with S100A1 (PubMed:18650434).
CC       Interacts with FKBP1A; this stabilizes the closed conformation of
CC       the channel. Interacts with CACNA1S; interaction with CACNA1S is
CC       important for activation of the RYR1 channel. Interacts with
CC       CACNB1. Interacts with TRDN and ASPH; these interactions stimulate
CC       RYR1 channel activity. Interacts with SELENON (By similarity).
CC       {ECO:0000250|UniProtKB:E9PZQ0, ECO:0000250|UniProtKB:P11716,
CC       ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434}.
CC   -!- INTERACTION:
CC       P54296:MYOM2; NbExp=2; IntAct=EBI-1221290, EBI-5357134;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:7556644}; Multi-pass membrane protein
CC       {ECO:0000305}. Sarcoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P11716}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but the 3D-
CC       structures show the presence of six transmembrane regions. Both N-
CC       terminus and C-terminus are cytoplasmic.
CC       {ECO:0000250|UniProtKB:P11716}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=P21817-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21817-2; Sequence=VSP_005951;
CC       Name=3;
CC         IsoId=P21817-3; Sequence=VSP_005952;
CC   -!- TISSUE SPECIFICITY: Skeletal muscle and brain (cerebellum and
CC       hippocampus). {ECO:0000269|PubMed:9607712}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein
CC       constitutes the 'foot' structure spanning the junctional gap
CC       between the sarcoplasmic reticulum (SR) and the T-tubule. Pore
CC       opening is mediated via the cytoplasmic calcium-binding domains
CC       that mediate a small rotation of the channel-forming transmembrane
CC       regions that then leads to channel opening.
CC       {ECO:0000250|UniProtKB:P11716}.
CC   -!- PTM: Channel activity is modulated by phosphorylation.
CC       Phosphorylation at Ser-2843 may increase channel activity.
CC       Repeated very high-level exercise increases phosphorylation at
CC       Ser-2843. {ECO:0000269|PubMed:18268335}.
CC   -!- PTM: Activated by reversible S-nitrosylation (By similarity).
CC       Repeated very high-level exercise increases S-nitrosylation
CC       (PubMed:18268335). {ECO:0000250|UniProtKB:P11716,
CC       ECO:0000269|PubMed:18268335}.
CC   -!- DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal
CC       dominant pharmacogenetic disorder of skeletal muscle and is one of
CC       the main causes of death due to anesthesia. In susceptible people,
CC       an MH episode can be triggered by all commonly used inhalational
CC       anesthetics such as halothane and by depolarizing muscle relaxants
CC       such as succinylcholine. The clinical features of the myopathy are
CC       hyperthermia, accelerated muscle metabolism, contractures,
CC       metabolic acidosis, tachycardia and death, if not treated with the
CC       postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can
CC       be determined with the 'in vitro' contracture test (IVCT):
CC       observing the magnitude of contractures induced in strips of
CC       muscle tissue by caffeine alone and halothane alone. Patients with
CC       normal response are MH normal (MHN), those with abnormal response
CC       to caffeine alone or halothane alone are MH equivocal (MHE(C) and
CC       MHE(H) respectively). {ECO:0000269|PubMed:10051009,
CC       ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851,
CC       ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602,
CC       ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482,
CC       ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529,
CC       ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893,
CC       ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492,
CC       ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788,
CC       ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402,
CC       ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627,
CC       ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887,
CC       ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667,
CC       ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329,
CC       ECO:0000269|PubMed:19685112, ECO:0000269|PubMed:20142353,
CC       ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838,
CC       ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:26115329,
CC       ECO:0000269|PubMed:26381711, ECO:0000269|PubMed:26631338,
CC       ECO:0000269|PubMed:27586648, ECO:0000269|PubMed:7751854,
CC       ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417,
CC       ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:8220423,
CC       ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151,
CC       ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902,
CC       ECO:0000269|PubMed:9497245}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Central core disease of muscle (CCD) [MIM:117000]:
CC       Autosomal dominant congenital myopathy, but a severe autosomal
CC       recessive form also exists. Both clinical and histological
CC       variability is observed. Affected individuals typically display
CC       hypotonia and proximal muscle weakness in infancy, leading to the
CC       delay of motor milestones. The clinical course of the disorder is
CC       usually slow or nonprogressive in adulthood, and the severity of
CC       the symptoms may vary from normal to significant muscle weakness.
CC       Microscopic examination of CCD-affected skeletal muscle reveals a
CC       predominance of type I fibers containing amorphous-looking areas
CC       (cores) that do not stain with oxidative and phosphorylase
CC       histochemical techniques. {ECO:0000269|PubMed:10097181,
CC       ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545,
CC       ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081,
CC       ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913,
CC       ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085,
CC       ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404,
CC       ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826,
CC       ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400,
CC       ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524,
CC       ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095,
CC       ECO:0000269|PubMed:26381711, ECO:0000269|PubMed:27234031,
CC       ECO:0000269|PubMed:27586648, ECO:0000269|PubMed:7829078,
CC       ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423,
CC       ECO:0000269|PubMed:9497245}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Multiminicore disease with external ophthalmoplegia
CC       (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular
CC       disorder. General features include neonatal hypotonia, delayed
CC       motor development, and generalized muscle weakness and amyotrophy,
CC       which may progress slowly or remain stable. Muscle biopsy shows
CC       multiple, poorly circumscribed, short areas of sarcomere
CC       disorganization and mitochondria depletion (areas termed
CC       minicores) in most muscle fibers. Typically, no dystrophic signs,
CC       such as muscle fiber necrosis or regeneration or significant
CC       endomysial fibrosis, are present in multiminicore disease.
CC       {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615,
CC       ECO:0000269|PubMed:20583297}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in RYR1 may be a cause of Samaritan
CC       myopathy, a congenital myopathy with benign course. Patients
CC       display severe hypotonia and respiratory distress at birth. Unlike
CC       other congenital myopathies, the health status constantly improves
CC       and patients are minimally affected at adulthood.
CC   -!- MISCELLANEOUS: Coexpression of normal and mutant Thr-4898 RYR1 in
CC       a 1:1 ratio produces RYR1 channels with normal halothane and
CC       caffeine sensitivities, but maximal levels of Ca(2+) release are
CC       reduced by 67%. Binding of [3H]ryanodine indicates that the
CC       heterozygous channel is activated by Ca(2+) concentrations 4-fold
CC       lower than normal. Single-cell analysis of cotransfected cells
CC       shows a significantly increased resting cytoplasmic Ca(2+) level
CC       and a significantly reduced luminal Ca(2+) level. These data
CC       indicated a leaky channel, possibly caused by a reduction in the
CC       Ca(2+) concentration required for channel activation. Comparison
CC       with 2 other coexpressed mutant/normal channels suggests that the
CC       Thr-4898 mutation produces one of the most abnormal RYR1 channels
CC       that has been investigated, and this level of abnormality is
CC       reflected in the severe and penetrant phenotype of affected CCD
CC       individuals. {ECO:0000269|PubMed:10097181}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR1 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ryanodine receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Ryanodine_receptor";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=RYR1 entry;
CC       URL="https://en.wikipedia.org/wiki/RYR1";
CC   -!- WEB RESOURCE: Name=Leiden Muscular Dystrophy pages Ryanodine
CC       receptor 1 (skeletal) (RYR1); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://www.dmd.nl/nmdb2/home.php?select_db=RYR1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05200; AAA60294.1; -; mRNA.
DR   EMBL; U48508; AAC51191.1; -; Genomic_DNA.
DR   EMBL; U48449; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48450; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48451; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48452; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48453; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48454; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48455; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48456; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48457; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48458; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48459; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48460; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48461; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48462; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48463; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48464; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48465; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48466; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48467; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48468; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48469; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48470; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48471; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48472; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48473; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48474; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48475; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48476; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48477; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48478; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48479; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48480; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48481; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48482; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48483; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48484; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48485; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48486; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48487; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48488; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48489; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48490; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48491; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48492; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48493; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48494; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48495; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48496; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48497; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48498; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48499; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48500; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48501; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48502; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48503; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48504; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48505; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48506; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48507; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; AC067969; AAF66076.1; -; Genomic_DNA.
DR   EMBL; AC005933; AAC71651.1; -; Genomic_DNA.
DR   EMBL; AC011469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M91455; AAA60295.1; -; Genomic_DNA.
DR   EMBL; S78717; AAB21245.2; -; Genomic_DNA.
DR   EMBL; S77392; AAB34356.1; -; Genomic_DNA.
DR   CCDS; CCDS33011.1; -. [P21817-1]
DR   CCDS; CCDS42563.1; -. [P21817-2]
DR   PIR; A35041; A35041.
DR   RefSeq; NP_000531.2; NM_000540.2. [P21817-1]
DR   RefSeq; NP_001036188.1; NM_001042723.1. [P21817-2]
DR   UniGene; Hs.466664; -.
DR   ProteinModelPortal; P21817; -.
DR   BioGrid; 112173; 8.
DR   DIP; DIP-29708N; -.
DR   ELM; P21817; -.
DR   IntAct; P21817; 12.
DR   MINT; MINT-1605046; -.
DR   STRING; 9606.ENSP00000352608; -.
DR   BindingDB; P21817; -.
DR   ChEMBL; CHEMBL1846; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB01219; Dantrolene.
DR   DrugBank; DB04786; Suramin.
DR   DrugBank; DB09085; Tetracaine.
DR   GuidetoPHARMACOLOGY; 747; -.
DR   TCDB; 1.A.3.1.2; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; P21817; -.
DR   PhosphoSitePlus; P21817; -.
DR   BioMuta; RYR1; -.
DR   DMDM; 108935904; -.
DR   PaxDb; P21817; -.
DR   PeptideAtlas; P21817; -.
DR   PRIDE; P21817; -.
DR   Ensembl; ENST00000355481; ENSP00000347667; ENSG00000196218. [P21817-2]
DR   Ensembl; ENST00000359596; ENSP00000352608; ENSG00000196218. [P21817-1]
DR   GeneID; 6261; -.
DR   KEGG; hsa:6261; -.
DR   UCSC; uc002oit.4; human. [P21817-1]
DR   CTD; 6261; -.
DR   DisGeNET; 6261; -.
DR   EuPathDB; HostDB:ENSG00000196218.11; -.
DR   GeneCards; RYR1; -.
DR   GeneReviews; RYR1; -.
DR   H-InvDB; HIX0039957; -.
DR   HGNC; HGNC:10483; RYR1.
DR   HPA; HPA056416; -.
DR   MalaCards; RYR1; -.
DR   MIM; 117000; phenotype.
DR   MIM; 145600; phenotype.
DR   MIM; 180901; gene.
DR   MIM; 255320; phenotype.
DR   neXtProt; NX_P21817; -.
DR   OpenTargets; ENSG00000196218; -.
DR   Orphanet; 169189; Autosomal dominant centronuclear myopathy.
DR   Orphanet; 324581; Benign Samaritan congenital myopathy.
DR   Orphanet; 597; Central core disease.
DR   Orphanet; 98905; Congenital multicore myopathy with external ophthalmoplegia.
DR   Orphanet; 99741; King-Denborough syndrome.
DR   Orphanet; 423; Malignant hyperthermia.
DR   Orphanet; 178145; Moderate multiminicore disease with hand involvement.
DR   PharmGKB; PA34896; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   InParanoid; P21817; -.
DR   KO; K04961; -.
DR   OMA; DIPARRN; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; P21817; -.
DR   TreeFam; TF315244; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   SIGNOR; P21817; -.
DR   ChiTaRS; RYR1; human.
DR   GeneWiki; RYR1; -.
DR   GenomeRNAi; 6261; -.
DR   PRO; PR:P21817; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000196218; -.
DR   CleanEx; HS_RYR1; -.
DR   ExpressionAtlas; P21817; baseline and differential.
DR   Genevisible; P21817; HS.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031674; C:I band; IDA:UniProtKB.
DR   GO; GO:0031301; C:integral component of organelle membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0030314; C:junctional membrane complex; IEA:Ensembl.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:1990425; C:ryanodine receptor complex; ISS:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0014802; C:terminal cisterna; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IMP:UniProtKB.
DR   GO; GO:0015278; F:calcium-release channel activity; TAS:ProtInc.
DR   GO; GO:0005516; F:calmodulin binding; ISS:BHF-UCL.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:CACAO.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISS:BHF-UCL.
DR   GO; GO:0071313; P:cellular response to caffeine; IMP:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; ISS:UniProtKB.
DR   GO; GO:0043931; P:ossification involved in bone maturation; ISS:UniProtKB.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISS:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0031000; P:response to caffeine; ISS:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0043588; P:skin development; ISS:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR033215; RyR1.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   PANTHER; PTHR13715:SF15; PTHR13715:SF15; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Complete proteome;
KW   Developmental protein; Direct protein sequencing; Disease mutation;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; S-nitrosylation;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   5038       Ryanodine receptor 1.
FT                                /FTId=PRO_0000219358.
FT   TOPO_DOM      1   4559       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4560   4580       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4581   4641       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4642   4662       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4663   4780       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4781   4803       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4804   4804       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4805   4821       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4822   4836       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4837   4857       Helical; Name=5.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4858   4880       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   INTRAMEM   4881   4900       Pore-forming.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4901   4920       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4921   4941       Helical; Name=6.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4942   5038       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   DOMAIN       97    152       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      159    204       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      210    264       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      270    327       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      335    392       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      581    797       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      841    954       1.
FT   REPEAT      955   1068       2.
FT   DOMAIN     1013   1208       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     1344   1359       3; truncated.
FT   DOMAIN     1356   1570       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     1372   1387       4; truncated.
FT   REPEAT     2726   2845       5.
FT   REPEAT     2846   2959       6.
FT   DOMAIN     4074   4102       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   NP_BIND    4210   4214       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   NP_BIND    4955   4960       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   NP_BIND    4980   4986       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   REGION      669    680       Interaction with FKBP1A.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   REGION      841   2959       6 X approximate repeats.
FT   REGION     3614   3643       Interaction with CALM.
FT                                {ECO:0000269|PubMed:18650434}.
FT   MOTIF      4895   4901       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   COMPBIAS   1873   1924       Glu-rich (acidic).
FT   COMPBIAS   4462   4532       Pro-rich.
FT   METAL      3892   3892       Calcium. {ECO:0000250|UniProtKB:P11716}.
FT   METAL      3966   3966       Calcium. {ECO:0000250|UniProtKB:P11716}.
FT   METAL      5002   5002       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   BINDING    4717   4717       Caffeine. {ECO:0000250|UniProtKB:P11716}.
FT   MOD_RES    1337   1337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    2345   2345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    2843   2843       Phosphoserine; by PKA and PKG.
FT                                {ECO:0000250|UniProtKB:E9PZQ0}.
FT   MOD_RES    3635   3635       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   MOD_RES    4467   4467       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    4471   4471       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    4864   4864       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   MOD_RES    4867   4867       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   VAR_SEQ    3481   3485       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:2298749}.
FT                                /FTId=VSP_005951.
FT   VAR_SEQ    3865   3869       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_005952.
FT   VARIANT      13     13       L -> R (in MHS1; dbSNP:rs193922744).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058560.
FT   VARIANT      13     13       L -> V (in CCD; autosomal recessive
FT                                form). {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045694.
FT   VARIANT      35     35       C -> R (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922747).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:9066328}.
FT                                /FTId=VAR_005589.
FT   VARIANT      40     40       G -> A (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071721.
FT   VARIANT      44     44       R -> C (in CCD and MHS1;
FT                                dbSNP:rs193922748).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045695.
FT   VARIANT     109    109       R -> W (in MMDO; dbSNP:rs118192173).
FT                                {ECO:0000269|PubMed:16380615}.
FT                                /FTId=VAR_032910.
FT   VARIANT     160    160       E -> G (in CCD; dbSNP:rs193922752).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_045696.
FT   VARIANT     163    163       R -> C (in CCD and MHS1; 2-3% of the
FT                                cases; increases calcium-induced calcium
FT                                release activity; dbSNP:rs118192161).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:8220423}.
FT                                /FTId=VAR_005590.
FT   VARIANT     163    163       R -> L (in MHS1; induces an increase
FT                                sensitivity to caffeine; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs193922753).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045697.
FT   VARIANT     165    165       G -> R (in MHS1; dbSNP:rs193922754).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045698.
FT   VARIANT     166    166       D -> N (in MHS1; dbSNP:rs193922755).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045699.
FT   VARIANT     177    177       R -> C (in MHS1; dbSNP:rs193922757).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045700.
FT   VARIANT     178    178       Y -> C (in MHS1).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045701.
FT   VARIANT     215    215       G -> E (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192115).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045702.
FT   VARIANT     226    226       M -> K (in MHS1; dbSNP:rs112596687).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058561.
FT   VARIANT     227    227       D -> V (in MHS1; dbSNP:rs193922760).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045703.
FT   VARIANT     248    248       G -> R (in MHS1; unknown pathological
FT                                significance; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs1801086).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_005591.
FT   VARIANT     291    291       A -> T (in dbSNP:rs2229140).
FT                                /FTId=VAR_051890.
FT   VARIANT     328    328       R -> W (in MHS1; has increased
FT                                sensitivity to both caffeine and
FT                                halothane; dbSNP:rs193922762).
FT                                {ECO:0000269|PubMed:12883402,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045704.
FT   VARIANT     341    341       G -> R (in MHS1; 10% of the cases;
FT                                increases calcium-induced calcium release
FT                                activity; dbSNP:rs121918592).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:8012359}.
FT                                /FTId=VAR_005592.
FT   VARIANT     367    367       R -> L (in MHS1; dbSNP:rs113332073).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058562.
FT   VARIANT     382    382       H -> N (in MHS1).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068510.
FT   VARIANT     401    401       R -> C (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922764).
FT                                {ECO:0000269|PubMed:12066726,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045705.
FT   VARIANT     401    401       R -> H (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922766).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045706.
FT   VARIANT     401    401       R -> S (in MHS1).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045707.
FT   VARIANT     402    402       M -> T (in MMDO; dbSNP:rs118192117).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063846.
FT   VARIANT     403    403       I -> M (in CCD and MHS1;
FT                                dbSNP:rs118192116).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:8220423}.
FT                                /FTId=VAR_005593.
FT   VARIANT     471    471       R -> C. {ECO:0000269|PubMed:1354642}.
FT                                /FTId=VAR_005594.
FT   VARIANT     485    485       M -> V (in dbSNP:rs147723844).
FT                                {ECO:0000269|PubMed:16380615}.
FT                                /FTId=VAR_032911.
FT   VARIANT     487    487       L -> P (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071722.
FT   VARIANT     518    518       V -> A (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071723.
FT   VARIANT     522    522       Y -> S (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192162).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:7829078}.
FT                                /FTId=VAR_005595.
FT   VARIANT     530    530       R -> H (in MHS1; dbSNP:rs111888148).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058563.
FT   VARIANT     533    533       R -> C (in MHS1; dbSNP:rs193922768).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045708.
FT   VARIANT     533    533       R -> H (in MHS1; dbSNP:rs144336148).
FT                                /FTId=VAR_008971.
FT   VARIANT     544    544       D -> Y (in MHS1; dbSNP:rs113812662).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058564.
FT   VARIANT     552    552       R -> W (in MHS1; dbSNP:rs193922770).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:9138151}.
FT                                /FTId=VAR_005596.
FT   VARIANT     614    614       R -> C (in CCD and MHS1; 3-5% of the
FT                                cases; increases calcium-induced calcium
FT                                release activity; dbSNP:rs118192172).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:12937085,
FT                                ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:1774074,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:7751854}.
FT                                /FTId=VAR_005597.
FT   VARIANT     614    614       R -> L (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922772).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:9389851}.
FT                                /FTId=VAR_005598.
FT   VARIANT     705    705       G -> R (probable disease-associated
FT                                mutation found in primary myopathy
FT                                causing fetal akinesia and pregnancy
FT                                loss; dbSNP:rs565825739).
FT                                {ECO:0000269|PubMed:27616680}.
FT                                /FTId=VAR_078775.
FT   VARIANT     899    899       N -> K (in dbSNP:rs201401814).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071724.
FT   VARIANT     974    974       V -> M (in dbSNP:rs748676912).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071725.
FT   VARIANT     975    975       R -> W (in CCD; unknown pathological
FT                                significance; dbSNP:rs371278145).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071726.
FT   VARIANT    1043   1043       R -> C (in MHS1; dbSNP:rs111272095).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058565.
FT   VARIANT    1043   1043       R -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs374776563).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071727.
FT   VARIANT    1056   1056       D -> H (in MHS1).
FT                                {ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_071728.
FT   VARIANT    1056   1056       D -> N (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071729.
FT   VARIANT    1058   1058       E -> K (in MHS1).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068511.
FT   VARIANT    1088   1088       Y -> C (probable disease-associated
FT                                mutation found in a family with Samaritan
FT                                myopathy). {ECO:0000269|PubMed:22752422}.
FT                                /FTId=VAR_068512.
FT   VARIANT    1109   1109       R -> K (in dbSNP:rs35719391).
FT                                /FTId=VAR_032912.
FT   VARIANT    1109   1109       R -> L. {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071730.
FT   VARIANT    1127   1127       R -> H (in MHS1; dbSNP:rs545579559).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071731.
FT   VARIANT    1342   1342       S -> G (in dbSNP:rs34694816).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_032913.
FT   VARIANT    1352   1352       A -> G (in MHS1; dbSNP:rs112105381).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058566.
FT   VARIANT    1393   1393       K -> R (in MHS1; unknown pathological
FT                                significance; dbSNP:rs137933390).
FT                                {ECO:0000269|PubMed:20142353,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_068513.
FT   VARIANT    1467   1467       K -> R (in MHS1; dbSNP:rs145573319).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071732.
FT   VARIANT    1489   1489       S -> N (in dbSNP:rs34404839).
FT                                /FTId=VAR_032914.
FT   VARIANT    1571   1571       I -> V (in MHS1; dbSNP:rs146429605).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071733.
FT   VARIANT    1679   1679       R -> H (may be associated with
FT                                susceptibility to malignant hyperthermia;
FT                                dbSNP:rs146504767).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068514.
FT   VARIANT    1704   1704       G -> S (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922779).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045709.
FT   VARIANT    1787   1787       P -> L (in MHS1; dbSNP:rs34934920).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:21674524,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_005599.
FT   VARIANT    1832   1832       G -> A (in dbSNP:rs193922784).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:8661021}.
FT                                /FTId=VAR_045710.
FT   VARIANT    2013   2013       K -> Q (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071734.
FT   VARIANT    2035   2035       H -> L (in MMDO; dbSNP:rs367543056).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063847.
FT   VARIANT    2060   2060       G -> C (in MHS1; dbSNP:rs35364374).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:16380615,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:20681998,
FT                                ECO:0000269|PubMed:21674524,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_005600.
FT   VARIANT    2101   2101       M -> K (in dbSNP:rs746818096).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045711.
FT   VARIANT    2117   2117       V -> L (in MHS1; dbSNP:rs193922788).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045712.
FT   VARIANT    2129   2129       D -> E (in MHS1; dbSNP:rs117886618).
FT                                {ECO:0000269|PubMed:11241852,
FT                                ECO:0000269|PubMed:12059893}.
FT                                /FTId=VAR_045713.
FT   VARIANT    2163   2163       R -> C (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs118192175).
FT                                {ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005601.
FT   VARIANT    2163   2163       R -> H (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192163).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005602.
FT   VARIANT    2163   2163       R -> P (in MHS1; dbSNP:rs118192163).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_008972.
FT   VARIANT    2168   2168       V -> M (in CCD and MHS1; no difference in
FT                                the thapsigargin-sensitive calcium stores
FT                                of cells carrying this mutation and the
FT                                wild-type; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs118192176).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12709367,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005603.
FT   VARIANT    2204   2204       H -> Q (in CCD; dbSNP:rs141646642).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068515.
FT   VARIANT    2206   2206       T -> M (in MHS1; induces an increase
FT                                sensitivity to caffeine;
FT                                dbSNP:rs118192177).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005604.
FT   VARIANT    2206   2206       T -> R (in MHS1; dbSNP:rs118192177).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_008973.
FT   VARIANT    2214   2214       V -> I (in MHS1; dbSNP:rs193922795).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045714.
FT   VARIANT    2248   2248       R -> C (in dbSNP:rs763352221).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071735.
FT   VARIANT    2248   2248       R -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs140152019).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071736.
FT   VARIANT    2280   2280       V -> I (in MHS1; dbSNP:rs193922797).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045715.
FT   VARIANT    2321   2321       I -> V (in dbSNP:rs34390345).
FT                                {ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_058567.
FT   VARIANT    2336   2336       R -> H (in MHS1; dbSNP:rs112563513).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058568.
FT   VARIANT    2342   2342       N -> S (in MHS1; dbSNP:rs147213895).
FT                                {ECO:0000269|PubMed:15221887}.
FT                                /FTId=VAR_045716.
FT   VARIANT    2344   2344       E -> D (in MHS1; unknown pathological
FT                                significance; dbSNP:rs193922798).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045717.
FT   VARIANT    2346   2346       V -> M (in MHS1; dbSNP:rs193922799).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045718.
FT   VARIANT    2347   2347       Missing (in MHS1).
FT                                {ECO:0000269|PubMed:11389482}.
FT                                /FTId=VAR_045719.
FT   VARIANT    2348   2348       E -> G (in MHS1; dbSNP:rs193922801).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045720.
FT   VARIANT    2350   2350       A -> T (in MHS1; reveals an altered
FT                                calcium dependence and increased caffeine
FT                                sensitivity; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs193922802).
FT                                {ECO:0000269|PubMed:11525881,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_045721.
FT   VARIANT    2351   2351       N -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs376176332).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071738.
FT   VARIANT    2354   2354       V -> M (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071739.
FT   VARIANT    2355   2355       R -> C (in MHS1).
FT                                {ECO:0000269|PubMed:12123492}.
FT                                /FTId=VAR_045722.
FT   VARIANT    2358   2358       I -> L (in MHS1; unknown pathological
FT                                significance; dbSNP:rs759306349).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071740.
FT   VARIANT    2367   2367       A -> T (in MHS1; dbSNP:rs146306934).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045723.
FT   VARIANT    2375   2375       G -> A (increases calcium-induced calcium
FT                                release activity; dbSNP:rs193922807).
FT                                {ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_077682.
FT   VARIANT    2383   2383       A -> Q (in MHS1; requires 2 nucleotide
FT                                substitutions; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071741.
FT   VARIANT    2400   2400       D -> G (in MHS1; dbSNP:rs976108591).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071742.
FT   VARIANT    2404   2404       E -> K (in MHS1; dbSNP:rs111364296).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058569.
FT   VARIANT    2421   2421       A -> P (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922808).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045724.
FT   VARIANT    2423   2423       M -> K (in MMDO and CCD; autosomal
FT                                recessive form; dbSNP:rs118192174).
FT                                {ECO:0000269|PubMed:16380615,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_032915.
FT   VARIANT    2428   2428       A -> T (in MHS1; induces an increase
FT                                sensitivity to caffeine;
FT                                dbSNP:rs193922809).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045725.
FT   VARIANT    2431   2431       D -> N (in MHS1; dbSNP:rs193922810).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045726.
FT   VARIANT    2434   2434       G -> R (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs121918593).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:7849712,
FT                                ECO:0000269|PubMed:7881417}.
FT                                /FTId=VAR_005605.
FT   VARIANT    2435   2435       R -> H (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs28933396).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:8220422}.
FT                                /FTId=VAR_005606.
FT   VARIANT    2435   2435       R -> L (in MHS1; dbSNP:rs28933396).
FT                                {ECO:0000269|PubMed:10051009,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_008974.
FT   VARIANT    2437   2437       A -> V (in MHS1; dbSNP:rs193922812).
FT                                {ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045727.
FT   VARIANT    2452   2452       R -> W (in MHS1; dbSNP:rs118192124).
FT                                {ECO:0000269|PubMed:10823104,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045728.
FT   VARIANT    2454   2454       R -> C (in MHS1; induces an increase
FT                                sensitivity to caffeine; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs193922816).
FT                                {ECO:0000269|PubMed:10612851,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_008975.
FT   VARIANT    2454   2454       R -> H (in MHS1; severe form; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192122).
FT                                {ECO:0000269|PubMed:10051009,
FT                                ECO:0000269|PubMed:10823104,
FT                                ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12709367,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_008976.
FT   VARIANT    2458   2458       R -> C (in MHS1; dbSNP:rs28933397).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9450902}.
FT                                /FTId=VAR_008977.
FT   VARIANT    2458   2458       R -> H (in MHS1; dbSNP:rs121918594).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9450902}.
FT                                /FTId=VAR_008978.
FT   VARIANT    2508   2508       R -> C (in MHS1 and CCD; increases
FT                                sensitivity to caffeine and 4-chloro-m-
FT                                cresol; decreases protein abundance;
FT                                increases calcium-induced calcium release
FT                                activity; dbSNP:rs118192178).
FT                                {ECO:0000269|PubMed:19685112,
FT                                ECO:0000269|PubMed:26381711,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_075399.
FT   VARIANT    2508   2508       R -> G (in CCD; increases sensitivity to
FT                                caffeine and 4-chloro-m-cresol;
FT                                dbSNP:rs118192178).
FT                                {ECO:0000269|PubMed:20142353,
FT                                ECO:0000269|PubMed:26381711}.
FT                                /FTId=VAR_068516.
FT   VARIANT    2508   2508       R -> H (in MHS1; increases sensitivity to
FT                                caffeine and 4-chloro-m-cresol; decreases
FT                                protein abundance; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922818).
FT                                {ECO:0000269|PubMed:26381711,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_077683.
FT   VARIANT    2509   2509       V -> I (in dbSNP:rs2071088).
FT                                /FTId=VAR_051891.
FT   VARIANT    2550   2550       L -> V (in dbSNP:rs193922821).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:8661021}.
FT                                /FTId=VAR_058570.
FT   VARIANT    2593   2593       R -> G (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071743.
FT   VARIANT    2627   2627       V -> M (in MHS1).
FT                                {ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_071744.
FT   VARIANT    2676   2676       R -> W (in MHS1; located on the same
FT                                allele as S-2787; dbSNP:rs193922826).
FT                                {ECO:0000269|PubMed:14732627,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045729.
FT   VARIANT    2730   2730       D -> G (in MHS1; dbSNP:rs112196644).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058571.
FT   VARIANT    2779   2779       E -> K (in dbSNP:rs2915952).
FT                                /FTId=VAR_051892.
FT   VARIANT    2787   2787       T -> S (in MHS1; located on the same
FT                                allele as W-2676; dbSNP:rs35180584).
FT                                {ECO:0000269|PubMed:14732627,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045730.
FT   VARIANT    2880   2880       E -> K (in MHS1; dbSNP:rs112772310).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058572.
FT   VARIANT    2963   2963       L -> P (in CCD; dbSNP:rs756870293).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076568.
FT   VARIANT    2976   2976       H -> Y. {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071745.
FT   VARIANT    3118   3118       A -> V (in dbSNP:rs2915960).
FT                                /FTId=VAR_045731.
FT   VARIANT    3217   3217       S -> P (in MHS1; dbSNP:rs113422327).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058573.
FT   VARIANT    3238   3238       E -> G (in CCD; unknown pathological
FT                                significance; dbSNP:rs200950673).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071746.
FT   VARIANT    3290   3290       E -> K (in MHS1; dbSNP:rs112151058).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058574.
FT   VARIANT    3326   3326       N -> K (in MMDO; dbSNP:rs367543057).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063848.
FT   VARIANT    3360   3360       P -> Q. {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071747.
FT   VARIANT    3366   3366       R -> H (in CCD; dbSNP:rs137932199).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068517.
FT   VARIANT    3402   3402       C -> G (in MMDO; dbSNP:rs367543058).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063849.
FT   VARIANT    3410   3410       P -> Q (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071748.
FT   VARIANT    3501   3501       D -> Y (in MHS1; dbSNP:rs763259167).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071749.
FT   VARIANT    3527   3527       P -> S (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192164).
FT                                {ECO:0000269|PubMed:12112081}.
FT                                /FTId=VAR_045732.
FT   VARIANT    3539   3539       R -> H (in CCD; autosomal recessive form;
FT                                dbSNP:rs143987857).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045733.
FT   VARIANT    3583   3583       E -> Q (in dbSNP:rs55876273).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058575.
FT   VARIANT    3711   3711       T -> R (in MHS1; unknown pathological
FT                                significance; dbSNP:rs375915752).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071750.
FT   VARIANT    3756   3756       Q -> E (in dbSNP:rs4802584).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_032916.
FT   VARIANT    3772   3772       R -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922839).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045734.
FT   VARIANT    3772   3772       R -> W (in MHS1; dbSNP:rs763112609).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058576.
FT   VARIANT    3806   3806       G -> R (in MHS1; dbSNP:rs111565359).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058577.
FT   VARIANT    3916   3916       I -> M (in MHS1; dbSNP:rs193922840).
FT                                {ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045735.
FT   VARIANT    3933   3933       Y -> C (in CCD and MHS1;
FT                                dbSNP:rs147136339).
FT                                {ECO:0000269|PubMed:20681998,
FT                                ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068518.
FT   VARIANT    4136   4136       R -> S (in MHS1; dbSNP:rs193922849).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045736.
FT   VARIANT    4178   4178       G -> V (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071751.
FT   VARIANT    4214   4216       Missing (in CCD).
FT                                /FTId=VAR_045737.
FT   VARIANT    4230   4230       M -> R (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071752.
FT   VARIANT    4234   4234       V -> L (in MHS1; dbSNP:rs193922852).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_045738.
FT   VARIANT    4493   4493       P -> A (in dbSNP:rs149455643).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068519.
FT   VARIANT    4501   4501       P -> L (in MHS1; dbSNP:rs73933023).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058578.
FT   VARIANT    4558   4558       R -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192130).
FT                                {ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045739.
FT   VARIANT    4637   4637       T -> A (in CCD; dbSNP:rs118192166).
FT                                {ECO:0000269|PubMed:11113224}.
FT                                /FTId=VAR_045740.
FT   VARIANT    4637   4637       T -> I (in core/rod disease;
FT                                dbSNP:rs118192134).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045741.
FT   VARIANT    4638   4638       G -> D (in CCD; dbSNP:rs118192135).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045742.
FT   VARIANT    4647   4648       Missing (in CCD).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045743.
FT   VARIANT    4650   4650       L -> P (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192138).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045744.
FT   VARIANT    4651   4651       H -> P (in CCD; dbSNP:rs118192139).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045745.
FT   VARIANT    4668   4668       P -> S (in dbSNP:rs193922863).
FT                                {ECO:0000269|PubMed:11928716}.
FT                                /FTId=VAR_045746.
FT   VARIANT    4684   4684       F -> S (in MHS1; dbSNP:rs193922864).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045747.
FT   VARIANT    4724   4724       K -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192141).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045748.
FT   VARIANT    4737   4737       R -> Q (in MHS1; dbSNP:rs193922868).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045749.
FT   VARIANT    4737   4737       R -> W (in MHS1; unknown pathological
FT                                significance; slightly increases Ca(2+)
FT                                release in response to 4-chloro-m-cresol;
FT                                dbSNP:rs193922867).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26631338}.
FT                                /FTId=VAR_045750.
FT   VARIANT    4743   4743       G -> D (in CCD; dbSNP:rs193922869).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068520.
FT   VARIANT    4793   4793       L -> P (in CCD; dbSNP:rs118192179).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045751.
FT   VARIANT    4796   4796       Y -> C (in CCD; dbSNP:rs118192167).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045752.
FT   VARIANT    4806   4806       N -> D (in CCD; dbSNP:rs886039586).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076569.
FT   VARIANT    4814   4814       L -> F (in CCD; dbSNP:rs118192142).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045753.
FT   VARIANT    4824   4824       L -> P (in MHS1; dbSNP:rs193922874).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045754.
FT   VARIANT    4825   4825       R -> C (in CCD; dbSNP:rs118192180).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045755.
FT   VARIANT    4826   4826       T -> I (in MHS1; dbSNP:rs121918595).
FT                                {ECO:0000269|PubMed:10888602,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045756.
FT   VARIANT    4837   4837       Q -> E (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071753.
FT   VARIANT    4838   4838       L -> V (in MHS1; dbSNP:rs193922878).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045757.
FT   VARIANT    4842   4842       V -> M (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922879).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045758.
FT   VARIANT    4846   4846       A -> V (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192143).
FT                                {ECO:0000269|PubMed:17204054,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045759.
FT   VARIANT    4849   4849       V -> I (in MHS1 and CCD; autosomal
FT                                recessive form; dbSNP:rs118192168).
FT                                {ECO:0000269|PubMed:12136074,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045760.
FT   VARIANT    4860   4860       Missing (in CCD).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045761.
FT   VARIANT    4861   4861       R -> C (in CCD; dbSNP:rs118192181).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045762.
FT   VARIANT    4861   4861       R -> H (in CCD and MHS1; release of
FT                                calcium from intracellular stores in the
FT                                absence of any pharmacological activator
FT                                of RYR; dbSNP:rs63749869).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14670767,
FT                                ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_045763.
FT   VARIANT    4863   4869       FYNKSED -> Y (in CCD).
FT                                /FTId=VAR_045764.
FT   VARIANT    4864   4864       Y -> C (in CCD; dbSNP:rs118192146).
FT                                {ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045765.
FT   VARIANT    4876   4876       K -> R (in MHS1; dbSNP:rs113210953).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045766.
FT   VARIANT    4882   4882       T -> M (in CCD; dbSNP:rs193922884).
FT                                {ECO:0000269|PubMed:18312400}.
FT                                /FTId=VAR_068521.
FT   VARIANT    4891   4891       G -> R (in CCD; dbSNP:rs118192149).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045767.
FT   VARIANT    4893   4893       R -> Q (in CCD; dbSNP:rs118192151).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045768.
FT   VARIANT    4893   4893       R -> W (in CCD; release of calcium from
FT                                intracellular stores in the absence of
FT                                any pharmacological activator of RYR;
FT                                smaller thapsigargin-sensitive
FT                                intracellular calcium stores; normal
FT                                sensitivity of the calcium release to the
FT                                RYR inhibitor dantrolene;
FT                                dbSNP:rs118192150).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045769.
FT   VARIANT    4897   4897       G -> A (in CCD).
FT                                {ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_071754.
FT   VARIANT    4897   4897       G -> V (in CCD; dbSNP:rs118192148).
FT                                {ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045770.
FT   VARIANT    4898   4898       I -> T (in CCD; severe phenotype;
FT                                dbSNP:rs118192170).
FT                                {ECO:0000269|PubMed:10097181,
FT                                ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_045771.
FT   VARIANT    4899   4899       G -> E (in CCD; dbSNP:rs118192183).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045772.
FT   VARIANT    4899   4899       G -> R (in CCD; release of calcium from
FT                                intracellular stores in the absence of
FT                                any pharmacological activator of RYR;
FT                                smaller thapsigargin-sensitive
FT                                intracellular calcium stores; normal
FT                                sensitivity of the calcium release to the
FT                                RYR inhibitor dantrolene;
FT                                dbSNP:rs193922891).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045773.
FT   VARIANT    4906   4906       A -> G (in MHS1; unknown pathological
FT                                significance; dbSNP:rs118192153).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071755.
FT   VARIANT    4906   4906       A -> V (in CCD; dbSNP:rs118192153).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045774.
FT   VARIANT    4914   4914       R -> G (in CCD; dbSNP:rs118192184).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045775.
FT   VARIANT    4914   4914       R -> T (in CCD; dbSNP:rs118192154).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045776.
FT   VARIANT    4927   4928       Missing (in CCD).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045777.
FT   VARIANT    4938   4938       I -> M (in CCD; dbSNP:rs118192159).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045778.
FT   VARIANT    4938   4938       I -> T (in MHS1; dbSNP:rs111657878).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058579.
FT   VARIANT    4939   4939       D -> E (in MHS1; dbSNP:rs193922895).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045779.
FT   VARIANT    4940   4940       A -> T (in CCD; dbSNP:rs118192158).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045780.
FT   VARIANT    4942   4942       G -> V (in MHS1; dbSNP:rs193922896).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045781.
FT   VARIANT    4973   4973       P -> L (in MHS1; dbSNP:rs146876145).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045782.
FT   MUTAGEN     522    522       Y->C: Increases calcium-induced calcium
FT                                release activity.
FT                                {ECO:0000269|PubMed:26115329}.
FT   MUTAGEN    2508   2508       R->K: Increases sensitivity to caffeine
FT                                and 4-chloro-m-cresol.
FT                                {ECO:0000269|PubMed:26381711}.
FT   MUTAGEN    2508   2508       R->S: Increases sensitivity to caffeine
FT                                and 4-chloro-m-cresol.
FT                                {ECO:0000269|PubMed:26381711}.
FT   CONFLICT   1365   1368       GEAQ -> RGA (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   2324   2324       N -> K (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   2840   2840       R -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   3380   3380       R -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   5038 AA;  565176 MW;  EC32277F4885CC7F CRC64;
     MGDAEGEDEV QFLRTDDEVV LQCSATVLKE QLKLCLAAEG FGNRLCFLEP TSNAQNVPPD
     LAICCFVLEQ SLSVRALQEM LANTVEAGVE SSQGGGHRTL LYGHAILLRH AHSRMYLSCL
     TTSRSMTDKL AFDVGLQEDA TGEACWWTMH PASKQRSEGE KVRVGDDIIL VSVSSERYLH
     LSTASGELQV DASFMQTLWN MNPICSRCEE GFVTGGHVLR LFHGHMDECL TISPADSDDQ
     RRLVYYEGGA VCTHARSLWR LEPLRISWSG SHLRWGQPLR VRHVTTGQYL ALTEDQGLVV
     VDASKAHTKA TSFCFRISKE KLDVAPKRDV EGMGPPEIKY GESLCFVQHV ASGLWLTYAA
     PDPKALRLGV LKKKAMLHQE GHMDDALSLT RCQQEESQAA RMIHSTNGLY NQFIKSLDSF
     SGKPRGSGPP AGTALPIEGV ILSLQDLIIY FEPPSEDLQH EEKQSKLRSL RNRQSLFQEE
     GMLSMVLNCI DRLNVYTTAA HFAEFAGEEA AESWKEIVNL LYELLASLIR GNRSNCALFS
     TNLDWLVSKL DRLEASSGIL EVLYCVLIES PEVLNIIQEN HIKSIISLLD KHGRNHKVLD
     VLCSLCVCNG VAVRSNQDLI TENLLPGREL LLQTNLINYV TSIRPNIFVG RAEGTTQYSK
     WYFEVMVDEV TPFLTAQATH LRVGWALTEG YTPYPGAGEG WGGNGVGDDL YSYGFDGLHL
     WTGHVARPVT SPGQHLLAPE DVISCCLDLS VPSISFRING CPVQGVFESF NLDGLFFPVV
     SFSAGVKVRF LLGGRHGEFK FLPPPGYAPC HEAVLPRERL HLEPIKEYRR EGPRGPHLVG
     PSRCLSHTDF VPCPVDTVQI VLPPHLERIR EKLAENIHEL WALTRIEQGW TYGPVRDDNK
     RLHPCLVDFH SLPEPERNYN LQMSGETLKT LLALGCHVGM ADEKAEDNLK KTKLPKTYMM
     SNGYKPAPLD LSHVRLTPAQ TTLVDRLAEN GHNVWARDRV GQGWSYSAVQ DIPARRNPRL
     VPYRLLDEAT KRSNRDSLCQ AVRTLLGYGY NIEPPDQEPS QVENQSRCDR VRIFRAEKSY
     TVQSGRWYFE FEAVTTGEMR VGWARPELRP DVELGADELA YVFNGHRGQR WHLGSEPFGR
     PWQPGDVVGC MIDLTENTII FTLNGEVLMS DSGSETAFRE IEIGDGFLPV CSLGPGQVGH
     LNLGQDVSSL RFFAICGLQE GFEPFAINMQ RPVTTWFSKG LPQFEPVPLE HPHYEVSRVD
     GTVDTPPCLR LTHRTWGSQN SLVEMLFLRL SLPVQFHQHF RCTAGATPLA PPGLQPPAED
     EARAAEPDPD YENLRRSAGG WSEAENGKEG TAKEGAPGGT PQAGGEAQPA RAENEKDATT
     EKNKKRGFLF KAKKVAMMTQ PPATPTLPRL PHDVVPADNR DDPEIILNTT TYYYSVRVFA
     GQEPSCVWAG WVTPDYHQHD MSFDLSKVRV VTVTMGDEQG NVHSSLKCSN CYMVWGGDFV
     SPGQQGRISH TDLVIGCLVD LATGLMTFTA NGKESNTFFQ VEPNTKLFPA VFVLPTHQNV
     IQFELGKQKN IMPLSAAMFQ SERKNPAPQC PPRLEMQMLM PVSWSRMPNH FLQVETRRAG
     ERLGWAVQCQ EPLTMMALHI PEENRCMDIL ELSERLDLQR FHSHTLRLYR AVCALGNNRV
     AHALCSHVDQ AQLLHALEDA HLPGPLRAGY YDLLISIHLE SACRSRRSML SEYIVPLTPE
     TRAITLFPPG RSTENGHPRH GLPGVGVTTS LRPPHHFSPP CFVAALPAAG AAEAPARLSP
     AIPLEALRDK ALRMLGEAVR DGGQHARDPV GGSVEFQFVP VLKLVSTLLV MGIFGDEDVK
     QILKMIEPEV FTEEEEEEDE EEEGEEEDEE EKEEDEEETA QEKEDEEKEE EEAAEGEKEE
     GLEEGLLQMK LPESVKLQMC HLLEYFCDQE LQHRVESLAA FAERYVDKLQ ANQRSRYGLL
     IKAFSMTAAE TARRTREFRS PPQEQINMLL QFKDGTDEED CPLPEEIRQD LLDFHQDLLA
     HCGIQLDGEE EEPEEETTLG SRLMSLLEKV RLVKKKEEKP EEERSAEESK PRSLQELVSH
     MVVRWAQEDF VQSPELVRAM FSLLHRQYDG LGELLRALPR AYTISPSSVE DTMSLLECLG
     QIRSLLIVQM GPQEENLMIQ SIGNIMNNKV FYQHPNLMRA LGMHETVMEV MVNVLGGGES
     KEIRFPKMVT SCCRFLCYFC RISRQNQRSM FDHLSYLLEN SGIGLGMQGS TPLDVAAASV
     IDNNELALAL QEQDLEKVVS YLAGCGLQSC PMLVAKGYPD IGWNPCGGER YLDFLRFAVF
     VNGESVEENA NVVVRLLIRK PECFGPALRG EGGSGLLAAI EEAIRISEDP ARDGPGIRRD
     RRREHFGEEP PEENRVHLGH AIMSFYAALI DLLGRCAPEM HLIQAGKGEA LRIRAILRSL
     VPLEDLVGII SLPLQIPTLG KDGALVQPKM SASFVPDHKA SMVLFLDRVY GIENQDFLLH
     VLDVGFLPDM RAAASLDTAT FSTTEMALAL NRYLCLAVLP LITKCAPLFA GTEHRAIMVD
     SMLHTVYRLS RGRSLTKAQR DVIEDCLMSL CRYIRPSMLQ HLLRRLVFDV PILNEFAKMP
     LKLLTNHYER CWKYYCLPTG WANFGVTSEE ELHLTRKLFW GIFDSLAHKK YDPELYRMAM
     PCLCAIAGAL PPDYVDASYS SKAEKKATVD AEGNFDPRPV ETLNVIIPEK LDSFINKFAE
     YTHEKWAFDK IQNNWSYGEN IDEELKTHPM LRPYKTFSEK DKEIYRWPIK ESLKAMIAWE
     WTIEKAREGE EEKTEKKKTR KISQSAQTYD PREGYNPQPP DLSAVTLSRE LQAMAEQLAE
     NYHNTWGRKK KQELEAKGGG THPLLVPYDT LTAKEKARDR EKAQELLKFL QMNGYAVTRG
     LKDMELDSSS IEKRFAFGFL QQLLRWMDIS QEFIAHLEAV VSSGRVEKSP HEQEIKFFAK
     ILLPLINQYF TNHCLYFLST PAKVLGSGGH ASNKEKEMIT SLFCKLAALV RHRVSLFGTD
     APAVVNCLHI LARSLDARTV MKSGPEIVKA GLRSFFESAS EDIEKMVENL RLGKVSQART
     QVKGVGQNLT YTTVALLPVL TTLFQHIAQH QFGDDVILDD VQVSCYRTLC SIYSLGTTKN
     TYVEKLRPAL GECLARLAAA MPVAFLEPQL NEYNACSVYT TKSPRERAIL GLPNSVEEMC
     PDIPVLERLM ADIGGLAESG ARYTEMPHVI EITLPMLCSY LPRWWERGPE APPSALPAGA
     PPPCTAVTSD HLNSLLGNIL RIIVNNLGID EASWMKRLAV FAQPIVSRAR PELLQSHFIP
     TIGRLRKRAG KVVSEEEQLR LEAKAEAQEG ELLVRDEFSV LCRDLYALYP LLIRYVDNNR
     AQWLTEPNPS AEELFRMVGE IFIYWSKSHN FKREEQNFVV QNEINNMSFL TADNKSKMAK
     AGDIQSGGSD QERTKKKRRG DRYSVQTSLI VATLKKMLPI GLNMCAPTDQ DLITLAKTRY
     ALKDTDEEVR EFLHNNLHLQ GKVEGSPSLR WQMALYRGVP GREEDADDPE KIVRRVQEVS
     AVLYYLDQTE HPYKSKKAVW HKLLSKQRRR AVVACFRMTP LYNLPTHRAC NMFLESYKAA
     WILTEDHSFE DRMIDDLSKA GEQEEEEEEV EEKKPDPLHQ LVLHFSRTAL TEKSKLDEDY
     LYMAYADIMA KSCHLEEGGE NGEAEEEVEV SFEEKQMEKQ RLLYQQARLH TRGAAEMVLQ
     MISACKGETG AMVSSTLKLG ISILNGGNAE VQQKMLDYLK DKKEVGFFQS IQALMQTCSV
     LDLNAFERQN KAEGLGMVNE DGTVINRQNG EKVMADDEFT QDLFRFLQLL CEGHNNDFQN
     YLRTQTGNTT TINIIICTVD YLLRLQESIS DFYWYYSGKD VIEEQGKRNF SKAMSVAKQV
     FNSLTEYIQG PCTGNQQSLA HSRLWDAVVG FLHVFAHMMM KLAQDSSQIE LLKELLDLQK
     DMVVMLLSLL EGNVVNGMIA RQMVDMLVES SSNVEMILKF FDMFLKLKDI VGSEAFQDYV
     TDPRGLISKK DFQKAMDSQK QFSGPEIQFL LSCSEADENE MINCEEFANR FQEPARDIGF
     NVAVLLTNLS EHVPHDPRLH NFLELAESIL EYFRPYLGRI EIMGASRRIE RIYFEISETN
     RAQWEMPQVK ESKRQFIFDV VNEGGEAEKM ELFVSFCEDT IFEMQIAAQI SEPEGEPETD
     EDEGAGAAEA GAEGAEEGAA GLEGTAATAA AGATARVVAA AGRALRGLSY RSLRRRVRRL
     RRLTAREAAT AVAALLWAAV TRAGAAGAGA AAGALGLLWG SLFGGGLVEG AKKVTVTELL
     AGMPDPTSDE VHGEQPAGPG GDADGEGASE GAGDAAEGAG DEEEAVHEAG PGGADGAVAV
     TDGGPFRPEG AGGLGDMGDT TPAEPPTPEG SPILKRKLGV DGVEEELPPE PEPEPEPELE
     PEKADAENGE KEEVPEPTPE PPKKQAPPSP PPKKEEAGGE FWGELEVQRV KFLNYLSRNF
     YTLRFLALFL AFAINFILLF YKVSDSPPGE DDMEGSAAGD VSGAGSGGSS GWGLGAGEEA
     EGDEDENMVY YFLEESTGYM EPALRCLSLL HTLVAFLCII GYNCLKVPLV IFKREKELAR
     KLEFDGLYIT EQPEDDDVKG QWDRLVLNTP SFPSNYWDKF VKRKVLDKHG DIYGRERIAE
     LLGMDLATLE ITAHNERKPN PPPGLLTWLM SIDVKYQIWK FGVIFTDNSF LYLGWYMVMS
     LLGHYNNFFF AAHLLDIAMG VKTLRTILSS VTHNGKQLVM TVGLLAVVVY LYTVVAFNFF
     RKFYNKSEDE DEPDMKCDDM MTCYLFHMYV GVRAGGGIGD EIEDPAGDEY ELYRVVFDIT
     FFFFVIVILL AIIQGLIIDA FGELRDQQEQ VKEDMETKCF ICGIGSDYFD TTPHGFETHT
     LEEHNLANYM FFLMYLINKD ETEHTGQESY VWKMYQERCW DFFPAGDCFR KQYEDQLS
//
ID   CAC1S_CYPCA             Reviewed;        1852 AA.
AC   P22316;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Dihydropyridine-sensitive L-type skeletal muscle calcium channel subunit alpha-1;
OS   Cyprinus carpio (Common carp).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Cyprinus.
OX   NCBI_TaxID=7962;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=1846962; DOI=10.1073/pnas.88.3.727;
RA   Grabner M., Friedrich K., Knaus H.-G., Striessnig J., Scheffauer F.,
RA   Staudinger R., Koch W.J., Schwartz A., Glossmann H.;
RT   "Calcium channels from Cyprinus carpio skeletal muscle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:727-731(1991).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, gene expression, cell motility, cell division and
CC       cell death. The isoform alpha-1S gives rise to L-type calcium
CC       currents. Long-lasting (L-type) calcium channels belong to the
CC       'high-voltage activated' (HVA) group. They are blocked by
CC       dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and B
CC       omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive
CC       to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA
CC       (omega-Aga-IVA). Calcium channels containing the alpha-1S subunit
CC       play an important role in excitation-contraction coupling in
CC       skeletal muscle (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity. An additional gamma subunit is present only in
CC       skeletal muscle L-type channel (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Skeletal muscle.
CC   -!- PTM: May be non-phosphorylated.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M62554; AAA49205.1; -; mRNA.
DR   PIR; A37860; A37860.
DR   ProteinModelPortal; P22316; -.
DR   HOVERGEN; HBG050763; -.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005450; VDCC_L_a1ssu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF190; PTHR10037:SF190; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01634; LVDCCALPHA1S.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1852       Dihydropyridine-sensitive L-type skeletal
FT                                muscle calcium channel subunit alpha-1.
FT                                /FTId=PRO_0000053948.
FT   TOPO_DOM      1     70       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     71     86       Helical; Name=S1 of repeat I.
FT   TOPO_DOM     87    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    127       Helical; Name=S2 of repeat I.
FT   TOPO_DOM    128    139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    140    155       Helical; Name=S3 of repeat I.
FT   TOPO_DOM    156    176       Extracellular. {ECO:0000255}.
FT   TRANSMEM    177    195       Helical; Name=S4 of repeat I.
FT   TOPO_DOM    196    214       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    215    234       Helical; Name=S5 of repeat I.
FT   TOPO_DOM    235    326       Extracellular. {ECO:0000255}.
FT   TRANSMEM    327    351       Helical; Name=S6 of repeat I.
FT   TOPO_DOM    352    447       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    448    466       Helical; Name=S1 of repeat II.
FT   TOPO_DOM    467    481       Extracellular. {ECO:0000255}.
FT   TRANSMEM    482    501       Helical; Name=S2 of repeat II.
FT   TOPO_DOM    502    509       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    510    528       Helical; Name=S3 of repeat II.
FT   TOPO_DOM    529    538       Extracellular. {ECO:0000255}.
FT   TRANSMEM    539    557       Helical; Name=S4 of repeat II.
FT   TOPO_DOM    558    576       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    577    596       Helical; Name=S5 of repeat II.
FT   TOPO_DOM    597    651       Extracellular. {ECO:0000255}.
FT   TRANSMEM    652    675       Helical; Name=S6 of repeat II.
FT   TOPO_DOM    676    815       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    816    834       Helical; Name=S1 of repeat III.
FT   TOPO_DOM    835    850       Extracellular. {ECO:0000255}.
FT   TRANSMEM    851    870       Helical; Name=S2 of repeat III.
FT   TOPO_DOM    871    882       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    883    901       Helical; Name=S3 of repeat III.
FT   TOPO_DOM    902    908       Extracellular. {ECO:0000255}.
FT   TRANSMEM    909    927       Helical; Name=S4 of repeat III.
FT   TOPO_DOM    928    946       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    947    966       Helical; Name=S5 of repeat III.
FT   TOPO_DOM    967   1056       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1057   1081       Helical; Name=S6 of repeat III.
FT   TOPO_DOM   1082   1134       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1135   1153       Helical; Name=S1 of repeat IV.
FT   TOPO_DOM   1154   1168       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1169   1188       Helical; Name=S2 of repeat IV.
FT   TOPO_DOM   1189   1196       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1197   1215       Helical; Name=S3 of repeat IV.
FT   TOPO_DOM   1216   1252       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1253   1271       Helical; Name=S4 of repeat IV.
FT   TOPO_DOM   1272   1290       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1291   1310       Helical; Name=S5 of repeat IV.
FT   TOPO_DOM   1311   1377       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1378   1402       Helical; Name=S6 of repeat IV.
FT   TOPO_DOM   1403   1852       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       57    354       I.
FT   REPEAT      433    679       II.
FT   REPEAT      802   1084       III.
FT   REPEAT     1121   1405       IV.
FT   DOMAIN     1418   1453       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND    1431   1442       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      374    391       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   REGION     1004   1093       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1358   1424       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1370   1413       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS      4     12       Poly-Gly.
FT   COMPBIAS    400    403       Poly-Leu.
FT   COMPBIAS    577    583       Poly-Leu.
FT   COMPBIAS   1062   1068       Poly-Ile.
FT   SITE        309    309       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        628    628       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1030   1030       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1344   1344       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES     407    407       Phosphothreonine; by PKA. {ECO:0000255}.
FT   MOD_RES    1413   1413       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1471   1471       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1523   1523       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1738   1738       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    470    470       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1157   1157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1852 AA;  210098 MW;  7D5FAE83501D6CDB CRC64;
     MESGSGGGGG GGVAALASFI MNEEELKRKQ REKLKKLQAT GGNPRPPRSL FFFTLKNPFR
     KTCINIVEWK PFEIIILLTI FANCVALAVF LPMPEEDTNN TNLTLESLEY IFLVIFTLEC
     FLKIVAYGLL FHEGAYLRNC WNILDFVIVF MGLFTLVVDT INTIAGVPTE KGGGFDMKAL
     RAFRVLRPLR LVSGVPSLQV VMSSILKSML PLFHIALLVF FMVHIYAIMG LELFKCKMHK
     TCYYQGTNII AVREGNEKPS PCAQAGHGRR CTINGTECRA GWPGPNFGIT HFDNSCFAML
     TVFQCITTES WTDVLYWIND AMGNDWPWIY FLTLILVGSF FILNLVLGAL SGEFTKEREE
     SRSRGEYQKL RERQQMDEDL EGYMEWITHA EVMDGDSEAL LLLRKDTDSE SDSLYQMLDQ
     QVIYFYRLAR RWNVVLRRKC HVWVKSKFFN WWVLLVVLLN TLVIAMEHHN QTEGLTSFQD
     TANVILLACF TIEMVMKMYA FGPRAYFMSI FNRFDCFVVT IGILEIILVV SNIMTPLGIS
     VMRCIRLLRL FKLTRYWTSL NNLVASLLNS VKSIASLLLL LFLFIVIFAL LGMQVFGGKF
     NFPDRVIQRS NFDNFPQALI SVFQVLTGEE WDSIMYNGIM AHGGPQSPGI LVSIYFIILY
     VCGNFVLLNV FLAIAVDNLA EAESLTAAQK EKAEEKARRK LMRTLPEKSE EEKALMAKRL
     MESRSKAEGM PTTAKLKIDE FESNVNEVKD PFPPADFPGD HEEVEPEIPI SPRPRPMADL
     QLKETVVPIA EASSFFIFGP QHKFRKLCHR IVNHTTFTNI ILLFILLSSI SLAAEDPIDP
     RSFRNKVLAY ADIVFTTVFT IEIVLKMTVY GAFLHTGSFC RNSFNILDLI VVGVSLLSMG
     MESSTISVVK ILRVLRVLRP LRAINRAKGL KHVVQCMFVA IKTIGNIVLV TMLLDFMFAC
     IGVQLFKGKL YYCTDPLQKT AEECQGTFLK HVPNSLHDIE VHQRMWVNSD FNFDNVLNGM
     LALFTISTFE GWPEILYKAI DSNAVDTGPL YNNRVGISIF FIIYIIIIAF FMMNIFVGFV
     IVTFQKQGEQ EYKDCELDKN QRQCVQYALK ARPLKCYIPK NPHQYRVWYF VTSCYFEYLM
     FFLIMLNTLC LGIQHCNQSD HITKLSDTLN LIFTVLFTGE MIVKLIAFKA KGYFGDPWNV
     FDFIIVVGSI VDVVLSEVDA ALEARGGLWC LHGCAEVNPM QAIAEAENVR VSITFFRLFR
     VLRLIKLLNR SEGIRNLLWT FIKSFQALPH VGLLIVMLFF IYAVIGMQMF GKVALVDGTE
     INRNNNFQTF PQAVLLLFRV ATGEQWPKVI LASMYGKLCD AKSDYGPGEE YTCGSSIAVF
     YFLSFYILCA FLIINLFVAI IMDNVDYLTR DWSILGPHHL DEFKKIWAEY DPEATGRIKH
     LDVVTLLRRI QPPLGFGKFC PHRSACKRLI SMNMPLNSDG TVTFNATLFA LVRTALKIKT
     EGNFEQANEE LRAIIKSIWK RTSMKLLDQV IPPIGEDEVT VGKFYATFLI QEHFRKFMQR
     QEEYYGYRPT KKNADEIKAG LRSIEEEAAP ELHRAISGDL IAEDDMERAL EAGEEGIYRR
     TGGLFGLHTD PFSSEPSSPL STQMTSQRPL QFVETRLEDI ESPPDSVFLP NTEFFPDNMP
     TTTNTNNNAN FVEDMSSRFT FENESLSAAA TRNYSYEDIR GSSSYVGGAS SVDDRRLSDF
     TVRTNITQFP YNPSYGPSKN QTATEASPAT DKLIQQALRD GGLDSLAEDP KFVSVTRKEL
     AEAINIGMED MEGMAQGIVN RQSGKVTKRK RRPIPVPPGT KSTKPKENTS AV
//
ID   CAC1D_RAT               Reviewed;        2203 AA.
AC   P27732; O09022; O09023; O09024; Q01542; Q62691; Q62815; Q63491;
AC   Q63492;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   20-DEC-2017, entry version 149.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1D;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 2;
DE   AltName: Full=Rat brain class D;
DE            Short=RBD;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.3;
GN   Name=Cacna1d; Synonyms=Cach3, Cacn4, Cacnl1a2, Cchl1a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Insulinoma;
RX   PubMed=7760845; DOI=10.1210/mend.9.1.7760845;
RA   Ihara Y., Yamada Y., Fujii Y., Gonoi T., Yano H., Yasuda K.,
RA   Inagaki N., Seino Y., Seino S.;
RT   "Molecular diversity and functional characterization of voltage-
RT   dependent calcium channels (CACN4) expressed in pancreatic beta-
RT   cells.";
RL   Mol. Endocrinol. 9:121-130(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 6; 7; 8 AND 13).
RC   TISSUE=Brain;
RX   PubMed=1648940; DOI=10.1016/0896-6273(91)90072-8;
RA   Hui A., Ellinor P.T., Krizanova O., Wang J.-J., Diebold R.J.,
RA   Schwartz A.;
RT   "Molecular cloning of multiple subtypes of a novel rat brain isoform
RT   of the alpha-1 subunit of the voltage-dependent calcium channel.";
RL   Neuron 7:35-44(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-125.
RX   PubMed=7553731; DOI=10.1007/BF02089942;
RA   Kamp T.J., Mitas M., Fields K.L., Asoh S., Chin H., Marban E.,
RA   Nirenberg M.;
RT   "Transcriptional regulation of the neuronal L-type calcium channel
RT   alpha 1D subunit gene.";
RL   Cell. Mol. Neurobiol. 15:307-326(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1100-1410 (ISOFORMS 4 AND 11).
RC   TISSUE=Kidney;
RX   PubMed=1279681; DOI=10.1073/pnas.89.21.10494;
RA   Yu A.S.L., Hebert S.C., Brenner B.M., Lytton J.;
RT   "Molecular characterization and nephron distribution of a family of
RT   transcripts encoding the pore-forming subunit of Ca2+ channels in the
RT   kidney.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10494-10498(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1218-1498 (ISOFORM 12).
RC   TISSUE=Osteosarcoma;
RX   PubMed=7479909; DOI=10.1073/pnas.92.24.10914;
RA   Barry E.L.R., Gesek F.A., Froehner S.C., Friedman P.A.;
RT   "Multiple calcium channel transcripts in rat osteosarcoma cells:
RT   selective activation of alpha 1D isoform by parathyroid hormone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10914-10918(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1200-1493 (ISOFORMS 3; 4; 5; 9 AND 10).
RC   TISSUE=Hepatoma;
RX   PubMed=9232351; DOI=10.1016/S0143-4160(97)90088-9;
RA   Brereton H.M., Harland M.L., Froscio M., Petronijevic T.,
RA   Barritt G.J.;
RT   "Novel variants of voltage-operated calcium channel alpha-1 subunit
RT   transcripts in a rat liver-derived cell line: deletion in the IVS4
RT   voltage sensing region.";
RL   Cell Calcium 22:39-52(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 1307-1479 (ISOFORM 3).
RX   PubMed=1692134; DOI=10.1073/pnas.87.9.3391;
RA   Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., Davidson N.;
RT   "Rat brain expresses a heterogeneous family of calcium channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3391-3395(1990).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF 1656-ILE-GLN-1657, INTERACTION WITH CABP1 AND
RP   CABP4, AND TISSUE SPECIFICITY.
RX   PubMed=17050707; DOI=10.1523/JNEUROSCI.3236-06.2006;
RA   Yang P.S., Alseikhan B.A., Hiel H., Grant L., Mori M.X., Yang W.,
RA   Fuchs P.A., Yue D.T.;
RT   "Switching of Ca2+-dependent inactivation of Ca(v)1.3 channels by
RT   calcium binding proteins of auditory hair cells.";
RL   J. Neurosci. 26:10677-10689(2006).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1D
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       {ECO:0000269|PubMed:17050707}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts with CABP1 and CABP4, resulting in a near elimination of
CC       calcium-dependent inactivation of the channel. Interacts with
CC       RIMBP2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O88871:Gabbr2; NbExp=6; IntAct=EBI-8072674, EBI-7090239;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC         Comment=The region sequenced in isoforms ROB3 and RKC5 is
CC         identical to CACN4.;
CC       Name=1; Synonyms=CACN4A;
CC         IsoId=P27732-1; Sequence=Displayed;
CC       Name=2; Synonyms=CACN4B;
CC         IsoId=P27732-2; Sequence=VSP_000923, VSP_000924;
CC       Name=3; Synonyms=CACH3A, RB48, RBD-55;
CC         IsoId=P27732-3; Sequence=VSP_000921;
CC       Name=4; Synonyms=Delta-IV-S3, RKC6;
CC         IsoId=P27732-4; Sequence=VSP_000919;
CC       Name=5; Synonyms=Delta-IV-S4;
CC         IsoId=P27732-5; Sequence=VSP_000922;
CC       Name=6; Synonyms=RB9;
CC         IsoId=P27732-6; Sequence=VSP_000920, VSP_000921;
CC       Name=7; Synonyms=RB11;
CC         IsoId=P27732-7; Sequence=VSP_000917;
CC       Name=8; Synonyms=RB34;
CC         IsoId=P27732-8; Sequence=VSP_000916;
CC       Name=9; Synonyms=RH1;
CC         IsoId=P27732-9; Sequence=VSP_000918;
CC       Name=10; Synonyms=RH2;
CC         IsoId=P27732-10; Sequence=VSP_000919, VSP_000922;
CC       Name=11; Synonyms=RKC5;
CC         IsoId=P27732-13; Sequence=Not described;
CC       Name=12; Synonyms=ROB3;
CC         IsoId=P27732-14; Sequence=Not described;
CC       Name=13; Synonyms=Truncated;
CC         IsoId=P27732-12; Sequence=VSP_000925, VSP_000926;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, pancreatic islets and B-
CC       lymphocytes. {ECO:0000269|PubMed:17050707}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1D subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38101; BAA07282.1; -; mRNA.
DR   EMBL; D38102; BAA07283.1; -; mRNA.
DR   EMBL; M57682; AAA42015.1; -; mRNA.
DR   EMBL; U14005; AAB60515.1; -; Genomic_DNA.
DR   EMBL; M99221; AAA40895.1; -; mRNA.
DR   EMBL; U31772; AAA89156.1; -; mRNA.
DR   EMBL; U49126; AAB61634.1; -; mRNA.
DR   EMBL; U49127; AAB61635.1; -; mRNA.
DR   EMBL; U49128; AAB61636.1; -; mRNA.
DR   PIR; JH0422; JH0422.
DR   PIR; T42742; T42742.
DR   RefSeq; NP_058994.1; NM_017298.1. [P27732-1]
DR   UniGene; Rn.89671; -.
DR   ProteinModelPortal; P27732; -.
DR   DIP; DIP-60740N; -.
DR   IntAct; P27732; 4.
DR   MINT; MINT-7965882; -.
DR   STRING; 10116.ENSRNOP00000051407; -.
DR   BindingDB; P27732; -.
DR   ChEMBL; CHEMBL4132; -.
DR   GuidetoPHARMACOLOGY; 530; -.
DR   TCDB; 1.A.1.11.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P27732; -.
DR   PhosphoSitePlus; P27732; -.
DR   PaxDb; P27732; -.
DR   PRIDE; P27732; -.
DR   GeneID; 29716; -.
DR   KEGG; rno:29716; -.
DR   CTD; 776; -.
DR   RGD; 70973; Cacna1d.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; P27732; -.
DR   KO; K04851; -.
DR   PhylomeDB; P27732; -.
DR   PRO; PR:P27732; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0051393; F:alpha-actinin binding; ISO:RGD.
DR   GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:RGD.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086059; F:voltage-gated calcium channel activity involved SA node cell action potential; ISO:RGD.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0070509; P:calcium ion import; IMP:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:RGD.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISO:RGD.
DR   GO; GO:0070838; P:divalent metal ion transport; IMP:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; ISO:RGD.
DR   GO; GO:0007613; P:memory; IEP:RGD.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IMP:RGD.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:1901016; P:regulation of potassium ion transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005452; LVDCC_a1dsu.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF139; PTHR10037:SF139; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01636; LVDCCALPHA1D.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1   2203       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1D.
FT                                /FTId=PRO_0000053936.
FT   TOPO_DOM      1    126       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    127    145       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    146    163       Extracellular. {ECO:0000255}.
FT   TRANSMEM    164    183       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    184    195       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    196    214       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    215    235       Extracellular. {ECO:0000255}.
FT   TRANSMEM    236    254       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    255    273       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    274    293       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    294    381       Extracellular. {ECO:0000255}.
FT   TRANSMEM    382    406       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    407    582       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    583    602       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    603    617       Extracellular. {ECO:0000255}.
FT   TRANSMEM    618    636       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    637    644       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    645    663       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    664    673       Extracellular. {ECO:0000255}.
FT   TRANSMEM    674    692       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    693    711       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    712    732       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    733    786       Extracellular. {ECO:0000255}.
FT   TRANSMEM    787    811       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    812    945       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    946    964       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    965    980       Extracellular. {ECO:0000255}.
FT   TRANSMEM    981   1000       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1001   1012       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1013   1031       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1032   1037       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1038   1057       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1058   1076       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1077   1096       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1097   1186       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1187   1207       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1208   1264       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1265   1283       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1284   1298       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1299   1318       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1319   1325       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1326   1347       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1348   1357       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1358   1377       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1378   1396       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1397   1416       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1417   1483       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1484   1508       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1509   2203       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      112    408       I.
FT   REPEAT      528    774       II.
FT   REPEAT      892   1174       III.
FT   REPEAT     1211   1486       IV.
FT   CA_BIND    1537   1548       {ECO:0000255}.
FT   REGION      429    446       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   REGION     1134   1224       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1464   1530       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1476   1519       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS      1      7       Poly-Met.
FT   COMPBIAS    712    718       Poly-Leu.
FT   COMPBIAS    886    897       Poly-Glu.
FT   SITE        364    364       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        763    763       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1160   1160       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1450   1450       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1519   1519       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    329    329       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     481    492       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:1648940}.
FT                                /FTId=VSP_000916.
FT   VAR_SEQ     493    512       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:1648940}.
FT                                /FTId=VSP_000917.
FT   VAR_SEQ    1322   1392       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:9232351}.
FT                                /FTId=VSP_000918.
FT   VAR_SEQ    1322   1349       Missing (in isoform 4 and isoform 10).
FT                                {ECO:0000303|PubMed:1279681,
FT                                ECO:0000303|PubMed:9232351}.
FT                                /FTId=VSP_000919.
FT   VAR_SEQ    1322   1348       GYFSDAWNTFDSLIVIGSIIDVALSEA -> HYFTDAWNTF
FT                                DALIVVGSVVDIAITEVN (in isoform 6).
FT                                {ECO:0000303|PubMed:1648940}.
FT                                /FTId=VSP_000920.
FT   VAR_SEQ    1349   1349       D -> DPSDSENIPLPTATPG (in isoform 6 and
FT                                isoform 3). {ECO:0000303|PubMed:1648940,
FT                                ECO:0000303|PubMed:9232351}.
FT                                /FTId=VSP_000921.
FT   VAR_SEQ    1354   1368       Missing (in isoform 10 and isoform 5).
FT                                {ECO:0000303|PubMed:9232351}.
FT                                /FTId=VSP_000922.
FT   VAR_SEQ    1642   1668       DDEVTVGKFYATFLIQDYFRKFKKRKE -> GNSRSGKSKA
FT                                WWGNTLRRTPRSPYRRD (in isoform 2).
FT                                {ECO:0000303|PubMed:7760845}.
FT                                /FTId=VSP_000923.
FT   VAR_SEQ    1669   2203       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7760845}.
FT                                /FTId=VSP_000924.
FT   VAR_SEQ    1686   1691       AGLRTL -> MLERML (in isoform 13).
FT                                {ECO:0000303|PubMed:1648940}.
FT                                /FTId=VSP_000925.
FT   VAR_SEQ    1692   2203       Missing (in isoform 13).
FT                                {ECO:0000303|PubMed:1648940}.
FT                                /FTId=VSP_000926.
FT   MUTAGEN    1656   1657       IQ->AA: Loss of calcium-dependent
FT                                inactivation related to the C-terminal
FT                                lobe of calmodulin.
FT                                {ECO:0000269|PubMed:17050707}.
FT   CONFLICT    124    124       D -> N (in Ref. 2; AAA42015).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       S -> Y (in Ref. 2; AAA42015).
FT                                {ECO:0000305}.
FT   CONFLICT    192    192       S -> Y (in Ref. 2; AAA42015).
FT                                {ECO:0000305}.
FT   CONFLICT    513    513       G -> C (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    522    560       Missing (in Ref. 2). {ECO:0000305}.
FT   CONFLICT   1452   1452       W -> R (in Ref. 5; AAA89156).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2203 AA;  250136 MW;  8E746A8D988050C6 CRC64;
     MMMMMMMKKM QHQRQQQEDH ANEANYARGT RLPISGEGPT SQPNSSKQTV LSWQAAIDAA
     RQAKAAQTMS TSAPPPVGSL SQRKRQQYAK SKKQGNSSNS RPARALFCLS LNNPIRRACI
     SIVDWKPFDI FILLAIFANC VALAIYIPFP EDDSNSTNHN LEKVEYAFLI IFTVETFLKI
     IASGLLLHPN ASVRNGWNLL DFVIVIVGLF SVILEQLTKE TEGGNHSSGK SGGFDVKALR
     AFRVLRPLRL VSGVPSLQVV LNSIIKAMVP LLHIALLVLF VIIIYAIIGL ELFIGKMHKT
     CFFADSDIVA EEDPAPCAFS GNGRQCAANG TECRSGWVGP NGGITNFDNF AFAMLTVFQC
     ITMEGWTDVL YWVNDAIGWE WPWVYFVSLI ILGSFFVLNL VLGVLSGEFS KEREKAKARG
     DFQKLREKQQ LEEDLKGYLD WITQAEDIDP ENEEEGGEEG KRNTSMPTSE TESVNTENVS
     GEGETQGCCG SLWCWWKRRG AAKTGPSGCR RWGQAISKSK LRSHGAREAL CVCRCSLESL
     VKLWTSRFSA HLQAAYVRPY SRRWRRWNRF NRRRCRAAVK SVTFYWLVIV LVFLNTLTIS
     SEHYNQPDWL TQIQDIANKV LLALFTCEML VKMYSLGLQA YFVSLFNRFD CFVVCGGITE
     TILVELELMS PLGVSVFRCV RLLRIFKVTR HWTSLSNLVA SLLNSMKSIA SLLLLLFLFI
     IIFSLLGMQL FGGKFNFDET QTKRSTFDNF PQALLTVFQI LTGEDWNAVM YDGIMAYGGP
     SSSGMIVCIY FIILFICGNY ILLKLFLAIA VDNLADAESL NTAQKEEAEE KERKKIARKE
     SLENKKNNKP EVNQIANSDN KVTIDDYQEE AEDKDPYPPC DVPVGEEEEE EEEDEPEVPA
     GPRPRRISEL NMKEKIAPIP EGSAFFILSK TNPIRVGCHK LINHHIFTNL ILVFIMLSSA
     ALAAEDPIRS HSFRNTILGY FDYAFTAIFT VEILLKMTTF GAFLHKGAFC RNYFNLLDML
     VVGVSLVSFG IQSSAISVVK ILRVLRVLRP LRAINRAKGL KHVVQCVFVA IRTIGNIMIV
     TTLLQFMFAC IGVQLFKGKF YRCTDEAKSN PEECRGLFIL YKDGDVDSPV VRERIWQNSD
     FNFDNVLSAM MALFTVSTFE GWPALLYKAI DSNGENVGPV YNYRVEISIF FIIYIIIVAF
     FMMNIFVGFV IVTFQEQGEK EYKNCELDKN QRQCVEYALK ARPLRRYIPK NPYQYKFWYV
     VNSSPFEYMM FVLIMLNTLC LAMQHYEQSK MFNDAMDILN MVFTGVFTVE MVLKVIAFKP
     KGYFSDAWNT FDSLIVIGSI IDVALSEADN SEESNRISIT FFRLFRVMRL VKLLSRGEGI
     RTLLWTFIKS FQALPYVALL IAMLFFIYAV IGMQMFGKVA MRDNNQINRN NNFQTFPQAV
     LLLFRCATGE AWQEIMLACL PGKLCDPDSD YNPGEEYTCG SNFAIVYFIS FYMLCAFLII
     NLFVAVIMDN FDYLTRDWSI LGPHHLDEFK RIWSEYDPEA KGRIKHLDVV TLLRRIQPPL
     GFGKLCPHRV ACKRLVAMNM PLNSDGTVMF NATLFALVRT ALKIKTEGNL EQANEELRAV
     IKKIWKKTSM KLLDQVVPPA GDDEVTVGKF YATFLIQDYF RKFKKRKEQG LVGKYPAKNT
     TIALQAGLRT LHDIGPEIRR AISCDLQDDE PEDSKPEEED VFKRNGALLG NYVNHVNSDR
     RESLQQTNTT HRPLHVQRPS IPPASDTEKP LFPPAGNSVC HNHHNHNSIG KQVPTSTNAN
     LNNANMSKAA HGKRPSIGDL EHVSENGHYS YKHDRELQRR SSIKRTRYYE TYIRSESGDE
     QLPTIFREDP EIHGYFRDPR CFGEQEYFSS EECCEDDSSP TWSRQNYSYY NRYPGSSMDF
     ERPRGYHHPQ GFLEDDDSPI GYDSRRSPRR RLLPPTPPSH RRSSFNFECL RRQNSQDDVL
     PSPALPHRAA LPLHLMQQQI MAVAGLDSSK AQKYSPSHST RSWATPPATP PYRDWTPCYT
     PLIQVDRSES MDQVNGSLPS LHRSSWYTDE PDISYRTFTP ASLTVPSSFR NKNSDKQRSA
     DSLVEAVLIS EGLGRYARDP KFVSATKHEI ADACDLTIDE MESAASTLLN GSVCPRANGD
     MGPISHRQDY ELQDFGPGYS DEEPDPGREE EDLADEMICI TTL
//
ID   ITPR_DROME              Reviewed;        2838 AA.
AC   P29993; Q24309; Q9U981; Q9VNC8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 3.
DT   20-DEC-2017, entry version 171.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor;
DE   AltName: Full=InsP3 receptor;
DE            Short=IP3R;
DE            Short=InsP3R;
GN   Name=Itp-r83A; Synonyms=dip, InsP3R, itpr; ORFNames=CG1063;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=1322910;
RA   Yoshikawa S., Tanimura T., Miyawaki A., Nakamura M., Yuzaki M.,
RA   Furuichi T., Mikoshiba K.;
RT   "Molecular cloning and characterization of the inositol 1,4,5-
RT   trisphosphate receptor in Drosophila melanogaster.";
RL   J. Biol. Chem. 267:16613-16619(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RC   TISSUE=Embryo;
RX   PubMed=10375644; DOI=10.1016/S0378-1119(99)00158-4;
RA   Sinha M., Hasan G.;
RT   "Sequencing and exon mapping of the inositol 1,4,5-trisphosphate
RT   receptor cDNA from Drosophila embryos suggests the presence of
RT   differentially regulated forms of RNA and protein.";
RL   Gene 233:271-276(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 2370-2837, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=1338312;
RA   Hasan G., Rosbash M.;
RT   "Drosophila homologs of two mammalian intracellular Ca(2+)-release
RT   channels: identification and expression patterns of the inositol
RT   1,4,5-triphosphate and the ryanodine receptor genes.";
RL   Development 116:967-975(1992).
CC   -!- FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second
CC       messenger that mediates the release of intracellular calcium. May
CC       be involved in visual and olfactory transduction, and myoblast
CC       proliferation. {ECO:0000269|PubMed:1322910}.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B; Synonyms=Head;
CC         IsoId=P29993-1; Sequence=Displayed;
CC       Name=A; Synonyms=Embryo;
CC         IsoId=P29993-2; Sequence=VSP_002703;
CC   -!- TISSUE SPECIFICITY: Segmental expression of isoform B is first
CC       detected in stage 13 embryos in lateral and posterior epidermis.
CC       Expression extends to head region during stages 13-17: gnathal
CC       buds, clypeolabrum, procephalic lobe, labial organ and anterior
CC       sense organs. Adults exhibit high expression in antenna and lower
CC       expression in retina, head, legs and thorax.
CC       {ECO:0000269|PubMed:1322910, ECO:0000269|PubMed:1338312}.
CC   -!- DEVELOPMENTAL STAGE: Isoform A is expressed only in early embryos.
CC       Isoform B is expressed from mid-late embryos to adults.
CC       Predominant expression is in the adult.
CC       {ECO:0000269|PubMed:1338312}.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90403; BAA14399.1; -; mRNA.
DR   EMBL; AJ238949; CAB51853.1; -; mRNA.
DR   EMBL; AE014297; AAF52015.2; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13240.1; -; Genomic_DNA.
DR   EMBL; Z18535; CAA79220.1; -; mRNA.
DR   PIR; A43360; A43360.
DR   RefSeq; NP_001287180.1; NM_001300251.1.
DR   RefSeq; NP_730941.1; NM_169060.2.
DR   RefSeq; NP_730942.1; NM_169061.2.
DR   UniGene; Dm.4462; -.
DR   ProteinModelPortal; P29993; -.
DR   BioGrid; 65871; 16.
DR   IntAct; P29993; 5.
DR   STRING; 7227.FBpp0078336; -.
DR   TCDB; 1.A.3.2.2; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   PaxDb; P29993; -.
DR   PRIDE; P29993; -.
DR   GeneID; 40664; -.
DR   KEGG; dme:Dmel_CG1063; -.
DR   CTD; 40664; -.
DR   FlyBase; FBgn0010051; Itp-r83A.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   InParanoid; P29993; -.
DR   KO; K04958; -.
DR   OrthoDB; EOG091G00T2; -.
DR   PhylomeDB; P29993; -.
DR   Reactome; R-DME-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-DME-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-DME-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-DME-5578775; Ion homeostasis.
DR   Reactome; R-DME-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   ChiTaRS; Itp-r83A; fly.
DR   GenomeRNAi; 40664; -.
DR   PRO; PR:P29993; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0010051; -.
DR   ExpressionAtlas; P29993; differential.
DR   Genevisible; P29993; DM.
DR   GO; GO:0044295; C:axonal growth cone; IDA:FlyBase.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:FlyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IDA:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:FlyBase.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IMP:FlyBase.
DR   GO; GO:0055089; P:fatty acid homeostasis; IMP:FlyBase.
DR   GO; GO:0007629; P:flight behavior; IMP:FlyBase.
DR   GO; GO:0030536; P:larval feeding behavior; IMP:FlyBase.
DR   GO; GO:0007591; P:molting cycle, chitin-based cuticle; IGI:FlyBase.
DR   GO; GO:0016319; P:mushroom body development; IMP:FlyBase.
DR   GO; GO:0000280; P:nuclear division; IDA:FlyBase.
DR   GO; GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IMP:FlyBase.
DR   GO; GO:0046000; P:positive regulation of ecdysteroid secretion; IMP:FlyBase.
DR   GO; GO:0060259; P:regulation of feeding behavior; IMP:FlyBase.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:FlyBase.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:FlyBase.
DR   GO; GO:0042594; P:response to starvation; IMP:FlyBase.
DR   GO; GO:0035071; P:salivary gland cell autophagic cell death; IMP:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW.
DR   GO; GO:0050909; P:sensory perception of taste; IDA:FlyBase.
DR   GO; GO:0030322; P:stabilization of membrane potential; IGI:FlyBase.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 2.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Developmental protein; Endoplasmic reticulum;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Olfaction; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1   2838       Inositol 1,4,5-trisphosphate receptor.
FT                                /FTId=PRO_0000153931.
FT   TOPO_DOM      1   2366       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2367   2387       Helical. {ECO:0000255}.
FT   TOPO_DOM   2388   2398       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2399   2419       Helical. {ECO:0000255}.
FT   TOPO_DOM   2420   2434       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2435   2455       Helical. {ECO:0000255}.
FT   TOPO_DOM   2456   2487       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2488   2508       Helical. {ECO:0000255}.
FT   TOPO_DOM   2509   2531       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2532   2552       Helical. {ECO:0000255}.
FT   TOPO_DOM   2553   2659       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2660   2680       Helical. {ECO:0000255}.
FT   TOPO_DOM   2681   2838       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      115    170       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      177    229       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      237    293       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      300    359       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      398    454       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      272    276       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      530    533       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      591    593       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   VAR_SEQ     981    989       Missing (in isoform A).
FT                                {ECO:0000303|PubMed:10375644}.
FT                                /FTId=VSP_002703.
FT   CONFLICT    183    183       Missing (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT    551    551       E -> Q (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT    726    726       P -> A (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   1079   1120       AASAASNEASQQQSQQQEPQTPGSSNETDPLDSAESVAAGA
FT                                A -> PLRPLAMRQVSSSRNNRNRRRLAAPMRLIPSTVPSL
FT                                WPPRC (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT   1150   1152       SDA -> TP (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   1394   1397       VQHF -> GVGHSV (in Ref. 2; CAB51853).
FT                                {ECO:0000305}.
FT   CONFLICT   1395   1395       Missing (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   1419   1419       A -> R (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   1466   1466       G -> R (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2108   2108       L -> V (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2333   2333       L -> V (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2452   2452       V -> I (in Ref. 5). {ECO:0000305}.
FT   CONFLICT   2483   2497       QLLYHCIYIAFCFCG -> STYTALYSVLLLR (in Ref.
FT                                1 and 2). {ECO:0000305}.
FT   CONFLICT   2511   2511       D -> H (in Ref. 5). {ECO:0000305}.
FT   CONFLICT   2802   2802       N -> F (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   2807   2807       L -> V (in Ref. 5). {ECO:0000305}.
SQ   SEQUENCE   2838 AA;  319107 MW;  0718F04D15BE00BB CRC64;
     MGDNIIGSAS FLHLGDIVSL YAEGSVCGFL STLGLVDDRT VVCPEAGDLS CPPKKFRDCL
     IKICPMNRYS AQKQFWKAAK QSASSNTDPN LLKRLHHAAE IEKKQNETEN KKLLGTSIQY
     GRAVVQLLHL KSNKYLTVNK RLPSLLEKNA MRVYLDANGN EGSWFYIKPF YKLRSIGDYV
     VVVGDKVILS PVNADQQNLH VAANYELPDN PGCKEVNVLN SSTSWKISLF MEHKENQEHI
     LKGGDVVRLF HAEQEKFLTM DEYKKQYHVF LRTTGRTSAT AATSSKALWE IEVVQHDSCR
     GGAGDWNSLY RFKHLATGHY LAAEAEIDVS AGAMSATSAS GHDLHLGDCS KDSGLSCSTM
     NSTINDKPKG KQYRLVSVPY SADIASVFVL DATTMARPDS LVPQSSYVRL QHICSNTWVH
     ATSIPIDADD DKPVMSMVCC SPIKEDKEAF ALIPVSPVEV RDLDFANDAC KVLATVTSKL
     DNGSISINER RALISLLQDI VYFIAGMENE QNKTKALEFT IKNPIRDRQK LLREQYILKQ
     LFKILQGPFQ EHTAGDGPFL RLDELSDPKN SPYKNIFRLC YRILRLSQQD YRKNQEYIAK
     HFGLMQKQIG YDILAEDTIT ALLHNNRKLL EKHITAAEIE TFVGLVRKNM HNWDSRFLDY
     LSDLCVSNRK AIAVTQELIC KSVLSDKNKD ILIETQVKAL RTGSGPVRCY KGNSEDVCLA
     TLAEDPGDDE DRSDVQSTST TTTWDSASLN EDDGTPSTGD KYEIHLKWTG QPTSRSMADL
     ASCDGGELEA AILNYYRHQL NLFSNMCLNR QYLALNELSP RLDIDLILKC MSDETMPYEL
     RASFCRLMLH LHVDRDPQEP VTPVKYARLW SEIPSKMSIQ DYDGKNQQPD QNKQACRAKF
     NTTIAFVENY LCNVATKVWL FTDQEQNKLT FEVVKLARDL IYFGFYSFSD LLRLTKTLLS
     ILDCVSDTSS GEFASTDIDS VEEETNAEAE GGVLRSIGDI NTVMTSLALG SVGQAIAAPT
     ISLQQRKSVS QLMKEYPLVM DTKLKIIEIL QFILDVRLDY RISCLLSIFK REFDESEVAA
     SAASNEASQQ QSQQQEPQTP GSSNETDPLD SAESVAAGAA AAAATTARQK NIDLESIGVQ
     AEGIFDCERS DAANLDLDGQ GGRTFLRVLL HLIMHDYAPL VSGALHLLFR HFSQRQEVLQ
     AFRQVQLLVS DSDVESYKQI KSDLDILRQS VEKSELWVYK AKATDELGAT DAGGDAVSLE
     YNAALSQEQR NEYRKVKEIL IRMNKFCVTA SGPGSVVKPR KHEQRLLRNV GVHTVVLDLL
     QNPYDEKDDE LMKELMCLAH EFLQNFCLGN QQNQVLLHNH LDLFLNPGIL EAKTVCAIFK
     DNLALCNEVT DKVVQHFVHC IEIHGRHVAY LQFLQTVVAA ENQFIRRCQD MVMQELINSG
     EDVLVFYNDK GSFNHFVQMM QQQMLGMEKL SDDSPLKYHV ELVKLLACCT MGKNVYTEIK
     CNNLLSLDDI VTIICHPLCM PEVKEAYVDF LNHCYIDTEV EMKEIYASGH MWSLFEKSFL
     VDINQLITNP AAASNKTLQA YVLNGVTNLL GSFFASPFSD QSAIVQSRQL IFVQLLQAAH
     RITQCRWLSL GDRFNVENCI RTLTESAKMR SIALPPELEQ QVATMSSKTA MLTRQTTKWL
     LASKQPKYEA QQAASLMRWD RSIIEGLQDI VSLLEDQLKP VVEAELSLLV DILYRSELLF
     PAGTEARKRC ESGGFIRKLI KHTEKLLEEK EERMCVKVLR TLREMMAIDV NYGEKGDALR
     QTLLLRYFQT KSTPRLPEDE VPLLAAPLMD PAKQNHLVTH GPGAKYLQRA GKTLHEMQNH
     LDREGASDLV VELVIKSVHS PNIFVEAVEL GIALLEGGNP IIQKGMFQKF LSDDLNQAFF
     KVFFEKMKDA QQEIKSTVTV NTTDIAAKAH EHKQDTNLEL DKIARKHGLK SNGVVITEEL
     KRELHNAGLA TARAYGNARN IHSGEESSAI SVNSPLEDIL AEKLEKHKDS RDQRNQLSNK
     VLVMQPILRF LQLLCENHNP DMQNLLRNQN NKTNNNLVSE TLMFLDCICG STTGGLGLLG
     LYINEHNLAL INQTLEALTE YCQGPCHENQ NCIATHESNG LDIITALILN NINPLGENRM
     DLVLELKNNA SKLLLAIMES RGDSENAERI LYNMNPKQLV EVACKAYHQE ELIDEQDDGD
     EPDAGSDDDD ATVSPREVGH NIYILCHQLA QHNKELAGLL KASEDPQSAS FDAKTSQALM
     YYATHTAQIE IVRNDRTLEQ IVFPIPEICE YLTTDTKIKI LNTAERDDQG SKLADFFDKA
     EEMFNEMKWQ KKLRSQPLLF WISSYMSLWS NILFNCVVVI NMIVAFFYPF DNTVPELSSH
     ISLLFWIITI FSLVIVLALP RESGIRTFIG SVILRFIFLL GPESTLCLLG VVTVTLKSVH
     IVSIMGNKGT LEKQLIKIIT DFQLLYHCIY IAFCFCGLIF HPFFYSLLLF DVVYREETLV
     NVIRSVTRNG RSIVLTAVLA LILVYLFSII GYMFFKDDFL VSVDFEEQDN APPPSVPLTL
     SVPVSGDSCS APDDLGNCQA AKEVAPPSAG GGEVKERSCD SLVMCIVTTL NQGLRNGGGI
     GDILRAPSSK EGLFVARVIY DLLFFFIVII IVLNLIFGVI IDTFADLRSE KQQKEAILKT
     TCFICSLNRS AFDNKTVSFE EHIKSEHNMW HYLYFIVLVK VKDPTEFTGP ESYVYAMVKA
     GILEWFPRLR AMSLAAVDAD GEQIELRSMQ AQLLDTQLLI KNLSTQLHEL KDHMTEQRKQ
     KQRLGLLNTT ANSLLPFQ
//
ID   UNC36_CAEEL             Reviewed;        1249 AA.
AC   P34374; A9Z1J5; P34372; P34373;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   25-OCT-2017, entry version 138.
DE   RecName: Full=Voltage-dependent calcium channel unc-36;
DE   AltName: Full=Pharyngeal calcium channel subunit alpha-2;
DE   AltName: Full=Uncoordinated protein 36;
DE   Flags: Precursor;
GN   Name=unc-36; Synonyms=unc-72; ORFNames=C50C3.9/C50C3.10/C50C3.11;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION.
RX   PubMed=8462849;
RA   Avery L.;
RT   "The genetics of feeding in Caenorhabditis elegans.";
RL   Genetics 133:897-917(1993).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8807295;
RA   Schafer W.R., Sanchez B.M., Kenyon C.J.;
RT   "Genes affecting sensitivity to serotonin in Caenorhabditis elegans.";
RL   Genetics 143:1219-1230(1996).
RN   [5]
RP   FUNCTION.
RX   PubMed=10571181; DOI=10.1016/S0092-8674(00)81525-1;
RA   Troemel E.R., Sagasti A., Bargmann C.I.;
RT   "Lateral signaling mediated by axon contact and calcium entry
RT   regulates asymmetric odorant receptor expression in C. elegans.";
RL   Cell 99:387-398(1999).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=16838374; DOI=10.1002/neu.20261;
RA   Frokjaer-Jensen C., Kindt K.S., Kerr R.A., Suzuki H.,
RA   Melnik-Martinez K., Gerstbreih B., Driscol M., Schafer W.R.;
RT   "Effects of voltage-gated calcium channel subunit genes on calcium
RT   influx in cultured C. elegans mechanosensory neurons.";
RL   J. Neurobiol. 66:1125-1139(2006).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-100 AND ASN-757, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: May act as an auxiliary subunit of the unc-2 voltage-
CC       gated calcium channel which appears to trigger calcium-activated
CC       signaling pathways that control the serotonin response. Inhibiting
CC       serotonin sensitivity of the vulval muscles results in egg laying
CC       defects. May act in both neurons and muscle cells to enhance motor
CC       activity as it is required for coordinated movement. Has a role in
CC       neural depolarization-induced calcium influx and pharyngeal
CC       pumping (PubMed:8462849, PubMed:8807295, PubMed:16838374).
CC       Involved in restricting the expression of the putative olfactory
CC       receptor str-2 to only one of the two AWC neurons
CC       (PubMed:10571181). {ECO:0000269|PubMed:10571181,
CC       ECO:0000269|PubMed:16838374, ECO:0000269|PubMed:8462849,
CC       ECO:0000269|PubMed:8807295}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P34374-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P34374-2; Sequence=VSP_036007;
CC   -!- TISSUE SPECIFICITY: Decendants of the cells AB and AB.p (that give
CC       rise to nearly all non-pharyngeal neurons), decendants of P1 (that
CC       give rise to body muscle) and cell lineages that give rise to the
CC       adult and juvenile motor neurons. Expressed in body wall, vulval
CC       muscle and pharyngeal muscle. {ECO:0000269|PubMed:16838374,
CC       ECO:0000269|PubMed:8807295}.
CC   -!- DISRUPTION PHENOTYPE: Worms exhibit a weak egg-laying constitutive
CC       (Egl-c) phenotype and slow irregular pharyngeal pumping.
CC       {ECO:0000269|PubMed:16838374}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080718; CCD66125.1; -; Genomic_DNA.
DR   EMBL; FO080718; CCD66126.1; -; Genomic_DNA.
DR   PIR; S44617; S44617.
DR   PIR; S44618; S44618.
DR   PIR; S44619; S44619.
DR   RefSeq; NP_001040851.1; NM_001047386.2. [P34374-1]
DR   RefSeq; NP_001040852.1; NM_001047387.2. [P34374-2]
DR   UniGene; Cel.16901; -.
DR   ProteinModelPortal; P34374; -.
DR   STRING; 6239.C50C3.9a.2; -.
DR   iPTMnet; P34374; -.
DR   PaxDb; P34374; -.
DR   EnsemblMetazoa; C50C3.9a; C50C3.9a; WBGene00006772. [P34374-1]
DR   GeneID; 176155; -.
DR   UCSC; C50C3.9a; c. elegans.
DR   CTD; 176155; -.
DR   WormBase; C50C3.9a; CE32168; WBGene00006772; unc-36.
DR   WormBase; C50C3.9b; CE39702; WBGene00006772; unc-36.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOGENOM; HOG000154779; -.
DR   InParanoid; P34374; -.
DR   OMA; EDKQQGY; -.
DR   OrthoDB; EOG091G00UY; -.
DR   PhylomeDB; P34374; -.
DR   PRO; PR:P34374; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00006772; -.
DR   ExpressionAtlas; P34374; baseline.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0005246; F:calcium channel regulator activity; IMP:WormBase.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0040011; P:locomotion; IMP:UniProtKB.
DR   GO; GO:0018991; P:oviposition; IMP:UniProtKB.
DR   GO; GO:0043050; P:pharyngeal pumping; IMP:UniProtKB.
DR   GO; GO:0040017; P:positive regulation of locomotion; IMP:WormBase.
DR   GO; GO:0035418; P:protein localization to synapse; IMP:WormBase.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:WormBase.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IMP:UniProtKB.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF00092; VWA; 1.
DR   Pfam; PF13519; VWA_2; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 2.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1249       Voltage-dependent calcium channel unc-36.
FT                                /FTId=PRO_0000022627.
FT   TOPO_DOM     20   1228       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1229   1248       Helical. {ECO:0000255}.
FT   TOPO_DOM   1249   1249       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      250    479       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    302    302       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    520    520       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    558    558       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    757    757       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    838    838       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    903    903       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    923    923       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1130   1130       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1   1145       Missing (in isoform b). {ECO:0000305}.
FT                                /FTId=VSP_036007.
SQ   SEQUENCE   1249 AA;  144376 MW;  533FF6059D375FB2 CRC64;
     MRVVHLLVVL ATYVSTTSSF NKESIKECAK VLSEHMKETF SKISHETILK QNYEKLVEEE
     QFDPRAELKK SKHRIEDYLK VRSQFAYKAK ISLEARSVRN DSTVNDPQSK SFIRFMSAKQ
     GNDGTTIYES NHLGKRLKVN ETKSFNLTQN ANFYTLPTSS VSSAVHIPTP LYDRNEDLLR
     KIDWSDIDAV YRTNREETKD LAFQLFCSEA GYMRYYPAAS WFWDNQDEHL DLFDCRNTEW
     YINSATNSKN VLIMLDMSGS MLGQRYEVAK QTTEAILETL SHNDYFNIMT FSKNTFLLDG
     CNGTNGLLQA TMRNKKALRR KMDTYQSEGK AEYEKALPLA FSVLLDLKGS YALYTKEEMS
     MMSANATNEY QFHLELPEHV LAATKQYIDS INNGGGDNNR GACENVIMLI TDGAPNAYKK
     IFDMYNADKK VRVFTFLVGD EAIDFNEVRE MACNNRGYMV HVANMADVDE KIHHYIRRMS
     RVVGRHYKES GQLSWWTGVY RERLYLPRPE IFAEPVPITN QSFAVMNKMA SRRKIRLQKS
     EARSRMFVTT VSYPVIVNET FMGVAAVNIP LTEVAQKSHP ANIGSKSYFF MLDQNGFVMT
     HPQLRPIDPF TKYHKQNYNN MDLLELEVGQ NQNVRSSQKS QAVSDLVCES GANYAECVDD
     LRKAVRKMII DCDNSDVQQL DVLYATELLD RVYPQTNTYY AECINHANFV LGLAVAKGDD
     YRVVKKQKKY DFGRVKMDWM GDKRWRLHPH WRYCFLNDTD THMSKEEAFE IYAQQMSDSG
     KAPLLCEYRR NLVEKLLLDM EATSNLIDSW DTQFNFMKNN LIHLAFFATP SGMIRYYNLT
     LQDYDYIDPY WSIFEHIGHL LSIEHAQESY NHFITDLNRK STDDRYYRRA VRMKDTIMFD
     VSNNSKIWYK SETQLTGYGL NENLTMLGQA FKAIYLDKAV LGVSGFEFAY DHVVDTMAEH
     GCPASDDRKW CVLLDEHAYV FFSNQNDISY EDYLVGKGKH ISQYFGGLNR IAQRAMALLV
     ENKFYTKLTY TDNQAVCKAE KVVTTSGNRL RPFYPIFRFL MQTFNFMVRL ASQISGGFLI
     WLPNIQFTEA YTASFHEGTD VYPCPKQSSF YFSNKDGKNR PGTTHLVNGN RSERPCKMNA
     KCSVKMEASF VDGTNLVMVW ITQDKASENC YDESECSMEI SNQVPFGFEE VKNEETCEEN
     EKRKSKANDV CYSIDDDDSE NERRPCSTSP TIVSIFQILF GVFLHFCIF
//
ID   MID1_YEAST              Reviewed;         548 AA.
AC   P41821; D6W0Q2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   20-DEC-2017, entry version 126.
DE   RecName: Full=Stretch-activated cation channel MID1;
DE   AltName: Full=Mating pheromone-induced death protein 2;
DE   Flags: Precursor;
GN   Name=MID1; OrderedLocusNames=YNL291C; ORFNames=N0530;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   GLYCOSYLATION.
RX   PubMed=7526155; DOI=10.1128/MCB.14.12.8259;
RA   Iida H., Nakamura H., Ono T., Okumura M.S., Anraku Y.;
RT   "MID1, a novel Saccharomyces cerevisiae gene encoding a plasma
RT   membrane protein, is required for Ca2+ influx and mating.";
RL   Mol. Cell. Biol. 14:8259-8271(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=8553702; DOI=10.1002/yea.320111311;
RA   Maurer K.C.T., Urbanus J.H.M., Planta R.J.;
RT   "Sequence analysis of a 30 kb DNA segment from yeast chromosome XIV
RT   carrying a ribosomal protein gene cluster, the genes encoding a plasma
RT   membrane protein and a subunit of replication factor C, and a novel
RT   putative serine/threonine protein kinase gene.";
RL   Yeast 11:1303-1310(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169873;
RA   Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K.,
RA   Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K.,
RA   Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M.,
RA   Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F.,
RA   Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F.,
RA   Doignon F., Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M.,
RA   Fritz C., Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N.,
RA   Goffeau A., Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D.,
RA   Hilbert H., Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A.,
RA   Jonniaux J.-L., Karpfinger-Hartl L., Lanfranchi G., Lepingle A.,
RA   Levesque H., Lyck R., Maftahi M., Mallet L., Maurer C.T.C.,
RA   Messenguy F., Mewes H.-W., Moestl D., Nasr F., Nicaud J.-M.,
RA   Niedenthal R.K., Pandolfo D., Pierard A., Piravandi E., Planta R.J.,
RA   Pohl T.M., Purnelle B., Rebischung C., Remacha M.A., Revuelta J.L.,
RA   Rinke M., Saiz J.E., Sartorello F., Scherens B., Sen-Gupta M.,
RA   Soler-Mira A., Urbanus J.H.M., Valle G., Van Dyck L., Verhasselt P.,
RA   Vierendeels F., Vissers S., Voet M., Volckaert G., Wach A.,
RA   Wambutt R., Wedler H., Zollner A., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV
RT   and its evolutionary implications.";
RL   Nature 387:93-98(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   FUNCTION.
RX   PubMed=10436155; DOI=10.1126/science.285.5429.882;
RA   Kanzaki M., Nagasawa M., Kojima I., Sato C., Naruse K., Sokabe M.,
RA   Iida H.;
RT   "Molecular identification of a eukaryotic, stretch-activated
RT   nonselective cation channel.";
RL   Science 285:882-886(1999).
RN   [6]
RP   FUNCTION, INTERACTION WITH CCH1, AND SUBCELLULAR LOCATION.
RX   PubMed=10958666; DOI=10.1128/MCB.20.18.6686-6694.2000;
RA   Locke E.G., Bonilla M., Liang L., Takita Y., Cunningham K.W.;
RT   "A homolog of voltage-gated Ca(2+) channels stimulated by depletion of
RT   secretory Ca(2+) in yeast.";
RL   Mol. Cell. Biol. 20:6686-6694(2000).
RN   [7]
RP   MUTAGENESIS OF CYS-417; CYS-431; CYS-434; CYS-491; CYS-498; CYS-506
RP   AND CYS-531.
RX   PubMed=11796727; DOI=10.1074/jbc.M111603200;
RA   Maruoka T., Nagasoe Y., Inoue S., Mori Y., Goto J., Ikeda M., Iida H.;
RT   "Essential hydrophilic carboxyl-terminal regions including cysteine
RT   residues of the yeast stretch-activated calcium-permeable channel
RT   Mid1.";
RL   J. Biol. Chem. 277:11645-11652(2002).
RN   [8]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [9]
RP   MUTAGENESIS OF PHE-356.
RX   PubMed=14697255; DOI=10.1016/j.bbrc.2003.11.166;
RA   Tada T., Ohmori M., Iida H.;
RT   "Phe356 in the yeast Ca2+ channel component Mid1 is a key residue for
RT   viability after exposure to alpha-factor.";
RL   Biochem. Biophys. Res. Commun. 313:752-757(2004).
RN   [10]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=14729456; DOI=10.1016/j.yexcr.2003.09.020;
RA   Yoshimura H., Tada T., Iida H.;
RT   "Subcellular localization and oligomeric structure of the yeast
RT   putative stretch-activated Ca2+ channel component Mid1.";
RL   Exp. Cell Res. 293:185-195(2004).
RN   [11]
RP   DELETION MUTANTS, AND SUBCELLULAR LOCATION.
RX   PubMed=16202999; DOI=10.1016/j.yexcr.2005.08.014;
RA   Ozeki-Miyawaki C., Moriya Y., Tatsumi H., Iida H., Sokabe M.;
RT   "Identification of functional domains of Mid1, a stretch-activated
RT   channel component, necessary for localization to the plasma membrane
RT   and Ca2+ permeation.";
RL   Exp. Cell Res. 311:84-95(2005).
RN   [12]
RP   FUNCTION.
RX   PubMed=16223494; DOI=10.1016/j.febslet.2005.09.058;
RA   Peiter E., Fischer M., Sidaway K., Roberts S.K., Sanders D.;
RT   "The Saccharomyces cerevisiae Ca2+ channel Cch1pMid1p is essential for
RT   tolerance to cold stress and iron toxicity.";
RL   FEBS Lett. 579:5697-5703(2005).
CC   -!- FUNCTION: Calcium-permeable, cation-selective stretch-activated
CC       channel (SAC). Required for calcium influx and for vitality of
CC       MATa cells in a late, pheromone-induced event of the mating
CC       process requiring calcium induced signaling. Functions together
CC       with CCH1 to ensure that adequate levels of Ca(2+) are supplied to
CC       PMR1 to sustain secretion and growth. Required for growth in low-
CC       calcium environments. Together with CCH1, essential for tolerance
CC       to iron stress, which leads to an increased oxidative poise, and
CC       to cold stress. {ECO:0000269|PubMed:10436155,
CC       ECO:0000269|PubMed:10958666, ECO:0000269|PubMed:16223494,
CC       ECO:0000269|PubMed:7526155}.
CC   -!- SUBUNIT: Interacts with CCH1 to form a Ca(2+) influx channel.
CC       Forms an oligomer with a molecular mass of 200 kDa by disulfide
CC       bonds. {ECO:0000269|PubMed:10958666, ECO:0000269|PubMed:14729456}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Endoplasmic reticulum.
CC       Membrane {ECO:0000305}; Single-pass type I membrane protein
CC       {ECO:0000305}. Note=Trafficking to the plasma membrane is
CC       dependent on the N-glycosylation and the transporter protein
CC       SEC12.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:7526155}.
CC   -!- MISCELLANEOUS: Present with 3210 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- MISCELLANEOUS: Truncation mutant consisting of amino acids 1-360
CC       is fully functional. Truncation mutants consisting of amino acids
CC       1-400 and 1-22 are partially functional. Truncation mutants
CC       consisting of amino acids 1-455, 1-133, and a mutant in which
CC       amino acids 3-22 are deleted, are not functional in Ca(2+) uptake.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D32133; BAA06859.1; -; Genomic_DNA.
DR   EMBL; U23084; AAC49109.1; -; Genomic_DNA.
DR   EMBL; Z71567; CAA96209.1; -; Genomic_DNA.
DR   EMBL; Z71566; CAA96208.1; -; Genomic_DNA.
DR   EMBL; BK006947; DAA10268.1; -; Genomic_DNA.
DR   PIR; A56353; A56353.
DR   RefSeq; NP_014108.1; NM_001183129.1.
DR   ProteinModelPortal; P41821; -.
DR   BioGrid; 35546; 125.
DR   DIP; DIP-5621N; -.
DR   IntAct; P41821; 2.
DR   MINT; MINT-492291; -.
DR   STRING; 4932.YNL291C; -.
DR   TCDB; 8.A.41.1.1; the stretch-activated calcium channel auxiliary protein, mid1 (mid1) family.
DR   MaxQB; P41821; -.
DR   PRIDE; P41821; -.
DR   EnsemblFungi; YNL291C; YNL291C; YNL291C.
DR   GeneID; 855425; -.
DR   KEGG; sce:YNL291C; -.
DR   EuPathDB; FungiDB:YNL291C; -.
DR   SGD; S000005235; MID1.
DR   HOGENOM; HOG000248364; -.
DR   InParanoid; P41821; -.
DR   KO; K08284; -.
DR   OMA; LVFQWDD; -.
DR   OrthoDB; EOG092C1T97; -.
DR   BioCyc; YEAST:G3O-33281-MONOMER; -.
DR   PRO; PR:P41821; -.
DR   Proteomes; UP000002311; Chromosome XIV.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:SGD.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:SGD.
DR   GO; GO:0005262; F:calcium channel activity; IMP:SGD.
DR   GO; GO:0015275; F:stretch-activated, cation-selective, calcium channel activity; IDA:SGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; IDA:SGD.
DR   Gene3D; 1.10.2000.10; -; 1.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR024338; Mid1/Ehs1.
DR   Pfam; PF12929; Mid1; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    548       Stretch-activated cation channel MID1.
FT                                /FTId=PRO_0000096483.
FT   TOPO_DOM     21    341       Extracellular. {ECO:0000255}.
FT   TRANSMEM    342    358       Helical. {ECO:0000255}.
FT   TOPO_DOM    359    548       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    431    450       Cys-rich.
FT   COMPBIAS    487    506       Cys-rich.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    112    112       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    159    159       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    238    238       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    285    285       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    291    291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    324    324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     356    356       F->A: Significantly low viability and
FT                                relatively normal Ca(2+) accumulation.
FT                                {ECO:0000269|PubMed:14697255}.
FT   MUTAGEN     356    356       F->H,Q,D,E,K,R: Substitution by
FT                                hydrophilic amino acids causes lethality
FT                                and low Ca(2+) accumulation.
FT                                {ECO:0000269|PubMed:14697255}.
FT   MUTAGEN     356    356       F->L,W,Y: Substitution by hydrophobic,
FT                                large amino acids does not cause
FT                                lethality nor low Ca(2+) accumulation.
FT                                {ECO:0000269|PubMed:14697255}.
FT   MUTAGEN     417    417       C->A: Non-functional.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     431    431       C->A: Non-functional.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     434    434       C->A: Non-functional.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     491    491       C->A: Functionally impaired.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     498    498       C->A: Non-functional.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     506    506       C->A: Functionally impaired.
FT                                {ECO:0000269|PubMed:11796727}.
FT   MUTAGEN     531    531       C->A: Functionally impaired.
FT                                {ECO:0000269|PubMed:11796727}.
SQ   SEQUENCE   548 AA;  61575 MW;  5FCDE044C5F9ACB4 CRC64;
     MIVWQALFVV YCLFTTSIHG LFQDFNPFAN KNISLKFPSL NRWEKNVMAT GQQTIINSDS
     IYEWTPILSN ITAGKKDSFV FTIDAEASGY GFAPTYEVLM FISGNICQMP MNRSDVDLTI
     YYSFNETVLE NPNIGQSAVF QDGYIQALAI SPVQSSSSNA TSTYSNLYVV AELVNSTTEQ
     PLSSSDASEN WEYRLSISEN DLVFQWDVRP WVEVLDTDMN SALLSTGNVT ADAKVYHNYS
     IYDPSLYDLY VYSYEDSVQL NQNYNLSLCA VKNGPYLVSS QNTSNATVTS NSTNPLERTD
     LAIQKKITEY GGSVTEMFYV TGLNASTTYV AYLTKKISNG DGLSSVGGIL FSHVYFTTRS
     TDVCSLIFGL DFCSDVAYSV PTSSFSVGNK TLMAQTYDHI AEALYANFSK ALQLISCDAD
     KDARYSPVMT CDDCAEAYRD WVCAVSIPRC TTTSSQYYIH RDKSHNRNDY LNKFIKPLDD
     YYEILPCIDM CYTLVRNCPS DFQFSCPNDL TTEDLLYQSY NFYMDTDYST CNYIGNSSLM
     VIHPLDDT
//
ID   ACHA9_RAT               Reviewed;         479 AA.
AC   P43144; Q6PW49;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-9;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-9;
DE            Short=NACHR alpha-9;
DE   Flags: Precursor;
GN   Name=Chrna9; Synonyms=Acra9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Olfactory epithelium;
RX   PubMed=7954834; DOI=10.1016/0092-8674(94)90555-X;
RA   Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S.F.;
RT   "Alpha 9: an acetylcholine receptor with novel pharmacological
RT   properties expressed in rat cochlear hair cells.";
RL   Cell 79:705-715(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10713500; DOI=10.1016/S0378-5955(99)00214-2;
RA   Katz E., Verbitsky M., Rothlin C.V., Vetter D.E., Heinemann S.F.,
RA   Elgoyhen A.B.;
RT   "High calcium permeability and calcium block of the alpha9 nicotinic
RT   acetylcholine receptor.";
RL   Hear. Res. 141:117-128(2000).
RN   [4]
RP   FUNCTION.
RX   PubMed=11044723; DOI=10.1016/S0028-3908(00)00124-6;
RA   Verbitsky M., Rothlin C.V., Katz E., Elgoyhen A.B.;
RT   "Mixed nicotinic-muscarinic properties of the alpha9 nicotinic
RT   cholinergic receptor.";
RL   Neuropharmacology 39:2515-2524(2000).
RN   [5]
RP   INTERACTION WITH CHRNA10, SUBUNIT, TISSUE SPECIFICITY, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11248107; DOI=10.1073/pnas.051622798;
RA   Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F.,
RA   Boulter J.;
RT   "Alpha10: a determinant of nicotinic cholinergic receptor function in
RT   mammalian vestibular and cochlear mechanosensory hair cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3501-3506(2001).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHRNA10.
RX   PubMed=12117536; DOI=10.1016/S0378-5955(02)00380-5;
RA   Weisstaub N., Vetter D.E., Elgoyhen A.B., Katz E.;
RT   "The alpha9alpha10 nicotinic acetylcholine receptor is permeable to
RT   and is modulated by divalent cations.";
RL   Hear. Res. 167:122-135(2002).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12401316; DOI=10.1016/S0306-4522(02)00274-9;
RA   Lips K.S., Pfeil U., Kummer W.;
RT   "Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine
RT   receptors in rat dorsal root ganglion neurons.";
RL   Neuroscience 115:1-5(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH CHRNA10.
RX   PubMed=14742688; DOI=10.1124/mol.65.2.453;
RA   Baker E.R., Zwart R., Sher E., Millar N.S.;
RT   "Pharmacological properties of alpha 9 alpha 10 nicotinic
RT   acetylcholine receptors revealed by heterologous expression of subunit
RT   chimeras.";
RL   Mol. Pharmacol. 65:453-460(2004).
RN   [9]
RP   SITE THR-86, AND MUTAGENESIS OF SER-36; SER-44; ALA-54; THR-86;
RP   ARG-101; SER-147 AND SER-166.
RX   PubMed=22774872; DOI=10.1111/j.1471-4159.2012.07867.x;
RA   Azam L., McIntosh J.M.;
RT   "Molecular basis for the differential sensitivity of rat and human
RT   alpha9alpha10 nAChRs to alpha-conotoxin RgIA.";
RL   J. Neurochem. 122:1137-1144(2012).
RN   [10]
RP   MUTAGENESIS OF TRP-176.
RX   PubMed=18295795; DOI=10.1016/j.jmb.2008.01.082;
RA   Ellison M., Feng Z.P., Park A.J., Zhang X., Olivera B.M.,
RA   McIntosh J.M., Norton R.S.;
RT   "Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR:
RT   structure and identification of key receptor-binding residues.";
RL   J. Mol. Biol. 377:1216-1227(2008).
RN   [11]
RP   SITE ASP-146, MUTAGENESIS OF THR-86 AND ASP-146, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [12]
RP   ERRATUM.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with
RT   the rat alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding induces a
CC       conformation change that leads to the opening of an ion-conducting
CC       channel across the plasma membrane. The channel is permeable to a
CC       range of divalent cations including calcium, the influx of which
CC       may activate a potassium current which hyperpolarizes the cell
CC       membrane. In the ear, this leads to a reduction in basilar
CC       membrane motion, altering the activity of auditory nerve fibers
CC       and reducing the range of dynamic hearing. This may protect
CC       against acoustic trauma. May also regulate keratinocyte adhesion.
CC       {ECO:0000269|PubMed:10713500, ECO:0000269|PubMed:11044723,
CC       ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688, ECO:0000269|PubMed:7954834,
CC       ECO:0000305}.
CC   -!- SUBUNIT: Can form homo- or heterooligomeric channels in
CC       conjunction with CHRNA10. The native outer hair cell receptor may
CC       be composed of CHRNA9-CHRNA10 heterooligomers. Interacts with the
CC       alpha-conotoxin RgIA (PubMed:25740413).
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688, ECO:0000269|PubMed:25740413,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000269|PubMed:10713500,
CC       ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:7954834}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in the nasal epithelium, in the outer
CC       hair cells of the cochlea, in the pars tuberalis of the
CC       hypophysis, and in the developing muscle of the tongue. Also
CC       expressed in the neurons of dorsal root ganglia.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12401316,
CC       ECO:0000269|PubMed:7954834}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist). {ECO:0000269|PubMed:7954834}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       9/CHRNA9 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12336; AAA56720.1; -; mRNA.
DR   EMBL; AY574257; AAS90353.1; -; mRNA.
DR   PIR; A55382; A55382.
DR   RefSeq; NP_075219.1; NM_022930.1.
DR   UniGene; Rn.54463; -.
DR   ProteinModelPortal; P43144; -.
DR   MINT; MINT-4996733; -.
DR   STRING; 10116.ENSRNOP00000003382; -.
DR   BindingDB; P43144; -.
DR   ChEMBL; CHEMBL2585; -.
DR   GuidetoPHARMACOLOGY; 469; -.
DR   PhosphoSitePlus; P43144; -.
DR   PaxDb; P43144; -.
DR   PRIDE; P43144; -.
DR   DNASU; 65024; -.
DR   Ensembl; ENSRNOT00000003382; ENSRNOP00000003382; ENSRNOG00000002484.
DR   GeneID; 65024; -.
DR   KEGG; rno:65024; -.
DR   UCSC; RGD:621534; rat.
DR   CTD; 55584; -.
DR   RGD; 621534; Chrna9.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P43144; -.
DR   KO; K04810; -.
DR   OMA; ATKNVIM; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P43144; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:P43144; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002484; -.
DR   Genevisible; P43144; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006812; P:cation transport; ISO:RGD.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; IEP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    479       Neuronal acetylcholine receptor subunit
FT                                alpha-9.
FT                                /FTId=PRO_0000000372.
FT   TOPO_DOM     26    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    262       Helical. {ECO:0000255}.
FT   TRANSMEM    269    287       Helical. {ECO:0000255}.
FT   TRANSMEM    302    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    476       Helical. {ECO:0000255}.
FT   SITE         86     86       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000269|PubMed:22774872}.
FT   SITE        146    146       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000269|PubMed:25740413}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250|UniProtKB:Q9UGM1}.
FT   DISULFID    219    220       {ECO:0000250|UniProtKB:Q9UGM1}.
FT   MUTAGEN      36     36       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      44     44       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10
FT                                receptorby the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      54     54       A->K: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10
FT                                receptorby the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      86     86       T->E: The CHRNA9-CHRNA10 receptor is 20-
FT                                fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN      86     86       T->I: The CHRNA9-CHRNA10 receptor is
FT                                1700-fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872,
FT                                ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     101    101       R->G: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     146    146       D->L: Complete loss of inhibition of the
FT                                CHRNA9-CHRNA10 receptor by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     147    147       S->A: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     166    166       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     176    176       W->T: The CHRNA9-CHRNA10 receptor is 8.5-
FT                                fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:18295795}.
FT   CONFLICT    425    425       T -> A (in Ref. 1; AAA56720).
FT                                {ECO:0000305}.
SQ   SEQUENCE   479 AA;  54526 MW;  CBB3E15E9DF68837 CRC64;
     MNRPHSCLSF CWMYFAASGI RAVETANGKY AQKLFSDLFE DYSSALRPVE DTDAVLNVTL
     QVTLSQIKDM DERNQILTAY LWIRQTWHDA YLTWDRDQYD RLDSIRIPSD LVWRPDIVLY
     NKADDESSEP VNTNVVLRYD GLITWDSPAI TKSSCVVDVT YFPFDSQQCN LTFGSWTYNG
     NQVDIFNALD SGDLSDFIED VEWEVHGMPA VKNVISYGCC SEPYPDVTFT LLLKRRSSFY
     IVNLLIPCVL ISFLAPLSFY LPAASGEKVS LGVTILLAMT VFQLMVAEIM PASENVPLIG
     KYYIATMALI TASTALTIMV MNIHFCGAEA RPVPHWAKVV ILKYMSRILF VYDVGESCLS
     PRHSQEPEQV TKVYSKLPES NLKTSRNKDL SRKKEVRKLL KNDLGYQGGI PQNTDSYCAR
     YEALTKNIEY IAKCLKDHKA TNSKGSEWKK VAKVIDRFFM WIFFAMVFVM TVLIIARAD
//
ID   TRPL_DROME              Reviewed;        1124 AA.
AC   P48994; C6TPC1; Q0E9E3; Q8IH62; Q8MKU9; Q9V5B2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 2.
DT   22-NOV-2017, entry version 166.
DE   RecName: Full=Transient-receptor-potential-like protein;
GN   Name=trpl; ORFNames=CG18345;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CALMODULIN-BINDING, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Oregon-R;
RX   PubMed=1314616; DOI=10.1016/0896-6273(92)90085-R;
RA   Phillips A.M., Bull A.L., Kelly L.E.;
RT   "Identification of a Drosophila gene encoding a calmodulin-binding
RT   protein with homology to the trp phototransduction gene.";
RL   Neuron 8:631-642(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley;
RA   Carlson J., Booth B., Frise E., Park S., Wan K., Yu C., Celniker S.;
RL   Submitted (AUG-2009) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   CALMODULIN-BINDING.
RX   PubMed=8670063; DOI=10.1042/bj3140497;
RA   Warr C.G., Kelly L.E.;
RT   "Identification and characterization of two distinct calmodulin-
RT   binding sites in the Trpl ion-channel protein of Drosophila
RT   melanogaster.";
RL   Biochem. J. 314:497-503(1996).
RN   [7]
RP   INTERACTION WITH TRP.
RX   PubMed=9215637; DOI=10.1016/S0092-8674(00)80302-5;
RA   Xu X.-Z.S., Li H.-S., Guggino W.B., Montell C.;
RT   "Coassembly of TRP and TRPL produces a distinct store-operated
RT   conductance.";
RL   Cell 89:1155-1164(1997).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF TRP-713 AND
RP   TRP-814.
RX   PubMed=9494079; DOI=10.1042/bj3301149;
RA   Lan L., Brereton H., Barritt G.J.;
RT   "The role of calmodulin-binding sites in the regulation of the
RT   Drosophila TRPL cation channel expressed in Xenopus laevis oocytes by
RT   ca2+, inositol 1,4,5-trisphosphate and GTP-binding proteins.";
RL   Biochem. J. 330:1149-1158(1998).
RN   [9]
RP   CALMODULIN-BINDING.
RX   PubMed=10371201; DOI=10.1016/S0014-5793(99)00588-8;
RA   Trost C., Marquart A., Zimmer S., Philipp S., Cavalie A.,
RA   Flockerzi V.;
RT   "Ca2+-dependent interaction of the trpl cation channel and
RT   calmodulin.";
RL   FEBS Lett. 451:257-263(1999).
RN   [10]
RP   FUNCTION.
RX   PubMed=9930700; DOI=10.1038/16703;
RA   Chyb S., Raghu P., Hardie R.C.;
RT   "Polyunsaturated fatty acids activate the Drosophila light-sensitive
RT   channels TRP and TRPL.";
RL   Nature 397:255-259(1999).
RN   [11]
RP   FUNCTION.
RX   PubMed=10908615;
RA   Agam K., von Campenhausen M., Levy S., Ben-Ami H.C., Cook B.,
RA   Kirschfeld K., Minke B.;
RT   "Metabolic stress reversibly activates the Drosophila light-sensitive
RT   channels TRP and TRPL in vivo.";
RL   J. Neurosci. 20:5748-5755(2000).
RN   [12]
RP   FUNCTION.
RX   PubMed=8918461;
RA   Obukhov A.G., Harteneck C., Zobel A., Harhammer R., Kalkbrenner F.,
RA   Leopoldt D., Luckhoff A., Nurnberg B., Schultz G.;
RT   "Direct activation of trpl cation channels by G alpha11 subunits.";
RL   EMBO J. 15:5833-5838(1996).
RN   [13]
RP   INTERACTION WITH TRPGAMMA.
RX   PubMed=10896160; DOI=10.1016/S0896-6273(00)81201-5;
RA   Xu X.-Z.S., Chien F., Butler A., Salkoff L., Montell C.;
RT   "TRPgamma, a Drosophila TRP-related subunit, forms a regulated cation
RT   channel with TRPL.";
RL   Neuron 26:647-657(2000).
RN   [14]
RP   INTERACTION WITH FKBP59, IDENTIFICATION IN A COMPLEX WITH INAD, AND
RP   MUTAGENESIS OF PRO-702 AND PRO-709.
RX   PubMed=11514552; DOI=10.1074/jbc.M104125200;
RA   Goel M., Garcia R., Estacion M., Schilling W.P.;
RT   "Regulation of Drosophila TRPL channels by immunophilin FKBP59.";
RL   J. Biol. Chem. 276:38762-38773(2001).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11931743; DOI=10.1016/S0896-6273(02)00630-X;
RA   Baehner M., Frechter S., Da Silva N., Minke B., Paulsen R., Huber A.;
RT   "Light-regulated subcellular translocation of Drosophila TRPL channels
RT   induces long-term adaptation and modifies the light-induced current.";
RL   Neuron 34:83-93(2002).
RN   [16]
RP   REVIEW.
RX   PubMed=11707492;
RA   Hardie R.C.;
RT   "Phototransduction in Drosophila melanogaster.";
RL   J. Exp. Biol. 204:3403-3409(2001).
CC   -!- FUNCTION: A light-sensitive calcium channel that is required for
CC       inositide-mediated Ca(2+) entry in the retina during phospholipase
CC       C (PLC)-mediated phototransduction. Required for vision in the
CC       dark and in dim light. Binds calmodulin. Trp and trpl act together
CC       in the light response, although it is unclear whether as
CC       heteromultimers or distinct units. Also forms a functional cation
CC       channel with Trpgamma. Activated by fatty acids, metabolic stress,
CC       inositols and GTP-binding proteins. {ECO:0000269|PubMed:10908615,
CC       ECO:0000269|PubMed:11931743, ECO:0000269|PubMed:8918461,
CC       ECO:0000269|PubMed:9494079, ECO:0000269|PubMed:9930700}.
CC   -!- SUBUNIT: Forms heteromultimers with Trpgamma and, to a lower
CC       extent, with trp. Interacts with FKBP59 in vivo and is found in
CC       the inaD signaling complex. {ECO:0000269|PubMed:10896160,
CC       ECO:0000269|PubMed:11514552, ECO:0000269|PubMed:9215637}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11931743,
CC       ECO:0000269|PubMed:9494079}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11931743, ECO:0000269|PubMed:9494079}. Note=In
CC       the dark, there is 20 fold more rhabdomeral trpl protein forming
CC       plasma membrane channels than in the light. In the light, the
CC       protein translocates to an intracellular compartment. Protein
CC       levels remain unchanged in light and dark conditions.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the rhabdomeres of
CC       photoreceptor cells. {ECO:0000269|PubMed:1314616}.
CC   -!- DOMAIN: Binding of calmodulin to binding site 1 is Ca(2+)
CC       dependent, whereas binding of calmodulin to site 2 is Ca(2+)
CC       independent.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN71152.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M88185; AAA28979.1; -; mRNA.
DR   EMBL; AE013599; AAF58904.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM68793.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM68794.2; -; Genomic_DNA.
DR   EMBL; BT001397; AAN71152.1; ALT_SEQ; mRNA.
DR   EMBL; BT099607; ACU45760.1; -; mRNA.
DR   PIR; JH0588; JH0588.
DR   RefSeq; NP_476895.1; NM_057547.5.
DR   RefSeq; NP_724822.1; NM_165694.3.
DR   RefSeq; NP_724823.2; NM_165695.2.
DR   UniGene; Dm.546; -.
DR   ProteinModelPortal; P48994; -.
DR   BioGrid; 61834; 9.
DR   IntAct; P48994; 2.
DR   STRING; 7227.FBpp0290876; -.
DR   TCDB; 1.A.4.1.8; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   PaxDb; P48994; -.
DR   PRIDE; P48994; -.
DR   EnsemblMetazoa; FBtr0088471; FBpp0087555; FBgn0005614.
DR   EnsemblMetazoa; FBtr0088473; FBpp0087557; FBgn0005614.
DR   EnsemblMetazoa; FBtr0301662; FBpp0290876; FBgn0005614.
DR   GeneID; 36003; -.
DR   KEGG; dme:Dmel_CG18345; -.
DR   UCSC; CG18345-RA; d. melanogaster.
DR   CTD; 36003; -.
DR   FlyBase; FBgn0005614; trpl.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   InParanoid; P48994; -.
DR   KO; K13803; -.
DR   OMA; SCMKWRR; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; P48994; -.
DR   Reactome; R-DME-3295583; TRP channels.
DR   Reactome; R-DME-5578775; Ion homeostasis.
DR   Reactome; R-DME-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P48994; -.
DR   ChiTaRS; trpl; fly.
DR   GenomeRNAi; 36003; -.
DR   PRO; PR:P48994; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0005614; -.
DR   ExpressionAtlas; P48994; differential.
DR   Genevisible; P48994; DM.
DR   GO; GO:0034703; C:cation channel complex; IPI:FlyBase.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0016027; C:inaD signaling complex; IPI:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016028; C:rhabdomere; IDA:FlyBase.
DR   GO; GO:0035997; C:rhabdomere microvillus membrane; IDA:FlyBase.
DR   GO; GO:0005262; F:calcium channel activity; IDA:FlyBase.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:FlyBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:FlyBase.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; NAS:UniProtKB.
DR   GO; GO:0010461; F:light-activated ion channel activity; IDA:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0007589; P:body fluid secretion; IMP:FlyBase.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IGI:FlyBase.
DR   GO; GO:0006816; P:calcium ion transport; IDA:FlyBase.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:FlyBase.
DR   GO; GO:0006812; P:cation transport; IDA:FlyBase.
DR   GO; GO:0071454; P:cellular response to anoxia; IGI:FlyBase.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; NAS:UniProtKB.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0007603; P:phototransduction, visible light; IMP:FlyBase.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0009416; P:response to light stimulus; TAS:FlyBase.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:FlyBase.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Repeat; Sensory transduction;
KW   Transmembrane; Transmembrane helix; Transport; Vision.
FT   CHAIN         1   1124       Transient-receptor-potential-like
FT                                protein.
FT                                /FTId=PRO_0000215359.
FT   TOPO_DOM      1    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical. {ECO:0000255}.
FT   TOPO_DOM    362    373       Extracellular. {ECO:0000255}.
FT   TRANSMEM    374    394       Helical. {ECO:0000255}.
FT   TOPO_DOM    395    431       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    432    452       Helical. {ECO:0000255}.
FT   TOPO_DOM    453    512       Extracellular. {ECO:0000255}.
FT   TRANSMEM    513    533       Helical. {ECO:0000255}.
FT   TOPO_DOM    534    548       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    549    569       Helical. {ECO:0000255}.
FT   TOPO_DOM    570    645       Extracellular. {ECO:0000255}.
FT   TRANSMEM    646    666       Helical. {ECO:0000255}.
FT   TOPO_DOM    667   1124       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       40     69       ANK 1.
FT   REPEAT       78    107       ANK 2.
FT   REPEAT      152    181       ANK 3.
FT   REGION      710    728       Calmodulin-binding 1.
FT   REGION      853    895       Calmodulin-binding 2.
FT   MUTAGEN     702    702       P->Q: Abolishes interaction with FKBP59.
FT                                {ECO:0000269|PubMed:11514552}.
FT   MUTAGEN     709    709       P->Q: Abolishes interaction with FKBP59.
FT                                {ECO:0000269|PubMed:11514552}.
FT   MUTAGEN     713    713       W->G: Disrupts Ca(2+) inflow through the
FT                                channel. Calmodulin has little effect on
FT                                Ca(2+) flow.
FT                                {ECO:0000269|PubMed:9494079}.
FT   MUTAGEN     814    814       W->G: Does not abolish Ca(2+) inflow
FT                                through the channel. Calmodulin has no
FT                                effect on initial rates.
FT                                {ECO:0000269|PubMed:9494079}.
FT   CONFLICT    228    229       II -> SS (in Ref. 1; AAA28979).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1124 AA;  127750 MW;  AF6323BA27626583 CRC64;
     MGRKKKLPTG VSSGVSHASS APKSVGGCCV PLGLPQPLLL EEKKFLLAVE RGDMPNVRRI
     LQKALRHQHI NINCMDPLGR RALTLAIDNE NLEMVELLVV MGVETKDALL HAINAEFVEA
     VELLLEHEEL IYKEGEPYSW QKVDINTAMF APDITPLMLA AHKNNFEILR ILLDRGAAVP
     VPHDIRCGCE ECVRLTAEDS LRHSLSRVNI YRALCSPSLI CLTSNDPIIT AFQLSWELRN
     LALTEQECKS EYMDLRRQCQ KFAVDLLDQT RTSNELAIIL NYDPQMSSYE PGDRMSLTRL
     VQAISYKQKK FVAHSNIQQL LSSIWYDGLP GFRRKSIVDK VICIAQVAVL FPLYCLIYMC
     APNCRTGQLM RKPFMKFLIH ASSYLFFLFI LILVSQRADD DFVRIFGTTR MKKELAEQEL
     RQRGQTPSKL ELIVVMYVIG FVWEEVQEIF AVGMKSYLRN MWNFIDFLRN SLYVSVMCLR
     AFAYIQQATE IARDPQMAYI PREKWHDFDP QLIAEGLFAA ANVFSALKLV HLFSINPHLG
     PLQISLGRMV IDIVKFFFIY TLVLFAFACG LNQLLWYFAA LEKSKCYVLP GGEADWGSHG
     DSCMKWRRFG NLFESSQSLF WASFGMVGLD DFELSGIKSY TRFWGLLMFG SYSVINVIVL
     LNLLIAMMSN SYAMIDEHSD TEWKFARTKL WMSYFEDSAT LPPPFNVLPS VKWVIRIFRK
     SSKTIDRQRS KKRKEQEQFS EYDNIMRSLV WRYVAAMHRK FENNPVSEDD INEVKSEINT
     MRYEMLEIFE NSGMDVSSAN KKERQPRPRR IKVWERRLMK GFQVAPVQNG CELDAFGNVN
     GQGEMQEIKV ESIPSKPAKE TAKERFQRVA RTVLLQSTTH KWNVVLRAAK DSQIGRCTKN
     ERKSLQNLGR AIEEAKRLIM LNPGCPSGRE SPIRIEFEDE KTSTLLELLN QISAEISDSE
     KPKIRPIWRP PLKTVPARAM AANNTRSLTA PELKISRKSS PAPTPTPTPG VSHTALSQFR
     NRELPLCPSK LIANSAPSAP TAPPKKSAPT APTPTYKPTT HAPFSVEGGN RENTRASDGV
     RSDNSNFDIH VVDLDEKGGH LGRDNVSDIS SIASTSPQRP KHRN
//
ID   TRPC1_HUMAN             Reviewed;         793 AA.
AC   P48995; Q14CE4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-OCT-2017, entry version 162.
DE   RecName: Full=Short transient receptor potential channel 1;
DE            Short=TrpC1;
DE   AltName: Full=Transient receptor protein 1;
DE            Short=TRP-1;
GN   Name=TRPC1; Synonyms=TRP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7589464; DOI=10.1016/0014-5793(95)01038-G;
RA   Zhu X., Chu P.B., Peyton M., Birnbaumer L.;
RT   "Molecular cloning of a widely expressed human homologue for the
RT   Drosophila trp gene.";
RL   FEBS Lett. 373:193-198(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   TISSUE=Brain;
RX   PubMed=7568191; DOI=10.1073/pnas.92.21.9652;
RA   Wes P.D., Chevesich J., Jeromin A., Rosenberg C., Stetten G.,
RA   Montell C.;
RT   "TRPC1, a human homolog of a Drosophila store-operated channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:9652-9656(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   TISSUE=Brain;
RX   PubMed=8663995; DOI=10.1016/S0896-6273(00)80145-2;
RA   Zitt C., Zobel A., Obukhov A.G., Harteneck C., Kalkbrenner F.,
RA   Lueckhoff A., Schultz G.;
RT   "Cloning and functional expression of a human Ca2+-permeable cation
RT   channel activated by calcium store depletion.";
RL   Neuron 16:1189-1196(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH ITPR3.
RX   PubMed=10766822; DOI=10.1074/jbc.275.16.11934;
RA   Lockwich T.P., Liu X., Singh B.B., Jadlowiec J., Weiland S.,
RA   Ambudkar I.S.;
RT   "Assembly of Trp1 in a signaling complex associated with caveolin-
RT   scaffolding lipid raft domains.";
RL   J. Biol. Chem. 275:11934-11942(2000).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=11139478; DOI=10.1161/01.RES.88.1.84;
RA   Xu S.-Z., Beech D.J.;
RT   "TrpC1 is a membrane-spanning subunit of store-operated Ca(2+)
RT   channels in native vascular smooth muscle cells.";
RL   Circ. Res. 88:84-87(2001).
RN   [8]
RP   SUBUNIT.
RX   PubMed=12032305; DOI=10.1073/pnas.102596199;
RA   Hofmann T., Schaefer M., Schultz G., Gudermann T.;
RT   "Subunit composition of mammalian transient receptor potential
RT   channels in living cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7461-7466(2002).
RN   [9]
RP   FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=15016832; DOI=10.1074/jbc.M313975200;
RA   Ahmmed G.U., Mehta D., Vogel S., Holinstat M., Paria B.C.,
RA   Tiruppathi C., Malik A.B.;
RT   "Protein kinase Calpha phosphorylates the TRPC1 channel and regulates
RT   store-operated Ca2+ entry in endothelial cells.";
RL   J. Biol. Chem. 279:20941-20949(2004).
RN   [10]
RP   INTERACTION WITH MX1.
RX   PubMed=15757897; DOI=10.1074/jbc.M500391200;
RA   Lussier M.P., Cayouette S., Lepage P.K., Bernier C.L., Francoeur N.,
RA   St-Hilaire M., Pinard M., Boulay G.;
RT   "MxA, a member of the dynamin superfamily, interacts with the ankyrin-
RT   like repeat domain of TRPC.";
RL   J. Biol. Chem. 280:19393-19400(2005).
RN   [11]
RP   INTERACTION WITH RNF24.
RX   PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009;
RA   Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.;
RT   "RNF24, a new TRPC interacting protein, causes the intracellular
RT   retention of TRPC.";
RL   Cell Calcium 43:432-443(2008).
RN   [12]
RP   INTERACTION WITH FKBP4.
RX   PubMed=19945390; DOI=10.1016/j.neuron.2009.09.025;
RA   Shim S., Yuan J.P., Kim J.Y., Zeng W., Huang G., Milshteyn A.,
RA   Kern D., Muallem S., Ming G.L., Worley P.F.;
RT   "Peptidyl-prolyl isomerase FKBP52 controls chemotropic guidance of
RT   neuronal growth cones via regulation of TRPC1 channel opening.";
RL   Neuron 64:471-483(2009).
CC   -!- FUNCTION: Thought to form a receptor-activated non-selective
CC       calcium permeant cation channel. Probably is operated by a
CC       phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases or G-protein coupled receptors. Seems to be also
CC       activated by intracellular calcium store depletion.
CC       {ECO:0000269|PubMed:15016832}.
CC   -!- SUBUNIT: Interacts with TRPC4AP (By similarity). Homotetramer and
CC       heterotetramer with TRPC4 and/or TRPC5. Interacts with TRPC3,
CC       TRPC4 and TRPC5. Interacts with ITPR3. Interacts with MX1 and
CC       RNF24. Interacts with FKBP4. {ECO:0000250,
CC       ECO:0000269|PubMed:10766822, ECO:0000269|PubMed:12032305,
CC       ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:17850865,
CC       ECO:0000269|PubMed:19945390}.
CC   -!- INTERACTION:
CC       Q03135:CAV1; NbExp=7; IntAct=EBI-929665, EBI-603614;
CC       Q96D31:ORAI1; NbExp=2; IntAct=EBI-929665, EBI-2291476;
CC       Q13563:PKD2; NbExp=4; IntAct=EBI-9830970, EBI-7813714;
CC       Q13586:STIM1; NbExp=6; IntAct=EBI-929665, EBI-448878;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P48995-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P48995-2; Sequence=VSP_006560;
CC   -!- TISSUE SPECIFICITY: Seems to be ubiquitous.
CC   -!- PTM: Activation of PRKCA induces phosphorylation of TRPC1 and
CC       subsequent Ca2+ entry into cells. {ECO:0000269|PubMed:15016832}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U31110; AAA93251.1; -; mRNA.
DR   EMBL; U31110; AAA93252.1; -; mRNA.
DR   EMBL; X89066; CAA61447.1; -; mRNA.
DR   EMBL; Z73903; CAA98108.1; -; mRNA.
DR   EMBL; CH471052; EAW78963.1; -; Genomic_DNA.
DR   EMBL; BC112338; AAI12339.1; -; mRNA.
DR   EMBL; BC113953; AAI13954.1; -; mRNA.
DR   CCDS; CCDS3126.1; -. [P48995-2]
DR   CCDS; CCDS58856.1; -. [P48995-1]
DR   PIR; S68238; S68238.
DR   RefSeq; NP_001238774.1; NM_001251845.1. [P48995-1]
DR   RefSeq; NP_003295.1; NM_003304.4. [P48995-2]
DR   UniGene; Hs.250687; -.
DR   UniGene; Hs.684389; -.
DR   ProteinModelPortal; P48995; -.
DR   BioGrid; 113071; 16.
DR   CORUM; P48995; -.
DR   DIP; DIP-35698N; -.
DR   IntAct; P48995; 42.
DR   STRING; 9606.ENSP00000273482; -.
DR   GuidetoPHARMACOLOGY; 486; -.
DR   TCDB; 1.A.4.1.3; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; P48995; -.
DR   PhosphoSitePlus; P48995; -.
DR   SwissPalm; P48995; -.
DR   BioMuta; TRPC1; -.
DR   DMDM; 1351302; -.
DR   MaxQB; P48995; -.
DR   PaxDb; P48995; -.
DR   PeptideAtlas; P48995; -.
DR   PRIDE; P48995; -.
DR   Ensembl; ENST00000273482; ENSP00000273482; ENSG00000144935. [P48995-2]
DR   Ensembl; ENST00000476941; ENSP00000419313; ENSG00000144935. [P48995-1]
DR   Ensembl; ENST00000612385; ENSP00000481537; ENSG00000144935. [P48995-2]
DR   GeneID; 7220; -.
DR   KEGG; hsa:7220; -.
DR   UCSC; uc003evb.4; human. [P48995-1]
DR   CTD; 7220; -.
DR   DisGeNET; 7220; -.
DR   EuPathDB; HostDB:ENSG00000144935.14; -.
DR   GeneCards; TRPC1; -.
DR   HGNC; HGNC:12333; TRPC1.
DR   HPA; CAB009387; -.
DR   HPA; HPA021130; -.
DR   MIM; 602343; gene.
DR   neXtProt; NX_P48995; -.
DR   OpenTargets; ENSG00000144935; -.
DR   PharmGKB; PA357; -.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000020589; -.
DR   HOVERGEN; HBG068337; -.
DR   InParanoid; P48995; -.
DR   KO; K04964; -.
DR   OMA; FVAQSNC; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; P48995; -.
DR   TreeFam; TF313147; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   ChiTaRS; TRPC1; human.
DR   GeneWiki; TRPC1; -.
DR   GenomeRNAi; 7220; -.
DR   PRO; PR:P48995; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000144935; -.
DR   CleanEx; HS_TRPC1; -.
DR   ExpressionAtlas; P48995; baseline and differential.
DR   Genevisible; P48995; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0005261; F:cation channel activity; EXP:Reactome.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006816; P:calcium ion transport; TAS:ProtInc.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0042438; P:melanin biosynthetic process; IDA:CACAO.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:BHF-UCL.
DR   GO; GO:0051592; P:response to calcium ion; IDA:BHF-UCL.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005457; TRPC1_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF56; PTHR10117:SF56; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01642; TRPCHANNEL1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    793       Short transient receptor potential
FT                                channel 1.
FT                                /FTId=PRO_0000215303.
FT   TOPO_DOM      1    386       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    387    407       Helical. {ECO:0000255}.
FT   TOPO_DOM    408    415       Extracellular. {ECO:0000255}.
FT   TRANSMEM    416    436       Helical. {ECO:0000255}.
FT   TOPO_DOM    437    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    475       Helical. {ECO:0000255}.
FT   TOPO_DOM    476    539       Extracellular. {ECO:0000255}.
FT   TRANSMEM    540    560       Helical. {ECO:0000255}.
FT   TOPO_DOM    561    586       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    587    607       Helical. {ECO:0000255}.
FT   TOPO_DOM    608    616       Extracellular. {ECO:0000255}.
FT   TRANSMEM    617    637       Helical. {ECO:0000255}.
FT   REPEAT       46     75       ANK 1.
FT   REPEAT       83    111       ANK 2.
FT   REPEAT      112    138       ANK 3.
FT   REPEAT      158    187       ANK 4.
FT   VAR_SEQ     110    143       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7568191,
FT                                ECO:0000303|PubMed:8663995}.
FT                                /FTId=VSP_006560.
SQ   SEQUENCE   793 AA;  91212 MW;  F4CC57ADDFA320AE CRC64;
     MMAALYPSTD LSGASSSSLP SSPSSSSPNE VMALKDVREV KEENTLNEKL FLLACDKGDY
     YMVKKILEEN SSGDLNINCV DVLGRNAVTI TIENENLDIL QLLLDYGCQS ADALLVAIDS
     EVVGAVDILL NHRPKRSSRP TIVKLMERIQ NPEYSTTMDV APVILAAHRN NYEILTMLLK
     QDVSLPKPHA VGCECTLCSA KNKKDSLRHS RFRLDIYRCL ASPALIMLTE EDPILRAFEL
     SADLKELSLV EVEFRNDYEE LARQCKMFAK DLLAQARNSR ELEVILNHTS SDEPLDKRGL
     LEERMNLSRL KLAIKYNQKE FVSQSNCQQF LNTVWFGQMS GYRRKPTCKK IMTVLTVGIF
     WPVLSLCYLI APKSQFGRII HTPFMKFIIH GASYFTFLLL LNLYSLVYNE DKKNTMGPAL
     ERIDYLLILW IIGMIWSDIK RLWYEGLEDF LEESRNQLSF VMNSLYLATF ALKVVAHNKF
     HDFADRKDWD AFHPTLVAEG LFAFANVLSY LRLFFMYTTS SILGPLQISM GQMLQDFGKF
     LGMFLLVLFS FTIGLTQLYD KGYTSKEQKD CVGIFCEQQS NDTFHSFIGT CFALFWYIFS
     LAHVAIFVTR FSYGEELQSF VGAVIVGTYN VVVVIVLTKL LVAMLHKSFQ LIANHEDKEW
     KFARAKLWLS YFDDKCTLPP PFNIIPSPKT ICYMISSLSK WICSHTSKGK VKRQNSLKEW
     RNLKQKRDEN YQKVMCCLVH RYLTSMRQKM QSTDQATVEN LNELRQDLSK FRNEIRDLLG
     FRTSKYAMFY PRN
//
ID   CCH1_YEAST              Reviewed;        2039 AA.
AC   P50077; D6VV00;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   20-DEC-2017, entry version 146.
DE   RecName: Full=Calcium-channel protein CCH1;
GN   Name=CCH1; OrderedLocusNames=YGR217W; ORFNames=G8501;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169869;
RA   Tettelin H., Agostoni-Carbone M.L., Albermann K., Albers M.,
RA   Arroyo J., Backes U., Barreiros T., Bertani I., Bjourson A.J.,
RA   Brueckner M., Bruschi C.V., Carignani G., Castagnoli L., Cerdan E.,
RA   Clemente M.L., Coblenz A., Coglievina M., Coissac E., Defoor E.,
RA   Del Bino S., Delius H., Delneri D., de Wergifosse P., Dujon B.,
RA   Durand P., Entian K.-D., Eraso P., Escribano V., Fabiani L.,
RA   Fartmann B., Feroli F., Feuermann M., Frontali L., Garcia-Gonzalez M.,
RA   Garcia-Saez M.I., Goffeau A., Guerreiro P., Hani J., Hansen M.,
RA   Hebling U., Hernandez K., Heumann K., Hilger F., Hofmann B.,
RA   Indge K.J., James C.M., Klima R., Koetter P., Kramer B., Kramer W.,
RA   Lauquin G., Leuther H., Louis E.J., Maillier E., Marconi A.,
RA   Martegani E., Mazon M.J., Mazzoni C., McReynolds A.D.K.,
RA   Melchioretto P., Mewes H.-W., Minenkova O., Mueller-Auer S.,
RA   Nawrocki A., Netter P., Neu R., Nombela C., Oliver S.G., Panzeri L.,
RA   Paoluzi S., Plevani P., Portetelle D., Portillo F., Potier S.,
RA   Purnelle B., Rieger M., Riles L., Rinaldi T., Robben J.,
RA   Rodrigues-Pousada C., Rodriguez-Belmonte E., Rodriguez-Torres A.M.,
RA   Rose M., Ruzzi M., Saliola M., Sanchez-Perez M., Schaefer B.,
RA   Schaefer M., Scharfe M., Schmidheini T., Schreer A., Skala J.,
RA   Souciet J.-L., Steensma H.Y., Talla E., Thierry A., Vandenbol M.,
RA   van der Aart Q.J.M., Van Dyck L., Vanoni M., Verhasselt P., Voet M.,
RA   Volckaert G., Wambutt R., Watson M.D., Weber N., Wedler E., Wedler H.,
RA   Wipfli P., Wolf K., Wright L.F., Zaccaria P., Zimmermann M.,
RA   Zollner A., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome VII.";
RL   Nature 387:81-84(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1184-2039.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8701610;
RX   DOI=10.1002/(SICI)1097-0061(19960330)12:4<385::AID-YEA910>3.3.CO;2-7;
RA   van der Aart Q.J.M., Kleine K., Steensma H.Y.;
RT   "Sequence analysis of the 43 kb CRM1-YLM9-PET54-DIE2-SMI1-PHO81-YHB4-
RT   PFK1 region from the right arm of Saccharomyces cerevisiae chromosome
RT   VII.";
RL   Yeast 12:385-390(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1184-2039.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9290212;
RX   DOI=10.1002/(SICI)1097-0061(19970915)13:11<1077::AID-YEA152>3.3.CO;2-P;
RA   Rieger M., Brueckner M., Schaefer M., Mueller-Auer S.;
RT   "Sequence analysis of 203 kilobases from Saccharomyces cerevisiae
RT   chromosome VII.";
RL   Yeast 13:1077-1090(1997).
RN   [5]
RP   FUNCTION.
RX   PubMed=9343395; DOI=10.1128/MCB.17.11.6339;
RA   Paidhungat M., Garrett S.;
RT   "A homolog of mammalian, voltage-gated calcium channels mediates yeast
RT   pheromone-stimulated Ca2+ uptake and exacerbates the cdc1(Ts) growth
RT   defect.";
RL   Mol. Cell. Biol. 17:6339-6347(1997).
RN   [6]
RP   FUNCTION, INTERACTION WITH MID1, AND SUBCELLULAR LOCATION.
RX   PubMed=10958666; DOI=10.1128/MCB.20.18.6686-6694.2000;
RA   Locke E.G., Bonilla M., Liang L., Takita Y., Cunningham K.W.;
RT   "A homolog of voltage-gated Ca(2+) channels stimulated by depletion of
RT   secretory Ca(2+) in yeast.";
RL   Mol. Cell. Biol. 20:6686-6694(2000).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass
RT   spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
CC   -!- FUNCTION: Voltage-gated, high-affinity calcium channel involved in
CC       calcium influx in response to some environmental stresses as well
CC       as exposure to mating pheromones. Functions together with MID1 to
CC       ensure that adequate levels of Ca(2+) are supplied to PMR1 to
CC       sustain secretion and growth. Required for growth in low-calcium
CC       environments. {ECO:0000269|PubMed:10958666,
CC       ECO:0000269|PubMed:9343395}.
CC   -!- SUBUNIT: Interacts with MID1 to form a Ca(2+) influx channel.
CC       {ECO:0000269|PubMed:10958666}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10958666}.
CC       Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z73002; CAA97244.1; -; Genomic_DNA.
DR   EMBL; Z73003; CAA97245.1; -; Genomic_DNA.
DR   EMBL; X87941; CAA61165.1; -; Genomic_DNA.
DR   EMBL; BK006941; DAA08311.1; -; Genomic_DNA.
DR   PIR; S64540; S64540.
DR   RefSeq; NP_011733.3; NM_001181346.3.
DR   ProteinModelPortal; P50077; -.
DR   BioGrid; 33470; 145.
DR   IntAct; P50077; 14.
DR   MINT; MINT-4487826; -.
DR   STRING; 4932.YGR217W; -.
DR   TCDB; 1.A.1.11.10; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P50077; -.
DR   MaxQB; P50077; -.
DR   PRIDE; P50077; -.
DR   EnsemblFungi; YGR217W; YGR217W; YGR217W.
DR   GeneID; 853131; -.
DR   KEGG; sce:YGR217W; -.
DR   EuPathDB; FungiDB:YGR217W; -.
DR   SGD; S000003449; CCH1.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000111448; -.
DR   InParanoid; P50077; -.
DR   KO; K21864; -.
DR   OMA; MLGDSAM; -.
DR   OrthoDB; EOG092C00XX; -.
DR   BioCyc; YEAST:G3O-30899-MONOMER; -.
DR   PRO; PR:P50077; -.
DR   Proteomes; UP000002311; Chromosome VII.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:SGD.
DR   GO; GO:0005262; F:calcium channel activity; IDA:SGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:SGD.
DR   GO; GO:0006816; P:calcium ion transport; IDA:SGD.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Stress response; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2039       Calcium-channel protein CCH1.
FT                                /FTId=PRO_0000054106.
FT   TRANSMEM    346    366       Helical. {ECO:0000255}.
FT   TRANSMEM    384    404       Helical. {ECO:0000255}.
FT   TRANSMEM    563    583       Helical. {ECO:0000255}.
FT   TRANSMEM    658    678       Helical. {ECO:0000255}.
FT   TRANSMEM    691    711       Helical. {ECO:0000255}.
FT   TRANSMEM    766    786       Helical. {ECO:0000255}.
FT   TRANSMEM    809    829       Helical. {ECO:0000255}.
FT   TRANSMEM    841    861       Helical. {ECO:0000255}.
FT   TRANSMEM    904    924       Helical. {ECO:0000255}.
FT   TRANSMEM    942    962       Helical. {ECO:0000255}.
FT   TRANSMEM    978    998       Helical. {ECO:0000255}.
FT   TRANSMEM   1207   1227       Helical. {ECO:0000255}.
FT   TRANSMEM   1247   1267       Helical. {ECO:0000255}.
FT   TRANSMEM   1277   1297       Helical. {ECO:0000255}.
FT   TRANSMEM   1340   1360       Helical. {ECO:0000255}.
FT   TRANSMEM   1408   1428       Helical. {ECO:0000255}.
FT   TRANSMEM   1452   1472       Helical. {ECO:0000255}.
FT   TRANSMEM   1529   1549       Helical. {ECO:0000255}.
FT   TRANSMEM   1554   1574       Helical. {ECO:0000255}.
FT   TRANSMEM   1596   1616       Helical. {ECO:0000255}.
FT   TRANSMEM   1618   1638       Helical. {ECO:0000255}.
FT   TRANSMEM   1654   1674       Helical. {ECO:0000255}.
FT   TRANSMEM   1748   1768       Helical. {ECO:0000255}.
FT   DOMAIN     1787   1822       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000244|PubMed:17287358}.
FT   CONFLICT   1185   1185       R -> Q (in Ref. 4; CAA61165).
FT                                {ECO:0000305}.
FT   CONFLICT   1203   1203       I -> N (in Ref. 4; CAA61165).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2039 AA;  234599 MW;  800B3825D6C6E527 CRC64;
     MQGRKRTLTE PFEPNTNPFG DNAAVMTENV EDNSETDGNR LESKPQALVP PALNIVPPES
     SIHSTEEKKG DEYNGNDKDS SLISNIFRTR VGRSSHENLS RPKLSLKTAS FGAAESSRRN
     VSPSTKSAKS SSQYIDLNDE RLRRRSFSSY SRSSSRRVSN SPSSTDRPPR SAKVLSLIAA
     DDMDDFEDLQ KGFKSAIDEE GLTWLPQLKS EKSRPVSDVG EDRGEGEQES IPDVHTPNVG
     ASATPGSIHL TPEPAQNGSV SEGLEGSINN SRKKPSPKFF HHLSPQKEDK DQTEVIEYAE
     DILDFETLQR KLESRPFVLY GHSLGVFSPT NPLRIKIARF LLHRRYSLLY NTLLTFYAIL
     LAIRTYNPHN VVFLYRFSNW TDYFIFILSA CFTGNDIAKI IAFGFWDDSE MFKAYGREYK
     SILQRSGIMK LYIYLREKYG RKLIDFIIPF RIISPGEETK YQRSSLSTSL TKPYGAKENQ
     RPFGTPRAFA RSSWNRIDLV SSVSFWLGMF LSIKSYDTKT GIRIFKPLAI LRILRLVNVD
     TGMPSILRGL KYGIPQLVNV SSMLVYFWIF FGILGVQIFQ GSFRRQCVWF NPEDPTDTYQ
     YDMQFCGGYL DPVTKRKQNY IYEDGSEGSV SKGFLCPQYS KCVSNANPYN GRISFDNIVN
     SMELVFVIMS ANTFTDLMYY TMDSDEMAAC LFFIVCIFVL TIWLLNLLIA VLVSSFEIAN
     EEYKKKKFIY GSRKTGYVAR IVTGYWKYFK LKANQTKFPN WSQKGLAIYS HVEFIFVILI
     ICDIGMRASV KVSTSANCNN ILLKTDRGIS IVLFIESLAR LVLYLPNMWK FLTKPSYVYD
     FIISIITLVI SCLAVEGVLG HMYAWLSIFH ISRFYRVIIS FNLTKKLWKQ ILSNGVMIWN
     LSSFYFFFTF LVAIIMAVYF EGVIPPEEMA DQPFGMYSLP NSFLSLFIIG STENWTDILY
     ALQKHSPNIS STFFCSVFFI IWFLLSNSVI LNIFIALISE SMEVKEEEKR PQQIKHYLKF
     VYPQKIQEYT HASLVARIRK KFFGGHRNED TRDFKQFLMR GTAIMNIAQN MGELADEFKE
     PPSENLFKKG LSKLTIGVPS LKRLRMFANN PFYKNSDVVF TETNDINGRT YILELNEYED
     EKLDYLKKYP LFNYSYYFFS PQHRFRRFCQ RLVPPSTGKR TDGSRFFEDS TDLYNKRSYF
     HHIERDVFVF IFALATILLI VCSCYVTPLY RMHHKMGTWN WSSALDCAFI GAFSIEFIVK
     TVADGFIYSP NAYLRNPWNF IDFCVLISMW INLIAYLKNN GNLSRIFKGL TALRALRCLT
     ISNTARQTFN LVMFDGLNKI FEAGLISLSL LFPFTVWGLS IFKGRLGTCN DGSLGRADCY
     NEYSNSVFQW DIMSPRVYQQ PYLHLDSFAS AFSSLYQIIS LEGWVDLLEN MMNSSGIGTP
     ATVMGSAGNA LFLVLFNFLS MVFILNLFVS FIVNNQARTT GSAYFTIEEK AWLESQKLLS
     QAKPKAIPNL IELSRVRQFF YQLAVEKKNF YYASFLQVVL YLHIIMLLSR SYNPGNLIGY
     QGVYFMFSTS VFLIQEALHM CGEGPRLYFR QKWNSIRLSI IIIAFIMNAV AFHVPASHYW
     FHNIKGFFLL VIFLFIIPQN DTLTELLETA MASLPPILSL TYTWGVLFLV YAIALNQIFG
     LTRLGSNTTD NINFRTVIKS MIVLFRCSFG EGWNYIMADL TVSEPYCSSD DNSTYTDCGS
     ETYAYLLLMS WNIISMYIFV NMFVSLIIGN FSYVYRSGGS RSGINRSEIK KYIEAWSKFD
     TDGTGELELS YLPRIMHSFD GPLSFKIWEG RLTIKSLVEN YMEVNPDDPY DVKIDLIGLN
     KELNTIDKAK IIQRKLQYRR FVQSIHYTNA YNGCIRFSDL LLQIPLYTAY SARECLGIDQ
     YVHHLYILGK VDKYLENQRN FDVLEMVVTR WKFHCRMKRT IEPEWDVKDP TVSSHISNIN
     VNLEPAPGIL EREPIATPRM DYGVNNFMWS PRMNQDSTME PPEEPIDNND DSANDLIDR
//
ID   CA2D1_HUMAN             Reviewed;        1103 AA.
AC   P54289; Q17R45; Q9UD80; Q9UD81; Q9UD82;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 3.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-1;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-1;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit alpha-2-1;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit delta-1;
DE   Flags: Precursor;
GN   Name=CACNA2D1; Synonyms=CACNL2A, CCHL2A, MHS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=1309651; DOI=10.1016/0896-6273(92)90109-Q;
RA   Williams M.E., Feldman D.H., McCue A.F., Brenner R., Velicelebi G.,
RA   Ellis S.B., Harpold M.M.;
RT   "Structure and functional expression of alpha 1, alpha 2, and beta
RT   subunits of a novel human neuronal calcium channel subtype.";
RL   Neuron 8:71-84(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 528-648 (ISOFORMS 1; 2; 3; 4 AND 5),
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RC   TISSUE=Neuroblastoma;
RX   PubMed=8107964; DOI=10.1016/0028-3908(93)90004-M;
RA   Brust P.F., Simerson S., McCue A.F., Deal C.R., Schoonmaker S.,
RA   Williams M.E., Velicelebi G., Johnson E.C., Harpold M.M., Ellis S.B.;
RT   "Human neuronal voltage-dependent calcium channels: studies on subunit
RT   structure and role in channel assembly.";
RL   Neuropharmacology 32:1089-1102(1993).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-136; ASN-324 AND ASN-675.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-348; ASN-475 AND ASN-824.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [7]
RP   INTERCHAIN DISULFIDE BOND, AND SUBUNIT.
RX   PubMed=22054663; DOI=10.1016/j.ceca.2011.10.002;
RA   Calderon-Rivera A., Andrade A., Hernandez-Hernandez O.,
RA   Gonzalez-Ramirez R., Sandoval A., Rivera M., Gomora J.C., Felix R.;
RT   "Identification of a disulfide bridge essential for structure and
RT   function of the voltage-gated Ca(2+) channel alpha(2)delta-1 auxiliary
RT   subunit.";
RL   Cell Calcium 51:22-30(2012).
CC   -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium
CC       channels regulates calcium current density and
CC       activation/inactivation kinetics of the calcium channel. Plays an
CC       important role in excitation-contraction coupling (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Dimer formed of alpha-2-1 and delta-1 chains; disulfide-
CC       linked. Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta
CC       (CACNB) and delta (CACNA2D) subunits in a 1:1:1:1 ratio (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Alpha-2a;
CC         IsoId=P54289-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha-2b;
CC         IsoId=P54289-2; Sequence=VSP_038348, VSP_038350;
CC       Name=3; Synonyms=Alpha-2c;
CC         IsoId=P54289-3; Sequence=VSP_038349, VSP_038350;
CC       Name=4; Synonyms=Alpha-2d;
CC         IsoId=P54289-4; Sequence=VSP_038349;
CC       Name=5; Synonyms=Alpha-2e;
CC         IsoId=P54289-5; Sequence=VSP_038348;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in skeletal muscle.
CC       Isoform 2 is expressed in the central nervous system. Isoform 2,
CC       isoform 4 and isoform 5 are expressed in neuroblastoma cells.
CC       Isoform 3, isoform 4 and isoform 5 are expressed in the aorta.
CC       {ECO:0000269|PubMed:1309651, ECO:0000269|PubMed:8107964}.
CC   -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent
CC       metal cations and is required to promote trafficking of the alpha-
CC       1 (CACNA1) subunit to the plasma membrane by an integrin-like
CC       switch. {ECO:0000250}.
CC   -!- PTM: Proteolytically processed into subunits alpha-2-1 and delta-1
CC       that are disulfide-linked. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Binds gabapentin, an antiepileptic drug.
CC   -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M76559; AAA51903.1; -; mRNA.
DR   EMBL; CH471091; EAW76990.1; -; Genomic_DNA.
DR   EMBL; BC117468; AAI17469.1; -; mRNA.
DR   EMBL; BC117470; AAI17471.1; -; mRNA.
DR   CCDS; CCDS5598.1; -. [P54289-2]
DR   PIR; JH0565; JH0565.
DR   RefSeq; NP_000713.2; NM_000722.3. [P54289-2]
DR   RefSeq; XP_005250627.1; XM_005250570.2. [P54289-1]
DR   RefSeq; XP_005250629.1; XM_005250572.2. [P54289-3]
DR   RefSeq; XP_005250630.1; XM_005250573.2. [P54289-5]
DR   RefSeq; XP_005250631.1; XM_005250574.2. [P54289-4]
DR   UniGene; Hs.282151; -.
DR   UniGene; Hs.592625; -.
DR   UniGene; Hs.743228; -.
DR   ProteinModelPortal; P54289; -.
DR   SMR; P54289; -.
DR   BioGrid; 107235; 49.
DR   IntAct; P54289; 9.
DR   STRING; 9606.ENSP00000349320; -.
DR   BindingDB; P54289; -.
DR   ChEMBL; CHEMBL1919; -.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB04838; Cyclandelate.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00270; Isradipine.
DR   DrugBank; DB00653; Magnesium Sulfate.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00401; Nisoldipine.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB04922; XP13512.
DR   TCDB; 8.A.18.1.1; the ca(2+) channel auxiliary subunit Alpha2Delta types 1-4 (cca-Alpha2Delta) family.
DR   iPTMnet; P54289; -.
DR   PhosphoSitePlus; P54289; -.
DR   SwissPalm; P54289; -.
DR   BioMuta; CACNA2D1; -.
DR   DMDM; 262527579; -.
DR   EPD; P54289; -.
DR   MaxQB; P54289; -.
DR   PaxDb; P54289; -.
DR   PeptideAtlas; P54289; -.
DR   PRIDE; P54289; -.
DR   Ensembl; ENST00000356253; ENSP00000348589; ENSG00000153956. [P54289-1]
DR   Ensembl; ENST00000356860; ENSP00000349320; ENSG00000153956. [P54289-2]
DR   GeneID; 781; -.
DR   KEGG; hsa:781; -.
DR   UCSC; uc003uhr.2; human. [P54289-1]
DR   CTD; 781; -.
DR   DisGeNET; 781; -.
DR   EuPathDB; HostDB:ENSG00000153956.15; -.
DR   GeneCards; CACNA2D1; -.
DR   HGNC; HGNC:1399; CACNA2D1.
DR   HPA; HPA008213; -.
DR   HPA; HPA008621; -.
DR   MalaCards; CACNA2D1; -.
DR   MIM; 114204; gene.
DR   neXtProt; NX_P54289; -.
DR   OpenTargets; ENSG00000153956; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 51083; Familial short QT syndrome.
DR   PharmGKB; PA86; -.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOVERGEN; HBG057779; -.
DR   InParanoid; P54289; -.
DR   KO; K04858; -.
DR   OMA; SGVLDCG; -.
DR   OrthoDB; EOG091G00UY; -.
DR   PhylomeDB; P54289; -.
DR   TreeFam; TF315824; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA2D1; human.
DR   GeneWiki; CACNA2D1; -.
DR   GenomeRNAi; 781; -.
DR   PRO; PR:P54289; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000153956; -.
DR   CleanEx; HS_CACNA2D1; -.
DR   ExpressionAtlas; P54289; baseline and differential.
DR   Genevisible; P54289; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; ISS:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISS:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IGI:ARUK-UCL.
DR   GO; GO:0086048; P:membrane depolarization during bundle of His cell action potential; IMP:BHF-UCL.
DR   GO; GO:1901843; P:positive regulation of high voltage-gated calcium channel activity; ISS:BHF-UCL.
DR   GO; GO:1902514; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; IGI:ARUK-UCL.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0098903; P:regulation of membrane repolarization during action potential; ISS:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013680; VDCC_a2/dsu.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF08473; VGCC_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1103       Voltage-dependent calcium channel subunit
FT                                alpha-2/delta-1.
FT                                /FTId=PRO_0000304633.
FT   CHAIN        25    956       Voltage-dependent calcium channel subunit
FT                                alpha-2-1. {ECO:0000250}.
FT                                /FTId=PRO_0000005001.
FT   CHAIN       957   1103       Voltage-dependent calcium channel subunit
FT                                delta-1. {ECO:0000250}.
FT                                /FTId=PRO_0000005002.
FT   TOPO_DOM     25   1073       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1074   1094       Helical. {ECO:0000255}.
FT   TOPO_DOM   1095   1103       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      253    430       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      446    556       Cache.
FT   MOTIF       259    263       MIDAS-like motif.
FT   METAL       259    259       Divalent metal cation. {ECO:0000250}.
FT   METAL       261    261       Divalent metal cation. {ECO:0000250}.
FT   METAL       263    263       Divalent metal cation. {ECO:0000250}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54290}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    324    324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    348    348       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    468    468       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    604    604       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    613    613       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    675    675       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    781    781       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    824    824       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    888    888       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    895    895       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    985    985       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    998    998       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    404   1059       Interchain (between alpha-2-1 and delta-1
FT                                chains).
FT   VAR_SEQ     531    554       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:8107964}.
FT                                /FTId=VSP_038349.
FT   VAR_SEQ     531    549       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:1309651,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8107964}.
FT                                /FTId=VSP_038348.
FT   VAR_SEQ     644    644       Y -> SKKGKMKD (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:1309651,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8107964}.
FT                                /FTId=VSP_038350.
FT   VARIANT    1019   1019       E -> D (in dbSNP:rs9886043).
FT                                /FTId=VAR_053960.
FT   VARIANT    1057   1057       D -> A (in dbSNP:rs35131433).
FT                                /FTId=VAR_035047.
FT   CONFLICT     99     99       R -> S (in Ref. 1; AAA51903).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       T -> R (in Ref. 1; AAA51903).
FT                                {ECO:0000305}.
FT   CONFLICT    395    395       D -> E (in Ref. 1; AAA51903).
FT                                {ECO:0000305}.
FT   CONFLICT    635    635       L -> I (in Ref. 4; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1103 AA;  124568 MW;  0749685DE9DB0700 CRC64;
     MAAGCLLALT LTLFQSLLIG PSSEEPFPSA VTIKSWVDKM QEDLVTLAKT ASGVNQLVDI
     YEKYQDLYTV EPNNARQLVE IAARDIEKLL SNRSKALVRL ALEAEKVQAA HQWREDFASN
     EVVYYNAKDD LDPEKNDSEP GSQRIKPVFI EDANFGRQIS YQHAAVHIPT DIYEGSTIVL
     NELNWTSALD EVFKKNREED PSLLWQVFGS ATGLARYYPA SPWVDNSRTP NKIDLYDVRR
     RPWYIQGAAS PKDMLILVDV SGSVSGLTLK LIRTSVSEML ETLSDDDFVN VASFNSNAQD
     VSCFQHLVQA NVRNKKVLKD AVNNITAKGI TDYKKGFSFA FEQLLNYNVS RANCNKIIML
     FTDGGEERAQ EIFNKYNKDK KVRVFTFSVG QHNYDRGPIQ WMACENKGYY YEIPSIGAIR
     INTQEYLDVL GRPMVLAGDK AKQVQWTNVY LDALELGLVI TGTLPVFNIT GQFENKTNLK
     NQLILGVMGV DVSLEDIKRL TPRFTLCPNG YYFAIDPNGY VLLHPNLQPK PIGVGIPTIN
     LRKRRPNIQN PKSQEPVTLD FLDAELENDI KVEIRNKMID GESGEKTFRT LVKSQDERYI
     DKGNRTYTWT PVNGTDYSLA LVLPTYSFYY IKAKLEETIT QARYSETLKP DNFEESGYTF
     IAPRDYCNDL KISDNNTEFL LNFNEFIDRK TPNNPSCNAD LINRVLLDAG FTNELVQNYW
     SKQKNIKGVK ARFVVTDGGI TRVYPKEAGE NWQENPETYE DSFYKRSLDN DNYVFTAPYF
     NKSGPGAYES GIMVSKAVEI YIQGKLLKPA VVGIKIDVNS WIENFTKTSI RDPCAGPVCD
     CKRNSDVMDC VILDDGGFLL MANHDDYTNQ IGRFFGEIDP SLMRHLVNIS VYAFNKSYDY
     QSVCEPGAAP KQGAGHRSAY VPSVADILQI GWWATAAAWS ILQQFLLSLT FPRLLEAVEM
     EDDDFTASLS KQSCITEQTQ YFFDNDSKSF SGVLDCGNCS RIFHGEKLMN TNLIFIMVES
     KGTCPCDTRL LIQAEQTSDG PNPCDMVKQP RYRKGPDVCF DNNVLEDYTD CGGVSGLNPS
     LWYIIGIQFL LLWLVSGSTH RLL
//
ID   CAC1B_DIPOM             Reviewed;        2326 AA.
AC   P56698;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 1.
DT   25-OCT-2017, entry version 97.
DE   RecName: Full=Probable voltage-dependent N-type calcium channel subunit alpha-1B;
DE   AltName: Full=DOE-4;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.2;
OS   Diplobatis ommata (Ocellated electric ray) (Discopyge ommata).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes;
OC   Elasmobranchii; Batoidea; Torpediniformes; Narcinidae; Diplobatis.
OX   NCBI_TaxID=1870830;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Electric lobe;
RX   PubMed=7683405; DOI=10.1073/pnas.90.9.3787;
RA   Horne W.A., Ellinor P.T., Inman I., Zhou M., Tsien R.W., Schwarz T.L.;
RT   "Molecular diversity of Ca2+ channel alpha 1 subunits from the marine
RT   ray Discopyge ommata.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3787-3791(1993).
CC   -!- FUNCTION: The isoform alpha-1B gives rise to N-type calcium
CC       currents. N-type calcium channels belong to the 'high-voltage
CC       activated' (HVA) group (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P56698-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56698-2; Sequence=VSP_000884;
CC   -!- TISSUE SPECIFICITY: Expression is higher in the electric lobe than
CC       in the forebrain.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; B47447; B47447.
DR   ProteinModelPortal; P56698; -.
DR   HOVERGEN; HBG050763; -.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005447; VDCC_N_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF161; PTHR10037:SF161; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01631; NVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2326       Probable voltage-dependent N-type calcium
FT                                channel subunit alpha-1B.
FT                                /FTId=PRO_0000053926.
FT   TOPO_DOM      1     88       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     89    107       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    108    125       Extracellular. {ECO:0000255}.
FT   TRANSMEM    126    145       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    146    156       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    157    176       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    177    180       Extracellular. {ECO:0000255}.
FT   TRANSMEM    181    199       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    200    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    238       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    239    323       Extracellular. {ECO:0000255}.
FT   TRANSMEM    324    348       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    349    472       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    473    491       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    492    506       Extracellular. {ECO:0000255}.
FT   TRANSMEM    507    526       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    527    534       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    535    552       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    553    563       Extracellular. {ECO:0000255}.
FT   TRANSMEM    564    582       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    583    601       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    602    621       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    622    674       Extracellular. {ECO:0000255}.
FT   TRANSMEM    675    699       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    700   1148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1149   1166       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1167   1182       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1183   1202       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1203   1214       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1215   1233       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1234   1243       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1244   1262       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1263   1281       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1282   1301       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1302   1388       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1389   1413       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1414   1468       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1469   1487       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1488   1502       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1503   1522       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1523   1530       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1531   1549       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1550   1558       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1559   1577       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1578   1596       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1597   1616       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1617   1680       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1681   1705       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1706   2326       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       75    351       I.
FT   REPEAT      458    702       II.
FT   REPEAT     1134   1416       III.
FT   REPEAT     1453   1708       IV.
FT   DOMAIN     1721   1756       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND    1734   1745       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      371    388       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS   1869   1873       Poly-Gln.
FT   COMPBIAS   2040   2046       Poly-His.
FT   SITE        306    306       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        653    653       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1362   1362       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1650   1650       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1716   1716       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1558   1558       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     406    406       D -> DDGLGIIYEPEQKPEDIQSVY (in isoform
FT                                2). {ECO:0000305}.
FT                                /FTId=VSP_000884.
SQ   SEQUENCE   2326 AA;  264517 MW;  D58DEAA09E819B6B CRC64;
     MARLGNDVPA CYGGSPAGGG RGANRHAGPQ AGQRGMYGSK SLAQRARTMA LYNPIPVRQN
     CLTVNRSLFI FSEDNIIRKY AKRITEWPPF EYMILATIIA NCIVLALEQH LPDGDKTPMS
     ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG ILTTIGTDFD
     LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMVPLLQIG LLLFFAILMF AIIGLEFYMG
     KFHKTCFSEE TNEPVEEFPC GTKYPSRLCP NGTVCKGYWN GPNFGITNFD NILFAVLTVF
     QCITMEGWTD MLYTANDALG NTWNWLYFIP LIVIGSFFML NLVLGVLSGE FAKERERVEN
     RRAFLKLRRQ QQVEQEFNRY LRWIHIAEEV MLAEEDKNAE DKCALDVLKR ATTKKSKNDL
     INAEEGEDHF TDISSVGFNR PSLKSVKNER SSYFRRKEKR FRFFIRRMVK SQSFYWIVLC
     LVGLNTLCVA IVHYDQPPLL TDALYFAEFV FLGLFLTEMS LKMYGLGPRN YFHSSFNCFD
     FGVIVGSIFE VVWTAVKPDT SFGISVLRAL RLLRIFKVTK YWNSLRNLVV SLLNSMKSII
     SLLFLLFLFI VVFALLGMQL FGGQFNFEDG TPPTNFDTFP AAILTVFQIL TGEDWNEVMY
     YGIEAHGGVK KGMFSSVYFI ILTLFGNYTL LNVFLAIAVD NLANAQELTK DEEEMEEANI
     QKNTIQKAME VADVSPISAT NLSIAAKDQQ KSFKSMSIWE QRTSQLRRQH ILTSQEALFN
     ELDDEQRRMY VSSHQIRPDM KTHLDRPLVV EPRNSTRKSA DKVCPSDCQE GEQERLVQPE
     SCEAPRRSHR HRDKLGEQDK GDGALDTGEP RANSKDDKRC SHRSHSKETE KERDEKGRKG
     ERSRSHEGGR RHHHAQSSLD DAPEREHRRH RSHRHGTEQQ HREANGTKGE RHSRAKDGSR
     SGGREGEAVS RSHHAEGAER RRKHRQKVAS TNESEEKREI GEKERETVLR ERRVHRVKET
     QPSQDSGTQG NVSLPPIGLQ HLPQQPEDAD NQKNIKLVTL PTGDAQNPAT VNIPVTVTTP
     AAEMTLLPIN NVAVDLENVM KPEEKKAENG DDLNEDGPRQ IPPFNSMFLF STTNPVRRAC
     HYIVNLRYFE MCILLVITMS SIALAAEDPV QGDAPRNNVL KYLDYVFTGV FTFEMVIKMI
     NLGLILHPGS YFRDLWNILD FIVVSGALVA FAFTGSRGKD LNTIKSLRVL RVLRPLKTIK
     RLPKLKAVFD CVVNSLKNVL NILIVYMLFM FIFAVIAVQL FKGKFFYCTD ESKDLEKDCR
     GQYLVYDNDE IEAEPREWKK CDFHYDNVLW ALLTLFTVST GEGWPTVLKN SIDATEEDQG
     PSPSYRMEMS IFYVVYFVVF PFFFVNIFVA LIIITFQEQG DKVMSDCSLE KNERACIDFA
     ISAKPLTRYM PQNKQTFQYK MWKFVVSPPF EYLIMALIAL NTIVLMMKFY NAPDPYDRML
     QYLNILFTFL FSMECVLKLI GFGVLNYFRD AWNVFDFVTV LGSITDILVT ELADSFINLS
     FLRLFRAARL IKLLRQGYTI RILLWTFVQS FKALPYVCLL IAMLFFIYAI IGMQVFGNIE
     LDDDGAINRH NNFRTFLQAV MLLLRSATGE GWQEIMLACL NQSPCDARSG IDGDECGSNF
     AYFYFVSFIF FSSFLMLNLF VAVIMDNFEY LTRDSSILGP HHLDEFIRVW AEYDPGARGR
     ITYNDMYEML RHMCPPLGLG KKCPARVAYK RLVRMNMPIA EDGSVHFTST LMALIRTALD
     VKISPGGAYQ QQCDAELRKE ITAVWPNLSQ KFLDILVPPQ RASELTVGKV YAALMIYDYY
     KQNKSKKVQQ QQQLSGLSQT RKSFFQRVVG VLAATQEEPS SYSTSHKNSV NPLYQGGRQK
     EPFSWLRSRD TCAEGKKEVP ESHPEEAGVT KSSSQAVEMR EMGSDLNHAD QSSLENYGRA
     ASMPRLTAET QKISRPSGRV RAPIADTSPM KRSVSTLTPQ RSHVMPDYSL ERVIPVQMPH
     HHHHHHRCHH RREKKQRSLE RATNRHADEE AGQLDAQLRD QSSKERERGR SQERRPPSSA
     EKQRYYSCDR YGSREPPQPR STDHSRSASP STGTEQGFHR QGSGSVNDSP LQSASGSSTP
     SRGRRQLPRT PLTPRPSVTY KTANSSPAHF GNLHDALPPS SPGRLSRGQS EHNHLLSGES
     QNRPYAGGDS RQPMGTRISS DPYLGFRSSC GSEDLELLEE TLTFEVAVAA TTATGRSPRT
     SSFTTQPPQS RRVPNGYHCN LGRSTGPSTA ASKRKYYRET DEDDWC
//
ID   CAC1E_DIPOM             Reviewed;        2223 AA.
AC   P56699;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 1.
DT   25-OCT-2017, entry version 86.
DE   RecName: Full=Probable voltage-dependent R-type calcium channel subunit alpha-1E;
DE   AltName: Full=DOE-1;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.3;
OS   Diplobatis ommata (Ocellated electric ray) (Discopyge ommata).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes;
OC   Elasmobranchii; Batoidea; Torpediniformes; Narcinidae; Diplobatis.
OX   NCBI_TaxID=1870830;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Electric lobe;
RX   PubMed=7683405; DOI=10.1073/pnas.90.9.3787;
RA   Horne W.A., Ellinor P.T., Inman I., Zhou M., Tsien R.W., Schwarz T.L.;
RT   "Molecular diversity of Ca2+ channel alpha 1 subunits from the marine
RT   ray Discopyge ommata.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3787-3791(1993).
CC   -!- FUNCTION: The isoform alpha-1E gives rise to R-type calcium
CC       currents. R-type calcium channels belong to the 'high-voltage
CC       activated' (HVA) group (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expression is higher in the forebrain than in
CC       the electric lobe.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A47447; A47447.
DR   ProteinModelPortal; P56699; -.
DR   PRIDE; P56699; -.
DR   HOVERGEN; HBG050763; -.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005449; VDCC_R_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF57; PTHR10037:SF57; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01633; RVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   2223       Probable voltage-dependent R-type calcium
FT                                channel subunit alpha-1E.
FT                                /FTId=PRO_0000053942.
FT   TOPO_DOM      1    102       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    103    121       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    122    139       Extracellular. {ECO:0000255}.
FT   TRANSMEM    140    159       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    160    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    189       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    190    194       Extracellular. {ECO:0000255}.
FT   TRANSMEM    195    213       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    214    232       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    233    252       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    253    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    363       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    364    490       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    491    509       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    510    524       Extracellular. {ECO:0000255}.
FT   TRANSMEM    525    544       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    545    552       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    553    571       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    572    581       Extracellular. {ECO:0000255}.
FT   TRANSMEM    582    600       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    601    619       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    620    639       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    640    692       Extracellular. {ECO:0000255}.
FT   TRANSMEM    693    717       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    718   1105       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1106   1124       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1125   1140       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1141   1160       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1161   1172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1173   1191       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1192   1205       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1206   1224       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1225   1243       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1244   1263       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1264   1349       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1350   1374       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1375   1429       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1430   1448       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1449   1463       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1464   1483       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1484   1491       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1492   1510       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1511   1519       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1520   1538       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1539   1557       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1558   1577       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1578   1638       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1639   1663       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1664   2223       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       89    366       I.
FT   REPEAT      478    720       II.
FT   REPEAT     1092   1377       III.
FT   REPEAT     1414   1666       IV.
FT   DOMAIN     1679   1714       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     439    450       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   CA_BIND    1692   1703       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      386    403       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS     33     40       Poly-Ala.
FT   COMPBIAS    729    735       Poly-Glu.
FT   COMPBIAS   1064   1068       Poly-Ser.
FT   SITE        321    321       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        671    671       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1323   1323       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1611   1611       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1674   1674       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1300   1300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1519   1519       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   2223 AA;  251829 MW;  59722DC03E1CFC5B CRC64;
     MARFGEAVGS LSADASSEQG RSRHQVPVTG ETAVAAAAAA VVAGAAQGSA GFKQTRAQRA
     RTMALYNPIP VRHNCLTANR SLFLFGEDNI VRKSARRVIE WPPFEYMILA TIIANCVVLA
     LEQHLPNGDK TPMAKSLEQT EPYFIGIFCF EAGIKIVALG FVFHKGSYLR NGWNVMDFIV
     VLSGLLATAA THFNLRTLRA VRVLRPLKLV SGIPSLQIVL KSIMKAMVPL LQIGLLLFFA
     ILMFAIIGLE FYYGKLHRTC YTDDAAAEEL DLQFPCGTQE PTRLCPNGTV CSYWIGPNDG
     ITQFDNILFA LLTVFQCITM EGWTTILYNT DDALGAMWNW LYFIPLIIIG SFFVLNLVLG
     VLSGEFAKER ERVENRRSFL KLRRQQQIER ELNGYRAWID KAEEVMLLEE NKNAGEKSAL
     HVLRRATIKK GRMEMIQTES SEDQYTEISS VGSPLARASI KSTKLLEGSS YFRRKERMLR
     ISIRHMVKSH AFYWIVLGLV ALNTVCVAVV HYDQPLWLSN FLYYAEFTFL GLFSSEMFLK
     MYGCGPRLYF HSSFNCFDCG VIIGSIFDVV WTIIRPETSF GISVLRALRL LRIFKITKYW
     ASLRNLVVSL MSSMKSIISL LFLLFLFIVV FALLGMQLFG GQFNFEEGTP PTNFDTFPAA
     IITVFQILTG EDWNEVMYNG IKSQGGVNSG MWSSVYFIVL TLFGNYTLLN VFLAIAVDNL
     ANAQELTKEE QEEEEAINQK HALQKAKEVS PMSAPGFPST EREFRRHKHM SIWEARTSQL
     RRRMQMSSRE ALFTDALQGL EGSRYRRHRS RIFEAESLRR LAEQQAAESH QLGEVGRREA
     FKSRSLRNSW QPAGPDKRSS SIKVNGEQGR ALGRSVEAGA SFRMAEPIRA RRRYRSLYKE
     AKMGLEESAE TSLSRRPGKN KEGRLLQQLC EEQESGQLTQ TPEVMDAQGQ MKAFSWQGEP
     HSSSMTRTPD VDTDPSGGNL EKESGRTPEN GKEESANTSE QVNEQSNWLN LQLNQQATPG
     DRELTTGTRD TKQDKTQEQT EIDVDCENTE TPMDSLVTPG NAYSSSSSVK EDEKKSKAII
     PYTSMFLFRK TNPIRRVCHF IVNLRYFEMC ILLVIAASSV ALAAEDPIHK DSARNQVLRY
     FDYVFTGVFT FEMVIKMIDI GLVFHEGSYF RDVWNILDFI VVSGALVAFA FTNLIGGSSG
     KDINTIKSLR VLRVLRPLKT IKRLPKLKAV FDCVVTSLKN VFNILIVYKL FMFIFAVIAV
     QLFKGKFFYC TDSSKMTKQD CRGQFVLYRQ RTKLSIENGN VTTFHYDNVV WALLTLFTVS
     TGEGWPQVLQ HSVDVTEADQ GPIPGNRMEM SIFYIVYFVV FPFFFVNIFV ALIIITFQEQ
     GDKMLEESSL EKNERACIDF AISAKPLTRY MPQNRQTFQY RVWQFVVSPS FEYTILTMIA
     LNTVVLMMKH HSPPPGFASV LKLMNIAFTI TFTLECILKI IAFGFLNYFR DSWNVFDFVT
     VVGSISEIIV TECNLKFVNL SFLKLFRAAR LIKLLRQGIT IRILLWTFVQ SFKALPYVCL
     LIAMLFFIYA IIGMQLFGNI GLDDHTPINR HNNFHTFFNA LMLLFRSATG ESWQEIMLAC
     LSGKECEGTR EPSCGTDVAY FYFVSFIFLC SFLMLNLFVA VIMDNFEYLT RDSSILGPHH
     LDEFVRVWAE YDRAACGRIH YTDMYQMLTL MSPPLGLGKK CPSKVAYKRL VLMNMPVTED
     KTVHFTSTLM GLIRTALQIK LARGGADKQQ LDAELRKEIM TIWPHLSQKT LDLLVPMHTY
     SDLTVGKIYA AMMIMDYYKQ SKNKKYQKLQ EEQSRTPMFQ RMEASSLPPQ IISSTKGLPY
     LQTGTGPDVD SRSEFTPLVP LPPVMFQQGR TSSQGEEIHK QRPKELKKIK LEYPHYGHYL
     PIENQGRAVS MPRLEIESAE DTSPLKRSLS TFAANHSNST WLNEYSLERA GPEDLYKRWS
     RRPLRPPSRS SNAGSRERGR SRERKHLLSP ERSVCSTGQC AHPSQHRGLD QRLSRSPSPG
     YSHRPREQVN SSVSESPVPS SSGTSPPKQG QRQLPQTPSK PRPLVSYSPV AQRGDVSGHC
     SPMCKETRYQ SLRVQPSKAL WSESPGRSRE SESQHSTPLR YISEPSLTLH DGPGSLDQAL
     GEETLTFEAA VATSLGRSHT ISSAPPLRQG WHLPNGSYRT RMMQSGAPST PDPYTHAEED
     DRC
//
ID   CCG7_HUMAN              Reviewed;         275 AA.
AC   P62955; Q52LL8; Q8VBX3; Q8WXS6; Q9BXT1;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 1.
DT   22-NOV-2017, entry version 109.
DE   RecName: Full=Voltage-dependent calcium channel gamma-7 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-7 subunit;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-7;
DE            Short=TARP gamma-7;
GN   Name=CACNG7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11170751; DOI=10.1006/geno.2000.6440;
RA   Burgess D.L., Gefrides L.A., Foreman P.J., Noebels J.L.;
RT   "A cluster of three novel Ca(2+) channel gamma subunit genes on
RT   chromosome 19q13.4: evolution and expression profile of the gamma
RT   subunit gene family.";
RL   Genomics 71:339-350(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11738816; DOI=10.1016/S0378-1119(01)00738-7;
RA   Chu P.-J., Robertson H.M., Best P.M.;
RT   "Calcium channel gamma subunits provide insights into the evolution of
RT   this gene family.";
RL   Gene 280:37-48(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11927536; DOI=10.1093/emboj/21.7.1514;
RA   Moss F.J., Viard P., Davies A., Bertaso F., Page K.M., Graham A.,
RA   Canti C., Plumpton M., Plumpton C., Clare J.J., Dolphin A.C.;
RT   "The novel product of a five-exon stargazin-related gene abolishes
RT   CaV2.2 calcium channel expression.";
RL   EMBO J. 21:1514-1523(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=21172611; DOI=10.1016/j.neuron.2010.11.026;
RA   Kato A.S., Gill M.B., Ho M.T., Yu H., Tu Y., Siuda E.R., Wang H.,
RA   Qian Y.W., Nisenbaum E.S., Tomita S., Bredt D.S.;
RT   "Hippocampal AMPA receptor gating controlled by both TARP and
RT   cornichon proteins.";
RL   Neuron 68:1082-1096(2010).
CC   -!- FUNCTION: Regulates the trafficking and gating properties of AMPA-
CC       selective glutamate receptors (AMPARs). Promotes their targeting
CC       to the cell membrane and synapses and modulates their gating
CC       properties by slowing their rates of activation, deactivation and
CC       desensitization and by mediating their resensitization. Displays
CC       subunit-specific AMPA receptor regulation. Shows specificity only
CC       for GRIA1 and GRIA2. Thought to stabilize the calcium channel in
CC       an inactivated (closed) state. {ECO:0000269|PubMed:21172611}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Acts as an auxiliary
CC       subunit for AMPA-selective glutamate receptors (AMPARs). Found in
CC       a complex with GRIA1, GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG3, CACNG4, CACNG5 and CACNG8.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:11170751}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF288387; AAK20030.1; -; mRNA.
DR   EMBL; AF361353; AAL50048.1; -; mRNA.
DR   EMBL; AF458897; AAM00594.1; -; mRNA.
DR   EMBL; BC069332; AAH69332.1; -; mRNA.
DR   EMBL; BC093869; AAH93869.1; -; mRNA.
DR   EMBL; BC113503; AAI13504.1; -; mRNA.
DR   CCDS; CCDS12868.1; -.
DR   RefSeq; NP_114102.2; NM_031896.4.
DR   RefSeq; XP_016882582.1; XM_017027093.1.
DR   UniGene; Hs.631597; -.
DR   ProteinModelPortal; P62955; -.
DR   STRING; 9606.ENSP00000222212; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   TCDB; 8.A.16.2.5; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; P62955; -.
DR   PhosphoSitePlus; P62955; -.
DR   BioMuta; CACNG7; -.
DR   DMDM; 51702249; -.
DR   PaxDb; P62955; -.
DR   PeptideAtlas; P62955; -.
DR   PRIDE; P62955; -.
DR   DNASU; 59284; -.
DR   Ensembl; ENST00000222212; ENSP00000222212; ENSG00000105605.
DR   Ensembl; ENST00000391767; ENSP00000375647; ENSG00000105605.
DR   GeneID; 59284; -.
DR   KEGG; hsa:59284; -.
DR   UCSC; uc002qcr.3; human.
DR   CTD; 59284; -.
DR   EuPathDB; HostDB:ENSG00000105605.7; -.
DR   GeneCards; CACNG7; -.
DR   HGNC; HGNC:13626; CACNG7.
DR   MIM; 606899; gene.
DR   neXtProt; NX_P62955; -.
DR   OpenTargets; ENSG00000105605; -.
DR   PharmGKB; PA26021; -.
DR   eggNOG; ENOG410IXFC; Eukaryota.
DR   eggNOG; ENOG410XUAQ; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233439; -.
DR   HOVERGEN; HBG025923; -.
DR   InParanoid; P62955; -.
DR   KO; K04872; -.
DR   OMA; VHMSASP; -.
DR   OrthoDB; EOG091G0F73; -.
DR   PhylomeDB; P62955; -.
DR   TreeFam; TF327980; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   GenomeRNAi; 59284; -.
DR   PRO; PR:P62955; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105605; -.
DR   CleanEx; HS_CACNG7; -.
DR   ExpressionAtlas; P62955; baseline and differential.
DR   Genevisible; P62955; HS.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; NAS:UniProtKB.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; NAS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IBA:GO_Central.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008371; VDCC_g7su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   PANTHER; PTHR12107:SF12; PTHR12107:SF12; 1.
DR   Pfam; PF13903; Claudin_2; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01795; VDCCGAMMA7.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    275       Voltage-dependent calcium channel gamma-7
FT                                subunit.
FT                                /FTId=PRO_0000164687.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical. {ECO:0000255}.
FT   TRANSMEM    129    149       Helical. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   MOD_RES     222    222       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P62956}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P62956}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P62956}.
FT   CONFLICT    191    275       GAGVMSVYLFTKRYAEEEMYRPHPAFYRPRLSDCSDYSGQF
FT                                LQPEAWRRGRSPSDISSDVSIQMTQNYPPAIKYPDHLHIST
FT                                SPC -> VTSVGPRL (in Ref. 1; AAK20030).
FT                                {ECO:0000305}.
SQ   SEQUENCE   275 AA;  31003 MW;  43CC82B9FA6A5C73 CRC64;
     MSHCSSRALT LLSSVFGACG LLLVGIAVST DYWLYMEEGT VLPQNQTTEV KMALHAGLWR
     VCFFAGREKG RCVASEYFLE PEINLVTENT ENILKTVRTA TPFPMVSLFL VFTAFVISNI
     GHIRPQRTIL AFVSGIFFIL SGLSLVVGLV LYISSINDEV MNRPSSSEQY FHYRYGWSFA
     FAASSFLLKE GAGVMSVYLF TKRYAEEEMY RPHPAFYRPR LSDCSDYSGQ FLQPEAWRRG
     RSPSDISSDV SIQMTQNYPP AIKYPDHLHI STSPC
//
ID   TRPV5_MOUSE             Reviewed;         723 AA.
AC   P69744; Q2TB50;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   25-OCT-2017, entry version 115.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 5;
DE            Short=TrpV5;
DE   AltName: Full=Calcium transport protein 2;
DE            Short=CaT2;
DE   AltName: Full=Epithelial calcium channel 1;
DE            Short=ECaC1;
DE   AltName: Full=Osm-9-like TRP channel 3;
DE            Short=OTRPC3;
GN   Name=Trpv5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Weber K., Zeitz U., Rump A., Erben R., Adamski J.;
RT   "Characterization of two epithelial calcium channel genes in mice.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF 403-VAL--SER-406.
RX   PubMed=12077127; DOI=10.1074/jbc.M202418200;
RA   Nilius B., Prenen J., Hoenderop J.G., Vennekens R., Hoefs S.,
RA   Weidema A.F., Droogmans G., Bindels R.J.M.;
RT   "Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and
RT   ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located
RT   between transmembrane segments 2 and 3.";
RL   J. Biol. Chem. 277:30852-30858(2002).
RN   [6]
RP   SUBUNIT, AND INTERACTION WITH TRPV6.
RX   PubMed=12574114; DOI=10.1093/emboj/cdg080;
RA   Hoenderop J.G., Voets T., Hoefs S., Weidema F., Prenen J., Nilius B.,
RA   Bindels R.J.M.;
RT   "Homo- and heterotetrameric architecture of the epithelial Ca2+
RT   channels TRPV5 and TRPV6.";
RL   EMBO J. 22:776-785(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, INTERACTION WITH S100A10 AND ANAX2, AND
RP   MUTAGENESIS OF THR-593.
RX   PubMed=12660155; DOI=10.1093/emboj/cdg162;
RA   van de Graaf S.F., Hoenderop J.G., Gkika D., Lamers D., Prenen J.,
RA   Rescher U., Gerke V., Staub O., Nilius B., Bindels R.J.M.;
RT   "Functional expression of the epithelial Ca(2+) channels (TRPV5 and
RT   TRPV6) requires association of the S100A10-annexin 2 complex.";
RL   EMBO J. 22:1478-1487(2003).
RN   [8]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=14679186; DOI=10.1172/JCI200319826;
RA   Hoenderop J.G., van Leeuwen J.P., van der Eerden B.C., Kersten F.F.,
RA   van der Kemp A.W., Merillat A.M., Waarsing J.H., Rossier B.C.,
RA   Vallon V., Hummler E., Bindels R.J.;
RT   "Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in
RT   mice lacking TRPV5.";
RL   J. Clin. Invest. 112:1906-1914(2003).
RN   [9]
RP   INTERACTION WITH CALMODULIN.
RX   PubMed=15123711; DOI=10.1074/jbc.M313637200;
RA   Lambers T.T., Weidema A.F., Nilius B., Hoenderop J.G., Bindels R.J.M.;
RT   "Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the
RT   Ca(2+)-sensor calmodulin.";
RL   J. Biol. Chem. 279:28855-28861(2004).
RN   [10]
RP   INTERACTION WITH BSPRY.
RX   PubMed=16380433; DOI=10.1681/ASN.2005101025;
RA   van de Graaf S.F.J., van der Kemp A.W.C.M., van den Berg D.,
RA   van Oorschot M., Hoenderop J.G.J., Bindels R.J.M.;
RT   "Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5
RT   activity.";
RL   J. Am. Soc. Nephrol. 17:26-30(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-678 AND SER-682, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27102152; DOI=10.18632/oncotarget.8779;
RA   van der Eerden B.C., Koek W.N., Roschger P., Zillikens M.C.,
RA   Waarsing J.H., van der Kemp A., Schreuders-Koedam M.,
RA   Fratzl-Zelman N., Leenen P.J., Hoenderop J.G., Klaushofer K.,
RA   Bindels R.J., van Leeuwen J.P.;
RT   "Lifelong challenge of calcium homeostasis in male mice lacking TRPV5
RT   leads to changes in bone and calcium metabolism.";
RL   Oncotarget 7:24928-24941(2016).
CC   -!- FUNCTION: Constitutively active calcium selective cation channel
CC       thought to be involved in Ca(2+) reabsorption in kidney and
CC       intestine (PubMed:12077127, PubMed:14679186). Required for normal
CC       Ca(2+) reabsorption in the kidney distal convoluted tubules
CC       (PubMed:14679186). The channel is activated by low internal
CC       calcium level and the current exhibits an inward rectification. A
CC       Ca(2+)-dependent feedback regulation includes fast channel
CC       inactivation and slow current decay (PubMed:12077127). Heteromeric
CC       assembly with TRPV6 seems to modify channel properties. TRPV5-
CC       TRPV6 heteromultimeric concatemers exhibit voltage-dependent
CC       gating (By similarity). {ECO:0000250|UniProtKB:Q9XSM3,
CC       ECO:0000269|PubMed:12077127, ECO:0000269|PubMed:14679186}.
CC   -!- ENZYME REGULATION: Activated by WNK3.
CC       {ECO:0000250|UniProtKB:Q9NQA5}.
CC   -!- SUBUNIT: Homotetramer and probably heterotetramer with TRPV6.
CC       Interacts with TRPV6 (PubMed:12574114). Interacts with S100A10 and
CC       probably with the ANAX2-S100A10 heterotetramer. The interaction
CC       with S100A10 is required for the trafficking to the plasma
CC       membrane (PubMed:12660155). Interacts with calmodulin
CC       (PubMed:15123711). Interacts with BSPRY, which results in its
CC       inactivation (PubMed:16380433). {ECO:0000269|PubMed:12574114,
CC       ECO:0000269|PubMed:12660155, ECO:0000269|PubMed:15123711,
CC       ECO:0000269|PubMed:16380433}.
CC   -!- INTERACTION:
CC       Q80UE6:Wnk4; NbExp=2; IntAct=EBI-538447, EBI-295378;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12660155}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12660155}. Note=Colocalized with S100A10 and
CC       ANAX2 along the apical domain of kidney distal tubular cells.
CC       {ECO:0000269|PubMed:12660155}.
CC   -!- TISSUE SPECIFICITY: Detected in kidney cortex (at protein level).
CC       {ECO:0000269|PubMed:14679186}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q9NQA5}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice appear grossly normal and are
CC       fertile. They display polyuria and increased urinary excretion of
CC       Ca(2+), due to defective Ca(2+) reabsorption in the kidney distal
CC       convoluted tubules. Likewise, they display increased urinary
CC       excretion of phosphate. Besides, their urine has a lower pH. The
CC       polyuria and the urine acidification may be a response to the high
CC       urinary Ca(2+) levels, preventing the formation of kidney stones
CC       (PubMed:14679186). Serum Ca(2+) and phosphate levels are normal,
CC       probably due to increased expression of TRPV6 and increased Ca(2+)
CC       absorption in the intestine. The increased expression of TRPV6 may
CC       be due to the increased serum levels of 1,25-dihydroxy-vitamin D3
CC       that are observed in mutant mice (PubMed:14679186,
CC       PubMed:27102152). Age-related changes in trabecular and cortical
CC       bone mass are accelerated in male mutant mice, including reduced
CC       trabecular and cortical bone thickness. Still, this has no effect
CC       on bone strength (PubMed:27102152). {ECO:0000269|PubMed:14679186,
CC       ECO:0000269|PubMed:27102152}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK085479; Type=Frameshift; Positions=579; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF336378; AAM53408.1; -; Genomic_DNA.
DR   EMBL; AK085479; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC110554; AAI10555.1; -; mRNA.
DR   EMBL; BC110555; AAI10556.1; -; mRNA.
DR   EMBL; CH466533; EDL13503.1; -; Genomic_DNA.
DR   CCDS; CCDS20053.1; -.
DR   RefSeq; NP_001007573.1; NM_001007572.2.
DR   RefSeq; XP_017176952.1; XM_017321463.1.
DR   UniGene; Mm.135734; -.
DR   ProteinModelPortal; P69744; -.
DR   SMR; P69744; -.
DR   BioGrid; 228781; 1.
DR   CORUM; P69744; -.
DR   IntAct; P69744; 2.
DR   STRING; 10090.ENSMUSP00000031901; -.
DR   iPTMnet; P69744; -.
DR   PhosphoSitePlus; P69744; -.
DR   PaxDb; P69744; -.
DR   PRIDE; P69744; -.
DR   Ensembl; ENSMUST00000031901; ENSMUSP00000031901; ENSMUSG00000036899.
DR   GeneID; 194352; -.
DR   KEGG; mmu:194352; -.
DR   UCSC; uc009bqd.1; mouse.
DR   CTD; 56302; -.
DR   MGI; MGI:2429764; Trpv5.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   GeneTree; ENSGT00550000074425; -.
DR   HOGENOM; HOG000234397; -.
DR   HOVERGEN; HBG061442; -.
DR   InParanoid; P69744; -.
DR   KO; K04974; -.
DR   OMA; NMRGAVG; -.
DR   OrthoDB; EOG091G0314; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-MMU-3295583; TRP channels.
DR   PRO; PR:P69744; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; ENSMUSG00000036899; -.
DR   ExpressionAtlas; P69744; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; NAS:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0035809; P:regulation of urine volume; IMP:UniProtKB.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008346; TRPV5.
DR   InterPro; IPR008344; TRPV5/TRPV6.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF11; PTHR10582:SF11; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01765; ECACCHANNEL.
DR   PRINTS; PR01767; ECACCHANNEL2.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    723       Transient receptor potential cation
FT                                channel subfamily V member 5.
FT                                /FTId=PRO_0000215351.
FT   TOPO_DOM      1    320       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    321    341       Helical. {ECO:0000255}.
FT   TOPO_DOM    342    380       Extracellular. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    412       Extracellular. {ECO:0000255}.
FT   TRANSMEM    413    433       Helical. {ECO:0000255}.
FT   TOPO_DOM    434    441       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    442    462       Helical. {ECO:0000255}.
FT   TOPO_DOM    463    485       Extracellular. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   INTRAMEM    517    537       Pore-forming. {ECO:0000305}.
FT   TRANSMEM    550    570       Helical. {ECO:0000255}.
FT   TOPO_DOM    571    723       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       38     68       ANK 1. {ECO:0000255}.
FT   REPEAT       72    101       ANK 2. {ECO:0000255}.
FT   REPEAT      110    139       ANK 3. {ECO:0000255}.
FT   REPEAT      156    185       ANK 4. {ECO:0000255}.
FT   REPEAT      189    222       ANK 5. {ECO:0000255}.
FT   REPEAT      232    261       ANK 6. {ECO:0000255}.
FT   REGION      591    595       Interaction with S100A10.
FT                                {ECO:0000269|PubMed:12660155}.
FT   REGION      643    646       Involved in Ca(2+)-dependent
FT                                inactivation. {ECO:0000250}.
FT   REGION      693    723       Involved in Ca(2+)-dependent
FT                                inactivation. {ECO:0000250}.
FT   METAL       535    535       Calcium; shared with neighboring
FT                                subunits. {ECO:0000250|UniProtKB:Q9R186}.
FT   MOD_RES     678    678       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     682    682       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MUTAGEN     403    406       VGAS->LGVT: Induces faster Ca(2+)-
FT                                dependent channel inactivation.
FT                                {ECO:0000269|PubMed:12077127}.
FT   MUTAGEN     593    593       T->A: Abolishes interaction with S100A10,
FT                                plasma membrane localization and channel
FT                                activity. {ECO:0000269|PubMed:12660155}.
FT   CONFLICT    302    302       E -> K (in Ref. 2; AK085479).
FT                                {ECO:0000305}.
SQ   SEQUENCE   723 AA;  82218 MW;  6668C67C47CBB443 CRC64;
     MGAKTPWIQL QKLLNWWVRD QDWNQHVDQL HMLQQKSIWE SPLLRAAKEN DMCTLKKLQH
     DQNCDFRQRG ALGETALHVA ALYDNLDAAI MLMEAAPYLV TESTLCEPFV GQTALHIAVM
     NQNVNLVRAL LARGASASAR ATGSAFHRSS HNLIYYGEHP LSFAACVGSE EIVRLLIEHG
     ADIRAQDSLG NTVLHILVLQ PNKTFACQMY NLLLSYDGGD HLKSLELVPN NQGLTPFKLA
     GVEGNTVMFQ HLMQKRKRIQ WSFGPLTSSL YDLTEIDSWG EELSFLELVV SSKKKEARQI
     LEQTPVKELV SLKWKKYGQP YFCLLGALYI FYMVCFTTCC VYRPLKFRDA NRTHVRDNTI
     MEQKSLQEAY VTYQDKIRLV GELVTVIGAV IILLLEIPDI FRVGASRYFG QTVLGGPFHV
     IIITYASLVL LTMAMRLTNV NGEVVPMSMA LVLGWCSVMY FARGFQMLGP FTIMIQKMIF
     GDLLRFCWLM AMVILGFASA FYIIFQTEDP DNLGEFSDYP TAMFSTFELF LTIIDGPANY
     RVDLPFMYSV TYATFAIIAT LLMLNLFIAM MGDTHWRVAQ ERDELWRAQV VATTVMLERK
     MPRFLWPRSG ICGCEYGLGD RWFLRVEHHQ EQNPYRVLRY VEAFKSSDKE EVQEQLSEKQ
     PSGTETGTLA RGSVVLQTPP LSRTTSLSSN SHRGWEILRR NTLGHLNLGL DPGEGDGEEI
     YQF
//
ID   CAC1A_DROME             Reviewed;        1851 AA.
AC   P91645; O01713; O01714; Q76NR8; Q76NR9; Q76NS0; Q9VYR8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 3.
DT   20-DEC-2017, entry version 171.
DE   RecName: Full=Voltage-dependent calcium channel type A subunit alpha-1;
DE   AltName: Full=Protein cacophony;
DE   AltName: Full=Protein nightblind A;
DE   AltName: Full=Protein no-on-transient B;
DE            Short=Dmca1A;
GN   Name=cac; Synonyms=nbA, nonB; ORFNames=CG43368;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM E), FUNCTION, TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RX   PubMed=8987815;
RA   Smith L.A., Wang X.J., Peixoto A.A., Neumann E.K., Hall L.M.,
RA   Hall J.C.;
RT   "A Drosophila calcium channel alpha1 subunit gene maps to a genetic
RT   locus associated with behavioral and visual defects.";
RL   J. Neurosci. 16:7868-7879(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9093853;
RA   Peixoto A.A., Smith L.A., Hall J.C.;
RT   "Genomic organization and evolution of alternative exons in a
RT   Drosophila calcium channel gene.";
RL   Genetics 145:1003-1013(1997).
RN   [5]
RP   RNA EDITING.
RX   PubMed=10966106; DOI=10.1016/S0092-8674(00)00049-0;
RA   Palladino M.J., Keegan L.P., O'Connell M.A., Reenan R.A.;
RT   "A-to-I pre-mRNA editing in Drosophila is primarily involved in adult
RT   nervous system function and integrity.";
RL   Cell 102:437-449(2000).
RN   [6]
RP   VARIANT ILE-1029, AND FUNCTION.
RX   PubMed=9649530;
RA   Smith L.A., Peixoto A.A., Kramer E.M., Villella A., Hall J.C.;
RT   "Courtship and visual defects of cacophony mutants reveal functional
RT   complexity of a calcium-channel alpha1 subunit in Drosophila.";
RL   Genetics 149:1407-1426(1998).
RN   [7]
RP   VARIANTS 284-LEU--CYS-1851 DEL AND GLU-989 DELINS LYS-LYS,
RP   CHARACTERIZATION OF VARIANTS 284-LEU--CYS-1851 DEL AND LYS-989,
RP   MUTAGENESIS OF ARG-1196 AND ARG-1205, AND FUNCTION.
RX   PubMed=28742085; DOI=10.1371/journal.pgen.1006905;
RG   Members of the UDN;
RA   Luo X., Rosenfeld J.A., Yamamoto S., Harel T., Zuo Z., Hall M.,
RA   Wierenga K.J., Pastore M.T., Bartholomew D., Delgado M.R.,
RA   Rotenberg J., Lewis R.A., Emrick L., Bacino C.A., Eldomery M.K.,
RA   Coban Akdemir Z., Xia F., Yang Y., Lalani S.R., Lotze T., Lupski J.R.,
RA   Lee B., Bellen H.J., Wangler M.F.;
RT   "Clinically severe CACNA1A alleles affect synaptic function and
RT   neurodegeneration differentially.";
RL   PLoS Genet. 13:E1006905-E1006905(2017).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, neurotransmitter release, gene expression, cell
CC       motility, cell division and cell death (By similarity). Probably
CC       encodes a dihydropyridine-insensitive current. Vital for survival
CC       to adulthood. {ECO:0000250|UniProtKB:O00555,
CC       ECO:0000269|PubMed:28742085, ECO:0000269|PubMed:8987815,
CC       ECO:0000269|PubMed:9649530}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=At least 2 regions (Exon IS4 and Exon I/II) undergo
CC         alternative splicing. The total number of isoforms is currently
CC         not known. {ECO:0000269|PubMed:12537572,
CC         ECO:0000269|PubMed:9093853};
CC       Name=E;
CC         IsoId=P91645-1; Sequence=Displayed;
CC         Note=Has exons IS4B and I/IIA.;
CC       Name=A;
CC         IsoId=P91645-2; Sequence=VSP_012741;
CC         Note=Has exons IS4B and I/IIA.;
CC       Name=B;
CC         IsoId=P91645-3; Sequence=VSP_000952;
CC         Note=Has exons IS4A and I/IIA.;
CC       Name=C;
CC         IsoId=P91645-4; Sequence=VSP_000953;
CC         Note=Has exons IS4B and I/IIB.;
CC       Name=D;
CC         IsoId=P91645-5; Sequence=VSP_000952, VSP_000953, VSP_012741;
CC         Note=Has exons IS4A and I/IIB.;
CC       Name=F;
CC         IsoId=P91645-6; Sequence=VSP_000952, VSP_000953;
CC         Note=Has exons IS4A and I/IIB.;
CC   -!- TISSUE SPECIFICITY: Expressed widely in the embryonic nervous
CC       system. {ECO:0000269|PubMed:8987815}.
CC   -!- DEVELOPMENTAL STAGE: Expression peaks in the first larval instar,
CC       midpupal, and late pupal stages. In late-stage embryos, it is
CC       expressed preferentially in the nervous system.
CC       {ECO:0000269|PubMed:8987815}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- RNA EDITING: Modified_positions=Undetermined; Note=Partially
CC       edited. 11 sites are edited by Adar.
CC       {ECO:0000269|PubMed:10966106};
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U55776; AAC47406.1; -; mRNA.
DR   EMBL; AE014298; AAF48120.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65322.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65323.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65324.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65325.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65326.1; -; Genomic_DNA.
DR   EMBL; U88664; AAB53271.1; -; Genomic_DNA.
DR   EMBL; U88665; AAB53272.1; -; Genomic_DNA.
DR   PIR; T13980; T13980.
DR   RefSeq; NP_001245639.1; NM_001258710.2. [P91645-1]
DR   RefSeq; NP_511133.2; NM_078578.5. [P91645-2]
DR   RefSeq; NP_996416.1; NM_206693.5. [P91645-6]
DR   RefSeq; NP_996417.1; NM_206694.4. [P91645-1]
DR   RefSeq; NP_996418.1; NM_206695.4. [P91645-5]
DR   RefSeq; NP_996419.1; NM_206696.5.
DR   RefSeq; NP_996420.1; NM_206697.4.
DR   UniGene; Dm.2395; -.
DR   PDB; 4Z89; X-ray; 2.64 A; a/b/c/d/e/f/g/h/i/j=1688-1702.
DR   PDB; 4Z8A; X-ray; 1.76 A; B=1688-1702.
DR   PDBsum; 4Z89; -.
DR   PDBsum; 4Z8A; -.
DR   ProteinModelPortal; P91645; -.
DR   SMR; P91645; -.
DR   BioGrid; 58563; 15.
DR   IntAct; P91645; 5.
DR   STRING; 7227.FBpp0298326; -.
DR   PaxDb; P91645; -.
DR   PRIDE; P91645; -.
DR   EnsemblMetazoa; FBtr0307318; FBpp0298319; FBgn0263111. [P91645-2]
DR   EnsemblMetazoa; FBtr0307319; FBpp0298320; FBgn0263111. [P91645-5]
DR   EnsemblMetazoa; FBtr0307320; FBpp0298321; FBgn0263111. [P91645-6]
DR   EnsemblMetazoa; FBtr0307322; FBpp0298323; FBgn0263111. [P91645-1]
DR   EnsemblMetazoa; FBtr0308609; FBpp0300833; FBgn0263111. [P91645-1]
DR   GeneID; 32158; -.
DR   KEGG; dme:Dmel_CG43368; -.
DR   CTD; 12285; -.
DR   FlyBase; FBgn0263111; cac.
DR   eggNOG; ENOG410INF8; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   InParanoid; P91645; -.
DR   OrthoDB; EOG091G0TKO; -.
DR   PhylomeDB; P91645; -.
DR   GenomeRNAi; 32158; -.
DR   PRO; PR:P91645; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0263111; -.
DR   ExpressionAtlas; P91645; differential.
DR   Genevisible; P91645; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:FlyBase.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:FlyBase.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0031594; C:neuromuscular junction; IMP:FlyBase.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:FlyBase.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IGI:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IMP:FlyBase.
DR   GO; GO:0008332; F:low voltage-gated calcium channel activity; IMP:FlyBase.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:FlyBase.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:FlyBase.
DR   GO; GO:0097352; P:autophagosome maturation; IMP:FlyBase.
DR   GO; GO:0006914; P:autophagy; IMP:FlyBase.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:FlyBase.
DR   GO; GO:0006816; P:calcium ion transport; IMP:FlyBase.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:FlyBase.
DR   GO; GO:0007268; P:chemical synaptic transmission; IDA:FlyBase.
DR   GO; GO:0007619; P:courtship behavior; IMP:FlyBase.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:FlyBase.
DR   GO; GO:0042045; P:epithelial fluid transport; IDA:FlyBase.
DR   GO; GO:0006887; P:exocytosis; IMP:FlyBase.
DR   GO; GO:0045433; P:male courtship behavior, veined wing generated song production; IMP:FlyBase.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0070050; P:neuron cellular homeostasis; IMP:FlyBase.
DR   GO; GO:0016322; P:neuron remodeling; IMP:FlyBase.
DR   GO; GO:0007269; P:neurotransmitter secretion; IMP:FlyBase.
DR   GO; GO:0007602; P:phototransduction; NAS:FlyBase.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IMP:FlyBase.
DR   GO; GO:0045887; P:positive regulation of synaptic growth at neuromuscular junction; IMP:FlyBase.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:FlyBase.
DR   GO; GO:0016057; P:regulation of membrane potential in photoreceptor cell; IGI:FlyBase.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IGI:FlyBase.
DR   GO; GO:0007632; P:visual behavior; NAS:FlyBase.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Developmental protein;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; RNA editing;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1851       Voltage-dependent calcium channel type A
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000053959.
FT   TOPO_DOM      1     38       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     39     57       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM     58     75       Extracellular. {ECO:0000255}.
FT   TRANSMEM     76     95       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM     96    107       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    129    133       Extracellular. {ECO:0000255}.
FT   TRANSMEM    134    152       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    153    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    191       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    192    288       Extracellular. {ECO:0000255}.
FT   TRANSMEM    289    313       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    314    441       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    442    460       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    461    475       Extracellular. {ECO:0000255}.
FT   TRANSMEM    476    495       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    496    503       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    504    522       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    523    531       Extracellular. {ECO:0000255}.
FT   TRANSMEM    532    550       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    551    569       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    570    589       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    590    642       Extracellular. {ECO:0000255}.
FT   TRANSMEM    643    667       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    668    767       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    768    786       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    787    802       Extracellular. {ECO:0000255}.
FT   TRANSMEM    803    822       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    823    834       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    835    853       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    854    866       Extracellular. {ECO:0000255}.
FT   TRANSMEM    867    885       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    886    904       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    905    924       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    925   1013       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1014   1038       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1039   1093       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1094   1122       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1123   1127       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1128   1147       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1148   1155       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1156   1174       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1175   1184       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1185   1203       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1204   1222       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1223   1242       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1243   1308       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1309   1333       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1334   1851       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       25    316       I.
FT   REPEAT      427    670       II.
FT   REPEAT      762   1049       III.
FT   REPEAT     1086   1347       IV.
FT   DOMAIN     1353   1388       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND    1366   1377       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION     1306   1348       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS    396    402       Poly-Glu.
FT   COMPBIAS    732    735       Poly-Glu.
FT   COMPBIAS   1736   1802       Arg-rich.
FT   SITE        271    271       Calcium ion selectivity and permeability.
FT   SITE        621    621       Calcium ion selectivity and permeability.
FT   SITE        989    989       Calcium ion selectivity and permeability.
FT   SITE       1281   1281       Calcium ion selectivity and permeability.
FT   MOD_RES    1348   1348       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    865    865       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     121    151       FMTQYPQIGPEVDLRTLRAIRVLRPLKLVSG -> AMTIFA
FT                                EANIDVDLRMLRSFRVLRPLKLVSR (in isoform F,
FT                                isoform D and isoform B). {ECO:0000305}.
FT                                /FTId=VSP_000952.
FT   VAR_SEQ     317    351       SNERNRVERRMEFQKCRFRAMFQTAMVSYLDWITQ -> AK
FT                                EREKVENRQEFLKLRRQQQLERELNGYVEWICK (in
FT                                isoform F, isoform D and isoform C).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000953.
FT   VAR_SEQ    1181   1183       Missing (in isoform A and isoform D).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_012741.
FT   VARIANT     284   1851       Missing (in cac-J; lethal at an embryonic
FT                                stage; loss of synaptic transmission).
FT                                {ECO:0000269|PubMed:28742085}.
FT   VARIANT     989    989       E -> K (in cac-F; lethal at the larval
FT                                stage 3; loss of synaptic transmission).
FT                                {ECO:0000269|PubMed:28742085}.
FT   VARIANT    1029   1029       F -> I (in cac-S; exhibits defects in the
FT                                patterning of courtship lovesong and a
FT                                subtle abnormality in visual physiology).
FT                                {ECO:0000269|PubMed:9649530}.
FT   MUTAGEN    1196   1196       R->Q: Homolog of Q-1664 variant in human.
FT                                Partially rescues the cac-F and cac-J
FT                                lethal phenotypes. Does not rescue the
FT                                loss of synaptic transmission cac-F and
FT                                cac-J variants. No effect on
FT                                photoreceptor morphology.
FT                                {ECO:0000269|PubMed:28742085}.
FT   MUTAGEN    1205   1205       R->P: Homolog of P-1673 variant in human.
FT                                Does not rescue cac-F and cac-J lethal
FT                                phenotypes. Highly increases amplitude on
FT                                the synaptic transmission. Induces severe
FT                                neurodegeneration in both photoreceptor
FT                                cell bodies and terminals.
FT                                {ECO:0000269|PubMed:28742085}.
FT   CONFLICT    514    514       S -> G (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT    815    815       I -> M (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT    839    839       N -> S (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT    906    906       N -> S (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT    937    937       S -> G (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1016   1016       M -> V (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1185   1185       N -> S (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1269   1269       Q -> H (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1368   1368       N -> G (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1580   1580       N -> D (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
FT   CONFLICT   1602   1602       R -> G (in Ref. 1; AAC47406).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1851 AA;  212471 MW;  4CC958CFBAE05EC2 CRC64;
     MGGPKKEENP PGGGPTSLFI LTEDNPIRKY TRFIIEWPPF EYAVLLTIIA NCVVLALEEH
     LPGGDKTVLA QKLEKTEAYF LCIFCVEASL KILALGLVLH KHSYLRNIWN IMDFFVVVTG
     FMTQYPQIGP EVDLRTLRAI RVLRPLKLVS GIPSLQVVLK SIIKAMAPLL QIGLLVLFAI
     VIFAIIGLEF YSGALHKTCY SLEDPNKLVK EGESETPCNT DNILEKATGS FVCNNTTSMC
     LEKWEGPNSG ITSFDNIGFA MLTVFQCITM EGWTAILYWT NDALGSAFNW IYFVPLIVIG
     SFFMLNLVLG VLSGEFSNER NRVERRMEFQ KCRFRAMFQT AMVSYLDWIT QAEEVILAEE
     RTTEEEKMHI MEARRRNAAK RKKLKSLGKS KSTDTEEEEA EEDYGDDGYL KTRSKPQGSC
     TGFWRAEKRF RFWIRHTVKT QWFYWFVIVL VFLNTVCVAV EHYGQPSFLT EFLYYAEFIF
     LGLFMSEMFI KMYALGPRIY FESSFNRFDC VVISGSIFEV IWSEVKGGSF GLSVLRALRL
     LRIFKVTKYW SSLRNLVISL LNSMRSIISL LFLLFLFILI FALLGMQLFG GQFNLPGGTP
     ETNFNTFPIA LLTVFQILTG EDWNEVMYQG IISQGGAQKG MIYSIYFIVL VLFGNYTLLN
     VFLAIAVDNL ANAQELTAAE EEQVEEDKEK QLQELEKEME ALQADGVHVE NGDGAVAPSK
     SKGKKKEEEK KEEEEVTEGP KPMLPYSSMF ILSPTNPIRR GAHWVVNLPY FDFFIMVVIS
     MSSIALAAED PVRENSRRNK ILNYFDYAFT GVFTIEMLLK IVDLGVILHP GSYLREFWNI
     MDAVVVICAA VSFGFDMSGS SAGQNLSTIK SLRVLRVLRP LKTIKRVPKL KAVFDCVVNS
     LKNVVNILIV YILFQFIFSV IGVQLFNGKF FYCTDESKHT SAECQGSYFK YEEDELLPKQ
     ELRVWKPRAF HYDNVAAAML TLFAVQTGEG WPQVLQHSMA ATYEDRGPIQ NFRIEMSIFY
     IVYFIVFPFF FVNIFVALII ITFQEQGEAE LQDGEIDKNQ KSCIDFTIGA RPLERYMPKN
     RNTFKYKVWR IVVSTPFEYF IMMLIVFNTL LLMMKYHNQG DMYEKSLKYI NMGFTGMFSV
     ETVLKIIGFG VKNFFKDPWN IFDLITVLGS IVDALWMEFG HDDSNSINVG FLRLFRAARL
     IKLLRQGYTI RILLWTFVQS FKALPYVCLL IAMLFFIYAI IGMQVFGNIK LGTVENSITR
     HNNFQSFIQG VMLLFRCATG EAWPNIMLAC LKGKACDDDA EKAPGEYCGS TLAYAYFVSF
     IFFCSFLMLN LFVAVIMDNF DYLTRDSSIL GAHHLDEFVR IWAEYDPNAT GKIHYTEMYD
     MLKNMDPPLG FGNKCPNRLA YKKLIRMNMP LDDELRVQFT TTLFALIREN LSIKMRAPEE
     MDQADMELRE TITNIWPLQA KKMLNLLVPP SDQLNKGKLS VGKIYAGFLI LESWRSTRFG
     QLDSGMPMLE LQDASRHPSQ ESLTGADAGH LHPGHSYMNG HRRSPSLRHN GSPLARSPSP
     RRRGHQYIHH DIGFSDTVSN VVEMVKETRH PRHGNSHPRY PRGSWSASTS PARSPSPSRY
     GGHLSRSKRT QLPYPTYGTT SLCQRSRSPS PARLQEMRER DRLGYGIDMG VTHVQHSYPT
     LASRRAGIGR RLPPTPSKPS TLQLKPTNIN FPKLNASPTH THHSTPHSVH SLPHHRDLLR
     DPRDMYYSSR ERERDRERLR DRDRDRDRDR LHEYDLRYEY RDRERELYER ERDREREVER
     ERLEYIAPLS FEQALAMGRT GRVLPSPVLN GFKPKSGLNP RHSDSDEEDW C
//
ID   CAC1D_HUMAN             Reviewed;        2161 AA.
AC   Q01668; B0FYA3; Q13916; Q13931; Q71UT1; Q9UDC3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 183.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1D;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 2;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.3;
GN   Name=CACNA1D; Synonyms=CACH3, CACN4, CACNL1A2, CCHL1A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM NEURONAL-TYPE).
RC   TISSUE=Neuroblastoma;
RX   PubMed=1309651; DOI=10.1016/0896-6273(92)90109-Q;
RA   Williams M.E., Feldman D.H., McCue A.F., Brenner R., Velicelebi G.,
RA   Ellis S.B., Harpold M.M.;
RT   "Structure and functional expression of alpha 1, alpha 2, and beta
RT   subunits of a novel human neuronal calcium channel subtype.";
RL   Neuron 8:71-84(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-CELL-TYPE).
RC   TISSUE=Pancreatic islet;
RX   PubMed=1309948; DOI=10.1073/pnas.89.2.584;
RA   Seino S., Chen L., Seino M., Blondel O., Takeda J., Johnson J.H.,
RA   Bell G.I.;
RT   "Cloning of the alpha 1 subunit of a voltage-dependent calcium channel
RT   expressed in pancreatic beta cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:584-588(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM BETA-CELL-TYPE), AND
RP   VARIANT MET-1 INS.
RX   PubMed=7557998; DOI=10.1006/geno.1995.1048;
RA   Yamada Y., Masuda K., Li Q., Ihara Y., Kubota A., Miura T.,
RA   Nakamura K., Fujii Y., Seino S., Seino Y.;
RT   "The structures of the human calcium channel alpha 1 subunit
RT   (CACNL1A2) and beta subunit (CACNLB3) genes.";
RL   Genomics 27:312-319(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND ALTERNATIVE SPLICING (ISOFORM 4).
RC   TISSUE=Pancreas;
RX   PubMed=18482979; DOI=10.1074/jbc.M802254200;
RA   Singh A., Gebhart M., Fritsch R., Sinnegger-Brauns M.J., Poggiani C.,
RA   Hoda J.C., Engel J., Romanin C., Striessnig J., Koschak A.;
RT   "Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type
RT   calcium channels by alternative splicing of a C-terminal regulatory
RT   domain.";
RL   J. Biol. Chem. 283:20733-20744(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-125.
RX   PubMed=9894156; DOI=10.1038/emm.1998.36;
RA   Kim H.-L., Chang Y.J., Lee S.M., Hong Y.-S.;
RT   "Genomic structure of the regulatory region of the voltage-gated
RT   calcium channel alpha 1D.";
RL   Exp. Mol. Med. 30:246-251(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 747-1039, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=1335101; DOI=10.1016/S0025-6196(12)61144-6;
RA   Oguro-Okano M., Griesmann G.E., Wieben E.D., Slaymaker S.J.,
RA   Snutch T.P., Lennon V.A.;
RT   "Molecular diversity of neuronal-type calcium channels identified in
RT   small cell lung carcinoma.";
RL   Mayo Clin. Proc. 67:1150-1159(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 502-510 IN COMPLEX WITH HLA.
RX   PubMed=21280120; DOI=10.1002/pro.559;
RA   Loll B., Ruckert C., Hee C.S., Saenger W., Uchanska-Ziegler B.,
RA   Ziegler A.;
RT   "Loss of recognition by cross-reactive T cells and its relation to a
RT   C-terminus-induced conformational reorientation of an HLA-B*2705-bound
RT   peptide.";
RL   Protein Sci. 20:278-290(2011).
RN   [9]
RP   VARIANT SANDD GLY-403 INS, AND CHARACTERIZATION OF VARIANT SANDD
RP   GLY-403 INS.
RX   PubMed=21131953; DOI=10.1038/nn.2694;
RA   Baig S.M., Koschak A., Lieb A., Gebhart M., Dafinger C., Nurnberg G.,
RA   Ali A., Ahmad I., Sinnegger-Brauns M.J., Brandt N., Engel J.,
RA   Mangoni M.E., Farooq M., Khan H.U., Nurnberg P., Striessnig J.,
RA   Bolz H.J.;
RT   "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with
RT   bradycardia and congenital deafness.";
RL   Nat. Neurosci. 14:77-84(2011).
RN   [10]
RP   VARIANT GLY-749.
RX   PubMed=22495309; DOI=10.1038/nature10989;
RA   O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P.,
RA   Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B.,
RA   Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E.,
RA   Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E.;
RT   "Sporadic autism exomes reveal a highly interconnected protein network
RT   of de novo mutations.";
RL   Nature 485:246-250(2012).
RN   [11]
RP   VARIANT ARG-407.
RX   PubMed=22542183; DOI=10.1016/j.neuron.2012.04.009;
RA   Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J.,
RA   Yamrom B., Lee Y.H., Narzisi G., Leotta A., Kendall J., Grabowska E.,
RA   Ma B., Marks S., Rodgers L., Stepansky A., Troge J., Andrews P.,
RA   Bekritsky M., Pradhan K., Ghiban E., Kramer M., Parla J., Demeter R.,
RA   Fulton L.L., Fulton R.S., Magrini V.J., Ye K., Darnell J.C.,
RA   Darnell R.B., Mardis E.R., Wilson R.K., Schatz M.C., McCombie W.R.,
RA   Wigler M.;
RT   "De novo gene disruptions in children on the autistic spectrum.";
RL   Neuron 74:285-299(2012).
RN   [12]
RP   VARIANTS PASNA ASP-403 AND MET-750, AND CHARACTERIZATION OF VARIANTS
RP   PASNA ASP-403 AND MET-750.
RX   PubMed=23913001; DOI=10.1038/ng.2695;
RA   Scholl U.I., Goh G., Stoelting G., de Oliveira R.C., Choi M.,
RA   Overton J.D., Fonseca A.L., Korah R., Starker L.F., Kunstman J.W.,
RA   Prasad M.L., Hartung E.A., Mauras N., Benson M.R., Brady T.,
RA   Shapiro J.R., Loring E., Nelson-Williams C., Libutti S.K., Mane S.,
RA   Hellman P., Westin G., Aakerstroem G., Bjoerklund P., Carling T.,
RA   Fahlke C., Hidalgo P., Lifton R.P.;
RT   "Somatic and germline CACNA1D calcium channel mutations in
RT   aldosterone-producing adenomas and primary aldosteronism.";
RL   Nat. Genet. 45:1050-1054(2013).
RN   [13]
RP   INVOLVEMENT IN AUTISM SPECTRUM DISORSERS, FUNCTION, AND
RP   CHARACTERIZATION OF VARIANTS ARG-407 AND GLY-749.
RX   PubMed=25620733; DOI=10.1016/j.biopsych.2014.11.020;
RA   Pinggera A., Lieb A., Benedetti B., Lampert M., Monteleone S.,
RA   Liedl K.R., Tuluc P., Striessnig J.;
RT   "CACNA1D de novo mutations in autism spectrum disorders activate
RT   Cav1.3 L-type calcium channels.";
RL   Biol. Psychiatry 77:816-822(2015).
RN   [14]
RP   INVOLVEMENT IN AUTISM SPECTRUM DISORSERS, FUNCTION, VARIANT LEU-401,
RP   AND CHARACTERIZATION OF VARIANT LEU-401.
RX   PubMed=28472301; DOI=10.1093/hmg/ddx175;
RA   Pinggera A., Mackenroth L., Rump A., Schallner J., Beleggia F.,
RA   Wollnik B., Striessnig J.;
RT   "New gain-of-function mutation shows CACNA1D as recurrently mutated
RT   gene in autism spectrum disorders and epilepsy.";
RL   Hum. Mol. Genet. 26:2923-2932(2017).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1D
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       {ECO:0000269|PubMed:18482979, ECO:0000269|PubMed:25620733,
CC       ECO:0000269|PubMed:28472301}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Channel activity is further modulated, depending on the presence
CC       of specific delta subunit isoforms. Interacts (via IQ domain) with
CC       CABP1 and CABP4 in a calcium independent manner (By similarity).
CC       Interacts with RIMBP2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18482979};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:18482979}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Neuronal-type;
CC         IsoId=Q01668-1; Sequence=Displayed;
CC       Name=Beta-cell-type;
CC         IsoId=Q01668-2; Sequence=VSP_000913, VSP_000914;
CC       Name=4; Synonyms=Ca(V)1.3(42A);
CC         IsoId=Q01668-4; Sequence=VSP_047921, VSP_047922;
CC         Note=Expressed at 5% to 15% of isoform Neuronal-type in brain
CC         tissues, increased current density.;
CC       Name=3;
CC         IsoId=Q01668-3; Sequence=VSP_046743, VSP_046744;
CC   -!- TISSUE SPECIFICITY: Expressed in pancreatic islets and in brain,
CC       where it has been seen in cerebral cortex, hippocampus, basal
CC       ganglia, habenula and thalamus. Expressed in the small cell lung
CC       carcinoma cell line SCC-9. No expression in skeletal muscle.
CC       {ECO:0000269|PubMed:1335101}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- POLYMORPHISM: A change from seven to eight ATG trinucleotide
CC       repeats, resulting in an additional N-terminal methionine, has
CC       been found in a patient with non-insulin-dependent diabetes
CC       mellitus (NIDDM). {ECO:0000269|PubMed:7557998}.
CC   -!- DISEASE: Sinoatrial node dysfunction and deafness (SANDD)
CC       [MIM:614896]: A disease characterized by congenital severe to
CC       profound deafness without vestibular dysfunction, associated with
CC       episodic syncope due to intermittent pronounced bradycardia.
CC       {ECO:0000269|PubMed:21131953}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Primary aldosteronism, seizures, and neurologic
CC       abnormalities (PASNA) [MIM:615474]: A disorder characterized by
CC       hypertension, hypokalemia, and high aldosterone levels with low
CC       plasma renin activity and an elevated aldosterone/renin ratio.
CC       Other features include generalized seizures, cerebral palsy,
CC       spasticity, intellectual disability, and developmental delay.
CC       {ECO:0000269|PubMed:23913001}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Gain of function variations affecting the gene
CC       represented in this entry may be associated with susceptibility to
CC       autism spetrum disorders. {ECO:0000269|PubMed:22495309,
CC       ECO:0000269|PubMed:22542183, ECO:0000269|PubMed:25620733,
CC       ECO:0000269|PubMed:28472301}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1D subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M76558; AAA58402.1; -; mRNA.
DR   EMBL; M83566; AAA35629.1; -; mRNA.
DR   EMBL; D43747; BAA07804.1; -; Genomic_DNA.
DR   EMBL; EU363339; ABY66526.1; -; mRNA.
DR   EMBL; AC005905; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012467; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024149; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132810; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF055575; AAD08651.1; -; Genomic_DNA.
DR   CCDS; CCDS2872.1; -. [Q01668-2]
DR   CCDS; CCDS46848.1; -. [Q01668-1]
DR   CCDS; CCDS46849.1; -. [Q01668-3]
DR   PIR; JH0564; JH0564.
DR   RefSeq; NP_000711.1; NM_000720.3. [Q01668-2]
DR   RefSeq; NP_001122311.1; NM_001128839.2. [Q01668-3]
DR   RefSeq; NP_001122312.1; NM_001128840.2. [Q01668-1]
DR   UniGene; Hs.476358; -.
DR   PDB; 3LV3; X-ray; 1.94 A; C=502-510.
DR   PDBsum; 3LV3; -.
DR   ProteinModelPortal; Q01668; -.
DR   SMR; Q01668; -.
DR   BioGrid; 107230; 1.
DR   DIP; DIP-48998N; -.
DR   IntAct; Q01668; 2.
DR   STRING; 9606.ENSP00000288139; -.
DR   BindingDB; Q01668; -.
DR   ChEMBL; CHEMBL4138; -.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00270; Isradipine.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00393; Nimodipine.
DR   DrugBank; DB00401; Nisoldipine.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 530; -.
DR   TCDB; 1.A.1.11.31; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q01668; -.
DR   PhosphoSitePlus; Q01668; -.
DR   DMDM; 116241275; -.
DR   PaxDb; Q01668; -.
DR   PeptideAtlas; Q01668; -.
DR   PRIDE; Q01668; -.
DR   Ensembl; ENST00000288139; ENSP00000288139; ENSG00000157388. [Q01668-2]
DR   Ensembl; ENST00000350061; ENSP00000288133; ENSG00000157388. [Q01668-1]
DR   Ensembl; ENST00000422281; ENSP00000409174; ENSG00000157388. [Q01668-3]
DR   GeneID; 776; -.
DR   KEGG; hsa:776; -.
DR   UCSC; uc003dgu.6; human. [Q01668-1]
DR   CTD; 776; -.
DR   DisGeNET; 776; -.
DR   EuPathDB; HostDB:ENSG00000157388.13; -.
DR   GeneCards; CACNA1D; -.
DR   HGNC; HGNC:1391; CACNA1D.
DR   HPA; HPA020215; -.
DR   MalaCards; CACNA1D; -.
DR   MIM; 114206; gene.
DR   MIM; 614896; phenotype.
DR   MIM; 615474; phenotype.
DR   neXtProt; NX_Q01668; -.
DR   OpenTargets; ENSG00000157388; -.
DR   Orphanet; 85142; Aldosterone-producing adenoma.
DR   Orphanet; 369929; Aldosterone-producing adenoma with seizures and neurological abnormalities.
DR   Orphanet; 324321; Sinoatrial node dysfunction and deafness.
DR   PharmGKB; PA84; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000231529; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; Q01668; -.
DR   KO; K04851; -.
DR   OMA; LIQVERP; -.
DR   OrthoDB; EOG091G0TKO; -.
DR   PhylomeDB; Q01668; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-HSA-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA1D; human.
DR   GeneWiki; Cav1.3; -.
DR   GenomeRNAi; 776; -.
DR   PRO; PR:Q01668; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000157388; -.
DR   CleanEx; HS_CACNA1D; -.
DR   ExpressionAtlas; Q01668; baseline and differential.
DR   Genevisible; Q01668; HS.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0030506; F:ankyrin binding; ISS:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086059; F:voltage-gated calcium channel activity involved SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0070509; P:calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISS:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:1901016; P:regulation of potassium ion transmembrane transporter activity; ISS:BHF-UCL.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:BHF-UCL.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005452; LVDCC_a1dsu.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF139; PTHR10037:SF139; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01636; LVDCCALPHA1D.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Deafness; Disease mutation;
KW   Disulfide bond; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Triplet repeat expansion; Voltage-gated channel.
FT   CHAIN         1   2161       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1D.
FT                                /FTId=PRO_0000053933.
FT   TOPO_DOM      1    126       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    127    145       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    146    163       Extracellular. {ECO:0000255}.
FT   TRANSMEM    164    183       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    184    195       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    196    214       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    215    235       Extracellular. {ECO:0000255}.
FT   TRANSMEM    236    254       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    255    273       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    274    293       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    294    381       Extracellular. {ECO:0000255}.
FT   TRANSMEM    382    406       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    407    523       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    524    543       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    544    558       Extracellular. {ECO:0000255}.
FT   TRANSMEM    559    577       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    578    585       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    586    604       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    605    614       Extracellular. {ECO:0000255}.
FT   TRANSMEM    615    633       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    634    652       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    653    673       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    674    727       Extracellular. {ECO:0000255}.
FT   TRANSMEM    728    752       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    753    886       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    887    905       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    906    921       Extracellular. {ECO:0000255}.
FT   TRANSMEM    922    941       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    942    953       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    954    972       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    973    978       Extracellular. {ECO:0000255}.
FT   TRANSMEM    979    998       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    999   1017       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1018   1037       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1038   1127       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1128   1148       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1149   1205       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1206   1224       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1225   1239       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1240   1259       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1260   1266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1267   1288       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1289   1313       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1314   1333       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1334   1352       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1353   1372       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1373   1439       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1440   1464       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1465   2161       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      113    409       I.
FT   REPEAT      509    755       II.
FT   REPEAT      873   1155       III.
FT   REPEAT     1192   1467       IV.
FT   CA_BIND    1493   1504       {ECO:0000250}.
FT   REGION      429    446       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   REGION     1075   1165       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1420   1486       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1432   1475       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS      1      7       Poly-Met.
FT   COMPBIAS    653    659       Poly-Leu.
FT   COMPBIAS    827    838       Poly-Glu.
FT   SITE        364    364       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        705    705       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1101   1101       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1406   1406       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1475   1475       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    329    329       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     373    392       MNDAMGFELPWVYFVSLVIF -> VNDAIGWEWPWVYFVSL
FT                                IIL (in isoform Beta-cell-type).
FT                                {ECO:0000303|PubMed:1309948}.
FT                                /FTId=VSP_000913.
FT   VAR_SEQ     493    493       C -> WCWWRRRGAAKAGPSGCRRWG (in isoform
FT                                Beta-cell-type).
FT                                {ECO:0000303|PubMed:1309948}.
FT                                /FTId=VSP_000914.
FT   VAR_SEQ    1291   1305       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18482979}.
FT                                /FTId=VSP_046743.
FT   VAR_SEQ    1642   1647       AGLRTL -> MLERML (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047921.
FT   VAR_SEQ    1648   2161       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047922.
FT   VAR_SEQ    1803   1811       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18482979}.
FT                                /FTId=VSP_046744.
FT   VARIANT       1      1       M -> MM (in a NIDDM patient).
FT                                {ECO:0000269|PubMed:7557998}.
FT                                /FTId=VAR_001497.
FT   VARIANT     401    401       V -> L (probable disease-associated
FT                                mutation found in a patient with autism
FT                                spectrum disorder; gain of function;
FT                                increases channel activity; the mutant
FT                                channel is activated at less depolarized
FT                                potentials with an increased current
FT                                density and impaired channel
FT                                inactivation).
FT                                {ECO:0000269|PubMed:28472301}.
FT                                /FTId=VAR_079531.
FT   VARIANT     403    403       G -> D (in PASNA; the mutant channel is
FT                                activated at less depolarized potentials;
FT                                results in increased current density and
FT                                impaired channel inactivation).
FT                                {ECO:0000269|PubMed:23913001}.
FT                                /FTId=VAR_070868.
FT   VARIANT     403    403       G -> GG (in SANDD; the mutant channels
FT                                are unable to conduct calcium ions
FT                                currents and have abnormal voltage-
FT                                dependent gating).
FT                                {ECO:0000269|PubMed:21131953}.
FT                                /FTId=VAR_069170.
FT   VARIANT     407    407       G -> R (probable disease-associated
FT                                mutation found in a patient with autism
FT                                spectrum disorder; gain of function;
FT                                increases channel activity; the mutant
FT                                channel is activated at less depolarized
FT                                potentials with an increased current
FT                                density and impaired channel
FT                                inactivation).
FT                                {ECO:0000269|PubMed:22542183,
FT                                ECO:0000269|PubMed:25620733}.
FT                                /FTId=VAR_079532.
FT   VARIANT     749    749       A -> G (probable disease-associated
FT                                mutation found in a patient with autism
FT                                spectrum disorder; gain of function;
FT                                increases channel activity; the mutant
FT                                channel is activated at less depolarized
FT                                potentials with an increased current
FT                                density and impaired channel
FT                                inactivation).
FT                                {ECO:0000269|PubMed:22495309,
FT                                ECO:0000269|PubMed:25620733}.
FT                                /FTId=VAR_079533.
FT   VARIANT     750    750       I -> M (in PASNA; the mutant channel is
FT                                activated at less depolarized potentials;
FT                                results in increased current density;
FT                                dbSNP:rs41276445).
FT                                {ECO:0000269|PubMed:23913001}.
FT                                /FTId=VAR_070869.
FT   VARIANT    2097   2097       D -> N (in dbSNP:rs41276455).
FT                                /FTId=VAR_061103.
FT   CONFLICT    576    576       S -> T (in Ref. 3; BAA07804).
FT                                {ECO:0000305}.
FT   CONFLICT    637    637       S -> C (in Ref. 1; AAA58402).
FT                                {ECO:0000305}.
FT   CONFLICT    650    650       I -> S (in Ref. 1; AAA58402).
FT                                {ECO:0000305}.
FT   CONFLICT    918    918       I -> T (in Ref. 3; BAA07804).
FT                                {ECO:0000305}.
FT   CONFLICT    960    960       M -> I (in Ref. 3; BAA07804).
FT                                {ECO:0000305}.
FT   CONFLICT   1289   1290       Missing (in Ref. 3; BAA07804).
FT                                {ECO:0000305}.
FT   CONFLICT   1346   1346       S -> F (in Ref. 1; AAA58402).
FT                                {ECO:0000305}.
FT   CONFLICT   1433   1433       Y -> H (in Ref. 1; AAA58402).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2161 AA;  245141 MW;  31B0ADFCDB30B575 CRC64;
     MMMMMMMKKM QHQRQQQADH ANEANYARGT RLPLSGEGPT SQPNSSKQTV LSWQAAIDAA
     RQAKAAQTMS TSAPPPVGSL SQRKRQQYAK SKKQGNSSNS RPARALFCLS LNNPIRRACI
     SIVEWKPFDI FILLAIFANC VALAIYIPFP EDDSNSTNHN LEKVEYAFLI IFTVETFLKI
     IAYGLLLHPN AYVRNGWNLL DFVIVIVGLF SVILEQLTKE TEGGNHSSGK SGGFDVKALR
     AFRVLRPLRL VSGVPSLQVV LNSIIKAMVP LLHIALLVLF VIIIYAIIGL ELFIGKMHKT
     CFFADSDIVA EEDPAPCAFS GNGRQCTANG TECRSGWVGP NGGITNFDNF AFAMLTVFQC
     ITMEGWTDVL YWMNDAMGFE LPWVYFVSLV IFGSFFVLNL VLGVLSGEFS KEREKAKARG
     DFQKLREKQQ LEEDLKGYLD WITQAEDIDP ENEEEGGEEG KRNTSMPTSE TESVNTENVS
     GEGENRGCCG SLCQAISKSK LSRRWRRWNR FNRRRCRAAV KSVTFYWLVI VLVFLNTLTI
     SSEHYNQPDW LTQIQDIANK VLLALFTCEM LVKMYSLGLQ AYFVSLFNRF DCFVVCGGIT
     ETILVELEIM SPLGISVFRC VRLLRIFKVT RHWTSLSNLV ASLLNSMKSI ASLLLLLFLF
     IIIFSLLGMQ LFGGKFNFDE TQTKRSTFDN FPQALLTVFQ ILTGEDWNAV MYDGIMAYGG
     PSSSGMIVCI YFIILFICGN YILLNVFLAI AVDNLADAES LNTAQKEEAE EKERKKIARK
     ESLENKKNNK PEVNQIANSD NKVTIDDYRE EDEDKDPYPP CDVPVGEEEE EEEEDEPEVP
     AGPRPRRISE LNMKEKIAPI PEGSAFFILS KTNPIRVGCH KLINHHIFTN LILVFIMLSS
     AALAAEDPIR SHSFRNTILG YFDYAFTAIF TVEILLKMTT FGAFLHKGAF CRNYFNLLDM
     LVVGVSLVSF GIQSSAISVV KILRVLRVLR PLRAINRAKG LKHVVQCVFV AIRTIGNIMI
     VTTLLQFMFA CIGVQLFKGK FYRCTDEAKS NPEECRGLFI LYKDGDVDSP VVRERIWQNS
     DFNFDNVLSA MMALFTVSTF EGWPALLYKA IDSNGENIGP IYNHRVEISI FFIIYIIIVA
     FFMMNIFVGF VIVTFQEQGE KEYKNCELDK NQRQCVEYAL KARPLRRYIP KNPYQYKFWY
     VVNSSPFEYM MFVLIMLNTL CLAMQHYEQS KMFNDAMDIL NMVFTGVFTV EMVLKVIAFK
     PKGYFSDAWN TFDSLIVIGS IIDVALSEAD PTESENVPVP TATPGNSEES NRISITFFRL
     FRVMRLVKLL SRGEGIRTLL WTFIKSFQAL PYVALLIAML FFIYAVIGMQ MFGKVAMRDN
     NQINRNNNFQ TFPQAVLLLF RCATGEAWQE IMLACLPGKL CDPESDYNPG EEYTCGSNFA
     IVYFISFYML CAFLIINLFV AVIMDNFDYL TRDWSILGPH HLDEFKRIWS EYDPEAKGRI
     KHLDVVTLLR RIQPPLGFGK LCPHRVACKR LVAMNMPLNS DGTVMFNATL FALVRTALKI
     KTEGNLEQAN EELRAVIKKI WKKTSMKLLD QVVPPAGDDE VTVGKFYATF LIQDYFRKFK
     KRKEQGLVGK YPAKNTTIAL QAGLRTLHDI GPEIRRAISC DLQDDEPEET KREEEDDVFK
     RNGALLGNHV NHVNSDRRDS LQQTNTTHRP LHVQRPSIPP ASDTEKPLFP PAGNSVCHNH
     HNHNSIGKQV PTSTNANLNN ANMSKAAHGK RPSIGNLEHV SENGHHSSHK HDREPQRRSS
     VKRTRYYETY IRSDSGDEQL PTICREDPEI HGYFRDPHCL GEQEYFSSEE CYEDDSSPTW
     SRQNYGYYSR YPGRNIDSER PRGYHHPQGF LEDDDSPVCY DSRRSPRRRL LPPTPASHRR
     SSFNFECLRR QSSQEEVPSS PIFPHRTALP LHLMQQQIMA VAGLDSSKAQ KYSPSHSTRS
     WATPPATPPY RDWTPCYTPL IQVEQSEALD QVNGSLPSLH RSSWYTDEPD ISYRTFTPAS
     LTVPSSFRNK NSDKQRSADS LVEAVLISEG LGRYARDPKF VSATKHEIAD ACDLTIDEME
     SAASTLLNGN VRPRANGDVG PLSHRQDYEL QDFGPGYSDE EPDPGRDEED LADEMICITT
     L
//
ID   CAC1B_RAT               Reviewed;        2336 AA.
AC   Q02294;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-NOV-2017, entry version 150.
DE   RecName: Full=Voltage-dependent N-type calcium channel subunit alpha-1B;
DE   AltName: Full=Brain calcium channel III;
DE            Short=BIII;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide isoform 5;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.2;
GN   Name=Cacna1b; Synonyms=Cach5, Cacnl1a5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1317580; DOI=10.1073/pnas.89.11.5058;
RA   Dubel S.J., Starr T.V.B., Hell J.W., Ahlijanian M.K., Enyeart J.J.,
RA   Catterall W.A., Snutch T.P.;
RT   "Molecular cloning of the alpha-1 subunit of an omega-conotoxin-
RT   sensitive calcium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:5058-5062(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1516-1679 (CLONE RBB-10).
RX   PubMed=1692134; DOI=10.1073/pnas.87.9.3391;
RA   Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., Davidson N.;
RT   "Rat brain expresses a heterogeneous family of calcium channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3391-3395(1990).
RN   [3]
RP   PHOSPHORYLATION.
RX   PubMed=8125957;
RA   Hell J.W., Appleyard S.M., Yokoyama C.T., Warner C., Catterall W.A.;
RT   "Differential phosphorylation of two size forms of the N-type calcium
RT   channel alpha 1 subunit which have different COOH termini.";
RL   J. Biol. Chem. 269:7390-7396(1994).
RN   [4]
RP   BETA-SUBUNIT BINDING DOMAIN.
RX   PubMed=7509046; DOI=10.1038/368067a0;
RA   Pragnell M., de Waard M., Mori Y., Tanabe T., Snutch T.P.,
RA   Campbell K.P.;
RT   "Calcium channel beta-subunit binds to a conserved motif in the I-II
RT   cytoplasmic linker of the alpha 1-subunit.";
RL   Nature 368:67-70(1994).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411; SER-746 AND
RP   SER-2253, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1B
CC       gives rise to N-type calcium currents. N-type calcium channels
CC       belong to the 'high-voltage activated' (HVA) group and are blocked
CC       by omega-conotoxin-GVIA (omega-CTx-GVIA) and by omega-agatoxin-
CC       IIIA (omega-Aga-IIIA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing alpha-1B subunit may play a role in
CC       directed migration of immature neurons.
CC   -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity. Interacts with RIMS1. Interacts with FMR1 (via
CC       C-terminus); this interaction induces a deacrease in the number of
CC       presynaptic functional CACNA1B channels at the cell surface.
CC       {ECO:0000250|UniProtKB:O55017}.
CC   -!- INTERACTION:
CC       P21707:Syt1; NbExp=2; IntAct=EBI-540038, EBI-458098;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=2 isoforms may be produced.;
CC       Name=1;
CC         IsoId=Q02294-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Central nervous system.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK.
CC       {ECO:0000269|PubMed:8125957}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92905; AAA42014.1; -; mRNA.
DR   PIR; B35901; B35901.
DR   UniGene; Rn.85880; -.
DR   PDB; 4DEX; X-ray; 2.00 A; B=358-468.
DR   PDBsum; 4DEX; -.
DR   ProteinModelPortal; Q02294; -.
DR   SMR; Q02294; -.
DR   CORUM; Q02294; -.
DR   IntAct; Q02294; 4.
DR   MINT; MINT-102470; -.
DR   STRING; 10116.ENSRNOP00000006162; -.
DR   BindingDB; Q02294; -.
DR   ChEMBL; CHEMBL5107; -.
DR   GuidetoPHARMACOLOGY; 533; -.
DR   iPTMnet; Q02294; -.
DR   PhosphoSitePlus; Q02294; -.
DR   PaxDb; Q02294; -.
DR   PRIDE; Q02294; -.
DR   UCSC; RGD:628852; rat. [Q02294-1]
DR   RGD; 628852; Cacna1b.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   HOGENOM; HOG000231530; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; Q02294; -.
DR   PhylomeDB; Q02294; -.
DR   PRO; PR:Q02294; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0043234; C:protein complex; IDA:RGD.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:RGD.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:RGD.
DR   GO; GO:0070509; P:calcium ion import; IMP:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IMP:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; IMP:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0008016; P:regulation of heart contraction; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0048265; P:response to pain; ISO:RGD.
DR   GO; GO:0033574; P:response to testosterone; IMP:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:RGD.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005447; VDCC_N_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF161; PTHR10037:SF161; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01631; NVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calcium;
KW   Calcium channel; Calcium transport; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Methylation; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   2336       Voltage-dependent N-type calcium channel
FT                                subunit alpha-1B.
FT                                /FTId=PRO_0000053924.
FT   TOPO_DOM      1     95       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     96    114       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    115    133       Extracellular. {ECO:0000255}.
FT   TRANSMEM    134    151       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    152    164       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    165    179       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    180    186       Extracellular. {ECO:0000255}.
FT   TRANSMEM    187    205       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    206    225       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    226    245       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    246    331       Extracellular. {ECO:0000255}.
FT   TRANSMEM    332    356       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    357    483       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    484    503       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    504    517       Extracellular. {ECO:0000255}.
FT   TRANSMEM    518    537       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    538    545       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    546    564       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    565    575       Extracellular. {ECO:0000255}.
FT   TRANSMEM    576    593       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    594    612       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    613    632       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    633    685       Extracellular. {ECO:0000255}.
FT   TRANSMEM    686    710       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    711   1143       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1144   1167       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1168   1184       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1185   1204       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1205   1212       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1213   1235       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1236   1250       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1251   1265       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1266   1286       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1287   1306       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1307   1392       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1393   1417       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1418   1474       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1475   1493       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1494   1507       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1508   1527       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1528   1536       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1537   1555       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1556   1563       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1564   1582       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1583   1601       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1602   1621       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1622   1683       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1684   1703       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1704   2336       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       82    359       I.
FT   REPEAT      469    713       II.
FT   REPEAT     1135   1421       III.
FT   REPEAT     1458   1711       IV.
FT   DOMAIN     1724   1759       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   NP_BIND     452    459       ATP. {ECO:0000255}.
FT   CA_BIND    1737   1748       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      379    396       Binding to the beta subunit.
FT   COMPBIAS   2049   2053       Poly-His.
FT   COMPBIAS   2115   2119       Poly-Ser.
FT   SITE        314    314       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        664    664       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1367   1367       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1655   1655       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES      22     22       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES     411    411       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     746    746       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     749    749       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES     784    784       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES    1067   1067       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES    1719   1719       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    2065   2065       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES    2221   2221       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES    2230   2230       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55017}.
FT   MOD_RES    2253   2253       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1563   1563       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1675   1675       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT   1538   1538       N -> D (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT   1579   1579       C -> L (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   HELIX       364    403       {ECO:0000244|PDB:4DEX}.
SQ   SEQUENCE   2336 AA;  262256 MW;  8D50AF67834FD1BC CRC64;
     MVRFGDELGG RYGGTGGGER ARGGGAGGAG GPGQGGLPPG QRVLYKQSIA QRARTMALYN
     PIPVKQNCFT VNRSLFVFSE DNVVRKYAKR ITEWPPFEYM ILATIIANCI VLALEQHLPD
     GDKTPMSERL DDTEPYFIGI FCFEAGIKII ALGFVFHKGS YLRNGWNVMD FVVVLTEILA
     TAGTDFDLRT LRAVRVLRPL KLVSGIPSLQ VVLKSIMKAM VPLLQIGLLL FFAILMFAII
     GLEFYMGKFH KACFPNSTDA EPVGDFPCGK EAPARLCDSD TECREYWPGP NFGITNFDNI
     LFAILTVFQC ITMEGWTDIL YNTNDAAGNT WNWLYFIPLI IIGSFFMLNL VLGVLSGEFA
     KERERVENRR AFLKLRRQQQ IERELNGYLE WIFKAEEVML AEEDKNAEEK SPLDAVLKRA
     ATKKSRNDLI HAEEGEDRFV DLCAAGSPFA RASLKSGKTE SSSYFRRKEK MFRFLIRRMV
     KAQSFYWVVL CVVALNTLCV AMVHYNQPQR LTTALYFAEF VFLGLFLTEM SLKMYGLGPR
     SYFRSSFNCF DFGVIVGSIF EVVWAAIKPG TSFGISVLRA LRLLRIFKVT KYWNSLRNLV
     VSLLNSMKSI ISLLFLLFLF IVVFALLGMQ LFGGQFNFQD ETPTTNFDTF PAAILTVFQI
     LTGEDWNAVM YHGIESQGGV SKGMFSSFYF IVLTLFGNYT LLNVFLAIAV DNLANAQELT
     KDEEEMEEAA NQKLALQKAK EVAEVSPMSA ANISIAARQQ NSAKARSVWE QRASQLRLQN
     LRASCEALYS EMDPEERLRY ASTRHVRPDM KTHMDRPLVV EPGRDGLRGP AGNKSKPEGT
     EATEGADPPR RHHRHRDRDK TSASTPAGGE QDRTDCPKAE STETGAREER ARPRRSHSKE
     APGADTQVRC ERSRRHHRRG SPEEATEREP RRHRAHRHAQ DSSKEGKEGT APVLVPKGER
     RARHRGPRTG PRETENSEEP TRRHRAKHKV PPTLEPPERE VAEKESNVVE GDKETRNHQP
     KEPRCDLEAI AVTGVGSLHM LPSTCLQKVD EQPEDADNQR NVTRMGSQPS DPSTTVHVPV
     TLTGPPGEAT VVPSANTDLE GQAEGKKEAE ADDVLRRGPR PIVPYSSMFC LSPTNLLRRF
     CHYIVTMRYF EMVILVVIAL SSIALAAEDP VRTDSFRNNA LKYMDYIFTG VFTFEMVIKM
     IDLGLLLHPG AYFRDLWNIL DFIVVSGALV AFAFSSFMGG SKGKDINTIK SLRVLRVLRP
     LKTIKRLPKL KAVFDCVVNS LKNVLNILIV YMLFMFIFAV IAVQLFKGKF FYCTDESKEL
     ERDCRGQYLD YEKEEVEAQP RQWKKYDFHY DNVLWALLTL FTVSTGEGWP MVLKHSVDAT
     YEEQGPSPGF RMELSIFYVV YFVVFPFFFV NIFVALIIIT FQEQGDKVMS ECSLEKNERA
     CIDFAISAKP LTRYMPQNKQ SFQYKTWTFV VSPPFEYFIM AMIALNTVVL MMKFYDAPYE
     YELMLKCLNI VFTSMFSLEC ILKIIAFGVL NYFRDAWNVF DFVTVLGSIT DILVTEIANN
     FINLSFLRLF RAARLIKLCR QGYTIRILLW TFVQSFKALP YVCLLIAMLF FIYAIIGMQV
     FGNIALDDGT SINRHNNFRT FLQALMLLFR SATGEAWHEI MLSCLGNRAC DPHANASECG
     SDFAYFYFVS FIFLCSFLML NLFVAVIMDN FEYLTRDSSI LGPHHLDEFI RVWAEYDPAA
     CGRISYNDMF EMLKHMSPPL GLGKKCPARV AYKRLVRMNM PISNEDMTVH FTSTLMALIR
     TALEIKLAPA GTKQHQCDAE LRKEISSVWA NLPQKTLDLL VPPHKPDEMT VGKVYAALMI
     FDFYKQNKTT RDQTHQAPGG LSQMGPVSLF HPLKATLEQT QPAVLRGARV FLRQKSATSL
     SNGGAIQTQE SGIKESLSWG TQRTQDVLYE ARAPLERGHS AEIPVGQPGA LAVDVQMQNM
     TLRGPDGEPQ PGLESQGRAA SMPRLAAETQ PAPNASPMKR SISTLAPRPH GTQLCNTVLD
     RPPPSQVSHH HHHRCHRRRD KKQRSLEKGP SLSVDTEGAP STAAGSGLPH GEGSTGCRRE
     RKQERGRSQE RRQPSSSSSE KQRFYSCDRF GSREPPQPKP SLSSHPISPT AALEPGPHPQ
     GSGSVNGSPL MSTSGASTPG RGGRRQLPQT PLTPRPSITY KTANSSPVHF AEGQSGLPAF
     SPGRLSRGLS EHNALLQKEP LSQPLASGSR IGSDPYLGQR LDSEASAHNL PEDTLTFEEA
     VATNSGRSSR TSYVSSLTSQ SHPLRRVPNG YHCTLGLSTG VRARHSYHHP DQDHWC
//
ID   CCG1_HUMAN              Reviewed;         222 AA.
AC   Q06432; B2R9N3; Q14D59;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   27-SEP-2017, entry version 142.
DE   RecName: Full=Voltage-dependent calcium channel gamma-1 subunit;
DE   AltName: Full=Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma;
GN   Name=CACNG1; Synonyms=CACNLG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal skeletal muscle;
RX   PubMed=8387489;
RA   Powers P.A., Liu S., Hogan K., Gregg R.G.;
RT   "Molecular characterization of the gene encoding the gamma subunit of
RT   the human skeletal muscle 1,4-dihydropyridine-sensitive Ca2+ channel
RT   (CACNLG), cDNA sequence, gene structure, and chromosomal location.";
RL   J. Biol. Chem. 268:9275-9279(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 102-147 AND 174-222.
RX   PubMed=8404045;
RA   Iles D.E., Segers B., Weghuis D.O., Suikerbuijk R., Wieringa B.;
RT   "Localization of the gamma-subunit of the skeletal muscle L-type
RT   voltage-dependent calcium channel gene (CACNLG) to human chromosome
RT   band 17q24 by in situ hybridization and identification of a
RT   polymorphic repetitive DNA sequence at the gene locus.";
RL   Cytogenet. Cell Genet. 64:227-230(1993).
CC   -!- FUNCTION: This protein is a subunit of the dihydropyridine (DHP)
CC       sensitive calcium channel. Plays a role in excitation-contraction
CC       coupling. The skeletal muscle DHP-sensitive Ca(2+) channel may
CC       function only as a multiple subunit complex.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma.
CC   -!- INTERACTION:
CC       A8KA83:-; NbExp=3; IntAct=EBI-9686780, EBI-10174961;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Skeletal muscle.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L07738; AAA51904.1; -; mRNA.
DR   EMBL; AK313852; BAG36580.1; -; mRNA.
DR   EMBL; CH471099; EAW89022.1; -; Genomic_DNA.
DR   EMBL; BC069493; AAH69493.1; -; mRNA.
DR   EMBL; BC113486; AAI13487.1; -; mRNA.
DR   EMBL; BC113492; AAI13493.1; -; mRNA.
DR   EMBL; Z19603; CAA79671.1; -; Genomic_DNA.
DR   EMBL; Z19587; CAB62573.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS11668.1; -.
DR   PIR; A46658; A46658.
DR   RefSeq; NP_000718.1; NM_000727.3.
DR   UniGene; Hs.147989; -.
DR   ProteinModelPortal; Q06432; -.
DR   BioGrid; 107240; 15.
DR   IntAct; Q06432; 2.
DR   STRING; 9606.ENSP00000226021; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB04842; Fluspirilene.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00528; Lercanidipine.
DR   DrugBank; DB00653; Magnesium Sulfate.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   TCDB; 8.A.16.1.1; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; Q06432; -.
DR   PhosphoSitePlus; Q06432; -.
DR   BioMuta; CACNG1; -.
DR   DMDM; 1168946; -.
DR   PaxDb; Q06432; -.
DR   PeptideAtlas; Q06432; -.
DR   PRIDE; Q06432; -.
DR   DNASU; 786; -.
DR   Ensembl; ENST00000226021; ENSP00000226021; ENSG00000108878.
DR   GeneID; 786; -.
DR   KEGG; hsa:786; -.
DR   UCSC; uc002jfu.4; human.
DR   CTD; 786; -.
DR   EuPathDB; HostDB:ENSG00000108878.4; -.
DR   GeneCards; CACNG1; -.
DR   HGNC; HGNC:1405; CACNG1.
DR   MIM; 114209; gene.
DR   neXtProt; NX_Q06432; -.
DR   OpenTargets; ENSG00000108878; -.
DR   PharmGKB; PA26015; -.
DR   eggNOG; ENOG410IH0I; Eukaryota.
DR   eggNOG; ENOG4111J5G; LUCA.
DR   GeneTree; ENSGT00390000007786; -.
DR   HOGENOM; HOG000293219; -.
DR   HOVERGEN; HBG003868; -.
DR   InParanoid; Q06432; -.
DR   KO; K04866; -.
DR   OMA; EKNCSYF; -.
DR   OrthoDB; EOG091G0IU0; -.
DR   PhylomeDB; Q06432; -.
DR   TreeFam; TF331651; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   GeneWiki; CACNG1; -.
DR   GenomeRNAi; 786; -.
DR   PRO; PR:Q06432; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108878; -.
DR   CleanEx; HS_CACNG1; -.
DR   Genevisible; Q06432; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; TAS:ProtInc.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0070296; P:sarcoplasmic reticulum calcium ion transport; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR005421; VDCC_g1su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   Pfam; PF13903; Claudin_2; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01601; VDCCGAMMA1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    222       Voltage-dependent calcium channel gamma-1
FT                                subunit.
FT                                /FTId=PRO_0000164669.
FT   TRANSMEM     11     29       Helical. {ECO:0000255}.
FT   TRANSMEM    105    129       Helical. {ECO:0000255}.
FT   TRANSMEM    140    155       Helical. {ECO:0000255}.
FT   TRANSMEM    180    204       Helical. {ECO:0000255}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     196    196       G -> S (in dbSNP:rs1799938).
FT                                /FTId=VAR_012063.
SQ   SEQUENCE   222 AA;  25028 MW;  EFEC34266CFC47CB CRC64;
     MSQTKMLKVR VTLFCILAGI VLAMTAVVTD HWAVLSPHME HHNTTCEAAH FGLWRICTKR
     IPMDDSKTCG PITLPGEKNC SYFRHFNPGE SSEIFEFTTQ KEYSISAAAI AIFSLGFIIL
     GSLCVLLSLG KKRDYLLRPA SMFYAFAGLC ILVSVEVMRQ SVKRMIDSED TVWIEYYYSW
     SFACACAAFI LLFLGGLALL LFSLPRMPRN PWESCMDAEP EH
//
ID   MCU_DANRE               Reviewed;         376 AA.
AC   Q08BI9;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 1.
DT   07-JUN-2017, entry version 67.
DE   RecName: Full=Calcium uniporter protein, mitochondrial;
DE   Flags: Precursor;
GN   Name=mcu; ORFNames=zgc:153607 {ECO:0000303|Ref.1};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria. Constitutes the pore-
CC       forming and calcium-conducting subunit of the uniporter complex
CC       (uniplex). Activity is regulated by micu1 and micu2. At low Ca(2+)
CC       levels mcu activity is down-regulated by micu1 and micu2; at
CC       higher Ca(2+) levels micu1 increases mcu activity. Mitochondrial
CC       calcium homeostasis plays key roles in cellular physiology and
CC       regulates cell bioenergetics, cytoplasmic calcium signals and
CC       activation of cell death pathways. Involved in buffering the
CC       amplitude of systolic calcium rises in cardiomyocytes. While
CC       dispensable for baseline homeostatic cardiac function, acts as a
CC       key regulator of short-term mitochondrial calcium loading
CC       underlying a 'fight-or-flight' response during acute stress: acts
CC       by mediating a rapid increase of mitochondrial calcium in
CC       pacemaker cells. {ECO:0000250|UniProtKB:Q3UMR5,
CC       ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- ENZYME REGULATION: Inhibited by ruthenium red or its derivative
CC       Ru360. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBUNIT: Component of the uniplex complex (By similarity).
CC       Homooligomer; forms a pentamer (By similarity).
CC       {ECO:0000250|UniProtKB:Q21121, ECO:0000250|UniProtKB:Q3UMR5,
CC       ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- DOMAIN: Forms a well-packed pentamer with an overall cylindrical
CC       shape. The inner core of the pentamer is formed with the second
CC       transmembrane region and the second coiled-coil region: while the
CC       transmembrane regions pack into a five-helix bundle having a
CC       largely polar pore across the membrane, the coiled-coil outside
CC       the membrane forms a pentamer with a hydrophobic core. The inner
CC       core is wrapped by the first transmembrane region through contacts
CC       between the first and the second transmembrane regions. The second
CC       transmembrane is followed by the inner juxtamembrane region (IJMH)
CC       that orients at a wide angle relative to the second transmembrane.
CC       The two core domains are held together on the periphery by the
CC       outer juxtamembrane helix (OJMH). {ECO:0000250|UniProtKB:Q21121}.
CC   -!- DOMAIN: The critical DXXE motif connecting the transmembrane
CC       regions forms a pentameric barrel that constitutes the mouth of
CC       the pore. Inside the barrel, two acidic residues are in position
CC       to form two carboxylate rings. In absence of SMDT1/EMRE regulator,
CC       the calcium ions cannot exit the channel, suggesting that
CC       SMDT1/EMRE-binding induces conformational rearrangements to allow
CC       calcium to exit. {ECO:0000250|UniProtKB:Q21121}.
CC   -!- DOMAIN: The N-terminal MCU domain is required for efficient Ca(2+)
CC       uptake and for interaction with MCUR1. It is not required for
CC       targeting to the mitochondria, oligomerization, interaction with
CC       MICU1 and MICU2, or assembly of the uniplex complex.
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC124705; AAI24706.1; -; mRNA.
DR   RefSeq; NP_001070793.1; NM_001077325.1.
DR   UniGene; Dr.122221; -.
DR   UniGene; Dr.74472; -.
DR   SMR; Q08BI9; -.
DR   STRING; 7955.ENSDARP00000108433; -.
DR   PaxDb; Q08BI9; -.
DR   PRIDE; Q08BI9; -.
DR   GeneID; 768182; -.
DR   KEGG; dre:768182; -.
DR   CTD; 90550; -.
DR   ZFIN; ZDB-GENE-061013-24; mcu.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   HOVERGEN; HBG060246; -.
DR   InParanoid; Q08BI9; -.
DR   KO; K20858; -.
DR   PhylomeDB; Q08BI9; -.
DR   PRO; PR:Q08BI9; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0034704; C:calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:1990246; C:uniplex complex; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0015292; F:uniporter activity; ISS:UniProtKB.
DR   GO; GO:0007015; P:actin filament organization; IMP:ZFIN.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0043009; P:chordate embryonic development; IMP:ZFIN.
DR   GO; GO:0060027; P:convergent extension involved in gastrulation; IMP:ZFIN.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0036444; P:mitochondrial calcium uptake; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; ISS:UniProtKB.
DR   GO; GO:0035786; P:protein complex oligomerization; ISS:UniProtKB.
DR   GO; GO:0008016; P:regulation of heart contraction; IGI:ZFIN.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     34       Mitochondrion. {ECO:0000255}.
FT   CHAIN        35    376       Calcium uniporter protein, mitochondrial.
FT                                /FTId=PRO_0000282978.
FT   TOPO_DOM     35    257       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    258    280       Helical. {ECO:0000255}.
FT   TOPO_DOM    281    289       Mitochondrial intermembrane.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    290    309       Helical. {ECO:0000255}.
FT   TOPO_DOM    310    376       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   REGION       99    189       N-terminal MCU domain.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   REGION      240    258       Outer juxtamembrane helix (OJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   REGION      307    316       Inner juxtamembrane helix (IJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   COILED      213    254       {ECO:0000255}.
FT   COILED      336    363       {ECO:0000255}.
FT   MOTIF       285    288       DXXE. {ECO:0000250|UniProtKB:Q21121}.
SQ   SEQUENCE   376 AA;  42864 MW;  EB9696F06AE12AC8 CRC64;
     MAAKVCRSVL LLSRSSGAVA SSAYPAFGVS SQRHQGTKTE ALSMSLGGHQ TVRRAHGLRT
     GGRCALFCHP SATLTAQGWK GSPSWQVQRL LCSPAAEDVS VVYQNGLPVI SVRLPSRRER
     CQFTLKPLSD TVGVFLQQLQ AEDRGIDRVT IYSADGARIA SSTGIDILLM DNFKLVINDT
     SYLVQPPRRD LLPHEDGERL NDVKILVQQL YTTLRIEEHQ LNKERELIGR LEDLNSQLQP
     LEKVKEELSK KAERRTTWVL WGGMAYMATQ FGILARLTWW EYSWDIMEPV TYFITYGTAM
     AMYAYFVLTR QEYLYPDARD RQYLLFFHRG AKRTRFDIEK YNKLKDAIAE AELDLKRLRD
     PLQLNLPIQQ IDTSKD
//
ID   PKD2_SCHPO              Reviewed;         710 AA.
AC   Q09917;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-OCT-2017, entry version 117.
DE   RecName: Full=TRP-like ion channel pkd2;
DE   AltName: Full=Polycystic kidney disease-related ion channel 2;
DE   Flags: Precursor;
GN   Name=pkd2; ORFNames=SPAC1F7.03;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   FUNCTION, INTERACTION WITH RHO1, AND SUBCELLULAR LOCATION.
RX   PubMed=15537393; DOI=10.1042/BJ20041710;
RA   Palmer C.P., Aydar E., Djamgoz M.B.;
RT   "A microbial TRP-like polycystic-kidney-disease-related ion channel
RT   gene.";
RL   Biochem. J. 387:211-219(2005).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-599 AND SER-632, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18257517; DOI=10.1021/pr7006335;
RA   Wilson-Grady J.T., Villen J., Gygi S.P.;
RT   "Phosphoproteome analysis of fission yeast.";
RL   J. Proteome Res. 7:1088-1097(2008).
CC   -!- FUNCTION: Acts as a key signaling component in the regulation of
CC       cell shape and cell wall synthesis through interaction with GTPase
CC       Rho1. {ECO:0000269|PubMed:15537393}.
CC   -!- SUBUNIT: Interacts with rho1. {ECO:0000269|PubMed:15537393}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15537393};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:15537393}. Golgi
CC       apparatus membrane {ECO:0000269|PubMed:15537393}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:15537393}.
CC   -!- SIMILARITY: Belongs to the transient receptor potential (TRP) ion
CC       channel family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAA91950.1; -; Genomic_DNA.
DR   PIR; S62575; S62575.
DR   RefSeq; NP_594489.1; NM_001019918.2.
DR   BioGrid; 278110; 4.
DR   MINT; MINT-4696381; -.
DR   STRING; 4896.SPAC1F7.03.1; -.
DR   TCDB; 1.A.4.9.2; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q09917; -.
DR   PRIDE; Q09917; -.
DR   EnsemblFungi; SPAC1F7.03.1; SPAC1F7.03.1:pep; SPAC1F7.03.
DR   GeneID; 2541613; -.
DR   KEGG; spo:SPAC1F7.03; -.
DR   EuPathDB; FungiDB:SPAC1F7.03; -.
DR   PomBase; SPAC1F7.03; pkd2.
DR   InParanoid; Q09917; -.
DR   OMA; MKDDRVS; -.
DR   OrthoDB; EOG092C186V; -.
DR   PhylomeDB; Q09917; -.
DR   PRO; PR:Q09917; -.
DR   Proteomes; UP000002485; Chromosome I.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:PomBase.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IDA:PomBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:PomBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:PomBase.
DR   GO; GO:0031520; C:plasma membrane of cell tip; IDA:PomBase.
DR   GO; GO:0005262; F:calcium channel activity; IMP:PomBase.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IMP:PomBase.
DR   GO; GO:0017157; P:regulation of exocytosis; IMP:PomBase.
DR   GO; GO:0032995; P:regulation of fungal-type cell wall biogenesis; IMP:PomBase.
DR   GO; GO:0061454; P:release of sequestered calcium ion into cytosol by Golgi; IGI:PomBase.
DR   InterPro; IPR010308; TRP-like_family.
DR   InterPro; IPR032800; TRP_N.
DR   Pfam; PF06011; TRP; 1.
DR   Pfam; PF14558; TRP_N; 1.
DR   SMART; SM01320; TRP_N; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Golgi apparatus; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    710       TRP-like ion channel pkd2.
FT                                /FTId=PRO_0000045821.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   TRANSMEM    197    217       Helical. {ECO:0000255}.
FT   TRANSMEM    322    342       Helical. {ECO:0000255}.
FT   TRANSMEM    376    396       Helical. {ECO:0000255}.
FT   TRANSMEM    404    424       Helical. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   TRANSMEM    492    512       Helical. {ECO:0000255}.
FT   TRANSMEM    525    545       Helical. {ECO:0000255}.
FT   TRANSMEM    555    575       Helical. {ECO:0000255}.
FT   MOD_RES     599    599       Phosphoserine.
FT                                {ECO:0000269|PubMed:18257517}.
FT   MOD_RES     632    632       Phosphoserine.
FT                                {ECO:0000269|PubMed:18257517}.
SQ   SEQUENCE   710 AA;  79989 MW;  0A4D5B7371F84278 CRC64;
     MRLWRSPLLL LVVVVELFSW ADALTRFISA DSLSTCMTDS QLSASKLYAS YFPDNQSVAF
     DISIQSLVST NVSIDVDISA YGIEIKKVID PCDMEISGFC PMQTGNIALS GSHTLTGEAL
     SILDSIPSIA YTVPDLDAVV TINIYESDTN TQLACVRTTV QNGRSVYHRA VYWVMCMVIG
     IPLLIFLLIS PVLQTPALWE IVETMITLFQ FAQIQALYSM MATSLPAIIY SWGRNFMWSM
     GIIRIGFMQD VFTWYVKSTG GTPSTLVDLG IHANVALAKR GIDLGSLAKR ATTTVTTSTS
     DSITLRGIKR ISYMMGIETT NFFATGFSFF IILLFFSLLV AMASRFIVEM VLLASRNQAL
     KKQRIRLYWK SISKGFFYRV IFVGFTQMSV LSMWEIYTRD SSALAFLSMY VIVDMAVLLC
     YAFVRTIQII RKTGPYSHPD VLYNLYSDTQ HLMRWGFMYV QLDVRFFYFT FPLLLITLVR
     SMFIGFGQGS PKVQGCAMFG ISVVVFALMV ILRPYATKHM NTLHIGVALM NLISGSFILV
     MCQAFYVEEL ARQVIGIIFF ALNAITMLLL ILGIFIRTLI VLFRKSGHGT YYRILDDQSE
     KATSYNKSIK DMSSSDMAFS DPAYSGTTLR SSVDLNTPEY PFSNRNDSDS TFTNNKYVSP
     WDAIEEASYA NLRGNTDVEQ PFMESDYTRI SENNNNAERR RKPLPNNAFR
//
ID   YVC1_YEAST              Reviewed;         675 AA.
AC   Q12324; D6W2E9; Q08500; Q7LGN3;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   22-NOV-2017, entry version 137.
DE   RecName: Full=Calcium channel YVC1;
DE   AltName: Full=TRP homolog;
DE   AltName: Full=Yeast vacuolar conductance protein 1;
GN   Name=YVC1 {ECO:0000312|SGD:S000005613}; OrderedLocusNames=YOR087W;
GN   ORFNames=YOR088W, YOR3151W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION,
RP   TOPOLOGY, AND IDENTIFICATION OF FRAMESHIFT.
RC   STRAIN=ATCC 201389 / BY4742;
RX   PubMed=11427713; DOI=10.1073/pnas.141036198;
RA   Palmer C.P., Zhou X.-L., Lin J., Loukin S.H., Kung C., Saimi Y.;
RT   "A TRP homolog in Saccharomyces cerevisiae forms an intracellular
RT   Ca(2+)-permeable channel in the yeast vacuolar membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7801-7805(2001).
RN   [2] {ECO:0000312|EMBL:CAA64009.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9200815;
RX   DOI=10.1002/(SICI)1097-0061(19970615)13:7<655::AID-YEA120>3.0.CO;2-I;
RA   Voss H., Benes V., Andrade M.A., Valencia A., Rechmann S., Teodoru C.,
RA   Schwager C., Paces V., Sander C., Ansorge W.;
RT   "DNA sequencing and analysis of 130 kb from yeast chromosome XV.";
RL   Yeast 13:655-672(1997).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:CAA99283.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169874;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W.,
RA   Arino J., Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R.,
RA   Boyer J., Camasses A., Casamayor A., Casas C., Cheret G.,
RA   Cziepluch C., Daignan-Fornier B., Dang V.-D., de Haan M., Delius H.,
RA   Durand P., Fairhead C., Feldmann H., Gaillon L., Galisson F.,
RA   Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E., Grivell L.A.,
RA   Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J.,
RA   Maarse A.C., Madania A., Mannhaupt G., Marck C., Martin R.P.,
RA   Mewes H.-W., Michaux G., Paces V., Parle-McDermott A.G., Pearson B.M.,
RA   Perrin A., Pettersson B., Poch O., Pohl T.M., Poirey R.,
RA   Portetelle D., Pujol A., Purnelle B., Ramezani Rad M., Rechmann S.,
RA   Schwager C., Schweizer M., Sor F., Sterky F., Tarassov I.A.,
RA   Teodoru C., Tettelin H., Thierry A., Tobiasch E., Tzermia M.,
RA   Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I., Vlcek C.,
RA   Voet M., Volckaert G., Voss H., Wambutt R., Wedler H., Wiemann S.,
RA   Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11781332; DOI=10.1083/jcb.200111004;
RA   Denis V., Cyert M.S.;
RT   "Internal Ca(2+) release in yeast is triggered by hypertonic shock and
RT   mediated by a TRP channel homologue.";
RL   J. Cell Biol. 156:29-34(2002).
RN   [6] {ECO:0000305}
RP   IDENTIFICATION OF FRAMESHIFT.
RX   PubMed=12748633; DOI=10.1038/nature01644;
RA   Kellis M., Patterson N., Endrizzi M., Birren B.W., Lander E.S.;
RT   "Sequencing and comparison of yeast species to identify genes and
RT   regulatory elements.";
RL   Nature 423:241-254(2003).
RN   [7]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [8]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 208353 / W303-1A;
RX   PubMed=16847258; DOI=10.1073/pnas.0604075103;
RA   Kim H., Melen K., Oesterberg M., von Heijne G.;
RT   "A global topology map of the Saccharomyces cerevisiae membrane
RT   proteome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11142-11147(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-636, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-636, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
CC   -!- FUNCTION: Required for release of calcium ions from the vacuole in
CC       response to hyperosmotic shock. {ECO:0000269|PubMed:11427713,
CC       ECO:0000269|PubMed:11781332}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:11427713, ECO:0000269|PubMed:11781332}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:11427713,
CC       ECO:0000269|PubMed:11781332}.
CC   -!- MISCELLANEOUS: Present with 1310 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA64009.1; Type=Frameshift; Positions=245; Evidence={ECO:0000305};
CC       Sequence=CAA99282.1; Type=Frameshift; Positions=245; Evidence={ECO:0000305};
CC       Sequence=CAA99283.1; Type=Frameshift; Positions=245; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X94335; CAA64009.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; Z74995; CAA99282.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; Z74995; CAA99283.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; Z74997; CAA99286.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA10865.1; -; Genomic_DNA.
DR   PIR; S61648; S61648.
DR   PIR; S66972; S66972.
DR   RefSeq; NP_014730.2; NM_001183506.1.
DR   ProteinModelPortal; Q12324; -.
DR   BioGrid; 34486; 136.
DR   DIP; DIP-4157N; -.
DR   IntAct; Q12324; 2.
DR   MINT; MINT-489917; -.
DR   STRING; 4932.YOR087W; -.
DR   TCDB; 1.A.4.4.1; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q12324; -.
DR   MaxQB; Q12324; -.
DR   PRIDE; Q12324; -.
DR   EnsemblFungi; YOR087W; YOR087W; YOR087W.
DR   GeneID; 854255; -.
DR   KEGG; sce:YOR087W; -.
DR   EuPathDB; FungiDB:YOR087W; -.
DR   SGD; S000005613; YVC1.
DR   HOGENOM; HOG000199455; -.
DR   InParanoid; Q12324; -.
DR   OMA; RATACEV; -.
DR   OrthoDB; EOG092C1F4Q; -.
DR   BioCyc; YEAST:G3O-33622-MONOMER; -.
DR   PRO; PR:Q12324; -.
DR   Proteomes; UP000002311; Chromosome XV.
DR   GO; GO:0000324; C:fungal-type vacuole; IDA:SGD.
DR   GO; GO:0000329; C:fungal-type vacuole membrane; IDA:SGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:1990816; C:vacuole-mitochondrion membrane contact site; IDA:SGD.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:SGD.
DR   GO; GO:0005262; F:calcium channel activity; IDA:SGD.
DR   GO; GO:0005267; F:potassium channel activity; IDA:SGD.
DR   GO; GO:0005272; F:sodium channel activity; IDA:SGD.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:SGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IMP:SGD.
DR   GO; GO:0030003; P:cellular cation homeostasis; IDA:SGD.
DR   InterPro; IPR024862; TRPV.
DR   PANTHER; PTHR10582; PTHR10582; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Vacuole.
FT   CHAIN         1    675       Calcium channel YVC1.
FT                                /FTId=PRO_0000215376.
FT   TOPO_DOM      1    236       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical. {ECO:0000255}.
FT   TOPO_DOM    258    295       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    296    316       Helical. {ECO:0000255}.
FT   TOPO_DOM    317    335       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    336    355       Helical. {ECO:0000255}.
FT   TOPO_DOM    356    376       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    377    397       Helical. {ECO:0000255}.
FT   TOPO_DOM    398    405       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    406    426       Helical. {ECO:0000255}.
FT   TOPO_DOM    427    436       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    675       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    573    576       Poly-Asp. {ECO:0000255}.
FT   MOD_RES     636    636       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18407956,
FT                                ECO:0000244|PubMed:19779198}.
SQ   SEQUENCE   675 AA;  77953 MW;  C8CE3B092A717306 CRC64;
     MVSANGDLHL PISNEQCMPE NNGSLGFEAP TPRQILRVTL NLKYLIDKVV PIVYDPNDIV
     CDHSEILSPK VVKLAYEACG GNPKDKANKR KYQSVIIFSL LKVCEWYSIL ATMEVHNAKL
     YETRNLASQQ LCKLLIEREE TRDLQFLFMQ LLLRRYVINE NDEDQEPLNA LELATDMHCT
     TVIGSSGFQR CLKWIWRGWI VQNGLDPTTF IKDDSLAEVS LISHFNPVRL KAPVYQNYLQ
     MIFSFLFLGL YTLVVNGKDS ERVQSFDLLE SIFYVFNTGF ILDELTKLYY IGYAHLSFWN
     LFNDTTYLII TFAMGFRAMS VTPLNAKYSS EDWDKISYRV LSCAAPFVWS RLLLYLESQR
     FIGIMLVILK HMMKESIVFF FLLFLIMIGF TQGFLGLDSA DGKRDITGPI LGNLTITVLG
     LGSFDVFEEF APPYAAILYY GYYFIVSVIL LNILIALYST AYQKVIDNAD DEYMALMSQK
     TLRYIRAPDE DVYVSPLNLI EVFMTPIFRI LPPKRAKDLS YTVMTIVYSP FLLLISVKET
     REARRIKYNR MKRLNDDANE YDTPWDLTDG YLDDDDGLFS DNRNSGMRAT QLKNSRSLKL
     QRTAEQEDVH FKVPKKWYKN VKKCSPSFEQ YDNDDTEDDA GEDKDEVKEL TKKVENLTAV
     ITDLLEKLDI KDKKE
//
ID   PKD2_HUMAN              Reviewed;         968 AA.
AC   Q13563; O60441; Q15764; Q2M1Q3; Q2M1Q5;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   20-DEC-2017, entry version 184.
DE   RecName: Full=Polycystin-2;
DE            Short=PC2 {ECO:0000303|PubMed:27991905};
DE   AltName: Full=Autosomal dominant polycystic kidney disease type II protein;
DE   AltName: Full=Polycystic kidney disease 2 protein;
DE   AltName: Full=Polycystwin {ECO:0000303|PubMed:8954772};
DE   AltName: Full=R48321;
DE   AltName: Full=Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};
GN   Name=PKD2 {ECO:0000312|HGNC:HGNC:9009};
GN   Synonyms=TRPP2 {ECO:0000303|PubMed:19556541,
GN   ECO:0000312|HGNC:HGNC:9009};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=8650545; DOI=10.1126/science.272.5266.1339;
RA   Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B.,
RA   Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A.,
RA   Kimberling W.J., Breuning M.H., Deltas C.C., Peters D.J.M., Somlo S.;
RT   "PKD2, a gene for polycystic kidney disease that encodes an integral
RT   membrane protein.";
RL   Science 272:1339-1342(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9286709; DOI=10.1006/geno.1997.4851;
RA   Hayashi T., Mochizuki T., Reynolds D.M., Wu G., Cai Y., Somlo S.;
RT   "Characterization of the exon structure of the polycystic kidney
RT   disease 2 gene (PKD2).";
RL   Genomics 44:131-136(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-28.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 361-968 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=8954772; DOI=10.1006/geno.1996.0584;
RA   Schneider M.C., Rodriguez A., Nomura H., Zhou J., Morton C.C.,
RA   Reeders S.T., Weremowicz S.;
RT   "A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for
RT   PKD2.";
RL   Genomics 38:1-4(1996).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10770959;
RA   Foggensteiner L., Bevan A.P., Thomas R., Coleman N., Boulter C.,
RA   Bradley J., Ibraghimov-Beskrovnaya O., Klinger K., Sandford R.;
RT   "Cellular and subcellular distribution of polycystin-2, the protein
RT   product of the PKD2 gene.";
RL   J. Am. Soc. Nephrol. 11:814-827(2000).
RN   [6]
RP   INTERACTION WITH CD2AP, AND SUBCELLULAR LOCATION.
RX   PubMed=10913159; DOI=10.1074/jbc.M006624200;
RA   Lehtonen S., Ora A., Olkkonen V.M., Geng L., Zerial M., Somlo S.,
RA   Lehtonen E.;
RT   "In vivo interaction of the adapter protein CD2-associated protein
RT   with the type 2 polycystic kidney disease protein, polycystin-2.";
RL   J. Biol. Chem. 275:32888-32893(2000).
RN   [7]
RP   INTERACTION WITH HAX1, AND SUBCELLULAR LOCATION.
RX   PubMed=10760273; DOI=10.1073/pnas.97.8.4017;
RA   Gallagher A.R., Cedzich A., Gretz N., Somlo S., Witzgall R.;
RT   "The polycystic kidney disease protein PKD2 interacts with Hax-1, a
RT   protein associated with the actin cytoskeleton.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4017-4022(2000).
RN   [8]
RP   REVIEW.
RX   PubMed=11698076; DOI=10.1016/S0165-6147(00)01832-0;
RA   Stayner C., Zhou J.;
RT   "Polycystin channels and kidney disease.";
RL   Trends Pharmacol. Sci. 22:543-546(2001).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANT PKD2
RP   VAL-511.
RX   PubMed=11854751; DOI=10.1038/ncb754;
RA   Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R.,
RA   Ehrlich B.E., Somlo S.;
RT   "Polycystin-2 is an intracellular calcium release channel.";
RL   Nat. Cell Biol. 4:191-197(2002).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS 2; 3; 4 AND 5).
RX   PubMed=16192288; DOI=10.1093/hmg/ddi356;
RA   Hackmann K., Markoff A., Qian F., Bogdanova N., Germino G.G.,
RA   Pennekamp P., Dworniczak B., Horst J., Gerke V.;
RT   "A splice form of polycystin-2, lacking exon 7, does not interact with
RT   polycystin-1.";
RL   Hum. Mol. Genet. 14:3249-3262(2005).
RN   [11]
RP   FUNCTION, INTERACTION WITH PACS1 AND PACS2, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT SER-812, AND MUTAGENESIS OF SER-812 AND
RP   815-ASP--ASP-817.
RX   PubMed=15692563; DOI=10.1038/sj.emboj.7600566;
RA   Koettgen M., Benzing T., Simmen T., Tauber R., Buchholz B.,
RA   Feliciangeli S., Huber T.B., Schermer B., Kramer-Zucker A.,
RA   Hoepker K., Simmen K.C., Tschucke C.C., Sandford R., Kim E.,
RA   Thomas G., Walz G.;
RT   "Trafficking of TRPP2 by PACS proteins represents a novel mechanism of
RT   ion channel regulation.";
RL   EMBO J. 24:705-716(2005).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT SER-76; SER-80 AND
RP   SER-812, AND MUTAGENESIS OF SER-76; SER-80; THR-721; SER-801; SER-812;
RP   SER-831 AND SER-943.
RX   PubMed=16551655; DOI=10.1093/hmg/ddl070;
RA   Streets A.J., Moon D.J., Kane M.E., Obara T., Ong A.C.;
RT   "Identification of an N-terminal glycogen synthase kinase 3
RT   phosphorylation site which regulates the functional localization of
RT   polycystin-2 in vivo and in vitro.";
RL   Hum. Mol. Genet. 15:1465-1473(2006).
RN   [13]
RP   FUNCTION, INTERACTION WITH TRPV4, AND SUBCELLULAR LOCATION.
RX   PubMed=18695040; DOI=10.1083/jcb.200805124;
RA   Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X.,
RA   Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T.,
RA   Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T.,
RA   Prenen J., Nilius B., Kuehn E.W., Walz G.;
RT   "TRPP2 and TRPV4 form a polymodal sensory channel complex.";
RL   J. Cell Biol. 182:437-447(2008).
RN   [14]
RP   GLYCOSYLATION AT ASN-328.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [15]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT SER-801, MUTAGENESIS
RP   OF SER-801 AND SER-804, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION
RP   WITH PKD1.
RX   PubMed=20881056; DOI=10.1091/mbc.E10-04-0377;
RA   Streets A.J., Needham A.J., Gill S.K., Ong A.C.;
RT   "Protein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is
RT   essential for its effects on cell growth and calcium channel
RT   activity.";
RL   Mol. Biol. Cell 21:3853-3865(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-812, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-812, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-829, TISSUE SPECIFICITY, AND MUTAGENESIS OF SER-829.
RX   PubMed=26269590; DOI=10.1074/jbc.M115.661082;
RA   del Rocio Cantero M., Velazquez I.F., Streets A.J., Ong A.C.M.,
RA   Cantiello H.F.;
RT   "The cAMP Signaling Pathway and Direct Protein Kinase A
RT   Phosphorylation Regulate Polycystin-2 (TRPP2) Channel Function.";
RL   J. Biol. Chem. 290:23888-23896(2015).
RN   [19]
RP   SUBCELLULAR LOCATION.
RX   PubMed=27259053; DOI=10.1016/j.ajhg.2016.05.004;
RG   Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group;
RG   Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease;
RA   Porath B., Gainullin V.G., Cornec-Le Gall E., Dillinger E.K.,
RA   Heyer C.M., Hopp K., Edwards M.E., Madsen C.D., Mauritz S.R.,
RA   Banks C.J., Baheti S., Reddy B., Herrero J.I., Banales J.M.,
RA   Hogan M.C., Tasic V., Watnick T.J., Chapman A.B., Vigneau C.,
RA   Lavainne F., Audrezet M.P., Ferec C., Le Meur Y., Torres V.E.,
RA   Harris P.C.;
RT   "Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause
RT   autosomal-dominant polycystic kidney and liver disease.";
RL   Am. J. Hum. Genet. 98:1193-1207(2016).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-604; PHE-605 AND
RP   736-LEU-ASN-737, AND CHARACTERIZATION OF VARIANTS PKD2 GLY-414;
RP   GLY-420 AND VAL-511.
RX   PubMed=27071085; DOI=10.1073/pnas.1517066113;
RA   Arif Pavel M., Lv C., Ng C., Yang L., Kashyap P., Lam C.,
RA   Valentino V., Fung H.Y., Campbell T., Moeller S.G., Zenisek D.,
RA   Holtzman N.G., Yu Y.;
RT   "Function and regulation of TRPP2 ion channel revealed by a gain-of-
RT   function mutant.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E2363-E2372(2016).
RN   [21]
RP   3D-STRUCTURE MODELING, PROTEIN SEQUENCE OF 711-715; 720-724; 804-808
RP   AND 823-827, IDENTIFICATION BY MASS SPECTROMETRY, DOMAIN,
RP   CALCIUM-BINDING, CIRCULAR DICHROISM, SUBUNIT, AND MUTAGENESIS OF
RP   THR-771; GLU-774; LEU-842; VAL-846; MET-849; ILE-853; ILE-856 AND
RP   VAL-863.
RX   PubMed=18694932; DOI=10.1074/jbc.M802743200;
RA   Celic A., Petri E.T., Demeler B., Ehrlich B.E., Boggon T.J.;
RT   "Domain mapping of the polycystin-2 C-terminal tail using de novo
RT   molecular modeling and biophysical analysis.";
RL   J. Biol. Chem. 283:28305-28312(2008).
RN   [22] {ECO:0000244|PDB:3HRN, ECO:0000244|PDB:3HRO}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 833-872, COILED COIL,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND MUTAGENESIS OF LEU-842; VAL-846;
RP   MET-849; ILE-860; VAL-863 AND LEU-867.
RX   PubMed=19556541; DOI=10.1073/pnas.0903684106;
RA   Yu Y., Ulbrich M.H., Li M.H., Buraei Z., Chen X.Z., Ong A.C., Tong L.,
RA   Isacoff E.Y., Yang J.;
RT   "Structural and molecular basis of the assembly of the TRPP2/PKD1
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:11558-11563(2009).
RN   [23] {ECO:0000244|PDB:2KQ6}
RP   STRUCTURE BY NMR OF 720-797.
RX   PubMed=20439752; DOI=10.1073/pnas.0912295107;
RA   Petri E.T., Celic A., Kennedy S.D., Ehrlich B.E., Boggon T.J.,
RA   Hodsdon M.E.;
RT   "Structure of the EF-hand domain of polycystin-2 suggests a mechanism
RT   for Ca2+-dependent regulation of polycystin-2 channel activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:9176-9181(2010).
RN   [24] {ECO:0000244|PDB:2Y4Q}
RP   STRUCTURE BY NMR OF 717-792 IN COMPLEX WITH CALCIUM, DOMAIN, AND
RP   MUTAGENESIS OF GLN-768 AND GLU-774.
RX   PubMed=24990821; DOI=10.1002/PRO.2513;
RA   Allen M.D., Qamar S., Vadivelu M.K., Sandford R.N., Bycroft M.;
RT   "A high-resolution structure of the EF-hand domain of human
RT   polycystin-2.";
RL   Protein Sci. 23:1301-1308(2014).
RN   [25] {ECO:0000244|PDB:5T4D}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.00 ANGSTROMS) OF 198-702, SUBUNIT,
RP   SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION AT ASN-328; ASN-362 AND
RP   ASN-375, AND DISULFIDE BONDS.
RX   PubMed=27768895; DOI=10.1016/j.cell.2016.09.048;
RA   Shen P.S., Yang X., DeCaen P.G., Liu X., Bulkley D., Clapham D.E.,
RA   Cao E.;
RT   "The structure of the polycystic kidney disease channel PKD2 in lipid
RT   nanodiscs.";
RL   Cell 167:763-773(2016).
RN   [26] {ECO:0000244|PDB:5K47}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS) OF 185-723,
RP   FUNCTION, SUBUNIT, TOPOLOGY, AND GLYCOSYLATION AT ASN-328; ASN-362 AND
RP   ASN-375.
RX   PubMed=27991905; DOI=10.1038/nsmb.3343;
RA   Grieben M., Pike A.C., Shintre C.A., Venturi E., El-Ajouz S.,
RA   Tessitore A., Shrestha L., Mukhopadhyay S., Mahajan P., Chalk R.,
RA   Burgess-Brown N.A., Sitsapesan R., Huiskonen J.T., Carpenter E.P.;
RT   "Structure of the polycystic kidney disease TRP channel polycystin-2
RT   (PC2).";
RL   Nat. Struct. Mol. Biol. 24:114-122(2017).
RN   [27] {ECO:0000244|PDB:5MKE, ECO:0000244|PDB:5MKF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS) IN COMPLEX WITH
RP   CALCIUM AND LIPIDS, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY,
RP   GLYCOSYLATION AT ASN-299; ASN-305; ASN-328; ASN-362 AND ASN-375, AND
RP   DISULFIDE BONDS.
RX   PubMed=28092368; DOI=10.1038/nsmb.3357;
RA   Wilkes M., Madej M.G., Kreuter L., Rhinow D., Heinz V., De Sanctis S.,
RA   Ruppel S., Richter R.M., Joos F., Grieben M., Pike A.C.,
RA   Huiskonen J.T., Carpenter E.P., Kuhlbrandt W., Witzgall R.,
RA   Ziegler C.;
RT   "Molecular insights into lipid-assisted Ca2+ regulation of the TRP
RT   channel polycystin-2.";
RL   Nat. Struct. Mol. Biol. 24:123-130(2017).
RN   [28]
RP   VARIANT PKD2 GLY-414.
RX   PubMed=9326320; DOI=10.1086/515497;
RA   Veldhuisen B., Saris J.J., de Haij S., Hayashi T., Reynolds D.M.,
RA   Mochizuki T., Elles R., Fossdal R., Bogdanova N., van Dijk M.A.,
RA   Coto E., Ravine D., Noerby S., Verellen-Dumoulin C., Breuning M.H.,
RA   Somlo S., Peters D.J.M.;
RT   "A spectrum of mutations in the second gene for autosomal dominant
RT   polycystic kidney disease (PKD2).";
RL   Am. J. Hum. Genet. 61:547-555(1997).
RN   [29]
RP   VARIANT PKD2 VAL-511.
RX   PubMed=10541293;
RA   Reynolds D.M., Hayashi T., Cai Y., Veldhuisen B., Watnick T.J.,
RA   Lens X.M., Mochizuki T., Qian F., Maeda Y., Li L., Fossdal R.,
RA   Coto E., Wu G., Breuning M.H., Germino G.G., Peters D.J.M., Somlo S.;
RT   "Aberrant splicing in the PKD2 gene as a cause of polycystic kidney
RT   disease.";
RL   J. Am. Soc. Nephrol. 10:2342-2351(1999).
RN   [30]
RP   VARIANT PKD2 PRO-356, AND VARIANT PRO-28.
RX   PubMed=10411676; DOI=10.1046/j.1523-1755.1999.00534.x;
RA   Torra R., Viribay M., Telleria D., Badenas C., Watson M., Harris P.C.,
RA   Darnell A., San Millan J.L.;
RT   "Seven novel mutations of the PKD2 gene in families with autosomal
RT   dominant polycystic kidney disease.";
RL   Kidney Int. 56:28-33(1999).
RN   [31]
RP   VARIANTS PKD2 ILE-479 DEL; 504-ARG--VAL-512 DEL AND TYR-684 DEL.
RX   PubMed=10835625; DOI=10.1038/75981;
RA   Watnick T.J., He N., Wang K., Liang Y., Parfrey P., Hefferton D.,
RA   St George-Hyslop P.H., Germino G.G., Pei Y.;
RT   "Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of
RT   trans-heterozygous mutations.";
RL   Nat. Genet. 25:143-144(2000).
RN   [32]
RP   VARIANT PKD2 TRP-322, AND VARIANTS LEU-24; PRO-28 AND LEU-800.
RX   PubMed=11968093; DOI=10.1002/humu.9035;
RA   Reiterova J., Stekrova J., Peters D.J.M., Kapras J., Kohoutova M.,
RA   Merta M., Zidovska J.;
RT   "Four novel mutations of the PKD2 gene in Czech families with
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 19:573-573(2002).
RN   [33]
RP   VARIANTS PKD2 PRO-356; GLY-414; ARG-632 AND GLN-807.
RX   PubMed=12707387; DOI=10.1097/01.ASN.0000061774.90975.25;
RA   Magistroni R., He N., Wang K., Andrew R., Johnson A., Gabow P.,
RA   Dicks E., Parfrey P., Torra R., San-Millan J.L., Coto E., Van Dijk M.,
RA   Breuning M., Peters D., Bogdanova N., Ligabue G., Albertazzi A.,
RA   Hateboer N., Demetriou K., Pierides A., Deltas C.,
RA   St George-Hyslop P., Ravine D., Pei Y.;
RT   "Genotype-renal function correlation in type 2 autosomal dominant
RT   polycystic kidney disease.";
RL   J. Am. Soc. Nephrol. 14:1164-1174(2003).
RN   [34]
RP   VARIANTS PKD2 GLN-306 AND GLY-420, AND VARIANT PRO-28.
RX   PubMed=14993477; DOI=10.1093/ndt/gfh083;
RA   Stekrova J., Reiterova J., Merta M., Damborsky J., Zidovska J.,
RA   Kebrdlova V., Kohoutova M.;
RT   "PKD2 mutations in a Czech population with autosomal dominant
RT   polycystic kidney disease.";
RL   Nephrol. Dial. Transplant. 19:1116-1122(2004).
RN   [35]
RP   VARIANT PKD2 GLN-322.
RX   PubMed=15772804; DOI=10.1007/s00109-005-0644-6;
RA   Peltola P., Lumiaho A., Miettinen R., Pihlajamaeki J., Sandford R.,
RA   Laakso M.;
RT   "Genetics and phenotypic characteristics of autosomal dominant
RT   polycystic kidney disease in Finns.";
RL   J. Mol. Med. 83:638-646(2005).
RN   [36]
RP   VARIANTS PRO-28; THR-190 AND CYS-482.
RX   PubMed=18837007; DOI=10.1002/humu.20842;
RA   Tan Y.-C., Blumenfeld J.D., Anghel R., Donahue S., Belenkaya R.,
RA   Balina M., Parker T., Levine D., Leonard D.G.B., Rennert H.;
RT   "Novel method for genomic analysis of PKD1 and PKD2 mutations in
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 30:264-273(2009).
RN   [37]
RP   VARIANT PKD2 PRO-384.
RX   PubMed=21115670; DOI=10.1093/ndt/gfq720;
RA   Hoefele J., Mayer K., Scholz M., Klein H.G.;
RT   "Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney
RT   disease (ADPKD).";
RL   Nephrol. Dial. Transplant. 26:2181-2188(2011).
CC   -!- FUNCTION: Functions as a cation channel involved in fluid-flow
CC       mechanosensation by the primary cilium in renal epithelium
CC       (PubMed:18695040). Functions as outward-rectifying K(+) channel,
CC       but is also permeable to Ca(2+), and to a much lesser degree also
CC       to Na(+) (PubMed:11854751, PubMed:15692563, PubMed:27071085,
CC       PubMed:27991905). May contribute to the release of Ca(2+) stores
CC       from the endoplasmic reticulum (PubMed:11854751, PubMed:20881056).
CC       Together with TRPV4, forms mechano- and thermosensitive channels
CC       in cilium (PubMed:18695040). PKD1 and PKD2 may function through a
CC       common signaling pathway that is necessary to maintain the normal,
CC       differentiated state of renal tubule cells. Acts as a regulator of
CC       cilium length, together with PKD1. The dynamic control of cilium
CC       length is essential in the regulation of mechanotransductive
CC       signaling. The cilium length response creates a negative feedback
CC       loop whereby fluid shear-mediated deflection of the primary
CC       cilium, which decreases intracellular cAMP, leads to cilium
CC       shortening and thus decreases flow-induced signaling. Also
CC       involved in left-right axis specification via its role in sensing
CC       nodal flow; forms a complex with PKD1L1 in cilia to facilitate
CC       flow detection in left-right patterning. Detection of asymmetric
CC       nodal flow gives rise to a Ca(2+) signal that is required for
CC       normal, asymmetric expression of genes involved in the
CC       specification of body left-right laterality (By similarity).
CC       {ECO:0000250|UniProtKB:O35245, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27991905, ECO:0000305}.
CC   -!- ENZYME REGULATION: Channnel activity is regulated by
CC       phosphorylation (PubMed:16551655, PubMed:20881056,
CC       PubMed:26269590). Channnel activity is regulated by intracellular
CC       Ca(2+) (PubMed:11854751). {ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:16551655, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:26269590}.
CC   -!- SUBUNIT: Homotetramer (PubMed:20881056, PubMed:27768895,
CC       PubMed:27991905, PubMed:28092368). Interacts with PKD1, giving
CC       rise to a complex formed by one PKD1 chain and a PKD2 homooligomer
CC       (PubMed:20881056, PubMed:19556541). In vitro results suggest
CC       assembly of a complex composed of one PKD1 chain and a PKD2
CC       trimer; the physiological significance of this is uncertain
CC       (PubMed:19556541). Isoform 1 interacts with PKD1 while isoform 3
CC       does not (By similarity). Interacts with PKD1L1. PKD1 requires the
CC       presence of PKD2 for stable expression (By similarity). Interacts
CC       with CD2AP (PubMed:10913159). Interacts with HAX1
CC       (PubMed:10760273). Interacts with NEK8 (By similarity). Part of a
CC       complex containing AKAP5, ADCY5, ADCY6 and PDE4C (By similarity).
CC       Interacts (via C-terminus) with TRPV4 (via C-terminus)
CC       (PubMed:18695040). Interacts (via C-terminal acidic region) with
CC       PACS1 and PACS2; these interactions retain the protein in the
CC       endoplasmic reticulum and prevent trafficking to the cell membrane
CC       (PubMed:15692563). {ECO:0000250|UniProtKB:O35245,
CC       ECO:0000269|PubMed:10760273, ECO:0000269|PubMed:10913159,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:18695040,
CC       ECO:0000269|PubMed:19556541, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}.
CC   -!- INTERACTION:
CC       Self; NbExp=8; IntAct=EBI-7813714, EBI-7813714;
CC       O35387:Hax1 (xeno); NbExp=3; IntAct=EBI-7813714, EBI-642449;
CC       Q02363:ID2; NbExp=7; IntAct=EBI-7813714, EBI-713450;
CC       Q91908:itpr1 (xeno); NbExp=2; IntAct=EBI-7813714, EBI-9633447;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-7813714, EBI-10171697;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-7813714, EBI-10171774;
CC       P43361:MAGEA8; NbExp=3; IntAct=EBI-7813714, EBI-10182930;
CC       P98161:PKD1; NbExp=8; IntAct=EBI-7813714, EBI-1752013;
CC       P98161-3:PKD1; NbExp=4; IntAct=EBI-9837017, EBI-15930070;
CC       O08852:Pkd1 (xeno); NbExp=2; IntAct=EBI-9837017, EBI-6666305;
CC       O15162:PLSCR1; NbExp=3; IntAct=EBI-7813714, EBI-740019;
CC       J9P3Y7:RYR2 (xeno); NbExp=2; IntAct=EBI-9837017, EBI-15630134;
CC       P48995:TRPC1; NbExp=3; IntAct=EBI-7813714, EBI-929665;
CC       P48995-2:TRPC1; NbExp=4; IntAct=EBI-7813714, EBI-9830970;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27259053}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10760273, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:28092368, ECO:0000305|PubMed:10913159}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:27768895,
CC       ECO:0000269|PubMed:27991905, ECO:0000269|PubMed:28092368}. Cell
CC       membrane {ECO:0000269|PubMed:15692563,
CC       ECO:0000269|PubMed:19556541, ECO:0000269|PubMed:26269590,
CC       ECO:0000269|PubMed:27071085, ECO:0000269|PubMed:27259053,
CC       ECO:0000269|PubMed:28092368}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:10770959}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:10770959}. Note=Retained in the endoplasmic
CC       reticulum by interaction with PACS1 and PACS2 (PubMed:15692563).
CC       Detected on kidney tubule basolateral membranes and basal
CC       cytoplasmic vesicles (PubMed:10770959). Cell surface and cilium
CC       localization requires GANAB (PubMed:27259053).
CC       {ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:27259053}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q13563-1; Sequence=Displayed;
CC       Name=2; Synonyms=delta6;
CC         IsoId=Q13563-2; Sequence=VSP_042479, VSP_042480;
CC       Name=3; Synonyms=delta7;
CC         IsoId=Q13563-3; Sequence=VSP_042481;
CC       Name=4; Synonyms=delta9;
CC         IsoId=Q13563-4; Sequence=VSP_042482, VSP_042483;
CC       Name=5; Synonyms=delta12/13;
CC         IsoId=Q13563-5; Sequence=VSP_042484;
CC         Note=Minor isoform.;
CC   -!- TISSUE SPECIFICITY: Detected in fetal and adult kidney
CC       (PubMed:10770959). Detected at the thick ascending limb of the
CC       loop of Henle, at distal tubules, including the distal convoluted
CC       tubule and cortical collecting tubules, with weak staining of the
CC       collecting duct (PubMed:10770959). Detected on placenta
CC       syncytiotrophoblasts (at protein level) (PubMed:26269590).
CC       Strongly expressed in ovary, fetal and adult kidney, testis, and
CC       small intestine. Not detected in peripheral leukocytes.
CC       {ECO:0000269|PubMed:10770959, ECO:0000269|PubMed:26269590,
CC       ECO:0000269|PubMed:8650545}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is involved in
CC       oligomerization and the interaction with PKD1 (PubMed:18694932,
CC       PubMed:19556541). The isolated coiled-coil domain forms a
CC       homotrimer in vitro; the homotrimer interacts with a single PKD1
CC       chain (PubMed:19556541). The coiled-coil domain binds calcium and
CC       undergoes a calcium-induced conformation change (in vitro)
CC       (PubMed:18694932). {ECO:0000269|PubMed:18694932,
CC       ECO:0000269|PubMed:19556541}.
CC   -!- PTM: Phosphorylated. Phosphorylation is important for protein
CC       function; a mutant that lacks the N-terminal phosphorylation sites
CC       cannot complement a zebrafish pkd2-deficient mutant
CC       (PubMed:16551655). PKD-mediated phosphorylation at the C-terminus
CC       regulates its function in the release of Ca(2+) stores from the
CC       endoplasmic reticulum (PubMed:20881056). PKA-mediated
CC       phosphorylation at a C-terminal site strongly increases the open
CC       probability of the channel, but does not increase single channel
CC       conductance (PubMed:26269590). {ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:20881056, ECO:0000269|PubMed:26269590}.
CC   -!- PTM: N-glycosylated. The four subunits in a tetramer probably
CC       differ in the extent of glycosylation; simultaneous glycosylation
CC       of all experimentally validated sites would probably create steric
CC       hindrance. Thus, glycosylation at Asn-305 is not compatible with
CC       glycosylation at Asn-328; only one of these two residues is
CC       glycosylated at a given time. {ECO:0000269|PubMed:28092368}.
CC   -!- DISEASE: Polycystic kidney disease 2 (PKD2) [MIM:613095]: A
CC       disorder characterized by progressive formation and enlargement of
CC       cysts in both kidneys, typically leading to end-stage renal
CC       disease in adult life. Cysts also occurs in the liver and other
CC       organs. It represents approximately 15% of the cases of autosomal
CC       dominant polycystic kidney disease. PKD2 is clinically milder than
CC       PKD1 but it has a deleterious impact on overall life expectancy.
CC       {ECO:0000269|PubMed:10411676, ECO:0000269|PubMed:10541293,
CC       ECO:0000269|PubMed:10835625, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:11968093, ECO:0000269|PubMed:12707387,
CC       ECO:0000269|PubMed:14993477, ECO:0000269|PubMed:15772804,
CC       ECO:0000269|PubMed:21115670, ECO:0000269|PubMed:27071085,
CC       ECO:0000269|PubMed:9326320}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The mechanisms that govern channel opening are
CC       complex and still under debate; heterologous expression of PKD2 by
CC       itself or together with PKD1 gives rise to very low or
CC       undetectable spontaneous ion channel activity, in spite of its
CC       presence at the cell membrane. {ECO:0000269|PubMed:19556541,
CC       ECO:0000269|PubMed:27768895}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Polycystin 2 - Not a C-type lectin;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_205";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U50928; AAC50520.1; -; mRNA.
DR   EMBL; AF004873; AAC16004.1; -; Genomic_DNA.
DR   EMBL; AF004859; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004860; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004861; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004862; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004863; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004864; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004865; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004866; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004867; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004868; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004869; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004870; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004871; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004872; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; BC112261; AAI12262.1; -; mRNA.
DR   EMBL; BC112263; AAI12264.1; -; mRNA.
DR   EMBL; U56813; AAC50933.1; -; mRNA.
DR   CCDS; CCDS3627.1; -. [Q13563-1]
DR   PIR; G02640; G02640.
DR   RefSeq; NP_000288.1; NM_000297.3. [Q13563-1]
DR   UniGene; Hs.181272; -.
DR   PDB; 2KLD; NMR; -; A=680-796.
DR   PDB; 2KLE; NMR; -; A=680-796.
DR   PDB; 2KQ6; NMR; -; A=720-797.
DR   PDB; 2Y4Q; NMR; -; A=717-792.
DR   PDB; 3HRN; X-ray; 1.90 A; A=833-895.
DR   PDB; 3HRO; X-ray; 1.90 A; A=833-872.
DR   PDB; 5K47; EM; 4.20 A; A/B/C/D=185-723.
DR   PDB; 5MKE; EM; 4.30 A; A/B/C/D=1-968.
DR   PDB; 5MKF; EM; 4.20 A; A/B/C/D=1-968.
DR   PDB; 5T4D; EM; 3.00 A; A/B/C/D=198-702.
DR   PDBsum; 2KLD; -.
DR   PDBsum; 2KLE; -.
DR   PDBsum; 2KQ6; -.
DR   PDBsum; 2Y4Q; -.
DR   PDBsum; 3HRN; -.
DR   PDBsum; 3HRO; -.
DR   PDBsum; 5K47; -.
DR   PDBsum; 5MKE; -.
DR   PDBsum; 5MKF; -.
DR   PDBsum; 5T4D; -.
DR   ProteinModelPortal; Q13563; -.
DR   SMR; Q13563; -.
DR   BioGrid; 111328; 44.
DR   CORUM; Q13563; -.
DR   DIP; DIP-47455N; -.
DR   ELM; Q13563; -.
DR   IntAct; Q13563; 25.
DR   MINT; MINT-6618167; -.
DR   STRING; 9606.ENSP00000237596; -.
DR   BindingDB; Q13563; -.
DR   GuidetoPHARMACOLOGY; 504; -.
DR   TCDB; 1.A.5.2.1; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q13563; -.
DR   PhosphoSitePlus; Q13563; -.
DR   BioMuta; PKD2; -.
DR   DMDM; 116242717; -.
DR   MaxQB; Q13563; -.
DR   PaxDb; Q13563; -.
DR   PeptideAtlas; Q13563; -.
DR   PRIDE; Q13563; -.
DR   DNASU; 5311; -.
DR   Ensembl; ENST00000237596; ENSP00000237596; ENSG00000118762. [Q13563-1]
DR   GeneID; 5311; -.
DR   KEGG; hsa:5311; -.
DR   UCSC; uc003hre.4; human. [Q13563-1]
DR   CTD; 5311; -.
DR   DisGeNET; 5311; -.
DR   EuPathDB; HostDB:ENSG00000118762.7; -.
DR   GeneCards; PKD2; -.
DR   GeneReviews; PKD2; -.
DR   HGNC; HGNC:9009; PKD2.
DR   HPA; CAB004544; -.
DR   HPA; HPA015794; -.
DR   MalaCards; PKD2; -.
DR   MIM; 173910; gene.
DR   MIM; 613095; phenotype.
DR   neXtProt; NX_Q13563; -.
DR   OpenTargets; ENSG00000118762; -.
DR   Orphanet; 730; Autosomal dominant polycystic kidney disease.
DR   PharmGKB; PA33343; -.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   InParanoid; Q13563; -.
DR   KO; K04986; -.
DR   OMA; QAWSRDN; -.
DR   OrthoDB; EOG091G034F; -.
DR   PhylomeDB; Q13563; -.
DR   TreeFam; TF316484; -.
DR   Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium.
DR   SIGNOR; Q13563; -.
DR   ChiTaRS; PKD2; human.
DR   EvolutionaryTrace; Q13563; -.
DR   GeneWiki; Polycystic_kidney_disease_2; -.
DR   GenomeRNAi; 5311; -.
DR   PRO; PR:Q13563; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000118762; -.
DR   CleanEx; HS_PKD2; -.
DR   ExpressionAtlas; Q13563; baseline and differential.
DR   Genevisible; Q13563; HS.
DR   GO; GO:0045180; C:basal cortex; IDA:BHF-UCL.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0036064; C:ciliary basal body; IDA:MGI.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0071458; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:BHF-UCL.
DR   GO; GO:0072686; C:mitotic spindle; IDA:BHF-UCL.
DR   GO; GO:0031514; C:motile cilium; ISS:BHF-UCL.
DR   GO; GO:0097730; C:non-motile cilium; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0002133; C:polycystin complex; ISS:BHF-UCL.
DR   GO; GO:0042805; F:actinin binding; IDA:BHF-UCL.
DR   GO; GO:0051117; F:ATPase binding; ISS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL.
DR   GO; GO:0043398; F:HLH domain binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IEA:Ensembl.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:BHF-UCL.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:BHF-UCL.
DR   GO; GO:0035904; P:aorta development; IEP:UniProtKB.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:BHF-UCL.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:UniProtKB.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IMP:BHF-UCL.
DR   GO; GO:0071464; P:cellular response to hydrostatic pressure; IDA:BHF-UCL.
DR   GO; GO:0071470; P:cellular response to osmotic stress; IDA:BHF-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; NAS:BHF-UCL.
DR   GO; GO:0051298; P:centrosome duplication; NAS:BHF-UCL.
DR   GO; GO:0042994; P:cytoplasmic sequestering of transcription factor; IMP:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; ISS:BHF-UCL.
DR   GO; GO:0003127; P:detection of nodal flow; ISS:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL.
DR   GO; GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0001892; P:embryonic placenta development; ISS:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IEP:UniProtKB.
DR   GO; GO:0001947; P:heart looping; IMP:BHF-UCL.
DR   GO; GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEP:UniProtKB.
DR   GO; GO:0072177; P:mesonephric duct development; IEP:UniProtKB.
DR   GO; GO:0072164; P:mesonephric tubule development; IEP:UniProtKB.
DR   GO; GO:0072218; P:metanephric ascending thin limb development; IEP:UniProtKB.
DR   GO; GO:0072214; P:metanephric cortex development; IEP:UniProtKB.
DR   GO; GO:0072219; P:metanephric cortical collecting duct development; IEP:UniProtKB.
DR   GO; GO:0072235; P:metanephric distal tubule development; IEP:UniProtKB.
DR   GO; GO:0072075; P:metanephric mesenchyme development; IEP:UniProtKB.
DR   GO; GO:0035502; P:metanephric part of ureteric bud development; IEP:UniProtKB.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072208; P:metanephric smooth muscle tissue development; IEP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; NAS:BHF-UCL.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL.
DR   GO; GO:0021915; P:neural tube development; IEP:UniProtKB.
DR   GO; GO:0060674; P:placenta blood vessel development; ISS:BHF-UCL.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; IMP:BHF-UCL.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0031587; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IMP:BHF-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0030814; P:regulation of cAMP metabolic process; ISS:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:0061441; P:renal artery morphogenesis; IEP:UniProtKB.
DR   GO; GO:0061333; P:renal tubule morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0021510; P:spinal cord development; IEP:UniProtKB.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Cell projection; Ciliopathy; Cilium;
KW   Coiled coil; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Methylation; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    968       Polycystin-2.
FT                                /FTId=PRO_0000164356.
FT   TOPO_DOM      1    219       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    220    241       Helical; Name=S1.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    242    468       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    469    489       Helical; Name=S2.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    490    505       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    506    526       Helical; Name=S3.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    527    552       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    553    573       Helical; Name=S4.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    574    597       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    598    619       Helical; Name=5.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    620    631       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   INTRAMEM    632    646       Pore-forming.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    647    654       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    655    675       Helical; Name=S6.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    676    968       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   DOMAIN      750    785       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448,
FT                                ECO:0000269|PubMed:18694932,
FT                                ECO:0000269|PubMed:24990821}.
FT   CA_BIND     763    774       {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000255|PROSITE-ProRule:PRU00448,
FT                                ECO:0000269|PubMed:18694932,
FT                                ECO:0000269|PubMed:24990821}.
FT   REGION      803    822       Linker. {ECO:0000305|PubMed:18694932}.
FT   REGION      810    821       Important for interaction with PACS1 and
FT                                PACS2. {ECO:0000269|PubMed:15692563}.
FT   COILED      833    872       {ECO:0000269|PubMed:19556541,
FT                                ECO:0000305|PubMed:18694932}.
FT   MOTIF       641    643       Selectivity filter.
FT                                {ECO:0000305|PubMed:28092368}.
FT   COMPBIAS     95    107       Poly-Glu.
FT   COMPBIAS    153    157       Poly-Arg.
FT   METAL       763    763       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       765    765       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       767    767       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       769    769       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       774    774       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MOD_RES      80     80       Phosphoserine.
FT                                {ECO:0000305|PubMed:16551655}.
FT   MOD_RES     137    137       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35245}.
FT   MOD_RES     801    801       Phosphoserine.
FT                                {ECO:0000269|PubMed:20881056,
FT                                ECO:0000305|PubMed:16551655}.
FT   MOD_RES     808    808       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35245}.
FT   MOD_RES     812    812       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000305|PubMed:15692563,
FT                                ECO:0000305|PubMed:16551655}.
FT   MOD_RES     829    829       Phosphoserine.
FT                                {ECO:0000305|PubMed:26269590}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    362    362       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    375    375       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   DISULFID    331    344       {ECO:0000244|PDB:5MKF,
FT                                ECO:0000244|PDB:5T4D,
FT                                ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:28092368}.
FT   VAR_SEQ     476    483       CEIIFCFF -> FICSSYGD (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042479.
FT   VAR_SEQ     484    968       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_042480.
FT   VAR_SEQ     517    572       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_042481.
FT   VAR_SEQ     633    646       IFTQFRIILGDINF -> IICSWRSSMIRTLK (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_042482.
FT   VAR_SEQ     647    968       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_042483.
FT   VAR_SEQ     748    841       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_042484.
FT   VARIANT      24     24       P -> L (in dbSNP:rs1004860210).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058820.
FT   VARIANT      28     28       R -> P (common polymorphism;
FT                                dbSNP:rs1805044).
FT                                {ECO:0000269|PubMed:10411676,
FT                                ECO:0000269|PubMed:11968093,
FT                                ECO:0000269|PubMed:14993477,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_011072.
FT   VARIANT     190    190       A -> T (in dbSNP:rs117078377).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058821.
FT   VARIANT     306    306       R -> Q (in PKD2; dbSNP:rs990932947).
FT                                {ECO:0000269|PubMed:14993477}.
FT                                /FTId=VAR_058822.
FT   VARIANT     322    322       R -> Q (in PKD2; dbSNP:rs145877597).
FT                                {ECO:0000269|PubMed:15772804}.
FT                                /FTId=VAR_058823.
FT   VARIANT     322    322       R -> W (in PKD2).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058824.
FT   VARIANT     356    356       A -> P (in PKD2).
FT                                {ECO:0000269|PubMed:10411676,
FT                                ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_011073.
FT   VARIANT     384    384       A -> P (in PKD2).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064394.
FT   VARIANT     414    414       W -> G (in PKD2; affects channel activity
FT                                as it is able to abolish channel currents
FT                                induced by the gain-of-function
FT                                artificial mutant P-604).
FT                                {ECO:0000269|PubMed:12707387,
FT                                ECO:0000269|PubMed:27071085,
FT                                ECO:0000269|PubMed:9326320}.
FT                                /FTId=VAR_009195.
FT   VARIANT     420    420       R -> G (in PKD2; affects channel activity
FT                                as it is able to abolish channel currents
FT                                induced by the gain-of-function
FT                                artificial mutant P-604).
FT                                {ECO:0000269|PubMed:14993477,
FT                                ECO:0000269|PubMed:27071085}.
FT                                /FTId=VAR_058825.
FT   VARIANT     452    452       I -> V (in dbSNP:rs1801612).
FT                                /FTId=VAR_014919.
FT   VARIANT     479    479       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011074.
FT   VARIANT     482    482       F -> C (in dbSNP:rs75762896).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058826.
FT   VARIANT     504    512       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011075.
FT   VARIANT     511    511       D -> V (in PKD2; loss of function in the
FT                                release of Ca(2+) stores from the
FT                                endoplasmic reticulum; no effect on
FT                                location at the endoplasmic reticulum;
FT                                affects channel activity as it is able to
FT                                abolish channel currents induced by the
FT                                gain-of-function artificial mutant P-604;
FT                                dbSNP:rs121918043).
FT                                {ECO:0000269|PubMed:10541293,
FT                                ECO:0000269|PubMed:11854751,
FT                                ECO:0000269|PubMed:27071085}.
FT                                /FTId=VAR_058827.
FT   VARIANT     632    632       C -> R (in PKD2).
FT                                {ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_058828.
FT   VARIANT     684    684       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011076.
FT   VARIANT     800    800       M -> L (in dbSNP:rs2234917).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058829.
FT   VARIANT     807    807       R -> Q (in PKD2; dbSNP:rs147654263).
FT                                {ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_058830.
FT   MUTAGEN      76     76       S->A: Abolishes phosphorylation of the N-
FT                                terminal domain. Abolishes the ability to
FT                                complement a pkd2-deficient zebrafish
FT                                mutant; when associated with A-80.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN      80     80       S->A: Decreases phosphorylation of the N-
FT                                terminal domain. Abolishes the ability to
FT                                complement a pkd2-deficient zebrafish
FT                                mutant; when associated with A-76.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     604    604       F->A,I: No effect on channel activation.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     604    604       F->P: Gain-of-function mutation resulting
FT                                in increased channel activity. Absence of
FT                                gain of function; when associated with F-
FT                                605 DEL; when associated with V-511; when
FT                                associated with G-414; when associated
FT                                with G-420. Increased channel activity;
FT                                when associated with 736-L-N-737 DEL.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     605    605       Missing: Abolishes increased channel
FT                                activity due to a gain of function
FT                                mutation; when associated with P-604.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     721    721       T->A: Decreases phosphorylation; when
FT                                associated with A-801; A-812; A-831 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     736    737       Missing: Increased channel activity; when
FT                                associated with P-604.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     768    768       Q->G: Strongly increases calcium binding
FT                                affinity. {ECO:0000269|PubMed:24990821}.
FT   MUTAGEN     771    771       T->A: Loss of calcium-binding site; when
FT                                associated with A-774.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     774    774       E->A: Loss of calcium-binding site; when
FT                                associated with A-771.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     774    774       E->Q: Abolishes calcium binding via the
FT                                EF-hand. {ECO:0000269|PubMed:24990821}.
FT   MUTAGEN     801    801       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-812; A-831 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     801    801       S->D: Phosphomimetic mutant. No effect on
FT                                release of Ca(2+) stores from the
FT                                endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     801    801       S->G: Loss of phosphorylation at this
FT                                site. Impairs release of Ca(2+) stores
FT                                from the endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     804    804       S->N: Loss of phosphorylation at Ser-801.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     812    812       S->A: Decreases interaction with PACS1
FT                                and enhances expression at the cell
FT                                membrane. Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-831 and
FT                                A-943. {ECO:0000269|PubMed:15692563,
FT                                ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     812    812       S->D: No effect on interaction with
FT                                PACS1. {ECO:0000269|PubMed:15692563}.
FT   MUTAGEN     815    817       DDD->AAA: Strongly decreases interaction
FT                                with PACS1 and enhances expression at the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:15692563}.
FT   MUTAGEN     829    829       S->A: Abolishes increased channel opening
FT                                in response to cAMP and phosphorylation
FT                                by PKA. {ECO:0000269|PubMed:26269590}.
FT   MUTAGEN     831    831       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-812 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     842    842       L->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-846; A-849; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     842    842       L->P: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     846    846       V->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-849; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     846    846       V->E: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     849    849       M->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     849    849       M->K: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     853    853       I->P: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     856    856       I->K: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     860    860       I->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     863    863       V->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-860 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     863    863       V->E: Loss of protein solubility; when
FT                                associated with K-849.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     867    867       L->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-860 and A-
FT                                863. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     943    943       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-812 and
FT                                A-831. {ECO:0000269|PubMed:16551655}.
FT   CONFLICT     45     45       G -> R (in Ref. 2; AAC16004).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       G -> V (in Ref. 4; AAC50933).
FT                                {ECO:0000305}.
FT   HELIX       217    241       {ECO:0000244|PDB:5T4D}.
FT   HELIX       246    257       {ECO:0000244|PDB:5T4D}.
FT   HELIX       276    283       {ECO:0000244|PDB:5T4D}.
FT   HELIX       286    291       {ECO:0000244|PDB:5T4D}.
FT   STRAND      304    306       {ECO:0000244|PDB:5T4D}.
FT   TURN        310    312       {ECO:0000244|PDB:5T4D}.
FT   STRAND      313    326       {ECO:0000244|PDB:5T4D}.
FT   HELIX       328    330       {ECO:0000244|PDB:5T4D}.
FT   HELIX       335    337       {ECO:0000244|PDB:5T4D}.
FT   TURN        338    340       {ECO:0000244|PDB:5T4D}.
FT   TURN        350    352       {ECO:0000244|PDB:5T4D}.
FT   TURN        364    366       {ECO:0000244|PDB:5T4D}.
FT   TURN        371    373       {ECO:0000244|PDB:5T4D}.
FT   STRAND      390    394       {ECO:0000244|PDB:5T4D}.
FT   HELIX       399    411       {ECO:0000244|PDB:5T4D}.
FT   STRAND      419    430       {ECO:0000244|PDB:5T4D}.
FT   TURN        431    434       {ECO:0000244|PDB:5T4D}.
FT   STRAND      435    444       {ECO:0000244|PDB:5T4D}.
FT   STRAND      452    460       {ECO:0000244|PDB:5T4D}.
FT   HELIX       468    491       {ECO:0000244|PDB:5T4D}.
FT   HELIX       506    527       {ECO:0000244|PDB:5T4D}.
FT   TURN        528    530       {ECO:0000244|PDB:5T4D}.
FT   HELIX       533    540       {ECO:0000244|PDB:5T4D}.
FT   HELIX       549    571       {ECO:0000244|PDB:5T4D}.
FT   HELIX       572    579       {ECO:0000244|PDB:5T4D}.
FT   HELIX       581    618       {ECO:0000244|PDB:5T4D}.
FT   STRAND      619    622       {ECO:0000244|PDB:5T4D}.
FT   HELIX       624    626       {ECO:0000244|PDB:5T4D}.
FT   HELIX       629    641       {ECO:0000244|PDB:5T4D}.
FT   HELIX       647    652       {ECO:0000244|PDB:5T4D}.
FT   HELIX       656    669       {ECO:0000244|PDB:5T4D}.
FT   TURN        670    672       {ECO:0000244|PDB:5T4D}.
FT   HELIX       673    692       {ECO:0000244|PDB:5T4D}.
FT   TURN        730    734       {ECO:0000244|PDB:2KLD}.
FT   HELIX       738    744       {ECO:0000244|PDB:2KLD}.
FT   TURN        745    747       {ECO:0000244|PDB:2KLD}.
FT   HELIX       752    762       {ECO:0000244|PDB:2KLD}.
FT   STRAND      763    766       {ECO:0000244|PDB:2KLD}.
FT   STRAND      767    771       {ECO:0000244|PDB:2Y4Q}.
FT   HELIX       773    777       {ECO:0000244|PDB:2KLD}.
FT   TURN        781    783       {ECO:0000244|PDB:2KLD}.
FT   STRAND      793    795       {ECO:0000244|PDB:2KQ6}.
FT   HELIX       836    894       {ECO:0000244|PDB:3HRN}.
SQ   SEQUENCE   968 AA;  109691 MW;  F8D2E760EBEA8B47 CRC64;
     MVNSSRVQPQ QPGDAKRPPA PRAPDPGRLM AGCAAVGASL AAPGGLCEQR GLEIEMQRIR
     QAAARDPPAG AAASPSPPLS SCSRQAWSRD NPGFEAEEEE EEVEGEEGGM VVEMDVEWRP
     GSRRSAASSA VSSVGARSRG LGGYHGAGHP SGRRRRREDQ GPPCPSPVGG GDPLHRHLPL
     EGQPPRVAWA ERLVRGLRGL WGTRLMEESS TNREKYLKSV LRELVTYLLF LIVLCILTYG
     MMSSNVYYYT RMMSQLFLDT PVSKTEKTNF KTLSSMEDFW KFTEGSLLDG LYWKMQPSNQ
     TEADNRSFIF YENLLLGVPR IRQLRVRNGS CSIPQDLRDE IKECYDVYSV SSEDRAPFGP
     RNGTAWIYTS EKDLNGSSHW GIIATYSGAG YYLDLSRTRE ETAAQVASLK KNVWLDRGTR
     ATFIDFSVYN ANINLFCVVR LLVEFPATGG VIPSWQFQPL KLIRYVTTFD FFLAACEIIF
     CFFIFYYVVE EILEIRIHKL HYFRSFWNCL DVVIVVLSVV AIGINIYRTS NVEVLLQFLE
     DQNTFPNFEH LAYWQIQFNN IAAVTVFFVW IKLFKFINFN RTMSQLSTTM SRCAKDLFGF
     AIMFFIIFLA YAQLAYLVFG TQVDDFSTFQ ECIFTQFRII LGDINFAEIE EANRVLGPIY
     FTTFVFFMFF ILLNMFLAII NDTYSEVKSD LAQQKAEMEL SDLIRKGYHK ALVKLKLKKN
     TVDDISESLR QGGGKLNFDE LRQDLKGKGH TDAEIEAIFT KYDQDGDQEL TEHEHQQMRD
     DLEKEREDLD LDHSSLPRPM SSRSFPRSLD DSEEDDDEDS GHSSRRRGSI SSGVSYEEFQ
     VLVRRVDRME HSIGSIVSKI DAVIVKLEIM ERAKLKRREV LGRLLDGVAE DERLGRDSEI
     HREQMERLVR EELERWESDD AASQISHGLG TPVGLNGQPR PRSSRPSSSQ STEGMEGAGG
     NGSSNVHV
//
ID   CAC1C_HUMAN             Reviewed;        2221 AA.
AC   Q13936; B2RUT3; E9PDJ0; Q13917; Q13918; Q13919; Q13920; Q13921;
AC   Q13922; Q13923; Q13924; Q13925; Q13926; Q13927; Q13928; Q13929;
AC   Q13930; Q13932; Q13933; Q14743; Q14744; Q15877; Q4VMI7; Q4VMI8;
AC   Q4VMI9; Q6PKM7; Q8N6C0; Q99025; Q99241; Q99875;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 4.
DT   22-NOV-2017, entry version 205.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
GN   Name=CACNA1C; Synonyms=CACH2, CACN2, CACNL1A1, CCHL1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1),
RP   AND VARIANTS VAL-1869 AND ARG-1893.
RC   TISSUE=Fetal fibroblast;
RX   PubMed=1316612; DOI=10.1073/pnas.89.10.4628;
RA   Soldatov N.M.;
RT   "Molecular diversity of L-type Ca2+ channel transcripts in human
RT   fibroblasts.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4628-4632(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 18 AND 28), NUCLEOTIDE SEQUENCE
RP   [GENOMIC DNA] OF 1822-1863, FUNCTION, TISSUE SPECIFICITY, AND VARIANT
RP   ARG-84.
RC   TISSUE=Heart;
RX   PubMed=8392192; DOI=10.1073/pnas.90.13.6228;
RA   Schultz D., Mikala G., Yatani A., Engle D.B., Iles D.E., Segers B.,
RA   Sinke R.J., Weghuis D.O., Kloeckner U., Wakamori M., Wang J.-J.,
RA   Melvin D., Varadi G., Schwartz A.;
RT   "Cloning, chromosomal localization, and functional expression of the
RT   alpha-1 subunit of the L-type voltage-dependent calcium channel from
RT   normal human heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6228-6232(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1112-1803 (ISOFORMS 24/27), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1364-1972 (ISOFORMS 11/12/19/20/21/22/23/30/31/32).
RC   TISSUE=Hippocampus, and Lung fibroblast;
RX   PubMed=7959794; DOI=10.1006/geno.1994.1347;
RA   Soldatov N.M.;
RT   "Genomic structure of human L-type Ca2+ channel.";
RL   Genomics 22:77-87(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 12; 19 AND 20), ALTERNATIVE
RP   SPLICING, FUNCTION, AND MUTAGENESIS OF GLY-954 AND TYR-958.
RC   TISSUE=Fibroblast;
RX   PubMed=7737988; DOI=10.1074/jbc.270.18.10540;
RA   Soldatov N.M., Bouron A., Reuter H.;
RT   "Different voltage-dependent inhibition by dihydropyridines of human
RT   Ca2+ channel splice variants.";
RL   J. Biol. Chem. 270:10540-10543(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 16 AND 17),
RP   ALTERNATIVE SPLICING, AND VARIANTS ARG-84; VAL-1869 AND ARG-1893.
RC   TISSUE=Heart;
RX   PubMed=9087614;
RA   Kloeckner U., Mikala G., Eisfeld J., Iles D.E., Strobeck M.,
RA   Mershon J.L., Schwartz A., Varadi G.;
RT   "Properties of three COOH-terminal splice variants of a human cardiac
RT   L-type Ca2+-channel alpha1-subunit.";
RL   Am. J. Physiol. 272:H1372-H1381(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 26 AND 27), ALTERNATIVE SPLICING
RP   (ISOFORMS 9 AND 10), AND FUNCTION.
RC   TISSUE=Hippocampus;
RX   PubMed=9013606; DOI=10.1074/jbc.272.6.3560;
RA   Soldatov N.M., Zuelke R.D., Bouron A., Reuter H.;
RT   "Molecular structures involved in L-type calcium channel inactivation.
RT   Role of the carboxyl-terminal region encoded by exons 40-42 in alpha1C
RT   subunit in the kinetics and Ca2+ dependence of inactivation.";
RL   J. Biol. Chem. 272:3560-3566(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 21; 22 AND 23), AND FUNCTION.
RX   PubMed=9607315; DOI=10.1016/S0014-5793(98)00425-6;
RA   Zuehlke R.D., Bouron A., Soldatov N.M., Reuter H.;
RT   "Ca2+ channel sensitivity towards the blocker isradipine is affected
RT   by alternative splicing of the human alpha1C subunit gene.";
RL   FEBS Lett. 427:220-224(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Intestinal smooth muscle;
RX   PubMed=12176756; DOI=10.1152/ajpcell.00140.2002;
RA   Lyford G.L., Strege P.R., Shepard A., Ou Y., Ermilov L., Miller S.M.,
RA   Gibbons S.J., Rae J.L., Szurszewski J.H., Farrugia G.;
RT   "Alpha(1C) (Ca(V)1.2) L-type calcium channel mediates mechanosensitive
RT   calcium regulation.";
RL   Am. J. Physiol. 283:C1001-C1008(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 13; 14; 15; 24 AND 25), FUNCTION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=17071743; DOI=10.1073/pnas.0606539103;
RA   Tiwari S., Zhang Y., Heller J., Abernethy D.R., Soldatov N.M.;
RT   "Atherosclerosis-related molecular alteration of the human CaV1.2
RT   calcium channel alpha1C subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17024-17029(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 11; 28; 29; 30; 31; 32 AND 33),
RP   ALTERNATIVE SPLICING, AND VARIANTS ARG-84; VAL-1869 AND ARG-1893.
RA   Soldatov N.;
RT   "Functional expression of splice variants of human l-type calcium
RT   channel (isoform 1 gene).";
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 35).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-180 (ISOFORM 34).
RX   PubMed=11741969; DOI=10.1074/jbc.C100642200;
RA   Blumenstein Y., Kanevsky N., Sahar G., Barzilai R., Ivanina T.,
RA   Dascal N.;
RT   "A novel long N-terminal isoform of human L-type Ca2+ channel is up-
RT   regulated by protein kinase C.";
RL   J. Biol. Chem. 277:3419-3423(2002).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1182-1503 (ISOFORMS 6/12/20/23/24), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1182-1503 (ISOFORMS
RP   7/13/16/17/18/21/22).
RC   TISSUE=Heart;
RX   PubMed=2173707;
RA   Perez-Reyes E., Wei X., Castellano A., Birnbaumer L.;
RT   "Molecular diversity of L-type calcium channels. Evidence for
RT   alternative splicing of the transcripts of three non-allelic genes.";
RL   J. Biol. Chem. 265:20430-20436(1990).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1140-1206.
RC   TISSUE=Heart;
RX   PubMed=1653763; DOI=10.1016/0888-7543(91)90471-P;
RA   Powers P.A., Gregg R.G., Lalley P.A., Liao M., Hogan K.;
RT   "Assignment of the human gene for the alpha 1 subunit of the cardiac
RT   DHP-sensitive Ca2+ channel (CCHL1A1) to chromosome 12p12-pter.";
RL   Genomics 10:835-839(1991).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1196-1421.
RC   TISSUE=Brain;
RX   PubMed=1335957; DOI=10.1016/S0888-7543(05)80135-1;
RA   Sun W., McPherson J.D., Hoang D.Q., Wasmuth J.J., Evans G.A.,
RA   Montal M.;
RT   "Mapping of a human brain voltage-gated calcium channel to human
RT   chromosome 12p13-pter.";
RL   Genomics 14:1092-1094(1992).
RN   [17]
RP   MUTAGENESIS, CALCIUM-BINDING, AND SITE.
RX   PubMed=8099908;
RA   Tang S., Mikala G., Bahinski A., Yatani A., Varadi G., Schwartz A.;
RT   "Molecular localization of ion selectivity sites within the pore of a
RT   human L-type cardiac calcium channel.";
RL   J. Biol. Chem. 268:13026-13029(1993).
RN   [18]
RP   INTERACTION WITH CACNA2D4.
RX   PubMed=12181424; DOI=10.1124/mol.62.3.485;
RA   Qin N., Yagel S., Momplaisir M.-L., Codd E.E., D'Andrea M.R.;
RT   "Molecular cloning and characterization of the human voltage-gated
RT   calcium channel alpha(2)delta-4 subunit.";
RL   Mol. Pharmacol. 62:485-496(2002).
RN   [19]
RP   INTERACTION WITH CABP1.
RX   PubMed=15140941; DOI=10.1523/JNEUROSCI.5523-03.2004;
RA   Zhou H., Kim S.-A., Kirk E.A., Tippens A.L., Sun H., Haeseleer F.,
RA   Lee A.;
RT   "Ca2+-binding protein-1 facilitates and forms a postsynaptic complex
RT   with Cav1.2 (L-type) Ca2+ channels.";
RL   J. Neurosci. 24:4698-4708(2004).
RN   [20]
RP   INTERACTION WITH CABP1.
RX   PubMed=15980432; DOI=10.1074/jbc.M504167200;
RA   Zhou H., Yu K., McCoy K.L., Lee A.;
RT   "Molecular mechanism for divergent regulation of Cav1.2 Ca2+ channels
RT   by calmodulin and Ca2+-binding protein-1.";
RL   J. Biol. Chem. 280:29612-29619(2005).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 428-445 IN COMPLEX WITH
RP   CACNB2.
RX   PubMed=15141227; DOI=10.1038/nature02588;
RA   Van Petegem F., Clark K.A., Chatelain F.C., Minor D.L. Jr.;
RT   "Structure of a complex between a voltage-gated calcium channel beta-
RT   subunit and an alpha-subunit domain.";
RL   Nature 429:671-675(2004).
RN   [22]
RP   VARIANT TS ARG-406, AND CHARACTERIZATION OF VARIANT TS ARG-406.
RX   PubMed=15454078; DOI=10.1016/j.cell.2004.09.011;
RA   Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P.,
RA   Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K.,
RA   Tager-Flusberg H., Priori S.G., Sanguinetti M.C., Keating M.T.;
RT   "Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder
RT   including arrhythmia and autism.";
RL   Cell 119:19-31(2004).
RN   [23]
RP   VARIANT TS SER-402.
RX   PubMed=15863612; DOI=10.1073/pnas.0502506102;
RA   Splawski I., Timothy K.W., Decher N., Kumar P., Sachse F.B.,
RA   Beggs A.H., Sanguinetti M.C., Keating M.T.;
RT   "Severe arrhythmia disorder caused by cardiac L-type calcium channel
RT   mutations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8089-8096(2005).
RN   [24]
RP   VARIANTS BRGDA3 VAL-39 AND ARG-490, AND CHARACTERIZATION OF VARIANTS
RP   BRGDA3 VAL-39 AND ARG-490.
RX   PubMed=17224476; DOI=10.1161/CIRCULATIONAHA.106.668392;
RA   Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O.,
RA   Sanguinetti M.C., Aizawa Y., Guerchicoff A., Pfeiffer R., Oliva A.,
RA   Wollnik B., Gelber P., Bonaros E.P. Jr., Burashnikov E., Wu Y.,
RA   Sargent J.D., Schickel S., Oberheiden R., Bhatia A., Hsu L.F.,
RA   Haissaguerre M., Schimpf R., Borggrefe M., Wolpert C.;
RT   "Loss-of-function mutations in the cardiac calcium channel underlie a
RT   new clinical entity characterized by ST-segment elevation, short QT
RT   intervals, and sudden cardiac death.";
RL   Circulation 115:442-449(2007).
RN   [25]
RP   VARIANT ARG-878.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
RN   [26]
RP   VARIANTS TS SER-381; ILE-456; ASP-582; HIS-858 AND CYS-1831, AND
RP   CHARACTERIZATION OF VARIANTS TS SER-381; ILE-456; ASP-582; HIS-858 AND
RP   CYS-1831.
RX   PubMed=24728418; DOI=10.1093/europace/euu063;
RA   Fukuyama M., Wang Q., Kato K., Ohno S., Ding W.G., Toyoda F., Itoh H.,
RA   Kimura H., Makiyama T., Ito M., Matsuura H., Horie M.;
RT   "Long QT syndrome type 8: novel CACNA1C mutations causing QT
RT   prolongation and variant phenotypes.";
RL   Europace 16:1828-1837(2014).
RN   [27]
RP   VARIANTS TS CYS-518 AND HIS-518, AND CHARACTERIZATION OF VARIANTS TS
RP   CYS-518 AND HIS-518.
RX   PubMed=26253506; DOI=10.1161/CIRCEP.115.002745;
RA   Boczek N.J., Ye D., Jin F., Tester D.J., Huseby A., Bos J.M.,
RA   Johnson A.J., Kanter R., Ackerman M.J.;
RT   "Identification and functional characterization of a novel CACNA1C-
RT   mediated cardiac disorder characterized by prolonged QT intervals with
RT   hypertrophic cardiomyopathy, congenital heart defects, and sudden
RT   cardiac death.";
RL   Circ. Arrhythm. Electrophysiol. 8:1122-1132(2015).
RN   [28]
RP   VARIANT TS THR-1186, AND CHARACTERIZATION OF VARIANT TS THR-1186.
RX   PubMed=25260352; DOI=10.1016/j.hrthm.2014.09.051;
RA   Boczek N.J., Miller E.M., Ye D., Nesterenko V.V., Tester D.J.,
RA   Antzelevitch C., Czosek R.J., Ackerman M.J., Ware S.M.;
RT   "Novel Timothy syndrome mutation leading to increase in CACNA1C window
RT   current.";
RL   Heart Rhythm 12:211-219(2015).
RN   [29]
RP   VARIANTS TS THR-28; GLY-860; THR-1186; VAL-1186; MET-1523; LYS-1544;
RP   ILE-1800 MET-1953 AND ILE-2097, CHARACTERIZATION OF VARIANTS TS
RP   THR-28; GLY-860; THR-1186; VAL-1186; MET-1523 AND LYS-1544, AND
RP   VARIANTS ARG-37; THR-304; LYS-477; SER-817; THR-1365; ILE-1755;
RP   GLY-1765; ASN-1787; MET-1835; ALA-1843; LYS-1948; CYS-1972; GLN-2056;
RP   ASN-2081; GLY-2122 AND SER-2174.
RX   PubMed=25633834; DOI=10.1016/j.yjmcc.2015.01.002;
RA   Wemhoener K., Friedrich C., Stallmeyer B., Coffey A.J., Grace A.,
RA   Zumhagen S., Seebohm G., Ortiz-Bonnin B., Rinne S., Sachse F.B.,
RA   Schulze-Bahr E., Decher N.;
RT   "Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2)
RT   cause non-syndromic long-QT but not Timothy syndrome.";
RL   J. Mol. Cell. Cardiol. 80:186-195(2015).
RN   [30]
RP   VARIANT HIS-1159.
RX   PubMed=26637798; DOI=10.1016/j.neuron.2015.11.009;
RA   D'Gama A.M., Pochareddy S., Li M., Jamuar S.S., Reiff R.E., Lam A.T.,
RA   Sestan N., Walsh C.A.;
RT   "Targeted DNA Sequencing from Autism Spectrum Disorder Brains
RT   Implicates Multiple Genetic Mechanisms.";
RL   Neuron 88:910-917(2015).
RN   [31]
RP   VARIANTS GLU-850 DEL AND SER-2091, AND CHARACTERIZATION OF VARIANTS
RP   GLU-850 DEL AND SER-2091.
RX   PubMed=27218670; DOI=10.1111/chd.12371;
RA   Sutphin B.S., Boczek N.J., Barajas-Martinez H., Hu D., Ye D.,
RA   Tester D.J., Antzelevitch C., Ackerman M.J.;
RT   "Molecular and functional characterization of rare CACNA1C variants in
RT   sudden unexplained death in the young.";
RL   Congenit. Heart Dis. 11:683-692(2016).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1C
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing the alpha-1C subunit play an important
CC       role in excitation-contraction coupling in the heart. The various
CC       isoforms display marked differences in the sensitivity to DHP
CC       compounds. Binding of calmodulin or CABP1 at the same regulatory
CC       sites results in an opposit effects on the channel function.
CC       {ECO:0000269|PubMed:12176756, ECO:0000269|PubMed:17071743,
CC       ECO:0000269|PubMed:7737988, ECO:0000269|PubMed:8392192,
CC       ECO:0000269|PubMed:9013606, ECO:0000269|PubMed:9607315}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts with CACNA2D4. Interacts (via the N-terminus and the C-
CC       terminal C and IQ motifs) with CABP1. The binding via the C motif
CC       is calcium independent whereas the binding via IQ requires the
CC       presence of calcium and is mutually exclusive with calmodulin
CC       binding. The binding to the cytoplasmic N-terminal domain is
CC       calcium independent but is essential for the channel modulation.
CC       Interacts (via C-terminal CDB motif) with CABP5; in a calcium-
CC       dependent manner (By similarity). Interacts with CIB1; the
CC       interaction increases upon cardiomyocytes hypertrophy (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:12181424,
CC       ECO:0000269|PubMed:15140941, ECO:0000269|PubMed:15141227,
CC       ECO:0000269|PubMed:15980432}.
CC   -!- INTERACTION:
CC       Q9NZU7:CABP1; NbExp=4; IntAct=EBI-1038838, EBI-907894;
CC       Q9NZU7-2:CABP1; NbExp=2; IntAct=EBI-15896749, EBI-15896740;
CC       Q02641-1:CACNB1; NbExp=2; IntAct=EBI-1038838, EBI-15707950;
CC       Q08289-1:CACNB2; NbExp=4; IntAct=EBI-1038838, EBI-15707999;
CC       P54284:CACNB3; NbExp=2; IntAct=EBI-1038838, EBI-1184651;
CC       P62158:CALM3; NbExp=21; IntAct=EBI-1038838, EBI-397435;
CC       P62161:Calm3 (xeno); NbExp=2; IntAct=EBI-1038838, EBI-397530;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P15381};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P15381}. Cell
CC       membrane {ECO:0000250|UniProtKB:P15381}. Note=The interaction
CC       between RRAD and CACNB2 regulates its trafficking to the cell
CC       membrane. {ECO:0000250|UniProtKB:P15381}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=37;
CC         Comment=Additional isoforms seem to exist. Exons 8A, 21, 22, 31,
CC         32, 33, 40B, 43A, 41A and 45 are alternatively spliced in a
CC         variety of combinations. Experimental confirmation may be
CC         lacking for some isoforms.;
CC       Name=1; Synonyms=HFCC, Fibroblast;
CC         IsoId=Q13936-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13936-2; Sequence=VSP_000894;
CC       Name=3;
CC         IsoId=Q13936-3; Sequence=VSP_000886;
CC         Note=Contains exon 8a.;
CC       Name=4;
CC         IsoId=Q13936-4; Sequence=VSP_000887;
CC         Note=Lacks exon 21.;
CC       Name=5;
CC         IsoId=Q13936-5; Sequence=VSP_000888;
CC         Note=Lacks exon 22.;
CC       Name=6;
CC         IsoId=Q13936-6; Sequence=VSP_000889;
CC         Note=Lacks exon 31.;
CC       Name=7;
CC         IsoId=Q13936-7; Sequence=VSP_000890;
CC         Note=Lacks exon 32.;
CC       Name=8;
CC         IsoId=Q13936-8; Sequence=VSP_000891;
CC         Note=Lacks exon 33.;
CC       Name=9;
CC         IsoId=Q13936-9; Sequence=VSP_000892;
CC         Note=Contains exon 40B and 43A.;
CC       Name=10;
CC         IsoId=Q13936-10; Sequence=VSP_000893;
CC         Note=Contains exon 41A.;
CC       Name=11; Synonyms=Alpha-1C.90;
CC         IsoId=Q13936-11; Sequence=VSP_000895;
CC         Note=Lacks exon 45.;
CC       Name=12; Synonyms=Alpha-1C.70;
CC         IsoId=Q13936-12; Sequence=VSP_000888, VSP_000889, VSP_000895;
CC       Name=13; Synonyms=Alpha-1C.127;
CC         IsoId=Q13936-13; Sequence=VSP_000888, VSP_000890, VSP_000893,
CC                                   VSP_000895;
CC       Name=14; Synonyms=Alpha-1C.126;
CC         IsoId=Q13936-14; Sequence=VSP_000888, VSP_000889, VSP_022504,
CC                                   VSP_000893, VSP_000895;
CC       Name=15; Synonyms=Alpha-1C.125;
CC         IsoId=Q13936-15; Sequence=VSP_000888, VSP_000889, VSP_022503,
CC                                   VSP_000893, VSP_000895;
CC       Name=16;
CC         IsoId=Q13936-16; Sequence=VSP_000885, VSP_000886, VSP_000888,
CC                                   VSP_000890;
CC       Name=17;
CC         IsoId=Q13936-17; Sequence=VSP_000885, VSP_000886, VSP_000888,
CC                                   VSP_000890, VSP_000895;
CC       Name=18; Synonyms=HHT-1;
CC         IsoId=Q13936-18; Sequence=VSP_000885, VSP_000886, VSP_000888,
CC                                   VSP_000890, VSP_000894;
CC       Name=19; Synonyms=Alpha-1C.76;
CC         IsoId=Q13936-19; Sequence=VSP_000887, VSP_000889, VSP_000891,
CC                                   VSP_000895;
CC       Name=20; Synonyms=Alpha-1C.77;
CC         IsoId=Q13936-20; Sequence=VSP_000887, VSP_000889, VSP_000895;
CC         Note=Predominant isoform in atherosclerotic vascular smooth
CC         muscle cells.;
CC       Name=21; Synonyms=Alpha-1C.69;
CC         IsoId=Q13936-21; Sequence=VSP_000887, VSP_000890, VSP_000895;
CC       Name=22; Synonyms=Alpha-1C.78;
CC         IsoId=Q13936-22; Sequence=VSP_000888, VSP_000890, VSP_000895;
CC       Name=23; Synonyms=Alpha-1C.105;
CC         IsoId=Q13936-23; Sequence=VSP_000886, VSP_000887, VSP_000889,
CC                                   VSP_000895;
CC       Name=24; Synonyms=Alpha-1C.71;
CC         IsoId=Q13936-24; Sequence=VSP_000888, VSP_000889, VSP_000893,
CC                                   VSP_000895;
CC       Name=25; Synonyms=Alpha-1C.73;
CC         IsoId=Q13936-25; Sequence=VSP_000888, VSP_000889, VSP_000891,
CC                                   VSP_000893, VSP_000895;
CC       Name=26; Synonyms=Alpha-1C.86;
CC         IsoId=Q13936-26; Sequence=VSP_000887, VSP_000889, VSP_000892,
CC                                   VSP_000895;
CC         Note=Not inhibited by calcium. Ref.3 (CAA84348) sequence is in
CC         conflict in position: 1573:A->T. {ECO:0000305};
CC       Name=27; Synonyms=Alpha-1C.72;
CC         IsoId=Q13936-27; Sequence=VSP_000887, VSP_000889, VSP_000893,
CC                                   VSP_000895;
CC       Name=28;
CC         IsoId=Q13936-28; Sequence=VSP_000885, VSP_000886, VSP_000888,
CC                                   VSP_000889, VSP_000891, VSP_000894;
CC       Name=29; Synonyms=Alpha-1C.74;
CC         IsoId=Q13936-29; Sequence=VSP_000887, VSP_000889, VSP_000891,
CC                                   VSP_000893, VSP_000895;
CC       Name=30; Synonyms=Alpha-1C.87;
CC         IsoId=Q13936-30; Sequence=VSP_000889, VSP_000895;
CC       Name=31; Synonyms=Alpha-1C.88;
CC         IsoId=Q13936-31; Sequence=VSP_000888, VSP_000895;
CC       Name=32; Synonyms=Alpha-1C.89;
CC         IsoId=Q13936-32; Sequence=VSP_000887, VSP_000891, VSP_000895;
CC       Name=33; Synonyms=Alpha-1C.85;
CC         IsoId=Q13936-33; Sequence=VSP_000887, VSP_000889;
CC       Name=34; Synonyms=Alpha-1C,long-NT;
CC         IsoId=Q13936-34; Sequence=VSP_035146;
CC         Note=Enhanced by PKC activator.;
CC       Name=35;
CC         IsoId=Q13936-35; Sequence=VSP_035877, VSP_000888, VSP_000890,
CC                                   VSP_000895;
CC       Name=36;
CC         IsoId=Q13936-36; Sequence=VSP_000886, VSP_000888, VSP_000890;
CC         Note=Gene prediction based on EST data.;
CC       Name=37;
CC         IsoId=Q13936-37; Sequence=VSP_000886, VSP_000888, VSP_000890,
CC                                   VSP_000895;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, jejunum, ovary,
CC       pancreatic beta-cells and vascular smooth muscle. Overall
CC       expression is reduced in atherosclerotic vascular smooth muscle.
CC       {ECO:0000269|PubMed:12176756, ECO:0000269|PubMed:17071743,
CC       ECO:0000269|PubMed:8392192}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- PTM: Phosphorylation by PKA activates the channel.
CC       {ECO:0000250|UniProtKB:P15381}.
CC   -!- DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder
CC       characterized by multiorgan dysfunction including lethal
CC       arrhythmias, webbing of fingers and toes, congenital heart
CC       disease, immune deficiency, intermittent hypoglycemia, cognitive
CC       abnormalities and autism. {ECO:0000269|PubMed:15454078,
CC       ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:24728418,
CC       ECO:0000269|PubMed:25260352, ECO:0000269|PubMed:25633834,
CC       ECO:0000269|PubMed:26253506}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease
CC       characterized by the association of Brugada syndrome with
CC       shortened QT intervals. Brugada syndrome is a tachyarrhythmia
CC       characterized by right bundle branch block and ST segment
CC       elevation on an electrocardiogram (ECG). It can cause the
CC       ventricles to beat so fast that the blood is prevented from
CC       circulating efficiently in the body. When this situation occurs,
CC       the individual will faint and may die in a few minutes if the
CC       heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1C subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA02500.2; Type=Frameshift; Positions=1844; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92269; AAA17030.1; -; Genomic_DNA.
DR   EMBL; M92270; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M92271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M92272; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M92273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M92274; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M92275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L04568; AAA02500.2; ALT_FRAME; Genomic_DNA.
DR   EMBL; L04569; AAA02501.1; -; mRNA.
DR   EMBL; L29529; AAA51899.1; -; mRNA.
DR   EMBL; Z26256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26258; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26259; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26260; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26262; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26264; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26265; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26266; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26267; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26269; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26272; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26274; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26276; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26278; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26279; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26284; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26286; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26288; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z26294; CAA81218.1; -; mRNA.
DR   EMBL; Z26295; CAA81219.1; -; mRNA.
DR   EMBL; Z26308; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z34809; CAA84340.1; -; mRNA.
DR   EMBL; Z34810; CAA84341.1; -; mRNA.
DR   EMBL; Z34811; CAA84342.1; -; mRNA.
DR   EMBL; Z34812; CAA84343.1; -; mRNA.
DR   EMBL; Z34813; CAA84344.1; -; mRNA.
DR   EMBL; Z34814; CAA84345.1; -; mRNA.
DR   EMBL; Z34815; CAA84346.1; -; mRNA.
DR   EMBL; Z34816; CAA84347.1; -; mRNA.
DR   EMBL; Z34817; CAA84348.1; -; mRNA.
DR   EMBL; Z34818; CAA84349.1; -; mRNA.
DR   EMBL; Z34819; CAA84350.1; -; mRNA.
DR   EMBL; Z34820; CAA84351.1; -; mRNA.
DR   EMBL; Z34821; CAA84352.1; -; mRNA.
DR   EMBL; Z34822; CAA84353.1; -; mRNA.
DR   EMBL; L29530; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29534; AAA51900.1; -; mRNA.
DR   EMBL; L29535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29536; AAA51901.1; -; mRNA.
DR   EMBL; L29537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29538; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L29539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z74996; CAA99284.1; -; mRNA.
DR   EMBL; AJ224873; CAA12174.1; -; mRNA.
DR   EMBL; AF465484; AAM70049.1; -; mRNA.
DR   EMBL; AY830711; AAX37354.1; -; mRNA.
DR   EMBL; AY830712; AAX37355.1; -; mRNA.
DR   EMBL; AY830713; AAX37356.1; -; mRNA.
DR   EMBL; AC005293; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005344; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005414; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005866; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006051; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007618; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146846; AAI46847.1; -; mRNA.
DR   EMBL; AY604867; AAT02226.1; -; mRNA.
DR   EMBL; M57971; AAA62832.1; -; mRNA.
DR   EMBL; M57972; AAB59461.1; -; mRNA.
DR   EMBL; M61130; AAA58409.1; -; Genomic_DNA.
DR   EMBL; M91370; AAA74590.1; -; Genomic_DNA.
DR   CCDS; CCDS44787.1; -. [Q13936-23]
DR   CCDS; CCDS44788.1; -. [Q13936-11]
DR   CCDS; CCDS44789.1; -. [Q13936-30]
DR   CCDS; CCDS44790.1; -. [Q13936-31]
DR   CCDS; CCDS44791.1; -. [Q13936-22]
DR   CCDS; CCDS44792.1; -. [Q13936-14]
DR   CCDS; CCDS44793.1; -. [Q13936-24]
DR   CCDS; CCDS44794.1; -. [Q13936-12]
DR   CCDS; CCDS44795.1; -. [Q13936-25]
DR   CCDS; CCDS44796.1; -. [Q13936-15]
DR   CCDS; CCDS44797.1; -. [Q13936-32]
DR   CCDS; CCDS44798.1; -. [Q13936-21]
DR   CCDS; CCDS44799.1; -. [Q13936-27]
DR   CCDS; CCDS44800.1; -. [Q13936-20]
DR   CCDS; CCDS44801.1; -. [Q13936-29]
DR   CCDS; CCDS53733.1; -. [Q13936-36]
DR   CCDS; CCDS53734.1; -. [Q13936-37]
DR   CCDS; CCDS53735.1; -. [Q13936-13]
DR   CCDS; CCDS53736.1; -. [Q13936-33]
DR   PIR; A23660; A23660.
DR   PIR; A44363; A44363.
DR   PIR; A45290; A45290.
DR   PIR; B23660; B23660.
DR   PIR; C23660; C23660.
DR   PIR; I54168; I54168.
DR   RefSeq; NP_000710.5; NM_000719.6. [Q13936-12]
DR   RefSeq; NP_001123299.1; NM_001129827.1. [Q13936-11]
DR   RefSeq; NP_001123301.1; NM_001129829.1. [Q13936-14]
DR   RefSeq; NP_001123302.2; NM_001129830.2.
DR   RefSeq; NP_001123303.1; NM_001129831.1. [Q13936-31]
DR   RefSeq; NP_001123304.1; NM_001129832.1. [Q13936-30]
DR   RefSeq; NP_001123305.1; NM_001129833.1. [Q13936-13]
DR   RefSeq; NP_001123306.1; NM_001129834.1. [Q13936-24]
DR   RefSeq; NP_001123307.1; NM_001129835.1. [Q13936-27]
DR   RefSeq; NP_001123308.1; NM_001129836.1. [Q13936-32]
DR   RefSeq; NP_001123309.1; NM_001129837.1. [Q13936-25]
DR   RefSeq; NP_001123310.1; NM_001129838.1. [Q13936-29]
DR   RefSeq; NP_001123311.1; NM_001129839.1. [Q13936-15]
DR   RefSeq; NP_001123312.1; NM_001129840.1. [Q13936-23]
DR   RefSeq; NP_001123313.1; NM_001129841.1. [Q13936-21]
DR   RefSeq; NP_001123314.1; NM_001129842.1. [Q13936-22]
DR   RefSeq; NP_001123315.1; NM_001129843.1. [Q13936-20]
DR   RefSeq; NP_001123316.1; NM_001129844.1. [Q13936-35]
DR   RefSeq; NP_001123318.1; NM_001129846.1. [Q13936-19]
DR   RefSeq; NP_001161095.1; NM_001167623.1. [Q13936-37]
DR   RefSeq; NP_001161096.2; NM_001167624.2.
DR   RefSeq; NP_001161097.1; NM_001167625.1.
DR   RefSeq; NP_955630.3; NM_199460.3.
DR   UniGene; Hs.118262; -.
DR   UniGene; Hs.690010; -.
DR   PDB; 1T0J; X-ray; 2.00 A; C=428-445.
DR   PDB; 2BE6; X-ray; 2.00 A; D/E/F=1659-1692.
DR   PDB; 2F3Y; X-ray; 1.45 A; B=1665-1685.
DR   PDB; 2F3Z; X-ray; 1.60 A; B=1665-1685.
DR   PDB; 2LQC; NMR; -; B=47-68.
DR   PDB; 3G43; X-ray; 2.10 A; E/F=1609-1682.
DR   PDB; 3OXQ; X-ray; 2.55 A; E/F=1609-1685.
DR   PDB; 5V2P; X-ray; 2.00 A; B=427-445.
DR   PDB; 5V2Q; X-ray; 1.70 A; B=427-445.
DR   PDBsum; 1T0J; -.
DR   PDBsum; 2BE6; -.
DR   PDBsum; 2F3Y; -.
DR   PDBsum; 2F3Z; -.
DR   PDBsum; 2LQC; -.
DR   PDBsum; 3G43; -.
DR   PDBsum; 3OXQ; -.
DR   PDBsum; 5V2P; -.
DR   PDBsum; 5V2Q; -.
DR   ProteinModelPortal; Q13936; -.
DR   SMR; Q13936; -.
DR   BioGrid; 107229; 14.
DR   DIP; DIP-29589N; -.
DR   IntAct; Q13936; 9.
DR   STRING; 9606.ENSP00000266376; -.
DR   BindingDB; Q13936; -.
DR   ChEMBL; CHEMBL1940; -.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB01373; Calcium.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB06751; Drotaverine.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00270; Isradipine.
DR   DrugBank; DB00653; Magnesium Sulfate.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00393; Nimodipine.
DR   DrugBank; DB00401; Nisoldipine.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 529; -.
DR   TCDB; 1.A.1.11.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q13936; -.
DR   PhosphoSitePlus; Q13936; -.
DR   BioMuta; CACNA1C; -.
DR   DMDM; 308153651; -.
DR   PaxDb; Q13936; -.
DR   PeptideAtlas; Q13936; -.
DR   PRIDE; Q13936; -.
DR   Ensembl; ENST00000344100; ENSP00000341092; ENSG00000151067. [Q13936-14]
DR   Ensembl; ENST00000347598; ENSP00000266376; ENSG00000151067. [Q13936-11]
DR   Ensembl; ENST00000399591; ENSP00000382500; ENSG00000151067. [Q13936-29]
DR   Ensembl; ENST00000399595; ENSP00000382504; ENSG00000151067. [Q13936-25]
DR   Ensembl; ENST00000399597; ENSP00000382506; ENSG00000151067. [Q13936-22]
DR   Ensembl; ENST00000399601; ENSP00000382510; ENSG00000151067. [Q13936-20]
DR   Ensembl; ENST00000399603; ENSP00000382512; ENSG00000151067. [Q13936-37]
DR   Ensembl; ENST00000399606; ENSP00000382515; ENSG00000151067. [Q13936-30]
DR   Ensembl; ENST00000399621; ENSP00000382530; ENSG00000151067. [Q13936-24]
DR   Ensembl; ENST00000399629; ENSP00000382537; ENSG00000151067. [Q13936-32]
DR   Ensembl; ENST00000399637; ENSP00000382546; ENSG00000151067. [Q13936-27]
DR   Ensembl; ENST00000399638; ENSP00000382547; ENSG00000151067. [Q13936-31]
DR   Ensembl; ENST00000399641; ENSP00000382549; ENSG00000151067. [Q13936-23]
DR   Ensembl; ENST00000399644; ENSP00000382552; ENSG00000151067. [Q13936-21]
DR   Ensembl; ENST00000399649; ENSP00000382557; ENSG00000151067. [Q13936-15]
DR   Ensembl; ENST00000399655; ENSP00000382563; ENSG00000151067. [Q13936-12]
DR   Ensembl; ENST00000402845; ENSP00000385724; ENSG00000151067. [Q13936-13]
DR   GeneID; 775; -.
DR   KEGG; hsa:775; -.
DR   UCSC; uc001qjz.3; human. [Q13936-1]
DR   CTD; 775; -.
DR   DisGeNET; 775; -.
DR   EuPathDB; HostDB:ENSG00000151067.20; -.
DR   GeneCards; CACNA1C; -.
DR   GeneReviews; CACNA1C; -.
DR   H-InvDB; HIX0010327; -.
DR   HGNC; HGNC:1390; CACNA1C.
DR   HPA; HPA039796; -.
DR   MalaCards; CACNA1C; -.
DR   MIM; 114205; gene.
DR   MIM; 601005; phenotype.
DR   MIM; 611875; phenotype.
DR   neXtProt; NX_Q13936; -.
DR   OpenTargets; ENSG00000151067; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 65283; Timothy syndrome.
DR   PharmGKB; PA83; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; Q13936; -.
DR   KO; K04850; -.
DR   PhylomeDB; Q13936; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-HSA-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   SIGNOR; Q13936; -.
DR   ChiTaRS; CACNA1C; human.
DR   EvolutionaryTrace; Q13936; -.
DR   GeneWiki; Cav1.2; -.
DR   GenomeRNAi; 775; -.
DR   PRO; PR:Q13936; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151067; -.
DR   ExpressionAtlas; Q13936; baseline and differential.
DR   Genevisible; Q13936; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IPI:UniProtKB.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0086056; F:voltage-gated calcium channel activity involved in AV node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; IDA:BHF-UCL.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL.
DR   GO; GO:0035585; P:calcium-mediated signaling using extracellular calcium source; TAS:BHF-UCL.
DR   GO; GO:0043010; P:camera-type eye development; IMP:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; IMP:UniProtKB.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IMP:BHF-UCL.
DR   GO; GO:0002520; P:immune system development; IMP:BHF-UCL.
DR   GO; GO:0098912; P:membrane depolarization during atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086045; P:membrane depolarization during AV node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0098911; P:regulation of ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005451; VDCC_L_a1csu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 2.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 5.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01635; LVDCCALPHA1C.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autism; Autism spectrum disorder;
KW   Brugada syndrome; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Long QT syndrome; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   2221       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1C.
FT                                /FTId=PRO_0000053928.
FT   TOPO_DOM      1    124       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    125    143       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    144    160       Extracellular. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    182    193       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    194    212       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    213    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    251       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    252    270       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    271    290       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    291    380       Extracellular. {ECO:0000255}.
FT   TRANSMEM    381    405       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    406    524       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    525    543       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    544    558       Extracellular. {ECO:0000255}.
FT   TRANSMEM    559    578       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    579    586       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    587    605       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    606    615       Extracellular. {ECO:0000255}.
FT   TRANSMEM    616    634       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    635    653       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    654    673       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    674    728       Extracellular. {ECO:0000255}.
FT   TRANSMEM    729    753       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    754    900       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    901    919       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    920    935       Extracellular. {ECO:0000255}.
FT   TRANSMEM    936    955       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    956    987       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    988   1006       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1007   1013       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1014   1032       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1033   1051       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1052   1071       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1072   1161       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1162   1186       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1187   1239       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1240   1258       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1259   1273       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1274   1293       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1294   1301       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1302   1320       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1321   1372       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1373   1391       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1392   1410       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1411   1430       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1431   1499       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1500   1524       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1525   2221       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      111    408       I.
FT   REPEAT      510    756       II.
FT   REPEAT      887   1189       III.
FT   REPEAT     1226   1527       IV.
FT   CA_BIND    1553   1564       {ECO:0000250}.
FT   REGION      428    445       AID/alpha-interaction domain; mediates
FT                                interaction with the beta subunit.
FT                                {ECO:0000250|UniProtKB:P22002}.
FT   REGION     1109   1199       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1478   1546       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1492   1535       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS    654    660       Poly-Leu.
FT   COMPBIAS    768    774       Poly-Glu.
FT   COMPBIAS   1167   1173       Poly-Ile.
FT   COMPBIAS   2084   2087       Poly-Gly.
FT   SITE        363    363       Calcium ion selectivity and permeability.
FT                                {ECO:0000269|PubMed:8099908}.
FT   SITE        706    706       Calcium ion selectivity and permeability.
FT                                {ECO:0000250|UniProtKB:P15381}.
FT   SITE       1135   1135       Calcium ion selectivity and permeability.
FT                                {ECO:0000269|PubMed:8099908}.
FT   SITE       1464   1464       Calcium ion selectivity and permeability.
FT                                {ECO:0000269|PubMed:8099908}.
FT   MOD_RES     469    469       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES     476    476       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES     808    808       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES     815    815       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES    1535   1535       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1718   1718       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES    1739   1739       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01815}.
FT   MOD_RES    1973   1973       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1981   1981       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1436   1436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1487   1487       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     29       Missing (in isoform 16, isoform 17,
FT                                isoform 18 and isoform 28).
FT                                {ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|PubMed:9087614,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000885.
FT   VAR_SEQ       1     16       MVNENTRMYIPEENHQ -> MLRAFVQPGTPAYQPLPSHLS
FT                                ANTEVKFKGTLVHEAQLNYFYISPG (in isoform
FT                                34). {ECO:0000303|PubMed:11741969}.
FT                                /FTId=VSP_035146.
FT   VAR_SEQ     306    308       Missing (in isoform 35).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035877.
FT   VAR_SEQ     372    391       VNDAVGRDWPWIYFVTLIII -> MQDAMGYELPWVYFVSL
FT                                VIF (in isoform 3, isoform 16, isoform
FT                                17, isoform 18, isoform 23, isoform 28,
FT                                isoform 36 and isoform 37).
FT                                {ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|PubMed:9087614,
FT                                ECO:0000303|PubMed:9607315,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000886.
FT   VAR_SEQ     932    951       Missing (in isoform 4, isoform 19,
FT                                isoform 20, isoform 21, isoform 23,
FT                                isoform 26, isoform 27, isoform 29,
FT                                isoform 32 and isoform 33).
FT                                {ECO:0000303|PubMed:7737988,
FT                                ECO:0000303|PubMed:9013606,
FT                                ECO:0000303|PubMed:9607315,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000887.
FT   VAR_SEQ     952    971       Missing (in isoform 5, isoform 12,
FT                                isoform 13, isoform 14, isoform 15,
FT                                isoform 16, isoform 17, isoform 18,
FT                                isoform 22, isoform 24, isoform 25,
FT                                isoform 28, isoform 31, isoform 35,
FT                                isoform 36 and isoform 37).
FT                                {ECO:0000303|PubMed:12176756,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:7737988,
FT                                ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|PubMed:9087614,
FT                                ECO:0000303|PubMed:9607315,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000888.
FT   VAR_SEQ    1297   1324       Missing (in isoform 6, isoform 12,
FT                                isoform 14, isoform 15, isoform 19,
FT                                isoform 20, isoform 23, isoform 24,
FT                                isoform 25, isoform 26, isoform 27,
FT                                isoform 28, isoform 29, isoform 30 and
FT                                isoform 33).
FT                                {ECO:0000303|PubMed:12176756,
FT                                ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:7737988,
FT                                ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|PubMed:9013606,
FT                                ECO:0000303|PubMed:9607315,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000889.
FT   VAR_SEQ    1325   1352       Missing (in isoform 7, isoform 13,
FT                                isoform 16, isoform 17, isoform 18,
FT                                isoform 21, isoform 22, isoform 35,
FT                                isoform 36 and isoform 37).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|PubMed:9087614,
FT                                ECO:0000303|PubMed:9607315}.
FT                                /FTId=VSP_000890.
FT   VAR_SEQ    1351   1363       Missing (in isoform 15).
FT                                {ECO:0000303|PubMed:17071743}.
FT                                /FTId=VSP_022503.
FT   VAR_SEQ    1353   1363       Missing (in isoform 8, isoform 19,
FT                                isoform 25, isoform 28, isoform 29 and
FT                                isoform 32).
FT                                {ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:7737988,
FT                                ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000891.
FT   VAR_SEQ    1363   1363       M -> MGPSCSHPPLAVLTAPPVADGFQ (in isoform
FT                                14). {ECO:0000303|PubMed:17071743}.
FT                                /FTId=VSP_022504.
FT   VAR_SEQ    1618   1699       LRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVVPPAGD
FT                                DEVTVGKFYATFLIQEYFRKFKKRKEQGLVGKPSQRNALSL
FT                                -> LREAELSSQVQYQAKEASLLERRRKSSHPKSSTKPNKL
FT                                LSSGGSTGWVEDARALEGQVLARGCGWLGSLEERERGPHHP
FT                                PLGF (in isoform 9 and isoform 26).
FT                                {ECO:0000303|PubMed:9013606}.
FT                                /FTId=VSP_000892.
FT   VAR_SEQ    1623   1623       E -> EEGPSPSEAHQGAEDPFRPA (in isoform 10,
FT                                isoform 13, isoform 14, isoform 15,
FT                                isoform 24, isoform 25, isoform 27 and
FT                                isoform 29).
FT                                {ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:9013606,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000893.
FT   VAR_SEQ    1864   1898       Missing (in isoform 11, isoform 12,
FT                                isoform 13, isoform 14, isoform 15,
FT                                isoform 17, isoform 19, isoform 20,
FT                                isoform 21, isoform 22, isoform 23,
FT                                isoform 24, isoform 25, isoform 26,
FT                                isoform 27, isoform 29, isoform 30,
FT                                isoform 31, isoform 32, isoform 35 and
FT                                isoform 37).
FT                                {ECO:0000303|PubMed:12176756,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17071743,
FT                                ECO:0000303|PubMed:7737988,
FT                                ECO:0000303|PubMed:9013606,
FT                                ECO:0000303|PubMed:9087614,
FT                                ECO:0000303|PubMed:9607315,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000895.
FT   VAR_SEQ    1864   1897       ERHVPMCEDLELRRDSGSAGTQAHCLLLRKANPS -> MHC
FT                                CDMLDGGTFPPALGPRRAPPCLHQQLQGSLAGLREDTPCIV
FT                                PGHASLCCSSRVGEWLPAGCTAPQHA (in isoform 2,
FT                                isoform 18 and isoform 28).
FT                                {ECO:0000303|PubMed:8392192,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_000894.
FT   VARIANT      28     28       A -> T (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance; increased channel
FT                                activity). {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075148.
FT   VARIANT      37     37       G -> R (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075149.
FT   VARIANT      39     39       A -> V (in BRGDA3; loss of function).
FT                                {ECO:0000269|PubMed:17224476}.
FT                                /FTId=VAR_044039.
FT   VARIANT      84     84       Q -> R (in dbSNP:rs1051345).
FT                                {ECO:0000269|PubMed:8392192,
FT                                ECO:0000269|PubMed:9087614,
FT                                ECO:0000269|Ref.10}.
FT                                /FTId=VAR_045987.
FT   VARIANT     304    304       I -> T (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075150.
FT   VARIANT     381    381       P -> S (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:24728418}.
FT                                /FTId=VAR_075151.
FT   VARIANT     391    391       I -> L (in dbSNP:rs1051356).
FT                                /FTId=VAR_045988.
FT   VARIANT     402    402       G -> S (in TS).
FT                                {ECO:0000269|PubMed:15863612}.
FT                                /FTId=VAR_026741.
FT   VARIANT     406    406       G -> R (in TS; causes a nearly complete
FT                                loss of voltage-dependent channel
FT                                inactivation).
FT                                {ECO:0000269|PubMed:15454078}.
FT                                /FTId=VAR_026742.
FT   VARIANT     456    456       M -> I (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:24728418}.
FT                                /FTId=VAR_075152.
FT   VARIANT     477    477       E -> K (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075153.
FT   VARIANT     490    490       G -> R (in BRGDA3; loss of function).
FT                                {ECO:0000269|PubMed:17224476}.
FT                                /FTId=VAR_044040.
FT   VARIANT     518    518       R -> C (in TS; only with cardiac
FT                                manifestation; decreased current density;
FT                                associated with slower inactivation;
FT                                altered localization).
FT                                {ECO:0000269|PubMed:26253506}.
FT                                /FTId=VAR_075154.
FT   VARIANT     518    518       R -> H (in TS; only with cardiac
FT                                manifestation; decreased current density;
FT                                associated with slower inactivation).
FT                                {ECO:0000269|PubMed:26253506}.
FT                                /FTId=VAR_075155.
FT   VARIANT     582    582       A -> D (in TS; only with cardiac
FT                                manifestation; gain of function effect on
FT                                channel activity; slower inactivation).
FT                                {ECO:0000269|PubMed:24728418}.
FT                                /FTId=VAR_075156.
FT   VARIANT     752    752       A -> T.
FT                                /FTId=VAR_001495.
FT   VARIANT     817    817       P -> S (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075157.
FT   VARIANT     850    850       Missing (rare variant; found in a case of
FT                                sudden unexplained death in the young;
FT                                unknown pathological significance;
FT                                results in reduced whole-cell calcium
FT                                currents). {ECO:0000269|PubMed:27218670}.
FT                                /FTId=VAR_076414.
FT   VARIANT     858    858       R -> H (in TS; only with cardiac
FT                                manifestation; gain of function effect on
FT                                channel activity; slower inactivation).
FT                                {ECO:0000269|PubMed:24728418}.
FT                                /FTId=VAR_075158.
FT   VARIANT     860    860       R -> G (in TS; only with cardiac
FT                                manifestation; gain of function
FT                                activity). {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075159.
FT   VARIANT     878    878       S -> R (found in a clear cell renal
FT                                carcinoma case; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064700.
FT   VARIANT    1159   1159       R -> H (found in a patient with autism;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:26637798}.
FT                                /FTId=VAR_078701.
FT   VARIANT    1186   1186       I -> T (in TS; electrophysiological
FT                                phenotype, characterized by loss of
FT                                current density and gain-of-function
FT                                shift in activation leading to increased
FT                                steady-state current; gain of function
FT                                activity). {ECO:0000269|PubMed:25260352,
FT                                ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_072381.
FT   VARIANT    1186   1186       I -> V (in TS; only with cardiac
FT                                manifestation; gain of function
FT                                activity). {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075160.
FT   VARIANT    1365   1365       A -> T (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075161.
FT   VARIANT    1523   1523       I -> M (in TS; only with cardiac
FT                                manifestation; gain of function
FT                                activity). {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075162.
FT   VARIANT    1544   1544       E -> K (in TS; only with cardiac
FT                                manifestation; gain of function
FT                                activity). {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075163.
FT   VARIANT    1755   1755       V -> I (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075164.
FT   VARIANT    1765   1765       A -> G (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075165.
FT   VARIANT    1787   1787       D -> N (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075166.
FT   VARIANT    1800   1800       T -> I (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075167.
FT   VARIANT    1831   1831       G -> C (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:24728418}.
FT                                /FTId=VAR_075168.
FT   VARIANT    1835   1835       T -> M (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075169.
FT   VARIANT    1843   1843       G -> A (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075170.
FT   VARIANT    1868   1868       P -> L (in dbSNP:rs10848683).
FT                                /FTId=VAR_059223.
FT   VARIANT    1869   1869       M -> V (in dbSNP:rs10774053).
FT                                {ECO:0000269|PubMed:1316612,
FT                                ECO:0000269|PubMed:9087614,
FT                                ECO:0000269|Ref.10}.
FT                                /FTId=VAR_059224.
FT   VARIANT    1893   1893       K -> R (in dbSNP:rs10774054).
FT                                {ECO:0000269|PubMed:1316612,
FT                                ECO:0000269|PubMed:9087614,
FT                                ECO:0000269|Ref.10}.
FT                                /FTId=VAR_061102.
FT   VARIANT    1948   1948       E -> K (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075171.
FT   VARIANT    1953   1953       T -> M (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075172.
FT   VARIANT    1972   1972       R -> C (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075173.
FT   VARIANT    2056   2056       R -> Q (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075174.
FT   VARIANT    2081   2081       T -> N (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075175.
FT   VARIANT    2091   2091       A -> S (rare variant; found in a case of
FT                                sudden unexplained death in the young;
FT                                unknown pathological significance;
FT                                results in increased whole-cell calcium
FT                                currents). {ECO:0000269|PubMed:27218670}.
FT                                /FTId=VAR_076415.
FT   VARIANT    2097   2097       V -> I (in TS; only with cardiac
FT                                manifestation; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075176.
FT   VARIANT    2122   2122       A -> G (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075177.
FT   VARIANT    2169   2169       A -> T.
FT                                /FTId=VAR_001496.
FT   VARIANT    2174   2174       N -> S (polymorphism).
FT                                {ECO:0000269|PubMed:25633834}.
FT                                /FTId=VAR_075178.
FT   MUTAGEN     363    363       E->K: Loss of selectivity for divalent
FT                                over monovalent cations.
FT                                {ECO:0000269|PubMed:8099908}.
FT   MUTAGEN     954    954       G->F: Affects voltage-dependent
FT                                inhibition by dihydropyridines; when
FT                                associated with I-958.
FT                                {ECO:0000269|PubMed:7737988}.
FT   MUTAGEN     958    958       Y->I: Affects voltage-dependent
FT                                inhibition by dihydropyridines; when
FT                                associated with F-954.
FT                                {ECO:0000269|PubMed:7737988}.
FT   MUTAGEN    1135   1135       E->K: Loss of selectivity for divalent
FT                                over monovalent cations.
FT                                {ECO:0000269|PubMed:8099908}.
FT   MUTAGEN    1464   1464       E->K: Loss of selectivity for divalent
FT                                over monovalent cations.
FT                                {ECO:0000269|PubMed:8099908}.
FT   CONFLICT   1072   1072       K -> Q (in Ref. 3; Z26272).
FT                                {ECO:0000305}.
FT   CONFLICT   1157   1157       N -> K (in Ref. 15; AAA58409).
FT                                {ECO:0000305}.
FT   CONFLICT   1244   1244       L -> P (in Ref. 16; AAA74590).
FT                                {ECO:0000305}.
FT   CONFLICT   1384   1384       L -> P (in Ref. 16; AAA74590).
FT                                {ECO:0000305}.
FT   CONFLICT   1412   1412       A -> V (in Ref. 12; AAI46847).
FT                                {ECO:0000305}.
FT   CONFLICT   1459   1459       R -> K (in Ref. 3; CAA81219).
FT                                {ECO:0000305}.
FT   CONFLICT   2205   2205       R -> A (in Ref. 3; CAA84340/CAA84341/
FT                                CAA84342/CAA84343/CAA84344/CAA84345/
FT                                CAA84346/CAA84347/CAA84348/CAA84349/
FT                                CAA84350/CAA84351, 7; CAA12174 and 9;
FT                                AAX37354/AAX37355/AAX37356).
FT                                {ECO:0000305}.
FT   CONFLICT   2205   2205       R -> G (in Ref. 1; AAA17030).
FT                                {ECO:0000305}.
FT   HELIX        48     65       {ECO:0000244|PDB:2LQC}.
FT   HELIX       429    443       {ECO:0000244|PDB:5V2Q}.
FT   HELIX      1609   1651       {ECO:0000244|PDB:3G43}.
FT   TURN       1661   1663       {ECO:0000244|PDB:2BE6}.
FT   HELIX      1666   1680       {ECO:0000244|PDB:2F3Z}.
SQ   SEQUENCE   2221 AA;  248977 MW;  7E755F7AF4C86769 CRC64;
     MVNENTRMYI PEENHQGSNY GSPRPAHANM NANAAAGLAP EHIPTPGAAL SWQAAIDAAR
     QAKLMGSAGN ATISTVSSTQ RKRQQYGKPK KQGSTTATRP PRALLCLTLK NPIRRACISI
     VEWKPFEIII LLTIFANCVA LAIYIPFPED DSNATNSNLE RVEYLFLIIF TVEAFLKVIA
     YGLLFHPNAY LRNGWNLLDF IIVVVGLFSA ILEQATKADG ANALGGKGAG FDVKALRAFR
     VLRPLRLVSG VPSLQVVLNS IIKAMVPLLH IALLVLFVII IYAIIGLELF MGKMHKTCYN
     QEGIADVPAE DDPSPCALET GHGRQCQNGT VCKPGWDGPK HGITNFDNFA FAMLTVFQCI
     TMEGWTDVLY WVNDAVGRDW PWIYFVTLII IGSFFVLNLV LGVLSGEFSK EREKAKARGD
     FQKLREKQQL EEDLKGYLDW ITQAEDIDPE NEDEGMDEEK PRNMSMPTSE TESVNTENVA
     GGDIEGENCG ARLAHRISKS KFSRYWRRWN RFCRRKCRAA VKSNVFYWLV IFLVFLNTLT
     IASEHYNQPN WLTEVQDTAN KALLALFTAE MLLKMYSLGL QAYFVSLFNR FDCFVVCGGI
     LETILVETKI MSPLGISVLR CVRLLRIFKI TRYWNSLSNL VASLLNSVRS IASLLLLLFL
     FIIIFSLLGM QLFGGKFNFD EMQTRRSTFD NFPQSLLTVF QILTGEDWNS VMYDGIMAYG
     GPSFPGMLVC IYFIILFICG NYILLNVFLA IAVDNLADAE SLTSAQKEEE EEKERKKLAR
     TASPEKKQEL VEKPAVGESK EEKIELKSIT ADGESPPATK INMDDLQPNE NEDKSPYPNP
     ETTGEEDEEE PEMPVGPRPR PLSELHLKEK AVPMPEASAF FIFSSNNRFR LQCHRIVNDT
     IFTNLILFFI LLSSISLAAE DPVQHTSFRN HILFYFDIVF TTIFTIEIAL KILGNADYVF
     TSIFTLEIIL KMTAYGAFLH KGSFCRNYFN ILDLLVVSVS LISFGIQSSA INVVKILRVL
     RVLRPLRAIN RAKGLKHVVQ CVFVAIRTIG NIVIVTTLLQ FMFACIGVQL FKGKLYTCSD
     SSKQTEAECK GNYITYKDGE VDHPIIQPRS WENSKFDFDN VLAAMMALFT VSTFEGWPEL
     LYRSIDSHTE DKGPIYNYRV EISIFFIIYI IIIAFFMMNI FVGFVIVTFQ EQGEQEYKNC
     ELDKNQRQCV EYALKARPLR RYIPKNQHQY KVWYVVNSTY FEYLMFVLIL LNTICLAMQH
     YGQSCLFKIA MNILNMLFTG LFTVEMILKL IAFKPKGYFS DPWNVFDFLI VIGSIIDVIL
     SETNHYFCDA WNTFDALIVV GSIVDIAITE VNPAEHTQCS PSMNAEENSR ISITFFRLFR
     VMRLVKLLSR GEGIRTLLWT FIKSFQALPY VALLIVMLFF IYAVIGMQVF GKIALNDTTE
     INRNNNFQTF PQAVLLLFRC ATGEAWQDIM LACMPGKKCA PESEPSNSTE GETPCGSSFA
     VFYFISFYML CAFLIINLFV AVIMDNFDYL TRDWSILGPH HLDEFKRIWA EYDPEAKGRI
     KHLDVVTLLR RIQPPLGFGK LCPHRVACKR LVSMNMPLNS DGTVMFNATL FALVRTALRI
     KTEGNLEQAN EELRAIIKKI WKRTSMKLLD QVVPPAGDDE VTVGKFYATF LIQEYFRKFK
     KRKEQGLVGK PSQRNALSLQ AGLRTLHDIG PEIRRAISGD LTAEEELDKA MKEAVSAASE
     DDIFRRAGGL FGNHVSYYQS DGRSAFPQTF TTQRPLHINK AGSSQGDTES PSHEKLVDST
     FTPSSYSSTG SNANINNANN TALGRLPRPA GYPSTVSTVE GHGPPLSPAI RVQEVAWKLS
     SNRERHVPMC EDLELRRDSG SAGTQAHCLL LRKANPSRCH SRESQAAMAG QEETSQDETY
     EVKMNHDTEA CSEPSLLSTE MLSYQDDENR QLTLPEEDKR DIRQSPKRGF LRSASLGRRA
     SFHLECLKRQ KDRGGDISQK TVLPLHLVHH QALAVAGLSP LLQRSHSPAS FPRPFATPPA
     TPGSRGWPPQ PVPTLRLEGV ESSEKLNSSF PSIHCGSWAE TTPGGGGSSA ARRVRPVSLM
     VPSQAGAPGR QFHGSASSLV EAVLISEGLG QFAQDPKFIE VTTQELADAC DMTIEEMESA
     ADNILSGGAP QSPNGALLPF VNCRDAGQDR AGGEEDAGCV RARGRPSEEE LQDSRVYVSS
     L
//
ID   ITPR1_HUMAN             Reviewed;        2758 AA.
AC   Q14643; E7EPX7; E9PDE9; Q14660; Q99897;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 3.
DT   20-DEC-2017, entry version 198.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor type 1;
DE   AltName: Full=IP3 receptor isoform 1;
DE            Short=IP3R 1;
DE            Short=InsP3R1;
DE   AltName: Full=Type 1 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 1 InsP3 receptor;
GN   Name=ITPR1; Synonyms=INSP3R1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Myeloid, and Uterus;
RX   PubMed=7945203; DOI=10.1042/bj3020781;
RA   Yamada N., Makino Y., Clark R.A., Pearson D.W., Mattei M.-G.,
RA   Guenet J.-L., Ohama E., Fujino I., Miyawaki A., Furuichi T.,
RA   Mikoshiba K.;
RT   "Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1:
RT   structure, function, regulation of expression and chromosomal
RT   localization.";
RL   Biochem. J. 302:781-790(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND PHOSPHORYLATION.
RC   TISSUE=T-cell;
RX   PubMed=7852357; DOI=10.1074/jbc.270.6.2833;
RA   Harnick D.J., Jayaraman T., Ma Y., Mulieri P., Go L.O., Marks A.R.;
RT   "The human type 1 inositol 1,4,5-trisphosphate receptor from T
RT   lymphocytes. Structure, localization, and tyrosine phosphorylation.";
RL   J. Biol. Chem. 270:2833-2840(1995).
RN   [3]
RP   SEQUENCE REVISION TO 431; 1012-1017; 1460; 1823; 2324; 2330; 2334;
RP   2337; 2346; 2358; 2361; 2372; 2396; 2418; 2426; 2434 AND 2741.
RA   Marks A.;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=7500840; DOI=10.1016/0169-328X(95)00089-B;
RA   Nucifora F.C. Jr., Li S.-H., Danoff S., Ullrich A., Ross C.A.;
RT   "Molecular cloning of a cDNA for the human inositol 1,4,5-
RT   trisphosphate receptor type 1, and the identification of a third
RT   alternatively spliced variant.";
RL   Brain Res. Mol. Brain Res. 32:291-296(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1548-1723 (ISOFORMS 3 AND 4).
RX   PubMed=8648241; DOI=10.1080/095530096145544;
RA   Yan J., Khanna K.K., Lavin M.F.;
RT   "Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing
RT   radiation.";
RL   Int. J. Radiat. Biol. 69:539-546(1996).
RN   [7]
RP   INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K.,
RA   Haeseleer F., Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [8]
RP   INTERACTION WITH CABP1.
RX   PubMed=14685260; DOI=10.1038/sj.emboj.7600037;
RA   Kasri N.N., Holmes A.M., Bultynck G., Parys J.B., Bootman M.D.,
RA   Rietdorf K., Missiaen L., McDonald F., De Smedt H., Conway S.J.,
RA   Holmes A.B., Berridge M.J., Roderick H.L.;
RT   "Regulation of InsP3 receptor activity by neuronal Ca2+-binding
RT   proteins.";
RL   EMBO J. 23:312-321(2004).
RN   [9]
RP   INTERACTION WITH ERP44.
RX   PubMed=15652484; DOI=10.1016/j.cell.2004.11.048;
RA   Higo T., Hattori M., Nakamura T., Natsume T., Michikawa T.,
RA   Mikoshiba K.;
RT   "Subtype-specific and ER lumenal environment-dependent regulation of
RT   inositol 1,4,5-trisphosphate receptor type 1 by ERp44.";
RL   Cell 120:85-98(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   INTERACTION WITH AHCYL1, AND MUTAGENESIS OF ARG-241; LYS-249; ARG-265;
RP   THR-267; ARG-269; ARG-504; ARG-506; LYS-508; ARG-511; TYR-567; ARG-568
RP   AND LYS-569.
RX   PubMed=16793548; DOI=10.1016/j.molcel.2006.05.017;
RA   Ando H., Mizutani A., Kiefer H., Tsuzurugi D., Michikawa T.,
RA   Mikoshiba K.;
RT   "IRBIT suppresses IP3 receptor activity by competing with IP3 for the
RT   common binding site on the IP3 receptor.";
RL   Mol. Cell 22:795-806(2006).
RN   [12]
RP   INTERACTION WITH MRVI1.
RX   PubMed=16990611; DOI=10.1182/blood-2005-10-026294;
RA   Antl M., von Bruehl M.-L., Eiglsperger C., Werner M., Konrad I.,
RA   Kocher T., Wilm M., Hofmann F., Massberg S., Schlossmann J.;
RT   "IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation
RT   and thrombus formation.";
RL   Blood 109:552-559(2007).
RN   [13]
RP   INVOLVEMENT IN SCA15.
RX   PubMed=17590087; DOI=10.1371/journal.pgen.0030108;
RA   van de Leemput J., Chandran J., Knight M.A., Holtzclaw L.A.,
RA   Scholz S., Cookson M.R., Houlden H., Gwinn-Hardy K., Fung H.-C.,
RA   Lin X., Hernandez D., Simon-Sanchez J., Wood N.W., Giunti P.,
RA   Rafferty I., Hardy J., Storey E., Gardner R.J.M., Forrest S.M.,
RA   Fisher E.M.C., Russell J.T., Cai H., Singleton A.B.;
RT   "Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia
RT   15 in humans.";
RL   PLoS Genet. 3:1076-1082(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   INTERACTION WITH AHCYL1 AND AHCYL2.
RX   PubMed=19220705; DOI=10.1111/j.1471-4159.2009.05979.x;
RA   Ando H., Mizutani A., Mikoshiba K.;
RT   "An IRBIT homologue lacks binding activity to inositol 1,4,5-
RT   trisphosphate receptor due to the unique N-terminal appendage.";
RL   J. Neurochem. 109:539-550(2009).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2512.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   INTERACTION WITH TESPA1.
RX   PubMed=23650607; DOI=10.1016/j.fob.2012.08.005;
RA   Matsuzaki H., Fujimoto T., Ota T., Ogawa M., Tsunoda T., Doi K.,
RA   Hamabashiri M., Tanaka M., Shirasawa S.;
RT   "Tespa1 is a novel inositol 1,4,5-trisphosphate receptor binding
RT   protein in T and B lymphocytes.";
RL   FEBS Open Bio 2:255-259(2012).
RN   [19]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.M113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from
RT   proteolytic cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   VARIANT SCA15 LEU-1059.
RX   PubMed=18579805; DOI=10.1212/01.wnl.0000311277.71046.a0;
RA   Hara K., Shiga A., Nozaki H., Mitsui J., Takahashi Y., Ishiguro H.,
RA   Yomono H., Kurisaki H., Goto J., Ikeuchi T., Tsuji S., Nishizawa M.,
RA   Onodera O.;
RT   "Total deletion and a missense mutation of ITPR1 in Japanese SCA15
RT   families.";
RL   Neurology 71:547-551(2008).
RN   [23]
RP   VARIANTS SCA29 ASP-602 AND MET-1562.
RX   PubMed=22986007; DOI=10.1186/1750-1172-7-67;
RA   Huang L., Chardon J.W., Carter M.T., Friend K.L., Dudding T.E.,
RA   Schwartzentruber J., Zou R., Schofield P.W., Douglas S., Bulman D.E.,
RA   Boycott K.M.;
RT   "Missense mutations in ITPR1 cause autosomal dominant congenital
RT   nonprogressive spinocerebellar ataxia.";
RL   Orphanet J. Rare Dis. 7:67-67(2012).
RN   [24]
RP   VARIANT SCA29 MET-1562.
RX   PubMed=26770814; DOI=10.1186/s40673-016-0040-8;
RA   Shadrina M.I., Shulskaya M.V., Klyushnikov S.A., Nikopensius T.,
RA   Nelis M., Kivistik P.A., Komar A.A., Limborska S.A.,
RA   Illarioshkin S.N., Slominsky P.A.;
RT   "ITPR1 gene p.Val1553Met mutation in Russian family with mild
RT   Spinocerebellar ataxia.";
RL   Cerebellum Ataxias 3:2-2(2016).
RN   [25]
RP   INVOLVEMENT IN GLSP, VARIANTS GLSP LEU-2601 AND LYS-2611 DEL,
RP   CHARACTERIZATION OF VARIANT GLSP LYS-2611 DEL, AND FUNCTION.
RX   PubMed=27108797; DOI=10.1016/j.ajhg.2016.03.004;
RA   Gerber S., Alzayady K.J., Burglen L., Bremond-Gignac D., Marchesin V.,
RA   Roche O., Rio M., Funalot B., Calmon R., Durr A.,
RA   Gil-da-Silva-Lopes V.L., Ribeiro Bittar M.F., Orssaud C., Heron B.,
RA   Ayoub E., Berquin P., Bahi-Buisson N., Bole C., Masson C., Munnich A.,
RA   Simons M., Delous M., Dollfus H., Boddaert N., Lyonnet S., Kaplan J.,
RA   Calvas P., Yule D.I., Rozet J.M., Fares Taie L.;
RT   "Recessive and dominant de novo ITPR1 mutations cause Gillespie
RT   syndrome.";
RL   Am. J. Hum. Genet. 98:971-980(2016).
RN   [26]
RP   INVOLVEMENT IN GLSP, VARIANTS GLSP GLN-2109; ARG-2554 AND LYS-2611
RP   DEL, AND SUBCELLULAR LOCATION.
RX   PubMed=27108798; DOI=10.1016/j.ajhg.2016.03.018;
RG   DDD Study;
RA   McEntagart M., Williamson K.A., Rainger J.K., Wheeler A.,
RA   Seawright A., De Baere E., Verdin H., Bergendahl L.T., Quigley A.,
RA   Rainger J., Dixit A., Sarkar A., Lopez Laso E., Sanchez-Carpintero R.,
RA   Barrio J., Bitoun P., Prescott T., Riise R., McKee S., Cook J.,
RA   McKie L., Ceulemans B., Meire F., Temple I.K., Prieur F., Williams J.,
RA   Clouston P., Nemeth A.H., Banka S., Bengani H., Handley M., Freyer E.,
RA   Ross A., van Heyningen V., Marsh J.A., Elmslie F., FitzPatrick D.R.;
RT   "A restricted repertoire of de novo mutations in ITPR1 cause Gillespie
RT   syndrome with evidence for dominant-negative effect.";
RL   Am. J. Hum. Genet. 98:981-992(2016).
CC   -!- FUNCTION: Intracellular channel that mediates calcium release from
CC       the endoplasmic reticulum following stimulation by inositol 1,4,5-
CC       trisphosphate (PubMed:27108797). Involved in the regulation of
CC       epithelial secretion of electrolytes and fluid through the
CC       interaction with AHCYL1 (By similarity). Plays a role in ER
CC       stress-induced apoptosis. Cytoplasmic calcium released from the ER
CC       triggers apoptosis by the activation of CaM kinase II, eventually
CC       leading to the activation of downstream apoptosis pathways (By
CC       similarity). {ECO:0000250|UniProtKB:P11881,
CC       ECO:0000269|PubMed:27108797}.
CC   -!- SUBUNIT: Homotetramer. Interacts with TRPC4. The PPXXF motif binds
CC       HOM1, HOM2 and HOM3. Interacts with RYR1, RYR2, ITPR1, SHANK1 and
CC       SHANK3. Interacts with ERP44 in a pH-, redox state- and calcium-
CC       dependent manner which results in the inhibition the calcium
CC       channel activity. The strength of this interaction inversely
CC       correlates with calcium concentration. Part of cGMP kinase
CC       signaling complex at least composed of ACTA2/alpha-actin,
CC       CNN1/calponin H1, PLN/phospholamban, PRKG1 and ITPR1. Interacts
CC       with MRVI1 and CABP1 (via N-terminus). Interacts with TESPA1.
CC       Interacts (when not phosphorylated) with AHCYL1 (when
CC       phosphorylated); the interaction suppresses inositol 1,4,5-
CC       trisphosphate binding to ITPR1 (PubMed:16793548). Interacts with
CC       AHCYL2 (with lower affinity than with AHCYL1) (PubMed:19220705).
CC       Interacts with BOK (via BH4 domain); protects ITPR1 from
CC       proteolysis by CASP3 during apoptosis (PubMed:23884412).
CC       {ECO:0000269|PubMed:12032348, ECO:0000269|PubMed:14685260,
CC       ECO:0000269|PubMed:15652484, ECO:0000269|PubMed:16793548,
CC       ECO:0000269|PubMed:16990611, ECO:0000269|PubMed:19220705,
CC       ECO:0000269|PubMed:23650607, ECO:0000269|PubMed:23884412}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=2; IntAct=EBI-465548, EBI-296087;
CC       P21796:VDAC1; NbExp=3; IntAct=EBI-465548, EBI-354158;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:27108798}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q9TU34}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:27108798}. Note=Endoplasmic reticulum and
CC       secretory granules (By similarity).
CC       {ECO:0000250|UniProtKB:Q9TU34}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There is a combination of three alternatively spliced
CC         domains at site SI, SIII and site SII (A and C). Experimental
CC         confirmation may be lacking for some isoforms.;
CC       Name=1; Synonyms=SISIIISIIAC;
CC         IsoId=Q14643-1; Sequence=Displayed;
CC       Name=2; Synonyms=SI-SIIISIIAC;
CC         IsoId=Q14643-2; Sequence=VSP_002687;
CC       Name=3; Synonyms=SISIII-SII;
CC         IsoId=Q14643-3; Sequence=VSP_002688, VSP_002689, VSP_002690;
CC       Name=4; Synonyms=SI-SIII-SII;
CC         IsoId=Q14643-4; Sequence=VSP_002687, VSP_002688, VSP_002689,
CC                                  VSP_002690;
CC       Name=5; Synonyms=SI-SIII-SIIAC;
CC         IsoId=Q14643-5; Sequence=VSP_002687, VSP_002688;
CC       Name=6; Synonyms=SISIIISIIA;
CC         IsoId=Q14643-6; Sequence=VSP_002690;
CC       Name=7; Synonyms=SI-SIII-SIIA;
CC         IsoId=Q14643-7; Sequence=VSP_002687, VSP_002690;
CC       Name=8; Synonyms=SI-SIII-SIIA;
CC         IsoId=Q14643-8; Sequence=VSP_002687, VSP_002688, VSP_002690;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- PTM: Phosphorylated on tyrosine residues.
CC       {ECO:0000269|PubMed:7852357}.
CC   -!- PTM: Ubiquitination at multiple lysines targets ITPR1 for
CC       proteasomal degradation. Approximately 40% of the ITPR1-associated
CC       ubiquitin is monoubiquitin, and polyubiquitins are both 'Lys-
CC       48'- and 'Lys-63'-linked (By similarity).
CC       {ECO:0000250|UniProtKB:P29994}.
CC   -!- PTM: Phosphorylated by cAMP kinase (PKA). Phosphorylation prevents
CC       the ligand-induced opening of the calcium channels.
CC       Phosphorylation by PKA increases the interaction with inositol
CC       1,4,5-trisphosphate and decreases the interaction with AHCYL1.
CC       {ECO:0000250|UniProtKB:P11881}.
CC   -!- PTM: Palmitoylated by ZDHHC6 in immune cells, leading to regulate
CC       ITPR1 stability and function. {ECO:0000250|UniProtKB:P11881}.
CC   -!- DISEASE: Spinocerebellar ataxia 15 (SCA15) [MIM:606658]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It
CC       is very slow progressing form with a wide range of onset, ranging
CC       from childhood to adult. Most patients remain ambulatory.
CC       {ECO:0000269|PubMed:17590087, ECO:0000269|PubMed:18579805}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia 29 (SCA29) [MIM:117360]: An
CC       autosomal dominant, congenital spinocerebellar ataxia
CC       characterized by early motor delay, hypotonia and mild cognitive
CC       delay. Affected individuals develop a very slowly progressive or
CC       non-progressive gait and limb ataxia associated with cerebellar
CC       atrophy on brain imaging. Additional variable features include
CC       nystagmus, dysarthria, and tremor. {ECO:0000269|PubMed:22986007,
CC       ECO:0000269|PubMed:26770814}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Gillespie syndrome (GLSP) [MIM:206700]: A rare disease
CC       characterized by bilateral iris hypoplasia, congenital hypotonia,
CC       non-progressive ataxia, progressive cerebellar atrophy, and mental
CC       retardation. {ECO:0000269|PubMed:27108797,
CC       ECO:0000269|PubMed:27108798}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Calcium appears to inhibit ligand binding to the
CC       receptor, most probably by interacting with a distinct calcium-
CC       binding protein which then inhibits the receptor.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -!- CAUTION: Alternative splice sites (AA 1053-1054) represent a non-
CC       canonical GA-AG donor-acceptor pair, but are well-supported by all
CC       available human transcripts, and by homologous transcripts in
CC       mouse, rat and cow. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26070; BAA05065.1; -; mRNA.
DR   EMBL; L38019; AAB04947.2; -; mRNA.
DR   EMBL; U23850; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC018816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069248; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090944; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S82269; AAD14386.1; -; mRNA.
DR   CCDS; CCDS46740.2; -. [Q14643-3]
DR   CCDS; CCDS54550.1; -. [Q14643-4]
DR   CCDS; CCDS54551.1; -. [Q14643-2]
DR   PIR; A55713; A55713.
DR   PIR; S54974; S54974.
DR   RefSeq; NP_001093422.2; NM_001099952.2. [Q14643-3]
DR   RefSeq; NP_001161744.1; NM_001168272.1. [Q14643-2]
DR   RefSeq; NP_002213.5; NM_002222.5. [Q14643-4]
DR   RefSeq; XP_011531985.1; XM_011533683.2. [Q14643-1]
DR   UniGene; Hs.567295; -.
DR   UniGene; Hs.715765; -.
DR   ProteinModelPortal; Q14643; -.
DR   BioGrid; 109913; 51.
DR   CORUM; Q14643; -.
DR   DIP; DIP-29714N; -.
DR   ELM; Q14643; -.
DR   IntAct; Q14643; 22.
DR   MINT; MINT-4991320; -.
DR   STRING; 9606.ENSP00000306253; -.
DR   BindingDB; Q14643; -.
DR   ChEMBL; CHEMBL4046; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04077; Glycerol.
DR   GuidetoPHARMACOLOGY; 743; -.
DR   TCDB; 1.A.3.2.6; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q14643; -.
DR   PhosphoSitePlus; Q14643; -.
DR   BioMuta; ITPR1; -.
DR   DMDM; 519668682; -.
DR   EPD; Q14643; -.
DR   MaxQB; Q14643; -.
DR   PaxDb; Q14643; -.
DR   PeptideAtlas; Q14643; -.
DR   PRIDE; Q14643; -.
DR   Ensembl; ENST00000302640; ENSP00000306253; ENSG00000150995. [Q14643-2]
DR   Ensembl; ENST00000354582; ENSP00000346595; ENSG00000150995. [Q14643-1]
DR   Ensembl; ENST00000357086; ENSP00000349597; ENSG00000150995. [Q14643-3]
DR   Ensembl; ENST00000443694; ENSP00000401671; ENSG00000150995. [Q14643-2]
DR   Ensembl; ENST00000456211; ENSP00000397885; ENSG00000150995. [Q14643-4]
DR   GeneID; 3708; -.
DR   KEGG; hsa:3708; -.
DR   UCSC; uc003bqc.3; human. [Q14643-1]
DR   CTD; 3708; -.
DR   DisGeNET; 3708; -.
DR   EuPathDB; HostDB:ENSG00000150995.18; -.
DR   GeneCards; ITPR1; -.
DR   GeneReviews; ITPR1; -.
DR   HGNC; HGNC:6180; ITPR1.
DR   HPA; HPA014765; -.
DR   HPA; HPA016487; -.
DR   MalaCards; ITPR1; -.
DR   MIM; 117360; phenotype.
DR   MIM; 147265; gene.
DR   MIM; 206700; phenotype.
DR   MIM; 606658; phenotype.
DR   neXtProt; NX_Q14643; -.
DR   OpenTargets; ENSG00000150995; -.
DR   Orphanet; 98769; Spinocerebellar ataxia type 15/16.
DR   Orphanet; 208513; Spinocerebellar ataxia type 29.
DR   PharmGKB; PA29978; -.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000007660; -.
DR   HOVERGEN; HBG052158; -.
DR   InParanoid; Q14643; -.
DR   KO; K04958; -.
DR   OMA; DPDDHYQ; -.
DR   OrthoDB; EOG091G00T2; -.
DR   PhylomeDB; Q14643; -.
DR   TreeFam; TF312815; -.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-1489509; DAG and IP3 signaling.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418457; cGMP effects.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; Q14643; -.
DR   SIGNOR; Q14643; -.
DR   ChiTaRS; ITPR1; human.
DR   GeneWiki; ITPR1; -.
DR   GenomeRNAi; 3708; -.
DR   PRO; PR:Q14643; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000150995; -.
DR   CleanEx; HS_ITPR1; -.
DR   ExpressionAtlas; Q14643; baseline and differential.
DR   Genevisible; Q14643; HS.
DR   GO; GO:0005955; C:calcineurin complex; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005637; C:nuclear inner membrane; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031088; C:platelet dense granule membrane; IDA:BHF-UCL.
DR   GO; GO:0031094; C:platelet dense tubular network; IDA:BHF-UCL.
DR   GO; GO:0031095; C:platelet dense tubular network membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; IDA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; NAS:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0042045; P:epithelial fluid transport; IEA:Ensembl.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0050849; P:negative regulation of calcium-mediated signaling; IDA:GO_Central.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0010506; P:regulation of autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0050882; P:voluntary musculoskeletal movement; IEA:Ensembl.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF48371; SSF48371; 4.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Disease mutation; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Isopeptide bond; Ligand-gated ion channel; Lipoprotein;
KW   Membrane; Mental retardation; Neurodegeneration; Palmitate;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Spinocerebellar ataxia; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   CHAIN         1   2758       Inositol 1,4,5-trisphosphate receptor
FT                                type 1.
FT                                /FTId=PRO_0000153920.
FT   TOPO_DOM      1   2282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2283   2303       Helical. {ECO:0000255}.
FT   TOPO_DOM   2304   2314       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2315   2335       Helical. {ECO:0000255}.
FT   TOPO_DOM   2336   2361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2362   2382       Helical. {ECO:0000255}.
FT   TOPO_DOM   2383   2405       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2406   2426       Helical. {ECO:0000255}.
FT   TOPO_DOM   2427   2448       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2449   2469       Helical. {ECO:0000255}.
FT   TOPO_DOM   2470   2577       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2578   2598       Helical. {ECO:0000255}.
FT   TOPO_DOM   2599   2758       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      112    166       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      173    223       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      231    287       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      294    373       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      379    435       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      265    269       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      508    511       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      567    569       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION     2472   2537       Interaction with ERP44. {ECO:0000250}.
FT   MOD_RES     482    482       Phosphotyrosine. {ECO:0000255}.
FT   MOD_RES    1598   1598       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1764   1764       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2664   2664       Phosphotyrosine. {ECO:0000255}.
FT   LIPID        56     56       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   LIPID       850    850       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   CARBOHYD   2512   2512       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CROSSLNK    917    917       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK    972    972       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1581   1581       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1780   1780       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1893   1893       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1894   1894       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1895   1895       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1910   1910       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1933   1933       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   2127   2127       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   2266   2266       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   VAR_SEQ     322    336       Missing (in isoform 2, isoform 4, isoform
FT                                5, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:7500840,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002687.
FT   VAR_SEQ     919    927       Missing (in isoform 3, isoform 4, isoform
FT                                5 and isoform 8).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002688.
FT   VAR_SEQ    1702   1725       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002689.
FT   VAR_SEQ    1726   1740       Missing (in isoform 3, isoform 4, isoform
FT                                6, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002690.
FT   VARIANT     602    602       N -> D (in SCA29; dbSNP:rs397514536).
FT                                {ECO:0000269|PubMed:22986007}.
FT                                /FTId=VAR_069567.
FT   VARIANT     769    769       M -> V (in dbSNP:rs35789999).
FT                                /FTId=VAR_037005.
FT   VARIANT    1059   1059       P -> L (in SCA15).
FT                                {ECO:0000269|PubMed:18579805}.
FT                                /FTId=VAR_069568.
FT   VARIANT    1430   1430       I -> V (in dbSNP:rs3749383).
FT                                /FTId=VAR_037006.
FT   VARIANT    1562   1562       V -> M (in SCA29; dbSNP:rs397514535).
FT                                {ECO:0000269|PubMed:22986007,
FT                                ECO:0000269|PubMed:26770814}.
FT                                /FTId=VAR_069569.
FT   VARIANT    2109   2109       E -> Q (in GLSP).
FT                                {ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077462.
FT   VARIANT    2554   2554       G -> R (in GLSP; dbSNP:rs752281590).
FT                                {ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077463.
FT   VARIANT    2601   2601       F -> L (in GLSP; dbSNP:rs878853176).
FT                                {ECO:0000269|PubMed:27108797}.
FT                                /FTId=VAR_077464.
FT   VARIANT    2611   2611       Missing (in GLSP; alters calcium release
FT                                of isoform 3).
FT                                {ECO:0000269|PubMed:27108797,
FT                                ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077465.
FT   MUTAGEN     241    241       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     249    249       K->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     265    265       R->Q: No effect on interaction with
FT                                AHCYL1. {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     267    267       T->A: No effect on interaction with
FT                                AHCYL1. {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     269    269       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     504    504       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     506    506       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     508    508       K->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     511    511       R->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     567    567       Y->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     568    568       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     569    569       K->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   CONFLICT   1557   1581       AIAIPVDLDSQVNNLFLKSHSIVQK -> HCHSRGPGQPSQ
FT                                QPLSQVPQHCAE (in Ref. 6; AAD14386).
FT                                {ECO:0000305}.
FT   CONFLICT   2302   2302       F -> L (in Ref. 2; AAB04947).
FT                                {ECO:0000305}.
FT   CONFLICT   2305   2305       F -> L (in Ref. 2; AAB04947).
FT                                {ECO:0000305}.
FT   CONFLICT   2448   2448       S -> A (in Ref. 4; U23850).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2758 AA;  313929 MW;  D29B072252B0D8E7 CRC64;
     MSDKMSSFLH IGDICSLYAE GSTNGFISTL GLVDDRCVVQ PETGDLNNPP KKFRDCLFKL
     CPMNRYSAQK QFWKAAKPGA NSTTDAVLLN KLHHAADLEK KQNETENRKL LGTVIQYGNV
     IQLLHLKSNK YLTVNKRLPA LLEKNAMRVT LDEAGNEGSW FYIQPFYKLR SIGDSVVIGD
     KVVLNPVNAG QPLHASSHQL VDNPGCNEVN SVNCNTSWKI VLFMKWSDNK DDILKGGDVV
     RLFHAEQEKF LTCDEHRKKQ HVFLRTTGRQ SATSATSSKA LWEVEVVQHD PCRGGAGYWN
     SLFRFKHLAT GHYLAAEVDP DFEEECLEFQ PSVDPDQDAS RSRLRNAQEK MVYSLVSVPE
     GNDISSIFEL DPTTLRGGDS LVPRNSYVRL RHLCTNTWVH STNIPIDKEE EKPVMLKIGT
     SPVKEDKEAF AIVPVSPAEV RDLDFANDAS KVLGSIAGKL EKGTITQNER RSVTKLLEDL
     VYFVTGGTNS GQDVLEVVFS KPNRERQKLM REQNILKQIF KLLQAPFTDC GDGPMLRLEE
     LGDQRHAPFR HICRLCYRVL RHSQQDYRKN QEYIAKQFGF MQKQIGYDVL AEDTITALLH
     NNRKLLEKHI TAAEIDTFVS LVRKNREPRF LDYLSDLCVS MNKSIPVTQE LICKAVLNPT
     NADILIETKL VLSRFEFEGV SSTGENALEA GEDEEEVWLF WRDSNKEIRS KSVRELAQDA
     KEGQKEDRDV LSYYRYQLNL FARMCLDRQY LAINEISGQL DVDLILRCMS DENLPYDLRA
     SFCRLMLHMH VDRDPQEQVT PVKYARLWSE IPSEIAIDDY DSSGASKDEI KERFAQTMEF
     VEEYLRDVVC QRFPFSDKEK NKLTFEVVNL ARNLIYFGFY NFSDLLRLTK ILLAILDCVH
     VTTIFPISKM AKGEENKGNN DVEKLKSSNV MRSIHGVGEL MTQVVLRGGG FLPMTPMAAA
     PEGNVKQAEP EKEDIMVMDT KLKIIEILQF ILNVRLDYRI SCLLCIFKRE FDESNSQTSE
     TSSGNSSQEG PSNVPGALDF EHIEEQAEGI FGGSEENTPL DLDDHGGRTF LRVLLHLTMH
     DYPPLVSGAL QLLFRHFSQR QEVLQAFKQV QLLVTSQDVD NYKQIKQDLD QLRSIVEKSE
     LWVYKGQGPD ETMDGASGEN EHKKTEEGNN KPQKHESTSS YNYRVVKEIL IRLSKLCVQE
     SASVRKSRKQ QQRLLRNMGA HAVVLELLQI PYEKAEDTKM QEIMRLAHEF LQNFCAGNQQ
     NQALLHKHIN LFLNPGILEA VTMQHIFMNN FQLCSEINER VVQHFVHCIE THGRNVQYIK
     FLQTIVKAEG KFIKKCQDMV MAELVNSGED VLVFYNDRAS FQTLIQMMRS ERDRMDENSP
     LMYHIHLVEL LAVCTEGKNV YTEIKCNSLL PLDDIVRVVT HEDCIPEVKI AYINFLNHCY
     VDTEVEMKEI YTSNHMWKLF ENFLVDICRA CNNTSDRKHA DSILEKYVTE IVMSIVTTFF
     SSPFSDQSTT LQTRQPVFVQ LLQGVFRVYH CNWLMPSQKA SVESCIRVLS DVAKSRAIAI
     PVDLDSQVNN LFLKSHSIVQ KTAMNWRLSA RNAARRDSVL AASRDYRNII ERLQDIVSAL
     EDRLRPLVQA ELSVLVDVLH RPELLFPENT DARRKCESGG FICKLIKHTK QLLEENEEKL
     CIKVLQTLRE MMTKDRGYGE KLISIDELDN AELPPAPDSE NATEELEPSP PLRQLEDHKR
     GEALRQVLVN RYYGNVRPSG RRESLTSFGN GPLSAGGPGK PGGGGGGSGS SSMSRGEMSL
     AEVQCHLDKE GASNLVIDLI MNASSDRVFH ESILLAIALL EGGNTTIQHS FFCRLTEDKK
     SEKFFKVFYD RMKVAQQEIK ATVTVNTSDL GNKKKDDEVD RDAPSRKKAK EPTTQITEEV
     RDQLLEASAA TRKAFTTFRR EADPDDHYQP GEGTQATADK AKDDLEMSAV ITIMQPILRF
     LQLLCENHNR DLQNFLRCQN NKTNYNLVCE TLQFLDCICG STTGGLGLLG LYINEKNVAL
     INQTLESLTE YCQGPCHENQ NCIATHESNG IDIITALILN DINPLGKKRM DLVLELKNNA
     SKLLLAIMES RHDSENAERI LYNMRPKELV EVIKKAYMQG EVEFEDGENG EDGAASPRNV
     GHNIYILAHQ LARHNKELQS MLKPGGQVDG DEALEFYAKH TAQIEIVRLD RTMEQIVFPV
     PSICEFLTKE SKLRIYYTTE RDEQGSKIND FFLRSEDLFN EMNWQKKLRA QPVLYWCARN
     MSFWSSISFN LAVLMNLLVA FFYPFKGVRG GTLEPHWSGL LWTAMLISLA IVIALPKPHG
     IRALIASTIL RLIFSVGLQP TLFLLGAFNV CNKIIFLMSF VGNCGTFTRG YRAMVLDVEF
     LYHLLYLVIC AMGLFVHEFF YSLLLFDLVY REETLLNVIK SVTRNGRSII LTAVLALILV
     YLFSIVGYLF FKDDFILEVD RLPNETAVPE TGESLASEFL FSDVCRVESG ENCSSPAPRE
     ELVPAEETEQ DKEHTCETLL MCIVTVLSHG LRSGGGVGDV LRKPSKEEPL FAARVIYDLL
     FFFMVIIIVL NLIFGVIIDT FADLRSEKQK KEEILKTTCF ICGLERDKFD NKTVTFEEHI
     KEEHNMWHYL CFIVLVKVKD STEYTGPESY VAEMIKERNL DWFPRMRAMS LVSSDSEGEQ
     NELRNLQEKL ESTMKLVTNL SGQLSELKDQ MTEQRKQKQR IGLLGHPPHM NVNPQQPA
//
ID   CLHM1_CAEEL             Reviewed;         329 AA.
AC   Q18593;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 2.
DT   22-NOV-2017, entry version 100.
DE   RecName: Full=Calcium homeostasis modulator protein {ECO:0000312|WormBase:C44B7.4};
GN   Name=clhm-1 {ECO:0000312|WormBase:C44B7.4};
GN   ORFNames=C44B7.4 {ECO:0000312|WormBase:C44B7.4};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF ASP-125.
RX   PubMed=23884934; DOI=10.1523/JNEUROSCI.5919-12.2013;
RA   Tanis J.E., Ma Z., Krajacic P., He L., Foskett J.K., Lamitina T.;
RT   "CLHM-1 is a functionally conserved and conditionally toxic Ca2+-
RT   permeable ion channel in Caenorhabditis elegans.";
RL   J. Neurosci. 33:12275-12286(2013).
CC   -!- FUNCTION: Pore-forming subunit of a voltage-gated ion channel.
CC       Permeable to monovalent cations, divalent cations and anions with
CC       selectivity Ca(2+) > Mg(2+) > Na(+) = K(+) > Cl(-). Acts both as a
CC       voltage-gated and calcium-activated ion channel. Required for
CC       normal locomotion. {ECO:0000269|PubMed:23884934}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23884934};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in head and body wall muscles, IL2,
CC       ASG, ASI, ASJ, PHA and PHB sensory neurons, and spermatheca.
CC       {ECO:0000269|PubMed:23884934}.
CC   -!- DISRUPTION PHENOTYPE: Uncoordinated locomotion with mutants
CC       showing reduced forward velocity, muscle force and power
CC       production. {ECO:0000269|PubMed:23884934}.
CC   -!- SIMILARITY: Belongs to the CALHM family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284602; CCD61557.1; -; Genomic_DNA.
DR   PIR; T15797; T15797.
DR   RefSeq; NP_495403.2; NM_063002.3.
DR   UniGene; Cel.15677; -.
DR   TCDB; 1.A.84.1.4; the calcium homeostasis modulator ca(2+) channel (calhm-c) family.
DR   PaxDb; Q18593; -.
DR   PRIDE; Q18593; -.
DR   EnsemblMetazoa; C44B7.4; C44B7.4; WBGene00016626.
DR   GeneID; 183429; -.
DR   KEGG; cel:CELE_C44B7.4; -.
DR   UCSC; C44B7.4; c. elegans.
DR   CTD; 183429; -.
DR   WormBase; C44B7.4; CE34753; WBGene00016626; clhm-1.
DR   eggNOG; ENOG410IEDF; Eukaryota.
DR   eggNOG; ENOG410XQ8H; LUCA.
DR   GeneTree; ENSGT00530000062796; -.
DR   HOGENOM; HOG000019373; -.
DR   InParanoid; Q18593; -.
DR   OMA; TFNPKEQ; -.
DR   OrthoDB; EOG091G0AYI; -.
DR   PhylomeDB; Q18593; -.
DR   PRO; PR:Q18593; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00016626; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0097730; C:non-motile cilium; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:WormBase.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:WormBase.
DR   GO; GO:0040012; P:regulation of locomotion; IMP:WormBase.
DR   InterPro; IPR029569; FAM26.
DR   PANTHER; PTHR32261; PTHR32261; 1.
DR   Pfam; PF14798; Ca_hom_mod; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    329       Calcium homeostasis modulator protein.
FT                                {ECO:0000305}.
FT                                /FTId=PRO_0000438169.
FT   TOPO_DOM      1     14       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     15     35       Helical. {ECO:0000255}.
FT   TOPO_DOM     36     53       Extracellular. {ECO:0000305}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75    103       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    191       Extracellular. {ECO:0000305}.
FT   TRANSMEM    192    212       Helical. {ECO:0000255}.
FT   TOPO_DOM    213    329       Cytoplasmic. {ECO:0000305}.
FT   CARBOHYD    148    148       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   MUTAGEN     125    125       D->A: Changes relative Ca2+ and Cl-
FT                                permeabilities.
FT                                {ECO:0000269|PubMed:23884934}.
SQ   SEQUENCE   329 AA;  37274 MW;  B7EEBDC0CBF561BA CRC64;
     MTTSINSVVT VFQNVFTNHG STLLNGILIA TTVGGQSLVR KLTFSCPCAY PLNIYHSLVF
     MFGPTAALLL IGITVNSTTW KLAHGFFFRV RDTRHSWKTT CVSWIEVLIQ SSVAPIAWLF
     VVFLDGGYYR CYRSHEFCLI SDAILCKNST ILNSYASTSS FNKISDNGKY CPPCICVPNP
     TDASYLEAES QIYAWGLLLF SGVAAFLVIT CNRMCDKYTL VQRQYVETYK NVETQKFDAV
     AKEHASQLAE HNARAFFGQK DWTKRDWDWV SGIPEVNNPL FARLRLIAAE KTQQTMYTPL
     QLWNDNKGYR IPQPDLQLTQ IIVDETKED
//
ID   TMCO1_CAEEL             Reviewed;         186 AA.
AC   Q19714;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 98.
DE   RecName: Full=Calcium load-activated calcium channel homolog {ECO:0000250|UniProtKB:Q9UM00};
DE            Short=CLAC channel {ECO:0000250|UniProtKB:Q9UM00};
GN   ORFNames=F22B5.10 {ECO:0000312|WormBase:F22B5.10};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION.
RX   PubMed=27212239; DOI=10.1016/j.cell.2016.04.051;
RA   Wang Q.C., Zheng Q., Tan H., Zhang B., Li X., Yang Y., Yu J., Liu Y.,
RA   Chai H., Wang X., Sun Z., Wang J.Q., Zhu S., Wang F., Yang M., Guo C.,
RA   Wang H., Zheng Q., Li Y., Chen Q., Zhou A., Tang T.S.;
RT   "TMCO1 is an ER Ca(2+) load-activated Ca(2+) channel.";
RL   Cell 165:1454-1466(2016).
CC   -!- FUNCTION: Calcium-selective channel required to prevent calcium
CC       stores from overfilling. {ECO:0000305|PubMed:27212239}.
CC   -!- SUBUNIT: Homodimer and homotetramer.
CC       {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9UM00}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SIMILARITY: Belongs to the TMCO1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284602; CAA90361.1; -; Genomic_DNA.
DR   PIR; T21243; T21243.
DR   RefSeq; NP_495786.1; NM_063385.5.
DR   UniGene; Cel.15336; -.
DR   ProteinModelPortal; Q19714; -.
DR   STRING; 6239.F22B5.10.1; -.
DR   EPD; Q19714; -.
DR   PaxDb; Q19714; -.
DR   PeptideAtlas; Q19714; -.
DR   EnsemblMetazoa; F22B5.10; F22B5.10; WBGene00009045.
DR   GeneID; 174352; -.
DR   KEGG; cel:CELE_F22B5.10; -.
DR   UCSC; F22B5.10; c. elegans.
DR   CTD; 174352; -.
DR   WormBase; F22B5.10; CE02196; WBGene00009045; -.
DR   eggNOG; KOG3312; Eukaryota.
DR   eggNOG; ENOG410XR8B; LUCA.
DR   GeneTree; ENSGT00390000002659; -.
DR   HOGENOM; HOG000240371; -.
DR   InParanoid; Q19714; -.
DR   KO; K21891; -.
DR   OMA; HKKKIER; -.
DR   OrthoDB; EOG091G0QPG; -.
DR   PhylomeDB; Q19714; -.
DR   PRO; PR:Q19714; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00009045; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IEA:InterPro.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:UniProtKB.
DR   InterPro; IPR002809; EMC3/TMCO1.
DR   InterPro; IPR008559; TMCO1.
DR   PANTHER; PTHR20917; PTHR20917; 1.
DR   Pfam; PF01956; DUF106; 1.
DR   PIRSF; PIRSF023322; DUF841_euk; 1.
DR   SMART; SM01415; DUF106; 1.
PE   3: Inferred from homology;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    186       Calcium load-activated calcium channel
FT                                homolog.
FT                                /FTId=PRO_0000437216.
FT   TOPO_DOM      1      6       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TOPO_DOM     28     87       Lumenal. {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TOPO_DOM    109    134       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   INTRAMEM    135    151       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TOPO_DOM    152    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   COILED       30     86       {ECO:0000255}.
SQ   SEQUENCE   186 AA;  21299 MW;  7CC420744A53E8C2 CRC64;
     MLGDCLLIIA IAFGTALAGE GITWLLVYRS DHYKRLKADM DKKTKKLEKK KQEVGDTNDK
     NIKRKLEREE ERLKATNRDM SMFKMKSMFA IGLAFTALLS TFNSIFEGRV VAKLPFYPIG
     FIQGLSHRNL IGEDMTDCSF IFLYILCTMT VRQNLQKILG FAPSRAMARQ QSSPWAPPNS
     QMNYLR
//
ID   MCU1_ARATH              Reviewed;         338 AA.
AC   Q1PE15; A0MFC5; O23200;
DT   26-NOV-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 1.
DT   20-DEC-2017, entry version 76.
DE   RecName: Full=Calcium uniporter protein 1, mitochondrial;
DE   Flags: Precursor;
GN   OrderedLocusNames=At4g36820 {ECO:0000312|Araport:AT4G36820};
GN   ORFNames=AP22.5 {ECO:0000312|EMBL:CAB80348.1},
GN   C7A10.540 {ECO:0000312|EMBL:CAB16819.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9461215; DOI=10.1038/35140;
RA   Bevan M., Bancroft I., Bent E., Love K., Goodman H.M., Dean C.,
RA   Bergkamp R., Dirkse W., van Staveren M., Stiekema W., Drost L.,
RA   Ridley P., Hudson S.-A., Patel K., Murphy G., Piffanelli P.,
RA   Wedler H., Wedler E., Wambutt R., Weitzenegger T., Pohl T., Terryn N.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Lecharny A.,
RA   Aubourg S., Gy I., Kreis M., Lao N., Kavanagh T., Hempel S.,
RA   Kotter P., Entian K.-D., Rieger M., Schaefer M., Funk B.,
RA   Mueller-Auer S., Silvey M., James R., Monfort A., Pons A.,
RA   Puigdomenech P., Douka A., Voukelatou E., Milioni D., Hatzopoulos P.,
RA   Piravandi E., Obermaier B., Hilbert H., Duesterhoeft A., Moores T.,
RA   Jones J.D.G., Eneva T., Palme K., Benes V., Rechmann S., Ansorge W.,
RA   Cooke R., Berger C., Delseny M., Voet M., Volckaert G., Mewes H.-W.,
RA   Klosterman S., Schueller C., Chalwatzis N.;
RT   "Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of
RT   Arabidopsis thaliana.";
RL   Nature 391:485-488(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=17147637; DOI=10.1111/j.1467-7652.2006.00183.x;
RA   Underwood B.A., Vanderhaeghen R., Whitford R., Town C.D., Hilson P.;
RT   "Simultaneous high-throughput recombinational cloning of open reading
RT   frames in closed and open configurations.";
RL   Plant Biotechnol. J. 4:317-324(2006).
RN   [5]
RP   GENE FAMILY, AND REVIEW.
RX   PubMed=22200666; DOI=10.1093/jxb/err394;
RA   Stael S., Wurzinger B., Mair A., Mehlmer N., Vothknecht U.C.,
RA   Teige M.;
RT   "Plant organellar calcium signalling: an emerging field.";
RL   J. Exp. Bot. 63:1525-1542(2012).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria. Constitutes a pore-
CC       forming and calcium-conducting subunit. Mitochondrial calcium
CC       homeostasis plays key roles in cellular physiology and regulates
CC       cell bioenergetics, cytoplasmic calcium signals and activation of
CC       cell death pathways. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABK28670.1; Type=Erroneous termination; Positions=339; Note=Translated as stop.; Evidence={ECO:0000305};
CC       Sequence=CAB16819.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB80348.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z99708; CAB16819.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161590; CAB80348.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE86706.1; -; Genomic_DNA.
DR   EMBL; DQ446903; ABE66118.1; -; mRNA.
DR   EMBL; DQ653251; ABK28670.1; ALT_SEQ; mRNA.
DR   PIR; G85434; G85434.
DR   RefSeq; NP_195400.2; NM_119846.4.
DR   UniGene; At.54635; -.
DR   SMR; Q1PE15; -.
DR   BioGrid; 15116; 8.
DR   STRING; 3702.AT4G36820.1; -.
DR   TCDB; 1.A.77.1.2; the mg(2+)/ca(2+) uniporter (mcu) family.
DR   PaxDb; Q1PE15; -.
DR   EnsemblPlants; AT4G36820.1; AT4G36820.1; AT4G36820.
DR   GeneID; 829835; -.
DR   Gramene; AT4G36820.1; AT4G36820.1; AT4G36820.
DR   KEGG; ath:AT4G36820; -.
DR   Araport; AT4G36820; -.
DR   TAIR; locus:2115205; AT4G36820.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   HOGENOM; HOG000239883; -.
DR   InParanoid; Q1PE15; -.
DR   KO; K20858; -.
DR   OMA; SHPKEET; -.
DR   OrthoDB; EOG09360N9O; -.
DR   PhylomeDB; Q1PE15; -.
DR   Reactome; R-ATH-8949215; Mitochondrial calcium ion transport.
DR   PRO; PR:Q1PE15; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q1PE15; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0015292; F:uniporter activity; IBA:GO_Central.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     36       Mitochondrion. {ECO:0000255}.
FT   CHAIN        37    338       Calcium uniporter protein 1,
FT                                mitochondrial.
FT                                /FTId=PRO_0000431370.
FT   TRANSMEM    233    253       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    263    280       Helical; Name=2. {ECO:0000255}.
SQ   SEQUENCE   338 AA;  38349 MW;  5DE85990FC0D3C04 CRC64;
     MVMMKKLLSN RLFNMSKTAS QSLMNCRTSS SSSLAMRTRV PKDIGEATID PEPGDLTISQ
     RFLNKFSMNG IDTTSKMSIG ESLMEKLKEM DMNKDRIRLD GLSHPKEETL GLTVQDVKKL
     LRAAEIEVIK TKLMETGKIW IRYSDFLGVC SDSSLDPSQG ALIAKMLDDS GNVIVMGNSV
     CLRPHQLTKS IEGLLPLSQI HNPNDPRRKE LNELEAIKTV IDQKAHSLVR RELWAGLGYL
     IIQTAGFMRL TFWDLTWDVM EPICFYVSSV YFMAGYTFFL KTSREPSFQG FYQSRFEAKQ
     RKLMQSEDFD VGRYDELKKL FNPKPSGAVP KILGSLQN
//
ID   MCU_CAEEL               Reviewed;         333 AA.
AC   Q21121;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   25-OCT-2017, entry version 103.
DE   RecName: Full=Calcium uniporter protein, mitochondrial {ECO:0000305};
DE            Short=cMCU {ECO:0000303|PubMed:27135929};
DE   Flags: Precursor;
GN   Name=mcu-1 {ECO:0000303|PubMed:25313960,
GN   ECO:0000312|WormBase:K02B2.3};
GN   ORFNames=K02B2.3 {ECO:0000312|WormBase:K02B2.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25313960; DOI=10.1016/j.devcel.2014.08.002;
RA   Xu S., Chisholm A.D.;
RT   "C. elegans epidermal wounding induces a mitochondrial ROS burst that
RT   promotes wound repair.";
RL   Dev. Cell 31:48-60(2014).
RN   [3] {ECO:0000312|PDB:5ID3}
RP   STRUCTURE BY NMR OF 167-317 OF MUTANT ALA-238, ENZYME REGULATION,
RP   SUBUNIT, DOMAIN, AND MUTAGENESIS OF SER-238.
RX   PubMed=27135929; DOI=10.1038/nature17656;
RA   Oxenoid K., Dong Y., Cao C., Cui T., Sancak Y., Markhard A.L.,
RA   Grabarek Z., Kong L., Liu Z., Ouyang B., Cong Y., Mootha V.K.,
RA   Chou J.J.;
RT   "Architecture of the mitochondrial calcium uniporter.";
RL   Nature 533:269-273(2016).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria (PubMed:25313960).
CC       Constitutes a pore-forming and calcium-conducting subunit (By
CC       similarity). Mitochondrial calcium homeostasis plays key roles in
CC       cellular physiology and regulates cell bioenergetics, cytoplasmic
CC       calcium signals and activation of cell death pathways (By
CC       similarity). Required for rapid mitochondrial calcium uptake and
CC       mitochondrial reactive oxygen species (mtROS) production after
CC       wounding (PubMed:25313960). {ECO:0000250|UniProtKB:Q8NE86,
CC       ECO:0000269|PubMed:25313960}.
CC   -!- ENZYME REGULATION: Inhibited by ruthenium red or its derivative
CC       Ru360; possibly by obstructing the pore.
CC       {ECO:0000269|PubMed:27135929}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-11465987, EBI-11465987;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- DOMAIN: Forms a well-packed pentamer with an overall cylindrical
CC       shape. The inner core of the pentamer is formed with the second
CC       transmembrane region and the second coiled-coil region (residues
CC       293-316): while the transmembrane regions pack into a five-helix
CC       bundle having a largely polar pore across the membrane, the
CC       coiled-coil outside the membrane forms a pentamer with a
CC       hydrophobic core, which may contribute to stabilizing the
CC       transmembrane pore structure. The transmembrane pore is wrapped by
CC       the first transmembrane region through contacts between the first
CC       and the second transmembrane regions. The second transmembrane is
CC       followed by the inner juxtamembrane region (IJMH) that orients at
CC       a wide angle relative to the second transmembrane. The two core
CC       domains are held together on the periphery by the outer
CC       juxtamembrane helix (OJMH), which contains a kink around Glu-204
CC       and interacts with the IJMH. {ECO:0000269|PubMed:27135929}.
CC   -!- DOMAIN: The critical DXXE motif connecting the transmembrane
CC       regions forms a pentameric barrel that constitutes the mouth of
CC       the pore. Inside the barrel, both acidic residues are in position
CC       to form two carboxylate rings: the Asp-240 ring is solvent
CC       exposed, and the Glu-243 ring is located deeper, guarding the
CC       entrance of the second transmembrane pore. In absence of emre-1
CC       regulator, the calcium ions cannot exit the channel, suggesting
CC       that emre-1-binding induces conformational rearrangements to allow
CC       calcium to exit. {ECO:0000269|PubMed:27135929}.
CC   -!- DISRUPTION PHENOTYPE: null mutants are viable and fertile but show
CC       strongly impaired mitochondrial calcium following laser or needle
CC       wounding. Reduced wound-induced mitoflashes.
CC       {ECO:0000269|PubMed:25313960}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284604; CCD61802.1; -; Genomic_DNA.
DR   PIR; B88700; B88700.
DR   RefSeq; NP_500892.1; NM_068491.4.
DR   UniGene; Cel.12690; -.
DR   PDB; 5ID3; NMR; -; A/B/C/D/E=167-318.
DR   PDBsum; 5ID3; -.
DR   ProteinModelPortal; Q21121; -.
DR   SMR; Q21121; -.
DR   DIP; DIP-61976N; -.
DR   IntAct; Q21121; 1.
DR   STRING; 6239.K02B2.3.1; -.
DR   EPD; Q21121; -.
DR   PaxDb; Q21121; -.
DR   PeptideAtlas; Q21121; -.
DR   EnsemblMetazoa; K02B2.3; K02B2.3; WBGene00019296.
DR   GeneID; 177362; -.
DR   KEGG; cel:CELE_K02B2.3; -.
DR   UCSC; K02B2.3.1; c. elegans.
DR   CTD; 177362; -.
DR   WormBase; K02B2.3; CE27192; WBGene00019296; mcu-1.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   GeneTree; ENSGT00390000004496; -.
DR   HOGENOM; HOG000008081; -.
DR   InParanoid; Q21121; -.
DR   KO; K20858; -.
DR   OMA; LGVVYCS; -.
DR   OrthoDB; EOG091G092C; -.
DR   PhylomeDB; Q21121; -.
DR   Reactome; R-CEL-8949215; Mitochondrial calcium ion transport.
DR   PRO; PR:Q21121; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00019296; -.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:1990246; C:uniplex complex; IBA:GO_Central.
DR   GO; GO:0005262; F:calcium channel activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0015292; F:uniporter activity; IBA:GO_Central.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0036444; P:mitochondrial calcium uptake; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:1903426; P:regulation of reactive oxygen species biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0061041; P:regulation of wound healing; IMP:UniProtKB.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     22       Mitochondrion. {ECO:0000255}.
FT   CHAIN        23    333       Calcium uniporter protein, mitochondrial.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000437212.
FT   TOPO_DOM     23    214       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    215    234       Helical. {ECO:0000269|PubMed:27135929}.
FT   TOPO_DOM    235    243       Mitochondrial intermembrane.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    244    260       Helical. {ECO:0000269|PubMed:27135929}.
FT   TOPO_DOM    261    333       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   REGION      195    213       Outer juxtamembrane helix (OJMH).
FT                                {ECO:0000269|PubMed:27135929}.
FT   REGION      262    271       Inner juxtamembrane helix (IJMH).
FT                                {ECO:0000269|PubMed:27135929}.
FT   COILED      180    193       {ECO:0000269|PubMed:27135929}.
FT   COILED      289    316       {ECO:0000269|PubMed:27135929}.
FT   MOTIF       240    243       DXXE. {ECO:0000269|PubMed:27135929}.
FT   MUTAGEN     238    238       S->A: Strongly reduced sensitivity to
FT                                ruthenium red inhibition.
FT                                {ECO:0000269|PubMed:27135929}.
FT   STRAND      168    171       {ECO:0000244|PDB:5ID3}.
FT   HELIX       180    192       {ECO:0000244|PDB:5ID3}.
FT   HELIX       195    202       {ECO:0000244|PDB:5ID3}.
FT   TURN        203    206       {ECO:0000244|PDB:5ID3}.
FT   HELIX       207    210       {ECO:0000244|PDB:5ID3}.
FT   HELIX       211    214       {ECO:0000244|PDB:5ID3}.
FT   TURN        215    217       {ECO:0000244|PDB:5ID3}.
FT   HELIX       218    225       {ECO:0000244|PDB:5ID3}.
FT   HELIX       227    233       {ECO:0000244|PDB:5ID3}.
FT   TURN        234    236       {ECO:0000244|PDB:5ID3}.
FT   HELIX       244    265       {ECO:0000244|PDB:5ID3}.
FT   TURN        266    269       {ECO:0000244|PDB:5ID3}.
FT   STRAND      276    278       {ECO:0000244|PDB:5ID3}.
FT   HELIX       293    314       {ECO:0000244|PDB:5ID3}.
SQ   SEQUENCE   333 AA;  38554 MW;  14398F25E6C4D4EE CRC64;
     MRNGRCLVTP FVTAQRLANL RNTLWNRQQI AFSTTTASSS TSPIQESSSP LSIRFEYGLP
     LLDVPLPSRN EPCQFTMRPL SDTIGSLCEF LRQEDRGIDY VAVYGTNGVK LATCTSIEHL
     LQFGSFRLRL NDKFFDVTVP KTGTMPYDSD KLRQLDDLRA TVASLHAALC VDEYKLSREK
     KLLLQLENAE TLLAPLHDAK RKIEQECEAH TDRVMWAGFA AMGVQTGLFA RLTWWEYSWD
     IMEPVTYFAT YSTVCATFGY YLYTQQSFEY PSARERVYTK QFYRRAQKQN FDIEKYNRLV
     TEVDELRNQL KRMRDPLFQH LPVSYLSNLE AEK
//
ID   CAC1D_DROME             Reviewed;        2516 AA.
AC   Q24270; Q8IP23; Q8IP24; Q8IP25; Q95U73; Q9V3P7;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2003, sequence version 2.
DT   27-SEP-2017, entry version 160.
DE   RecName: Full=Voltage-dependent calcium channel type D subunit alpha-1;
DE            Short=DmCa1D;
GN   Name=Ca-alpha1D; Synonyms=DroCa1, l(2)35Fa; ORFNames=CG4894;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Canton-S; TISSUE=Head;
RX   PubMed=7869089;
RA   Zheng W., Feng G., Ren D., Eberl D.F., Hannan F., Dubald M.,
RA   Hall L.M.;
RT   "Cloning and characterization of a calcium channel alpha 1 subunit
RT   from Drosophila melanogaster with similarity to the rat brain type D
RT   isoform.";
RL   J. Neurosci. 15:1132-1143(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10471707;
RA   Ashburner M., Misra S., Roote J., Lewis S.E., Blazej R.G., Davis T.,
RA   Doyle C., Galle R.F., George R.A., Harris N.L., Hartzell G.,
RA   Harvey D.A., Hong L., Houston K.A., Hoskins R.A., Johnson G.,
RA   Martin C., Moshrefi A.R., Palazzolo M., Reese M.G., Spradling A.C.,
RA   Tsang G., Wan K.H., Whitelaw K., Celniker S.E., Rubin G.M.;
RT   "An exploration of the sequence of a 2.9-Mb region of the genome of
RT   Drosophila melanogaster: the Adh region.";
RL   Genetics 153:179-219(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1895-2300 (ISOFORM D).
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   MUTAGENESIS OF CYS-629.
RX   PubMed=9502794;
RA   Ren D., Xu H., Eberl D.F., Chopra M., Hall L.M.;
RT   "A mutation affecting dihydropyridine-sensitive current levels and
RT   activation kinetics in Drosophila muscle and mammalian heart calcium
RT   channels.";
RL   J. Neurosci. 18:2335-2341(1998).
RN   [7]
RP   MUTAGENESIS OF CYS-629.
RX   PubMed=9539432;
RA   Eberl D.F., Ren D., Feng G., Lorenz L.J., van Vactor D., Hall L.M.;
RT   "Genetic and developmental characterization of Dmca1D, a calcium
RT   channel alpha-1 subunit gene in Drosophila melanogaster.";
RL   Genetics 148:1159-1169(1998).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. Encodes a
CC       dihydropyridine- and diltiazem-sensitive current in larval body
CC       wall muscle. Vital for embryonic development.
CC       {ECO:0000269|PubMed:7869089}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=Q24270-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q24270-3; Sequence=VSP_017568;
CC         Note=No experimental confirmation available.;
CC       Name=C;
CC         IsoId=Q24270-4; Sequence=VSP_017569;
CC         Note=No experimental confirmation available.;
CC       Name=D;
CC         IsoId=Q24270-2; Sequence=VSP_007604, VSP_007605;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the adult body, head and leg.
CC       Highly expressed in the embryonic nervous system.
CC   -!- DEVELOPMENTAL STAGE: Faintly expressed in embryos at 9-12 hours.
CC       Expression increases rapidly as the nervous system matures,
CC       peaking just prior to hatching. A second peak is observed in late
CC       pupal stages around 73-108 hours postpuparium.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1, Met-494, Met-539, Met-544
CC       or Met-553 is the initiator. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL13497.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00690; AAA81883.1; -; mRNA.
DR   EMBL; AE014134; AAF53504.1; -; Genomic_DNA.
DR   EMBL; AE014134; AAN10929.1; -; Genomic_DNA.
DR   EMBL; AE014134; AAN10930.1; -; Genomic_DNA.
DR   EMBL; AE014134; AAN10931.1; -; Genomic_DNA.
DR   EMBL; AY058268; AAL13497.1; ALT_INIT; mRNA.
DR   RefSeq; NP_525104.2; NM_080365.3. [Q24270-3]
DR   RefSeq; NP_602305.1; NM_134429.3. [Q24270-1]
DR   RefSeq; NP_723952.1; NM_165146.2. [Q24270-4]
DR   RefSeq; NP_723953.1; NM_165147.2. [Q24270-2]
DR   UniGene; Dm.4099; -.
DR   ProteinModelPortal; Q24270; -.
DR   SMR; Q24270; -.
DR   BioGrid; 60962; 3.
DR   IntAct; Q24270; 7.
DR   STRING; 7227.FBpp0089047; -.
DR   PaxDb; Q24270; -.
DR   PRIDE; Q24270; -.
DR   EnsemblMetazoa; FBtr0090003; FBpp0089046; FBgn0001991. [Q24270-2]
DR   EnsemblMetazoa; FBtr0090004; FBpp0089047; FBgn0001991. [Q24270-4]
DR   EnsemblMetazoa; FBtr0090005; FBpp0089048; FBgn0001991. [Q24270-3]
DR   EnsemblMetazoa; FBtr0090006; FBpp0089049; FBgn0001991. [Q24270-1]
DR   GeneID; 34950; -.
DR   KEGG; dme:Dmel_CG4894; -.
DR   CTD; 34950; -.
DR   FlyBase; FBgn0001991; Ca-alpha1D.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   InParanoid; Q24270; -.
DR   KO; K04851; -.
DR   OMA; LIQVERP; -.
DR   OrthoDB; EOG091G0TKO; -.
DR   PhylomeDB; Q24270; -.
DR   ChiTaRS; Ca-alpha1D; fly.
DR   GenomeRNAi; 34950; -.
DR   PRO; PR:Q24270; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0001991; -.
DR   ExpressionAtlas; Q24270; differential.
DR   Genevisible; Q24270; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:FlyBase.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:FlyBase.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IGI:FlyBase.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:FlyBase.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:FlyBase.
DR   GO; GO:0006816; P:calcium ion transport; NAS:FlyBase.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:FlyBase.
DR   GO; GO:0042045; P:epithelial fluid transport; IDA:FlyBase.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; TAS:FlyBase.
DR   GO; GO:0016322; P:neuron remodeling; IMP:FlyBase.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2516       Voltage-dependent calcium channel type D
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000053960.
FT   TOPO_DOM      1    615       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    616    634       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    635    653       Extracellular. {ECO:0000255}.
FT   TRANSMEM    654    671       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    672    684       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    685    699       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    700    711       Extracellular. {ECO:0000255}.
FT   TRANSMEM    712    730       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    731    750       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    751    770       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    771    853       Extracellular. {ECO:0000255}.
FT   TRANSMEM    854    878       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    879    985       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    986   1005       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1006   1018       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1019   1038       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1039   1047       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1048   1066       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1067   1076       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1077   1095       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1096   1114       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1115   1134       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1135   1190       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1191   1215       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1216   1339       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1340   1363       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1364   1380       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1381   1400       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1401   1408       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1409   1431       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1432   1439       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1440   1454       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1455   1475       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1476   1495       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1496   1584       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1585   1609       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1610   1664       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1665   1683       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1684   1697       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1698   1717       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1718   1726       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1727   1745       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1746   1777       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1778   1796       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1797   1815       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1816   1835       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1836   1902       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1903   1921       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1922   2516       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      602    883       I.
FT   REPEAT      971   1217       II.
FT   REPEAT     1331   1613       III.
FT   REPEAT     1648   1929       IV.
FT   CA_BIND    1957   1968       {ECO:0000250}.
FT   REGION     1533   1622       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1885   1948       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1896   1937       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS     59     62       Poly-Val.
FT   COMPBIAS    208    211       Poly-Gly.
FT   COMPBIAS    262    267       Poly-Ser.
FT   COMPBIAS    322    328       Poly-Ala.
FT   COMPBIAS    460    463       Poly-Glu.
FT   COMPBIAS   1115   1121       Poly-Leu.
FT   COMPBIAS   1288   1292       Poly-Glu.
FT   COMPBIAS   1591   1597       Poly-Ile.
FT   COMPBIAS   2466   2469       Poly-Asn.
FT   SITE        836    836       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1168   1168       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1559   1559       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1869   1869       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1937   1937       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    644    644       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    647    647       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ    1293   1329       VDEEGMITARPRRMSEVNTATKILPIPPGTSFFLFSQ ->
FT                                DSNSEVSARVTARPRRLSEVSMKKTKKPIPRGSAFFIFSY
FT                                (in isoform B). {ECO:0000305}.
FT                                /FTId=VSP_017568.
FT   VAR_SEQ    1496   1496       K -> KYVVKCVVVAIKTIGNIMLVTYLLQFMFAVIGVQLF
FT                                K (in isoform C). {ECO:0000305}.
FT                                /FTId=VSP_017569.
FT   VAR_SEQ    2282   2300       NRNRGILLHPYNNVYAPNG -> LRTQWCSSWPRTHDPIDT
FT                                S (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_007604.
FT   VAR_SEQ    2301   2516       Missing (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_007605.
FT   MUTAGEN     629    629       C->Y: In AR66; slower channel activation
FT                                and reduction of peak current.
FT                                {ECO:0000269|PubMed:9502794,
FT                                ECO:0000269|PubMed:9539432}.
FT   CONFLICT    134    134       P -> A (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       F -> L (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT    678    678       N -> D (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT    683    683       R -> G (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT    696    696       I -> M (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT   1390   1390       I -> M (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT   1433   1433       N -> D (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
FT   CONFLICT   2479   2479       N -> S (in Ref. 1; AAA81883).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2516 AA;  276700 MW;  8CFC07499E750901 CRC64;
     MGGGELVNCI AYDDNTLVIE RKPSPSSPST SRRYLKAETP TRGSRKYNRK SSAKSDLEVV
     VVKPEHHHQH RSPTITLPVP ANPLTTSASA GSSPTGAGLA AGLGTASGTV LQQSCSALDP
     PEDSNQPSGT RRRPTSTELA LSNVTSQIVN NATYKLDFKQ RRHKSNNGGS ESGSLTGIAT
     GPATSPAGPT GPTSSSGKRR KSSCTSCGGG GISAPPPRLT PEEAWQLQPQ NSVTSAGSTN
     SSFSSGGGRD DNSSYSAVGG DSSSSNSCNC DITGDNSTLH GFGVGDVCSF IADCDDNSED
     DDGDPNNQDL SSQTLRTAAI VAAVAAAAKE QAQEQSLADC ESFSDRRQDA DEDVRIIQDC
     CGGNNDSLED VGEVDDNADV VVRKNSRNRP SIRRTCRITE EDDDEDENAD YGDFDREDQE
     LDDEEPEGTT IDIDEQEQQH DQGDSAEEED DDEDVDEYFE EEEDDTQAFS PFYSSSAELI
     DNFGGGAGKF FNIMDFERGA SGEGGFSPNG NGGPGSGDVS RTARYDSGEG DLGGGNNIMG
     IDSMGIANIP ETMNGTTIGP SGAGGQKGGA AAGAAGQKRQ QRRGKPQPDR PQRALFCLSV
     KNPLRALCIR IVEWKPFEFL ILLTIFANCI ALAVYTPYPG SDSNVTNQTL EKVEYVFLVI
     FTAECVMKIL AYGFVLHNGA YLRNGWNLLD FTIVVIGAIS TALSQLMKDA FDVKALRAFR
     VLRPLRLVSG VPSLQVVLNS ILKAMVPLFH IALLVLFVII IYAIIGLELF SGKLHKACRD
     EITGEYEENI RPCGVGYQCP PGYKCYGGWD GPNDGITNFD NFGLAMLTVF QCVTLEGWTD
     VLYSIQDAMG SDWQWMYFIS MVILGAFFVM NLILGVLSGE FSKERNKAKN RGDFQKLREK
     QQIEEDLRGY LDWITQAEDI EPDAVGGLIS DGKGKQPNEM DSTENLGEEM PEVQMTESRW
     RKMKKDFDRV NRRMRRACRK AVKSQAFYWL IIVLVFLNTG VLATEHYGQL DWLDNFQEYT
     NVFFIGLFTC EMLLKMYSLG FQGYFVSLFN RFDCFVVIGS ITETLLTNTG MMPPLGVSVL
     RCVRLLRVFK VTKYWRSLSN LVASLLNSIQ SIASLLLLLF LFIVIFALLG MQVFGGKFNF
     DGKEEKYRMN FDCFWQALLT VFQIMTGEDW NAVMYVGINA YGGVSSYGAL ACIYFIILFI
     CGNYILLNVF LAIAVDNLAD ADSLSEVEKE EEPHDESAQK KSHSPTPTID GMDDHLSIDI
     DMEQQELDDE DKMDHETLSD EEVREMCEEE EEVDEEGMIT ARPRRMSEVN TATKILPIPP
     GTSFFLFSQT NRFRVFCHWL CNHSNFGNII LCCIMFSSAM LAAENPLRAN DDLNKVLNKF
     DYFFTAVFTI ELILKLISYG FVLHDGAFCR SAFNLLDLLV VCVSLISLVS SSNAISVVKI
     LRVLRVLRPL RAINRAKGLK HVVQCVIVAV KTIGNIVLVT CLLQFMFAVI GVQLFKGKFF
     KCTDGSKMTQ DECYGTYLVY DDGDVHKPRL REREWSNNRF HFDDVAKGML TLFTVSTFEG
     WPGLLYVSID SNKENGGPIH NFRPIVAAYY IIYIIIIAFF MVNIFVGFVI VTFQNEGEQE
     YKNCDLDKNQ RNCIEFALKA KPVRRYIPKH GIQYKVWWFV TSSSFEYTIF ILIMINTVTL
     AMKFYNQPLW YTELLDALNM IFTAVFALEF VFKLAAFRFK NYFGDAWNVF DFIIVLGSFI
     DIVYSEIKSK DTSQIAECDI VEGCKSTKKS AGSNLISINF FRLFRVMRLV KLLSKGEGIR
     TLLWTFIKSF QALPYVALLI VLLFFIYAVV GMQVFGKIAL DGGNAITANN NFQTFQQAVL
     VLFRSATGEA WQEIMMSCSA QPDVKCDMNS DTPGEPCGSS IAYPYFISFY VLCSFLIINL
     FVAVIMDNFD YLTRDWSILG PHHLDEFIRL WSEYDPDAKG RIKHLDVVTL LRKISPPLGF
     GKLCPHRMAC KRLVSMNMPL NSDGTVLFNA TLFAVVRTSL SIKTDGNIDD ANSELRATIK
     QIWKRTNPKL LDQVVPPPGN DDEVTVGKFY ATYLIQDYFR RFKKRKEQEG KEGHPDSNTV
     TLQAGLRTLH EVSPALKRAI SGNLDELDQE PEPMHRRHHT LFGSVWSSIR RHGNGTFRRS
     AKATASQSNG ALAIGGSASA ALGVGGSSLV LGSSDPAGGD YLYDTLNRSV ADGVNNITRN
     IMQARLAAAG KLQDELQGAG SGGELRTFGE SISMRPLAKN GGGAATVAGT LPPEANAINY
     DNRNRGILLH PYNNVYAPNG ALPGHERMIQ STPASPYDQR RLPTSSDMNG LAESLIGGVL
     AAEGLGKYCD SEFVGTAARE MREALDMTPE EMNLAAHQIL SNEHSLSLIG SSNGSIFGGS
     AGGLGGAGSG GVGGLGGSSS IRNAFGGSGS GPSSLSPQHQ PYSGTLNSPP IPDNRLRRVA
     TVTTTNNNNK SQVSQNNSNS LNVRANANSQ MNMSPTGQPV QQQSPLRGQG NQTYSS
//
ID   RYR_DROME               Reviewed;        5127 AA.
AC   Q24498; Q24321; Q24499; Q24500; Q24501; Q8MKS3; Q8MKS4; Q8MKS5;
AC   Q9V4Y7;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 3.
DT   22-NOV-2017, entry version 159.
DE   RecName: Full=Ryanodine receptor;
DE   AltName: Full=Ryanodine receptor 44F;
GN   Name=RyR {ECO:0000312|FlyBase:FBgn0011286};
GN   Synonyms=dry, Rya-r44F {ECO:0000312|FlyBase:FBgn0011286};
GN   ORFNames=CG10844 {ECO:0000312|FlyBase:FBgn0011286};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|EMBL:AAF59036.2};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS A; B; C AND D), FUNCTION,
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8276118; DOI=10.1016/0014-5793(94)80634-9;
RA   Takeshima H., Nishi M., Iwabe N., Miyata T., Hosoya T., Masai I.,
RA   Hotta Y.;
RT   "Isolation and characterization of a gene for a ryanodine
RT   receptor/calcium release channel in Drosophila melanogaster.";
RL   FEBS Lett. 337:81-87(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3] {ECO:0000305}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:12537572};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE OF 4619-5127, DEVELOPMENTAL STAGE, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain {ECO:0000269|PubMed:1338312};
RX   PubMed=1338312;
RA   Hasan G., Rosbash M.;
RT   "Drosophila homologs of two mammalian intracellular Ca(2+)-release
RT   channels: identification and expression patterns of the inositol
RT   1,4,5-triphosphate and the ryanodine receptor genes.";
RL   Development 116:967-975(1992).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10811919; DOI=10.1073/pnas.110145997;
RA   Sullivan K.M.C., Scott K., Zuker C.S., Rubin G.M.;
RT   "The ryanodine receptor is essential for larval development in
RT   Drosophila melanogaster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5942-5947(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
CC   -!- FUNCTION: Intracellular calcium channel that is required for
CC       proper muscle function during embryonic development and may be
CC       essential for excitation-contraction coupling in larval body wall
CC       muscles. {ECO:0000269|PubMed:10811919,
CC       ECO:0000269|PubMed:8276118}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Note=The
CC       number of predicted transmembrane domains varies between
CC       orthologs, but both N-terminus and C-terminus seem to be
CC       cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-2; Sequence=Displayed;
CC       Name=B {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-3; Sequence=VSP_050196;
CC       Name=C {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-4; Sequence=VSP_050195;
CC       Name=D {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-5; Sequence=VSP_050195, VSP_050196;
CC   -!- TISSUE SPECIFICITY: During embryonic stages 9-10, expression is
CC       seen in mesoderm of all segments in progenitors of the cephalic
CC       and somatic muscles. Adults exhibit high expression in tubular
CC       'jump' muscles of thorax and leg, and lower expression in the
CC       brain, ventral ganglion, head muscles and proboscis muscles.
CC       {ECO:0000269|PubMed:10811919, ECO:0000269|PubMed:1338312,
CC       ECO:0000269|PubMed:8276118}.
CC   -!- DEVELOPMENTAL STAGE: Abundant in 6-12 hours embryos, reduced
CC       expression in second and third instar larval stages and adults.
CC       {ECO:0000269|PubMed:1338312, ECO:0000269|PubMed:8276118}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305}.
CC   -!- MISCELLANEOUS: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity and maintains the channel in an open conformation. The
CC       calcium release channel is modulated by calcium ions, magnesium
CC       ions, ATP and calmodulin (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D17389; BAA04212.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41469.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41470.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41471.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAF59036.2; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71082.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71083.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71084.1; -; Genomic_DNA.
DR   EMBL; Z18536; CAA79221.1; -; mRNA.
DR   PIR; B49131; B49131.
DR   PIR; S40450; S40450.
DR   RefSeq; NP_476991.1; NM_057643.4. [Q24498-2]
DR   RefSeq; NP_476992.1; NM_057644.4. [Q24498-3]
DR   RefSeq; NP_476993.1; NM_057645.3. [Q24498-4]
DR   RefSeq; NP_476994.1; NM_057646.4. [Q24498-5]
DR   UniGene; Dm.22868; -.
DR   ProteinModelPortal; Q24498; -.
DR   SMR; Q24498; -.
DR   BioGrid; 71972; 9.
DR   IntAct; Q24498; 13.
DR   STRING; 7227.FBpp0293114; -.
DR   BindingDB; Q24498; -.
DR   ChEMBL; CHEMBL6045; -.
DR   TCDB; 1.A.3.1.5; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q24498; -.
DR   PaxDb; Q24498; -.
DR   PRIDE; Q24498; -.
DR   EnsemblMetazoa; FBtr0088637; FBpp0087718; FBgn0011286. [Q24498-4]
DR   EnsemblMetazoa; FBtr0088638; FBpp0087719; FBgn0011286. [Q24498-3]
DR   EnsemblMetazoa; FBtr0088639; FBpp0087720; FBgn0011286. [Q24498-5]
DR   EnsemblMetazoa; FBtr0088640; FBpp0087721; FBgn0011286. [Q24498-2]
DR   GeneID; 49090; -.
DR   KEGG; dme:Dmel_CG10844; -.
DR   CTD; 49090; -.
DR   FlyBase; FBgn0011286; RyR.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   InParanoid; Q24498; -.
DR   KO; K04962; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; Q24498; -.
DR   GenomeRNAi; 49090; -.
DR   PRO; PR:Q24498; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0011286; -.
DR   ExpressionAtlas; Q24498; differential.
DR   Genevisible; Q24498; DM.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; TAS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; TAS:UniProtKB.
DR   GO; GO:0060047; P:heart contraction; IMP:FlyBase.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0035206; P:regulation of hemocyte proliferation; IMP:FlyBase.
DR   GO; GO:0072347; P:response to anesthetic; IMP:FlyBase.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 2.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Developmental protein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Sarcoplasmic reticulum; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   5127       Ryanodine receptor.
FT                                /FTId=PRO_0000219364.
FT   TOPO_DOM      1   4451       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4452   4472       Helical. {ECO:0000255}.
FT   TRANSMEM   4651   4671       Helical. {ECO:0000255}.
FT   TRANSMEM   4683   4703       Helical. {ECO:0000255}.
FT   TRANSMEM   4742   4762       Helical. {ECO:0000255}.
FT   TRANSMEM   4885   4905       Helical. {ECO:0000255}.
FT   TRANSMEM   4924   4944       Helical. {ECO:0000255}.
FT   INTRAMEM   4974   4983       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4984   5024       Helical. {ECO:0000255}.
FT   TOPO_DOM   5025   5127       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       94    148       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      155    200       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      210    264       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      270    328       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      336    394       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      577    803       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      845    956       1. {ECO:0000250|UniProtKB:Q15413}.
FT   REPEAT      957   1075       2. {ECO:0000250|UniProtKB:Q15413}.
FT   DOMAIN     1032   1217       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1452   1673       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2822   2945       3. {ECO:0000250|UniProtKB:Q15413}.
FT   REPEAT     2946   3063       4. {ECO:0000250|UniProtKB:Q15413}.
FT   REGION      845   3063       4 X approximate repeats.
FT   COMPBIAS   4686   4711       Gly-rich.
FT   SITE       4162   4162       Important for activation by Ca(2+).
FT                                {ECO:0000250}.
FT   MOD_RES    1459   1459       Phosphoserine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   VAR_SEQ    1135   1165       VTKMHAGSIEHFGVRYEAGDVIGCFIDVKEQ -> EEKVYG
FT                                GVSESFGKQCGPGDIVGVFLDLADH (in isoform C
FT                                and isoform D).
FT                                {ECO:0000303|PubMed:8276118}.
FT                                /FTId=VSP_050195.
FT   VAR_SEQ    1876   1889       Missing (in isoform B and isoform D).
FT                                {ECO:0000303|PubMed:8276118}.
FT                                /FTId=VSP_050196.
FT   CONFLICT    314    316       CLR -> SW (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   1045   1079       VRTLLVYGYVLDPPTGEGTEALLAEAQRLKFAGFR -> SA
FT                                NAPGLRICLGSSDGRRNGGTSGRGTTPQVRRIP (in
FT                                Ref. 1; BAA41469/BAA41470/BAA41471/
FT                                BAA04212). {ECO:0000305}.
FT   CONFLICT   2282   2282       L -> I (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   2550   2550       I -> S (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   2927   2927       A -> P (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   3214   3214       L -> Q (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   3361   3361       A -> G (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   4096   4096       T -> I (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   4633   4633       Y -> D (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   4695   4695       I -> T (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5022   5024       DAF -> AL (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5073   5073       M -> I (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5077   5077       M -> L (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5103   5127       WDFFPVGDCFRKQYEDELSGGGGGG -> GTSSQWETASAS
FT                                NTRMSFPAEAAAA (in Ref. 4). {ECO:0000305}.
SQ   SEQUENCE   5127 AA;  581012 MW;  01B637D778DECE6A CRC64;
     MAEAEGGSEQ DDVSFLRTED MVTLSCTATG ERVCLAAEGF GNRHCFLENI ADKNVPPDLS
     QCVFVIEQAL SVRALQELVT AAGSETGKGT GSGHRTLLYG NAILLRHHNS DMYLACLSTS
     SSNDKLSFDV GLQEHSQGEA CWWTVHPASK QRSEGEKVRV GDDLILVSVA TERYLHTTKE
     NEQSIVNASF HVTHWSVQPY GTGISRMKYV GYVFGGDVLR FFHGGDECLT IPSTWGREAG
     QNIVIYEGGV VMAQARSLWR LELARTKWTG GFINWYHPMR IRHITTGRYL GVNDSNELIL
     VKKEEASIAT TTFCLRQEKD DEKKVLEDKD LEVIGSPIIK YGDTTVIVQH CETSLWLSYK
     SYETKKKGVG KVEEKQAILH EEGKMDDCLD FSRSQEEESK TARVIRKCSS LFTQFITALE
     TLQSNRRHSI FFQKVNLNEM VMCLEDLINY FSQPEDDMEH EEKQNRFRAL RNRQDLFQEE
     GVLNLILEAI DKINIITSQG FLASFLAGDE TGQSWDLIST YLYQLLAAII KGNHTNCAQF
     ANSNRLNWLF SRLGSQASSE GSGMLDVLHC VLIDSPEALN MMRDEHIKVI ISLLEKHGRD
     PKVLDVLCSL CVGNGVAVRS SQNNICDFLL PGKNLLLQTL LVDHVASIRP NIFVGRVDGS
     SMYQKWYFEV TMDHIEQTTH MMPHLRIGWA NTSGYVPYPG GGKKWGGNGV GDDLYSFGFD
     GAFLWTGGRK TLVVDALPEE PFIRKGDVIG VAIDLSVPII TFTFNGVKVR GSFRDFNLDG
     MFFPVMSCSS KLSCRFLFGG DHGRLKFAPP MGFSALVQCL MPQQILSLDP CFYFGNLAKN
     VLAGPWLIED DTAFVPKPVD TTGVTLPSSV DQIKEKLAEN IHEMWALNKI EAGWSWGEHR
     DDYHRIHPCL THFEKLPAAE KRYDNQLAVQ TLKTIISLGY YITMDKPPAR IRPVRLPNEI
     FMQGNGYKPA PLDLSAVTLT PKLEELVDQL AENTHNLWAR ERIQQGWTYG LNEDSENHRS
     PHLVPYAKVD EAIKKANRDT ASETVRTLLV YGYVLDPPTG EGTEALLAEA QRLKFAGFRT
     YRVERNYAVT SGKWYFEFEV LTSGPMRVGW ARADCYPGAM LGSEDTSWAF DGHNVTKMHA
     GSIEHFGVRY EAGDVIGCFI DVKEQTISFS LNGELLMDAL GGETTFADVT AEGVGFVPAC
     TLGVGQKARL IYGQDVDSLK FFTTCGLQEG YEPFCVNMRR PVTHWYTKDQ PIFENTEEMP
     DCRIDVTRIP GGADTPPHLK ISHNTFETME KANWEFLRLS LPVTCMGEFI SEQEKARRWD
     EIKNRQYRLM REAEIAAQMQ VQTQAAHMDH MLKGGFNMND IKGLTRNFDE HADAEADHMM
     RGPNRPPRKG SLTRNITFET DMSAALDEMQ RSTSVLDMNG LGEEMDDKKK RGRSPFKFFS
     KKSRDQSREK MGARTLDTSL ERRNTVAHGR NVVNQQMTTR APTLRLNNAE IPPSPVPQGP
     KQLSGSNLGQ QPVETSGDEM FDAECLKLIN EYFYGVRIFP GQDPTHVYVG WVTTQYHLHS
     REFNKNKVRR GSVYIEDDYE MAIERIDRQS CYVVRADELF NEVTQDASGK GASQGMFVGC
     FVDTATGIIR FTCEGKDTSH RWMMEPDTKL FPAIFVEATS KEILQIELGR TPTTLPLSAA
     VLPTSDKHIN PQSPPRLKVQ CLRPHQWARV PNTALQVHAL KLSDVRGWSM LCEDPVSMLA
     LHIPEEDRCI DILELIEMDK LLSFHAHSLT LYAALCYQSN YRAAHALCQH VDQKQLLYAI
     RSEYMSGPLR QGFYDLLIAL HLESHATTME VCKNEYITPL GAELKELYSD EEMQHSLRSL
     VTESVRPQLR MTEITPPVIA TSSMPSVSSE PIPDIDQLYS PKFPLEVVRQ FVMEALKDAV
     EINQVHNRDP IGWTNENLFL PLIKLTDRLL LVGVLTDEDV QRLLVMIDPE TWDQAFEREG
     KDEHRKGLLT MKMAEGAKLQ MCYLLHHLYD TQLRHRVESI IAFSHDFVGD LQTDQLRRYI
     EIKQSDLPSA VAAKKTKEFR CPPREQMNQI LCFKNLEPDD QDNCTCGLEL RGRLGDFHDS
     LMQKVSLNAL QEPDGVEGTA IEEVKTGPIT KIYNFINTVK ELEEGPKEVE EPEKKTPEEV
     FRKVLIKTIV SWAEESQIEN PKLVREMFSL LLRQYDTVGE LVRALEKTYV INTRARDDVA
     EMWVGLSQIR ALLPVQMSQE EEELMRKRLW KLVNNATFFQ HPDLIRILRV HENVMAVMMN
     TLGRRAQAQS DAPTQSEVAE GAPSKEKDTS HEMVVACCRF LCYFCRTGRQ NQKAMFDHFD
     FLLDNANILL ARPSLRGSTP LDVAYSSLME NTELALALRE HYLEKIAVYL SRCGLQSNSE
     LVEKGYPDLG WDPVEGERYL DFLRYCVWVN GESVEENANL VIRLLIRRPE CLGPALRGEG
     EGLFRAIVEA NRMSERISDR CKMQDEAEGT IAGLNFTHPL PEGEEDEDYI DTGAAILNFY
     CTLVDLLGRC APDASVIEQG KNESLRARAI LRSLVPLEDL QGVLSLKFTL SQTAPGEEKP
     KSDMPSGLLP NNKQSIVLFL ERVYGIEAQD LFYRLLEDAF LPDLRTATIL DKSDGSESDM
     ALAMNRYIGN SILPLLIKHS KFYNEAENYA SLLDATLHTV YRLSKNRMLT KGQREAVSDF
     LVALTSQMQP AMLLKLLRKL TVDVSKLSEY TTVALRLLTL HFDRCAKYYG STQGQGSYGA
     SSDEEKRLTM LLFSNIFDSL SNMDYDPELF GKALPCLIAI GCALPPDYSL SKNTDEDYYG
     RQMGAPDQPQ YMPNPIDTNN VHLDNDLNSL VQKFSEHYHD AWASRRLEGG WTYGDIRSDN
     DRKHPRLKPY NMLSEYERER YRDPVRECLK GLLAIGWTVE HSEVEVALNH RGSTRRQSKP
     QINEFQNEGS PFNYNPHPVD MSNLTLSREM QNMAERLAEN SHDIWAKKKN EELNGCGGVI
     HPQLVPYDLL TDKEKKKDRE RSQEFLKYMQ YQGYKLHKPS KGGAVEEGGA TQAAVELRFS
     YSLLEKLIQY LDRATINMKL LKPSTTFSRR SSFKTATRDI KFFSKVVLPL MEKYFSTHRN
     YFIAIATATN NIGAASLKEK EMVASIFCKL AALLRNRLSA FGPDVRITVR CLQVLVKGID
     ARTLTKNCPE FIRTSMLTFF NQTSDDLGNT ILNLQDGKYS HLRGTHLKTS TSLGYVNQVV
     LPVLTAMFDH LAACDYGSDL LLDEIQVASY KILAALYHLG TDGTLTHDRK YLKTEIERHR
     PALGSCLGAY SSCFPVAFLE PHLNKHNQYS LLNRIADHSL EAQDIMVKME SCMPNLETIL
     AEVDQFVESD KTYNDAPHII DVILPLLCAY LPFWWSQGPD NVSPTSGNHV TMVTADHMNP
     LLRNVLKMIK KNIGNDNAPW MTRIAAYTQQ IIINTSEELL KDPFLPLAER VKKRTENMLH
     KEDSMRGFIK SATDDTSQVE TQLQEDWNLL VRDIYSFYPL LIKYVDLQRN HWLKDNIPEA
     EELYNHVAEI FNIWSKSQYF LKEEQNFISA NEIDNMALIM PTATRRSAIS EGAPAVGGKV
     KKKKKNRDKK RDKDKEVQAS LMVACLKRLL PVGLNLFAGR EQELVQHCKD RYLKKMPEYD
     VIEFARNQLT LPDKLDPSDE MSWQHYLYSK LGKTEEPVDE QALEKANVNS NEKGKDKTQE
     TVDRIVAMAK VLFGLHMIDH PQQQSKNVYR SVVSIQRKRA VIACFRQTSL HSLPRHRACN
     IFARSYYEQW LQEENVGQEV MVEDLTQTFE DSEKSKKEGE ETDSKPDPLT QLVTTFCRGA
     MTERSGALQE DLLYMSYAQI AAKSTGKEEE EGGDEEGGEG GEEGEGTSIH EQEMEKQKLL
     FHQARLSNRG VAEMVLLHIS ASKGIPSEMV MTTLNLGIAI LRGGNIDIQM GMLNHLKEKK
     DVGFFTSIAG LMNSCSVLDL DAFERNTKAE GLGVGSEGAA GEKNMHDAEF TCALFRFIQL
     TCEGHNLEWQ NYLRTQAGNT TTVNVVICTV DYLLRLQESI MDFYWHYSSK EIIDPAGKAN
     FFKAIEVASQ VFNTLTEVIQ GPCTLNQQAL AHSRLWDAVG GFLFLFSHMQ DKLSKHSSQV
     DLLKELLNLQ KDMITMMLSM LEGNVVNGTI GKQMVDTLVE SASNVELILK YFDMFLKLAD
     LIESPSFHEV DMKNEGWVTP KDFREKMEQS KNYTPEEMDF LLACCERNHE GKIDYRAFVE
     HFHEPSKEIG FNLAVLLTNL SEHMPNEPRL ARFLETAGSV LNYFEPFLGR IEILGSSKRI
     ERVYFEIKDS NIEQWEKPQI RESKRAFFYS IVTEGGDKEK LEAFVNFCED AIFEMTHASG
     LMATDDGGGN VKRDTAYSSY MSEEEEERAA RDPIRRTITA VKEGLKFGVH MLSPANIKHQ
     IGVMQTKSIP ELIVGFFKII FYIFYYTGYA HFCVVRYIFG ILLNLMRGPA PEQEEEPVVE
     EETFGRALPP LPLEEPPGTV QAFGLDINKE ENGMYKVVVH ESPANSSMEE GGESSPEDGA
     AASGELVEGE PHQEPISIVD LLGGEAAKKA AQERQEAQKA QEAAMASIEA EAKKSSSAPQ
     ETPAVHQIDF SQYTHRAVSF LARNFYNLKY VALVLAFSIN FMLLFYKVTS FTEEADSSAE
     EELILGSGSG GGADITGSGF GGSGDGGSGD GEMEDEIPEL VHVDEDFFYM EHVLRIAACL
     HSLVSLAMLI AYYHLKVPLA IFKREKEIAR RLEFEGLFIA EQPEDDDFKS HWDKLVISAK
     SFPVNYWDKF VKKKVRQKYS ETYDFDSISN LLGMEKSTFA AQESEETGIF KYIMNIDWRY
     QVWKAGVTFT DNAFLYSLWY FSFSVMGNFN NFFFAAHLLD VAVGFKTLRT ILQSVTHNGK
     QLVLTVMLLT IIVYIYTVIA FNFFRKFYIQ EEDEEVDKKC HDMLTCFVFH LYKGVRAGGG
     IGDEIGDPDG DDYEVYRIIF DITFFFFVII ILLAIIQGLI IDAFGELRDQ LESVKDNMES
     NCFICGMGKD FFDIVPHGFD THVQKEHNLA NYMFFLMHLI NKPDTEYTGQ ETYVWNMYQQ
     RSWDFFPVGD CFRKQYEDEL SGGGGGG
//
ID   CAC1M_MUSDO             Reviewed;        1687 AA.
AC   Q25452;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   27-SEP-2017, entry version 90.
DE   RecName: Full=Muscle calcium channel subunit alpha-1;
DE   AltName: Full=MDL-alpha-1;
OS   Musca domestica (House fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Muscoidea; Muscidae; Musca.
OX   NCBI_TaxID=7370;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle;
RX   PubMed=8313972; DOI=10.1016/0014-5793(94)80413-3;
RA   Grabner M., Bachmann A., Rosenthal F., Striessnig J., Schultz C.,
RA   Tautz D., Glossmann H.;
RT   "Insect calcium channels. Molecular cloning of an alpha 1-subunit from
RT   housefly (Musca domestica) muscle.";
RL   FEBS Lett. 339:189-194(1994).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death (By similarity). MDL-
CC       alpha1 encodes a dihydropyridine- and diltiazem-sensitive current
CC       in larval body wall muscle. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the larval body
CC       wall musculature. In adults, highest expression in thorax followed
CC       by head and at a lower extent by abdomen.
CC   -!- DEVELOPMENTAL STAGE: Late embryonic.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z31723; CAA83514.1; -; mRNA.
DR   PIR; S41742; S41742.
DR   ProteinModelPortal; Q25452; -.
DR   PRIDE; Q25452; -.
DR   Proteomes; UP000095301; Whole Genome Shotgun Assembly.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1687       Muscle calcium channel subunit alpha-1.
FT                                /FTId=PRO_0000053961.
FT   TOPO_DOM      1     61       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     62     80       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM     81     99       Extracellular. {ECO:0000255}.
FT   TRANSMEM    100    117       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    118    130       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    131    145       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    146    157       Extracellular. {ECO:0000255}.
FT   TRANSMEM    158    176       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    177    196       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    197    216       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    217    302       Extracellular. {ECO:0000255}.
FT   TRANSMEM    303    327       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    328    434       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    435    454       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    455    467       Extracellular. {ECO:0000255}.
FT   TRANSMEM    468    487       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    488    496       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    497    515       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    516    525       Extracellular. {ECO:0000255}.
FT   TRANSMEM    526    544       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    545    563       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    564    583       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    584    639       Extracellular. {ECO:0000255}.
FT   TRANSMEM    640    664       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    665    785       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    786    809       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    810    826       Extracellular. {ECO:0000255}.
FT   TRANSMEM    827    846       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    847    854       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    855    877       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    878    885       Extracellular. {ECO:0000255}.
FT   TRANSMEM    886    900       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    901    921       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    922    941       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM    942   1030       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1031   1055       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1056   1110       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1111   1129       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1130   1143       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1144   1163       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1164   1172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1173   1191       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1192   1219       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1220   1238       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1239   1257       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1258   1277       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1278   1343       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1344   1362       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1363   1687       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       48    330       I.
FT   REPEAT      420    667       II.
FT   REPEAT      777   1059       III.
FT   REPEAT     1096   1370       IV.
FT   CA_BIND    1398   1409       {ECO:0000250}.
FT   REGION      979   1068       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1327   1389       Dihydropyridine binding. {ECO:0000250}.
FT   REGION     1337   1378       Phenylalkylamine binding. {ECO:0000250}.
FT   COMPBIAS    564    570       Poly-Leu.
FT   COMPBIAS   1037   1043       Poly-Ile.
FT   SITE        285    285       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        617    617       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1005   1005       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1311   1311       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1378   1378       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD     90     90       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1687 AA;  193875 MW;  628606AFE46DDDEF CRC64;
     MDDAVCPTET DNVQNKQKAT TPKRTQRRGG KQQLDRPERA LFCLTLKNPL RIFCIKIVDS
     KLFEYFILLT IFANCVALAV YTPYPSGDSN ITNQMLEKIE YIFLVIFTSE CVMKIIAYGF
     VLHTGSYLRN GWNFLDFFIV VIGMISTALS NLVKEGFDVK ALRAFRVLRP LRLVSGVPSL
     QVVLNSILKA MIPLLHIALL VLFVIIIYAI IGLELFSGKL HKTCRHSNTG EYLNDLDELH
     ACGVGFKCPS GYECFDDWVG PNDGITNFDN FGLSMLTVFQ CITLEGWTDV LYSIQDAMGS
     SWEWIYFVSM VILGAFFVMN LILGVLSGEF SKERTKAKNR GDFQKLREKQ QIEEDLRGYL
     DWITQAEDIE PDPDAQIIED CHKNKVKEVV SIDNLKDHEN ETQQTDSWFR SQKKYLERIN
     RRIRRACRKA VKSQAFYWLI ILLVFLNTGV LATEHYRQPI WLDQFQEYTN IFFIALFTCE
     MILKMYSLGF QGYFVSLFNR FDCFVVIGSI SEMVLTSSEL MAPLGVSVLR CVRLLRVFKV
     TKYWHSLSNL VASLLNSIQS IASLLLLLFL FIVIFGLLGM QVFGGRFTFK PEEEKPRSNF
     DSFYQSLLTV FQILTGEDWN VVMYDGIRAY GGVFSFGIVA CIYYIILFIC GNYILLNVFL
     AIAVDNLADA DSLSTIEKED ESQIQLDNQI KNEMENEEYL QNGDHISFKA EFGADLDTYL
     QDEECGSYSD DENTYNKLGG VKQRVSSLPR RNTNTDMDRI KKDIPYGTSF FIFSHTNRFR
     IFCHRLCNHS NFGNFILCCI MFSSAMLAAE NPLKADASRN IVLNKFDYFF TAVFTIELVL
     KLISYGFVLH DGAFCRSAFN LLDLLVVCVS LISIFFNSNA ISVVKILRVL RVLRPLRAIN
     RAKGLKHVVQ CVIVAVKTIG NIVLVTCLLQ FMFAVIGVQL FKGKFFSCSD GSKVYESDCH
     GTYLFYENGD INKPRLKERE WKNNKFHFDD VAKAMLTLFT VSTFEGWPTL LYVSIDSNKE
     NGGPIYNFRP IVAAYYIIYI IIIAFFMVNI FVGFVIVTFQ NEGEQEYKNC ELDKNQRNCI
     EFALKAKPVR RYIPKHSIQY KVWWFVTSSS FEYSIFVLIM INTVTLAMKF YKQPEYYSEI
     LDALNMIFTA VFSLEFIFKL AAFRFKNYFG DAWNTFDFII VLGSFIDIVY SEIKTKEQAL
     ATCDGQSCNK AKGGSTLISI NFFRLFRVMR LVKLLSKGEG IRTLLWTFIK SFQALPYVAL
     LIVMLFFIYA VIGMQVFGKI MLEEGTSIDR NNNFQTFPQA VLVLFRSATG EAWQEIMMAC
     SPRDDVKCDP ESDAVNNCGS SIAFPYFISF YVLCSFLIIN LFVAVIMDNF DYLTRDWSIL
     GPHHLDEFIR LWSEYDPDAK GRIKHLDVVT LLRKISPPLG FGKLCPHRMA CKRLVSMNMP
     LNSDGTVLFN ATLFAVVRLP LAIKTDGNID EANAELRATI KQIWKRTNPR LLDQVVLTGN
     DDEVTVGKFY ATYLIQDYFR RFKKRKEQEG KCDQTENAVT LQAGLRTLQQ NSPALKRTIS
     GYLDELASEA DPMHRRHHSL FGKVMSSLLR HEEITSSKIK HLSRTKTIPY QVEFLQHKVQ
     LERNKDCLTS ASDDISIEKI IRKQNKYNGQ YFNSEANFMD NIKYTPRYDG EEYEMEDPKS
     KDKDEEF
//
ID   MCU_DICDI               Reviewed;         275 AA.
AC   Q54LT0;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   05-JUL-2017, entry version 62.
DE   RecName: Full=Calcium uniporter protein, mitochondrial;
DE            Short=DdMCU {ECO:0000303|PubMed:24889638};
DE   Flags: Precursor;
GN   ORFNames=DDB0186972 {ECO:0000312|EMBL:EAL64239.1};
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [2]
RP   FUNCTION, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=24889638; DOI=10.1073/pnas.1400514111;
RA   Kovacs-Bogdan E., Sancak Y., Kamer K.J., Plovanich M., Jambhekar A.,
RA   Huber R.J., Myre M.A., Blower M.D., Mootha V.K.;
RT   "Reconstitution of the mitochondrial calcium uniporter in yeast.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:8985-8990(2014).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria (PubMed:24889638).
CC       Constitutes a pore-forming and calcium-conducting subunit
CC       (PubMed:24889638). Mitochondrial calcium homeostasis plays key
CC       roles in cellular physiology and regulates cell bioenergetics,
CC       cytoplasmic calcium signals and activation of cell death pathways.
CC       {ECO:0000250|UniProtKB:Q8NE86, ECO:0000269|PubMed:24889638}.
CC   -!- ENZYME REGULATION: Inhibited by ruthenium red or its derivative
CC       Ru360. {ECO:0000269|PubMed:24889638}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:24889638}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24889638}.
CC   -!- DOMAIN: Forms a well-packed pentamer with an overall cylindrical
CC       shape. The inner core of the pentamer is formed with the second
CC       transmembrane region and the second coiled-coil region: while the
CC       transmembrane regions pack into a five-helix bundle having a
CC       largely polar pore across the membrane, the coiled-coil outside
CC       the membrane forms a pentamer with a hydrophobic core. The inner
CC       core is wrapped by the first transmembrane region through contacts
CC       between the first and the second transmembrane regions. The second
CC       transmembrane is followed by the inner juxtamembrane region (IJMH)
CC       that orients at a wide angle relative to the second transmembrane.
CC       The two core domains are held together on the periphery by the
CC       outer juxtamembrane helix (OJMH). {ECO:0000250|UniProtKB:Q21121}.
CC   -!- DOMAIN: The critical DXXE motif connecting the transmembrane
CC       regions forms a pentameric barrel that constitutes the mouth of
CC       the pore. Inside the barrel, two acidic residues are in position
CC       to form two carboxylate rings. {ECO:0000250|UniProtKB:Q21121}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000085; EAL64239.1; -; Genomic_DNA.
DR   RefSeq; XP_637750.1; XM_632658.1.
DR   STRING; 44689.DDB0186972; -.
DR   TCDB; 1.A.77.1.4; the mg(2+)/ca(2+) uniporter (mcu) family.
DR   PaxDb; Q54LT0; -.
DR   GeneID; 8625616; -.
DR   KEGG; ddi:DDB_G0286429; -.
DR   dictyBase; DDB_G0286429; -.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   InParanoid; Q54LT0; -.
DR   KO; K20858; -.
DR   OMA; EFTYEAL; -.
DR   PhylomeDB; Q54LT0; -.
DR   PRO; PR:Q54LT0; -.
DR   Proteomes; UP000002195; Chromosome 4.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:dictyBase.
DR   GO; GO:1990246; C:uniplex complex; IBA:GO_Central.
DR   GO; GO:0005262; F:calcium channel activity; IBA:GO_Central.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; IC:dictyBase.
DR   GO; GO:0015292; F:uniporter activity; IBA:GO_Central.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0036444; P:mitochondrial calcium uptake; IMP:dictyBase.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   3: Inferred from homology;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     28       Mitochondrion. {ECO:0000255}.
FT   CHAIN        29    275       Calcium uniporter protein, mitochondrial.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000437214.
FT   TOPO_DOM     29    165       Mitochondrial matrix.
FT                                {ECO:0000305|PubMed:24889638}.
FT   TRANSMEM    166    186       Helical. {ECO:0000255}.
FT   TOPO_DOM    187    192       Mitochondrial intermembrane.
FT                                {ECO:0000305|PubMed:24889638}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TOPO_DOM    214    275       Mitochondrial matrix.
FT                                {ECO:0000305|PubMed:24889638}.
FT   REGION      147    165       Outer juxtamembrane helix (OJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   REGION      214    223       Inner juxtamembrane helix (IJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   COILED      125    157       {ECO:0000255}.
FT   COILED      244    270       {ECO:0000255}.
FT   MOTIF       192    195       DXXE. {ECO:0000250|UniProtKB:Q21121}.
SQ   SEQUENCE   275 AA;  31756 MW;  6D4C7343C458696D CRC64;
     MNSFVIRNGF GLVRTFNTRL FTTSTQNLEG ELKTILGQAK VSKLQEKLKL DPRSKITFND
     FKGIAKEVGI EEKEINSVSN ALAQSGSIIY LPNSLNENLK TSVFTKPAHI YQSLEHILDI
     ENKGVGLNKL IESKKSEINS LRQKIQPLEE KKQVIDRKAH RRATAIIWTG LGYCFAQAAI
     LARLTWWDLS WDIIEPVSYF LTFGSVLIGY TYFTMTKTEF TYEALNHRLF SKRQDKLFKR
     NNFPKEDYEN LVQAIDKKEK ELKELELATK YDHTH
//
ID   TMCO1_DICDI             Reviewed;         186 AA.
AC   Q54TU8;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   25-OCT-2017, entry version 65.
DE   RecName: Full=Calcium load-activated calcium channel homolog {ECO:0000250|UniProtKB:Q9UM00};
DE            Short=CLAC channel {ECO:0000250|UniProtKB:Q9UM00};
GN   Name=tmco1; ORFNames=DDB_G0281489;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Calcium-selective channel required to prevent calcium
CC       stores from overfilling. {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SUBUNIT: Homodimer and homotetramer.
CC       {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9UM00}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SIMILARITY: Belongs to the TMCO1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000041; EAL66726.1; -; Genomic_DNA.
DR   RefSeq; XP_640713.1; XM_635621.1.
DR   STRING; 44689.DDB0205621; -.
DR   PaxDb; Q54TU8; -.
DR   EnsemblProtists; EAL66726; EAL66726; DDB_G0281489.
DR   GeneID; 8623100; -.
DR   KEGG; ddi:DDB_G0281489; -.
DR   dictyBase; DDB_G0281489; -.
DR   eggNOG; KOG3312; Eukaryota.
DR   eggNOG; ENOG410XR8B; LUCA.
DR   InParanoid; Q54TU8; -.
DR   KO; K21891; -.
DR   OMA; HKKKIER; -.
DR   PhylomeDB; Q54TU8; -.
DR   PRO; PR:Q54TU8; -.
DR   Proteomes; UP000002195; Chromosome 3.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IEA:InterPro.
DR   InterPro; IPR002809; EMC3/TMCO1.
DR   InterPro; IPR008559; TMCO1.
DR   PANTHER; PTHR20917; PTHR20917; 1.
DR   Pfam; PF01956; DUF106; 1.
DR   PIRSF; PIRSF023322; DUF841_euk; 1.
DR   SMART; SM01415; DUF106; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    186       Calcium load-activated calcium channel
FT                                homolog.
FT                                /FTId=PRO_0000331204.
FT   TOPO_DOM      1      5       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM      6     26       Helical. {ECO:0000255}.
FT   TOPO_DOM     27     86       Lumenal. {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    139       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   INTRAMEM    140    156       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TOPO_DOM    157    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   COILED       31     91       {ECO:0000255}.
SQ   SEQUENCE   186 AA;  20965 MW;  8694FF260BB0F088 CRC64;
     MAALEVLFIL FVSIASSLAS EGVSWLLVYR TENYKRGKAN IDRLQIQLDK LVDQESETSS
     LSKKGNKDKK IEKIEEQLKI ANKELSFSKM KSMFAVAISM IALFSYLNRI FDGVVVCKLP
     FVPIGFLQGI SHRTIAGDDY TDCSMTFIYA ICSMFIRNNI QLILGTAPPK TKQANPWALP
     EEKKTR
//
ID   YVC1_CANAL              Reviewed;         675 AA.
AC   Q5A2J7; A0A1D8PI36;
DT   07-JAN-2015, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2017, sequence version 2.
DT   22-NOV-2017, entry version 67.
DE   RecName: Full=Calcium channel YVC1 {ECO:0000305};
DE   AltName: Full=Vacuolar transiant receptor potential (TPR) channel YVC1 {ECO:0000303|PubMed:25308698};
DE   AltName: Full=Yeast vacuolar conductance protein 1 {ECO:0000250|UniProtKB:Q12324};
GN   Name=YVC1; OrderedLocusNames=CAALFM_C207730WA;
GN   ORFNames=CaO19.2209, CaO19.9754;
OS   Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Debaryomycetaceae;
OC   Candida/Lodderomyces clade; Candida.
OX   NCBI_TaxID=237561;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=SC5314 / ATCC MYA-2876;
RX   PubMed=15123810; DOI=10.1073/pnas.0401648101;
RA   Jones T., Federspiel N.A., Chibana H., Dungan J., Kalman S.,
RA   Magee B.B., Newport G., Thorstenson Y.R., Agabian N., Magee P.T.,
RA   Davis R.W., Scherer S.;
RT   "The diploid genome sequence of Candida albicans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:7329-7334(2004).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=SC5314 / ATCC MYA-2876;
RX   PubMed=17419877; DOI=10.1186/gb-2007-8-4-r52;
RA   van het Hoog M., Rast T.J., Martchenko M., Grindle S., Dignard D.,
RA   Hogues H., Cuomo C., Berriman M., Scherer S., Magee B.B., Whiteway M.,
RA   Chibana H., Nantel A., Magee P.T.;
RT   "Assembly of the Candida albicans genome into sixteen supercontigs
RT   aligned on the eight chromosomes.";
RL   Genome Biol. 8:RESEARCH52.1-RESEARCH52.12(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND GENOME
RP   REANNOTATION.
RC   STRAIN=SC5314 / ATCC MYA-2876;
RX   PubMed=24025428; DOI=10.1186/gb-2013-14-9-r97;
RA   Muzzey D., Schwartz K., Weissman J.S., Sherlock G.;
RT   "Assembly of a phased diploid Candida albicans genome facilitates
RT   allele-specific measurements and provides a simple model for repeat
RT   and indel structure.";
RL   Genome Biol. 14:RESEARCH97.1-RESEARCH97.14(2013).
RN   [4]
RP   INDUCTION, AND FUNCTION.
RX   PubMed=21457451; DOI=10.1111/j.1567-1364.2011.00730.x;
RA   Wang H., Liang Y., Zhang B., Zheng W., Xing L., Li M.;
RT   "Alkaline stress triggers an immediate calcium fluctuation in Candida
RT   albicans mediated by Rim101p and Crz1p transcription factors.";
RL   FEMS Yeast Res. 11:430-439(2011).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=25308698; DOI=10.1016/j.freeradbiomed.2014.09.011;
RA   Yu Q., Zhang B., Yang B., Chen J., Wang H., Jia C., Ding X., Xu N.,
RA   Dong Y., Zhang B., Xing L., Li M.;
RT   "Interaction between the vacuole, the mitochondria and oxidative
RT   stress response is governed by the transient receptor potential
RT   channel in Candida albicans.";
RL   Free Radic. Biol. Med. 77:152-167(2014).
RN   [6]
RP   SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=24368068; DOI=10.1016/j.ijmm.2013.11.022;
RA   Yu Q., Wang F., Zhao Q., Chen J., Zhang B., Ding X., Wang H., Yang B.,
RA   Lu G., Zhang B., Li M.;
RT   "A novel role of the vacuolar calcium channel Yvc1 in stress response,
RT   morphogenesis and pathogenicity of Candida albicans.";
RL   Int. J. Med. Microbiol. 304:339-350(2014).
CC   -!- FUNCTION: Vacuolar calcium channel involved in the release of
CC       calcium ions from the vacuole in response to hyperosmotic or
CC       alkaline stress. Required for activation of CAP1-related
CC       transcription of oxidative stress response (OSR) genes, but also
CC       for maintaining the stability of both the mitochondria and the
CC       vacuole in a potassium- and calcium-dependent manner. Contributes
CC       to pathogenicity. Plays a key role in hyphal polarized growth and
CC       re-orientation to host-signals through its contribution to the
CC       localization of the Spitzenkoerper to the hyphal tips.
CC       {ECO:0000269|PubMed:21457451, ECO:0000269|PubMed:24368068,
CC       ECO:0000269|PubMed:25308698}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:24368068}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- INDUCTION: Expression is down-regulated in response to alkaline pH
CC       when CRZ1 or RIM101 are deleted. {ECO:0000269|PubMed:21457451}.
CC   -!- DISRUPTION PHENOTYPE: Leads to hypersensitivity to oxidative
CC       stress, increased sensitivity to killing by macrophages, reduced
CC       ability to invade epithelium cells, and attenuated virulence in a
CC       mouse model. Shows defects in hyphal maintenance, hyphal growth
CC       and flocculation. Prevents the localization of the Spitzenkoerper
CC       to hyphal tips. Enhances mitochondrial depolarization and
CC       apoptosis. {ECO:0000269|PubMed:24368068,
CC       ECO:0000269|PubMed:25308698}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP017624; AOW27771.1; -; Genomic_DNA.
DR   RefSeq; XP_716049.2; XM_710956.2.
DR   PRIDE; Q5A2J7; -.
DR   EnsemblFungi; AOW27771; AOW27771; CAALFM_C207730WA.
DR   GeneID; 3642303; -.
DR   KEGG; cal:CAALFM_C207730WA; -.
DR   CGD; CAL0000187018; YVC1.
DR   OrthoDB; EOG092C1F4Q; -.
DR   PRO; PR:Q5A2J7; -.
DR   Proteomes; UP000000559; Chromosome 2.
DR   GO; GO:0000329; C:fungal-type vacuole membrane; IDA:CGD.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IMP:CGD.
DR   GO; GO:0000128; P:flocculation; IMP:CGD.
DR   GO; GO:0036267; P:invasive filamentous growth; IMP:CGD.
DR   GO; GO:0009405; P:pathogenesis; IMP:CGD.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Stress response; Transmembrane;
KW   Transmembrane helix; Transport; Vacuole; Virulence.
FT   CHAIN         1    675       Calcium channel YVC1.
FT                                /FTId=PRO_0000431482.
FT   TRANSMEM    244    264       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    355    375       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    440    460       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    495    515       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    518    538       Helical; Name=8. {ECO:0000255}.
FT   COILED      644    675       {ECO:0000255}.
SQ   SEQUENCE   675 AA;  77357 MW;  F38D821CF64ECC17 CRC64;
     MSELDLEENN PLLPPSQIND ENYEGSIFGE DARFCPNSRQ VFRICSNLKL LIDKIIPICF
     KEDEITSSNS AILSDPVIDL VYQAAGGKGD GKEGTSSYKY RGSLVFCLLK VCDWYWQQAE
     FELSDNELYS LRALTAQTIA AIIIEREKRD KYLFLNMLCH RYTICVNGVD ATPVSALEMA
     VDMHSTIVIG SSGYQRCIKW LWRGWIIQSS TDPHSYVLYK GAASQSFRTH FDPARIKTPL
     YQNILEIFLS IIYLIIFTIV VNTHSTLTGD IDFFETVLYL FTVGYILDEF IKFYHVGWNY
     LGFWNAFNDT MYCILTVAVC FRIASVNSHG ATRIKYDEIS FRVLACASPL MWSRLLLFLD
     AYKFVGAMIV VLKTMMKESI LFFFLLFVVI VGFLQGFIGL DSSDGKNEAT QRILISLVKA
     VIGGSSFEDM GNLVPPYASV LYYFYQFMLT VILMNILIAL YSTAYAAIVE NATDEYFALV
     AHKTLRYIRA PDQNLYVPPF NLIELLITPI GWFVSTSTWK NINYYVMLVI YSPLLAYITS
     DELSNARRIQ YNRFKGVPDD ANEIDTEWDL TDGYDEDSPG DGDDCWDRIR ERNSEITEEL
     RIQREGERQD PEFMINTHQF SEKIDKIVKP VGQASKVGVN WQIYEVIEKI DKLTNLLEVV
     VAENKELKKR LENKA
//
ID   CRCM1_XENLA             Reviewed;         258 AA.
AC   Q5EAU0;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   20-DEC-2017, entry version 44.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai-1;
DE   AltName: Full=Transmembrane protein 142A;
GN   Name=orai1; Synonyms=tmem142a;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Egg;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q96D31}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC090244; AAH90244.1; -; mRNA.
DR   EMBL; BC097707; AAH97707.1; -; mRNA.
DR   RefSeq; NP_001089486.1; NM_001096017.1.
DR   UniGene; Xl.53899; -.
DR   GeneID; 734537; -.
DR   KEGG; xla:734537; -.
DR   CTD; 734537; -.
DR   Xenbase; XB-GENE-5781724; orai2.
DR   HOVERGEN; HBG081343; -.
DR   KO; K16056; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015279; F:store-operated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0002115; P:store-operated calcium entry; ISS:UniProtKB.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Glycoprotein; Immunity; Ion channel; Ion transport;
KW   Membrane; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    258       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234386.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     81       Helical. {ECO:0000255}.
FT   TOPO_DOM     82     91       Extracellular. {ECO:0000255}.
FT   TRANSMEM     92    112       Helical. {ECO:0000255}.
FT   TOPO_DOM    113    145       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TOPO_DOM    167    192       Extracellular. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TOPO_DOM    214    258       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   258 AA;  28737 MW;  E56D2B7C18CA1855 CRC64;
     MYPECGVETK SRPCSKQLQE EVSYPEWISR SYVELMSLNE HSMQALSWRK LYLSRAKLKA
     SSRTSALLSG FAMVAMVEVQ LEPNHAYPPG LLIAFSACTT VLVAVHLFAL MVSTCILPNI
     EAVSNVHNLN SVKESPHERM HHHIELAWAF STVIGTLLFL AEVVLLCWVK FLPVNSPKIS
     SNETSAVSSG QAAAITSTAI MVPFGLVFIV FAVHFYRSLV SHKTDRQFQE LNELAELAQL
     QDQLDHRGDP VQSPVHYA
//
ID   CRCM1_RAT               Reviewed;         304 AA.
AC   Q5M848;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   20-DEC-2017, entry version 83.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai-1;
DE   AltName: Full=Transmembrane protein 142A;
GN   Name=Orai1; Synonyms=Cracm1, Tmem142a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   INTERACTION WITH CALM.
RX   PubMed=23109337; DOI=10.1074/jbc.M112.380964;
RA   Liu Y., Zheng X., Mueller G.A., Sobhany M., DeRose E.F., Zhang Y.,
RA   London R.E., Birnbaumer L.;
RT   "Crystal structure of calmodulin binding domain of orai1 in complex
RT   with Ca2+ calmodulin displays a unique binding mode.";
RL   J. Biol. Chem. 287:43030-43041(2012).
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores and channel activation by the Ca(2+) sensor, STIM1.
CC       CRAC channels are the main pathway for Ca(2+) influx in T-cells
CC       and promote the immune response to pathogens by activating the
CC       transcription factor NFAT. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SUBUNIT: Interacts with STIM1 and STIM2; this regulates channel
CC       activity (By similarity). Interacts with CALM; this may displace
CC       STIM1 and STIM2 and might thereby modulate channel activity
CC       (PubMed:23109337). Interacts with CRACR2A/EFCAB4B; the interaction
CC       is direct and takes place in absence of Ca(2+) (By similarity).
CC       Forms a complex with CRACR2A/EFCAB4B and STIM1 at low
CC       concentration of Ca(2+), the complex dissociates at elevated
CC       Ca(2+) concentrations (By similarity). Interacts with SLC35G1 (By
CC       similarity). Interacts with UBQLN1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q96D31, ECO:0000269|PubMed:23109337}.
CC   -!- INTERACTION:
CC       D4A5X1:Stim2; NbExp=3; IntAct=EBI-9700451, EBI-9700435;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q96D31}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q96D31}. Cytoplasmic vesicle, autophagosome
CC       {ECO:0000250|UniProtKB:Q96D31}. Note=Colocalizes with UBQLN1 in
CC       the autophagosome. Colocalizes with STIM1 at the cell membrane.
CC       {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- PTM: Cys-196 is oxidated, leading to inactivate channel activity.
CC       {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC088225; AAH88225.1; -; mRNA.
DR   RefSeq; NP_001014004.1; NM_001013982.1.
DR   UniGene; Rn.3869; -.
DR   CORUM; Q5M848; -.
DR   IntAct; Q5M848; 2.
DR   STRING; 10116.ENSRNOP00000001806; -.
DR   ChEMBL; CHEMBL3721308; -.
DR   PaxDb; Q5M848; -.
DR   PRIDE; Q5M848; -.
DR   GeneID; 304496; -.
DR   KEGG; rno:304496; -.
DR   UCSC; RGD:1311873; rat.
DR   CTD; 84876; -.
DR   RGD; 1311873; Orai1.
DR   eggNOG; KOG4298; Eukaryota.
DR   eggNOG; ENOG4110DSB; LUCA.
DR   HOGENOM; HOG000246925; -.
DR   HOVERGEN; HBG081343; -.
DR   InParanoid; Q5M848; -.
DR   KO; K16056; -.
DR   PhylomeDB; Q5M848; -.
DR   PRO; PR:Q5M848; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005776; C:autophagosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0043234; C:protein complex; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IMP:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0070509; P:calcium ion import; ISO:RGD.
DR   GO; GO:0061180; P:mammary gland epithelium development; ISO:RGD.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0002115; P:store-operated calcium entry; IMP:RGD.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome;
KW   Cytoplasmic vesicle; Glycoprotein; Immunity; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN         1    304       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234383.
FT   TOPO_DOM      1     88       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     89    106       Helical. {ECO:0000255}.
FT   TOPO_DOM    107    120       Extracellular. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical. {ECO:0000255}.
FT   TOPO_DOM    142    174       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    175    195       Helical. {ECO:0000255}.
FT   TOPO_DOM    196    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TOPO_DOM    259    304       Cytoplasmic. {ECO:0000250}.
FT   REGION       71     91       Interaction with STIM1. {ECO:0000250}.
FT   REGION      275    295       Interaction with STIM1. {ECO:0000250}.
FT   COMPBIAS     43     49       Poly-Pro.
FT   MOD_RES     298    298       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q96D31}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   304 AA;  33040 MW;  98264D8880982C74 CRC64;
     MHPEPAPPPN NSNPELPLSG GSSTSGSRRS RRRSGDGEPT GAPPLPPPPA VSYPDWIGQS
     YSEVMSLNEH SMQALSWRKL YLSRAKLKAS SRTSALLSGF AMVAMVEVQL DTDHDYPPGL
     LIVFSACTTV LVAVHLFALM ISTCILPNIE AVSNVHNLNS VKESPHERMH RHIELAWAFS
     TVIGTLLFLA EVVLLCWVKF LPLKRQAGQP SPTKPPTEPA VVVANSSNNG GITPGEAAAI
     ASTAIMVPCG LVFIVFAVHF YRSLVSHKTD RQFQELNELA EFARLQDQLD HRGDHSLTPG
     THYA
//
ID   CRCM1_CHICK             Reviewed;         226 AA.
AC   Q5ZL05;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   20-DEC-2017, entry version 65.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai-1;
DE   AltName: Full=Transmembrane protein 142A;
GN   Name=ORAI1; Synonyms=CRACM1, TMEM142A; ORFNames=RCJMB04_8f15;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=CB; TISSUE=Bursa of Fabricius;
RX   PubMed=15642098; DOI=10.1186/gb-2004-6-1-r6;
RA   Caldwell R.B., Kierzek A.M., Arakawa H., Bezzubov Y., Zaim J.,
RA   Fiedler P., Kutter S., Blagodatski A., Kostovska D., Koter M.,
RA   Plachy J., Carninci P., Hayashizaki Y., Buerstedde J.-M.;
RT   "Full-length cDNAs from chicken bursal lymphocytes to facilitate gene
RT   function analysis.";
RL   Genome Biol. 6:R6.1-R6.9(2005).
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q96D31}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ719929; CAG31588.1; -; mRNA.
DR   RefSeq; NP_001025829.1; NM_001030658.1.
DR   UniGene; Gga.22197; -.
DR   STRING; 9031.ENSGALP00000006734; -.
DR   PaxDb; Q5ZL05; -.
DR   GeneID; 416845; -.
DR   KEGG; gga:416845; -.
DR   CTD; 84876; -.
DR   eggNOG; KOG4298; Eukaryota.
DR   eggNOG; ENOG4110DSB; LUCA.
DR   HOGENOM; HOG000246925; -.
DR   HOVERGEN; HBG081343; -.
DR   InParanoid; Q5ZL05; -.
DR   KO; K16056; -.
DR   PhylomeDB; Q5ZL05; -.
DR   PRO; PR:Q5ZL05; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015279; F:store-operated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0002115; P:store-operated calcium entry; ISS:UniProtKB.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Glycoprotein; Immunity; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    226       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234384.
FT   TOPO_DOM      1     56       Extracellular. {ECO:0000255}.
FT   TRANSMEM     57     77       Helical. {ECO:0000255}.
FT   TOPO_DOM     78    110       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    111    131       Helical. {ECO:0000255}.
FT   TOPO_DOM    132    159       Extracellular. {ECO:0000255}.
FT   TRANSMEM    160    180       Helical. {ECO:0000255}.
FT   TOPO_DOM    181    226       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   226 AA;  25130 MW;  54B8C571B58DB801 CRC64;
     MSLNEHSMQA LSWRKLYLSR AKLKASSRTS ALLSGFAMVA MVEVQLDAEH DYPRGLLIAF
     SACTTVLVAV HLFALMISTC ILPNIEAVSN VHNLNSVKES PHERMHRHIE LAWAFSTVIG
     TLLFLAEVVL LCWVKFLPLK KNPLDPAENS NSSITSGQAA AIASTSIMVP FGLIFIVFAV
     HFYRSLVSHK TDRQFQELNE LAEFAWLQDQ LDHRGDAISP AVTHFA
//
ID   TRPC6_MOUSE             Reviewed;         930 AA.
AC   Q61143; B9EIW2; Q9Z2J1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   20-DEC-2017, entry version 159.
DE   RecName: Full=Short transient receptor potential channel 6 {ECO:0000250|UniProtKB:Q9Y210};
DE            Short=TrpC6 {ECO:0000303|PubMed:14761972};
DE   AltName: Full=Calcium entry channel;
DE   AltName: Full=Transient receptor protein 6;
DE            Short=TRP-6;
GN   Name=Trpc6 {ECO:0000303|PubMed:14761972, ECO:0000312|MGI:MGI:109523};
GN   Synonyms=Trp6, Trrp6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9368034; DOI=10.1074/jbc.272.47.29672;
RA   Boulay G., Zhu X., Peyton M., Jiang M., Hurst R., Stefani E.,
RA   Birnbaumer L.;
RT   "Cloning and expression of a novel mammalian homolog of Drosophila
RT   transient receptor potential (Trp) involved in calcium entry secondary
RT   to activation of receptors coupled by the Gq class of G protein.";
RL   J. Biol. Chem. 272:29672-29680(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=DBA/2J;
RX   PubMed=10050885; DOI=10.1038/sj.onc.1202445;
RA   Buess M., Engler O., Hirsch H.H., Moroni C.;
RT   "Search for oncogenic regulators in an autocrine tumor model using
RT   differential display PCR: identification of novel candidate genes
RT   including the calcium channel mtrp6.";
RL   Oncogene 18:1487-1494(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 631-739.
RC   TISSUE=Brain;
RX   PubMed=8646775; DOI=10.1016/S0092-8674(00)81233-7;
RA   Zhu X., Jiang M., Peyton M., Boulay G., Hurst R., Stefani E.,
RA   Birnbaumer L.;
RT   "trp, a novel mammalian gene family essential for agonist-activated
RT   capacitative Ca2+ entry.";
RL   Cell 85:661-671(1996).
RN   [6]
RP   PHOSPHORYLATION BY FYN.
RX   PubMed=14761972; DOI=10.1074/jbc.M311274200;
RA   Hisatsune C., Kuroda Y., Nakamura K., Inoue T., Nakamura T.,
RA   Michikawa T., Mizutani A., Mikoshiba K.;
RT   "Regulation of TRPC6 channel activity by tyrosine phosphorylation.";
RL   J. Biol. Chem. 279:18887-18894(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-814, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Thought to form a receptor-activated non-selective
CC       calcium permeant cation channel. Probably is operated by a
CC       phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases or G-protein coupled receptors. Activated by
CC       diacylglycerol (DAG) in a membrane-delimited fashion,
CC       independently of protein kinase C. Seems not to be activated by
CC       intracellular calcium store depletion.
CC       {ECO:0000250|UniProtKB:Q9Y210}.
CC   -!- SUBUNIT: Homodimer; forms channel complex. Interacts with MX1 and
CC       RNF24. {ECO:0000250|UniProtKB:Q9Y210}.
CC   -!- INTERACTION:
CC       Q96D31:ORAI1 (xeno); NbExp=2; IntAct=EBI-15563578, EBI-2291476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q9Y210}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9Y210}.
CC   -!- TISSUE SPECIFICITY: Lung and brain.
CC   -!- PTM: Phosphorylated by FYN, leading to an increase of TRPC6
CC       channel activity. {ECO:0000269|PubMed:14761972}.
CC   -!- PTM: N-glycosylated.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U49069; AAC06146.1; -; mRNA.
DR   EMBL; AF057748; AAC64394.1; -; mRNA.
DR   EMBL; CH466522; EDL24958.1; -; Genomic_DNA.
DR   EMBL; BC141131; AAI41132.1; -; mRNA.
DR   CCDS; CCDS22815.1; -.
DR   RefSeq; NP_038866.2; NM_013838.2.
DR   RefSeq; XP_006509913.1; XM_006509850.3.
DR   UniGene; Mm.325086; -.
DR   ProteinModelPortal; Q61143; -.
DR   BioGrid; 204332; 1.
DR   DIP; DIP-60893N; -.
DR   IntAct; Q61143; 3.
DR   STRING; 10090.ENSMUSP00000057965; -.
DR   ChEMBL; CHEMBL1795081; -.
DR   GuidetoPHARMACOLOGY; 491; -.
DR   iPTMnet; Q61143; -.
DR   PhosphoSitePlus; Q61143; -.
DR   MaxQB; Q61143; -.
DR   PaxDb; Q61143; -.
DR   PRIDE; Q61143; -.
DR   Ensembl; ENSMUST00000050433; ENSMUSP00000057965; ENSMUSG00000031997.
DR   GeneID; 22068; -.
DR   KEGG; mmu:22068; -.
DR   UCSC; uc009odl.1; mouse.
DR   CTD; 7225; -.
DR   MGI; MGI:109523; Trpc6.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000020590; -.
DR   HOVERGEN; HBG068337; -.
DR   InParanoid; Q61143; -.
DR   KO; K04969; -.
DR   OMA; NRGPAYM; -.
DR   OrthoDB; EOG091G01FB; -.
DR   TreeFam; TF313147; -.
DR   Reactome; R-MMU-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-MMU-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-MMU-3295583; TRP channels.
DR   PRO; PR:Q61143; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   Bgee; ENSMUSG00000031997; -.
DR   ExpressionAtlas; Q61143; baseline and differential.
DR   Genevisible; Q61143; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISA:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0036057; C:slit diaphragm; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IEA:Ensembl.
DR   GO; GO:0042805; F:actinin binding; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0030276; F:clathrin binding; IEA:Ensembl.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; ISO:MGI.
DR   GO; GO:0005216; F:ion channel activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IDA:MGI.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISO:MGI.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:MGI.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0007338; P:single fertilization; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005462; TRPC6_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF7; PTHR10117:SF7; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01647; TRPCHANNEL6.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 2.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    930       Short transient receptor potential
FT                                channel 6.
FT                                /FTId=PRO_0000215323.
FT   TOPO_DOM      1    437       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    438    458       Helical. {ECO:0000255}.
FT   TOPO_DOM    459    486       Extracellular. {ECO:0000255}.
FT   TRANSMEM    487    507       Helical. {ECO:0000255}.
FT   TOPO_DOM    508    520       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    521    541       Helical. {ECO:0000255}.
FT   TOPO_DOM    542    591       Extracellular. {ECO:0000255}.
FT   TRANSMEM    592    612       Helical. {ECO:0000255}.
FT   TOPO_DOM    613    635       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    636    656       Helical. {ECO:0000255}.
FT   TOPO_DOM    657    705       Extracellular. {ECO:0000255}.
FT   TRANSMEM    706    726       Helical. {ECO:0000255}.
FT   TOPO_DOM    727    930       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       96    125       ANK 1.
FT   REPEAT      131    160       ANK 2.
FT   REPEAT      162    188       ANK 3.
FT   REPEAT      217    246       ANK 4.
FT   MOD_RES     814    814       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    560    560       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT      3     56       Missing (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    105    105       A -> V (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       R -> W (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
FT   CONFLICT    134    134       N -> D (in Ref. 2; AAC64394).
FT                                {ECO:0000305}.
FT   CONFLICT    184    184       A -> S (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       Y -> D (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
FT   CONFLICT    436    437       RG -> PR (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
FT   CONFLICT    905    905       T -> S (in Ref. 1; AAC06146).
FT                                {ECO:0000305}.
SQ   SEQUENCE   930 AA;  106681 MW;  9501C8D50FF33430 CRC64;
     MSQSPRFVTR RGGSLKAAPG AGTRRNESQD YLLMDELGDD GYPQLPLPPY GYYPSFRGNE
     NRLTHRRQTI LREKGRRLAN RGPAYMFNDH STSLSIEEER FLDAAEYGNI PVVRKMLEEC
     HSLNVNCVDY MGQNALQLAV ANEHLEITEL LLKKENLSRV GDALLLAISK GYVRIVEAIL
     NHPAFAEGKR LATSPSQSEL QQDDFYAYDE DGTRFSHDVT PIILAAHCQE YEIVHTLLRK
     GARIERPHDY FCKCTECSQK QKHDSFSHSR SRINAYKGLA SPAYLSLSSE DPVMTALELS
     NELAVLANIE KEFKNDYRKL SMQCKDFVVG LLDLCRNTEE VEAILNGDAE TRQPGDFGRP
     NLSRLKLAIK YEVKKFVAHP NCQQQLLSIW YENLSGLRQQ TMAVKFLVVL AVAIGLPFLA
     LIYWCAPCSK MGKILRGPFM KFVAHAASFT IFLGLLVMNA ADRFEGTKLL PNETSTDNAR
     QLFRMKTSCF SWMEMLIISW VIGMIWAECK EIWTQGPKEY LFELWNMLDF GMLAIFAASF
     IARFMAFWHA SKAQSIIDAN DTLKDLTKVT LGDNVKYYNL ARIKWDPTDP QIISEGLYAI
     AVVLSFSRIA YILPANESFG PLQISLGRTV KDIFKFMVIF IMVFVAFMIG MFNLYSYYIG
     AKQNEAFTTV EESFKTLFWA IFGLSEVKSV VINYNHKFIE NIGYVLYGVY NVTMVIVLLN
     MLIAMINSSF QEIEDDADVE WKFARAKLWF SYFEEGRTLP VPFNLVPSPK SLLYLLLKFK
     KWMCELIQGQ KQGFQEDAEM NKRNEEKKFG ISGSHEDLSK FSLDKNQLAH NKQSSTRSSE
     DYHLNSFSNP PRQYQKIMKR LIKRYVLQAQ IDKESDEVNE GELKEIKQDI SSLRYELLEE
     KSQNTEDLAE LIRKLGERLS LEPKLEESRR
//
ID   CAC1E_MOUSE             Reviewed;        2272 AA.
AC   Q61290;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 150.
DE   RecName: Full=Voltage-dependent R-type calcium channel subunit alpha-1E;
DE   AltName: Full=Brain calcium channel II;
DE            Short=BII;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 6;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.3;
GN   Name=Cacna1e; Synonyms=Cach6, Cacnl1a6, Cchra1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=8071363;
RA   Williams M.E., Marubio L.M., Deal C.R., Hans M., Brust P.F.,
RA   Philipson L.H., Miller R.J., Johnson E.C., Harpold M.M., Ellis S.B.;
RT   "Structure and functional characterization of neuronal alpha 1E
RT   calcium channel subtypes.";
RL   J. Biol. Chem. 269:22347-22357(1994).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=17114649; DOI=10.1074/mcp.M600046-MCP200;
RA   Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA   Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,
RA   Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
RT   "Qualitative and quantitative analyses of protein phosphorylation in
RT   naive and stimulated mouse synaptosomal preparations.";
RL   Mol. Cell. Proteomics 6:283-293(2007).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-20; SER-428;
RP   THR-441; SER-746; SER-816; SER-856 AND SER-2054, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1E
CC       gives rise to R-type calcium currents. R-type calcium channels
CC       belong to the 'high-voltage activated' (HVA) group and are blocked
CC       by nickel, and partially by omega-agatoxin-IIIA (omega-Aga-IIIA).
CC       They are however insensitive to dihydropyridines (DHP), omega-
CC       conotoxin-GVIA (omega-CTx-GVIA), and omega-agatoxin-IVA (omega-
CC       Aga-IVA). Calcium channels containing alpha-1E subunit could be
CC       involved in the modulation of firing patterns of neurons which is
CC       important for information processing.
CC   -!- SUBUNIT: Interacts with EFHC1. Voltage-dependent calcium channels
CC       are multisubunit complexes, consisting of alpha-1, alpha-2, beta
CC       and delta subunits in a 1:1:1:1 ratio. The channel activity is
CC       directed by the pore-forming and voltage-sensitive alpha-1
CC       subunit. In many cases, this subunit is sufficient to generate
CC       voltage-sensitive calcium channel activity. The auxiliary subunits
CC       beta and alpha-2/delta linked by a disulfide bridge regulate the
CC       channel activity.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in neuronal tissues, retina, spleen,
CC       and pancreatic islet cells.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1E subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L29346; AAA59206.1; -; mRNA.
DR   PIR; C54972; C54972.
DR   UniGene; Mm.267517; -.
DR   ProteinModelPortal; Q61290; -.
DR   IntAct; Q61290; 2.
DR   STRING; 10090.ENSMUSP00000004214; -.
DR   TCDB; 1.A.1.11.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q61290; -.
DR   PhosphoSitePlus; Q61290; -.
DR   EPD; Q61290; -.
DR   MaxQB; Q61290; -.
DR   PaxDb; Q61290; -.
DR   PRIDE; Q61290; -.
DR   MGI; MGI:106217; Cacna1e.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; Q61290; -.
DR   PhylomeDB; Q61290; -.
DR   ChiTaRS; Cacna1e; mouse.
DR   PRO; PR:Q61290; -.
DR   Proteomes; UP000000589; Unplaced.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; TAS:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0001662; P:behavioral fear response; IMP:MGI.
DR   GO; GO:0048266; P:behavioral response to pain; IMP:MGI.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0042596; P:fear response; IMP:MGI.
DR   GO; GO:0030317; P:flagellated sperm motility; IMP:MGI.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:MGI.
DR   GO; GO:0007626; P:locomotory behavior; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0050877; P:nervous system process; IMP:MGI.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:MGI.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:MGI.
DR   GO; GO:0090273; P:regulation of somatostatin secretion; IMP:MGI.
DR   GO; GO:0048265; P:response to pain; IMP:MGI.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:MGI.
DR   GO; GO:0019226; P:transmission of nerve impulse; IMP:MGI.
DR   GO; GO:0008542; P:visual learning; IMP:MGI.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005449; VDCC_R_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF57; PTHR10037:SF57; 2.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01633; RVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2272       Voltage-dependent R-type calcium channel
FT                                subunit alpha-1E.
FT                                /FTId=PRO_0000053939.
FT   TOPO_DOM      1     90       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     91    109       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    110    128       Extracellular. {ECO:0000255}.
FT   TRANSMEM    129    147       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    148    159       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    160    174       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    175    186       Extracellular. {ECO:0000255}.
FT   TRANSMEM    187    206       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    207    224       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    246    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    351       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    352    477       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    478    497       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    498    510       Extracellular. {ECO:0000255}.
FT   TRANSMEM    511    530       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    531    539       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    540    558       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    559    568       Extracellular. {ECO:0000255}.
FT   TRANSMEM    569    587       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    588    606       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    607    626       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    627    679       Extracellular. {ECO:0000255}.
FT   TRANSMEM    680    704       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    705   1150       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1151   1167       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1168   1191       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1192   1211       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1212   1219       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1220   1242       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1243   1256       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1257   1274       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1275   1293       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1294   1313       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1314   1400       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1401   1424       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1425   1481       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1482   1500       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1501   1515       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1516   1535       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1536   1543       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1544   1562       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1563   1573       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1574   1592       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1593   1611       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1612   1631       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1632   1700       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1701   1726       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1727   2272       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       77    355       I.
FT   REPEAT      463    707       II.
FT   REPEAT     1143   1429       III.
FT   REPEAT     1466   1729       IV.
FT   DOMAIN     1742   1777       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     427    438       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   CA_BIND    1755   1766       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      375    392       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS    717    722       Poly-Glu.
FT   COMPBIAS    751    754       Poly-Arg.
FT   COMPBIAS    770    773       Poly-Arg.
FT   COMPBIAS   1108   1112       Poly-Glu.
FT   COMPBIAS   1115   1118       Poly-Lys.
FT   COMPBIAS   1231   1234       Poly-Val.
FT   COMPBIAS   2244   2247       Poly-Arg.
FT   SITE        310    310       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        658    658       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1375   1375       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1666   1666       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     441    441       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     737    737       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q07652}.
FT   MOD_RES     746    746       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     794    794       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q07652}.
FT   MOD_RES     816    816       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     856    856       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     948    948       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q07652}.
FT   MOD_RES    1099   1099       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q07652}.
FT   MOD_RES    1737   1737       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    2054   2054       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    2073   2073       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q07652}.
FT   CARBOHYD    255    255       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1569   1569       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1692   1692       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   2272 AA;  257236 MW;  70D9200B9E0C87A1 CRC64;
     MARFGEAVVV GRPGSGDGDS DQSRNRQGTP VPASGPAAAY KQSKAQRART MALYNPIPVR
     QNCFTVNRSL FIFGEDNIVR KYAKKLIDWP PFEYMILATI IANCIVLALE QHLPEDDKTP
     MSRRLEKTEP YFIGIFCFEA GIKIVALGFI FHKGSYLRNG WNVMDFIVVL SGILATAGTH
     FNTHVDLRAL RAVRVLRPLK LVSGIPSLQI VLKSIMKAMV PLLQIGLLLF FAILMFAIIG
     LEFYSGKLHR ACFMNNSGIL EGFDPPHPCG VQGCPAGYEC KDWIGPNDGI TQFDNILFAV
     LTVFQCITME GWTTVLYNTN DALGATWNWL YFIPLIIIGS FFVLNLVLGV LSGEFAKERE
     RVENRRAFMK LRRQQQIERE LNGYRAWIDK AEEVMLAEEN KNSGTSALEV LRRATIKRSR
     TEAMTRDSSD EHCVDISSVG TPLARASIKS TKVDGASYFR HKERLLRISI RHMVKSQVFY
     WIVLSVVALN TACVAIVHHN QPQWLTHLLY YAEFLFLGLF LLEMSLKMYG MGPRLYFHSS
     FNCFDFGVTV GSIFEVVWAI FRPGTSFGIS VLRALRLLRI FKITKYWASL RNLVVSLMSS
     MKSIISLLFL LFLFIVVFAL LGMQLFGGRF NFNDGTPSAN FDTFPAAIMT VFQILTGEDW
     NEVMYNGIRS QGGVSSGMWS AIYFIVLTLF GNYTLLNVFL AIAVDNLANA QELTKDEQEE
     EEAFNQKHAL QKAKEVSPMS APNMPSIERD RRRRHHMSMW EPRSSHLRER RRRHHMSVWE
     QRTSQLRRHM QMSSQEALNK EEAPPMNPLN PLNPLSPLNP LNAHPSLYRR PRPIEGLALG
     LGLEKCEEER ISRGGSLKGD IGGLTSALDN QRSPLSLGKR EPPWLPRSCH GNCDPIQQEA
     GGGETVVTFE DRARHRQSQR RSRHRRVRTE GKDSASASRS RSASQERSLD EGVSVEGEKE
     HEPHSSHRSK EPTIHEEERT QDLRRTNSLM VPRGSGLVGA LDEAETPLVQ PQPELEVGKD
     AALTEQEAEG SSEQALLGDV QLDVGRGISQ SEPDLSCMTA NMDKATTEST SVTVAIPDVD
     PLVDSTVVNI SNKTDGEASP LKEAETKEEE EEVEKKKKQK KEKRETGKAM VPHSSMFIFS
     TTNPIRRACH YIVNLRYFEM CILLVIAASS IALAAEDPVL TNSERNKVLR YFDYVFTGVF
     TFEMVIKMID QGLILQDGSY FRDLWNILDF VVVVGALVAF ALANALGTNK GRDIKTIKSL
     RVLRVLRPLK TIKRLPKLKA VFDCVVTSLK NVFNILIVYK LFMFIFAVIA VQLFKGKFFY
     CTDSSKDTEK ECIGNYVDHE KNKMEVKGRE WKRHEFHYDN IIWALLTLFT VSTGEGWPQV
     LQHSVDVTEE DRGPSRSNRM EMSIFYVVYF VVFPFFFVNI FVALIIITFQ EQGDKMMEEC
     SLEKNERACI DFAISAKPLT RYMPQNRHTF QYRVWHFVVS PSFEYTIMAM IALNTVVLMM
     KYYTAPCTYE LALKYLNIAF TMVFSLECVL KVIAFGFLNY FRDTWNIFDF ITVIGSITEI
     ILTDSKLVNT SGFNMSFLKL FRAARLIKLL RQGYTIRILL WTFVQSFKAL PYVCLLIAML
     FFIYAIIGMQ VFGNIKLDEE SHINRHNNFR SFFGSLMLLF RSATGEAWQE IMLSCLGEKG
     CEPDTTAPSG QNESERCGTD LAYVYFVSFI FFCSFLMLNL FVAVIMDNFE YLTRDSSILG
     PHHLDEFVRV WAEYDRAACG RIHYTEMYEM LTLMSPPLGL GKRCPSKVAY KRLVLMNMPV
     AEDMTVHFTS TLMALIRTAL DIKIAKGGAD RQQLDSELQK ETLAIWPHLS QKMLDLLVPM
     PKASDLTVGK IYAAMMIMDY YKQSKVKKQR QQLEEQKNAP MFQRMEPSSL PQEIIANAKA
     LPYLQQDPVS GLSGRSGYPS MSPLSPQEIF QLACMDPADD GQFQEQQSLV VTDPSSMRRS
     FSTIRDKRSN SSWLEEFSME RSSENTYKSR RRSYHSSLRL SAHRLNSDSG HKSDTHRSGG
     RERGRSKERK HLLSPDVSRC NSEERGTQAD WESPERRQSR SPSEGRSQTP NRQGTGSLSE
     SSIPSISDTS TPRRSRRQLP PVPPKPRPLL SYSSLMRHTG GISPPPDGSE GGSPLASQAL
     ESNSACLTES SNSLHPQQGQ HPSPQHYISE PYLALHEDSH ASDCGEEETL TFEAAVATSL
     GRSNTIGSAP PLRHSWQMPN GHYRRRRWGA WAGMMCGAVS DLLSDTEEDD KC
//
ID   ITPR3_RAT               Reviewed;        2670 AA.
AC   Q63269;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 157.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor type 3;
DE   AltName: Full=IP3 receptor isoform 3;
DE            Short=IP3R 3;
DE            Short=InsP3R3;
DE   AltName: Full=Type 3 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 3 InsP3 receptor;
GN   Name=Itpr3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8388391;
RA   Blondel O., Takeda J., Janssen H., Seino S., Bell G.I.;
RT   "Sequence and functional characterization of a third inositol
RT   trisphosphate receptor subtype, IP3R-3, expressed in pancreatic
RT   islets, kidney, gastrointestinal tract, and other tissues.";
RL   J. Biol. Chem. 268:11356-11363(1993).
RN   [2]
RP   INTERACTION WITH SIGMAR1.
RX   PubMed=11149946; DOI=10.1073/pnas.98.2.491;
RA   Hayashi T., Su T.-P.;
RT   "Regulating ankyrin dynamics: roles of sigma-1 receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:491-496(2001).
RN   [3]
RP   INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K.,
RA   Haeseleer F., Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-934 AND SER-2669, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.M113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from
RT   proteolytic cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
CC   -!- FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second
CC       messenger that mediates the release of intracellular calcium.
CC   -!- SUBUNIT: Homotetramer. Interacts with TRPC1, TRPC3, TRPC4.
CC       Interacts with TRPV4 (By similarity). Interacts with SIGMAR1
CC       (PubMed:11149946). Interacts with AKT1 and PML. Interacts with
CC       LRMP (via coiled-coil domain) (By similarity). Interacts with
CC       CABP1 (PubMed:12032348). Interacts with TMBIM4/LFG4 (By
CC       similarity). Interacts with CEMIP (By similarity). Interacts with
CC       TESPA1 (By similarity). Interacts with TMEM203 (By similarity).
CC       Interacts with BOK; regulates ITPR3 expression (PubMed:23884412).
CC       {ECO:0000250|UniProtKB:P70227, ECO:0000250|UniProtKB:Q14573,
CC       ECO:0000269|PubMed:11149946, ECO:0000269|PubMed:12032348,
CC       ECO:0000269|PubMed:23884412}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- PTM: Phosphorylated on tyrosine residues. Phosphorylated by AKT1
CC       on serine and/or threonine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06096; AAA41446.1; -; mRNA.
DR   PIR; A46719; A46719.
DR   RefSeq; NP_037270.1; NM_013138.1.
DR   UniGene; Rn.11242; -.
DR   ProteinModelPortal; Q63269; -.
DR   BioGrid; 247708; 2.
DR   CORUM; Q63269; -.
DR   IntAct; Q63269; 1.
DR   STRING; 10116.ENSRNOP00000011516; -.
DR   ChEMBL; CHEMBL2846; -.
DR   TCDB; 1.A.3.2.5; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q63269; -.
DR   PhosphoSitePlus; Q63269; -.
DR   PaxDb; Q63269; -.
DR   PRIDE; Q63269; -.
DR   GeneID; 25679; -.
DR   KEGG; rno:25679; -.
DR   UCSC; RGD:2934; rat.
DR   CTD; 3710; -.
DR   RGD; 2934; Itpr3.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   HOGENOM; HOG000007660; -.
DR   HOVERGEN; HBG052158; -.
DR   InParanoid; Q63269; -.
DR   KO; K04960; -.
DR   PhylomeDB; Q63269; -.
DR   PRO; PR:Q63269; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0005903; C:brush border; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043209; C:myelin sheath; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; TAS:RGD.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; IDA:RGD.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:RGD.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:RGD.
DR   GO; GO:0000822; F:inositol hexakisphosphate binding; IDA:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:RGD.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   GO; GO:0050913; P:sensory perception of bitter taste; ISO:RGD.
DR   GO; GO:0050916; P:sensory perception of sweet taste; ISO:RGD.
DR   GO; GO:0050917; P:sensory perception of umami taste; ISO:RGD.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Endoplasmic reticulum; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   2670       Inositol 1,4,5-trisphosphate receptor
FT                                type 3.
FT                                /FTId=PRO_0000153930.
FT   TOPO_DOM      1   2201       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2202   2222       Helical. {ECO:0000255}.
FT   TOPO_DOM   2223   2233       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2234   2254       Helical. {ECO:0000255}.
FT   TOPO_DOM   2255   2263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2264   2284       Helical. {ECO:0000255}.
FT   TOPO_DOM   2285   2324       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2325   2345       Helical. {ECO:0000255}.
FT   TOPO_DOM   2346   2367       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2368   2388       Helical. {ECO:0000255}.
FT   TOPO_DOM   2389   2495       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2496   2516       Helical. {ECO:0000255}.
FT   TOPO_DOM   2517   2670       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      113    173       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      174    224       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      232    288       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      295    372       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      378    434       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      266    270       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      507    510       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      567    569       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   MOD_RES     916    916       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES     934    934       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1152   1152       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70227}.
FT   MOD_RES    1813   1813       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    1832   1832       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    1834   1834       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    2608   2608       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    2669   2669       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
SQ   SEQUENCE   2670 AA;  304286 MW;  13C787E4C2886E45 CRC64;
     MNEMSSFLHI GDIVSLYAEG SVNGFISTLG LVDDRCVVEP AAGDLDNPPK KFRDCLFKVC
     PMNRYSAQKQ YWKAKQTKQD KEKIADVVLL QKLQHAAQME QKQNDTENKK VHGDVVKYGS
     VIQLLHMKSN KYLTVNKRLP ALLEKNAMRV TLDATGNEGS WLFIQPFWKL RSNGDNVVVG
     DKVILNPVNA GQPLHASNYE LSDNVGCKEV NSVNCNTSWK INLFMQFRDH LEEVLKGGDV
     VRLFHAEQEK FLTCDEYRGK LQVFLRTTLR QSATSATSSN ALWEVEVVHH DPCRGGAGHW
     NGLYRFKHLA TGNYLAAEEN PSYKGDVSDP KAAGPGAQSR TGRRNAGEKI KYRLVAVPHG
     NDIASLFELD PTTLQKTDSF VPRNSYVRLR HLCTNTWIQS TNAPIDVEEE RPIRLMLGTC
     PTKEDKEAFA IVSVPVSEIR DLDFANDASS MLASAVEKLN EGFISQNDRR FVIQLLEDLV
     FFVSDVPNNG QNVLDIMVTK PNRERQKLMR DENILKQIFG ILKAPFRDKG GEGPLVRLEE
     LSDQKNAPYQ YMFRLCYRVL RHSQEDYRKN QEHIAKQFGM MQSQIGYDIL AEDTITALLH
     NNRKLLEKHI TKTEVETFVS LVRKNREPRF LDYLSDLCVS NRIAIPVTQE LICKCVLDPK
     NSDILIQTEL RPVKEMAQSH EYLSIEYSEE EVWLTWTDRN NEHHEKSVRQ LAQEARAGNA
     HDENVLSYYR YQLKLFARMC LDRQYLAIDE ISKQLGVELL FLCMADEMLP FDLRASFCHL
     MLHVHVDRDP QELVTPVKFA RLWTEIPTAI TIKDYDSNLN ASRDDKKNKF ASTMEFVEDY
     LNNVVGEAVP FANDEKNILT FEVVSLAHNL IYFGFYSFSE LLRLTRTLLG IIDCIQAPAA
     VLQAYEEPGG KNVRRSIQGV GHMMSTMVLS RKQSVFGASS LPTGVGVPEQ LDRSKFEDNE
     HTVVMETKLK ILEILQFILN VRLDYRISYL LSVFKKEFVE VFPMQDSGAD GTAPAFDSST
     ANMNLDRIGE QAEAMFGVGK TSSMLEVDDE GGRMFLRVLL HLTMHDYPPL VSGALQLLFK
     HFSQRQEAMH TFKQVQLLIS AQDVENYKVI KSELDRLRTM VEKSELWVDK KGSVKGEEGE
     AGASKDKKER PSDEEGFLQP HGEKSSENYQ IVKGILERLN KMCGVGEQMR KKQQRLLKNM
     DAHKVMLDLL QIPYDKNDNK MMEILRYTHQ FLQKFCAGNP GNQALLHKHL QLFLTPGLLE
     AETMQHIFLN NYQLCSEISE PVLQHFVHCW PTHGRHVQYL DFLHTVIKAE GKYVKKCQDM
     IMTELTNAGD DVVVFYNDKA SLAHLLDMMK AARDGVEDHS PLMYHISLVD LLAACAEGKN
     VYTEIKCTSL LPLEDVVSVV THEDCITEVK MAYVNFVNHC YVDTEVEMKE IYTSNHIWTL
     FENFTLDMAL VCNKREKRLS DPTLEKYVLT VVLDTISAFF SSPFSENSTS LQTHQTIVVQ
     LLQSTTRLLE CPWLQQQHKG SVEACVRTLA MVAKSRAILL PMDLDAHMSA LLSSGGSCSA
     AAQRSAANYK TATRTFPRVI PTANQWDYKN IIEKLQDIIT ALEERLKPLV QAELSVLVDM
     LHWPELLFLE GSEAYQRCES GGFLSKLIRH TKGLMESEEK LCVKVLRTLQ QMLQKKSKYG
     DRGNQLRKML LQNYLQNRKS GPRGELTDPT GSGVDQDWSA IAATQCRLDK EGATKLVCDL
     ITSTKNEKIF QESIGLAIRL LDGGNTEIQK SFYNLMTSDK KSERFFKVLH DRMKRAQQET
     KSTVAVNMSD LGSQPREDRE PADPTTKGRV SSFSMPSSSR YSLGPGLHRG HDVSERAQNN
     EMGTSVLIMR PILRFLQLLC ENHNRDLQNF LRCQNNKTNY NLVCETLQFL DIMCGSTTGG
     LGLLGLYINE DNVGLVIQTL ETLTEYCQGP CHENQTCIVT HESNGIDIIT ALILNDISPL
     CKYRMDLVLQ LKDNASKLLL ALMESRHDSE NAERILISLR PQELVDVIKK AYLQEEEREN
     SEVSPREVGH NIYILALQLS RHNKQLQHLL KPVKRIQEEE AEGISSMLSL NNKQLSQMLK
     SSAPAQEEEE DPLAYYENHT SQIEIVRQDR SMEQIVFPVP AICQFLTEET KHRLFTTTEQ
     DEQGSKVSDF FDQSSFLHNE MEWQRRLRSM PLIYWFSRRM TLWGSISFNL AVFINIIIAF
     FYPYVEGAST GVLGSPLISL LFWILICFSI AALFTKHYSV RPLIVALVLR SIYYLGIGPT
     LNILGALNLT NKIVFVVSFV GNRGTFIRGY KAMVMDMEFL YHVGYILTSV LGLFAHELFY
     SILLFDLIYR EETLFNVIKS VTRNGRSILL TALLALILVY LFSIVGFLFL KDDFILEVDR
     LPGNHSRAST LGMPHGAATF MGTCSGDKMD CVSEVSVPEI LEEDEELDST ERACDTLLMC
     IVTVMNHGLR NGGGVGDILR KPSKDESLFP ARVVYDLLFF FIVIIIVLNL IFGVIIDTFA
     DLRSEKQKKE EILKTTCFIC GLERDKFDNK TVSFEEHIKL EHNMWNYLYF IVLVRVKNKT
     DYTGPESYVA QMIKNKNLDW FPRMRAMSLV SGEGEGEQNE IRILQEKLGS TMKLVSHLTA
     QLNELKEQMT EQRKRRQRLG FVDVQNCMSR
//
ID   TMCO1_DANRE             Reviewed;         188 AA.
AC   Q6DGW9; A8E529; B0S7X3; Q568F9;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   25-OCT-2017, entry version 92.
DE   RecName: Full=Calcium load-activated calcium channel {ECO:0000250|UniProtKB:Q9UM00};
DE            Short=CLAC channel {ECO:0000250|UniProtKB:Q9UM00};
DE   AltName: Full=Transmembrane and coiled-coil domain-containing protein 1 {ECO:0000250|UniProtKB:Q9UM00};
GN   Name=tmco1 {ECO:0000312|ZFIN:ZDB-GENE-050417-344};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen;
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C.,
RA   Muffato M., Collins J.E., Humphray S., McLaren K., Matthews L.,
RA   McLaren S., Sealy I., Caccamo M., Churcher C., Scott C., Barrett J.C.,
RA   Koch R., Rauch G.J., White S., Chow W., Kilian B., Quintais L.T.,
RA   Guerra-Assuncao J.A., Zhou Y., Gu Y., Yen J., Vogel J.H., Eyre T.,
RA   Redmond S., Banerjee R., Chi J., Fu B., Langley E., Maguire S.F.,
RA   Laird G.K., Lloyd D., Kenyon E., Donaldson S., Sehra H.,
RA   Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Eliott D., Threadgold G.,
RA   Harden G., Ware D., Mortimer B., Kerry G., Heath P., Phillimore B.,
RA   Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S., Pelan S.,
RA   Griffiths G., Smith M., Glithero R., Howden P., Barker N., Stevens C.,
RA   Harley J., Holt K., Panagiotidis G., Lovell J., Beasley H.,
RA   Henderson C., Gordon D., Auger K., Wright D., Collins J., Raisen C.,
RA   Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J.,
RA   Babbage A., Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S.,
RA   Wray P., Ellington A., Matthews N., Ellwood M., Woodmansey R.,
RA   Clark G., Cooper J., Tromans A., Grafham D., Skuce C., Pandian R.,
RA   Andrews R., Harrison E., Kimberley A., Garnett J., Fosker N., Hall R.,
RA   Garner P., Kelly D., Bird C., Palmer S., Gehring I., Berger A.,
RA   Dooley C.M., Ersan-Urun Z., Eser C., Geiger H., Geisler M.,
RA   Karotki L., Kirn A., Konantz J., Konantz M., Oberlander M.,
RA   Rudolph-Geiger S., Teucke M., Osoegawa K., Zhu B., Rapp A., Widaa S.,
RA   Langford C., Yang F., Carter N.P., Harrow J., Ning Z., Herrero J.,
RA   Searle S.M., Enright A., Geisler R., Plasterk R.H., Lee C.,
RA   Westerfield M., de Jong P.J., Zon L.I., Postlethwait J.H.,
RA   Nusslein-Volhard C., Hubbard T.J., Roest Crollius H., Rogers J.,
RA   Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the
RT   human genome.";
RL   Nature 496:498-503(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo, Liver, and Olfactory epithelium;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RX   PubMed=27212239; DOI=10.1016/j.cell.2016.04.051;
RA   Wang Q.C., Zheng Q., Tan H., Zhang B., Li X., Yang Y., Yu J., Liu Y.,
RA   Chai H., Wang X., Sun Z., Wang J.Q., Zhu S., Wang F., Yang M., Guo C.,
RA   Wang H., Zheng Q., Li Y., Chen Q., Zhou A., Tang T.S.;
RT   "TMCO1 is an ER Ca(2+) load-activated Ca(2+) channel.";
RL   Cell 165:1454-1466(2016).
CC   -!- FUNCTION: Calcium-selective channel required to prevent calcium
CC       stores from overfilling, thereby playing a key role in calcium
CC       homeostasis (PubMed:27212239). In response to endoplasmic
CC       reticulum overloading, assembles into a homotetramer, forming a
CC       functional calcium-selective channel, regulating the calcium
CC       content in endoplasmic reticulum store (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UM00, ECO:0000305|PubMed:27212239}.
CC   -!- SUBUNIT: Homodimer and homotetramer. Homodimer under resting
CC       conditions; forms homotetramers following and endoplasmic
CC       reticulum calcium overload. {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9UM00}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9UM00}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q9UM00}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9UM00}. Note=The first transmembrane
CC       region is required for localization to the endoplasmic reticulum.
CC       {ECO:0000250|UniProtKB:Q9UM00}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6DGW9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6DGW9-2; Sequence=VSP_058496;
CC         Note=Ref.2 (AAH92873/AAI64974) sequences are in conflict in
CC         position: 9:A->S. {ECO:0000305};
CC   -!- SIMILARITY: Belongs to the TMCO1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX927144; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC076218; AAH76218.1; -; mRNA.
DR   EMBL; BC092873; AAH92873.1; -; mRNA.
DR   EMBL; BC152265; AAI52266.1; -; mRNA.
DR   EMBL; BC153441; AAI53442.1; -; mRNA.
DR   EMBL; BC164974; AAI64974.1; -; mRNA.
DR   RefSeq; NP_001002575.1; NM_001002575.1. [Q6DGW9-1]
DR   UniGene; Dr.13739; -.
DR   STRING; 7955.ENSDARP00000091049; -.
DR   PaxDb; Q6DGW9; -.
DR   Ensembl; ENSDART00000100276; ENSDARP00000091049; ENSDARG00000069099. [Q6DGW9-1]
DR   Ensembl; ENSDART00000127371; ENSDARP00000106023; ENSDARG00000069099. [Q6DGW9-2]
DR   GeneID; 378980; -.
DR   KEGG; dre:378980; -.
DR   CTD; 54499; -.
DR   ZFIN; ZDB-GENE-050417-344; tmco1.
DR   eggNOG; KOG3312; Eukaryota.
DR   eggNOG; ENOG410XR8B; LUCA.
DR   GeneTree; ENSGT00390000002659; -.
DR   HOGENOM; HOG000240371; -.
DR   HOVERGEN; HBG054437; -.
DR   KO; K21891; -.
DR   OMA; HKKKIER; -.
DR   OrthoDB; EOG091G0QPG; -.
DR   PhylomeDB; Q6DGW9; -.
DR   TreeFam; TF315045; -.
DR   PRO; PR:Q6DGW9; -.
DR   Proteomes; UP000000437; Chromosome 8.
DR   Bgee; ENSDARG00000069099; -.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006983; P:ER overload response; ISS:UniProtKB.
DR   InterPro; IPR002809; EMC3/TMCO1.
DR   InterPro; IPR008559; TMCO1.
DR   PANTHER; PTHR20917; PTHR20917; 1.
DR   Pfam; PF01956; DUF106; 1.
DR   PIRSF; PIRSF023322; DUF841_euk; 1.
DR   SMART; SM01415; DUF106; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Endoplasmic reticulum;
KW   Golgi apparatus; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    188       Calcium load-activated calcium channel.
FT                                /FTId=PRO_0000437215.
FT   TOPO_DOM      1      8       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     90       Lumenal. {ECO:0000250|UniProtKB:Q9UM00}.
FT   TRANSMEM     91    111       Helical. {ECO:0000255}.
FT   TOPO_DOM    112    133       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   INTRAMEM    134    154       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   TOPO_DOM    155    188       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9UM00}.
FT   COILED       32     89       {ECO:0000255}.
FT   VAR_SEQ       1     23       MSTMFADTILIVFISICTALLAE -> MQDKYSSKAALQFV
FT                                SLCFT (in isoform 2).
FT                                /FTId=VSP_058496.
FT   CONFLICT     34     34       D -> G (in Ref. 2; AAI53442).
FT                                {ECO:0000305}.
FT   CONFLICT     71     71       R -> G (in Ref. 2; AAI53442).
FT                                {ECO:0000305}.
SQ   SEQUENCE   188 AA;  21310 MW;  055C7526D96BA6C7 CRC64;
     MSTMFADTIL IVFISICTAL LAEGITWVLV YRTDKYKRLK AEVEKQSKKL EKKKETITES
     AGRQQKKKIE RQEEKLKNNN RDLSMVRMKS MFAIGFCFTA LMGMFNSIFD GRVVAKLPFV
     PLSYIQGLSH RNLLGEDYTD CSFIFLYILC TMSIRQNIQK MLGLAPSRAA TKQAGGFLGP
     PPQAAKFS
//
ID   PKD2_DANRE              Reviewed;         904 AA.
AC   Q6IVV8; Q2VF27;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 106.
DE   RecName: Full=Polycystin-2 {ECO:0000303|PubMed:16216239};
DE   AltName: Full=Curly up {ECO:0000303|PubMed:17360770};
DE            Short=Cup {ECO:0000303|PubMed:17360770};
DE   AltName: Full=Polycystic kidney disease 2 protein homolog;
DE   AltName: Full=Transient receptor potential cation channel subfamily P member 2;
GN   Name=pkd2 {ECO:0000312|ZFIN:ZDB-GENE-040827-4};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000312|EMBL:AAT39122.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15269167; DOI=10.1242/dev.01240;
RA   Sun Z., Amsterdam A., Pazour G.J., Cole D.G., Miller M.S., Hopkins N.;
RT   "A genetic screen in zebrafish identifies cilia genes as a principal
RT   cause of cystic kidney.";
RL   Development 131:4085-4093(2004).
RN   [2] {ECO:0000312|EMBL:ABA60692.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=16216239; DOI=10.1016/j.ydbio.2005.08.047;
RA   Bisgrove B.W., Snarr B.S., Emrazian A., Yost H.J.;
RT   "Polaris and polycystin-2 in dorsal forerunner cells and Kupffer's
RT   vesicle are required for specification of the zebrafish left-right
RT   axis.";
RL   Dev. Biol. 287:274-288(2005).
RN   [3] {ECO:0000312|Ensembl:ENSDARP00000027024, ECO:0000312|Proteomes:UP000000437}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen {ECO:0000312|Ensembl:ENSDARP00000027024,
RC   ECO:0000312|Proteomes:UP000000437};
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C.,
RA   Muffato M., Collins J.E., Humphray S., McLaren K., Matthews L.,
RA   McLaren S., Sealy I., Caccamo M., Churcher C., Scott C., Barrett J.C.,
RA   Koch R., Rauch G.J., White S., Chow W., Kilian B., Quintais L.T.,
RA   Guerra-Assuncao J.A., Zhou Y., Gu Y., Yen J., Vogel J.H., Eyre T.,
RA   Redmond S., Banerjee R., Chi J., Fu B., Langley E., Maguire S.F.,
RA   Laird G.K., Lloyd D., Kenyon E., Donaldson S., Sehra H.,
RA   Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Eliott D., Threadgold G.,
RA   Harden G., Ware D., Mortimer B., Kerry G., Heath P., Phillimore B.,
RA   Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S., Pelan S.,
RA   Griffiths G., Smith M., Glithero R., Howden P., Barker N., Stevens C.,
RA   Harley J., Holt K., Panagiotidis G., Lovell J., Beasley H.,
RA   Henderson C., Gordon D., Auger K., Wright D., Collins J., Raisen C.,
RA   Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J.,
RA   Babbage A., Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S.,
RA   Wray P., Ellington A., Matthews N., Ellwood M., Woodmansey R.,
RA   Clark G., Cooper J., Tromans A., Grafham D., Skuce C., Pandian R.,
RA   Andrews R., Harrison E., Kimberley A., Garnett J., Fosker N., Hall R.,
RA   Garner P., Kelly D., Bird C., Palmer S., Gehring I., Berger A.,
RA   Dooley C.M., Ersan-Urun Z., Eser C., Geiger H., Geisler M.,
RA   Karotki L., Kirn A., Konantz J., Konantz M., Oberlander M.,
RA   Rudolph-Geiger S., Teucke M., Osoegawa K., Zhu B., Rapp A., Widaa S.,
RA   Langford C., Yang F., Carter N.P., Harrow J., Ning Z., Herrero J.,
RA   Searle S.M., Enright A., Geisler R., Plasterk R.H., Lee C.,
RA   Westerfield M., de Jong P.J., Zon L.I., Postlethwait J.H.,
RA   Nusslein-Volhard C., Hubbard T.J., Roest Crollius H., Rogers J.,
RA   Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the
RT   human genome.";
RL   Nature 496:498-503(2013).
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16943304; DOI=10.1681/ASN.2006040412;
RA   Obara T., Mangos S., Liu Y., Zhao J., Wiessner S., Kramer-Zucker A.G.,
RA   Olale F., Schier A.F., Drummond I.A.;
RT   "Polycystin-2 immunolocalization and function in zebrafish.";
RL   J. Am. Soc. Nephrol. 17:2706-2718(2006).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND PHOSPHORYLATION.
RX   PubMed=16551655; DOI=10.1093/hmg/ddl070;
RA   Streets A.J., Moon D.J., Kane M.E., Obara T., Ong A.C.;
RT   "Identification of an N-terminal glycogen synthase kinase 3
RT   phosphorylation site which regulates the functional localization of
RT   polycystin-2 in vivo and in vitro.";
RL   Hum. Mol. Genet. 15:1465-1473(2006).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, AND MUTAGENESIS
RP   OF LEU-351.
RX   PubMed=17360770; DOI=10.1242/dev.02827;
RA   Schottenfeld J., Sullivan-Brown J., Burdine R.D.;
RT   "Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-
RT   specific expression of southpaw.";
RL   Development 134:1605-1615(2007).
RN   [7]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23376035; DOI=10.1016/j.yjmcc.2013.01.015;
RA   Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z.,
RA   Harris P.C., Torres V.E., Ehrlich B.E.;
RT   "Polycystin-2 mutations lead to impaired calcium cycling in the heart
RT   and predispose to dilated cardiomyopathy.";
RL   J. Mol. Cell. Cardiol. 58:199-208(2013).
RN   [8]
RP   DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26432887; DOI=10.1242/bio.014076;
RA   Roxo-Rosa M., Jacinto R., Sampaio P., Lopes S.S.;
RT   "The zebrafish Kupffer's vesicle as a model system for the molecular
RT   mechanisms by which the lack of Polycystin-2 leads to stimulation of
RT   CFTR.";
RL   Biol. Open 4:1356-1366(2015).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25660539; DOI=10.1016/j.cub.2014.12.051;
RA   Yuan S., Zhao L., Brueckner M., Sun Z.;
RT   "Intraciliary calcium oscillations initiate vertebrate left-right
RT   asymmetry.";
RL   Curr. Biol. 25:556-567(2015).
CC   -!- FUNCTION: Functions as non-selective cation channel (By
CC       similarity). Required for normal oscillation of Ca(2+) levels
CC       within cilia; these oscillations of the intraciliary Ca(2+) levels
CC       can trigger cytoplasmic Ca(2+) signaling cascades
CC       (PubMed:25660539). May contribute to the release of Ca(2+) stores
CC       from the endoplasmic reticulum (By similarity). Required for
CC       normal temporal variation of the intracellular Ca(2+) levels in
CC       the heart (PubMed:23376035). Plays a role in fluid-flow
CC       mechanosensation (By similarity). Required for normal
CC       specification of the body left-right axis during embryogenesis,
CC       most likely via its role in ciliary Ca(2+) oscillations in
CC       Kupffer's vesicle (PubMed:15269167, PubMed:16216239,
CC       PubMed:16943304, PubMed:17360770, PubMed:23376035,
CC       PubMed:25660539). {ECO:0000250|UniProtKB:O35245,
CC       ECO:0000250|UniProtKB:Q13563, ECO:0000269|PubMed:15269167,
CC       ECO:0000269|PubMed:16216239, ECO:0000269|PubMed:16943304,
CC       ECO:0000269|PubMed:17360770, ECO:0000269|PubMed:23376035,
CC       ECO:0000269|PubMed:25660539}.
CC   -!- ENZYME REGULATION: Channnel activity is regulated by
CC       phosphorylation. Channnel activity is regulated by intracellular
CC       Ca(2+). {ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with pkd1l1 (By
CC       similarity). {ECO:0000250|UniProtKB:H2LRU7,
CC       ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:16943304}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:16943304}. Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:23376035}. Apical cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:26432887}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell projection, cilium
CC       {ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:26432887}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000269|PubMed:26432887}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:16943304}. Note=Detected at the basolateral
CC       cell membrane and on apical, lumenal cilia in anterior, proximal
CC       pronephric ducts, and in intracellular vesicles in the posterior
CC       part of the pronephric duct. Detected on apical cell membranes on
CC       epithelial cells in the ear. {ECO:0000269|PubMed:16943304}.
CC   -!- TISSUE SPECIFICITY: Detected along cilia and at the cilium basal
CC       body in Kupffer's vesicle at the 10 somite stage
CC       (PubMed:26432887). Detected in heart at 48hpf (PubMed:23376035).
CC       Detected in muscle and pronephric kidney at 48 hpf
CC       (PubMed:16943304). Detected on trunk muscle sarcolemma and
CC       sarcomere, on ependymal cell cilia in brain, at the apical cell
CC       membrane in epithelial cells in the ear, at the lateral line organ
CC       and olfactory placode at 56 hpf (PubMed:16943304). Detected in
CC       adult kidney (at protein level) (PubMed:16943304).
CC       {ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:26432887}.
CC   -!- DEVELOPMENTAL STAGE: First detected at the onset of gastrulation
CC       in a band at the blastoderm margin (PubMed:16216239,
CC       PubMed:17360770). Ubiquitous during gastrulation, somatogenesis
CC       and at 48 hpf (PubMed:16943304). During gastrulation, detected at
CC       the hypoblast of the dorsal midline and in dorsal forerunner cells
CC       that form a ciliated Kupffer's vesicle later on (PubMed:16216239,
CC       PubMed:17360770, PubMed:26432887). Ubiquitous during early somite
CC       stages, with high levels of expression in Kupffer's vesicle
CC       (PubMed:16216239, PubMed:17360770). At subsequent stages, detected
CC       in pronephric duct primordia and neural floorplate
CC       (PubMed:16216239, PubMed:16943304, PubMed:17360770,
CC       PubMed:26432887). Highly expressed in brain at 24 hpf
CC       (PubMed:16216239). At 3 dpf, detected at pharyngeal arches and the
CC       pectoral fin bud (PubMed:16216239). {ECO:0000269|PubMed:16216239,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:26432887}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is involved in
CC       oligomerization. The coiled-coil domain binds calcium and
CC       undergoes a calcium-induced conformation change (in vitro).
CC       {ECO:0000250|UniProtKB:Q13563}.
CC   -!- PTM: Phosphorylated. Phosphorylation is important for protein
CC       function; a mutant human construct that lacks the N-terminal
CC       phosphorylation sites cannot complement a zebrafish pkd2-deficient
CC       mutant. {ECO:0000269|PubMed:16551655}.
CC   -!- PTM: N-glycosylated. The four subunits in a tetramer probably
CC       differ in the extent of glycosylation; simultaneous glycosylation
CC       of all experimentally validated sites would probably create steric
CC       hindrance. {ECO:0000250|UniProtKB:Q13563}.
CC   -!- DISRUPTION PHENOTYPE: Morpholino knockdown of the protein impairs
CC       specification of the left-right axis during embryonic development
CC       and randomization of heart and gut looping, plus misexpression of
CC       left-side specific genes (PubMed:16216239, PubMed:16943304,
CC       PubMed:17360770, PubMed:26432887, PubMed:25660539). Morpholino
CC       knockdown of the protein causes body curvature, tail curling,
CC       hydrocephalus and kidney cysts (PubMed:15269167, PubMed:16216239,
CC       PubMed:16943304, PubMed:16551655, PubMed:17360770,
CC       PubMed:23376035, PubMed:26432887). Morpholino knockdown has no
CC       effect on number, length or motility of pronephric cilia, but the
CC       fluid flow through the pronephric ducts seems to be impaired due
CC       to physical obstruction of the ducts (PubMed:16943304). Likewise,
CC       morpholino knockdown of the protein has no effect on the motility
CC       of cilia in Kupffer's vesicle (PubMed:25660539). Morpholino
CC       knockdown of the protein leads to an increase of the volume of
CC       Kupffer's vesicle, without any change in the proliferation of the
CC       cells that line the vesicle (PubMed:26432887). Morpholino
CC       knockdown of the protein leads to impaired heart function,
CC       characterized by arrhytmia and frequently associated with
CC       pericardial and abdominal edema and atrioventricular block
CC       (PubMed:23376035). {ECO:0000269|PubMed:15269167,
CC       ECO:0000269|PubMed:16216239, ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:23376035, ECO:0000269|PubMed:26432887}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY618926; AAT39122.1; -; mRNA.
DR   EMBL; DQ175629; ABA60692.1; -; mRNA.
DR   EMBL; CR788312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001002310.1; NM_001002310.1.
DR   RefSeq; XP_009292468.1; XM_009294193.2.
DR   UniGene; Dr.92211; -.
DR   SMR; Q6IVV8; -.
DR   STRING; 7955.ENSDARP00000027024; -.
DR   PaxDb; Q2VF27; -.
DR   Ensembl; ENSDART00000020412; ENSDARP00000027024; ENSDARG00000014098.
DR   GeneID; 432387; -.
DR   KEGG; dre:432387; -.
DR   CTD; 5311; -.
DR   ZFIN; ZDB-GENE-040827-4; pkd2.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   KO; K04986; -.
DR   OMA; QAWSRDN; -.
DR   OrthoDB; EOG091G034F; -.
DR   TreeFam; TF316484; -.
DR   PRO; PR:Q6IVV8; -.
DR   Proteomes; UP000000437; Chromosome 1.
DR   Bgee; ENSDARG00000014098; -.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ZFIN.
DR   GO; GO:0005929; C:cilium; IDA:ZFIN.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ZFIN.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:ZFIN.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0061371; P:determination of heart left/right asymmetry; IMP:ZFIN.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:ZFIN.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IMP:ZFIN.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; IMP:ZFIN.
DR   GO; GO:0007507; P:heart development; IMP:CACAO.
DR   GO; GO:0003146; P:heart jogging; IMP:ZFIN.
DR   GO; GO:0001947; P:heart looping; IMP:ZFIN.
DR   GO; GO:0001822; P:kidney development; IMP:ZFIN.
DR   GO; GO:0070121; P:Kupffer's vesicle development; IMP:ZFIN.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:ZFIN.
DR   GO; GO:0051284; P:positive regulation of sequestering of calcium ion; IMP:CACAO.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; IMP:ZFIN.
DR   GO; GO:0072114; P:pronephros morphogenesis; IMP:ZFIN.
DR   GO; GO:0072019; P:proximal convoluted tubule development; IMP:ZFIN.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:ZFIN.
DR   GO; GO:0032965; P:regulation of collagen biosynthetic process; IMP:ZFIN.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Sarcoplasmic reticulum;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    904       Polycystin-2.
FT                                /FTId=PRO_0000439854.
FT   TOPO_DOM      1    155       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    156    177       Helical; Name=S1.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    178    404       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    405    425       Helical; Name=S2.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    426    441       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    442    462       Helical; Name=S3.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    463    489       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    490    510       Helical; Name=S4.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    511    534       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    535    556       Helical; Name=5.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    557    568       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   INTRAMEM    569    583       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    584    591       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    592    612       Helical; Name=S6.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    613    904       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   DOMAIN      687    722       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     700    711       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      740    759       Linker. {ECO:0000250|UniProtKB:Q13563}.
FT   COILED      770    809       {ECO:0000250|UniProtKB:Q13563}.
FT   MOTIF       578    580       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       700    700       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       702    702       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       704    704       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       706    706       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       711    711       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    267    280       {ECO:0000250|UniProtKB:Q13563}.
FT   MUTAGEN     351    351       L->P: In ty30b; curly tail phenotype and
FT                                impaired left-right patterning.
FT                                {ECO:0000269|PubMed:17360770}.
FT   CONFLICT     15     15       A -> V (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       L -> P (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       G -> R (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    334    334       T -> A (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    604    608       FIFMI -> LIFMV (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
SQ   SEQUENCE   904 AA;  103269 MW;  53B45F174BB50E5E CRC64;
     MSSSRVRPQA PQSPAASASA SPPPHEGIEM EKMHHEEVGL GVPDETPSSP PTSSSRQAWS
     RDNPGFEPEE GMMEADWPPE SQGRRSVSTT SSSSSGGVPG NFSGISARIN RGLYPTPPAQ
     EHRSCGKRIL EKMRVLWDTR LLGESNSNRE MYLKTVLREM ITYILFLLTL CIITYGMVST
     NMYYYTKVMS QLFLDTPLSS GEPTNFKSLS TMEDFWKFTE GPFLNGMYWE LWYNNKSLPE
     NQSLIYYENL LLGVPRLRQL RVRNESCSVH EDLRDEVYDC YNVYSPANED KAPFGPKNGT
     AWRFKDESSL GESSYWGQVS TYGGGGYYQD LSRTREKSAN QLQELKNNLW LDRGTRAVFL
     DFSIYNGNVN LFCIVRLLVE FPATGGAVPS WQFQTVRLLR YVSSWDYFVG MCEVSFCLFV
     LYYLVEEALE IRLHRLRYFK SLWNCLDVLI VALSVPAIIM NICRTSAVSH RLHFLLENHS
     TYPNFEPLAR LQVHFNNLAA IIVFLSWVKL FKFINFNKTM NQLSTTMSRC AKDLMGFAIM
     FFIVFLAYAQ LAYLVFGTQV NDFSTFQACI FTQFRIILGD FDFSEIEEAD SVLGPIYFTT
     FVFFIFMILL NMFLAIINDT YSEVKADMAQ QRSEMEITDL IKKSYNRAMV KLKLKKSSIN
     DIPDSLQQAA GKLSFDELRQ DLRGKGHSDA EIEAIFAKYD LDGDQELTEH EHQQMRDDLE
     KEREDLDLEH SSLPRPASGR SFSRSQDDSE EDDDEDSGHS SRRRGSSSGG VSYEEFQVLV
     RRVDRMEHSI GSIVSKIDAV IVKLEAMERA KMKRRDVLGR ILDGVMEDER MGRDPELQRE
     QMDRLVRDEL ERWESDDTMS QVSHHHHQAT PIISSAQLRP RSSRPPSSLS NEGPDAAASG
     PAHL
//
ID   CA2D2_MOUSE             Reviewed;        1154 AA.
AC   Q6PHS9; B2RY16; Q3TPT9; Q3TSS6; Q6REE3; Q8C8R8; Q8CHE9; Q920H5;
AC   Q920H6; Q9EQG2; Q9R142;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 108.
DE   RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-2;
DE   AltName: Full=Protein ducky;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-2;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit alpha-2-2;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit delta-2;
DE   Flags: Precursor;
GN   Name=Cacna2d2; Synonyms=Kiaa0558;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=TKDU;
RX   PubMed=11130987; DOI=10.1007/s003350010211;
RA   Barclay J., Rees M.;
RT   "Genomic organization of the mouse and human alpha2delta2 voltage-
RT   dependent calcium channel subunit genes.";
RL   Mamm. Genome 11:1142-1144(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND INVOLVEMENT IN DU.
RC   STRAIN=TKDU;
RX   PubMed=11487633;
RA   Barclay J., Balaguero N., Mione M., Ackerman S.L., Letts V.A.,
RA   Brodbeck J., Canti C., Meir A., Page K.M., Kusumi K., Perez-Reyes E.,
RA   Lander E.S., Frankel W.N., Gardiner R.M., Dolphin A.C., Rees M.;
RT   "Ducky mouse phenotype of epilepsy and ataxia is associated with
RT   mutations in the Cacna2d2 gene and decreased calcium channel current
RT   in cerebellar Purkinje cells.";
RL   J. Neurosci. 21:6095-6104(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANT
RP   VARIANT ILE-TYR-LYS-ASP-ASN-ARG-ASN-LEU-PHE-GLU-VAL-GLN-GLU-ASN-GLU-
RP   PRO-GLN-LYS-LEU-VAL-GLU-LYS-VAL-ALA-GLY-ASP-ILE-GLU-SER-LEU-LEU-ASP-
RP   ARG-LYS-VAL-GLN-ALA-LEU-LYS-99 INS.
RC   STRAIN=DBA/2J;
RX   PubMed=14660671; DOI=10.1074/jbc.M308778200;
RA   Brill J., Klocke R., Paul D., Boison D., Gouder N., Klugbauer N.,
RA   Hofmann F., Becker C.-M., Becker K.;
RT   "entla, a novel epileptic and ataxic Cacna2d2 mutant of the mouse.";
RL   J. Biol. Chem. 279:7322-7330(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 788-1154 (ISOFORM 6).
RC   STRAIN=C57BL/6J; TISSUE=Hippocampus, Medulla oblongata, and Retina;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 53-1154 (ISOFORM 5).
RX   PubMed=12465718; DOI=10.1093/dnares/9.5.179;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Hara Y., Nagase T.,
RA   Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene:
RT   I. The complete nucleotide sequences of 100 mouse KIAA-homologous
RT   cDNAs identified by screening of terminal sequences of cDNA clones
RT   randomly sampled from size-fractionated libraries.";
RL   DNA Res. 9:179-188(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 932-1154.
RX   PubMed=10766861; DOI=10.1074/jbc.275.16.12237;
RA   Gao B., Sekido Y., Maximov A., Saad M., Forgacs E., Latif F.,
RA   Wei M.-H., Lerman M., Lee J.-H., Perez-Reyes E., Bezprozvanny I.,
RA   Minna J.D.;
RT   "Functional properties of a new voltage-dependent calcium channel
RT   alpha(2)delta auxiliary subunit gene (CACNA2D2).";
RL   J. Biol. Chem. 275:12237-12242(2000).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=10762351; DOI=10.1046/j.1460-9568.2000.01009.x;
RA   Hobom M., Dai S., Marais E., Lacinova L., Hofmann F., Klugbauer N.;
RT   "Neuronal distribution and functional characterization of the calcium
RT   channel alpha2delta-2 subunit.";
RL   Eur. J. Neurosci. 12:1217-1226(2000).
RN   [9]
RP   DISULFIDE BONDS, GLYCOSYLATION, PROTEOLYTIC PROCESSING, AND
RP   GABAPENTIN-BINDING.
RX   PubMed=11306709;
RA   Marais E., Klugbauer N., Hofmann F.;
RT   "Calcium channel alpha(2)delta subunits-structure and Gabapentin
RT   binding.";
RL   Mol. Pharmacol. 59:1243-1248(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INVOLVEMENT IN DU.
RX   PubMed=11756448; DOI=10.1074/jbc.M109404200;
RA   Brodbeck J., Davies A., Courtney J.-M., Meir A., Balaguero N.,
RA   Canti C., Moss F.J., Page K.M., Pratt W.S., Hunt S.P., Barclay J.,
RA   Rees M., Dolphin A.C.;
RT   "The ducky mutation in Cacna2d2 results in altered Purkinje cell
RT   morphology and is associated with the expression of a truncated alpha
RT   2 delta-2 protein with abnormal function.";
RL   J. Biol. Chem. 277:7684-7693(2002).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15331424; DOI=10.1016/S0002-9440(10)63362-7;
RA   Ivanov S.V., Ward J.M., Tessarollo L., McAreavey D., Sachdev V.,
RA   Fananapazir L., Banks M.K., Morris N., Djurickovic D.,
RA   Devor-Henneman D.E., Wei M.-H., Alvord G.W., Gao B., Richardson J.A.,
RA   Minna J.D., Rogawski M.A., Lerman M.I.;
RT   "Cerebellar ataxia, seizures, premature death, and cardiac
RT   abnormalities in mice with targeted disruption of the Cacna2d2 gene.";
RL   Am. J. Pathol. 165:1007-1018(2004).
RN   [12]
RP   METAL-BINDING, MIDAS-LIKE MOTIF, AND MUTAGENESIS OF ASP-300; SER-302
RP   AND SER-304.
RX   PubMed=16061813; DOI=10.1073/pnas.0504183102;
RA   Canti C., Nieto-Rostro M., Foucault I., Heblich F., Wratten J.,
RA   Richards M.W., Hendrich J., Douglas L., Page K.M., Davies A.,
RA   Dolphin A.C.;
RT   "The metal-ion-dependent adhesion site in the Von Willebrand factor-A
RT   domain of alpha2delta subunits is key to trafficking voltage-gated
RT   Ca2+ channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:11230-11235(2005).
RN   [13]
RP   GLYCOSYLATION, AND LACK OF PROTEOLYTIC PROCESSING.
RX   PubMed=17052222; DOI=10.1042/BST0340894;
RA   Douglas L., Davies A., Wratten J., Dolphin A.C.;
RT   "Do voltage-gated calcium channel alpha2delta subunits require
RT   proteolytic processing into alpha2 and delta to be functional?";
RL   Biochem. Soc. Trans. 34:894-898(2006).
RN   [14]
RP   SUBCELLULAR LOCATION, INTERACTION WITH STOML2, GABAPENTIN-BINDING, AND
RP   MUTAGENESIS OF ARG-282.
RX   PubMed=16928863; DOI=10.1523/JNEUROSCI.2764-06.2006;
RA   Davies A., Douglas L., Hendrich J., Wratten J., Tran Van Minh A.,
RA   Foucault I., Koch D., Pratt W.S., Saibil H.R., Dolphin A.C.;
RT   "The calcium channel alpha2delta-2 subunit partitions with CaV2.1 into
RT   lipid rafts in cerebellum: implications for localization and
RT   function.";
RL   J. Neurosci. 26:8748-8757(2006).
RN   [15]
RP   INVOLVEMENT IN DU.
RX   PubMed=17135419; DOI=10.1523/JNEUROSCI.3080-06.2006;
RA   Donato R., Page K.M., Koch D., Nieto-Rostro M., Foucault I.,
RA   Davies A., Wilkinson T., Rees M., Edwards F.A., Dolphin A.C.;
RT   "The ducky(2J) mutation in Cacna2d2 results in reduced spontaneous
RT   Purkinje cell activity and altered gene expression.";
RL   J. Neurosci. 26:12576-12586(2006).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Heart;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium
CC       channels regulates calcium current density and
CC       activation/inactivation kinetics of the calcium channel. Acts as a
CC       regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type
CC       (CACNA1B), L-type (CACNA1C OR CACNA1D) and possibly T-type
CC       (CACNA1G). {ECO:0000269|PubMed:15331424}.
CC   -!- SUBUNIT: Dimer formed of alpha-2-2 and delta-2 chains; disulfide-
CC       linked. Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta
CC       (CACNB) and delta (CACNA2D) subunits in a 1:1:1:1 ratio
CC       (Probable). {ECO:0000305|PubMed:11306709}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Colocalizes with CACNA1A in
CC       lipid raft fractions. {ECO:0000269|PubMed:11756448,
CC       ECO:0000269|PubMed:16928863}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Alpha2delta-2a;
CC         IsoId=Q6PHS9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PHS9-2; Sequence=VSP_028061, VSP_028062;
CC       Name=3; Synonyms=Alpha2delta-2c;
CC         IsoId=Q6PHS9-3; Sequence=VSP_028063;
CC       Name=4; Synonyms=Alpha2delta-2b;
CC         IsoId=Q6PHS9-4; Sequence=VSP_028061;
CC       Name=5;
CC         IsoId=Q6PHS9-5; Sequence=VSP_028061, VSP_028062, VSP_028063;
CC       Name=6;
CC         IsoId=Q6PHS9-6; Sequence=VSP_028062, VSP_028063;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain in a
CC       restricted pattern. Also expressed at lower level in kidney and
CC       testis Not expressed in lung at any moment of development. In
CC       brain, it localizes to sections of P21 brain. Expressed at high
CC       level in the cerebellum, with moderate levels in medulla, pons,
CC       and striatum. Also expressed in cortex, hippocampus, habenula and
CC       nucleus reticularis thalami (nRT). Strongly expressed in
CC       cerebellar Purkinje cells. {ECO:0000269|PubMed:10762351}.
CC   -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent
CC       metal cations and is required to promote trafficking of the alpha-
CC       1 (CACNA1) subunit to the plasma membrane by an integrin-like
CC       switch.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11306709,
CC       ECO:0000269|PubMed:17052222}.
CC   -!- PTM: May be proteolytically processed into subunits alpha-2-2 and
CC       delta-2 that are disulfide-linked. It is however unclear whether
CC       such cleavage really takes place in vivo and has a functional
CC       role. According to PubMed:11306709, it is processed, at least in
CC       vitro, while according to PubMed:17052222, it is only poorly
CC       processed in vivo. {ECO:0000269|PubMed:11306709}.
CC   -!- DISEASE: Note=Defects in Cacna2d2 are the cause of ducky phenotype
CC       (du). Du mice have spike-wave seizures characteristic of absence
CC       epilepsy and ataxia, with accompanying decreased calcium channel
CC       current in cerebellar Purkinje cells.
CC       {ECO:0000269|PubMed:11487633, ECO:0000269|PubMed:11756448,
CC       ECO:0000269|PubMed:14660671, ECO:0000269|PubMed:17135419}.
CC   -!- DISRUPTION PHENOTYPE: Mice exhibit growth retardation, reduced
CC       life span, ataxic gait with apoptosis of cerebellar granule cells
CC       followed by Purkinje cell depletion, enhanced susceptibility to
CC       seizures, and cardiac abnormalities.
CC       {ECO:0000269|PubMed:15331424}.
CC   -!- MISCELLANEOUS: Binds gabapentin, an antiepileptic drug.
CC   -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL01651.1; Type=Frameshift; Positions=301; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF247139; AAG47846.1; -; mRNA.
DR   EMBL; AF247141; AAL01650.1; -; mRNA.
DR   EMBL; AF247142; AAL01651.1; ALT_FRAME; mRNA.
DR   EMBL; AY502107; AAR89454.1; -; mRNA.
DR   EMBL; AK044603; BAC31998.1; -; mRNA.
DR   EMBL; AK164143; BAE37646.1; -; mRNA.
DR   EMBL; AK161839; BAE36599.1; -; mRNA.
DR   EMBL; BC056389; AAH56389.1; -; mRNA.
DR   EMBL; BC158058; AAI58059.1; -; mRNA.
DR   EMBL; AB093246; BAC41430.1; -; mRNA.
DR   EMBL; AF169633; AAD48037.1; -; mRNA.
DR   CCDS; CCDS52916.1; -. [Q6PHS9-1]
DR   CCDS; CCDS52917.1; -. [Q6PHS9-2]
DR   CCDS; CCDS72304.1; -. [Q6PHS9-3]
DR   CCDS; CCDS72305.1; -. [Q6PHS9-5]
DR   RefSeq; NP_001167518.1; NM_001174047.1. [Q6PHS9-3]
DR   RefSeq; NP_001167519.1; NM_001174048.1. [Q6PHS9-5]
DR   RefSeq; NP_001167520.1; NM_001174049.1. [Q6PHS9-4]
DR   RefSeq; NP_001167521.1; NM_001174050.1. [Q6PHS9-2]
DR   RefSeq; NP_064659.2; NM_020263.3. [Q6PHS9-1]
DR   RefSeq; XP_011241201.1; XM_011242899.2. [Q6PHS9-6]
DR   UniGene; Mm.273084; -.
DR   ProteinModelPortal; Q6PHS9; -.
DR   IntAct; Q6PHS9; 1.
DR   STRING; 10090.ENSMUSP00000082173; -.
DR   PhosphoSitePlus; Q6PHS9; -.
DR   PaxDb; Q6PHS9; -.
DR   PRIDE; Q6PHS9; -.
DR   Ensembl; ENSMUST00000010210; ENSMUSP00000010210; ENSMUSG00000010066. [Q6PHS9-2]
DR   Ensembl; ENSMUST00000085092; ENSMUSP00000082173; ENSMUSG00000010066. [Q6PHS9-1]
DR   Ensembl; ENSMUST00000166799; ENSMUSP00000126029; ENSMUSG00000010066. [Q6PHS9-6]
DR   Ensembl; ENSMUST00000168532; ENSMUSP00000132512; ENSMUSG00000010066. [Q6PHS9-3]
DR   Ensembl; ENSMUST00000170737; ENSMUSP00000125943; ENSMUSG00000010066. [Q6PHS9-5]
DR   GeneID; 56808; -.
DR   KEGG; mmu:56808; -.
DR   UCSC; uc009rli.2; mouse. [Q6PHS9-2]
DR   UCSC; uc009rlj.2; mouse. [Q6PHS9-4]
DR   UCSC; uc012haf.1; mouse. [Q6PHS9-1]
DR   UCSC; uc057apw.1; mouse. [Q6PHS9-3]
DR   UCSC; uc057apx.1; mouse. [Q6PHS9-5]
DR   CTD; 9254; -.
DR   MGI; MGI:1929813; Cacna2d2.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOVERGEN; HBG057779; -.
DR   InParanoid; Q6PHS9; -.
DR   KO; K04859; -.
DR   PhylomeDB; Q6PHS9; -.
DR   TreeFam; TF315824; -.
DR   Reactome; R-MMU-422356; Regulation of insulin secretion.
DR   Reactome; R-MMU-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-MMU-5576893; Phase 2 - plateau phase.
DR   PRO; PR:Q6PHS9; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   Bgee; ENSMUSG00000010066; -.
DR   ExpressionAtlas; Q6PHS9; baseline and differential.
DR   Genevisible; Q6PHS9; MM.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IC:MGI.
DR   GO; GO:0048747; P:muscle fiber development; IMP:MGI.
DR   GO; GO:0007528; P:neuromuscular junction development; IMP:MGI.
DR   GO; GO:0046622; P:positive regulation of organ growth; IMP:MGI.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; IMP:MGI.
DR   GO; GO:0060024; P:rhythmic synaptic transmission; IMP:MGI.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013680; VDCC_a2/dsu.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF08473; VGCC_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   1154       Voltage-dependent calcium channel subunit
FT                                alpha-2/delta-2.
FT                                /FTId=PRO_0000304640.
FT   CHAIN        19   1004       Voltage-dependent calcium channel subunit
FT                                alpha-2-2. {ECO:0000255}.
FT                                /FTId=PRO_0000304641.
FT   CHAIN      1005   1154       Voltage-dependent calcium channel subunit
FT                                delta-2. {ECO:0000255}.
FT                                /FTId=PRO_0000304642.
FT   TOPO_DOM     19   1116       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1117   1137       Helical. {ECO:0000255}.
FT   TOPO_DOM   1138   1154       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      294    472       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      488    577       Cache.
FT   MOTIF       300    304       MIDAS-like motif.
FT   METAL       300    300       Divalent metal cation. {ECO:0000305}.
FT   METAL       302    302       Divalent metal cation. {ECO:0000305}.
FT   METAL       304    304       Divalent metal cation. {ECO:0000305}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    389    389       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    510    510       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    543    543       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    627    627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    864    864       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    446   1101       Interchain (between alpha-2-2 and delta-2
FT                                chains). {ECO:0000250}.
FT   VAR_SEQ     665    672       LPISKLKD -> Y (in isoform 2, isoform 4
FT                                and isoform 5).
FT                                {ECO:0000303|PubMed:12465718,
FT                                ECO:0000303|PubMed:14660671,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_028061.
FT   VAR_SEQ     873    873       K -> KQ (in isoform 2, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:12465718,
FT                                ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_028062.
FT   VAR_SEQ    1079   1080       HS -> HCPA (in isoform 3, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:11130987,
FT                                ECO:0000303|PubMed:11487633,
FT                                ECO:0000303|PubMed:12465718,
FT                                ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_028063.
FT   VARIANT      99     99       E -> EIYKDNRNLFEVQENEPQKLVEKVAGDIESLLDRKV
FT                                QALK (in du; variant allele entla).
FT   MUTAGEN     282    282       R->A: Induces a strong decrease in
FT                                gabapentin-binding.
FT                                {ECO:0000269|PubMed:16928863}.
FT   MUTAGEN     300    300       D->A: Abolishes metal-binding and ability
FT                                to regulate calcium current.
FT                                {ECO:0000269|PubMed:16061813}.
FT   MUTAGEN     302    302       S->A: Abolishes metal-binding and ability
FT                                to regulate calcium current.
FT                                {ECO:0000269|PubMed:16061813}.
FT   MUTAGEN     304    304       S->A: Abolishes metal-binding and ability
FT                                to regulate calcium current.
FT                                {ECO:0000269|PubMed:16061813}.
FT   CONFLICT    657    657       S -> R (in Ref. 1; AAG47846, 2; AAL01650
FT                                and 3; AAR89454). {ECO:0000305}.
FT   CONFLICT    704    704       N -> S (in Ref. 1; AAG47846, 2; AAL01650
FT                                and 3; AAR89454). {ECO:0000305}.
FT   CONFLICT    710    710       N -> D (in Ref. 1; AAG47846, 2; AAL01650
FT                                and 3; AAR89454). {ECO:0000305}.
SQ   SEQUENCE   1154 AA;  130385 MW;  AE4F646D89A96053 CRC64;
     MAVPARTCGA SWPGPVRTAR PWPGRGPRPC PDPRGPASGP ARPLLLLLPP LLLLPLLTAP
     GASAYSFPQQ HTMQHWARRL EQEIDGVMRI FGGVQQLREI YKDNRNLFEV QENEPQKLVE
     KVAGDIESLL DRKVQALKRL ADAAENFQKA HRWQDNIKEE DIMYYDAKAD AELDDPESED
     MERGSKTSAL RLDFIEDPNF KNKVNYSYTA VQIPTDIYKG STVILNELNW TEALENVFIE
     NRRQDPTLLW QVFGSATGVT RYYPATPWRA PKKIDLYDVR RRPWYIQGAS SPKDMVIIVD
     VSGSVSGLTL KLMKTSVCEM LDTLSDDDYV NVASFNEKAQ PVSCFTHLVQ ANVRNKKVFK
     EAVQGMVAKG TTGYKAGFEY AFDQLQNSNI TRANCNKMIM MFTDGGEDRV QDVFEKYNWP
     NRTVRVFTFS VGQHNYDVTP LQWMACTNKG YYFEIPSIGA IRINTQEYLD VLGRPMVLAG
     KDAKQVQWTN VYEDALGLGL VVTGTLPVFN LTQDGPGEKK NQLILGVMGI DVALNDIKRL
     TPNYTLGANG YVFAIDLNGY VLLHPNLKPQ TTNFREPVTL DFLDAELEDE NKEEIRRSMI
     DGDKGHKQIR TLVKSLDERY IDEVIRNYTW VPIRSTNYSL GLVLPPYSTY YLQANLSDQI
     LQVKLPISKL KDFEFLLPSS FESEGHVFIA PREYCKDLNA SDNNTEFLKN FIELMEKVTP
     DSKQCNNFLL HNLILDTGIT QQLVERVWRD QDLNTYSLLA VFAATDGGIT RVFPNKAAED
     WTENPEPFNA SFYRRSLDNH GYIFKPPHQD SLLRPLELEN DTVGVLVSTA VELSLGRRTL
     RPAVVGVKLD LEAWAEKFKV LASNRTHQDQ PQKCGPSSHC EMDCEVNNED LLCVLIDDGG
     FLVLSNQNHQ WDQVGRFFSE VDANLMLALY NNSFYTRKES YDYQAACAPQ PPGNLGAAPR
     GVFVPTIADF LNLAWWTSAA AWSLFQQLLY GLIYHSWFQA DPAEAEGSPE TRESSCVMKQ
     TQYYFGSVNA SYNAIIDCGN CSRLFHAQRL TNTNLLFVVA EKPLCSQCEA GRLLQKETHS
     DGPEQCELVQ RPRYRRGPHI CFDYNATEDT SDCGRGASFP PSLGVLVSLQ LLLLLGLPPR
     PQPQVHSFAA SRHL
//
ID   CRCM1_DANRE             Reviewed;         222 AA.
AC   Q6TLE6; Q504L0;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   20-DEC-2017, entry version 74.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai-1;
DE   AltName: Full=Transmembrane protein 142A;
GN   Name=orai1; Synonyms=tmem142a; ORFNames=zgc:109721;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney marrow;
RX   PubMed=15520368; DOI=10.1073/pnas.0407241101;
RA   Song H.-D., Sun X.-J., Deng M., Zhang G.-W., Zhou Y., Wu X.-Y.,
RA   Sheng Y., Chen Y., Ruan Z., Jiang C.-L., Fan H.-Y., Zon L.I.,
RA   Kanki J.P., Liu T.X., Look A.T., Chen Z.;
RT   "Hematopoietic gene expression profile in zebrafish kidney marrow.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:16240-16245(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores. {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q96D31}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q96D31}.
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY394960; AAQ94587.1; -; mRNA.
DR   EMBL; BC094965; AAH94965.1; -; mRNA.
DR   RefSeq; NP_991163.1; NM_205600.1.
DR   UniGene; Dr.85339; -.
DR   SMR; Q6TLE6; -.
DR   STRING; 7955.ENSDARP00000022726; -.
DR   PaxDb; Q6TLE6; -.
DR   GeneID; 402892; -.
DR   KEGG; dre:402892; -.
DR   CTD; 402892; -.
DR   ZFIN; ZDB-GENE-050522-100; orai1b.
DR   eggNOG; KOG4298; Eukaryota.
DR   eggNOG; ENOG4110DSB; LUCA.
DR   HOGENOM; HOG000246925; -.
DR   HOVERGEN; HBG081343; -.
DR   InParanoid; Q6TLE6; -.
DR   KO; K16056; -.
DR   PhylomeDB; Q6TLE6; -.
DR   TreeFam; TF313576; -.
DR   PRO; PR:Q6TLE6; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015279; F:store-operated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0045214; P:sarcomere organization; IMP:ZFIN.
DR   GO; GO:0002115; P:store-operated calcium entry; ISS:UniProtKB.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Glycoprotein; Immunity; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    222       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234385.
FT   TOPO_DOM      1     30       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     31     48       Helical. {ECO:0000255}.
FT   TOPO_DOM     49     58       Extracellular. {ECO:0000255}.
FT   TRANSMEM     59     79       Helical. {ECO:0000255}.
FT   TOPO_DOM     80    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TOPO_DOM    134    154       Extracellular. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
FT   TOPO_DOM    176    222       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    148    148       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    129    129       G -> E (in Ref. 1; AAQ94587).
FT                                {ECO:0000305}.
FT   CONFLICT    145    145       G -> D (in Ref. 1; AAQ94587).
FT                                {ECO:0000305}.
SQ   SEQUENCE   222 AA;  24633 MW;  A5B735B035D78894 CRC64;
     MKMSRSEHSL QALSWRKLYL SRAKLKASSR TSALLSGFAM VAMVEVQLDT NHDYPPGLLI
     AFSACTTVLV AVHLFALMVS TCILPNIEAV SNVHNLNSVK ESPHERMHRH IELAWAFSTV
     IGTLLFLAGV VLLCWVKFLP IKPKGQKNGT VSAGVAAAIT STSIMVPFGL VFIVFAVHFY
     RSLVSHKTDR QFQELEELED LQNELDHREE VSTLQSPGSL YP
//
ID   CTSR4_HUMAN             Reviewed;         472 AA.
AC   Q7RTX7; A1A4W6; Q5VY71;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 1.
DT   25-OCT-2017, entry version 119.
DE   RecName: Full=Cation channel sperm-associated protein 4;
DE            Short=CatSper4;
GN   Name=CATSPER4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=12932298; DOI=10.1186/1477-7827-1-53;
RA   Lobley A., Pierron V., Reynolds L., Allen L., Michalovich D.;
RT   "Identification of human and mouse CatSper3 and CatSper4 genes:
RT   characterisation of a common interaction domain and evidence for
RT   expression in testis.";
RL   Reprod. Biol. Endocrinol. 1:53-53(2003).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [5]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412338; DOI=10.1038/nature09769;
RA   Strunker T., Goodwin N., Brenker C., Kashikar N.D., Weyand I.,
RA   Seifert R., Kaupp U.B.;
RT   "The CatSper channel mediates progesterone-induced Ca2+ influx in
RT   human sperm.";
RL   Nature 471:382-386(2011).
RN   [6]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=26989199; DOI=10.1126/science.aad6887;
RA   Miller M.R., Mannowetz N., Iavarone A.T., Safavi R., Gracheva E.O.,
RA   Smith J.F., Hill R.Z., Bautista D.M., Kirichok Y., Lishko P.V.;
RT   "Unconventional endocannabinoid signaling governs sperm activation via
RT   sex hormone progesterone.";
RL   Science 352:555-559(2016).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in calcium-dependent physiological responses essential for
CC       successful fertilization, such as sperm hyperactivation, acrosome
CC       reaction and chemotaxis towards the oocyte.
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339}.
CC   -!- ENZYME REGULATION: The CatSper calcium channel is indirectly
CC       activated by extracellular progesterone and prostaglandins
CC       following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 >
CC       PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199).
CC       The CatSper calcium channel is directly inhibited by
CC       endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199).
CC       Indirect activation by progesterone takes place via the following
CC       mechanism: progesterone binds and activates the acylglycerol
CC       lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor,
CC       relieving inhibition of the CatSper channel (PubMed:26989199). The
CC       primary effect of progesterone activation is to shift voltage
CC       dependence towards more physiological, negative membrane
CC       potentials; it is not mediated by metabotropic receptors and
CC       second messengers (PubMed:21412338, PubMed:21412339). Sperm
CC       capacitation enhances the effect of progesterone by providing
CC       additional negative shift. Also activated by the elevation of
CC       intracellular pH (PubMed:21412338, PubMed:21412339).
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339,
CC       ECO:0000269|PubMed:26989199}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Component of the CatSper
CC       complex. Interacts with CATSPER1 (By similarity). {ECO:0000250,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane;
CC       Multi-pass membrane protein. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7RTX7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7RTX7-2; Sequence=VSP_026979, VSP_026980;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:12932298,
CC       ECO:0000269|PubMed:17347248}.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28139.1; Type=Frameshift; Positions=21; Evidence={ECO:0000305};
CC       Sequence=CAH71538.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL355877; CAH71538.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC128138; AAI28139.1; ALT_FRAME; mRNA.
DR   EMBL; BC128139; AAI28140.1; -; mRNA.
DR   EMBL; BN000273; CAE30475.1; -; mRNA.
DR   CCDS; CCDS30645.1; -. [Q7RTX7-1]
DR   RefSeq; NP_937770.1; NM_198137.1. [Q7RTX7-1]
DR   UniGene; Hs.123532; -.
DR   ProteinModelPortal; Q7RTX7; -.
DR   BioGrid; 132049; 4.
DR   STRING; 9606.ENSP00000390423; -.
DR   GuidetoPHARMACOLOGY; 391; -.
DR   TCDB; 1.A.1.19.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q7RTX7; -.
DR   PhosphoSitePlus; Q7RTX7; -.
DR   BioMuta; CATSPER4; -.
DR   DMDM; 74713153; -.
DR   PaxDb; Q7RTX7; -.
DR   PeptideAtlas; Q7RTX7; -.
DR   PRIDE; Q7RTX7; -.
DR   Ensembl; ENST00000456354; ENSP00000390423; ENSG00000188782. [Q7RTX7-1]
DR   Ensembl; ENST00000518899; ENSP00000429464; ENSG00000188782. [Q7RTX7-2]
DR   GeneID; 378807; -.
DR   KEGG; hsa:378807; -.
DR   UCSC; uc009vsf.4; human. [Q7RTX7-1]
DR   CTD; 378807; -.
DR   EuPathDB; HostDB:ENSG00000188782.7; -.
DR   GeneCards; CATSPER4; -.
DR   HGNC; HGNC:23220; CATSPER4.
DR   HPA; HPA045257; -.
DR   MIM; 609121; gene.
DR   neXtProt; NX_Q7RTX7; -.
DR   OpenTargets; ENSG00000188782; -.
DR   PharmGKB; PA134941696; -.
DR   eggNOG; ENOG410II5Y; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000119325; -.
DR   HOGENOM; HOG000112053; -.
DR   HOVERGEN; HBG102124; -.
DR   InParanoid; Q7RTX7; -.
DR   KO; K16892; -.
DR   PhylomeDB; Q7RTX7; -.
DR   TreeFam; TF343841; -.
DR   Reactome; R-HSA-1300642; Sperm Motility And Taxes.
DR   GeneWiki; CatSper4; -.
DR   GenomeRNAi; 378807; -.
DR   PRO; PR:Q7RTX7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000188782; -.
DR   CleanEx; HS_CATSPER4; -.
DR   ExpressionAtlas; Q7RTX7; baseline and differential.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0036128; C:CatSper complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0097228; C:sperm principal piece; IEA:Ensembl.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0030317; P:flagellated sperm motility; IEA:Ensembl.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0032570; P:response to progesterone; TAS:Reactome.
DR   GO; GO:0006814; P:sodium ion transport; IEA:Ensembl.
DR   GO; GO:0048240; P:sperm capacitation; IEA:Ensembl.
DR   GO; GO:0035036; P:sperm-egg recognition; TAS:Reactome.
DR   InterPro; IPR028744; CatSper4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF225; PTHR10037:SF225; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cell projection; Cilium; Complete proteome;
KW   Developmental protein; Differentiation; Flagellum; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   Spermatogenesis; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    472       Cation channel sperm-associated protein
FT                                4.
FT                                /FTId=PRO_0000295681.
FT   TOPO_DOM      1     90       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     91    111       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    112    130       Extracellular. {ECO:0000255}.
FT   TRANSMEM    131    151       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    152    157       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    179    179       Extracellular. {ECO:0000255}.
FT   TRANSMEM    180    197       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    198    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    238    246       Extracellular. {ECO:0000255}.
FT   INTRAMEM    247    267       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    268    284       Extracellular. {ECO:0000255}.
FT   TRANSMEM    285    305       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    306    472       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ     227    242       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026979.
FT   VAR_SEQ     401    472       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026980.
FT   VARIANT      77     77       Q -> R (in dbSNP:rs11247866).
FT                                /FTId=VAR_033310.
FT   VARIANT     124    124       L -> F (in dbSNP:rs12138368).
FT                                /FTId=VAR_033311.
FT   VARIANT     293    293       I -> V (in dbSNP:rs17257155).
FT                                /FTId=VAR_033312.
FT   VARIANT     436    436       D -> N (in dbSNP:rs6657616).
FT                                /FTId=VAR_033313.
SQ   SEQUENCE   472 AA;  54092 MW;  5AC94CD0971A25FE CRC64;
     MRDNEKAWWQ QWTSHTGLEG WGGTQEDRMG FGGAVAALRG RPSPLQSTIH ESYGRPEEQV
     LINRQEITNK ADAWDMQEFI THMYIKQLLR HPAFQLLLAL LLVINAITIA LRTNSYLDQK
     HYELFSTIDD IVLTILLCEV LLGWLNGFWI FWKDGWNILN FIIVFILLLR FFINEINIPS
     INYTLRALRL VHVCMAVEPL ARIIRVILQS VPDMANIMVL ILFFMLVFSV FGVTLFGAFV
     PKHFQNIQVA LYTLFICITQ DGWVDIYSDF QTEKREYAME IGGAIYFTIF ITIGAFIGIN
     LFVIVVTTNL EQMMKAGEQG QQQRITFSET GAEEEEENDQ LPLVHCVVAR SEKSGLLQEP
     LAGGPLSNLS ENTCDNFCLV LEAIQENLRQ YKEIRDELNM IVEEVRAIRF NQEQESEVLN
     RRSSTSGSLE TTSSKDIRQM SQQQDLLSAL VSMEKVHDSS SQILLKKHKS SH
//
ID   CA2D4_HUMAN             Reviewed;        1137 AA.
AC   Q7Z3S7; Q7Z3S8; Q86XZ5; Q8IZS9;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   25-OCT-2017, entry version 113.
DE   RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-4;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-4;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit alpha-2-4;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit delta-4;
DE   Flags: Precursor;
GN   Name=CACNA2D4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4; 5 AND 6), FUNCTION, TISSUE
RP   SPECIFICITY, LACK OF GABAPENTIN-BINDING, INTERACTION WITH CACNA1C AND
RP   CACNB3, AND VARIANT VAL-327.
RX   PubMed=12181424; DOI=10.1124/mol.62.3.485;
RA   Qin N., Yagel S., Momplaisir M.-L., Codd E.E., D'Andrea M.R.;
RT   "Molecular cloning and characterization of the human voltage-gated
RT   calcium channel alpha(2)delta-4 subunit.";
RL   Mol. Pharmacol. 62:485-496(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   VAL-327.
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN RCD4.
RX   PubMed=17033974; DOI=10.1086/508944;
RA   Wycisk K.A., Zeitz C., Feil S., Wittmer M., Forster U., Neidhardt J.,
RA   Wissinger B., Zrenner E., Wilke R., Kohl S., Berger W.;
RT   "Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes
RT   autosomal recessive cone dystrophy.";
RL   Am. J. Hum. Genet. 79:973-977(2006).
CC   -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium
CC       channels regulates calcium current density and
CC       activation/inactivation kinetics of the calcium channel.
CC       {ECO:0000269|PubMed:12181424}.
CC   -!- SUBUNIT: Dimer formed of alpha-2-2 and delta-2 chains; disulfide-
CC       linked. Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta
CC       (CACNB) and delta (CACNA2D) subunits in a 1:1:1:1 ratio
CC       (Probable). Interacts with CACNA1C and CACNB3.
CC       {ECO:0000269|PubMed:12181424, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Alpha2delta-4a;
CC         IsoId=Q7Z3S7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z3S7-2; Sequence=VSP_028070;
CC         Note=No experimental confirmation available. May be due to an
CC         intron retention.;
CC       Name=4; Synonyms=Alpha2delta-4b;
CC         IsoId=Q7Z3S7-4; Sequence=VSP_028069;
CC       Name=5; Synonyms=Alpha2delta-4c;
CC         IsoId=Q7Z3S7-5; Sequence=VSP_028071;
CC       Name=6; Synonyms=Alpha2delta-4d;
CC         IsoId=Q7Z3S7-6; Sequence=VSP_028069, VSP_028071;
CC       Name=7;
CC         IsoId=Q7Z3S7-7; Sequence=VSP_044107, VSP_044108, VSP_044109,
CC                                  VSP_044110;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in certain types of
CC       endocrine cells. Present in the Paneth cells of the small
CC       intestine. Also present in the erythroblasts in the fetal liver,
CC       in the cells of the zona reticularis of the adrenal gland and in
CC       the basophils of the pituitary. Present at low level in some brain
CC       regions such as the cerebellum (at protein level).
CC       {ECO:0000269|PubMed:12181424}.
CC   -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent
CC       metal cations and is required to promote trafficking of the alpha-
CC       1 (CACNA1) subunit to the plasma membrane by an integrin-like
CC       switch. {ECO:0000250}.
CC   -!- PTM: May be proteolytically processed into subunits alpha-2-4 and
CC       delta-4 that are disulfide-linked. It is however unclear whether
CC       such cleavage really takes place in vivo and has a functional role
CC       (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Retinal cone dystrophy 4 (RCD4) [MIM:610478]:
CC       Characterized by minimal symptoms except for slowly progressive
CC       reduction in visual acuity. {ECO:0000269|PubMed:17033974}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: In contrast to CACNA2D1 and CACNA2D2, it does not
CC       bind gabapentin, an antiepileptic drug.
CC   -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH48288.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC       Sequence=AAN06672.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF516695; AAN06672.1; ALT_INIT; mRNA.
DR   EMBL; BX537436; CAD97678.1; -; mRNA.
DR   EMBL; BX537437; CAD97679.1; -; mRNA.
DR   EMBL; AC005342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC048288; AAH48288.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS44785.1; -. [Q7Z3S7-1]
DR   RefSeq; NP_758952.4; NM_172364.4. [Q7Z3S7-1]
DR   UniGene; Hs.13768; -.
DR   ProteinModelPortal; Q7Z3S7; -.
DR   STRING; 9606.ENSP00000372169; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   TCDB; 8.A.18.4.1; the ca(2+) channel auxiliary subunit Alpha2Delta types 1-4 (cca-Alpha2Delta) family.
DR   iPTMnet; Q7Z3S7; -.
DR   PhosphoSitePlus; Q7Z3S7; -.
DR   BioMuta; CACNA2D4; -.
DR   DMDM; 296434419; -.
DR   PaxDb; Q7Z3S7; -.
DR   PeptideAtlas; Q7Z3S7; -.
DR   PRIDE; Q7Z3S7; -.
DR   DNASU; 93589; -.
DR   Ensembl; ENST00000382722; ENSP00000372169; ENSG00000151062. [Q7Z3S7-1]
DR   Ensembl; ENST00000545595; ENSP00000442329; ENSG00000151062. [Q7Z3S7-7]
DR   Ensembl; ENST00000585708; ENSP00000467697; ENSG00000151062. [Q7Z3S7-6]
DR   Ensembl; ENST00000586184; ENSP00000465060; ENSG00000151062. [Q7Z3S7-5]
DR   Ensembl; ENST00000588077; ENSP00000468530; ENSG00000151062. [Q7Z3S7-4]
DR   GeneID; 93589; -.
DR   KEGG; hsa:93589; -.
DR   UCSC; uc058jsm.1; human. [Q7Z3S7-1]
DR   CTD; 93589; -.
DR   DisGeNET; 93589; -.
DR   EuPathDB; HostDB:ENSG00000151062.14; -.
DR   GeneCards; CACNA2D4; -.
DR   H-InvDB; HIX0010321; -.
DR   H-InvDB; HIX0171624; -.
DR   HGNC; HGNC:20202; CACNA2D4.
DR   HPA; HPA031952; -.
DR   MalaCards; CACNA2D4; -.
DR   MIM; 608171; gene.
DR   MIM; 610478; phenotype.
DR   neXtProt; NX_Q7Z3S7; -.
DR   OpenTargets; ENSG00000151062; -.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 215; Congenital stationary night blindness.
DR   PharmGKB; PA130546913; -.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOGENOM; HOG000010247; -.
DR   HOVERGEN; HBG107124; -.
DR   InParanoid; Q7Z3S7; -.
DR   KO; K04861; -.
DR   OMA; EDKQQGY; -.
DR   OrthoDB; EOG091G00UY; -.
DR   PhylomeDB; Q7Z3S7; -.
DR   TreeFam; TF315824; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA2D4; human.
DR   GenomeRNAi; 93589; -.
DR   PRO; PR:Q7Z3S7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151062; -.
DR   CleanEx; HS_CACNA2D4; -.
DR   ExpressionAtlas; Q7Z3S7; baseline and differential.
DR   Genevisible; Q7Z3S7; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013680; VDCC_a2/dsu.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF08473; VGCC_alpha2; 1.
DR   Pfam; PF13768; VWA_3; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1137       Voltage-dependent calcium channel subunit
FT                                alpha-2/delta-4.
FT                                /FTId=PRO_0000304655.
FT   CHAIN        20    991       Voltage-dependent calcium channel subunit
FT                                alpha-2-4. {ECO:0000255}.
FT                                /FTId=PRO_0000304656.
FT   CHAIN       992   1137       Voltage-dependent calcium channel subunit
FT                                delta-4. {ECO:0000255}.
FT                                /FTId=PRO_0000304657.
FT   TOPO_DOM     20   1115       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1116   1136       Helical. {ECO:0000255}.
FT   TOPO_DOM   1137   1137       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      291    473       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      487    580       Cache.
FT   MOTIF       297    301       MIDAS-like motif.
FT   METAL       297    297       Divalent metal cation. {ECO:0000250}.
FT   METAL       299    299       Divalent metal cation. {ECO:0000250}.
FT   METAL       301    301       Divalent metal cation. {ECO:0000250}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    664    664       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    447   1097       Interchain (between alpha-2-4 and delta-4
FT                                chains). {ECO:0000250}.
FT   VAR_SEQ       1    855       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044107.
FT   VAR_SEQ       1     76       MVCGCSALLPLPNPRPTMPATPNFLANPSSSSRWIPLQPMP
FT                                VAWAFVQKTSALLWLLLLGTSLSPAWGQAKIPLET -> MA
FT                                VALGTRRRDR (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:12181424}.
FT                                /FTId=VSP_028069.
FT   VAR_SEQ     872    886       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044108.
FT   VAR_SEQ     908    911       TGRF -> SDYV (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044109.
FT   VAR_SEQ     912   1137       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044110.
FT   VAR_SEQ     975   1137       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_028070.
FT   VAR_SEQ    1104   1137       ENAQDCGGASDTSASPPLLLLPVCAWGLLPQLLR -> VRV
FT                                EADRGWAGFSSPNPLCLGLCPCRQEHIGMPMNTPVPVLLGG
FT                                NIRVYAL (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:12181424}.
FT                                /FTId=VSP_028071.
FT   VARIANT     327    327       I -> V (in dbSNP:rs10735005).
FT                                {ECO:0000269|PubMed:12181424,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_035049.
FT   VARIANT     863    863       R -> H (in dbSNP:rs36077411).
FT                                /FTId=VAR_035050.
FT   VARIANT     869    869       T -> M (in dbSNP:rs35331095).
FT                                /FTId=VAR_035051.
FT   CONFLICT    368    368       K -> N (in Ref. 2; CAD97678).
FT                                {ECO:0000305}.
FT   CONFLICT    650    650       V -> A (in Ref. 1; AAN06672).
FT                                {ECO:0000305}.
FT   CONFLICT    710    710       T -> A (in Ref. 2; CAD97679).
FT                                {ECO:0000305}.
FT   CONFLICT    879    879       C -> Y (in Ref. 1; AAN06672).
FT                                {ECO:0000305}.
FT   CONFLICT   1034   1034       G -> E (in Ref. 2; CAD97679).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1137 AA;  127938 MW;  BF7FD169E1AF34F7 CRC64;
     MVCGCSALLP LPNPRPTMPA TPNFLANPSS SSRWIPLQPM PVAWAFVQKT SALLWLLLLG
     TSLSPAWGQA KIPLETVKLW ADTFGGDLYN TVTKYSGSLL LQKKYKDVES SLKIEEVDGL
     ELVRKFSEDM ENMLRRKVEA VQNLVEAAEE ADLNHEFNES LVFDYYNSVL INERDEKGNF
     VELGAEFLLE SNAHFSNLPV NTSISSVQLP TNVYNKDPDI LNGVYMSEAL NAVFVENFQR
     DPTLTWQYFG SATGFFRIYP GIKWTPDENG VITFDCRNRG WYIQAATSPK DIVILVDVSG
     SMKGLRMTIA KHTITTILDT LGENDFINII AYNDYVHYIE PCFKGILVQA DRDNREHFKL
     LVEELMVKGV GVVDQALREA FQILKQFQEA KQGSLCNQAI MLISDGAVED YEPVFEKYNW
     PDCKVRVFTY LIGREVSFAD RMKWIACNNK GYYTQISTLA DTQENVMEYL HVLSRPMVIN
     HDHDIIWTEA YMDSKLLSSQ AQSLTLLTTV AMPVFSKKNE TRSHGILLGV VGSDVALREL
     MKLAPRYKLG VHGYAFLNTN NGYILSHPDL RPLYREGKKL KPKPNYNSVD LSEVEWEDQA
     ESLRTAMINR ETGTLSMDVK VPMDKGKRVL FLTNDYFFTD ISDTPFSLGV VLSRGHGEYI
     LLGNTSVEEG LHDLLHPDLA LAGDWIYCIT DIDPDHRKLS QLEAMIRFLT RKDPDLECDE
     ELVREVLFDA VVTAPMEAYW TALALNMSEE SEHVVDMAFL GTRAGLLRSS LFVGSEKVSD
     RKFLTPEDEA SVFTLDRFPL WYRQASEHPA GSFVFNLRWA EGPESAGEPM VVTASTAVAV
     TVDKRTAIAA AAGVQMKLEF LQRKFWAATR QCSTVDGPCT QSCEDSDLDC FVIDNNGFIL
     ISKRSRETGR FLGEVDGAVL TQLLSMGVFS QVTMYDYQAM CKPSSHHHSA AQPLVSPISA
     FLTATRWLLQ ELVLFLLEWS VWGSWYDRGA EAKSVFHHSH KHKKQDPLQP CDTEYPVFVY
     QPAIREANGI VECGPCQKVF VVQQIPNSNL LLLVTDPTCD CSIFPPVLQE ATEVKYNASV
     KCDRMRSQKL RRRPDSCHAF HPEENAQDCG GASDTSASPP LLLLPVCAWG LLPQLLR
//
ID   PK1L3_HUMAN             Reviewed;        1732 AA.
AC   Q7Z443;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Polycystic kidney disease protein 1-like 3;
DE   AltName: Full=PC1-like 3 protein;
DE   AltName: Full=Polycystin-1L3;
DE   Flags: Precursor;
GN   Name=PKD1L3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=12782129; DOI=10.1016/S0888-7543(03)00048-X;
RA   Li A., Tian X., Sung S.-W., Somlo S.;
RT   "Identification of two novel polycystic kidney disease-1-like genes in
RT   human and mouse genomes.";
RL   Genomics 81:596-608(2003).
RN   [2]
RP   ERRATUM.
RA   Li A., Tian X., Sung S.-W., Somlo S.;
RL   Genomics 82:498-500(2003).
RN   [3]
RP   ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18535624; DOI=10.1038/embor.2008.89;
RA   Inada H., Kawabata F., Ishimaru Y., Fushiki T., Matsunami H.,
RA   Tominaga M.;
RT   "Off-response property of an acid-activated cation channel complex
RT   PKD1L3-PKD2L1.";
RL   EMBO Rep. 9:690-697(2008).
RN   [4]
RP   ENZYME REGULATION.
RX   PubMed=19464260; DOI=10.1016/j.bbrc.2009.05.069;
RA   Ishii S., Misaka T., Kishi M., Kaga T., Ishimaru Y., Abe K.;
RT   "Acetic acid activates PKD1L3-PKD2L1 channel--a candidate sour taste
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 385:346-350(2009).
RN   [5]
RP   FUNCTION.
RX   PubMed=19812697; DOI=10.1371/journal.pone.0007347;
RA   Huque T., Cowart B.J., Dankulich-Nagrudny L., Pribitkin E.A.,
RA   Bayley D.L., Spielman A.I., Feldman R.S., Mackler S.A., Brand J.G.;
RT   "Sour ageusia in two individuals implicates ion channels of the ASIC
RT   and PKD families in human sour taste perception at the anterior
RT   tongue.";
RL   PLoS ONE 4:E7347-E7347(2009).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PKD2L1.
RX   PubMed=20538909; DOI=10.1096/fj.10-162925;
RA   Ishimaru Y., Katano Y., Yamamoto K., Akiba M., Misaka T.,
RA   Roberts R.W., Asakura T., Matsunami H., Abe K.;
RT   "Interaction between PKD1L3 and PKD2L1 through their transmembrane
RT   domains is required for localization of PKD2L1 at taste pores in taste
RT   cells of circumvallate and foliate papillae.";
RL   FASEB J. 24:4058-4067(2010).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=22420714; DOI=10.1111/j.1742-4658.2012.08566.x;
RA   Ishii S., Kurokawa A., Kishi M., Yamagami K., Okada S., Ishimaru Y.,
RA   Misaka T.;
RT   "The response of PKD1L3/PKD2L1 to acid stimuli is inhibited by
RT   capsaicin and its pungent analogs.";
RL   FEBS J. 279:1857-1870(2012).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23212381; DOI=10.1038/ncomms2257;
RA   Yu Y., Ulbrich M.H., Li M.H., Dobbins S., Zhang W.K., Tong L.,
RA   Isacoff E.Y., Yang J.;
RT   "Molecular mechanism of the assembly of an acid-sensing receptor ion
RT   channel complex.";
RL   Nat. Commun. 3:1252-1252(2012).
CC   -!- FUNCTION: Component of a calcium channel. May act as a sour taste
CC       receptor by forming a calcium channel with PKD1L3 in gustatory
CC       cells; however, its contribution to sour taste perception is
CC       unclear in vivo and may be indirect. {ECO:0000269|PubMed:12782129,
CC       ECO:0000269|PubMed:19812697, ECO:0000269|PubMed:23212381}.
CC   -!- ENZYME REGULATION: The calcium channel is gated following an off-
CC       response property by acid: gated open after the removal of acid
CC       stimulus, but not during acid application.
CC       {ECO:0000269|PubMed:18535624, ECO:0000269|PubMed:19464260,
CC       ECO:0000269|PubMed:22420714}.
CC   -!- SUBUNIT: Calcium channels are probably composed of 3 subunit of
CC       PKD2L1 and 1 subunit of PKD1L3.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18535624,
CC       ECO:0000269|PubMed:20538909, ECO:0000269|PubMed:23212381}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:18535624,
CC       ECO:0000269|PubMed:20538909, ECO:0000269|PubMed:23212381}.
CC       Note=Interaction with PKD2L1 is required for localization to the
CC       cell membrane.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, weakly in heart
CC       and lung. {ECO:0000269|PubMed:12782129}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- CAUTION: PKD1L3 and PKD2L1 have been defined as sour taste
CC       receptor in gustatory cells based on a number of indirect
CC       evidences in mouse. Some data confirm this hypothesis in human: in
CC       2 patients with sour ageusia that are unresponsive to sour
CC       stimuli, but show normal responses to bitter, sweet, and salty
CC       stimuli, expression of PKD1L3 and PKD2L1 is absent in the anterior
CC       part of the tongue (PubMed:19812697). However, a number of
CC       experiments have recently shown that the sour taste receptor
CC       activity is probably indirect. {ECO:0000305|PubMed:19812697}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY164485; AAO32798.1; -; mRNA.
DR   CCDS; CCDS73912.1; -.
DR   RefSeq; NP_853514.1; NM_181536.1.
DR   UniGene; Hs.675286; -.
DR   ProteinModelPortal; Q7Z443; -.
DR   SMR; Q7Z443; -.
DR   BioGrid; 131173; 2.
DR   IntAct; Q7Z443; 1.
DR   MINT; MINT-6743423; -.
DR   TCDB; 1.A.5.1.2; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q7Z443; -.
DR   PhosphoSitePlus; Q7Z443; -.
DR   BioMuta; PKD1L3; -.
DR   DMDM; 74713456; -.
DR   EPD; Q7Z443; -.
DR   MaxQB; Q7Z443; -.
DR   PeptideAtlas; Q7Z443; -.
DR   PRIDE; Q7Z443; -.
DR   Ensembl; ENST00000620267; ENSP00000480090; ENSG00000277481.
DR   GeneID; 342372; -.
DR   KEGG; hsa:342372; -.
DR   UCSC; uc059wxm.1; human.
DR   CTD; 342372; -.
DR   DisGeNET; 342372; -.
DR   EuPathDB; HostDB:ENSG00000277481.1; -.
DR   GeneCards; PKD1L3; -.
DR   H-InvDB; HIX0038832; -.
DR   HGNC; HGNC:21716; PKD1L3.
DR   MIM; 607895; gene.
DR   neXtProt; NX_Q7Z443; -.
DR   OpenTargets; ENSG00000277481; -.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230856; -.
DR   HOVERGEN; HBG066396; -.
DR   InParanoid; Q7Z443; -.
DR   KO; K04989; -.
DR   OMA; THFHLNI; -.
DR   OrthoDB; EOG091G004D; -.
DR   PhylomeDB; Q7Z443; -.
DR   GenomeRNAi; 342372; -.
DR   PRO; PR:Q7Z443; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000277481; -.
DR   CleanEx; HS_PKD1L3; -.
DR   GO; GO:0034703; C:cation channel complex; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; ISS:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0006812; P:cation transport; ISS:BHF-UCL.
DR   GO; GO:0071468; P:cellular response to acidic pH; ISS:BHF-UCL.
DR   GO; GO:0001581; P:detection of chemical stimulus involved in sensory perception of sour taste; ISS:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0001822; P:kidney development; IEA:InterPro.
DR   GO; GO:0050915; P:sensory perception of sour taste; IMP:UniProtKB.
DR   Gene3D; 2.60.60.20; -; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR000434; PC1.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF08016; PKD_channel; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00500; POLYCYSTIN1.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Lectin; Membrane; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1732       Polycystic kidney disease protein 1-like
FT                                3.
FT                                /FTId=PRO_0000322578.
FT   TOPO_DOM     24    697       Extracellular. {ECO:0000255}.
FT   TRANSMEM    698    718       Helical. {ECO:0000255}.
FT   TOPO_DOM    719    905       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    906    926       Helical. {ECO:0000255}.
FT   TOPO_DOM    927    939       Extracellular. {ECO:0000255}.
FT   TRANSMEM    940    960       Helical. {ECO:0000255}.
FT   TOPO_DOM    961   1154       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1155   1175       Helical. {ECO:0000255}.
FT   TOPO_DOM   1176   1198       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1199   1219       Helical. {ECO:0000255}.
FT   TOPO_DOM   1220   1280       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1281   1301       Helical. {ECO:0000255}.
FT   TOPO_DOM   1302   1462       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1463   1483       Helical. {ECO:0000255}.
FT   TOPO_DOM   1484   1501       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1502   1522       Helical. {ECO:0000255}.
FT   TOPO_DOM   1523   1550       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1551   1571       Helical. {ECO:0000255}.
FT   TOPO_DOM   1572   1592       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1593   1613       Helical. {ECO:0000255}.
FT   TOPO_DOM   1614   1625       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1626   1646       Helical. {ECO:0000255}.
FT   TOPO_DOM   1647   1658       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1659   1679       Helical. {ECO:0000255}.
FT   TOPO_DOM   1680   1732       Extracellular. {ECO:0000255}.
FT   DOMAIN       30    138       C-type lectin.
FT   DOMAIN      632    681       GPS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00098}.
FT   DOMAIN      743    860       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   REGION     1613   1651       Channel pore-region.
FT   COMPBIAS   1274   1277       Poly-Lys.
FT   CARBOHYD    286    286       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    363    363       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    515    515       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    537    537       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    575    575       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     51    137       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   DISULFID    112    129       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   VARIANT     120    120       I -> F (in dbSNP:rs16973585).
FT                                /FTId=VAR_039453.
FT   VARIANT     211    211       S -> P (in dbSNP:rs4788591).
FT                                /FTId=VAR_039454.
FT   VARIANT     274    274       K -> E (in dbSNP:rs12708923).
FT                                /FTId=VAR_039455.
FT   VARIANT     429    429       T -> S (in dbSNP:rs7185272).
FT                                /FTId=VAR_039456.
FT   VARIANT     471    471       A -> D (in dbSNP:rs16973537).
FT                                /FTId=VAR_039457.
FT   VARIANT     571    571       H -> Q (in dbSNP:rs1559401).
FT                                /FTId=VAR_039458.
FT   VARIANT     593    593       V -> M (in dbSNP:rs9925415).
FT                                /FTId=VAR_039459.
FT   VARIANT     903    903       V -> I (in dbSNP:rs9921412).
FT                                /FTId=VAR_039460.
FT   VARIANT    1176   1176       S -> R (in dbSNP:rs1035543).
FT                                /FTId=VAR_039461.
FT   VARIANT    1474   1474       Y -> C (in dbSNP:rs13335617).
FT                                /FTId=VAR_039462.
SQ   SEQUENCE   1732 AA;  195894 MW;  64847A1C8BE5A6A1 CRC64;
     MFFKGGSWLW LYIRTSIILG SELNSPAPHG QNNCYQLNRF QCSFEEAQHY CHVQRGFLAH
     IWNKEVQDLI RDYLEEGKKW WIGQNVMPLK KHQDNKYPAD VAANGPPKPL SCTYLSRNFI
     RISSKGDKCL LKYYFICQTG DFLDGDAHYE RNGNNSHLYQ RHKKTKRGVA IARDKMPPGP
     GHLPTTCHYP LPAHLSKTLC HPISQFPSVL SSITSQVTSA ASEPSSQPLP VITQLTMPVS
     VTHAGQSLAE TTSSPKEEGH PNTFTSYLQV SLQKASGQVI DEIAGNFSRA VHGLQALNKL
     QEACEFLQKL TALTPRFSKP AQVNLINSLI YLSEELLRIP FQNNNSLGFK VPPTVCPFHS
     LNNVTKAGEG SWLESKRHTE PVEDILEMSL VEFGNIGEAF LEQNQSPESS VTLTSANATL
     LLSRQNISTL PLSSYTLGHP APVRLGFPSA LALKELLNKH PGVNVQITGL AFNPFKDLDN
     RNIVGSIGSV LLSANRKLLQ VHDLMEDIEI MLWRNVSLET HPTSLNMSTH QLTITVNVTS
     LEKSLIVSID PDSPLLMTLY LGFQYQPNCT HFHLNITLPK DKVWQKDEEY TWVLNPEHLQ
     HGIGTYYITA VLSERQEGAQ QTPSLVSVIT AVTQCYYWEI HNQTWSSAGC QVGPQSTILR
     TQCLCNHLTF FASDFFVVPR TVNVEDTIKL FLRVTNNPVG VSLLASLLGF YVITVVWARK
     KDQADMQKVK VTVLADNDPS AQFHYLIQVY TGYRRSAATT AKVVITLYGS EGRSEPHHLC
     DPQKTVFERG GLDVFLLTTW TSLGNLHSLR LWHDNSGVSP SWYVSQVIVC DMAVKRKWHF
     LCNCWLAVDL GDCELDRVFI PVSKRELFSF RHLFSSMIVE KFTQDYLWLS IATRHPWNQF
     TRVQRLSCCM TLLLCNMVIN VMFWKINSTT AKRDEQMRPF AVAWSELLVS IHTAVILFPI
     NLVIGRLFPL IEPQETLPLF PPIQASCLSD ASVEPLSATM VVEELKETVR FLLRRNTYLL
     SKCEQPPWSS WDITKLVKLL SSLVSSHLEG QGCHQQGERH WARVVPENHH HFCCYLHRVL
     QRLKSHLGTL GLTQGHQSCD FLDAASQLQK LQELLETHIL PTEQEPSREV TSFAILSSEE
     GKKPISNGLS KWLTSVCWLL LGFTSLASAF FTALYSLELS KDQATSWMIS IILSVLQNIF
     ISQPVKVVFF TFLYSLMMSR MPRLNKENEQ QTKRILALLA KCSSSVPGSR DKNNPVYVAP
     AINSPTKHPE RTLKKKKLFK LTGDILVQIL FLTLLMTAIY SAKNSNRFYL HQAIWKTFSH
     QFSEIKLLQD FYPWANHILL PSLYGDYRGK NAVLEPSHCK CGVQLIFQIP RTKTYEKVDE
     GQLAFCDNGH TCGRPKSLFP GLHLRRFSYI CSPRPMVLIP TDELHERLTS KNENGFSYIM
     RGAFFTSLRL ESFTSLQMSK KGCVWSIISQ VIYYLLVCYY AFIQGCQLKQ QKWRFFTGKR
     NILDTSIILI SFILLGLDMK SISLHKKNMA RYRDDQDRFI SFYEAVKVNS AATHLVGFPV
     LLATVQLWNL LRHSPRLRVI SRTLSRAWDE VVGFLLIILI LLTGYAIAFN LLFGCSISDY
     RTFFSSAVTV VGLLMGISHQ EEVFALDPVL GTFLILTSVI LMVLVVINLF VSAILMAFGK
     ERKSLKKEAA LIDTLLQKLS NLLGISWPQK TSSEQAATTA VGSDTEVLDE LP
//
ID   CTSR3_MOUSE             Reviewed;         395 AA.
AC   Q80W99; Q5FWA9; Q9D5T9;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   25-OCT-2017, entry version 106.
DE   RecName: Full=Cation channel sperm-associated protein 3;
DE            Short=CatSper3;
GN   Name=Catsper3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, INTERACTION WITH CATSPER1, AND
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=BALB/cJ; TISSUE=Testis;
RX   PubMed=17227845; DOI=10.1073/pnas.0610286104;
RA   Qi H., Moran M.M., Navarro B., Chong J.A., Krapivinsky G.,
RA   Krapivinsky L., Kirichok Y., Ramsey I.S., Quill T.A., Clapham D.E.;
RT   "All four CatSper ion channel proteins are required for male fertility
RT   and sperm cell hyperactivated motility.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1219-1223(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16107607; DOI=10.1095/biolreprod.105.045468;
RA   Jin J.-L., O'Doherty A.M., Wang S., Zheng H., Sanders K.M., Yan W.;
RT   "Catsper3 and catsper4 encode two cation channel-like proteins
RT   exclusively expressed in the testis.";
RL   Biol. Reprod. 73:1235-1242(2005).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17344468; DOI=10.1095/biolreprod.107.060186;
RA   Jin J.-L., Jin N., Zheng H., Ro S., Tafolla D., Sanders K.M., Yan W.;
RT   "Catsper3 and catsper4 are essential for sperm hyperactivated motility
RT   and male fertility in the mouse.";
RL   Biol. Reprod. 77:37-44(2007).
RN   [7]
RP   LACK OF ACTIVATION BY PROGESTERONE AND PGE1.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [8]
RP   IDENTIFICATION IN THE CATSPER COMPLEX.
RC   STRAIN=C57BL/6J;
RX   PubMed=21224844; DOI=10.1038/ncomms1153;
RA   Chung J.J., Navarro B., Krapivinsky G., Krapivinsky L., Clapham D.E.;
RT   "A novel gene required for male fertility and functional CATSPER
RT   channel formation in spermatozoa.";
RL   Nat. Commun. 2:153-153(2011).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in sperm cell hyperactivation. Controls calcium entry to mediate
CC       the hyperactivated motility, a step needed for sperm motility
CC       which is essential late in the preparation of sperm for
CC       fertilization. Activated by intracellular alkalinization.
CC       {ECO:0000269|PubMed:17227845, ECO:0000269|PubMed:17344468}.
CC   -!- ENZYME REGULATION: In contrast to the human ortholog, not
CC       activated by progesterone. {ECO:0000269|PubMed:21412339}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Component of the CatSper
CC       complex. Interacts with CATSPER1. {ECO:0000269|PubMed:17227845,
CC       ECO:0000269|PubMed:21224844, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q91ZR5:Catsper1; NbExp=2; IntAct=EBI-15619135, EBI-15619083;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000269|PubMed:16107607, ECO:0000269|PubMed:17227845}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16107607,
CC       ECO:0000269|PubMed:17227845}. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q80W99-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q80W99-2; Sequence=VSP_026978;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:16107607,
CC       ECO:0000269|PubMed:17227845}.
CC   -!- DEVELOPMENTAL STAGE: Detected in hte testis during postnatal
CC       development at day 15. Restricted to the late-stage germline cells
CC       that line the seminiferous tubules. {ECO:0000269|PubMed:17347248}.
CC   -!- DISRUPTION PHENOTYPE: Mice are normal but males are sterile. Male
CC       sterility is due to defects in sperm motility unability to
CC       fertilize intact eggs. {ECO:0000269|PubMed:17227845,
CC       ECO:0000269|PubMed:17344468}.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH89518.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY263400; AAP21831.1; -; mRNA.
DR   EMBL; AK014942; BAB29631.1; -; mRNA.
DR   EMBL; BC089518; AAH89518.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS26555.1; -. [Q80W99-2]
DR   CCDS; CCDS56885.1; -. [Q80W99-1]
DR   RefSeq; NP_001239416.1; NM_001252487.1. [Q80W99-1]
DR   RefSeq; NP_084048.1; NM_029772.4. [Q80W99-2]
DR   RefSeq; XP_006517518.1; XM_006517455.2. [Q80W99-1]
DR   UniGene; Mm.159795; -.
DR   ProteinModelPortal; Q80W99; -.
DR   BioGrid; 218352; 1.
DR   DIP; DIP-60802N; -.
DR   IntAct; Q80W99; 1.
DR   STRING; 10090.ENSMUSP00000021961; -.
DR   GuidetoPHARMACOLOGY; 390; -.
DR   TCDB; 1.A.1.19.3; the voltage-gated ion channel (vic) superfamily.
DR   PhosphoSitePlus; Q80W99; -.
DR   PaxDb; Q80W99; -.
DR   PRIDE; Q80W99; -.
DR   Ensembl; ENSMUST00000021961; ENSMUSP00000021961; ENSMUSG00000021499. [Q80W99-1]
DR   Ensembl; ENSMUST00000109898; ENSMUSP00000105524; ENSMUSG00000021499. [Q80W99-2]
DR   GeneID; 76856; -.
DR   KEGG; mmu:76856; -.
DR   UCSC; uc007qsb.2; mouse. [Q80W99-2]
DR   UCSC; uc007qsc.2; mouse. [Q80W99-1]
DR   CTD; 347732; -.
DR   MGI; MGI:1924106; Catsper3.
DR   eggNOG; ENOG410IF9A; Eukaryota.
DR   eggNOG; ENOG4111SVN; LUCA.
DR   GeneTree; ENSGT00760000119325; -.
DR   HOGENOM; HOG000112052; -.
DR   HOVERGEN; HBG099875; -.
DR   InParanoid; Q80W99; -.
DR   KO; K16891; -.
DR   OMA; YWKDGYN; -.
DR   OrthoDB; EOG091G0D3H; -.
DR   PhylomeDB; Q80W99; -.
DR   TreeFam; TF343841; -.
DR   Reactome; R-MMU-1300642; Sperm Motility And Taxes.
DR   PRO; PR:Q80W99; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   Bgee; ENSMUSG00000021499; -.
DR   CleanEx; MM_CATSPER3; -.
DR   ExpressionAtlas; Q80W99; baseline and differential.
DR   Genevisible; Q80W99; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:MGI.
DR   GO; GO:0036128; C:CatSper complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0030317; P:flagellated sperm motility; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006814; P:sodium ion transport; IMP:MGI.
DR   GO; GO:0048240; P:sperm capacitation; IMP:MGI.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cell projection; Cilium; Complete proteome;
KW   Developmental protein; Differentiation; Flagellum; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Spermatogenesis;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    395       Cation channel sperm-associated protein
FT                                3.
FT                                /FTId=PRO_0000295680.
FT   TOPO_DOM      1     49       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     50     70       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     71     87       Extracellular. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    109    110       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    111    131       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    132    141       Extracellular. {ECO:0000255}.
FT   TRANSMEM    142    161       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    162    179       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    201    209       Extracellular. {ECO:0000255}.
FT   INTRAMEM    210    230       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    231    248       Extracellular. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    270    395       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ      84     96       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_026978.
FT   CONFLICT    314    314       S -> T (in Ref. 1; AAP21831).
FT                                {ECO:0000305}.
SQ   SEQUENCE   395 AA;  45486 MW;  10641E91039210A6 CRC64;
     MSQHFHHNPV RVKSGSLFAT ASEALQARLS KIKRKDKECQ AYFRKVIKST FFQIVMITTV
     TTNSFLLVLG TNYDIQFEFF RTFEVSELFF VSVYVCEFLM KVYVDPITYW KDGYNILDVI
     ILIILTIPYL LRKIKGNHSA YLHFADGIQS LRILKLISYS RGIRTLIIAV GETVYTVASV
     LTLLFLLMFV FAILGFCLFG VTDRGDLENW GNLASAFFTL FSLATVDGWT DLQEELDKRK
     FTVSRAFTIL FILLASFIFL NMFVGVMIMH TEDSMKKFER DLTLERNLAI MEEKQIILKR
     QQEEVNRLMN TQKSGSMNFI DMVEGFKKTL RHTDPMVLDD FSTSLSFIDI YLVTLDNQDV
     IVSKLQELYC EIVNVLSLML EDMPKESSSS LSGLS
//
ID   CTSR4_MOUSE             Reviewed;         442 AA.
AC   Q8BVN3; A2A9K6;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   25-OCT-2017, entry version 121.
DE   RecName: Full=Cation channel sperm-associated protein 4;
DE            Short=CatSper4;
GN   Name=Catsper4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16107607; DOI=10.1095/biolreprod.105.045468;
RA   Jin J.-L., O'Doherty A.M., Wang S., Zheng H., Sanders K.M., Yan W.;
RT   "Catsper3 and catsper4 encode two cation channel-like proteins
RT   exclusively expressed in the testis.";
RL   Biol. Reprod. 73:1235-1242(2005).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17344468; DOI=10.1095/biolreprod.107.060186;
RA   Jin J.-L., Jin N., Zheng H., Ro S., Tafolla D., Sanders K.M., Yan W.;
RT   "Catsper3 and catsper4 are essential for sperm hyperactivated motility
RT   and male fertility in the mouse.";
RL   Biol. Reprod. 77:37-44(2007).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH
RP   CATSPER1, AND DISRUPTION PHENOTYPE.
RX   PubMed=17227845; DOI=10.1073/pnas.0610286104;
RA   Qi H., Moran M.M., Navarro B., Chong J.A., Krapivinsky G.,
RA   Krapivinsky L., Kirichok Y., Ramsey I.S., Quill T.A., Clapham D.E.;
RT   "All four CatSper ion channel proteins are required for male fertility
RT   and sperm cell hyperactivated motility.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1219-1223(2007).
RN   [8]
RP   LACK OF ACTIVATION BY PROGESTERONE AND PGE1.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [9]
RP   IDENTIFICATION IN THE CATSPER COMPLEX.
RC   STRAIN=C57BL/6J;
RX   PubMed=21224844; DOI=10.1038/ncomms1153;
RA   Chung J.J., Navarro B., Krapivinsky G., Krapivinsky L., Clapham D.E.;
RT   "A novel gene required for male fertility and functional CATSPER
RT   channel formation in spermatozoa.";
RL   Nat. Commun. 2:153-153(2011).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in sperm cell hyperactivation. Controls calcium entry to mediate
CC       the hyperactivated motility, a step needed for sperm motility
CC       which is essential late in the preparation of sperm for
CC       fertilization. Activated by intracellular alkalinization.
CC       {ECO:0000269|PubMed:17227845, ECO:0000269|PubMed:17344468}.
CC   -!- ENZYME REGULATION: In contrast to the human ortholog, not
CC       activated by progesterone. {ECO:0000269|PubMed:21412339}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Component of the CatSper
CC       complex. Interacts with CATSPER1. {ECO:0000269|PubMed:17227845,
CC       ECO:0000269|PubMed:21224844, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q91ZR5:Catsper1; NbExp=2; IntAct=EBI-15619199, EBI-15619083;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000269|PubMed:16107607, ECO:0000269|PubMed:17227845}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16107607,
CC       ECO:0000269|PubMed:17227845}. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:16107607,
CC       ECO:0000269|PubMed:17227845}.
CC   -!- DEVELOPMENTAL STAGE: Detected in hte testis during postnatal
CC       development at day 15. Restricted to the late-stage germline cells
CC       that line the seminiferous tubules. {ECO:0000269|PubMed:17347248}.
CC   -!- DISRUPTION PHENOTYPE: Mice are normal but males are sterile. Male
CC       sterility is due to defects in sperm motility unability to
CC       fertilize intact eggs. {ECO:0000269|PubMed:17227845,
CC       ECO:0000269|PubMed:17344468}.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAM21941.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK077145; BAC36641.1; -; mRNA.
DR   EMBL; AL627314; CAM21940.1; -; Genomic_DNA.
DR   EMBL; AL627314; CAM21941.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC108974; AAI08975.1; -; mRNA.
DR   EMBL; BC108975; AAI08976.1; -; mRNA.
DR   CCDS; CCDS18766.1; -.
DR   RefSeq; NP_001123502.1; NM_001130030.1.
DR   RefSeq; NP_808534.1; NM_177866.4.
DR   UniGene; Mm.79072; -.
DR   ProteinModelPortal; Q8BVN3; -.
DR   BioGrid; 236869; 1.
DR   DIP; DIP-60803N; -.
DR   IntAct; Q8BVN3; 1.
DR   STRING; 10090.ENSMUSP00000051694; -.
DR   GuidetoPHARMACOLOGY; 391; -.
DR   TCDB; 1.A.1.19.3; the voltage-gated ion channel (vic) superfamily.
DR   PhosphoSitePlus; Q8BVN3; -.
DR   PaxDb; Q8BVN3; -.
DR   PRIDE; Q8BVN3; -.
DR   Ensembl; ENSMUST00000055892; ENSMUSP00000051694; ENSMUSG00000048003.
DR   GeneID; 329954; -.
DR   KEGG; mmu:329954; -.
DR   UCSC; uc008veh.2; mouse.
DR   CTD; 378807; -.
DR   MGI; MGI:3043288; Catsper4.
DR   eggNOG; ENOG410II5Y; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000119325; -.
DR   HOGENOM; HOG000112053; -.
DR   HOVERGEN; HBG102124; -.
DR   InParanoid; Q8BVN3; -.
DR   KO; K16892; -.
DR   OMA; WLNGFWI; -.
DR   OrthoDB; EOG091G07AU; -.
DR   PhylomeDB; Q8BVN3; -.
DR   TreeFam; TF343841; -.
DR   Reactome; R-MMU-1300642; Sperm Motility And Taxes.
DR   PRO; PR:Q8BVN3; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   Bgee; ENSMUSG00000048003; -.
DR   CleanEx; MM_CATSPER4; -.
DR   ExpressionAtlas; Q8BVN3; baseline and differential.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:MGI.
DR   GO; GO:0036128; C:CatSper complex; IDA:UniProtKB.
DR   GO; GO:0097228; C:sperm principal piece; IDA:MGI.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0030317; P:flagellated sperm motility; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006814; P:sodium ion transport; IMP:MGI.
DR   GO; GO:0048240; P:sperm capacitation; IMP:MGI.
DR   InterPro; IPR028744; CatSper4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF225; PTHR10037:SF225; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Developmental protein;
KW   Differentiation; Flagellum; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Spermatogenesis; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    442       Cation channel sperm-associated protein
FT                                4.
FT                                /FTId=PRO_0000295682.
FT   TOPO_DOM      1     66       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     67     87       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     88    106       Extracellular. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    128    136       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    158    158       Extracellular. {ECO:0000255}.
FT   TRANSMEM    159    173       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    174    195       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    196    216       Helical; Name=Segment S5.
FT   TOPO_DOM    217    222       Extracellular. {ECO:0000255}.
FT   INTRAMEM    223    243       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    244    260       Extracellular. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    282    442       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   442 AA;  51130 MW;  B4A41CAA47F0AE21 CRC64;
     MSEKHKWWQQ VENIDITHLG PKRKAYELLG RHEEQVLINR RDVMEKKDAW DVQEFITQMY
     IKQLLRHPAF QLLLAFLLLS NAITIALRTN SYLGQKHYEL FSTIDDIVLT ILICEVLLGW
     LNGFWIFWKD GWNILNFAIV FILFMGFFIK QLDMVAITYP LRVLRLVHVC MAVEPLARII
     KVILQSMPDL ANVMALILFF MLVFSVFGVT LFGAFVPKHF QNMGVALYTL FICITQDGWL
     DIYTDFQMDE REYAMEVGGA IYFAVFITLG AFIGLNLFVV VVTTNLEQMM KTGEEEGHLN
     IKFTETEEDE DWTDELPLVH CTEARKDTST VPKEPLVGGP LSNLTEKTCD NFCLVLEAIQ
     ENLMEYKEIR EELNMIVEEV SSIRFNQEQQ NVILHKYTSK SATFLSEPPE GANKQDLITA
     LVSREKVSDS NINMVNKHKF SH
//
ID   TPC2_MOUSE              Reviewed;         731 AA.
AC   Q8BWC0; Q6NSV0; Q8BTJ7; Q8R396;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   25-OCT-2017, entry version 117.
DE   RecName: Full=Two pore calcium channel protein 2;
DE   AltName: Full=Voltage-dependent calcium channel protein TPC2;
GN   Name=Tpcn2; Synonyms=Tpc2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Heart;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   STRAIN=Czech II; TISSUE=Eye, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19387438; DOI=10.1038/nature08030;
RA   Calcraft P.J., Ruas M., Pan Z., Cheng X., Arredouani A., Hao X.,
RA   Tang J., Rietdorf K., Teboul L., Chuang K.T., Lin P., Xiao R.,
RA   Wang C., Zhu Y., Lin Y., Wyatt C.N., Parrington J., Ma J., Evans A.M.,
RA   Galione A., Zhu M.X.;
RT   "NAADP mobilizes calcium from acidic organelles through two-pore
RT   channels.";
RL   Nature 459:596-600(2009).
RN   [4]
RP   GLYCOSYLATION AT ASN-594 AND ASN-601, SUBCELLULAR LOCATION, SUBUNIT,
RP   TISSUE SPECIFICITY, TOPOLOGY, AND MUTAGENESIS OF ASN-594 AND ASN-601.
RX   PubMed=19557428; DOI=10.1007/s00424-009-0690-y;
RA   Zong X., Schieder M., Cuny H., Fenske S., Gruner C., Roetzer K.,
RA   Griesbeck O., Harz H., Biel M., Wahl-Schott C.;
RT   "The two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release
RT   from lysosomal stores.";
RL   Pflugers Arch. 458:891-899(2009).
RN   [5]
RP   FUNCTION, MUTAGENESIS OF ASN-257 AND GLU-643, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20495006; DOI=10.1074/jbc.C110.143123;
RA   Schieder M., Roetzer K., Brueggemann A., Biel M., Wahl-Schott C.A.;
RT   "Characterizatgmion of two-pore channel 2 (TPCN2)-mediated Ca2+
RT   currents in isolated lysosomes.";
RL   J. Biol. Chem. 285:21219-21222(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=20547763; DOI=10.1074/jbc.M110.129833;
RA   Tugba Durlu-Kandilci N., Ruas M., Chuang K.T., Brading A.,
RA   Parrington J., Galione A.;
RT   "TPC2 proteins mediate nicotinic acid adenine dinucleotide phosphate
RT   (NAADP)- and agonist-evoked contractions of smooth muscle.";
RL   J. Biol. Chem. 285:24925-24932(2010).
CC   -!- FUNCTION: Nicotinic acid adenine dinucleotide phosphate (NAADP)
CC       receptor that may function as one of the major voltage-gated
CC       Ca(2+) channels (VDCC) across the lysosomal membrane. Involved in
CC       smooth muscle contraction. {ECO:0000269|PubMed:19387438,
CC       ECO:0000269|PubMed:20495006, ECO:0000269|PubMed:20547763}.
CC   -!- SUBUNIT: Homodimer (PubMed:19557428). Interacts with LRRK2.
CC       Interacts with HAX1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8NHX9, ECO:0000305|PubMed:19557428}.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane
CC       {ECO:0000269|PubMed:19557428, ECO:0000269|PubMed:20495006}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:19557428,
CC       ECO:0000269|PubMed:20495006}. Note=Only the acidic lysosomal
CC       fraction is sensitive to NAADP.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8BWC0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8BWC0-2; Sequence=VSP_023009, VSP_023010;
CC       Name=3;
CC         IsoId=Q8BWC0-3; Sequence=VSP_023008;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:19557428}.
CC   -!- DOMAIN: Each of the two internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively
CC       charged transmembrane segment (S4). S4 segments probably represent
CC       the voltage-sensor and are characterized by a series of positively
CC       charged amino acids at every third position (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19557428}.
CC   -!- DISRUPTION PHENOTYPE: Loss of NAADP-mediated calcium release.
CC       {ECO:0000269|PubMed:19387438}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. Two pore calcium channel subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC41072.1; Type=Frameshift; Positions=318; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK052930; BAC35207.1; -; mRNA.
DR   EMBL; AK090059; BAC41072.1; ALT_FRAME; mRNA.
DR   EMBL; BC025890; AAH25890.1; -; mRNA.
DR   EMBL; BC069857; AAH69857.1; -; mRNA.
DR   CCDS; CCDS40203.1; -. [Q8BWC0-1]
DR   RefSeq; NP_666318.2; NM_146206.5. [Q8BWC0-1]
DR   UniGene; Mm.102235; -.
DR   ProteinModelPortal; Q8BWC0; -.
DR   STRING; 10090.ENSMUSP00000061308; -.
DR   iPTMnet; Q8BWC0; -.
DR   PhosphoSitePlus; Q8BWC0; -.
DR   PaxDb; Q8BWC0; -.
DR   PRIDE; Q8BWC0; -.
DR   Ensembl; ENSMUST00000058022; ENSMUSP00000061308; ENSMUSG00000048677. [Q8BWC0-1]
DR   GeneID; 233979; -.
DR   KEGG; mmu:233979; -.
DR   UCSC; uc009kqw.1; mouse. [Q8BWC0-2]
DR   UCSC; uc009kqx.1; mouse. [Q8BWC0-1]
DR   CTD; 219931; -.
DR   MGI; MGI:2385297; Tpcn2.
DR   eggNOG; ENOG410KCTV; Eukaryota.
DR   eggNOG; ENOG4111V21; LUCA.
DR   GeneTree; ENSGT00530000063660; -.
DR   HOGENOM; HOG000154668; -.
DR   HOVERGEN; HBG079776; -.
DR   InParanoid; Q8BWC0; -.
DR   KO; K14077; -.
DR   OMA; SSVIWVN; -.
DR   OrthoDB; EOG091G045K; -.
DR   PhylomeDB; Q8BWC0; -.
DR   TreeFam; TF328550; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q8BWC0; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000048677; -.
DR   CleanEx; MM_TPCN2; -.
DR   ExpressionAtlas; Q8BWC0; baseline and differential.
DR   Genevisible; Q8BWC0; MM.
DR   GO; GO:0010008; C:endosome membrane; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:MGI.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0007040; P:lysosome organization; ISO:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0010506; P:regulation of autophagy; ISO:MGI.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0033280; P:response to vitamin D; IEA:Ensembl.
DR   GO; GO:0006939; P:smooth muscle contraction; IMP:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028798; TPC2.
DR   PANTHER; PTHR10037:SF92; PTHR10037:SF92; 1.
DR   Pfam; PF00520; Ion_trans; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Lysosome;
KW   Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    731       Two pore calcium channel protein 2.
FT                                /FTId=PRO_0000276857.
FT   TOPO_DOM      1     68       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM     90    111       Extracellular. {ECO:0000255}.
FT   TRANSMEM    112    132       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    133    139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    161    167       Extracellular. {ECO:0000255}.
FT   TRANSMEM    168    188       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    189    203       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    225    238       Extracellular. {ECO:0000255}.
FT   INTRAMEM    239    263       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    264    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    292    417       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    439    449       Extracellular. {ECO:0000255}.
FT   TRANSMEM    450    470       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    471    486       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    487    507       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    508    524       Extracellular. {ECO:0000255}.
FT   TRANSMEM    525    542       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    543    564       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    565    585       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    586    618       Extracellular. {ECO:0000255}.
FT   INTRAMEM    619    641       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    642    656       Extracellular. {ECO:0000255}.
FT   TRANSMEM    657    677       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    678    731       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    594    594       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19557428}.
FT   CARBOHYD    601    601       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19557428}.
FT   VAR_SEQ       1    526       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023008.
FT   VAR_SEQ       1    453       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023009.
FT   VAR_SEQ     454    514       GILDYIFILYYLLELLFKVFALGLPGYLSYHSNVFDGLLTI
FT                                ILLVSEICTLAVYRLPHSGW -> MAAWDLGVSYGWAQPPL
FT                                LLGAFSAWCPYSDYCCLFTPAASSPHPSAPPDFLTCLLCLP
FT                                R (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023010.
FT   MUTAGEN     257    257       N->A: Complete loss of selectivity for
FT                                calcium over monocovalent cations.
FT                                {ECO:0000269|PubMed:20495006}.
FT   MUTAGEN     594    594       N->A: Loss of N-glycosylation; when
FT                                associated with N-601.
FT                                {ECO:0000269|PubMed:19557428}.
FT   MUTAGEN     601    601       N->A: Loss of N-glycosylation; when
FT                                associated with N-594.
FT                                {ECO:0000269|PubMed:19557428}.
FT   MUTAGEN     643    643       E->A: Partial loss of selectivity for
FT                                calcium over monocovalent cations.
FT                                {ECO:0000269|PubMed:20495006}.
FT   CONFLICT    127    127       K -> E (in Ref. 1; BAC41072).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       I -> V (in Ref. 1; BAC41072).
FT                                {ECO:0000305}.
FT   CONFLICT    272    272       F -> L (in Ref. 1; BAC41072).
FT                                {ECO:0000305}.
SQ   SEQUENCE   731 AA;  83595 MW;  3C76487441344AD7 CRC64;
     MAAEEQPLLG RDRGSGQVHS GAAADQELCI DQAVVFIEDA IKYRSIYHRM DAGSLWLYRW
     YYSNVCQRVL GFIIFLILIL AFVEVPSSFT KTADVRYRSQ PWQPPCGLTE TIEAFCLLAF
     LVDLSVKGYL VGQAQLQQNL WLLAYFMVLV VSVVDWIVSL SLACEEPLRM RRLLRPFFLL
     QNSSMMKKTL KCIRWSLPEM ASVGLLLAIH LCLFTIIGML LFTIGEKDEA QDQERLAYFR
     NLPEALTSLL VLLTTSNNPD VMIPAYTQNR AFALFFIVFT LIGSLFLMNL LTAIIYNQFR
     GYLMKSLQTS LFRRRLGARA AYEVLASRAG PAGTTPELVG VNPETFLPVL QKTQLNKTHK
     QAIMQKVQSY EGRPMLADEF QKLFDEVDKG LAKERPLKPQ YQSPFLQTAQ FIFSHHYFDY
     LGNLVALGNL LSICVFLVLD SDLLPGERDD FVLGILDYIF ILYYLLELLF KVFALGLPGY
     LSYHSNVFDG LLTIILLVSE ICTLAVYRLP HSGWKPEQYG PLSLWDMTRL MNTLIVFRFL
     RIIPNIKPMA EVANTILGLI PNLRAFGGIL VVAYYVFAMI GINLFRGVIV PPGNSSLVPD
     NNSAVCGSFE QLGYWPNNFD DFAAALITLW NVMVVNNWQV ILEAYKRYAG PWSMVYFVLW
     WLVSSVIWIN LFLALLLENF LHRWDPQGHK QLLVGTKQMS VELMFRDILE EPKEEELMEK
     LHKHPHLHLC R
//
ID   MCU_DROME               Reviewed;         366 AA.
AC   Q8IQ70; E1NZC4; M9NF23; Q7KU70; X2JAQ2;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 2.
DT   30-AUG-2017, entry version 115.
DE   RecName: Full=Calcium uniporter protein, mitochondrial {ECO:0000305};
DE   Flags: Precursor;
GN   ORFNames=CG18769 {ECO:0000312|FlyBase:FBgn0042185};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Berkeley; TISSUE=Embryo, and Head;
RA   Celniker S., Carlson J., Wan K., Pfeiffer B., Frise E., George R.,
RA   Hoskins R., Stapleton M., Pacleb J., Park S., Svirskas R., Smith E.,
RA   Yu C., Rubin G.;
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria. Constitutes a pore-
CC       forming and calcium-conducting subunit. Mitochondrial calcium
CC       homeostasis plays key roles in cellular physiology and regulates
CC       cell bioenergetics, cytoplasmic calcium signals and activation of
CC       cell death pathways. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- ENZYME REGULATION: Inhibited by ruthenium red or its derivative
CC       Ru360. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=A {ECO:0000312|FlyBase:FBgn0042185}, B
CC       {ECO:0000312|FlyBase:FBgn0042185}, C
CC       {ECO:0000312|FlyBase:FBgn0042185}, D
CC       {ECO:0000312|FlyBase:FBgn0042185};
CC         IsoId=Q8IQ70-1; Sequence=Displayed;
CC       Name=2; Synonyms=G {ECO:0000312|FlyBase:FBgn0042185};
CC         IsoId=Q8IQ70-2; Sequence=VSP_058493;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=3; Synonyms=E {ECO:0000312|FlyBase:FBgn0042185};
CC         IsoId=Q8IQ70-3; Sequence=VSP_058492;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=4; Synonyms=H {ECO:0000312|FlyBase:FBgn0042185};
CC         IsoId=Q8IQ70-4; Sequence=VSP_058494;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=5; Synonyms=I {ECO:0000312|FlyBase:FBgn0042185};
CC         IsoId=Q8IQ70-5; Sequence=VSP_058495;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC   -!- DOMAIN: Forms a well-packed pentamer with an overall cylindrical
CC       shape. The inner core of the pentamer is formed with the second
CC       transmembrane region and the second coiled-coil region: while the
CC       transmembrane regions pack into a five-helix bundle having a
CC       largely polar pore across the membrane, the coiled-coil outside
CC       the membrane forms a pentamer with a hydrophobic core. The inner
CC       core is wrapped by the first transmembrane region through contacts
CC       between the first and the second transmembrane regions. The second
CC       transmembrane is followed by the inner juxtamembrane region (IJMH)
CC       that orients at a wide angle relative to the second transmembrane.
CC       The two core domains are held together on the periphery by the
CC       outer juxtamembrane helix (OJMH). {ECO:0000250|UniProtKB:Q21121}.
CC   -!- DOMAIN: The critical DXXE motif connecting the transmembrane
CC       regions forms a pentameric barrel that constitutes the mouth of
CC       the pore. Inside the barrel, two acidic residues are in position
CC       to form two carboxylate rings. {ECO:0000250|UniProtKB:Q21121}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014296; AAG22325.2; -; Genomic_DNA.
DR   EMBL; AE014296; AAN12082.2; -; Genomic_DNA.
DR   EMBL; AE014296; AAN12083.2; -; Genomic_DNA.
DR   EMBL; AE014296; AAS65071.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAS65072.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAS65073.2; -; Genomic_DNA.
DR   EMBL; AE014296; AFH04318.1; -; Genomic_DNA.
DR   EMBL; AE014296; AHN57979.1; -; Genomic_DNA.
DR   EMBL; AY051736; AAK93160.1; -; mRNA.
DR   EMBL; AY122129; AAM52641.1; -; mRNA.
DR   EMBL; BT125673; ADN90233.1; -; mRNA.
DR   RefSeq; NP_001246647.1; NM_001259718.1. [Q8IQ70-4]
DR   RefSeq; NP_001286954.1; NM_001300025.1. [Q8IQ70-5]
DR   RefSeq; NP_652706.3; NM_144449.4. [Q8IQ70-1]
DR   RefSeq; NP_729173.1; NM_168169.3. [Q8IQ70-1]
DR   RefSeq; NP_729174.2; NM_168170.2. [Q8IQ70-1]
DR   RefSeq; NP_996002.2; NM_206280.2. [Q8IQ70-2]
DR   RefSeq; NP_996003.1; NM_206281.2. [Q8IQ70-3]
DR   RefSeq; NP_996004.1; NM_206282.2. [Q8IQ70-1]
DR   UniGene; Dm.7990; -.
DR   ProteinModelPortal; Q8IQ70; -.
DR   SMR; Q8IQ70; -.
DR   IntAct; Q8IQ70; 64.
DR   STRING; 7227.FBpp0300166; -.
DR   PaxDb; Q8IQ70; -.
DR   PRIDE; Q8IQ70; -.
DR   EnsemblMetazoa; FBtr0076970; FBpp0076679; FBgn0042185. [Q8IQ70-1]
DR   EnsemblMetazoa; FBtr0076971; FBpp0076680; FBgn0042185. [Q8IQ70-1]
DR   EnsemblMetazoa; FBtr0076972; FBpp0076681; FBgn0042185. [Q8IQ70-1]
DR   EnsemblMetazoa; FBtr0076973; FBpp0076682; FBgn0042185. [Q8IQ70-1]
DR   EnsemblMetazoa; FBtr0076974; FBpp0076683; FBgn0042185. [Q8IQ70-3]
DR   EnsemblMetazoa; FBtr0307510; FBpp0300165; FBgn0042185. [Q8IQ70-2]
DR   EnsemblMetazoa; FBtr0307511; FBpp0300166; FBgn0042185. [Q8IQ70-4]
DR   EnsemblMetazoa; FBtr0344294; FBpp0310698; FBgn0042185. [Q8IQ70-5]
DR   GeneID; 59223; -.
DR   KEGG; dme:Dmel_CG18769; -.
DR   UCSC; CG18769-RA; d. melanogaster. [Q8IQ70-1]
DR   UCSC; CG18769-RB; d. melanogaster.
DR   FlyBase; FBgn0042185; CG18769.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   GeneTree; ENSGT00390000004496; -.
DR   KO; K20858; -.
DR   OMA; CHMLLAR; -.
DR   OrthoDB; EOG091G092C; -.
DR   PhylomeDB; Q8IQ70; -.
DR   Reactome; R-DME-8949215; Mitochondrial calcium ion transport.
DR   Reactome; R-DME-8949664; Processing of SMDT1.
DR   GenomeRNAi; 59223; -.
DR   PRO; PR:Q8IQ70; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0042185; -.
DR   Genevisible; Q7KU70; DM.
DR   GO; GO:0005739; C:mitochondrion; IDA:FlyBase.
DR   GO; GO:1990246; C:uniplex complex; ISS:FlyBase.
DR   GO; GO:0005262; F:calcium channel activity; ISS:FlyBase.
DR   GO; GO:0015292; F:uniporter activity; ISS:FlyBase.
DR   GO; GO:0007615; P:anesthesia-resistant memory; IMP:FlyBase.
DR   GO; GO:0072375; P:medium-term memory; IMP:FlyBase.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; IMP:FlyBase.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; IMP:FlyBase.
DR   GO; GO:0036444; P:mitochondrial calcium uptake; IMP:FlyBase.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     53       Mitochondrion. {ECO:0000255}.
FT   CHAIN        54    366       Calcium uniporter protein, mitochondrial.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000437213.
FT   TOPO_DOM     54    232       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    233    255       Helical. {ECO:0000255}.
FT   TOPO_DOM    256    264       Mitochondrial intermembrane.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   TRANSMEM    265    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    366       Mitochondrial matrix.
FT                                {ECO:0000250|UniProtKB:Q8NE86}.
FT   REGION      215    233       Outer juxtamembrane helix (OJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   REGION      282    291       Inner juxtamembrane helix (IJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   COILED      197    226       {ECO:0000255}.
FT   COILED      313    335       {ECO:0000255}.
FT   MOTIF       260    263       DXXE. {ECO:0000250|UniProtKB:Q21121}.
FT   COMPBIAS     20     23       Poly-Thr. {ECO:0000255}.
FT   VAR_SEQ       1     81       Missing (in isoform 3).
FT                                /FTId=VSP_058492.
FT   VAR_SEQ      71     71       G -> GDITRLTLAELRTRLKALGLSAAGRKQVLVERLTRS
FT                                TTCSATTLPRTTGSNLSPEVFIGGLVNNSNTTSEPKNTVQQ
FT                                N (in isoform 2).
FT                                /FTId=VSP_058493.
FT   VAR_SEQ      71     71       G -> GGHSSSQHVDEQAGCDDKIREKKSKSNHCLVKYRKG
FT                                DQETEKGTNPCGAQEFKESNSFAGTQVHSLKKRIKNRKIKK
FT                                KLILNRKKKKKKTCN (in isoform 4).
FT                                /FTId=VSP_058494.
FT   VAR_SEQ      72     72       Missing (in isoform 5).
FT                                /FTId=VSP_058495.
SQ   SEQUENCE   366 AA;  42478 MW;  B5AB29FAA90D15FD CRC64;
     MSRNRAAMVS AFRLFLRPAT TTTHRSLALR LAPGTTFALH LRPCHELQQH RSFASTAEDG
     ETDKHKKPTT GEDIYVEYVN GMPHMTVRLP SRNELCQFAL KPISHNVGDL LAMLRAEDRG
     IDRAAVINKH GVRIASSCTI ESLLDDSFSI QINNRTLDVN PPKRDKVTLE SMDKVGDVRK
     VIAQLYEAFN VGEYQLEKSN QLAKELETLR YELEPLEEKK LELSKKAARR TNFMTWMGLG
     LMSVQFGILA RLTWWEYSWD IMEPVTYFVT YGTTMAMYAY YCVTKREYMM EDVKNREFSL
     SLYRNAKKVQ FDVEHYNELK RKSAELEYNL RRINDPLNMQ LPSHLVRTQE NTPPTLTEEK
     AERKYT
//
ID   CAHM1_HUMAN             Reviewed;         346 AA.
AC   Q8IU99; Q5W091;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   22-NOV-2017, entry version 119.
DE   RecName: Full=Calcium homeostasis modulator protein 1;
DE   AltName: Full=Protein FAM26C;
GN   Name=CALHM1; Synonyms=FAM26C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-86.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   GLYCOSYLATION AT ASN-140, VARIANT PRO-86, POLYMORPHISM, AND
RP   MUTAGENESIS OF ASN-72; ASN-74 AND ASN-140.
RX   PubMed=18585350; DOI=10.1016/j.cell.2008.05.048;
RA   Dreses-Werringloer U., Lambert J.-C., Vingtdeux V., Zhao H., Vais H.,
RA   Siebert A., Jain A., Koppel J., Rovelet-Lecrux A., Hannequin D.,
RA   Pasquier F., Galimberti D., Scarpini E., Mann D., Lendon C.,
RA   Campion D., Amouyel P., Davies P., Foskett J.K., Campagne F.,
RA   Marambaud P.;
RT   "A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels,
RT   and Alzheimer's disease risk.";
RL   Cell 133:1149-1161(2008).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=19997627; DOI=10.1371/journal.pone.0007682;
RA   Moyer B.D., Hevezi P., Gao N., Lu M., Kalabat D., Soto H.,
RA   Echeverri F., Laita B., Yeh S.A., Zoller M., Zlotnik A.;
RT   "Expression of genes encoding multi-transmembrane proteins in specific
RT   primate taste cell populations.";
RL   PLoS ONE 4:E7682-E7682(2009).
RN   [5]
RP   FUNCTION.
RX   PubMed=21574960; DOI=10.1042/BJ20110479;
RA   Gallego-Sandin S., Alonso M.T., Garcia-Sancho J.;
RT   "Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content
RT   of the endoplasmic reticulum (ER) and triggers ER stress.";
RL   Biochem. J. 437:469-475(2011).
RN   [6]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASN-72; ASP-121; GLU-163 AND ASP-166.
RX   PubMed=22711817; DOI=10.1073/pnas.1204023109;
RA   Ma Z., Siebert A.P., Cheung K.H., Lee R.J., Johnson B., Cohen A.S.,
RA   Vingtdeux V., Marambaud P., Foskett J.K.;
RT   "Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit
RT   of an ion channel that mediates extracellular Ca2+ regulation of
RT   neuronal excitability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E1963-E1971(2012).
RN   [7]
RP   FUNCTION, SUBUNIT, TOPOLOGY, AND SUBCELLULAR LOCATION.
RX   PubMed=23300080; DOI=10.1074/jbc.M112.409789;
RA   Siebert A.P., Ma Z., Grevet J.D., Demuro A., Parker I., Foskett J.K.;
RT   "Structural and functional similarities of calcium homeostasis
RT   modulator 1 (CALHM1) ion channel with connexins, pannexins, and
RT   innexins.";
RL   J. Biol. Chem. 288:6140-6153(2013).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF TRP-114 AND ASN-140.
RX   PubMed=23345406; DOI=10.1242/jcs.117135;
RA   Dreses-Werringloer U., Vingtdeux V., Zhao H., Chandakkar P.,
RA   Davies P., Marambaud P.;
RT   "CALHM1 controls Ca2+-dependent MEK/ERK/RSK/MSK signaling in
RT   neurons.";
RL   J. Cell Sci. 126:1199-1206(2013).
RN   [9]
RP   VARIANT PRO-86.
RX   PubMed=19472444; DOI=10.1111/j.1469-1809.2009.00509.x;
RA   Beecham G.W., Schnetz-Boutaud N., Haines J.L., Pericak-Vance M.A.;
RT   "CALHM1 polymorphism is not associated with late-onset Alzheimer
RT   disease.";
RL   Ann. Hum. Genet. 73:379-381(2009).
RN   [10]
RP   VARIANT PRO-86.
RX   PubMed=19070563; DOI=10.1016/j.cell.2008.11.030;
RA   Bertram L., Schjeide B.M., Hooli B., Mullin K., Hiltunen M.,
RA   Soininen H., Ingelsson M., Lannfelt L., Blacker D., Tanzi R.E.;
RT   "No association between CALHM1 and Alzheimer's disease risk.";
RL   Cell 135:993-994(2008).
RN   [11]
RP   VARIANT PRO-86.
RX   PubMed=19191331; DOI=10.1002/humu.20989;
RA   Minster R.L., Demirci F.Y., DeKosky S.T., Kamboh M.I.;
RT   "No association between CALHM1 variation and risk of Alzheimer
RT   disease.";
RL   Hum. Mutat. 30:E566-E569(2009).
RN   [12]
RP   VARIANT PRO-86.
RX   PubMed=19191332; DOI=10.1002/humu.20990;
RA   Sleegers K., Brouwers N., Bettens K., Engelborghs S., van Miegroet H.,
RA   De Deyn P.P., Van Broeckhoven C.;
RT   "No association between CALHM1 and risk for Alzheimer dementia in a
RT   Belgian population.";
RL   Hum. Mutat. 30:E570-E574(2009).
RN   [13]
RP   VARIANT PRO-86.
RX   PubMed=19545933; DOI=10.1016/j.neurobiolaging.2009.05.008;
RA   Tan E.K., Ho P., Cheng S.Y., Yih Y., Li H.H., Fook-Chong S., Lee W.L.,
RA   Zhao Y.;
RT   "CALHM1 variant is not associated with Alzheimer's disease among
RT   Asians.";
RL   Neurobiol. Aging 32:546.E11-546.E12(2011).
RN   [14]
RP   VARIANT PRO-86.
RX   PubMed=19655363; DOI=10.1002/ajmg.b.31014;
RA   Inoue K., Tanaka N., Yamashita F., Sawano Y., Asada T., Goto Y.;
RT   "The P86L common allele of CALHM1 does not influence risk for
RT   Alzheimer disease in Japanese cohorts.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 153:532-535(2010).
RN   [15]
RP   VARIANT PRO-86.
RX   PubMed=20061624; DOI=10.3233/JAD-2010-1207;
RA   Cui P.J., Zheng L., Cao L., Wang Y., Deng Y.L., Wang G., Xu W.,
RA   Tang H.D., Ma J.F., Zhang T., Ding J.Q., Cheng Q., Chen S.D.;
RT   "CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in
RT   the Chinese population.";
RL   J. Alzheimers Dis. 19:31-35(2010).
RN   [16]
RP   VARIANT PRO-86.
RX   PubMed=20164592; DOI=10.3233/JAD-2010-1357;
RA   Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J.,
RA   Hernandez I., Marin J., Martinez-Lage P., Alegret M., Carrasco J.M.,
RA   Moreno C., Real L.M., Gonzalez-Perez A., Tarraga L., Ruiz A.;
RT   "CALHM1 P86L polymorphism is associated with late-onset Alzheimer's
RT   disease in a recessive model.";
RL   J. Alzheimers Dis. 20:247-251(2010).
RN   [17]
RP   VARIANT PRO-86.
RX   PubMed=20847397; DOI=10.3233/JAD-2010-100933;
RA   Lambert J.C., Sleegers K., Gonzalez-Perez A., Ingelsson M.,
RA   Beecham G.W., Hiltunen M., Combarros O., Bullido M.J., Brouwers N.,
RA   Bettens K., Berr C., Pasquier F., Richard F., Dekosky S.T.,
RA   Hannequin D., Haines J.L., Tognoni G., Fievet N., Dartigues J.F.,
RA   Tzourio C., Engelborghs S., Arosio B., Coto E., De Deyn P.,
RA   Del Zompo M., Mateo I., Boada M., Antunez C., Lopez-Arrieta J.,
RA   Epelbaum J., Schjeide B.M., Frank-Garcia A., Giedraitis V.,
RA   Helisalmi S., Porcellini E., Pilotto A., Forti P., Ferri R.,
RA   Delepine M., Zelenika D., Lathrop M., Scarpini E., Siciliano G.,
RA   Solfrizzi V., Sorbi S., Spalletta G., Ravaglia G., Valdivieso F.,
RA   Vepsalainen S., Alvarez V., Bosco P., Mancuso M., Panza F.,
RA   Nacmias B., Bossu P., Hanon O., Piccardi P., Annoni G., Mann D.,
RA   Marambaud P., Seripa D., Galimberti D., Tanzi R.E., Bertram L.,
RA   Lendon C., Lannfelt L., Licastro F., Campion D., Pericak-Vance M.A.,
RA   Soininen H., Van Broeckhoven C., Alperovitch A., Ruiz A., Kamboh M.I.,
RA   Amouyel P.;
RT   "The CALHM1 P86L polymorphism is a genetic modifier of age at onset in
RT   Alzheimer's disease: a meta-analysis study.";
RL   J. Alzheimers Dis. 22:247-255(2010).
RN   [18]
RP   VARIANT PRO-86.
RX   PubMed=21378601; DOI=10.1097/YPG.0b013e3283457bcc;
RA   Feher A., Juhasz A., Rimanoczy A., Pakaski M., Kalman J., Janka Z.;
RT   "No association between CALHM1 polymorphism and Alzheimer's disease
RT   risk in a Hungarian population.";
RL   Psychiatr. Genet. 21:249-252(2011).
CC   -!- FUNCTION: Pore-forming subunit of a voltage-gated ion channel
CC       required for sensory perception of sweet, bitter and umami tastes.
CC       Specifically present in type II taste bud cells, where it plays a
CC       central role in sweet, bitter and umami taste perception by
CC       inducing ATP release from the cell, ATP acting as a
CC       neurotransmitter to activate afferent neural gustatory pathways.
CC       Acts both as a voltage-gated and calcium-activated ion channel:
CC       mediates neuronal excitability in response to changes in
CC       extracellular Ca(2+) concentration. Has poor ion selectivity and
CC       forms a wide pore (around 14 Angstroms) that mediates permeation
CC       of Ca(2+), Na(+) and K(+), as well as permeation of monovalent
CC       anions. Acts as an activator of the ERK1 and ERK2 cascade.
CC       Triggers endoplasmic reticulum stress by reducing the calcium
CC       content of the endoplasmic reticulum. May indirectly control
CC       amyloid precursor protein (APP) proteolysis and aggregated
CC       amyloid-beta (Abeta) peptides levels in a Ca(2+) dependent manner.
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:21574960,
CC       ECO:0000269|PubMed:22711817, ECO:0000269|PubMed:23300080,
CC       ECO:0000269|PubMed:23345406}.
CC   -!- ENZYME REGULATION: Inhibited by Gd(3+), Ruthenium Red, and Zn(2+)
CC       and partially inhibited by 2-aminoethoxydiphenyl borate.
CC       {ECO:0000269|PubMed:22711817}.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:18585350,
CC       ECO:0000269|PubMed:23300080}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1790341, EBI-1790341;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:22711817,
CC       ECO:0000269|PubMed:23300080}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:18585350}; Multi-pass membrane protein.
CC       Note=Colocalizes with HSPA5 at the endoplasmic reticulum.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in adult brain.
CC       Detected also in retinoic acid-differentiated SH-SY5Y cells.
CC       Specifically expressed in circumvallate taste bud cells.
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:19997627}.
CC   -!- POLYMORPHISM: Leu-86 causes a dysregulation of Ca(2+) homeostasis
CC       and amyloid precursor protein (APP) metabolism and has been
CC       suggested to be a risk factor for the development of Alzheimer
CC       disease (PubMed:18585350, PubMed:20061624, PubMed:20164592).
CC       However, this association with Alzheimer disease could not be
CC       confirmed in a number of studies performed in different
CC       populations (PubMed:19472444, PubMed:19070563, PubMed:19191331,
CC       PubMed:19191332, PubMed:19545933, PubMed:19655363,
CC       PubMed:21378601). According to a meta-analysis study, Leu-86 is
CC       likely not a genetic determinant of Alzheimer disease but may
CC       modulate age of onset by interacting with the effect of the APOE*4
CC       allele of the APOE gene (PubMed:20847397).
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:19070563,
CC       ECO:0000269|PubMed:19191331, ECO:0000269|PubMed:19191332,
CC       ECO:0000269|PubMed:19472444, ECO:0000269|PubMed:19545933,
CC       ECO:0000269|PubMed:19655363, ECO:0000269|PubMed:20061624,
CC       ECO:0000269|PubMed:20164592, ECO:0000269|PubMed:20847397,
CC       ECO:0000269|PubMed:21378601}.
CC   -!- SIMILARITY: Belongs to the CALHM family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139339; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036193; AAH36193.1; -; mRNA.
DR   EMBL; BC036208; AAH36208.1; -; mRNA.
DR   CCDS; CCDS7550.1; -.
DR   RefSeq; NP_001001412.3; NM_001001412.3.
DR   UniGene; Hs.680365; -.
DR   ProteinModelPortal; Q8IU99; -.
DR   STRING; 9606.ENSP00000329926; -.
DR   TCDB; 1.A.84.1.1; the calcium homeostasis modulator ca(2+) channel (calhm-c) family.
DR   iPTMnet; Q8IU99; -.
DR   PhosphoSitePlus; Q8IU99; -.
DR   BioMuta; CALHM1; -.
DR   DMDM; 68565595; -.
DR   PaxDb; Q8IU99; -.
DR   PRIDE; Q8IU99; -.
DR   DNASU; 255022; -.
DR   Ensembl; ENST00000329905; ENSP00000329926; ENSG00000185933.
DR   GeneID; 255022; -.
DR   KEGG; hsa:255022; -.
DR   UCSC; uc001kxe.3; human.
DR   CTD; 255022; -.
DR   DisGeNET; 255022; -.
DR   EuPathDB; HostDB:ENSG00000185933.6; -.
DR   GeneCards; CALHM1; -.
DR   H-InvDB; HIX0201512; -.
DR   HGNC; HGNC:23494; CALHM1.
DR   HPA; HPA018317; -.
DR   MIM; 612234; gene.
DR   neXtProt; NX_Q8IU99; -.
DR   OpenTargets; ENSG00000185933; -.
DR   PharmGKB; PA162380954; -.
DR   eggNOG; ENOG410IG7G; Eukaryota.
DR   eggNOG; ENOG410YNIM; LUCA.
DR   GeneTree; ENSGT00530000062796; -.
DR   HOGENOM; HOG000111295; -.
DR   HOVERGEN; HBG096020; -.
DR   InParanoid; Q8IU99; -.
DR   KO; K19738; -.
DR   OMA; VMNNNVS; -.
DR   OrthoDB; EOG091G09L8; -.
DR   PhylomeDB; Q8IU99; -.
DR   TreeFam; TF329085; -.
DR   GenomeRNAi; 255022; -.
DR   PRO; PR:Q8IU99; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000185933; -.
DR   CleanEx; HS_CALHM1; -.
DR   Genevisible; Q8IU99; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0015867; P:ATP transport; ISS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0050913; P:sensory perception of bitter taste; ISS:UniProtKB.
DR   GO; GO:0050916; P:sensory perception of sweet taste; ISS:UniProtKB.
DR   GO; GO:0050917; P:sensory perception of umami taste; ISS:UniProtKB.
DR   InterPro; IPR029568; CALHM1.
DR   InterPro; IPR029569; FAM26.
DR   PANTHER; PTHR32261; PTHR32261; 1.
DR   PANTHER; PTHR32261:SF2; PTHR32261:SF2; 1.
DR   Pfam; PF14798; Ca_hom_mod; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    346       Calcium homeostasis modulator protein 1.
FT                                /FTId=PRO_0000186723.
FT   TOPO_DOM      1     17       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     18     38       Helical. {ECO:0000255}.
FT   TOPO_DOM     39     50       Extracellular. {ECO:0000255}.
FT   TRANSMEM     51     71       Helical. {ECO:0000255}.
FT   TOPO_DOM     72    108       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    109    129       Helical. {ECO:0000255}.
FT   TOPO_DOM    130    181       Extracellular. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical. {ECO:0000255}.
FT   TOPO_DOM    203    346       Cytoplasmic. {ECO:0000255}.
FT   SITE         74     74       Not glycosylated.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18585350}.
FT   VARIANT      86     86       L -> P (in dbSNP:rs2986017).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18585350,
FT                                ECO:0000269|PubMed:19070563,
FT                                ECO:0000269|PubMed:19191331,
FT                                ECO:0000269|PubMed:19191332,
FT                                ECO:0000269|PubMed:19472444,
FT                                ECO:0000269|PubMed:19545933,
FT                                ECO:0000269|PubMed:19655363,
FT                                ECO:0000269|PubMed:20061624,
FT                                ECO:0000269|PubMed:20164592,
FT                                ECO:0000269|PubMed:20847397,
FT                                ECO:0000269|PubMed:21378601}.
FT                                /FTId=VAR_023095.
FT   MUTAGEN      72     72       N->G: Significant inhibition on the
FT                                control of cytosolic Ca(2+) levels. Does
FT                                not affect ion channel activity.
FT                                {ECO:0000269|PubMed:18585350,
FT                                ECO:0000269|PubMed:22711817}.
FT   MUTAGEN      74     74       N->A: Has no effect on glycosylation.
FT                                {ECO:0000269|PubMed:18585350}.
FT   MUTAGEN     114    114       W->A: Impairs ability to activate the
FT                                ERK1 and ERK2 cascade.
FT                                {ECO:0000269|PubMed:23345406}.
FT   MUTAGEN     121    121       D->C: Impaired ion channel activity in
FT                                response to change in extracellular
FT                                Ca(2+) concentration.
FT                                {ECO:0000269|PubMed:22711817}.
FT   MUTAGEN     121    121       D->E: No effect.
FT                                {ECO:0000269|PubMed:22711817}.
FT   MUTAGEN     140    140       N->A: Prevents glycosylation and impairs
FT                                ability to activate the ERK1 and ERK2
FT                                cascade. {ECO:0000269|PubMed:18585350,
FT                                ECO:0000269|PubMed:23345406}.
FT   MUTAGEN     163    163       E->A: No effect.
FT                                {ECO:0000269|PubMed:22711817}.
FT   MUTAGEN     166    166       D->R: No effect.
FT                                {ECO:0000269|PubMed:22711817}.
FT   CONFLICT    264    264       H -> N (in Ref. 2; AAH36193/AAH36208).
FT                                {ECO:0000305}.
SQ   SEQUENCE   346 AA;  38264 MW;  13A1FBA6592A9EC1 CRC64;
     MMDKFRMIFQ FLQSNQESFM NGICGIMALA SAQMYSAFDF NCPCLPGYNA AYSAGILLAP
     PLVLFLLGLV MNNNVSMLAE EWKRPLGRRA KDPAVLRYMF CSMAQRALIA PVVWVAVTLL
     DGKCFLCAFC TAVPVSALGN GSLAPGLPAP ELARLLARVP CPEIYDGDWL LAREVAVRYL
     RCISQALGWS FVLLTTLLAF VVRSVRPCFT QAAFLKSKYW SHYIDIERKL FDETCTEHAK
     AFAKVCIQQF FEAMNHDLEL GHTHGTLATA PASAAAPTTP DGAEEEREKL RGITDQGTMN
     RLLTSWHKCK PPLRLGQEEP PLMGNGWAGG GPRPPRKEVA TYFSKV
//
ID   CA2D3_HUMAN             Reviewed;        1091 AA.
AC   Q8IZS8; B2RPL6; Q9NY16; Q9NY18;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   25-OCT-2017, entry version 111.
DE   RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-3;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-3;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit alpha-2-3;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit delta-3;
DE   Flags: Precursor;
GN   Name=CACNA2D3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=11245980; DOI=10.1016/S0378-1119(00)00600-4;
RA   Hanke S., Bugert P., Chudek J., Kovacs G.;
RT   "Cloning a calcium channel alpha2delta-3 subunit gene from a putative
RT   tumor suppressor gene region at chromosome 3p21.1 in conventional
RT   renal cell carcinoma.";
RL   Gene 264:69-75(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12181424; DOI=10.1124/mol.62.3.485;
RA   Qin N., Yagel S., Momplaisir M.-L., Codd E.E., D'Andrea M.R.;
RT   "Molecular cloning and characterization of the human voltage-gated
RT   calcium channel alpha(2)delta-4 subunit.";
RL   Mol. Pharmacol. 62:485-496(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11687876; DOI=10.1007/s00232-001-0072-7;
RA   Gong H.C., Hang J., Kohler W., Li L., Su T.-Z.;
RT   "Tissue-specific expression and gabapentin-binding properties of
RT   calcium channel alpha2delta subunit subtypes.";
RL   J. Membr. Biol. 184:35-43(2001).
CC   -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium
CC       channels regulates calcium current density and
CC       activation/inactivation kinetics of the calcium channel. Acts as a
CC       regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type
CC       (CACNA1B), L-type (CACNA1C OR CACNA1D) but not T-type (CACNA1G)
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Dimer formed of alpha-2-2 and delta-2 chains; disulfide-
CC       linked. Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta
CC       (CACNB) and delta (CACNA2D) subunits in a 1:1:1:1 ratio (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IZS8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZS8-2; Sequence=VSP_028064;
CC       Name=3;
CC         IsoId=Q8IZS8-3; Sequence=VSP_028064, VSP_028065, VSP_028066,
CC                                  VSP_028067;
CC   -!- TISSUE SPECIFICITY: Only detected in brain. Not present in lung,
CC       testis, aorta, spleen, jejunum, ventricular muscle and kidney (at
CC       protein level). According to PubMed:11687876, it is brain-
CC       specific, while according to PubMed:11245980, it is widely
CC       expressed. {ECO:0000269|PubMed:11687876}.
CC   -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent
CC       metal cations and is required to promote trafficking of the alpha-
CC       1 (CACNA1) subunit to the plasma membrane by an integrin-like
CC       switch. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: May be proteolytically processed into subunits alpha-2-3 and
CC       delta-3 that are disulfide-linked. It is however unclear whether
CC       such cleavage really takes place in vivo and has a functional role
CC       (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: In contrast to CACNA2D1 and CACNA2D2, it does not
CC       bind gabapentin, an antiepileptic drug.
CC   -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272268; CAB75962.1; -; mRNA.
DR   EMBL; AJ272213; CAB75878.1; -; mRNA.
DR   EMBL; AF516696; AAN06673.1; -; mRNA.
DR   EMBL; BC137502; AAI37503.1; -; mRNA.
DR   EMBL; BC137505; AAI37506.1; -; mRNA.
DR   CCDS; CCDS54598.1; -. [Q8IZS8-1]
DR   RefSeq; NP_060868.2; NM_018398.2. [Q8IZS8-1]
DR   UniGene; Hs.656687; -.
DR   ProteinModelPortal; Q8IZS8; -.
DR   BioGrid; 120911; 10.
DR   STRING; 9606.ENSP00000419101; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00421; Spironolactone.
DR   TCDB; 8.A.18.3.1; the ca(2+) channel auxiliary subunit Alpha2Delta types 1-4 (cca-Alpha2Delta) family.
DR   iPTMnet; Q8IZS8; -.
DR   PhosphoSitePlus; Q8IZS8; -.
DR   BioMuta; CACNA2D3; -.
DR   DMDM; 74723683; -.
DR   PaxDb; Q8IZS8; -.
DR   PeptideAtlas; Q8IZS8; -.
DR   PRIDE; Q8IZS8; -.
DR   Ensembl; ENST00000288197; ENSP00000288197; ENSG00000157445. [Q8IZS8-1]
DR   Ensembl; ENST00000415676; ENSP00000389506; ENSG00000157445. [Q8IZS8-1]
DR   Ensembl; ENST00000471363; ENSP00000418228; ENSG00000157445. [Q8IZS8-3]
DR   Ensembl; ENST00000474759; ENSP00000419101; ENSG00000157445. [Q8IZS8-1]
DR   Ensembl; ENST00000490478; ENSP00000417279; ENSG00000157445. [Q8IZS8-2]
DR   Ensembl; ENST00000620722; ENSP00000478969; ENSG00000157445. [Q8IZS8-3]
DR   GeneID; 55799; -.
DR   KEGG; hsa:55799; -.
DR   UCSC; uc003dhf.3; human. [Q8IZS8-1]
DR   CTD; 55799; -.
DR   DisGeNET; 55799; -.
DR   EuPathDB; HostDB:ENSG00000157445.14; -.
DR   GeneCards; CACNA2D3; -.
DR   HGNC; HGNC:15460; CACNA2D3.
DR   HPA; HPA030849; -.
DR   HPA; HPA030850; -.
DR   MIM; 606399; gene.
DR   neXtProt; NX_Q8IZS8; -.
DR   OpenTargets; ENSG00000157445; -.
DR   PharmGKB; PA26013; -.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOGENOM; HOG000010247; -.
DR   HOVERGEN; HBG107124; -.
DR   InParanoid; Q8IZS8; -.
DR   KO; K04860; -.
DR   OMA; KHEFDAD; -.
DR   OrthoDB; EOG091G00UY; -.
DR   PhylomeDB; Q8IZS8; -.
DR   TreeFam; TF315824; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA2D3; human.
DR   GenomeRNAi; 55799; -.
DR   PRO; PR:Q8IZS8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000157445; -.
DR   CleanEx; HS_CACNA2D3; -.
DR   ExpressionAtlas; Q8IZS8; baseline and differential.
DR   Genevisible; Q8IZS8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013680; VDCC_a2/dsu.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF08473; VGCC_alpha2; 1.
DR   Pfam; PF13768; VWA_3; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29   1091       Voltage-dependent calcium channel subunit
FT                                alpha-2/delta-3.
FT                                /FTId=PRO_0000304646.
FT   CHAIN        29      ?       Voltage-dependent calcium channel subunit
FT                                alpha-2-3. {ECO:0000255}.
FT                                /FTId=PRO_0000304647.
FT   CHAIN         ?   1091       Voltage-dependent calcium channel subunit
FT                                delta-3. {ECO:0000255}.
FT                                /FTId=PRO_0000304648.
FT   TOPO_DOM     29   1068       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1069   1089       Helical. {ECO:0000255}.
FT   TOPO_DOM   1090   1091       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      256    438       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      452    549       Cache.
FT   MOTIF       262    266       MIDAS-like motif.
FT   METAL       262    262       Divalent metal cation. {ECO:0000250}.
FT   METAL       264    264       Divalent metal cation. {ECO:0000250}.
FT   METAL       266    266       Divalent metal cation. {ECO:0000250}.
FT   MOD_RES     924    924       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8CFG5}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    309    309       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    553    553       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    632    632       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    793    793       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    412   1055       Interchain (between alpha-2-3 and delta-3
FT                                chains). {ECO:0000250}.
FT   VAR_SEQ       1     94       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11245980}.
FT                                /FTId=VSP_028064.
FT   VAR_SEQ     461    466       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11245980}.
FT                                /FTId=VSP_028065.
FT   VAR_SEQ     595    619       KRVLVMTNDYYYTDIKGTPFSLGVA -> FRCGAFQRSWEI
FT                                FLPRECNHRRRPA (in isoform 3).
FT                                {ECO:0000303|PubMed:11245980}.
FT                                /FTId=VSP_028066.
FT   VAR_SEQ     620   1091       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11245980}.
FT                                /FTId=VSP_028067.
SQ   SEQUENCE   1091 AA;  123011 MW;  4E5E50BD38F05082 CRC64;
     MAGPGSPRRA SRGASALLAA ALLYAALGDV VRSEQQIPLS VVKLWASAFG GEIKSIAAKY
     SGSQLLQKKY KEYEKDVAIE EIDGLQLVKK LAKNMEEMFH KKSEAVRRLV EAAEEAHLKH
     EFDADLQYEY FNAVLINERD KDGNFLELGK EFILAPNDHF NNLPVNISLS DVQVPTNMYN
     KDPAIVNGVY WSESLNKVFV DNFDRDPSLI WQYFGSAKGF FRQYPGIKWE PDENGVIAFD
     CRNRKWYIQA ATSPKDVVIL VDVSGSMKGL RLTIAKQTVS SILDTLGDDD FFNIIAYNEE
     LHYVEPCLNG TLVQADRTNK EHFREHLDKL FAKGIGMLDI ALNEAFNILS DFNHTGQGSI
     CSQAIMLITD GAVDTYDTIF AKYNWPDRKV RIFTYLIGRE AAFADNLKWM ACANKGFFTQ
     ISTLADVQEN VMEYLHVLSR PKVIDQEHDV VWTEAYIDST LPQAQKLTDD QGPVLMTTVA
     MPVFSKQNET RSKGILLGVV GTDVPVKELL KTIPKYKLGI HGYAFAITNN GYILTHPELR
     LLYEEGKKRR KPNYSSVDLS EVEWEDRDDV LRNAMVNRKT GKFSMEVKKT VDKGKRVLVM
     TNDYYYTDIK GTPFSLGVAL SRGHGKYFFR GNVTIEEGLH DLEHPDVSLA DEWSYCNTDL
     HPEHRHLSQL EAIKLYLKGK EPLLQCDKEL IQEVLFDAVV SAPIEAYWTS LALNKSENSD
     KGVEVAFLGT RTGLSRINLF VGAEQLTNQD FLKAGDKENI FNADHFPLWY RRAAEQIPGS
     FVYSIPFSTG PVNKSNVVTA STSIQLLDER KSPVVAAVGI QMKLEFFQRK FWTASRQCAS
     LDGKCSISCD DETVNCYLID NNGFILVSED YTQTGDFFGE IEGAVMNKLL TMGSFKRITL
     YDYQAMCRAN KESSDGAHGL LDPYNAFLSA VKWIMTELVL FLVEFNLCSW WHSDMTAKAQ
     KLKQTLEPCD TEYPAFVSER TIKETTGNIA CEDCSKSFVI QQIPSSNLFM VVVDSSCLCE
     SVAPITMAPI EIRYNESLKC ERLKAQKIRR RPESCHGFHP EENARECGGA PSLQAQTVLL
     LLPLLLMLFS R
//
ID   MCU_HUMAN               Reviewed;         351 AA.
AC   Q8NE86; B2RDF3; B3KXV7; Q96FL3;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-OCT-2017, entry version 120.
DE   RecName: Full=Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886};
DE            Short=HsMCU {ECO:0000303|PubMed:27135929};
DE   AltName: Full=Coiled-coil domain-containing protein 109A {ECO:0000305};
DE   Flags: Precursor;
GN   Name=MCU {ECO:0000303|PubMed:21685886, ECO:0000312|HGNC:HGNC:23526};
GN   Synonyms=C10orf42 {ECO:0000312|HGNC:HGNC:23526},
GN   CCDC109A {ECO:0000312|HGNC:HGNC:23526};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   FUNCTION, MUTAGENESIS OF 261-ASP--GLU-264, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=21685888; DOI=10.1038/nature10230;
RA   De Stefani D., Raffaello A., Teardo E., Szabo I., Rizzuto R.;
RT   "A forty-kilodalton protein of the inner membrane is the mitochondrial
RT   calcium uniporter.";
RL   Nature 476:336-340(2011).
RN   [7]
RP   FUNCTION, OLIGOMERIZATION, SUBUNIT, INTERACTION WITH MICU1,
RP   MUTAGENESIS OF GLU-257; SER-259 AND 261-ASP--GLU-264, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21685886; DOI=10.1038/nature10234;
RA   Baughman J.M., Perocchi F., Girgis H.S., Plovanich M.,
RA   Belcher-Timme C.A., Sancak Y., Bao X.R., Strittmatter L.,
RA   Goldberger O., Bogorad R.L., Koteliansky V., Mootha V.K.;
RT   "Integrative genomics identifies MCU as an essential component of the
RT   mitochondrial calcium uniporter.";
RL   Nature 476:341-345(2011).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MICU1.
RX   PubMed=23101630; DOI=10.1016/j.cell.2012.10.011;
RA   Mallilankaraman K., Doonan P., Cardenas C., Chandramoorthy H.C.,
RA   Muller M., Miller R., Hoffman N.E., Gandhirajan R.K., Molgo J.,
RA   Birnbaum M.J., Rothberg B.S., Mak D.O., Foskett J.K., Madesh M.;
RT   "MICU1 is an essential gatekeeper for MCU-mediated mitochondrial
RT   Ca(2+) uptake that regulates cell survival.";
RL   Cell 151:630-644(2012).
RN   [9]
RP   FUNCTION.
RX   PubMed=22904319; DOI=10.1074/jbc.M112.392084;
RA   Alam M.R., Groschner L.N., Parichatikanond W., Kuo L.,
RA   Bondarenko A.I., Rost R., Waldeck-Weiermair M., Malli R., Graier W.F.;
RT   "Mitochondrial Ca2+ uptake 1 (MICU1) and mitochondrial ca2+ uniporter
RT   (MCU) contribute to metabolism-secretion coupling in clonal pancreatic
RT   beta-cells.";
RL   J. Biol. Chem. 287:34445-34454(2012).
RN   [10]
RP   PHOSPHORYLATION AT SER-57 AND SER-92, AND MUTAGENESIS OF SER-57 AND
RP   SER-92.
RX   PubMed=23051746; DOI=10.1038/nature11444;
RA   Joiner M.L., Koval O.M., Li J., He B.J., Allamargot C., Gao Z.,
RA   Luczak E.D., Hall D.D., Fink B.D., Chen B., Yang J., Moore S.A.,
RA   Scholz T.D., Strack S., Mohler P.J., Sivitz W.I., Song L.S.,
RA   Anderson M.E.;
RT   "CaMKII determines mitochondrial stress responses in heart.";
RL   Nature 491:269-273(2012).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH MCUR1 AND MICU1.
RX   PubMed=23178883; DOI=10.1038/ncb2622;
RA   Mallilankaraman K., Cardenas C., Doonan P.J., Chandramoorthy H.C.,
RA   Irrinki K.M., Golenar T., Csordas G., Madireddi P., Yang J.,
RA   Muller M., Miller R., Kolesar J.E., Molgo J., Kaufman B.,
RA   Hajnoczky G., Foskett J.K., Madesh M.;
RT   "MCUR1 is an essential component of mitochondrial Ca(2+) uptake that
RT   regulates cellular metabolism.";
RL   Nat. Cell Biol. 14:1336-1343(2012).
RN   [12]
RP   FUNCTION.
RX   PubMed=22829870; DOI=10.1371/journal.pone.0039722;
RA   Tarasov A.I., Semplici F., Ravier M.A., Bellomo E.A., Pullen T.J.,
RA   Gilon P., Sekler I., Rizzuto R., Rutter G.A.;
RT   "The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced
RT   ATP increases in pancreatic beta-cells.";
RL   PLoS ONE 7:E39722-E39722(2012).
RN   [13]
RP   FUNCTION.
RX   PubMed=22822213; DOI=10.1073/pnas.1210718109;
RA   Drago I., De Stefani D., Rizzuto R., Pozzan T.;
RT   "Mitochondrial Ca2+ uptake contributes to buffering cytoplasmic Ca2+
RT   peaks in cardiomyocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12986-12991(2012).
RN   [14]
RP   IDENTIFICATION.
RX   PubMed=22605770; DOI=10.1126/science.1214977;
RA   Bick A.G., Calvo S.E., Mootha V.K.;
RT   "Evolutionary diversity of the mitochondrial calcium uniporter.";
RL   Science 336:886-886(2012).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH MICU1.
RX   PubMed=24332854; DOI=10.1016/j.celrep.2013.11.026;
RA   Hoffman N.E., Chandramoorthy H.C., Shamugapriya S., Zhang X.,
RA   Rajan S., Mallilankaraman K., Gandhirajan R.K., Vagnozzi R.J.,
RA   Ferrer L.M., Sreekrishnanilayam K., Natarajaseenivasan K., Vallem S.,
RA   Force T., Choi E.T., Cheung J.Y., Madesh M.;
RT   "MICU1 motifs define mitochondrial calcium uniporter binding and
RT   activity.";
RL   Cell Rep. 5:1576-1588(2013).
RN   [16]
RP   INDUCTION.
RX   PubMed=23246404; DOI=10.1016/j.cub.2012.11.026;
RA   Marchi S., Lupini L., Patergnani S., Rimessi A., Missiroli S.,
RA   Bonora M., Bononi A., Corra F., Giorgi C., De Marchi E., Poletti F.,
RA   Gafa R., Lanza G., Negrini M., Rizzuto R., Pinton P.;
RT   "Downregulation of the mitochondrial calcium uniporter by cancer-
RT   related miR-25.";
RL   Curr. Biol. 23:58-63(2013).
RN   [17]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   SER-259.
RX   PubMed=23755363; DOI=10.7554/eLife.00704;
RA   Chaudhuri D., Sancak Y., Mootha V.K., Clapham D.E.;
RT   "MCU encodes the pore conducting mitochondrial calcium currents.";
RL   Elife 2:E00704-E00704(2013).
RN   [18]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE UNIPLEX COMPLEX.
RX   PubMed=24231807; DOI=10.1126/science.1242993;
RA   Sancak Y., Markhard A.L., Kitami T., Kovacs-Bogdan E., Kamer K.J.,
RA   Udeshi N.D., Carr S.A., Chaudhuri D., Clapham D.E., Li A.A.,
RA   Calvo S.E., Goldberger O., Mootha V.K.;
RT   "EMRE is an essential component of the mitochondrial calcium uniporter
RT   complex.";
RL   Science 342:1379-1382(2013).
RN   [19]
RP   PHOSPHORYLATION.
RX   PubMed=24800979; DOI=10.1089/ars.2013.5394;
RA   O-Uchi J., Jhun B.S., Xu S., Hurst S., Raffaello A., Liu X., Yi B.,
RA   Zhang H., Gross P., Mishra J., Ainbinder A., Kettlewell S.,
RA   Smith G.L., Dirksen R.T., Wang W., Rizzuto R., Sheu S.S.;
RT   "Adrenergic signaling regulates mitochondrial Ca2+ uptake through
RT   Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+
RT   uniporter.";
RL   Antioxid. Redox Signal. 21:863-879(2014).
RN   [20]
RP   INTERACTION WITH SLC25A23.
RX   PubMed=24430870; DOI=10.1091/mbc.E13-08-0502;
RA   Hoffman N.E., Chandramoorthy H.C., Shanmughapriya S., Zhang X.Q.,
RA   Vallem S., Doonan P.J., Malliankaraman K., Guo S., Rajan S.,
RA   Elrod J.W., Koch W.J., Cheung J.Y., Madesh M.;
RT   "SLC25A23 augments mitochondrial Ca(2+) uptake, interacts with MCU,
RT   and induces oxidative stress-mediated cell death.";
RL   Mol. Biol. Cell 25:936-947(2014).
RN   [21]
RP   FUNCTION.
RX   PubMed=24560927; DOI=10.1016/j.molcel.2014.01.013;
RA   Patron M., Checchetto V., Raffaello A., Teardo E., Vecellio Reane D.,
RA   Mantoan M., Granatiero V., Szabo I., De Stefani D., Rizzuto R.;
RT   "MICU1 and MICU2 finely tune the mitochondrial Ca(2+) uniporter by
RT   exerting opposite effects on MCU activity.";
RL   Mol. Cell 53:726-737(2014).
RN   [22]
RP   COMMENT ON PUBMED:23051746 RESULTS.
RX   PubMed=25254480; DOI=10.1038/nature13626;
RA   Fieni F., Johnson D.E., Hudmon A., Kirichok Y.;
RT   "Mitochondrial Ca2+ uniporter and CaMKII in heart.";
RL   Nature 513:E1-E2(2014).
RN   [23]
RP   COMMENT ON PUBMED:25254480 RESULTS.
RX   PubMed=25254481; DOI=10.1038/nature13627;
RA   Joiner M.L., Koval O.M., Li J., He B.J., Allamargot C., Gao Z.,
RA   Luczak E.D., Hall D.D., Fink B.D., Chen B., Yang J., Moore S.A.,
RA   Scholz T.D., Strack S., Mohler P.J., Sivitz W.I., Song L.S.,
RA   Anderson M.E.;
RT   "Joiner et al. reply.";
RL   Nature 513:E3-E3(2014).
RN   [24]
RP   INDUCTION.
RX   PubMed=25764156; DOI=10.3390/ijms16035420;
RA   Pan L., Huang B.J., Ma X.E., Wang S.Y., Feng J., Lv F., Liu Y.,
RA   Liu Y., Li C.M., Liang D.D., Li J., Xu L., Chen Y.H.;
RT   "MiR-25 protects cardiomyocytes against oxidative damage by targeting
RT   the mitochondrial calcium uniporter.";
RL   Int. J. Mol. Sci. 16:5420-5433(2015).
RN   [25]
RP   FUNCTION, AND MUTAGENESIS OF 261-ASP--GLU-264.
RX   PubMed=25603276; DOI=10.1038/ncomms7081;
RA   Wu Y., Rasmussen T.P., Koval O.M., Joiner M.L., Hall D.D., Chen B.,
RA   Luczak E.D., Wang Q., Rokita A.G., Wehrens X.H., Song L.S.,
RA   Anderson M.E.;
RT   "The mitochondrial uniporter controls fight or flight heart rate
RT   increases.";
RL   Nat. Commun. 6:6081-6081(2015).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   FUNCTION.
RX   PubMed=26903221; DOI=10.1016/j.bbamem.2016.02.022;
RA   Matesanz-Isabel J., Arias-Del-Val J., Alvarez-Illera P.,
RA   Fonteriz R.I., Montero M., Alvarez J.;
RT   "Functional roles of MICU1 and MICU2 in mitochondrial Ca(2+) uptake.";
RL   Biochim. Biophys. Acta 1858:1110-1117(2016).
RN   [28]
RP   INTERACTION WITH MCUR1 AND CCDC90B.
RX   PubMed=27184846; DOI=10.1016/j.celrep.2016.04.050;
RA   Tomar D., Dong Z., Shanmughapriya S., Koch D.A., Thomas T.,
RA   Hoffman N.E., Timbalia S.A., Goldman S.J., Breves S.L., Corbally D.P.,
RA   Nemani N., Fairweather J.P., Cutri A.R., Zhang X., Song J., Jana F.,
RA   Huang J., Barrero C., Rabinowitz J.E., Luongo T.S., Schumacher S.M.,
RA   Rockman M.E., Dietrich A., Merali S., Caplan J., Stathopulos P.,
RA   Ahima R.S., Cheung J.Y., Houser S.R., Koch W.J., Patel V., Gohil V.M.,
RA   Elrod J.W., Rajan S., Madesh M.;
RT   "MCUR1 is a scaffold factor for the MCU complex function and promotes
RT   mitochondrial bioenergetics.";
RL   Cell Rep. 15:1673-1685(2016).
RN   [29]
RP   FUNCTION, AND TOPOLOGY.
RX   PubMed=27099988; DOI=10.7554/eLife.15545;
RA   Tsai M.F., Phillips C.B., Ranaghan M., Tsai C.W., Wu Y., Willliams C.,
RA   Miller C.;
RT   "Dual functions of a small regulatory subunit in the mitochondrial
RT   calcium uniporter complex.";
RL   Elife 5:0-0(2016).
RN   [30]
RP   MUTAGENESIS OF GLU-257; SER-259; ASP-261 AND GLU-264.
RX   PubMed=27135929; DOI=10.1038/nature17656;
RA   Oxenoid K., Dong Y., Cao C., Cui T., Sancak Y., Markhard A.L.,
RA   Grabarek Z., Kong L., Liu Z., Ouyang B., Cong Y., Mootha V.K.,
RA   Chou J.J.;
RT   "Architecture of the mitochondrial calcium uniporter.";
RL   Nature 533:269-273(2016).
RN   [31]
RP   INTERACTION WITH MCUR1.
RX   PubMed=26976564; DOI=10.1073/pnas.1602264113;
RA   Chaudhuri D., Artiga D.J., Abiria S.A., Clapham D.E.;
RT   "Mitochondrial calcium uniporter regulator 1 (MCUR1) regulates the
RT   calcium threshold for the mitochondrial permeability transition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E1872-E1880(2016).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 75-185, FUNCTION, SUBUNIT,
RP   INTERACTION WITH MCUR1; MICU1 AND MICU2, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF SER-92 AND LYS-180, AND DOMAIN.
RX   PubMed=26341627; DOI=10.15252/embr.201540436;
RA   Lee Y., Min C.K., Kim T.G., Song H.K., Lim Y., Kim D., Shin K.,
RA   Kang M., Kang J.Y., Youn H.S., Lee J.G., An J.Y., Park K.R., Lim J.J.,
RA   Kim J.H., Kim J.H., Park Z.Y., Kim Y.S., Wang J., Kim D.H., Eom S.H.;
RT   "Structure and function of the N-terminal domain of the human
RT   mitochondrial calcium uniporter.";
RL   EMBO Rep. 16:1318-1333(2015).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria (PubMed:21685888,
CC       PubMed:21685886, PubMed:23101630, PubMed:22904319,
CC       PubMed:23178883, PubMed:22829870, PubMed:22822213,
CC       PubMed:24332854, PubMed:23755363, PubMed:26341627). Constitutes
CC       the pore-forming and calcium-conducting subunit of the uniporter
CC       complex (uniplex) (PubMed:23755363). Activity is regulated by
CC       MICU1 and MICU2. At low Ca(2+) levels MCU activity is down-
CC       regulated by MICU1 and MICU2; at higher Ca(2+) levels MICU1
CC       increases MCU activity (PubMed:24560927, PubMed:26903221).
CC       Mitochondrial calcium homeostasis plays key roles in cellular
CC       physiology and regulates cell bioenergetics, cytoplasmic calcium
CC       signals and activation of cell death pathways. Involved in
CC       buffering the amplitude of systolic calcium rises in
CC       cardiomyocytes (PubMed:22822213). While dispensable for baseline
CC       homeostatic cardiac function, acts as a key regulator of short-
CC       term mitochondrial calcium loading underlying a 'fight-or-flight'
CC       response during acute stress: acts by mediating a rapid increase
CC       of mitochondrial calcium in pacemaker cells (PubMed:25603276).
CC       participates in mitochondrial permeability transition during
CC       ischemia-reperfusion injury (By similarity). Regulates glucose-
CC       dependent insulin secretion in pancreatic beta-cells by regulating
CC       mitochondrial calcium uptake (PubMed:22904319, PubMed:22829870).
CC       Mitochondrial calcium uptake in skeletal muscle cells is involved
CC       in muscle size in adults (By similarity). Regulates synaptic
CC       vesicle endocytosis kinetics in central nerve terminal (By
CC       similarity). Involved in antigen processing and presentation (By
CC       similarity). {ECO:0000250|UniProtKB:Q3UMR5,
CC       ECO:0000269|PubMed:21685886, ECO:0000269|PubMed:21685888,
CC       ECO:0000269|PubMed:22822213, ECO:0000269|PubMed:22829870,
CC       ECO:0000269|PubMed:22904319, ECO:0000269|PubMed:23101630,
CC       ECO:0000269|PubMed:23178883, ECO:0000269|PubMed:23755363,
CC       ECO:0000269|PubMed:24332854, ECO:0000269|PubMed:24560927,
CC       ECO:0000269|PubMed:25603276, ECO:0000269|PubMed:26341627,
CC       ECO:0000269|PubMed:26903221}.
CC   -!- ENZYME REGULATION: Inhibited by ruthenium red or its derivative
CC       Ru360. {ECO:0000269|PubMed:23755363}.
CC   -!- SUBUNIT: Component of the uniplex complex, composed of MCU, MCUB,
CC       MICU1, MICU2 and EMRE/SMDT1 (PubMed:24231807). Homooligomer
CC       (PubMed:21685886, PubMed:26341627). Forms a pentamer (By
CC       similarity). Heterooligomer with CCDC109B/MCUB; this inhibits
CC       channel activity (By similarity). Interacts with MICU1; MICU1 acts
CC       as an essential regulator for MCU (PubMed:21685886,
CC       PubMed:23101630, PubMed:23178883, PubMed:24332854,
CC       PubMed:26341627). Interacts with MCUR1 (PubMed:23178883,
CC       PubMed:26341627, PubMed:27184846, PubMed:26976564). Interacts with
CC       CCDC90B (PubMed:27184846). Interactions with MICU1 and MCUR1 are
CC       mutually exclusive (PubMed:23178883). Interacts with MICU2
CC       (PubMed:26341627). Interacts with SLC25A23 (PubMed:24430870).
CC       {ECO:0000250|UniProtKB:Q21121, ECO:0000250|UniProtKB:Q3UMR5,
CC       ECO:0000269|PubMed:21685886, ECO:0000269|PubMed:23101630,
CC       ECO:0000269|PubMed:23178883, ECO:0000269|PubMed:24231807,
CC       ECO:0000269|PubMed:24332854, ECO:0000269|PubMed:24430870,
CC       ECO:0000269|PubMed:26341627, ECO:0000269|PubMed:26976564,
CC       ECO:0000269|PubMed:27184846}.
CC   -!- INTERACTION:
CC       Q96AQ8:MCUR1; NbExp=4; IntAct=EBI-15932889, EBI-14404755;
CC       Q9BPX6:MICU1; NbExp=2; IntAct=EBI-15932889, EBI-2371996;
CC       Q9BPX6-1:MICU1; NbExp=2; IntAct=EBI-15932889, EBI-5456336;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:21685886, ECO:0000269|PubMed:21685888,
CC       ECO:0000269|PubMed:23755363, ECO:0000269|PubMed:24231807,
CC       ECO:0000269|PubMed:27099988, ECO:0000305|PubMed:26341627}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:21685886,
CC       ECO:0000269|PubMed:21685888, ECO:0000269|PubMed:24231807}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NE86-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NE86-2; Sequence=VSP_024263;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8NE86-3; Sequence=VSP_041687;
CC   -!- INDUCTION: MCU transcripts are down-regulated by microRNA miR-25
CC       (PubMed:23246404). Down-regulation by miR-25 may protect
CC       cardiomyocytes against oxidative damage in cardiomyocytes
CC       (PubMed:25764156). {ECO:0000269|PubMed:23246404,
CC       ECO:0000269|PubMed:25764156}.
CC   -!- DOMAIN: The N-terminal MCU domain is required for efficient Ca(2+)
CC       uptake and for interaction with MCUR1. It is not required for
CC       targeting to the mitochondria, oligomerization, interaction with
CC       MICU1 and MICU2, or assembly of the uniplex complex.
CC       {ECO:0000269|PubMed:26341627}.
CC   -!- DOMAIN: Forms a well-packed pentamer with an overall cylindrical
CC       shape. The inner core of the pentamer is formed with the second
CC       transmembrane region and the second coiled-coil region: while the
CC       transmembrane regions pack into a five-helix bundle having a
CC       largely polar pore across the membrane, the coiled-coil outside
CC       the membrane forms a pentamer with a hydrophobic core. The inner
CC       core is wrapped by the first transmembrane region through contacts
CC       between the first and the second transmembrane regions. The second
CC       transmembrane is followed by the inner juxtamembrane region (IJMH)
CC       that orients at a wide angle relative to the second transmembrane.
CC       The two core domains are held together on the periphery by the
CC       outer juxtamembrane helix (OJMH). {ECO:0000250|UniProtKB:Q21121}.
CC   -!- DOMAIN: The critical DXXE motif connecting the transmembrane
CC       regions forms a pentameric barrel that constitutes the mouth of
CC       the pore. Inside the barrel, two acidic residues are in position
CC       to form two carboxylate rings. In absence of SMDT1/EMRE regulator,
CC       the calcium ions cannot exit the channel, suggesting that
CC       SMDT1/EMRE-binding induces conformational rearrangements to allow
CC       calcium to exit. {ECO:0000250|UniProtKB:Q21121}.
CC   -!- PTM: Phosphorylation by CaMK2 in heart leads to increased MCU
CC       current (PubMed:23051746, PubMed:25254481). The regulation of MCU
CC       by CaMK2 is however subject to discussion: another group was
CC       unable to reproduce these results (PubMed:25254480).
CC       Phosphorylated on tyrosines by PTK2B/PYK2, promoting
CC       oligomerization (PubMed:24800979). {ECO:0000269|PubMed:24800979,
CC       ECO:0000305|PubMed:23051746, ECO:0000305|PubMed:25254480,
CC       ECO:0000305|PubMed:25254481}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK315519; BAG37900.1; -; mRNA.
DR   EMBL; AK128016; BAG54619.1; -; mRNA.
DR   EMBL; AC016542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54461.1; -; Genomic_DNA.
DR   EMBL; BC010682; AAH10682.1; -; mRNA.
DR   EMBL; BC034235; AAH34235.1; -; mRNA.
DR   CCDS; CCDS59218.1; -. [Q8NE86-2]
DR   CCDS; CCDS59219.1; -. [Q8NE86-3]
DR   CCDS; CCDS7317.1; -. [Q8NE86-1]
DR   RefSeq; NP_001257608.1; NM_001270679.1. [Q8NE86-2]
DR   RefSeq; NP_001257609.1; NM_001270680.1. [Q8NE86-3]
DR   RefSeq; NP_612366.1; NM_138357.2. [Q8NE86-1]
DR   UniGene; Hs.591366; -.
DR   PDB; 4XSJ; X-ray; 1.80 A; A=75-165.
DR   PDB; 4XTB; X-ray; 1.50 A; A=75-185.
DR   PDB; 5BZ6; X-ray; 2.75 A; A=75-165.
DR   PDB; 5KUE; X-ray; 1.50 A; A=72-189.
DR   PDB; 5KUG; X-ray; 1.90 A; A=72-189.
DR   PDB; 5KUI; X-ray; 2.70 A; A=72-189.
DR   PDB; 5KUJ; X-ray; 1.60 A; A=72-189.
DR   PDBsum; 4XSJ; -.
DR   PDBsum; 4XTB; -.
DR   PDBsum; 5BZ6; -.
DR   PDBsum; 5KUE; -.
DR   PDBsum; 5KUG; -.
DR   PDBsum; 5KUI; -.
DR   PDBsum; 5KUJ; -.
DR   ProteinModelPortal; Q8NE86; -.
DR   SMR; Q8NE86; -.
DR   BioGrid; 124733; 40.
DR   CORUM; Q8NE86; -.
DR   DIP; DIP-60468N; -.
DR   IntAct; Q8NE86; 13.
DR   MINT; MINT-8051705; -.
DR   STRING; 9606.ENSP00000362144; -.
DR   iPTMnet; Q8NE86; -.
DR   PhosphoSitePlus; Q8NE86; -.
DR   SwissPalm; Q8NE86; -.
DR   DMDM; 74730222; -.
DR   EPD; Q8NE86; -.
DR   MaxQB; Q8NE86; -.
DR   PaxDb; Q8NE86; -.
DR   PeptideAtlas; Q8NE86; -.
DR   PRIDE; Q8NE86; -.
DR   TopDownProteomics; Q8NE86-3; -. [Q8NE86-3]
DR   DNASU; 90550; -.
DR   Ensembl; ENST00000357157; ENSP00000349680; ENSG00000156026. [Q8NE86-2]
DR   Ensembl; ENST00000373053; ENSP00000362144; ENSG00000156026. [Q8NE86-1]
DR   Ensembl; ENST00000536019; ENSP00000440913; ENSG00000156026. [Q8NE86-3]
DR   GeneID; 90550; -.
DR   KEGG; hsa:90550; -.
DR   UCSC; uc001jtc.3; human. [Q8NE86-1]
DR   CTD; 90550; -.
DR   DisGeNET; 90550; -.
DR   EuPathDB; HostDB:ENSG00000156026.14; -.
DR   GeneCards; MCU; -.
DR   HGNC; HGNC:23526; MCU.
DR   HPA; HPA016480; -.
DR   MIM; 614197; gene.
DR   neXtProt; NX_Q8NE86; -.
DR   OpenTargets; ENSG00000156026; -.
DR   PharmGKB; PA134888841; -.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   GeneTree; ENSGT00390000004496; -.
DR   HOGENOM; HOG000008081; -.
DR   HOVERGEN; HBG060246; -.
DR   InParanoid; Q8NE86; -.
DR   KO; K20858; -.
DR   OMA; LGVVYCS; -.
DR   OrthoDB; EOG091G092C; -.
DR   PhylomeDB; Q8NE86; -.
DR   TreeFam; TF314435; -.
DR   Reactome; R-HSA-8949215; Mitochondrial calcium ion transport.
DR   Reactome; R-HSA-8949664; Processing of SMDT1.
DR   ChiTaRS; MCU; human.
DR   GenomeRNAi; 90550; -.
DR   PRO; PR:Q8NE86; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000156026; -.
DR   CleanEx; HS_CCDC109A; -.
DR   ExpressionAtlas; Q8NE86; baseline and differential.
DR   Genevisible; Q8NE86; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:1990246; C:uniplex complex; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0015292; F:uniporter activity; IDA:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:UniProtKB.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0036444; P:mitochondrial calcium uptake; IDA:MGI.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB.
DR   GO; GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0035786; P:protein complex oligomerization; IDA:UniProtKB.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium;
KW   Calcium channel; Calcium transport; Coiled coil; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Phosphoprotein; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1     50       Mitochondrion. {ECO:0000255}.
FT   CHAIN        51    351       Calcium uniporter protein, mitochondrial.
FT                                /FTId=PRO_0000282976.
FT   TOPO_DOM     51    233       Mitochondrial matrix.
FT                                {ECO:0000305|PubMed:27099988}.
FT   TRANSMEM    234    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    265       Mitochondrial intermembrane.
FT                                {ECO:0000305|PubMed:27099988}.
FT   TRANSMEM    266    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    351       Mitochondrial matrix.
FT                                {ECO:0000269|PubMed:23755363,
FT                                ECO:0000305|PubMed:27099988}.
FT   REGION       75    165       N-terminal MCU domain.
FT                                {ECO:0000269|PubMed:26341627}.
FT   REGION      216    234       Outer juxtamembrane helix (OJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   REGION      283    292       Inner juxtamembrane helix (IJMH).
FT                                {ECO:0000250|UniProtKB:Q21121}.
FT   COILED      192    223       {ECO:0000255}.
FT   COILED      311    339       {ECO:0000255}.
FT   MOTIF       261    264       DXXE. {ECO:0000250|UniProtKB:Q21121}.
FT   MOD_RES      57     57       Phosphoserine; by CaMK2.
FT                                {ECO:0000305|PubMed:23051746}.
FT   MOD_RES      92     92       Phosphoserine; by CaMK2.
FT                                {ECO:0000305|PubMed:23051746}.
FT   MOD_RES     332    332       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UMR5}.
FT   VAR_SEQ       1     50       MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSR
FT                                HRQQQHHRT -> M (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041687.
FT   VAR_SEQ     166    219       DLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELIER
FT                                LEDLKEQLAPLEK -> VEMGFCHVGQNGFELLTSSYLPAS
FT                                ASQSAEIIA (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024263.
FT   MUTAGEN      57     57       S->A: Decreased MCU current; when
FT                                associated with A-92.
FT                                {ECO:0000269|PubMed:23051746}.
FT   MUTAGEN      92     92       S->A: Decreased MCU current; when
FT                                associated with A-57.
FT                                {ECO:0000269|PubMed:23051746}.
FT   MUTAGEN      92     92       S->A: Impairs Ca(2+) uptake, but has no
FT                                effect on oligomerization and interaction
FT                                with MCU1 and MCU2.
FT                                {ECO:0000269|PubMed:26341627}.
FT   MUTAGEN     180    180       K->A: No effect on Ca(2+) uptake,
FT                                oligomerization and interaction with MCU1
FT                                and MCU2. {ECO:0000269|PubMed:26341627}.
FT   MUTAGEN     257    257       E->A: According to a report, inhibits
FT                                calcium uptake. According to a subsequent
FT                                report, does not affect greatly calcium
FT                                uptake. {ECO:0000269|PubMed:21685886,
FT                                ECO:0000269|PubMed:27135929}.
FT   MUTAGEN     257    257       E->S: Does not affect greatly calcium
FT                                uptake. {ECO:0000269|PubMed:27135929}.
FT   MUTAGEN     259    259       S->A: Does not inhibit calcium uptake.
FT                                Strongly reduced sensitivity to ruthenium
FT                                red inhibition.
FT                                {ECO:0000269|PubMed:21685886,
FT                                ECO:0000269|PubMed:23755363}.
FT   MUTAGEN     259    259       S->R: Prevents entrance of calcium into
FT                                the pore. {ECO:0000269|PubMed:27135929}.
FT   MUTAGEN     261    264       DIME->AIMA: Dominant negative (DN)
FT                                mutant; inhibits calcium uptake. Inhibits
FT                                calcium channel activity. Expression of
FT                                the dominant negative protein in mice,
FT                                leads to mice that are incapable of
FT                                physiological fight or flight heart rate
FT                                acceleration.
FT                                {ECO:0000269|PubMed:21685886,
FT                                ECO:0000269|PubMed:21685888,
FT                                ECO:0000269|PubMed:25603276}.
FT   MUTAGEN     261    261       D->E: Partially functional; does not
FT                                completely abolish calcium channel
FT                                activity. {ECO:0000269|PubMed:27135929}.
FT   MUTAGEN     264    264       E->D: Abolishes calcium channel activity.
FT                                {ECO:0000269|PubMed:27135929}.
FT   CONFLICT    107    107       S -> P (in Ref. 1; BAG37900).
FT                                {ECO:0000305}.
FT   CONFLICT    142    142       D -> Y (in Ref. 1; BAG37900).
FT                                {ECO:0000305}.
FT   STRAND       76     80       {ECO:0000244|PDB:4XTB}.
FT   STRAND       83     88       {ECO:0000244|PDB:4XTB}.
FT   STRAND       91     93       {ECO:0000244|PDB:5KUI}.
FT   STRAND       97    100       {ECO:0000244|PDB:4XTB}.
FT   TURN        103    105       {ECO:0000244|PDB:4XTB}.
FT   HELIX       108    118       {ECO:0000244|PDB:4XTB}.
FT   STRAND      125    128       {ECO:0000244|PDB:4XTB}.
FT   STRAND      137    140       {ECO:0000244|PDB:5KUI}.
FT   HELIX       141    144       {ECO:0000244|PDB:4XTB}.
FT   STRAND      149    153       {ECO:0000244|PDB:4XTB}.
FT   STRAND      156    160       {ECO:0000244|PDB:4XTB}.
FT   HELIX       168    172       {ECO:0000244|PDB:4XTB}.
SQ   SEQUENCE   351 AA;  39867 MW;  50205D01055D66E4 CRC64;
     MAAAAGRSLL LLLSSRGGGG GGAGGCGALT AGCFPGLGVS RHRQQQHHRT VHQRIASWQN
     LGAVYCSTVV PSDDVTVVYQ NGLPVISVRL PSRRERCQFT LKPISDSVGV FLRQLQEEDR
     GIDRVAIYSP DGVRVAASTG IDLLLLDDFK LVINDLTYHV RPPKRDLLSH ENAATLNDVK
     TLVQQLYTTL CIEQHQLNKE RELIERLEDL KEQLAPLEKV RIEISRKAEK RTTLVLWGGL
     AYMATQFGIL ARLTWWEYSW DIMEPVTYFI TYGSAMAMYA YFVMTRQEYV YPEARDRQYL
     LFFHKGAKKS RFDLEKYNQL KDAIAQAEMD LKRLRDPLQV HLPLRQIGEK D
//
ID   CTSR1_HUMAN             Reviewed;         780 AA.
AC   Q8NEC5; Q96P76;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   22-NOV-2017, entry version 132.
DE   RecName: Full=Cation channel sperm-associated protein 1;
DE            Short=CatSper1;
DE            Short=hCatSper;
GN   Name=CATSPER1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT ILE-652.
RX   PubMed=11595941; DOI=10.1038/35098027;
RA   Ren D., Navarro B., Perez G., Jackson A.C., Hsu S., Shi Q.,
RA   Tilly J.L., Clapham D.E.;
RT   "A sperm ion channel required for sperm motility and male fertility.";
RL   Nature 413:603-609(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-652.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INDUCTION.
RX   PubMed=14688170; DOI=10.1093/humrep/deh043;
RA   Nikpoor P., Mowla S.J., Movahedin M., Ziaee S.A.-M., Tiraihi T.;
RT   "CatSper gene expression in postnatal development of mouse testis and
RT   in subfertile men with deficient sperm motility.";
RL   Hum. Reprod. 19:124-128(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16625279; DOI=10.1111/j.1745-7262.2006.00132.x;
RA   Li H.-G., Liao A.-H., Ding X.-F., Zhou H., Xiong C.-L.;
RT   "The expression and significance of CATSPER1 in human testis and
RT   ejaculated spermatozoa.";
RL   Asian J. Androl. 8:301-306(2006).
RN   [6]
RP   INTERACTION WITH CACNA1I.
RX   PubMed=16740636; DOI=10.1074/jbc.M511288200;
RA   Zhang D., Chen J., Saraf A., Cassar S., Han P., Rogers J.C.,
RA   Brioni J.D., Sullivan J.P., Gopalakrishnan M.;
RT   "Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of
RT   T-type calcium channel activity.";
RL   J. Biol. Chem. 281:22332-22341(2006).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [8]
RP   INVOLVEMENT IN SPGF7.
RX   PubMed=19344877; DOI=10.1016/j.ajhg.2009.03.004;
RA   Avenarius M.R., Hildebrand M.S., Zhang Y., Meyer N.C., Smith L.L.H.,
RA   Kahrizi K., Najmabadi H., Smith R.J.H.;
RT   "Human male infertility caused by mutations in the CATSPER1 channel
RT   protein.";
RL   Am. J. Hum. Genet. 84:505-510(2009).
RN   [9]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412338; DOI=10.1038/nature09769;
RA   Strunker T., Goodwin N., Brenker C., Kashikar N.D., Weyand I.,
RA   Seifert R., Kaupp U.B.;
RT   "The CatSper channel mediates progesterone-induced Ca2+ influx in
RT   human sperm.";
RL   Nature 471:382-386(2011).
RN   [10]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=26989199; DOI=10.1126/science.aad6887;
RA   Miller M.R., Mannowetz N., Iavarone A.T., Safavi R., Gracheva E.O.,
RA   Smith J.F., Hill R.Z., Bautista D.M., Kirichok Y., Lishko P.V.;
RT   "Unconventional endocannabinoid signaling governs sperm activation via
RT   sex hormone progesterone.";
RL   Science 352:555-559(2016).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in calcium-dependent physiological responses essential for
CC       successful fertilization, such as sperm hyperactivation, acrosome
CC       reaction and chemotaxis towards the oocyte.
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339}.
CC   -!- ENZYME REGULATION: The CatSper calcium channel is indirectly
CC       activated by extracellular progesterone and prostaglandins
CC       following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 >
CC       PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199).
CC       The CatSper calcium channel is directly inhibited by
CC       endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199).
CC       Indirect activation by progesterone takes place via the following
CC       mechanism: progesterone binds and activates the acylglycerol
CC       lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor,
CC       relieving inhibition of the CatSper channel (PubMed:26989199). The
CC       primary effect of progesterone activation is to shift voltage
CC       dependence towards more physiological, negative membrane
CC       potentials; it is not mediated by metabotropic receptors and
CC       second messengers (PubMed:21412338, PubMed:21412339). Sperm
CC       capacitation enhances the effect of progesterone by providing
CC       additional negative shift. Also activated by the elevation of
CC       intracellular pH (PubMed:21412338, PubMed:21412339).
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339,
CC       ECO:0000269|PubMed:26989199}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Component of the CatSper
CC       complex. Interacts with CATSPER3 and CATSPER4 (By similarity).
CC       Interacts with Ca(v)3.3/CACNA1I, leading to suppress T-type
CC       calcium channel activity. {ECO:0000250,
CC       ECO:0000269|PubMed:16740636, ECO:0000305}.
CC   -!- INTERACTION:
CC       O95994:AGR2; NbExp=3; IntAct=EBI-744545, EBI-712648;
CC       P02652:APOA2; NbExp=5; IntAct=EBI-744545, EBI-1171525;
CC       Q9P0X4:CACNA1I; NbExp=5; IntAct=EBI-744545, EBI-1220829;
CC       Q9UKJ5:CHIC2; NbExp=3; IntAct=EBI-744545, EBI-741528;
CC       Q9H2X0:CHRD; NbExp=3; IntAct=EBI-744545, EBI-947551;
CC       P50402:EMD; NbExp=8; IntAct=EBI-744545, EBI-489887;
CC       P08151:GLI1; NbExp=4; IntAct=EBI-744545, EBI-308084;
CC       Q5VWX1:KHDRBS2; NbExp=5; IntAct=EBI-744545, EBI-742808;
CC       Q5T749:KPRP; NbExp=4; IntAct=EBI-744545, EBI-10981970;
CC       P60412:KRTAP10-11; NbExp=5; IntAct=EBI-744545, EBI-10217483;
CC       P60410:KRTAP10-8; NbExp=9; IntAct=EBI-744545, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=9; IntAct=EBI-744545, EBI-10172052;
CC       P60328:KRTAP12-3; NbExp=4; IntAct=EBI-744545, EBI-11953334;
CC       Q9BYQ6:KRTAP4-11; NbExp=5; IntAct=EBI-744545, EBI-10302392;
CC       Q9BQ66:KRTAP4-12; NbExp=10; IntAct=EBI-744545, EBI-739863;
CC       Q9BYR0:KRTAP4-7; NbExp=3; IntAct=EBI-744545, EBI-10302547;
CC       Q6L8H2:KRTAP5-3; NbExp=4; IntAct=EBI-744545, EBI-11974251;
CC       Q6L8G9:KRTAP5-6; NbExp=5; IntAct=EBI-744545, EBI-10250562;
CC       P26371:KRTAP5-9; NbExp=7; IntAct=EBI-744545, EBI-3958099;
CC       Q9BYQ4:KRTAP9-2; NbExp=9; IntAct=EBI-744545, EBI-1044640;
CC       Q9BYQ3:KRTAP9-3; NbExp=4; IntAct=EBI-744545, EBI-1043191;
CC       Q9BYQ2:KRTAP9-4; NbExp=3; IntAct=EBI-744545, EBI-10185730;
CC       Q5T752:LCE1D; NbExp=4; IntAct=EBI-744545, EBI-11741311;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-744545, EBI-724076;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-744545, EBI-742948;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-744545, EBI-945833;
CC       O15162:PLSCR1; NbExp=3; IntAct=EBI-744545, EBI-740019;
CC       Q9NRY6:PLSCR3; NbExp=5; IntAct=EBI-744545, EBI-750734;
CC       Q8HWS3:RFX6; NbExp=5; IntAct=EBI-744545, EBI-746118;
CC       O76081:RGS20; NbExp=4; IntAct=EBI-744545, EBI-1052678;
CC       Q9UFD9:RIMBP3; NbExp=3; IntAct=EBI-744545, EBI-10182375;
CC       O75711:SCRG1; NbExp=3; IntAct=EBI-744545, EBI-10189029;
CC       O60504:SORBS3; NbExp=4; IntAct=EBI-744545, EBI-741237;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-744545, EBI-742487;
CC       Q12933:TRAF2; NbExp=3; IntAct=EBI-744545, EBI-355744;
CC       Q15654:TRIP6; NbExp=6; IntAct=EBI-744545, EBI-742327;
CC       O14817:TSPAN4; NbExp=4; IntAct=EBI-744545, EBI-8652667;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000269|PubMed:16625279}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:16625279}. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:11595941,
CC       ECO:0000269|PubMed:16625279, ECO:0000269|PubMed:17347248}.
CC   -!- DEVELOPMENTAL STAGE: Expressed meiotically and post-meiotically.
CC       {ECO:0000269|PubMed:16625279}.
CC   -!- INDUCTION: Down-regulated in patients lacking sperm motility.
CC       {ECO:0000269|PubMed:14688170}.
CC   -!- DISEASE: Spermatogenic failure 7 (SPGF7) [MIM:612997]: An
CC       infertility disorder characterized by non-motile sperm or sperm
CC       motility below the normal threshold, low sperm count, increased
CC       abnormally structured spermatozoa, and reduced semen volume.
CC       {ECO:0000269|PubMed:19344877}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF407333; AAL14105.1; -; mRNA.
DR   EMBL; AP006287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032950; AAH32950.1; -; mRNA.
DR   EMBL; BC036522; AAH36522.1; -; mRNA.
DR   CCDS; CCDS8127.1; -.
DR   RefSeq; NP_444282.3; NM_053054.3.
DR   UniGene; Hs.189105; -.
DR   ProteinModelPortal; Q8NEC5; -.
DR   BioGrid; 125556; 35.
DR   IntAct; Q8NEC5; 103.
DR   MINT; MINT-1453027; -.
DR   STRING; 9606.ENSP00000309052; -.
DR   GuidetoPHARMACOLOGY; 388; -.
DR   TCDB; 1.A.1.19.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q8NEC5; -.
DR   PhosphoSitePlus; Q8NEC5; -.
DR   BioMuta; CATSPER1; -.
DR   DMDM; 296439381; -.
DR   PaxDb; Q8NEC5; -.
DR   PeptideAtlas; Q8NEC5; -.
DR   PRIDE; Q8NEC5; -.
DR   Ensembl; ENST00000312106; ENSP00000309052; ENSG00000175294.
DR   GeneID; 117144; -.
DR   KEGG; hsa:117144; -.
DR   UCSC; uc001ogt.3; human.
DR   CTD; 117144; -.
DR   DisGeNET; 117144; -.
DR   EuPathDB; HostDB:ENSG00000175294.5; -.
DR   GeneCards; CATSPER1; -.
DR   GeneReviews; CATSPER1; -.
DR   H-InvDB; HIX0201680; -.
DR   HGNC; HGNC:17116; CATSPER1.
DR   MalaCards; CATSPER1; -.
DR   MIM; 606389; gene.
DR   MIM; 612997; phenotype.
DR   neXtProt; NX_Q8NEC5; -.
DR   OpenTargets; ENSG00000175294; -.
DR   Orphanet; 276234; Non-syndromic male infertility due to sperm motility disorder.
DR   PharmGKB; PA38438; -.
DR   eggNOG; KOG2302; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000112051; -.
DR   HOVERGEN; HBG098336; -.
DR   InParanoid; Q8NEC5; -.
DR   KO; K16889; -.
DR   OMA; VCLNTIM; -.
DR   OrthoDB; EOG091G0KAS; -.
DR   PhylomeDB; Q8NEC5; -.
DR   TreeFam; TF329330; -.
DR   Reactome; R-HSA-1300642; Sperm Motility And Taxes.
DR   GeneWiki; CatSper1; -.
DR   GenomeRNAi; 117144; -.
DR   PRO; PR:Q8NEC5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000175294; -.
DR   CleanEx; HS_CATSPER1; -.
DR   Genevisible; Q8NEC5; HS.
DR   GO; GO:0036128; C:CatSper complex; ISS:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0030317; P:flagellated sperm motility; IEA:Ensembl.
DR   GO; GO:0007342; P:fusion of sperm to egg plasma membrane involved in single fertilization; IEA:Ensembl.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; TAS:Reactome.
DR   GO; GO:0035036; P:sperm-egg recognition; TAS:Reactome.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR028746; CatSper1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF216; PTHR10037:SF216; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Developmental protein;
KW   Differentiation; Flagellum; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Reference proteome; Spermatogenesis; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    780       Cation channel sperm-associated protein
FT                                1.
FT                                /FTId=PRO_0000295674.
FT   TOPO_DOM      1    445       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    446    466       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    467    485       Extracellular. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    507    515       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    516    536       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    537    541       Extracellular. {ECO:0000255}.
FT   TRANSMEM    542    562       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    563    579       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    580    600       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    601    615       Extracellular. {ECO:0000255}.
FT   INTRAMEM    616    636       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    637    646       Extracellular. {ECO:0000255}.
FT   TRANSMEM    647    667       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    668    780       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     26    315       His-rich.
FT   VARIANT     133    133       G -> S (in dbSNP:rs1203998).
FT                                /FTId=VAR_033304.
FT   VARIANT     652    652       V -> I (in dbSNP:rs3814747).
FT                                {ECO:0000269|PubMed:11595941,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_033305.
FT   VARIANT     730    730       T -> P (in dbSNP:rs34958219).
FT                                /FTId=VAR_033306.
FT   CONFLICT     88     88       G -> V (in Ref. 2; AAH32950).
FT                                {ECO:0000305}.
SQ   SEQUENCE   780 AA;  90091 MW;  E09C4339F8AF5044 CRC64;
     MDQNSVPEKA QNEADTNNAD RFFRSHSSPP HHRPGHSRAL HHYELHHHGV PHQRGESHHP
     PEFQDFHDQA LSSHVHQSHH HSEARNHGRA HGPTGFGLAP SQGAVPSHRS YGEDYHDELQ
     RDGRRHHDGS QYGGFHQQSD SHYHRGSHHG RPQYLGENLS HYSSGVPHHG EASHHGGSYL
     PHGPNPYSES FHHSEASHLS GLQHDESQHH QVPHRGWPHH HQVHHHGRSR HHEAHQHGKS
     PHHGETISPH SSVGSYQRGI SDYHSEYHQG DHHPSEYHHG DHPHHTQHHY HQTHRHRDYH
     QHQDHHGAYH SSYLHGDYVQ STSQLSIPHT SRSLIHDAPG PAASRTGVFP YHVAHPRGSA
     HSMTRSSSTI RSRVTQMSKK VHTQDISTKH SEDWGKEEGQ FQKRKTGRLQ RTRKKGHSTN
     LFQWLWEKLT FLIQGFREMI RNLTQSLAFE TFIFFVVCLN TVMLVAQTFA EVEIRGEWYF
     MALDSIFFCI YVVEALLKII ALGLSYFFDF WNNLDFFIMA MAVLDFLLMQ THSFAIYHQS
     LFRILKVFKS LRALRAIRVL RRLSFLTSVQ EVTGTLGQSL PSIAAILILM FTCLFLFSAV
     LRALFRKSDP KRFQNIFTTI FTLFTLLTLD DWSLIYMDSR AQGAWYIIPI LVIYIIIQYF
     IFLNLVITVL VDSFQTALFK GLEKAKQERA ARIQEKLLED SLTELRAAEP KEVASEGTML
     KRLIEKKFGT MTEKQQELLF HYLQLVASVE QEQQKFRSQA AVIDEIVDTT FEAGEEDFRN
//
ID   TRPV3_HUMAN             Reviewed;         790 AA.
AC   Q8NET8; Q8NDW7; Q8NET9; Q8NFH2;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   22-NOV-2017, entry version 127.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 3;
DE            Short=TrpV3;
DE   AltName: Full=Vanilloid receptor-like 3;
DE            Short=VRL-3;
GN   Name=TRPV3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   INTERACTION WITH TRPV1, AND VARIANTS VAL-25 AND GLY-117.
RX   PubMed=12077606; DOI=10.1038/nature00894;
RA   Smith G.D., Gunthorpe M.J., Kelsell R.E., Hayes P.D., Reilly P.,
RA   Facer P., Wright J.E., Jerman J.C., Walhin J.-P., Ooi L., Egerton J.,
RA   Charles K.J., Smart D., Randall A.D., Anand P., Davis J.B.;
RT   "TRPV3 is a temperature-sensitive vanilloid receptor-like protein.";
RL   Nature 418:186-190(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12077604; DOI=10.1038/nature00882;
RA   Xu H., Ramsey I.S., Kotecha S.A., Moran M.M., Chong J.A., Lawson D.,
RA   Ge P., Lilly J., Silos-Santiago I., Xie Y., DiStefano P.S., Curtis R.,
RA   Clapham D.E.;
RT   "TRPV3 is a calcium-permeable temperature-sensitive cation channel.";
RL   Nature 418:181-186(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RA   Poea-Guyon S., Renard S., Chalon P., Kaghad M., Caput D., Besnard F.;
RT   "Human TRPV3, a new member of the vanilloid receptor family.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION AS NEGATIVE REGULATOR OF HAIR GROWTH, AND TISSUE SPECIFICITY.
RX   PubMed=21593771; DOI=10.1038/jid.2011.122;
RA   Borbiro I., Lisztes E., Toth B.I., Czifra G., Olah A., Szollosi A.G.,
RA   Szentandrassy N., Nanasi P.P., Peter Z., Paus R., Kovacs L., Biro T.;
RT   "Activation of transient receptor potential vanilloid-3 inhibits human
RT   hair growth.";
RL   J. Invest. Dermatol. 131:1605-1614(2011).
RN   [5]
RP   INVOLVEMENT IN FNEPPK2, VARIANT FNEPPK2 PRO-580, AND CHARACTERIZATION
RP   OF VARIANT FNEPPK2 PRO-580.
RX   PubMed=25285920; DOI=10.1038/jid.2014.429;
RA   He Y., Zeng K., Zhang X., Chen Q., Wu J., Li H., Zhou Y., Glusman G.,
RA   Roach J., Etheridge A., Qing S., Tian Q., Lee I., Tian X., Wang X.,
RA   Wu Z., Hood L., Ding Y., Wang K.;
RT   "A gain-of-function mutation in TRPV3 causes focal palmoplantar
RT   keratoderma in a Chinese family.";
RL   J. Invest. Dermatol. 135:907-909(2015).
RN   [6]
RP   VARIANTS OLMS SER-573; CYS-573 AND GLY-692, AND CHARACTERIZATION OF
RP   VARIANTS OLMS SER-573; CYS-573 AND GLY-692.
RX   PubMed=22405088; DOI=10.1016/j.ajhg.2012.02.006;
RA   Lin Z., Chen Q., Lee M., Cao X., Zhang J., Ma D., Chen L., Hu X.,
RA   Wang H., Wang X., Zhang P., Liu X., Guan L., Tang Y., Yang H., Tu P.,
RA   Bu D., Zhu X., Wang K., Li R., Yang Y.;
RT   "Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted
RT   syndrome.";
RL   Am. J. Hum. Genet. 90:558-564(2012).
RN   [7]
RP   VARIANT OLMS SER-573.
RX   PubMed=22835024; DOI=10.1111/j.1365-2133.2012.11115.x;
RA   Lai-Cheong J.E., Sethuraman G., Ramam M., Stone K., Simpson M.A.,
RA   McGrath J.A.;
RT   "Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3
RT   gene in an Indian boy with sporadic Olmsted syndrome.";
RL   Br. J. Dermatol. 167:440-442(2012).
CC   -!- FUNCTION: Putative receptor-activated non-selective calcium
CC       permeant cation channel. It is activated by innocuous (warm)
CC       temperatures and shows an increased response at noxious
CC       temperatures greater than 39 degrees Celsius. Activation exhibits
CC       an outward rectification. May associate with TRPV1 and may
CC       modulate its activity. Is a negative regulator of hair growth and
CC       cycling: TRPV3-coupled signaling suppresses keratinocyte
CC       proliferation in hair follicles and induces apoptosis and
CC       premature hair follicle regression (catagen).
CC       {ECO:0000269|PubMed:12077604, ECO:0000269|PubMed:12077606,
CC       ECO:0000269|PubMed:21593771}.
CC   -!- SUBUNIT: May form a heteromeric channel with TRPV1. Interacts with
CC       TRPV1. {ECO:0000269|PubMed:12077606}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NET8-1; Sequence=Displayed;
CC       Name=2; Synonyms=A;
CC         IsoId=Q8NET8-2; Sequence=VSP_013433;
CC       Name=3; Synonyms=B;
CC         IsoId=Q8NET8-3; Sequence=VSP_013434, VSP_013435;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in CNS. Widely expressed
CC       at low levels. Detected in dorsal root ganglion (at protein
CC       level). Expressed in the keratinocyte layers of the outer root
CC       sheath and, to lesser extent, to the matrix of the hair follicles
CC       (at protein level). {ECO:0000269|PubMed:12077604,
CC       ECO:0000269|PubMed:12077606, ECO:0000269|PubMed:21593771}.
CC   -!- DISEASE: Olmsted syndrome (OLMS) [MIM:614594]: A rare congenital
CC       disorder characterized by bilateral mutilating palmoplantar
CC       keratoderma and periorificial keratotic plaques with severe
CC       itching at all lesions. Diffuse alopecia, constriction of digits,
CC       and onychodystrophy have also been reported. Infections and
CC       squamous cell carcinomas can arise on the keratotic areas. The
CC       digital constriction may progress to autoamputation of fingers and
CC       toes. {ECO:0000269|PubMed:22405088, ECO:0000269|PubMed:22835024}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Palmoplantar keratoderma, non-epidermolytic, focal 2
CC       (FNEPPK2) [MIM:616400]: A dermatological disorder characterized by
CC       non-epidermolytic, abnormal thickening of the skin on the palms
CC       and soles. Focal palmoplantar keratoderma consists of localized
CC       areas of hyperkeratosis located mainly on pressure points and
CC       sites of recurrent friction. {ECO:0000269|PubMed:25285920}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Transient receptor potential cation channel,
CC       subfamily V, member 3 (TRPV3); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/TRPV3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ487035; CAD31711.2; -; mRNA.
DR   EMBL; AF514998; AAM54027.1; -; mRNA.
DR   EMBL; AY118267; AAM80558.1; -; mRNA.
DR   EMBL; AY118268; AAM80559.1; -; mRNA.
DR   CCDS; CCDS11029.1; -. [Q8NET8-1]
DR   CCDS; CCDS58500.1; -. [Q8NET8-2]
DR   RefSeq; NP_659505.1; NM_145068.3. [Q8NET8-1]
DR   UniGene; Hs.446255; -.
DR   ProteinModelPortal; Q8NET8; -.
DR   SMR; Q8NET8; -.
DR   BioGrid; 127821; 4.
DR   STRING; 9606.ENSP00000461518; -.
DR   BindingDB; Q8NET8; -.
DR   ChEMBL; CHEMBL5522; -.
DR   DrugBank; DB00825; Menthol.
DR   GuidetoPHARMACOLOGY; 509; -.
DR   TCDB; 1.A.4.2.9; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q8NET8; -.
DR   PhosphoSitePlus; Q8NET8; -.
DR   BioMuta; TRPV3; -.
DR   DMDM; 62901456; -.
DR   PaxDb; Q8NET8; -.
DR   PeptideAtlas; Q8NET8; -.
DR   PRIDE; Q8NET8; -.
DR   Ensembl; ENST00000301365; ENSP00000301365; ENSG00000167723. [Q8NET8-2]
DR   Ensembl; ENST00000572519; ENSP00000460215; ENSG00000167723. [Q8NET8-3]
DR   Ensembl; ENST00000576742; ENSP00000461518; ENSG00000167723. [Q8NET8-1]
DR   GeneID; 162514; -.
DR   KEGG; hsa:162514; -.
DR   UCSC; uc002fvr.4; human. [Q8NET8-1]
DR   CTD; 162514; -.
DR   DisGeNET; 162514; -.
DR   EuPathDB; HostDB:ENSG00000167723.14; -.
DR   GeneCards; TRPV3; -.
DR   H-InvDB; HIX0013427; -.
DR   HGNC; HGNC:18084; TRPV3.
DR   HPA; HPA069550; -.
DR   MalaCards; TRPV3; -.
DR   MIM; 607066; gene.
DR   MIM; 614594; phenotype.
DR   MIM; 616400; phenotype.
DR   neXtProt; NX_Q8NET8; -.
DR   OpenTargets; ENSG00000167723; -.
DR   Orphanet; 659; Mutilating palmoplantar keratoderma with periorificial keratotic plaques.
DR   PharmGKB; PA38481; -.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   GeneTree; ENSGT00550000074425; -.
DR   HOGENOM; HOG000234630; -.
DR   HOVERGEN; HBG054085; -.
DR   InParanoid; Q8NET8; -.
DR   KO; K04972; -.
DR   OMA; KHEGFYF; -.
DR   OrthoDB; EOG091G020O; -.
DR   PhylomeDB; Q8NET8; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   GeneWiki; TRPV3; -.
DR   GenomeRNAi; 162514; -.
DR   PRO; PR:Q8NET8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000167723; -.
DR   CleanEx; HS_TRPV3; -.
DR   ExpressionAtlas; Q8NET8; baseline and differential.
DR   Genevisible; Q8NET8; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005262; F:calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0042636; P:negative regulation of hair cycle; IMP:UniProtKB.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IEA:Ensembl.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008347; TRPV1-4_channel.
DR   InterPro; IPR024866; TRPV3_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF6; PTHR10582:SF6; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Disease mutation; Ion channel;
KW   Ion transport; Membrane; Palmoplantar keratoderma; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    790       Transient receptor potential cation
FT                                channel subfamily V member 3.
FT                                /FTId=PRO_0000215345.
FT   TOPO_DOM      1    439       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    440    460       Helical. {ECO:0000255}.
FT   TOPO_DOM    461    487       Extracellular. {ECO:0000255}.
FT   TRANSMEM    488    508       Helical. {ECO:0000255}.
FT   TOPO_DOM    509    523       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    524    544       Helical. {ECO:0000255}.
FT   TOPO_DOM    545    545       Extracellular. {ECO:0000255}.
FT   TRANSMEM    546    566       Helical. {ECO:0000255}.
FT   TOPO_DOM    567    589       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    590    610       Helical. {ECO:0000255}.
FT   INTRAMEM    621    637       Pore-forming. {ECO:0000255}.
FT   TRANSMEM    650    670       Helical. {ECO:0000255}.
FT   TOPO_DOM    671    790       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      214    243       ANK 1.
FT   REPEAT      261    291       ANK 2.
FT   REPEAT      340    369       ANK 3.
FT   VAR_SEQ     759    759       T -> TA (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_013433.
FT   VAR_SEQ     760    765       DFNKIQ -> GTVAVR (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_013434.
FT   VAR_SEQ     766    790       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_013435.
FT   VARIANT      25     25       I -> V (in dbSNP:rs322965).
FT                                {ECO:0000269|PubMed:12077606}.
FT                                /FTId=VAR_052388.
FT   VARIANT     117    117       R -> G (in dbSNP:rs322937).
FT                                {ECO:0000269|PubMed:12077606}.
FT                                /FTId=VAR_052389.
FT   VARIANT     573    573       G -> C (in OLMS; gain of function
FT                                mutation; results in constitutive channel
FT                                activation; dbSNP:rs199473704).
FT                                {ECO:0000269|PubMed:22405088}.
FT                                /FTId=VAR_067920.
FT   VARIANT     573    573       G -> S (in OLMS; gain of function
FT                                mutation; results in constitutive channel
FT                                activation; dbSNP:rs199473704).
FT                                {ECO:0000269|PubMed:22405088,
FT                                ECO:0000269|PubMed:22835024}.
FT                                /FTId=VAR_067921.
FT   VARIANT     580    580       Q -> P (in FNEPPK2; gain of function
FT                                mutation; dbSNP:rs786205869).
FT                                {ECO:0000269|PubMed:25285920}.
FT                                /FTId=VAR_073832.
FT   VARIANT     692    692       W -> G (in OLMS; gain of function
FT                                mutation; results in constitutive channel
FT                                activation; dbSNP:rs199473705).
FT                                {ECO:0000269|PubMed:22405088}.
FT                                /FTId=VAR_067922.
FT   VARIANT     774    774       T -> I (in dbSNP:rs7212634).
FT                                /FTId=VAR_052390.
FT   CONFLICT    283    283       E -> G (in Ref. 3; AAM80558/AAM80559).
FT                                {ECO:0000305}.
SQ   SEQUENCE   790 AA;  90636 MW;  31EB9973C015B611 CRC64;
     MKAHPKEMVP LMGKRVAAPS GNPAILPEKR PAEITPTKKS AHFFLEIEGF EPNPTVAKTS
     PPVFSKPMDS NIRQCISGNC DDMDSPQSPQ DDVTETPSNP NSPSAQLAKE EQRRKKRRLK
     KRIFAAVSEG CVEELVELLV ELQELCRRRH DEDVPDFLMH KLTASDTGKT CLMKALLNIN
     PNTKEIVRIL LAFAEENDIL GRFINAEYTE EAYEGQTALN IAIERRQGDI AALLIAAGAD
     VNAHAKGAFF NPKYQHEGFY FGETPLALAA CTNQPEIVQL LMEHEQTDIT SRDSRGNNIL
     HALVTVAEDF KTQNDFVKRM YDMILLRSGN WELETTRNND GLTPLQLAAK MGKAEILKYI
     LSREIKEKRL RSLSRKFTDW AYGPVSSSLY DLTNVDTTTD NSVLEITVYN TNIDNRHEML
     TLEPLHTLLH MKWKKFAKHM FFLSFCFYFF YNITLTLVSY YRPREEEAIP HPLALTHKMG
     WLQLLGRMFV LIWAMCISVK EGIAIFLLRP SDLQSILSDA WFHFVFFIQA VLVILSVFLY
     LFAYKEYLAC LVLAMALGWA NMLYYTRGFQ SMGMYSVMIQ KVILHDVLKF LFVYIVFLLG
     FGVALASLIE KCPKDNKDCS SYGSFSDAVL ELFKLTIGLG DLNIQQNSKY PILFLFLLIT
     YVILTFVLLL NMLIALMGET VENVSKESER IWRLQRARTI LEFEKMLPEW LRSRFRMGEL
     CKVAEDDFRL CLRINEVKWT EWKTHVSFLN EDPGPVRRTD FNKIQDSSRN NSKTTLNAFE
     EVEEFPETSV
//
ID   TPC2_HUMAN              Reviewed;         752 AA.
AC   Q8NHX9; Q9NT82;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   25-OCT-2017, entry version 130.
DE   RecName: Full=Two pore calcium channel protein 2;
DE   AltName: Full=Voltage-dependent calcium channel protein TPC2;
GN   Name=TPCN2; Synonyms=TPC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND VARIANTS PRO-564 AND GLU-734.
RX   PubMed=19387438; DOI=10.1038/nature08030;
RA   Calcraft P.J., Ruas M., Pan Z., Cheng X., Arredouani A., Hao X.,
RA   Tang J., Rietdorf K., Teboul L., Chuang K.T., Lin P., Xiao R.,
RA   Wang C., Zhu Y., Lin Y., Wyatt C.N., Parrington J., Ma J., Evans A.M.,
RA   Galione A., Zhu M.X.;
RT   "NAADP mobilizes calcium from acidic organelles through two-pore
RT   channels.";
RL   Nature 459:596-600(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS PRO-564 AND
RP   GLU-734.
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 382-752, AND VARIANTS
RP   PRO-564 AND GLU-734.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19620632; DOI=10.1083/jcb.200904073;
RA   Brailoiu E., Churamani D., Cai X., Schrlau M.G., Brailoiu G.C.,
RA   Gao X., Hooper R., Boulware M.J., Dun N.J., Marchant J.S., Patel S.;
RT   "Essential requirement for two-pore channel 1 in NAADP-mediated
RT   calcium signaling.";
RL   J. Cell Biol. 186:201-209(2009).
RN   [6]
RP   INTERACTION WITH LRRK2.
RX   PubMed=22012985; DOI=10.1093/hmg/ddr481;
RA   Gomez-Suaga P., Luzon-Toro B., Churamani D., Zhang L., Bloor-Young D.,
RA   Patel S., Woodman P.G., Churchill G.C., Hilfiker S.;
RT   "Leucine-rich repeat kinase 2 regulates autophagy through a calcium-
RT   dependent pathway involving NAADP.";
RL   Hum. Mol. Genet. 21:511-525(2012).
RN   [7]
RP   INTERACTION WITH HAX1.
RX   PubMed=24188827; DOI=10.1016/j.febslet.2013.10.031;
RA   Lam A.K., Galione A., Lai F.A., Zissimopoulos S.;
RT   "Hax-1 identified as a two-pore channel (TPC)-binding protein.";
RL   FEBS Lett. 587:3782-3786(2013).
RN   [8]
RP   VARIANTS LEU-484 AND GLU-734, AND ASSOCIATION WITH SHEP10.
RX   PubMed=18488028; DOI=10.1038/ng.160;
RA   Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T.,
RA   Jakobsdottir M., Steinberg S., Gudjonsson S.A., Palsson A.,
RA   Thorleifsson G., Palsson S., Sigurgeirsson B., Thorisdottir K.,
RA   Ragnarsson R., Benediktsdottir K.R., Aben K.K., Vermeulen S.H.,
RA   Goldstein A.M., Tucker M.A., Kiemeney L.A., Olafsson J.H., Gulcher J.,
RA   Kong A., Thorsteinsdottir U., Stefansson K.;
RT   "Two newly identified genetic determinants of pigmentation in
RT   Europeans.";
RL   Nat. Genet. 40:835-837(2008).
CC   -!- FUNCTION: Nicotinic acid adenine dinucleotide phosphate (NAADP)
CC       receptor that may function as one of the major voltage-gated
CC       Ca(2+) channels (VDCC) across the lysosomal membrane. May be
CC       involved in smooth muscle contraction.
CC       {ECO:0000269|PubMed:19387438, ECO:0000269|PubMed:19620632}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with LRRK2
CC       (PubMed:22012985). Interacts with HAX1 (PubMed:24188827).
CC       {ECO:0000250|UniProtKB:Q8BWC0, ECO:0000269|PubMed:22012985,
CC       ECO:0000269|PubMed:24188827}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-5239949, EBI-5239949;
CC       O00165:HAX1; NbExp=4; IntAct=EBI-5239949, EBI-357001;
CC       P42345:MTOR; NbExp=2; IntAct=EBI-5239949, EBI-359260;
CC       Q9ULQ1:TPCN1; NbExp=9; IntAct=EBI-5239949, EBI-5239895;
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Note=Only the acidic lysosomal
CC       fraction is sensitive to NAADP. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at high level in
CC       liver and kidney. {ECO:0000269|PubMed:19387438}.
CC   -!- DOMAIN: Each of the two internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively
CC       charged transmembrane segment (S4). S4 segments probably represent
CC       the voltage-sensor and are characterized by a series of positively
CC       charged amino acids at every third position (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- POLYMORPHISM: Genetic variants in TPCN2 define the skin/hair/eye
CC       pigmentation variation locus 10 (SHEP10) [MIM:612267]. Hair, eye
CC       and skin pigmentation are among the most visible examples of human
CC       phenotypic variation, with a broad normal range that is subject to
CC       substantial geographic stratification. In the case of skin,
CC       individuals tend to have lighter pigmentation with increasing
CC       distance from the equator. By contrast, the majority of variation
CC       in human eye and hair color is found among individuals of European
CC       ancestry, with most other human populations fixed for brown eyes
CC       and black hair. {ECO:0000269|PubMed:18488028}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. Two pore calcium channel subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY029200; AAK31802.1; -; mRNA.
DR   EMBL; AP003071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063008; AAH63008.1; -; mRNA.
DR   EMBL; AL137479; CAB70760.1; -; mRNA.
DR   CCDS; CCDS8189.1; -.
DR   PIR; T46421; T46421.
DR   RefSeq; NP_620714.2; NM_139075.3.
DR   UniGene; Hs.131851; -.
DR   ProteinModelPortal; Q8NHX9; -.
DR   BioGrid; 128596; 59.
DR   IntAct; Q8NHX9; 3.
DR   STRING; 9606.ENSP00000294309; -.
DR   GuidetoPHARMACOLOGY; 393; -.
DR   TCDB; 1.A.1.11.19; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q8NHX9; -.
DR   PhosphoSitePlus; Q8NHX9; -.
DR   BioMuta; TPCN2; -.
DR   DMDM; 125991221; -.
DR   EPD; Q8NHX9; -.
DR   MaxQB; Q8NHX9; -.
DR   PaxDb; Q8NHX9; -.
DR   PeptideAtlas; Q8NHX9; -.
DR   PRIDE; Q8NHX9; -.
DR   Ensembl; ENST00000294309; ENSP00000294309; ENSG00000162341.
DR   GeneID; 219931; -.
DR   KEGG; hsa:219931; -.
DR   UCSC; uc001oos.3; human.
DR   CTD; 219931; -.
DR   DisGeNET; 219931; -.
DR   EuPathDB; HostDB:ENSG00000162341.15; -.
DR   GeneCards; TPCN2; -.
DR   H-InvDB; HIX0019754; -.
DR   HGNC; HGNC:20820; TPCN2.
DR   HPA; HPA016561; -.
DR   HPA; HPA027080; -.
DR   MIM; 612163; gene.
DR   MIM; 612267; phenotype.
DR   neXtProt; NX_Q8NHX9; -.
DR   OpenTargets; ENSG00000162341; -.
DR   PharmGKB; PA134937857; -.
DR   eggNOG; ENOG410INF1; Eukaryota.
DR   eggNOG; ENOG4111V21; LUCA.
DR   GeneTree; ENSGT00530000063660; -.
DR   HOGENOM; HOG000154668; -.
DR   HOVERGEN; HBG079776; -.
DR   InParanoid; Q8NHX9; -.
DR   KO; K14077; -.
DR   OMA; SSVIWVN; -.
DR   OrthoDB; EOG091G045K; -.
DR   PhylomeDB; Q8NHX9; -.
DR   TreeFam; TF328550; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; TPCN2; human.
DR   GeneWiki; TPCN2; -.
DR   GenomeRNAi; 219931; -.
DR   PRO; PR:Q8NHX9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162341; -.
DR   CleanEx; HS_TPCN2; -.
DR   ExpressionAtlas; Q8NHX9; baseline and differential.
DR   Genevisible; Q8NHX9; HS.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007040; P:lysosome organization; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0010506; P:regulation of autophagy; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0033280; P:response to vitamin D; IEA:Ensembl.
DR   GO; GO:0006939; P:smooth muscle contraction; ISS:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028798; TPC2.
DR   PANTHER; PTHR10037:SF92; PTHR10037:SF92; 1.
DR   Pfam; PF00520; Ion_trans; 2.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Lysosome; Membrane;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    752       Two pore calcium channel protein 2.
FT                                /FTId=PRO_0000276856.
FT   TOPO_DOM      1     84       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     85    105       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    106    127       Extracellular. {ECO:0000255}.
FT   TRANSMEM    128    148       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    149    155       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    177    183       Extracellular. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    205    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    240    254       Extracellular. {ECO:0000255}.
FT   INTRAMEM    255    279       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    280    289       Extracellular. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    311    436       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    437    459       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    460    465       Extracellular. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    487    502       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    503    523       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    524    554       Extracellular. {ECO:0000255}.
FT   TRANSMEM    555    575       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    576    580       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    581    601       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    602    635       Extracellular. {ECO:0000255}.
FT   INTRAMEM    636    658       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    659    673       Extracellular. {ECO:0000255}.
FT   TRANSMEM    674    694       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    695    752       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     17     20       Poly-Gly.
FT   CARBOHYD    611    611       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    618    618       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     376    376       K -> R (in dbSNP:rs3750965).
FT                                /FTId=VAR_030492.
FT   VARIANT     484    484       M -> L (associated with SHEP10;
FT                                dbSNP:rs35264875).
FT                                {ECO:0000269|PubMed:18488028}.
FT                                /FTId=VAR_047956.
FT   VARIANT     564    564       L -> P (in dbSNP:rs2376558).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:19387438}.
FT                                /FTId=VAR_030493.
FT   VARIANT     734    734       G -> E (associated with SHEP10;
FT                                dbSNP:rs3829241).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:18488028,
FT                                ECO:0000269|PubMed:19387438}.
FT                                /FTId=VAR_030494.
SQ   SEQUENCE   752 AA;  85243 MW;  8A0794952A46C67E CRC64;
     MAEPQAESEP LLGGARGGGG DWPAGLTTYR SIQVGPGAAA RWDLCIDQAV VFIEDAIQYR
     SINHRVDASS MWLYRRYYSN VCQRTLSFTI FLILFLAFIE TPSSLTSTAD VRYRAAPWEP
     PCGLTESVEV LCLLVFAADL SVKGYLFGWA HFQKNLWLLG YLVVLVVSLV DWTVSLSLVC
     HEPLRIRRLL RPFFLLQNSS MMKKTLKCIR WSLPEMASVG LLLAIHLCLF TMFGMLLFAG
     GKQDDGQDRE RLTYFQNLPE SLTSLLVLLT TANNPDVMIP AYSKNRAYAI FFIVFTVIGS
     LFLMNLLTAI IYSQFRGYLM KSLQTSLFRR RLGTRAAFEV LSSMVGEGGA FPQAVGVKPQ
     NLLQVLQKVQ LDSSHKQAMM EKVRSYGSVL LSAEEFQKLF NELDRSVVKE HPPRPEYQSP
     FLQSAQFLFG HYYFDYLGNL IALANLVSIC VFLVLDADVL PAERDDFILG ILNCVFIVYY
     LLEMLLKVFA LGLRGYLSYP SNVFDGLLTV VLLVLEISTL AVYRLPHPGW RPEMVGLLSL
     WDMTRMLNML IVFRFLRIIP SMKLMAVVAS TVLGLVQNMR AFGGILVVVY YVFAIIGINL
     FRGVIVALPG NSSLAPANGS APCGSFEQLE YWANNFDDFA AALVTLWNLM VVNNWQVFLD
     AYRRYSGPWS KIYFVLWWLV SSVIWVNLFL ALILENFLHK WDPRSHLQPL AGTPEATYQM
     TVELLFRDIL EEPGEDELTE RLSQHPHLWL CR
//
ID   PK1L1_MOUSE             Reviewed;        2615 AA.
AC   Q8R526; F6VYK1; J3QMZ2;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   19-FEB-2014, sequence version 2.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Polycystic kidney disease protein 1-like 1;
DE   AltName: Full=PC1-like 1 protein;
DE   AltName: Full=Polycystin-1L1;
DE   AltName: Full=Protein rikishi;
GN   Name=Pkd1l1; Synonyms=Rks;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1504-2034.
RC   TISSUE=Testis;
RX   PubMed=11863367; DOI=10.1006/geno.2002.6719;
RA   Yuasa T., Venugopal B., Weremowicz S., Morton C.C., Guo L., Zhou J.;
RT   "The sequence, expression, and chromosomal localization of a novel
RT   polycystic kidney disease 1-like gene, PKD1L1, in human.";
RL   Genomics 79:376-386(2002).
RN   [3]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=20080492; DOI=10.1177/0300985809353553;
RA   Vogel P., Read R., Hansen G.M., Freay L.C., Zambrowicz B.P.,
RA   Sands A.T.;
RT   "Situs inversus in Dpcd/Poll-/-, Nme7-/-, and Pkd1l1-/- mice.";
RL   Vet. Pathol. 47:120-131(2010).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PKD2, MUTAGENESIS OF
RP   ASP-411, AND TISSUE SPECIFICITY.
RX   PubMed=21307093; DOI=10.1242/dev.058149;
RA   Field S., Riley K.L., Grimes D.T., Hilton H., Simon M.,
RA   Powles-Glover N., Siggers P., Bogani D., Greenfield A., Norris D.P.;
RT   "Pkd1l1 establishes left-right asymmetry and physically interacts with
RT   Pkd2.";
RL   Development 138:1131-1142(2011).
RN   [5]
RP   FUNCTION.
RX   PubMed=24336289; DOI=10.1038/nature12832;
RA   DeCaen P.G., Delling M., Vien T.N., Clapham D.E.;
RT   "Direct recording and molecular identification of the calcium channel
RT   of primary cilia.";
RL   Nature 504:315-318(2013).
CC   -!- FUNCTION: Component of a ciliary calcium channel that controls
CC       calcium concentration within primary cilia without affecting
CC       cytoplasmic calcium concentration. Forms a heterodimer with PKD2L1
CC       in primary cilia and forms a calcium-permeant ciliary channel that
CC       regulates sonic hedgehog/SHH signaling and GLI2 transcription.
CC       Does not constitute the pore-forming subunit. Also involved in
CC       left/right axis specification downstream of nodal flow: forms a
CC       complex with PKD2 in cilia to facilitate flow detection in
CC       left/right patterning. {ECO:0000269|PubMed:21307093,
CC       ECO:0000269|PubMed:24336289}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes with PKD2 proteins to form a
CC       calcium channel. Interacts with PKD2L1; to form ciliary calcium
CC       channel. Interacts with PKD2. {ECO:0000269|PubMed:21307093}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000269|PubMed:21307093}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21307093}.
CC   -!- TISSUE SPECIFICITY: In testis, strong expression in Leydig cells,
CC       low level in seminal ducts, myoid cells and tunica vaginalis.
CC       Other tissues, including adrenal gland and heart myocardium, also
CC       show low expression. In embryo, highly expressed in the node.
CC       {ECO:0000269|PubMed:21307093}.
CC   -!- DISRUPTION PHENOTYPE: Situs inversus in approximately one third of
CC       the homozygous mutant mice. No other notable phenotype (such as
CC       espiratory tract lesions, hydrocephalus, and male infertility) is
CC       observed. {ECO:0000269|PubMed:20080492}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL645571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB061684; BAB85808.1; -; mRNA.
DR   UniGene; Mm.146711; -.
DR   SMR; Q8R526; -.
DR   STRING; 10090.ENSMUSP00000120803; -.
DR   iPTMnet; Q8R526; -.
DR   PhosphoSitePlus; Q8R526; -.
DR   PaxDb; Q8R526; -.
DR   PRIDE; Q8R526; -.
DR   MGI; MGI:2156538; Pkd1l1.
DR   eggNOG; ENOG410IQ5F; Eukaryota.
DR   eggNOG; ENOG410ZBZ7; LUCA.
DR   InParanoid; Q8R526; -.
DR   PRO; PR:Q8R526; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_PKD1L1; -.
DR   GO; GO:0034704; C:calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; IMP:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0097730; C:non-motile cilium; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0003127; P:detection of nodal flow; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:MGI.
DR   GO; GO:0007507; P:heart development; IMP:MGI.
DR   GO; GO:0070986; P:left/right axis specification; IMP:BHF-UCL.
DR   GO; GO:0060972; P:left/right pattern formation; IMP:MGI.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 2.60.60.20; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR022409; PKD/Chitinase_dom.
DR   InterPro; IPR002859; PKD/REJ-like.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR000601; PKD_dom.
DR   InterPro; IPR035986; PKD_dom_sf.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR014010; REJ_dom.
DR   Pfam; PF00801; PKD; 1.
DR   Pfam; PF08016; PKD_channel; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   Pfam; PF02010; REJ; 1.
DR   SMART; SM00308; LH2; 1.
DR   SMART; SM00089; PKD; 2.
DR   SUPFAM; SSF49299; SSF49299; 2.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   PROSITE; PS50093; PKD; 1.
DR   PROSITE; PS50095; PLAT; 1.
DR   PROSITE; PS51111; REJ; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   2615       Polycystic kidney disease protein 1-like
FT                                1.
FT                                /FTId=PRO_0000164359.
FT   TOPO_DOM      1   1524       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1525   1545       Helical. {ECO:0000255}.
FT   TOPO_DOM   1546   1732       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1733   1753       Helical. {ECO:0000255}.
FT   TOPO_DOM   1754   1772       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1773   1793       Helical. {ECO:0000255}.
FT   TOPO_DOM   1794   1905       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1906   1926       Helical. {ECO:0000255}.
FT   TOPO_DOM   1927   1950       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1951   1971       Helical. {ECO:0000255}.
FT   TOPO_DOM   1972   2057       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2058   2078       Helical. {ECO:0000255}.
FT   TOPO_DOM   2079   2288       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2289   2309       Helical. {ECO:0000255}.
FT   TOPO_DOM   2310   2332       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2333   2353       Helical. {ECO:0000255}.
FT   TOPO_DOM   2354   2379       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2380   2400       Helical. {ECO:0000255}.
FT   TOPO_DOM   2401   2405       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2406   2426       Helical. {ECO:0000255}.
FT   TOPO_DOM   2427   2483       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2484   2504       Helical. {ECO:0000255}.
FT   TOPO_DOM   2505   2615       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      291    373       PKD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      375    456       PKD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      457   1349       REJ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00511}.
FT   DOMAIN     1465   1511       GPS.
FT   DOMAIN     1573   1690       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   CARBOHYD    224    224       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    306    306       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    390    390       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    534    534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    619    619       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1458   1458       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1510   1510       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     411    411       D->G: In rks; mice exhibit gross left-
FT                                right abnormalities. Embryos do not show
FT                                defects in kidney development. The nodes
FT                                appear normal.
FT                                {ECO:0000269|PubMed:21307093}.
FT   CONFLICT   1680   1681       KL -> RQ (in Ref. 2; BAB85808).
FT                                {ECO:0000305}.
FT   CONFLICT   1699   1700       WK -> LQ (in Ref. 2; BAB85808).
FT                                {ECO:0000305}.
FT   CONFLICT   1789   1789       L -> F (in Ref. 2; BAB85808).
FT                                {ECO:0000305}.
FT   CONFLICT   1833   1833       Q -> H (in Ref. 2; BAB85808).
FT                                {ECO:0000305}.
FT   CONFLICT   1846   1846       N -> T (in Ref. 2; BAB85808).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2615 AA;  290844 MW;  EBA1538C9D3AB74C CRC64;
     MDVDEDQHAV AVLHHKIQAN PELCVSDEQD SCPSDAPKGT ARDPESQKPS SPAPWDKNVL
     NTGSEERLSF INGEPQAPPN WDEGTNSFSN PPPGISHTCN LSASWYHPES SSPLTQHPPR
     ATLVTQPENV EHFAICCFPE TDAQALPALG IRVHVASGTA LCLLLDFGDN CGAQMRLCTL
     AGATTVTGYH QYRKEGVYEL KAVVHDFHRA EELGPYYVDI SHGNVSVFMN SSSIHDSEAL
     SFADSLPQQR GTVVVHCFSS ISSYNVSFIS QTQVASGQAW CGVTVGYKMQ SVSVYTNGTV
     FAANTNITFV AITEETIPLE FAWYFGENPP VMTTSRSIRR RLSVPQWYRV KVKATSRIGS
     VVSEPHLIRV QKRIMANRLV STASALVNAN VSFECRLNFG TDVAYLWNFG DDTIELGSSS
     SSHVYSREGE FTVEVLAFNN VSSTTLRKQL FIVREPCQPP PVKNMGPAKV QIWRSQPLRL
     GVTFEAAILC NISQGLSYTW SFVSAEMTTV TLPTAVNTRR QTIMLPSYTL ECGNYTAIAK
     VQIKGSMVYS NYCVGVEVRA RAPVSVISEG THIFISTATS TFIILRGAQS YDPDNPGAAL
     RYHWTCTAAS SPRWPCFDNS TSYQVDTQAP AISFPAKWLS ECCDQFLVTL TVSSRGQNSS
     QALMFLSTRP DLAFRFVHIS WVNFRDISVN WNEEVSLRAV CEDCGDVPDL TYSWDLFLVN
     ATEKSAVEVP FCSTVGLLGA LALGTSLKSS KSDLPSNLRA PLTPHSPEPS PTPLGWTALS
     NLGSISAEST AGGHHVPASG AVAGSGEPME EYSSLSSLAE EALMTNSSEG SWPSPSSSTD
     FDDFEAYYSD IQEAVLSLGR QPGTSTNFQE AGPSLSAEES ASYGDNLLGP FLHTGRAKPT
     LMIDWPKALV SQAAFHGYTT SGIMGPAVTI KPFSLSSGKT YVLQASVASK HVLLGKAQLY
     LTVNQAPQDM SCQVRPHHGM EAYTIFSVFC MSGKPDFHYE FRYRIGNTSS HTLYRGQDTQ
     HYFLLPAGDS SDNYKVIVST EITDGHGSKV QPCTVAVTVL PRYHGNDCCD KELYNSTLES
     LSTLRLAGSY METRNYITMI TGILSRLYVE SRNTSSCGQW SQIQDVLISS ACKVPYTDQE
     GMMDSIHILR DLISFPNKLS LTSAMCIFKY TKMFLAQGQF SRRLLVDKKL RVEFVLLISG
     VWEAAKEDAR DGDYLQEEGM KIISDMLLAC LSDEHQIHVS TGQMEFQTLL HRSPQSSIQN
     LGFVQVHFPS DLASLHSTTQ EATQSSCYIS QLMFFMKSPY LGGQVPGQVG GVMIPRLYSC
     ESRRPILRGQ LETPVTMEFG EEDYLHKRNP AMFVLLRDEV NVHRFTGLSE NSQESLQIHI
     KFSKPVTRPF PIILLVRFSE KATPSDFLVK RVYFWDEQTV QMYVPAAPWK GANVGYLSLL
     DADYDRKPPN KYLAGAVNYT VHFQWIQCVF WDKTEWRSEG PYPQPGSSPE KVNCSYHHLA
     PVSVLRRKLN ATLEVSSISE FQSHPHNLLP GIFSAFLLVL YGILVSKSRY VDCHEKKNPG
     FIFLEEDTLP GYQLYAVVID TGFRSPVRFT SKVFIVLCGE NGCSETKELC CPEKPLFGRN
     SRHTFILSIP NQLGPLQKIR LWHDSSGSSP CWFISHVMVK ELCSGQAWFF SAQCWLAVSK
     LGGHVLREFF CLSHGLGFWK LFYSKFTEYL EDFHIWLSLY SQPPSRSYLH TQRLAVSFCL
     LCVYSCLTAL VTVRDHQQRP LDVGPTAITL EPFCMALLCT LLACPVAQLL SLLFRCSKEA
     RGDMQASTQW PLRGVKTETP QGHDSSGRPD SRQPSPHPTS DLLPWNDQAW RIAASSSAVV
     CSPFPMEACS HKHHDLREKS HYSPPSSQAP GSGFEELGSQ KSRVCLLWSS SVAWAISGSA
     SLACGLGTGF LGYWFVPAQC MWWLYLLLLS LVCCAFITQP LMICLAALVF AWKRKHDSKF
     FTESLQDATK GLDLELEEHS RTRVPLSPIS YSPDTAEEAE RVLATRQRER HLRWAQTPSK
     AKLRVTGERL RRESIMQAAL RDMTTHSIML LLLLFIAYGR FCPGEISLNH AIRKAFTRKA
     NHSLGDLSST EDWWDWTLST LLDELYPERT SARAWGAQPG ALGGQCHLIG PPVVKLLKIS
     AGTACTPPRP FSELVEDVLP MHSNDLDLEN QNVSPGGPET CGVKKESYMH SLGKTRHEAH
     AALTALRASK WIDHSTRAMS VHFTLYNPPT QLFTSVILGT ECLPSGGLVP SFLVESFRIF
     YSDSALKYLL MLSELLFLVL NVIHLCFQLW GMTTKGILSY WRKPRHWLEL SMVGVAIAYY
     AASGHLTTLA VNITDQFHKG LYQRLVDIGL MVSWHQRARC LQGILLFLWM LKYVHLLSSL
     STMTPFSAVT CFPLFRVLLV GALLLAAHYH SRWFLLFTGT LSHGTSAEAF PGLLLQFPGR
     SKKDSWHNCL KSDHGVMRCY YGTLFLLLAT LGFRMLRATF LTVFQNRKSS HRKPLVTLKD
     IAVYTWHKVL TLLGLETTLE ETEVATDHIY YLDEFSSLLD ELLMKIDGLS DSLELSILEN
     QWKRALESRA GDSPPVGSSE YQATGVSGPL AAESE
//
ID   MCLN3_HUMAN             Reviewed;         553 AA.
AC   Q8TDD5; Q5T4H5; Q5T4H6; Q9NV09;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   20-DEC-2017, entry version 126.
DE   RecName: Full=Mucolipin-3 {ECO:0000303|PubMed:19497048};
DE   AltName: Full=Transient receptor potential channel mucolipin 3;
DE            Short=TRPML3 {ECO:0000303|PubMed:18369318};
GN   Name=MCOLN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Falardeau J.L., Kennedy J.C., Acierno J.S. Jr., Slaugenhaupt S.A.;
RT   "Cloning of the MCOLN3 gene.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   FUNCTION, ENZYME REGULATION, AND MUTAGENESIS OF HIS-252; HIS-273;
RP   HIS-283 AND ALA-419.
RX   PubMed=18369318; DOI=10.1038/emboj.2008.56;
RA   Kim H.J., Li Q., Tjon-Kon-Sang S., So I., Kiselyov K., Soyombo A.A.,
RA   Muallem S.;
RT   "A novel mode of TRPML3 regulation by extracytosolic pH absent in the
RT   varitint-waddler phenotype.";
RL   EMBO J. 27:1197-1205(2008).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19497048; DOI=10.1111/j.1600-0854.2009.00935.x;
RA   Martina J.A., Lelouvier B., Puertollano R.;
RT   "The calcium channel mucolipin-3 is a novel regulator of trafficking
RT   along the endosomal pathway.";
RL   Traffic 10:1143-1156(2009).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, GLYCOSYLATION, AND MUTAGENESIS OF
RP   ASP-458 AND 458-ASP-ASP-459.
RX   PubMed=19522758; DOI=10.1111/j.1600-0854.2009.00924.x;
RA   Kim H.J., Soyombo A.A., Tjon-Kon-Sang S., So I., Muallem S.;
RT   "The Ca(2+) channel TRPML3 regulates membrane trafficking and
RT   autophagy.";
RL   Traffic 10:1157-1167(2009).
RN   [7]
RP   FUNCTION, ENZYME REGULATION, AND MUTAGENESIS OF HIS-283; ALA-419;
RP   GLU-449 AND ASP-459.
RX   PubMed=20378547; DOI=10.1074/jbc.M109.078204;
RA   Kim H.J., Yamaguchi S., Li Q., So I., Muallem S.;
RT   "Properties of the TRPML3 channel pore and its stable expansion by the
RT   Varitint-Waddler-causing mutation.";
RL   J. Biol. Chem. 285:16513-16520(2010).
RN   [8]
RP   SUBUNIT, AND FUNCTION.
RX   PubMed=19885840; DOI=10.1002/jcp.21956;
RA   Curcio-Morelli C., Zhang P., Venugopal B., Charles F.A.,
RA   Browning M.F., Cantiello H.F., Slaugenhaupt S.A.;
RT   "Functional multimerization of mucolipin channel proteins.";
RL   J. Cell. Physiol. 222:328-335(2010).
RN   [9]
RP   FUNCTION.
RX   PubMed=21245134; DOI=10.1074/jbc.M110.169185;
RA   Lelouvier B., Puertollano R.;
RT   "Mucolipin-3 regulates luminal calcium, acidification, and membrane
RT   fusion in the endosomal pathway.";
RL   J. Biol. Chem. 286:9826-9832(2011).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=23469151; DOI=10.1371/journal.pone.0058174;
RA   Guo Z., Grimm C., Becker L., Ricci A.J., Heller S.;
RT   "A novel ion channel formed by interaction of TRPML3 with TRPV5.";
RL   PLoS ONE 8:E58174-E58174(2013).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.62 ANGSTROMS), FUNCTION, ENZYME
RP   REGULATION, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT, GLYCOSYLATION AT
RP   ASN-138 AND ASN-172, AND MUTAGENESIS OF ASP-108; ASP-111; ASP-112;
RP   TYR-423 AND PHE-497.
RX   PubMed=29106414; DOI=10.1038/nsmb.3502;
RA   Zhou X., Li M., Su D., Jia Q., Li H., Li X., Yang J.;
RT   "Cryo-EM structures of the human endolysosomal TRPML3 channel in three
RT   distinct states.";
RL   Nat. Struct. Mol. Biol. 0:0-0(2017).
CC   -!- FUNCTION: Nonselective ligand-gated cation channel probably
CC       playing a role in the regulation of membrane trafficking events.
CC       Acts as Ca(2+)-permeable cation channel with inwardly rectifying
CC       activity (PubMed:18369318, PubMed:19497048, PubMed:19522758,
CC       PubMed:19885840, PubMed:29106414). Mediates release of Ca(2+) from
CC       endosomes to the cytoplasm, contributes to endosomal acidification
CC       and is involved in the regulation of membrane trafficking and
CC       fusion in the endosomal pathway (PubMed:21245134). Does not seem
CC       to act as mechanosensory transduction channel in inner ear sensory
CC       hair cells. Proposed to play a critical role at the cochlear
CC       stereocilia ankle-link region during hair-bundle growth (By
CC       similarity). Involved in the regulation of autophagy
CC       (PubMed:19522758). Through association with GABARAPL2 may be
CC       involved in autophagosome formation possibly providing Ca(2+) for
CC       the fusion process (By similarity). Through a possible and
CC       probably tissue-specific heteromerization with MCOLN1 may be at
CC       least in part involved in many lysosome-dependent cellular events
CC       (PubMed:19885840). Possible heteromeric ion channel assemblies
CC       with TRPV5 show pharmacological similarity with TRPML3
CC       (PubMed:23469151). {ECO:0000250|UniProtKB:Q8R4F0,
CC       ECO:0000269|PubMed:18369318, ECO:0000269|PubMed:19497048,
CC       ECO:0000269|PubMed:19522758, ECO:0000269|PubMed:19885840,
CC       ECO:0000269|PubMed:20378547, ECO:0000269|PubMed:21245134,
CC       ECO:0000269|PubMed:23469151, ECO:0000269|PubMed:29106414,
CC       ECO:0000305}.
CC   -!- ENZYME REGULATION: Inhibited by lumenal H(+) and Na(+)
CC       (PubMed:18369318, PubMed:29106414). The channel pore shows dynamic
CC       behavior and undergoes spontaneous, Ca(2+)-dependent modulation
CC       when conducting Ca(2+) (PubMed:20378547).
CC       {ECO:0000269|PubMed:18369318, ECO:0000269|PubMed:20378547,
CC       ECO:0000269|PubMed:29106414}.
CC   -!- SUBUNIT: Homotetramer (PubMed:29106414). Can heterooligomerize
CC       with MCOLN1; heteromeric assemblies have different channel
CC       properties as compared to the respective homooligomers and may be
CC       tissue-specific (PubMed:19885840). May heterooligomerize with
CC       TRPV5 to form a functional distinct ion channel (PubMed:23469151).
CC       Interacts with GABARAPL2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R4F0, ECO:0000269|PubMed:19885840,
CC       ECO:0000269|PubMed:29106414, ECO:0000305|PubMed:23469151}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19522758,
CC       ECO:0000269|PubMed:29106414}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:29106414}. Early endosome membrane
CC       {ECO:0000269|PubMed:19497048, ECO:0000269|PubMed:19522758}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:29106414}. Late endosome
CC       membrane {ECO:0000269|PubMed:19497048,
CC       ECO:0000269|PubMed:19522758}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:29106414}. Lysosome membrane
CC       {ECO:0000269|PubMed:19522758}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:29106414}. Cytoplasmic vesicle, autophagosome
CC       membrane {ECO:0000269|PubMed:19522758}. Note=Recycles between the
CC       plasma membrane and intracellular compartments by a dynamin-
CC       dependent endocytic pathway (PubMed:19522758). Under normal
CC       conditions, only a very minor proportion is present at the cell
CC       membrane (PubMed:19522758). In the cochlea located at the base of
CC       stereocilia near the position of the ankle links (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R4F0, ECO:0000269|PubMed:19522758}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDD5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDD5-2; Sequence=VSP_010823;
CC   -!- DOMAIN: The most N-terminal extracellular/lumenal domain (referred
CC       to as I-II linker or polycystin-mucolipin domain) contributes to a
CC       structure with a four-fold rotational symmetry in a tetrameric
CC       assembly; the structure contains a central highly electronegative
CC       pore with a 14 A diameter. The pore is critical for Ca(2+) and pH
CC       regulation. The protruding structure formed by the I-II linkers
CC       may contain all the interaction sites with lipids and proteins in
CC       the endolysosomal lumen. {ECO:0000250|UniProtKB:Q9GZU1}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19885840}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       Polycystin subfamily. MCOLN3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF475085; AAL84622.1; -; mRNA.
DR   EMBL; AK001868; BAA91951.1; -; mRNA.
DR   EMBL; AL358789; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS58009.1; -. [Q8TDD5-2]
DR   CCDS; CCDS701.1; -. [Q8TDD5-1]
DR   RefSeq; NP_001240622.1; NM_001253693.1. [Q8TDD5-2]
DR   RefSeq; NP_060768.8; NM_018298.10. [Q8TDD5-1]
DR   RefSeq; XP_005271060.1; XM_005271003.1. [Q8TDD5-1]
DR   RefSeq; XP_006710813.1; XM_006710750.1. [Q8TDD5-1]
DR   UniGene; Hs.535239; -.
DR   PDB; 6AYE; EM; 4.06 A; A/B/C/D=1-553.
DR   PDB; 6AYF; EM; 3.62 A; A/B/C/D=1-553.
DR   PDB; 6AYG; EM; 4.65 A; A/B/C/D=1-553.
DR   PDBsum; 6AYE; -.
DR   PDBsum; 6AYF; -.
DR   PDBsum; 6AYG; -.
DR   ProteinModelPortal; Q8TDD5; -.
DR   SMR; Q8TDD5; -.
DR   BioGrid; 120571; 60.
DR   IntAct; Q8TDD5; 1.
DR   STRING; 9606.ENSP00000304843; -.
DR   BindingDB; Q8TDD5; -.
DR   ChEMBL; CHEMBL1293243; -.
DR   GuidetoPHARMACOLOGY; 503; -.
DR   TCDB; 1.A.5.3.4; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q8TDD5; -.
DR   PhosphoSitePlus; Q8TDD5; -.
DR   SwissPalm; Q8TDD5; -.
DR   BioMuta; MCOLN3; -.
DR   DMDM; 50401084; -.
DR   MaxQB; Q8TDD5; -.
DR   PaxDb; Q8TDD5; -.
DR   PeptideAtlas; Q8TDD5; -.
DR   PRIDE; Q8TDD5; -.
DR   Ensembl; ENST00000341115; ENSP00000342698; ENSG00000055732. [Q8TDD5-2]
DR   Ensembl; ENST00000370589; ENSP00000359621; ENSG00000055732. [Q8TDD5-1]
DR   GeneID; 55283; -.
DR   KEGG; hsa:55283; -.
DR   UCSC; uc001dkp.4; human. [Q8TDD5-1]
DR   CTD; 55283; -.
DR   DisGeNET; 55283; -.
DR   EuPathDB; HostDB:ENSG00000055732.12; -.
DR   GeneCards; MCOLN3; -.
DR   HGNC; HGNC:13358; MCOLN3.
DR   HPA; HPA018106; -.
DR   HPA; HPA062137; -.
DR   MIM; 607400; gene.
DR   neXtProt; NX_Q8TDD5; -.
DR   OpenTargets; ENSG00000055732; -.
DR   PharmGKB; PA134947324; -.
DR   eggNOG; KOG3733; Eukaryota.
DR   eggNOG; ENOG410Z1HH; LUCA.
DR   GeneTree; ENSGT00390000017126; -.
DR   HOGENOM; HOG000232158; -.
DR   HOVERGEN; HBG052430; -.
DR   InParanoid; Q8TDD5; -.
DR   KO; K04994; -.
DR   OMA; CGWLILG; -.
DR   OrthoDB; EOG091G026A; -.
DR   PhylomeDB; Q8TDD5; -.
DR   TreeFam; TF317783; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   GeneWiki; MCOLN3; -.
DR   GenomeRNAi; 55283; -.
DR   PRO; PR:Q8TDD5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000055732; -.
DR   CleanEx; HS_MCOLN3; -.
DR   ExpressionAtlas; Q8TDD5; baseline and differential.
DR   Genevisible; Q8TDD5; HS.
DR   GO; GO:0000421; C:autophagosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   Pfam; PF08016; PKD_channel; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasmic vesicle; Disulfide bond; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Lipid-binding; Lysosome; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    553       Mucolipin-3.
FT                                /FTId=PRO_0000215367.
FT   TOPO_DOM      1     62       Cytoplasmic.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM     63     83       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM     84    283       Extracellular.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM    284    304       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    305    341       Cytoplasmic.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM    342    362       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    363    371       Extracellular.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM    372    392       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    393    414       Cytoplasmic.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM    415    435       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    436    443       Extracellular.
FT                                {ECO:0000269|PubMed:29106414}.
FT   INTRAMEM    444    464       Pore-forming.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    465    475       Extracellular.
FT                                {ECO:0000269|PubMed:29106414}.
FT   TRANSMEM    476    497       Helical. {ECO:0000269|PubMed:29106414}.
FT   TOPO_DOM    498    553       Cytoplasmic.
FT                                {ECO:0000269|PubMed:29106414}.
FT   REGION       52     62       Interaction with phosphoinositides.
FT                                {ECO:0000250|UniProtKB:F6RG56}.
FT   REGION      104    118       Extracellular/lumenal pore loop.
FT                                {ECO:0000250|UniProtKB:Q9GZU1}.
FT   MOTIF       456    459       Selectivity filter.
FT                                {ECO:0000269|PubMed:29106414}.
FT   SITE        305    305       Interaction with phosphoinositides.
FT                                {ECO:0000250|UniProtKB:F6RG56}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:29106414}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:29106414}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    159    185       {ECO:0000250|UniProtKB:Q9GZU1}.
FT   DISULFID    238    269       {ECO:0000250|UniProtKB:Q9GZU1}.
FT   VAR_SEQ      77    132       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010823.
FT   MUTAGEN     108    108       D->N: Abolishes basal channel activity
FT                                without affecting channel activation by a
FT                                synthetic agonist; when associated with
FT                                N-111 and N-112.
FT                                {ECO:0000269|PubMed:29106414}.
FT   MUTAGEN     111    111       D->N: Abolishes basal channel activity
FT                                without affecting channel activation by a
FT                                synthetic agonist; when associated with
FT                                N-108 and N-112.
FT                                {ECO:0000269|PubMed:29106414}.
FT   MUTAGEN     112    112       D->N: Abolishes basal channel activity
FT                                without affecting channel activation by a
FT                                synthetic agonist; when associated with
FT                                N-108 and N-111.
FT                                {ECO:0000269|PubMed:29106414}.
FT   MUTAGEN     252    252       H->A: Increases inhibition by lumenal
FT                                H(+). Decreases inhibition by lumenal
FT                                H(+); when associated with A-283.
FT                                {ECO:0000269|PubMed:18369318}.
FT   MUTAGEN     273    273       H->A: Increases inhibition by lumenal
FT                                H(+). Decreases inhibition by lumenal
FT                                H(+); when associated with A-283.
FT                                {ECO:0000269|PubMed:18369318}.
FT   MUTAGEN     283    283       H->A: Constitutive active channel;
FT                                abolishes inhibition by lumenal H(+);
FT                                retains the Ca(2+)-dependent inactivation
FT                                of the Ca(2+) current. Decreases
FT                                inhibition by lumenal H(+); when
FT                                associated with A-252. Decreases
FT                                inhibition by lumenal H(+); when
FT                                associated with A-273.
FT                                {ECO:0000269|PubMed:18369318}.
FT   MUTAGEN     283    283       H->R: Increases inhibition by lumenal
FT                                H(+). {ECO:0000269|PubMed:18369318}.
FT   MUTAGEN     419    419       A->P: Constitutive active channel;
FT                                abolishes inhibition by lumenal H(+);
FT                                increases the pore diameter.
FT                                {ECO:0000269|PubMed:18369318,
FT                                ECO:0000269|PubMed:20378547}.
FT   MUTAGEN     423    423       Y->A: Nearly abolishes channel activation
FT                                by a synthetic agonist.
FT                                {ECO:0000269|PubMed:29106414}.
FT   MUTAGEN     449    449       E->A: Constitutive active channel;
FT                                greatly impairs inhibition by lumenal
FT                                Na(+). {ECO:0000269|PubMed:20378547}.
FT   MUTAGEN     449    449       E->K: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:20378547}.
FT   MUTAGEN     458    459       DD->KK: Enhances endocytosis.
FT                                {ECO:0000269|PubMed:19522758}.
FT   MUTAGEN     458    458       D->K: Nearly abolishes channel activity;
FT                                inhibits starvation-induced autophagy.
FT                                {ECO:0000269|PubMed:19522758}.
FT   MUTAGEN     459    459       D->A: Decreases in Ca(2+) permeability
FT                                and selectivity; decreases channel pore
FT                                dynamic behavior.
FT                                {ECO:0000269|PubMed:20378547}.
FT   MUTAGEN     497    497       F->A: Nearly abolishes channel activation
FT                                by a synthetic agonist.
FT                                {ECO:0000269|PubMed:29106414}.
FT   CONFLICT      9      9       S -> C (in Ref. 2; BAA91951).
FT                                {ECO:0000305}.
SQ   SEQUENCE   553 AA;  64248 MW;  2E63DA196379F9E3 CRC64;
     MADPEVVVSS CSSHEEENRC NFNQQTSPSE ELLLEDQMRR KLKFFFMNPC EKFWARGRKP
     WKLAIQILKI AMVTIQLVLF GLSNQMVVAF KEENTIAFKH LFLKGYMDRM DDTYAVYTQS
     DVYDQLIFAV NQYLQLYNVS VGNHAYENKG TKQSAMAICQ HFYKRGNIYP GNDTFDIDPE
     IETECFFVEP DEPFHIGTPA ENKLNLTLDF HRLLTVELQF KLKAINLQTV RHQELPDCYD
     FTLTITFDNK AHSGRIKISL DNDISIRECK DWHVSGSIQK NTHYMMIFDA FVILTCLVSL
     ILCIRSVIRG LQLQQEFVNF FLLHYKKEVS VSDQMEFVNG WYIMIIISDI LTIIGSILKM
     EIQAKSLTSY DVCSILLGTS TMLVWLGVIR YLGFFAKYNL LILTLQAALP NVIRFCCCAA
     MIYLGYCFCG WIVLGPYHDK FRSLNMVSEC LFSLINGDDM FATFAKMQQK SYLVWLFSRI
     YLYSFISLFI YMILSLFIAL ITDTYETIKQ YQQDGFPETE LRTFISECKD LPNSGKYRLE
     DDPPVSLFCC CKK
//
ID   PK1L1_HUMAN             Reviewed;        2849 AA.
AC   Q8TDX9; Q6UWK1;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=Polycystic kidney disease protein 1-like 1;
DE   AltName: Full=PC1-like 1 protein;
DE   AltName: Full=Polycystin-1L1;
GN   Name=PKD1L1; ORFNames=UNQ5785/PRO19563;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11863367; DOI=10.1006/geno.2002.6719;
RA   Yuasa T., Venugopal B., Weremowicz S., Morton C.C., Guo L., Zhou J.;
RT   "The sequence, expression, and chromosomal localization of a novel
RT   polycystic kidney disease 1-like gene, PKD1L1, in human.";
RL   Genomics 79:376-386(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2247-2573 (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   FUNCTION, INTERACTION WITH PKD2L1, AND SUBCELLULAR LOCATION.
RX   PubMed=24336289; DOI=10.1038/nature12832;
RA   DeCaen P.G., Delling M., Vien T.N., Clapham D.E.;
RT   "Direct recording and molecular identification of the calcium channel
RT   of primary cilia.";
RL   Nature 504:315-318(2013).
RN   [4]
RP   INVOLVEMENT IN HTX8, AND VARIANT HTX8 SER-1691.
RX   PubMed=27616478; DOI=10.1016/j.ajhg.2016.07.011;
RA   Vetrini F., D'Alessandro L.C., Akdemir Z.C., Braxton A., Azamian M.S.,
RA   Eldomery M.K., Miller K., Kois C., Sack V., Shur N., Rijhsinghani A.,
RA   Chandarana J., Ding Y., Holtzman J., Jhangiani S.N., Muzny D.M.,
RA   Gibbs R.A., Eng C.M., Hanchard N.A., Harel T., Rosenfeld J.A.,
RA   Belmont J.W., Lupski J.R., Yang Y.;
RT   "Bi-allelic mutations in PKD1L1 are associated with laterality defects
RT   in humans.";
RL   Am. J. Hum. Genet. 99:886-893(2016).
RN   [5]
RP   VARIANT ILE-906.
RX   PubMed=20869035; DOI=10.1016/j.ajhg.2010.08.015;
RA   Funari V.A., Krakow D., Nevarez L., Chen Z., Funari T.L.,
RA   Vatanavicharn N., Wilcox W.R., Rimoin D.L., Nelson S.F., Cohn D.H.;
RT   "BMPER mutation in diaphanospondylodysostosis identified by ancestral
RT   autozygosity mapping and targeted high-throughput sequencing.";
RL   Am. J. Hum. Genet. 87:532-537(2010).
CC   -!- FUNCTION: Component of a ciliary calcium channel that controls
CC       calcium concentration within primary cilia without affecting
CC       cytoplasmic calcium concentration. Forms a heterodimer with PKD2L1
CC       in primary cilia and forms a calcium-permeant ciliary channel that
CC       regulates sonic hedgehog/SHH signaling and GLI2 transcription.
CC       Does not constitute the pore-forming subunit. Also involved in
CC       left/right axis specification downstream of nodal flow: forms a
CC       complex with PKD2 in cilia to facilitate flow detection in
CC       left/right patterning. {ECO:0000269|PubMed:24336289}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes with PKD2 proteins to form a
CC       calcium channel. Interacts with PKD2L1; to form ciliary calcium
CC       channel. Interacts with PKD2. {ECO:0000269|PubMed:24336289}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000269|PubMed:24336289}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24336289}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDX9-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q8TDX9-2; Sequence=VSP_013215, VSP_013216;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in testis and in fetal and adult
CC       heart.
CC   -!- DISEASE: Heterotaxy, visceral, 8, autosomal (HTX8) [MIM:617205]: A
CC       form of visceral heterotaxy, a complex disorder due to disruption
CC       of the normal left-right asymmetry of the thoracoabdominal organs.
CC       Visceral heterotaxy or situs ambiguus results in randomization of
CC       the placement of visceral organs, including the heart, lungs,
CC       liver, spleen, and stomach. The organs are oriented randomly with
CC       respect to the left-right axis and with respect to one another. It
CC       can been associated with a variety of congenital defects including
CC       cardiac malformations. HTX8 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:27616478}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ89117.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB061683; BAB85807.1; -; mRNA.
DR   EMBL; AY358757; AAQ89117.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34633.1; -. [Q8TDX9-1]
DR   RefSeq; NP_612152.1; NM_138295.4. [Q8TDX9-1]
DR   UniGene; Hs.195979; -.
DR   ProteinModelPortal; Q8TDX9; -.
DR   BioGrid; 127967; 1.
DR   MINT; MINT-5002126; -.
DR   STRING; 9606.ENSP00000289672; -.
DR   TCDB; 1.A.5.1.3; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q8TDX9; -.
DR   PhosphoSitePlus; Q8TDX9; -.
DR   BioMuta; PKD1L1; -.
DR   DMDM; 23821932; -.
DR   EPD; Q8TDX9; -.
DR   PaxDb; Q8TDX9; -.
DR   PeptideAtlas; Q8TDX9; -.
DR   PRIDE; Q8TDX9; -.
DR   Ensembl; ENST00000289672; ENSP00000289672; ENSG00000158683. [Q8TDX9-1]
DR   GeneID; 168507; -.
DR   KEGG; hsa:168507; -.
DR   UCSC; uc003tny.3; human. [Q8TDX9-1]
DR   CTD; 168507; -.
DR   DisGeNET; 168507; -.
DR   EuPathDB; HostDB:ENSG00000158683.7; -.
DR   GeneCards; PKD1L1; -.
DR   HGNC; HGNC:18053; PKD1L1.
DR   HPA; HPA020422; -.
DR   HPA; HPA022424; -.
DR   MalaCards; PKD1L1; -.
DR   MIM; 609721; gene.
DR   MIM; 617205; phenotype.
DR   neXtProt; NX_Q8TDX9; -.
DR   OpenTargets; ENSG00000158683; -.
DR   PharmGKB; PA38282; -.
DR   eggNOG; ENOG410IQ5F; Eukaryota.
DR   eggNOG; ENOG410ZBZ7; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000115551; -.
DR   HOVERGEN; HBG053602; -.
DR   InParanoid; Q8TDX9; -.
DR   KO; K04987; -.
DR   OMA; EFSYQIG; -.
DR   OrthoDB; EOG091G004D; -.
DR   PhylomeDB; Q8TDX9; -.
DR   TreeFam; TF316484; -.
DR   GenomeRNAi; 168507; -.
DR   PRO; PR:Q8TDX9; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000158683; -.
DR   CleanEx; HS_PKD1L1; -.
DR   ExpressionAtlas; Q8TDX9; baseline and differential.
DR   Genevisible; Q8TDX9; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; ISS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0003127; P:detection of nodal flow; ISS:BHF-UCL.
DR   GO; GO:0070986; P:left/right axis specification; ISS:BHF-UCL.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 2.60.60.20; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR022409; PKD/Chitinase_dom.
DR   InterPro; IPR002859; PKD/REJ-like.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR000601; PKD_dom.
DR   InterPro; IPR035986; PKD_dom_sf.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR014010; REJ_dom.
DR   Pfam; PF00801; PKD; 1.
DR   Pfam; PF08016; PKD_channel; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   Pfam; PF02010; REJ; 1.
DR   SMART; SM00308; LH2; 1.
DR   SMART; SM00089; PKD; 2.
DR   SUPFAM; SSF49299; SSF49299; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   PROSITE; PS50093; PKD; 1.
DR   PROSITE; PS50095; PLAT; 1.
DR   PROSITE; PS51111; REJ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cell projection; Cilium; Complete proteome;
KW   Glycoprotein; Heterotaxy; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   2849       Polycystic kidney disease protein 1-like
FT                                1.
FT                                /FTId=PRO_0000164358.
FT   TOPO_DOM      1   1748       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1749   1769       Helical. {ECO:0000255}.
FT   TOPO_DOM   1770   1956       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1957   1977       Helical. {ECO:0000255}.
FT   TOPO_DOM   1978   1992       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1993   2013       Helical. {ECO:0000255}.
FT   TOPO_DOM   2014   2135       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2136   2156       Helical. {ECO:0000255}.
FT   TOPO_DOM   2157   2174       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2175   2195       Helical. {ECO:0000255}.
FT   TOPO_DOM   2196   2281       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2282   2302       Helical. {ECO:0000255}.
FT   TOPO_DOM   2303   2522       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2523   2543       Helical. {ECO:0000255}.
FT   TOPO_DOM   2544   2562       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2563   2583       Helical. {ECO:0000255}.
FT   TOPO_DOM   2584   2616       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2617   2637       Helical. {ECO:0000255}.
FT   TOPO_DOM   2638   2646       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2647   2667       Helical. {ECO:0000255}.
FT   TOPO_DOM   2668   2711       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2712   2732       Helical. {ECO:0000255}.
FT   TOPO_DOM   2733   2849       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      508    590       PKD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      592    673       PKD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      674   1571       REJ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00511}.
FT   DOMAIN     1688   1734       GPS.
FT   DOMAIN     1796   1913       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   CARBOHYD      8      8       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    376    376       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    447    447       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    482    482       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    514    514       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    605    605       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    657    657       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    751    751       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    875    875       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    926    926       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    937    937       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1233   1233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1301   1301       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1306   1306       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1572   1572       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1681   1681       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1716   1716       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2426   2426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ    2563   2573       LSVVGVSLTYY -> VASLVSFSFEK (in isoform
FT                                2). {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013215.
FT   VAR_SEQ    2574   2849       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013216.
FT   VARIANT     312    312       V -> F (in dbSNP:rs2686817).
FT                                /FTId=VAR_024566.
FT   VARIANT     812    812       D -> N (in dbSNP:rs17131915).
FT                                /FTId=VAR_050552.
FT   VARIANT     879    879       T -> A (in dbSNP:rs11972142).
FT                                /FTId=VAR_050553.
FT   VARIANT     894    894       V -> I (in dbSNP:rs56100904).
FT                                /FTId=VAR_061522.
FT   VARIANT     906    906       V -> I (in dbSNP:rs141681038).
FT                                {ECO:0000269|PubMed:20869035}.
FT                                /FTId=VAR_065825.
FT   VARIANT    1053   1053       R -> P (in dbSNP:rs10274334).
FT                                /FTId=VAR_024567.
FT   VARIANT    1272   1272       K -> E (in dbSNP:rs1470859).
FT                                /FTId=VAR_024568.
FT   VARIANT    1691   1691       C -> S (in HTX8; dbSNP:rs886037834).
FT                                {ECO:0000269|PubMed:27616478}.
FT                                /FTId=VAR_077879.
FT   VARIANT    2057   2057       R -> H (in dbSNP:rs17131834).
FT                                /FTId=VAR_061523.
FT   VARIANT    2410   2410       E -> K (in dbSNP:rs2290386).
FT                                /FTId=VAR_021944.
FT   VARIANT    2603   2603       L -> F (in dbSNP:rs59848490).
FT                                /FTId=VAR_061524.
FT   VARIANT    2685   2685       A -> T (in dbSNP:rs13231277).
FT                                /FTId=VAR_050554.
SQ   SEQUENCE   2849 AA;  315435 MW;  A0E60E88E7DDAA75 CRC64;
     MAEEAAQNIS DDQERCLQAA CCLSFGGELS VSTDKSWGLH LCSCSPPGGG LWVEVYANHV
     LLMSDGKCGC PWCALNGKAE DRESQSPSSS ASRQKNIWKT TSEAALSVVN EKTQAVVNEK
     TQAPLDCDNS ADRIPHKPFI IIARAWSSGG PRFHHRRLCA TGTADSTFSA LLQLQGTTSA
     AAPCSLKMEA SCCVLRLLCC AEDVATGLLP GTVTMETPTK VARPTQTSSQ RVPLWPISHF
     PTSPRSSHGL PPGIPRTPSF TASQSGSEIL YPPTQHPPVA ILARNSDNFM NPVLNCSLEV
     EARAPPNLGF RVHMASGEAL CLMMDFGDSS GVEMRLHNMS EAMAVTAYHQ YSKGIFFHLL
     HFQLDMSTYK EAETQNTTLN VYLCQSENSC LEDSDPSNLG YELISAFVTK GVYMLKAVIY
     NEFHGTEVEL GPYYVEIGHE AVSAFMNSSS VHEDEVLVFA DSQVNQKSTV VIHHFPSIPS
     YNVSFISQTQ VGDSQAWHSM TVWYKMQSVS VYTNGTVFAT DTDITFTAVT KETIPLEFEW
     YFGEDPPVRT TSRSIKKRLS IPQWYRVMVK ASNRMSSVVS EPHVIRVQKK IVANRLTSPS
     SALVNASVAF ECWINFGTDV AYLWDFGDGT VSLGSSSSSH VYSREGEFTV EVLAFNNVSA
     STLRQQLFIV CEPCQPPLVK NMGPGKVQIW RSQPVRLGVT FEAAVFCDIS QGLSYTWNLM
     DSEGLPVSLP AAVDTHRQTL ILPSHTLEYG NYTALAKVQI EGSVVYSNYC VGLEVRAQAP
     VSVISEGTHL FFSRTTSSPI VLRGTQSFDP DDPGATLRYH WECATAGSPA HPCFDSSTAH
     QLDAAAPTVS FEAQWLSDSY DQFLVMLRVS SGGRNSSETR VFLSPYPDSA FRFVHISWVS
     FKDTFVNWND ELSLQAMCED CSEIPNLSYS WDLFLVNATE KNRIEVPFCR VVGLLGSLGL
     GAISESSQLN LLPTEPGTAD PDATTTPFSR EPSPVTLGQP ATSAPRGTPT EPMTGVYWIP
     PAGDSAVLGE APEEGSLDLE PGPQSKGSLM TGRSERSQPT HSPDPHLSDF EAYYSDIQEA
     IPSGGRQPAK DTSFPGSGPS LSAEESPGDG DNLVDPSLSA GRAEPVLMID WPKALLGRAV
     FQGYSSSGIT EQTVTIKPYS LSSGETYVLQ VSVASKHGLL GKAQLYLTVN PAPRDMACQV
     QPHHGLEAHT VFSVFCMSGK PDFHYEFSYQ IGNTSKHTLY HGRDTQYYFV LPAGEHLDNY
     KVMVSTEITD GKGSKVQPCT VVVTVLPRYH GNDCLGEDLY NSSLKNLSTL QLMGSYTEIR
     NYITVITRIL SRLSKEDKTA SCNQWSRIQD ALISSVCRLA FVDQEEMIGS VLMLRDLVSF
     SNKLGFMSAV LILKYTRALL AQGQFSGPFV IDKGVRLELI GLISRVWEVS EQENSKEEVY
     RHEEGITVIS DLLLGCLSLN HVSTGQMEFR TLLHYNLQSS VQSLGSVQVH LPGDLAGHSP
     AGAETQSPCY ISQLILFKKN PYPGSQAPGQ IGGVVGLNLY TCSSRRPINR QWLRKPVMVE
     FGEEDGLDNR RNKTTFVLLR DKVNLHQFTE LSENPQESLQ IEIEFSKPVT RAFPVMLLVR
     FSEKPTPSDF LVKQIYFWDE SIVQIYIPAA SQKDASVGYL SLLDADYDRK PPNRYLAKAV
     NYTVHFQWIR CLFWDKREWK SERFSPQPGT SPEKVNCSYH RLAAFALLRR KLKASFEVSD
     ISKLQSHPEN LLPSIFIMGS VILYGFLVAK SRQVDHHEKK KAGYIFLQEA SLPGHQLYAV
     VIDTGFRAPA RLTSKVYIVL CGDNGLSETK ELSCPEKPLF ERNSRHTFIL SAPAQLGLLR
     KIRLWHDSRG PSPGWFISHV MVKELHTGQG WFFPAQCWLS AGRHDGRVER ELTCLQGGLG
     FRKLFYCKFT EYLEDFHVWL SVYSRPSSSR YLHTPRLTVS FSLLCVYACL TALVAAGGQE
     QPHLDVSPTL GSFRVGLLCT LLASPGAQLL SLLFRLSKEA PGSARVEPHS PLRGGAQTEA
     PHGPNSWGRI PDAQEPRKQP ASAILSGSGR AQRKAASDNG TACPAPKLQV HGADHSRTSL
     MGKSHCCPPH TQAPSSGLEG LMPQWSRALQ PWWSSAVWAI CGTASLACSL GTGFLAYRFG
     QEQCVQWLHL LSLSVVCCIF ITQPLMVCLM ALGFAWKRRA DNHFFTESLC EATRDLDSEL
     AERSWTRLPF SSSCSIPDCA GEVEKVLAAR QQARHLRWAH PPSKAQLRGT RQRMRRESRT
     RAALRDISMD ILMLLLLLCV IYGRFSQDEY SLNQAIRKEF TRNARNCLGG LRNIADWWDW
     SLTTLLDGLY PGGTPSARVP GAQPGALGGK CYLIGSSVIR QLKVFPRHLC KPPRPFSALI
     EDSIPTCSPE VGGPENPYLI DPENQNVTLN GPGGCGTRED CVLSLGRTRT EAHTALSRLR
     ASMWIDRSTR AVSVHFTLYN PPTQLFTSVS LRVEILPTGS LVPSSLVESF SIFRSDSALQ
     YHLMLPQLVF LALSLIHLCV QLYRMMDKGV LSYWRKPRNW LELSVVGVSL TYYAVSGHLV
     TLAGDVTNQF HRGLCRAFMD LTLMASWNQR ARWLRGILLF LFTLKCVYLP GIQNTMASCS
     SMMRHSLPSI FVAGLVGALM LAALSHLHRF LLSMWVLPPG TFTDAFPGLL FHFPRRSQKD
     CLLGLSKSDQ RAMACYFGIL LIVSATLCFG MLRGFLMTLP QKRKSFQSKS FVRLKDVTAY
     MWEKVLTFLR LETPKLEEAE MVENHNYYLD EFANLLDELL MKINGLSDSL QLPLLEKTSN
     NTGEARTEES PLVDISSYQA AEPADIKDF
//
ID   CCG6_RAT                Reviewed;         260 AA.
AC   Q8VHW7; Q8VHW6;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   30-AUG-2017, entry version 96.
DE   RecName: Full=Voltage-dependent calcium channel gamma-6 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-6 subunit;
GN   Name=Cacng6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11738816; DOI=10.1016/S0378-1119(01)00738-7;
RA   Chu P.-J., Robertson H.M., Best P.M.;
RT   "Calcium channel gamma subunits provide insights into the evolution of
RT   this gene family.";
RL   Gene 280:37-48(2001).
CC   -!- FUNCTION: Thought to stabilize the calcium channel in an
CC       inactivated (closed) state. {ECO:0000250}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q8VHW7-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q8VHW7-2; Sequence=VSP_005074;
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF361343; AAL50038.1; -; mRNA.
DR   EMBL; AF361344; AAL50039.1; -; mRNA.
DR   RefSeq; NP_542425.1; NM_080694.1. [Q8VHW7-1]
DR   RefSeq; XP_008756971.1; XM_008758749.1. [Q8VHW7-2]
DR   UniGene; Rn.91033; -.
DR   STRING; 10116.ENSRNOP00000019211; -.
DR   PaxDb; Q8VHW7; -.
DR   Ensembl; ENSRNOT00000081837; ENSRNOP00000074853; ENSRNOG00000057852. [Q8VHW7-1]
DR   GeneID; 140727; -.
DR   KEGG; rno:140727; -.
DR   UCSC; RGD:628806; rat. [Q8VHW7-1]
DR   CTD; 59285; -.
DR   RGD; 628806; Cacng6.
DR   eggNOG; ENOG410IWHM; Eukaryota.
DR   eggNOG; ENOG4111I1Z; LUCA.
DR   GeneTree; ENSGT00390000007786; -.
DR   HOGENOM; HOG000293219; -.
DR   HOVERGEN; HBG003868; -.
DR   InParanoid; Q8VHW7; -.
DR   KO; K04871; -.
DR   OMA; GEANCTY; -.
DR   OrthoDB; EOG091G0HUO; -.
DR   PhylomeDB; Q8VHW7; -.
DR   TreeFam; TF331651; -.
DR   Reactome; R-RNO-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-RNO-5576893; Phase 2 - plateau phase.
DR   PRO; PR:Q8VHW7; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000057852; -.
DR   Genevisible; Q8VHW7; RN.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008370; VDCC_g6su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   Pfam; PF13903; Claudin_2; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01794; VDCCGAMMA6.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    260       Voltage-dependent calcium channel gamma-6
FT                                subunit.
FT                                /FTId=PRO_0000164686.
FT   TRANSMEM     43     63       Helical. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   VAR_SEQ     136    181       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:11738816}.
FT                                /FTId=VSP_005074.
SQ   SEQUENCE   260 AA;  28255 MW;  DBE75E0F21C2BFC5 CRC64;
     MMWSNFFMQE EDRRRTAVGR RRAQEQQNLG LTPEREGKIK LGLLVAIVGA TLAVLAVGTE
     FWVELNTYKT NGSAVCEAAH LGLWKVCIKR LWQADVPAGR ETCGPAELPG EANCTYFKFF
     TTGENAHIFQ RTTKKEVNLA AAVIAVLGLT AMALGCLCVI MVLSKGAEFL LRLGAVCFGL
     SGLLLFVSLE VFRHSVRALL QGVNPETPPA PRLAYEYSWS LGCGVGAGLI LLLGGVCFLL
     LTLPSWPWRS LCPKRGGPTA
//
ID   CCG5_RAT                Reviewed;         275 AA.
AC   Q8VHW8;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   25-OCT-2017, entry version 92.
DE   RecName: Full=Voltage-dependent calcium channel gamma-5 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-5 subunit;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-5;
DE            Short=TARP gamma-5;
GN   Name=Cacng5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11738816; DOI=10.1016/S0378-1119(01)00738-7;
RA   Chu P.-J., Robertson H.M., Best P.M.;
RT   "Calcium channel gamma subunits provide insights into the evolution of
RT   this gene family.";
RL   Gene 280:37-48(2001).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH GRIA1; GRIA2;
RP   GRIA3 AND GRIA4.
RX   PubMed=18817736; DOI=10.1016/j.neuron.2008.07.034;
RA   Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S.;
RT   "AMPA receptor subunit-specific regulation by a distinct family of
RT   type II TARPs.";
RL   Neuron 59:986-996(2008).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH GRIA1; GRIA2 AND GRIA4.
RX   PubMed=19234459; DOI=10.1038/nn.2266;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RT   "Selective regulation of long-form calcium-permeable AMPA receptors by
RT   an atypical TARP, gamma-5.";
RL   Nat. Neurosci. 12:277-285(2009).
RN   [4]
RP   ERRATUM.
RX   DOI=10.1038/nn0609-808c;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RL   Nat. Neurosci. 12:808-808(2009).
RN   [5]
RP   SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19265014; DOI=10.1126/science.1167852;
RA   Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B.,
RA   Chisaka O., Jonas P., Schulte U., Fakler B., Kloecker N.;
RT   "Functional proteomics identify cornichon proteins as auxiliary
RT   subunits of AMPA receptors.";
RL   Science 323:1313-1319(2009).
CC   -!- FUNCTION: Regulates the gating properties of AMPA-selective
CC       glutamate receptors (AMPARs). Modulates their gating properties by
CC       accelerating their rates of activation, deactivation and
CC       desensitization. Displays subunit-specific AMPA receptor
CC       regulation. Shows specificity for GRIA1, GRIA4 and the long
CC       isoform of GRIA2. According to PubMed:18817736, shows only
CC       specificity for GRIA2 and specifically to the form of GRIA2 for
CC       which a single amino acid in the pore region has been edited from
CC       a glutamine to an arginine residue. Thought to stabilize the
CC       calcium channel in an inactivated (closed) state.
CC       {ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19234459}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Acts as an auxiliary
CC       subunit for AMPA-selective glutamate receptors (AMPARs). Found in
CC       a complex with GRIA1, GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG3, CACNG4, CACNG7 and CACNG8. Interacts with GRIA1, GRIA2,
CC       GRIA3 and GRIA4. {ECO:0000269|PubMed:18817736,
CC       ECO:0000269|PubMed:19234459, ECO:0000269|PubMed:19265014}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Cell junction, synapse, postsynaptic cell
CC       membrane, postsynaptic density {ECO:0000269|PubMed:18817736}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF361342; AAL50037.1; -; mRNA.
DR   RefSeq; NP_542424.1; NM_080693.1.
DR   RefSeq; XP_017452463.1; XM_017596974.1.
DR   UniGene; Rn.81219; -.
DR   STRING; 10116.ENSRNOP00000004578; -.
DR   PaxDb; Q8VHW8; -.
DR   PRIDE; Q8VHW8; -.
DR   Ensembl; ENSRNOT00000004578; ENSRNOP00000004578; ENSRNOG00000003288.
DR   GeneID; 140726; -.
DR   KEGG; rno:140726; -.
DR   UCSC; RGD:628805; rat.
DR   CTD; 27091; -.
DR   RGD; 628805; Cacng5.
DR   eggNOG; ENOG410IXFC; Eukaryota.
DR   eggNOG; ENOG410XUAQ; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233439; -.
DR   HOVERGEN; HBG025923; -.
DR   InParanoid; Q8VHW8; -.
DR   KO; K04870; -.
DR   OMA; LKCPEYE; -.
DR   OrthoDB; EOG091G0F73; -.
DR   PhylomeDB; Q8VHW8; -.
DR   Reactome; R-RNO-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-RNO-5576893; Phase 2 - plateau phase.
DR   PRO; PR:Q8VHW8; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003288; -.
DR   Genevisible; Q8VHW8; RN.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IBA:GO_Central.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008369; VDCC_g5su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   PANTHER; PTHR12107:SF4; PTHR12107:SF4; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01793; VDCCGAMMA5.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Postsynaptic cell membrane; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    275       Voltage-dependent calcium channel gamma-5
FT                                subunit.
FT                                /FTId=PRO_0000164683.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical. {ECO:0000255}.
FT   TRANSMEM    129    149       Helical. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
SQ   SEQUENCE   275 AA;  30924 MW;  31177F24A99A34CC CRC64;
     MSTCGRKALT LLSSVFAVCG LGLLGIAVST DYWLYLEEGI ILPQNQSTEV KMSLHSGLWR
     VCFLAGEERG RCFTIEYVMP MNSQMTSEST VNVLKMIRSA TPFPLVSLFF MFIGFILSNI
     GHIRPHRTIL AFVSGIFFIL SGLSLVVGLV LYISSINDEM LNRTKDAETY FNYKYGWSFA
     FAAISFLLTE SAGVMSVYLF MKRYTAEDMY RPHPGFYRPR LSNCSDYSGQ FLHPDAWIRG
     RSPSDISSDA SLQMNSNYPA LLKCPDYDQM SSSPC
//
ID   CCG8_HUMAN              Reviewed;         425 AA.
AC   Q8WXS5; Q9BXT0; Q9BY23;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   25-OCT-2017, entry version 124.
DE   RecName: Full=Voltage-dependent calcium channel gamma-8 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-8 subunit;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-8;
DE            Short=TARP gamma-8;
GN   Name=CACNG8; Synonyms=CACNG6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11738816; DOI=10.1016/S0378-1119(01)00738-7;
RA   Chu P.-J., Robertson H.M., Best P.M.;
RT   "Calcium channel gamma subunits provide insights into the evolution of
RT   this gene family.";
RL   Gene 280:37-48(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-204.
RC   TISSUE=Cerebellum;
RA   Black J.L. III, Kryzer T.J., Lennon V.A.;
RT   "Proposed Homo sapiens voltage-gated calcium channel gamma-6
RT   subunit.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-425.
RX   PubMed=11170751; DOI=10.1006/geno.2000.6440;
RA   Burgess D.L., Gefrides L.A., Foreman P.J., Noebels J.L.;
RT   "A cluster of three novel Ca(2+) channel gamma subunit genes on
RT   chromosome 19q13.4: evolution and expression profile of the gamma
RT   subunit gene family.";
RL   Genomics 71:339-350(2001).
RN   [5]
RP   FUNCTION.
RX   PubMed=21172611; DOI=10.1016/j.neuron.2010.11.026;
RA   Kato A.S., Gill M.B., Ho M.T., Yu H., Tu Y., Siuda E.R., Wang H.,
RA   Qian Y.W., Nisenbaum E.S., Tomita S., Bredt D.S.;
RT   "Hippocampal AMPA receptor gating controlled by both TARP and
RT   cornichon proteins.";
RL   Neuron 68:1082-1096(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=20805473; DOI=10.1073/pnas.1011706107;
RA   Shi Y., Suh Y.H., Milstein A.D., Isozaki K., Schmid S.M., Roche K.W.,
RA   Nicoll R.A.;
RT   "Functional comparison of the effects of TARPs and cornichons on AMPA
RT   receptor trafficking and gating.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:16315-16319(2010).
CC   -!- FUNCTION: Regulates the trafficking and gating properties of AMPA-
CC       selective glutamate receptors (AMPARs). Promotes their targeting
CC       to the cell membrane and synapses and modulates their gating
CC       properties by slowing their rates of activation, deactivation and
CC       desensitization and by mediating their resensitization. Does not
CC       show subunit-specific AMPA receptor regulation and regulates all
CC       AMPAR subunits. Thought to stabilize the calcium channel in an
CC       inactivated (closed) state. {ECO:0000269|PubMed:20805473,
CC       ECO:0000269|PubMed:21172611}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Acts as an auxiliary
CC       subunit for AMPA-selective glutamate receptors (AMPARs). Found in
CC       a complex with GRIA1, GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG3, CACNG4, CACNG5 and CACNG7. Interacts with CNIH2 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Cell junction, synapse, postsynaptic cell
CC       membrane, postsynaptic density {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK15019.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAL50049.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF361354; AAL50049.1; ALT_FRAME; mRNA.
DR   EMBL; AC008440; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF234892; AAK15019.1; ALT_SEQ; mRNA.
DR   EMBL; AF288388; AAK20031.1; -; mRNA.
DR   CCDS; CCDS33104.1; -.
DR   RefSeq; NP_114101.4; NM_031895.5.
DR   UniGene; Hs.631595; -.
DR   ProteinModelPortal; Q8WXS5; -.
DR   STRING; 9606.ENSP00000270458; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   TCDB; 8.A.16.2.6; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; Q8WXS5; -.
DR   PhosphoSitePlus; Q8WXS5; -.
DR   BioMuta; CACNG8; -.
DR   DMDM; 313104245; -.
DR   EPD; Q8WXS5; -.
DR   PaxDb; Q8WXS5; -.
DR   PeptideAtlas; Q8WXS5; -.
DR   PRIDE; Q8WXS5; -.
DR   Ensembl; ENST00000638874; ENSP00000492637; ENSG00000142408.
DR   GeneID; 59283; -.
DR   KEGG; hsa:59283; -.
DR   UCSC; uc061clu.1; human.
DR   CTD; 59283; -.
DR   DisGeNET; 59283; -.
DR   EuPathDB; HostDB:ENSG00000142408.2; -.
DR   GeneCards; CACNG8; -.
DR   H-InvDB; HIX0202898; -.
DR   HGNC; HGNC:13628; CACNG8.
DR   HPA; HPA041351; -.
DR   MIM; 606900; gene.
DR   neXtProt; NX_Q8WXS5; -.
DR   OpenTargets; ENSG00000142408; -.
DR   PharmGKB; PA26022; -.
DR   eggNOG; ENOG410IJVW; Eukaryota.
DR   eggNOG; ENOG4110B1C; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233440; -.
DR   HOVERGEN; HBG003682; -.
DR   InParanoid; Q8WXS5; -.
DR   KO; K04873; -.
DR   OrthoDB; EOG091G0D2Z; -.
DR   PhylomeDB; Q8WXS5; -.
DR   TreeFam; TF327980; -.
DR   Reactome; R-HSA-399719; Trafficking of AMPA receptors.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   Reactome; R-HSA-5682910; LGI-ADAM interactions.
DR   ChiTaRS; CACNG8; human.
DR   GenomeRNAi; 59283; -.
DR   PRO; PR:Q8WXS5; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000142408; -.
DR   CleanEx; HS_CACNG6; -.
DR   CleanEx; HS_CACNG8; -.
DR   Genevisible; Q8WXS5; HS.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; NAS:UniProtKB.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; NAS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IBA:GO_Central.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008372; VDCC_g8su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01796; VDCCGAMMA8.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Synapse; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    425       Voltage-dependent calcium channel gamma-8
FT                                subunit.
FT                                /FTId=PRO_0000164690.
FT   TRANSMEM     19     39       Helical. {ECO:0000255}.
FT   TRANSMEM    129    149       Helical. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TRANSMEM    208    228       Helical. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical. {ECO:0000255}.
FT   COMPBIAS    247    380       Gly-rich.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VHW2}.
FT   MOD_RES     255    255       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VHW2}.
FT   CONFLICT     16     16       E -> K (in Ref. 3; AAK15019).
FT                                {ECO:0000305}.
FT   CONFLICT    362    362       A -> S (in Ref. 1; AAL50049).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       G -> R (in Ref. 1; AAL50049).
FT                                {ECO:0000305}.
FT   CONFLICT    394    394       A -> T (in Ref. 1; AAL50049).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       E -> G (in Ref. 1; AAL50049).
FT                                {ECO:0000305}.
SQ   SEQUENCE   425 AA;  43313 MW;  E8C33CC5CF6184A1 CRC64;
     MESLKRWNEE RGLWCEKGVQ VLLTTVGAFA AFGLMTIAIS TDYWLYTRAL ICNTTNLTAG
     GDDGTPHRGG GGASEKKDPG GLTHSGLWRI CCLEGLKRGV CVKINHFPED TDYDHDSAEY
     LLRVVRASSI FPILSAILLL LGGVCVAASR VYKSKRNIIL GAGILFVAAG LSNIIGVIVY
     ISANAGEPGP KRDEEKKNHY SYGWSFYFGG LSFILAEVIG VLAVNIYIER SREAHCQSRS
     DLLKAGGGAG GSGGSGPSAI LRLPSYRFRY RRRSRSSSRS SEPSPSRDAS PGGPGGPGFA
     STDISMYTLS RDPSKGSVAA GLAGAGGGGG GAVGAFGGAA GGAGGGGGGG GGAGAERDRG
     GASGFLTLHN AFPKEAGGGV TVTVTGPPAP PAPAPPAPSA PAPGTLAKEA AASNTNTLNR
     KTTPV
//
ID   CTSR1_MOUSE             Reviewed;         686 AA.
AC   Q91ZR5; Q4PZC3; Q4PZC4; Q4PZC5; Q4PZC6; Q4PZD2;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 115.
DE   RecName: Full=Cation channel sperm-associated protein 1;
DE            Short=CatSper1;
GN   Name=Catsper1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY,
RP   TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=11595941; DOI=10.1038/35098027;
RA   Ren D., Navarro B., Perez G., Jackson A.C., Hsu S., Shi Q.,
RA   Tilly J.L., Clapham D.E.;
RT   "A sperm ion channel required for sperm motility and male fertility.";
RL   Nature 413:603-609(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 19-307, AND VARIANTS HIS-PRO-25
RP   INS; ARG-52; GLN-160 DEL; ILE-270 AND SER-276.
RC   STRAIN=2, 35, 41, 47, 49, 51, 58, 61, 63, and 72;
RX   PubMed=15930155; DOI=10.1093/molbev/msi178;
RA   Podlaha O., Webb D.M., Tucker P.K., Zhang J.;
RT   "Positive selection for indel substitutions in the rodent sperm
RT   protein catsper1.";
RL   Mol. Biol. Evol. 22:1845-1852(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=14657352; DOI=10.1073/pnas.2536658100;
RA   Carlson A.E., Westenbroek R.E., Quill T., Ren D., Clapham D.E.,
RA   Hille B., Garbers D.L., Babcock D.F.;
RT   "CatSper1 required for evoked Ca2+ entry and control of flagellar
RT   function in sperm.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:14864-14868(2003).
RN   [4]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=14688170; DOI=10.1093/humrep/deh043;
RA   Nikpoor P., Mowla S.J., Movahedin M., Ziaee S.A.-M., Tiraihi T.;
RT   "CatSper gene expression in postnatal development of mouse testis and
RT   in subfertile men with deficient sperm motility.";
RL   Hum. Reprod. 19:124-128(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=16036917; DOI=10.1074/jbc.M501430200;
RA   Carlson A.E., Quill T.A., Westenbroek R.E., Schuh S.M., Hille B.,
RA   Babcock D.F.;
RT   "Identical phenotypes of CatSper1 and CatSper2 null sperm.";
RL   J. Biol. Chem. 280:32238-32244(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=16467839; DOI=10.1038/nature04417;
RA   Kirichok Y., Navarro B., Clapham D.E.;
RT   "Whole-cell patch-clamp measurements of spermatozoa reveal an
RT   alkaline-activated Ca2+ channel.";
RL   Nature 439:737-740(2006).
RN   [7]
RP   FUNCTION.
RX   PubMed=17174296; DOI=10.1016/j.ydbio.2006.11.007;
RA   Marquez B., Ignotz G., Suarez S.S.;
RT   "Contributions of extracellular and intracellular Ca2+ to regulation
RT   of sperm motility: release of intracellular stores can hyperactivate
RT   CatSper1 and CatSper2 null sperm.";
RL   Dev. Biol. 303:214-221(2007).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH CATSPERB AND HSPA1B.
RX   PubMed=17478420; DOI=10.1074/jbc.M701083200;
RA   Liu J., Xia J., Cho K.-H., Clapham D.E., Ren D.;
RT   "CatSperbeta, a novel transmembrane protein in the CatSper channel
RT   complex.";
RL   J. Biol. Chem. 282:18945-18952(2007).
RN   [9]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [10]
RP   INTERACTION WITH CATSPER3 AND CATSPER4.
RX   PubMed=17227845; DOI=10.1073/pnas.0610286104;
RA   Qi H., Moran M.M., Navarro B., Chong J.A., Krapivinsky G.,
RA   Krapivinsky L., Kirichok Y., Ramsey I.S., Quill T.A., Clapham D.E.;
RT   "All four CatSper ion channel proteins are required for male fertility
RT   and sperm cell hyperactivated motility.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1219-1223(2007).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH CATSPERB; CATSPERG2 AND HSPA1B.
RX   PubMed=19516020; DOI=10.1095/biolreprod.109.077107;
RA   Wang H., Liu J., Cho K.-H., Ren D.;
RT   "A novel, single, transmembrane protein CATSPERG is associated with
RT   CATSPER1 channel protein.";
RL   Biol. Reprod. 81:539-544(2009).
RN   [12]
RP   LACK OF ACTIVATION BY PROGESTERONE AND PGE1.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [13]
RP   IDENTIFICATION IN THE CATSPER COMPLEX.
RC   STRAIN=C57BL/6J;
RX   PubMed=21224844; DOI=10.1038/ncomms1153;
RA   Chung J.J., Navarro B., Krapivinsky G., Krapivinsky L., Clapham D.E.;
RT   "A novel gene required for male fertility and functional CATSPER
RT   channel formation in spermatozoa.";
RL   Nat. Commun. 2:153-153(2011).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in sperm cell hyperactivation. Controls calcium entry to mediate
CC       the hyperactivated motility, a step needed for sperm motility
CC       which is essential late in the preparation of sperm for
CC       fertilization. Activated by intracellular alkalinization.
CC       {ECO:0000269|PubMed:11595941, ECO:0000269|PubMed:14657352,
CC       ECO:0000269|PubMed:16036917, ECO:0000269|PubMed:16467839,
CC       ECO:0000269|PubMed:17174296}.
CC   -!- ENZYME REGULATION: In contrast to the human ortholog, not
CC       activated by progesterone. {ECO:0000269|PubMed:21412339}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Interacts with
CC       Ca(v)3.3/CACNA1I, leading to suppress T-type calcium channel
CC       activity (By similarity). Component of the CatSper complex.
CC       Interacts with CATSPER3 and CATSPER4. {ECO:0000250,
CC       ECO:0000269|PubMed:17227845, ECO:0000269|PubMed:17478420,
CC       ECO:0000269|PubMed:19516020, ECO:0000269|PubMed:21224844,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q80W99:Catsper3; NbExp=2; IntAct=EBI-15619083, EBI-15619135;
CC       Q8BVN3:Catsper4; NbExp=2; IntAct=EBI-15619083, EBI-15619199;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000269|PubMed:11595941}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11595941}. Note=Specifically located in the
CC       principal piece of sperm tail.
CC   -!- TISSUE SPECIFICITY: Testis-specific.
CC       {ECO:0000269|PubMed:11595941}.
CC   -!- DEVELOPMENTAL STAGE: Detected only after round spermatids are
CC       produced approximately at day 18. {ECO:0000269|PubMed:14688170,
CC       ECO:0000269|PubMed:17347248}.
CC   -!- DISRUPTION PHENOTYPE: Mice are normal but males are sterile. Male
CC       sterility is due to defects in sperm motility unability to
CC       fertilize intact eggs. In mice lacking Catsper1, sperm lacks
CC       CatSper2 protein, while in mice lacking CatSper1, sperm lacks
CC       CatSper1 protein, suggesting that stable expression of CatSper1
CC       protein requires CatSper2 and vice versa.
CC       {ECO:0000269|PubMed:11595941}.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF407332; AAL14104.1; -; mRNA.
DR   EMBL; DQ021482; AAY63820.1; -; Genomic_DNA.
DR   EMBL; DQ021483; AAY63821.1; -; Genomic_DNA.
DR   EMBL; DQ021484; AAY63822.1; -; Genomic_DNA.
DR   EMBL; DQ021485; AAY63823.1; -; Genomic_DNA.
DR   EMBL; DQ021486; AAY63824.1; -; Genomic_DNA.
DR   EMBL; DQ021488; AAY63826.1; -; Genomic_DNA.
DR   EMBL; DQ021489; AAY63827.1; -; Genomic_DNA.
DR   EMBL; DQ021490; AAY63828.1; -; Genomic_DNA.
DR   EMBL; DQ021491; AAY63829.1; -; Genomic_DNA.
DR   EMBL; DQ021492; AAY63830.1; -; Genomic_DNA.
DR   CCDS; CCDS29456.1; -.
DR   RefSeq; NP_647462.1; NM_139301.2.
DR   UniGene; Mm.87321; -.
DR   ProteinModelPortal; Q91ZR5; -.
DR   BioGrid; 230434; 6.
DR   DIP; DIP-60800N; -.
DR   IntAct; Q91ZR5; 3.
DR   STRING; 10090.ENSMUSP00000045430; -.
DR   GuidetoPHARMACOLOGY; 388; -.
DR   TCDB; 1.A.1.19.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q91ZR5; -.
DR   PhosphoSitePlus; Q91ZR5; -.
DR   PaxDb; Q91ZR5; -.
DR   PRIDE; Q91ZR5; -.
DR   DNASU; 225865; -.
DR   Ensembl; ENSMUST00000043380; ENSMUSP00000045430; ENSMUSG00000038498.
DR   GeneID; 225865; -.
DR   KEGG; mmu:225865; -.
DR   UCSC; uc008gcp.1; mouse.
DR   CTD; 117144; -.
DR   MGI; MGI:2179947; Catsper1.
DR   eggNOG; ENOG410IP4H; Eukaryota.
DR   eggNOG; ENOG410Y55D; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000112051; -.
DR   InParanoid; Q91ZR5; -.
DR   KO; K16889; -.
DR   OMA; IYIDNRA; -.
DR   OrthoDB; EOG091G0KAS; -.
DR   PhylomeDB; Q91ZR5; -.
DR   TreeFam; TF329330; -.
DR   Reactome; R-MMU-1300642; Sperm Motility And Taxes.
DR   PRO; PR:Q91ZR5; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000038498; -.
DR   CleanEx; MM_CATSPER1; -.
DR   Genevisible; Q91ZR5; MM.
DR   GO; GO:0036128; C:CatSper complex; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0030317; P:flagellated sperm motility; IMP:MGI.
DR   GO; GO:0007342; P:fusion of sperm to egg plasma membrane involved in single fertilization; IMP:MGI.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:MGI.
DR   GO; GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; IMP:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IMP:MGI.
DR   InterPro; IPR028746; CatSper1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF216; PTHR10037:SF216; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Developmental protein;
KW   Differentiation; Flagellum; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Spermatogenesis; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    686       Cation channel sperm-associated protein
FT                                1.
FT                                /FTId=PRO_0000295675.
FT   TOPO_DOM      1    349       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    350    370       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    371    383       Extracellular. {ECO:0000255}.
FT   TRANSMEM    384    404       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    405    417       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    439    447       Extracellular. {ECO:0000255}.
FT   TRANSMEM    448    468       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    469    485       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    507    521       Extracellular. {ECO:0000255}.
FT   INTRAMEM    522    542       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    543    552       Extracellular. {ECO:0000255}.
FT   TRANSMEM    553    573       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    574    686       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     12    255       His-rich.
FT   VARIANT      25     25       S -> SHP (in strain: 72).
FT   VARIANT      52     52       M -> R (in strain: 2, 47 and 58).
FT                                {ECO:0000269|PubMed:15930155}.
FT   VARIANT     160    160       Missing (in strain: 47).
FT                                {ECO:0000269|PubMed:15930155}.
FT   VARIANT     270    270       T -> I (in strain: 72).
FT                                {ECO:0000269|PubMed:15930155}.
FT   VARIANT     276    276       Y -> S (in strain: 72).
FT                                {ECO:0000269|PubMed:15930155}.
SQ   SEQUENCE   686 AA;  78706 MW;  2E85FFE72B3147BC CRC64;
     MDQSSRRDES YHETHPGSLD PSHQSHPHPH PHPTLHRPNQ GGVYYDSPQH GMFQQPYQQH
     GGFHQQNELQ HLREFSDSHD NAFSHHSYQQ DRAGVSTLPN NISHAYGGSH PLAESQHSGG
     PQSGPRIDPN HHPHQDDPHR PSEPLSHPSS TGSHQGTTHQ QYHERSHHLN PQQNRDHADT
     ISYRSSTRFY RSHAPFSRQE RPHLHADHHH EGHHAHSHHG EHPHHKEQRH YHGDHMHHHI
     HHRSPSASQL SHKSHSTLAT SPSHVGSKST ASGARYTFGA RSQIFGKAQS RESLRESASL
     SEGEDHVQKR KKAQRAHKKA HTGNIFQLLW EKISHLLLGL QQMILSLTQS LGFETFIFIV
     VCLNTVILVA QTFTELEIRG EWYFMVLDSI FLSIYVLEAV LKLIALGLEY FYDPWNNLDF
     FIMVMAVLDF VLLQINSLSY SFYNHSLFRI LKVFKSMRAL RAIRVLRRLS ILTSLHEVAG
     TLSGSLPSIT AILTLMFTCL FLFSVVLRAL FQDSDPKRFQ NIFTTLFTLF TMLTLDDWSL
     IYIDNRAQGA WYIIPILMIY IVIQYFIFLN LVIAVLVDNF QMALLKGLEK VKLEQAARVH
     EKLLDDSLTD LNKADANAQM TEEALKMQLI EGMFGNMTVK QRVLHFQFLQ LVAAVEQHQQ
     KFRSQAYVID ELVDMAFEAG DDDYGK
//
ID   TRPM7_MOUSE             Reviewed;        1863 AA.
AC   Q923J1; A2AI58; Q8C7S7; Q8CE54; Q921Y5; Q925B2; Q9CUT2; Q9JLQ1;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 134.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 7;
DE            EC=2.7.11.1;
DE   AltName: Full=Channel-kinase 1;
DE   AltName: Full=Long transient receptor potential channel 7;
DE            Short=LTrpC-7;
DE            Short=LTrpC7;
DE   AltName: Full=Transient receptor potential-phospholipase C-interacting kinase;
DE            Short=TRP-PLIK;
GN   Name=Trpm7; Synonyms=Chak, Ltrpc7;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND FUNCTION.
RX   PubMed=11385574; DOI=10.1038/35079092;
RA   Nadler M.J.S., Hermosura M.C., Inabe K., Perraud A.-L., Zhu Q.,
RA   Stokes A.J., Kurosaki T., Kinet J.-P., Penner R., Scharenberg A.M.,
RA   Fleig A.;
RT   "LTRPC7 is a Mg.ATP-regulated divalent cation channel required for
RT   cell viability.";
RL   Nature 411:590-595(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, PHOSPHORYLATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF GLY-1797; CYS-1810 AND CYS-1813.
RC   STRAIN=BALB/cJ;
RX   PubMed=11161216; DOI=10.1126/science.1058519;
RA   Runnels L.W., Yue L., Clapham D.E.;
RT   "TRP-PLIK, a bifunctional protein with kinase and ion channel
RT   activities.";
RL   Science 291:1043-1047(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Matsushita M.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-372; 632-1146 AND
RP   1243-1863.
RC   STRAIN=C57BL/6J; TISSUE=Head, and Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1687-1863.
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1502, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1255 AND SER-1445, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Heart, Kidney, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   PHOSPHORYLATION AT SER-1224; SER-1300; SER-1385; SER-1386; THR-1404;
RP   THR-1466; SER-1498; SER-1567; SER-1846 AND SER-1849.
RX   PubMed=22222377; DOI=10.1016/j.bbrc.2011.12.085;
RA   Kim T.Y., Shin S.K., Song M.Y., Lee J.E., Park K.S.;
RT   "Identification of the phosphorylation sites on intact TRPM7 channels
RT   from mammalian cells.";
RL   Biochem. Biophys. Res. Commun. 417:1030-1034(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1551-1828, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=11389851; DOI=10.1016/S1097-2765(01)00256-8;
RA   Yamaguchi H., Matsushita M., Nairn A.C., Kuriyan J.;
RT   "Crystal structure of the atypical protein kinase domain of a TRP
RT   channel with phosphotransferase activity.";
RL   Mol. Cell 7:1047-1057(2001).
CC   -!- FUNCTION: Essential ion channel and serine/threonine-protein
CC       kinase. Divalent cation channel permeable to calcium and
CC       magnesium. Has a central role in magnesium ion homeostasis and in
CC       the regulation of anoxic neuronal cell death. Involved in TNF-
CC       induced necroptosis downstream of MLKL by mediating calcium
CC       influx. The kinase activity is essential for the channel function.
CC       May be involved in a fundamental process that adjusts plasma
CC       membrane divalent cation fluxes according to the metabolic state
CC       of the cell. Phosphorylates annexin A1 (ANXA1).
CC       {ECO:0000269|PubMed:11385574}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:11389851};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:11389851};
CC   -!- SUBUNIT: Forms heterodimers with TRPM6. Interacts with PLCB1 (By
CC       similarity). Homodimer. {ECO:0000250,
CC       ECO:0000269|PubMed:11389851}.
CC   -!- INTERACTION:
CC       P60710:Actb; NbExp=2; IntAct=EBI-8010314, EBI-353957;
CC       Q3U1J4:Ddb1; NbExp=2; IntAct=EBI-8010314, EBI-2552275;
CC       O00571:DDX3X (xeno); NbExp=2; IntAct=EBI-8010314, EBI-353779;
CC       Q8VDD5:Myh9; NbExp=4; IntAct=EBI-8010314, EBI-400906;
CC       Q8N488:RYBP (xeno); NbExp=3; IntAct=EBI-8010314, EBI-752324;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Found to be expressed in brain and skeletal
CC       muscle, with stronger signals in kidney, heart, liver and spleen.
CC       {ECO:0000269|PubMed:11161216}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:11161216,
CC       ECO:0000269|PubMed:22222377}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the protein
CC       kinase superfamily. Alpha-type protein kinase family. ALPK
CC       subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the transient
CC       receptor (TC 1.A.4) family. LTrpC subfamily. TRPM7 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY032951; AAK50377.1; -; mRNA.
DR   EMBL; AF376052; AAK57433.1; -; mRNA.
DR   EMBL; AF149013; AAF73131.1; -; mRNA.
DR   EMBL; AL732330; CAM14550.1; -; Genomic_DNA.
DR   EMBL; AK049329; BAC33685.1; -; mRNA.
DR   EMBL; AK029000; BAC26234.1; -; mRNA.
DR   EMBL; AK014698; BAB29509.1; -; mRNA.
DR   EMBL; BC009137; AAH09137.1; -; mRNA.
DR   CCDS; CCDS16689.1; -.
DR   RefSeq; NP_001157797.1; NM_001164325.1.
DR   RefSeq; NP_067425.2; NM_021450.2.
DR   UniGene; Mm.244705; -.
DR   PDB; 1IA9; X-ray; 2.00 A; A/B=1549-1828.
DR   PDB; 1IAH; X-ray; 2.40 A; A/B=1549-1828.
DR   PDB; 1IAJ; X-ray; 2.80 A; A/B=1549-1828.
DR   PDBsum; 1IA9; -.
DR   PDBsum; 1IAH; -.
DR   PDBsum; 1IAJ; -.
DR   ProteinModelPortal; Q923J1; -.
DR   SMR; Q923J1; -.
DR   BioGrid; 208438; 1.
DR   IntAct; Q923J1; 105.
DR   MINT; MINT-2524821; -.
DR   STRING; 10090.ENSMUSP00000099513; -.
DR   ChEMBL; CHEMBL3714706; -.
DR   GuidetoPHARMACOLOGY; 499; -.
DR   iPTMnet; Q923J1; -.
DR   PhosphoSitePlus; Q923J1; -.
DR   MaxQB; Q923J1; -.
DR   PaxDb; Q923J1; -.
DR   PRIDE; Q923J1; -.
DR   Ensembl; ENSMUST00000103224; ENSMUSP00000099513; ENSMUSG00000027365.
DR   GeneID; 58800; -.
DR   KEGG; mmu:58800; -.
DR   UCSC; uc008mef.2; mouse.
DR   CTD; 54822; -.
DR   MGI; MGI:1929996; Trpm7.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOVERGEN; HBG055663; -.
DR   InParanoid; Q923J1; -.
DR   KO; K04982; -.
DR   OMA; KQGPTNP; -.
DR   OrthoDB; EOG091G0DHL; -.
DR   PhylomeDB; Q923J1; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-MMU-3295583; TRP channels.
DR   EvolutionaryTrace; Q923J1; -.
DR   PRO; PR:Q923J1; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000027365; -.
DR   ExpressionAtlas; Q923J1; baseline and differential.
DR   Genevisible; Q923J1; MM.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0001726; C:ruffle; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005262; F:calcium channel activity; IDA:MGI.
DR   GO; GO:0016301; F:kinase activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017022; F:myosin binding; IPI:MGI.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031032; P:actomyosin structure organization; IDA:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IDA:MGI.
DR   GO; GO:0016340; P:calcium-dependent cell-matrix adhesion; IDA:MGI.
DR   GO; GO:0010961; P:cellular magnesium ion homeostasis; IEA:InterPro.
DR   GO; GO:0070266; P:necroptotic process; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:MGI.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   Gene3D; 1.20.5.1010; -; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   InterPro; IPR029601; TRPM7.
DR   InterPro; IPR032415; TRPM_tetra.
DR   InterPro; IPR037162; TRPM_tetra_sf.
DR   PANTHER; PTHR13800:SF8; PTHR13800:SF8; 1.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF16519; TRPM_tetra; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calcium; Calcium channel;
KW   Calcium transport; Coiled coil; Complete proteome; Ion channel;
KW   Ion transport; Kinase; Membrane; Metal-binding; Necrosis;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   CHAIN         1   1863       Transient receptor potential cation
FT                                channel subfamily M member 7.
FT                                /FTId=PRO_0000215332.
FT   TOPO_DOM      1    755       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    756    776       Helical. {ECO:0000255}.
FT   TOPO_DOM    777    855       Extracellular. {ECO:0000255}.
FT   TRANSMEM    856    876       Helical. {ECO:0000255}.
FT   TOPO_DOM    877    918       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    919    939       Helical. {ECO:0000255}.
FT   TOPO_DOM    940    962       Extracellular. {ECO:0000255}.
FT   TRANSMEM    963    983       Helical. {ECO:0000255}.
FT   TOPO_DOM    984    995       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    996   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1035       Extracellular. {ECO:0000255}.
FT   INTRAMEM   1036   1056       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM   1057   1074       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1075   1095       Helical. {ECO:0000255}.
FT   TOPO_DOM   1096   1863       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN     1592   1822       Alpha-type protein kinase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00501}.
FT   NP_BIND    1792   1798       ATP.
FT   COILED     1198   1250       {ECO:0000250}.
FT   ACT_SITE   1765   1765       Proton acceptor.
FT   METAL      1751   1751       Zinc.
FT   METAL      1808   1808       Zinc.
FT   METAL      1810   1810       Zinc.
FT   METAL      1814   1814       Zinc.
FT   BINDING    1622   1622       ATP.
FT   BINDING    1646   1646       ATP.
FT   BINDING    1718   1718       ATP.
FT   BINDING    1767   1767       ATP.
FT   BINDING    1775   1775       ATP.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES    1224   1224       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1255   1255       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    1300   1300       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1385   1385       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1386   1386       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1389   1389       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES    1394   1394       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES    1403   1403       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES    1404   1404       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1445   1445       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    1466   1466       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1498   1498       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1502   1502       Phosphoserine.
FT                                {ECO:0000244|PubMed:19144319}.
FT   MOD_RES    1525   1525       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96QT4}.
FT   MOD_RES    1567   1567       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1846   1846       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MOD_RES    1849   1849       Phosphoserine.
FT                                {ECO:0000269|PubMed:22222377}.
FT   MUTAGEN    1797   1797       G->D: Severe reduction of kinase
FT                                activity. {ECO:0000269|PubMed:11161216}.
FT   MUTAGEN    1810   1810       C->A: Loss of kinase activity; when
FT                                associated with A-1813.
FT                                {ECO:0000269|PubMed:11161216}.
FT   MUTAGEN    1813   1813       C->A: Loss of kinase activity; when
FT                                associated with A-1820.
FT                                {ECO:0000269|PubMed:11161216}.
FT   CONFLICT     66     66       K -> R (in Ref. 3; AAF73131).
FT                                {ECO:0000305}.
FT   CONFLICT    338    338       L -> F (in Ref. 5; BAB29509).
FT                                {ECO:0000305}.
FT   CONFLICT    723    723       K -> E (in Ref. 5; BAC33685).
FT                                {ECO:0000305}.
FT   CONFLICT    810    810       I -> T (in Ref. 5; BAC33685).
FT                                {ECO:0000305}.
FT   CONFLICT   1494   1494       Missing (in Ref. 2; AAK57433 and 5;
FT                                BAC26234). {ECO:0000305}.
FT   HELIX      1555   1562       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1563   1565       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1576   1583       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1585   1588       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1590   1595       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1598   1600       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1605   1613       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1620   1632       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1633   1635       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1641   1648       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1650   1655       {ECO:0000244|PDB:1IA9}.
FT   TURN       1657   1659       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1664   1689       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1704   1708       {ECO:0000244|PDB:1IA9}.
FT   TURN       1709   1712       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1713   1719       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1726   1729       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1741   1756       {ECO:0000244|PDB:1IA9}.
FT   TURN       1757   1759       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1760   1764       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1767   1769       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1772   1775       {ECO:0000244|PDB:1IAJ}.
FT   STRAND     1777   1780       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1786   1788       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1790   1793       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1800   1807       {ECO:0000244|PDB:1IA9}.
FT   HELIX      1812   1816       {ECO:0000244|PDB:1IA9}.
FT   STRAND     1822   1824       {ECO:0000244|PDB:1IAJ}.
SQ   SEQUENCE   1863 AA;  212399 MW;  87551B4431CAD773 CRC64;
     MSQKSWIEST LTKRECVYII PSSKDPHRCL PGCQICQQLV RCFCGRLVKQ HACFTASLAM
     KYSDVKLGEH FNQAIEEWSV EKHTEQSPTD AYGVINFQGG SHSYRAKYVR LSYDTKPEII
     LQLLLKEWQM ELPKLVISVH GGMQKFELHP RIKQLLGKGL IKAAVTTGAW ILTGGVNTGV
     AKHVGDALKE HASRSSRKIC TIGIAPWGVI ENRNDLVGRD VVAPYQTLLN PLSKLNVLNN
     LHSHFILVDD GTVGKYGAEV RLRRELEKTI NQQRIHARIG QGVPVVALIF EGGPNVILTV
     LEYLQESPPV PVVVCEGTGR AADLLAYIHK QTEEGGNLPD AAEPDIISTI KKTFNFGQSE
     AVHLFQTMME CMKKKELITV FHIGSEDHQD IDVAILTALL KGTNASAFDQ LILTLAWDRV
     DIAKNHVFVY GQQWLVGSLE QAMLDALVMD RVSFVKLLIE NGVSMHKFLT IPRLEELYNT
     KQGPTNPMLF HLIRDVKQGN LPPGYKITLI DIGLVIEYLM GGTYRCTYTR KRFRLIYNSL
     GGNNRRSGRN TSSSTPQLRK SHETFGNRAD KKEKMRHNHF IKTAQPYRPK MDASMEEGKK
     KRTKDEIVDI DDPETKRFPY PLNELLIWAC LMKRQVMARF LWQHGEESMA KALVACKIYR
     SMAYEAKQSD LVDDTSEELK QYSNDFGQLA VELLEQSFRQ DETMAMKLLT YELKNWSNST
     CLKLAVSSRL RPFVAHTCTQ MLLSDMWMGR LNMRKNSWYK VILSILVPPA ILMLEYKTKA
     EMSHIPQSQD AHQMTMEDSE NNFHNITEEI PMEVFKEVKI LDSSDGKNEM EIHIKSKKLP
     ITRKFYAFYH APIVKFWFNT LAYLGFLMLY TFVVLVKMEQ LPSVQEWIVI AYIFTYAIEK
     VREVFMSEAG KISQKIKVWF SDYFNVSDTI AIISFFVGFG LRFGAKWNYI NAYDNHVFVA
     GRLIYCLNII FWYVRLLDFL AVNQQAGPYV MMIGKMVANM FYIVVIMALV LLSFGVPRKA
     ILYPHEEPSW SLAKDIVFHP YWMIFGEVYA YEIDVCANDS TLPTICGPGT WLTPFLQAVY
     LFVQYIIMVN LLIAFFNNVY LQVKAISNIV WKYQRYHFIM AYHEKPVLPP PLIILSHIVS
     LFCCVCKRRK KDKTSDGPKL FLTEEDQKKL HDFEEQCVEM YFDEKDDKFN SGSEERIRVT
     FERVEQMSIQ IKEVGDRVNY IKRSLQSLDS QIGHLQDLSA LTVDTLKTLT AQKASEASKV
     HNEITRELSI SKHLAQNLID DVPVRPLWKK PSAVNTLSSS LPQGDRESNN PFLCNIFMKD
     EKDPQYNLFG QDLPVIPQRK EFNIPEAGSS CGALFPSAVS PPELRQRRHG VEMLKIFNKN
     QKLGSSPNSS PHMSSPPTKF SVSTPSQPSC KSHLESTTKD QEPIFYKAAE GDNIEFGAFV
     GHRDSMDLQR FKETSNKIRE LLSNDTPENT LKHVGAAGYS ECCKTSTSLH SVQAESCSRR
     ASTEDSPEVD SKAALLPDWL RDRPSNREMP SEGGTLNGLA SPFKPVLDTN YYYSAVERNN
     LMRLSQSIPF VPVPPRGEPV TVYRLEESSP SILNNSMSSW SQLGLCAKIE FLSKEEMGGG
     LRRAVKVLCT WSEHDILKSG HLYIIKSFLP EVINTWSSIY KEDTVLHLCL REIQQQRAAQ
     KLTFAFNQMK PKSIPYSPRF LEVFLLYCHS AGQWFAVEEC MTGEFRKYNN NNGDEIIPTN
     TLEEIMLAFS HWTYEYTRGE LLVLDLQGVG ENLTDPSVIK AEEKRSCDMV FGPANLGEDA
     IKNFRAKHHC NSCCRKLKLP DLKRNDYTPD KIIFPQDESS DLNLQSGNST KESEATNSVR
     LML
//
ID   RYR2_HUMAN              Reviewed;        4967 AA.
AC   Q92736; Q15411; Q546N8; Q5T3P2;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   22-NOV-2017, entry version 194.
DE   RecName: Full=Ryanodine receptor 2;
DE            Short=RYR-2;
DE            Short=RyR2;
DE            Short=hRYR-2;
DE   AltName: Full=Cardiac muscle ryanodine receptor;
DE   AltName: Full=Cardiac muscle ryanodine receptor-calcium release channel;
DE   AltName: Full=Type 2 ryanodine receptor;
GN   Name=RYR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Heart muscle;
RX   PubMed=8809036; DOI=10.1042/bj3180477;
RA   Tunwell R.E.A., Wickenden C., Bertrand B.M.A., Shevchenko V.I.,
RA   Walsh M.B., Allen P.D., Lai F.A.;
RT   "The human cardiac muscle ryanodine receptor-calcium release channel:
RT   identification, primary structure and topological analysis.";
RL   Biochem. J. 318:477-487(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARVD2 GLN-176;
RP   PRO-433; ILE-2386 AND MET-2504.
RX   PubMed=11159936; DOI=10.1093/hmg/10.3.189;
RA   Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F.,
RA   Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C.,
RA   Thiene G., Danieli G.A., Rampazzo A.;
RT   "Identification of mutations in the cardiac ryanodine receptor gene in
RT   families affected with arrhythmogenic right ventricular cardiomyopathy
RT   type 2 (ARVD2).";
RL   Hum. Mol. Genet. 10:189-194(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-87 AND 533-681, DEVELOPMENTAL STAGE,
RP   AND INDUCTION BY TGFB1.
RC   TISSUE=Heart muscle, and Myometrium;
RX   PubMed=9148749; DOI=10.1042/bj3220777;
RA   Awad S.S., Lamb H.K., Morgan J.M., Dunlop W., Gillespie J.I.;
RT   "Differential expression of ryanodine receptor RyR2 mRNA in the non-
RT   pregnant and pregnant human myometrium.";
RL   Biochem. J. 322:777-783(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4292-4479, AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum, and Hippocampus;
RX   PubMed=9607712; DOI=10.1016/S0306-4522(97)00612-X;
RA   Martin C., Chapman K.E., Seckl J.R., Ashley R.H.;
RT   "Partial cloning and differential expression of ryanodine
RT   receptor/calcium-release channel genes in human tissues including the
RT   hippocampus and cerebellum.";
RL   Neuroscience 85:205-216(1998).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH FKBP1B; PP1; PP2A AKAP6 AND
RP   PKA, INTERACTION WITH FKBP1B; PKA; PP1 AND PP2A, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, MUTAGENESIS OF SER-2808, AND PHOSPHORYLATION AT
RP   SER-2808.
RX   PubMed=10830164; DOI=10.1016/S0092-8674(00)80847-8;
RA   Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D.,
RA   Rosemblit N., Marks A.R.;
RT   "PKA phosphorylation dissociates FKBP12.6 from the calcium release
RT   channel (ryanodine receptor): defective regulation in failing
RT   hearts.";
RL   Cell 101:365-376(2000).
RN   [7]
RP   INTERACTION WITH CALM AND S100A1.
RX   PubMed=18650434; DOI=10.1074/jbc.M804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [8]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-2808 AND SER-2814.
RX   PubMed=20056922; DOI=10.1161/CIRCRESAHA.109.203836;
RA   Neef S., Dybkova N., Sossalla S., Ort K.R., Fluschnik N., Neumann K.,
RA   Seipelt R., Schondube F.A., Hasenfuss G., Maier L.S.;
RT   "CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+
RT   levels in right atrial myocardium of patients with atrial
RT   fibrillation.";
RL   Circ. Res. 106:1134-1144(2010).
RN   [9]
RP   REVIEW.
RX   PubMed=11805843; DOI=10.1038/415198a;
RA   Bers D.M.;
RT   "Cardiac excitation-contraction coupling.";
RL   Nature 415:198-205(2002).
RN   [10]
RP   REVIEW.
RX   PubMed=19482609; DOI=10.2741/3591;
RA   Currie S.;
RT   "Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping
RT   the balance right.";
RL   Front. Biosci. 14:5134-5156(2009).
RN   [11]
RP   REVIEW.
RX   PubMed=21472222; DOI=10.3892/mmr_00000240;
RA   Ozawa T.;
RT   "Modulation of ryanodine receptor Ca2+ channels.";
RL   Mol. Med. Report. 3:199-204(2010).
RN   [12]
RP   REVIEW.
RX   PubMed=20961976; DOI=10.1101/cshperspect.a003996;
RA   Lanner J.T., Georgiou D.K., Joshi A.D., Hamilton S.L.;
RT   "Ryanodine receptors: structure, expression, molecular details, and
RT   function in calcium release.";
RL   Cold Spring Harb. Perspect. Biol. 2:E3996-E3996(2010).
RN   [13] {ECO:0000244|PDB:4JKQ}
RP   X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS) OF 1-606, AND CHARACTERIZATION
RP   OF VARIANT CPVT1 PHE-419.
RX   PubMed=25372681; DOI=10.1107/S1399004714020343;
RA   Borko L., Bauerova-Hlinkova V., Hostinova E., Gasperik J., Beck K.,
RA   Lai F.A., Zahradnikova A., Sevcik J.;
RT   "Structural insights into the human RyR2 N-terminal region involved in
RT   cardiac arrhythmias.";
RL   Acta Crystallogr. D 70:2897-2912(2014).
RN   [14]
RP   VARIANTS CPVT1 LEU-2246; SER-2474; LYS-4104 AND CYS-4497.
RX   PubMed=11208676; DOI=10.1161/01.CIR.103.2.196;
RA   Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R.,
RA   Sorrentino V.V., Danieli G.A.;
RT   "Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie
RT   catecholaminergic polymorphic ventricular tachycardia.";
RL   Circulation 103:196-200(2001).
RN   [15]
RP   VARIANTS CPVT1 SER-2328; ARG-4201 AND PHE-4653, AND VARIANT ARG-2958.
RX   PubMed=11157710; DOI=10.1161/01.CIR.103.4.485;
RA   Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M.,
RA   Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M.,
RA   Toivonen L., Stephan D.A., Kontula K.;
RT   "Mutations of the cardiac ryanodine receptor (RyR2) gene in familial
RT   polymorphic ventricular tachycardia.";
RL   Circulation 103:485-490(2001).
RN   [16]
RP   VARIANTS CPVT1 LEU-2246; ASP-2311; SER-2474; PHE-3778; SER-3946;
RP   SER-3946; LYS-4104; CYS-4497; ILE-4771; GLY-4860; MET-4867; ASP-4895
RP   AND LYS-4950.
RX   PubMed=12093772; DOI=10.1161/01.CIR.0000020013.73106.D8;
RA   Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F.,
RA   Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R.,
RA   Cruz Filho F.E.S., Vignati G., Benatar A., DeLogu A.;
RT   "Clinical and molecular characterization of patients with
RT   catecholaminergic polymorphic ventricular tachycardia.";
RL   Circulation 106:69-74(2002).
RN   [17]
RP   VARIANTS CPVT1 GLN-176; TRP-420; PRO-433; ILE-2386; CYS-2392 AND
RP   MET-2504.
RX   PubMed=12106942; DOI=10.1016/S0735-1097(02)01946-0;
RA   Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N.,
RA   Turrini P., Thiene G., Danieli G.A., Nava A.;
RT   "Screening for ryanodine receptor type 2 mutations in families with
RT   effort-induced polymorphic ventricular arrhythmias and sudden death:
RT   early diagnosis of asymptomatic carriers.";
RL   J. Am. Coll. Cardiol. 40:341-349(2002).
RN   [18]
RP   VARIANTS CPVT1 ILE-2306; LEU-4902 AND GLN-4959.
RX   PubMed=14571276; DOI=10.1038/sj.ejhg.5201061;
RA   Laitinen P.J., Swan H., Kontula K.;
RT   "Molecular genetics of exercise-induced polymorphic ventricular
RT   tachycardia: identification of three novel cardiac ryanodine receptor
RT   mutations and two common calsequestrin 2 amino-acid polymorphisms.";
RL   Eur. J. Hum. Genet. 11:888-891(2003).
RN   [19]
RP   VARIANTS CPVT1 SER-164; LEU-414; PHE-419; THR-2403; CYS-4499;
RP   THR-4510; ARG-4671 AND VAL-4848.
RX   PubMed=15466642; DOI=10.1161/01.CIR.0000144471.98080.CA;
RA   Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M.,
RA   Ackerman M.J.;
RT   "Spectrum and frequency of cardiac channel defects in swimming-
RT   triggered arrhythmia syndromes.";
RL   Circulation 110:2119-2124(2004).
RN   [20]
RP   VARIANTS CPVT1 ILE-4504 AND ALA-4880.
RX   PubMed=15046072;
RA   Bagattin A., Veronese C., Rampazzo A., Danieli G.A.;
RT   "Gene symbol: RYR2. Disease: effort-induced polymorphic ventricular
RT   arrhythmias.";
RL   Hum. Genet. 114:404-404(2004).
RN   [21]
RP   VARIANTS CPVT1 PRO-2387 AND PRO-4607.
RX   PubMed=15046073;
RA   Bagattin A., Veronese C., Rampazzo A., Danieli G.A.;
RT   "Gene symbol: RYR2. Disease: effort-induced polymorphic ventricular
RT   arrhythmias.";
RL   Hum. Genet. 114:405-405(2004).
RN   [22]
RP   VARIANTS CPVT1 TRP-420; LEU-2246; SER-4097; LYS-4146; PRO-4158 AND
RP   CYS-4497.
RX   PubMed=15544015; DOI=10.4065/79.11.1380;
RA   Tester D.J., Spoon D.B., Valdivia H.H., Makielski J.C., Ackerman M.J.;
RT   "Targeted mutational analysis of the RyR2-encoded cardiac ryanodine
RT   receptor in sudden unexplained death: a molecular autopsy of 49
RT   medical examiner/coroner's cases.";
RL   Mayo Clin. Proc. 79:1380-1384(2004).
RN   [23]
RP   VARIANTS CPVT1 GLN-176; LEU-414; PHE-419; ALA-466; THR-2403; PHE-3800;
RP   THR-4124; CYS-4499; THR-4510; THR-4556; VAL-4848 AND GLN-4959.
RX   PubMed=16188589; DOI=10.1016/j.hrthm.2005.07.012;
RA   Tester D.J., Kopplin L.J., Will M.L., Ackerman M.J.;
RT   "Spectrum and prevalence of cardiac ryanodine receptor (RyR2)
RT   mutations in a cohort of unrelated patients referred explicitly for
RT   long QT syndrome genetic testing.";
RL   Heart Rhythm 2:1099-1105(2005).
RN   [24]
RP   VARIANT GLU-4955.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C.,
RA   Patry L., Massicotte C., Ambalavanan A., Spiegelman D., Diallo O.,
RA   Henrion E., Dionne-Laporte A., Fougerat A., Pshezhetsky A.V.,
RA   Venkateswaran S., Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
RN   [25]
RP   CHARACTERIZATION OF VARIANT CPVT1 GLY-4860.
RX   PubMed=17984046; DOI=10.1073/pnas.0706573104;
RA   Jiang D., Chen W., Wang R., Zhang L., Chen S.R.W.;
RT   "Loss of luminal Ca(2+) activation in the cardiac ryanodine receptor
RT   is associated with ventricular fibrillation and sudden death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:18309-18314(2007).
RN   [26]
RP   VARIANT CPVT1 PRO-4159.
RX   PubMed=24793461; DOI=10.1016/j.hrthm.2014.04.037;
RA   Di Pino A., Caruso E., Costanzo L., Guccione P.;
RT   "A novel RyR2 mutation in a 2-year-old baby presenting with atrial
RT   fibrillation, atrial flutter, and atrial ectopic tachycardia.";
RL   Heart Rhythm 11:1480-1483(2014).
RN   [27]
RP   VARIANT ASP-29.
RX   PubMed=25463374; DOI=10.1016/j.ijcard.2014.11.119;
RA   Cheung J.W., Meli A.C., Xie W., Mittal S., Reiken S., Wronska A.,
RA   Xu L., Steinberg J.S., Markowitz S.M., Iwai S., Lacampagne A.,
RA   Lerman B.B., Marks A.R.;
RT   "Short-coupled polymorphic ventricular tachycardia at rest linked to a
RT   novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under
RT   non-stress conditions.";
RL   Int. J. Cardiol. 180:228-236(2015).
RN   [28]
RP   CHARACTERIZATION OF VARIANT ASP-29.
RX   PubMed=26405799; DOI=10.1371/journal.pone.0139058;
RA   Xiao Z., Guo W., Yuen S.M., Wang R., Zhang L., Van Petegem F.,
RA   Chen S.R.;
RT   "The H29D nutation does not enhance cytosolic Ca2+ activation of the
RT   cardiac ryanodine receptor.";
RL   PLoS ONE 10:E0139058-E0139058(2015).
RN   [29]
RP   CHARACTERIZATION OF VARIANTS CVPT1 SER-3946; THR-4124; PRO-4158 AND
RP   PRO-4159, MUTAGENESIS OF GLY-3946; MET-3978 AND HIS-4108, AND
RP   FUNCTION.
RX   PubMed=27733687; DOI=10.1074/jbc.M116.756528;
RA   Xiao Z., Guo W., Sun B., Hunt D.J., Wei J., Liu Y., Wang Y., Wang R.,
RA   Jones P.P., Back T.G., Chen S.R.;
RT   "Enhanced cytosolic Ca2+ activation underlies a common defect of
RT   central domain cardiac ryanodine receptor mutations linked to
RT   arrhythmias.";
RL   J. Biol. Chem. 291:24528-24537(2016).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm and thereby plays a
CC       key role in triggering cardiac muscle contraction. Aberrant
CC       channel activation can lead to cardiac arrhythmia. In cardiac
CC       myocytes, calcium release is triggered by increased Ca(2+) levels
CC       due to activation of the L-type calcium channel CACNA1C. The
CC       calcium channel activity is modulated by formation of
CC       heterotetramers with RYR3. Required for cellular calcium ion
CC       homeostasis. Required for embryonic heart development.
CC       {ECO:0000269|PubMed:10830164, ECO:0000269|PubMed:20056922,
CC       ECO:0000269|PubMed:27733687}.
CC   -!- ENZYME REGULATION: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity. Channel activity is regulated by calmodulin
CC       (CALM). The calcium release is activated by increased cytoplasmic
CC       calcium levels, by nitric oxyde (NO), caffeine and ATP. Channel
CC       activity is inhibited by magnesium ions, possibly by competition
CC       for calcium binding sites. {ECO:0000250|UniProtKB:P11716}.
CC   -!- SUBUNIT: Homotetramer. Can also form heterotetramers with RYR1 and
CC       RYR3 (By similarity). Interacts with FKBP1A and FKBP1B; these
CC       interactions may stabilize the channel in its closed state and
CC       prevent Ca(2+) leaks. Interacts with CALM and S100A1; these
CC       interactions regulate channel activity. Identified in a complex
CC       composed of RYR2, FKBP1B, PKA catalytic subunit, PRKAR2A, AKAP6,
CC       and the protein phosphatases PP2A and PP1. Interacts directly with
CC       FKBP1B, PKA, PP1 and PP2A. Interacts with SELENON (By similarity).
CC       {ECO:0000250|UniProtKB:P30957, ECO:0000269|PubMed:10830164,
CC       ECO:0000269|PubMed:18650434}.
CC   -!- INTERACTION:
CC       P62942:FKBP1A; NbExp=2; IntAct=EBI-1170425, EBI-1027571;
CC       P68106:FKBP1B; NbExp=5; IntAct=EBI-1170425, EBI-6693977;
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-1170425, EBI-389668;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10830164}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10830164}. Membrane
CC       {ECO:0000305|PubMed:10830164}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:10830164}. Sarcoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P30957}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-
CC       terminus and C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92736-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92736-2; Sequence=VSP_005953;
CC   -!- TISSUE SPECIFICITY: Detected in heart muscle (at protein level).
CC       Heart muscle, brain (cerebellum and hippocampus) and placenta.
CC       {ECO:0000269|PubMed:10830164, ECO:0000269|PubMed:9607712}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in myometrium during pregnancy.
CC       {ECO:0000269|PubMed:9148749}.
CC   -!- INDUCTION: By TGFB1. {ECO:0000269|PubMed:9148749}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305}.
CC   -!- PTM: Channel activity is modulated by phosphorylation.
CC       Phosphorylation at Ser-2808 and Ser-2814 increases the open
CC       probability of the calcium channel. Phosphorylation is increased
CC       in failing heart, leading to calcium leaks and increased
CC       cytoplasmic Ca(2+) levels. {ECO:0000269|PubMed:10830164,
CC       ECO:0000269|PubMed:20056922}.
CC   -!- PTM: Phosphorylation at Ser-2031 by PKA enhances the response to
CC       lumenal calcium. {ECO:0000250}.
CC   -!- DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2
CC       (ARVD2) [MIM:600996]: A congenital heart disease characterized by
CC       infiltration of adipose and fibrous tissue into the right
CC       ventricle and loss of myocardial cells, resulting in ventricular
CC       and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Ventricular tachycardia, catecholaminergic polymorphic,
CC       1, with or without atrial dysfunction and/or dilated
CC       cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder
CC       characterized by stress-induced, bidirectional ventricular
CC       tachycardia that may degenerate into cardiac arrest and cause
CC       sudden death. Patients present with recurrent syncope, seizures,
CC       or sudden death after physical activity or emotional stress. CPVT1
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:11157710,
CC       ECO:0000269|PubMed:11208676, ECO:0000269|PubMed:12093772,
CC       ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:14571276,
CC       ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073,
CC       ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015,
CC       ECO:0000269|PubMed:16188589, ECO:0000269|PubMed:17984046,
CC       ECO:0000269|PubMed:24793461, ECO:0000269|PubMed:25372681,
CC       ECO:0000269|PubMed:27733687}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH71369.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAH71393.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAH73918.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI14440.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI15350.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI15936.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI22065.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ryanodine receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Ryanodine_receptor";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=RYR2 entry;
CC       URL="https://en.wikipedia.org/wiki/RYR2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X98330; CAA66975.1; -; mRNA.
DR   EMBL; AJ300340; CAC18855.1; -; Genomic_DNA.
DR   EMBL; AJ300341; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300342; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300343; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300347; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300349; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300351; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300353; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300355; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300364; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300363; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300362; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300361; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300360; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300359; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300358; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300357; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300356; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300373; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300372; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300371; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300370; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300369; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300368; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300367; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300366; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300365; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300382; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300381; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300380; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300379; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300378; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300377; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300376; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300375; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300374; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300399; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300398; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300397; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300396; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300395; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300394; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300393; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300392; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300391; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300416; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300415; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300414; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300413; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300412; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300411; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300410; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300409; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300408; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300433; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300432; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300431; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300430; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300429; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300428; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300427; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300426; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300425; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300444; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300443; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300442; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300441; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300440; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300439; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300438; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300437; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300436; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300435; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300434; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300424; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300423; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300422; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300421; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300420; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300419; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300418; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300417; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300407; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300406; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300405; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300404; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300403; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300402; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300401; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300400; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300390; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300389; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300388; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300387; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300386; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300385; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300384; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300383; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300354; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300352; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300350; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300348; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300346; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300345; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300344; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH71369.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH71393.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL356773; CAH73918.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL359924; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI14440.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI15350.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI15936.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI22065.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; Y08218; CAA69395.1; -; mRNA.
DR   EMBL; X91869; CAA62975.1; -; mRNA.
DR   EMBL; AJ002511; CAA05502.1; -; mRNA.
DR   CCDS; CCDS55691.1; -. [Q92736-1]
DR   PIR; S72269; S72269.
DR   RefSeq; NP_001026.2; NM_001035.2. [Q92736-1]
DR   RefSeq; XP_006711868.1; XM_006711805.3. [Q92736-2]
DR   UniGene; Hs.109514; -.
DR   UniGene; Hs.738571; -.
DR   PDB; 4JKQ; X-ray; 2.39 A; A=1-606.
DR   PDBsum; 4JKQ; -.
DR   ProteinModelPortal; Q92736; -.
DR   SMR; Q92736; -.
DR   BioGrid; 112174; 26.
DR   DIP; DIP-38325N; -.
DR   IntAct; Q92736; 12.
DR   MINT; MINT-1201008; -.
DR   STRING; 9606.ENSP00000355533; -.
DR   ChEMBL; CHEMBL4403; -.
DR   DrugBank; DB09085; Tetracaine.
DR   GuidetoPHARMACOLOGY; 748; -.
DR   TCDB; 1.A.3.1.1; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q92736; -.
DR   PhosphoSitePlus; Q92736; -.
DR   BioMuta; RYR2; -.
DR   DMDM; 308153558; -.
DR   EPD; Q92736; -.
DR   MaxQB; Q92736; -.
DR   PaxDb; Q92736; -.
DR   PeptideAtlas; Q92736; -.
DR   PRIDE; Q92736; -.
DR   Ensembl; ENST00000366574; ENSP00000355533; ENSG00000198626. [Q92736-1]
DR   GeneID; 6262; -.
DR   KEGG; hsa:6262; -.
DR   UCSC; uc001hyl.2; human. [Q92736-1]
DR   CTD; 6262; -.
DR   DisGeNET; 6262; -.
DR   EuPathDB; HostDB:ENSG00000198626.15; -.
DR   GeneCards; RYR2; -.
DR   GeneReviews; RYR2; -.
DR   HGNC; HGNC:10484; RYR2.
DR   HPA; HPA020028; -.
DR   MalaCards; RYR2; -.
DR   MIM; 180902; gene.
DR   MIM; 600996; phenotype.
DR   MIM; 604772; phenotype.
DR   neXtProt; NX_Q92736; -.
DR   OpenTargets; ENSG00000198626; -.
DR   Orphanet; 3286; Catecholaminergic polymorphic ventricular tachycardia.
DR   Orphanet; 293899; Familial isolated arrhythmogenic ventricular dysplasia, biventricular form.
DR   Orphanet; 293888; Familial isolated arrhythmogenic ventricular dysplasia, left dominant form.
DR   Orphanet; 293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   InParanoid; Q92736; -.
DR   KO; K04962; -.
DR   OMA; EHMPNDT; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; Q92736; -.
DR   TreeFam; TF315244; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   SIGNOR; Q92736; -.
DR   ChiTaRS; RYR2; human.
DR   GeneWiki; Ryanodine_receptor_2; -.
DR   GenomeRNAi; 6262; -.
DR   PRO; PR:Q92736; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000198626; -.
DR   CleanEx; HS_RYR2; -.
DR   ExpressionAtlas; Q92736; baseline and differential.
DR   Genevisible; Q92736; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; ISS:BHF-UCL.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL.
DR   GO; GO:0015278; F:calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0044325; F:ion channel binding; ISS:BHF-UCL.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0043924; F:suramin binding; IMP:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; IDA:BHF-UCL.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:BHF-UCL.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; ISS:BHF-UCL.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISS:BHF-UCL.
DR   GO; GO:0005513; P:detection of calcium ion; IDA:BHF-UCL.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072599; P:establishment of protein localization to endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0003220; P:left ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL.
DR   GO; GO:1901896; P:positive regulation of calcium-transporting ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0010460; P:positive regulation of heart rate; ISS:BHF-UCL.
DR   GO; GO:0051284; P:positive regulation of sequestering of calcium ion; IDA:BHF-UCL.
DR   GO; GO:0098735; P:positive regulation of the force of heart contraction; IMP:BHF-UCL.
DR   GO; GO:0086029; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; ISS:BHF-UCL.
DR   GO; GO:0098910; P:regulation of atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098904; P:regulation of AV node cell action potential; IMP:BHF-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISS:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:0098907; P:regulation of SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098911; P:regulation of ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IMP:BHF-UCL.
DR   GO; GO:0031000; P:response to caffeine; IDA:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; ISS:BHF-UCL.
DR   GO; GO:0014850; P:response to muscle activity; IMP:BHF-UCL.
DR   GO; GO:0035994; P:response to muscle stretch; IMP:BHF-UCL.
DR   GO; GO:0051775; P:response to redox state; IDA:BHF-UCL.
DR   GO; GO:0070296; P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL.
DR   GO; GO:0097050; P:type B pancreatic cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; ISS:BHF-UCL.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Cardiomyopathy; Coiled coil;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   4967       Ryanodine receptor 2.
FT                                /FTId=PRO_0000219361.
FT   TOPO_DOM      1   4281       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4282   4302       Helical. {ECO:0000255}.
FT   TRANSMEM   4504   4524       Helical. {ECO:0000255}.
FT   TRANSMEM   4580   4600       Helical. {ECO:0000255}.
FT   TRANSMEM   4730   4750       Helical. {ECO:0000255}.
FT   TRANSMEM   4769   4789       Helical. {ECO:0000255}.
FT   INTRAMEM   4820   4829       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4850   4870       Helical. {ECO:0000255}.
FT   TOPO_DOM   4871   4967       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      110    165       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      172    217       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      225    280       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      286    343       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      351    408       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      599    809       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      853    966       1.
FT   REPEAT      967   1080       2.
FT   DOMAIN     1025   1222       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1337   1562       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2692   2810       3.
FT   REPEAT     2812   2925       4.
FT   REGION      853   2925       4 X approximate repeats.
FT   REGION     3581   3610       Interaction with CALM.
FT                                {ECO:0000269|PubMed:18650434}.
FT   COILED     4412   4445       {ECO:0000255}.
FT   COMPBIAS   4414   4455       Glu-rich (acidic).
FT   MOD_RES    1341   1341       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    1869   1869       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B0LPN4}.
FT   MOD_RES    2031   2031       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2369   2369       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2697   2697       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B0LPN4}.
FT   MOD_RES    2797   2797       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2808   2808       Phosphoserine; by CaMK2D and PKA.
FT                                {ECO:0000269|PubMed:10830164,
FT                                ECO:0000269|PubMed:20056922}.
FT   MOD_RES    2811   2811       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2814   2814       Phosphoserine; by CaMK2D.
FT                                {ECO:0000269|PubMed:20056922}.
FT   MOD_RES    2947   2947       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   VAR_SEQ    3715   3715       E -> EVTGSQRSK (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005953.
FT   VARIANT      29     29       H -> D (found in a patient with short-
FT                                coupled polymorphic ventricular
FT                                tachycardia at rest; unknown pathological
FT                                significance; no effect on cytosolic
FT                                Ca(2+) activation).
FT                                {ECO:0000269|PubMed:25463374,
FT                                ECO:0000269|PubMed:26405799}.
FT                                /FTId=VAR_075283.
FT   VARIANT     164    164       P -> S (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642}.
FT                                /FTId=VAR_044086.
FT   VARIANT     176    176       R -> Q (in ARVD2 and CPVT1;
FT                                dbSNP:rs794728708).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044087.
FT   VARIANT     414    414       R -> L (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044088.
FT   VARIANT     419    419       I -> F (in CPVT1; decreases protein
FT                                stability). {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589,
FT                                ECO:0000269|PubMed:25372681}.
FT                                /FTId=VAR_044089.
FT   VARIANT     420    420       R -> W (in CPVT1; dbSNP:rs190140598).
FT                                {ECO:0000269|PubMed:12106942,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044090.
FT   VARIANT     433    433       L -> P (in ARVD2 and CPVT1;
FT                                dbSNP:rs121918602).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_011395.
FT   VARIANT     466    466       P -> A (in CPVT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079513.
FT   VARIANT     507    507       V -> I (in dbSNP:rs16835270).
FT                                /FTId=VAR_044091.
FT   VARIANT    1886   1886       G -> S (in dbSNP:rs3766871).
FT                                /FTId=VAR_022078.
FT   VARIANT    2246   2246       S -> L (in CPVT1; dbSNP:rs121918597).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_011396.
FT   VARIANT    2306   2306       V -> I (in CPVT1; dbSNP:rs794728746).
FT                                {ECO:0000269|PubMed:14571276}.
FT                                /FTId=VAR_023694.
FT   VARIANT    2311   2311       E -> D (in CPVT1; dbSNP:rs794728747).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044092.
FT   VARIANT    2328   2328       P -> S (in CPVT1; dbSNP:rs121918603).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011397.
FT   VARIANT    2386   2386       N -> I (in ARVD2 and CPVT1;
FT                                dbSNP:rs121918601).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_011398.
FT   VARIANT    2387   2387       A -> P (in CPVT1).
FT                                {ECO:0000269|PubMed:15046073}.
FT                                /FTId=VAR_044093.
FT   VARIANT    2392   2392       Y -> C (in CPVT1; dbSNP:rs772220753).
FT                                {ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_044094.
FT   VARIANT    2403   2403       A -> T (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044095.
FT   VARIANT    2474   2474       R -> S (in CPVT1; dbSNP:rs121918598).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_011399.
FT   VARIANT    2504   2504       T -> M (in ARVD2 and CPVT1;
FT                                dbSNP:rs769219555).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_044096.
FT   VARIANT    2958   2958       Q -> R (in dbSNP:rs34967813).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011590.
FT   VARIANT    3778   3778       L -> F (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044097.
FT   VARIANT    3800   3800       C -> F (in CPVT1).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079514.
FT   VARIANT    3946   3946       G -> S (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation;
FT                                dbSNP:rs794728777).
FT                                {ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_044098.
FT   VARIANT    4097   4097       N -> S (in CPVT1; dbSNP:rs794728784).
FT                                {ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044099.
FT   VARIANT    4104   4104       N -> K (in CPVT1; dbSNP:rs121918599).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_011400.
FT   VARIANT    4124   4124       S -> T (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:16188589,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_079515.
FT   VARIANT    4146   4146       E -> K (in CPVT1).
FT                                {ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044100.
FT   VARIANT    4158   4158       T -> P (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:15544015,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_044101.
FT   VARIANT    4159   4159       Q -> P (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:24793461,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_079516.
FT   VARIANT    4201   4201       Q -> R (in CPVT1; dbSNP:rs121918605).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011401.
FT   VARIANT    4497   4497       R -> C (in CPVT1; dbSNP:rs121918600).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_011402.
FT   VARIANT    4499   4499       F -> C (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044102.
FT   VARIANT    4504   4504       M -> I (in CPVT1).
FT                                {ECO:0000269|PubMed:15046072}.
FT                                /FTId=VAR_044103.
FT   VARIANT    4510   4510       A -> T (in CPVT1; dbSNP:rs397516510).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044104.
FT   VARIANT    4556   4556       A -> T (in CPVT1).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079517.
FT   VARIANT    4607   4607       A -> P (in CPVT1).
FT                                {ECO:0000269|PubMed:15046073}.
FT                                /FTId=VAR_044105.
FT   VARIANT    4653   4653       V -> F (in CPVT1; dbSNP:rs121918604).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011403.
FT   VARIANT    4671   4671       G -> R (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642}.
FT                                /FTId=VAR_044106.
FT   VARIANT    4771   4771       V -> I (in CPVT1; dbSNP:rs794728804).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044107.
FT   VARIANT    4848   4848       I -> V (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044108.
FT   VARIANT    4860   4860       A -> G (in CPVT1; diminishes the response
FT                                to activation by luminal Ca(2+) but has
FT                                little effect on the sensitivity of the
FT                                channel to activation by cytosolic
FT                                Ca(2+); shows caffeine-induced Ca(2+)
FT                                release but exhibits no store-overload-
FT                                induced Ca(2+) release (SOICR); HL1
FT                                cardiac cells transfected with the G-4860
FT                                mutant displayed attenuated SOICR
FT                                activity compared to cells transfected
FT                                with wild-type RYR2; dbSNP:rs121918606).
FT                                {ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:17984046}.
FT                                /FTId=VAR_044109.
FT   VARIANT    4867   4867       I -> M (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044110.
FT   VARIANT    4880   4880       V -> A (in CPVT1).
FT                                {ECO:0000269|PubMed:15046072}.
FT                                /FTId=VAR_044111.
FT   VARIANT    4895   4895       N -> D (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044112.
FT   VARIANT    4902   4902       P -> L (in CPVT1).
FT                                {ECO:0000269|PubMed:14571276}.
FT                                /FTId=VAR_023695.
FT   VARIANT    4950   4950       E -> K (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044113.
FT   VARIANT    4955   4955       G -> E (probable disease-associated
FT                                mutation found in a patient with
FT                                intellectual disability, seizures, short
FT                                stature and severe atrial arrhythmias).
FT                                {ECO:0000269|PubMed:25356899}.
FT                                /FTId=VAR_078648.
FT   VARIANT    4959   4959       R -> Q (in CPVT1; dbSNP:rs794728811).
FT                                {ECO:0000269|PubMed:14571276,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_023696.
FT   MUTAGEN    2808   2808       S->A: Abolishes phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:10830164}.
FT   MUTAGEN    3946   3946       G->A: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    3978   3978       M->I: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    4108   4108       H->N: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    4108   4108       H->Q: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   CONFLICT   1037   1037       L -> P (in Ref. 1; CAA66975 and 2;
FT                                CAC18855). {ECO:0000305}.
FT   CONFLICT   2785   2789       WGWRI -> RTMRT (in Ref. 1; CAA66975 and
FT                                2; CAC18855). {ECO:0000305}.
FT   STRAND       19     28       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       31     38       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       48     51       {ECO:0000244|PDB:4JKQ}.
FT   TURN         53     57       {ECO:0000244|PDB:4JKQ}.
FT   HELIX        63     65       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       67     73       {ECO:0000244|PDB:4JKQ}.
FT   TURN        108    110       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      118    127       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      129    132       {ECO:0000244|PDB:4JKQ}.
FT   TURN        139    141       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      145    151       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      159    166       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      180    185       {ECO:0000244|PDB:4JKQ}.
FT   TURN        186    188       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      191    196       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      198    208       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      212    218       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      233    238       {ECO:0000244|PDB:4JKQ}.
FT   TURN        239    242       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      243    246       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      250    252       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       256    258       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      261    263       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       265    269       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       271    273       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      275    280       {ECO:0000244|PDB:4JKQ}.
FT   TURN        283    286       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      295    299       {ECO:0000244|PDB:4JKQ}.
FT   TURN        300    302       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      305    308       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      310    312       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      314    317       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       319    321       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       324    327       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      329    336       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      340    342       {ECO:0000244|PDB:4JKQ}.
FT   TURN        356    358       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      360    365       {ECO:0000244|PDB:4JKQ}.
FT   TURN        366    368       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      371    375       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      388    396       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      403    407       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       410    437       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       442    444       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       449    462       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       472    491       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       494    506       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      508    510       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       511    518       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       520    541       {ECO:0000244|PDB:4JKQ}.
SQ   SEQUENCE   4967 AA;  564567 MW;  44984485F8677B42 CRC64;
     MADGGEGEDE IQFLRTDDEV VLQCTATIHK EQQKLCLAAE GFGNRLCFLE STSNSKNVPP
     DLSICTFVLE QSLSVRALQE MLANTVEKSE GQVDVEKWKF MMKTAQGGGH RTLLYGHAIL
     LRHSYSGMYL CCLSTSRSST DKLAFDVGLQ EDTTGEACWW TIHPASKQRS EGEKVRVGDD
     LILVSVSSER YLHLSYGNGS LHVDAAFQQT LWSVAPISSG SEAAQGYLIG GDVLRLLHGH
     MDECLTVPSG EHGEEQRRTV HYEGGAVSVH ARSLWRLETL RVAWSGSHIR WGQPFRLRHV
     TTGKYLSLME DKNLLLMDKE KADVKSTAFT FRSSKEKLDV GVRKEVDGMG TSEIKYGDSV
     CYIQHVDTGL WLTYQSVDVK SVRMGSIQRK AIMHHEGHMD DGISLSRSQH EESRTARVIR
     STVFLFNRFI RGLDALSKKA KASTVDLPIE SVSLSLQDLI GYFHPPDEHL EHEDKQNRLR
     ALKNRQNLFQ EEGMINLVLE CIDRLHVYSS AAHFADVAGR EAGESWKSIL NSLYELLAAL
     IRGNRKNCAQ FSGSLDWLIS RLERLEASSG ILEVLHCVLV ESPEALNIIK EGHIKSIISL
     LDKHGRNHKV LDVLCSLCVC HGVAVRSNQH LICDNLLPGR DLLLQTRLVN HVSSMRPNIF
     LGVSEGSAQY KKWYYELMVD HTEPFVTAEA THLRVGWAST EGYSPYPGGG EEWGGNGVGD
     DLFSYGFDGL HLWSGCIART VSSPNQHLLR TDDVISCCLD LSAPSISFRI NGQPVQGMFE
     NFNIDGLFFP VVSFSAGIKV RFLLGGRHGE FKFLPPPGYA PCYEAVLPKE KLKVEHSREY
     KQERTYTRDL LGPTVSLTQA AFTPIPVDTS QIVLPPHLER IREKLAENIH ELWVMNKIEL
     GWQYGPVRDD NKRQHPCLVE FSKLPEQERN YNLQMSLETL KTLLALGCHV GISDEHAEDK
     VKKMKLPKNY QLTSGYKPAP MDLSFIKLTP SQEAMVDKLA ENAHNVWARD RIRQGWTYGI
     QQDVKNRRNP RLVPYTLLDD RTKKSNKDSL REAVRTLLGY GYNLEAPDQD HAARAEVCSG
     TGERFRIFRA EKTYAVKAGR WYFEFETVTA GDMRVGWSRP GCQPDQELGS DERAFAFDGF
     KAQRWHQGNE HYGRSWQAGD VVGCMVDMNE HTMMFTLNGE ILLDDSGSEL AFKDFDVGDG
     FIPVCSLGVA QVGRMNFGKD VSTLKYFTIC GLQEGYEPFA VNTNRDITMW LSKRLPQFLQ
     VPSNHEHIEV TRIDGTIDSS PCLKVTQKSF GSQNSNTDIM FYRLSMPIEC AEVFSKTVAG
     GLPGAGLFGP KNDLEDYDAD SDFEVLMKTA HGHLVPDRVD KDKEATKPEF NNHKDYAQEK
     PSRLKQRFLL RRTKPDYSTS HSARLTEDVL ADDRDDYDFL MQTSTYYYSV RIFPGQEPAN
     VWVGWITSDF HQYDTGFDLD RVRTVTVTLG DEKGKVHESI KRSNCYMVCA GESMSPGQGR
     NNNGLEIGCV VDAASGLLTF IANGKELSTY YQVEPSTKLF PAVFAQATSP NVFQFELGRI
     KNVMPLSAGL FKSEHKNPVP QCPPRLHVQF LSHVLWSRMP NQFLKVDVSR ISERQGWLVQ
     CLDPLQFMSL HIPEENRSVD ILELTEQEEL LKFHYHTLRL YSAVCALGNH RVAHALCSHV
     DEPQLLYAIE NKYMPGLLRA GYYDLLIDIH LSSYATARLM MNNEYIVPMT EETKSITLFP
     DENKKHGLPG IGLSTSLRPR MQFSSPSFVS ISNECYQYSP EFPLDILKSK TIQMLTEAVK
     EGSLHARDPV GGTTEFLFVP LIKLFYTLLI MGIFHNEDLK HILQLIEPSV FKEAATPEEE
     SDTLEKELSV DDAKLQGAGE EEAKGGKRPK EGLLQMKLPE PVKLQMCLLL QYLCDCQVRH
     RIEAIVAFSD DFVAKLQDNQ RFRYNEVMQA LNMSAALTAR KTKEFRSPPQ EQINMLLNFK
     DDKSECPCPE EIRDQLLDFH EDLMTHCGIE LDEDGSLDGN SDLTIRGRLL SLVEKVTYLK
     KKQAEKPVES DSKKSSTLQQ LISETMVRWA QESVIEDPEL VRAMFVLLHR QYDGIGGLVR
     ALPKTYTING VSVEDTINLL ASLGQIRSLL SVRMGKEEEK LMIRGLGDIM NNKVFYQHPN
     LMRALGMHET VMEVMVNVLG GGESKEITFP KMVANCCRFL CYFCRISRQN QKAMFDHLSY
     LLENSSVGLA SPAMRGSTPL DVAAASVMDN NELALALREP DLEKVVRYLA GCGLQSCQML
     VSKGYPDIGW NPVEGERYLD FLRFAVFCNG ESVEENANVV VRLLIRRPEC FGPALRGEGG
     NGLLAAMEEA IKIAEDPSRD GPSPNSGSSK TLDTEEEEDD TIHMGNAIMT FYSALIDLLG
     RCAPEMHLIH AGKGEAIRIR SILRSLIPLG DLVGVISIAF QMPTIAKDGN VVEPDMSAGF
     CPDHKAAMVL FLDRVYGIEV QDFLLHLLEV GFLPDLRAAA SLDTAALSAT DMALALNRYL
     CTAVLPLLTR CAPLFAGTEH HASLIDSLLH TVYRLSKGCS LTKAQRDSIE VCLLSICGQL
     RPSMMQHLLR RLVFDVPLLN EHAKMPLKLL TNHYERCWKY YCLPGGWGNF GAASEEELHL
     SRKLFWGIFD ALSQKKYEQE LFKLALPCLS AVAGALPPDY MESNYVSMME KQSSMDSEGN
     FNPQPVDTSN ITIPEKLEYF INKYAEHSHD KWSMDKLANG WIYGEIYSDS SKVQPLMKPY
     KLLSEKEKEI YRWPIKESLK TMLAWGWRIE RTREGDSMAL YNRTRRISQT SQVSVDAAHG
     YSPRAIDMSN VTLSRDLHAM AEMMAENYHN IWAKKKKMEL ESKGGGNHPL LVPYDTLTAK
     EKAKDREKAQ DILKFLQING YAVSRGFKDL ELDTPSIEKR FAYSFLQQLI RYVDEAHQYI
     LEFDGGSRGK GEHFPYEQEI KFFAKVVLPL IDQYFKNHRL YFLSAASRPL CSGGHASNKE
     KEMVTSLFCK LGVLVRHRIS LFGNDATSIV NCLHILGQTL DARTVMKTGL ESVKSALRAF
     LDNAAEDLEK TMENLKQGQF THTRNQPKGV TQIINYTTVA LLPMLSSLFE HIGQHQFGED
     LILEDVQVSC YRILTSLYAL GTSKSIYVER QRSALGECLA AFAGAFPVAF LETHLDKHNI
     YSIYNTKSSR ERAALSLPTN VEDVCPNIPS LEKLMEEIVE LAESGIRYTQ MPHVMEVILP
     MLCSYMSRWW EHGPENNPER AEMCCTALNS EHMNTLLGNI LKIIYNNLGI DEGAWMKRLA
     VFSQPIINKV KPQLLKTHFL PLMEKLKKKA ATVVSEEDHL KAEARGDMSE AELLILDEFT
     TLARDLYAFY PLLIRFVDYN RAKWLKEPNP EAEELFRMVA EVFIYWSKSH NFKREEQNFV
     VQNEINNMSF LITDTKSKMS KAAVSDQERK KMKRKGDRYS MQTSLIVAAL KRLLPIGLNI
     CAPGDQELIA LAKNRFSLKD TEDEVRDIIR SNIHLQGKLE DPAIRWQMAL YKDLPNRTDD
     TSDPEKTVER VLDIANVLFH LEQKSKRVGR RHYCLVEHPQ RSKKAVWHKL LSKQRKRAVV
     ACFRMAPLYN LPRHRAVNLF LQGYEKSWIE TEEHYFEDKL IEDLAKPGAE PPEEDEGTKR
     VDPLHQLILL FSRTALTEKC KLEEDFLYMA YADIMAKSCH DEEDDDGEEE VKSFEEKEME
     KQKLLYQQAR LHDRGAAEMV LQTISASKGE TGPMVAATLK LGIAILNGGN STVQQKMLDY
     LKEKKDVGFF QSLAGLMQSC SVLDLNAFER QNKAEGLGMV TEEGSGEKVL QDDEFTCDLF
     RFLQLLCEGH NSDFQNYLRT QTGNNTTVNI IISTVDYLLR VQESISDFYW YYSGKDVIDE
     QGQRNFSKAI QVAKQVFNTL TEYIQGPCTG NQQSLAHSRL WDAVVGFLHV FAHMQMKLSQ
     DSSQIELLKE LMDLQKDMVV MLLSMLEGNV VNGTIGKQMV DMLVESSNNV EMILKFFDMF
     LKLKDLTSSD TFKEYDPDGK GVISKRDFHK AMESHKHYTQ SETEFLLSCA ETDENETLDY
     EEFVKRFHEP AKDIGFNVAV LLTNLSEHMP NDTRLQTFLE LAESVLNYFQ PFLGRIEIMG
     SAKRIERVYF EISESSRTQW EKPQVKESKR QFIFDVVNEG GEKEKMELFV NFCEDTIFEM
     QLAAQISESD LNERSANKEE SEKERPEEQG PRMAFFSILT VRSALFALRY NILTLMRMLS
     LKSLKKQMKK VKKMTVKDMV TAFFSSYWSI FMTLLHFVAS VFRGFFRIIC SLLLGGSLVE
     GAKKIKVAEL LANMPDPTQD EVRGDGEEGE RKPLEAALPS EDLTDLKELT EESDLLSDIF
     GLDLKREGGQ YKLIPHNPNA GLSDLMSNPV PMPEVQEKFQ EQKAKEEEKE EKEETKSEPE
     KAEGEDGEKE EKAKEDKGKQ KLRQLHTHRY GEPEVPESAF WKKIIAYQQK LLNYFARNFY
     NMRMLALFVA FAINFILLFY KVSTSSVVEG KELPTRSSSE NAKVTSLDSS SHRIIAVHYV
     LEESSGYMEP TLRILAILHT VISFFCIIGY YCLKVPLVIF KREKEVARKL EFDGLYITEQ
     PSEDDIKGQW DRLVINTQSF PNNYWDKFVK RKVMDKYGEF YGRDRISELL GMDKAALDFS
     DAREKKKPKK DSSLSAVLNS IDVKYQMWKL GVVFTDNSFL YLAWYMTMSV LGHYNNFFFA
     AHLLDIAMGF KTLRTILSSV THNGKQLVLT VGLLAVVVYL YTVVAFNFFR KFYNKSEDGD
     TPDMKCDDML TCYMFHMYVG VRAGGGIGDE IEDPAGDEYE IYRIIFDITF FFFVIVILLA
     IIQGLIIDAF GELRDQQEQV KEDMETKCFI CGIGNDYFDT VPHGFETHTL QEHNLANYLF
     FLMYLINKDE TEHTGQESYV WKMYQERCWE FFPAGDCFRK QYEDQLN
//
ID   TPC1_ARATH              Reviewed;         733 AA.
AC   Q94KI8; Q948T1; Q9ZT83;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 127.
DE   RecName: Full=Two pore calcium channel protein 1;
DE   AltName: Full=Calcium channel protein 1;
DE            Short=AtCCH1;
DE   AltName: Full=Fatty acid oxygenation up-regulated protein 2;
DE   AltName: Full=Voltage-dependent calcium channel protein TPC1;
DE            Short=AtTPC1;
GN   Name=TPC1; Synonyms=CCH1, FOU2; OrderedLocusNames=At4g03560;
GN   ORFNames=F9H3.19, T5L23.5;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Leaf;
RX   PubMed=11577183; DOI=10.1093/pcp/pce145;
RA   Furuichi T., Cunningham K.W., Muto S.;
RT   "A putative two pore channel AtTPC1 mediates Ca(2+) flux in
RT   Arabidopsis leaf cells.";
RL   Plant Cell Physiol. 42:900-905(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=15772667; DOI=10.1038/nature03381;
RA   Peiter E., Maathuis F.J.M., Mills L.N., Knight H., Pelloux J.,
RA   Hetherington A.M., Sanders D.;
RT   "The vacuolar Ca(2+)-activated channel TPC1 regulates germination and
RT   stomatal movement.";
RL   Nature 434:404-408(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   REVIEW.
RX   PubMed=12175911; DOI=10.1016/S0005-2736(02)00509-6;
RA   White P.J., Bowen H.C., Demidchik V., Nichols C., Davies J.M.;
RT   "Genes for calcium-permeable channels in the plasma membrane of plant
RT   root cells.";
RL   Biochim. Biophys. Acta 1564:299-309(2002).
RN   [6]
RP   FUNCTION.
RX   PubMed=15464979; DOI=10.1016/j.bbrc.2004.09.015;
RA   Kawano T., Kadono T., Fumoto K., Lapeyrie F., Kuse M., Isobe M.,
RA   Furuichi T., Muto S.;
RT   "Aluminum as a specific inhibitor of plant TPC1 Ca(2+) channels.";
RL   Biochem. Biophys. Res. Commun. 324:40-45(2004).
RN   [7]
RP   REVIEW.
RX   PubMed=17355948; DOI=10.1093/jxb/erm035;
RA   Pottosin I.I., Schoenknecht G.;
RT   "Vacuolar calcium channels.";
RL   J. Exp. Bot. 58:1559-1569(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=17151019; DOI=10.1074/mcp.M600250-MCP200;
RA   Jaquinod M., Villiers F., Kieffer-Jaquinod S., Hugouvieux V.,
RA   Bruley C., Garin J., Bourguignon J.;
RT   "A proteomics dissection of Arabidopsis thaliana vacuoles isolated
RT   from cell culture.";
RL   Mol. Cell. Proteomics 6:394-412(2007).
RN   [9]
RP   MUTAGENESIS OF ASP-454.
RX   PubMed=17981874; DOI=10.1093/pcp/pcm151;
RA   Bonaventure G., Gfeller A., Rodriguez V.M., Armand F., Farmer E.E.;
RT   "The fou2 gain-of-function allele and the wild-type allele of two pore
RT   channel 1 contribute to different extents or by different mechanisms
RT   to defense gene expression in Arabidopsis.";
RL   Plant Cell Physiol. 48:1775-1789(2007).
RN   [10]
RP   MUTAGENESIS OF ASP-454.
RX   PubMed=17253984; DOI=10.1111/j.1365-313X.2006.03002.x;
RA   Bonaventure G., Gfeller A., Proebsting W.M., Hoertensteiner S.,
RA   Chetelat A., Martinoia E., Farmer E.E.;
RT   "A gain-of-function allele of TPC1 activates oxylipin biogenesis after
RT   leaf wounding in Arabidopsis.";
RL   Plant J. 49:889-898(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
CC   -!- FUNCTION: Functions as a voltage-gated inward-rectifying Ca(2+)
CC       channel (VDCC) across the vacuole membrane. Is one of the
CC       essential components of the slow vacuolar (SV) channel. Acts as
CC       the major ROS-responsive Ca(2+) channel and is the possible target
CC       of Al-dependent inhibition. Involved in the regulation of
CC       germination and stomatal movement. {ECO:0000269|PubMed:15464979,
CC       ECO:0000269|PubMed:15772667}.
CC   -!- ENZYME REGULATION: Inhibited by Al(3+).
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1552909, EBI-1552909;
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:15772667, ECO:0000269|PubMed:17151019}; Multi-
CC       pass membrane protein {ECO:0000255, ECO:0000269|PubMed:15772667}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11577183}.
CC   -!- DOMAIN: Each of the two internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively
CC       charged transmembrane segment (S4). S4 segments probably represent
CC       the voltage-sensor and are characterized by a series of positively
CC       charged amino acids (By similarity). {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Plants display an impairment of both the
CC       Ca(2+) inhibition of stomatal guard cell opening and abscisic acid
CC       (ABA) inhibition of seed germination.
CC       {ECO:0000269|PubMed:15772667}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. Two pore calcium channel subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD11598.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAD15312.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB77841.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB053952; BAB55460.1; -; mRNA.
DR   EMBL; AF360372; AAK39554.1; -; mRNA.
DR   EMBL; AC005142; AAD15312.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF071527; AAD11598.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161497; CAB77841.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE82337.1; -; Genomic_DNA.
DR   PIR; B85045; B85045.
DR   RefSeq; NP_567258.1; NM_116594.5.
DR   UniGene; At.3957; -.
DR   PDB; 5DQQ; X-ray; 2.87 A; A=12-733.
DR   PDB; 5E1J; X-ray; 3.31 A; A=1-733.
DR   PDB; 5TUA; X-ray; 3.30 A; A=1-733.
DR   PDBsum; 5DQQ; -.
DR   PDBsum; 5E1J; -.
DR   PDBsum; 5TUA; -.
DR   ProteinModelPortal; Q94KI8; -.
DR   SMR; Q94KI8; -.
DR   BioGrid; 10969; 8.
DR   DIP; DIP-39873N; -.
DR   IntAct; Q94KI8; 1.
DR   STRING; 3702.AT4G03560.1; -.
DR   TCDB; 1.A.1.11.26; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q94KI8; -.
DR   SwissPalm; Q94KI8; -.
DR   PaxDb; Q94KI8; -.
DR   PRIDE; Q94KI8; -.
DR   EnsemblPlants; AT4G03560.1; AT4G03560.1; AT4G03560.
DR   GeneID; 825655; -.
DR   Gramene; AT4G03560.1; AT4G03560.1; AT4G03560.
DR   KEGG; ath:AT4G03560; -.
DR   Araport; AT4G03560; -.
DR   TAIR; locus:2128716; AT4G03560.
DR   eggNOG; ENOG410INF7; Eukaryota.
DR   eggNOG; ENOG410XZT8; LUCA.
DR   HOGENOM; HOG000029959; -.
DR   InParanoid; Q94KI8; -.
DR   KO; K16900; -.
DR   OMA; WLGFHTF; -.
DR   OrthoDB; EOG093603ZA; -.
DR   PhylomeDB; Q94KI8; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q94KI8; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q94KI8; baseline and differential.
DR   Genevisible; Q94KI8; AT.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:TAIR.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000325; C:plant-type vacuole; IDA:TAIR.
DR   GO; GO:0005886; C:plasma membrane; TAS:TAIR.
DR   GO; GO:0005774; C:vacuolar membrane; IDA:TAIR.
DR   GO; GO:0005773; C:vacuole; IDA:TAIR.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:TAIR.
DR   GO; GO:0006816; P:calcium ion transport; IMP:TAIR.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:TAIR.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0080141; P:regulation of jasmonic acid biosynthetic process; IMP:TAIR.
DR   GO; GO:0010119; P:regulation of stomatal movement; IMP:TAIR.
DR   GO; GO:0009845; P:seed germination; IMP:TAIR.
DR   CDD; cd00051; EFh; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028801; TPC1.
DR   PANTHER; PTHR10037:SF231; PTHR10037:SF231; 1.
DR   Pfam; PF00520; Ion_trans; 2.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Vacuole; Voltage-gated channel.
FT   CHAIN         1    733       Two pore calcium channel protein 1.
FT                                /FTId=PRO_0000343169.
FT   TOPO_DOM      1     71       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM     93    120       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    142    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    180    180       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    181    199       Helical; Voltage-sensor; Name=S4 of
FT                                repeat I. {ECO:0000255}.
FT   TOPO_DOM    200    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    240    245       Vacuolar. {ECO:0000255}.
FT   INTRAMEM    246    260       Pore-forming; Name=Pore-forming 1.
FT   TOPO_DOM    261    282       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    304    428       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    429    449       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    450    465       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    487    498       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    499    519       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    520    528       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    529    546       Helical; Voltage-sensor; Name=S4 of
FT                                repeat II. {ECO:0000255}.
FT   TOPO_DOM    547    557       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    558    578       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    579    615       Vacuolar. {ECO:0000255}.
FT   INTRAMEM    616    630       Pore-forming; Name=Pore-forming 2.
FT   TOPO_DOM    631    651       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    652    672       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    673    733       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      322    357       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      363    398       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MUTAGEN     454    454       D->N: In fou2; shows elevated LOX and AOS
FT                                activity levels and an increased
FT                                resistance to B.cinerea. Strongly
FT                                increases oxylipin biogenesis in response
FT                                to wounding.
FT                                {ECO:0000269|PubMed:17253984,
FT                                ECO:0000269|PubMed:17981874}.
FT   CONFLICT     33     33       K -> R (in Ref. 1; BAB55460).
FT                                {ECO:0000305}.
FT   CONFLICT    256    256       Y -> F (in Ref. 1; BAB55460).
FT                                {ECO:0000305}.
FT   CONFLICT    612    612       N -> T (in Ref. 1; BAB55460).
FT                                {ECO:0000305}.
FT   HELIX        33     46       {ECO:0000244|PDB:5DQQ}.
FT   HELIX        62     71       {ECO:0000244|PDB:5DQQ}.
FT   HELIX        73     91       {ECO:0000244|PDB:5DQQ}.
FT   STRAND       95     97       {ECO:0000244|PDB:5E1J}.
FT   STRAND       98    102       {ECO:0000244|PDB:5DQQ}.
FT   STRAND      106    108       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       117    136       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       137    141       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       144    149       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       151    172       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       189    196       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       200    237       {ECO:0000244|PDB:5DQQ}.
FT   STRAND      239    241       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       242    244       {ECO:0000244|PDB:5DQQ}.
FT   TURN        245    250       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       251    262       {ECO:0000244|PDB:5DQQ}.
FT   TURN        263    266       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       267    270       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       272    277       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       281    294       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       296    334       {ECO:0000244|PDB:5DQQ}.
FT   STRAND      339    343       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       344    357       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       367    376       {ECO:0000244|PDB:5DQQ}.
FT   STRAND      377    379       {ECO:0000244|PDB:5TUA}.
FT   STRAND      382    384       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       385    397       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       418    427       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       430    456       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       461    486       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       488    493       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       495    516       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       525    532       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       533    547       {ECO:0000244|PDB:5DQQ}.
FT   TURN        549    551       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       552    586       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       595    602       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       605    609       {ECO:0000244|PDB:5DQQ}.
FT   STRAND      613    615       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       616    628       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       633    643       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       648    659       {ECO:0000244|PDB:5DQQ}.
FT   TURN        660    662       {ECO:0000244|PDB:5DQQ}.
FT   HELIX       663    685       {ECO:0000244|PDB:5DQQ}.
SQ   SEQUENCE   733 AA;  84873 MW;  1CA978D6B8BFF445 CRC64;
     MEDPLIGRDS LGGGGTDRVR RSEAITHGTP FQKAAALVDL AEDGIGLPVE ILDQSSFGES
     ARYYFIFTRL DLIWSLNYFA LLFLNFFEQP LWCEKNPKPS CKDRDYYYLG ELPYLTNAES
     IIYEVITLAI LLVHTFFPIS YEGSRIFWTS RLNLVKVACV VILFVDVLVD FLYLSPLAFD
     FLPFRIAPYV RVIIFILSIR ELRDTLVLLS GMLGTYLNIL ALWMLFLLFA SWIAFVMFED
     TQQGLTVFTS YGATLYQMFI LFTTSNNPDV WIPAYKSSRW SSVFFVLYVL IGVYFVTNLI
     LAVVYDSFKE QLAKQVSGMD QMKRRMLEKA FGLIDSDKNG EIDKNQCIKL FEQLTNYRTL
     PKISKEEFGL IFDELDDTRD FKINKDEFAD LCQAIALRFQ KEEVPSLFEH FPQIYHSALS
     QQLRAFVRSP NFGYAISFIL IINFIAVVVE TTLDIEESSA QKPWQVAEFV FGWIYVLEMA
     LKIYTYGFEN YWREGANRFD FLVTWVIVIG ETATFITPDE NTFFSNGEWI RYLLLARMLR
     LIRLLMNVQR YRAFIATFIT LIPSLMPYLG TIFCVLCIYC SIGVQVFGGL VNAGNKKLFE
     TELAEDDYLL FNFNDYPNGM VTLFNLLVMG NWQVWMESYK DLTGTWWSIT YFVSFYVITI
     LLLLNLVVAF VLEAFFTELD LEEEEKCQGQ DSQEKRNRRR SAGSKSRSQR VDTLLHHMLG
     DELSKPECST SDT
//
ID   FLOWR_DROME             Reviewed;         194 AA.
AC   Q95T12; Q8IQM8; Q9VUU2;
DT   24-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   20-DEC-2017, entry version 114.
DE   RecName: Full=Calcium channel flower {ECO:0000303|PubMed:19737521};
DE            Short=3L5 {ECO:0000303|PubMed:19737521};
GN   Name=fwe; Synonyms=flower; ORFNames=CG6151;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000312|EMBL:AAN11767.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAN11767.1}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAL25424.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAL25424.1};
RC   TISSUE=Embryo {ECO:0000269|PubMed:12537569};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [4] {ECO:0000305}
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-79 AND
RP   GLY-128.
RX   PubMed=19737521; DOI=10.1016/j.cell.2009.06.033;
RA   Yao C.-K., Lin Y.Q., Ly C.V., Ohyama T., Haueter C.M.,
RA   Moiseenkova-Bell V.Y., Wensel T.G., Bellen H.J.;
RT   "A synaptic vesicle-associated Ca2+ channel promotes endocytosis and
RT   couples exocytosis to endocytosis.";
RL   Cell 138:947-960(2009).
CC   -!- FUNCTION: A calcium channel that regulates synaptic endocytosis
CC       and hence couples exo- with endocytosis. Isoform A and isoform B
CC       are mainly required in the nervous system and necessary in
CC       photoreceptor cells. {ECO:0000269|PubMed:19737521}.
CC   -!- SUBUNIT: Homomultimer; Isoform B. {ECO:0000269|PubMed:19737521}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-169467, EBI-169467;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane {ECO:0000269|PubMed:19737521}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:19737521}. Note=Upon
CC       fusion of the synaptic vesicle with the presynaptic membrane,
CC       protein is present in the periactive zones, where endocytosis is
CC       known to occur. {ECO:0000255, ECO:0000269|PubMed:19737521}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:19737521};
CC         IsoId=Q95T12-1; Sequence=Displayed;
CC       Name=B {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:19737521};
CC         IsoId=Q95T12-2; Sequence=VSP_053166;
CC       Name=C {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:19737521};
CC         IsoId=Q95T12-3; Sequence=VSP_053165;
CC   -!- TISSUE SPECIFICITY: Isoform B is expressed in the neuropils of
CC       embryonic, larval, adult CNS, and R1-R6 terminals. Expression in
CC       the central nervous system (CNS) starts at embryonic stage 13.
CC       {ECO:0000269|PubMed:19737521}.
CC   -!- DISRUPTION PHENOTYPE: Impaired intracellular resting calcium
CC       levels and impaired endocytosis in presynaptic terminals,
CC       exocytosis is normal. Mutant boutons at the neuromuscular
CC       junctions exhibit a significant depletion in the number of
CC       synaptic vesicles. There are numerous extra boutons which are
CC       often small, clustered, and flowery in nature. Mutant nerve
CC       terminals display omega structures and collared pits.
CC       {ECO:0000269|PubMed:19737521}.
CC   -!- SIMILARITY: Belongs to the calcium channel flower family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014296; AAF49581.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11767.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11768.1; -; Genomic_DNA.
DR   EMBL; AY060385; AAL25424.1; -; mRNA.
DR   RefSeq; NP_648804.1; NM_140547.5. [Q95T12-1]
DR   RefSeq; NP_730071.1; NM_168632.4. [Q95T12-3]
DR   RefSeq; NP_730072.1; NM_168633.4. [Q95T12-2]
DR   UniGene; Dm.4008; -.
DR   BioGrid; 65034; 6.
DR   IntAct; Q95T12; 11.
DR   MINT; MINT-338184; -.
DR   STRING; 7227.FBpp0075297; -.
DR   TCDB; 1.A.55.1.2; the synaptic vesicle-associated ca(2+) channel, flower (flower) family.
DR   PaxDb; Q95T12; -.
DR   PRIDE; Q95T12; -.
DR   EnsemblMetazoa; FBtr0075541; FBpp0075296; FBgn0261722. [Q95T12-2]
DR   EnsemblMetazoa; FBtr0075542; FBpp0075297; FBgn0261722. [Q95T12-1]
DR   EnsemblMetazoa; FBtr0075543; FBpp0075298; FBgn0261722. [Q95T12-3]
DR   GeneID; 39720; -.
DR   KEGG; dme:Dmel_CG6151; -.
DR   UCSC; CG6151-RA; d. melanogaster. [Q95T12-1]
DR   UCSC; CG6151-RB; d. melanogaster.
DR   UCSC; CG6151-RC; d. melanogaster.
DR   CTD; 39720; -.
DR   FlyBase; FBgn0261722; fwe.
DR   eggNOG; KOG4085; Eukaryota.
DR   eggNOG; ENOG4111G4Q; LUCA.
DR   GeneTree; ENSGT00390000000529; -.
DR   InParanoid; Q95T12; -.
DR   OMA; DDGMTWW; -.
DR   OrthoDB; EOG091G0TAC; -.
DR   PhylomeDB; Q95T12; -.
DR   GenomeRNAi; 39720; -.
DR   PRO; PR:Q95T12; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0261722; -.
DR   ExpressionAtlas; Q95T12; differential.
DR   Genevisible; Q95T12; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030285; C:integral component of synaptic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0044214; C:spanning component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0005262; F:calcium channel activity; IDA:FlyBase.
DR   GO; GO:0005261; F:cation channel activity; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006816; P:calcium ion transport; IDA:FlyBase.
DR   GO; GO:0035212; P:cell competition in a multicellular organism; IMP:FlyBase.
DR   GO; GO:0046530; P:photoreceptor cell differentiation; IMP:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:FlyBase.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:FlyBase.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IMP:UniProtKB.
DR   InterPro; IPR019365; TVP18/Ca-channel_flower.
DR   PANTHER; PTHR13314; PTHR13314; 1.
DR   Pfam; PF10233; Cg6151-P; 1.
DR   SMART; SM01077; Cg6151-P; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell junction; Complete proteome; Cytoplasmic vesicle; Endocytosis;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    194       Calcium channel flower.
FT                                /FTId=PRO_0000389234.
FT   TRANSMEM     35     55       Helical. {ECO:0000255}.
FT   TRANSMEM     66     88       Helical. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical. {ECO:0000255}.
FT   SITE         79     79       Calcium ion selectivity.
FT                                {ECO:0000269|PubMed:19737521}.
FT   VAR_SEQ     147    194       KASAEDMRAAAQQTFGGNTPAQTNDRAGIVNNAQPFSFTGA
FT                                VGTDSNV -> NKHIFLVRNYI (in isoform C).
FT                                {ECO:0000303|PubMed:10731132,
FT                                ECO:0000303|PubMed:19737521}.
FT                                /FTId=VSP_053165.
FT   VAR_SEQ     150    194       AEDMRAAAQQTFGGNTPAQTNDRAGIVNNAQPFSFTGAVGT
FT                                DSNV -> REDMAAAATSPTQMAGSQAGGQMQMGGDQHITL
FT                                MEDPDVWRPT (in isoform B).
FT                                {ECO:0000303|PubMed:10731132,
FT                                ECO:0000303|PubMed:19737521}.
FT                                /FTId=VSP_053166.
FT   MUTAGEN      79     79       E->Q: Heterologous expression in salivary
FT                                glands shows inhibition of calcium
FT                                influx. {ECO:0000269|PubMed:19737521}.
FT   MUTAGEN     128    128       G->D: In allele DB25; defect in synaptic
FT                                transmission and homozygous lethal.
FT                                {ECO:0000269|PubMed:19737521}.
SQ   SEQUENCE   194 AA;  20620 MW;  2D2817158AD73A57 CRC64;
     MSFAEKITGL LARPNQQDPI GPEQPWYLKY GSRLLGIVAA FFAILFGLWN VFSIITLSVS
     CLVAGILQMV AGFVVMLLEA PCCFVCFGQV NEIAEKVESK PLYFRAGLYI AMAIPPIILC
     FGLASLFGSG LIFGTGVVYG MMALGKKASA EDMRAAAQQT FGGNTPAQTN DRAGIVNNAQ
     PFSFTGAVGT DSNV
//
ID   CRCM1_HUMAN             Reviewed;         301 AA.
AC   Q96D31; Q3MHV3; Q6DHX2; Q96BP7; Q96K71;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   20-DEC-2017, entry version 131.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai-1;
DE   AltName: Full=Transmembrane protein 142A;
GN   Name=ORAI1; Synonyms=CRACM1, TMEM142A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA), AND VARIANT
RP   GLY-218.
RC   TISSUE=Bone marrow, Ovary, Prostate, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 22-301 (ISOFORM ALPHA), AND
RP   VARIANT GLY-218.
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   INVOLVEMENT IN IMD9.
RX   PubMed=16147976; DOI=10.1084/jem.20050687;
RA   Feske S., Prakriya M., Rao A., Lewis R.S.;
RT   "A severe defect in CRAC Ca2+ channel activation and altered K+
RT   channel gating in T cells from immunodeficient patients.";
RL   J. Exp. Med. 202:651-662(2005).
RN   [4]
RP   FUNCTION.
RX   PubMed=16766533; DOI=10.1074/jbc.C600126200;
RA   Soboloff J., Spassova M.A., Tang X.D., Hewavitharana T., Xu W.,
RA   Gill D.L.;
RT   "Orai1 and STIM reconstitute store-operated calcium channel
RT   function.";
RL   J. Biol. Chem. 281:20661-20665(2006).
RN   [5]
RP   FUNCTION.
RX   PubMed=16807233; DOI=10.1074/jbc.M604589200;
RA   Mercer J.C., Dehaven W.I., Smyth J.T., Wedel B., Boyles R.R.,
RA   Bird G.S., Putney J.W. Jr.;
RT   "Large store-operated calcium selective currents due to co-expression
RT   of Orai1 or Orai2 with the intracellular calcium sensor, Stim1.";
RL   J. Biol. Chem. 281:24979-24990(2006).
RN   [6]
RP   FUNCTION.
RX   PubMed=16733527; DOI=10.1038/ncb1435;
RA   Peinelt C., Vig M., Koomoa D.L., Beck A., Nadler M.J.S.,
RA   Koblan-Huberson M., Lis A., Fleig A., Penner R., Kinet J.-P.;
RT   "Amplification of CRAC current by STIM1 and CRACM1 (Orai1).";
RL   Nat. Cell Biol. 8:771-773(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16645049; DOI=10.1126/science.1127883;
RA   Vig M., Peinelt C., Beck A., Koomoa D.L., Rabah D.,
RA   Koblan-Huberson M., Kraft S., Turner H., Fleig A., Penner R.,
RA   Kinet J.-P.;
RT   "CRACM1 is a plasma membrane protein essential for store-operated Ca2+
RT   entry.";
RL   Science 312:1220-1223(2006).
RN   [8]
RP   INTERACTION WITH STIM1 AND STIM2.
RX   PubMed=17905723; DOI=10.1096/fj.07-9449com;
RA   Parvez S., Beck A., Peinelt C., Soboloff J., Lis A.,
RA   Monteilh-Zoller M., Gill D.L., Fleig A., Penner R.;
RT   "STIM2 protein mediates distinct store-dependent and store-independent
RT   modes of CRAC channel activation.";
RL   FASEB J. 22:752-761(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-295 AND SER-298, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, INTERACTION WITH STIM1, SUBCELLULAR LOCATION, TOPOLOGY,
RP   SUBUNIT, AND GLYCOSYLATION.
RX   PubMed=19249086; DOI=10.1016/j.cell.2009.02.014;
RA   Park C.Y., Hoover P.J., Mullins F.M., Bachhawat P., Covington E.D.,
RA   Raunser S., Walz T., Garcia K.C., Dolmetsch R.E., Lewis R.S.;
RT   "STIM1 clusters and activates CRAC channels via direct binding of a
RT   cytosolic domain to Orai1.";
RL   Cell 136:876-890(2009).
RN   [11]
RP   INTERACTION WITH SLC35G1.
RX   PubMed=22084111; DOI=10.1073/pnas.1117231108;
RA   Krapivinsky G., Krapivinsky L., Stotz S.C., Manasian Y., Clapham D.E.;
RT   "POST, partner of stromal interaction molecule 1 (STIM1), targets
RT   STIM1 to multiple transporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:19234-19239(2011).
RN   [12]
RP   ALTERNATIVE INITIATION, AND SUBCELLULAR LOCATION.
RX   PubMed=22641696; DOI=10.1242/jcs.104919;
RA   Fukushima M., Tomita T., Janoshazi A., Putney J.W.;
RT   "Alternative translation initiation gives rise to two isoforms of
RT   orai1 with distinct plasma membrane mobilities.";
RL   J. Cell Sci. 125:4354-4361(2012).
RN   [13]
RP   INTERACTION WITH ASPH.
RX   PubMed=22586105; DOI=10.1073/pnas.1200667109;
RA   Srikanth S., Jew M., Kim K.D., Yee M.K., Abramson J., Gwack Y.;
RT   "Junctate is a Ca2+-sensing structural component of Orai1 and stromal
RT   interaction molecule 1 (STIM1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:8682-8687(2012).
RN   [14]
RP   INTERACTION WITH CRACR2A, AND MUTAGENESIS OF 85-LYS--LYS-87.
RX   PubMed=20418871; DOI=10.1038/ncb2045;
RA   Srikanth S., Jung H.J., Kim K.D., Souda P., Whitelegge J., Gwack Y.;
RT   "A novel EF-hand protein, CRACR2A, is a cytosolic Ca2+ sensor that
RT   stabilizes CRAC channels in T cells.";
RL   Nat. Cell Biol. 12:436-446(2010).
RN   [15]
RP   FUNCTION, INTERACTION WITH UBQLN1, SUBCELLULAR LOCATION,
RP   UBIQUITINATION, AND DEGRADATION VIA AUTOPHAGY.
RX   PubMed=23307288; DOI=10.1007/s10059-013-2268-7;
RA   Lee J.E., Jeon I.S., Han N.E., Song H.J., Kim E.G., Choi J.W.,
RA   Song K.D., Lee H.K., Choi J.K.;
RT   "Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization.";
RL   Mol. Cells 35:41-46(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, INVOLVEMENT IN TAM2, VARIANT TAM2 LEU-245, AND
RP   CHARACTERIZATION OF VARIANT TAM2 LEU-245.
RX   PubMed=24591628; DOI=10.1073/pnas.1312520111;
RA   Nesin V., Wiley G., Kousi M., Ong E.C., Lehmann T., Nicholl D.J.,
RA   Suri M., Shahrizaila N., Katsanis N., Gaffney P.M., Wierenga K.J.,
RA   Tsiokas L.;
RT   "Activating mutations in STIM1 and ORAI1 cause overlapping syndromes
RT   of tubular myopathy and congenital miosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:4197-4202(2014).
RN   [18]
RP   INTERACTION WITH STIM1, AND SUBCELLULAR LOCATION.
RX   PubMed=27185316; DOI=10.1159/000445574;
RA   Zhang L., Wang L., Li S., Xue J., Luo D.;
RT   "Calsequestrin-1 regulates store-operated Ca2+ entry by inhibiting
RT   STIM1 aggregation.";
RL   Cell. Physiol. Biochem. 38:2183-2193(2016).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH STIM1, OXIDATION, AND
RP   MUTAGENESIS OF CYS-195.
RX   PubMed=28219928; DOI=10.15252/embj.201592481;
RA   Ben-Kasus Nissim T., Zhang X., Elazar A., Roy S., Stolwijk J.A.,
RA   Zhou Y., Motiani R.K., Gueguinou M., Hempel N., Hershfinkel M.,
RA   Gill D.L., Trebak M., Sekler I.;
RT   "Mitochondria control store-operated Ca(2+) entry through Na(+) and
RT   redox signals.";
RL   EMBO J. 36:797-815(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 69-88 IN COMPLEX WITH CALM,
RP   AND INTERACTION WITH CALM.
RX   PubMed=23109337; DOI=10.1074/jbc.M112.380964;
RA   Liu Y., Zheng X., Mueller G.A., Sobhany M., DeRose E.F., Zhang Y.,
RA   London R.E., Birnbaumer L.;
RT   "Crystal structure of calmodulin binding domain of orai1 in complex
RT   with Ca2+ calmodulin displays a unique binding mode.";
RL   J. Biol. Chem. 287:43030-43041(2012).
RN   [21]
RP   STRUCTURE BY NMR OF 272-292 IN COMPLEX WITH STIM1, INTERACTION WITH
RP   STIM1, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ARG-281;
RP   ASP-284; LEU-286; ASP-287; ARG-289 AND ASP-291.
RX   PubMed=24351972; DOI=10.1038/ncomms3963;
RA   Stathopulos P.B., Schindl R., Fahrner M., Zheng L.,
RA   Gasmi-Seabrook G.M., Muik M., Romanin C., Ikura M.;
RT   "STIM1/Orai1 coiled-coil interplay in the regulation of store-operated
RT   calcium entry.";
RL   Nat. Commun. 4:2963-2963(2013).
RN   [22]
RP   VARIANT IMD9 TRP-91, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=16582901; DOI=10.1038/nature04702;
RA   Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.-H., Tanasa B.,
RA   Hogan P.G., Lewis R.S., Daly M., Rao A.;
RT   "A mutation in Orai1 causes immune deficiency by abrogating CRAC
RT   channel function.";
RL   Nature 441:179-185(2006).
RN   [23]
RP   VARIANTS TAM2 SER-98; MET-107 AND MET-184, AND SUBCELLULAR LOCATION.
RX   PubMed=28058752; DOI=10.1002/humu.23172;
RA   Boehm J., Bulla M., Urquhart J.E., Malfatti E., Williams S.G.,
RA   O'Sullivan J., Szlauer A., Koch C., Baranello G., Mora M.,
RA   Ripolone M., Violano R., Moggio M., Kingston H., Dawson T.,
RA   DeGoede C.G., Nixon J., Boland A., Deleuze J.F., Romero N.,
RA   Newman W.G., Demaurex N., Laporte J.;
RT   "ORAI1 mutations with distinct channel gating defects in tubular
RT   aggregate myopathy.";
RL   Hum. Mutat. 38:426-438(2017).
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores and channel activation by the Ca(2+) sensor, STIM1
CC       (PubMed:16582901, PubMed:16645049, PubMed:16733527,
CC       PubMed:16766533, PubMed:16807233, PubMed:19249086,
CC       PubMed:23307288, PubMed:24351972, PubMed:24591628,
CC       PubMed:28219928). CRAC channels are the main pathway for Ca(2+)
CC       influx in T-cells and promote the immune response to pathogens by
CC       activating the transcription factor NFAT (PubMed:16582901).
CC       {ECO:0000269|PubMed:16582901, ECO:0000269|PubMed:16645049,
CC       ECO:0000269|PubMed:16733527, ECO:0000269|PubMed:16766533,
CC       ECO:0000269|PubMed:16807233, ECO:0000269|PubMed:19249086,
CC       ECO:0000269|PubMed:23307288, ECO:0000269|PubMed:24351972,
CC       ECO:0000269|PubMed:24591628, ECO:0000269|PubMed:28219928}.
CC   -!- SUBUNIT: Interacts with STIM1 and STIM2; this regulates channel
CC       activity (PubMed:17905723, PubMed:19249086, PubMed:24351972,
CC       PubMed:28219928, PubMed:27185316). Interacts with CALM; this may
CC       displace STIM1 and STIM2 and might thereby modulate channel
CC       activity (PubMed:23109337). Interacts with CRACR2A/EFCAB4B; the
CC       interaction is direct and takes place in absence of Ca(2+)
CC       (PubMed:20418871). Forms a complex with CRACR2A/EFCAB4B and STIM1
CC       at low concentration of Ca(2+), the complex dissociates at
CC       elevated Ca(2+) concentrations. Interacts with ASPH (isoform 8)
CC       (PubMed:22586105). Interacts with SLC35G1 (PubMed:22084111).
CC       Interacts with UBQLN1 (PubMed:23307288).
CC       {ECO:0000269|PubMed:17905723, ECO:0000269|PubMed:19249086,
CC       ECO:0000269|PubMed:20418871, ECO:0000269|PubMed:22084111,
CC       ECO:0000269|PubMed:22586105, ECO:0000269|PubMed:23109337,
CC       ECO:0000269|PubMed:23307288, ECO:0000269|PubMed:24351972,
CC       ECO:0000269|PubMed:28219928}.
CC   -!- INTERACTION:
CC       Self; NbExp=9; IntAct=EBI-2291476, EBI-2291476;
CC       O75185:ATP2C2; NbExp=10; IntAct=EBI-2291476, EBI-2939806;
CC       P62161:Calm3 (xeno); NbExp=5; IntAct=EBI-2291476, EBI-397530;
CC       Q9BSW2:CRACR2A; NbExp=6; IntAct=EBI-2291476, EBI-739773;
CC       Q9BRQ5:ORAI3; NbExp=4; IntAct=EBI-2291476, EBI-4279484;
CC       Q13586:STIM1; NbExp=19; IntAct=EBI-2291476, EBI-448878;
CC       P48995:TRPC1; NbExp=2; IntAct=EBI-2291476, EBI-929665;
CC       Q13507:TRPC3; NbExp=2; IntAct=EBI-2291476, EBI-520807;
CC       Q61143:Trpc6 (xeno); NbExp=2; IntAct=EBI-2291476, EBI-15563578;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16582901,
CC       ECO:0000269|PubMed:16645049, ECO:0000269|PubMed:19249086,
CC       ECO:0000269|PubMed:22641696, ECO:0000269|PubMed:23307288,
CC       ECO:0000269|PubMed:24351972, ECO:0000269|PubMed:27185316,
CC       ECO:0000269|PubMed:28058752, ECO:0000269|PubMed:28219928}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16582901,
CC       ECO:0000269|PubMed:16645049, ECO:0000269|PubMed:19249086,
CC       ECO:0000269|PubMed:22641696, ECO:0000269|PubMed:24351972}.
CC       Note=Isoform beta is more mobile in the plasma membrane
CC       (PubMed:23307288). Colocalizes with STIM1 at the cell membrane
CC       (PubMed:27185316). {ECO:0000269|PubMed:23307288,
CC       ECO:0000269|PubMed:27185316}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=alpha;
CC         IsoId=Q96D31-1; Sequence=Displayed;
CC       Name=beta;
CC         IsoId=Q96D31-2; Sequence=VSP_044421;
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19249086}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:23307288}.
CC   -!- PTM: Cys-195 is oxidated, leading to inactivate channel activity.
CC       {ECO:0000269|PubMed:28219928}.
CC   -!- DISEASE: Immunodeficiency 9 (IMD9) [MIM:612782]: An immune
CC       disorder characterized by recurrent infections, impaired
CC       activation and proliferative response of T-cells, decreased T-cell
CC       production of cytokines, and normal lymphocytes counts and serum
CC       immunoglobulin levels. In surviving patients ectodermal dysplasia
CC       with anhidrosis and non-progressive myopathy may be observed.
CC       {ECO:0000269|PubMed:16147976, ECO:0000269|PubMed:16582901}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]: A
CC       rare congenital myopathy characterized by regular arrays of
CC       membrane tubules on muscle biopsies without additional
CC       histopathological hallmarks. Tubular aggregates in muscle are
CC       structures of variable appearance consisting of an outer tubule
CC       containing either one or more microtubule-like structures or
CC       amorphous material. TAM2 patients have myopathy and pupillary
CC       abnormalities. {ECO:0000269|PubMed:24591628,
CC       ECO:0000269|PubMed:28058752}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: According to a report, ORAI1 has been shown to
CC       colocalize with UBQLN1 in the autophagosome as a target for
CC       autophagic degradation; ORAI1 is however not an autophagosomal
CC       protein. {ECO:0000269|PubMed:23307288}.
CC   -!- MISCELLANEOUS: In Greek mythology, the 'Orai' are the keepers of
CC       the gates of heaven: Eunomia (order or harmony), Dike (justice)
CC       and Eirene (peace). {ECO:0000303|PubMed:16582901}.
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13386.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI04634.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB55068.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=ORAI1base; Note=ORAI1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/ORAI1base/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC013386; AAH13386.1; ALT_INIT; mRNA.
DR   EMBL; BC015369; AAH15369.2; -; mRNA.
DR   EMBL; BC075831; AAH75831.1; -; mRNA.
DR   EMBL; BC104633; AAI04634.1; ALT_INIT; mRNA.
DR   EMBL; AK027372; BAB55068.1; ALT_INIT; mRNA.
DR   RefSeq; NP_116179.2; NM_032790.3. [Q96D31-1]
DR   UniGene; Hs.55148; -.
DR   PDB; 2MAK; NMR; -; B/D=272-292.
DR   PDB; 4EHQ; X-ray; 1.90 A; G=69-88.
DR   PDBsum; 2MAK; -.
DR   PDBsum; 4EHQ; -.
DR   ProteinModelPortal; Q96D31; -.
DR   SMR; Q96D31; -.
DR   BioGrid; 124321; 34.
DR   CORUM; Q96D31; -.
DR   DIP; DIP-46289N; -.
DR   IntAct; Q96D31; 10.
DR   MINT; MINT-6780078; -.
DR   STRING; 9606.ENSP00000328216; -.
DR   BindingDB; Q96D31; -.
DR   ChEMBL; CHEMBL2384891; -.
DR   TCDB; 1.A.52.1.1; the ca(2+) release-activated ca(2+) (crac) channel (crac-c) family.
DR   iPTMnet; Q96D31; -.
DR   PhosphoSitePlus; Q96D31; -.
DR   SwissPalm; Q96D31; -.
DR   DMDM; 97180269; -.
DR   EPD; Q96D31; -.
DR   MaxQB; Q96D31; -.
DR   PaxDb; Q96D31; -.
DR   PeptideAtlas; Q96D31; -.
DR   PRIDE; Q96D31; -.
DR   TopDownProteomics; Q96D31-2; -. [Q96D31-2]
DR   Ensembl; ENST00000616379; ENSP00000480616; ENSG00000276045.
DR   GeneID; 84876; -.
DR   KEGG; hsa:84876; -.
DR   UCSC; uc031zps.1; human. [Q96D31-1]
DR   CTD; 84876; -.
DR   DisGeNET; 84876; -.
DR   EuPathDB; HostDB:ENSG00000276045.1; -.
DR   GeneCards; ORAI1; -.
DR   HGNC; HGNC:25896; ORAI1.
DR   HPA; HPA016583; -.
DR   HPA; HPA061823; -.
DR   MalaCards; ORAI1; -.
DR   MIM; 610277; gene.
DR   MIM; 612782; phenotype.
DR   MIM; 615883; phenotype.
DR   neXtProt; NX_Q96D31; -.
DR   Orphanet; 317428; Combined immunodeficiency due to ORAI1 deficiency.
DR   Orphanet; 2593; Tubular aggregate myopathy.
DR   PharmGKB; PA162398445; -.
DR   eggNOG; KOG4298; Eukaryota.
DR   eggNOG; ENOG4110DSB; LUCA.
DR   HOGENOM; HOG000246925; -.
DR   HOVERGEN; HBG081343; -.
DR   InParanoid; Q96D31; -.
DR   KO; K16056; -.
DR   OrthoDB; EOG091G0E4P; -.
DR   PhylomeDB; Q96D31; -.
DR   TreeFam; TF313576; -.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SIGNOR; Q96D31; -.
DR   GeneWiki; ORAI1; -.
DR   GenomeRNAi; 84876; -.
DR   PRO; PR:Q96D31; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000276045; -.
DR   CleanEx; HS_ORAI1; -.
DR   Genevisible; Q96D31; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0002115; P:store-operated calcium entry; IDA:UniProtKB.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative initiation; Calcium;
KW   Calcium channel; Calcium transport; Calmodulin-binding; Cell membrane;
KW   Complete proteome; Disease mutation; Glycoprotein; Immunity;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   CHAIN         1    301       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234381.
FT   TOPO_DOM      1     87       Cytoplasmic.
FT                                {ECO:0000269|PubMed:19249086}.
FT   TRANSMEM     88    105       Helical. {ECO:0000255}.
FT   TOPO_DOM    106    119       Extracellular. {ECO:0000255}.
FT   TRANSMEM    120    140       Helical. {ECO:0000255}.
FT   TOPO_DOM    141    173       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    174    194       Helical. {ECO:0000255}.
FT   TOPO_DOM    195    234       Extracellular. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TOPO_DOM    256    301       Cytoplasmic.
FT                                {ECO:0000269|PubMed:19249086}.
FT   REGION       70     90       Interaction with STIM1.
FT   REGION      272    292       Interaction with STIM1.
FT   COMPBIAS      3     47       Pro-rich.
FT   MOD_RES     295    295       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     70       Missing (in isoform beta). {ECO:0000305}.
FT                                /FTId=VSP_044421.
FT   VARIANT      91     91       R -> W (in IMD9; dbSNP:rs118203993).
FT                                {ECO:0000269|PubMed:16582901}.
FT                                /FTId=VAR_026226.
FT   VARIANT      98     98       G -> S (in TAM2; constitutively active
FT                                Ca(+2) channel, independently of STIM
FT                                proteins; no effect on localization to
FT                                the cell membrane).
FT                                {ECO:0000269|PubMed:28058752}.
FT                                /FTId=VAR_078083.
FT   VARIANT     107    107       V -> M (in TAM2; constitutively active
FT                                Ca(+2) channel, independently of STIM
FT                                proteins; no effect on localization to
FT                                the cell membrane).
FT                                {ECO:0000269|PubMed:28058752}.
FT                                /FTId=VAR_078084.
FT   VARIANT     184    184       T -> M (in TAM2; mediates excessive
FT                                Ca(2+) entry when gated by STIM1; no
FT                                effect on localization to the cell
FT                                membrane). {ECO:0000269|PubMed:28058752}.
FT                                /FTId=VAR_078085.
FT   VARIANT     218    218       S -> G (in dbSNP:rs3741596).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038608.
FT   VARIANT     245    245       P -> L (in TAM2; increases activation of
FT                                the Ca2+ release-activated Ca2+ (CRAC)
FT                                channel; dbSNP:rs587777528).
FT                                {ECO:0000269|PubMed:24591628}.
FT                                /FTId=VAR_071473.
FT   MUTAGEN      85     87       KLK->ALA: Impairs interaction with
FT                                CRACR2A/EFCAB4B.
FT                                {ECO:0000269|PubMed:20418871}.
FT   MUTAGEN     195    195       C->S: Abolishes oxidation and channel
FT                                inhibition.
FT                                {ECO:0000269|PubMed:28219928}.
FT   MUTAGEN     281    281       R->A: Strongly reduces calcium current.
FT                                {ECO:0000269|PubMed:24351972}.
FT   MUTAGEN     284    284       D->A: Reduces the maximum current; when
FT                                associated with A-287 and A-291.
FT                                {ECO:0000269|PubMed:24351972}.
FT   MUTAGEN     286    286       L->S: Strongly reduces calcium current.
FT                                {ECO:0000269|PubMed:24351972}.
FT   MUTAGEN     287    287       D->A: Reduces the maximum current; when
FT                                associated with A-284 and A-291.
FT                                {ECO:0000269|PubMed:24351972}.
FT   MUTAGEN     289    289       R->A: Strongly reduces calcium current.
FT                                {ECO:0000269|PubMed:24351972}.
FT   MUTAGEN     291    291       D->A: Reduces the maximum current; when
FT                                associated with A-284 and A-287.
FT                                {ECO:0000269|PubMed:24351972}.
FT   CONFLICT    255    255       V -> F (in Ref. 2; BAB55068).
FT                                {ECO:0000305}.
FT   HELIX        76     86       {ECO:0000244|PDB:4EHQ}.
FT   HELIX       272    288       {ECO:0000244|PDB:2MAK}.
SQ   SEQUENCE   301 AA;  32668 MW;  F85F7C06F36628D4 CRC64;
     MHPEPAPPPS RSSPELPPSG GSTTSGSRRS RRRSGDGEPP GAPPPPPSAV TYPDWIGQSY
     SEVMSLNEHS MQALSWRKLY LSRAKLKASS RTSALLSGFA MVAMVEVQLD ADHDYPPGLL
     IAFSACTTVL VAVHLFALMI STCILPNIEA VSNVHNLNSV KESPHERMHR HIELAWAFST
     VIGTLLFLAE VVLLCWVKFL PLKKQPGQPR PTSKPPASGA AANVSTSGIT PGQAAAIAST
     TIMVPFGLIF IVFAVHFYRS LVSHKTDRQF QELNELAEFA RLQDQLDHRG DHPLTPGSHY
     A
//
ID   CTSR2_HUMAN             Reviewed;         530 AA.
AC   Q96P56; Q8NHT9; Q96P54; Q96P55;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   25-OCT-2017, entry version 131.
DE   RecName: Full=Cation channel sperm-associated protein 2;
DE            Short=CatSper2;
GN   Name=CATSPER2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11675491; DOI=10.1073/pnas.221454998;
RA   Quill T.A., Ren D., Clapham D.E., Garbers D.L.;
RT   "A voltage-gated ion channel expressed specifically in spermatozoa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12527-12531(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INVOLVEMENT IN DIS.
RX   PubMed=12825070; DOI=10.1038/sj.ejhg.5200991;
RA   Avidan N., Tamary H., Dgany O., Cattan D., Pariente A., Thulliez M.,
RA   Borot N., Moati L., Barthelme A., Shalmon L., Krasnov T.,
RA   Ben-Asher E., Olender T., Khen M., Yaniv I., Zaizov R., Shalev H.,
RA   Delaunay J., Fellous M., Lancet D., Beckmann J.S.;
RT   "CATSPER2, a human autosomal nonsyndromic male infertility gene.";
RL   Eur. J. Hum. Genet. 11:497-502(2003).
RN   [4]
RP   INTERACTION WITH CACNA1I.
RX   PubMed=16740636; DOI=10.1074/jbc.M511288200;
RA   Zhang D., Chen J., Saraf A., Cassar S., Han P., Rogers J.C.,
RA   Brioni J.D., Sullivan J.P., Gopalakrishnan M.;
RT   "Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of
RT   T-type calcium channel activity.";
RL   J. Biol. Chem. 281:22332-22341(2006).
RN   [5]
RP   INVOLVEMENT IN DIS.
RX   PubMed=17098888; DOI=10.1136/jmg.2006.045765;
RA   Zhang Y., Malekpour M., Al-Madani N., Kahrizi K., Zanganeh M.,
RA   Mohseni M., Mojahedi F., Daneshi A., Najmabadi H., Smith R.J.H.;
RT   "Sensorineural deafness and male infertility: a contiguous gene
RT   deletion syndrome.";
RL   J. Med. Genet. 44:233-240(2007).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=17347248; DOI=10.1093/molehr/gam009;
RA   Li H.-G., Ding X.-F., Liao A.-H., Kong X.-B., Xiong C.-L.;
RT   "Expression of CatSper family transcripts in the mouse testis during
RT   post-natal development and human ejaculated spermatozoa: relationship
RT   to sperm motility.";
RL   Mol. Hum. Reprod. 13:299-306(2007).
RN   [7]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412338; DOI=10.1038/nature09769;
RA   Strunker T., Goodwin N., Brenker C., Kashikar N.D., Weyand I.,
RA   Seifert R., Kaupp U.B.;
RT   "The CatSper channel mediates progesterone-induced Ca2+ influx in
RT   human sperm.";
RL   Nature 471:382-386(2011).
RN   [8]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21412339; DOI=10.1038/nature09767;
RA   Lishko P.V., Botchkina I.L., Kirichok Y.;
RT   "Progesterone activates the principal Ca2+ channel of human sperm.";
RL   Nature 471:387-391(2011).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=26989199; DOI=10.1126/science.aad6887;
RA   Miller M.R., Mannowetz N., Iavarone A.T., Safavi R., Gracheva E.O.,
RA   Smith J.F., Hill R.Z., Bautista D.M., Kirichok Y., Lishko P.V.;
RT   "Unconventional endocannabinoid signaling governs sperm activation via
RT   sex hormone progesterone.";
RL   Science 352:555-559(2016).
CC   -!- FUNCTION: Voltage-gated calcium channel that plays a central role
CC       in calcium-dependent physiological responses essential for
CC       successful fertilization, such as sperm hyperactivation, acrosome
CC       reaction and chemotaxis towards the oocyte.
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339}.
CC   -!- ENZYME REGULATION: The CatSper calcium channel is indirectly
CC       activated by extracellular progesterone and prostaglandins
CC       following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 >
CC       PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199).
CC       The CatSper calcium channel is directly inhibited by
CC       endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199).
CC       Indirect activation by progesterone takes place via the following
CC       mechanism: progesterone binds and activates the acylglycerol
CC       lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor,
CC       relieving inhibition of the CatSper channel (PubMed:26989199). The
CC       primary effect of progesterone activation is to shift voltage
CC       dependence towards more physiological, negative membrane
CC       potentials; it is not mediated by metabotropic receptors and
CC       second messengers (PubMed:21412338, PubMed:21412339). Sperm
CC       capacitation enhances the effect of progesterone by providing
CC       additional negative shift. Also activated by the elevation of
CC       intracellular pH (PubMed:21412338, PubMed:21412339).
CC       {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339,
CC       ECO:0000269|PubMed:26989199}.
CC   -!- SUBUNIT: Heterotetramer; possibly composed of CATSPER1, CATSPER2,
CC       CATSPER3 and CATSPER4 (Potential). Component of the CatSper
CC       complex. Interacts with Ca(v)3.3/CACNA1I, leading to suppress T-
CC       type calcium channel activity. {ECO:0000269|PubMed:16740636,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q9P0X4:CACNA1I; NbExp=3; IntAct=EBI-2215024, EBI-1220829;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Note=Specifically located in the principal piece of sperm tail.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Variant 2;
CC         IsoId=Q96P56-1; Sequence=Displayed;
CC       Name=2; Synonyms=Variant 1;
CC         IsoId=Q96P56-2; Sequence=VSP_026976;
CC       Name=3; Synonyms=Variant 3;
CC         IsoId=Q96P56-3; Sequence=VSP_026975, VSP_026977;
CC       Name=4;
CC         IsoId=Q96P56-4; Sequence=VSP_026973, VSP_026974;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:11675491,
CC       ECO:0000269|PubMed:17347248}.
CC   -!- DISEASE: Deafness-infertility syndrome (DIS) [MIM:611102]:
CC       Characterized by deafness and infertility and is caused by large
CC       contiguous gene deletions at 15q15.3 that removes both STRC and
CC       CATSPER2 genes. {ECO:0000269|PubMed:12825070,
CC       ECO:0000269|PubMed:17098888}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cation channel sperm-associated (TC
CC       1.A.1.19) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF411817; AAL26490.1; -; mRNA.
DR   EMBL; AF411818; AAL26491.1; -; mRNA.
DR   EMBL; AF411819; AAL26492.1; -; mRNA.
DR   EMBL; BC028728; AAH28728.1; -; mRNA.
DR   EMBL; BC064387; AAH64387.1; -; mRNA.
DR   CCDS; CCDS10099.1; -. [Q96P56-1]
DR   CCDS; CCDS32216.1; -. [Q96P56-2]
DR   RefSeq; NP_001269238.1; NM_001282309.1. [Q96P56-2]
DR   RefSeq; NP_473361.1; NM_054020.3.
DR   RefSeq; NP_742093.1; NM_172095.2. [Q96P56-1]
DR   RefSeq; XP_016877393.1; XM_017021904.1. [Q96P56-1]
DR   UniGene; Hs.657395; -.
DR   UniGene; Hs.662284; -.
DR   ProteinModelPortal; Q96P56; -.
DR   IntAct; Q96P56; 1.
DR   STRING; 9606.ENSP00000299989; -.
DR   GuidetoPHARMACOLOGY; 389; -.
DR   TCDB; 1.A.1.19.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q96P56; -.
DR   PhosphoSitePlus; Q96P56; -.
DR   BioMuta; CATSPER2; -.
DR   DMDM; 156631018; -.
DR   PaxDb; Q96P56; -.
DR   PeptideAtlas; Q96P56; -.
DR   PRIDE; Q96P56; -.
DR   DNASU; 117155; -.
DR   Ensembl; ENST00000321596; ENSP00000321463; ENSG00000166762. [Q96P56-1]
DR   Ensembl; ENST00000396879; ENSP00000380088; ENSG00000166762. [Q96P56-2]
DR   Ensembl; ENST00000433380; ENSP00000389746; ENSG00000166762. [Q96P56-3]
DR   GeneID; 117155; -.
DR   KEGG; hsa:117155; -.
DR   UCSC; uc001zsh.5; human. [Q96P56-1]
DR   CTD; 117155; -.
DR   DisGeNET; 117155; -.
DR   EuPathDB; HostDB:ENSG00000166762.16; -.
DR   GeneCards; CATSPER2; -.
DR   GeneReviews; CATSPER2; -.
DR   HGNC; HGNC:18810; CATSPER2.
DR   MalaCards; CATSPER2; -.
DR   MIM; 607249; gene.
DR   MIM; 611102; phenotype.
DR   neXtProt; NX_Q96P56; -.
DR   OpenTargets; ENSG00000166762; -.
DR   Orphanet; 94064; Deafness-infertility syndrome.
DR   PharmGKB; PA38691; -.
DR   eggNOG; ENOG410INF6; Eukaryota.
DR   eggNOG; ENOG4111GC6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000007710; -.
DR   HOVERGEN; HBG107782; -.
DR   InParanoid; Q96P56; -.
DR   KO; K16890; -.
DR   PhylomeDB; Q96P56; -.
DR   TreeFam; TF343585; -.
DR   Reactome; R-HSA-1300642; Sperm Motility And Taxes.
DR   GeneWiki; CatSper2; -.
DR   GenomeRNAi; 117155; -.
DR   PRO; PR:Q96P56; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166762; -.
DR   CleanEx; HS_CATSPER2; -.
DR   ExpressionAtlas; Q96P56; baseline and differential.
DR   Genevisible; Q96P56; HS.
DR   GO; GO:0036128; C:CatSper complex; ISS:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0030317; P:flagellated sperm motility; IEA:InterPro.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:0032570; P:response to progesterone; TAS:Reactome.
DR   GO; GO:0035036; P:sperm-egg recognition; TAS:Reactome.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR028747; CatSper2.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   PANTHER; PTHR10037:SF189; PTHR10037:SF189; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cell projection; Cilium; Complete proteome;
KW   Developmental protein; Differentiation; Flagellum; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   Spermatogenesis; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    530       Cation channel sperm-associated protein
FT                                2.
FT                                /FTId=PRO_0000295676.
FT   TOPO_DOM      1    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    134    145       Extracellular. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    167    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    200    205       Extracellular. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    227    242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    264    282       Extracellular. {ECO:0000255}.
FT   INTRAMEM    283    303       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    304    320       Extracellular. {ECO:0000255}.
FT   TRANSMEM    321    341       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    342    530       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    385    464       Ser-rich.
FT   VAR_SEQ     188    199       SLLPEVVVLVGV -> VRIEILRVRLVG (in isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026973.
FT   VAR_SEQ     200    530       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026974.
FT   VAR_SEQ     393    414       SSRGASQQRESLDLSEVSEVES -> RSFGLGDSCARKSAR
FT                                ANGNGSG (in isoform 3).
FT                                {ECO:0000303|PubMed:11675491}.
FT                                /FTId=VSP_026975.
FT   VAR_SEQ     393    394       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11675491,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026976.
FT   VAR_SEQ     415    530       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11675491}.
FT                                /FTId=VSP_026977.
FT   VARIANT       8      8       E -> G (in dbSNP:rs2614835).
FT                                /FTId=VAR_033307.
FT   VARIANT      57     57       V -> I (in dbSNP:rs8042868).
FT                                /FTId=VAR_033308.
FT   CONFLICT     46     46       E -> K (in Ref. 2; AAH28728).
FT                                {ECO:0000305}.
SQ   SEQUENCE   530 AA;  62041 MW;  8561CC0E9F3590B0 CRC64;
     MAAYQQEEQM QLPRADAIRS RLIDTFSLIE HLQGLSQAVP RHTIRELLDP SRQKKLVLGD
     QHQLVRFSIK PQRIEQISHA QRLLSRLHVR CSQRPPLSLW AGWVLECPLF KNFIIFLVFL
     NTIILMVEIE LLESTNTKLW PLKLTLEVAA WFILLIFILE ILLKWLSNFS VFWKSAWNVF
     DFVVTMLSLL PEVVVLVGVT GQSVWLQLLR ICRVLRSLKL LAQFRQIQII ILVLVRALKS
     MTFLLMLLLI FFYIFAVTGV YVFSEYTRSP RQDLEYHVFF SDLPNSLVTV FILFTLDHWY
     ALLQDVWKVP EVSRIFSSIY FILWLLLGSI IFRSIIVAMM VTNFQNIRKE LNEEMARREV
     QLKADMFKRQ IIQRRKNMSH EALTSSHSKI EDSSRGASQQ RESLDLSEVS EVESNYGATE
     EDLITSASKT EETLSKKREY QSSSCVSSTS SSYSSSSESR FSESIGRLDW ETLVHENLPG
     LMEMDQDDRV WPRDSLFRYF ELLEKLQYNL EERKKLQEFA VQALMNLEDK
//
ID   PANX1_HUMAN             Reviewed;         426 AA.
AC   Q96RD7; O75968; Q543A0; Q6UW26; Q96AM9; Q96L77; Q96RS5;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   20-DEC-2017, entry version 139.
DE   RecName: Full=Pannexin-1;
GN   Name=PANX1; Synonyms=MRS1; ORFNames=UNQ2529/PRO6028;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT HIS-5.
RA   Bolger G.B., Steele M.R.;
RT   "A novel cDNA of unknown function.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND VARIANT
RP   HIS-5.
RX   PubMed=15028292; DOI=10.1016/j.ygeno.2003.09.025;
RA   Baranova A., Ivanov D., Petrash N., Pestova A., Skoblov M.,
RA   Kelmanson I., Shagin D., Nazarenko S., Geraymovych E., Litvin O.,
RA   Tiunova A., Born T.L., Usman N., Staroverov D., Lukyanov S.,
RA   Panchin Y.;
RT   "The mammalian pannexin family is homologous to the invertebrate
RT   innexin gap junction proteins.";
RL   Genomics 83:706-716(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT HIS-5.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT HIS-5.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 62-426.
RA   Baranova A.V., Ivanov D.V., Borodina T.A., Panchin Y.V., Shagin D.A.,
RA   Lukyanov S.A.;
RT   "Genomic organization of putative human gap junction proteins PANX1
RT   and PANX2.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16908669; DOI=10.1083/jcb.200601115;
RA   Vanden Abeele F., Bidaux G., Gordienko D., Beck B., Panchin Y.V.,
RA   Baranova A.V., Ivanov D.V., Skryma R., Prevarskaya N.;
RT   "Functional implications of calcium permeability of the channel formed
RT   by pannexin 1.";
RL   J. Cell Biol. 174:535-546(2006).
RN   [9]
RP   GLYCOSYLATION AT ASN-255, HOMOHEXAMERIZATION, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF ASN-255.
RX   PubMed=17715132; DOI=10.1074/jbc.M702422200;
RA   Boassa D., Ambrosi C., Qiu F., Dahl G., Gaietta G., Sosinsky G.;
RT   "Pannexin1 channels contain a glycosylation site that targets the
RT   hexamer to the plasma membrane.";
RL   J. Biol. Chem. 282:31733-31743(2007).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF CYS-347.
RX   PubMed=20829356; DOI=10.1074/jbc.M110.101014;
RA   Bunse S., Schmidt M., Prochnow N., Zoidl G., Dermietzel R.;
RT   "Intracellular cysteine 346 is essentially involved in regulating
RT   Panx1 channel activity.";
RL   J. Biol. Chem. 285:38444-38452(2010).
CC   -!- FUNCTION: Structural component of the gap junctions and the
CC       hemichannels. May play a role as a Ca(2+)-leak channel to regulate
CC       ER Ca(2+) homeostasis. {ECO:0000269|PubMed:16908669,
CC       ECO:0000269|PubMed:20829356}.
CC   -!- SUBUNIT: Homohexamer. Forms homomeric or PANX1/PANX2-heteromeric
CC       intercellular channels on coexpression in paired Xenopus oocytes
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255|PROSITE-ProRule:PRU00351}. Cell
CC       junction, gap junction {ECO:0000269|PubMed:16908669,
CC       ECO:0000269|PubMed:17715132}. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000255|PROSITE-
CC       ProRule:PRU00351}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96RD7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RD7-2; Sequence=VSP_011476;
CC   -!- PTM: S-nitrosylation inhibits channel currents and ATP release.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the pannexin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00351}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Pannexin entry;
CC       URL="https://en.wikipedia.org/wiki/Pannexin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF093239; AAC61779.1; -; mRNA.
DR   EMBL; AF398509; AAK91714.1; -; mRNA.
DR   EMBL; AF398508; AAK91713.1; -; Genomic_DNA.
DR   EMBL; AF398506; AAK91713.1; JOINED; Genomic_DNA.
DR   EMBL; AF398507; AAK91713.1; JOINED; Genomic_DNA.
DR   EMBL; AY048509; AAL06604.1; -; Genomic_DNA.
DR   EMBL; AY359023; AAQ89382.1; -; mRNA.
DR   EMBL; AK074897; BAC11276.1; -; mRNA.
DR   EMBL; AP003966; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016931; AAH16931.1; -; mRNA.
DR   EMBL; AH010945; AAK73361.1; -; Genomic_DNA.
DR   CCDS; CCDS8296.1; -. [Q96RD7-1]
DR   RefSeq; NP_056183.2; NM_015368.3. [Q96RD7-1]
DR   UniGene; Hs.591976; -.
DR   ProteinModelPortal; Q96RD7; -.
DR   BioGrid; 117295; 12.
DR   DIP; DIP-43936N; -.
DR   IntAct; Q96RD7; 9.
DR   MINT; MINT-3379479; -.
DR   STRING; 9606.ENSP00000227638; -.
DR   ChEMBL; CHEMBL3779756; -.
DR   DrugBank; DB01032; Probenecid.
DR   TCDB; 1.A.25.2.1; the gap junction-forming innexin (innexin) family.
DR   iPTMnet; Q96RD7; -.
DR   PhosphoSitePlus; Q96RD7; -.
DR   BioMuta; PANX1; -.
DR   DMDM; 317373551; -.
DR   EPD; Q96RD7; -.
DR   MaxQB; Q96RD7; -.
DR   PaxDb; Q96RD7; -.
DR   PeptideAtlas; Q96RD7; -.
DR   PRIDE; Q96RD7; -.
DR   Ensembl; ENST00000227638; ENSP00000227638; ENSG00000110218. [Q96RD7-1]
DR   Ensembl; ENST00000436171; ENSP00000411461; ENSG00000110218. [Q96RD7-2]
DR   GeneID; 24145; -.
DR   KEGG; hsa:24145; -.
DR   UCSC; uc001peq.4; human. [Q96RD7-1]
DR   CTD; 24145; -.
DR   DisGeNET; 24145; -.
DR   EuPathDB; HostDB:ENSG00000110218.8; -.
DR   GeneCards; PANX1; -.
DR   H-InvDB; HIX0010028; -.
DR   HGNC; HGNC:8599; PANX1.
DR   HPA; HPA016930; -.
DR   MIM; 608420; gene.
DR   neXtProt; NX_Q96RD7; -.
DR   OpenTargets; ENSG00000110218; -.
DR   PharmGKB; PA32929; -.
DR   eggNOG; ENOG410II5X; Eukaryota.
DR   eggNOG; ENOG410YA5H; LUCA.
DR   GeneTree; ENSGT00390000009703; -.
DR   HOVERGEN; HBG053497; -.
DR   InParanoid; Q96RD7; -.
DR   KO; K03443; -.
DR   OMA; MVTCIAV; -.
DR   OrthoDB; EOG091G086D; -.
DR   PhylomeDB; Q96RD7; -.
DR   TreeFam; TF333142; -.
DR   Reactome; R-HSA-112303; Electric Transmission Across Gap Junctions.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   ChiTaRS; PANX1; human.
DR   GeneWiki; PANX1; -.
DR   GenomeRNAi; 24145; -.
DR   PRO; PR:Q96RD7; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110218; -.
DR   CleanEx; HS_PANX1; -.
DR   ExpressionAtlas; Q96RD7; baseline and differential.
DR   Genevisible; Q96RD7; HS.
DR   GO; GO:0032059; C:bleb; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005921; C:gap junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0055077; F:gap junction hemi-channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0022840; F:leak channel activity; IMP:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:BHF-UCL.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0050717; P:positive regulation of interleukin-1 alpha secretion; IEA:Ensembl.
DR   GO; GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:BHF-UCL.
DR   GO; GO:0034214; P:protein hexamerization; IDA:UniProtKB.
DR   GO; GO:0033198; P:response to ATP; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   InterPro; IPR000990; Innexin.
DR   Pfam; PF00876; Innexin; 1.
DR   PROSITE; PS51013; PANNEXIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Gap junction; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   S-nitrosylation; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    426       Pannexin-1.
FT                                /FTId=PRO_0000208484.
FT   TOPO_DOM      1     40       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     41     61       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM     62    106       Extracellular. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    128    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    239    266       Extracellular. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    288    426       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      40     40       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:Q9JIP4}.
FT   MOD_RES     347    347       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:Q9JIP4}.
FT   CARBOHYD    255    255       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17715132}.
FT   VAR_SEQ     401    404       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15028292,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_011476.
FT   VARIANT       5      5       Q -> H (in dbSNP:rs1138800).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:15028292,
FT                                ECO:0000269|PubMed:16303743,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_016098.
FT   VARIANT     272    272       I -> V (in dbSNP:rs12793348).
FT                                /FTId=VAR_031225.
FT   MUTAGEN     255    255       N->Q: Impairs glycosylation.
FT                                {ECO:0000269|PubMed:17715132}.
FT   MUTAGEN     347    347       C->S: Leaky hemichannel conductive at
FT                                resting potential.
FT                                {ECO:0000269|PubMed:20829356}.
FT   CONFLICT    182    185       Missing (in Ref. 7; AAK73361).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       D -> V (in Ref. 7; AAK73361).
FT                                {ECO:0000305}.
SQ   SEQUENCE   426 AA;  48050 MW;  368B48E0709424FB CRC64;
     MAIAQLATEY VFSDFLLKEP TEPKFKGLRL ELAVDKMVTC IAVGLPLLLI SLAFAQEISI
     GTQISCFSPS SFSWRQAAFV DSYCWAAVQQ KNSLQSESGN LPLWLHKFFP YILLLFAILL
     YLPPLFWRFA AAPHICSDLK FIMEELDKVY NRAIKAAKSA RDLDMRDGAC SVPGVTENLG
     QSLWEVSESH FKYPIVEQYL KTKKNSNNLI IKYISCRLLT LIIILLACIY LGYYFSLSSL
     SDEFVCSIKS GILRNDSTVP DQFQCKLIAV GIFQLLSVIN LVVYVLLAPV VVYTLFVPFR
     QKTDVLKVYE ILPTFDVLHF KSEGYNDLSL YNLFLEENIS EVKSYKCLKV LENIKSSGQG
     IDPMLLLTNL GMIKMDVVDG KTPMSAEMRE EQGNQTAELQ GMNIDSETKA NNGEKNARQR
     LLDSSC
//
ID   TRPM6_HUMAN             Reviewed;        2022 AA.
AC   Q9BX84; Q6VPR8; Q6VPR9; Q6VPS0; Q6VPS1; Q6VPS2;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 2.
DT   22-NOV-2017, entry version 141.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 6;
DE            EC=2.7.11.1;
DE   AltName: Full=Channel kinase 2;
DE   AltName: Full=Melastatin-related TRP cation channel 6;
GN   Name=TRPM6; Synonyms=CHAK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRPM6A), AND CHARACTERIZATION.
RC   TISSUE=Kidney;
RX   PubMed=11357414;
RA   Riazanova L.V., Pavur K.S., Petrov A.N., Dorovkov M.V., Riazanov A.G.;
RT   "Novel type of signaling molecules: protein kinases covalently linked
RT   to ion channels.";
RL   Mol. Biol. (Mosk.) 35:321-332(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRPM6A), AND VARIANT HOMG1
RP   LEU-141.
RC   TISSUE=Kidney, and Small intestine;
RX   PubMed=12032568; DOI=10.1038/ng889;
RA   Schlingmann K.P., Weber S., Peters M., Niemann Nejsum L.N.,
RA   Vitzthum H., Klingel K., Kratz M., Haddad E., Ristoff E., Dinour D.,
RA   Syrrou M., Nielsen S., Sassen M.C., Waldegger S., Seyberth H.W.,
RA   Konrad M.;
RT   "Hypomagnesemia with secondary hypocalcemia is caused by mutations in
RT   TRPM6, a new member of the TRPM gene family.";
RL   Nat. Genet. 31:166-170(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TRPM6A; TRPM6B; TRPM6C; TRPM6T;
RP   M6-KINASE 1; M6-KINASE 2 AND M6-KINASE 3), CHARACTERIZATION OF VARIANT
RP   HOMG1 LEU-141, AND INTERACTION WITH TRPM7.
RC   TISSUE=Lung cancer;
RX   PubMed=14976260; DOI=10.1073/pnas.0305252101;
RA   Chubanov V., Waldegger S., Mederos y Schnitzler M., Vitzthum H.,
RA   Sassen M.C., Seyberth H.W., Konrad M., Gudermann T.;
RT   "Disruption of TRPM6/TRPM7 complex formation by a mutation in the
RT   TRPM6 gene causes hypomagnesemia with secondary hypocalcemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:2894-2899(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   INTERACTION WITH RACK1, PHOSPHORYLATION AT THR-1851, AND MUTAGENESIS
RP   OF LYS-1804 AND THR-1851.
RX   PubMed=18258429; DOI=10.1016/j.cub.2007.12.058;
RA   Cao G., Thebault S., van der Wijst J., van der Kemp A., Lasonder E.,
RA   Bindels R.J., Hoenderop J.G.;
RT   "RACK1 inhibits TRPM6 activity via phosphorylation of the fused alpha-
RT   kinase domain.";
RL   Curr. Biol. 18:168-176(2008).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-75; ILE-338; CYS-1007; ARG-1243;
RP   ARG-1274; ILE-1393; GLU-1584; ARG-1663; SER-1673 AND ILE-1724.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [7]
RP   VARIANTS HOMG1 PRO-708; GLY-872; CYS-1053; PRO-1143 AND ASN-1754,
RP   VARIANT ARG-1663, CHARACTERIZATION OF VARIANTS HOMG1 PRO-708; GLY-872;
RP   CYS-1053; PRO-1143 AND ASN-1754, CHARACTERIZATION OF VARIANT ARG-1663,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=23942199; DOI=10.1038/ejhg.2013.178;
RA   Lainez S., Schlingmann K.P., van der Wijst J., Dworniczak B.,
RA   van Zeeland F., Konrad M., Bindels R.J., Hoenderop J.G.;
RT   "New TRPM6 missense mutations linked to hypomagnesemia with secondary
RT   hypocalcemia.";
RL   Eur. J. Hum. Genet. 22:497-504(2014).
CC   -!- FUNCTION: Essential ion channel and serine/threonine-protein
CC       kinase. Crucial for magnesium homeostasis. Has an important role
CC       in epithelial magnesium transport and in the active magnesium
CC       absorption in the gut and kidney. Isoforms of the type M6-kinase
CC       lack the ion channel region.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Forms heterodimers with TRPM7. TRPM6 requires the
CC       presence of TRPM7 to be targeted to the cell membrane (in HEK 293
CC       cells). Interacts (via kinase domain) with RACK1.
CC       {ECO:0000269|PubMed:14976260, ECO:0000269|PubMed:18258429}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23942199};
CC       Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=TRPM6a;
CC         IsoId=Q9BX84-1; Sequence=Displayed;
CC       Name=TRPM6b;
CC         IsoId=Q9BX84-2; Sequence=VSP_012069;
CC       Name=TRPM6c;
CC         IsoId=Q9BX84-3; Sequence=VSP_012070;
CC       Name=TRPM6t;
CC         IsoId=Q9BX84-4; Sequence=VSP_012075, VSP_012076;
CC       Name=M6-kinase 1;
CC         IsoId=Q9BX84-5; Sequence=VSP_012074;
CC         Note=Lacks the ion channel region.;
CC       Name=M6-kinase 2;
CC         IsoId=Q9BX84-6; Sequence=VSP_012073;
CC         Note=Lacks the ion channel region.;
CC       Name=M6-kinase 3;
CC         IsoId=Q9BX84-7; Sequence=VSP_012071, VSP_012072;
CC         Note=Lacks the ion channel region.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney and colon. Isoform
CC       TRPM6a and isoform TRPM6b, are coexpressed with TRPM7 in kidney,
CC       and testis, and are also found in several cell lines of lung
CC       origin. Isoform TRPM6c is detected only in testis and in NCI-H510A
CC       small cell lung carcinoma cells.
CC   -!- DISEASE: Hypomagnesemia 1 (HOMG1) [MIM:602014]: A disorder due to
CC       a primary defect in intestinal magnesium absorption. It is
CC       characterized by low levels of serum magnesium alongside with a
CC       normal renal magnesium secretion, secondary hypocalcemia and
CC       calcinocis. Affected individuals show neurologic symptoms of
CC       hypomagnesemic hypocalcemia, including seizures and muscle spasms,
CC       during infancy. Hypocalcemia is secondary to parathyroid failure
CC       resulting from magnesium deficiency. Untreated, the disorder may
CC       be fatal or may result in neurological damage.
CC       {ECO:0000269|PubMed:12032568, ECO:0000269|PubMed:14976260,
CC       ECO:0000269|PubMed:23942199}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the protein
CC       kinase superfamily. Alpha-type protein kinase family. ALPK
CC       subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the transient
CC       receptor (TC 1.A.4) family. LTrpC subfamily. TRPM6 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF350881; AAK31202.2; -; mRNA.
DR   EMBL; AF448232; AAM21562.1; -; mRNA.
DR   EMBL; AY333282; AAR03487.1; -; mRNA.
DR   EMBL; AY333283; AAR03488.1; -; mRNA.
DR   EMBL; AY333284; AAR03489.1; -; mRNA.
DR   EMBL; AY333285; AAR03490.1; -; mRNA.
DR   EMBL; AY333286; AAR03491.1; -; mRNA.
DR   EMBL; AY333287; AAR03492.1; -; mRNA.
DR   EMBL; AY333288; AAR03493.1; -; mRNA.
DR   EMBL; AL354795; CAH70894.1; -; Genomic_DNA.
DR   CCDS; CCDS55318.1; -. [Q9BX84-3]
DR   CCDS; CCDS55319.1; -. [Q9BX84-2]
DR   CCDS; CCDS6647.1; -. [Q9BX84-1]
DR   RefSeq; NP_001170781.1; NM_001177310.1. [Q9BX84-2]
DR   RefSeq; NP_001170782.1; NM_001177311.1. [Q9BX84-3]
DR   RefSeq; NP_060132.3; NM_017662.4. [Q9BX84-1]
DR   UniGene; Hs.272225; -.
DR   ProteinModelPortal; Q9BX84; -.
DR   SMR; Q9BX84; -.
DR   CORUM; Q9BX84; -.
DR   IntAct; Q9BX84; 3.
DR   MINT; MINT-6699468; -.
DR   STRING; 9606.ENSP00000354006; -.
DR   BindingDB; Q9BX84; -.
DR   ChEMBL; CHEMBL1628470; -.
DR   GuidetoPHARMACOLOGY; 498; -.
DR   TCDB; 1.A.4.5.8; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9BX84; -.
DR   PhosphoSitePlus; Q9BX84; -.
DR   BioMuta; TRPM6; -.
DR   DMDM; 56404951; -.
DR   MaxQB; Q9BX84; -.
DR   PaxDb; Q9BX84; -.
DR   PeptideAtlas; Q9BX84; -.
DR   PRIDE; Q9BX84; -.
DR   Ensembl; ENST00000360774; ENSP00000354006; ENSG00000119121. [Q9BX84-1]
DR   Ensembl; ENST00000361255; ENSP00000354962; ENSG00000119121. [Q9BX84-3]
DR   Ensembl; ENST00000449912; ENSP00000396672; ENSG00000119121. [Q9BX84-2]
DR   GeneID; 140803; -.
DR   KEGG; hsa:140803; -.
DR   UCSC; uc004ajk.1; human. [Q9BX84-1]
DR   CTD; 140803; -.
DR   DisGeNET; 140803; -.
DR   EuPathDB; HostDB:ENSG00000119121.21; -.
DR   GeneCards; TRPM6; -.
DR   H-InvDB; HIX0008102; -.
DR   HGNC; HGNC:17995; TRPM6.
DR   MalaCards; TRPM6; -.
DR   MIM; 602014; phenotype.
DR   MIM; 607009; gene.
DR   neXtProt; NX_Q9BX84; -.
DR   OpenTargets; ENSG00000119121; -.
DR   Orphanet; 30924; Primary hypomagnesemia with secondary hypocalcemia.
DR   PharmGKB; PA38479; -.
DR   eggNOG; ENOG410INBW; Eukaryota.
DR   eggNOG; ENOG410ZSH9; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOGENOM; HOG000230920; -.
DR   HOVERGEN; HBG055663; -.
DR   InParanoid; Q9BX84; -.
DR   KO; K04981; -.
DR   OMA; NERMAMK; -.
DR   OrthoDB; EOG091G0DHL; -.
DR   PhylomeDB; Q9BX84; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   GeneWiki; TRPM6; -.
DR   GenomeRNAi; 140803; -.
DR   PRO; PR:Q9BX84; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000119121; -.
DR   CleanEx; HS_TRPM6; -.
DR   ExpressionAtlas; Q9BX84; baseline and differential.
DR   Genevisible; Q9BX84; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   GO; GO:0009636; P:response to toxic substance; IDA:UniProtKB.
DR   Gene3D; 1.20.5.1010; -; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   InterPro; IPR029597; TRPM6.
DR   InterPro; IPR032415; TRPM_tetra.
DR   InterPro; IPR037162; TRPM_tetra_sf.
DR   PANTHER; PTHR13800:SF15; PTHR13800:SF15; 1.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF16519; TRPM_tetra; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Disease mutation;
KW   Ion channel; Ion transport; Kinase; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Primary hypomagnesemia; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   CHAIN         1   2022       Transient receptor potential cation
FT                                channel subfamily M member 6.
FT                                /FTId=PRO_0000215329.
FT   TOPO_DOM      1    741       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    742    762       Helical. {ECO:0000255}.
FT   TOPO_DOM    763    841       Extracellular. {ECO:0000255}.
FT   TRANSMEM    842    862       Helical. {ECO:0000255}.
FT   TOPO_DOM    863    905       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    906    926       Helical. {ECO:0000255}.
FT   TOPO_DOM    927    939       Extracellular. {ECO:0000255}.
FT   TRANSMEM    940    960       Helical. {ECO:0000255}.
FT   TOPO_DOM    961    972       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    973    993       Helical. {ECO:0000255}.
FT   TOPO_DOM    994   1012       Extracellular. {ECO:0000255}.
FT   INTRAMEM   1013   1033       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM   1034   1047       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1048   1068       Helical. {ECO:0000255}.
FT   TOPO_DOM   1069   2022       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN     1750   1980       Alpha-type protein kinase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00501}.
FT   NP_BIND    1950   1956       ATP. {ECO:0000250}.
FT   ACT_SITE   1923   1923       Proton acceptor. {ECO:0000250}.
FT   METAL      1909   1909       Zinc. {ECO:0000250}.
FT   METAL      1966   1966       Zinc. {ECO:0000250}.
FT   METAL      1968   1968       Zinc. {ECO:0000250}.
FT   METAL      1972   1972       Zinc. {ECO:0000250}.
FT   BINDING    1780   1780       ATP. {ECO:0000250}.
FT   BINDING    1804   1804       ATP. {ECO:0000250}.
FT   BINDING    1876   1876       ATP. {ECO:0000250}.
FT   BINDING    1925   1925       ATP. {ECO:0000250}.
FT   BINDING    1933   1933       ATP. {ECO:0000250}.
FT   MOD_RES    1851   1851       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18258429}.
FT   VAR_SEQ       1     11       MKEQPVLERLQ -> MIILSK (in isoform
FT                                TRPM6b). {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012069.
FT   VAR_SEQ       1     11       MKEQPVLERLQ -> MTAPVT (in isoform
FT                                TRPM6c). {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012070.
FT   VAR_SEQ     281    281       R -> P (in isoform M6-kinase 3).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012071.
FT   VAR_SEQ     282   1734       Missing (in isoform M6-kinase 3).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012072.
FT   VAR_SEQ     500   1666       Missing (in isoform M6-kinase 2).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012073.
FT   VAR_SEQ     547   1595       Missing (in isoform M6-kinase 1).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012074.
FT   VAR_SEQ    1926   1943       GVGENLTDPSVIKPEVKQ -> ALWFWDSMLKARLGGWRM
FT                                (in isoform TRPM6t).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012075.
FT   VAR_SEQ    1944   2022       Missing (in isoform TRPM6t).
FT                                {ECO:0000303|PubMed:14976260}.
FT                                /FTId=VSP_012076.
FT   VARIANT      75     75       G -> V (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042387.
FT   VARIANT     141    141       S -> L (in HOMG1; impairs heterodimer
FT                                formation resulting in intracellular
FT                                retention; dbSNP:rs121912625).
FT                                {ECO:0000269|PubMed:12032568,
FT                                ECO:0000269|PubMed:14976260}.
FT                                /FTId=VAR_019963.
FT   VARIANT     338    338       M -> I (in dbSNP:rs56155062).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042388.
FT   VARIANT     708    708       L -> P (in HOMG1; loss of function; no
FT                                effect on cell membrane localization).
FT                                {ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_071480.
FT   VARIANT     872    872       E -> G (in HOMG1; loss of function; no
FT                                effect on cell membrane localization).
FT                                {ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_071481.
FT   VARIANT     948    948       F -> L (in dbSNP:rs13290391).
FT                                /FTId=VAR_052380.
FT   VARIANT    1007   1007       W -> C (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042389.
FT   VARIANT    1053   1053       Y -> C (in HOMG1; loss of function; no
FT                                effect on cell membrane localization).
FT                                {ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_071482.
FT   VARIANT    1071   1071       N -> D (in dbSNP:rs2274922).
FT                                /FTId=VAR_019964.
FT   VARIANT    1143   1143       L -> P (in HOMG1; loss of function; no
FT                                effect on cell membrane localization).
FT                                {ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_071483.
FT   VARIANT    1243   1243       H -> R (in dbSNP:rs55694430).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042390.
FT   VARIANT    1274   1274       Q -> R (in dbSNP:rs34608911).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042391.
FT   VARIANT    1393   1393       V -> I (in dbSNP:rs3750425).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_019965.
FT   VARIANT    1584   1584       K -> E (in dbSNP:rs2274924).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_019966.
FT   VARIANT    1663   1663       Q -> R (no effect on function or cell
FT                                membrane localization; dbSNP:rs55679040).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_042392.
FT   VARIANT    1673   1673       L -> S (in dbSNP:rs56254742).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042393.
FT   VARIANT    1724   1724       T -> I (in dbSNP:rs56290308).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042394.
FT   VARIANT    1754   1754       S -> N (in HOMG1; loss of function; no
FT                                effect on cell membrane localization).
FT                                {ECO:0000269|PubMed:23942199}.
FT                                /FTId=VAR_071484.
FT   MUTAGEN    1804   1804       K->R: Abolishes kinase activity but does
FT                                not affect expression levels or binding
FT                                to RACK1. {ECO:0000269|PubMed:18258429}.
FT   MUTAGEN    1851   1851       T->A: Significantly decreases
FT                                autophosphorylation. Does not alter
FT                                binding to RACK1 but prevents inhibition
FT                                by RACK1. {ECO:0000269|PubMed:18258429}.
FT   MUTAGEN    1851   1851       T->D: Significantly decreases
FT                                autophosphorylation. Does not alter
FT                                binding to RACK1 or inhibition by RACK1.
FT                                {ECO:0000269|PubMed:18258429}.
SQ   SEQUENCE   2022 AA;  231708 MW;  59346B3BE3300466 CRC64;
     MKEQPVLERL QSQKSWIKGV FDKRECSTII PSSKNPHRCT PVCQVCQNLI RCYCGRLIGD
     HAGIDYSWTI SAAKGKESEQ WSVEKHTTKS PTDTFGTINF QDGEHTHHAK YIRTSYDTKL
     DHLLHLMLKE WKMELPKLVI SVHGGIQNFT MPSKFKEIFS QGLVKAAETT GAWIITEGIN
     TGVSKHVGDA LKSHSSHSLR KIWTVGIPPW GVIENQRDLI GKDVVCLYQT LDNPLSKLTT
     LNSMHSHFIL SDDGTVGKYG NEMKLRRNLE KYLSLQKIHC RSRQGVPVVG LVVEGGPNVI
     LSVWETVKDK DPVVVCEGTG RAADLLAFTH KHLADEGMLR PQVKEEIICM IQNTFNFSLK
     QSKHLFQILM ECMVHRDCIT IFDADSEEQQ DLDLAILTAL LKGTNLSASE QLNLAMAWDR
     VDIAKKHILI YEQHWKPDAL EQAMSDALVM DRVDFVKLLI EYGVNLHRFL TIPRLEELYN
     TKQGPTNTLL HHLVQDVKQH TLLSGYRITL IDIGLVVEYL IGRAYRSNYT RKHFRALYNN
     LYRKYKHQRH SSGNRNESAE STLHSQFIRT AQPYKFKEKS IVLHKSRKKS KEQNVSDDPE
     STGFLYPYND LLVWAVLMKR QKMAMFFWQH GEEATVKAVI ACILYRAMAH EAKESHMVDD
     ASEELKNYSK QFGQLALDLL EKAFKQNERM AMTLLTYELR NWSNSTCLKL AVSGGLRPFV
     SHTCTQMLLT DMWMGRLKMR KNSWLKIIIS IILPPTILTL EFKSKAEMSH VPQSQDFQFM
     WYYSDQNASS SKESASVKEY DLERGHDEKL DENQHFGLES GHQHLPWTRK VYEFYSAPIV
     KFWFYTMAYL AFLMLFTYTV LVEMQPQPSV QEWLVSIYIF TNAIEVVREI CISEPGKFTQ
     KVKVWISEYW NLTETVAIGL FSAGFVLRWG DPPFHTAGRL IYCIDIIFWF SRLLDFFAVN
     QHAGPYVTMI AKMTANMFYI VIIMAIVLLS FGVARKAILS PKEPPSWSLA RDIVFEPYWM
     IYGEVYAGEI DVCSSQPSCP PGSFLTPFLQ AVYLFVQYII MVNLLIAFFN NVYLDMESIS
     NNLWKYNRYR YIMTYHEKPW LPPPLILLSH VGLLLRRLCC HRAPHDQEEG DVGLKLYLSK
     EDLKKLHDFE EQCVEKYFHE KMEDVNCSCE ERIRVTSERV TEMYFQLKEM NEKVSFIKDS
     LLSLDSQVGH LQDLSALTVD TLKVLSAVDT LQEDEALLAK RKHSTCKKLP HSWSNVICAE
     VLGSMEIAGE KKYQYYSMPS SLLRSLAGGR HPPRVQRGAL LEITNSKREA TNVRNDQERQ
     ETQSSIVVSG VSPNRQAHSK YGQFLLVPSN LKRVPFSAET VLPLSRPSVP DVLATEQDIQ
     TEVLVHLTGQ TPVVSDWASV DEPKEKHEPI AHLLDGQDKA EQVLPTLSCT PEPMTMSSPL
     SQAKIMQTGG GYVNWAFSEG DETGVFSIKK KWQTCLPSTC DSDSSRSEQH QKQAQDSSLS
     DNSTRSAQSS ECSEVGPWLQ PNTSFWINPL RRYRPFARSH SFRFHKEEKL MKICKIKNLS
     GSSEIGQGAW VKAKMLTKDR RLSKKKKNTQ GLQVPIITVN ACSQSDQLNP EPGENSISEE
     EYSKNWFTVS KFSHTGVEPY IHQKMKTKEI GQCAIQISDY LKQSQEDLSK NSLWNSRSTN
     LNRNSLLKSS IGVDKISASL KSPQEPHHHY SAIERNNLMR LSQTIPFTPV QLFAGEEITV
     YRLEESSPLN LDKSMSSWSQ RGRAAMIQVL SREEMDGGLR KAMRVVSTWS EDDILKPGQV
     FIVKSFLPEV VRTWHKIFQE STVLHLCLRE IQQQRAAQKL IYTFNQVKPQ TIPYTPRFLE
     VFLIYCHSAN QWLTIEKYMT GEFRKYNNNN GDEITPTNTL EELMLAFSHW TYEYTRGELL
     VLDLQGVGEN LTDPSVIKPE VKQSRGMVFG PANLGEDAIR NFIAKHHCNS CCRKLKLPDL
     KRNDYSPERI NSTFGLEIKI ESAEEPPARE TGRNSPEDDM QL
//
ID   CCG6_HUMAN              Reviewed;         260 AA.
AC   Q9BXT2;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   27-SEP-2017, entry version 121.
DE   RecName: Full=Voltage-dependent calcium channel gamma-6 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-6 subunit;
GN   Name=CACNG6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11170751; DOI=10.1006/geno.2000.6440;
RA   Burgess D.L., Gefrides L.A., Foreman P.J., Noebels J.L.;
RT   "A cluster of three novel Ca(2+) channel gamma subunit genes on
RT   chromosome 19q13.4: evolution and expression profile of the gamma
RT   subunit gene family.";
RL   Genomics 71:339-350(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11738816; DOI=10.1016/S0378-1119(01)00738-7;
RA   Chu P.-J., Robertson H.M., Best P.M.;
RT   "Calcium channel gamma subunits provide insights into the evolution of
RT   this gene family.";
RL   Gene 280:37-48(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Thought to stabilize the calcium channel in an
CC       inactivated (closed) state. {ECO:0000250}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF288386; AAK20029.1; -; mRNA.
DR   EMBL; AF361352; AAL50047.1; -; mRNA.
DR   EMBL; BC021552; AAH21552.1; -; mRNA.
DR   CCDS; CCDS12870.1; -.
DR   RefSeq; NP_114103.2; NM_031897.2.
DR   RefSeq; NP_665813.1; NM_145814.1.
DR   RefSeq; NP_665814.1; NM_145815.1.
DR   UniGene; Hs.631560; -.
DR   ProteinModelPortal; Q9BXT2; -.
DR   STRING; 9606.ENSP00000252729; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   TCDB; 8.A.16.1.2; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; Q9BXT2; -.
DR   PhosphoSitePlus; Q9BXT2; -.
DR   BioMuta; CACNG6; -.
DR   DMDM; 20532019; -.
DR   EPD; Q9BXT2; -.
DR   PaxDb; Q9BXT2; -.
DR   PeptideAtlas; Q9BXT2; -.
DR   PRIDE; Q9BXT2; -.
DR   DNASU; 59285; -.
DR   Ensembl; ENST00000252729; ENSP00000252729; ENSG00000130433.
DR   GeneID; 59285; -.
DR   KEGG; hsa:59285; -.
DR   UCSC; uc002qct.4; human.
DR   CTD; 59285; -.
DR   DisGeNET; 59285; -.
DR   EuPathDB; HostDB:ENSG00000130433.7; -.
DR   GeneCards; CACNG6; -.
DR   HGNC; HGNC:13625; CACNG6.
DR   HPA; HPA056615; -.
DR   MIM; 606898; gene.
DR   neXtProt; NX_Q9BXT2; -.
DR   OpenTargets; ENSG00000130433; -.
DR   PharmGKB; PA26020; -.
DR   eggNOG; ENOG410IWHM; Eukaryota.
DR   eggNOG; ENOG4111I1Z; LUCA.
DR   GeneTree; ENSGT00390000007786; -.
DR   HOGENOM; HOG000293219; -.
DR   HOVERGEN; HBG003868; -.
DR   InParanoid; Q9BXT2; -.
DR   KO; K04871; -.
DR   OMA; GEANCTY; -.
DR   OrthoDB; EOG091G0HUO; -.
DR   PhylomeDB; Q9BXT2; -.
DR   TreeFam; TF331651; -.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   GenomeRNAi; 59285; -.
DR   PRO; PR:Q9BXT2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130433; -.
DR   CleanEx; HS_CACNG6; -.
DR   ExpressionAtlas; Q9BXT2; baseline and differential.
DR   Genevisible; Q9BXT2; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; NAS:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; NAS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; NAS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008370; VDCC_g6su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   Pfam; PF13903; Claudin_2; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01794; VDCCGAMMA6.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    260       Voltage-dependent calcium channel gamma-6
FT                                subunit.
FT                                /FTId=PRO_0000164684.
FT   TRANSMEM     43     63       Helical. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   VARIANT     252    252       C -> S (in dbSNP:rs12980121).
FT                                /FTId=VAR_061540.
SQ   SEQUENCE   260 AA;  28129 MW;  674433E331FD9974 CRC64;
     MMWSNFFLQE ENRRRGAAGR RRAHGQGRSG LTPEREGKVK LALLLAAVGA TLAVLSVGTE
     FWVELNTYKA NGSAVCEAAH LGLWKACTKR LWQADVPVDR DTCGPAELPG EANCTYFKFF
     TTGENARIFQ RTTKKEVNLA AAVIAVLGLA VMALGCLCII MVLSKGAEFL LRVGAVCFGL
     SGLLLLVSLE VFRHSVRALL QRVSPEPPPA PRLTYEYSWS LGCGVGAGLI LLLGAGCFLL
     LTLPSWPWGS LCPKRGHRAT
//
ID   MCU4_ARATH              Reviewed;         293 AA.
AC   Q9FJV7;
DT   26-NOV-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   20-DEC-2017, entry version 88.
DE   RecName: Full=Calcium uniporter protein 4, mitochondrial;
DE   Flags: Precursor;
GN   OrderedLocusNames=At5g42610 {ECO:0000312|Araport:AT5G42610};
GN   ORFNames=MFO20.2 {ECO:0000312|EMBL:BAB10499.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9734815; DOI=10.1093/dnares/5.3.203;
RA   Kotani H., Nakamura Y., Sato S., Asamizu E., Kaneko T., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. VI.
RT   Sequence features of the regions of 1,367,185 bp covered by 19
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:203-216(1998).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Xiao Y.-L., Underwood B.A., Moskal W.A. Jr., Wang W., Redman J.C.,
RA   Wu H.C., Utterback T., Town C.D.;
RT   "Reconstruction of cDNA sequences for hypothetical genes in
RT   Arabidopsis thaliana from 5' and 3' RACE products.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Underwood B.A., Xiao Y.-L., Moskal W.A. Jr., Monaghan E.L., Wang W.,
RA   Redman J.C., Wu H.C., Utterback T., Town C.D.;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   GENE FAMILY, AND REVIEW.
RX   PubMed=22200666; DOI=10.1093/jxb/err394;
RA   Stael S., Wurzinger B., Mair A., Mehlmer N., Vothknecht U.C.,
RA   Teige M.;
RT   "Plant organellar calcium signalling: an emerging field.";
RL   J. Exp. Bot. 63:1525-1542(2012).
CC   -!- FUNCTION: Mitochondrial inner membrane calcium uniporter that
CC       mediates calcium uptake into mitochondria. Constitutes a pore-
CC       forming and calcium-conducting subunit. Mitochondrial calcium
CC       homeostasis plays key roles in cellular physiology and regulates
CC       cell bioenergetics, cytoplasmic calcium signals and activation of
CC       cell death pathways. {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8NE86}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8NE86}.
CC   -!- SIMILARITY: Belongs to the MCU (TC 1.A.77) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB013391; BAB10499.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED94835.1; -; Genomic_DNA.
DR   EMBL; AY735694; AAU44564.1; -; mRNA.
DR   EMBL; AY773901; AAV63930.1; -; mRNA.
DR   RefSeq; NP_199075.1; NM_123625.4.
DR   UniGene; At.51076; -.
DR   ProteinModelPortal; Q9FJV7; -.
DR   STRING; 3702.AT5G42610.1; -.
DR   PaxDb; Q9FJV7; -.
DR   EnsemblPlants; AT5G42610.1; AT5G42610.1; AT5G42610.
DR   GeneID; 834268; -.
DR   Gramene; AT5G42610.1; AT5G42610.1; AT5G42610.
DR   KEGG; ath:AT5G42610; -.
DR   Araport; AT5G42610; -.
DR   TAIR; locus:2163842; AT5G42610.
DR   eggNOG; KOG2966; Eukaryota.
DR   eggNOG; ENOG410Y3YU; LUCA.
DR   HOGENOM; HOG000239883; -.
DR   InParanoid; Q9FJV7; -.
DR   KO; K20858; -.
DR   OMA; QICCESC; -.
DR   OrthoDB; EOG09360N9O; -.
DR   PhylomeDB; Q9FJV7; -.
DR   Reactome; R-ATH-8949215; Mitochondrial calcium ion transport.
DR   PRO; PR:Q9FJV7; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9FJV7; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0015292; F:uniporter activity; IBA:GO_Central.
DR   InterPro; IPR006769; Coiled-coil-dom_prot_109_C.
DR   Pfam; PF04678; MCU; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix; Transport.
FT   TRANSIT       1      5       Mitochondrion. {ECO:0000255}.
FT   CHAIN         6    293       Calcium uniporter protein 4,
FT                                mitochondrial.
FT                                /FTId=PRO_0000431373.
FT   TRANSMEM    189    209       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical; Name=2. {ECO:0000255}.
SQ   SEQUENCE   293 AA;  34260 MW;  8AF24707C9652990 CRC64;
     MALRRAITKR LIDCYRSDVT QQHSFFRQLS PYNMKIHRQY MTSPNGPNLT DRIVGIRIES
     VSPPRREETP VMGLSVSETK KLLRLYQMEK VKERLREIPK SSVSYWEFIQ ICCESCGNDE
     QGSQMAKSLD HSGCVVVLGD IVFLHPHQIA KSMEAMIKQT SVLPNDPRKE ELVQLATTKK
     SIDIEARRIV QAELYCGLGF LAVQTIGFMR LTFWELSWDV MEPICFFVTT IHFILGYIFF
     LRTSTEPSFE GLFRQRFKTK QKKLMERHGF DFLRYNELNS LFTTFPCKFH YPV
//
ID   TRPV6_HUMAN             Reviewed;         765 AA.
AC   Q9H1D0; A4D2I8; Q8TDL3; Q8WXR8; Q96LC5; Q9H1D1; Q9H296;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 3.
DT   25-OCT-2017, entry version 157.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 6;
DE            Short=TrpV6;
DE   AltName: Full=CaT-like {ECO:0000303|PubMed:11278579};
DE            Short=CaT-L {ECO:0000303|PubMed:11278579};
DE   AltName: Full=Calcium transport protein 1 {ECO:0000303|PubMed:11097838};
DE            Short=CaT1 {ECO:0000303|PubMed:11097838};
DE   AltName: Full=Epithelial calcium channel 2;
DE            Short=ECaC2;
GN   Name=TRPV6; Synonyms=ECAC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11097838; DOI=10.1006/bbrc.2000.3716;
RA   Peng J.-B., Chen X.Z., Berger U.V., Weremowicz S., Morton C.C.,
RA   Vassilev P.M., Brown E.M., Hediger M.A.;
RT   "Human calcium transport protein CaT1.";
RL   Biochem. Biophys. Res. Commun. 278:326-332(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=11545681; DOI=10.1186/1472-6793-1-11;
RA   Wood R.J., Tchack L., Taparia S.;
RT   "1,25-dihydroxyvitamin D3 increases the expression of the CaT1
RT   epithelial calcium channel in the Caco-2 human intestinal cell line.";
RL   BMC Physiol. 1:11-11(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=11549322; DOI=10.1006/geno.2001.6606;
RA   Peng J.-B., Brown E.M., Hediger M.A.;
RT   "Structural conservation of the genes encoding CaT1, CaT2, and related
RT   cation channels.";
RL   Genomics 76:99-109(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS ARG-197; VAL-418 AND
RP   THR-721, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=11278579; DOI=10.1074/jbc.M009895200;
RA   Wissenbach U., Niemeyer B.A., Fixemer T., Schneidewind A., Trost C.,
RA   Cavalie A., Reus K., Meese E., Bonkhoff H., Flockerzi V.;
RT   "Expression of CaT-like, a novel calcium selective channel, correlates
RT   with the malignancy of prostate cancer.";
RL   J. Biol. Chem. 276:19461-19468(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Peng J.-B., Brown E.M., Hediger M.A.;
RT   "A CaT1 splice variant lacking ankyrin repeats.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kelsell R.E.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-197; VAL-418 AND
RP   THR-721.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 41-765.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CALMODULIN,
RP   PHOSPHORYLATION AT THR-742, AND MUTAGENESIS OF THR-742.
RX   PubMed=11248124; DOI=10.1073/pnas.051511398;
RA   Niemeyer B.A., Bergs C., Wissenbach U., Flockerzi V., Trost C.;
RT   "Competitive regulation of CaT-like-mediated Ca2+ entry by protein
RT   kinase C and calmodulin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3600-3605(2001).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-582, AND
RP   CALMODULIN-BINDING REGION.
RX   PubMed=15184369; DOI=10.1074/jbc.M404679200;
RA   Bodding M., Flockerzi V.;
RT   "Ca2+ dependence of the Ca2+-selective TRPV6 channel.";
RL   J. Biol. Chem. 279:36546-36552(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, IDENTIFICATION OF
RP   NON-CANONICAL INITIATION CODON, SUBCELLULAR LOCATION, GLYCOSYLATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=23612980; DOI=10.1074/jbc.M113.469726;
RA   Fecher-Trost C., Wissenbach U., Beck A., Schalkowsky P., Stoerger C.,
RA   Doerr J., Dembek A., Simon-Thomas M., Weber A., Wollenberg P.,
RA   Ruppert T., Middendorff R., Maurer H.H., Flockerzi V.;
RT   "The in vivo TRPV6 protein starts at a non-AUG triplet, decoded as
RT   methionine, upstream of canonical initiation at AUG.";
RL   J. Biol. Chem. 288:16629-16644(2013).
RN   [14]
RP   INTERACTION WITH TCAF1 AND TCAF2.
RX   PubMed=25559186; DOI=10.1083/jcb.201402076;
RA   Gkika D., Lemonnier L., Shapovalov G., Gordienko D., Poux C.,
RA   Bernardini M., Bokhobza A., Bidaux G., Degerny C., Verreman K.,
RA   Guarmit B., Benahmed M., de Launoit Y., Bindels R.J., Fiorio Pla A.,
RA   Prevarskaya N.;
RT   "TRP channel-associated factors are a novel protein family that
RT   regulates TRPM8 trafficking and activity.";
RL   J. Cell Biol. 208:89-107(2015).
CC   -!- FUNCTION: Calcium selective cation channel that mediates Ca(2+)
CC       uptake in various tissues, including the intestine
CC       (PubMed:11097838, PubMed:11278579, PubMed:11248124
CC       PubMed:15184369, PubMed:23612980). Important for normal Ca(2+) ion
CC       homeostasis in the body, including bone and skin (By similarity).
CC       The channel is activated by low internal calcium level, probably
CC       including intracellular calcium store depletion, and the current
CC       exhibits an inward rectification (PubMed:15184369). Inactivation
CC       includes both a rapid Ca(2+)-dependent and a slower Ca(2+)-
CC       calmodulin-dependent mechanism; the latter may be regulated by
CC       phosphorylation. In vitro, is slowly inhibited by Mg(2+) in a
CC       voltage-independent manner. Heteromeric assembly with TRPV5 seems
CC       to modify channel properties. TRPV5-TRPV6 heteromultimeric
CC       concatemers exhibit voltage-dependent gating.
CC       {ECO:0000250|UniProtKB:Q91WD2, ECO:0000269|PubMed:11097838,
CC       ECO:0000269|PubMed:11248124, ECO:0000269|PubMed:11278579,
CC       ECO:0000269|PubMed:15184369, ECO:0000269|PubMed:23612980}.
CC   -!- SUBUNIT: Homotetramer and probably heterotetramer with TRPV5.
CC       Interacts with TRPV5. Interacts with S100A10 and probably with the
CC       ANAX2-S100A10 heterotetramer. The interaction with S100A10 is
CC       required for the trafficking to the plasma membrane. Interacts
CC       with BSPRY (By similarity). Interacts with TCAF1 and TCAF2 isoform
CC       2 (PubMed:25559186). Interacts with calmodulin (PubMed:11248124).
CC       {ECO:0000250|UniProtKB:Q91WD2, ECO:0000269|PubMed:11248124,
CC       ECO:0000269|PubMed:25559186}.
CC   -!- INTERACTION:
CC       P18031:PTPN1; NbExp=6; IntAct=EBI-7198335, EBI-968788;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11097838,
CC       ECO:0000269|PubMed:11248124, ECO:0000269|PubMed:11278579,
CC       ECO:0000269|PubMed:15184369, ECO:0000269|PubMed:23612980}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:Q91WD2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H1D0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H1D0-2; Sequence=VSP_013439;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the
CC       gastrointestinal tract, including esophagus, stomach, duodenum,
CC       jejunum, ileum and colon, and in pancreas, placenta, prostate and
CC       salivary gland. Expressed at moderate levels in liver, kidney and
CC       testis. Expressed in trophoblasts of placenta villus trees (at
CC       protein level)(PubMed:23612980). Expressed in locally advanced
CC       prostate cancer, metastatic and androgen-insensitive prostatic
CC       lesions but not detected in healthy prostate tissue and benign
CC       prostatic hyperplasia. {ECO:0000269|PubMed:11097838,
CC       ECO:0000269|PubMed:11278579, ECO:0000269|PubMed:23612980}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000269|PubMed:23612980}.
CC   -!- PTM: Phosphorylation at Tyr-201 by SRC leads to an increased
CC       calcium influx through the channel. Probably dephosphorylated at
CC       this site by PTPN1 (By similarity). Phosphorylation by PRKCA at
CC       the calmodulin binding site delays channel inactivation
CC       (PubMed:11248124). {ECO:0000250|UniProtKB:Q9R186,
CC       ECO:0000269|PubMed:11248124}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV6 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK50426.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=AAL40230.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=AAM00356.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=AAO38052.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=BAF84396.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=CAC20416.2; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=CAC20417.2; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC       Sequence=CAD32311.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000305|PubMed:23612980};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=TRPV6 entry;
CC       URL="https://en.wikipedia.org/wiki/TRPV6";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/trpv5/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TRPV6ID44425ch7q34.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF304463; AAG41951.1; -; mRNA.
DR   EMBL; AF365927; AAL40230.1; ALT_SEQ; mRNA.
DR   EMBL; AF365928; AAM00356.1; ALT_SEQ; mRNA.
DR   EMBL; AH010730; AAK50426.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ243500; CAC20416.2; ALT_SEQ; mRNA.
DR   EMBL; AJ243501; CAC20417.2; ALT_SEQ; mRNA.
DR   EMBL; AJ487964; CAD32311.1; ALT_SEQ; mRNA.
DR   EMBL; AY225461; AAO38052.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK291707; BAF84396.1; ALT_SEQ; mRNA.
DR   EMBL; CH236959; EAL23776.1; -; Genomic_DNA.
DR   CCDS; CCDS5874.2; -. [Q9H1D0-1]
DR   PIR; JC7531; JC7531.
DR   RefSeq; NP_061116.5; NM_018646.5. [Q9H1D0-1]
DR   UniGene; Hs.302740; -.
DR   ProteinModelPortal; Q9H1D0; -.
DR   SMR; Q9H1D0; -.
DR   BioGrid; 120683; 15.
DR   IntAct; Q9H1D0; 2.
DR   MINT; MINT-1472896; -.
DR   STRING; 9606.ENSP00000352358; -.
DR   BindingDB; Q9H1D0; -.
DR   ChEMBL; CHEMBL1628465; -.
DR   TCDB; 1.A.4.2.11; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9H1D0; -.
DR   PhosphoSitePlus; Q9H1D0; -.
DR   DMDM; 62901469; -.
DR   PaxDb; Q9H1D0; -.
DR   PeptideAtlas; Q9H1D0; -.
DR   PRIDE; Q9H1D0; -.
DR   DNASU; 55503; -.
DR   Ensembl; ENST00000638686; ENSP00000492723; ENSG00000165125. [Q9H1D0-1]
DR   GeneID; 55503; -.
DR   KEGG; hsa:55503; -.
DR   UCSC; uc003wbx.4; human. [Q9H1D0-1]
DR   CTD; 55503; -.
DR   DisGeNET; 55503; -.
DR   EuPathDB; HostDB:ENSG00000165125.17; -.
DR   GeneCards; TRPV6; -.
DR   H-InvDB; HIX0007162; -.
DR   HGNC; HGNC:14006; TRPV6.
DR   HPA; HPA062864; -.
DR   MIM; 606680; gene.
DR   neXtProt; NX_Q9H1D0; -.
DR   OpenTargets; ENSG00000165125; -.
DR   PharmGKB; PA37832; -.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   GeneTree; ENSGT00550000074425; -.
DR   HOVERGEN; HBG061442; -.
DR   InParanoid; Q9H1D0; -.
DR   KO; K04975; -.
DR   OrthoDB; EOG091G0314; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   SIGNOR; Q9H1D0; -.
DR   GeneWiki; TRPV6; -.
DR   GenomeRNAi; 55503; -.
DR   PRO; PR:Q9H1D0; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000165125; -.
DR   CleanEx; HS_TRPV6; -.
DR   ExpressionAtlas; Q9H1D0; baseline and differential.
DR   Genevisible; Q9H1D0; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0017158; P:regulation of calcium ion-dependent exocytosis; NAS:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; ISS:UniProtKB.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008344; TRPV5/TRPV6.
DR   InterPro; IPR008345; TRPV6_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01765; ECACCHANNEL.
DR   PRINTS; PR01766; ECACCHANNEL1.
DR   SMART; SM00248; ANK; 5.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    765       Transient receptor potential cation
FT                                channel subfamily V member 6.
FT                                /FTId=PRO_0000215354.
FT   TRANSMEM    368    388       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   TRANSMEM    426    448       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   TRANSMEM    464    483       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   TRANSMEM    490    509       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   TRANSMEM    530    552       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   INTRAMEM    566    585       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q9R186}.
FT   TRANSMEM    597    617       Helical. {ECO:0000250|UniProtKB:Q9R186}.
FT   REPEAT       84    114       ANK 1.
FT   REPEAT      118    147       ANK 2.
FT   REPEAT      156    185       ANK 3.
FT   REPEAT      202    231       ANK 4.
FT   REPEAT      235    277       ANK 5.
FT   REPEAT      279    308       ANK 5.
FT   REGION      133    143       Interaction with calmodulin.
FT                                {ECO:0000250}.
FT   REGION      638    642       Interaction with S100A10. {ECO:0000250}.
FT   REGION      731    751       Interaction with calmodulin.
FT                                {ECO:0000269|PubMed:11248124,
FT                                ECO:0000269|PubMed:15184369}.
FT   MOTIF       581    585       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:Q9R186}.
FT   METAL       582    582       Calcium; shared with neighboring
FT                                subunits. {ECO:0000250|UniProtKB:Q9R186}.
FT   MOD_RES     201    201       Phosphotyrosine; by SRC.
FT                                {ECO:0000250|UniProtKB:Q9R186}.
FT   MOD_RES     742    742       Phosphothreonine; by PKC/PRKCA.
FT                                {ECO:0000269|PubMed:11248124}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      65    232       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_013439.
FT   VARIANT     197    197       C -> R (in dbSNP:rs4987657).
FT                                {ECO:0000269|PubMed:11278579,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022251.
FT   VARIANT     399    399       R -> Q (in dbSNP:rs4987665).
FT                                /FTId=VAR_052393.
FT   VARIANT     418    418       M -> V (in dbSNP:rs4987667).
FT                                {ECO:0000269|PubMed:11278579,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022252.
FT   VARIANT     721    721       M -> T (in dbSNP:rs4987682).
FT                                {ECO:0000269|PubMed:11278579,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022253.
FT   MUTAGEN     582    582       D->A: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:15184369}.
FT   MUTAGEN     742    742       T->A: Abolishes phosphorylation by
FT                                PKC/PRKCA, achieves faster channel
FT                                inactivation and no effect on binding to
FT                                calmodulin.
FT                                {ECO:0000269|PubMed:11248124}.
FT   CONFLICT     77     77       N -> D (in Ref. 1; AAG41951).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       Q -> H (in Ref. 1; AAG41951).
FT                                {ECO:0000305}.
SQ   SEQUENCE   765 AA;  87286 MW;  626D515E12112546 CRC64;
     MGPLQGDGGP ALGGADVAPR LSPVRVWPRP QAPKEPALHP MGLSLPKEKG LILCLWSKFC
     RWFQRRESWA QSRDEQNLLQ QKRIWESPLL LAAKDNDVQA LNKLLKYEDC KVHQRGAMGE
     TALHIAALYD NLEAAMVLME AAPELVFEPM TSELYEGQTA LHIAVVNQNM NLVRALLARR
     ASVSARATGT AFRRSPCNLI YFGEHPLSFA ACVNSEEIVR LLIEHGADIR AQDSLGNTVL
     HILILQPNKT FACQMYNLLL SYDRHGDHLQ PLDLVPNHQG LTPFKLAGVE GNTVMFQHLM
     QKRKHTQWTY GPLTSTLYDL TEIDSSGDEQ SLLELIITTK KREARQILDQ TPVKELVSLK
     WKRYGRPYFC MLGAIYLLYI ICFTMCCIYR PLKPRTNNRT SPRDNTLLQQ KLLQEAYMTP
     KDDIRLVGEL VTVIGAIIIL LVEVPDIFRM GVTRFFGQTI LGGPFHVLII TYAFMVLVTM
     VMRLISASGE VVPMSFALVL GWCNVMYFAR GFQMLGPFTI MIQKMIFGDL MRFCWLMAVV
     ILGFASAFYI IFQTEDPEEL GHFYDYPMAL FSTFELFLTI IDGPANYNVD LPFMYSITYA
     AFAIIATLLM LNLLIAMMGD THWRVAHERD ELWRAQIVAT TVMLERKLPR CLWPRSGICG
     REYGLGDRWF LRVEDRQDLN RQRIQRYAQA FHTRGSEDLD KDSVEKLELG CPFSPHLSLP
     MPSVSRSTSR SSANWERLRQ GTLRRDLRGI INRGLEDGES WEYQI
//
ID   TRPV4_HUMAN             Reviewed;         871 AA.
AC   Q9HBA0; B7ZKQ6; Q17R79; Q2Y122; Q2Y123; Q2Y124; Q86YZ6; Q8NDY7;
AC   Q8NG64; Q96Q92; Q96RS7; Q9HBC0;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 4;
DE            Short=TrpV4;
DE   AltName: Full=Osm-9-like TRP channel 4;
DE            Short=OTRPC4;
DE   AltName: Full=Transient receptor potential protein 12;
DE            Short=TRP12;
DE   AltName: Full=Vanilloid receptor-like channel 2;
DE   AltName: Full=Vanilloid receptor-like protein 2;
DE            Short=VRL-2;
DE   AltName: Full=Vanilloid receptor-related osmotically-activated channel;
DE            Short=VR-OAC;
GN   Name=TRPV4; Synonyms=VRL2, VROAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11081638; DOI=10.1016/S0092-8674(00)00143-4;
RA   Liedtke W.B., Choe Y., Marti-Renom M.A., Bell A.M., Denis C.S.,
RA   Sali A., Hudspeth A.J., Friedman J.M., Heller S.;
RT   "Vanilloid receptor-related osmotically activated channel (VR-OAC), a
RT   candidate vertebrate osmoreceptor.";
RL   Cell 103:525-535(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Kidney cortex;
RX   PubMed=11025659; DOI=10.1038/35036318;
RA   Strotmann R., Harteneck C., Nunnenmacher K., Schultz G., Plant T.D.;
RT   "OTRPC4, a nonselective cation channel that confers sensitivity to
RT   extracellular osmolarity.";
RL   Nat. Cell Biol. 2:695-702(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12692122; DOI=10.1074/jbc.M302561200;
RA   Suzuki M., Mizuno A., Kodaira K., Imai M.;
RT   "Impaired pressure sensation in mice lacking TRPV4.";
RL   J. Biol. Chem. 278:22664-22668(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ishibashi K.;
RT   "Molecular cloning of a new member of vanilloid receptor channel-like
RT   proteins.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kelsell R.E.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT MTD PRO-618.
RC   TISSUE=Aortic endothelium;
RA   Xu F., Satoh E., Iijima T.;
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5 AND 6), SUBCELLULAR
RP   LOCATION, AND SELF-ASSOCIATION.
RX   PubMed=16293632; DOI=10.1074/jbc.M511456200;
RA   Arniges M., Fernandez-Fernandez J.M., Albrecht N., Schaefer M.,
RA   Valverde M.A.;
RT   "Human TRPV4 channel splice variants revealed a key role of ankyrin
RT   domains in multimerization and trafficking.";
RL   J. Biol. Chem. 281:1580-1586(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 69-871.
RA   Derst C., Schafer M.K.;
RT   "Cloning of mouse and human vanilloid receptor-like protein 2 (VRL-
RT   2).";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   FUNCTION, INTERACTION WITH CALMODULIN, AND MUTAGENESIS OF
RP   186-ARG--SER-824 AND ARG-828.
RX   PubMed=12724311; DOI=10.1074/jbc.M302590200;
RA   Strotmann R., Schultz G., Plant T.D.;
RT   "Ca2+-dependent potentiation of the nonselective cation channel TRPV4
RT   is mediated by a C-terminal calmodulin binding site.";
RL   J. Biol. Chem. 278:26541-26549(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH ITPR3, AND SUBCELLULAR LOCATION.
RX   PubMed=18826956; DOI=10.1074/jbc.C800184200;
RA   Garcia-Elias A., Lorenzo I.M., Vicente R., Valverde M.A.;
RT   "IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli
RT   via a calmodulin-binding site.";
RL   J. Biol. Chem. 283:31284-31288(2008).
RN   [13]
RP   FUNCTION, INTERACTION WITH PKD2, AND SUBCELLULAR LOCATION.
RX   PubMed=18695040; DOI=10.1083/jcb.200805124;
RA   Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X.,
RA   Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T.,
RA   Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T.,
RA   Prenen J., Nilius B., Kuehn E.W., Walz G.;
RT   "TRPP2 and TRPV4 form a polymodal sensory channel complex.";
RL   J. Cell Biol. 182:437-447(2008).
RN   [14]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19759329; DOI=10.1152/ajpcell.00204.2009;
RA   Itoh Y., Hatano N., Hayashi H., Onozaki K., Miyazawa K., Muraki K.;
RT   "An environmental sensor, TRPV4 is a novel regulator of intracellular
RT   Ca2+ in human synoviocytes.";
RL   Am. J. Physiol. 297:C1082-C1090(2009).
RN   [15]
RP   INVOLVEMENT IN SSQTL1, AND ASSOCIATION OF VARIANT SER-19 WITH
RP   HYPONATREMIA.
RX   PubMed=19666518; DOI=10.1073/pnas.0904084106;
RA   Tian W., Fu Y., Garcia-Elias A., Fernandez-Fernandez J.M., Vicente R.,
RA   Kramer P.L., Klein R.F., Hitzemann R., Orwoll E.S., Wilmot B.,
RA   McWeeney S., Valverde M.A., Cohen D.M.;
RT   "A loss-of-function nonsynonymous polymorphism in the osmoregulatory
RT   TRPV4 gene is associated with human hyponatremia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:14034-14039(2009).
RN   [16]
RP   SUBUNIT.
RX   PubMed=22328087; DOI=10.1093/hmg/dds032;
RA   Lanciotti A., Brignone M.S., Molinari P., Visentin S., De Nuccio C.,
RA   Macchia G., Aiello C., Bertini E., Aloisi F., Petrucci T.C.,
RA   Ambrosini E.;
RT   "Megalencephalic leukoencephalopathy with subcortical cysts protein 1
RT   functionally cooperates with the TRPV4 cation channel to activate the
RT   response of astrocytes to osmotic stress: dysregulation by
RT   pathological mutations.";
RL   Hum. Mol. Genet. 21:2166-2180(2012).
RN   [17]
RP   FUNCTION, VARIANT MTD LEU-799, AND CHARACTERIZATION OF VARIANT MTD
RP   LEU-799.
RX   PubMed=26249260; DOI=10.1002/ajmg.a.37182;
RA   Hurd L., Kirwin S.M., Boggs M., Mackenzie W.G., Bober M.B.,
RA   Funanage V.L., Duncan R.L.;
RT   "A mutation in TRPV4 results in altered chondrocyte calcium signaling
RT   in severe metatropic dysplasia.";
RL   Am. J. Med. Genet. A 167A:2286-2293(2015).
RN   [18]
RP   INVOLVEMENT IN ANFH2.
RX   PubMed=27330106; DOI=10.1136/jmedgenet-2016-103829;
RA   Mah W., Sonkusare S.K., Wang T., Azeddine B., Pupavac M.,
RA   Carrot-Zhang J., Hong K., Majewski J., Harvey E.J., Russell L.,
RA   Chalk C., Rosenblatt D.S., Nelson M.T., Seguin C.;
RT   "Gain-of-function mutation in TRPV4 identified in patients with
RT   osteonecrosis of the femoral head.";
RL   J. Med. Genet. 53:705-709(2016).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 149-397 ALONE AND IN COMPLEX
RP   WITH ATP.
RX   PubMed=22702953; DOI=10.1021/bi300279b;
RA   Inada H., Procko E., Sotomayor M., Gaudet R.;
RT   "Structural and biochemical consequences of disease-causing mutations
RT   in the ankyrin repeat domain of the human TRPV4 channel.";
RL   Biochemistry 51:6195-6206(2012).
RN   [20]
RP   VARIANTS BCYM3 GLN-616 AND ILE-620, AND CHARACTERIZATION OF VARIANTS
RP   BCYM3 GLN-616 AND ILE-620.
RX   PubMed=18587396; DOI=10.1038/ng.166;
RA   Rock M.J., Prenen J., Funari V.A., Funari T.L., Merriman B.,
RA   Nelson S.F., Lachman R.S., Wilcox W.R., Reyno S., Quadrelli R.,
RA   Vaglio A., Owsianik G., Janssens A., Voets T., Ikegawa S., Nagai T.,
RA   Rimoin D.L., Nilius B., Cohn D.H.;
RT   "Gain-of-function mutations in TRPV4 cause autosomal dominant
RT   brachyolmia.";
RL   Nat. Genet. 40:999-1003(2008).
RN   [21]
RP   VARIANTS SMDK GLY-333; HIS-594 AND SER-716, AND VARIANTS MTD PHE-331
RP   AND LEU-799.
RX   PubMed=19232556; DOI=10.1016/j.ajhg.2009.01.021;
RA   Krakow D., Vriens J., Camacho N., Luong P., Deixler H., Funari T.L.,
RA   Bacino C.A., Irons M.B., Holm I.A., Sadler L., Okenfuss E.B.,
RA   Janssens A., Voets T., Rimoin D.L., Lachman R.S., Nilius B.,
RA   Cohn D.H.;
RT   "Mutations in the gene encoding the calcium-permeable ion channel
RT   TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and
RT   metatropic dysplasia.";
RL   Am. J. Hum. Genet. 84:307-315(2009).
RN   [22]
RP   VARIANTS MTD ILE-89; ARG-197; PHE-331; PHE-471 DEL; MET-604; LEU-617;
RP   PRO-618; LYS-797 AND LEU-799.
RX   PubMed=20425821; DOI=10.1002/ajmg.a.33392;
RA   Camacho N., Krakow D., Johnykutty S., Katzman P.J., Pepkowitz S.,
RA   Vriens J., Nilius B., Boyce B.F., Cohn D.H.;
RT   "Dominant TRPV4 mutations in nonlethal and lethal metatropic
RT   dysplasia.";
RL   Am. J. Med. Genet. A 152:1169-1177(2010).
RN   [23]
RP   INVOLVEMENT IN SEDM, VARIANT PSTD HIS-594, AND VARIANTS LYS-183;
RP   CYS-602; LYS-797 AND LEU-799.
RX   PubMed=20503319; DOI=10.1002/ajmg.a.33414;
RA   Nishimura G., Dai J., Lausch E., Unger S., Megarbane A., Kitoh H.,
RA   Kim O.H., Cho T.J., Bedeschi F., Benedicenti F., Mendoza-Londono R.,
RA   Silengo M., Schmidt-Rimpler M., Spranger J., Zabel B., Ikegawa S.,
RA   Superti-Furga A.;
RT   "Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio
RT   syndrome type 2), and parastremmatic dysplasia are caused by TRPV4
RT   mutations.";
RL   Am. J. Med. Genet. A 152:1443-1449(2010).
RN   [24]
RP   VARIANTS MTD PHE-199; ALA-295; THR-331; PHE-342; PHE-471 DEL; LEU-592;
RP   LYS-775; ALA-799; SER-799; LEU-799 AND ARG-799, AND VARIANTS SMDK
RP   LYS-278; HIS-594; PRO-596; TRP-600; ILE-625; MET-709; TYR-777 AND
RP   LYS-797.
RX   PubMed=20577006; DOI=10.1136/jmg.2009.075358;
RA   Dai J., Kim O.H., Cho T.J., Schmidt-Rimpler M., Tonoki H.,
RA   Takikawa K., Haga N., Miyoshi K., Kitoh H., Yoo W.J., Choi I.H.,
RA   Song H.R., Jin D.K., Kim H.T., Kamasaki H., Bianchi P.,
RA   Grigelioniene G., Nampoothiri S., Minagawa M., Miyagawa S.I.,
RA   Fukao T., Marcelis C., Jansweijer M.C., Hennekam R.C., Bedeschi F.,
RA   Mustonen A., Jiang Q., Ohashi H., Furuichi T., Unger S., Zabel B.,
RA   Lausch E., Superti-Furga A., Nishimura G., Ikegawa S.;
RT   "Novel and recurrent TRPV4 mutations and their association with
RT   distinct phenotypes within the TRPV4 dysplasia family.";
RL   J. Med. Genet. 47:704-709(2010).
RN   [25]
RP   VARIANTS CMT2C TRP-315 AND CYS-316, VARIANT HMN8 HIS-269, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20037588; DOI=10.1038/ng.508;
RA   Auer-Grumbach M., Olschewski A., Papic L., Kremer H., McEntagart M.E.,
RA   Uhrig S., Fischer C., Frohlich E., Balint Z., Tang B., Strohmaier H.,
RA   Lochmuller H., Schlotter-Weigel B., Senderek J., Krebs A., Dick K.J.,
RA   Petty R., Longman C., Anderson N.E., Padberg G.W., Schelhaas H.J.,
RA   van Ravenswaaij-Arts C.M., Pieber T.R., Crosby A.H., Guelly C.;
RT   "Alterations in the ankyrin domain of TRPV4 cause congenital distal
RT   SMA, scapuloperoneal SMA and HMSN2C.";
RL   Nat. Genet. 42:160-164(2010).
RN   [26]
RP   VARIANT CMT2C HIS-269, VARIANT SPSMA CYS-316, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20037587; DOI=10.1038/ng.509;
RA   Deng H.X., Klein C.J., Yan J., Shi Y., Wu Y., Fecto F., Yau H.J.,
RA   Yang Y., Zhai H., Siddique N., Hedley-Whyte E.T., Delong R.,
RA   Martina M., Dyck P.J., Siddique T.;
RT   "Scapuloperoneal spinal muscular atrophy and CMT2C are allelic
RT   disorders caused by alterations in TRPV4.";
RL   Nat. Genet. 42:165-169(2010).
RN   [27]
RP   VARIANTS CMT2C CYS-269 AND HIS-269.
RX   PubMed=20037586; DOI=10.1038/ng.512;
RA   Landoure G., Zdebik A.A., Martinez T.L., Burnett B.G., Stanescu H.C.,
RA   Inada H., Shi Y., Taye A.A., Kong L., Munns C.H., Choo S.S.,
RA   Phelps C.B., Paudel R., Houlden H., Ludlow C.L., Caterina M.J.,
RA   Gaudet R., Kleta R., Fischbeck K.H., Sumner C.J.;
RT   "Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.";
RL   Nat. Genet. 42:170-174(2010).
RN   [28]
RP   VARIANTS CMT2C TRP-315 AND TYR-542.
RX   PubMed=21115951; DOI=10.1212/WNL.0b013e3181ffe4bb;
RA   Chen D.H., Sul Y., Weiss M., Hillel A., Lipe H., Wolff J.,
RA   Matsushita M., Raskind W., Bird T.;
RT   "CMT2C with vocal cord paresis associated with short stature and
RT   mutations in the TRPV4 gene.";
RL   Neurology 75:1968-1975(2010).
RN   [29]
RP   VARIANTS FDAB VAL-270; PRO-271 AND LEU-273, AND CHARACTERIZATION OF
RP   VARIANTS FDAB VAL-270; PRO-271 AND LEU-273.
RX   PubMed=21964574; DOI=10.1038/ng.945;
RA   Lamande S.R., Yuan Y., Gresshoff I.L., Rowley L., Belluoccio D.,
RA   Kaluarachchi K., Little C.B., Botzenhart E., Zerres K., Amor D.J.,
RA   Cole W.G., Savarirayan R., McIntyre P., Bateman J.F.;
RT   "Mutations in TRPV4 cause an inherited arthropathy of hands and
RT   feet.";
RL   Nat. Genet. 43:1142-1146(2011).
RN   [30]
RP   VARIANTS CMT2C CYS-232 AND HIS-316, AND CHARACTERIZATION OF VARIANTS
RP   CMT2C CYS-232; CYS-269; HIS-269 AND HIS-316.
RX   PubMed=21288981; DOI=10.1212/WNL.0b013e31820f2de3;
RA   Klein C.J., Shi Y., Fecto F., Donaghy M., Nicholson G.,
RA   McEntagart M.E., Crosby A.H., Wu Y., Lou H., McEvoy K.M., Siddique T.,
RA   Deng H.X., Dyck P.J.;
RT   "TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-
RT   Tooth neuropathies.";
RL   Neurology 76:887-894(2011).
RN   [31]
RP   VARIANTS HMN8 ARG-97 AND CYS-232, AND CHARACTERIZATION OF VARIANT HMN8
RP   ARG-97.
RX   PubMed=22526352; DOI=10.1007/s10048-012-0328-7;
RA   Fiorillo C., Moro F., Brisca G., Astrea G., Nesti C., Balint Z.,
RA   Olschewski A., Meschini M.C., Guelly C., Auer-Grumbach M., Battini R.,
RA   Pedemonte M., Romano A., Menchise V., Biancheri R., Santorelli F.M.,
RA   Bruno C.;
RT   "TRPV4 mutations in children with congenital distal spinal muscular
RT   atrophy.";
RL   Neurogenetics 13:195-203(2012).
CC   -!- FUNCTION: Non-selective calcium permeant cation channel involved
CC       in osmotic sensitivity and mechanosensitivity. Activation by
CC       exposure to hypotonicity within the physiological range exhibits
CC       an outward rectification (PubMed:18826956, PubMed:18695040). Also
CC       activated by heat, low pH, citrate and phorbol esters
CC       (PubMed:18826956, PubMed:18695040). Increase of intracellular
CC       Ca(2+) potentiates currents. Channel activity seems to be
CC       regulated by a calmodulin-dependent mechanism with a negative
CC       feedback mechanism (PubMed:12724311, PubMed:18826956). Promotes
CC       cell-cell junction formation in skin keratinocytes and plays an
CC       important role in the formation and/or maintenance of functional
CC       intercellular barriers (By similarity). Acts as a regulator of
CC       intracellular Ca(2+) in synoviocytes (PubMed:19759329). Plays an
CC       obligatory role as a molecular component in the nonselective
CC       cation channel activation induced by 4-alpha-phorbol 12,13-
CC       didecanoate and hypotonic stimulation in synoviocytes and also
CC       regulates production of IL-8 (PubMed:19759329). Together with
CC       PKD2, forms mechano- and thermosensitive channels in cilium
CC       (PubMed:18695040). Negatively regulates expression of PPARGC1A,
CC       UCP1, oxidative metabolism and respiration in adipocytes (By
CC       similarity). Regulates expression of chemokines and cytokines
CC       related to proinflammatory pathway in adipocytes (By similarity).
CC       Together with AQP5, controls regulatory volume decrease in
CC       salivary epithelial cells (By similarity). Required for normal
CC       development and maintenance of bone and cartilage
CC       (PubMed:26249260). {ECO:0000250|UniProtKB:Q9EPK8,
CC       ECO:0000269|PubMed:11025659, ECO:0000269|PubMed:12724311,
CC       ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:18826956,
CC       ECO:0000269|PubMed:19759329, ECO:0000269|PubMed:26249260}.
CC   -!- SUBUNIT: Homotetramer (Probable). Self-associates in a isoform-
CC       specific manner (PubMed:16293632). Isoforms 1/A and 5/D but not
CC       isoform 2/B, 4/C and 6/E can oligomerize (PubMed:16293632).
CC       Interacts with calmodulin (PubMed:12724311). Interacts with Map7
CC       and Src family Tyr protein kinases LYN, SRC, FYN, HCK, LCK and YES
CC       (By similarity). Interacts with CTNNB1 (By similarity). The TRPV4
CC       and CTNNB1 complex can interact with CDH1 (By similarity).
CC       Interacts with PACSIN1, PACSIN2 and PACSIN3 (via SH3 domain) (By
CC       similarity). Part of a complex containing MLC1, AQP4, HEPACAM and
CC       ATP1B1 (PubMed:22328087). Interacts with ITPR3 (PubMed:18826956).
CC       Interacts with AQP5; the interaction is probably indirect and
CC       regulates TRPV4 activation by hypotonicity (By similarity).
CC       Interacts with ANO1 (By similarity). Interacts (via C-terminus)
CC       with PKD2 (via C-terminus) (PubMed:18695040).
CC       {ECO:0000250|UniProtKB:Q9EPK8, ECO:0000269|PubMed:12724311,
CC       ECO:0000269|PubMed:16293632, ECO:0000269|PubMed:18695040,
CC       ECO:0000269|PubMed:18826956, ECO:0000269|PubMed:22328087,
CC       ECO:0000269|PubMed:22702953, ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-962786, EBI-962786;
CC       A0A0G2K4I1:Aqp4 (xeno); NbExp=2; IntAct=EBI-962786, EBI-15907702;
CC       P47863-1:Aqp4 (xeno); NbExp=2; IntAct=EBI-962786, EBI-15907676;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:18826956}; Multi-
CC       pass membrane protein. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:Q9EPK8}. Cell projection, cilium
CC       {ECO:0000269|PubMed:18695040}. Note=Assembly of the putative
CC       homotetramer occurs primarily in the endoplasmic reticulum.
CC       {ECO:0000269|PubMed:16293632, ECO:0000269|PubMed:20037587,
CC       ECO:0000269|PubMed:20037588}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=A;
CC         IsoId=Q9HBA0-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, OTRPC4beta;
CC         IsoId=Q9HBA0-2; Sequence=VSP_013436;
CC       Name=3; Synonyms=TRPV-SV;
CC         IsoId=Q9HBA0-3; Sequence=VSP_013437;
CC       Name=4; Synonyms=C;
CC         IsoId=Q9HBA0-4; Sequence=VSP_026615;
CC       Name=5; Synonyms=D;
CC         IsoId=Q9HBA0-5; Sequence=VSP_026614;
CC       Name=6; Synonyms=E;
CC         IsoId=Q9HBA0-6; Sequence=VSP_026615, VSP_013436;
CC   -!- TISSUE SPECIFICITY: Found in the synoviocytes from patients with
CC       (RA) and without (CTR) rheumatoid arthritis (at protein level).
CC       {ECO:0000269|PubMed:19759329}.
CC   -!- POLYMORPHISM: Genetic variations in TRPV4 determine the sodium
CC       serum level quantitative trait locus 1 (SSQTL1) [MIM:613508]. In
CC       some populations, variant Pro19Ser has been shown to be
CC       significantly associated with hyponatremia defined as serum sodium
CC       concentration below or equal to 135 mEq/L.
CC   -!- DISEASE: Brachyolmia 3 (BCYM3) [MIM:113500]: A form of
CC       brachyolmia, a clinically and genetically heterogeneous skeletal
CC       dysplasia primarily affecting the spine and characterized by a
CC       short trunk, short stature, and platyspondyly. BCYM3 is an
CC       autosomal dominant form with severe scoliosis with or without
CC       kyphosis, and flattened irregular cervical vertebrae.
CC       {ECO:0000269|PubMed:18587396}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spondylometaphyseal dysplasia Kozlowski type (SMDK)
CC       [MIM:184252]: A form of spondylometaphyseal dysplasia, a group of
CC       short stature disorders distinguished by abnormalities in the
CC       vertebrae and the metaphyses of the tubular bones. It is
CC       characterized by postnatal dwarfism, significant scoliosis and
CC       mild metaphyseal abnormalities in the pelvis. The vertebrae
CC       exhibit platyspondyly and overfaced pedicles.
CC       {ECO:0000269|PubMed:19232556, ECO:0000269|PubMed:20577006}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Metatropic dysplasia (MTD) [MIM:156530]: A severe
CC       spondyloepimetaphyseal dysplasia characterized by short limbs with
CC       limitation and enlargement of joints and usually severe
CC       kyphoscoliosis. Radiologic features include severe platyspondyly,
CC       severe metaphyseal enlargement and shortening of long bones.
CC       {ECO:0000269|PubMed:19232556, ECO:0000269|PubMed:20425821,
CC       ECO:0000269|PubMed:20577006, ECO:0000269|PubMed:26249260,
CC       ECO:0000269|Ref.6}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Neuronopathy, distal hereditary motor, 8 (HMN8)
CC       [MIM:600175]: A clinically variable, neuromuscular disorder
CC       characterized by congenital lower motor neuron disorder restricted
CC       to the lower part of the body. Clinical manifestations include
CC       non-progressive muscular atrophy, thigh muscle atrophy, weak thigh
CC       adductors, weak knee and foot extensors, minimal jaw muscle and
CC       neck flexor weakness, flexion contractures of knees and pes
CC       equinovarus. Tendon reflexes are normal.
CC       {ECO:0000269|PubMed:20037588, ECO:0000269|PubMed:22526352}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2C (CMT2C) [MIM:606071]: An
CC       axonal form of Charcot-Marie-Tooth disease, a disorder of the
CC       peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the
CC       distal muscles of the arms. Charcot-Marie-Tooth disease is
CC       classified in two main groups on the basis of electrophysiologic
CC       properties and histopathology: primary peripheral demyelinating
CC       neuropathies (designated CMT1 when they are dominantly inherited)
CC       and primary peripheral axonal neuropathies (CMT2). Neuropathies of
CC       the CMT2 group are characterized by signs of axonal degeneration
CC       in the absence of obvious myelin alterations, normal or slightly
CC       reduced nerve conduction velocities, and progressive distal muscle
CC       weakness and atrophy. Nerve conduction velocities are normal or
CC       slightly reduced. {ECO:0000269|PubMed:20037586,
CC       ECO:0000269|PubMed:20037587, ECO:0000269|PubMed:20037588,
CC       ECO:0000269|PubMed:21115951, ECO:0000269|PubMed:21288981}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Scapuloperoneal spinal muscular atrophy (SPSMA)
CC       [MIM:181405]: A clinically variable neuromuscular disorder
CC       characterized by neurogenic scapuloperoneal amyotrophy, laryngeal
CC       palsy, congenital absence of muscles, progressive scapuloperoneal
CC       atrophy and progressive distal weakness and amyotrophy.
CC       {ECO:0000269|PubMed:20037587}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloepiphyseal dysplasia Maroteaux type (SEDM)
CC       [MIM:184095]: A clinically variable spondyloepiphyseal dysplasia
CC       with manifestations limited to the musculoskeletal system.
CC       Clinical features include short stature, brachydactyly,
CC       platyspondyly, short and stubby hands and feet, epiphyseal
CC       hypoplasia of the large joints, and iliac hypoplasia. Intelligence
CC       is normal. {ECO:0000269|PubMed:20503319}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Parastremmatic dwarfism (PSTD) [MIM:168400]: A bone
CC       dysplasia characterized by severe dwarfism, kyphoscoliosis,
CC       distortion and bowing of the extremities, and contractures of the
CC       large joints. Radiographically, the disease is characterized by a
CC       combination of decreased bone density, bowing of the long bones,
CC       platyspondyly and striking irregularities of endochondral
CC       ossification with areas of calcific stippling and streaking in
CC       radiolucent epiphyses, metaphyses and apophyses.
CC       {ECO:0000269|PubMed:20503319}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Digital arthropathy-brachydactyly, familial (FDAB)
CC       [MIM:606835]: A disorder characterized by irregularities in the
CC       proximal articular surfaces of the distal interphalangeal joints
CC       of the hand. Individuals appear normal at birth, with no clinical
CC       or radiographic evidence of a developmental skeletal dysplasia.
CC       The earliest changes appear during the first decade of life. By
CC       adulthood, all interphalangeal, metacarpophalangeal, and
CC       metatarsophalangeal joints are affected by a deforming, painful
CC       osteoarthritis. The remainder of the skeleton is clinically and
CC       radiographically unaffected. {ECO:0000269|PubMed:21964574}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Avascular necrosis of the femoral head, primary 2 (ANFH2)
CC       [MIM:617383]: A disease characterized by mechanical failure of the
CC       subchondral bone, and degeneration of the hip joint. It usually
CC       leads to destruction of the hip joint in the third to fifth decade
CC       of life. The clinical manifestations, such as pain on exertion, a
CC       limping gait, and a discrepancy in leg length, cause considerable
CC       disability. {ECO:0000269|PubMed:27330106}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF263523; AAG28029.1; -; mRNA.
DR   EMBL; AF258465; AAG16127.1; -; mRNA.
DR   EMBL; AB100308; BAC55864.1; -; mRNA.
DR   EMBL; AB032427; BAB69040.1; -; mRNA.
DR   EMBL; AB073669; BAC06573.1; -; mRNA.
DR   EMBL; AJ296305; CAC82937.1; -; mRNA.
DR   EMBL; DQ059644; AAZ04918.1; -; mRNA.
DR   EMBL; DQ059645; AAZ04919.1; -; mRNA.
DR   EMBL; DQ059646; AAZ04920.1; -; mRNA.
DR   EMBL; CH471054; EAW97879.1; -; Genomic_DNA.
DR   EMBL; BC117426; AAI17427.1; -; mRNA.
DR   EMBL; BC143315; AAI43316.1; -; mRNA.
DR   EMBL; AF279673; AAK69487.1; -; mRNA.
DR   CCDS; CCDS53827.1; -. [Q9HBA0-6]
DR   CCDS; CCDS53828.1; -. [Q9HBA0-4]
DR   CCDS; CCDS53829.1; -. [Q9HBA0-5]
DR   CCDS; CCDS9134.1; -. [Q9HBA0-1]
DR   CCDS; CCDS9135.1; -. [Q9HBA0-2]
DR   RefSeq; NP_001170899.1; NM_001177428.1. [Q9HBA0-4]
DR   RefSeq; NP_001170902.1; NM_001177431.1. [Q9HBA0-5]
DR   RefSeq; NP_001170904.1; NM_001177433.1. [Q9HBA0-6]
DR   RefSeq; NP_067638.3; NM_021625.4. [Q9HBA0-1]
DR   RefSeq; NP_671737.1; NM_147204.2. [Q9HBA0-2]
DR   RefSeq; XP_005253975.1; XM_005253918.1. [Q9HBA0-1]
DR   RefSeq; XP_016875263.1; XM_017019774.1. [Q9HBA0-1]
DR   UniGene; Hs.506713; -.
DR   PDB; 4DX1; X-ray; 2.85 A; A/B=149-397.
DR   PDB; 4DX2; X-ray; 2.95 A; A/B=149-397.
DR   PDBsum; 4DX1; -.
DR   PDBsum; 4DX2; -.
DR   ProteinModelPortal; Q9HBA0; -.
DR   SMR; Q9HBA0; -.
DR   BioGrid; 121883; 12.
DR   CORUM; Q9HBA0; -.
DR   DIP; DIP-35702N; -.
DR   IntAct; Q9HBA0; 8.
DR   MINT; MINT-4535111; -.
DR   STRING; 9606.ENSP00000261740; -.
DR   BindingDB; Q9HBA0; -.
DR   ChEMBL; CHEMBL3119; -.
DR   GuidetoPHARMACOLOGY; 510; -.
DR   iPTMnet; Q9HBA0; -.
DR   PhosphoSitePlus; Q9HBA0; -.
DR   BioMuta; TRPV4; -.
DR   DMDM; 62901470; -.
DR   MaxQB; Q9HBA0; -.
DR   PaxDb; Q9HBA0; -.
DR   PeptideAtlas; Q9HBA0; -.
DR   PRIDE; Q9HBA0; -.
DR   Ensembl; ENST00000261740; ENSP00000261740; ENSG00000111199. [Q9HBA0-1]
DR   Ensembl; ENST00000418703; ENSP00000406191; ENSG00000111199. [Q9HBA0-1]
DR   Ensembl; ENST00000536838; ENSP00000444336; ENSG00000111199. [Q9HBA0-5]
DR   Ensembl; ENST00000537083; ENSP00000442738; ENSG00000111199. [Q9HBA0-2]
DR   Ensembl; ENST00000541794; ENSP00000442167; ENSG00000111199. [Q9HBA0-4]
DR   Ensembl; ENST00000544971; ENSP00000443611; ENSG00000111199. [Q9HBA0-6]
DR   GeneID; 59341; -.
DR   KEGG; hsa:59341; -.
DR   UCSC; uc001tpg.3; human. [Q9HBA0-1]
DR   CTD; 59341; -.
DR   DisGeNET; 59341; -.
DR   EuPathDB; HostDB:ENSG00000111199.10; -.
DR   GeneCards; TRPV4; -.
DR   GeneReviews; TRPV4; -.
DR   HGNC; HGNC:18083; TRPV4.
DR   HPA; HPA007150; -.
DR   MalaCards; TRPV4; -.
DR   MIM; 113500; phenotype.
DR   MIM; 156530; phenotype.
DR   MIM; 168400; phenotype.
DR   MIM; 181405; phenotype.
DR   MIM; 184095; phenotype.
DR   MIM; 184252; phenotype.
DR   MIM; 600175; phenotype.
DR   MIM; 605427; gene.
DR   MIM; 606071; phenotype.
DR   MIM; 606835; phenotype.
DR   MIM; 613508; phenotype.
DR   MIM; 617383; phenotype.
DR   neXtProt; NX_Q9HBA0; -.
DR   OpenTargets; ENSG00000111199; -.
DR   Orphanet; 93304; Autosomal dominant brachyolmia.
DR   Orphanet; 99937; Autosomal dominant Charcot-Marie-Tooth disease type 2C.
DR   Orphanet; 1216; Autosomal dominant congenital benign spinal muscular atrophy.
DR   Orphanet; 85169; Familial digital arthropathy-brachydactyly.
DR   Orphanet; 2635; Metatropic dysplasia.
DR   Orphanet; 2646; Parastremmatic dwarfism.
DR   Orphanet; 263482; Spondyloepiphyseal dysplasia, Maroteaux type.
DR   Orphanet; 93314; Spondylometaphyseal dysplasia, Kozlowski type.
DR   PharmGKB; PA38293; -.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   GeneTree; ENSGT00550000074425; -.
DR   HOVERGEN; HBG054085; -.
DR   InParanoid; Q9HBA0; -.
DR   KO; K04973; -.
DR   OMA; KVCNEDQ; -.
DR   OrthoDB; EOG091G016O; -.
DR   PhylomeDB; Q9HBA0; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   SignaLink; Q9HBA0; -.
DR   SIGNOR; Q9HBA0; -.
DR   GeneWiki; TRPV4; -.
DR   GenomeRNAi; 59341; -.
DR   PRO; PR:Q9HBA0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111199; -.
DR   ExpressionAtlas; Q9HBA0; baseline and differential.
DR   Genevisible; Q9HBA0; HS.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISS:BHF-UCL.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0030175; C:filopodium; ISS:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; ISS:BHF-UCL.
DR   GO; GO:0030426; C:growth cone; ISS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0030027; C:lamellipodium; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; ISS:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; ISS:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; ISS:BHF-UCL.
DR   GO; GO:0043014; F:alpha-tubulin binding; ISS:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0048487; F:beta-tubulin binding; ISS:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IMP:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008017; F:microtubule binding; ISS:BHF-UCL.
DR   GO; GO:0005034; F:osmosensor activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0005080; F:protein kinase C binding; ISS:BHF-UCL.
DR   GO; GO:0042169; F:SH2 domain binding; ISS:BHF-UCL.
DR   GO; GO:0015275; F:stretch-activated, cation-selective, calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; ISS:BHF-UCL.
DR   GO; GO:0007015; P:actin filament organization; ISS:BHF-UCL.
DR   GO; GO:0097497; P:blood vessel endothelial cell delamination; IMP:UniProtKB.
DR   GO; GO:0070509; P:calcium ion import; ISS:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IMP:UniProtKB.
DR   GO; GO:0006884; P:cell volume homeostasis; TAS:UniProtKB.
DR   GO; GO:0007043; P:cell-cell junction assembly; ISS:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0071476; P:cellular hypotonic response; IMP:UniProtKB.
DR   GO; GO:0071477; P:cellular hypotonic salinity response; IEA:Ensembl.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0071470; P:cellular response to osmotic stress; ISS:UniProtKB.
DR   GO; GO:0043622; P:cortical microtubule organization; ISS:BHF-UCL.
DR   GO; GO:0002024; P:diet induced thermogenesis; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl.
DR   GO; GO:0046785; P:microtubule polymerization; ISS:BHF-UCL.
DR   GO; GO:0050891; P:multicellular organismal water homeostasis; IMP:UniProtKB.
DR   GO; GO:1903444; P:negative regulation of brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0007231; P:osmosensory signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; IEA:Ensembl.
DR   GO; GO:2000340; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:2000507; P:positive regulation of energy homeostasis; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:2000778; P:positive regulation of interleukin-6 secretion; IEA:Ensembl.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; IEA:Ensembl.
DR   GO; GO:0071642; P:positive regulation of macrophage inflammatory protein 1 alpha production; IEA:Ensembl.
DR   GO; GO:0031117; P:positive regulation of microtubule depolymerization; ISS:BHF-UCL.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; IEA:Ensembl.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; IMP:UniProtKB.
DR   GO; GO:0047484; P:regulation of response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; TAS:UniProtKB.
DR   GO; GO:1903759; P:signal transduction involved in regulation of aerobic respiration; IEA:Ensembl.
DR   GO; GO:0030103; P:vasopressin secretion; IEA:Ensembl.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008347; TRPV1-4_channel.
DR   InterPro; IPR008348; TRPV4_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF4; PTHR10582:SF4; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   PRINTS; PR01769; VRL2RECEPTOR.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; ATP-binding; Calcium;
KW   Calcium channel; Calcium transport; Calmodulin-binding; Cell junction;
KW   Cell membrane; Cell projection; Charcot-Marie-Tooth disease; Cilium;
KW   Complete proteome; Disease mutation; Dwarfism; Ion channel;
KW   Ion transport; Membrane; Neurodegeneration; Neuropathy;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    871       Transient receptor potential cation
FT                                channel subfamily V member 4.
FT                                /FTId=PRO_0000215347.
FT   TOPO_DOM      1    465       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   TOPO_DOM    487    508       Extracellular. {ECO:0000255}.
FT   TRANSMEM    509    529       Helical. {ECO:0000255}.
FT   TOPO_DOM    530    550       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    551    571       Helical. {ECO:0000255}.
FT   TOPO_DOM    572    572       Extracellular. {ECO:0000255}.
FT   TRANSMEM    573    593       Helical. {ECO:0000255}.
FT   TOPO_DOM    594    616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    617    637       Helical. {ECO:0000255}.
FT   INTRAMEM    648    678       Pore-forming. {ECO:0000305}.
FT   TRANSMEM    691    711       Helical. {ECO:0000255}.
FT   TOPO_DOM    712    871       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      237    266       ANK 1.
FT   REPEAT      284    313       ANK 2.
FT   REPEAT      369    398       ANK 3.
FT   REGION      812    831       Interaction with calmodulin and ITPR3.
FT                                {ECO:0000269|PubMed:12724311,
FT                                ECO:0000269|PubMed:18826956}.
FT   BINDING     192    192       ATP. {ECO:0000269|PubMed:22702953}.
FT   BINDING     201    201       ATP. {ECO:0000269|PubMed:22702953}.
FT   BINDING     239    239       ATP. {ECO:0000269|PubMed:22702953}.
FT   BINDING     248    248       ATP. {ECO:0000269|PubMed:22702953}.
FT   MOD_RES     110    110       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9EPK8}.
FT   MOD_RES     805    805       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9EPK8}.
FT   MOD_RES     824    824       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPK8}.
FT   VAR_SEQ      28     61       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:16293632}.
FT                                /FTId=VSP_026614.
FT   VAR_SEQ     239    285       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:16293632}.
FT                                /FTId=VSP_026615.
FT   VAR_SEQ     385    444       Missing (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:16293632,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_013436.
FT   VAR_SEQ     844    871       PLDSMGNPRCDGHQQGYPRKWRTDDAPL -> RHLCRVRRK
FT                                R (in isoform 3).
FT                                {ECO:0000303|PubMed:12692122}.
FT                                /FTId=VSP_013437.
FT   VARIANT      19     19       P -> S (associated with lower sodium
FT                                concentraions in serum; shows diminished
FT                                response to hypotonic stress relative to
FT                                wild-type; dbSNP:rs3742030).
FT                                /FTId=VAR_052391.
FT   VARIANT      89     89       T -> I (in MTD; lethal form;
FT                                dbSNP:rs397514473).
FT                                {ECO:0000269|PubMed:20425821}.
FT                                /FTId=VAR_064517.
FT   VARIANT      97     97       P -> R (in HMN8; loss of function
FT                                mutation; dbSNP:rs876661124).
FT                                {ECO:0000269|PubMed:22526352}.
FT                                /FTId=VAR_067989.
FT   VARIANT     183    183       E -> K (found in a patient with
FT                                spondyloepiphyseal dysplasia Maroteaux
FT                                type; dbSNP:rs387906324).
FT                                {ECO:0000269|PubMed:20503319}.
FT                                /FTId=VAR_064518.
FT   VARIANT     197    197       K -> R (in MTD; lethal form;
FT                                dbSNP:rs387906903).
FT                                {ECO:0000269|PubMed:20425821}.
FT                                /FTId=VAR_064519.
FT   VARIANT     199    199       L -> F (in MTD; dbSNP:rs515726167).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064520.
FT   VARIANT     232    232       R -> C (in HMN8 and CMT2C; does not
FT                                affect channel localization to plasma
FT                                membrane; results in increased agonist-
FT                                induced channel activity and increased
FT                                basal intracellular calcium
FT                                concentration; causes increased cell
FT                                death; dbSNP:rs387906904).
FT                                {ECO:0000269|PubMed:21288981,
FT                                ECO:0000269|PubMed:22526352}.
FT                                /FTId=VAR_067990.
FT   VARIANT     269    269       R -> C (in CMT2C; dbSNP:rs267607146).
FT                                {ECO:0000269|PubMed:20037586,
FT                                ECO:0000269|PubMed:21288981}.
FT                                /FTId=VAR_063528.
FT   VARIANT     269    269       R -> H (in HMN8 and CMT2C; increased
FT                                agonist-induced channel activity and
FT                                increased basal intracellular calcium
FT                                concentration; causes increased cell
FT                                death; dbSNP:rs267607144).
FT                                {ECO:0000269|PubMed:20037586,
FT                                ECO:0000269|PubMed:20037587,
FT                                ECO:0000269|PubMed:20037588,
FT                                ECO:0000269|PubMed:21288981}.
FT                                /FTId=VAR_063529.
FT   VARIANT     270    270       G -> V (in FDAB; poorly expressed on the
FT                                cell surface; mutant channels show a
FT                                significantly reduced response to
FT                                agonists; dbSNP:rs387907220).
FT                                {ECO:0000269|PubMed:21964574}.
FT                                /FTId=VAR_068498.
FT   VARIANT     271    271       R -> P (in FDAB; poorly expressed on the
FT                                cell surface; mutant channels show a
FT                                significantly reduced response to
FT                                agonists; dbSNP:rs387907219).
FT                                {ECO:0000269|PubMed:21964574}.
FT                                /FTId=VAR_068499.
FT   VARIANT     273    273       F -> L (in FDAB; poorly expressed on the
FT                                cell surface; mutant channels show a
FT                                significantly reduced response to
FT                                agonists; dbSNP:rs515726170).
FT                                {ECO:0000269|PubMed:21964574}.
FT                                /FTId=VAR_068500.
FT   VARIANT     278    278       E -> K (in SMDK; dbSNP:rs267607148).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064521.
FT   VARIANT     295    295       T -> A (in MTD; dbSNP:rs515726171).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064522.
FT   VARIANT     315    315       R -> W (in CMT2C; dbSNP:rs267607143).
FT                                {ECO:0000269|PubMed:20037588,
FT                                ECO:0000269|PubMed:21115951}.
FT                                /FTId=VAR_063541.
FT   VARIANT     316    316       R -> C (in CMT2C and SPSMA;
FT                                dbSNP:rs267607145).
FT                                {ECO:0000269|PubMed:20037587,
FT                                ECO:0000269|PubMed:20037588}.
FT                                /FTId=VAR_063530.
FT   VARIANT     316    316       R -> H (in CMT2C; does not affect channel
FT                                localization to plasma membrane; results
FT                                in increased agonist-induced channel
FT                                activity and increased basal
FT                                intracellular calcium concentration;
FT                                causes increased cell death;
FT                                dbSNP:rs387906905).
FT                                {ECO:0000269|PubMed:21288981}.
FT                                /FTId=VAR_067991.
FT   VARIANT     331    331       I -> F (in MTD; dbSNP:rs121912636).
FT                                {ECO:0000269|PubMed:19232556,
FT                                ECO:0000269|PubMed:20425821}.
FT                                /FTId=VAR_062331.
FT   VARIANT     331    331       I -> T (in MTD; dbSNP:rs515726172).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064523.
FT   VARIANT     333    336       Missing (in SMDK).
FT                                /FTId=VAR_067992.
FT   VARIANT     333    333       D -> G (in SMDK; dbSNP:rs121912634).
FT                                {ECO:0000269|PubMed:19232556}.
FT                                /FTId=VAR_062332.
FT   VARIANT     342    342       V -> F (in MTD; dbSNP:rs515726152).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064524.
FT   VARIANT     471    471       Missing (in MTD; lethal form).
FT                                {ECO:0000269|PubMed:20425821,
FT                                ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064525.
FT   VARIANT     542    542       S -> Y (in CMT2C; dbSNP:rs387906902).
FT                                {ECO:0000269|PubMed:21115951}.
FT                                /FTId=VAR_067993.
FT   VARIANT     592    592       F -> L (in MTD; dbSNP:rs515726158).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064526.
FT   VARIANT     594    594       R -> H (in SMDK and PSTD;
FT                                dbSNP:rs77975504).
FT                                {ECO:0000269|PubMed:19232556,
FT                                ECO:0000269|PubMed:20503319,
FT                                ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_062333.
FT   VARIANT     596    596       L -> P (in SMDK; dbSNP:rs515726159).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064527.
FT   VARIANT     600    600       G -> W (in SMDK; dbSNP:rs515726160).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064528.
FT   VARIANT     602    602       Y -> C (found in a patient with
FT                                spondyloepiphyseal dysplasia Maroteaux
FT                                type; dbSNP:rs267607150).
FT                                {ECO:0000269|PubMed:20503319}.
FT                                /FTId=VAR_064529.
FT   VARIANT     604    604       I -> M (in MTD; lethal form;
FT                                dbSNP:rs515726161).
FT                                {ECO:0000269|PubMed:20425821}.
FT                                /FTId=VAR_064530.
FT   VARIANT     616    616       R -> Q (in BCYM3; this mutation results
FT                                in a gain of function and a constitutive
FT                                activation of the channel;
FT                                dbSNP:rs121912632).
FT                                {ECO:0000269|PubMed:18587396}.
FT                                /FTId=VAR_054805.
FT   VARIANT     617    617       F -> L (in MTD; dbSNP:rs515726162).
FT                                {ECO:0000269|PubMed:20425821}.
FT                                /FTId=VAR_064531.
FT   VARIANT     618    618       L -> P (in MTD; dbSNP:rs515726163).
FT                                {ECO:0000269|PubMed:20425821,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_064532.
FT   VARIANT     620    620       V -> I (in BCYM3; this mutation results
FT                                in a gain of function and a constitutive
FT                                activation of the channel;
FT                                dbSNP:rs121912633).
FT                                {ECO:0000269|PubMed:18587396}.
FT                                /FTId=VAR_054806.
FT   VARIANT     625    625       M -> I (in SMDK; dbSNP:rs515726164).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064533.
FT   VARIANT     709    709       L -> M (in SMDK; dbSNP:rs116571438).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064534.
FT   VARIANT     716    716       A -> S (in SMDK; dbSNP:rs121912635).
FT                                {ECO:0000269|PubMed:19232556}.
FT                                /FTId=VAR_062334.
FT   VARIANT     775    775       R -> K (in MTD).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064535.
FT   VARIANT     777    777       C -> Y (in SMDK; dbSNP:rs515726165).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064536.
FT   VARIANT     797    797       E -> K (in MTD and SMDK; also found in a
FT                                patient with spondyloepiphyseal dysplasia
FT                                Maroteaux type; dbSNP:rs267607149).
FT                                {ECO:0000269|PubMed:20425821,
FT                                ECO:0000269|PubMed:20503319,
FT                                ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064537.
FT   VARIANT     799    799       P -> A (in MTD; dbSNP:rs267607147).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064538.
FT   VARIANT     799    799       P -> L (in MTD; also found in a patient
FT                                with spondyloepiphyseal dysplasia
FT                                Maroteaux type; dbSNP:rs121912637).
FT                                {ECO:0000269|PubMed:19232556,
FT                                ECO:0000269|PubMed:20425821,
FT                                ECO:0000269|PubMed:20503319,
FT                                ECO:0000269|PubMed:20577006,
FT                                ECO:0000269|PubMed:26249260}.
FT                                /FTId=VAR_062335.
FT   VARIANT     799    799       P -> R (in MTD; dbSNP:rs121912637).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064539.
FT   VARIANT     799    799       P -> S (in MTD; dbSNP:rs267607147).
FT                                {ECO:0000269|PubMed:20577006}.
FT                                /FTId=VAR_064540.
FT   MUTAGEN     816    821       RLRRDR->ELEEDE: Loss of calmodulin
FT                                binding; when associated with A-828.
FT   MUTAGEN     821    824       RWSS->AASA: Loss of calmodulin binding.
FT   MUTAGEN     822    822       W->A: Loss of Ca(2+) dependent current
FT                                potentiation.
FT   MUTAGEN     828    828       R->A: Loss of calmodulin binding; when
FT                                associated with 816-ELEEDE-821.
FT                                {ECO:0000269|PubMed:12724311}.
FT   CONFLICT    385    385       I -> V (in Ref. 1; AAG28029).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       V -> A (in Ref. 6; BAC06573).
FT                                {ECO:0000305}.
FT   CONFLICT    781    781       D -> N (in Ref. 1; AAG28029).
FT                                {ECO:0000305}.
FT   CONFLICT    820    820       D -> T (in Ref. 4; BAB69040).
FT                                {ECO:0000305}.
FT   CONFLICT    861    861       P -> T (in Ref. 6; BAC06573).
FT                                {ECO:0000305}.
FT   CONFLICT    867    867       D -> E (in Ref. 2; AAG16127).
FT                                {ECO:0000305}.
FT   HELIX       151    159       {ECO:0000244|PDB:4DX1}.
FT   HELIX       164    166       {ECO:0000244|PDB:4DX1}.
FT   HELIX       169    175       {ECO:0000244|PDB:4DX1}.
FT   HELIX       183    185       {ECO:0000244|PDB:4DX1}.
FT   STRAND      188    190       {ECO:0000244|PDB:4DX1}.
FT   HELIX       194    200       {ECO:0000244|PDB:4DX1}.
FT   HELIX       209    220       {ECO:0000244|PDB:4DX1}.
FT   HELIX       223    228       {ECO:0000244|PDB:4DX1}.
FT   STRAND      234    239       {ECO:0000244|PDB:4DX1}.
FT   HELIX       241    247       {ECO:0000244|PDB:4DX1}.
FT   HELIX       251    260       {ECO:0000244|PDB:4DX1}.
FT   HELIX       271    273       {ECO:0000244|PDB:4DX2}.
FT   TURN        276    279       {ECO:0000244|PDB:4DX1}.
FT   HELIX       288    294       {ECO:0000244|PDB:4DX1}.
FT   HELIX       298    306       {ECO:0000244|PDB:4DX1}.
FT   HELIX       324    331       {ECO:0000244|PDB:4DX1}.
FT   HELIX       336    356       {ECO:0000244|PDB:4DX1}.
FT   STRAND      357    360       {ECO:0000244|PDB:4DX1}.
FT   HELIX       362    364       {ECO:0000244|PDB:4DX2}.
FT   HELIX       373    379       {ECO:0000244|PDB:4DX1}.
FT   HELIX       383    395       {ECO:0000244|PDB:4DX1}.
SQ   SEQUENCE   871 AA;  98281 MW;  C62056B86C5A6FB6 CRC64;
     MADSSEGPRA GPGEVAELPG DESGTPGGEA FPLSSLANLF EGEDGSLSPS PADASRPAGP
     GDGRPNLRMK FQGAFRKGVP NPIDLLESTL YESSVVPGPK KAPMDSLFDY GTYRHHSSDN
     KRWRKKIIEK QPQSPKAPAP QPPPILKVFN RPILFDIVSR GSTADLDGLL PFLLTHKKRL
     TDEEFREPST GKTCLPKALL NLSNGRNDTI PVLLDIAERT GNMREFINSP FRDIYYRGQT
     ALHIAIERRC KHYVELLVAQ GADVHAQARG RFFQPKDEGG YFYFGELPLS LAACTNQPHI
     VNYLTENPHK KADMRRQDSR GNTVLHALVA IADNTRENTK FVTKMYDLLL LKCARLFPDS
     NLEAVLNNDG LSPLMMAAKT GKIGIFQHII RREVTDEDTR HLSRKFKDWA YGPVYSSLYD
     LSSLDTCGEE ASVLEILVYN SKIENRHEML AVEPINELLR DKWRKFGAVS FYINVVSYLC
     AMVIFTLTAY YQPLEGTPPY PYRTTVDYLR LAGEVITLFT GVLFFFTNIK DLFMKKCPGV
     NSLFIDGSFQ LLYFIYSVLV IVSAALYLAG IEAYLAVMVF ALVLGWMNAL YFTRGLKLTG
     TYSIMIQKIL FKDLFRFLLV YLLFMIGYAS ALVSLLNPCA NMKVCNEDQT NCTVPTYPSC
     RDSETFSTFL LDLFKLTIGM GDLEMLSSTK YPVVFIILLV TYIILTFVLL LNMLIALMGE
     TVGQVSKESK HIWKLQWATT ILDIERSFPV FLRKAFRSGE MVTVGKSSDG TPDRRWCFRV
     DEVNWSHWNQ NLGIINEDPG KNETYQYYGF SHTVGRLRRD RWSSVVPRVV ELNKNSNPDE
     VVVPLDSMGN PRCDGHQQGY PRKWRTDDAP L
//
ID   TRPM3_HUMAN             Reviewed;        1732 AA.
AC   Q9HCF6; A2A3F6; A9Z1Y7; Q5VW02; Q5VW03; Q5VW04; Q5W5T7; Q86SH0;
AC   Q86SH6; Q86UL0; Q86WK1; Q86WK2; Q86WK3; Q86WK4; Q86YZ9; Q86Z00;
AC   Q86Z01; Q9H0X2;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 4.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 3;
DE   AltName: Full=Long transient receptor potential channel 3;
DE            Short=LTrpC-3;
DE            Short=LTrpC3;
DE   AltName: Full=Melastatin-2;
DE            Short=MLSN2;
GN   Name=TRPM3; Synonyms=KIAA1616, LTRPC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 10), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=12672799; DOI=10.1074/jbc.M300945200;
RA   Grimm C., Kraft R., Sauerbruch S., Schultz G., Harteneck C.;
RT   "Molecular and functional characterization of the melastatin-related
RT   cation channel TRPM3.";
RL   J. Biol. Chem. 278:21493-21501(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 12).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-324 (ISOFORM 11).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 154-1732 (ISOFORMS 1; 2; 3; 4; 5 AND 6),
RP   VARIANT THR-1732, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12672827; DOI=10.1074/jbc.M211232200;
RA   Lee N., Chen J., Sun L., Wu S., Gray K.R., Rich A., Huang M.,
RA   Lin J.-H., Feder J.N., Janovitz E.B., Levesque P.C., Blanar M.A.;
RT   "Expression and characterization of human transient receptor potential
RT   melastatin 3 (hTRPM3).";
RL   J. Biol. Chem. 278:20890-20897(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 154-1732 (ISOFORMS 1; 2; 4;
RP   7 AND 8), AND VARIANT THR-1732.
RC   TISSUE=Brain;
RA   Okabayashi K., Hirano K., Sano M., Murahashi Y., Miyauchi A.,
RA   Gonoi T.;
RT   "ProX human full-length cDNA cloning project.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 716-1732 (ISOFORMS
RP   1/2/3/4/5/7/8), AND VARIANTS LYS-1717 AND THR-1732.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
CC   -!- FUNCTION: Calcium channel mediating constitutive calcium ion
CC       entry. Its activity is increased by reduction in extracellular
CC       osmolarity, by store depletion and muscarinic receptor activation.
CC       {ECO:0000269|PubMed:12672799, ECO:0000269|PubMed:12672827}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:12672827};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:12672827}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC       Name=1; Synonyms=TRPM3f;
CC         IsoId=Q9HCF6-1; Sequence=Displayed;
CC       Name=2; Synonyms=TRPM3a;
CC         IsoId=Q9HCF6-2; Sequence=VSP_012826;
CC       Name=3; Synonyms=TRPM3b;
CC         IsoId=Q9HCF6-3; Sequence=VSP_012826, VSP_012828;
CC       Name=4; Synonyms=TRPM3d;
CC         IsoId=Q9HCF6-4; Sequence=VSP_012826, VSP_012829;
CC       Name=5; Synonyms=TRPM3e;
CC         IsoId=Q9HCF6-5; Sequence=VSP_012826, VSP_012828, VSP_012829;
CC       Name=6; Synonyms=TRPM3c;
CC         IsoId=Q9HCF6-6; Sequence=VSP_012826, VSP_012830;
CC       Name=7;
CC         IsoId=Q9HCF6-7; Sequence=VSP_012829;
CC       Name=8;
CC         IsoId=Q9HCF6-8; Sequence=VSP_012826, VSP_012827, VSP_012829;
CC       Name=10;
CC         IsoId=Q9HCF6-10; Sequence=VSP_012826, VSP_012831, VSP_012832;
CC       Name=11;
CC         IsoId=Q9HCF6-11; Sequence=VSP_039107;
CC       Name=12;
CC         IsoId=Q9HCF6-12; Sequence=VSP_043515, VSP_012826, VSP_043516;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in the kidney and, at
CC       lower levels, in brain, testis, ovary, pancreas and spinal cord.
CC       Expression in the brain and kidney was determined at protein
CC       level. In the kidney, expressed predominantly in the collecting
CC       tubular epithelium in the medulla, medullary rays, and
CC       periglomerular regions; in the brain, highest levels are found in
CC       the cerebellum, choroid plexus, the locus coeruleus, the posterior
CC       thalamus and the substantia nigra. Down-regulated in renal tumors
CC       compared to normal kidney. {ECO:0000269|PubMed:12672799,
CC       ECO:0000269|PubMed:12672827}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       LTrpC subfamily. TRPM3 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB66480.2; Type=Miscellaneous discrepancy; Note=Cloning artifact in C-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAM13096.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM13169.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM15782.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM17596.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM22746.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ505025; CAD43604.1; -; mRNA.
DR   EMBL; AJ505026; CAD43605.1; -; mRNA.
DR   EMBL; AL159990; CAI12193.1; -; Genomic_DNA.
DR   EMBL; AL356318; CAI12193.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAI96096.1; -; Genomic_DNA.
DR   EMBL; AL159990; CAI96096.1; JOINED; Genomic_DNA.
DR   EMBL; AL159990; CAM13096.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161913; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM13169.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM15782.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM17596.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM22746.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL160273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL592438; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC121821; AAI21822.2; -; mRNA.
DR   EMBL; BC134414; AAI34415.1; -; mRNA.
DR   EMBL; BC142972; AAI42973.1; -; mRNA.
DR   EMBL; AL136545; CAB66480.2; ALT_SEQ; mRNA.
DR   EMBL; AF536748; AAO49153.1; -; mRNA.
DR   EMBL; AF536749; AAO49154.1; -; mRNA.
DR   EMBL; AF536750; AAO49155.1; -; mRNA.
DR   EMBL; AF536751; AAO49156.1; -; mRNA.
DR   EMBL; AF536752; AAO49157.1; -; mRNA.
DR   EMBL; AF536753; AAO49158.1; -; mRNA.
DR   EMBL; AB099661; BAC55102.1; -; mRNA.
DR   EMBL; AB099662; BAC55103.1; -; mRNA.
DR   EMBL; AB099663; BAC55104.1; -; mRNA.
DR   EMBL; AB099664; BAC55105.1; -; mRNA.
DR   EMBL; AB099665; BAC55106.1; -; mRNA.
DR   EMBL; AB046836; BAB13442.1; -; mRNA.
DR   CCDS; CCDS43835.1; -. [Q9HCF6-2]
DR   CCDS; CCDS6637.1; -. [Q9HCF6-12]
DR   RefSeq; NP_001007472.2; NM_001007471.2. [Q9HCF6-2]
DR   RefSeq; NP_996831.1; NM_206948.2. [Q9HCF6-12]
DR   RefSeq; XP_011517340.1; XM_011519038.2. [Q9HCF6-1]
DR   RefSeq; XP_011517341.1; XM_011519039.2. [Q9HCF6-7]
DR   RefSeq; XP_011517343.1; XM_011519041.2. [Q9HCF6-3]
DR   RefSeq; XP_011517346.1; XM_011519044.2. [Q9HCF6-5]
DR   RefSeq; XP_011517348.1; XM_011519046.2. [Q9HCF6-4]
DR   RefSeq; XP_011517349.1; XM_011519047.2. [Q9HCF6-10]
DR   RefSeq; XP_016870631.1; XM_017015142.1. [Q9HCF6-11]
DR   UniGene; Hs.47288; -.
DR   ProteinModelPortal; Q9HCF6; -.
DR   SMR; Q9HCF6; -.
DR   BioGrid; 123085; 8.
DR   MINT; MINT-4713703; -.
DR   STRING; 9606.ENSP00000366314; -.
DR   GuidetoPHARMACOLOGY; 495; -.
DR   TCDB; 1.A.4.5.6; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9HCF6; -.
DR   PhosphoSitePlus; Q9HCF6; -.
DR   BioMuta; TRPM3; -.
DR   DMDM; 322510140; -.
DR   MaxQB; Q9HCF6; -.
DR   PaxDb; Q9HCF6; -.
DR   PeptideAtlas; Q9HCF6; -.
DR   PRIDE; Q9HCF6; -.
DR   DNASU; 80036; -.
DR   Ensembl; ENST00000361823; ENSP00000355395; ENSG00000083067. [Q9HCF6-12]
DR   Ensembl; ENST00000377110; ENSP00000366314; ENSG00000083067. [Q9HCF6-2]
DR   Ensembl; ENST00000377111; ENSP00000366315; ENSG00000083067. [Q9HCF6-10]
DR   GeneID; 80036; -.
DR   KEGG; hsa:80036; -.
DR   UCSC; uc004aic.4; human. [Q9HCF6-1]
DR   CTD; 80036; -.
DR   DisGeNET; 80036; -.
DR   EuPathDB; HostDB:ENSG00000083067.22; -.
DR   GeneCards; TRPM3; -.
DR   HGNC; HGNC:17992; TRPM3.
DR   MIM; 608961; gene.
DR   neXtProt; NX_Q9HCF6; -.
DR   OpenTargets; ENSG00000083067; -.
DR   PharmGKB; PA38271; -.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOGENOM; HOG000230920; -.
DR   HOVERGEN; HBG058254; -.
DR   InParanoid; Q9HCF6; -.
DR   KO; K04978; -.
DR   PhylomeDB; Q9HCF6; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   ChiTaRS; TRPM3; human.
DR   GeneWiki; TRPM3; -.
DR   GenomeRNAi; 80036; -.
DR   PRO; PR:Q9HCF6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000083067; -.
DR   ExpressionAtlas; Q9HCF6; baseline and differential.
DR   Genevisible; Q9HCF6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0005261; F:cation channel activity; IDA:MGI.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006812; P:cation transport; IDA:MGI.
DR   GO; GO:0016048; P:detection of temperature stimulus; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   GO; GO:0050951; P:sensory perception of temperature stimulus; IEA:InterPro.
DR   Gene3D; 1.20.5.1010; -; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR029583; TRPM3.
DR   InterPro; IPR032415; TRPM_tetra.
DR   InterPro; IPR037162; TRPM_tetra_sf.
DR   PANTHER; PTHR13800:SF7; PTHR13800:SF7; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF16519; TRPM_tetra; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1732       Transient receptor potential cation
FT                                channel subfamily M member 3.
FT                                /FTId=PRO_0000215328.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TOPO_DOM     25    794       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    795    815       Helical. {ECO:0000255}.
FT   TOPO_DOM    816    897       Extracellular. {ECO:0000255}.
FT   TRANSMEM    898    918       Helical. {ECO:0000255}.
FT   TOPO_DOM    919    964       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    965    985       Helical. {ECO:0000255}.
FT   TOPO_DOM    986    995       Extracellular. {ECO:0000255}.
FT   TRANSMEM    996   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1028       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1029   1049       Helical. {ECO:0000255}.
FT   TOPO_DOM   1050   1116       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1117   1137       Helical. {ECO:0000255}.
FT   TOPO_DOM   1138   1732       Cytoplasmic. {ECO:0000255}.
FT   COILED     1241   1301       {ECO:0000255}.
FT   VAR_SEQ       1    153       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043515.
FT   VAR_SEQ       1     59       MPEPWGTVYFLGIAQVFSFLFSWWNLEGVMNQADAPRPLNW
FT                                TIRKLCHAAFLPSVRLLK -> MGKKWRDAAEMERGCSDRE
FT                                DNAESRRRSRSASRGRFAESWKRLSSKQGSTKRSGLPSQQT
FT                                P (in isoform 11).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_039107.
FT   VAR_SEQ     326    350       Missing (in isoform 2, isoform 3, isoform
FT                                4, isoform 5, isoform 6, isoform 8,
FT                                isoform 10 and isoform 12).
FT                                {ECO:0000303|PubMed:12672799,
FT                                ECO:0000303|PubMed:12672827,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012826.
FT   VAR_SEQ     409   1732       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043516.
FT   VAR_SEQ     535    552       Missing (in isoform 8).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012827.
FT   VAR_SEQ     569    569       K -> KREYPGFGWIYFK (in isoform 3 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:12672827}.
FT                                /FTId=VSP_012828.
FT   VAR_SEQ     617    626       Missing (in isoform 4, isoform 5, isoform
FT                                7 and isoform 8).
FT                                {ECO:0000303|PubMed:12672827,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012829.
FT   VAR_SEQ    1088   1088       P -> RKQVYDSHTPKSA (in isoform 6).
FT                                {ECO:0000303|PubMed:12672827}.
FT                                /FTId=VSP_012830.
FT   VAR_SEQ    1344   1350       GEETMSP -> EHPLYSV (in isoform 10).
FT                                {ECO:0000303|PubMed:12672799}.
FT                                /FTId=VSP_012831.
FT   VAR_SEQ    1351   1732       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:12672799}.
FT                                /FTId=VSP_012832.
FT   VARIANT    1653   1653       T -> I (in dbSNP:rs13440436).
FT                                /FTId=VAR_057305.
FT   VARIANT    1695   1695       R -> Q (in dbSNP:rs6560142).
FT                                /FTId=VAR_021257.
FT   VARIANT    1717   1717       R -> K (in dbSNP:rs41287373).
FT                                {ECO:0000269|PubMed:10997877}.
FT                                /FTId=VAR_061862.
FT   VARIANT    1732   1732       N -> T (in dbSNP:rs17535963).
FT                                {ECO:0000269|PubMed:10997877,
FT                                ECO:0000269|PubMed:12672827,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_057306.
FT   CONFLICT    335    335       R -> H (in Ref. 6; BAC55103).
FT                                {ECO:0000305}.
FT   CONFLICT    695    695       C -> Y (in Ref. 6; BAC55106).
FT                                {ECO:0000305}.
FT   CONFLICT   1032   1032       D -> E (in Ref. 6; BAC55106).
FT                                {ECO:0000305}.
FT   CONFLICT   1730   1730       K -> Q (in Ref. 6; BAC55104).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1732 AA;  197571 MW;  0D6BE312C56646A4 CRC64;
     MPEPWGTVYF LGIAQVFSFL FSWWNLEGVM NQADAPRPLN WTIRKLCHAA FLPSVRLLKA
     QKSWIERAFY KRECVHIIPS TKDPHRCCCG RLIGQHVGLT PSISVLQNEK NESRLSRNDI
     QSEKWSISKH TQLSPTDAFG TIEFQGGGHS NKAMYVRVSF DTKPDLLLHL MTKEWQLELP
     KLLISVHGGL QNFELQPKLK QVFGKGLIKA AMTTGAWIFT GGVNTGVIRH VGDALKDHAS
     KSRGKICTIG IAPWGIVENQ EDLIGRDVVR PYQTMSNPMS KLTVLNSMHS HFILADNGTT
     GKYGAEVKLR RQLEKHISLQ KINTRCLPFF SLDSRLFYSF WGSCQLDSVG IGQGVPVVAL
     IVEGGPNVIS IVLEYLRDTP PVPVVVCDGS GRASDILAFG HKYSEEGGLI NESLRDQLLV
     TIQKTFTYTR TQAQHLFIIL MECMKKKELI TVFRMGSEGH QDIDLAILTA LLKGANASAP
     DQLSLALAWN RVDIARSQIF IYGQQWPVGS LEQAMLDALV LDRVDFVKLL IENGVSMHRF
     LTISRLEELY NTRHGPSNTL YHLVRDVKKG NLPPDYRISL IDIGLVIEYL MGGAYRCNYT
     RKRFRTLYHN LFGPKRPKAL KLLGMEDDIP LRRGRKTTKK REEEVDIDLD DPEINHFPFP
     FHELMVWAVL MKRQKMALFF WQHGEEAMAK ALVACKLCKA MAHEASENDM VDDISQELNH
     NSRDFGQLAV ELLDQSYKQD EQLAMKLLTY ELKNWSNATC LQLAVAAKHR DFIAHTCSQM
     LLTDMWMGRL RMRKNSGLKV ILGILLPPSI LSLEFKNKDD MPYMSQAQEI HLQEKEAEEP
     EKPTKEKEEE DMELTAMLGR NNGESSRKKD EEEVQSKHRL IPLGRKIYEF YNAPIVKFWF
     YTLAYIGYLM LFNYIVLVKM ERWPSTQEWI VISYIFTLGI EKMREILMSE PGKLLQKVKV
     WLQEYWNVTD LIAILLFSVG MILRLQDQPF RSDGRVIYCV NIIYWYIRLL DIFGVNKYLG
     PYVMMIGKMM IDMMYFVIIM LVVLMSFGVA RQAILFPNEE PSWKLAKNIF YMPYWMIYGE
     VFADQIDPPC GQNETREDGK IIQLPPCKTG AWIVPAIMAC YLLVANILLV NLLIAVFNNT
     FFEVKSISNQ VWKFQRYQLI MTFHERPVLP PPLIIFSHMT MIFQHLCCRW RKHESDPDER
     DYGLKLFITD DELKKVHDFE EQCIEEYFRE KDDRFNSSND ERIRVTSERV ENMSMRLEEV
     NEREHSMKAS LQTVDIRLAQ LEDLIGRMAT ALERLTGLER AESNKIRSRT SSDCTDAAYI
     VRQSSFNSQE GNTFKLQESI DPAGEETMSP TSPTLMPRMR SHSFYSVNMK DKGGIEKLES
     IFKERSLSLH RATSSHSVAK EPKAPAAPAN TLAIVPDSRR PSSCIDIYVS AMDELHCDID
     PLDNSVNILG LGEPSFSTPV PSTAPSSSAY ATLAPTDRPP SRSIDFEDIT SMDTRSFSSD
     YTHLPECQNP WDSEPPMYHT IERSKSSRYL ATTPFLLEEA PIVKSHSFMF SPSRSYYANF
     GVPVKTAEYT SITDCIDTRC VNAPQAIADR AAFPGGLGDK VEDLTCCHPE REAELSHPSS
     DSEENEAKGR RATIAISSQE GDNSERTLSN NITVPKIERA NSYSAEEPSA PYAHTRKSFS
     ISDKLDRQRN TASLRNPFQR SKSSKPEGRG DSLSMRRLSR TSAFQSFESK HN
//
ID   PANX1_MOUSE             Reviewed;         426 AA.
AC   Q9JIP4; Q5RL18; Q9CXS7;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   07-JUN-2017, entry version 122.
DE   RecName: Full=Pannexin-1;
GN   Name=Panx1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10898987; DOI=10.1016/S0960-9822(00)00576-5;
RA   Panchin Y., Kelmanson I., Matz M., Lukyanov K., Usman N., Lukyanov S.;
RT   "A ubiquitous family of putative gap junction molecules.";
RL   Curr. Biol. 10:R473-R474(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Embryonic head, Eye, and Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   GLYCOSYLATION AT ASN-254, AND MUTAGENESIS OF ASN-254.
RX   PubMed=17925379; DOI=10.1242/jcs.009514;
RA   Penuela S., Bhalla R., Gong X.Q., Cowan K.N., Celetti S.J.,
RA   Cowan B.J., Bai D., Shao Q., Laird D.W.;
RT   "Pannexin 1 and pannexin 3 are glycoproteins that exhibit many
RT   distinct characteristics from the connexin family of gap junction
RT   proteins.";
RL   J. Cell Sci. 120:3772-3783(2007).
RN   [6]
RP   S-NITROSYLATION AT CYS-40 AND CYS-346, AND MUTAGENESIS OF CYS-40;
RP   CYS-346 AND CYS-426.
RX   PubMed=23033481; DOI=10.1074/jbc.M112.397976;
RA   Lohman A.W., Weaver J.L., Billaud M., Sandilos J.K., Griffiths R.,
RA   Straub A.C., Penuela S., Leitinger N., Laird D.W., Bayliss D.A.,
RA   Isakson B.E.;
RT   "S-nitrosylation inhibits pannexin 1 channel function.";
RL   J. Biol. Chem. 287:39602-39612(2012).
CC   -!- FUNCTION: Structural component of the gap junctions and the
CC       hemichannels. May play a role as a Ca(2+)-leak channel to regulate
CC       ER Ca(2+) homeostasis (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homohexamer. Forms homomeric or PANX1/PANX2-heteromeric
CC       intercellular channels on coexpression in paired Xenopus oocytes.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P97382:Kcnab3; NbExp=2; IntAct=EBI-6272917, EBI-7261133;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255|PROSITE-ProRule:PRU00351}. Cell
CC       junction, gap junction. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000255|PROSITE-
CC       ProRule:PRU00351}.
CC   -!- TISSUE SPECIFICITY: Widely expressed, including in cartilage,
CC       skin, spleen and brain.
CC   -!- PTM: N-glycosylation may play a role in cell surface targeting.
CC       {ECO:0000269|PubMed:17925379}.
CC   -!- PTM: S-nitrosylation inhibits channel currents and ATP release.
CC       {ECO:0000269|PubMed:23033481}.
CC   -!- SIMILARITY: Belongs to the pannexin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00351}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF207817; AAF75838.1; -; mRNA.
DR   EMBL; AK014033; BAB29125.1; -; mRNA.
DR   EMBL; AK053871; BAC35567.1; -; mRNA.
DR   EMBL; AK089764; BAC40956.1; -; mRNA.
DR   EMBL; CH466522; EDL25014.1; -; Genomic_DNA.
DR   EMBL; BC049074; AAH49074.1; -; mRNA.
DR   CCDS; CCDS22832.1; -.
DR   RefSeq; NP_062355.2; NM_019482.2.
DR   UniGene; Mm.142253; -.
DR   IntAct; Q9JIP4; 4.
DR   STRING; 10090.ENSMUSP00000126405; -.
DR   iPTMnet; Q9JIP4; -.
DR   PhosphoSitePlus; Q9JIP4; -.
DR   EPD; Q9JIP4; -.
DR   MaxQB; Q9JIP4; -.
DR   PaxDb; Q9JIP4; -.
DR   PRIDE; Q9JIP4; -.
DR   Ensembl; ENSMUST00000164273; ENSMUSP00000126405; ENSMUSG00000031934.
DR   GeneID; 55991; -.
DR   KEGG; mmu:55991; -.
DR   UCSC; uc009ofi.1; mouse.
DR   CTD; 24145; -.
DR   MGI; MGI:1860055; Panx1.
DR   eggNOG; ENOG410II5X; Eukaryota.
DR   eggNOG; ENOG410YA5H; LUCA.
DR   GeneTree; ENSGT00390000009703; -.
DR   HOGENOM; HOG000063721; -.
DR   HOVERGEN; HBG053497; -.
DR   InParanoid; Q9JIP4; -.
DR   KO; K03443; -.
DR   OMA; MVTCIAV; -.
DR   OrthoDB; EOG091G086D; -.
DR   PhylomeDB; Q9JIP4; -.
DR   TreeFam; TF333142; -.
DR   Reactome; R-MMU-112303; Electric Transmission Across Gap Junctions.
DR   Reactome; R-MMU-844456; The NLRP3 inflammasome.
DR   ChiTaRS; Panx1; mouse.
DR   PRO; PR:Q9JIP4; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   Bgee; ENSMUSG00000031934; -.
DR   CleanEx; MM_PANX1; -.
DR   ExpressionAtlas; Q9JIP4; baseline and differential.
DR   Genevisible; Q9JIP4; MM.
DR   GO; GO:0032059; C:bleb; ISO:MGI.
DR   GO; GO:0012505; C:endomembrane system; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005921; C:gap junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IPI:MGI.
DR   GO; GO:0051015; F:actin filament binding; IDA:MGI.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0015267; F:channel activity; IGI:MGI.
DR   GO; GO:0055077; F:gap junction hemi-channel activity; ISS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0022840; F:leak channel activity; ISS:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; ISO:MGI.
DR   GO; GO:0097110; F:scaffold protein binding; IEA:Ensembl.
DR   GO; GO:0022829; F:wide pore channel activity; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; ISO:MGI.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; IMP:MGI.
DR   GO; GO:0050717; P:positive regulation of interleukin-1 alpha secretion; IMP:MGI.
DR   GO; GO:0050718; P:positive regulation of interleukin-1 beta secretion; IMP:MGI.
DR   GO; GO:0034214; P:protein hexamerization; ISS:UniProtKB.
DR   GO; GO:0033198; P:response to ATP; IMP:MGI.
DR   GO; GO:0002931; P:response to ischemia; IGI:MGI.
DR   GO; GO:0055085; P:transmembrane transport; IGI:MGI.
DR   InterPro; IPR000990; Innexin.
DR   Pfam; PF00876; Innexin; 1.
DR   PROSITE; PS51013; PANNEXIN; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Endoplasmic reticulum; Gap junction;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; S-nitrosylation; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    426       Pannexin-1.
FT                                /FTId=PRO_0000208485.
FT   TOPO_DOM      1     40       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     41     61       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM     62    106       Extracellular. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    128    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    238    277       Extracellular. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00351}.
FT   TOPO_DOM    299    426       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      40     40       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:23033481}.
FT   MOD_RES     346    346       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:23033481}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17925379}.
FT   MUTAGEN      40     40       C->A: Abolishes S-nitrosylation; when
FT                                associated with Ala-346.
FT                                {ECO:0000269|PubMed:23033481}.
FT   MUTAGEN     254    254       N->Q: Impairs glycosylation.
FT                                {ECO:0000269|PubMed:17925379}.
FT   MUTAGEN     346    346       C->A: Abolishes S-nitrosylation; when
FT                                associated with Ala-40.
FT                                {ECO:0000269|PubMed:23033481}.
FT   MUTAGEN     426    426       C->A: No effect on S-nitrosylation.
FT                                {ECO:0000269|PubMed:23033481}.
FT   CONFLICT    296    296       I -> T (in Ref. 1; AAF75838).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       A -> R (in Ref. 1; AAF75838).
FT                                {ECO:0000305}.
FT   CONFLICT    422    426       LNPSC -> CESVLLMVSFLNFKPVTSVADAPLLDL (in
FT                                Ref. 1; AAF75838). {ECO:0000305}.
SQ   SEQUENCE   426 AA;  48167 MW;  86AF6167C5D39565 CRC64;
     MAIAHLATEY VFSDFLLKEP TEPKFKGLRL ELAVDKMVTC IAVGLPLLLI SLAFAQEISI
     GTQISCFSPS SFSWRQAAFV DSYCWAAVQQ KSSLQSESGN LPLWLHKFFP YILLLFAILL
     YLPALFWRFS AAPHLCSDLK FIMEELDKVY NRAIKAAKSA RDLDLRDGPG PPGVTENVGQ
     SLWEISESHF KYPIVEQYLK TKKNSSHLIM KYISCRLVTF VVILLACIYL SYYFSLSSLS
     DEFLCSIKSG VLKNDSTIPD RFQCKLIAVG IFQLLSLINL IVYALLIPVV VYTFFIPFRQ
     KTDILKVYEI LPTFDVLHFK SEGYNDLSLY NLFLEENISE LKSYKCLKVL ENIKSNGQGI
     DPMLLLTNLG MIKMDIIDGK IPTSLQTKGE DQGSQRVEFK DLDLSSEAAA NNGEKNSRQR
     LLNPSC
//
ID   CCGL_MOUSE              Reviewed;         211 AA.
AC   Q9JJV3; Q543K0;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 112.
DE   RecName: Full=Voltage-dependent calcium channel gamma-like subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-like subunit;
DE   AltName: Full=Transmembrane protein 37;
GN   Name=Tmem37; Synonyms=Cacng5, Pr, Pr1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Kidney;
RX   PubMed=10734232; DOI=10.1016/S0014-5793(00)01306-5;
RA   Klugbauer N., Dai S., Specht V., Lacinova L., Marais E., Bohn G.,
RA   Hofmann F.;
RT   "A family of gamma-like calcium channel subunits.";
RL   FEBS Lett. 470:189-197(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Head, Kidney, and Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Thought to stabilize the calcium channel in an
CC       inactivated (closed) state (By similarity). Modulates calcium
CC       current when coexpressed with CACNA1G. {ECO:0000250,
CC       ECO:0000269|PubMed:10734232}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272046; CAB86387.1; -; mRNA.
DR   EMBL; AK002424; BAB22091.1; -; mRNA.
DR   EMBL; AK050134; BAC34086.1; -; mRNA.
DR   EMBL; AK086093; BAC39608.1; -; mRNA.
DR   EMBL; BC024613; AAH24613.1; -; mRNA.
DR   CCDS; CCDS15229.1; -.
DR   RefSeq; NP_062305.1; NM_019432.2.
DR   UniGene; Mm.24750; -.
DR   ProteinModelPortal; Q9JJV3; -.
DR   SMR; Q9JJV3; -.
DR   STRING; 10090.ENSMUSP00000050862; -.
DR   TCDB; 8.A.16.6.1; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; Q9JJV3; -.
DR   PhosphoSitePlus; Q9JJV3; -.
DR   PaxDb; Q9JJV3; -.
DR   PRIDE; Q9JJV3; -.
DR   Ensembl; ENSMUST00000056089; ENSMUSP00000050862; ENSMUSG00000050777.
DR   GeneID; 170706; -.
DR   KEGG; mmu:170706; -.
DR   UCSC; uc007cjd.1; mouse.
DR   CTD; 140738; -.
DR   MGI; MGI:2157899; Tmem37.
DR   eggNOG; ENOG410IE8N; Eukaryota.
DR   eggNOG; ENOG4111WUN; LUCA.
DR   GeneTree; ENSGT00390000006225; -.
DR   HOGENOM; HOG000111447; -.
DR   HOVERGEN; HBG028482; -.
DR   InParanoid; Q9JJV3; -.
DR   OMA; MFWCEFT; -.
DR   OrthoDB; EOG091G0ROD; -.
DR   PhylomeDB; Q9JJV3; -.
DR   TreeFam; TF333259; -.
DR   PRO; PR:Q9JJV3; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   Bgee; ENSMUSG00000050777; -.
DR   CleanEx; MM_TMEM37; -.
DR   Genevisible; Q9JJV3; MM.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR029372; Tmem37.
DR   PANTHER; PTHR31767; PTHR31767; 1.
DR   Pfam; PF15108; TMEM37; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    211       Voltage-dependent calcium channel gamma-
FT                                like subunit.
FT                                /FTId=PRO_0000164693.
FT   TRANSMEM     25     45       Helical. {ECO:0000255}.
FT   TRANSMEM     96    116       Helical. {ECO:0000255}.
FT   TRANSMEM    131    151       Helical. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
SQ   SEQUENCE   211 AA;  23230 MW;  A1A05270E971CC03 CRC64;
     MTAIGAQAHK LLGLKRPHRS FFESFIRTLI IVCTALAVVL SSVSICDGHW LLVEDHLFGL
     WYFCTIGNHS EPHCLRDLSQ AHMPGLAVGM GLARSVAAMA VVAAIFGLEM LIVSQVCEDV
     RSRRKWAIGS YLLLVAFILS SGGLLTFIIL LKNQINLLGF TLMFWCEFTA SFLFFLNAAS
     GLHINSLTQP WDPPAGTLAY RKRGYDGTSL I
//
ID   CCG3_MOUSE              Reviewed;         315 AA.
AC   Q9JJV5; A6H6R5;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   20-DEC-2017, entry version 118.
DE   RecName: Full=Voltage-dependent calcium channel gamma-3 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-3 subunit;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-3;
DE            Short=TARP gamma-3;
GN   Name=Cacng3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10734232; DOI=10.1016/S0014-5793(00)01306-5;
RA   Klugbauer N., Dai S., Specht V., Lacinova L., Marais E., Bohn G.,
RA   Hofmann F.;
RT   "A family of gamma-like calcium channel subunits.";
RL   FEBS Lett. 470:189-197(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH AP4M1 AND GRIA1, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 227-TYR--THR-240.
RX   PubMed=18341993; DOI=10.1016/j.neuron.2008.02.012;
RA   Matsuda S., Miura E., Matsuda K., Kakegawa W., Kohda K., Watanabe M.,
RA   Yuzaki M.;
RT   "Accumulation of AMPA receptors in autophagosomes in neuronal axons
RT   lacking adaptor protein AP-4.";
RL   Neuron 57:730-745(2008).
CC   -!- FUNCTION: Regulates the trafficking to the somatodendritic
CC       compartment and gating properties of AMPA-selective glutamate
CC       receptors (AMPARs) (PubMed:18341993). Promotes their targeting to
CC       the cell membrane and synapses and modulates their gating
CC       properties by slowing their rates of activation, deactivation and
CC       desensitization. Does not show subunit-specific AMPA receptor
CC       regulation and regulates all AMPAR subunits. Thought to stabilize
CC       the calcium channel in an inactivated (closed) state (By
CC       similarity). {ECO:0000250|UniProtKB:Q8VHX0,
CC       ECO:0000269|PubMed:18341993}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Acts as an auxiliary
CC       subunit for AMPA-selective glutamate receptors (AMPARs). Found in
CC       a complex with GRIA1, GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG4, CACNG5, CACNG7 and CACNG8 (By similarity). Interacts with
CC       AP4M1 and GRIA1; associates GRIA1 with the adaptor protein complex
CC       4 (AP-4) to target GRIA1 to the somatodendritic compartment of
CC       neurons (PubMed:18341993). {ECO:0000250|UniProtKB:Q8VHX0,
CC       ECO:0000269|PubMed:18341993}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}. Note=Displays a somatodendritic
CC       localization and is excluded from axons in neurons.
CC       {ECO:0000269|PubMed:18341993}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272044; CAB86385.1; -; mRNA.
DR   EMBL; CH466531; EDL17281.1; -; Genomic_DNA.
DR   EMBL; BC138673; AAI38674.1; -; mRNA.
DR   EMBL; BC145971; AAI45972.1; -; mRNA.
DR   CCDS; CCDS21816.1; -.
DR   RefSeq; NP_062303.2; NM_019430.2.
DR   UniGene; Mm.444212; -.
DR   ProteinModelPortal; Q9JJV5; -.
DR   STRING; 10090.ENSMUSP00000081664; -.
DR   iPTMnet; Q9JJV5; -.
DR   PhosphoSitePlus; Q9JJV5; -.
DR   PaxDb; Q9JJV5; -.
DR   PeptideAtlas; Q9JJV5; -.
DR   PRIDE; Q9JJV5; -.
DR   Ensembl; ENSMUST00000084615; ENSMUSP00000081664; ENSMUSG00000066189.
DR   GeneID; 54376; -.
DR   KEGG; mmu:54376; -.
DR   UCSC; uc009jov.3; mouse.
DR   CTD; 10368; -.
DR   MGI; MGI:1859165; Cacng3.
DR   eggNOG; ENOG410IFNQ; Eukaryota.
DR   eggNOG; ENOG4110ISU; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233440; -.
DR   HOVERGEN; HBG003682; -.
DR   InParanoid; Q9JJV5; -.
DR   KO; K04868; -.
DR   OMA; GVIAVHM; -.
DR   OrthoDB; EOG091G0D2Z; -.
DR   TreeFam; TF327980; -.
DR   Reactome; R-MMU-399719; Trafficking of AMPA receptors.
DR   Reactome; R-MMU-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-MMU-5576893; Phase 2 - plateau phase.
DR   Reactome; R-MMU-5682910; LGI-ADAM interactions.
DR   PRO; PR:Q9JJV5; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000066189; -.
DR   ExpressionAtlas; Q9JJV5; baseline and differential.
DR   Genevisible; Q9JJV5; MM.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:MGI.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:UniProtKB.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0008104; P:protein localization; IMP:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IMP:UniProtKB.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IBA:GO_Central.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR008368; VDCC_gsu.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    315       Voltage-dependent calcium channel gamma-3
FT                                subunit.
FT                                /FTId=PRO_0000164676.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TRANSMEM    135    155       Helical. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   MOD_RES     248    248       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VHX0}.
FT   MUTAGEN     227    240       YRYRFRRRSSSRST->ARARARRRAAARAA: Decreased
FT                                interaction with AP4M1. Has no effect on
FT                                interaction with GRIA1. Dominant negative
FT                                mutant which alters AMPARs localization
FT                                to the somatodendritic compartment.
FT                                {ECO:0000269|PubMed:18341993}.
FT   CONFLICT     61     61       S -> F (in Ref. 1; CAB86385).
FT                                {ECO:0000305}.
SQ   SEQUENCE   315 AA;  35516 MW;  FB4EA036C494B6AD CRC64;
     MRMCDRGIQM LITTVGAFAA FSLMTIAVGT DYWLYSRGVC RTKSTSDNET SRKNEEVMTH
     SGLWRTCCLE GAFRGVCKKI DHFPEDADYE QDTAEYLLRA VRASSVFPIL SVTLLFFGGL
     CVAASEFHRS RHSVILSAGI FFVSAGLSNI IGIIVYISAN AGDPGQRDSK KSYSYGWSFY
     FGAFSFIIAE IVGVVAVHIY IEKHQQLRAR SHSELLKKST FARLPPYRYR FRRRSSSRST
     EPRSRDLSPI SKGFHTIPST DISMFTLSRD PSKLTMGTLL NSDRDHAFLQ FHNSTPKEFK
     ESLHNNPANR RTTPV
//
ID   ACH10_RAT               Reviewed;         447 AA.
AC   Q9JLB5;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-10;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-10;
DE            Short=NACHR alpha-10;
DE   Flags: Precursor;
GN   Name=Chrna10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHRNA9, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11248107; DOI=10.1073/pnas.051622798;
RA   Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F.,
RA   Boulter J.;
RT   "Alpha10: a determinant of nicotinic cholinergic receptor function in
RT   mammalian vestibular and cochlear mechanosensory hair cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3501-3506(2001).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=12117536; DOI=10.1016/S0378-5955(02)00380-5;
RA   Weisstaub N., Vetter D.E., Elgoyhen A.B., Katz E.;
RT   "The alpha9alpha10 nicotinic acetylcholine receptor is permeable to
RT   and is modulated by divalent cations.";
RL   Hear. Res. 167:122-135(2002).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=12401316; DOI=10.1016/S0306-4522(02)00274-9;
RA   Lips K.S., Pfeil U., Kummer W.;
RT   "Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine
RT   receptors in rat dorsal root ganglion neurons.";
RL   Neuroscience 115:1-5(2002).
RN   [4]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15356192; DOI=10.1523/JNEUROSCI.2102-04.2004;
RA   Katz E., Elgoyhen A.B., Gomez-Casati M.E., Knipper M., Vetter D.E.,
RA   Fuchs P.A., Glowatzki E.;
RT   "Developmental regulation of nicotinic synapses on cochlear inner hair
RT   cells.";
RL   J. Neurosci. 24:7814-7820(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=14742688; DOI=10.1124/mol.65.2.453;
RA   Baker E.R., Zwart R., Sher E., Millar N.S.;
RT   "Pharmacological properties of alpha 9 alpha 10 nicotinic
RT   acetylcholine receptors revealed by heterologous expression of subunit
RT   chimeras.";
RL   Mol. Pharmacol. 65:453-460(2004).
RN   [6]
RP   SITE HIS-31, AND SUBUNIT.
RX   PubMed=26395518; DOI=10.1038/srep14261;
RA   Xu S., Zhang T., Kompella S.N., Yan M., Lu A., Wang Y., Shao X.,
RA   Chi C., Adams D.J., Ding J., Wang C.;
RT   "Conotoxin alphaD-GeXXA utilizes a novel strategy to antagonize
RT   nicotinic acetylcholine receptors.";
RL   Sci. Rep. 5:14261-14268(2015).
RN   [7]
RP   MUTAGENESIS OF GLU-221 AND PRO-224, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [8]
RP   ERRATUM.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with
RT   the rat alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding may induce an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. The channel is permeable to a range of divalent cations
CC       including calcium, the influx of which may activate a potassium
CC       current which hyperpolarizes the cell membrane. In the ear, this
CC       leads to a reduction in basilar membrane motion, altering the
CC       activity of auditory nerve fibers and reducing the range of
CC       dynamic hearing. This may protect against acoustic trauma.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688}.
CC   -!- SUBUNIT: Forms heterooligomeric channels in conjunction with
CC       CHRNA9. The native outer hair cell receptor may be composed of
CC       CHRNA9-CHRNA10 heterooligomers. Interacts with the conotoxin GeXXA
CC       (PubMed:26395518). Interacts with the alpha-conotoxin RgIA
CC       (PubMed:25740413). {ECO:0000269|PubMed:25740413,
CC       ECO:0000269|PubMed:26395518}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the outer hair cells of the
CC       cochlea and the neurons of dorsal root ganglia.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12401316}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the inner hair cells of the ear
CC       is lost at the onset of hearing, around P12. This correlates with
CC       a loss of sensitivity of these cells to cholinergic stimuli.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:15356192}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist).
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       10/CHRNA10 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF196344; AAF27624.1; -; mRNA.
DR   RefSeq; NP_072161.1; NM_022639.1.
DR   RefSeq; XP_017445156.1; XM_017589667.1.
DR   UniGene; Rn.48767; -.
DR   ProteinModelPortal; Q9JLB5; -.
DR   SMR; Q9JLB5; -.
DR   STRING; 10116.ENSRNOP00000027506; -.
DR   BindingDB; Q9JLB5; -.
DR   ChEMBL; CHEMBL3461; -.
DR   GuidetoPHARMACOLOGY; 470; -.
DR   PaxDb; Q9JLB5; -.
DR   PRIDE; Q9JLB5; -.
DR   Ensembl; ENSRNOT00000027507; ENSRNOP00000027506; ENSRNOG00000020293.
DR   GeneID; 64574; -.
DR   KEGG; rno:64574; -.
DR   UCSC; RGD:620142; rat.
DR   CTD; 57053; -.
DR   RGD; 620142; Chrna10.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q9JLB5; -.
DR   KO; K04811; -.
DR   OMA; AQRCHED; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9JLB5; -.
DR   TreeFam; TF315605; -.
DR   PRO; PR:Q9JLB5; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020293; -.
DR   Genevisible; Q9JLB5; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IMP:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    447       Neuronal acetylcholine receptor subunit
FT                                alpha-10.
FT                                /FTId=PRO_0000000377.
FT   TOPO_DOM     25    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    268    288       Helical. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    425       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   SITE         31     31       Involved in the interaction with the
FT                                conotoxin GeXXA.
FT                                {ECO:0000269|PubMed:26395518}.
FT   CARBOHYD     40     40       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     56     56       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    154    168       {ECO:0000250}.
FT   DISULFID    218    219       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   MUTAGEN     221    221       E->Q: CHRNA9-CHRNA10 receptor is 25-fold
FT                                less potently inhibited by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     224    224       P->Q: CHRNA9-CHRNA10 receptor is 300-fold
FT                                less potently inhibited by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
SQ   SEQUENCE   447 AA;  49820 MW;  EEE49D93490B698F CRC64;
     MGTRSHYLDL GFLLLLFLPA ECLGAEGRLA HKLFRDLFAN YTSALRPVAD TDQTLNVTLE
     VTLSQIIDMD ERNQVLTLYL WIRQEWTDAY LHWDPKAYGD LDAIRIPSRL VWRPDIVLYN
     KADTQPPASA STNVVVRHDG AVRWDAPAIT RSSCRVDVSA FPFDAQRCGL TFGSWTHGGH
     QLDVRPRGTS ASLADFVENV EWRVLGMPAR RRVLTYGCCS EPYPDVTFTL LLRRRAAAYV
     CNLLLPCVFI SLLAPLAFHL PADSGEKVSL GVTVLLALTV FQLILAESMP PAESVPLIGK
     YYMATMTMVT FSTALTILIM NLHYCGPNAH PVPAWARVLL LGHLAKGLCV RERGEPCGQS
     KPLESAPSLQ PPPASPAGPC HEPRCLCHQE ALLHHIASIA STFRSHRAAQ RRHEDWKRLA
     RVMDRFFLGI FFCMALVMSL IVLVQAL
//
ID   IPLA_DICDI              Reviewed;        3177 AA.
AC   Q9NA13; Q54D11;
DT   22-SEP-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor-like protein A;
GN   Name=iplA; ORFNames=DDB_G0292564;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=AX2;
RX   PubMed=10970875; DOI=10.1093/emboj/19.17.4846;
RA   Traynor D., Milne J.L.S., Insall R.H., Kay R.R.;
RT   "Ca(2+) signalling is not required for chemotaxis in Dictyostelium.";
RL   EMBO J. 19:4846-4854(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12211100; DOI=10.1002/cm.10068;
RA   Levi S., Polyakov M.V., Egelhoff T.T.;
RT   "Myosin II dynamics in Dictyostelium: determinants for filament
RT   assembly and translocation to the cell cortex during chemoattractant
RT   responses.";
RL   Cell Motil. Cytoskeleton 53:177-188(2002).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15760480; DOI=10.1186/1471-2121-6-13;
RA   Schaloske R.H., Lusche D.F., Bezares-Roder K., Happle K., Malchow D.,
RA   Schlatterer C.;
RT   "Ca2+ regulation in the absence of the iplA gene product in
RT   Dictyostelium discoideum.";
RL   BMC Cell Biol. 6:13-13(2005).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17077123; DOI=10.1242/jcs.03248;
RA   Shanley L.J., Walczysko P., Bain M., MacEwan D.J., Zhao M.;
RT   "Influx of extracellular Ca2+ is necessary for electrotaxis in
RT   Dictyostelium.";
RL   J. Cell Sci. 119:4741-4748(2006).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18196962; DOI=10.4161/auto.5521;
RA   Lam D., Golstein P.;
RT   "A specific pathway inducing autophagic cell death is marked by an
RT   IP3R mutation.";
RL   Autophagy 4:349-350(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=17854889; DOI=10.1016/j.ceca.2007.08.002;
RA   Malchow D., Lusche D.F., De Lozanne A., Schlatterer C.;
RT   "A fast Ca2+-induced Ca2+-release mechanism in Dictyostelium
RT   discoideum.";
RL   Cell Calcium 43:521-530(2008).
RN   [8]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=18486207; DOI=10.1016/j.ceca.2008.04.001;
RA   Ludlow M.J., Traynor D., Fisher P.R., Ennion S.J.;
RT   "Purinergic-mediated Ca2+ influx in Dictyostelium discoideum.";
RL   Cell Calcium 44:567-579(2008).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18077554; DOI=10.1091/mbc.E07-08-0823;
RA   Lam D., Kosta A., Luciani M.F., Golstein P.;
RT   "The inositol 1,4,5-trisphosphate receptor is required to signal
RT   autophagic cell death.";
RL   Mol. Biol. Cell 19:691-700(2008).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19133302; DOI=10.1016/j.bbamcr.2008.12.005;
RA   Giusti C., Tresse E., Luciani M.-F., Golstein P.;
RT   "Autophagic cell death: Analysis in Dictyostelium.";
RL   Biochim. Biophys. Acta 1793:1422-1431(2009).
CC   -!- FUNCTION: May be a receptor for inositol 1,4,5 trisphosphate which
CC       governs calcium fluxes from the endoplasmic reticulum stores into
CC       the cytosol. May be involved in autophagic cell death.
CC       {ECO:0000269|PubMed:10970875, ECO:0000269|PubMed:12211100,
CC       ECO:0000269|PubMed:15760480, ECO:0000269|PubMed:17077123,
CC       ECO:0000269|PubMed:17854889, ECO:0000269|PubMed:18077554,
CC       ECO:0000269|PubMed:18196962, ECO:0000269|PubMed:19133302}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low during growth and rises to
CC       a peak at 9 hours of development when chemotactic aggregation to
CC       cyclic AMP is near its height; levels then decrease through the
CC       end of development. {ECO:0000269|PubMed:10970875}.
CC   -!- DISRUPTION PHENOTYPE: Null cells show abolition of calcium entry
CC       in response to chemoattractant, response to cyclic AMP and normal
CC       increase in free cytosolic calcium that follows chemotactic
CC       stimulation. Cells show formation of smaller fruiting bodies and
CC       abolition of autophagic cell death. Cells show absence of
CC       vacuolization. {ECO:0000269|PubMed:10970875,
CC       ECO:0000269|PubMed:12211100, ECO:0000269|PubMed:15760480,
CC       ECO:0000269|PubMed:17077123, ECO:0000269|PubMed:18077554,
CC       ECO:0000269|PubMed:18196962, ECO:0000269|PubMed:18486207,
CC       ECO:0000269|PubMed:19133302}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ277590; CAB97127.1; -; Genomic_DNA.
DR   EMBL; AAFI02000194; EAL61085.1; -; Genomic_DNA.
DR   RefSeq; XP_629509.1; XM_629507.1.
DR   ProteinModelPortal; Q9NA13; -.
DR   STRING; 44689.DDB0201571; -.
DR   PaxDb; Q9NA13; -.
DR   PRIDE; Q9NA13; -.
DR   EnsemblProtists; EAL61085; EAL61085; DDB_G0292564.
DR   GeneID; 8628760; -.
DR   KEGG; ddi:DDB_G0292564; -.
DR   dictyBase; DDB_G0292564; iplA.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   InParanoid; Q9NA13; -.
DR   OMA; TEVICRE; -.
DR   Reactome; R-DDI-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-DDI-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-DDI-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-DDI-5578775; Ion homeostasis.
DR   PRO; PR:Q9NA13; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:dictyBase.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:dictyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; ISS:dictyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:dictyBase.
DR   GO; GO:0005262; F:calcium channel activity; ISS:dictyBase.
DR   GO; GO:0005509; F:calcium ion binding; IMP:dictyBase.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; ISS:dictyBase.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:dictyBase.
DR   GO; GO:0031152; P:aggregation involved in sorocarp development; IMP:dictyBase.
DR   GO; GO:0048102; P:autophagic cell death; IMP:dictyBase.
DR   GO; GO:0006816; P:calcium ion transport; IMP:dictyBase.
DR   GO; GO:0097231; P:cell motility in response to calcium ion; IMP:dictyBase.
DR   GO; GO:0030244; P:cellulose biosynthetic process; IMP:dictyBase.
DR   GO; GO:0006935; P:chemotaxis; IMP:dictyBase.
DR   GO; GO:0034670; P:chemotaxis to arachidonic acid; IMP:dictyBase.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:dictyBase.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SUPFAM; SSF100909; SSF100909; 3.
DR   SUPFAM; SSF48371; SSF48371; 2.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   3177       Inositol 1,4,5-trisphosphate receptor-
FT                                like protein A.
FT                                /FTId=PRO_0000384448.
FT   TOPO_DOM      1   1175       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1176   1196       Helical. {ECO:0000255}.
FT   TOPO_DOM   1197   2723       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2724   2744       Helical. {ECO:0000255}.
FT   TOPO_DOM   2745   2769       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2770   2790       Helical. {ECO:0000255}.
FT   TOPO_DOM   2791   2853       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2854   2874       Helical. {ECO:0000255}.
FT   TOPO_DOM   2875   2896       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2897   2917       Helical. {ECO:0000255}.
FT   TOPO_DOM   2918   2995       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2996   3016       Helical. {ECO:0000255}.
FT   TOPO_DOM   3017   3177       Cytoplasmic. {ECO:0000255}.
FT   REGION      289    293       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      608    611       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      692    694       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   COILED     3118   3177       {ECO:0000255}.
FT   COMPBIAS     69     72       Poly-Gln.
FT   COMPBIAS     89     99       Poly-Asn.
FT   COMPBIAS    102    105       Poly-Asn.
FT   COMPBIAS    108    116       Poly-Asn.
FT   COMPBIAS    336    342       Poly-Gln.
FT   COMPBIAS    367    406       Poly-Asn.
FT   COMPBIAS    544    551       Poly-Ser.
FT   COMPBIAS    571    575       Poly-Thr.
FT   COMPBIAS    581    608       Poly-Asn.
FT   COMPBIAS    964    973       Poly-Gly.
FT   COMPBIAS   1022   1026       Poly-Thr.
FT   COMPBIAS   1035   1048       Poly-Asn.
FT   COMPBIAS   1066   1076       Poly-Asn.
FT   COMPBIAS   1107   1119       Poly-Gln.
FT   COMPBIAS   1448   1457       Poly-Gln.
FT   COMPBIAS   1476   1492       Poly-Thr.
FT   COMPBIAS   1721   1731       Poly-Asn.
FT   COMPBIAS   2120   2137       Poly-Asn.
FT   COMPBIAS   2138   2146       Poly-Gly.
FT   COMPBIAS   2156   2160       Poly-Gly.
FT   COMPBIAS   2201   2204       Poly-Gln.
FT   COMPBIAS   2389   2401       Poly-Asn.
FT   CARBOHYD   1275   1275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1460   1460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1591   1591       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1662   1662       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1678   1678       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1722   1722       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1725   1725       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1730   1730       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1731   1731       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1736   1736       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1745   1745       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1748   1748       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1768   1768       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1827   1827       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1833   1833       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1967   1967       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2035   2035       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2048   2048       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2057   2057       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2106   2106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2124   2124       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2170   2170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2173   2173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2370   2370       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2377   2377       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2392   2392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2644   2644       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2967   2967       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   3177 AA;  360531 MW;  381ECEA20A7C84A2 CRC64;
     MEEKNVNLKT GDLVTFFSEQ EEEDGYFSKS HDSAVMSNNK SKDCVFKVYP FTQYTARKAL
     KKKAKRKLQQ QQADGADANN TNSSSGGGNS NNNNNNNSNS SNNNNSSNNN NNNNNNGTTN
     ANGENVNNEV TDLELKQLEE YQDLEDVSNE STLIQLEGRD LVYGQIVQLY QPSSNQFLFA
     RNNIVGFRQD GSQKCYFKIT PRFQNQDGCK VFSEDLVLLR HEKTGLFLNQ QNFIIDQGVF
     GIGLSENGTF WKMAVSDVDG KSGLNILKAN EPFRLFHREG GFVKVSNDKT TFTYNTKTPS
     SINSLFEIEF ENNNLISPLL RSQKDLQLQQ KDNTDQLQQQ QQKDKDKDNP LKQSYGSLSN
     SNILLQNNNN NNNNNNSNNN NNSNNNSNNS NGNNSNGNNN NNNSNNIFTS NEVHIGQSFW
     IRLVGTKKYL SLKESSDDSL KDNPLIVVTE DQKYSPSATF SFVKRDKANE DVIFGSFVRI
     QSLSKQYLHF ISDETFHHNG ELVGSKKYYK NDDFQIKQIP KSQLEDYGFV LSRINKIQNY
     LYQSSSNSSS SLMSSINGIG QSSFSSLAGA TTTTTNSGGS NNINNNNNNN NNNNNNNNNN
     NNNNNNNNID KKRATVQEIK AIIVEFIKFC TQSEVEDPLD REGTPIKTHQ KLLSHPSHLS
     VLLDYLKRLF EPFDPASILF VYRLLKQMAK SNIKNGIIIN EHLDQISPPS IRDKTIPLHF
     GAILYEVYKN NNILLEALTE DKVQEFINVI KQKKEPKYME LLSEICICYG KPIVKNQQYL
     CDLLLEKNSN LLFKTRVIGG SLEIERQNPA PKWVDITAFA LSVDEKTHRY FEQSLALYSN
     VSKGRNYNGI RLVGQRITHK ECLLALKEES LPYSLRGCYI NILIHVYMDC HPQHYVPQIN
     YVWNPSIVNN TKTIELLQLY QQYNITGSLH QRNSSIQNPY STVSNGNISI SSNNPISTTN
     TTTGSGGGGG GSGFMPTVGP SYGQASSPLS NGAIVNSLAS TNLNNQTPTS LNLFNLNSPN
     NTTTTTNNST NNTTNNNTNN NNNNNNTNSL ITSTTHLIQL VSPQQNNNSN NNNNNNILNS
     IPTSPIVGST NHGQLSHSGS NQTPLYQQQQ QQQQQQQQQN SLSLFREDDI FSTFVNLEIQ
     ADKEPSTTTQ LLISLLSKSE YFSNFNNGFP TSHRPQLAFF HKILIAVGYA FKFGFFRKKE
     RVLLKRLRYI LEFEHEPVNT FKEVDLGRTM GGSRMLEDES VIYVSIKIEI VNILHLMLSF
     QKKNIMDVFL YDFSNMSQSA FSQPENVKNQ LIDRLTTNYQ RDGHQDLSLC TVLFKLLKHE
     NNQLSSLSLS LLNRIYKYRS IYAMLWSPIQ KLFLLPNELT PTYKESLQKM ESLTVTCFAP
     LTDDSTQESL RSLAFFIHLV TDSDPIKLVK NQKLLHVIGV HKTIIGVLKI GCSLDDLILD
     QSQPQHSQQQ QQQHQQQPIN ISGSIDESSS TIPPLTTTTT TTTTTTTTTT TTQQSINFKS
     LLNSKTNSQS IHVAKIFRSC YEFLKVFCRD NRENQKVLFG EIEFLIGHLI RYGNVFGTVE
     TLIEVFKNNI ELAINFGNSP YLKLLVKFII NLSIDQLDPM FLRLLSVLIL PCNENSVIEN
     QISVTNLFKE YKSKISKLLV PISTMKEVMK DPKLLSKHYN VNSSNVYKLH LALQEILNHS
     LNDDGAGIGI GTTVIGGSII GGSITTTAQT NINTITNTPT NNNSNNSNNN NTTNNNGTIS
     HRHSNSTNTT QSVYPRLIRS SAKAQIVNSS VEILPKEFVI NLELILLLKA CSHGINTPTE
     VICREFLSMG ECFDILIVRS DGNGKENSSL MINETKEYLE NNLLFRFKSA YLSFLHEVFF
     NSDTLKGDLL ALQLNHDLWS LIDQFTNQLN HLVTICAMNQ MGQLYYVQMA RNIIIPMVSV
     LERFYSQCFY FDKATQIHLT YSGRLMASLM KLYWKDPSLT IPFNQQNTSR YQSSLNMSPT
     NYDDSDTSEG GYHPILQGLD PEERVNIYSN LVKCLKAMDR SALSPIVPAS VSTINISNVI
     KGCEDVINRT EHPNSRNRTE TIDSSNSSPP LILSKSSSIY IDFTRLNNFV KLSKIRGYTE
     IAMMVNQSLS ITPFIISHPN YNSNNSNNGN NNNNNNNGGG GNGNGGTIRS NSYISGGGGG
     STTKRRTSRN NSNISDISNS GKGGSTISNR FQNSFSNTFI QQQQIGITNQ RHINSGNTNI
     VTTVTSKSTN FLEILVFQLR NSLYDNDEMK INCIRILSSL LYINKERKPD IQNIMTDLYC
     HSAVIGLLSS KNIEIQFESL SLLLALLDDS VNVDNPLPNP KVKDDIQSHF SSSPDIQFFR
     DIYAMIERAK INLRDTKRNI HRIEHVKMGN NTVLGGNLTS KNSIKSSINN GNNSNNNNNR
     NGRVIDGCET NPYSTEFQLL QNIFRVLQLL CQGTTNIFKK SIRSQPDNYK SYDILKEMCQ
     FLKILETIVN IDSDSIELGL RFFACMKEIV KNTPENQIAV TNVQVCKAVC NILKKTKEND
     PSKELKELKY LDLKIEVVDF LLHVIDKEDP RVMSKLIPEL DYKVIESNTQ VISQRSNHET
     NEKSIKLASM TFRLIKILAD NDKSHNIQLE DCLLKCGEHC KSRIGRVELL YQNKLERIYF
     PIPNYSRRLI LEDKEQSKIK NDENLLQENL EEHFINNKIS WNKATEKIDA FMDYSEYKLI
     ELEHLHNLKL NSMSYYLVSH TDKFKFLSFF LALIINLLLI IYSINSPPDL KQFKSDISDD
     YGIASWWAGF LPLTILQTIC CILACVGFFL RKGPVLLYQN WVNYLKTHGH KKNFMFYTND
     QRMHSLRQTF KYKFIPLNAK FLMTDLKAVY NILAVICSVL GIIYSPYFFA FHIFQFSLNT
     KALSLVLKAI TMNKKTLLVM GVFILQAIYL LSIFSFVWFQ EHYKDDDSEY MCGSLLQCFI
     TNLYYGVPSQ GQLIQFIKYN FPNNYLNTTD STGSPTLEPI KTSNTVSARI IGWTVFNVAF
     YVVISLILLN VILGIIVDTF GQLRDQRAET EDYKSNVCFI CSIERETFQK NSIEFKKHIE
     DDHNKWHYLY FFAYLKERCT NNQMNQLSEL ECSIADGITN RSYISFFPIE MSMSLQGIEN
     ANRKKEESID QHAKLLDDVE KKITHNISTQ FNQSISLLID EIKNLRQQVS DLKQQQK
//
ID   CA2D2_HUMAN             Reviewed;        1150 AA.
AC   Q9NY47; A7MD15; Q9NY48; Q9UEW0; Q9Y268;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2012, sequence version 2.
DT   25-OCT-2017, entry version 123.
DE   RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-2;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-2;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit alpha-2-2;
DE   Contains:
DE     RecName: Full=Voltage-dependent calcium channel subunit delta-2;
DE   Flags: Precursor;
GN   Name=CACNA2D2; Synonyms=KIAA0558;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), AND TISSUE SPECIFICITY.
RX   PubMed=9880589;
RA   Klugbauer N., Lacinova L., Marais E., Hobom M., Hofmann F.;
RT   "Molecular diversity of the calcium channel alpha2delta subunit.";
RL   J. Neurosci. 19:684-691(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RX   PubMed=10766861; DOI=10.1074/jbc.275.16.12237;
RA   Gao B., Sekido Y., Maximov A., Saad M., Forgacs E., Latif F.,
RA   Wei M.-H., Lerman M., Lee J.-H., Perez-Reyes E., Bezprozvanny I.,
RA   Minna J.D.;
RT   "Functional properties of a new voltage-dependent calcium channel
RT   alpha(2)delta auxiliary subunit gene (CACNA2D2).";
RL   J. Biol. Chem. 275:12237-12242(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Thyroid;
RX   PubMed=10762351; DOI=10.1046/j.1460-9568.2000.01009.x;
RA   Hobom M., Dai S., Marais E., Lacinova L., Hofmann F., Klugbauer N.;
RT   "Neuronal distribution and functional characterization of the calcium
RT   channel alpha2delta-2 subunit.";
RL   Eur. J. Neurosci. 12:1217-1226(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DISULFIDE BONDS, TISSUE SPECIFICITY, AND GABAPENTIN-BINDING.
RX   PubMed=11687876; DOI=10.1007/s00232-001-0072-7;
RA   Gong H.C., Hang J., Kohler W., Li L., Su T.-Z.;
RT   "Tissue-specific expression and gabapentin-binding properties of
RT   calcium channel alpha2delta subunit subtypes.";
RL   J. Membr. Biol. 184:35-43(2001).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 5).
RX   PubMed=15000524; DOI=10.1023/B:JOBB.0000008028.41056.58;
RA   Klugbauer N., Marais E., Hofmann F.;
RT   "Calcium channel alpha2delta subunits: differential expression,
RT   function, and drug binding.";
RL   J. Bioenerg. Biomembr. 35:639-647(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=12555074; DOI=10.1038/sj.onc.1206134;
RA   Carboni G.L., Gao B., Nishizaki M., Xu K., Minna J.D., Roth J.A.,
RA   Ji L.;
RT   "CACNA2D2-mediated apoptosis in NSCLC cells is associated with
RT   alterations of the intracellular calcium signaling and disruption of
RT   mitochondria membrane integrity.";
RL   Oncogene 22:615-626(2003).
RN   [11]
RP   FUNCTION.
RX   PubMed=15111129; DOI=10.1016/j.abb.2004.03.010;
RA   Lacinova L., Klugbauer N.;
RT   "Modulation of gating currents of the Ca(v)3.1 calcium channel by
RT   alpha 2 delta 2 and gamma 5 subunits.";
RL   Arch. Biochem. Biophys. 425:207-213(2004).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-386.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
CC   -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium
CC       channels regulates calcium current density and
CC       activation/inactivation kinetics of the calcium channel. Acts as a
CC       regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type
CC       (CACNA1B), L-type (CACNA1C OR CACNA1D) and possibly T-type
CC       (CACNA1G). Overexpression induces apoptosis.
CC       {ECO:0000269|PubMed:12555074, ECO:0000269|PubMed:15111129}.
CC   -!- SUBUNIT: Dimer formed of alpha-2-2 and delta-2 chains; disulfide-
CC       linked. Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta
CC       (CACNB) and delta (CACNA2D) subunits in a 1:1:1:1 ratio (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Colocalizes with CACNA1A in
CC       lipid raft fractions. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Alpha2delta-2a;
CC         IsoId=Q9NY47-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha2delta-2b;
CC         IsoId=Q9NY47-2; Sequence=VSP_028059;
CC       Name=3;
CC         IsoId=Q9NY47-3; Sequence=VSP_028059, VSP_028060;
CC       Name=4;
CC         IsoId=Q9NY47-4; Sequence=VSP_028058, VSP_028059, VSP_028060;
CC       Name=5; Synonyms=Alpha2delta-2c;
CC         IsoId=Q9NY47-5; Sequence=VSP_028060;
CC   -!- TISSUE SPECIFICITY: Predominantly present in cerebellar cortex.
CC       Present in various lung tumor cell lines, while it is absent in
CC       normal lung (at protein level). Highly expressed in heart, lung,
CC       testis, pancreas and skeletal muscle. Also expressed in kidney,
CC       liver, placenta and brain. {ECO:0000269|PubMed:10766861,
CC       ECO:0000269|PubMed:11687876, ECO:0000269|PubMed:9880589}.
CC   -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent
CC       metal cations and is required to promote trafficking of the alpha-
CC       1 (CACNA1) subunit to the plasma membrane by an integrin-like
CC       switch. {ECO:0000250}.
CC   -!- PTM: May be proteolytically processed into subunits alpha-2-2 and
CC       delta-2 that are disulfide-linked. It is however unclear whether
CC       such cleavage really takes place in vivo and has a functional role
CC       (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Binds gabapentin, an antiepileptic drug.
CC   -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF042792; AAB96913.1; -; mRNA.
DR   EMBL; AF042793; AAB96914.1; -; mRNA.
DR   EMBL; AF040709; AAC70914.1; -; mRNA.
DR   EMBL; AJ251367; CAB86192.1; -; mRNA.
DR   EMBL; AJ251368; CAB86193.1; -; mRNA.
DR   EMBL; AB011130; BAA25484.1; -; mRNA.
DR   EMBL; AL450422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z75742; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z75743; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW65121.1; -; Genomic_DNA.
DR   EMBL; BC152438; AAI52439.1; -; mRNA.
DR   CCDS; CCDS33763.1; -. [Q9NY47-2]
DR   CCDS; CCDS54588.1; -. [Q9NY47-1]
DR   CCDS; CCDS63647.1; -. [Q9NY47-3]
DR   CCDS; CCDS77748.1; -. [Q9NY47-4]
DR   RefSeq; NP_001005505.1; NM_001005505.2. [Q9NY47-3]
DR   RefSeq; NP_001167522.1; NM_001174051.2. [Q9NY47-1]
DR   RefSeq; NP_001278030.1; NM_001291101.1. [Q9NY47-4]
DR   RefSeq; NP_006021.2; NM_006030.3. [Q9NY47-2]
DR   UniGene; Hs.476273; -.
DR   UniGene; Hs.674666; -.
DR   ProteinModelPortal; Q9NY47; -.
DR   BioGrid; 114678; 28.
DR   IntAct; Q9NY47; 2.
DR   STRING; 9606.ENSP00000418081; -.
DR   BindingDB; Q9NY47; -.
DR   ChEMBL; CHEMBL3896; -.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB00270; Isradipine.
DR   DrugBank; DB01054; Nitrendipine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB04922; XP13512.
DR   TCDB; 8.A.18.2.1; the ca(2+) channel auxiliary subunit Alpha2Delta types 1-4 (cca-Alpha2Delta) family.
DR   iPTMnet; Q9NY47; -.
DR   PhosphoSitePlus; Q9NY47; -.
DR   BioMuta; CACNA2D2; -.
DR   DMDM; 387912827; -.
DR   MaxQB; Q9NY47; -.
DR   PaxDb; Q9NY47; -.
DR   PeptideAtlas; Q9NY47; -.
DR   PRIDE; Q9NY47; -.
DR   Ensembl; ENST00000266039; ENSP00000266039; ENSG00000007402. [Q9NY47-3]
DR   Ensembl; ENST00000360963; ENSP00000354228; ENSG00000007402. [Q9NY47-4]
DR   Ensembl; ENST00000424201; ENSP00000390329; ENSG00000007402. [Q9NY47-2]
DR   Ensembl; ENST00000479441; ENSP00000418081; ENSG00000007402. [Q9NY47-1]
DR   GeneID; 9254; -.
DR   KEGG; hsa:9254; -.
DR   UCSC; uc003dap.4; human. [Q9NY47-1]
DR   CTD; 9254; -.
DR   DisGeNET; 9254; -.
DR   EuPathDB; HostDB:ENSG00000007402.11; -.
DR   GeneCards; CACNA2D2; -.
DR   HGNC; HGNC:1400; CACNA2D2.
DR   HPA; HPA034771; -.
DR   HPA; HPA071829; -.
DR   MalaCards; CACNA2D2; -.
DR   MIM; 607082; gene.
DR   neXtProt; NX_Q9NY47; -.
DR   OpenTargets; ENSG00000007402; -.
DR   PharmGKB; PA26012; -.
DR   eggNOG; KOG2353; Eukaryota.
DR   eggNOG; ENOG410XPDX; LUCA.
DR   GeneTree; ENSGT00530000062904; -.
DR   HOGENOM; HOG000004860; -.
DR   HOVERGEN; HBG057779; -.
DR   InParanoid; Q9NY47; -.
DR   KO; K04859; -.
DR   TreeFam; TF315824; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; CACNA2D2; human.
DR   GeneWiki; CACNA2D2; -.
DR   GenomeRNAi; 9254; -.
DR   PRO; PR:Q9NY47; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000007402; -.
DR   CleanEx; HS_CACNA2D2; -.
DR   ExpressionAtlas; Q9NY47; baseline and differential.
DR   Genevisible; Q9NY47; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; TAS:Reactome.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0048747; P:muscle fiber development; IEA:Ensembl.
DR   GO; GO:0007528; P:neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0046622; P:positive regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0060024; P:rhythmic synaptic transmission; IEA:Ensembl.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR013680; VDCC_a2/dsu.
DR   InterPro; IPR013608; VWA_N.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF08473; VGCC_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   Pfam; PF08399; VWA_N; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   1150       Voltage-dependent calcium channel subunit
FT                                alpha-2/delta-2.
FT                                /FTId=PRO_0000304637.
FT   CHAIN        19   1001       Voltage-dependent calcium channel subunit
FT                                alpha-2-2. {ECO:0000255}.
FT                                /FTId=PRO_0000304638.
FT   CHAIN      1002   1150       Voltage-dependent calcium channel subunit
FT                                delta-2. {ECO:0000255}.
FT                                /FTId=PRO_0000304639.
FT   TOPO_DOM     19   1113       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1114   1134       Helical. {ECO:0000255}.
FT   TOPO_DOM   1135   1150       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      291    469       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      485    574       Cache.
FT   MOTIF       297    301       MIDAS-like motif.
FT   METAL       297    297       Divalent metal cation. {ECO:0000250}.
FT   METAL       299    299       Divalent metal cation. {ECO:0000250}.
FT   METAL       301    301       Divalent metal cation. {ECO:0000250}.
FT   CARBOHYD    386    386       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    507    507       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    540    540       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    624    624       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    861    861       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    443   1098       Interchain (between alpha-2-2 and delta-2
FT                                chains). {ECO:0000250}.
FT   VAR_SEQ       1     69       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9880589}.
FT                                /FTId=VSP_028058.
FT   VAR_SEQ     662    669       LPISKLKD -> Y (in isoform 2, isoform 3
FT                                and isoform 4).
FT                                {ECO:0000303|PubMed:10762351,
FT                                ECO:0000303|PubMed:10766861,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9628581,
FT                                ECO:0000303|PubMed:9880589}.
FT                                /FTId=VSP_028059.
FT   VAR_SEQ    1076   1077       HS -> HCPA (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:10766861,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9628581,
FT                                ECO:0000303|PubMed:9880589}.
FT                                /FTId=VSP_028060.
FT   VARIANT     138    138       A -> V (in dbSNP:rs35497591).
FT                                /FTId=VAR_035048.
FT   VARIANT     334    334       E -> K (in dbSNP:rs743855).
FT                                /FTId=VAR_057782.
FT   CONFLICT    663    663       P -> R (in Ref. 3; CAB86193).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1150 AA;  129817 MW;  502B86A5E6279AA0 CRC64;
     MAVPARTCGA SRPGPARTAR PWPGCGPHPG PGTRRPTSGP PRPLWLLLPL LPLLAAPGAS
     AYSFPQQHTM QHWARRLEQE VDGVMRIFGG VQQLREIYKD NRNLFEVQEN EPQKLVEKVA
     GDIESLLDRK VQALKRLADA AENFQKAHRW QDNIKEEDIV YYDAKADAEL DDPESEDVER
     GSKASTLRLD FIEDPNFKNK VNYSYAAVQI PTDIYKGSTV ILNELNWTEA LENVFMENRR
     QDPTLLWQVF GSATGVTRYY PATPWRAPKK IDLYDVRRRP WYIQGASSPK DMVIIVDVSG
     SVSGLTLKLM KTSVCEMLDT LSDDDYVNVA SFNEKAQPVS CFTHLVQANV RNKKVFKEAV
     QGMVAKGTTG YKAGFEYAFD QLQNSNITRA NCNKMIMMFT DGGEDRVQDV FEKYNWPNRT
     VRVFTFSVGQ HNYDVTPLQW MACANKGYYF EIPSIGAIRI NTQEYLDVLG RPMVLAGKEA
     KQVQWTNVYE DALGLGLVVT GTLPVFNLTQ DGPGEKKNQL ILGVMGIDVA LNDIKRLTPN
     YTLGANGYVF AIDLNGYVLL HPNLKPQTTN FREPVTLDFL DAELEDENKE EIRRSMIDGN
     KGHKQIRTLV KSLDERYIDE VTRNYTWVPI RSTNYSLGLV LPPYSTFYLQ ANLSDQILQV
     KLPISKLKDF EFLLPSSFES EGHVFIAPRE YCKDLNASDN NTEFLKNFIE LMEKVTPDSK
     QCNNFLLHNL ILDTGITQQL VERVWRDQDL NTYSLLAVFA ATDGGITRVF PNKAAEDWTE
     NPEPFNASFY RRSLDNHGYV FKPPHQDALL RPLELENDTV GILVSTAVEL SLGRRTLRPA
     VVGVKLDLEA WAEKFKVLAS NRTHQDQPQK CGPNSHCEMD CEVNNEDLLC VLIDDGGFLV
     LSNQNHQWDQ VGRFFSEVDA NLMLALYNNS FYTRKESYDY QAACAPQPPG NLGAAPRGVF
     VPTVADFLNL AWWTSAAAWS LFQQLLYGLI YHSWFQADPA EAEGSPETRE SSCVMKQTQY
     YFGSVNASYN AIIDCGNCSR LFHAQRLTNT NLLFVVAEKP LCSQCEAGRL LQKETHSDGP
     EQCELVQRPR YRRGPHICFD YNATEDTSDC GRGASFPPSL GVLVSLQLLL LLGLPPRPQP
     QVLVHASRRL
//
ID   PK2L1_HUMAN             Reviewed;         805 AA.
AC   Q9P0L9; O75972; Q5W039; Q9UP35; Q9UPA2;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 150.
DE   RecName: Full=Polycystic kidney disease 2-like 1 protein;
DE   AltName: Full=Polycystin-2 homolog;
DE   AltName: Full=Polycystin-2L1;
DE   AltName: Full=Polycystin-L;
DE   AltName: Full=Polycystin-L1;
GN   Name=PKD2L1; Synonyms=PKD2L, PKDL, TRPP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT ILE-393.
RC   TISSUE=Retina;
RX   PubMed=9748274; DOI=10.1074/jbc.273.40.25967;
RA   Nomura H., Turco A.E., Pei Y., Kalaydjieva L., Schiavello T.,
RA   Weremowicz S., Ji W., Morton C.C., Meisler M., Reeders S.T., Zhou J.;
RT   "Identification of PKDL, a novel polycystic kidney disease 2-like gene
RT   whose murine homologue is deleted in mice with kidney and retinal
RT   defects.";
RL   J. Biol. Chem. 273:25967-25973(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=10602992; DOI=10.1007/s003350010009;
RA   Guo L., Chen M., Basora N., Zhou J.;
RT   "The human polycystic kidney disease 2-like (PKDL) gene: exon/intron
RT   structure and evidence for a novel splicing mechanism.";
RL   Mamm. Genome 11:46-50(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 96-805 (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=9878261; DOI=10.1006/geno.1998.5618;
RA   Wu G., Hayashi T., Park J.-H., Dixit M., Reynolds D.M., Li L.,
RA   Maeda Y., Cai Y., Coca-Prados M., Somlo S.;
RT   "Identification of PKD2L, a human PKD2-related gene: tissue-specific
RT   expression and mapping to chromosome 10q25.";
RL   Genomics 54:564-568(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 43-805 (ISOFORMS 1 AND 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10602361; DOI=10.1038/sj.ejhg.5200383;
RA   Veldhuisen B., Spruit L., Dauwerse H.G., Breuning M.H., Peters D.J.M.;
RT   "Genes homologous to the autosomal dominant polycystic kidney disease
RT   genes (PKD1 and PKD2).";
RL   Eur. J. Hum. Genet. 7:860-872(1999).
RN   [8]
RP   FUNCTION.
RX   PubMed=10517637; DOI=10.1038/43907;
RA   Chen X.-Z., Vassilev P.M., Basora N., Peng J.-B., Nomura H., Segal Y.,
RA   Brown E.M., Reeders S.T., Hediger M.A., Zhou J.;
RT   "Polycystin-L is a calcium-regulated cation channel permeable to
RT   calcium ions.";
RL   Nature 401:383-386(1999).
RN   [9]
RP   REVIEW.
RX   PubMed=11698076; DOI=10.1016/S0165-6147(00)01832-0;
RA   Stayner C., Zhou J.;
RT   "Polycystin channels and kidney disease.";
RL   Trends Pharmacol. Sci. 22:543-546(2001).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS 2 AND 5).
RX   PubMed=11959145;
RA   Li Q., Liu Y., Zhao W., Chen X.Z.;
RT   "The calcium-binding EF-hand in polycystin-L is not a domain for
RT   channel activation and ensuing inactivation.";
RL   FEBS Lett. 516:270-278(2002).
RN   [11]
RP   ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18535624; DOI=10.1038/embor.2008.89;
RA   Inada H., Kawabata F., Ishimaru Y., Fushiki T., Matsunami H.,
RA   Tominaga M.;
RT   "Off-response property of an acid-activated cation channel complex
RT   PKD1L3-PKD2L1.";
RL   EMBO Rep. 9:690-697(2008).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=19464260; DOI=10.1016/j.bbrc.2009.05.069;
RA   Ishii S., Misaka T., Kishi M., Kaga T., Ishimaru Y., Abe K.;
RT   "Acetic acid activates PKD1L3-PKD2L1 channel--a candidate sour taste
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 385:346-350(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19812697; DOI=10.1371/journal.pone.0007347;
RA   Huque T., Cowart B.J., Dankulich-Nagrudny L., Pribitkin E.A.,
RA   Bayley D.L., Spielman A.I., Feldman R.S., Mackler S.A., Brand J.G.;
RT   "Sour ageusia in two individuals implicates ion channels of the ASIC
RT   and PKD families in human sour taste perception at the anterior
RT   tongue.";
RL   PLoS ONE 4:E7347-E7347(2009).
RN   [14]
RP   SUBUNIT, AND CALCIUM-BINDING.
RX   PubMed=20408813; DOI=10.1042/BJ20091843;
RA   Molland K.L., Narayanan A., Burgner J.W., Yernool D.A.;
RT   "Identification of the structural motif responsible for trimeric
RT   assembly of the C-terminal regulatory domains of polycystin channels
RT   PKD2L1 and PKD2.";
RL   Biochem. J. 429:171-183(2010).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PKD1L1.
RX   PubMed=20538909; DOI=10.1096/fj.10-162925;
RA   Ishimaru Y., Katano Y., Yamamoto K., Akiba M., Misaka T.,
RA   Roberts R.W., Asakura T., Matsunami H., Abe K.;
RT   "Interaction between PKD1L3 and PKD2L1 through their transmembrane
RT   domains is required for localization of PKD2L1 at taste pores in taste
RT   cells of circumvallate and foliate papillae.";
RL   FASEB J. 24:4058-4067(2010).
RN   [16]
RP   ENZYME REGULATION.
RX   PubMed=22420714; DOI=10.1111/j.1742-4658.2012.08566.x;
RA   Ishii S., Kurokawa A., Kishi M., Yamagami K., Okada S., Ishimaru Y.,
RA   Misaka T.;
RT   "The response of PKD1L3/PKD2L1 to acid stimuli is inhibited by
RT   capsaicin and its pungent analogs.";
RL   FEBS J. 279:1857-1870(2012).
RN   [17]
RP   INTERACTION WITH RACK1.
RX   PubMed=22174419; DOI=10.1074/jbc.M111.305854;
RA   Yang J., Wang Q., Zheng W., Tuli J., Li Q., Wu Y., Hussein S.,
RA   Dai X.Q., Shafiei S., Li X.G., Shen P.Y., Tu J.C., Chen X.Z.;
RT   "Receptor for activated C kinase 1 (RACK1) inhibits function of
RT   transient receptor potential (TRP)-type channel Pkd2L1 through
RT   physical interaction.";
RL   J. Biol. Chem. 287:6551-6561(2012).
RN   [18]
RP   FUNCTION, SUBUNIT, INTERACTION WITH PKD1L1, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 523-GLU--GLU-525.
RX   PubMed=24336289; DOI=10.1038/nature12832;
RA   DeCaen P.G., Delling M., Vien T.N., Clapham D.E.;
RT   "Direct recording and molecular identification of the calcium channel
RT   of primary cilia.";
RL   Nature 504:315-318(2013).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.69 ANGSTROMS) OF 699-737, SUBUNIT,
RP   CALCIUM-BINDING, AND MUTAGENESIS OF LEU-710; VAL-714; LEU-717;
RP   ILE-728; VAL-731 AND LEU-735.
RX   PubMed=22193359; DOI=10.1016/j.bbapap.2011.12.002;
RA   Molland K.L., Paul L.N., Yernool D.A.;
RT   "Crystal structure and characterization of coiled-coil domain of the
RT   transient receptor potential channel PKD2L1.";
RL   Biochim. Biophys. Acta 1824:413-421(2012).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 699-743, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-523 AND ASP-525.
RX   PubMed=23212381; DOI=10.1038/ncomms2257;
RA   Yu Y., Ulbrich M.H., Li M.H., Dobbins S., Zhang W.K., Tong L.,
RA   Isacoff E.Y., Yang J.;
RT   "Molecular mechanism of the assembly of an acid-sensing receptor ion
RT   channel complex.";
RL   Nat. Commun. 3:1252-1252(2012).
CC   -!- FUNCTION: Pore-forming subunit of a ciliary calcium channel that
CC       controls calcium concentration within primary cilia without
CC       affecting cytoplasmic calcium concentration. Forms a heterodimer
CC       with PKD1L1 in primary cilia and forms a calcium-permeant ciliary
CC       channel that regulates sonic hedgehog/SHH signaling and GLI2
CC       transcription. May act as a sour taste receptor by forming a
CC       calcium channel with PKD1L3 in gustatory cells; however, its
CC       contribution to sour taste perception is unclear in vivo and may
CC       be indirect. {ECO:0000269|PubMed:10517637,
CC       ECO:0000269|PubMed:19812697, ECO:0000269|PubMed:23212381,
CC       ECO:0000269|PubMed:24336289}.
CC   -!- ENZYME REGULATION: The calcium channel is gated following an off-
CC       response property by acid: gated open after the removal of acid
CC       stimulus, but not during acid application.
CC       {ECO:0000269|PubMed:18535624, ECO:0000269|PubMed:19464260,
CC       ECO:0000269|PubMed:22420714}.
CC   -!- SUBUNIT: Homotrimer; trimerization is independent of calcium-
CC       binding. Calcium channels are probably composed of 3 subunit of
CC       PKD2L1 and 1 subunit of some PKD1 protein (PKD1, PKD1L1, PKD1L2 or
CC       PKDL3). Interacts with PKD1. Interacts with PKD1L1; to form
CC       ciliary calcium channel. Interacts with PKD1L3, to form putative
CC       sour taste receptor. Interacts with RACK1; inhibits the channel
CC       activity possibly by impairing localization to the cell membrane.
CC       {ECO:0000269|PubMed:20408813, ECO:0000269|PubMed:20538909,
CC       ECO:0000269|PubMed:22174419, ECO:0000269|PubMed:22193359,
CC       ECO:0000269|PubMed:23212381, ECO:0000269|PubMed:24336289}.
CC   -!- INTERACTION:
CC       Q8N6F1-2:CLDN19; NbExp=3; IntAct=EBI-7956847, EBI-12256978;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane; Multi-pass
CC       membrane protein. Cell membrane; Multi-pass membrane protein.
CC       Endoplasmic reticulum {ECO:0000250}. Note=Interaction with PKD1 or
CC       PKD1L3 is required for localization to the cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9P0L9-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKDLdel15, PCL-TS, Testis isoform;
CC         IsoId=Q9P0L9-2; Sequence=VSP_004730, VSP_004731;
CC       Name=3; Synonyms=PKDLdel5;
CC         IsoId=Q9P0L9-3; Sequence=VSP_004729;
CC       Name=4; Synonyms=PKDLdel456;
CC         IsoId=Q9P0L9-4; Sequence=VSP_004728;
CC         Note=Unusual intron exon spliced junction.;
CC       Name=5; Synonyms=PCL-LV, Liver isoform;
CC         IsoId=Q9P0L9-5; Sequence=VSP_053718;
CC   -!- TISSUE SPECIFICITY: Expressed in adult heart, skeletal muscle,
CC       brain, spleen, testis, retina and liver. According to
CC       PubMed:9748274, expressed at high levels in fetal tissues,
CC       including kidney and liver, and down-regulated in adult tissues.
CC       According to PubMed:10602361, expressed in fetal brain, but not
CC       expressed in fetal lung, liver or kidney. Isoform 4 appears to be
CC       expressed only in transformed lymphoblasts.
CC       {ECO:0000269|PubMed:10602361, ECO:0000269|PubMed:9748274}.
CC   -!- DOMAIN: The EF-hand domain probably mediates calcium-binding. It
CC       is not required for channel activation (PubMed:11959145).
CC       {ECO:0000269|PubMed:11959145}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- CAUTION: PKD1L3 and PKD2L1 have been defined as sour taste
CC       receptor in gustatory cells based on a number of indirect
CC       evidences in mouse. Some data confirm this hypothesis in human: in
CC       2 patients with sour ageusia that are unresponsive to sour
CC       stimuli, but show normal responses to bitter, sweet, and salty
CC       stimuli, expression of PKD1L3 and PKD2L1 is absent in the anterior
CC       part of the tongue (PubMed:19812697). However, a number of
CC       experiments have recently shown that the sour taste receptor
CC       activity is probably indirect. {ECO:0000305|PubMed:19812697}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF073481; AAD41638.1; -; mRNA.
DR   EMBL; AF153474; AAF28108.1; -; Genomic_DNA.
DR   EMBL; AF153459; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153460; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153461; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153462; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153463; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153464; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153465; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153466; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153467; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153468; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153469; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153470; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153471; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153472; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AF153473; AAF28108.1; JOINED; Genomic_DNA.
DR   EMBL; AL139819; CAH72822.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49833.1; -; Genomic_DNA.
DR   EMBL; BC025665; AAH25665.1; -; mRNA.
DR   EMBL; AF094827; AAD08695.1; -; mRNA.
DR   EMBL; AF053316; AAD51859.1; -; mRNA.
DR   CCDS; CCDS7492.1; -. [Q9P0L9-1]
DR   RefSeq; NP_001240766.1; NM_001253837.1.
DR   RefSeq; NP_057196.2; NM_016112.2. [Q9P0L9-1]
DR   UniGene; Hs.159241; -.
DR   PDB; 3TE3; X-ray; 2.69 A; A/B/C/D/E/F=699-737.
DR   PDB; 4GIF; X-ray; 2.80 A; A=699-743.
DR   PDBsum; 3TE3; -.
DR   PDBsum; 4GIF; -.
DR   ProteinModelPortal; Q9P0L9; -.
DR   SMR; Q9P0L9; -.
DR   BioGrid; 114499; 2.
DR   IntAct; Q9P0L9; 2.
DR   MINT; MINT-3973148; -.
DR   STRING; 9606.ENSP00000325296; -.
DR   GuidetoPHARMACOLOGY; 505; -.
DR   TCDB; 1.A.5.1.3; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q9P0L9; -.
DR   PhosphoSitePlus; Q9P0L9; -.
DR   BioMuta; PKD2L1; -.
DR   DMDM; 23821938; -.
DR   PaxDb; Q9P0L9; -.
DR   PeptideAtlas; Q9P0L9; -.
DR   PRIDE; Q9P0L9; -.
DR   DNASU; 9033; -.
DR   Ensembl; ENST00000318222; ENSP00000325296; ENSG00000107593. [Q9P0L9-1]
DR   GeneID; 9033; -.
DR   KEGG; hsa:9033; -.
DR   UCSC; uc001kqx.2; human. [Q9P0L9-1]
DR   CTD; 9033; -.
DR   DisGeNET; 9033; -.
DR   EuPathDB; HostDB:ENSG00000107593.16; -.
DR   GeneCards; PKD2L1; -.
DR   HGNC; HGNC:9011; PKD2L1.
DR   HPA; CAB022621; -.
DR   MIM; 604532; gene.
DR   neXtProt; NX_Q9P0L9; -.
DR   OpenTargets; ENSG00000107593; -.
DR   PharmGKB; PA33344; -.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   InParanoid; Q9P0L9; -.
DR   KO; K04990; -.
DR   OMA; FSTFVKC; -.
DR   OrthoDB; EOG091G034F; -.
DR   PhylomeDB; Q9P0L9; -.
DR   TreeFam; TF316484; -.
DR   GeneWiki; PKD2L1; -.
DR   GenomeRNAi; 9033; -.
DR   PRO; PR:Q9P0L9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107593; -.
DR   CleanEx; HS_PKD2L1; -.
DR   ExpressionAtlas; Q9P0L9; baseline and differential.
DR   Genevisible; Q9P0L9; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; ISS:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0005261; F:cation channel activity; IDA:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:BHF-UCL.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0005272; F:sodium channel activity; IDA:BHF-UCL.
DR   GO; GO:0033040; F:sour taste receptor activity; IEA:Ensembl.
DR   GO; GO:0006812; P:cation transport; ISS:BHF-UCL.
DR   GO; GO:0071468; P:cellular response to acidic pH; ISS:BHF-UCL.
DR   GO; GO:0001581; P:detection of chemical stimulus involved in sensory perception of sour taste; ISS:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   GO; GO:0050915; P:sensory perception of sour taste; IMP:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Cell projection; Cilium;
KW   Coiled coil; Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    805       Polycystic kidney disease 2-like 1
FT                                protein.
FT                                /FTId=PRO_0000164360.
FT   TOPO_DOM      1    103       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    313       Extracellular. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical. {ECO:0000255}.
FT   TOPO_DOM    335    347       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    348    368       Helical. {ECO:0000255}.
FT   TOPO_DOM    369    384       Extracellular. {ECO:0000255}.
FT   TRANSMEM    385    405       Helical. {ECO:0000255}.
FT   TOPO_DOM    406    476       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    477    497       Helical. {ECO:0000255}.
FT   TOPO_DOM    498    511       Extracellular. {ECO:0000255}.
FT   INTRAMEM    512    526       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    527    539       Extracellular. {ECO:0000255}.
FT   TRANSMEM    540    560       Helical. {ECO:0000255}.
FT   TOPO_DOM    561    805       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      633    668       EF-hand.
FT   CA_BIND     646    657       {ECO:0000255}.
FT   REGION      704    763       Required for protein homotrimerization.
FT   COILED      650    686       {ECO:0000255}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    210    223       {ECO:0000250|UniProtKB:Q13563}.
FT   VAR_SEQ     225    344       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10602361}.
FT                                /FTId=VSP_004728.
FT   VAR_SEQ     245    319       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_004729.
FT   VAR_SEQ     638    666       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_053718.
FT   VAR_SEQ     751    760       KEQAIWKHPQ -> RFPIKEKRKP (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_004730.
FT   VAR_SEQ     761    805       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_004731.
FT   VARIANT     278    278       R -> Q (in dbSNP:rs17112895).
FT                                /FTId=VAR_050555.
FT   VARIANT     378    378       R -> W (in dbSNP:rs7909153).
FT                                /FTId=VAR_050556.
FT   VARIANT     393    393       V -> I (in dbSNP:rs2278842).
FT                                {ECO:0000269|PubMed:9748274}.
FT                                /FTId=VAR_024569.
FT   VARIANT     681    681       R -> L (in dbSNP:rs6584356).
FT                                /FTId=VAR_024570.
FT   VARIANT     788    788       A -> D (in dbSNP:rs12782963).
FT                                /FTId=VAR_050557.
FT   MUTAGEN     523    525       DFD->AFA: Abolishes ion channel activity.
FT                                {ECO:0000269|PubMed:24336289}.
FT   MUTAGEN     523    523       D->Q: Increased permeability of
FT                                dimethylamine and trimethylamine and
FT                                decreased permeability of magnesium.
FT                                {ECO:0000269|PubMed:23212381}.
FT   MUTAGEN     525    525       D->K: Increased permeability of
FT                                dimethylamine and trimethylamine and
FT                                decreased permeability of magnesium.
FT                                {ECO:0000269|PubMed:23212381}.
FT   MUTAGEN     530    530       D->A: Does not affect ion channel
FT                                activity.
FT   MUTAGEN     710    710       L->A: Abolishes homotrimer formation;
FT                                when associated with A-714; A-717; A-728;
FT                                A-731 and A-735.
FT                                {ECO:0000269|PubMed:22193359}.
FT   MUTAGEN     714    714       V->A: Abolishes homotrimer formation;
FT                                when associated with A-710; A-717; A-728;
FT                                A-731 and A-735.
FT                                {ECO:0000269|PubMed:22193359}.
FT   MUTAGEN     717    717       L->A: Abolishes homotrimer formation;
FT                                when associated with A-710; A-714; A-728;
FT                                A-731 and A-735.
FT                                {ECO:0000269|PubMed:22193359}.
FT   MUTAGEN     728    728       I->A: Abolishes homotrimer formation;
FT                                when associated with A-710; A-714; A-717;
FT                                A-731 and A-735.
FT                                {ECO:0000269|PubMed:22193359}.
FT   MUTAGEN     731    731       V->A: Abolishes homotrimer formation;
FT                                when associated with A-710; A-714; A-717;
FT                                A-728 and A-735.
FT                                {ECO:0000269|PubMed:22193359}.
FT   MUTAGEN     735    735       L->A: Abolishes homotrimer formation;
FT                                when associated with A-710; A-714; A-717;
FT                                A-728 and A-731.
FT                                {ECO:0000269|PubMed:22193359}.
FT   CONFLICT     13     13       Q -> H (in Ref. 1; AAD41638).
FT                                {ECO:0000305}.
FT   HELIX       704    731       {ECO:0000244|PDB:3TE3}.
FT   HELIX       734    741       {ECO:0000244|PDB:4GIF}.
SQ   SEQUENCE   805 AA;  91982 MW;  3714C07F4B71F9C6 CRC64;
     MNAVGSPEGQ ELQKLGSGAW DNPAYSGPPS PHGTLRVCTI SSTGPLQPQP KKPEDEPQET
     AYRTQVSSCC LHICQGIRGL WGTTLTENTA ENRELYIKTT LRELLVYIVF LVDICLLTYG
     MTSSSAYYYT KVMSELFLHT PSDTGVSFQA ISSMADFWDF AQGPLLDSLY WTKWYNNQSL
     GHGSHSFIYY ENMLLGVPRL RQLKVRNDSC VVHEDFREDI LSCYDVYSPD KEEQLPFGPF
     NGTAWTYHSQ DELGGFSHWG RLTSYSGGGY YLDLPGSRQG SAEALRALQE GLWLDRGTRV
     VFIDFSVYNA NINLFCVLRL VVEFPATGGA IPSWQIRTVK LIRYVSNWDF FIVGCEVIFC
     VFIFYYVVEE ILELHIHRLR YLSSIWNILD LVVILLSIVA VGFHIFRTLE VNRLMGKLLQ
     QPNTYADFEF LAFWQTQYNN MNAVNLFFAW IKIFKYISFN KTMTQLSSTL ARCAKDILGF
     AVMFFIVFFA YAQLGYLLFG TQVENFSTFI KCIFTQFRII LGDFDYNAID NANRILGPAY
     FVTYVFFVFF VLLNMFLAII NDTYSEVKEE LAGQKDELQL SDLLKQGYNK TLLRLRLRKE
     RVSDVQKVLQ GGEQEIQFED FTNTLRELGH AEHEITELTA TFTKFDRDGN RILDEKEQEK
     MRQDLEEERV ALNTEIEKLG RSIVSSPQGK SGPEAARAGG WVSGEEFYML TRRVLQLETV
     LEGVVSQIDA VGSKLKMLER KGWLAPSPGV KEQAIWKHPQ PAPAVTPDPW GVQGGQESEV
     PYKREEEALE ERRLSRGEIP TLQRS
//
ID   CAC1I_HUMAN             Reviewed;        2223 AA.
AC   Q9P0X4; B0QY12; B0QY13; B0QY14; O95504; Q5JZ88; Q7Z6S9; Q8NFX6;
AC   Q9NZC8; Q9UH15; Q9UH30; Q9ULU9; Q9UNE6;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 150.
DE   RecName: Full=Voltage-dependent T-type calcium channel subunit alpha-1I;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav3.3;
DE            Short=Ca(v)3.3;
GN   Name=CACNA1I; Synonyms=KIAA1120;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=10454147; DOI=10.1016/S0304-3940(99)00319-5;
RA   Mittman S., Guo J., Emerick M.C., Agnew W.S.;
RT   "Structure and alternative splicing of the gene encoding alpha1I, a
RT   human brain T calcium channel alpha1 subunit.";
RL   Neurosci. Lett. 269:121-124(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10749850; DOI=10.1074/jbc.C000090200;
RA   Monteil A., Chemin J., Leuranguer V., Altier C., Mennessier G.,
RA   Bourinet E., Lory P., Nargeot J.;
RT   "Specific properties of T-type calcium channels generated by the human
RT   alpha1I subunit.";
RL   J. Biol. Chem. 275:16530-16535(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANT VAL-1040.
RC   TISSUE=Brain;
RX   PubMed=12080115; DOI=10.1016/S0006-3495(02)75164-3;
RA   Gomora J.C., Murbartian J., Arias J.M., Lee J.-H., Perez-Reyes E.;
RT   "Cloning and expression of the human T-type channel Ca(v)3.3: insights
RT   into prepulse facilitation.";
RL   Biophys. J. 83:229-241(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1200-2223 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [6]
RP   INTERACTION WITH CATSPER1 AND CATSPER2.
RX   PubMed=16740636; DOI=10.1074/jbc.M511288200;
RA   Zhang D., Chen J., Saraf A., Cassar S., Han P., Rogers J.C.,
RA   Brioni J.D., Sullivan J.P., Gopalakrishnan M.;
RT   "Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of
RT   T-type calcium channel activity.";
RL   J. Biol. Chem. 281:22332-22341(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. This channel gives
CC       rise to T-type calcium currents. T-type calcium channels belong to
CC       the "low-voltage activated (LVA)" group and are strongly blocked
CC       by nickel and mibefradil. A particularity of this type of channels
CC       is an opening at quite negative potentials, and a voltage-
CC       dependent inactivation. T-type channels serve pacemaking functions
CC       in both central neurons and cardiac nodal cells and support
CC       calcium signaling in secretory cells and vascular smooth muscle.
CC       They may also be involved in the modulation of firing patterns of
CC       neurons which is important for information processing as well as
CC       in cell growth processes. Gates in voltage ranges similar to, but
CC       higher than alpha 1G or alpha 1H (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CATSPER1 and CATSPER2, leading to suppress
CC       T-type calcium channel activity. {ECO:0000269|PubMed:16740636}.
CC   -!- INTERACTION:
CC       Q8NEC5:CATSPER1; NbExp=5; IntAct=EBI-1220829, EBI-744545;
CC       Q96P56:CATSPER2; NbExp=3; IntAct=EBI-1220829, EBI-2215024;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Delta36b;
CC         IsoId=Q9P0X4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P0X4-2; Sequence=VSP_000951;
CC       Name=3; Synonyms=Alpha1I-a;
CC         IsoId=Q9P0X4-3; Sequence=VSP_000950, VSP_000951;
CC       Name=4;
CC         IsoId=Q9P0X4-4; Sequence=VSP_000950;
CC   -!- TISSUE SPECIFICITY: Brain specific.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- PTM: In response to raising of intracellular calcium, the T-type
CC       channels are activated by CaM-kinase II. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1I subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF129133; AAD45251.1; -; mRNA.
DR   EMBL; AF142567; AAF25722.1; -; mRNA.
DR   EMBL; AF211189; AAF44626.1; -; mRNA.
DR   EMBL; AF393329; AAM67414.1; -; mRNA.
DR   EMBL; AL008716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB032946; BAA86434.1; -; mRNA.
DR   CCDS; CCDS46710.1; -. [Q9P0X4-1]
DR   CCDS; CCDS46711.1; -. [Q9P0X4-4]
DR   RefSeq; NP_001003406.1; NM_001003406.1. [Q9P0X4-4]
DR   RefSeq; NP_066919.2; NM_021096.3. [Q9P0X4-1]
DR   UniGene; Hs.125116; -.
DR   ProteinModelPortal; Q9P0X4; -.
DR   SMR; Q9P0X4; -.
DR   BioGrid; 114425; 1.
DR   IntAct; Q9P0X4; 3.
DR   STRING; 9606.ENSP00000385019; -.
DR   BindingDB; Q9P0X4; -.
DR   ChEMBL; CHEMBL5558; -.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00617; Paramethadione.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 537; -.
DR   TCDB; 1.A.1.11.7; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9P0X4; -.
DR   PhosphoSitePlus; Q9P0X4; -.
DR   BioMuta; CACNA1I; -.
DR   DMDM; 23396521; -.
DR   EPD; Q9P0X4; -.
DR   PaxDb; Q9P0X4; -.
DR   PeptideAtlas; Q9P0X4; -.
DR   PRIDE; Q9P0X4; -.
DR   Ensembl; ENST00000401624; ENSP00000383887; ENSG00000100346. [Q9P0X4-2]
DR   Ensembl; ENST00000402142; ENSP00000385019; ENSG00000100346. [Q9P0X4-1]
DR   Ensembl; ENST00000404898; ENSP00000384093; ENSG00000100346. [Q9P0X4-4]
DR   Ensembl; ENST00000407673; ENSP00000385680; ENSG00000100346. [Q9P0X4-3]
DR   GeneID; 8911; -.
DR   KEGG; hsa:8911; -.
DR   UCSC; uc003ayc.5; human. [Q9P0X4-1]
DR   CTD; 8911; -.
DR   DisGeNET; 8911; -.
DR   EuPathDB; HostDB:ENSG00000100346.17; -.
DR   GeneCards; CACNA1I; -.
DR   HGNC; HGNC:1396; CACNA1I.
DR   MIM; 608230; gene.
DR   neXtProt; NX_Q9P0X4; -.
DR   OpenTargets; ENSG00000100346; -.
DR   PharmGKB; PA26011; -.
DR   eggNOG; KOG2302; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00830000128242; -.
DR   HOVERGEN; HBG050764; -.
DR   InParanoid; Q9P0X4; -.
DR   KO; K04856; -.
DR   OMA; SPSVNCT; -.
DR   OrthoDB; EOG091G02L1; -.
DR   PhylomeDB; Q9P0X4; -.
DR   TreeFam; TF313555; -.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   ChiTaRS; CACNA1I; human.
DR   GeneWiki; CACNA1I; -.
DR   GenomeRNAi; 8911; -.
DR   PRO; PR:Q9P0X4; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100346; -.
DR   Genevisible; Q9P0X4; HS.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0008332; F:low voltage-gated calcium channel activity; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0070509; P:calcium ion import; IEA:InterPro.
DR   GO; GO:0030317; P:flagellated sperm motility; IEA:InterPro.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0030431; P:sleep; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR030162; CACNA1I.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR005445; VDCC_T_a1.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF209; PTHR10037:SF209; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01629; TVDCCALPHA1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2223       Voltage-dependent T-type calcium channel
FT                                subunit alpha-1I.
FT                                /FTId=PRO_0000053957.
FT   TOPO_DOM      1     78       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     79     99       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    100    120       Extracellular. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    142    148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    149    168       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    169    173       Extracellular. {ECO:0000255}.
FT   TRANSMEM    174    191       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    192    211       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    233    377       Extracellular. {ECO:0000255}.
FT   TRANSMEM    378    398       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    399    640       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    641    661       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    662    676       Extracellular. {ECO:0000255}.
FT   TRANSMEM    677    697       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    698    702       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    703    721       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    722    729       Extracellular. {ECO:0000255}.
FT   TRANSMEM    730    753       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    754    764       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    765    785       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    786    841       Extracellular. {ECO:0000255}.
FT   TRANSMEM    842    862       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    863   1166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1167   1187       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1188   1209       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1210   1230       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1231   1244       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1245   1265       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1266   1272       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1273   1294       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1295   1304       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1305   1325       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1326   1410       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1411   1431       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1432   1485       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1486   1506       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1507   1522       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1523   1543       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1544   1556       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1557   1577       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1578   1583       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1584   1607       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1608   1621       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1622   1642       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1643   1709       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1710   1730       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1731   2223       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       66    401       I.
FT   REPEAT      626    865       II.
FT   REPEAT     1157   1434       III.
FT   REPEAT     1472   1733       IV.
FT   COMPBIAS    608    613       Poly-Glu.
FT   COMPBIAS   1775   1783       Poly-Gly.
FT   COMPBIAS   2110   2120       Poly-Gly.
FT   COMPBIAS   2138   2145       Poly-Pro.
FT   SITE        357    357       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        821    821       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1380   1380       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1678   1678       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES    1058   1058       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0Y8}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    244    244       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    311    311       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1342   1342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1345   1345       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     488    523       HGKTKGQGDEGRHLGSRHCQTLHGPASPGNDHSGRE -> Q
FT                                (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10749850,
FT                                ECO:0000303|PubMed:12080115}.
FT                                /FTId=VSP_000950.
FT   VAR_SEQ    2010   2223       ATGSDTSLDASPSSSAGSLQTTLEDSLTLSDSPRRALGPPA
FT                                PAPGPRAGLSPAARRRLSLRGRGLFSLRGLRAHQRSHSSGG
FT                                STSPGCTHHDSMDPSDEEGRGGAGGGGAGSEHSETLSSLSL
FT                                TSLFCPPPPPPAPGLTPARKFSSTSSLAAPGRPHAAALAHG
FT                                LARSPSWAADRSKDPPGRAPLPMGLGPLAPPPQPLPGELEP
FT                                GDAASKRKR -> VPTPPRP (in isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:10454147,
FT                                ECO:0000303|PubMed:10749850}.
FT                                /FTId=VSP_000951.
FT   VARIANT    1040   1040       I -> V (in dbSNP:rs136853).
FT                                {ECO:0000269|PubMed:12080115}.
FT                                /FTId=VAR_013883.
FT   VARIANT    1513   1513       T -> M (in dbSNP:rs8141262).
FT                                /FTId=VAR_048745.
FT   VARIANT    1782   1782       G -> A (in dbSNP:rs2294369).
FT                                /FTId=VAR_013884.
FT   VARIANT    1782   1782       G -> R (in dbSNP:rs2294369).
FT                                /FTId=VAR_020050.
SQ   SEQUENCE   2223 AA;  245103 MW;  3CAE4D1C4289D08B CRC64;
     MAESASPPSS SAAAPAAEPG VTTEQPGPRS PPSSPPGLEE PLDGADPHVP HPDLAPIAFF
     CLRQTTSPRN WCIKMVCNPW FECVSMLVIL LNCVTLGMYQ PCDDMDCLSD RCKILQVFDD
     FIFIFFAMEM VLKMVALGIF GKKCYLGDTW NRLDFFIVMA GMVEYSLDLQ NINLSAIRTV
     RVLRPLKAIN RVPSMRILVN LLLDTLPMLG NVLLLCFFVF FIFGIIGVQL WAGLLRNRCF
     LEENFTIQGD VALPPYYQPE EDDEMPFICS LSGDNGIMGC HEIPPLKEQG RECCLSKDDV
     YDFGAGRQDL NASGLCVNWN RYYNVCRTGS ANPHKGAINF DNIGYAWIVI FQVITLEGWV
     EIMYYVMDAH SFYNFIYFIL LIIVGSFFMI NLCLVVIATQ FSETKQREHR LMLEQRQRYL
     SSSTVASYAE PGDCYEEIFQ YVCHILRKAK RRALGLYQAL QSRRQALGPE APAPAKPGPH
     AKEPRHYHGK TKGQGDEGRH LGSRHCQTLH GPASPGNDHS GRELCPQHSP LDATPHTLVQ
     PIPATLASDP ASCPCCQHED GRRPSGLGST DSGQEGSGSG SSAGGEDEAD GDGARSSEDG
     ASSELGKEEE EEEQADGAVW LCGDVWRETR AKLRGIVDSK YFNRGIMMAI LVNTVSMGIE
     HHEQPEELTN ILEICNVVFT SMFALEMILK LAAFGLFDYL RNPYNIFDSI IVIISIWEIV
     GQADGGLSVL RTFRLLRVLK LVRFMPALRR QLVVLMKTMD NVATFCMLLM LFIFIFSILG
     MHIFGCKFSL RTDTGDTVPD RKNFDSLLWA IVTVFQILTQ EDWNVVLYNG MASTSPWASL
     YFVALMTFGN YVLFNLLVAI LVEGFQAEGD ANRSYSDEDQ SSSNIEEFDK LQEGLDSSGD
     PKLCPIPMTP NGHLDPSLPL GGHLGPAGAA GPAPRLSLQP DPMLVALGSR KSSVMSLGRM
     SYDQRSLSSS RSSYYGPWGR SAAWASRRSS WNSLKHKPPS AEHESLLSAE RGGGARVCEV
     AADEGPPRAA PLHTPHAHHI HHGPHLAHRH RHHRRTLSLD NRDSVDLAEL VPAVGAHPRA
     AWRAAGPAPG HEDCNGRMPS IAKDVFTKMG DRGDRGEDEE EIDYTLCFRV RKMIDVYKPD
     WCEVREDWSV YLFSPENRFR VLCQTIIAHK LFDYVVLAFI FLNCITIALE RPQIEAGSTE
     RIFLTVSNYI FTAIFVGEMT LKVVSLGLYF GEQAYLRSSW NVLDGFLVFV SIIDIVVSLA
     SAGGAKILGV LRVLRLLRTL RPLRVISRAP GLKLVVETLI SSLKPIGNIV LICCAFFIIF
     GILGVQLFKG KFYHCLGVDT RNITNRSDCM AANYRWVHHK YNFDNLGQAL MSLFVLASKD
     GWVNIMYNGL DAVAVDQQPV TNHNPWMLLY FISFLLIVSF FVLNMFVGVV VENFHKCRQH
     QEAEEARRRE EKRLRRLEKK RRKAQRLPYY ATYCHTRLLI HSMCTSHYLD IFITFIICLN
     VVTMSLEHYN QPTSLETALK YCNYMFTTVF VLEAVLKLVA FGLRRFFKDR WNQLDLAIVL
     LSVMGITLEE IEINAALPIN PTIIRIMRVL RIARVLKLLK MATGMRALLD TVVQALPQVG
     NLGLLFMLLF FIYAALGVEL FGKLVCNDEN PCEGMSRHAT FENFGMAFLT LFQVSTGDNW
     NGIMKDTLRD CTHDERSCLS SLQFVSPLYF VSFVLTAQFV LINVVVAVLM KHLDDSNKEA
     QEDAEMDAEL ELEMAHGLGP GPRLPTGSPG APGRGPGGAG GGGDTEGGLC RRCYSPAQEN
     LWLDSVSLII KDSLEGELTI IDNLSGSIFH HYSSPAGCKK CHHDKQEVQL AETEAFSLNS
     DRSSSILLGD DLSLEDPTAC PPGRKDSKGE LDPPEPMRVG DLGECFFPLS STAVSPDPEN
     FLCEMEEIPF NPVRSWLKHD SSQAPPSPFS PDASSPLLPM PAEFFHPAVS ASQKGPEKGT
     GTGTLPKIAL QGSWASLRSP RVNCTLLRQA TGSDTSLDAS PSSSAGSLQT TLEDSLTLSD
     SPRRALGPPA PAPGPRAGLS PAARRRLSLR GRGLFSLRGL RAHQRSHSSG GSTSPGCTHH
     DSMDPSDEEG RGGAGGGGAG SEHSETLSSL SLTSLFCPPP PPPAPGLTPA RKFSSTSSLA
     APGRPHAAAL AHGLARSPSW AADRSKDPPG RAPLPMGLGP LAPPPQPLPG ELEPGDAASK
     RKR
//
ID   TRPV6_RAT               Reviewed;         767 AA.
AC   Q9R186;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 2.
DT   20-DEC-2017, entry version 126.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 6;
DE            Short=TrpV6;
DE   AltName: Full=Calcium transport protein 1 {ECO:0000303|PubMed:10428857};
DE            Short=CaT1 {ECO:0000303|PubMed:11287959};
DE   AltName: Full=Epithelial calcium channel 2;
DE            Short=ECaC2;
GN   Name=Trpv6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Intestine;
RX   PubMed=10428857; DOI=10.1074/jbc.274.32.22739;
RA   Peng J.-B., Chen X.Z., Berger U.V., Vassilev P.M., Tsukaguchi H.,
RA   Brown E.M., Hediger M.A.;
RT   "Molecular cloning and characterization of a channel-like transporter
RT   mediating intestinal calcium absorption.";
RL   J. Biol. Chem. 274:22739-22746(1999).
RN   [2]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11287959; DOI=10.1038/35070596;
RA   Yue L., Peng J.B., Hediger M.A., Clapham D.E.;
RT   "CaT1 manifests the pore properties of the calcium-release-activated
RT   calcium channel.";
RL   Nature 410:705-709(2001).
RN   [3]
RP   PHOSPHORYLATION AT TYR-201 AND TYR-202, AND MUTAGENESIS OF TYR-201 AND
RP   TYR-202.
RX   PubMed=17197020; DOI=10.1016/j.ceca.2006.11.008;
RA   Sternfeld L., Anderie I., Schmid A., Al-Shaldi H., Krause E., Magg T.,
RA   Schreiner D., Hofer H.W., Schulz I.;
RT   "Identification of tyrosines in the putative regulatory site of the
RT   Ca2+ channel TRPV6.";
RL   Cell Calcium 42:91-102(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 41-709, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND REPEATS.
RX   PubMed=27296226; DOI=10.1038/nature17975;
RA   Saotome K., Singh A.K., Yelshanskaya M.V., Sobolevsky A.I.;
RT   "Crystal structure of the epithelial calcium channel TRPV6.";
RL   Nature 534:506-511(2016).
CC   -!- FUNCTION: Calcium selective cation channel that mediates Ca(2+)
CC       uptake in various tissues, including the intestine
CC       (PubMed:10428857, PubMed:11287959, PubMed:27296226). Important for
CC       normal Ca(2+) ion homeostasis in the body, including bone and skin
CC       (By similarity). The channel is activated by low internal calcium
CC       level, probably including intracellular calcium store depletion,
CC       and the current exhibits an inward rectification (PubMed:10428857,
CC       PubMed:11287959, PubMed:27296226). Inactivation includes both a
CC       rapid Ca(2+)-dependent and a slower Ca(2+)-calmodulin-dependent
CC       mechanism; the latter may be regulated by phosphorylation. In
CC       vitro, is slowly inhibited by Mg(2+) in a voltage-independent
CC       manner. Heteromeric assembly with TRPV5 seems to modify channel
CC       properties. TRPV5-TRPV6 heteromultimeric concatemers exhibit
CC       voltage-dependent gating (By similarity).
CC       {ECO:0000250|UniProtKB:Q91WD2, ECO:0000250|UniProtKB:Q9H1D0,
CC       ECO:0000269|PubMed:10428857, ECO:0000269|PubMed:11287959,
CC       ECO:0000269|PubMed:27296226}.
CC   -!- SUBUNIT: Homotetramer (PubMed:27296226). Probably forms also
CC       heterotetramers with TRPV5. Interacts with TRPV5. Interacts with
CC       S100A10 and probably with the ANAX2-S100A10 heterotetramer. The
CC       interaction with S100A10 is required for the trafficking to the
CC       plasma membrane. Interacts with calmodulin. Interacts with BSPRY.
CC       Interacts with TCAF1 and TCAF2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9H1D0, ECO:0000269|PubMed:27296226}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-7198720, EBI-7198720;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10428857,
CC       ECO:0000269|PubMed:17197020, ECO:0000269|PubMed:27296226}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:27296226}.
CC   -!- TISSUE SPECIFICITY: Expressed in duodenum, proximal jejunum,
CC       cecum, and colon. {ECO:0000269|PubMed:10428857}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000250|UniProtKB:Q9H1D0}.
CC   -!- PTM: Phosphorylation at Tyr-201 and Tyr-202 by SRC leads to an
CC       increased calcium influx through the channel. Probably
CC       dephosphorylated at these sites by PTPN1.
CC       {ECO:0000269|PubMed:17197020}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV6 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-41 is the initiator.
CC       In human and mouse, initiation starts at a conserved non-canonical
CC       ACG threonine codon decoded as Met-1 upstream of the canonical
CC       initiation at Met-41. {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000250|UniProtKB:Q9H1D0}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD47636.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000250|UniProtKB:Q9H1D0};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF160798; AAD47636.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_446138.1; NM_053686.1.
DR   UniGene; Rn.205943; -.
DR   PDB; 5IWK; X-ray; 3.25 A; A=41-709.
DR   PDB; 5IWP; X-ray; 3.65 A; A=41-709.
DR   PDB; 5IWR; X-ray; 3.85 A; A=41-709.
DR   PDB; 5IWT; X-ray; 3.80 A; A=41-709.
DR   PDB; 5WO6; X-ray; 3.31 A; A=41-708.
DR   PDB; 5WO7; X-ray; 3.25 A; A=41-709.
DR   PDB; 5WO8; X-ray; 3.40 A; A=41-709.
DR   PDB; 5WO9; X-ray; 3.70 A; A=41-709.
DR   PDB; 5WOA; X-ray; 3.90 A; A=41-709.
DR   PDBsum; 5IWK; -.
DR   PDBsum; 5IWP; -.
DR   PDBsum; 5IWR; -.
DR   PDBsum; 5IWT; -.
DR   PDBsum; 5WO6; -.
DR   PDBsum; 5WO7; -.
DR   PDBsum; 5WO8; -.
DR   PDBsum; 5WO9; -.
DR   PDBsum; 5WOA; -.
DR   SMR; Q9R186; -.
DR   DIP; DIP-47769N; -.
DR   IntAct; Q9R186; 1.
DR   STRING; 10116.ENSRNOP00000020616; -.
DR   TCDB; 1.A.4.2.7; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9R186; -.
DR   PhosphoSitePlus; Q9R186; -.
DR   PaxDb; Q9R186; -.
DR   GeneID; 114246; -.
DR   KEGG; rno:114246; -.
DR   UCSC; RGD:69335; rat.
DR   CTD; 55503; -.
DR   RGD; 69335; Trpv6.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   HOGENOM; HOG000234397; -.
DR   HOVERGEN; HBG061442; -.
DR   InParanoid; Q9R186; -.
DR   KO; K04975; -.
DR   PRO; PR:Q9R186; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IC:RGD.
DR   GO; GO:0005623; C:cell; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; TAS:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0070509; P:calcium ion import; IDA:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IMP:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0035898; P:parathyroid hormone secretion; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; ISS:UniProtKB.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008344; TRPV5/TRPV6.
DR   InterPro; IPR008345; TRPV6_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01765; ECACCHANNEL.
DR   PRINTS; PR01766; ECACCHANNEL1.
DR   SMART; SM00248; ANK; 5.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    767       Transient receptor potential cation
FT                                channel subfamily V member 6.
FT                                /FTId=PRO_0000215356.
FT   TOPO_DOM      1    366       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27296226}.
FT   TRANSMEM    367    387       Helical. {ECO:0000269|PubMed:27296226}.
FT   TOPO_DOM    388    424       Extracellular.
FT                                {ECO:0000269|PubMed:27296226}.
FT   TRANSMEM    425    447       Helical. {ECO:0000269|PubMed:27296226}.
FT   TOPO_DOM    448    462       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27296226}.
FT   TRANSMEM    463    482       Helical. {ECO:0000269|PubMed:27296226}.
FT   TOPO_DOM    483    488       Extracellular.
FT                                {ECO:0000269|PubMed:27296226}.
FT   TRANSMEM    489    508       Helical. {ECO:0000269|PubMed:27296226}.
FT   TOPO_DOM    509    528       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    529    551       Helical. {ECO:0000269|PubMed:27296226}.
FT   INTRAMEM    565    584       Pore-forming.
FT                                {ECO:0000269|PubMed:27296226}.
FT   TRANSMEM    596    616       Helical. {ECO:0000269|PubMed:27296226}.
FT   TOPO_DOM    617    767       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27296226}.
FT   REPEAT       84    114       ANK 1. {ECO:0000255}.
FT   REPEAT      118    147       ANK 2. {ECO:0000255}.
FT   REPEAT      156    185       ANK 3. {ECO:0000255}.
FT   REPEAT      202    231       ANK 4. {ECO:0000255}.
FT   REPEAT      235    276       ANK 5. {ECO:0000255}.
FT   REPEAT      278    307       ANK 6. {ECO:0000255}.
FT   REGION      133    143       Interaction with calmodulin.
FT                                {ECO:0000250}.
FT   REGION      637    641       Interaction with S100A10. {ECO:0000250}.
FT   REGION      689    707       Interaction with calmodulin.
FT                                {ECO:0000250}.
FT   MOTIF       580    584       Selectivity filter.
FT                                {ECO:0000269|PubMed:27296226}.
FT   METAL       581    581       Calcium; shared with neighboring
FT                                subunits. {ECO:0000269|PubMed:27296226}.
FT   MOD_RES     201    201       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:17197020}.
FT   MOD_RES     202    202       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:17197020}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     201    201       Y->F: Prevents up-regulation of the
FT                                channel by phosphorylation; when
FT                                associated with F-202.
FT                                {ECO:0000269|PubMed:17197020}.
FT   MUTAGEN     202    202       Y->F: Prevents up-regulation of the
FT                                channel by phosphorylation; when
FT                                associated with F-201.
FT                                {ECO:0000269|PubMed:17197020}.
FT   HELIX        70     86       {ECO:0000244|PDB:5WO7}.
FT   HELIX        88     94       {ECO:0000244|PDB:5WO7}.
FT   HELIX        98    105       {ECO:0000244|PDB:5WO7}.
FT   TURN        106    108       {ECO:0000244|PDB:5WO8}.
FT   HELIX       122    128       {ECO:0000244|PDB:5WO7}.
FT   HELIX       132    141       {ECO:0000244|PDB:5WO7}.
FT   HELIX       143    146       {ECO:0000244|PDB:5WO7}.
FT   TURN        154    157       {ECO:0000244|PDB:5WO7}.
FT   HELIX       160    166       {ECO:0000244|PDB:5WO7}.
FT   HELIX       170    178       {ECO:0000244|PDB:5WO7}.
FT   HELIX       190    192       {ECO:0000244|PDB:5WO7}.
FT   HELIX       206    212       {ECO:0000244|PDB:5WO7}.
FT   HELIX       216    224       {ECO:0000244|PDB:5WO7}.
FT   HELIX       239    244       {ECO:0000244|PDB:5WO7}.
FT   HELIX       249    261       {ECO:0000244|PDB:5WO7}.
FT   STRAND      267    269       {ECO:0000244|PDB:5WO7}.
FT   TURN        271    273       {ECO:0000244|PDB:5WO7}.
FT   HELIX       282    289       {ECO:0000244|PDB:5WO7}.
FT   HELIX       292    300       {ECO:0000244|PDB:5WO7}.
FT   STRAND      303    309       {ECO:0000244|PDB:5WO7}.
FT   STRAND      312    317       {ECO:0000244|PDB:5WO7}.
FT   TURN        320    322       {ECO:0000244|PDB:5WO7}.
FT   STRAND      323    326       {ECO:0000244|PDB:5WO8}.
FT   TURN        327    329       {ECO:0000244|PDB:5WO7}.
FT   HELIX       331    337       {ECO:0000244|PDB:5WO7}.
FT   HELIX       341    346       {ECO:0000244|PDB:5WO7}.
FT   HELIX       352    361       {ECO:0000244|PDB:5WO7}.
FT   TURN        362    364       {ECO:0000244|PDB:5WO7}.
FT   HELIX       365    387       {ECO:0000244|PDB:5WO7}.
FT   HELIX       397    399       {ECO:0000244|PDB:5IWK}.
FT   TURN        401    404       {ECO:0000244|PDB:5WO7}.
FT   TURN        418    420       {ECO:0000244|PDB:5WO6}.
FT   HELIX       421    442       {ECO:0000244|PDB:5WO7}.
FT   HELIX       463    481       {ECO:0000244|PDB:5WO7}.
FT   TURN        482    484       {ECO:0000244|PDB:5WO7}.
FT   HELIX       487    489       {ECO:0000244|PDB:5IWK}.
FT   HELIX       490    501       {ECO:0000244|PDB:5WO7}.
FT   HELIX       504    510       {ECO:0000244|PDB:5WO7}.
FT   HELIX       515    530       {ECO:0000244|PDB:5WO7}.
FT   HELIX       533    552       {ECO:0000244|PDB:5WO7}.
FT   TURN        556    558       {ECO:0000244|PDB:5WO7}.
FT   HELIX       565    576       {ECO:0000244|PDB:5WO7}.
FT   STRAND      586    588       {ECO:0000244|PDB:5WO7}.
FT   HELIX       592    613       {ECO:0000244|PDB:5WO7}.
FT   TURN        614    617       {ECO:0000244|PDB:5WO7}.
FT   TURN        618    620       {ECO:0000244|PDB:5IWK}.
FT   HELIX       622    646       {ECO:0000244|PDB:5WO7}.
FT   STRAND      649    652       {ECO:0000244|PDB:5WO6}.
FT   STRAND      655    659       {ECO:0000244|PDB:5WO7}.
FT   STRAND      662    664       {ECO:0000244|PDB:5WO7}.
FT   STRAND      668    675       {ECO:0000244|PDB:5WO7}.
SQ   SEQUENCE   767 AA;  87362 MW;  2197726C2F583720 CRC64;
     MGPLQREGRP ALGDANVAPG SSPGGVWHQP QPPKDSAFHP MGWSLPKEKG LILCLWNKFC
     RWFHRRESWA QSRDEQNLLQ QKRIWESPLL LAAKENNVQA LIKLLKFEGC EVHQKGAMGE
     TALHIAALYD NLEAAMVLME AAPELVFEPM TSELYEGQTA LHIAVINQNV NLVRALLARG
     ASVSARATGS VFHYRPHNLI YYGEHPLSFA ACVGSEEIVR LLIEHGADIR AQDSLGNTVL
     HILILQPNKT FACQMYNLLL SYDGGDHLKS LELVPNNQGL TPFKLAGVEG NIVMFQHLMQ
     KRKHIQWTYG PLTSTLYDLT EIDSSGDDQS LLELIVTTKK REARQILDQT PVKELVSLKW
     KRYGRPYFCV LGAIYVLYII CFTMCCVYRP LKPRITNRTN PRDNTLLQQK LLQEAYVTPK
     DDLRLVGELV SIVGAVIILL VEIPDIFRLG VTRFFGQTIL GGPFHVIIVT YAFMVLVTMV
     MRLTNSDGEV VPMSFALVLG WCNVMYFARG FQMLGPFTIM IQKMIFGDLM RFCWLMAVVI
     LGFASAFYII FQTEDPDELG HFYDYPMALF STFELFLTII DGPANYDVDL PFMYSITYAA
     FAIIATLLML NLLIAMMGDT HWRVAHERDE LWRAQVVATT VMLERKLPRC LWPRSGICGR
     EYGLGDRWFL RVEDRQDLNR QRIRRYAQAF QQQDDLYSED LEKDSGEKLE MARPFGAYLS
     FPTPSVSRST SRSSTNWDRL RQGALRKDLQ GIINRGLEDG EGWEYQI
//
ID   TRPC2_MOUSE             Reviewed;        1172 AA.
AC   Q9R244; Q9ES59; Q9ES60; Q9R243;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   22-NOV-2017, entry version 152.
DE   RecName: Full=Short transient receptor potential channel 2;
DE            Short=TrpC2;
DE   AltName: Full=Transient receptor protein 2;
DE            Short=TRP-2;
DE            Short=mTrp2;
GN   Name=Trpc2; Synonyms=Trp2, Trrp2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=10051594; DOI=10.1073/pnas.96.5.2060;
RA   Vannier B., Peyton M., Boulay G., Brown D., Qin N., Jiang M., Zhu X.,
RA   Birnbaumer L.;
RT   "Mouse trp2, the homologue of the human trpc2 pseudogene, encodes
RT   mTrp2, a store depletion-activated capacitative Ca2+ entry channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2060-2064(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RX   PubMed=10998353; DOI=10.1042/0264-6021:3510115;
RA   Hofmann T., Schaefer M., Schultz G., Gudermann T.;
RT   "Cloning, expression and subcellular localization of two novel splice
RT   variants of mouse transient receptor potential channel 2.";
RL   Biochem. J. 351:115-122(2000).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11972034; DOI=10.1073/pnas.082127599;
RA   Leypold B.G., Yu C.R., Leinders-Zufall T., Kim M.M., Zufall F.,
RA   Axel R.;
RT   "Altered sexual and social behaviors in trp2 mutant mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:6376-6381(2002).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11823606; DOI=10.1126/science.1069259;
RA   Stowers L., Holy T.E., Meister M., Dulac C., Koentges G.;
RT   "Loss of sex discrimination and male-male aggression in mice deficient
RT   for TRP2.";
RL   Science 295:1493-1500(2002).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20596023; DOI=10.1038/nature09142;
RA   Haga S., Hattori T., Sato T., Sato K., Matsuda S., Kobayakawa R.,
RA   Sakano H., Yoshihara Y., Kikusui T., Touhara K.;
RT   "The male mouse pheromone ESP1 enhances female sexual receptive
RT   behaviour through a specific vomeronasal receptor.";
RL   Nature 466:118-122(2010).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24089208; DOI=10.1038/nature12579;
RA   Ferrero D.M., Moeller L.M., Osakada T., Horio N., Li Q., Roy D.S.,
RA   Cichy A., Spehr M., Touhara K., Liberles S.D.;
RT   "A juvenile mouse pheromone inhibits sexual behaviour through the
RT   vomeronasal system.";
RL   Nature 502:368-371(2013).
CC   -!- FUNCTION: Thought to form a receptor-activated non-selective
CC       calcium permeant cation channel. Probably is operated by a
CC       phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases or G-protein coupled receptors. May also be
CC       activated by intracellular calcium store depletion. Plays a role
CC       in mediating responsivity to pheromones that elicit aggressive and
CC       mating behaviors. Required for response to the Esp1 pheromone
CC       which enhances female sexual receptive behavior and to the Esp22
CC       pheromone which inhibits adult male mating behavior.
CC       {ECO:0000269|PubMed:11823606, ECO:0000269|PubMed:11972034,
CC       ECO:0000269|PubMed:20596023, ECO:0000269|PubMed:24089208}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=Q9R244-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9R244-2; Sequence=VSP_006562;
CC       Name=3; Synonyms=Alpha;
CC         IsoId=Q9R244-3; Sequence=VSP_006564;
CC       Name=4; Synonyms=Beta;
CC         IsoId=Q9R244-4; Sequence=VSP_006563, VSP_006565;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is ubiquitously expressed at low
CC       levels. Isoform 4 is expressed exclusively in vomeronasal organ.
CC   -!- DISRUPTION PHENOTYPE: Reduced electrophysiological response to
CC       pheromone mixtures in the vomeronasal organ. Mutant males and
CC       nursing females are docile and fail to initiate aggressive attacks
CC       on intruder males. Males display normal mating behavior towards
CC       females but display increased sexual behavior towards prepubescent
CC       females even when presented simultaneously with adult estrus
CC       females and also show increased sexual behavior towards juvenile
CC       and adult males. Lack of response to Esp1.
CC       {ECO:0000269|PubMed:11823606, ECO:0000269|PubMed:11972034,
CC       ECO:0000269|PubMed:20596023, ECO:0000269|PubMed:24089208}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF111108; AAD17196.1; -; mRNA.
DR   EMBL; AF111107; AAD17195.1; -; mRNA.
DR   EMBL; AF230803; AAG29951.1; -; mRNA.
DR   EMBL; AF230802; AAG29950.1; -; mRNA.
DR   CCDS; CCDS52333.1; -. [Q9R244-4]
DR   RefSeq; NP_001103367.1; NM_001109897.2. [Q9R244-4]
DR   UniGene; Mm.292904; -.
DR   ProteinModelPortal; Q9R244; -.
DR   SMR; Q9R244; -.
DR   CORUM; Q9R244; -.
DR   DIP; DIP-61090N; -.
DR   IntAct; Q9R244; 2.
DR   STRING; 10090.ENSMUSP00000081903; -.
DR   GuidetoPHARMACOLOGY; 487; -.
DR   iPTMnet; Q9R244; -.
DR   PhosphoSitePlus; Q9R244; -.
DR   PaxDb; Q9R244; -.
DR   PRIDE; Q9R244; -.
DR   DNASU; 22064; -.
DR   Ensembl; ENSMUST00000124189; ENSMUSP00000116934; ENSMUSG00000100254. [Q9R244-4]
DR   GeneID; 22064; -.
DR   KEGG; mmu:22064; -.
DR   UCSC; uc009iqm.2; mouse. [Q9R244-3]
DR   UCSC; uc009iqn.2; mouse. [Q9R244-2]
DR   UCSC; uc012fqr.2; mouse. [Q9R244-1]
DR   UCSC; uc012fqs.2; mouse. [Q9R244-4]
DR   CTD; 7221; -.
DR   MGI; MGI:109527; Trpc2.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000137678; -.
DR   HOVERGEN; HBG101351; -.
DR   InParanoid; Q9R244; -.
DR   KO; K04965; -.
DR   OrthoDB; EOG091G0KP0; -.
DR   PhylomeDB; Q9R244; -.
DR   PRO; PR:Q9R244; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000100254; -.
DR   Genevisible; Q9R244; MM.
DR   GO; GO:0032590; C:dendrite membrane; IMP:MGI.
DR   GO; GO:0012505; C:endomembrane system; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:MGI.
DR   GO; GO:0000139; C:Golgi membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005635; C:nuclear envelope; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005516; F:calmodulin binding; IDA:MGI.
DR   GO; GO:0003684; F:damaged DNA binding; IEA:InterPro.
DR   GO; GO:0019992; F:diacylglycerol binding; IMP:MGI.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IDA:MGI.
DR   GO; GO:0007340; P:acrosome reaction; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0008050; P:female courtship behavior; IMP:MGI.
DR   GO; GO:0002121; P:inter-male aggressive behavior; IMP:MGI.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0048047; P:mating behavior, sex discrimination; IMP:MGI.
DR   GO; GO:1902436; P:negative regulation of male mating behavior; IGI:MGI.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IPI:MGI.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
DR   GO; GO:0019236; P:response to pheromone; IMP:MGI.
DR   GO; GO:0000012; P:single strand break repair; IEA:InterPro.
DR   GO; GO:0002124; P:territorial aggressive behavior; IMP:MGI.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005458; TRPC2_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   InterPro; IPR002706; Xrcc1_N.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF6; PTHR10117:SF6; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   Pfam; PF01834; XRCC1_N; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01643; TRPCHANNEL2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1172       Short transient receptor potential
FT                                channel 2.
FT                                /FTId=PRO_0000215307.
FT   TOPO_DOM      1    659       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    660    680       Helical. {ECO:0000255}.
FT   TOPO_DOM    681    702       Extracellular. {ECO:0000255}.
FT   TRANSMEM    703    723       Helical. {ECO:0000255}.
FT   TOPO_DOM    724    738       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    739    759       Helical. {ECO:0000255}.
FT   TOPO_DOM    760    789       Extracellular. {ECO:0000255}.
FT   TRANSMEM    790    810       Helical. {ECO:0000255}.
FT   TOPO_DOM    811    833       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    834    854       Helical. {ECO:0000255}.
FT   TOPO_DOM    855    899       Extracellular. {ECO:0000255}.
FT   TRANSMEM    900    920       Helical. {ECO:0000255}.
FT   TOPO_DOM    921   1172       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      301    330       ANK 1.
FT   REPEAT      377    406       ANK 2.
FT   REPEAT      430    459       ANK 3.
FT   COMPBIAS   1140   1143       Poly-Ser.
FT   VAR_SEQ       1    111       MLMSRTDSKSGKNRSGVRMFKDGDFLTPASGESWDRLRLTC
FT                                SQPFTRHQSFGLAFLRVRSSLGSLADPVVDPSAPGSSGLNQ
FT                                NSTDVLESDPRPWLTNPSIRRTFFPDPQT -> MGTKTHPV
FT                                VPW (in isoform 2).
FT                                {ECO:0000303|PubMed:10051594}.
FT                                /FTId=VSP_006562.
FT   VAR_SEQ       2    287       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10998353}.
FT                                /FTId=VSP_006564.
FT   VAR_SEQ       2    283       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10998353}.
FT                                /FTId=VSP_006563.
FT   VAR_SEQ     284    287       LVPK -> DPLS (in isoform 4).
FT                                {ECO:0000303|PubMed:10998353}.
FT                                /FTId=VSP_006565.
FT   CONFLICT    628    628       K -> R (in Ref. 1; AAD17195/AAD17196).
FT                                {ECO:0000305}.
FT   CONFLICT    633    633       F -> S (in Ref. 1; AAD17195/AAD17196).
FT                                {ECO:0000305}.
FT   CONFLICT    653    653       Q -> R (in Ref. 2; AAG29951/AAG29950).
FT                                {ECO:0000305}.
FT   CONFLICT    774    774       Y -> C (in Ref. 1; AAD17195/AAD17196).
FT                                {ECO:0000305}.
FT   CONFLICT    797    797       A -> T (in Ref. 1; AAD17195/AAD17196).
FT                                {ECO:0000305}.
FT   CONFLICT   1161   1161       L -> P (in Ref. 2; AAG29951/AAG29950).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1172 AA;  130531 MW;  D9A9A9FEE01D1536 CRC64;
     MLMSRTDSKS GKNRSGVRMF KDGDFLTPAS GESWDRLRLT CSQPFTRHQS FGLAFLRVRS
     SLGSLADPVV DPSAPGSSGL NQNSTDVLES DPRPWLTNPS IRRTFFPDPQ TSTKEISELK
     GMLKQLQPGP LGRAARMVLS AARKAPPASV VSPNNSHGEP GPSRAESAEP RAEEPNRKTA
     VGRRKRRKVQ EPRRSLSNSS SQPNRRTGRT RQRQHRPQTK SDDGGVQAAG QCPICAGFFS
     IETLPQHAAT CGESPPPQPA SPASLSSSES VLRRHHVALT PVPLVPKPQP NWTEIVNKKL
     KFPPTLLRAI QEGQLGLVQQ LLESSSDASG AGPGGPLRNV EESEDRSWRE ALNLAIRLGH
     EVITDVLLAN VKFDFRQIHE ALLVAVDTNQ PAVVRRLLAR LEREKGRKVD TKSFSLAFFD
     SSIDGSRFAP GVTPLTLACQ KDLYEIAQLL MDQGHTIARP HPVSCACLEC SNARRYDLLK
     FSLSRINTYR GIASRAHLSL ASEDAMLAAF QLSRELRRLA RKEPEFKPQY IALESLCQDY
     GFELLGMCRN QSEVTAVLND LGEDSETEPE AEGLGQAFEE GIPNLARLRL AVNYNQKQFV
     AHPICQQVLS SIWCGNLAGW RGSTTIWKLF VAFLIFLTMP FLCIGYWLAP KSQLGRLLKI
     PVLKFLLHSA SYLWFLIFLL GESLVMETQL STFKGRSQSV WETSLHMIWV TGFLWFECKE
     VWIEGLRSYL LDWWNFLDVV ILSLYLASFA LRLLLAGLAY MHCRDASDST TCRYFTTAER
     SEWRTEDPQF LAEVLFAVTS MLSFTRLAYI LPAHESLGTL QISIGKMIDD MIRFMFILMI
     ILTAFLCGLN NIYVPYQESE KLGNFNETFQ FLFWTMFGME EHTVVDMPQF LVPEFVGRAM
     YGIFTIVMVI VLLNMLIAMI TNSFQKIEDD ADVEWKFARS KLYLSYFREG LTLPVPFNIL
     PSPKAAFYLV RRIFRFLCCG SSCCKAKKSD YPPIGTFTNP GARAGSAGEG ERVSYRLRVI
     KALVQRYIET ARREFEETRR KDLGNRLTEL TKTVSRLQSE VASVQKNLAA GGAPRPPDGA
     SILSRYITRV RNSFQNLGPP TSDTPAELTM PGIVETEVSL GDGLDGTGEA GAPAPGEPGS
     SSSAHVLVHR EQEAEGSGDL LLEGDLETKG ES
//
ID   RYR3_RABIT              Reviewed;        4872 AA.
AC   Q9TS33;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Ryanodine receptor 3;
DE            Short=RYR-3;
DE            Short=RyR3;
DE   AltName: Full=Brain ryanodine receptor-calcium release channel;
DE   AltName: Full=Brain-type ryanodine receptor;
DE   AltName: Full=Type 3 ryanodine receptor;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1330694; DOI=10.1016/0014-5793(92)80941-9;
RA   Hakamata Y., Nakai J., Takeshima H., Imoto K.;
RT   "Primary structure and distribution of a novel ryanodine
RT   receptor/calcium release channel from rabbit brain.";
RL   FEBS Lett. 312:229-235(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, REGULATION BY RYANODINE; CALMODULIN; CALCIUM LEVELS;
RP   MAGNESIUM; ATP; CAFFEINE AND RUTHENIUM RED, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=9305876; DOI=10.1074/jbc.272.39.24234;
RA   Chen S.R., Li X., Ebisawa K., Zhang L.;
RT   "Functional characterization of the recombinant type 3 Ca2+ release
RT   channel (ryanodine receptor) expressed in HEK293 cells.";
RL   J. Biol. Chem. 272:24234-24246(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), ALTERNATIVE
RP   SPLICING, FUNCTION, SUBUNIT, INTERACTION WITH RYR2, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=12471029; DOI=10.1074/jbc.M210410200;
RA   Jiang D., Xiao B., Li X., Chen S.R.;
RT   "Smooth muscle tissues express a major dominant negative splice
RT   variant of the type 3 Ca2+ release channel (ryanodine receptor).";
RL   J. Biol. Chem. 278:4763-4769(2003).
RN   [4]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF GLU-3885.
RX   PubMed=9614063; DOI=10.1074/jbc.273.24.14675;
RA   Chen S.R., Ebisawa K., Li X., Zhang L.;
RT   "Molecular identification of the ryanodine receptor Ca2+ sensor.";
RL   J. Biol. Chem. 273:14675-14678(1998).
RN   [5]
RP   FUNCTION, SUBUNIT, DOMAIN, INTERACTION WITH FKBP1A, SUBCELLULAR
RP   LOCATION, MEMBRANE TOPOLOGY, ELECTRON MICROSCOPY, REGULATION BY
RP   RYANODINE; CALCIUM LEVELS; MAGNESIUM; ATP AND CAFFEINE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10358090; DOI=10.1074/jbc.274.24.17297;
RA   Murayama T., Oba T., Katayama E., Oyamada H., Oguchi K., Kobayashi M.,
RA   Otsuka K., Ogawa Y.;
RT   "Further characterization of the type 3 ryanodine receptor (RyR3)
RT   purified from rabbit diaphragm.";
RL   J. Biol. Chem. 274:17297-17308(1999).
RN   [6]
RP   INTERACTION WITH RYR2, AND FUNCTION.
RX   PubMed=12213830; DOI=10.1074/jbc.M208210200;
RA   Xiao B., Masumiya H., Jiang D., Wang R., Sei Y., Zhang L.,
RA   Murayama T., Ogawa Y., Lai F.A., Wagenknecht T., Chen S.R.;
RT   "Isoform-dependent formation of heteromeric Ca2+ release channels
RT   (ryanodine receptors).";
RL   J. Biol. Chem. 277:41778-41785(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16176801; DOI=10.1016/j.bbrc.2005.09.027;
RA   Conti A., Reggiani C., Sorrentino V.;
RT   "Selective expression of the type 3 isoform of ryanodine receptor Ca2+
RT   release channel (RyR3) in a subset of slow fibers in diaphragm and
RT   cephalic muscles of adult rabbits.";
RL   Biochem. Biophys. Res. Commun. 337:195-200(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH CALM, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16274254; DOI=10.1021/bi051251t;
RA   Yamaguchi N., Xu L., Pasek D.A., Evans K.E., Chen S.R., Meissner G.;
RT   "Calmodulin regulation and identification of calmodulin binding region
RT   of type-3 ryanodine receptor calcium release channel.";
RL   Biochemistry 44:15074-15081(2005).
RN   [9]
RP   INTERACTION WITH SELENON, AND SUBCELLULAR LOCATION.
RX   PubMed=18713863; DOI=10.1073/pnas.0806015105;
RA   Jurynec M.J., Xia R., Mackrill J.J., Gunther D., Crawford T.,
RA   Flanigan K.M., Abramson J.J., Howard M.T., Grunwald D.J.;
RT   "Selenoprotein N is required for ryanodine receptor calcium release
RT   channel activity in human and zebrafish muscle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12485-12490(2008).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm in muscle and
CC       thereby plays a role in triggering muscle contraction. May
CC       regulate Ca(2+) release by other calcium channels. Calcium channel
CC       that mediates Ca(2+)-induced Ca(2+) release from the endoplasmic
CC       reticulum in non-muscle cells. Plays a role in cellular calcium
CC       signaling. Contributes to cellular calcium ion homeostasis.
CC       Isoform 2 lacks a predicted transmembrane segment and does not
CC       form functional calcium channels by itself; however, it can form
CC       tetramers with isoforms that contain the full complement of
CC       transmembrane segments and modulate their activity.
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12213830,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:9305876, ECO:0000269|PubMed:9614063}.
CC   -!- SUBUNIT: Homotetramer. Isoform 2 can form tetramers with isoform
CC       1. Heterotetramer with RYR2. Interacts with FKBP1A. Interacts with
CC       CALM. Interacts with SELENON (PubMed:18713863).
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12213830,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:18713863, ECO:0000269|PubMed:9614063}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-9542578, EBI-9542578;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane; Multi-pass
CC       membrane protein. Membrane; Multi-pass membrane protein. Microsome
CC       membrane; Multi-pass membrane protein. Sarcoplasmic reticulum
CC       {ECO:0000269|PubMed:18713863}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-
CC       terminus and C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9TS33-1; Sequence=Displayed;
CC       Name=2; Synonyms=AS-8a;
CC         IsoId=Q9TS33-2; Sequence=VSP_042306;
CC         Note=Lacks a predicted transmembrane segment and does not form
CC         functional calcium channels.;
CC       Name=3;
CC         IsoId=Q9TS33-3; Sequence=VSP_042305;
CC       Name=4;
CC         IsoId=Q9TS33-4; Sequence=VSP_042307;
CC   -!- TISSUE SPECIFICITY: Detected in skeletal muscle from young rabbits
CC       and in adult diaphragm muscle (at protein level). Detected in
CC       brain, especially in corpus striatum, thalamus and hippocampus.
CC       Detected in taenia coli, uterus, vas deferens, aorta, stomach,
CC       small intestine, heart, diaphragm and ureter. Isoform 2 is highly
CC       expressed in uterus and aorta, and at much lower levels in heart,
CC       brain and diaphragm. {ECO:0000269|PubMed:10358090,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:1330694,
CC       ECO:0000269|PubMed:16176801, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:9305876}.
CC   -!- DEVELOPMENTAL STAGE: Ubiquitous in skeletal muscle in neonates and
CC       in 15 day old rabbits. In adult, detected in diaphragm muscle, and
CC       in a subset of skeletal muscles including digastricus,
CC       pterygoideus, tongue and masseter. {ECO:0000269|PubMed:16176801}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305|PubMed:10358090}.
CC   -!- MISCELLANEOUS: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open calcium-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity. Channel activity is regulated by calmodulin
CC       (CALM). The calcium release is activated by elevated cytoplasmic
CC       calcium levels in the micromolar range, by caffeine and adenine
CC       nucleotides, such as AMP and ATP. Inhibited by Mg(2+) and
CC       ruthenium red.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X68650; CAC16153.1; -; mRNA.
DR   PIR; S27272; S27272.
DR   RefSeq; NP_001076231.1; NM_001082762.1. [Q9TS33-1]
DR   UniGene; Ocu.3278; -.
DR   ProteinModelPortal; Q9TS33; -.
DR   STRING; 9986.ENSOCUP00000024658; -.
DR   GeneID; 100009545; -.
DR   KEGG; ocu:100009545; -.
DR   CTD; 6263; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   KO; K04963; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; TAS:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0071286; P:cellular response to magnesium ion; IDA:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; NAS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 3.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Complete proteome; Endoplasmic reticulum;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Microsome; Receptor; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   4872       Ryanodine receptor 3.
FT                                /FTId=PRO_0000415649.
FT   TOPO_DOM      1   4188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4189   4209       Helical. {ECO:0000255}.
FT   TRANSMEM   4412   4432       Helical. {ECO:0000255}.
FT   TRANSMEM   4487   4507       Helical. {ECO:0000255}.
FT   TRANSMEM   4612   4632       Helical. {ECO:0000255}.
FT   TRANSMEM   4635   4655       Helical. {ECO:0000255}.
FT   TRANSMEM   4674   4694       Helical. {ECO:0000255}.
FT   INTRAMEM   4725   4734       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4755   4775       Helical. {ECO:0000255}.
FT   TOPO_DOM   4776   4872       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      100    155       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      162    207       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      215    269       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      275    333       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      343    400       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      585    796       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      840    953       1.
FT   REPEAT      954   1068       2.
FT   DOMAIN     1012   1208       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1254   1466       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2592   2710       3.
FT   REPEAT     2711   2823       4.
FT   REGION      840   2823       4 X approximate repeats.
FT   REGION     2325   2338       Interaction with FKBP1A. {ECO:0000250}.
FT   REGION     3472   3501       Interaction with CALM.
FT                                {ECO:0000269|PubMed:16274254}.
FT   SITE       3885   3885       Important for activation by Ca(2+).
FT   VAR_SEQ    3341   3345       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12471029,
FT                                ECO:0000303|PubMed:9305876}.
FT                                /FTId=VSP_042305.
FT   VAR_SEQ    4406   4434       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12471029}.
FT                                /FTId=VSP_042306.
FT   VAR_SEQ    4791   4841       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:12471029}.
FT                                /FTId=VSP_042307.
FT   MUTAGEN    3885   3885       E->A: Reduces calcium-sensitivity by over
FT                                10000-fold. {ECO:0000269|PubMed:9614063}.
SQ   SEQUENCE   4872 AA;  551929 MW;  D1DC6B85CD6B93E6 CRC64;
     MAEGGEGGED EIQFLRTEDE VVLQCIATVH KEQRKFCLAA EGLGNRLCFL EPTSEAKFIP
     PDLCVCNFVL EQSLSVRALQ EMLANTGENG GEGAAQGGGH RTLLYGHAIL LRHSFSGMYL
     TCLTTSRSQT DKLAFDVGLR EHATGEACWW TIHPASKQRS EGEKVRIGDD LILVSVSSER
     YLHLSISNGN IQVDASFMQT LWNVHPTCSG SSIEEGYLLG GHVVRLFHGH DECLTIPSTD
     QNDSQHRRIF YEAGGAGTRA RSLWRVEPLR ISWSGSNIRW GQAFRLRHLT TGHYLALTED
     QGLLLQDRGK ADTKSTAFSF RPSKETKEKL DSSHKRDIEG MGVPEIKYGD SVCFVQHIAS
     GLWVTYKAQD AKTSRLGPLK RKVILHQEGH MDDGLTLQRC QREESQAARI IRNTTALFSQ
     FVSGNNRTAA PVTLPIEEVL QTLHDLIAYF QPPEEEMQHE DKQNKLRSLK NRQNLFKEEG
     MLALVLNCID RLNIYNSVAH FAGIAREESG MAWKEVLSLL YKLLAALIRG NRNTCAQFSN
     NLDWLISKLD RLESSSGILE VLHCILIESP EALNLIAEGH IKSIISLLDK HGRNHKVLDV
     LCSLCLCNGV AVRANQNLIC DNLLPRRNLL LQTRLINDVT SIRPNIFLGV AEGSAQYKKW
     YFELIIDQVD PFLTAEPTHL RVGWASSSGY APYPGGGEGW GGNGVGDDLY SYGFDGLHLW
     SGRIPRAVAS INQHLLKSDD VVSCCLDLGV PSISFRINGQ PVQGMFENFN TDGLFFPVMS
     FSAGVKVRFL MGGRHGEFKF LPPSGYAPCY EALLPKEKMR LEPVKEYKRD AEGVRDLLGT
     TQFLSQASFI PCPIDTSQVV LPPHLEKIRD RLAENIHELW GMNKIELGWT FGKMRDDNKR
     QHPCLVEFSK LPETEKNYNL QMSTETLKTL LALGCHIAHV NPAAEEDLKK VKLPKNYMMS
     NGYKPAPLDL SDVKLLPPQE ILVDKLAENA HNVWAKDRIK QGWTYGIQQD LKNKRNPRLV
     PYALLDERTK KSNRDSLREA VRTFVGYGYN IEPSDQELAD PAVEKVSIDK IRFFRVERSY
     AVRSGKWYFE FEVVTGGDMR VGWARPGCRP DIELGPMTKP LCLKAAGASV GTKVVGILGV
     PWQPGDVVGC MINLDDASMI FTLNGELLIT NKGSELAFAD YEIENGFVPI CSLGLSQIGR
     MNLGTDASTF KFYTMCGLQE GFEPFAVNMN RDVAMWFSKR LPTFVNVPKD HPHIEVVRID
     GTMDSPPCLK VTHKTFGTQN SNANMIYCRL SMPVECHSSF SHSPCLDSEA FQKRKQMQEI
     LSHTTTQCFY SIRIFAGQDP SCVWVGWVTP DYHLYSEKFD LNKNCTVTVT LGDERGRVHE
     SVKRSNCYMV WGGDVVASSQ RSSRSNVDLE IGCLVDLAMG MLSFSANGKE LGTCYQVEPN
     TKVFPAVFLQ PTSTSLFQFE LGKLKNAMPL SAAIFKSEEK NPVPQCPPRL DVQTIQPVLW
     SRMPNSFLKV ETERVSERHG WVVQCLEPLQ MMALHIPEEN RCVDILELCE QEDLMQFHYH
     TLRLYSAVCA LGNSRVAYAL CSHVDLSQLF HAIDNKYLPG LLRSGFYDLL ISIHLANAKE
     RKLMMKNEYI IPITSTTRNI RLYPDESKKH GLPGVGPRTC LKPGFKFSTP CFVVTNEERQ
     KQSPEIPLEI LKMKALSMLT EAVQCSGAHI RDPVGGSVEF QFVPVLKLVG TLLVMGVFCD
     DDVRQILLLI DPSVFGEHSA DTEEGAEKEE VSQVEEKAVE AGEKTSKEAR KEAPVRGLLQ
     TRLPESVKLQ MCELLSYLCD CELQHRVEAI VAFGDIYVSK LQANQKFRYN ELMQALNMSA
     ALTARKTREF RSPPQEQINM LLNFQLGENC PCPEEIREEL YDFHEDLLVH CGVPLEEEEE
     EEEDTSWTGK LRTLVYKIKG PPKPEKEQPT EEEERCPTTL KELISQTMIR WAQEDQIQDA
     ELVRMMFNLL RRQYDSIGEL LQALRKTYTI SHASVSDTIN LLAALGQIRS LLSVRMGREE
     ELLMINGLGD IMNNKVFYQH PNLMRVLGMH ETVMEVMVNV LGTEKSQIAF PKMVASCCRF
     LCYFCRISRQ NQKAMFEHLS YLLENSSVGL ASPSMRGSTP LDVAASSVMD NNELALGLEE
     PDLEKVVTYL AGCGLQSCPM LLAKGYPDVG WNPIEGERYL SFLRFAVFVN SESVEENASV
     VVKLLIRRPE CFGPALRGEG GNGLLAAMQG AIKISESPAL DLPSQGYKRE VPEDGEEEEE
     IVHMGNAIMS FYSALIDLLG RCAPEMHLIQ TGKGEAIRIR SILRSLVPTE DLVGIISIPL
     KLPSLNKDGS VSEPDMAANF CPDHKAPMVL FLDRVYGIKD QTFLLHLLEV GFLPDLRASA
     SLDTVALSTT ESALALNRYI CSAVLPLLTR CAPLFAGTEH YTSLIDSTLQ TIYRLSKGRS
     LTKAQRDTIE ECLLAICNHL RPSMLQQLLR RLVFDVPQLN DYCKMPLKLL TNHFEQCWKY
     YCLPSGWGSY GLAVEEELHL TEKLFWGIFD SLSHKKYDPD LFRMSLPCLS AIAGALPPDY
     LDTRITATLE KQVSVDADGN FDPKPINTIN FSLPEKLEYI VTKYAEHSHD KWACEKSQSG
     WKYGISLDEN VKTHPLIRPF KTLTEKEKEI YRWPARESLK TMLAVGWTVE RTKEGEALVQ
     LRENEKLRSV SQTSQGNSYN PAPLDLSNVV LSRELQGMVE VVAENYHNIW AKKKKLELES
     KGGGSHPLLV PYDTLTAKEK FRDREKAQDL FKFLQVNGVI VSRGMKDMEL DAFSMEKRFA
     YKFLKKILKY VDSAQEFIAH LEAIVSSGKT EKSPHDQEIK FFAKVLLPLV DQYFTNHRLY
     FLSSPLKPLS SSGYASHKEK EMVASLFCKL AALVRHRISL FGSDSTTMVS CLHILAQTLD
     TRTVMKSGSE LVKAGLRAFF ESAAEDLEKT SENLKLGKFT HSRTQIKGVS QNINYTTVAL
     LPILTSIFEH VAQHQFGVDL LLGDVQISCY RILCSLYSLG TGKNIYVERQ RPALGECLAS
     LAAAIPVAFL EPTLNRYNAL SVFNTKTPRE RSILGMPDTV EEMCPDIPQL EGLMKEINDL
     AESGARYTEM PHVIEVILPM LCNYLSYWWE RGPENLSPST GPCCSKVTSE HLSLILGNIL
     KIINNNLGID EASWMKRIAV YAQPIISKAR PDLLRSHFIP TLEKLKKKAV KTVQEEEQLK
     ADGKGDTQEA ELLILDEFAI LCRDLYAFYP MLIRYVDNNR SNWLKSPDGD SDQLFRMVAE
     VFILWCKSHN FKREEQNFVI QNEINNLAFL TGDSKSKMSK AMQVKSGGQD QERKKTKRRG
     DLYSIQTSLI VAALKKMLPI GLNMCTPGDQ ELISLAKSRY SYRDTDEEVK EHLRNNLHLQ
     EKSDDPAVKW QLNLYKDVLK SEEPSNPEKT VERVQRISAA VFHLEQVEQP LRSKKAVWHK
     LLSKQRKRAV VACFRMAPLY NLPRHRSINL FLHGYQRFWI ETEEYSFEEK LVQDLAKSPK
     VEEEEEEEME KQPDPLHQII LHFSRNALTE RSKLEDDPLY TSYSSMMAKS CQSGEDEEEE
     DKEKTFEEKE MEKQKTLYQQ ARLHERGAAE MVLQMISASK GEMSPMVVET LKLGIAILNG
     GNAGVQQKML DYLKVKKDAG FFQSLSGLMQ SCSVLDLNAF ERQNKAEGLG MVTEEGTLIV
     RERGEKVLQN DEFTRDLFRF LQLLCEGHNS DFQNFLRTQM GNTTTVNVII STVDYLLRLQ
     ESISDFYWYY SGKDIIDESG QHNFSKALAV TKQIFNSLTE YIQGPCIGNQ QSLAHSRLWD
     AVVGFLHVFA NMQMKLSQDS SQIELLKELL DLLQDMVVML LSLLEGNVVN GTIGKQMVDT
     LVESSTNVEM ILKFFDMFLK LKDLTSSDTF KEYDPDGKGI ISKKEFQKAM EGQKQYTQSE
     IDFLLSCAEA DENDMFNYID FVDRFHEPAK DIGFNVAVLL TNLSEHMPND SRLKCLLDPA
     ESVLNYFEPY LGRIEIMGGA KKIERVYFEI SESSRTQWEK PQVKESKRQF IFDVVNEGGE
     QEKMELFVNF CEDTIFEMQL ASQISESDSA DRPEEEEGDE ESSYVLEING EEEEDKSFES
     ASAFAMACAS LKRNITNLLR KATLKNLRKQ YRNVKKMTAK ELVKVFFSFF WMLFVGLFQL
     FFTIVGGIFQ ILWSTVFGGG LVEGAKNIRV TKILGDMPDP TQFGIHDDAM EAERAEVAEA
     GITTELVHFV KGERGDTELM SDLFGLHPKK EGGVKHGPEV GLGDLSEIIG KDEPPTLEST
     VRKKRKAQAA ETKAEHEAEG KVESEKADLE DGEKEDKAKE EERAEYLWAE VTKKKKRRRG
     QKVEKPEAFM ANFFKGLEIY QTKLLHYLAR NFYNLRFLAL FVAFAINFIL LFYKVTEEPL
     EEETEDVANL WNSLNDEEEE EAMVFFVLQE STGYMAPTLR ALAVVHTIIS LVCVVGYYCL
     KVPLVVFKRE KEIARKLEFD GLYITEQPSE DDIKGQWDRL VINTPSFPHN YWDKFVKRKV
     INKYGDLYGA ERIAELLGLD KNALDFSPVE ETTAEAASLV SWLSSIDMKY HIWKLGVVFT
     DNSFLYLAWY TTMSVLGHYN NFFFAAHLLD IAMGFKTLRT ILSSVTHNGK QLVLTVGLLA
     VVVYLYTVVA FNFFRKFYNK SEDDDEPDMK CDDMMTCYLF HMYVGVRAGG GIGDEIEDPA
     GDPYEMYRIV FDITFFFFVI VILLAIIQGL IIDAFGELRD QQEQVREDME TKCFICGIGN
     DYFDTTPHGF ETHTLQEHNL ANYLFFLMYL INKDETEHTG QESYVWKMYQ ERCWDFFPAG
     DCFRKQYEDQ LG
//
ID   CRCM1_DROME             Reviewed;         351 AA.
AC   Q9U6B8; B7YZJ7; Q0E937; Q1HCN1; Q7JQY5; Q7KRH6; Q8IGA6; Q9V892;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   20-DEC-2017, entry version 123.
DE   RecName: Full=Calcium release-activated calcium channel protein 1;
DE   AltName: Full=Protein orai;
DE   AltName: Full=dOrai;
GN   Name=olf186-F; Synonyms=CRACM1, olf186; ORFNames=CG11430;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Embryo;
RX   PubMed=16751269; DOI=10.1073/pnas.0603161103;
RA   Zhang S.L., Yeromin A.V., Zhang X.H.-F., Yu Y., Safrina O., Penna A.,
RA   Roos J., Stauderman K.A., Cahalan M.D.;
RT   "Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate
RT   Ca2+ release-activated Ca2+ channel activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9357-9362(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   STRAIN=Canton-S; TISSUE=Head;
RA   Chodagam S., Tickoo S.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND E).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E.,
RA   George R.A., Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G.,
RA   Miranda A., Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S.,
RA   Patel S., Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M.,
RA   Celniker S.E.;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION.
RX   PubMed=16582901; DOI=10.1038/nature04702;
RA   Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.-H., Tanasa B.,
RA   Hogan P.G., Lewis R.S., Daly M., Rao A.;
RT   "A mutation in Orai1 causes immune deficiency by abrogating CRAC
RT   channel function.";
RL   Nature 441:179-185(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=16645049; DOI=10.1126/science.1127883;
RA   Vig M., Peinelt C., Beck A., Koomoa D.L., Rabah D.,
RA   Koblan-Huberson M., Kraft S., Turner H., Fleig A., Penner R.,
RA   Kinet J.-P.;
RT   "CRACM1 is a plasma membrane protein essential for store-operated Ca2+
RT   entry.";
RL   Science 312:1220-1223(2006).
CC   -!- FUNCTION: Ca(2+) release-activated Ca(2+) (CRAC) channel subunit
CC       which mediates Ca(2+) influx following depletion of intracellular
CC       Ca(2+) stores. Regulates transcription factor NFAT nuclear import.
CC       {ECO:0000269|PubMed:16582901, ECO:0000269|PubMed:16645049}.
CC   -!- INTERACTION:
CC       Self; NbExp=8; IntAct=EBI-118501, EBI-118501;
CC       P83094:Stim; NbExp=4; IntAct=EBI-118501, EBI-109721;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A {ECO:0000312|FlyBase:FBgn0041585}; Synonyms=B
CC       {ECO:0000312|FlyBase:FBgn0041585}, F
CC       {ECO:0000312|FlyBase:FBgn0041585};
CC         IsoId=Q9U6B8-1; Sequence=Displayed;
CC       Name=E {ECO:0000312|FlyBase:FBgn0041585}; Synonyms=G
CC       {ECO:0000312|FlyBase:FBgn0041585};
CC         IsoId=Q9U6B8-3; Sequence=VSP_018313;
CC         Note=No experimental confirmation available.;
CC       Name=C {ECO:0000305};
CC         IsoId=Q9U6B8-4; Sequence=VSP_021772, VSP_021773;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: In Greek mythology, the 'Orai' are the keepers of
CC       the gates of heaven: Eunomia (order or harmony), Dike (justice)
CC       and Eirene (peace).
CC   -!- SIMILARITY: Belongs to the Orai family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ503470; ABF54966.1; -; mRNA.
DR   EMBL; AF188634; AAF01457.1; -; mRNA.
DR   EMBL; AE013599; AAF57780.2; -; Genomic_DNA.
DR   EMBL; AE013599; AAS64814.2; -; Genomic_DNA.
DR   EMBL; AE013599; ACL83150.1; -; Genomic_DNA.
DR   EMBL; AE013599; AGB93595.1; -; Genomic_DNA.
DR   EMBL; AY071273; AAL48895.1; -; mRNA.
DR   EMBL; BT001876; AAN71648.1; -; mRNA.
DR   EMBL; BT003591; AAO39594.1; -; mRNA.
DR   RefSeq; NP_001137696.1; NM_001144224.2. [Q9U6B8-3]
DR   RefSeq; NP_001261063.1; NM_001274134.1. [Q9U6B8-3]
DR   RefSeq; NP_611273.1; NM_137429.3. [Q9U6B8-1]
DR   RefSeq; NP_725727.1; NM_170626.2. [Q9U6B8-1]
DR   RefSeq; NP_995881.2; NM_206159.2. [Q9U6B8-1]
DR   UniGene; Dm.7627; -.
DR   PDB; 4HKR; X-ray; 3.35 A; A/B=133-341.
DR   PDB; 4HKS; X-ray; 3.35 A; A/B=133-341.
DR   PDBsum; 4HKR; -.
DR   PDBsum; 4HKS; -.
DR   ProteinModelPortal; Q9U6B8; -.
DR   SMR; Q9U6B8; -.
DR   BioGrid; 62725; 3.
DR   DIP; DIP-59770N; -.
DR   IntAct; Q9U6B8; 1.
DR   MINT; MINT-1600663; -.
DR   STRING; 7227.FBpp0113106; -.
DR   TCDB; 1.A.52.1.5; the ca(2+) release-activated ca(2+) (crac) channel (crac-c) family.
DR   PaxDb; Q9U6B8; -.
DR   PRIDE; Q9U6B8; -.
DR   EnsemblMetazoa; FBtr0086795; FBpp0085974; FBgn0041585. [Q9U6B8-1]
DR   EnsemblMetazoa; FBtr0086797; FBpp0085976; FBgn0041585. [Q9U6B8-1]
DR   EnsemblMetazoa; FBtr0114614; FBpp0113106; FBgn0041585. [Q9U6B8-3]
DR   EnsemblMetazoa; FBtr0336698; FBpp0307679; FBgn0041585. [Q9U6B8-1]
DR   EnsemblMetazoa; FBtr0336699; FBpp0307680; FBgn0041585. [Q9U6B8-3]
DR   GeneID; 37040; -.
DR   KEGG; dme:Dmel_CG11430; -.
DR   CTD; 37040; -.
DR   FlyBase; FBgn0041585; olf186-F.
DR   eggNOG; KOG4298; Eukaryota.
DR   eggNOG; ENOG4110DSB; LUCA.
DR   GeneTree; ENSGT00390000015354; -.
DR   InParanoid; Q9U6B8; -.
DR   KO; K16056; -.
DR   OMA; FSKPRRI; -.
DR   OrthoDB; EOG091G0E4P; -.
DR   GenomeRNAi; 37040; -.
DR   PRO; PR:Q9U6B8; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0041585; -.
DR   ExpressionAtlas; Q9U6B8; differential.
DR   Genevisible; Q9U6B8; DM.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IMP:FlyBase.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0051533; P:positive regulation of NFAT protein import into nucleus; IMP:UniProtKB.
DR   GO; GO:0002115; P:store-operated calcium entry; IMP:FlyBase.
DR   InterPro; IPR012446; CRAC_channel.
DR   PANTHER; PTHR31501; PTHR31501; 1.
DR   Pfam; PF07856; Orai-1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    351       Calcium release-activated calcium channel
FT                                protein 1.
FT                                /FTId=PRO_0000234388.
FT   TOPO_DOM      1    163       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    164    181       Helical. {ECO:0000255}.
FT   TOPO_DOM    182    191       Extracellular. {ECO:0000255}.
FT   TRANSMEM    192    212       Helical. {ECO:0000255}.
FT   TOPO_DOM    213    248       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical. {ECO:0000255}.
FT   TOPO_DOM    270    277       Extracellular. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    351       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    109    114       Poly-Pro.
FT   VAR_SEQ       1    121       MSVWTTANNSGLETPTKSPITSSVPRAARSSAVITTGNHQQ
FT                                HHFQHVVAAAVAAATSVATGHQFQQQFPLHAHPHPQHHSNS
FT                                PTGSGSNSNNSAGFQRTSISNSLLQFPPPPPPSSQNQAK
FT                                -> MPPFEEGESKPEEQIPLKPPRRHKKMKSADQEAAQTPA
FT                                EDHEEEQLLPGSGTSNLRYARANLSQSSLMLSHQQGSFESS
FT                                TERTASSETLDVMPISRRYQVHPQPNRLGIRQPASALASAL
FT                                HATARLAASVDAYTAAATATAATGDYGDYMRPQPNLGHAHQ
FT                                LPLTQTTQTAQPLHHQLPAHQLGNLRASNFVGSSRYLYHSQ
FT                                FNSNSPQTRRFTAQRDGSPAYAASVAAASAAAAASAVAPIA
FT                                PLAPLASIASPPFAAQPPPFQLRTYQQNQSYRFQ (in
FT                                isoform E).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_018313.
FT   VAR_SEQ     122    132       PRGHHRTASSS -> AGRTVQIDCRI (in isoform
FT                                C). {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_021772.
FT   VAR_SEQ     133    351       Missing (in isoform C).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_021773.
FT   CONFLICT     28     28       A -> S (in Ref. 1; ABF54966).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       H -> HPH (in Ref. 1; ABF54966).
FT                                {ECO:0000305}.
FT   HELIX       145    179       {ECO:0000244|PDB:4HKR}.
FT   HELIX       192    215       {ECO:0000244|PDB:4HKR}.
FT   TURN        216    218       {ECO:0000244|PDB:4HKR}.
FT   HELIX       237    271       {ECO:0000244|PDB:4HKR}.
FT   TURN        272    274       {ECO:0000244|PDB:4HKR}.
FT   HELIX       276    285       {ECO:0000244|PDB:4HKR}.
FT   HELIX       287    306       {ECO:0000244|PDB:4HKR}.
FT   HELIX       308    331       {ECO:0000244|PDB:4HKR}.
SQ   SEQUENCE   351 AA;  38507 MW;  328A586D251D3335 CRC64;
     MSVWTTANNS GLETPTKSPI TSSVPRAARS SAVITTGNHQ QHHFQHVVAA AVAAATSVAT
     GHQFQQQFPL HAHPHPQHHS NSPTGSGSNS NNSAGFQRTS ISNSLLQFPP PPPPSSQNQA
     KPRGHHRTAS SSMSQSGEDL HSPTYLSWRK LQLSRAKLKA SSKTSALLSG FAMVAMVEVQ
     LDHDTNVPPG MLIAFAICTT LLVAVHMLAL MISTCILPNI ETVCNLHSIS LVHESPHERL
     HWYIETAWAF STLLGLILFL LEIAILCWVK FYDLSPPAAW SACVVLIPVM IIFMAFAIHF
     YRSLVSHKYE VTVSGIRELE MLKEQMEQDH LEHHNNIRNN GMNYGASGDI V
//
ID   CCG4_HUMAN              Reviewed;         327 AA.
AC   Q9UBN1; B2RCK0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 143.
DE   RecName: Full=Voltage-dependent calcium channel gamma-4 subunit;
DE   AltName: Full=Neuronal voltage-gated calcium channel gamma-4 subunit;
DE   AltName: Full=Transmembrane AMPAR regulatory protein gamma-4;
DE            Short=TARP gamma-4;
GN   Name=CACNG4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10613843; DOI=10.1101/gr.9.12.1204;
RA   Burgess D.L., Davis C.F., Gefrides L.A., Noebels J.L.;
RT   "Identification of three novel Ca(2+) channel gamma subunit genes
RT   reveals molecular diversification by tandem and chromosome
RT   duplication.";
RL   Genome Res. 9:1204-1213(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Black J.L. III, Lennon V.A.;
RT   "Identification of the Homo sapiens putative voltage-gated calcium
RT   channel gamma-4 subunit.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=21172611; DOI=10.1016/j.neuron.2010.11.026;
RA   Kato A.S., Gill M.B., Ho M.T., Yu H., Tu Y., Siuda E.R., Wang H.,
RA   Qian Y.W., Nisenbaum E.S., Tomita S., Bredt D.S.;
RT   "Hippocampal AMPA receptor gating controlled by both TARP and
RT   cornichon proteins.";
RL   Neuron 68:1082-1096(2010).
CC   -!- FUNCTION: Regulates the trafficking and gating properties of AMPA-
CC       selective glutamate receptors (AMPARs). Promotes their targeting
CC       to the cell membrane and synapses and modulates their gating
CC       properties by slowing their rates of activation, deactivation and
CC       desensitization and by mediating their resensitization. Does not
CC       show subunit-specific AMPA receptor regulation and regulates all
CC       AMPAR subunits. Thought to stabilize the calcium channel in an
CC       inactivated (closed) state. {ECO:0000269|PubMed:21172611}.
CC   -!- SUBUNIT: The L-type calcium channel is composed of five subunits:
CC       alpha-1, alpha-2/delta, beta and gamma. Acts as an auxiliary
CC       subunit for AMPA-selective glutamate receptors (AMPARs). Found in
CC       a complex with GRIA1, GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG3, CACNG5, CACNG7 and CACNG8 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. CACNG
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF142625; AAF03090.1; -; Genomic_DNA.
DR   EMBL; AF142622; AAF03090.1; JOINED; Genomic_DNA.
DR   EMBL; AF142623; AAF03090.1; JOINED; Genomic_DNA.
DR   EMBL; AF142624; AAF03090.1; JOINED; Genomic_DNA.
DR   EMBL; AF162692; AAF14538.1; -; mRNA.
DR   EMBL; AK315149; BAG37597.1; -; mRNA.
DR   EMBL; CH471099; EAW89020.1; -; Genomic_DNA.
DR   EMBL; BC034532; AAH34532.1; -; mRNA.
DR   CCDS; CCDS11667.1; -.
DR   RefSeq; NP_055220.1; NM_014405.3.
DR   UniGene; Hs.514423; -.
DR   ProteinModelPortal; Q9UBN1; -.
DR   SMR; Q9UBN1; -.
DR   BioGrid; 117994; 18.
DR   STRING; 9606.ENSP00000262138; -.
DR   ChEMBL; CHEMBL2363032; -.
DR   TCDB; 8.A.16.2.3; the ca(+) channel auxiliary subunit Gama1-Gama8 (ccaGama) family.
DR   iPTMnet; Q9UBN1; -.
DR   PhosphoSitePlus; Q9UBN1; -.
DR   BioMuta; CACNG4; -.
DR   DMDM; 10719940; -.
DR   PaxDb; Q9UBN1; -.
DR   PeptideAtlas; Q9UBN1; -.
DR   PRIDE; Q9UBN1; -.
DR   DNASU; 27092; -.
DR   Ensembl; ENST00000262138; ENSP00000262138; ENSG00000075461.
DR   GeneID; 27092; -.
DR   KEGG; hsa:27092; -.
DR   UCSC; uc002jft.3; human.
DR   CTD; 27092; -.
DR   DisGeNET; 27092; -.
DR   EuPathDB; HostDB:ENSG00000075461.5; -.
DR   GeneCards; CACNG4; -.
DR   HGNC; HGNC:1408; CACNG4.
DR   HPA; HPA005803; -.
DR   HPA; HPA065370; -.
DR   MIM; 606404; gene.
DR   neXtProt; NX_Q9UBN1; -.
DR   OpenTargets; ENSG00000075461; -.
DR   PharmGKB; PA26018; -.
DR   eggNOG; ENOG410IJYN; Eukaryota.
DR   eggNOG; ENOG4111W1R; LUCA.
DR   GeneTree; ENSGT00550000074547; -.
DR   HOGENOM; HOG000233440; -.
DR   HOVERGEN; HBG003682; -.
DR   InParanoid; Q9UBN1; -.
DR   KO; K04869; -.
DR   OMA; ICNGTNL; -.
DR   OrthoDB; EOG091G0D2Z; -.
DR   PhylomeDB; Q9UBN1; -.
DR   TreeFam; TF327980; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-399719; Trafficking of AMPA receptors.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   Reactome; R-HSA-5682910; LGI-ADAM interactions.
DR   GeneWiki; CACNG4; -.
DR   GenomeRNAi; 27092; -.
DR   PRO; PR:Q9UBN1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000075461; -.
DR   CleanEx; HS_CACNG4; -.
DR   ExpressionAtlas; Q9UBN1; baseline and differential.
DR   Genevisible; Q9UBN1; HS.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; ISS:UniProtKB.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0036477; C:somatodendritic compartment; IEA:Ensembl.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0016247; F:channel regulator activity; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0051899; P:membrane depolarization; TAS:Reactome.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR005423; VDCC_g4su.
DR   InterPro; IPR008368; VDCC_gsu.
DR   PANTHER; PTHR12107:SF7; PTHR12107:SF7; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01792; VDCCGAMMA.
DR   PRINTS; PR01603; VDCCGAMMA4.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    327       Voltage-dependent calcium channel gamma-4
FT                                subunit.
FT                                /FTId=PRO_0000164678.
FT   TOPO_DOM      1      9       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     10     30       Helical. {ECO:0000255}.
FT   TOPO_DOM     31    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    136       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TOPO_DOM    158    186       Extracellular. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    327       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JJV4}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   327 AA;  36579 MW;  79630ACC03B1DAE6 CRC64;
     MVRCDRGLQM LLTTAGAFAA FSLMAIAIGT DYWLYSSAHI CNGTNLTMDD GPPPRRARGD
     LTHSGLWRVC CIEGIYKGHC FRINHFPEDN DYDHDSSEYL LRIVRASSVF PILSTILLLL
     GGLCIGAGRI YSRKNNIVLS AGILFVAAGL SNIIGIIVYI SSNTGDPSDK RDEDKKNHYN
     YGWSFYFGAL SFIVAETVGV LAVNIYIEKN KELRFKTKRE FLKASSSSPY ARMPSYRYRR
     RRSRSSSRST EASPSRDVSP MGLKITGAIP MGELSMYTLS REPLKVTTAA SYSPDQEASF
     LQVHDFFQQD LKEGFHVSML NRRTTPV
//
ID   TRPC4_HUMAN             Reviewed;         977 AA.
AC   Q9UBN4; B1ALE0; B1ALE1; B1ALE2; Q15721; Q3SWS6; Q96P03; Q96P04;
AC   Q96P05; Q9UIB0; Q9UIB1; Q9UIB2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 170.
DE   RecName: Full=Short transient receptor potential channel 4;
DE            Short=TrpC4;
DE   AltName: Full=Trp-related protein 4;
DE            Short=hTrp-4;
DE            Short=hTrp4;
GN   Name=TRPC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA).
RC   TISSUE=Kidney;
RX   PubMed=11042129; DOI=10.1042/bj3510735;
RA   McKay R.R., Szymeczek-Seay C.L., Lievremont J.-P., Bird G.S., Zitt C.,
RA   Juengling E., Lueckhoff A., Putney J.W. Jr.;
RT   "Cloning and expression of the human transient receptor potential 4
RT   (TRP4) gene: localization and functional expression of human TRP4 and
RT   TRP3.";
RL   Biochem. J. 351:735-746(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA; DELTA AND GAMMA).
RC   TISSUE=Embryonic kidney;
RX   PubMed=11163362; DOI=10.1016/S0014-5793(00)02362-0;
RA   Mery L., Magnino F., Schmidt K., Krause K.-H., Dufour J.-F.;
RT   "Alternative splice variants of hTrp4 differentially interact with the
RT   C-terminal portion of the inositol 1,4,5-trisphosphate receptors.";
RL   FEBS Lett. 487:377-383(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA; EPSILON; ETA AND
RP   ZETA), AND SUBCELLULAR LOCATION.
RX   PubMed=11713258; DOI=10.1074/jbc.M109850200;
RA   Schaefer M., Plant T.D., Stresow N., Albrecht N., Schultz G.;
RT   "Functional differences between TRPC4 splice variants.";
RL   J. Biol. Chem. 277:3752-3759(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 514-633.
RC   TISSUE=Kidney;
RX   PubMed=8646775; DOI=10.1016/S0092-8674(00)81233-7;
RA   Zhu X., Jiang M., Peyton M., Boulay G., Hurst R., Stefani E.,
RA   Birnbaumer L.;
RT   "trp, a novel mammalian gene family essential for agonist-activated
RT   capacitative Ca2+ entry.";
RL   Cell 85:661-671(1996).
RN   [8]
RP   MUTAGENESIS OF 975-THR--LEU-977, INTERACTION WITH SLC9A3R1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12154080;
RA   Mery L., Strauss B., Dufour J.F., Krause K.H., Hoth M.;
RT   "The PDZ-interacting domain of TRPC4 controls its localization and
RT   surface expression in HEK293 cells.";
RL   J. Cell Sci. 115:3497-3508(2002).
RN   [9]
RP   SUBUNIT.
RX   PubMed=12032305; DOI=10.1073/pnas.102596199;
RA   Hofmann T., Schaefer M., Schultz G., Gudermann T.;
RT   "Subunit composition of mammalian transient receptor potential
RT   channels in living cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7461-7466(2002).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EPB41L2.
RX   PubMed=16254212; DOI=10.1161/01.RES.0000193597.65217.00;
RA   Cioffi D.L., Wu S., Alexeyev M., Goodman S.R., Zhu M.X., Stevens T.;
RT   "Activation of the endothelial store-operated ISOC Ca2+ channel
RT   requires interaction of protein 4.1 with TRPC4.";
RL   Circ. Res. 97:1164-1172(2005).
RN   [11]
RP   INTERACTION WITH MX1.
RX   PubMed=15757897; DOI=10.1074/jbc.M500391200;
RA   Lussier M.P., Cayouette S., Lepage P.K., Bernier C.L., Francoeur N.,
RA   St-Hilaire M., Pinard M., Boulay G.;
RT   "MxA, a member of the dynamin superfamily, interacts with the ankyrin-
RT   like repeat domain of TRPC.";
RL   J. Biol. Chem. 280:19393-19400(2005).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-959 AND
RP   TYR-972, AND MUTAGENESIS OF TYR-959 AND TYR-972.
RX   PubMed=16144838; DOI=10.1074/jbc.M503646200;
RA   Odell A.F., Scott J.L., Van Helden D.F.;
RT   "Epidermal growth factor induces tyrosine phosphorylation, membrane
RT   insertion, and activation of transient receptor potential channel 4.";
RL   J. Biol. Chem. 280:37974-37987(2005).
RN   [13]
RP   INTERACTION WITH RNF24.
RX   PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009;
RA   Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.;
RT   "RNF24, a new TRPC interacting protein, causes the intracellular
RT   retention of TRPC.";
RL   Cell Calcium 43:432-443(2008).
RN   [14]
RP   INTERACTION WITH SPTAN1 AND SPTBN5.
RX   PubMed=18048348; DOI=10.1074/jbc.M709729200;
RA   Odell A.F., Van Helden D.F., Scott J.L.;
RT   "The spectrin cytoskeleton influences the surface expression and
RT   activation of human transient receptor potential channel 4 channels.";
RL   J. Biol. Chem. 283:4395-4407(2008).
RN   [15]
RP   INTERACTION WITH SESTD1.
RX   PubMed=20164195; DOI=10.1074/jbc.M109.068304;
RA   Miehe S., Bieberstein A., Arnould I., Ihdene O., Rutten H.,
RA   Strubing C.;
RT   "The phospholipid-binding protein SESTD1 is a novel regulator of the
RT   transient receptor potential channels TRPC4 and TRPC5.";
RL   J. Biol. Chem. 285:12426-12434(2010).
RN   [16]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH CDH5 AND CTNNB1.
RX   PubMed=19996314; DOI=10.1074/jbc.M109.060301;
RA   Graziani A., Poteser M., Heupel W.M., Schleifer H., Krenn M.,
RA   Drenckhahn D., Romanin C., Baumgartner W., Groschner K.;
RT   "Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the
RT   vascular endothelium: evidence for a regulatory TRPC4-beta-catenin
RT   interaction.";
RL   J. Biol. Chem. 285:4213-4223(2010).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-138.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Form a receptor-activated non-selective calcium permeant
CC       cation channel. Acts as a cell-cell contact-dependent endothelial
CC       calcium entry channel. Probably operated by a phosphatidylinositol
CC       second messenger system activated by receptor tyrosine kinases or
CC       G-protein coupled receptors. Mediates cation entry, with an
CC       enhanced permeability to barium over calcium. May also be
CC       activated by intracellular calcium store depletion.
CC       {ECO:0000269|PubMed:16144838, ECO:0000269|PubMed:19996314}.
CC   -!- SUBUNIT: Interacts with TRPC4AP (By similarity). Homotetramer and
CC       heterotetramer with TRPC1 and/or TRPC5. Isoform alpha but not
CC       isoform beta associates with inositol 1,4,5-trisphosphate receptor
CC       (ITPR). Interacts with (via PDZ-binding domain) with
CC       SLC9A3R1/NHERF. Interacts with MX1 and RNF24. Interacts (via CIRB
CC       domain) with SESTD1 (via spectrin 1 repeat). Interacts with CDH5
CC       and CTNNB1. Interacts with SPTAN1 (via C-terminal spectrin
CC       repeats) and SPTBN5 (via C-terminus). Interacts (via protein 4.1-
CC       binding domain) with EPB41L2. {ECO:0000250,
CC       ECO:0000269|PubMed:12032305, ECO:0000269|PubMed:12154080,
CC       ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:16254212,
CC       ECO:0000269|PubMed:17850865, ECO:0000269|PubMed:18048348,
CC       ECO:0000269|PubMed:19996314, ECO:0000269|PubMed:20164195}.
CC   -!- INTERACTION:
CC       P20591:MX1; NbExp=2; IntAct=EBI-929504, EBI-929476;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       membrane; Multi-pass membrane protein. Note=Enhanced insertion
CC       into the cell membrane after activation of the EGF receptor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=Alpha;
CC         IsoId=Q9UBN4-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q9UBN4-2; Sequence=VSP_006569;
CC       Name=Delta;
CC         IsoId=Q9UBN4-3; Sequence=VSP_006568;
CC       Name=Gamma;
CC         IsoId=Q9UBN4-4; Sequence=VSP_006567, VSP_006569;
CC       Name=Epsilon;
CC         IsoId=Q9UBN4-5; Sequence=VSP_041262;
CC       Name=Zeta;
CC         IsoId=Q9UBN4-6; Sequence=VSP_041439;
CC       Name=Eta;
CC         IsoId=Q9UBN4-7; Sequence=VSP_047747, VSP_047748;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in placenta. Expressed at
CC       lower levels in heart, pancreas, kidney and brain. Expressed in
CC       endothelial cells. Isoform alpha was found to be the predominant
CC       isoform. Isoform beta was not found in pancreas and brain.
CC       {ECO:0000269|PubMed:19996314}.
CC   -!- DOMAIN: The protein 4.1-binding domain (654-685) is required for
CC       binding to EPB41L2 and channel activation.
CC   -!- DOMAIN: The calmodulin- and inositol 1,4,5-trisphosphate receptor-
CC       binding (CIRB) domain (695-724) is sufficient for the interaction
CC       with SESTD1.
CC   -!- DOMAIN: The spectrin-binding domain (730-758) is required for
CC       binding to SPTAN1 and SPTBN5.
CC   -!- PTM: Phosphorylation modulates TRPC channel function by regulating
CC       the level of TRPC4 at the cell surface and by increasing the
CC       association with SLC9A3R1/NHERF. {ECO:0000269|PubMed:16144838}.
CC   -!- MISCELLANEOUS: The interaction with spectrin is important in
CC       controlling the translocation of TRPC4 channels to the plasma
CC       membrane following EGF stimulation.
CC   -!- MISCELLANEOUS: The cell membrane presentation, the calcium entry
CC       function and the interaction with junctional proteins (CTNNB1 and
CC       CDH5) are controlled by endothelial cell-cell contacts.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF063822; AAF22927.1; -; mRNA.
DR   EMBL; AF063823; AAF22928.1; -; mRNA.
DR   EMBL; AF063824; AAF22929.1; -; mRNA.
DR   EMBL; AF063825; AAF22930.1; -; mRNA.
DR   EMBL; AF175406; AAD51736.1; -; mRNA.
DR   EMBL; AF421358; AAL24549.1; -; mRNA.
DR   EMBL; AF421359; AAL24550.1; -; mRNA.
DR   EMBL; AF421360; AAL24551.1; -; mRNA.
DR   EMBL; AF421361; AAL24552.1; -; mRNA.
DR   EMBL; AF421362; AAL24553.1; -; mRNA.
DR   EMBL; AL138679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08595.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08596.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08597.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08598.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08600.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08601.1; -; Genomic_DNA.
DR   EMBL; BC104725; AAI04726.1; -; mRNA.
DR   EMBL; U40983; AAC50630.1; -; mRNA.
DR   CCDS; CCDS45035.1; -. [Q9UBN4-6]
DR   CCDS; CCDS45036.1; -. [Q9UBN4-4]
DR   CCDS; CCDS45037.1; -. [Q9UBN4-5]
DR   CCDS; CCDS45038.1; -. [Q9UBN4-2]
DR   CCDS; CCDS45039.1; -. [Q9UBN4-3]
DR   CCDS; CCDS9365.1; -. [Q9UBN4-1]
DR   RefSeq; NP_001129427.1; NM_001135955.1. [Q9UBN4-2]
DR   RefSeq; NP_001129428.1; NM_001135956.1. [Q9UBN4-4]
DR   RefSeq; NP_001129429.1; NM_001135957.1. [Q9UBN4-3]
DR   RefSeq; NP_001129430.1; NM_001135958.1. [Q9UBN4-6]
DR   RefSeq; NP_003297.1; NM_003306.1. [Q9UBN4-5]
DR   RefSeq; NP_057263.1; NM_016179.2. [Q9UBN4-1]
DR   UniGene; Hs.262960; -.
DR   ProteinModelPortal; Q9UBN4; -.
DR   BioGrid; 113074; 12.
DR   CORUM; Q9UBN4; -.
DR   IntAct; Q9UBN4; 2.
DR   MINT; MINT-157838; -.
DR   STRING; 9606.ENSP00000369003; -.
DR   GuidetoPHARMACOLOGY; 489; -.
DR   TCDB; 1.A.4.1.12; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9UBN4; -.
DR   PhosphoSitePlus; Q9UBN4; -.
DR   BioMuta; TRPC4; -.
DR   DMDM; 13633994; -.
DR   EPD; Q9UBN4; -.
DR   PaxDb; Q9UBN4; -.
DR   PeptideAtlas; Q9UBN4; -.
DR   PRIDE; Q9UBN4; -.
DR   Ensembl; ENST00000338947; ENSP00000342580; ENSG00000133107. [Q9UBN4-6]
DR   Ensembl; ENST00000355779; ENSP00000348025; ENSG00000133107. [Q9UBN4-3]
DR   Ensembl; ENST00000358477; ENSP00000351264; ENSG00000133107. [Q9UBN4-2]
DR   Ensembl; ENST00000379673; ENSP00000368995; ENSG00000133107. [Q9UBN4-4]
DR   Ensembl; ENST00000379679; ENSP00000369001; ENSG00000133107. [Q9UBN4-6]
DR   Ensembl; ENST00000379705; ENSP00000369027; ENSG00000133107. [Q9UBN4-1]
DR   Ensembl; ENST00000488717; ENSP00000435969; ENSG00000133107. [Q9UBN4-7]
DR   Ensembl; ENST00000625583; ENSP00000486109; ENSG00000133107. [Q9UBN4-5]
DR   GeneID; 7223; -.
DR   KEGG; hsa:7223; -.
DR   UCSC; uc001uws.4; human. [Q9UBN4-1]
DR   CTD; 7223; -.
DR   DisGeNET; 7223; -.
DR   EuPathDB; HostDB:ENSG00000133107.14; -.
DR   GeneCards; TRPC4; -.
DR   HGNC; HGNC:12336; TRPC4.
DR   MIM; 603651; gene.
DR   neXtProt; NX_Q9UBN4; -.
DR   OpenTargets; ENSG00000133107; -.
DR   PharmGKB; PA37009; -.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000151279; -.
DR   HOVERGEN; HBG068337; -.
DR   InParanoid; Q9UBN4; -.
DR   KO; K04967; -.
DR   OMA; CILVDHR; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; Q9UBN4; -.
DR   TreeFam; TF313147; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling.
DR   ChiTaRS; TRPC4; human.
DR   GeneWiki; TRPC4; -.
DR   GenomeRNAi; 7223; -.
DR   PRO; PR:Q9UBN4; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000133107; -.
DR   CleanEx; HS_TRPC4; -.
DR   ExpressionAtlas; Q9UBN4; baseline and differential.
DR   Genevisible; Q9UBN4; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030863; C:cortical cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IPI:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:Ensembl.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0070509; P:calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006816; P:calcium ion transport; TAS:ProtInc.
DR   GO; GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005460; TRPC4_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF25; PTHR10117:SF25; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01645; TRPCHANNEL4.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Coiled coil; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    977       Short transient receptor potential
FT                                channel 4.
FT                                /FTId=PRO_0000215314.
FT   TOPO_DOM      1    329       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical. {ECO:0000255}.
FT   TOPO_DOM    351    362       Extracellular. {ECO:0000255}.
FT   TRANSMEM    363    383       Helical. {ECO:0000255}.
FT   TOPO_DOM    384    436       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    469       Extracellular. {ECO:0000255}.
FT   TRANSMEM    470    490       Helical. {ECO:0000255}.
FT   TOPO_DOM    491    511       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    512    532       Helical. {ECO:0000255}.
FT   TOPO_DOM    533    599       Extracellular. {ECO:0000255}.
FT   TRANSMEM    600    620       Helical. {ECO:0000255}.
FT   TOPO_DOM    621    977       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       31     60       ANK 1.
FT   REPEAT       69     97       ANK 2.
FT   REPEAT       98    124       ANK 3.
FT   REPEAT      141    170       ANK 4.
FT   REGION       87    172       Multimerization domain. {ECO:0000250}.
FT   REGION      254    304       Multimerization domain. {ECO:0000250}.
FT   REGION      615    977       Binds to ITPR1, ITPR2 and ITPR3.
FT   REGION      975    977       PDZ-binding domain.
FT   COILED      223    260       {ECO:0000255}.
FT   COMPBIAS    377    382       Poly-Leu.
FT   MOD_RES     959    959       Phosphotyrosine; by FYN.
FT                                {ECO:0000269|PubMed:16144838}.
FT   MOD_RES     972    972       Phosphotyrosine; by FYN.
FT                                {ECO:0000269|PubMed:16144838}.
FT   VAR_SEQ     127    299       Missing (in isoform Zeta).
FT                                {ECO:0000303|PubMed:11713258}.
FT                                /FTId=VSP_041439.
FT   VAR_SEQ     300    323       FVAQPNCQQLLASRWYDEFPGWRR -> ASYGEKLNRCGMA
FT                                DFRTTSMIGGI (in isoform Eta).
FT                                {ECO:0000303|PubMed:11713258}.
FT                                /FTId=VSP_047747.
FT   VAR_SEQ     324    977       Missing (in isoform Eta).
FT                                {ECO:0000303|PubMed:11713258}.
FT                                /FTId=VSP_047748.
FT   VAR_SEQ     629    693       Missing (in isoform Gamma).
FT                                {ECO:0000303|PubMed:11163362}.
FT                                /FTId=VSP_006567.
FT   VAR_SEQ     693    693       G -> GVRTQH (in isoform Epsilon).
FT                                {ECO:0000303|PubMed:11713258}.
FT                                /FTId=VSP_041262.
FT   VAR_SEQ     730    870       Missing (in isoform Delta).
FT                                {ECO:0000303|PubMed:11163362}.
FT                                /FTId=VSP_006568.
FT   VAR_SEQ     785    868       Missing (in isoform Beta and isoform
FT                                Gamma). {ECO:0000303|PubMed:11163362,
FT                                ECO:0000303|PubMed:11713258}.
FT                                /FTId=VSP_006569.
FT   VARIANT     138    138       E -> K (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036452.
FT   MUTAGEN     959    959       Y->F: Reduced EGF-induced phosphorylation
FT                                and decreased association with
FT                                SLC9A3R1/NHERF. Loss of EGF-induced
FT                                phosphorylation and decreased association
FT                                with SLC9A3R1/NHERF; when associated with
FT                                F-972. {ECO:0000269|PubMed:16144838}.
FT   MUTAGEN     972    972       Y->F: Reduced EGF-induced phosphorylation
FT                                and decreased association with
FT                                SLC9A3R1/NHERF. Loss of EGF-induced
FT                                phosphorylation and decreased association
FT                                with SLC9A3R1/NHERF; when associated with
FT                                F-959. {ECO:0000269|PubMed:16144838}.
FT   MUTAGEN     975    977       Missing: Loss of interaction with
FT                                SLC9A3R1/NHERF.
FT                                {ECO:0000269|PubMed:12154080}.
SQ   SEQUENCE   977 AA;  112101 MW;  77E4D27C374D660E CRC64;
     MAQFYYKRNV NAPYRDRIPL RIVRAESELS PSEKAYLNAV EKGDYASVKK SLEEAEIYFK
     ININCIDPLG RTALLIAIEN ENLELIELLL SFNVYVGDAL LHAIRKEVVG AVELLLNHKK
     PSGEKQVPPI LLDKQFSEFT PDITPIILAA HTNNYEIIKL LVQKGVSVPR PHEVRCNCVE
     CVSSSDVDSL RHSRSRLNIY KALASPSLIA LSSEDPFLTA FQLSWELQEL SKVENEFKSE
     YEELSRQCKQ FAKDLLDQTR SSRELEIILN YRDDNSLIEE QSGNDLARLK LAIKYRQKEF
     VAQPNCQQLL ASRWYDEFPG WRRRHWAVKM VTCFIIGLLF PVFSVCYLIA PKSPLGLFIR
     KPFIKFICHT ASYLTFLFLL LLASQHIDRS DLNRQGPPPT IVEWMILPWV LGFIWGEIKQ
     MWDGGLQDYI HDWWNLMDFV MNSLYLATIS LKIVAFVKYS ALNPRESWDM WHPTLVAEAL
     FAIANIFSSL RLISLFTANS HLGPLQISLG RMLLDILKFL FIYCLVLLAF ANGLNQLYFY
     YEETKGLTCK GIRCEKQNNA FSTLFETLQS LFWSIFGLIN LYVTNVKAQH EFTEFVGATM
     FGTYNVISLV VLLNMLIAMM NNSYQLIADH ADIEWKFART KLWMSYFEEG GTLPTPFNVI
     PSPKSLWYLI KWIWTHLCKK KMRRKPESFG TIGRRAADNL RRHHQYQEVM RNLVKRYVAA
     MIRDAKTEEG LTEENFKELK QDISSFRFEV LGLLRGSKLS TIQSANASKE SSNSADSDEK
     SDSEGNSKDK KKNFSLFDLT TLIHPRSAAI ASERHNISNG SALVVQEPPR EKQRKVNFVT
     DIKNFGLFHR RSKQNAAEQN ANQIFSVSEE VARQQAAGPL ERNIQLESRG LASRGDLSIP
     GLSEQCVLVD HRERNTDTLG LQVGKRVCPF KSEKVVVEDT VPIIPKEKHA KEEDSSIDYD
     LNLPDTVTHE DYVTTRL
//
ID   ACHA9_HUMAN             Reviewed;         479 AA.
AC   Q9UGM1; Q14CY7; Q4W5A2; Q9NYV2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-9;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-9;
DE            Short=NACHR alpha-9;
DE   Flags: Precursor;
GN   Name=CHRNA9; Synonyms=NACHRA9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHRNA10,
RP   SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT
RP   SER-442.
RC   TISSUE=Embryo;
RX   PubMed=11752216; DOI=10.1124/mol.61.1.150;
RA   Sgard F., Charpantier E., Bertrand S., Walker N., Caput D., Graham D.,
RA   Bertrand D., Besnard F.;
RT   "A novel human nicotinic receptor subunit, alpha10, that confers
RT   functionality to the alpha9-subunit.";
RL   Mol. Pharmacol. 61:150-159(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-442.
RX   PubMed=12697997; DOI=10.1159/000069804;
RA   Lustig L.R., Peng H.;
RT   "Chromosome location and characterization of the human nicotinic
RT   acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) gene.";
RL   Cytogenet. Genome Res. 98:154-159(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-442.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-476, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11021840; DOI=10.1016/S0002-9440(10)64651-2;
RA   Nguyen V.T., Ndoye A., Grando S.A.;
RT   "Novel human alpha9 acetylcholine receptor regulating keratinocyte
RT   adhesion is targeted by Pemphigus vulgaris autoimmunity.";
RL   Am. J. Pathol. 157:1377-1391(2000).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15531379; DOI=10.1016/j.lfs.2004.05.031;
RA   Peng H., Ferris R.L., Matthews T., Hiel H., Lopez-Albaitero A.,
RA   Lustig L.R.;
RT   "Characterization of the human nicotinic acetylcholine receptor
RT   subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in
RT   lymphocytes.";
RL   Life Sci. 76:263-280(2004).
RN   [7]
RP   MUTAGENESIS OF ILE-86, AND SUBUNIT.
RX   PubMed=22774872; DOI=10.1111/j.1471-4159.2012.07867.x;
RA   Azam L., McIntosh J.M.;
RT   "Molecular basis for the differential sensitivity of rat and human
RT   alpha9alpha10 nAChRs to alpha-conotoxin RgIA.";
RL   J. Neurochem. 122:1137-1144(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) OF 26-237, FUNCTION,
RP   SUBCELLULAR LOCATION, DISULFIDE BOND, AND GLYCOSYLATION.
RX   PubMed=25282151; DOI=10.1038/nsmb.2900;
RA   Zouridakis M., Giastas P., Zarkadas E., Chroni-Tzartou D.,
RA   Bregestovski P., Tzartos S.J.;
RT   "Crystal structures of free and antagonist-bound states of human
RT   alpha9 nicotinic receptor extracellular domain.";
RL   Nat. Struct. Mol. Biol. 21:976-980(2014).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding induces a
CC       conformation change that leads to the opening of an ion-conducting
CC       channel across the plasma membrane (PubMed:11752216,
CC       PubMed:25282151). The channel is permeable to a range of divalent
CC       cations including calcium, the influx of which may activate a
CC       potassium current which hyperpolarizes the cell membrane
CC       (PubMed:11752216, PubMed:25282151). In the ear, this may lead to a
CC       reduction in basilar membrane motion, altering the activity of
CC       auditory nerve fibers and reducing the range of dynamic hearing.
CC       This may protect against acoustic trauma. May also regulate
CC       keratinocyte adhesion (PubMed:11021840).
CC       {ECO:0000269|PubMed:11021840, ECO:0000269|PubMed:11752216,
CC       ECO:0000269|PubMed:25282151, ECO:0000305}.
CC   -!- SUBUNIT: Can form homo- or heterooligomeric channels in
CC       conjunction with CHRNA10 (PubMed:11752216). The native outer hair
CC       cell receptor may be composed of CHRNA9-CHRNA10 heterooligomers.
CC       Interacts with the alpha-conotoxon RgIA (PubMed:22774872).
CC       {ECO:0000269|PubMed:11752216, ECO:0000269|PubMed:22774872}.
CC   -!- INTERACTION:
CC       P60616:- (xeno); NbExp=2; IntAct=EBI-9008641, EBI-16123259;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000269|PubMed:25282151}; Multi-pass membrane
CC       protein {ECO:0000305|PubMed:25282151}.
CC   -!- TISSUE SPECIFICITY: Expressed in cochlea, keratinocytes, pituitary
CC       gland, B-cells and T-cells. {ECO:0000269|PubMed:11021840,
CC       ECO:0000269|PubMed:11752216, ECO:0000269|PubMed:15531379}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25282151}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist). {ECO:0000305|PubMed:11752216}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       9/CHRNA9 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243342; CAB65091.1; -; mRNA.
DR   EMBL; AY123244; AAM74523.1; -; Genomic_DNA.
DR   EMBL; AC118275; AAY40986.1; -; Genomic_DNA.
DR   EMBL; BC113549; AAI13550.1; -; mRNA.
DR   EMBL; BC113575; AAI13576.1; -; mRNA.
DR   EMBL; AF227732; AAF61920.1; -; mRNA.
DR   CCDS; CCDS3459.1; -.
DR   RefSeq; NP_060051.2; NM_017581.3.
DR   UniGene; Hs.272278; -.
DR   PDB; 4D01; X-ray; 1.80 A; A=26-237.
DR   PDB; 4UXU; X-ray; 1.71 A; A/B=26-237.
DR   PDB; 4UY2; X-ray; 2.70 A; A/B=26-237.
DR   PDBsum; 4D01; -.
DR   PDBsum; 4UXU; -.
DR   PDBsum; 4UY2; -.
DR   ProteinModelPortal; Q9UGM1; -.
DR   SMR; Q9UGM1; -.
DR   BioGrid; 120731; 75.
DR   CORUM; Q9UGM1; -.
DR   DIP; DIP-61053N; -.
DR   IntAct; Q9UGM1; 1.
DR   STRING; 9606.ENSP00000312663; -.
DR   BindingDB; Q9UGM1; -.
DR   ChEMBL; CHEMBL2184; -.
DR   DrugBank; DB05069; ATG003.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB05137; Lobeline.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB05740; RPI-78M.
DR   DrugBank; DB08837; Tetraethylammonium.
DR   GuidetoPHARMACOLOGY; 469; -.
DR   iPTMnet; Q9UGM1; -.
DR   PhosphoSitePlus; Q9UGM1; -.
DR   BioMuta; CHRNA9; -.
DR   DMDM; 308153406; -.
DR   MaxQB; Q9UGM1; -.
DR   PaxDb; Q9UGM1; -.
DR   PeptideAtlas; Q9UGM1; -.
DR   PRIDE; Q9UGM1; -.
DR   DNASU; 55584; -.
DR   Ensembl; ENST00000310169; ENSP00000312663; ENSG00000174343.
DR   GeneID; 55584; -.
DR   KEGG; hsa:55584; -.
DR   UCSC; uc003gva.2; human.
DR   CTD; 55584; -.
DR   DisGeNET; 55584; -.
DR   EuPathDB; HostDB:ENSG00000174343.5; -.
DR   GeneCards; CHRNA9; -.
DR   H-InvDB; HIX0031380; -.
DR   HGNC; HGNC:14079; CHRNA9.
DR   MIM; 605116; gene.
DR   neXtProt; NX_Q9UGM1; -.
DR   OpenTargets; ENSG00000174343; -.
DR   PharmGKB; PA26493; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q9UGM1; -.
DR   KO; K04810; -.
DR   OMA; ATKNVIM; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9UGM1; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   ChiTaRS; CHRNA9; human.
DR   GeneWiki; CHRNA9; -.
DR   GenomeRNAi; 55584; -.
DR   PRO; PR:Q9UGM1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000174343; -.
DR   CleanEx; HS_CHRNA9; -.
DR   Genevisible; Q9UGM1; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium channel; Calcium transport;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    479       Neuronal acetylcholine receptor subunit
FT                                alpha-9.
FT                                /FTId=PRO_0000000371.
FT   TOPO_DOM     26    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    262       Helical. {ECO:0000255}.
FT   TRANSMEM    269    287       Helical. {ECO:0000255}.
FT   TRANSMEM    302    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    476       Helical. {ECO:0000255}.
FT   SITE        146    146       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000250|UniProtKB:P43144}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000269|PubMed:25282151}.
FT   DISULFID    219    220       {ECO:0000269|PubMed:25282151}.
FT   VARIANT      96     96       R -> Q (in dbSNP:rs10024518).
FT                                /FTId=VAR_031151.
FT   VARIANT     315    315       A -> V (in dbSNP:rs55633891).
FT                                /FTId=VAR_060996.
FT   VARIANT     442    442       N -> S (in dbSNP:rs10009228).
FT                                {ECO:0000269|PubMed:11752216,
FT                                ECO:0000269|PubMed:12697997,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_025425.
FT   MUTAGEN      86     86       I->T: The CHRNA9-CHRNA10 receptor is 250-
FT                                fold more potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   HELIX        30     39       {ECO:0000244|PDB:4UXU}.
FT   STRAND       49     51       {ECO:0000244|PDB:4UY2}.
FT   STRAND       56     71       {ECO:0000244|PDB:4UXU}.
FT   TURN         72     75       {ECO:0000244|PDB:4UXU}.
FT   STRAND       76     93       {ECO:0000244|PDB:4UXU}.
FT   HELIX        96     98       {ECO:0000244|PDB:4UXU}.
FT   TURN         99    101       {ECO:0000244|PDB:4UXU}.
FT   STRAND      104    108       {ECO:0000244|PDB:4UXU}.
FT   HELIX       109    111       {ECO:0000244|PDB:4UXU}.
FT   STRAND      117    119       {ECO:0000244|PDB:4UXU}.
FT   STRAND      134    138       {ECO:0000244|PDB:4UXU}.
FT   STRAND      140    154       {ECO:0000244|PDB:4UXU}.
FT   STRAND      156    158       {ECO:0000244|PDB:4UXU}.
FT   STRAND      164    177       {ECO:0000244|PDB:4UXU}.
FT   TURN        180    182       {ECO:0000244|PDB:4UXU}.
FT   STRAND      183    191       {ECO:0000244|PDB:4UXU}.
FT   STRAND      201    207       {ECO:0000244|PDB:4UXU}.
FT   STRAND      209    217       {ECO:0000244|PDB:4UXU}.
FT   TURN        218    220       {ECO:0000244|PDB:4UXU}.
FT   STRAND      224    235       {ECO:0000244|PDB:4UXU}.
SQ   SEQUENCE   479 AA;  54807 MW;  AA6B46B559D6111D CRC64;
     MNWSHSCISF CWIYFAASRL RAAETADGKY AQKLFNDLFE DYSNALRPVE DTDKVLNVTL
     QITLSQIKDM DERNQILTAY LWIRQIWHDA YLTWDRDQYD GLDSIRIPSD LVWRPDIVLY
     NKADDESSEP VNTNVVLRYD GLITWDAPAI TKSSCVVDVT YFPFDNQQCN LTFGSWTYNG
     NQVDIFNALD SGDLSDFIED VEWEVHGMPA VKNVISYGCC SEPYPDVTFT LLLKRRSSFY
     IVNLLIPCVL ISFLAPLSFY LPAASGEKVS LGVTILLAMT VFQLMVAEIM PASENVPLIG
     KYYIATMALI TASTALTIMV MNIHFCGAEA RPVPHWARVV ILKYMSRVLF VYDVGESCLS
     PHHSRERDHL TKVYSKLPES NLKAARNKDL SRKKDMNKRL KNDLGCQGKN PQEAESYCAQ
     YKVLTRNIEY IAKCLKDHKA TNSKGSEWKK VAKVIDRFFM WIFFIMVFVM TILIIARAD
//
ID   TRPC5_HUMAN             Reviewed;         973 AA.
AC   Q9UL62; B2RP53; O75233; Q5JXY8; Q9Y514;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Short transient receptor potential channel 5;
DE            Short=TrpC5;
DE   AltName: Full=Transient receptor protein 5;
DE            Short=TRP-5;
DE            Short=hTRP-5;
DE            Short=hTRP5;
GN   Name=TRPC5; Synonyms=TRP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=10493832; DOI=10.1006/geno.1999.5924;
RA   Sossey-Alaoui K., Lyon J.A., Jones L., Abidi F.E., Hartung A.J.,
RA   Hane B., Schwartz C.E., Stevenson R.E., Srivastava A.K.;
RT   "Molecular cloning and characterization of TRPC5 (HTRP5), the human
RT   homologue of a mouse brain receptor-activated capacitative Ca(2+)
RT   entry channel.";
RL   Genomics 60:330-340(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9687496; DOI=10.1093/emboj/17.15.4274;
RA   Philipp S., Hambrecht J., Braslavski L., Schroth G., Freichel M.,
RA   Murakami M., Cavalie A., Flockerzi V.;
RT   "A novel capacitative calcium entry channel expressed in excitable
RT   cells.";
RL   EMBO J. 17:4274-4282(1998).
RN   [6]
RP   SUBUNIT.
RX   PubMed=12032305; DOI=10.1073/pnas.102596199;
RA   Hofmann T., Schaefer M., Schultz G., Gudermann T.;
RT   "Subunit composition of mammalian transient receptor potential
RT   channels in living cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7461-7466(2002).
RN   [7]
RP   INTERACTION WITH MX1.
RX   PubMed=15757897; DOI=10.1074/jbc.M500391200;
RA   Lussier M.P., Cayouette S., Lepage P.K., Bernier C.L., Francoeur N.,
RA   St-Hilaire M., Pinard M., Boulay G.;
RT   "MxA, a member of the dynamin superfamily, interacts with the ankyrin-
RT   like repeat domain of TRPC.";
RL   J. Biol. Chem. 280:19393-19400(2005).
RN   [8]
RP   INTERACTION WITH CABP1.
RX   PubMed=15895247; DOI=10.1007/s00424-005-1419-1;
RA   Kinoshita-Kawada M., Tang J., Xiao R., Kaneko S., Foskett J.K.,
RA   Zhu M.X.;
RT   "Inhibition of TRPC5 channels by Ca2+-binding protein 1 in Xenopus
RT   oocytes.";
RL   Pflugers Arch. 450:345-354(2005).
RN   [9]
RP   FUNCTION AS CALCIUM CHANNEL, ENZYME REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16284075; DOI=10.1113/jphysiol.2005.097998;
RA   Shimizu S., Yoshida T., Wakamori M., Ishii M., Okada T., Takahashi M.,
RA   Seto M., Sakurada K., Kiuchi Y., Mori Y.;
RT   "Ca2+-calmodulin-dependent myosin light chain kinase is essential for
RT   activation of TRPC5 channels expressed in HEK293 cells.";
RL   J. Physiol. (Lond.) 570:219-235(2006).
RN   [10]
RP   INTERACTION WITH RNF24.
RX   PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009;
RA   Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.;
RT   "RNF24, a new TRPC interacting protein, causes the intracellular
RT   retention of TRPC.";
RL   Cell Calcium 43:432-443(2008).
RN   [11]
RP   INTERACTION WITH SESTD1.
RX   PubMed=20164195; DOI=10.1074/jbc.M109.068304;
RA   Miehe S., Bieberstein A., Arnould I., Ihdene O., Rutten H.,
RA   Strubing C.;
RT   "The phospholipid-binding protein SESTD1 is a novel regulator of the
RT   transient receptor potential channels TRPC4 and TRPC5.";
RL   J. Biol. Chem. 285:12426-12434(2010).
RN   [12]
RP   VARIANT THR-667.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
CC   -!- FUNCTION: Thought to form a receptor-activated non-selective
CC       calcium permeant cation channel. Probably is operated by a
CC       phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases or G-protein coupled receptors. Has also been
CC       shown to be calcium-selective (By similarity). May also be
CC       activated by intracellular calcium store depletion. {ECO:0000250,
CC       ECO:0000269|PubMed:16284075}.
CC   -!- ENZYME REGULATION: Calcium channel activity is enhanced by MYLK,
CC       that promotes its subcellular localization at the plasma membrane.
CC       {ECO:0000269|PubMed:16284075}.
CC   -!- SUBUNIT: Interacts with TRPC4AP (By similarity). Homotetramer and
CC       heterotetramer with TRPC1 and/or TRPC4. Interacts with NHERF (By
CC       similarity). Interacts with MX1 and RNF24. Interacts (via C-
CC       terminus) with CABP1. Interacts with SESTD1 (via the spectrin 1
CC       repeat). {ECO:0000250, ECO:0000269|PubMed:12032305,
CC       ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:15895247,
CC       ECO:0000269|PubMed:17850865, ECO:0000269|PubMed:20164195}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16284075};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16284075}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain with higher levels in fetal
CC       brain. Found in cerebellum and occipital pole.
CC       {ECO:0000269|PubMed:9687496}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC5 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF054568; AAF00002.1; -; mRNA.
DR   EMBL; AC005191; AAC24563.1; -; Genomic_DNA.
DR   EMBL; AL049563; CAI43017.1; -; Genomic_DNA.
DR   EMBL; AC005191; CAI43017.1; JOINED; Genomic_DNA.
DR   EMBL; CH471120; EAX02630.1; -; Genomic_DNA.
DR   EMBL; BC137271; AAI37272.1; -; mRNA.
DR   EMBL; BC137274; AAI37275.1; -; mRNA.
DR   CCDS; CCDS14561.1; -.
DR   RefSeq; NP_036603.1; NM_012471.2.
DR   RefSeq; XP_016885263.1; XM_017029774.1.
DR   UniGene; Hs.657709; -.
DR   ProteinModelPortal; Q9UL62; -.
DR   BioGrid; 113075; 18.
DR   IntAct; Q9UL62; 1.
DR   STRING; 9606.ENSP00000262839; -.
DR   ChEMBL; CHEMBL1250411; -.
DR   GuidetoPHARMACOLOGY; 490; -.
DR   TCDB; 1.A.4.1.7; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9UL62; -.
DR   PhosphoSitePlus; Q9UL62; -.
DR   BioMuta; TRPC5; -.
DR   DMDM; 10720321; -.
DR   EPD; Q9UL62; -.
DR   MaxQB; Q9UL62; -.
DR   PaxDb; Q9UL62; -.
DR   PeptideAtlas; Q9UL62; -.
DR   PRIDE; Q9UL62; -.
DR   Ensembl; ENST00000262839; ENSP00000262839; ENSG00000072315.
DR   GeneID; 7224; -.
DR   KEGG; hsa:7224; -.
DR   UCSC; uc004epl.2; human.
DR   CTD; 7224; -.
DR   DisGeNET; 7224; -.
DR   EuPathDB; HostDB:ENSG00000072315.3; -.
DR   GeneCards; TRPC5; -.
DR   HGNC; HGNC:12337; TRPC5.
DR   MIM; 300334; gene.
DR   neXtProt; NX_Q9UL62; -.
DR   OpenTargets; ENSG00000072315; -.
DR   PharmGKB; PA37010; -.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000020589; -.
DR   HOVERGEN; HBG068337; -.
DR   InParanoid; Q9UL62; -.
DR   KO; K04968; -.
DR   OMA; GFNEYVH; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; Q9UL62; -.
DR   TreeFam; TF313147; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling.
DR   ChiTaRS; TRPC5; human.
DR   GeneWiki; TRPC5; -.
DR   GenomeRNAi; 7224; -.
DR   PRO; PR:Q9UL62; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000072315; -.
DR   CleanEx; HS_TRPC5; -.
DR   Genevisible; Q9UL62; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0003779; F:actin binding; IEA:Ensembl.
DR   GO; GO:0042805; F:actinin binding; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0030276; F:clathrin binding; IEA:Ensembl.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:Ensembl.
DR   GO; GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006816; P:calcium ion transport; TAS:ProtInc.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:1902630; P:regulation of membrane hyperpolarization; IEA:Ensembl.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005461; TRPC5_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF24; PTHR10117:SF24; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01646; TRPCHANNEL5.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    973       Short transient receptor potential
FT                                channel 5.
FT                                /FTId=PRO_0000215318.
FT   TOPO_DOM      1    330       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    331    351       Helical. {ECO:0000255}.
FT   TOPO_DOM    352    398       Extracellular. {ECO:0000255}.
FT   TRANSMEM    399    419       Helical. {ECO:0000255}.
FT   TOPO_DOM    420    437       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    438    458       Helical. {ECO:0000255}.
FT   TOPO_DOM    459    470       Extracellular. {ECO:0000255}.
FT   TRANSMEM    471    491       Helical. {ECO:0000255}.
FT   TOPO_DOM    492    512       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    513    533       Helical. {ECO:0000255}.
FT   TOPO_DOM    534    603       Extracellular. {ECO:0000255}.
FT   TRANSMEM    604    624       Helical. {ECO:0000255}.
FT   TOPO_DOM    625    973       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       31     60       ANK 1.
FT   REPEAT       69     97       ANK 2.
FT   REPEAT       98    124       ANK 3.
FT   REPEAT      141    170       ANK 4.
FT   REGION      971    973       Essential for binding to NHERF PDZ
FT                                domain. {ECO:0000250}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     667    667       P -> T (found in a patient with severe
FT                                delayed speech, autism spectrum and
FT                                Gilles de la Tourette disorders).
FT                                {ECO:0000269|PubMed:23033978}.
FT                                /FTId=VAR_069415.
FT   VARIANT     702    702       R -> H (in dbSNP:rs36047478).
FT                                /FTId=VAR_052369.
SQ   SEQUENCE   973 AA;  111412 MW;  FBC8CBF17BE42166 CRC64;
     MAQLYYKKVN YSPYRDRIPL QIVRAETELS AEEKAFLNAV EKGDYATVKQ ALQEAEIYYN
     VNINCMDPLG RSALLIAIEN ENLEIMELLL NHSVYVGDAL LYAIRKEVVG AVELLLSYRR
     PSGEKQVPTL MMDTQFSEFT PDITPIMLAA HTNNYEIIKL LVQKRVTIPR PHQIRCNCVE
     CVSSSEVDSL RHSRSRLNIY KALASPSLIA LSSEDPILTA FRLGWELKEL SKVENEFKAE
     YEELSQQCKL FAKDLLDQAR SSRELEIILN HRDDHSEELD PQKYHDLAKL KVAIKYHQKE
     FVAQPNCQQL LATLWYDGFP GWRRKHWVVK LLTCMTIGFL FPMLSIAYLI SPRSNLGLFI
     KKPFIKFICH TASYLTFLFM LLLASQHIVR TDLHVQGPPP TVVEWMILPW VLGFIWGEIK
     EMWDGGFTEY IHDWWNLMDF AMNSLYLATI SLKIVAYVKY NGSRPREEWE MWHPTLIAEA
     LFAISNILSS LRLISLFTAN SHLGPLQISL GRMLLDILKF LFIYCLVLLA FANGLNQLYF
     YYETRAIDEP NNCKGIRCEK QNNAFSTLFE TLQSLFWSVF GLLNLYVTNV KARHEFTEFV
     GATMFGTYNV ISLVVLLNML IAMMNNSYQL IADHADIEWK FARTKLWMSY FDEGGTLPPP
     FNIIPSPKSF LYLGNWFNNT FCPKRDPDGR RRRRNLRSFT ERNADSLIQN QHYQEVIRNL
     VKRYVAAMIR NSKTHEGLTE ENFKELKQDI SSFRYEVLDL LGNRKHPRSF STSSTELSQR
     DDNNDGSGGA RAKSKSVSFN LGCKKKTCHG PPLIRTMPRS SGAQGKSKAE SSSKRSFMGP
     SLKKLGLLFS KFNGHMSEPS SEPMYTISDG IVQQHCMWQD IRYSQMEKGK AEACSQSEIN
     LSEVELGEVQ GAAQSSECPL ACSSSLHCAS SICSSNSKLL DSSEDVFETW GEACDLLMHK
     WGDGQEEQVT TRL
//
ID   TPC1_HUMAN              Reviewed;         816 AA.
AC   Q9ULQ1; A7E258; Q86XS9; Q8NC20;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 3.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Two pore calcium channel protein 1;
DE   AltName: Full=Voltage-dependent calcium channel protein TPC1;
GN   Name=TPCN1; Synonyms=KIAA1169, TPC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=19387438; DOI=10.1038/nature08030;
RA   Calcraft P.J., Ruas M., Pan Z., Cheng X., Arredouani A., Hao X.,
RA   Tang J., Rietdorf K., Teboul L., Chuang K.T., Lin P., Xiao R.,
RA   Wang C., Zhu Y., Lin Y., Wyatt C.N., Parrington J., Ma J., Evans A.M.,
RA   Galione A., Zhu M.X.;
RT   "NAADP mobilizes calcium from acidic organelles through two-pore
RT   channels.";
RL   Nature 459:596-600(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, MUTAGENESIS OF LEU-273, AND SUBCELLULAR LOCATION.
RX   PubMed=19620632; DOI=10.1083/jcb.200904073;
RA   Brailoiu E., Churamani D., Cai X., Schrlau M.G., Brailoiu G.C.,
RA   Gao X., Hooper R., Boulware M.J., Dun N.J., Marchant J.S., Patel S.;
RT   "Essential requirement for two-pore channel 1 in NAADP-mediated
RT   calcium signaling.";
RL   J. Cell Biol. 186:201-209(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Nicotinic acid adenine dinucleotide phosphate (NAADP)
CC       receptor that may function as one of the major voltage-gated
CC       Ca(2+) channels (VDCC) across the lysosomal and endosomal
CC       membrane. {ECO:0000269|PubMed:19620632}.
CC   -!- SUBUNIT: Dimer. {ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-5239895, EBI-5239895;
CC       O00165:HAX1; NbExp=2; IntAct=EBI-5239895, EBI-357001;
CC       Q8NHX9:TPCN2; NbExp=9; IntAct=EBI-5239895, EBI-5239949;
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane
CC       {ECO:0000269|PubMed:19620632}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19620632}. Endosome membrane
CC       {ECO:0000269|PubMed:19620632}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19620632}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9ULQ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULQ1-2; Sequence=VSP_023003, VSP_023004, VSP_023005;
CC       Name=3;
CC         IsoId=Q9ULQ1-3; Sequence=VSP_041346;
CC   -!- TISSUE SPECIFICITY: Highest expression found in the heart and
CC       kidney, and lowest expression found in the spleen.
CC       {ECO:0000269|PubMed:10574461}.
CC   -!- DOMAIN: Each of the two internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively
CC       charged transmembrane segment (S4). S4 segments probably represent
CC       the voltage-sensor and are characterized by a series of positively
CC       charged amino acids at every third position (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. Two pore calcium channel subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK057414; Type=Frameshift; Positions=273; Evidence={ECO:0000305};
CC       Sequence=BAA86483.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY083666; AAM01199.1; -; mRNA.
DR   EMBL; AB032995; BAA86483.2; ALT_INIT; mRNA.
DR   EMBL; AK057414; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK075071; BAC11385.1; -; mRNA.
DR   EMBL; AC010178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC089999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136795; AAI36796.1; -; mRNA.
DR   EMBL; BC136796; AAI36797.1; -; mRNA.
DR   EMBL; BC150203; AAI50204.1; -; mRNA.
DR   EMBL; BC152423; AAI52424.1; -; mRNA.
DR   CCDS; CCDS31908.1; -. [Q9ULQ1-1]
DR   CCDS; CCDS44985.1; -. [Q9ULQ1-3]
DR   RefSeq; NP_001137291.1; NM_001143819.2. [Q9ULQ1-3]
DR   RefSeq; NP_001288143.1; NM_001301214.1.
DR   RefSeq; NP_060371.2; NM_017901.5. [Q9ULQ1-1]
DR   RefSeq; XP_011536792.1; XM_011538490.2. [Q9ULQ1-3]
DR   RefSeq; XP_011536794.1; XM_011538492.2. [Q9ULQ1-1]
DR   UniGene; Hs.524763; -.
DR   ProteinModelPortal; Q9ULQ1; -.
DR   BioGrid; 119760; 8.
DR   IntAct; Q9ULQ1; 3.
DR   STRING; 9606.ENSP00000438125; -.
DR   GuidetoPHARMACOLOGY; 392; -.
DR   TCDB; 1.A.1.11.25; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9ULQ1; -.
DR   PhosphoSitePlus; Q9ULQ1; -.
DR   BioMuta; TPCN1; -.
DR   DMDM; 125991219; -.
DR   PaxDb; Q9ULQ1; -.
DR   PeptideAtlas; Q9ULQ1; -.
DR   PRIDE; Q9ULQ1; -.
DR   Ensembl; ENST00000335509; ENSP00000335300; ENSG00000186815. [Q9ULQ1-1]
DR   Ensembl; ENST00000541517; ENSP00000438125; ENSG00000186815. [Q9ULQ1-3]
DR   Ensembl; ENST00000550785; ENSP00000448083; ENSG00000186815. [Q9ULQ1-3]
DR   GeneID; 53373; -.
DR   KEGG; hsa:53373; -.
DR   UCSC; uc001tuw.4; human. [Q9ULQ1-1]
DR   CTD; 53373; -.
DR   DisGeNET; 53373; -.
DR   EuPathDB; HostDB:ENSG00000186815.12; -.
DR   GeneCards; TPCN1; -.
DR   HGNC; HGNC:18182; TPCN1.
DR   HPA; HPA039757; -.
DR   MIM; 609666; gene.
DR   neXtProt; NX_Q9ULQ1; -.
DR   OpenTargets; ENSG00000186815; -.
DR   PharmGKB; PA134922711; -.
DR   eggNOG; ENOG410INF7; Eukaryota.
DR   eggNOG; ENOG410XZT8; LUCA.
DR   GeneTree; ENSGT00530000063660; -.
DR   HOGENOM; HOG000006773; -.
DR   HOVERGEN; HBG080605; -.
DR   InParanoid; Q9ULQ1; -.
DR   KO; K16896; -.
DR   OMA; WLGFHTF; -.
DR   OrthoDB; EOG091G038K; -.
DR   PhylomeDB; Q9ULQ1; -.
DR   TreeFam; TF328550; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; TPCN1; human.
DR   GeneWiki; TPCN1; -.
DR   GenomeRNAi; 53373; -.
DR   PRO; PR:Q9ULQ1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000186815; -.
DR   CleanEx; HS_TPCN1; -.
DR   ExpressionAtlas; Q9ULQ1; baseline and differential.
DR   Genevisible; Q9ULQ1; HS.
DR   GO; GO:0005768; C:endosome; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:ParkinsonsUK-UCL.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028801; TPC1.
DR   PANTHER; PTHR10037:SF231; PTHR10037:SF231; 1.
DR   Pfam; PF00520; Ion_trans; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Lysosome; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    816       Two pore calcium channel protein 1.
FT                                /FTId=PRO_0000276853.
FT   TOPO_DOM      1    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    134    134       Extracellular. {ECO:0000255}.
FT   TRANSMEM    135    155       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    156    177       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    199    200       Extracellular. {ECO:0000255}.
FT   TRANSMEM    201    220       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    221    234       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    256    262       Extracellular. {ECO:0000255}.
FT   INTRAMEM    263    286       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    287    294       Extracellular. {ECO:0000255}.
FT   TRANSMEM    295    315       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    316    444       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    445    465       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    466    479       Extracellular. {ECO:0000255}.
FT   TRANSMEM    480    500       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    501    503       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    504    526       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    527    534       Extracellular. {ECO:0000255}.
FT   TRANSMEM    535    549       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    550    573       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    574    594       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    595    629       Extracellular. {ECO:0000255}.
FT   INTRAMEM    630    653       Helical; Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    654    670       Extracellular. {ECO:0000255}.
FT   TRANSMEM    671    691       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    692    816       Cytoplasmic. {ECO:0000255}.
FT   COILED      769    796       {ECO:0000255}.
FT   CARBOHYD    599    599       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    611    611       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    616    616       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    366       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023003.
FT   VAR_SEQ       1      1       M -> MESCYIAQAGLELLGSSSSPTLTSQSAEITEDASNG
FT                                GVSEQHPWPSGFERELKPETISSPGYHILRATGEENM (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041346.
FT   VAR_SEQ     569    618       SLGLTLLIFYYSFAIVGMEFFCGIVFPNCCNTSTVADAYRW
FT                                RNHTVGNRT -> RYCQPPPWPAGPGAVWQCPVGAGAEWQS
FT                                GERSSTKDCNRGPDGAPRSLES (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023004.
FT   VAR_SEQ     619    816       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023005.
FT   MUTAGEN     273    273       L->P: Loss of NAADP-mediated cytoplasmic
FT                                calcium release.
FT                                {ECO:0000269|PubMed:19620632}.
FT   CONFLICT    621    621       E -> G (in Ref. 4; AK057414).
FT                                {ECO:0000305}.
SQ   SEQUENCE   816 AA;  94147 MW;  D6D26BFAF33E1463 CRC64;
     MAVSLDDDVP LILTLDEGGS APLAPSNGLG QEELPSKNGG SYAIHDSQAP SLSSGGESSP
     SSPAHNWEMN YQEAAIYLQE GENNDKFFTH PKDAKALAAY LFAHNHLFYL MELATALLLL
     LLSLCEAPAV PALRLGIYVH ATLELFALMV VVFELCMKLR WLGLHTFIRH KRTMVKTSVL
     VVQFVEAIVV LVRQMSHVRV TRALRCIFLV DCRYCGGVRR NLRQIFQSLP PFMDILLLLL
     FFMIIFAILG FYLFSPNPSD PYFSTLENSI VSLFVLLTTA NFPDVMMPSY SRNPWSCVFF
     IVYLSIELYF IMNLLLAVVF DTFNDIEKRK FKSLLLHKRT AIQHAYRLLI SQRRPAGISY
     RQFEGLMRFY KPRMSARERY LTFKALNQNN TPLLSLKDFY DIYEVAALKW KAKKNREHWF
     DELPRTALLI FKGINILVKS KAFQYFMYLV VAVNGVWILV ETFMLKGGNF FSKHVPWSYL
     VFLTIYGVEL FLKVAGLGPV EYLSSGWNLF DFSVTVFAFL GLLALALNME PFYFIVVLRP
     LQLLRLFKLK ERYRNVLDTM FELLPRMASL GLTLLIFYYS FAIVGMEFFC GIVFPNCCNT
     STVADAYRWR NHTVGNRTVV EEGYYYLNNF DNILNSFVTL FELTVVNNWY IIMEGVTSQT
     SHWSRLYFMT FYIVTMVVMT IIVAFILEAF VFRMNYSRKN QDSEVDGGIT LEKEISKEEL
     VAVLELYREA RGASSDVTRL LETLSQMERY QQHSMVFLGR RSRTKSDLSL KMYQEEIQEW
     YEEHAREQEQ QRQLSSSAAP AAQQPPGSRQ RSQTVT
//
ID   TMCO1_HUMAN             Reviewed;         188 AA.
AC   Q9UM00; B2REA0; O75545; Q9BZS3; Q9BZU8;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 139.
DE   RecName: Full=Calcium load-activated calcium channel {ECO:0000305|PubMed:27212239};
DE            Short=CLAC channel {ECO:0000305|PubMed:27212239};
DE   AltName: Full=Transmembrane and coiled-coil domain-containing protein 1 {ECO:0000305};
DE   AltName: Full=Transmembrane and coiled-coil domains protein 4 {ECO:0000305};
DE   AltName: Full=Xenogeneic cross-immune protein PCIA3 {ECO:0000303|Ref.2};
GN   Name=TMCO1 {ECO:0000312|HGNC:HGNC:18188};
GN   Synonyms=TMCC4 {ECO:0000312|HGNC:HGNC:18188};
GN   ORFNames=PNAS-10 {ECO:0000303|Ref.4}, PNAS-136 {ECO:0000303|Ref.4},
GN   UNQ151/PRO177 {ECO:0000303|PubMed:12975309};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Gastric adenocarcinoma;
RX   PubMed=10393320; DOI=10.1093/oxfordjournals.jbchem.a022435;
RA   Iwamuro S., Saeki M., Kato S.;
RT   "Multi-ubiquitination of a nascent membrane protein produced in a
RT   rabbit reticulocyte lysate.";
RL   J. Biochem. 126:48-53(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Deng H.-X., Wei Y.-Q., Zhao X., Yang H.-S., Wang R., Yang J.-L.;
RT   "Identification of angiogenesis-related genes from placenta by
RT   xenogeneic antibody screening.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Promyelocytic leukemia;
RA   Yu W.-Q., Sun B.-Z., Chai Y.-B., Zhu F., Liu X.-S., Li Z., Lu F.,
RA   Yan W., Yang H., Zhao Z.-L.;
RT   "Human acute promyelocytic leukemia cell line NB4's
RT   apoptosis/differentiation related genes.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-188, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   INVOLVEMENT IN CFSMR, TISSUE SPECIFICITY, AND VARIANT CFSMR
RP   47-SER--SER-188 DEL.
RX   PubMed=20018682; DOI=10.1073/pnas.0908457107;
RA   Xin B., Puffenberger E.G., Turben S., Tan H., Zhou A., Wang H.;
RT   "Homozygous frameshift mutation in TMCO1 causes a syndrome with
RT   craniofacial dysmorphism, skeletal anomalies, and mental
RT   retardation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:258-263(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-188, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INVOLVEMENT IN POAG.
RX   PubMed=21532571; DOI=10.1038/ng.824;
RA   Burdon K.P., Macgregor S., Hewitt A.W., Sharma S., Chidlow G.,
RA   Mills R.A., Danoy P., Casson R., Viswanathan A.C., Liu J.Z.,
RA   Landers J., Henders A.K., Wood J., Souzeau E., Crawford A., Leo P.,
RA   Wang J.J., Rochtchina E., Nyholt D.R., Martin N.G., Montgomery G.W.,
RA   Mitchell P., Brown M.A., Mackey D.A., Craig J.E.;
RT   "Genome-wide association study identifies susceptibility loci for open
RT   angle glaucoma at TMCO1 and CDKN2B-AS1.";
RL   Nat. Genet. 43:574-578(2011).
RN   [16]
RP   INVOLVEMENT IN POAG, AND TISSUE SPECIFICITY.
RX   PubMed=22714896; DOI=10.1167/iovs.11-9047;
RA   Sharma S., Burdon K.P., Chidlow G., Klebe S., Crawford A.,
RA   Dimasi D.P., Dave A., Martin S., Javadiyan S., Wood J.P., Casson R.,
RA   Danoy P., Griggs K., Hewitt A.W., Landers J., Mitchell P.,
RA   Mackey D.A., Craig J.E.;
RT   "Association of genetic variants in the TMCO1 gene with clinical
RT   parameters related to glaucoma and characterization of the protein in
RT   the eye.";
RL   Invest. Ophthalmol. Vis. Sci. 53:4917-4925(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   VARIANT CFSMR 87-ARG--SER-188 DEL.
RX   PubMed=23320496; DOI=10.1111/cge.12088;
RA   Caglayan A.O., Per H., Akgumus G., Gumus H., Baranoski J.,
RA   Canpolat M., Calik M., Yikilmaz A., Bilguvar K., Kumandas S.,
RA   Gunel M.;
RT   "Whole-exome sequencing identified a patient with TMCO1 defect
RT   syndrome and expands the phenotic spectrum.";
RL   Clin. Genet. 84:394-395(2013).
RN   [19]
RP   VARIANT CFSMR 87-ARG--SER-188 DEL.
RX   PubMed=24194475; DOI=10.1002/ajmg.a.36248;
RA   Alanay Y., Erguener B., Utine E., Hacariz O., Kiper P.O.,
RA   Taskiran E.Z., Percin F., Uz E., Sagiroglu M.S., Yuksel B.,
RA   Boduroglu K., Akarsu N.A.;
RT   "TMCO1 deficiency causes autosomal recessive cerebrofaciothoracic
RT   dysplasia.";
RL   Am. J. Med. Genet. A 164A:291-304(2014).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, TOPOLOGY, AND MUTAGENESIS OF
RP   ASP-140.
RX   PubMed=27212239; DOI=10.1016/j.cell.2016.04.051;
RA   Wang Q.C., Zheng Q., Tan H., Zhang B., Li X., Yang Y., Yu J., Liu Y.,
RA   Chai H., Wang X., Sun Z., Wang J.Q., Zhu S., Wang F., Yang M., Guo C.,
RA   Wang H., Zheng Q., Li Y., Chen Q., Zhou A., Tang T.S.;
RT   "TMCO1 is an ER Ca(2+) load-activated Ca(2+) channel.";
RL   Cell 165:1454-1466(2016).
CC   -!- FUNCTION: Calcium-selective channel required to prevent calcium
CC       stores from overfilling, thereby playing a key role in calcium
CC       homeostasis (PubMed:27212239). In response to endoplasmic
CC       reticulum overloading, assembles into a homotetramer, forming a
CC       functional calcium-selective channel, regulating the calcium
CC       content in endoplasmic reticulum store (PubMed:27212239).
CC       {ECO:0000269|PubMed:27212239}.
CC   -!- SUBUNIT: Homodimer and homotetramer (PubMed:27212239). Homodimer
CC       under resting conditions; forms homotetramers following and
CC       endoplasmic reticulum calcium overload (PubMed:27212239).
CC       {ECO:0000269|PubMed:27212239}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10393320, ECO:0000269|PubMed:27212239}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:10393320,
CC       ECO:0000269|PubMed:27212239}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10393320}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10393320}. Note=The first transmembrane region
CC       is required for localization to the endoplasmic reticulum
CC       (PubMed:27212239). A publication reported localization in
CC       cytoplasm and nucleus (PubMed:22714896). Nuclear localization is
CC       however in contradiction with two other reports (PubMed:10393320,
CC       PubMed:27212239). {ECO:0000269|PubMed:10393320,
CC       ECO:0000269|PubMed:22714896, ECO:0000269|PubMed:27212239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UM00-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UM00-2; Sequence=VSP_019505;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues,
CC       with higher levels in thymus, prostate, testis and small intestine
CC       and lower levels in brain, placenta, lung and kidney
CC       (PubMed:10393320, PubMed:20018682). Present in most tissues in the
CC       eye, including the trabecular meshwork and retina (at protein
CC       level) (PubMed:22714896). {ECO:0000269|PubMed:10393320,
CC       ECO:0000269|PubMed:20018682, ECO:0000269|PubMed:22714896}.
CC   -!- DISEASE: Craniofacial dysmorphism, skeletal anomalies and mental
CC       retardation syndrome (CFSMR) [MIM:213980]: A disorder
CC       characterized by craniofacial and skeletal anomalies, associated
CC       with mental retardation. Typical craniofacial dysmorphism include
CC       brachycephaly, highly arched bushy eyebrows, synophrys, long
CC       eyelashes, low-set ears, microdontism of primary teeth, and
CC       generalized gingival hyperplasia, whereas Sprengel deformity of
CC       scapula, fusion of spine, rib abnormities, pectus excavatum, and
CC       pes planus represent skeletal anomalies.
CC       {ECO:0000269|PubMed:20018682, ECO:0000269|PubMed:23320496,
CC       ECO:0000269|PubMed:24194475}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Glaucoma, primary open angle (POAG) [MIM:137760]: A
CC       complex and genetically heterogeneous ocular disorder
CC       characterized by a specific pattern of optic nerve and visual
CC       field defects. The angle of the anterior chamber of the eye is
CC       open, and usually the intraocular pressure is increased. However,
CC       glaucoma can occur at any intraocular pressure. The disease is
CC       generally asymptomatic until the late stages, by which time
CC       significant and irreversible optic nerve damage has already taken
CC       place. In some cases, POAG shows digenic inheritance involving
CC       mutations in CYP1B1 and MYOC genes. {ECO:0000269|PubMed:21532571,
CC       ECO:0000269|PubMed:22714896}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the TMCO1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC25388.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAK07514.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAK07549.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB020980; BAA86974.1; -; mRNA.
DR   EMBL; AY763589; AAV34755.1; -; mRNA.
DR   EMBL; AF070626; AAC25388.1; ALT_INIT; mRNA.
DR   EMBL; AF274935; AAK07514.1; ALT_FRAME; mRNA.
DR   EMBL; AF277194; AAK07549.1; ALT_FRAME; mRNA.
DR   EMBL; AY359027; AAQ89386.1; -; mRNA.
DR   EMBL; AK316610; BAG38197.1; -; mRNA.
DR   EMBL; AL451074; CAH74064.1; -; Genomic_DNA.
DR   EMBL; BC000104; AAH00104.1; -; mRNA.
DR   RefSeq; NP_061899.2; NM_019026.4.
DR   UniGene; Hs.31498; -.
DR   ProteinModelPortal; Q9UM00; -.
DR   BioGrid; 119995; 45.
DR   IntAct; Q9UM00; 25.
DR   STRING; 9606.ENSP00000375975; -.
DR   TCDB; 1.A.106.1.1; the calcium load-activated calcium channel (clac) family.
DR   iPTMnet; Q9UM00; -.
DR   PhosphoSitePlus; Q9UM00; -.
DR   SwissPalm; Q9UM00; -.
DR   BioMuta; TMCO1; -.
DR   DMDM; 74753399; -.
DR   EPD; Q9UM00; -.
DR   PaxDb; Q9UM00; -.
DR   PeptideAtlas; Q9UM00; -.
DR   PRIDE; Q9UM00; -.
DR   TopDownProteomics; Q9UM00-1; -. [Q9UM00-1]
DR   DNASU; 54499; -.
DR   Ensembl; ENST00000392129; ENSP00000375975; ENSG00000143183. [Q9UM00-1]
DR   GeneID; 54499; -.
DR   KEGG; hsa:54499; -.
DR   UCSC; uc057mzb.1; human. [Q9UM00-1]
DR   CTD; 54499; -.
DR   DisGeNET; 54499; -.
DR   EuPathDB; HostDB:ENSG00000143183.16; -.
DR   GeneCards; TMCO1; -.
DR   HGNC; HGNC:18188; TMCO1.
DR   HPA; HPA054768; -.
DR   MalaCards; TMCO1; -.
DR   MIM; 137760; phenotype.
DR   MIM; 213980; phenotype.
DR   MIM; 614123; gene.
DR   neXtProt; NX_Q9UM00; -.
DR   OpenTargets; ENSG00000143183; -.
DR   Orphanet; 1394; Cerebro-facio-thoracic dysplasia.
DR   PharmGKB; PA142670792; -.
DR   eggNOG; KOG3312; Eukaryota.
DR   eggNOG; ENOG410XR8B; LUCA.
DR   GeneTree; ENSGT00390000002659; -.
DR   HOGENOM; HOG000240371; -.
DR   HOVERGEN; HBG054437; -.
DR   InParanoid; Q9UM00; -.
DR   KO; K21891; -.
DR   PhylomeDB; Q9UM00; -.
DR   TreeFam; TF315045; -.
DR   ChiTaRS; TMCO1; human.
DR   GeneWiki; TMCO1; -.
DR   GenomeRNAi; 54499; -.
DR   PRO; PR:Q9UM00; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143183; -.
DR   CleanEx; HS_TMCO1; -.
DR   ExpressionAtlas; Q9UM00; baseline and differential.
DR   Genevisible; Q9UM00; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006983; P:ER overload response; IDA:UniProtKB.
DR   InterPro; IPR002809; EMC3/TMCO1.
DR   InterPro; IPR008559; TMCO1.
DR   PANTHER; PTHR20917; PTHR20917; 1.
DR   Pfam; PF01956; DUF106; 1.
DR   PIRSF; PIRSF023322; DUF841_euk; 1.
DR   SMART; SM01415; DUF106; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glaucoma; Golgi apparatus; Ion channel;
KW   Ion transport; Membrane; Mental retardation; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    188       Calcium load-activated calcium channel.
FT                                /FTId=PRO_0000244076.
FT   TOPO_DOM      1      9       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27212239}.
FT   TRANSMEM     10     30       Helical. {ECO:0000255}.
FT   TOPO_DOM     31     90       Lumenal. {ECO:0000305|PubMed:27212239}.
FT   TRANSMEM     91    111       Helical. {ECO:0000255}.
FT   TOPO_DOM    112    137       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27212239}.
FT   INTRAMEM    138    154       Pore-forming.
FT                                {ECO:0000305|PubMed:27212239}.
FT   TOPO_DOM    155    188       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27212239}.
FT   COILED       32     89       {ECO:0000255}.
FT   COMPBIAS    180    183       Poly-Pro.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     188    188       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ      64     82       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_019505.
FT   VARIANT      47    188       Missing (in CFSMR).
FT                                {ECO:0000269|PubMed:20018682}.
FT                                /FTId=VAR_076652.
FT   VARIANT      87    188       Missing (in CFSMR).
FT                                {ECO:0000269|PubMed:23320496,
FT                                ECO:0000269|PubMed:24194475}.
FT                                /FTId=VAR_076653.
FT   MUTAGEN     140    140       D->A: Abolishes the calcium channel
FT                                activity. {ECO:0000269|PubMed:27212239}.
FT   MUTAGEN     140    140       D->E: Retains some of the calcium channel
FT                                activity. {ECO:0000269|PubMed:27212239}.
FT   CONFLICT    129    129       S -> P (in Ref. 4; AAK07514/AAK07549).
FT                                {ECO:0000305}.
SQ   SEQUENCE   188 AA;  21175 MW;  FB77BFC4F0629EB1 CRC64;
     MSTMFADTLL IVFISVCTAL LAEGITWVLV YRTDKYKRLK AEVEKQSKKL EKKKETITES
     AGRQQKKKIE RQEEKLKNNN RDLSMVRMKS MFAIGFCFTA LMGMFNSIFD GRVVAKLPFT
     PLSYIQGLSH RNLLGDDTTD CSFIFLYILC TMSIRQNIQK ILGLAPSRAA TKQAGGFLGP
     PPPSGKFS
//
ID   TRPG_DROME              Reviewed;        1128 AA.
AC   Q9VJJ7; A4V0S8; Q9N6L1;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   22-NOV-2017, entry version 146.
DE   RecName: Full=Transient receptor potential-gamma protein;
DE            Short=TRPgamma;
DE   AltName: Full=Transient receptor potential cation channel gamma;
GN   Name=Trpgamma; ORFNames=CG5996;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH TRP AND TRPL,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Head;
RX   PubMed=10896160; DOI=10.1016/S0896-6273(00)81201-5;
RA   Xu X.-Z.S., Chien F., Butler A., Salkoff L., Montell C.;
RT   "TRPgamma, a Drosophila TRP-related subunit, forms a regulated cation
RT   channel with TRPL.";
RL   Neuron 26:647-657(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: A light-sensitive calcium channel that is required for
CC       inositide-mediated Ca(2+) entry in the retina during phospholipase
CC       C (PLC)-mediated phototransduction (By similarity). Forms a
CC       regulated cation channel when heteromultimerized with trpl.
CC       {ECO:0000250, ECO:0000269|PubMed:10896160}.
CC   -!- SUBUNIT: Interacts preferentially with trpl and interacts to a
CC       lower extent with trp. {ECO:0000269|PubMed:10896160}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the rhabdomeres of
CC       photoreceptor cells. {ECO:0000269|PubMed:10896160}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ277967; CAB96204.1; -; mRNA.
DR   EMBL; AJ277968; CAB96205.1; -; mRNA.
DR   EMBL; AE014134; AAF53548.2; -; Genomic_DNA.
DR   EMBL; AE014134; AAN10950.1; -; Genomic_DNA.
DR   RefSeq; NP_609802.1; NM_135958.5.
DR   RefSeq; NP_723983.1; NM_165169.5.
DR   ProteinModelPortal; Q9VJJ7; -.
DR   SMR; Q9VJJ7; -.
DR   BioGrid; 60999; 1.
DR   IntAct; Q9VJJ7; 2.
DR   STRING; 7227.FBpp0080498; -.
DR   PaxDb; Q9VJJ7; -.
DR   PRIDE; Q9VJJ7; -.
DR   EnsemblMetazoa; FBtr0080945; FBpp0080498; FBgn0032593.
DR   EnsemblMetazoa; FBtr0080946; FBpp0080499; FBgn0032593.
DR   GeneID; 34991; -.
DR   KEGG; dme:Dmel_CG5996; -.
DR   UCSC; CG5996-RA; d. melanogaster.
DR   CTD; 34991; -.
DR   FlyBase; FBgn0032593; Trpgamma.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   InParanoid; Q9VJJ7; -.
DR   KO; K04967; -.
DR   OrthoDB; EOG091G029I; -.
DR   PhylomeDB; Q9VJJ7; -.
DR   Reactome; R-DME-3295583; TRP channels.
DR   Reactome; R-DME-5578775; Ion homeostasis.
DR   Reactome; R-DME-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; Q9VJJ7; -.
DR   GenomeRNAi; 34991; -.
DR   PRO; PR:Q9VJJ7; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0032593; -.
DR   ExpressionAtlas; Q9VJJ7; differential.
DR   Genevisible; Q9VJJ7; DM.
DR   GO; GO:0034703; C:cation channel complex; IPI:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:FlyBase.
DR   GO; GO:1990635; C:proximal dendrite; IDA:FlyBase.
DR   GO; GO:0016028; C:rhabdomere; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:FlyBase.
DR   GO; GO:0022833; F:mechanically gated channel activity; IDA:FlyBase.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0007628; P:adult walking behavior; IMP:FlyBase.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:FlyBase.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; ISS:UniProtKB.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; IMP:FlyBase.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0009416; P:response to light stimulus; ISS:UniProtKB.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; Sensory transduction; Transmembrane;
KW   Transmembrane helix; Transport; Vision.
FT   CHAIN         1   1128       Transient receptor potential-gamma
FT                                protein.
FT                                /FTId=PRO_0000215358.
FT   TOPO_DOM      1    325       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    403       Extracellular. {ECO:0000255}.
FT   TRANSMEM    404    424       Helical. {ECO:0000255}.
FT   TOPO_DOM    425    444       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    445    465       Helical. {ECO:0000255}.
FT   TOPO_DOM    466    492       Extracellular. {ECO:0000255}.
FT   TRANSMEM    493    513       Helical. {ECO:0000255}.
FT   TOPO_DOM    514    535       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    536    556       Helical. {ECO:0000255}.
FT   TOPO_DOM    557    629       Extracellular. {ECO:0000255}.
FT   TRANSMEM    630    650       Helical. {ECO:0000255}.
FT   TOPO_DOM    651   1128       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       57     86       ANK 1.
FT   REPEAT      131    160       ANK 2.
FT   CONFLICT    195    195       S -> G (in Ref. 1; CAB96204/CAB96205).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       F -> L (in Ref. 1; CAB96204/CAB96205).
FT                                {ECO:0000305}.
FT   CONFLICT   1053   1053       D -> N (in Ref. 1; CAB96204/CAB96205).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1128 AA;  127109 MW;  A0B519C7DFBE5983 CRC64;
     MMEEENTIRP HQEIRQLTLE EKKFLLAVER GDMAGTRRML QKAQDTEYIN VNCVDPLGRT
     ALLMAIDNEN LEMVELLINY NVDTKDALLH SISEEFVEAV EVLLDHENVT FHSEGNHSWE
     SASEDTSTFT PDITPLILAA HRDNYEIIKI LLDRGAVLPM PHDVRCGCDE CVQSRQEDSL
     RHSRSRINAY RALASPSLIA LSSKDPILTA FELSWELRRL SFLEHEFKNE YQELRKQCQD
     FATALLDHTR TSHELEILLN HDPTGPVYEH GERMHLNRLK LAIKLRQKKF VAHSNVQQLL
     ASIWYEGLPG FRRKNMALQA VDIIRIGIMF PIFSLAYILA PYSSIGQTMR KPFIKFICHS
     ASYFTFLFLL MLASQRIETF IGGWFFADSS GMLNTMEELP TKRGAKPTFI EWLILAWVSG
     LIWSEVKQLW DVGLQEYLND MWNVIDFVTN SLYVATVALR VVSFFQVQKE MIYNSHATDL
     PRERWDAWDP MLISEGLFSA ANIFSSLKLV YIFSVNPHLG PLQVSLSRMV MDIMKFFFLY
     VLVLFAFGSG LNQLLWYYAD LEKKRCPEVS PMSALLNMNG TNDPNACIVW RRFSNLFETT
     QTLFWAVFGL IDLDSFELDG IKIFTRFWGM LMFGTYSVIN IVVLLNLLIA MMNHSYQLIS
     ERADVEWKFA RSKLWISYFE EGGTCPPPFN IIPTPKSIWY AIKWMRRVFC SGSSAARREH
     LKTIRRKAQQ ASDRDFKYQQ IMRNLVRRYV TVEQRKAESQ GVTEDDVNEI KQDISAFRCE
     LVEILKNSGM DTNVTAGQGG GGGGKKNRQK ERRLMKGFNI APPGSTGSLA PVAEFSTSLD
     NYDNQHEILS STLSTLFTPN FMHKRQQSQA GSGGGGSESP TTPTAPQGTQ GAAMTASSQV
     TKYNKSALKP YNKRIAGHKK RWGTLIEAAK VGNVSKMLGR SKSEDSVCNS SHTSTPVHGQ
     MRVTYAQNSP QQEYGYHGET SSTTISTPTP TISVVSNSPA AHAGVGSHFF HTTSGLTAIA
     ALKRKRKKFS SSKNICPVTE SVAAANAAEI LNDKTLKRVS SYPAAEAGVQ HNPAQLVKPR
     RHEQTQSQHD SVETNSTFTL SIDPSNTSVN SREPLISTSC VSTTGAIG
//
ID   TRPV2_RAT               Reviewed;         761 AA.
AC   Q9WUD2; Q5FWT3; Q9JMI8; Q9QYH8;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   22-NOV-2017, entry version 145.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 2;
DE            Short=TrpV2;
DE   AltName: Full=Osm-9-like TRP channel 2;
DE            Short=OTRPC2;
DE   AltName: Full=Stretch-activated channel 2B;
DE   AltName: Full=Vanilloid receptor-like protein 1;
DE            Short=VRL-1;
GN   Name=Trpv2; Synonyms=Sac2b, Vrl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10201375; DOI=10.1038/18906;
RA   Caterina M.J., Rosen T.A., Tominaga M., Brake A.J., Julius D.;
RT   "A capsaicin-receptor homologue with a high threshold for noxious
RT   heat.";
RL   Nature 398:436-441(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Ishibashi K.;
RT   "Molecular cloning of a stretch activated channel from rat kidney.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Suzuki M.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RX   PubMed=14622291; DOI=10.1046/j.1432-1033.2003.03811.x;
RA   Jahnel R., Bender O., Munter L.M., Dreger M., Gillen C., Hucho F.;
RT   "Dual expression of mouse and rat VRL-1 in the dorsal root ganglion
RT   derived cell line F-11 and biochemical analysis of VRL-1 after
RT   heterologous expression.";
RL   Eur. J. Biochem. 270:4264-4271(2003).
RN   [6]
RP   INTERACTION WITH SLC50A1, AND SUBCELLULAR LOCATION.
RX   PubMed=14991772; DOI=10.1002/jcb.10775;
RA   Barnhill J.C., Stokes A.J., Koblan-Huberson M., Shimoda L.M.,
RA   Muraguchi A., Adra C.N., Turner H.;
RT   "RGA protein associates with a TRPV ion channel during biosynthesis
RT   and trafficking.";
RL   J. Cell. Biochem. 91:808-820(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, SUBUNIT,
RP   PHOSPHORYLATION, AND INTERACTION WITH PRKAR2 AND ACBD3.
RX   PubMed=15249591; DOI=10.1084/jem.20032082;
RA   Stokes A.J., Shimoda L.M., Koblan-Huberson M., Adra C.N., Turner H.;
RT   "A TRPV2-PKA signaling module for transduction of physical stimuli in
RT   mast cells.";
RL   J. Exp. Med. 200:137-147(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-82 AND SER-760,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 75-321, AND ANK REPEATS.
RX   PubMed=16809337; DOI=10.1074/jbc.C600153200;
RA   Jin X., Touhey J., Gaudet R.;
RT   "Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion
RT   channel.";
RL   J. Biol. Chem. 281:25006-25010(2006).
CC   -!- FUNCTION: Calcium-permeable, non-selective cation channel with an
CC       outward rectification. Seems to be regulated, at least in part, by
CC       growth factors, like IGF1, PDGF and morphogenetic
CC       neuropeptide/head activator. May transduce physical stimuli in
CC       mast cells. Activated by temperatures higher than 52 degrees
CC       Celsius; is not activated by vanilloids and acidic pH (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:10201375,
CC       ECO:0000269|PubMed:15249591}.
CC   -!- SUBUNIT: Homotetramer (Probable). Interacts with a cAMP-dependent
CC       protein kinase type II regulatory subunit (PRKAR2A or PRKAR2B) and
CC       ACBD3. Interacts with SLC50A1; the interaction probably occurs
CC       intracellularly and depends on TRPV2 N-glycosylation.
CC       {ECO:0000269|PubMed:14991772, ECO:0000269|PubMed:15249591,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-11689641, EBI-11689641;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasm {ECO:0000250}. Melanosome {ECO:0000250}.
CC       Note=Translocates from the cytoplasm to the plasma membrane upon
CC       ligand stimulation. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in dorsal
CC       root ganglia, trigeminal ganglia, spinal chord (Lissauer's tract,
CC       dorsal horn and dorsal columns) (at protein level).
CC       {ECO:0000269|PubMed:10201375, ECO:0000269|PubMed:15249591}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:14622291}.
CC   -!- PTM: Phosphorylated by PKA. {ECO:0000269|PubMed:15249591}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       TrpV subfamily. TRPV2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA93435.1; Type=Frameshift; Positions=758; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF129113; AAD26364.1; -; mRNA.
DR   EMBL; AB029330; BAA88637.1; -; mRNA.
DR   EMBL; AB022332; BAA93435.1; ALT_FRAME; mRNA.
DR   EMBL; BC089215; AAH89215.1; -; mRNA.
DR   RefSeq; NP_001257726.1; NM_001270797.1.
DR   RefSeq; NP_001257727.1; NM_001270798.1.
DR   RefSeq; NP_058903.2; NM_017207.3.
DR   UniGene; Rn.206528; -.
DR   PDB; 2ETA; X-ray; 2.20 A; A/B=75-321.
DR   PDB; 2ETB; X-ray; 1.65 A; A=75-321.
DR   PDB; 2ETC; X-ray; 3.10 A; A/B=62-326.
DR   PDB; 5HI9; EM; 4.40 A; A/B/C/D=1-761.
DR   PDBsum; 2ETA; -.
DR   PDBsum; 2ETB; -.
DR   PDBsum; 2ETC; -.
DR   PDBsum; 5HI9; -.
DR   ProteinModelPortal; Q9WUD2; -.
DR   SMR; Q9WUD2; -.
DR   DIP; DIP-60657N; -.
DR   IntAct; Q9WUD2; 1.
DR   STRING; 10116.ENSRNOP00000004248; -.
DR   BindingDB; Q9WUD2; -.
DR   ChEMBL; CHEMBL2863; -.
DR   GuidetoPHARMACOLOGY; 508; -.
DR   iPTMnet; Q9WUD2; -.
DR   PhosphoSitePlus; Q9WUD2; -.
DR   SwissPalm; Q9WUD2; -.
DR   PaxDb; Q9WUD2; -.
DR   PRIDE; Q9WUD2; -.
DR   GeneID; 29465; -.
DR   KEGG; rno:29465; -.
DR   UCSC; RGD:3965; rat.
DR   CTD; 51393; -.
DR   RGD; 3965; Trpv2.
DR   eggNOG; KOG3676; Eukaryota.
DR   eggNOG; ENOG4110DG4; LUCA.
DR   HOGENOM; HOG000234630; -.
DR   HOVERGEN; HBG054085; -.
DR   InParanoid; Q9WUD2; -.
DR   KO; K04971; -.
DR   PhylomeDB; Q9WUD2; -.
DR   TreeFam; TF314711; -.
DR   EvolutionaryTrace; Q9WUD2; -.
DR   PRO; PR:Q9WUD2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044295; C:axonal growth cone; ISO:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0012505; C:endomembrane system; IDA:UniProtKB.
DR   GO; GO:0032584; C:growth cone membrane; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IDA:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005261; F:cation channel activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:RGD.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISO:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISO:RGD.
DR   GO; GO:0009408; P:response to heat; IDA:RGD.
DR   GO; GO:0009266; P:response to temperature stimulus; ISO:RGD.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008347; TRPV1-4_channel.
DR   InterPro; IPR024865; TRPV2_channel.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF5; PTHR10582:SF5; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Complete proteome; Cytoplasm; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    761       Transient receptor potential cation
FT                                channel subfamily V member 2.
FT                                /FTId=PRO_0000215344.
FT   TOPO_DOM      1    392       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    393    413       Helical. {ECO:0000255}.
FT   TOPO_DOM    414    433       Extracellular. {ECO:0000255}.
FT   TRANSMEM    434    454       Helical. {ECO:0000255}.
FT   TOPO_DOM    455    460       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical. {ECO:0000255}.
FT   TOPO_DOM    482    495       Extracellular. {ECO:0000255}.
FT   TRANSMEM    496    516       Helical. {ECO:0000255}.
FT   TOPO_DOM    517    537       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    538    558       Helical. {ECO:0000255}.
FT   INTRAMEM    573    609       Pore-forming. {ECO:0000255}.
FT   TRANSMEM    622    642       Helical. {ECO:0000255}.
FT   TOPO_DOM    643    761       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       73    115       ANK 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REPEAT      116    162       ANK 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REPEAT      163    208       ANK 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REPEAT      209    244       ANK 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REPEAT      245    293       ANK 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REPEAT      294    320       ANK 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00023,
FT                                ECO:0000269|PubMed:16809337}.
FT   REGION        1    390       Required for interaction with SLC50A1.
FT                                {ECO:0000269|PubMed:14991772}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WTR1}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     748    748       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WTR1}.
FT   MOD_RES     760    760       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD    571    571       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    572    572       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    151    151       L -> P (in Ref. 1 and 4). {ECO:0000305}.
FT   CONFLICT    158    158       T -> I (in Ref. 4; AAH89215).
FT                                {ECO:0000305}.
FT   CONFLICT    713    713       A -> V (in Ref. 4; AAH89215).
FT                                {ECO:0000305}.
FT   HELIX        77     86       {ECO:0000244|PDB:2ETB}.
FT   HELIX        89     92       {ECO:0000244|PDB:2ETB}.
FT   HELIX        95    102       {ECO:0000244|PDB:2ETB}.
FT   HELIX       109    111       {ECO:0000244|PDB:2ETB}.
FT   TURN        114    116       {ECO:0000244|PDB:2ETB}.
FT   HELIX       120    126       {ECO:0000244|PDB:2ETB}.
FT   HELIX       136    145       {ECO:0000244|PDB:2ETB}.
FT   HELIX       152    154       {ECO:0000244|PDB:2ETB}.
FT   TURN        160    164       {ECO:0000244|PDB:2ETB}.
FT   HELIX       167    173       {ECO:0000244|PDB:2ETB}.
FT   HELIX       177    185       {ECO:0000244|PDB:2ETB}.
FT   HELIX       197    199       {ECO:0000244|PDB:2ETB}.
FT   STRAND      203    205       {ECO:0000244|PDB:2ETB}.
FT   HELIX       213    219       {ECO:0000244|PDB:2ETB}.
FT   HELIX       223    231       {ECO:0000244|PDB:2ETB}.
FT   STRAND      233    235       {ECO:0000244|PDB:2ETA}.
FT   HELIX       249    256       {ECO:0000244|PDB:2ETB}.
FT   HELIX       261    281       {ECO:0000244|PDB:2ETB}.
FT   HELIX       287    289       {ECO:0000244|PDB:2ETB}.
FT   HELIX       298    304       {ECO:0000244|PDB:2ETB}.
FT   HELIX       308    321       {ECO:0000244|PDB:2ETB}.
SQ   SEQUENCE   761 AA;  86706 MW;  8977CDE1D5351EC8 CRC64;
     MTSASSPPAF RLETSDGDEE GNAEVNKGKQ EPPPMESPFQ REDRNSSPQI KVNLNFIKRP
     PKNTSAPSQQ EPDRFDRDRL FSVVSRGVPE ELTGLLEYLR WNSKYLTDSA YTEGSTGKTC
     LMKAVLNLQD GVNACIMPLL QIDKDSGNPK LLVNAQCTDE FYQGHSALHI AIEKRSLQCV
     KLLVENGADV HLRACGRFFQ KHQGTCFYFG ELPLSLAACT KQWDVVTYLL ENPHQPASLE
     ATDSLGNTVL HALVMIADNS PENSALVIHM YDGLLQMGAR LCPTVQLEEI SNHQGLTPLK
     LAAKEGKIEI FRHILQREFS GPYQPLSRKF TEWCYGPVRV SLYDLSSVDS WEKNSVLEII
     AFHCKSPNRH RMVVLEPLNK LLQEKWDRLV SRFFFNFACY LVYMFIFTVV AYHQPSLDQP
     AIPSSKATFG ESMLLLGHIL ILLGGIYLLL GQLWYFWRRR LFIWISFMDS YFEILFLLQA
     LLTVLSQVLR FMETEWYLPL LVLSLVLGWL NLLYYTRGFQ HTGIYSVMIQ KVILRDLLRF
     LLVYLVFLFG FAVALVSLSR EARSPKAPED NNSTVTEQPT VGQEEEPAPY RSILDASLEL
     FKFTIGMGEL AFQEQLRFRG VVLLLLLAYV LLTYVLLLNM LIALMSETVN HVADNSWSIW
     KLQKAISVLE MENGYWWCRR KKHREGRLLK VGTRGDGTPD ERWCFRVEEV NWAAWEKTLP
     TLSEDPSGPG ITGNKKNPTS KPGKNSASEE DHLPLQVLQS P
//
ID   TRPC6_HUMAN             Reviewed;         931 AA.
AC   Q9Y210; Q52M59; Q9HCW3; Q9NQA8; Q9NQA9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   20-DEC-2017, entry version 165.
DE   RecName: Full=Short transient receptor potential channel 6;
DE            Short=TrpC6 {ECO:0000303|PubMed:9930701};
DE   AltName: Full=Transient receptor protein 6;
DE            Short=TRP-6;
GN   Name=TRPC6 {ECO:0000303|PubMed:9930701, ECO:0000312|HGNC:HGNC:12338};
GN   Synonyms=TRP6 {ECO:0000303|Ref.5};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=9930701; DOI=10.1038/16711;
RA   Hofmann T., Obukhov A.G., Schaefer M., Harteneck C., Gudermann T.,
RA   Schultz G.;
RT   "Direct activation of human TRPC6 and TRPC3 channels by
RT   diacylglycerol.";
RL   Nature 397:259-263(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=9925922;
RA   D'Esposito M., Strazzullo M., Cuccurese M., Spalluto C., Rocchi M.,
RA   D'Urso M., Ciccodicola A.;
RT   "Identification and assignment of the human transient receptor
RT   potential channel 6 gene TRPC6 to chromosome 11q21-22.";
RL   Cytogenet. Cell Genet. 83:46-47(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=10816590; DOI=10.1074/jbc.M003408200;
RA   Philipp S., Trost C., Warnat J., Rautmann J., Himmerkus N.,
RA   Schroth G., Kretz O., Nastainczyk W., Cavalie A., Hoth M.,
RA   Flockerzi V.;
RT   "TRP4 (CCE1) protein is part of native calcium release-activated Ca2+-
RT   like channels in adrenal cells.";
RL   J. Biol. Chem. 275:23965-23972(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 487-643.
RA   Fenech C.J., Prestwich S.A., Zholos A.V., Bolton T.B.;
RT   "The capacitative calcium entry cation channel Trp6 is expressed in
RT   the muscularis externa of the guinea pig ileum and in a human jejunum
RT   smooth muscle cell line.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   GLYCOSYLATION AT ASN-473 AND ASN-561, AND MUTAGENESIS OF ASN-561.
RX   PubMed=12970363; DOI=10.1074/jbc.M302983200;
RA   Dietrich A., Mederos y Schnitzler M., Emmel J., Kalwa H., Hofmann T.,
RA   Gudermann T.;
RT   "N-linked protein glycosylation is a major determinant for basal TRPC3
RT   and TRPC6 channel activity.";
RL   J. Biol. Chem. 278:47842-47852(2003).
RN   [7]
RP   INTERACTION WITH MX1.
RX   PubMed=15757897; DOI=10.1074/jbc.M500391200;
RA   Lussier M.P., Cayouette S., Lepage P.K., Bernier C.L., Francoeur N.,
RA   St-Hilaire M., Pinard M., Boulay G.;
RT   "MxA, a member of the dynamin superfamily, interacts with the ankyrin-
RT   like repeat domain of TRPC.";
RL   J. Biol. Chem. 280:19393-19400(2005).
RN   [8]
RP   INTERACTION WITH RNF24, AND MUTAGENESIS OF ASN-125; ASN-127; CYS-128
RP   AND ASP-130.
RX   PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009;
RA   Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.;
RT   "RNF24, a new TRPC interacting protein, causes the intracellular
RT   retention of TRPC.";
RL   Cell Calcium 43:432-443(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-815, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [10]
RP   VARIANTS FSGS2 SER-143; THR-270; CYS-895 AND LYS-897, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15924139; DOI=10.1038/ng1592;
RA   Reiser J., Polu K.R., Moller C.C., Kenlan P., Altintas M.M., Wei C.,
RA   Faul C., Herbert S., Villegas I., Avila-Casado C., McGee M.,
RA   Sugimoto H., Brown D., Kalluri R., Mundel P., Smith P.L.,
RA   Clapham D.E., Pollak M.R.;
RT   "TRPC6 is a glomerular slit diaphragm-associated channel required for
RT   normal renal function.";
RL   Nat. Genet. 37:739-744(2005).
RN   [11]
RP   VARIANT FSGS2 GLN-112.
RX   PubMed=15879175; DOI=10.1126/science.1106215;
RA   Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T.,
RA   Hawkins A.F., Daskalakis N., Kwan S.Y., Ebersviller S.,
RA   Burchette J.L., Pericak-Vance M.A., Howell D.N., Vance J.M.,
RA   Rosenberg P.B.;
RT   "A mutation in the TRPC6 cation channel causes familial focal
RT   segmental glomerulosclerosis.";
RL   Science 308:1801-1804(2005).
RN   [12]
RP   VARIANT SER-15, AND MUTAGENESIS OF GLN-889.
RX   PubMed=19124028; DOI=10.1016/j.mrfmmm.2008.11.021;
RA   Zhu B., Chen N., Wang Z.H., Pan X.X., Ren H., Zhang W., Wang W.M.;
RT   "Identification and functional analysis of a novel TRPC6 mutation
RT   associated with late onset familial focal segmental glomerulosclerosis
RT   in Chinese patients.";
RL   Mutat. Res. 664:84-90(2009).
RN   [13]
RP   VARIANTS FSGS2 SER-109; SER-125 AND PRO-780.
RX   PubMed=19458060; DOI=10.1093/ndt/gfp229;
RG   FSGS Study Group;
RA   Santin S., Ars E., Rossetti S., Salido E., Silva I., Garcia-Maset R.,
RA   Gimenez I., Ruiz P., Mendizabal S., Luciano Nieto J., Pena A.,
RA   Camacho J.A., Fraga G., Cobo M.A., Bernis C., Ortiz A.,
RA   de Pablos A.L., Sanchez-Moreno A., Pintos G., Mirapeix E.,
RA   Fernandez-Llama P., Ballarin J., Torra R., Zamora I., Lopez-Hellin J.,
RA   Madrid A., Ventura C., Vilalta R., Espinosa L., Garcia C., Melgosa M.,
RA   Navarro M., Gimenez A., Cots J.V., Alexandra S., Caramelo C.,
RA   Egido J., San Jose M.D., de la Cerda F., Sala P., Raspall F., Vila A.,
RA   Daza A.M., Vazquez M., Ecija J.L., Espinosa M., Justa M.L., Poveda R.,
RA   Aparicio C., Rosell J., Muley R., Montenegro J., Gonzalez D.,
RA   Hidalgo E., de Frutos D.B., Trillo E., Gracia S., de los Rios F.J.;
RT   "TRPC6 mutational analysis in a large cohort of patients with focal
RT   segmental glomerulosclerosis.";
RL   Nephrol. Dial. Transplant. 24:3089-3096(2009).
RN   [14]
RP   VARIANTS SER-15 AND VAL-404, VARIANTS FSGS2 SER-143; THR-270 AND
RP   874-LYS--ARG-931 DEL, CHARACTERIZATION OF VARIANT FSGS2 SER-143,
RP   MUTAGENESIS OF MET-132, AND FUNCTION.
RX   PubMed=19936226; DOI=10.1371/journal.pone.0007771;
RA   Heeringa S.F., Moeller C.C., Du J., Yue L., Hinkes B., Chernin G.,
RA   Vlangos C.N., Hoyer P.F., Reiser J., Hildebrandt F.;
RT   "A novel TRPC6 mutation that causes childhood FSGS.";
RL   PLoS ONE 4:E7771-E7771(2009).
RN   [15]
RP   VARIANTS FSGS2 ALA-TYR-MET-PHE-88 INS AND ASP-757.
RX   PubMed=20798252; DOI=10.2215/CJN.01190210;
RA   Buescher A.K., Kranz B., Buescher R., Hildebrandt F., Dworniczak B.,
RA   Pennekamp P., Kuwertz-Broeking E., Wingen A.M., John U., Kemper M.,
RA   Monnens L., Hoyer P.F., Weber S., Konrad M.;
RT   "Immunosuppression and renal outcome in congenital and pediatric
RT   steroid-resistant nephrotic syndrome.";
RL   Clin. J. Am. Soc. Nephrol. 5:2075-2084(2010).
RN   [16]
RP   VARIANTS FSGS2 SER-125 AND LEU-218, AND VARIANT LEU-895.
RX   PubMed=21734084; DOI=10.2215/CJN.07830910;
RA   Gigante M., Caridi G., Montemurno E., Soccio M., d'Apolito M.,
RA   Cerullo G., Aucella F., Schirinzi A., Emma F., Massella L.,
RA   Messina G., De Palo T., Ranieri E., Ghiggeri G.M., Gesualdo L.;
RT   "TRPC6 mutations in children with steroid-resistant nephrotic syndrome
RT   and atypical phenotype.";
RL   Clin. J. Am. Soc. Nephrol. 6:1626-1634(2011).
RN   [17]
RP   VARIANT FSGS2 HIS-360.
RX   PubMed=22732337;
RA   Buescher A.K., Konrad M., Nagel M., Witzke O., Kribben A., Hoyer P.F.,
RA   Weber S.;
RT   "Mutations in podocyte genes are a rare cause of primary FSGS
RT   associated with ESRD in adult patients.";
RL   Clin. Nephrol. 78:47-53(2012).
RN   [18]
RP   VARIANT FSGS2 ALA-395, AND VARIANT VAL-404.
RX   PubMed=21511817; DOI=10.1093/ndt/gfr202;
RA   Mir S., Yavascan O., Berdeli A., Sozeri B.;
RT   "TRPC6 gene variants in Turkish children with steroid-resistant
RT   nephrotic syndrome.";
RL   Nephrol. Dial. Transplant. 27:205-209(2012).
RN   [19]
RP   VARIANTS FSGS2 THR-270; CYS-895; GLU-897 DEL AND LYS-897.
RX   PubMed=23014460; DOI=10.1038/ki.2012.349;
RA   Barua M., Brown E.J., Charoonratana V.T., Genovese G., Sun H.,
RA   Pollak M.R.;
RT   "Mutations in the INF2 gene account for a significant proportion of
RT   familial but not sporadic focal and segmental glomerulosclerosis.";
RL   Kidney Int. 83:316-322(2013).
RN   [20]
RP   VARIANTS FSGS2 GLN-175 AND CYS-895, CHARACTERIZATION OF VARIANTS FSGS2
RP   GLN-175 AND CYS-895, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23291369; DOI=10.1093/ndt/gfs572;
RA   Hofstra J.M., Lainez S., van Kuijk W.H., Schoots J., Baltissen M.P.,
RA   Hoefsloot L.H., Knoers N.V., Berden J.H., Bindels R.J.,
RA   van der Vlag J., Hoenderop J.G., Wetzels J.F., Nijenhuis T.;
RT   "New TRPC6 gain-of-function mutation in a non-consanguineous Dutch
RT   family with late-onset focal segmental glomerulosclerosis.";
RL   Nephrol. Dial. Transplant. 28:1830-1838(2013).
RN   [21]
RP   MUTAGENESIS OF ASN-110; MET-132; 755-GLU--GLY-757; 755-GLU-GLU-756;
RP   826-LYS-LYS-827 AND GLN-889, VARIANTS FSGS2 SER-109; GLN-112; SER-125;
RP   SER-143; GLN-175; LEU-218; ALA-395; ASP-757; PRO-780; CYS-895; LEU-895
RP   AND LYS-897, CHARACTERIZATION OF VARIANTS FSGS2 SER-109; GLN-112;
RP   SER-125; SER-143; GLN-175; LEU-218; ALA-395; ASP-757; PRO-780;
RP   CYS-895; LEU-895 AND LYS-897, VARIANT VAL-404, CHARACTERIZATION OF
RP   VARIANT VAL-404, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26892346; DOI=10.1681/ASN.2015030318;
RA   Riehle M., Buescher A.K., Gohlke B.O., Kassmann M.,
RA   Kolatsi-Joannou M., Braesen J.H., Nagel M., Becker J.U., Winyard P.,
RA   Hoyer P.F., Preissner R., Krautwurst D., Gollasch M., Weber S.,
RA   Harteneck C.;
RT   "TRPC6 G757D Loss-of-Function Mutation Associates with FSGS.";
RL   J. Am. Soc. Nephrol. 27:2771-2783(2016).
CC   -!- FUNCTION: Thought to form a receptor-activated non-selective
CC       calcium permeant cation channel (PubMed:19936226,
CC       PubMed:23291369). Probably is operated by a phosphatidylinositol
CC       second messenger system activated by receptor tyrosine kinases or
CC       G-protein coupled receptors. Activated by diacylglycerol (DAG) in
CC       a membrane-delimited fashion, independently of protein kinase C
CC       (PubMed:26892346). Seems not to be activated by intracellular
CC       calcium store depletion. {ECO:0000269|PubMed:19936226,
CC       ECO:0000269|PubMed:23291369, ECO:0000269|PubMed:26892346}.
CC   -!- SUBUNIT: Homodimer; forms channel complex (PubMed:26892346).
CC       Interacts with MX1 and RNF24 (PubMed:15757897, PubMed:17850865).
CC       {ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:17850865,
CC       ECO:0000269|PubMed:26892346}.
CC   -!- INTERACTION:
CC       P20591:MX1; NbExp=4; IntAct=EBI-929362, EBI-929476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23291369,
CC       ECO:0000269|PubMed:26892346}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y210-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y210-2; Sequence=VSP_006572;
CC       Name=3;
CC         IsoId=Q9Y210-3; Sequence=VSP_006573;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in placenta, lung, spleen,
CC       ovary and small intestine. Expressed in podocytes and is a
CC       component of the glomerular slit diaphragm.
CC       {ECO:0000269|PubMed:15924139}.
CC   -!- PTM: Phosphorylated by FYN, leading to an increase of TRPC6
CC       channel activity. {ECO:0000250|UniProtKB:Q61143}.
CC   -!- DISEASE: Focal segmental glomerulosclerosis 2 (FSGS2)
CC       [MIM:603965]: A renal pathology defined by the presence of
CC       segmental sclerosis in glomeruli and resulting in proteinuria,
CC       reduced glomerular filtration rate and progressive decline in
CC       renal function. Renal insufficiency often progresses to end-stage
CC       renal disease, a highly morbid state requiring either dialysis
CC       therapy or kidney transplantation. {ECO:0000269|PubMed:15879175,
CC       ECO:0000269|PubMed:15924139, ECO:0000269|PubMed:19458060,
CC       ECO:0000269|PubMed:19936226, ECO:0000269|PubMed:20798252,
CC       ECO:0000269|PubMed:21511817, ECO:0000269|PubMed:21734084,
CC       ECO:0000269|PubMed:22732337, ECO:0000269|PubMed:23014460,
CC       ECO:0000269|PubMed:23291369, ECO:0000269|PubMed:26892346}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       STrpC subfamily. TRPC6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF080394; AAC63289.2; -; mRNA.
DR   EMBL; AJ006276; CAA06943.1; -; mRNA.
DR   EMBL; AJ271066; CAC01684.1; -; mRNA.
DR   EMBL; AJ271067; CAC01685.1; -; mRNA.
DR   EMBL; AJ271068; CAC01686.1; -; mRNA.
DR   EMBL; BC093658; AAH93658.1; -; mRNA.
DR   EMBL; BC093660; AAH93660.1; -; mRNA.
DR   EMBL; AJ007018; CAC06090.1; -; mRNA.
DR   CCDS; CCDS8311.1; -. [Q9Y210-1]
DR   RefSeq; NP_004612.2; NM_004621.5. [Q9Y210-1]
DR   RefSeq; XP_016873710.1; XM_017018221.1. [Q9Y210-2]
DR   UniGene; Hs.159003; -.
DR   ProteinModelPortal; Q9Y210; -.
DR   SMR; Q9Y210; -.
DR   BioGrid; 113076; 12.
DR   IntAct; Q9Y210; 2.
DR   STRING; 9606.ENSP00000340913; -.
DR   BindingDB; Q9Y210; -.
DR   ChEMBL; CHEMBL2417347; -.
DR   GuidetoPHARMACOLOGY; 491; -.
DR   TCDB; 1.A.4.1.5; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9Y210; -.
DR   PhosphoSitePlus; Q9Y210; -.
DR   BioMuta; TRPC6; -.
DR   DMDM; 6686048; -.
DR   EPD; Q9Y210; -.
DR   PaxDb; Q9Y210; -.
DR   PeptideAtlas; Q9Y210; -.
DR   PRIDE; Q9Y210; -.
DR   Ensembl; ENST00000344327; ENSP00000340913; ENSG00000137672. [Q9Y210-1]
DR   Ensembl; ENST00000348423; ENSP00000343672; ENSG00000137672. [Q9Y210-2]
DR   Ensembl; ENST00000360497; ENSP00000353687; ENSG00000137672. [Q9Y210-3]
DR   GeneID; 7225; -.
DR   KEGG; hsa:7225; -.
DR   UCSC; uc001pgk.4; human. [Q9Y210-1]
DR   CTD; 7225; -.
DR   DisGeNET; 7225; -.
DR   EuPathDB; HostDB:ENSG00000137672.12; -.
DR   GeneCards; TRPC6; -.
DR   HGNC; HGNC:12338; TRPC6.
DR   HPA; HPA045098; -.
DR   HPA; HPA062164; -.
DR   MalaCards; TRPC6; -.
DR   MIM; 603652; gene.
DR   MIM; 603965; phenotype.
DR   neXtProt; NX_Q9Y210; -.
DR   OpenTargets; ENSG00000137672; -.
DR   Orphanet; 93213; Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis.
DR   PharmGKB; PA37011; -.
DR   eggNOG; KOG3609; Eukaryota.
DR   eggNOG; ENOG410XQ0Y; LUCA.
DR   GeneTree; ENSGT00760000119180; -.
DR   HOGENOM; HOG000020590; -.
DR   HOVERGEN; HBG068337; -.
DR   InParanoid; Q9Y210; -.
DR   KO; K04969; -.
DR   OMA; NRGPAYM; -.
DR   OrthoDB; EOG091G01FB; -.
DR   PhylomeDB; Q9Y210; -.
DR   TreeFam; TF313147; -.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling.
DR   SIGNOR; Q9Y210; -.
DR   ChiTaRS; TRPC6; human.
DR   GeneWiki; TRPC6; -.
DR   GenomeRNAi; 7225; -.
DR   PRO; PR:Q9Y210; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000137672; -.
DR   CleanEx; HS_TRPC6; -.
DR   ExpressionAtlas; Q9Y210; baseline and differential.
DR   Genevisible; Q9Y210; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0036057; C:slit diaphragm; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:Ensembl.
DR   GO; GO:0042805; F:actinin binding; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0005261; F:cation channel activity; IDA:UniProtKB.
DR   GO; GO:0030276; F:clathrin binding; IEA:Ensembl.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0015279; F:store-operated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006812; P:cation transport; TAS:ProtInc.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0006828; P:manganese ion transport; IBA:GO_Central.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IDA:MGI.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0007338; P:single fertilization; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR004729; TRP_channel.
DR   InterPro; IPR013555; TRP_dom.
DR   InterPro; IPR005462; TRPC6_channel.
DR   InterPro; IPR002153; TRPC_channel.
DR   PANTHER; PTHR10117; PTHR10117; 1.
DR   PANTHER; PTHR10117:SF7; PTHR10117:SF7; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08344; TRP_2; 1.
DR   PRINTS; PR01097; TRNSRECEPTRP.
DR   PRINTS; PR01647; TRPCHANNEL6.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   TIGRFAMs; TIGR00870; trp; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 2.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Disease mutation;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    931       Short transient receptor potential
FT                                channel 6.
FT                                /FTId=PRO_0000215322.
FT   TOPO_DOM      1    438       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    439    459       Helical. {ECO:0000255}.
FT   TOPO_DOM    460    487       Extracellular. {ECO:0000255}.
FT   TRANSMEM    488    508       Helical. {ECO:0000255}.
FT   TOPO_DOM    509    521       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    522    542       Helical. {ECO:0000255}.
FT   TOPO_DOM    543    592       Extracellular. {ECO:0000255}.
FT   TRANSMEM    593    613       Helical. {ECO:0000255}.
FT   TOPO_DOM    614    636       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    637    657       Helical. {ECO:0000255}.
FT   TOPO_DOM    658    706       Extracellular. {ECO:0000255}.
FT   TRANSMEM    707    727       Helical. {ECO:0000255}.
FT   TOPO_DOM    728    931       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       97    126       ANK 1.
FT   REPEAT      132    161       ANK 2.
FT   REPEAT      163    189       ANK 3.
FT   REPEAT      218    247       ANK 4.
FT   MOD_RES     815    815       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   CARBOHYD    473    473       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12970363}.
FT   CARBOHYD    561    561       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12970363}.
FT   VAR_SEQ     316    431       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10816590}.
FT                                /FTId=VSP_006572.
FT   VAR_SEQ     377    431       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10816590}.
FT                                /FTId=VSP_006573.
FT   VARIANT      15     15       P -> S (polymorphism).
FT                                {ECO:0000269|PubMed:19124028,
FT                                ECO:0000269|PubMed:19936226}.
FT                                /FTId=VAR_079784.
FT   VARIANT      88     88       F -> FAYMF (in FSGS2; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:20798252}.
FT                                /FTId=VAR_079785.
FT   VARIANT     109    109       G -> S (in FSGS2; increases calcium ion
FT                                transport). {ECO:0000269|PubMed:19458060,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_079786.
FT   VARIANT     112    112       P -> Q (in FSGS2; increases calcium ion
FT                                transport; dbSNP:rs121434390).
FT                                {ECO:0000269|PubMed:15879175,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_026730.
FT   VARIANT     125    125       N -> S (in FSGS2; unknown pathological
FT                                significance; decreases calcium ion
FT                                transport; dbSNP:rs146776939).
FT                                {ECO:0000269|PubMed:19458060,
FT                                ECO:0000269|PubMed:21734084,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_067247.
FT   VARIANT     143    143       N -> S (in FSGS2; increases cation
FT                                channel activity; does not change the
FT                                outward peak current; increases
FT                                significantly the inward peak current
FT                                amplitude; increases calcium ion
FT                                transport; dbSNP:rs121434391).
FT                                {ECO:0000269|PubMed:15924139,
FT                                ECO:0000269|PubMed:19936226,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_026731.
FT   VARIANT     157    157       N -> T (in dbSNP:rs35857503).
FT                                /FTId=VAR_038419.
FT   VARIANT     175    175       R -> Q (in FSGS2; increases cation
FT                                channel activity; does not change plasma
FT                                membrane expression; increases calcium
FT                                ion transport).
FT                                {ECO:0000269|PubMed:23291369,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_079787.
FT   VARIANT     218    218       H -> L (in FSGS2; increases calcium ion
FT                                transport; dbSNP:rs779430565).
FT                                {ECO:0000269|PubMed:21734084,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_067248.
FT   VARIANT     270    270       S -> T (in FSGS2; dbSNP:rs121434392).
FT                                {ECO:0000269|PubMed:15924139,
FT                                ECO:0000269|PubMed:19936226,
FT                                ECO:0000269|PubMed:23014460}.
FT                                /FTId=VAR_026732.
FT   VARIANT     360    360       R -> H (in FSGS2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22732337}.
FT                                /FTId=VAR_079788.
FT   VARIANT     395    395       L -> A (in FSGS2; unknown pathological
FT                                significance; requires 2 nucleotide
FT                                substitutions; decreases calcium ion
FT                                transport). {ECO:0000269|PubMed:21511817,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_079789.
FT   VARIANT     404    404       A -> V (polymorphism; increases calcium
FT                                ion transport; dbSNP:rs36111323).
FT                                {ECO:0000269|PubMed:19936226,
FT                                ECO:0000269|PubMed:21511817,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_061861.
FT   VARIANT     757    757       G -> D (in FSGS2; decreases calcium ion
FT                                transport; does not change localization
FT                                at cell membrane; does not affect
FT                                homodimer formation).
FT                                {ECO:0000269|PubMed:20798252,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_079790.
FT   VARIANT     780    780       L -> P (in FSGS2; unknown pathological
FT                                significance; decreases calcium ion
FT                                transport). {ECO:0000269|PubMed:19458060,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_079791.
FT   VARIANT     874    931       Missing (in FSGS2).
FT                                {ECO:0000269|PubMed:19936226}.
FT                                /FTId=VAR_079792.
FT   VARIANT     895    895       R -> C (in FSGS2; increases cation
FT                                channel activity; does not change plasma
FT                                membrane expression; significantly
FT                                reduces the ratio of cell-surface to
FT                                total expression; increases calcium ion
FT                                transport; dbSNP:rs121434394).
FT                                {ECO:0000269|PubMed:15924139,
FT                                ECO:0000269|PubMed:23014460,
FT                                ECO:0000269|PubMed:23291369,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_026733.
FT   VARIANT     895    895       R -> L (in FSGS2; decreases calcium ion
FT                                transport). {ECO:0000269|PubMed:21734084,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_067249.
FT   VARIANT     897    897       E -> K (in FSGS2; increases calcium ion
FT                                transport; dbSNP:rs121434395).
FT                                {ECO:0000269|PubMed:15924139,
FT                                ECO:0000269|PubMed:23014460,
FT                                ECO:0000269|PubMed:26892346}.
FT                                /FTId=VAR_026734.
FT   VARIANT     897    897       Missing (in FSGS2).
FT                                {ECO:0000269|PubMed:23014460}.
FT                                /FTId=VAR_079793.
FT   MUTAGEN     110    110       N->H: Increases calcium ion transport.
FT                                {ECO:0000269|PubMed:26892346}.
FT   MUTAGEN     125    125       N->A: No effect on RNF24-binding; when
FT                                associated with A-127; A-128 and A-130.
FT                                {ECO:0000269|PubMed:17850865}.
FT   MUTAGEN     127    127       N->A: No effect on RNF24-binding; when
FT                                associated with A-125; A-128 and A-130.
FT                                {ECO:0000269|PubMed:17850865}.
FT   MUTAGEN     128    128       C->A: No effect on RNF24-binding; when
FT                                associated with A-125; A-127 and A-130.
FT                                {ECO:0000269|PubMed:17850865}.
FT   MUTAGEN     130    130       D->A: No effect on RNF24-binding; when
FT                                associated with A-125; A-127 and A-128.
FT                                {ECO:0000269|PubMed:17850865}.
FT   MUTAGEN     132    132       M->T: Increases cation channel activity.
FT                                Increases significantly inward and
FT                                outward currents and does not show
FT                                channel inactivation. Increases calcium
FT                                ion transport.
FT                                {ECO:0000269|PubMed:19936226,
FT                                ECO:0000269|PubMed:26892346}.
FT   MUTAGEN     561    561       N->Q: Constitutively activates channel.
FT                                {ECO:0000269|PubMed:12970363}.
FT   MUTAGEN     755    757       EEG->KKR: Decreases calcium ion
FT                                transport. {ECO:0000269|PubMed:26892346}.
FT   MUTAGEN     755    756       EE->KK: Increases calcium ion transport.
FT                                {ECO:0000269|PubMed:26892346}.
FT   MUTAGEN     826    827       KK->EE: Decreases calcium ion transport.
FT                                {ECO:0000269|PubMed:26892346}.
FT   MUTAGEN     889    889       Q->K: Increases calcium transport.
FT                                Increases calcium ion transport.
FT                                {ECO:0000269|PubMed:19124028,
FT                                ECO:0000269|PubMed:26892346}.
FT   CONFLICT    336    336       C -> R (in Ref. 3; CAC01686).
FT                                {ECO:0000305}.
FT   CONFLICT    585    585       K -> R (in Ref. 5; CAC06090).
FT                                {ECO:0000305}.
FT   CONFLICT    613    613       I -> T (in Ref. 3; CAC01686).
FT                                {ECO:0000305}.
SQ   SEQUENCE   931 AA;  106326 MW;  7C955C2B0389AC47 CRC64;
     MSQSPAFGPR RGSSPRGAAG AAARRNESQD YLLMDSELGE DGCPQAPLPC YGYYPCFRGS
     DNRLAHRRQT VLREKGRRLA NRGPAYMFSD RSTSLSIEEE RFLDAAEYGN IPVVRKMLEE
     CHSLNVNCVD YMGQNALQLA VANEHLEITE LLLKKENLSR VGDALLLAIS KGYVRIVEAI
     LSHPAFAEGK RLATSPSQSE LQQDDFYAYD EDGTRFSHDV TPIILAAHCQ EYEIVHTLLR
     KGARIERPHD YFCKCNDCNQ KQKHDSFSHS RSRINAYKGL ASPAYLSLSS EDPVMTALEL
     SNELAVLANI EKEFKNDYKK LSMQCKDFVV GLLDLCRNTE EVEAILNGDV ETLQSGDHGR
     PNLSRLKLAI KYEVKKFVAH PNCQQQLLSI WYENLSGLRQ QTMAVKFLVV LAVAIGLPFL
     ALIYWFAPCS KMGKIMRGPF MKFVAHAASF TIFLGLLVMN AADRFEGTKL LPNETSTDNA
     KQLFRMKTSC FSWMEMLIIS WVIGMIWAEC KEIWTQGPKE YLFELWNMLD FGMLAIFAAS
     FIARFMAFWH ASKAQSIIDA NDTLKDLTKV TLGDNVKYYN LARIKWDPSD PQIISEGLYA
     IAVVLSFSRI AYILPANESF GPLQISLGRT VKDIFKFMVI FIMVFVAFMI GMFNLYSYYI
     GAKQNEAFTT VEESFKTLFW AIFGLSEVKS VVINYNHKFI ENIGYVLYGV YNVTMVIVLL
     NMLIAMINSS FQEIEDDADV EWKFARAKLW FSYFEEGRTL PVPFNLVPSP KSLFYLLLKL
     KKWISELFQG HKKGFQEDAE MNKINEEKKL GILGSHEDLS KLSLDKKQVG HNKQPSIRSS
     EDFHLNSFNN PPRQYQKIMK RLIKRYVLQA QIDKESDEVN EGELKEIKQD ISSLRYELLE
     EKSQNTEDLA ELIRELGEKL SMEPNQEETN R
//
